PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Irie, HY; Shrestha, Y; Selfors, LM; Frye, F; Iida, N; Wang, ZG; Zou, LH; Yao, J; Lu, YL; Epstein, CB; Natesan, S; Richardson, AL; Polyak, K; Mills, GB; Hahn, WC; Brugge, JS				Irie, Hanna Y.; Shrestha, Yashaswi; Selfors, Laura M.; Frye, Fabianne; Iida, Naoko; Wang, Zhigang; Zou, Lihua; Yao, Jun; Lu, Yiling; Epstein, Charles B.; Natesan, Sridaran; Richardson, Andrea L.; Polyak, Kornelia; Mills, Gordon B.; Hahn, William C.; Brugge, Joan S.			PTK6 Regulates IGF-1-Induced Anchorage-Independent Survival	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; BRK TYROSINE KINASE; BREAST-CANCER CELLS; LONG-TERM SURVIVAL; FACTOR-I RECEPTOR; GROWTH-FACTOR; IGF-I; OVARIAN-CANCER; EXPRESSION; ANOIKIS	Background: Proteins that are required for anchorage-independent survival of tumor cells represent attractive targets for therapeutic intervention since this property is believed to be critical for survival of tumor cells displaced from their natural niches. Anchorage-independent survival is induced by growth factor receptor hyperactivation in many cell types. We aimed to identify molecules that critically regulate IGF-1-induced anchorage-independent survival. Methods and Results: We conducted a high-throughput siRNA screen and identified PTK6 as a critical component of IGF-1 receptor (IGF-1R)-induced anchorage-independent survival of mammary epithelial cells. PTK6 downregulation induces apoptosis of breast and ovarian cancer cells deprived of matrix attachment, whereas its overexpression enhances survival. Reverse-phase protein arrays and subsequent analyses revealed that PTK6 forms a complex with IGF-1R and the adaptor protein IRS-1, and modulates anchorage-independent survival by regulating IGF-1R expression and phosphorylation. PTK6 is highly expressed not only in the previously reported Her2(+) breast cancer subtype, but also in high grade ER(+), Luminal B tumors and high expression is associated with adverse outcomes. Conclusions: These findings highlight PTK6 as a critical regulator of anchorage-independent survival of breast and ovarian tumor cells via modulation of IGF-1 receptor signaling, thus supporting PTK6 as a potential therapeutic target for multiple tumor types. The combined genomic and proteomic approaches in this report provide an effective strategy for identifying oncogenes and their mechanism of action.	[Irie, Hanna Y.; Selfors, Laura M.; Frye, Fabianne; Iida, Naoko; Hahn, William C.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Irie, Hanna Y.; Shrestha, Yashaswi; Yao, Jun; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wang, Zhigang; Zou, Lihua; Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lu, Yiling; Mills, Gordon B.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Epstein, Charles B.; Natesan, Sridaran] Sanofi Aventis, Cambridge, MA USA; [Epstein, Charles B.; Hahn, William C.] Broad Inst Harvard & Massachusetts Inst Technol M, Cambridge, MA USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; University of Texas System; UTMD Anderson Cancer Center; Sanofi-Aventis; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Irie, HY (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	Joan_Brugge@hms.harvard.edu		SELFORS, LAURA/0000-0002-1317-7353; Epstein, Charles B./0000-0001-8358-8345	National Institutes of Health (NIH) [CA105134, 5K08 CA107231]; Sanofi-Aventis; NATIONAL CANCER INSTITUTE [R33CA128625, P01CA099031, K08CA107231, P50CA098258, P30CA016672, P50CA089393, R01CA105134] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sanofi-Aventis(Sanofi-Aventis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health (NIH) grant CA105134, a grant from Sanofi-Aventis, and a gift from Lee Jeans through the Entertainment Industry Foundation to JSB. HYI was supported by 5K08 CA107231 (NIH), the Terri Brodeur Breast Cancer Research Foundation and a Development Pilot Award from the SPORE in Breast Cancer (NIH P50 CA089393). YS was supported by a fellowship from the Department of Defense (DoD) (W81XWH-08-1-0767), and WH was supported by W81XWH-07-1-0408 (DoD) and R33 CA128625 (NIH/National Cancer Institute [NCI]). GBM and YL were supported by the Kleberg Center for Molecular Markers, P30 CA1667 and P01CA099031. ZW was supported by a grant from the Breast Cancer Research Foundation. JY, KP and LZ were supported by the Specialized Programs of Research Excellence (SPORE) in Breast Cancer (NIH P50 CA089393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA A, 1994, GENE CHROMOSOME CANC, V11, P63, DOI 10.1002/gcc.2870110110; Aubele M, 2008, BRIT J CANCER, V99, P1089, DOI 10.1038/sj.bjc.6604660; Aubele M, 2007, BRIT J CANCER, V96, P801, DOI 10.1038/sj.bjc.6603613; Aubele M, 2009, VIRCHOWS ARCH, V455, P117, DOI 10.1007/s00428-009-0809-8; Barker KT, 1997, ONCOGENE, V15, P799, DOI 10.1038/sj.onc.1201241; Baserga R, 1999, EXP CELL RES, V253, P1, DOI 10.1006/excr.1999.4667; BERNS EMJJ, 1992, EUR J CANCER, V28A, P697, DOI 10.1016/S0959-8049(05)80129-7; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Born M, 2005, J PATHOL, V205, P592, DOI 10.1002/path.1720; Brauer PM, 2010, BBA-REV CANCER, V1806, P66, DOI 10.1016/j.bbcan.2010.02.003; Brokaw J, 2007, GROWTH FACTORS, V25, P346, DOI 10.1080/08977190701838402; Chen HY, 2004, MOL CELL BIOL, V24, P10558, DOI 10.1128/MCB.24.24.10558-10572.2004; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Derry JJ, 2003, ONCOGENE, V22, P4212, DOI 10.1038/sj.onc.1206465; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Eisenberg-Lerner A, 2009, APOPTOSIS, V14, P376, DOI 10.1007/s10495-008-0307-5; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Haegebarth A, 2005, CELL CYCLE, V4, P1239, DOI 10.4161/cc.4.9.1965; Haegebarth A, 2009, GASTROENTEROLOGY, V137, P945, DOI 10.1053/j.gastro.2009.05.054; Harvey AJ, 2009, AM J PATHOL, V175, P1226, DOI 10.2353/ajpath.2009.080811; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kamalati T, 2000, ONCOGENE, V19, P5471, DOI 10.1038/sj.onc.1203931; Kamalati T, 1996, J BIOL CHEM, V271, P30956, DOI 10.1074/jbc.271.48.30956; Kim HI, 2009, J BIOCHEM, V146, P133, DOI 10.1093/jb/mvp050; Klinakis A, 2009, P NATL ACAD SCI USA, V106, P2359, DOI 10.1073/pnas.0810221106; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Litzenburger BC, 2009, CLIN CANCER RES, V15, P226, DOI 10.1158/1078-0432.CCR-08-0801; Lu XS, 2008, BREAST CANCER RES TR, V108, P191, DOI 10.1007/s10549-007-9596-6; Martin MJ, 2006, MOL CELL BIOL, V26, P1754, DOI 10.1128/MCB.26.5.1754-1769.2006; Martin SS, 2004, ONCOGENE, V23, P4641, DOI 10.1038/sj.onc.1207595; Matros E, 2005, BREAST CANCER RES TR, V91, P179, DOI 10.1007/s10549-004-7603-8; Mawji IA, 2007, CANCER RES, V67, P8307, DOI 10.1158/0008-5472.CAN-07-1687; MITCHELL PJ, 1994, ONCOGENE, V9, P2383; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Ostrander JH, 2007, CANCER RES, V67, P4199, DOI 10.1158/0008-5472.CAN-06-3409; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Qiu HQ, 2005, ONCOGENE, V24, P5656, DOI 10.1038/sj.onc.1208721; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Schmandt RE, 2006, CANCER BIOL THER, V5, P1136, DOI 10.4161/cbt.5.9.2953; Serfas MS, 2003, ONCOL RES, V13, P409; Simpson CD, 2009, CANCER RES, V69, P2739, DOI 10.1158/0008-5472.CAN-08-2530; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Weaver AM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1794; Xiang B, 2008, P NATL ACAD SCI USA, V105, P12463, DOI 10.1073/pnas.0805009105	54	54	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11729	10.1371/journal.pone.0011729	http://dx.doi.org/10.1371/journal.pone.0011729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668531	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800009
J	Chen, L; Zhong, DB; Zhang, DH; Shi, LN; Zhou, GF; Gong, MQ; Zhou, HY; Sun, Y; Ma, L; He, J; Hong, SC; Zhou, D; Xiong, CR; Chen, C; Zou, P; Zhu, CL; Yan, GY				Chen, Lin; Zhong, Daibin; Zhang, Donghui; Shi, Linna; Zhou, Guofa; Gong, Maoqing; Zhou, Huayun; Sun, Yan; Ma, Lei; He, Ji; Hong, Shanchao; Zhou, Dan; Xiong, Chunrong; Chen, Chen; Zou, Ping; Zhu, Changliang; Yan, Guiyun			Molecular Ecology of Pyrethroid Knockdown Resistance in Culex pipiens pallens Mosquitoes	PLOS ONE			English	Article							ANOPHELES-GAMBIAE S.S; SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; KDR MUTATION; WEST-AFRICA; INCIPIENT SPECIATION; CROSS-RESISTANCE; GERMAN-COCKROACH; POINT MUTATIONS; BURKINA-FASO	Pyrethroid insecticides have been extensively used in China and worldwide for public health pest control. Accurate resistance monitoring is essential to guide the rational use of insecticides and resistance management. Here we examined the nucleotide diversity of the para-sodium channel gene, which confers knockdown resistance (kdr) in Culex pipiens pallens mosquitoes in China. The sequence analysis of the para-sodium channel gene identified L1014F and L1014S mutations. We developed and validated allele-specific PCR and the real-time TaqMan methods for resistance diagnosis. The real-time TaqMan method is more superior to the allele-specific PCR method as evidenced by higher amplification rate and better sensitivity and specificity. Significant positive correlation between kdr allele frequency and bioassay-based resistance phenotype demonstrates that the frequency of L1014F and L1014S mutations in the kdr gene can be used as a molecular marker for deltamethrin resistance monitoring in natural Cx. pipiens pallens populations in the East China region. The laboratory selection experiment found that L1014F mutation frequency, but not L1014S mutation, responded to deltamethrin selection, suggesting that the L1014F mutation is the key mutation conferring resistance to deltamethrin. High L1014F mutation frequency detected in six populations of Cx. pipens pallens suggests high prevalence of pyrethroid resistance in Eastern China, calling for further surveys to map the resistance in China and for investigating alternative mosquito control strategies.	[Chen, Lin; Zhang, Donghui; Shi, Linna; Sun, Yan; Ma, Lei; He, Ji; Hong, Shanchao; Zhou, Dan; Chen, Chen; Zou, Ping; Zhu, Changliang] Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Chen, Lin; Zhang, Donghui; Shi, Linna; Sun, Yan; Ma, Lei; He, Ji; Hong, Shanchao; Zhou, Dan; Chen, Chen; Zou, Ping; Zhu, Changliang] Key Lab Modern Pathogen Biol Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Zhong, Daibin; Zhou, Guofa; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Gong, Maoqing] Shandong Inst Parasit Dis, Jining, Shandong, Peoples R China; [Zhou, Huayun; Xiong, Chunrong] Jiangsu Inst Parasit Dis, Wuxi, Jiangsu, Peoples R China	Nanjing Medical University; University of California System; University of California Irvine	Chen, L (corresponding author), Nanjing Med Univ, Dept Pathogen Biol, Nanjing, Jiangsu, Peoples R China.	clzhu@njmu.edu.cn; guiyuny@uci.edu	Zhong, Daibin/GRF-0564-2022		National Institutes of Health of US [R01 AI075746]; National Science and Technology Major Project of China [2008ZX10004-010]; National Natural Science Foundation of China [30972564, 30901244]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075746] Funding Source: NIH RePORTER	National Institutes of Health of US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science and Technology Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health of US (R01 AI075746), National Science and Technology Major Project of China (No. 2008ZX10004-010) and National Natural Science Foundation of China (No. 30972564 and 30901244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott F F, 1925, Cal West Med, V23, P758; [Anonymous], 1998, WHOCDCMAL98; Anstead JA, 2005, INSECT BIOCHEM MOLEC, V35, P249, DOI 10.1016/j.ibmb.2004.12.004; Awolola TS, 2003, TROP MED INT HEALTH, V8, P420, DOI 10.1046/j.1365-3156.2003.01034.x; Baker MB, 2007, J ECON ENTOMOL, V100, P1871, DOI 10.1603/0022-0493(2007)100[1871:PAIOCO]2.0.CO;2; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Berticat C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-104; Bourguet D, 2004, EVOLUTION, V58, P128, DOI 10.1111/j.0014-3820.2004.tb01579.x; Cao GC, 2006, PEST MANAG SCI, V62, P746, DOI 10.1002/ps.1234; Chandre F, 1999, J AM MOSQUITO CONTR, V15, P53; Chandre F, 2000, MED VET ENTOMOL, V14, P81, DOI 10.1046/j.1365-2915.2000.00212.x; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Cui F, 2006, PEST MANAG SCI, V62, P1013, DOI 10.1002/ps.1288; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Diabate A, 2004, J AM MOSQUITO CONTR, V20, P195; Dong K, 1997, INSECT BIOCHEM MOLEC, V27, P93, DOI 10.1016/S0965-1748(96)00082-3; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; FINNEY DJ, 1971, METHOD INFORM MED, V10, P237; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Jia BT, 2009, PEST MANAG SCI, V65, P996, DOI 10.1002/ps.1785; Labbe P, 2007, PLOS GENET, V3, P2190, DOI 10.1371/journal.pgen.0030205; Li AY, 2003, J MED ENTOMOL, V40, P942, DOI 10.1603/0022-2585-40.6.942; Luby J P, 1979, Epidemiol Rev, V1, P55; Martin RL, 2000, INSECT BIOCHEM MOLEC, V30, P1051, DOI 10.1016/S0965-1748(00)00080-1; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McAbee RD, 2004, PEST MANAG SCI, V60, P359, DOI 10.1002/ps.799; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Pinto J, 2006, MED VET ENTOMOL, V20, P27, DOI 10.1111/j.1365-2915.2006.00611.x; Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; ROWLAND M, 1991, MED VET ENTOMOL, V5, P193, DOI 10.1111/j.1365-2915.1991.tb00542.x; SCOTT JG, 1994, COMP BIOCHEM PHYS B, V109, P191, DOI 10.1016/0305-0491(94)90002-7; Smith JL, 2004, AM J TROP MED HYG, V70, P339, DOI 10.4269/ajtmh.2004.70.339; Song FL, 2007, INT J PEST MANAGE, V53, P25, DOI 10.1080/09670870601002625; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Verhaeghen K, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-84; VULULE JM, 1994, MED VET ENTOMOL, V8, P71, DOI 10.1111/j.1365-2915.1994.tb00389.x; Wang TY, 2005, ENVIRON INT, V31, P813, DOI 10.1016/j.envint.2005.05.043; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wondji CS, 2008, TROP MED INT HEALTH, V13, P548, DOI 10.1111/j.1365-3156.2008.02033.x; Wong MH, 2005, CHEMOSPHERE, V60, P740, DOI 10.1016/j.chemosphere.2005.04.028; Yawson AE, 2004, MED VET ENTOMOL, V18, P372, DOI 10.1111/j.0269-283X.2004.00519.x; Zhou L, 2009, J MED ENTOMOL, V46, P321, DOI 10.1603/033.046.0217	49	60	68	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11681	10.1371/journal.pone.0011681	http://dx.doi.org/10.1371/journal.pone.0011681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657783	Green Published, gold			2022-12-27	WOS:000280197500022
J	Shirai, Y; Kouzuki, T; Kakefuda, K; Moriguchi, S; Oyagi, A; Horie, K; Morita, S; Shimazawa, M; Fukunaga, K; Takeda, J; Saito, N; Hara, H				Shirai, Yasuhito; Kouzuki, Takeshi; Kakefuda, Kenichi; Moriguchi, Shigeki; Oyagi, Atsushi; Horie, Kyoji; Morita, Shin-ya; Shimazawa, Masamitsu; Fukunaga, Kohji; Takeda, Junji; Saito, Naoaki; Hara, Hideaki			Essential Role of Neuron-Enriched Diacylglycerol Kinase (DGK), DGK beta in Neurite Spine Formation, Contributing to Cognitive Function	PLOS ONE			English	Article							MOLECULAR-CLONING; MAMMALIAN TARGET; GAMMA; CELL; LOCALIZATION; ACTIVATION; BRAIN	Background: Diacylglycerol (DG) kinase (DGK) phosphorylates DG to produce phosphatidic acid (PA). Of the 10 subtypes of mammalian DGKs, DGK beta is a membrane-localized subtype and abundantly expressed in the cerebral cortex, hippocampus, and caudate-putamen. However, its physiological roles in neurons and higher brain function have not been elucidated. Methodology/Principal Findings: We, therefore, developed DGKb KO mice using the Sleeping Beauty transposon system, and found that its long-term potentiation in the hippocampal CA1 region was reduced, causing impairment of cognitive functions including spatial and long-term memories in Y-maze and Morris water-maze tests. The primary cultured hippocampal neurons from KO mice had less branches and spines compared to the wild type. This morphological impairment was rescued by overexpression of DGKb. In addition, overexpression of DGKb in SH-SY5Y cells or primary cultured mouse hippocampal neurons resulted in branch-and spine-formation, while a splice variant form of DGKb, which has kinase activity but loses membrane localization, did not induce branches and spines. In the cells overexpressing DGKb but not the splice variant form, DGK product, PA, was increased and the substrate, DG, was decreased on the plasma membrane. Importantly, lower spine density and abnormality of PA and DG contents in the CA1 region of the KO mice were confirmed. Conclusions/Significance: These results demonstrate that membrane-localized DGKb regulates spine formation by regulation of lipids, contributing to the maintenance of neural networks in synaptic transmission of cognitive processes including memory.	[Shirai, Yasuhito; Kouzuki, Takeshi; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 657, Japan; [Kakefuda, Kenichi; Oyagi, Atsushi; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Moriguchi, Shigeki; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Dept Social & Environm Med, Grad Sch Med, Suita, Osaka, Japan; [Morita, Shin-ya] Kobe Univ, Pharmaceut Technol Lab, Kobe, Hyogo 657, Japan	Kobe University; Gifu Pharmaceutical University; Tohoku University; Osaka University; Kobe University	Shirai, Y (corresponding author), Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 657, Japan.	hidehara@gifu-pu.ac.jp	Morita, Shin-ya/U-2793-2019; Shirai, Yasuhito/O-3255-2018; Fukunaga, Kohji/AAI-8811-2021	Morita, Shin-ya/0000-0003-4079-707X; Fukunaga, Kohji/0000-0001-8526-2824	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by a Grant-in-Aid for Scientific Research from the Global Center of Excellence (GCOE) Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and the Takeda Science Foundation. The funders had no role in study design, data collection and any analysis, decision to publish, or preparation of the manuscript.	Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; Aragones J, 2001, J BIOL CHEM, V276, P10548, DOI 10.1074/jbc.M006180200; Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Goto K, 2006, ADV ENZYME REGUL, V46, P192, DOI 10.1016/j.advenzreg.2006.01.005; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Horne EA, 2007, J NEUROSCI, V27, P3523, DOI 10.1523/JNEUROSCI.4340-06.2007; Hozumi Y, 2008, EUR J NEUROSCI, V28, P2409, DOI 10.1111/j.1460-9568.2008.06547.x; Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kim HJ, 2009, MOL PHARMACOL, V75, P1021, DOI 10.1124/mol.108.052357; Kim K, 2010, J NEUROCHEM, V112, P577, DOI 10.1111/j.1471-4159.2009.06499.x; Kim K, 2009, EMBO J, V28, P1170, DOI 10.1038/emboj.2009.44; Kobayashi N, 2007, EUR J CELL BIOL, V86, P433, DOI 10.1016/j.ejcb.2007.05.002; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; LOVINGER DM, 1987, BRAIN RES, V436, P177, DOI 10.1016/0006-8993(87)91573-3; Matsubara T, 2006, J BIOL CHEM, V281, P6152, DOI 10.1074/jbc.M509873200; MATUS A, 2005, CURR OPIN NEUROBIOL, V5, P771; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Moriguchi S, 2008, J NEUROCHEM, V106, P1092, DOI 10.1111/j.1471-4159.2008.05440.x; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Sakai N, 2004, GENES CELLS, V9, P945, DOI 10.1111/j.1365-2443.2004.00779.x; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Stace C, 2008, ADV ENZYME REGUL, V48, P55, DOI 10.1016/j.advenzreg.2007.11.008; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; THOMAS JVV, 2005, J NEUROSCI, V25, P9488; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; Yakubchyk Y, 2005, MOL CELL BIOL, V25, P7289, DOI 10.1128/MCB.25.16.7289-7302.2005; ZHA Y, 2006, NATURE IMMUNOL, V11, P1166	38	54	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11602	10.1371/journal.pone.0011602	http://dx.doi.org/10.1371/journal.pone.0011602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657643	Green Published, gold, Green Submitted			2022-12-27	WOS:000279924500006
J	Frost, JM; Udayashankar, R; Moore, HD; Moore, GE				Frost, Jennifer M.; Udayashankar, Ramya; Moore, Harry D.; Moore, Gudrun E.			Telomeric NAP1L4 and OSBPL5 of the KCNQ1 Cluster, and the DECORIN Gene Are Not Imprinted in Human Trophoblast Stem Cells	PLOS ONE			English	Article							REPRESSIVE HISTONE METHYLATION; PLACENTA; DOMAIN; LINES	Background: Genomic imprinting of the largest known cluster, the Kcnq1/KCNQ1 domain on mChr7/hChr11, displays significant differences between mouse and man. Of the fourteen transcripts in this cluster, imprinting of six is ubiquitous in mice and humans, however, imprinted expression of the other eight transcripts is only found in the mouse placenta. The human orthologues of the latter eight transcripts are biallelically expressed, at least from the first trimester onwards. However, as early development is less divergent between species, placental specific imprinting may be present in very early gestation in both mice and humans. Methodology/Principal Findings: Human embryonic stem (hES) cells can be differentiated to embryoid bodies and then to trophoblast stem (EB-TS) cells. Using EB-TS cells as a model of post-implantation invading cytotrophoblast, we analysed allelic expression of two telomeric transcripts whose imprinting is placental specific in the mouse, as well as the ncRNA KCNQ1OT1, whose imprinted expression is ubiquitous in early human and mouse development. KCNQ1OT1 expression was monoallelic in all samples but OSBPL5 and NAP1L4 expression was biallelic in EB-TS cells, as well as undifferentiated hES cells and first trimester human fetal placenta. DCN on hChr12, another gene imprinted in the mouse placenta only, was also biallelically expressed in EB-TS cells. The germline maternal methylation imprint at the KvDMR was maintained in both undifferentiated hES cells and EB-TS cells. Conclusions/Significance: The question of placental specific imprinting in the human has not been answered fully. Using a model of human trophoblast very early in gestation we show a lack of imprinting of two telomeric genes in the KCNQ1 region and of DCN, whose imprinted expression is placental specific in mice, providing further evidence to suggest that humans do not exhibit placental specific imprinting. The maintenance of both differential methylation of the KvDMR and monoallelic expression of KCNQ1OT1 indicates that the region is appropriately regulated epigenetically in vitro. Human gestational load is less than in the mouse, resulting in reduced need for maternal resource competition, and therefore maybe also a lack of placental specific imprinting. If genomic imprinting exists to control fetal acquisition of maternal resources driven by the placenta, placenta-specific imprinting may be less important in the human than the mouse.	[Frost, Jennifer M.; Moore, Gudrun E.] UCL, Clin & Mol Genet Unit, Inst Child Hlth, London, England; [Frost, Jennifer M.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Udayashankar, Ramya; Moore, Harry D.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of London; University College London; Imperial College London; University of Sheffield	Frost, JM (corresponding author), UCL, Clin & Mol Genet Unit, Inst Child Hlth, London, England.	j.frost@ich.ucl.ac.uk	Moore, Gudrun/A-2092-2009; Frost, Jennifer/D-1867-2015	Frost, Jennifer/0000-0002-3057-6313	MRC; Wellcome Trust; SPARKS; Wellbeing of Women; Infertility Research Trust; Sheffield Hospitals Charitable Trust; MRC [G0801059] Funding Source: UKRI; Medical Research Council [G0801059] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); SPARKS; Wellbeing of Women(Wellbeing of Women (WoW)); Infertility Research Trust; Sheffield Hospitals Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JMF was an MRC PhD Student. The work in GEM research group at ICH laboratory is supported by the MRC, Wellcome Trust, SPARKS and Wellbeing of Women. RU is grateful to the Infertility Research Trust for her studentship. Aspects of the study in Sheffield were also supported by the Medical Research Council and Sheffield Hospitals Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; King A, 2000, PLACENTA, V21, pS113, DOI 10.1053/plac.1999.0526; Knox K, 2008, GENOME RES, V18, P695, DOI 10.1101/gr.071407.107; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Mancini-DiNardo D, 2006, GENE DEV, V20, P1268, DOI 10.1101/gad.1416906; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Redrup L, 2009, DEVELOPMENT, V136, P525, DOI 10.1242/dev.031328; Schulz LC, 2008, PLACENTA, V29, pS10, DOI 10.1016/j.placenta.2007.10.009; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467	19	10	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11595	10.1371/journal.pone.0011595	http://dx.doi.org/10.1371/journal.pone.0011595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644730	Green Accepted, Green Published, gold			2022-12-27	WOS:000279884900026
J	Leuner, B; Glasper, ER; Gould, E				Leuner, Benedetta; Glasper, Erica R.; Gould, Elizabeth			Sexual Experience Promotes Adult Neurogenesis in the Hippocampus Despite an Initial Elevation in Stress Hormones	PLOS ONE			English	Article							DENTATE GYRUS; MALE-RATS; CELL-PROLIFERATION; STIMULATED NEUROGENESIS; ENHANCES NEUROGENESIS; PYRAMIDAL NEURONS; APICAL DENDRITES; SPATIAL MEMORY; BEHAVIOR; ANXIETY	Aversive stressful experiences are typically associated with increased anxiety and a predisposition to develop mood disorders. Negative stress also suppresses adult neurogenesis and restricts dendritic architecture in the hippocampus, a brain region associated with anxiety regulation. The effects of aversive stress on hippocampal structure and function have been linked to stress-induced elevations in glucocorticoids. Normalizing corticosterone levels prevents some of the deleterious consequences of stress, including increased anxiety and suppressed structural plasticity in the hippocampus. Here we examined whether a rewarding stressor, namely sexual experience, also adversely affects hippocampal structure and function in adult rats. Adult male rats were exposed to a sexually-receptive female once (acute) or once daily for 14 consecutive days (chronic) and levels of circulating glucocorticoids were measured. Separate cohorts of sexually experienced rats were injected with the thymidine analog bromodeoxyuridine in order to measure cell proliferation and neurogenesis in the hippocampus. In addition, brains were processed using Golgi impregnation to assess the effects of sexual experience on dendritic spines and dendritic complexity in the hippocampus. Finally, to evaluate whether sexual experience alters hippocampal function, rats were tested on two tests of anxiety-like behavior: novelty suppressed feeding and the elevated plus maze. We found that acute sexual experience increased circulating corticosterone levels and the number of new neurons in the hippocampus. Chronic sexual experience no longer produced an increase in corticosterone levels but continued to promote adult neurogenesis and stimulate the growth of dendritic spines and dendritic architecture. Chronic sexual experience also reduced anxiety-like behavior. These findings suggest that a rewarding experience not only buffers against the deleterious actions of early elevated glucocorticoids but actually promotes neuronal growth and reduces anxiety.	[Leuner, Benedetta; Glasper, Erica R.; Gould, Elizabeth] Princeton Univ, Dept Psychol, Inst Neurosci, Princeton, NJ 08544 USA	Princeton University	Leuner, B (corresponding author), Princeton Univ, Dept Psychol, Inst Neurosci, Princeton, NJ 08544 USA.	goulde@princeton.edu	GLASPER, ERICA/GOK-0082-2022	GLASPER, ERICA/0000-0003-1938-2144	National Alliance for Research on Schizophrenia and Depression; National Institute of Mental Health [MH084148, MH54970]; National Institute on Aging; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH084148, R01MH054970, K99MH084148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG033461] Funding Source: NIH RePORTER	National Alliance for Research on Schizophrenia and Depression(NARSAD); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was supported by a Young Investigator Award from the National Alliance for Research on Schizophrenia and Depression (B. L.), grants from the National Institute of Mental Health (MH084148 to B. L. and MH54970 to E. G.) and a Ruth L. Kirschstein postdoctoral NRSA fellowship from the National Institute on Aging (E. R. G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzoulatos E, 2008, HORM BEHAV, V54, P735, DOI 10.1016/j.yhbeh.2008.08.001; Bannerman DM, 2002, BEHAV NEUROSCI, V116, P884, DOI 10.1037//0735-7044.116.5.884; Belke TW, 2005, BEHAV PROCESS, V68, P165, DOI 10.1016/j.beproc.2004.12.006; Bonilla-Jaime H, 2006, HORM BEHAV, V49, P376, DOI 10.1016/j.yhbeh.2005.08.005; Brene S, 2007, PHYSIOL BEHAV, V92, P136, DOI 10.1016/j.physbeh.2007.05.015; Brown DA, 2007, J APPL PHYSIOL, V103, P1979, DOI 10.1152/japplphysiol.00706.2007; Calvo N, 1998, BRAIN RES, V800, P227, DOI 10.1016/S0006-8993(98)00515-0; CAMERON HA, 1994, NEUROSCIENCE, V61, P203, DOI 10.1016/0306-4522(94)90224-0; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Conrad Cheryl D, 2006, Behav Cogn Neurosci Rev, V5, P41, DOI 10.1177/1534582306289043; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; Droste SK, 2007, NEUROENDOCRINOLOGY, V86, P26, DOI 10.1159/000104770; Eadie BD, 2005, J COMP NEUROL, V486, P39, DOI 10.1002/cne.20493; Edinger KL, 2007, PHYSIOL BEHAV, V92, P443, DOI 10.1016/j.physbeh.2007.04.018; Eisch AJ, 2006, HIPPOCAMPUS, V16, P271, DOI 10.1002/hipo.20161; EVERITT BJ, 1987, J COMP PSYCHOL, V101, P395, DOI 10.1037/0735-7036.101.4.395; Flanagan-Cato LM, 2006, J NEUROENDOCRINOL, V18, P857, DOI 10.1111/j.1365-2826.2006.01483.x; Gould E, 1997, J NEUROSCI, V17, P2492; Gould E, 1998, P NATL ACAD SCI USA, V95, P3168, DOI 10.1073/pnas.95.6.3168; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Hull EM, 2007, HORM BEHAV, V52, P45, DOI 10.1016/j.yhbeh.2007.03.030; HUNDT AG, 1963, SCIENCE, V142, P1087, DOI 10.1126/science.142.3595.1087; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; MAGARINOS AM, 1995, NEUROSCIENCE, V69, P89, DOI 10.1016/0306-4522(95)00259-L; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; Mitra R, 2008, P NATL ACAD SCI USA, V105, P5573, DOI 10.1073/pnas.0705615105; Neumann ID, 2009, FRONT NEUROENDOCRIN, V30, P483, DOI 10.1016/j.yfrne.2009.04.012; Paredes RG, 2009, ILAR J, V50, P15, DOI 10.1093/ilar.50.1.15; PITCHERS KK, 2009, BIOL PSYCHI IN PRESS; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Rodriguez-Manzo G, 1999, PHYSIOL BEHAV, V67, P651, DOI 10.1016/S0031-9384(99)00119-5; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Spritzer MD, 2009, BEHAV BRAIN RES, V200, P106, DOI 10.1016/j.bbr.2009.01.003; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Stranahan AM, 2006, NAT NEUROSCI, V9, P526, DOI 10.1038/nn1668; Takahashi T, 2009, NEUROSCIENCE, V158, P402, DOI 10.1016/j.neuroscience.2008.10.048; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tenk CM, 2009, HORM BEHAV, V55, P93, DOI 10.1016/j.yhbeh.2008.08.012; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Waldherr M, 2007, P NATL ACAD SCI USA, V104, P16681, DOI 10.1073/pnas.0705860104; Waldherr M, 2010, HORM BEHAV, V57, P222, DOI 10.1016/j.yhbeh.2009.11.006; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A	49	116	118	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11597	10.1371/journal.pone.0011597	http://dx.doi.org/10.1371/journal.pone.0011597			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644737	Green Published, Green Submitted, gold			2022-12-27	WOS:000279884900027
J	Xu, CF; Yu, CH; Xu, L; Miao, M; Li, YM				Xu, Chengfu; Yu, Chaohui; Xu, Lei; Miao, Min; Li, Youming			High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study	PLOS ONE			English	Article							METABOLIC SYNDROME; OXIDATIVE STRESS; PREVALENCE; STEATOHEPATITIS; INDIVIDUALS; ASSOCIATION; POPULATION; MORTALITY; GLUCOSE	Nonalcoholic fatty liver disease (NAFLD) is a common form of chronic liver disease, and serum uric acid is observed to be significantly elevated in NAFLD patients. However, whether this elevation is causal, a bystander, or a consequence of NAFLD remains unclear. We performed a population-based prospective study among the employees of Zhenhai Refining & Chemical Company Ltd., Ningbo, China to investigate whether the elevation of serum uric acid has a casual role for NAFLD. A total of 6890 initially NAFLD-free subjects were followed up for 3 years. Overall, 11.80% (813/6890) subjects developed NAFLD over 3 years of follow-up. The cumulative incidence of NAFLD increased with progressively higher baseline serum uric acid levels (the cumulative incidence was 7.2%, 9.5%, 11.5%, 13.8%, and 17.2% in quintile 1, quintile 2, 3, 4 and 5, respectively; P value for trend <0.001). Cox proportional hazards regression analyses showed that serum uric acid levels were independently and positively associated with the risk for incident NAFLD; the age-, gender- and metabolic syndrome adjusted hazard ratio (95% CI) for the subjects in quintile 2, 3, 4 and 5 versus quintile 1 was 1.18 (0.91-1.54), 1.32 (1.03-1.70), 1.39 (1.09-1.78) and 1.50 (1.18-1.92), respectively. Taken together, our prospective observational study showed that elevation of serum uric acid levels independently predicts increase risk for incident NAFLD.	[Xu, Chengfu; Yu, Chaohui; Xu, Lei; Li, Youming] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Lei; Miao, Min] Ningbo 1 Hosp, Dept Gastroenterol, Ningbo, Zhejiang, Peoples R China	Zhejiang University	Li, YM (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Coll Med, Hangzhou 310003, Zhejiang, Peoples R China.	xiaofu@zju.edu.cn		Ma, Han/0000-0001-9985-3035	Chinese State Key Project for High-tech [2006AA02A308]; National Science & Technology Pillar Program [2008BAI52B03]; National Natural Science Foundation of China [30871154]; Science & Technology Foundation of Zhejiang Province [2008C13027-1]	Chinese State Key Project for High-tech; National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Foundation of Zhejiang Province	This study was supported by Chinese State Key Project for High-tech (No. 2006AA02A308), National Science & Technology Pillar Program (No. 2008BAI52B03), National Natural Science Foundation of China (No. 30871154) and Science & Technology Foundation of Zhejiang Province (No. 2008C13027-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Baskol G, 2007, CLIN BIOCHEM, V40, P776, DOI 10.1016/j.clinbiochem.2007.02.006; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cerda C, 2007, J HEPATOL, V47, P412, DOI 10.1016/j.jhep.2007.04.012; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Hayden Melvin R, 2004, Nutr Metab (Lond), V1, P10, DOI 10.1186/1743-7075-1-10; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hjortnaes J, 2007, J RHEUMATOL, V34, P1882; Jankowska EA, 2009, JAMA-J AM MED ASSOC, V301, P1892, DOI 10.1001/jama.2009.639; Jimba S, 2005, DIABETIC MED, V22, P1141, DOI 10.1111/j.1464-5491.2005.01582.x; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Mahmoodi BK, 2009, JAMA-J AM MED ASSOC, V301, P1790, DOI 10.1001/jama.2009.565; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; XU CF, 2010, HEPATOLOGY IN PRESS, DOI DOI 10.1002/HEP.23798; Yoo TW, 2005, CIRC J, V69, P928, DOI 10.1253/circj.69.928; Zhou M, 2009, EUR J ENDOCRINOL, V161, P723, DOI 10.1530/EJE-09-0585	33	105	118	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11578	10.1371/journal.pone.0011578	http://dx.doi.org/10.1371/journal.pone.0011578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644649	gold, Green Submitted, Green Published			2022-12-27	WOS:000279884900017
J	Pajalunga, D; Puggioni, EMR; Mazzola, A; Leva, V; Montecucco, A; Crescenzi, M				Pajalunga, Deborah; Puggioni, Eleonora M. R.; Mazzola, Alessia; Leva, Valentina; Montecucco, Alessandra; Crescenzi, Marco			DNA Replication Is Intrinsically Hindered in Terminally Differentiated Myotubes	PLOS ONE			English	Article							CELL-CYCLE; HISTONE H2AX; S-PHASE; REGENERATION; REQUIREMENT; PROGRESSION; CHECKPOINT; INDUCTION; INFECTION; REENTRY	Background: Terminally differentiated (TD) cells permanently exit the mitotic cycle while acquiring specialized characteristics. Although TD cells can be forced to reenter the cell cycle by different means, they cannot be made to stably proliferate, as attempts to induce their replication constantly result in cell death or indefinite growth arrest. There is currently no biological explanation for this failure. Principal Findings: Here we show that TD mouse myotubes, reactivated by depletion of the p21 and p27 cell cycle inhibitors, are unable to complete DNA replication and sustain heavy DNA damage, which triggers apoptosis or results in mitotic catastrophe. In striking contrast, quiescent, non-TD fibroblasts and myoblasts, reactivated in the same way, fully replicate their DNA, do not suffer DNA damage, and proliferate even in the absence of growth factors. Similar results are obtained when myotubes and fibroblasts are reactivated by forced expression of E1A or cyclin D1 and cdk4. Conclusions: We conclude that the inability of myotubes to complete DNA replication must be ascribed to peculiar features inherent in their TD state, rather than to the reactivation method. On reviewing the literature concerning reactivation of other TD cell types, we propose that similar mechanisms underlie the general inability of all kinds of TD cells to proliferate in response to otherwise mitogenic stimuli. These results define an unexpected basis for the well known incompetence of mammalian postmitotic cells to proliferate. Furthermore, this trait might contribute to explain the inability of these cells to play a role in tissue repair, unlike their counterparts in extensively regenerating species.	[Pajalunga, Deborah; Puggioni, Eleonora M. R.; Mazzola, Alessia; Crescenzi, Marco] Natl Inst Hlth, Dept Cell Biol & Neurosci, Rome, Italy; [Leva, Valentina; Montecucco, Alessandra] Inst Mol Genet, Natl Res Council, Pavia, Italy	Istituto Superiore di Sanita (ISS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR)	Pajalunga, D (corresponding author), Natl Inst Hlth, Dept Cell Biol & Neurosci, Rome, Italy.	marco.crescenzi@iss.it	Crescenzi, Marco/J-3603-2018; Montecucco, Alessandra/B-8041-2015; pajalunga, deborah/K-2423-2018	Crescenzi, Marco/0000-0003-0156-1494; Montecucco, Alessandra/0000-0002-9388-9149; pajalunga, deborah/0000-0003-4892-8396	Telethon Italy [GGP05006]	Telethon Italy(Fondazione Telethon)	This study has been funded by Telethon Italy (http://www.telethon.it), grant no. GGP05006. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Banerjee NS, 2006, J VIROL, V80, P6517, DOI 10.1128/JVI.02499-05; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Boye Erik, 2009, V521, P55, DOI [10.1007/978-1-60327-815-7_4, 10.1007/978-1-60327-817-5_4]; Brockes JP, 2005, SCIENCE, V310, P1919, DOI 10.1126/science.1115200; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; CONNOLLY JA, 1986, EUR J CELL BIOL, V39, P341; CRESCENZI M, 1995, J CELL PHYSIOL, V162, P26, DOI 10.1002/jcp.1041620105; CRESCENZI M, 1995, ANN NY ACAD SCI, V752, P9, DOI 10.1111/j.1749-6632.1995.tb17402.x; CRESCENZI M, 2002, REACTIVATION CELL CY; Endo T, 1998, J CELL SCI, V111, P1081; Endo T., 1989, CELLULAR MOL BIOL MU, P95; FEDDERSEN RM, 1992, NEURON, V9, P955, DOI 10.1016/0896-6273(92)90247-B; FOGEL M, 1967, P NATL ACAD SCI USA, V58, P967, DOI 10.1073/pnas.58.3.967; Gottifredi V, 2005, SEMIN CELL DEV BIOL, V16, P355, DOI 10.1016/j.semcdb.2005.02.011; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HJIANTONIOU E, 2007, DIFFERENTIATION; Kirshenbaum LA, 1996, DEV BIOL, V179, P402, DOI 10.1006/dbio.1996.0270; Latella L, 2000, CELL DEATH DIFFER, V7, P145, DOI 10.1038/sj.cdd.4400592; Latella L, 2001, MOL CELL BIOL, V21, P5631, DOI 10.1128/MCB.21.16.5631-5643.2001; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Pajalunga D, 1999, ONCOGENE, V18, P5054, DOI 10.1038/sj.onc.1202897; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; SACCO A, 2002, MOL B INT U, V17, P45; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smith DS, 2000, CELL GROWTH DIFFER, V11, P625; SULG M, 2009, J NEUROCHEM; Tamamori-Adachi M, 2003, CIRC RES, V92, pE12, DOI 10.1161/01.RES.0000049105.15329.1C; Tanaka EM, 2003, CELL, V113, P559, DOI 10.1016/S0092-8674(03)00395-7; Tanaka T, 2007, CELL PROLIFERAT, V40, P1; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Tiainen M, 1996, CELL GROWTH DIFFER, V7, P1039; Tiainen M, 1996, MOL CELL BIOL, V16, P5302; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Vitolo B, 2005, EUR J HISTOCHEM, V49, P349; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; YAFFE D, 1967, NATURE, V215, P421, DOI 10.1038/215421a0	42	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11559	10.1371/journal.pone.0011559	http://dx.doi.org/10.1371/journal.pone.0011559			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644635	Green Published, gold, Green Submitted			2022-12-27	WOS:000279822300013
J	Cahill, MJ; Koser, CU; Ross, NE; Archer, JAC				Cahill, Matt J.; Koser, Claudio U.; Ross, Nicholas E.; Archer, John A. C.			Read Length and Repeat Resolution: Exploring Prokaryote Genomes Using Next-Generation Sequencing Technologies	PLOS ONE			English	Article							BACTERIAL GENOMES; ALGORITHMS; ALIGNMENT; GENETICS; IMPACT	Background: There are a growing number of next-generation sequencing technologies. At present, the most cost-effective options also produce the shortest reads. However, even for prokaryotes, there is uncertainty concerning the utility of these technologies for the de novo assembly of complete genomes. This reflects an expectation that short reads will be unable to resolve small, but presumably abundant, repeats. Methodology/Principal Findings: Using a simple model of repeat assembly, we develop and test a technique that, for any read length, can estimate the occurrence of unresolvable repeats in a genome, and thus predict the number of gaps that would need to be closed to produce a complete sequence. We apply this technique to 818 prokaryote genome sequences. This provides a quantitative assessment of the relative performance of various lengths. Notably, unpaired reads of only 150nt can reconstruct approximately 50% of the analysed genomes with fewer than 96 repeat-induced gaps. Nonetheless, there is considerable variation amongst prokaryotes. Some genomes can be assembled to near contiguity using very short reads while others require much longer reads. Conclusions: Given the diversity of prokaryote genomes, a sequencing strategy should be tailored to the organism under study. Our results will provide researchers with a practical resource to guide the selection of the appropriate read length.	[Cahill, Matt J.; Koser, Claudio U.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Ross, Nicholas E.] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3EH, England; [Archer, John A. C.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Div Chem & Biol Engn, Thuwal, Saudi Arabia	University of Cambridge; University of Cambridge; King Abdullah University of Science & Technology	Cahill, MJ (corresponding author), Univ Cambridge, Dept Genet, Downing St, Cambridge CB2 3EH, England.	john.archer@kaust.edu.sa	Archer, John/D-5200-2012; Archer, John/AAW-1990-2021; Köser, Claudio/I-3740-2013	Archer, John/0000-0002-3302-3933; Köser, Claudio/0000-0002-0232-846X	Cambridge European Trust; Clare Hall, Cambridge	Cambridge European Trust; Clare Hall, Cambridge	CUK is a recipient of a Gates Cambridge Scholarship and received additional funding from the Cambridge European Trust and Clare Hall, Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2003, GENETICS, V164, P1279; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bryant DW, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-69; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Farrer RA, 2009, FEMS MICROBIOL LETT, V291, P103, DOI 10.1111/j.1574-6968.2008.01441.x; Fraser CM, 2002, J BACTERIOL, V184, P6403, DOI 10.1128/JB.184.23.6403-6405.2002; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Haubold B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-541; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Kingsford C, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-21; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; LANDER E S, 1988, Genomics, V2, P231; MacCallum I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r103; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Mardis E, 2002, GENOME RES, V12, P669, DOI 10.1101/gr.032102; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; Treangen TJ, 2009, FEMS MICROBIOL REV, V33, P539, DOI 10.1111/j.1574-6976.2009.00169.x; Wendl MC, 2002, GENOME RES, V12, P1943, DOI 10.1101/gr.655102; Whiteford N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni170; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	29	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11518	10.1371/journal.pone.0011518	http://dx.doi.org/10.1371/journal.pone.0011518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634954	Green Published, gold, Green Submitted			2022-12-27	WOS:000279781600006
J	Jugessur, A; Shi, M; Gjessing, HK; Lie, RT; Wilcox, AJ; Weinberg, CR; Christensen, K; Boyles, AL; Daack-Hirsch, S; Nguyen, TT; Christiansen, L; Lidral, AC; Murray, JC				Jugessur, Astanand; Shi, Min; Gjessing, Hakon Kristian; Lie, Rolv Terje; Wilcox, Allen James; Weinberg, Clarice Ring; Christensen, Kaare; Boyles, Abee Lowman; Daack-Hirsch, Sandra; Nguyen, Truc Trung; Christiansen, Lene; Lidral, Andrew Carl; Murray, Jeffrey Clark			Maternal Genes and Facial Clefts in Offspring: A Comprehensive Search for Genetic Associations in Two Population-Based Cleft Studies from Scandinavia	PLOS ONE			English	Article							MILLER-DIEKER-SYNDROME; SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; TUMOR-SUPPRESSOR GENE; CANDIDATE-GENE; ORAL CLEFTS; SKELETAL DEVELOPMENT; GENOME-SCAN; PALATE; LIP; MICE	Background: Fetal conditions can in principle be affected by the mother's genotype working through the prenatal environment. Methodology/Principal Findings: Genotypes for 1536 SNPs in 357 cleft candidate genes were available from a previous analysis in which we focused on fetal gene effects [1]. After data-cleaning, genotypes for 1315 SNPs in 334 autosomal genes were available for the current analysis of maternal gene effects. Two complementary statistical methods, TRIMM and HAPLIN, were used to detect multi-marker effects in population-based samples from Norway (562 case-parent and 592 control-parent triads) and Denmark (235 case-parent triads). We analyzed isolated cleft lip with or without cleft palate (iCL/P) and isolated cleft palate only (iCP) separately and assessed replication by looking for genes detected in both populations by both methods. In iCL/P, neither TRIMM nor HAPLIN detected more genes than expected by chance alone; furthermore, the selected genes were not replicated across the two methods. In iCP, however, FLNB was identified by both methods in both populations. Although HIC1 and ZNF189 did not fully satisfy our stringency criterion for replication, they were strongly associated with iCP in TRIMM analyses of the Norwegian triads. Conclusion/Significance: Except for FLNB, HIC1 and ZNF189, maternal genes did not appear to influence the risk of clefting in our data. This is consistent with recent epidemiological findings showing no apparent difference between mother-to-offspring and father-to-offspring recurrence of clefts in these two populations. It is likely that fetal genes make the major genetic contribution to clefting risk in these populations, but we cannot rule out the possibility that maternal genes can affect risk through interactions with specific teratogens or fetal genes.	[Jugessur, Astanand; Gjessing, Hakon Kristian] Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway; [Jugessur, Astanand] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Shi, Min; Weinberg, Clarice Ring] NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA; [Gjessing, Hakon Kristian; Lie, Rolv Terje] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Lie, Rolv Terje; Nguyen, Truc Trung] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Wilcox, Allen James; Boyles, Abee Lowman] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Christensen, Kaare; Christiansen, Lene; Murray, Jeffrey Clark] Univ So Denmark, Dept Epidemiol, Odense, Denmark; [Daack-Hirsch, Sandra] Univ Iowa, Coll Nursing, Iowa City, IA 52242 USA; [Lidral, Andrew Carl; Murray, Jeffrey Clark] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Lidral, Andrew Carl; Murray, Jeffrey Clark] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Lidral, Andrew Carl; Murray, Jeffrey Clark] Univ Iowa, Dept Biol Sci, Iowa City, IA USA	Norwegian Institute of Public Health (NIPH); Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Bergen; Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Southern Denmark; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Jugessur, A (corresponding author), Norwegian Inst Publ Hlth, Div Epidemiol, Oslo, Norway.	jeff-murray@uiowa.edu	Christensen, Kaare/C-2360-2009; Wilcox, Allen J/C-7723-2019; Gjessing, Hakon K/A-5871-2012; Shi, Min/GXM-3977-2022	Christensen, Kaare/0000-0002-5429-5292; Wilcox, Allen J/0000-0002-3376-1311; Weinberg, Clarice/0000-0002-7713-8556; Boyles, Abee/0000-0002-8711-2077; Daack-Hirsch, Sandra/0000-0003-1192-7154	National Institutes of Health (NIH) [N01-HG-65403, DE08559, P60 DE13076, NIH P30 ES05605, RO1 DE-11948-04]; National Institute of Environmental Health Sciences; Norwegian Research Council [NFR 177522]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P60DE013076, R01DE008559, R01DE011948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, ZIAES045005, ZIAES049027] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Center for Inherited Disease Research (CIDR) is fully funded through a federal contract from the National Institutes of Health (NIH) to The Johns Hopkins University, Contract Number N01-HG-65403. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences; by NIH grants DE08559, P60 DE13076, NIH P30 ES05605, and RO1 DE-11948-04; and by the Norwegian Research Council (NFR 177522). We also thank the US National Institute of Dental and Craniofacial Research (NIDCR) for underwriting a significant proportion of the genotyping costs by CIDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bille C, 2005, CLEFT PALATE-CRAN J, V42, P255, DOI 10.1597/03-139.1; BINGLE GJ, 1977, AM J HUM GENET, V29, P605; Boyles AL, 2009, GENET EPIDEMIOL, V33, P247, DOI 10.1002/gepi.20376; Brunetti-Pierri N, 2008, AM J MED GENET A, V146A, P2804, DOI 10.1002/ajmg.a.32530; Carter MG, 2000, HUM MOL GENET, V9, P413, DOI 10.1093/hmg/9.3.413; Castanet M, 2002, HUM MOL GENET, V11, P2051, DOI 10.1093/hmg/11.17.2051; Chong SS, 1997, HUM MOL GENET, V6, P147, DOI 10.1093/hmg/6.2.147; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fisher R.A., 1958, STAT METHODS RES WOR; GJESSING HK, 2006, ANN HUM GENET, P1; Grimm C, 1999, HUM MOL GENET, V8, P697, DOI 10.1093/hmg/8.4.697; GROSEN D, 2009, J MED GENET; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Hirotsune S, 1997, GENOME RES, V7, P625, DOI 10.1101/gr.7.6.625; Isidor B, 2008, AM J MED GENET A, V146A, P1593, DOI 10.1002/ajmg.a.32217; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; LETTERIO JJ, 1994, SCIENCE, V264, P1936, DOI 10.1126/science.8009224; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; Mansilla MA, 2006, CLEFT PALATE-CRAN J, V43, P21, DOI 10.1597/04-169R.1; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Marazita ML, 2004, AM J MED GENET A, V126A, P111, DOI 10.1002/ajmg.a.20564; Moreno LM, 2009, HUM MOL GENET, V18, P4879, DOI 10.1093/hmg/ddp444; Mossey PA, 2002, CLEFT LIP PALATE ORI; POPLIKER M, 1987, DEV BIOL, V119, P38, DOI 10.1016/0012-1606(87)90204-1; R Development Core Team, 2006, R LANG ENV STAT COMP; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; SCHAID DJ, 1993, AM J HUM GENET, V53, P1114; SCHWEDER T, 1982, BIOMETRIKA, V69, P493; Shi M, 2007, AM J HUM GENET, V81, P53, DOI 10.1086/518670; Shi M, 2007, AM J HUM GENET, V80, P76, DOI 10.1086/510518; Shi Min, 2008, Birth Defects Research, V84, P16, DOI 10.1002/bdrc.20117; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802; Wilcox AJ, 1998, AM J EPIDEMIOL, V148, P893; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104; Zhu JL, 2002, BRIT J CANCER, V87, P524, DOI 10.1038/sj.bjc.6600488	47	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11493	10.1371/journal.pone.0011493	http://dx.doi.org/10.1371/journal.pone.0011493			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634891	gold, Green Published			2022-12-27	WOS:000279715300008
J	Dehghani, N; Cash, SS; Chen, CC; Hagler, DJ; Huang, MX; Dale, AM; Halgren, E				Dehghani, Nima; Cash, Sydney S.; Chen, Chih C.; Hagler, Donald J., Jr.; Huang, Mingxiong; Dale, Anders M.; Halgren, Eric			Divergent Cortical Generators of MEG and EEG during Human Sleep Spindles Suggested by Distributed Source Modeling	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HIGH-RESOLUTION; BRAIN ACTIVITY; PREFRONTAL CORTEX; MAGNETOENCEPHALOGRAPHY; LOCALIZATION; OSCILLATIONS; SEGMENTATION; WAVES; FMRI	Background: Sleep spindles are similar to 1-second bursts of 10-15 Hz activity, occurring during normal stage 2 sleep. In animals, sleep spindles can be synchronous across multiple cortical and thalamic locations, suggesting a distributed stable phase-locked generating system. The high synchrony of spindles across scalp EEG sites suggests that this may also be true in humans. However, prior MEG studies suggest multiple and varying generators. Methodology/Principal Findings: We recorded 306 channels of MEG simultaneously with 60 channels of EEG during naturally occurring spindles of stage 2 sleep in 7 healthy subjects. High-resolution structural MRI was obtained in each subject, to define the shells for a boundary element forward solution and to reconstruct the cortex providing the solution space for a noise-normalized minimum norm source estimation procedure. Integrated across the entire duration of all spindles, sources estimated from EEG and MEG are similar, diffuse and widespread, including all lobes from both hemispheres. However, the locations, phase and amplitude of sources simultaneously estimated from MEG versus EEG are highly distinct during the same spindles. Specifically, the sources estimated from EEG are highly synchronous across the cortex, whereas those from MEG rapidly shift in phase, hemisphere, and the location within the hemisphere. Conclusions/Significance: The heterogeneity of MEG sources implies that multiple generators are active during human sleep spindles. If the source modeling is correct, then EEG spindles are generated by a different, diffusely synchronous system. Animal studies have identified two thalamo-cortical systems, core and matrix, that produce focal or diffuse activation and thus could underlie MEG and EEG spindles, respectively. Alternatively, EEG spindles could reflect overlap at the sensors of the same sources as are seen from the MEG. Although our results generally match human intracranial recordings, additional improvements are possible and simultaneous intra-and extra-cranial measures are needed to test their accuracy.	[Dehghani, Nima; Hagler, Donald J., Jr.; Huang, Mingxiong; Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Dehghani, Nima; Cash, Sydney S.; Chen, Chih C.] Harvard Univ, Sch Med, Martinos Ctr Biomed Imaging, Boston, MA USA; [Dehghani, Nima] CNRS, UNIC, Lab Computat Neurosci, Gif Sur Yvette, France; [Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Chen, Chih C.] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA	University of California System; University of California San Diego; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Massachusetts General Hospital; National Taiwan University; National Taiwan University Hospital; University of California System; University of California San Diego	Dehghani, N (corresponding author), Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA.	ehalgren@ucsd.edu		Dehghani, Nima/0000-0003-2032-8903	National Institutes of Health (NIH) [EB009282, NS18741, NS44623]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS018741, R01NS044623] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants EB009282, NS18741, and NS44623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors SP, 2010, HUM BRAIN MAPP, V31, P140, DOI 10.1002/hbm.20851; Anderer P, 2001, NEUROSCIENCE, V103, P581, DOI 10.1016/S0306-4522(01)00028-8; [Anonymous], [No title captured]; Asano E, 2007, CLIN NEUROPHYSIOL, V118, P1360, DOI 10.1016/j.clinph.2007.02.021; Bazhenov M, 2002, J NEUROSCI, V22, P8691; Benesty J, 2005, IEEE SIGNAL PROC LET, V12, P827, DOI 10.1109/LSP.2005.859517; Buchner Helmut, 1995, Brain Topography, V8, P137, DOI 10.1007/BF01199777; Buzsaki G., 2006, RHYTHMS BRAIN; CADERAS M, 1982, CLIN ELECTROENCEPHAL, V13, P216, DOI 10.1177/155005948201300402; COHEN D, 1983, ELECTROEN CLIN NEURO, V56, P38, DOI 10.1016/0013-4694(83)90005-6; Contreras D, 1997, J NEUROSCI, V17, P1179; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dale AM, 2001, CURR OPIN NEUROBIOL, V11, P202, DOI 10.1016/S0959-4388(00)00197-5; DEHGHANI N, 2010, J NEUROPHYSIOL; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; Destexhe A, 1998, J NEUROPHYSIOL, V79, P999; Dhond RP, 2001, J NEUROSCI, V21, P3564, DOI 10.1523/JNEUROSCI.21-10-03564.2001; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Gibbs F., 1950, ATLAS ELECTROENCEPHA; Gumenyuk V, 2009, J SLEEP RES, V18, P245, DOI 10.1111/j.1365-2869.2008.00717.x; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; HUGHES JR, 1976, ELECTROEN CLIN NEURO, V40, P261, DOI 10.1016/0013-4694(76)90150-4; Ishii R, 2003, NEUROSCI LETT, V340, P25, DOI 10.1016/S0304-3940(03)00048-X; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; KIM U, 1995, J NEUROPHYSIOL, V74, P1301, DOI 10.1152/jn.1995.74.3.1301; Komssi S, 2004, CLIN NEUROPHYSIOL, V115, P534, DOI 10.1016/j.clinph.2003.10.034; Liu AK, 2002, HUM BRAIN MAPP, V16, P47, DOI 10.1002/hbm.10024; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; LOOMIS ALFRED L., 1935, SCIENCE, V81, P597, DOI 10.1126/science.81.2111.597; Lutkenhoner B, 2003, J PHYSIOL-PARIS, V97, P641, DOI 10.1016/j.jphysparis.2004.01.020; Malow BA, 1999, CLIN NEUROPHYSIOL, V110, P687, DOI 10.1016/S1388-2457(99)00008-5; Manshanden I, 2002, CLIN NEUROPHYSIOL, V113, P1937, DOI 10.1016/S1388-2457(02)00304-8; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MEIJS JWH, 1987, ELECTROEN CLIN NEURO, V66, P286, DOI 10.1016/0013-4694(87)90078-2; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Nakabayashi T, 2001, PSYCHIAT CLIN NEUROS, V55, P57, DOI 10.1046/j.1440-1819.2001.00785.x; Nakamura M, 2003, NEUROSCI RES, V45, P419, DOI 10.1016/S0168-0102(03)00007-5; NAKASATO N, 1990, ELECTROEN CLIN NEURO, V76, P123, DOI 10.1016/0013-4694(90)90210-B; Nunez PL, 2000, BRAIN TOPOGR, V13, P79, DOI 10.1023/A:1026683200895; Ramon C, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-10; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Shih JJ, 2000, J CLIN NEUROPHYSIOL, V17, P224, DOI 10.1097/00004691-200003000-00011; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P50, DOI 10.1152/jn.1961.24.1.50; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; Urakami Y, 2008, J CLIN NEUROPHYSIOL, V25, P13, DOI 10.1097/WNP.0b013e318162a8a4; WOLTERS CH, 2005, NEUROIMAGE; Yoshida H, 1996, BRAIN TOPOGR, V8, P303, DOI 10.1007/BF01184789; Zepelin H, 1994, PRINCIPLES PRACTICE, P91; Zikopoulos B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000848; Zygierewicz J, 1999, CLIN NEUROPHYSIOL, V110, P2136, DOI 10.1016/S1388-2457(99)00175-3	57	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11454	10.1371/journal.pone.0011454	http://dx.doi.org/10.1371/journal.pone.0011454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628643	Green Published, gold			2022-12-27	WOS:000279589300005
J	Riede, T; Fisher, JH; Goller, F				Riede, Tobias; Fisher, John H.; Goller, Franz			Sexual Dimorphism of the Zebra Finch Syrinx Indicates Adaptation for High Fundamental Frequencies in Males	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SYSTEM CONTROLLING SONG; ANDROGEN RECEPTOR; VOCAL MUSCLES; SONGBIRDS; SELECTION; BRAIN; LATERALIZATION; MODULATION; EXPRESSION	Background: In many songbirds the larger vocal repertoire of males is associated with sexual dimorphism of the vocal control centers and muscles of the vocal organ, the syrinx. However, it is largely unknown how these differences are translated into different acoustic behavior. Methodology/Principal Findings: Here we show that the sound generating structures of the syrinx, the labia and the associated cartilaginous framework, also display sexual dimorphism. One of the bronchial half rings that position and tense the labia is larger in males, and the size and shape of the labia differ between males and females. The functional consequences of these differences were explored by denervating syringeal muscles. After denervation, both sexes produced equally low fundamental frequencies, but the driving pressure generally increased and was higher in males. Denervation strongly affected the relationship between driving pressure and fundamental frequency. Conclusions/Significance: The syringeal modifications in the male syrinx, in concert with dimorphisms in neural control and muscle mass, are most likely the foundation for the potential to generate an enhanced frequency range. Sexually dimorphic vocal behavior therefore arises from finely tuned modifications at every level of the motor cascade. This sexual dimorphism in frequency control illustrates a significant evolutionary step towards increased vocal complexity in birds.	[Riede, Tobias; Goller, Franz] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Riede, Tobias] Univ Utah, Natl Ctr Voice & Speech, Salt Lake City, UT USA; [Fisher, John H.] Univ Utah, Dept Physiol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Riede, T (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	t.riede@utah.edu	Riede, Tobias/J-9092-2012	Riede, Tobias/0000-0001-6875-0017; Riede, Tobias/0000-0001-9606-0742	NIH [DC04390, DC06876]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004390, R01DC006876] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by NIH grant DC04390 and DC06876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; CATCHPOLE CK, 1980, BEHAVIOUR, V74, P149, DOI 10.1163/156853980X00366; CHAMBERLAIN DR, 1968, AUK, V85, P244; Chan RW, 2007, ANN BIOMED ENG, V35, P1471, DOI 10.1007/s10439-007-9314-x; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; ECKEL HE, 1996, INT C SERIES, P382; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Fay R. R., 1988, HEARING VERTEBRATES; Fee MS, 2002, J COMP PHYSIOL A, V188, P829, DOI 10.1007/s00359-002-0349-z; Fine ML, 2008, T AM FISH SOC, V137, P627, DOI 10.1577/T04-134.1; Floody OR, 1997, HORM BEHAV, V31, P25, DOI 10.1006/hbeh.1997.1368; GAUNT AS, 1982, BIRD RESP, P71; Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Larsen ON, 2002, J EXP BIOL, V205, P25; LUINE V, 1980, BRAIN RES, V192, P89, DOI 10.1016/0006-8993(80)91011-2; Luther D, 2010, P R SOC B, V277, P469, DOI 10.1098/rspb.2009.1571; Mindlin GB, 2005, PHYS BIRDSONG; MISKIMEN MILDR D., 1951, AUK, V68, P493; Morse P.M., 1948, VIBRATION SOUND; MORTON ES, 1975, AM NAT, V109, P17, DOI 10.1086/282971; NEGUS V. E., 1949, COMP ANATOMY PHYSL L; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Price T, 1998, PHILOS T R SOC B, V353, P251, DOI 10.1098/rstb.1998.0207; Riebel K, 2003, ADV STUD BEHAV, V33, P49, DOI 10.1016/S0065-3454(03)33002-5; Riede T, 2006, P NATL ACAD SCI USA, V103, P5543, DOI 10.1073/pnas.0601262103; Riede T, 2010, J MORPHOL, V271, P1, DOI 10.1002/jmor.10774; Riede T, 2010, J ANAT, V216, P23, DOI 10.1111/j.1469-7580.2009.01161.x; RYAN MJ, 1988, AM ZOOL, V28, P885; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; Suthers RA, 2004, ANN NY ACAD SCI, V1016, P109, DOI 10.1196/annals.1298.041; Suthers RA, 1999, DESIGN OF ANIMAL COMMUNICATION, P37; Tang YP, 2009, DEV NEUROBIOL, V69, P462, DOI 10.1002/dneu.20721; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Veney SL, 2005, J COMP PHYSIOL A, V191, P97, DOI 10.1007/s00359-004-0577-5; Veney SL, 2004, GEN COMP ENDOCR, V136, P192, DOI 10.1016/j.ygcen.2003.12.017; VICARIO DS, 1995, J NEUROPHYSIOL, V73, P2602, DOI 10.1152/jn.1995.73.6.2602; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; Wade J, 2000, J COMP NEUROL, V426, P154; Wade J, 2002, BRAIN RES, V929, P191, DOI 10.1016/S0006-8993(01)03389-3; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Williams H, 2004, ANN NY ACAD SCI, V1016, P1, DOI 10.1196/annals.1298.029; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; WILLIAMS H, 1989, J COMP PSYCHOL, V103, P366, DOI 10.1037/0735-7036.103.4.366; Wind J., 1970, PHYLOGENY ONTOGENY H; ZANN R, 1984, Z TIERPSYCHOL, V66, P328; Zann RA., 1996, ZEBRA FINCH SYNTHESI	50	33	33	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11368	10.1371/journal.pone.0011368	http://dx.doi.org/10.1371/journal.pone.0011368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614010	Green Published, Green Submitted, gold			2022-12-27	WOS:000279369900017
J	Cree, BAC; Rioux, JD; McCauley, JL; Gourraud, PAFD; Goyette, P; McElroy, J; De Jager, P; Santaniello, A; Vyse, TJ; Gregersen, PK; Mirel, D; Hafler, DA; Haines, JL; Pericak-Vance, MA; Compston, A; Sawcer, SJ; Oksenberg, JR; Hauser, SL				Cree, Bruce A. C.; Rioux, John D.; McCauley, Jacob L.; Gourraud, Pierre-Antoine F. D.; Goyette, Philippe; McElroy, Joseph; De Jager, Philip; Santaniello, Adam; Vyse, Timothy J.; Gregersen, Peter K.; Mirel, Daniel; Hafler, David A.; Haines, Jonathan L.; Pericak-Vance, Margaret A.; Compston, Alastair; Sawcer, Stephen J.; Oksenberg, Jorge R.; Hauser, Stephen L.		IMAGEN; IMSGC	A Major Histocompatibility Class I Locus Contributes to Multiple Sclerosis Susceptibility Independently from HLA-DRB1*15:01	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; EXTENDED HUMAN MHC; HLA-G MOLECULES; LINKAGE-DISEQUILIBRIUM; ASSOCIATION; EXPRESSION; REGION; DISEASE; COMPLEX; GENES	Background: In Northern European descended populations, genetic susceptibility for multiple sclerosis (MS) is associated with alleles of the human leukocyte antigen (HLA) Class II gene DRB1. Whether other major histocompatibility complex (MHC) genes contribute to MS susceptibility is controversial. Methodology/Principal Findings: A case control analysis was performed using 958 single nucleotide polymorphisms (SNPs) spanning the MHC assayed in two independent datasets. The discovery dataset consisted of 1,018 cases and 1,795 controls and the replication dataset was composed of 1,343 cases and 1,379 controls. The most significantly MS-associated SNP in the discovery dataset was rs3135391, a Class II SNP known to tag the HLA-DRB1*15:01 allele, the primary MS susceptibility allele in the MHC (O.R. = 3.04, p<1 x 10(-78)). To control for the effects of the HLA-DRB1*15:01 haplotype, case control analysis was performed adjusting for this HLA-DRB1*15: 01 tagging SNP. After correction for multiple comparisons (false discovery rate =.05) 52 SNPs in the Class I, II and III regions were significantly associated with MS susceptibility in both datasets using the Cochran Armitage trend test. The discovery and replication datasets were merged and subjects carrying the HLA-DRB1*15:01 tagging SNP were excluded. Association tests showed that 48 of the 52 replicated SNPs retained significant associations with MS susceptibility independently of the HLA-DRB1*15:01 as defined by the tagging SNP. 20 Class I SNPs were associated with MS susceptibility with p-values <= 1 x 10(-8). The most significantly associated SNP was rs4959039, a SNP in the downstream un-translated region of the non-classical HLA-G gene (Odds ratio 1.59, 95% CI 1.40, 1.81, p = 8.45 x 10(-13)) and is in linkage disequilibrium with several nearby SNPs. Logistic regression modeling showed that this SNP's contribution to MS susceptibility was independent of the Class II and Class III SNPs identified in this screen. Conclusions: A MHC Class I locus contributes to MS susceptibility independently of the HLA-DRB1*15:01 haplotype.	[Cree, Bruce A. C.; Gourraud, Pierre-Antoine F. D.; McElroy, Joseph; Santaniello, Adam; Oksenberg, Jorge R.; Hauser, Stephen L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Rioux, John D.; Goyette, Philippe] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [McCauley, Jacob L.] Miami Univ, Sch Med, Dept Human Genet, Dr John T MacDonald Fdn, Miami, FL USA; [De Jager, Philip] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [De Jager, Philip] Harvard Univ, Sch Med, Partners Healthcare Ctr Genet & Genom, Cambridge, MA 02138 USA; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Rheumatol, London, England; [Gregersen, Peter K.] Robert S Boas Ctr Genom & Human Genet, Feinstein Inst Med Res, Manhasset, NY USA; [Mirel, Daniel] MIT & Harvard, Broad Inst, Cambridge, MA USA; [Hafler, David A.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hafler, David A.; Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN USA; [Pericak-Vance, Margaret A.] Miami Univ, Sch Med, Hussman Inst Human Genom, Miami, FL USA; [Compston, Alastair; Sawcer, Stephen J.] Univ Cambridge, Neurol Unit, Dept Clin Neurosci, Cambridge, England	University of California System; University of California San Francisco; Universite de Montreal; Harvard University; Brigham & Women's Hospital; Harvard University; Partners Healthcare System; Imperial College London; Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yale University; Vanderbilt University; University of Cambridge	Cree, BAC (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	bruce.cree@ucsf.edu	Hauser, Stephen L/J-2978-2016; de Bakker, Paul IW/B-8730-2009; Haines, Jonathan/C-3374-2012; Rioux, John D/A-9599-2015; Gourraud, Pierre-Antoine FD/O-3024-2015; Cree, Bruce C/AAV-6109-2020	de Bakker, Paul IW/0000-0001-7735-7858; Haines, Jonathan/0000-0002-4351-4728; Rioux, John D/0000-0001-7560-8326; Cree, Bruce C/0000-0001-7689-2533; Klareskog, Lars/0000-0001-9601-6186; Gourraud, Pierre-Antoine/0000-0003-1131-9554; Alfredsson, Lars/0000-0003-1688-6697	National Institutes of Allergy and Infectious Diseases [AI067152]; National Institute of Neurological Disease and Stroke [NS21799, K23 NS048869]; National Multiple Sclerosis Society (NMSS); Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; National Center for Research Resources [U54 RR020278];  [RO1NS049477]; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS048869, R01NS049477, R01NS046297] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported primarily by a grant from the National Institutes of Allergy and Infectious Diseases (AI067152). Additional support was received from the National Institute of Neurological Disease and Stroke (NS21799) to SLH and (K23 NS048869) to BACC. PLD was supported by a Harry Weaver Neuroscience Scholar Award of the National Multiple Sclerosis Society (NMSS). The IMSGC is supported by RO1NS049477. The authors also thank the NMSS and Nancy Davis Foundation for support of DNA collections. They acknowledge use of DNA from the British 1958 Birth Cohort collection (D. Strachan, S. Ring, W. McArdle and M. Pembrey), funded by the Medical Research Council grant G0000934 and Wellcome Trust grant 068545/Z/02. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation in the manuscript.	Apps R, 2008, TRENDS IMMUNOL, V29, P313, DOI 10.1016/j.it.2008.02.012; Bainbridge D, 2001, TRENDS IMMUNOL, V22, P548, DOI 10.1016/S1471-4906(01)02031-2; Barcellos LF, 2002, BRAIN, V125, P150; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Brynedal B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000664; Burfoot RK, 2008, TISSUE ANTIGENS, V71, P42, DOI 10.1111/j.1399-0039.2007.00962.x; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chao MJ, 2007, HUM MOL GENET, V16, P1951, DOI 10.1093/hmg/ddm142; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Fainardi E, 2006, MULT SCLER J, V12, P2, DOI 10.1191/1352458506ms1241oa; Fainardi E, 2003, J NEUROIMMUNOL, V142, P149, DOI 10.1016/S0165-5728(03)00266-2; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Goris A, 2009, J NEUROIMMUNOL, V210, P113, DOI 10.1016/j.jneuroim.2009.03.001; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huang YH, 2009, ANN NEUROL, V66, P171, DOI 10.1002/ana.21705; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Kroner A, 2007, HUM IMMUNOL, V68, P422, DOI 10.1016/j.humimm.2007.01.012; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Marrosu MG, 1997, AM J HUM GENET, V61, P454; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Pazmany L, 1996, SCIENCE, V274, P792, DOI 10.1126/science.274.5288.792; Rioux JD, 2009, P NATL ACAD SCI USA, V106, P18680, DOI 10.1073/pnas.0909307106; Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741; Rouas-Freiss N, 2007, SEMIN CANCER BIOL, V17, P413, DOI 10.1016/j.semcancer.2007.07.003; Sawcer S, 2005, AM J HUM GENET, V77, P454; Urosevic M, 2007, SEMIN CANCER BIOL, V17, P480, DOI 10.1016/j.semcancer.2007.09.001; Wiendl H, 2000, ANN NEUROL, V48, P679, DOI 10.1002/1531-8249(200010)48:4<679::AID-ANA19>3.3.CO;2-M; Wiendl H, 2005, BRAIN, V128, P2689, DOI 10.1093/brain/awh609; Yeo TW, 2007, ANN NEUROL, V61, P228, DOI 10.1002/ana.21063	38	40	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11296	10.1371/journal.pone.0011296	http://dx.doi.org/10.1371/journal.pone.0011296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593013	Green Published, gold, Green Submitted			2022-12-27	WOS:000279140800007
J	Mizuno, N; Hosogi, N; Park, P; Takumi, S				Mizuno, Nobuyuki; Hosogi, Naoki; Park, Pyoyun; Takumi, Shigeo			Hypersensitive Response-Like Reaction Is Associated with Hybrid Necrosis in Interspecific Crosses between Tetraploid Wheat and Aegilops tauschii Coss	PLOS ONE			English	Article							COMMON WHEAT; WILD WHEAT; ALTERNATIVE OXIDASE; HEXAPLOID WHEAT; F-1 HYBRID; RESPIRATION CAPACITY; NICOTIANA-TABACUM; NATURAL VARIATION; DURUM-WHEAT; GENES	Background: Hybrid speciation is classified into homoploid and polyploid based on ploidy level. Common wheat is an allohexaploid species that originated from a naturally occurring interploidy cross between tetraploid wheat and diploid wild wheat Aegilops tauschii Coss. Aegilops tauschii provides wide naturally occurring genetic variation. Sometimes its triploid hybrids with tetraploid wheat show the following four types of hybrid growth abnormalities: types II and III hybrid necrosis, hybrid chlorosis, and severe growth abortion. The growth abnormalities in the triploid hybrids could act as postzygotic hybridization barriers to prevent formation of hexaploid wheat. Methodology/Principal Findings: Here, we report on the geographical and phylogenetic distribution of Ae. tauschii accessions inducing the hybrid growth abnormalities and showed that they are widely distributed across growth habitats in Ae. tauschii. Molecular and cytological characterization of the type III necrosis phenotype was performed. The hybrid abnormality causing accessions were widely distributed across growth habitats in Ae. tauschii. Transcriptome analysis showed that a number of defense-related genes such as pathogenesis-related genes were highly up-regulated in the type III necrosis lines. Transmission electron microscope observation revealed that cell death occurred accompanied by generation of reactive oxygen species in leaves undergoing type III necrosis. The reduction of photosynthetic activity occurred prior to the appearance of necrotic symptoms on the leaves exhibiting hybrid necrosis. Conclusions/Significance: Taking these results together strongly suggests that an autoimmune response might be triggered by intergenomic incompatibility between the tetraploid wheat and Ae. tauschii genomes in type III necrosis, and that genetically programmed cell death could be regarded as a hypersensitive response-like cell death similar to that observed in Arabidopsis intraspecific and Nicotiana interspecific hybrids. Only Ae. tauschii accessions without such inhibiting factors could be candidates for the D-genome donor for the present hexaploid wheat.	[Mizuno, Nobuyuki; Takumi, Shigeo] Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo 657, Japan; [Hosogi, Naoki; Park, Pyoyun] Kobe Univ, Grad Sch Agr Sci, Lab Stress Cytol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Mizuno, N (corresponding author), Kobe Univ, Grad Sch Agr Sci, Lab Plant Genet, Kobe, Hyogo 657, Japan.	takumi@kobe-u.ac.jp		Hosogi, Naoki/0000-0001-6662-1940	Ministry of Education, Culture, Sports, Science and Technology of Japan [21380005]; Ministry of Agriculture, Forestry and Fisheries of Japan [TRC-1003)]; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Basic Research B, No. 21380005) and from the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics for Agricultural Innovation, TRC-1003) to ST, and by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, MOL PLANT, V2, P32, DOI 10.1093/mp/ssn075; Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bomblies K, 2007, NAT REV GENET, V8, P382, DOI 10.1038/nrg2082; Chu CG, 2006, THEOR APPL GENET, V112, P1374, DOI 10.1007/s00122-006-0239-9; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; DHALIWAL H S, 1986, Wheat Information Service, P27; Dilkes BP, 2008, PLOS BIOL, V6, P2707, DOI 10.1371/journal.pbio.0060308; DIXON WJ, 1990, BMDP STATISTICAL SOF, V1, P339; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Dvorak J, 1998, THEOR APPL GENET, V97, P657, DOI 10.1007/s001220050942; Gehring M, 2004, PLANT CELL, V16, pS203, DOI 10.1105/tpc.017988; HERMSEN JGT, 1972, EUPHYTICA, V21, P204, DOI 10.1007/BF00036760; Hori K, 2003, THEOR APPL GENET, V107, P806, DOI 10.1007/s00122-003-1342-9; Jeuken MJW, 2009, PLANT CELL, V21, P3368, DOI 10.1105/tpc.109.070334; Jwa NS, 2006, PLANT PHYSIOL BIOCH, V44, P261, DOI 10.1016/j.plaphy.2006.06.010; Kawaura K, 2008, FUNCT INTEGR GENOMIC, V8, P277, DOI 10.1007/s10142-008-0076-9; KIHARA H, 1949, P 8 INT C GEN HER S, P307; Kihara H, 1944, AGR HORTIC, V19, P889; Krattinger SG, 2009, SCIENCE, V323, P1360, DOI 10.1126/science.1166453; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LIN BY, 1984, GENETICS, V107, P103; Masuda Y, 2007, PLANT CELL REP, V26, P1595, DOI 10.1007/s00299-007-0352-5; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Matsuoka Y, 2007, THEOR APPL GENET, V115, P509, DOI 10.1007/s00122-007-0584-3; Matsuoka Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003138; Matsuoka Y, 2009, PLANT SYST EVOL, V279, P233, DOI 10.1007/s00606-009-0159-7; McFadden E.S., 1944, REC GENET SOC AM, V13, P26; Mino M, 2002, PLANT PHYSIOL, V130, P1776, DOI 10.1104/pp.006023; Mizuno N, 2010, MOL ECOL, V19, P999, DOI 10.1111/j.1365-294X.2010.04537.x; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Murray JW, 2006, TRENDS PLANT SCI, V11, P152, DOI 10.1016/j.tplants.2006.01.007; NISHIKAWA K, 1962, JPN J GENET, V37, P227, DOI 10.1266/jjg.37.227; NISHIKAWA K., 1962, SEIKEN ZIHO, V14, P45; NISHIKAWA KOZO, 1960, SEIKEN ZIHO, V11, P21; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; RILEY R, 1958, NATURE, V182, P713, DOI 10.1038/182713a0; Shinogi Takeshi, 2003, Journal of General Plant Pathology, V69, P7, DOI 10.1007/s10327-002-0013-z; Sugie A, 2007, GENES GENET SYST, V82, P231, DOI 10.1266/ggs.82.231; Sugie A, 2006, GENES GENET SYST, V81, P349, DOI 10.1266/ggs.81.349; Takumi S, 2002, GENES GENET SYST, V77, P81, DOI 10.1266/ggs.77.81; Takumi S, 2009, PLANT BREEDING, V128, P585, DOI 10.1111/j.1439-0523.2009.01630.x; Takumi S, 2009, BREEDING SCI, V59, P579, DOI 10.1270/jsbbs.59.579; Tsunewaki K., 1970, Seiken Ziho, P67; TSUNEWAKI K, 1992, GENOME, V35, P594, DOI 10.1139/g92-089; TSUNEWAKI K, 1966, JPN J BOT, V19, P175; TSUNEWAKI K, 1961, WHEAT INFORM SERV, V12, P1; TSUNEWAKI KOICHIRO, 1960, JAPANESE JOUR GENETICS, V35, P71, DOI 10.1266/jjg.35.71; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681	50	54	54	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11326	10.1371/journal.pone.0011326	http://dx.doi.org/10.1371/journal.pone.0011326			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593003	Green Submitted, Green Published, gold			2022-12-27	WOS:000279140800023
J	Dieng, H; Saifur, RGM; Abu Hassan, A; Salmah, MRC; Boots, M; Satho, T; Jaal, Z; AbuBakar, S				Dieng, Hamady; Saifur, Rahman G. M.; Abu Hassan, Ahmad; Salmah, M. R. Che; Boots, Michael; Satho, Tomomitsu; Jaal, Zairi; AbuBakar, Sazaly			Indoor-Breeding of Aedes albopictus in Northern Peninsular Malaysia and Its Potential Epidemiological Implications	PLOS ONE			English	Article							DENGUE TRANSMISSION; JAPANESE ENCEPHALITIS; ACTIVITY PATTERNS; VIRUS-INFECTION; HOST-SEEKING; PUERTO-RICO; AEGYPTI; MOSQUITO; DIPTERA; CULICIDAE	Background: The mosquito Ae. albopictus is usually adapted to the peri-domestic environment and typically breeds outdoors. However, we observed its larvae in most containers within homes in northern peninsular Malaysia. To anticipate the epidemiological implications of this indoor-breeding, we assessed some fitness traits affecting vectorial capacity during colonization process. Specifically, we examined whether Ae. albopictus exhibits increased survival, gonotrophic activity and fecundity due to the potential increase in blood feeding opportunities. Methodology/Principal Findings: In a series of experiments involving outdoors and indoors breeding populations, we found that Ae. albopictus lives longer in the indoor environment. We also observed increased nighttime biting activity and lifetime fecundity in indoor/domestic adapted females, although they were similar to recently colonized females in body size. Conclusion/Significance: Taken together these data suggest that accommodation of Ae. albopictus to indoor/domestic environment may increase its lifespan, blood feeding success, nuisance and thus vectorial capacity (both in terms of increased vector-host contacts and vector population density). These changes in the breeding behavior of Ae. albopictus, a potential vector of several human pathogens including dengue viruses, require special attention.	[Dieng, Hamady; Saifur, Rahman G. M.; Abu Hassan, Ahmad; Salmah, M. R. Che; Jaal, Zairi] Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia; [Boots, Michael] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Satho, Tomomitsu] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka 81401, Japan; [AbuBakar, Sazaly] Univ Malaya, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Sains Malaysia; University of Sheffield; Fukuoka University; Universiti Malaya	Dieng, H (corresponding author), Univ Sains Malaysia, Sch Biol Sci, George Town, Malaysia.	hamachan1@yahoo.com	abubakar, sazaly/B-3957-2010; ahmad, abuhassan/E-5918-2013; Ahmad, Abu Hassan/C-2706-2011	abubakar, sazaly/0000-0002-9267-1420; 	RU [1001/229/29301/CIPS/AUPE001];  [07-05-16-MG1-GMB15];  [1001/PBIOLOGI/842004]	RU; ; 	The research was partially funded by grants 07-05-16-MG1-GMB15, 1001/PBIOLOGI/842004 and fellowship grant #RU:1001/229/29301/CIPS/AUPE001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F., 2006, American Journal of Environmental Sciences, V2, P121, DOI 10.3844/ajessp.2006.121.128; Ali M, 2003, AM J TROP MED HYG, V69, P634, DOI 10.4269/ajtmh.2003.69.634; Almeida APG, 2005, J MED ENTOMOL, V42, P419, DOI 10.1603/0022-2585(2005)042[0419:BAVCOA]2.0.CO;2; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Briegel H, 2001, J MED ENTOMOL, V38, P566, DOI 10.1603/0022-2585-38.4.566; Burke DS, 2001, FIELDS VIROLOGY, P1043, DOI 10.1093/emboj/cdg270; CHADEE DD, 1990, ANN TROP MED PARASIT, V84, P429, DOI 10.1080/00034983.1990.11812492; Chadee DD, 2002, J VECTOR ECOL, V27, P172; Chadee DD, 2000, J VECTOR ECOL, V25, P158; CHAN KL, 1971, B WORLD HEALTH ORGAN, V44, P629; Chow VTK, 1998, AM J TROP MED HYG, V58, P578, DOI 10.4269/ajtmh.1998.58.578; Clements A. N., 1992, BIOL MOSQUITOES, V1; CLEMENTS AN, 1999, BIOL MOSQUITOES, V2, pR16; Deen JL, 2004, TROP MED INT HEALTH, V9, P1, DOI 10.1046/j.1365-3156.2003.01159.x; DYE C, 1992, ANNU REV ENTOMOL, V37, P1, DOI 10.1146/annurev.en.37.010192.000245; Effler PV, 2005, EMERG INFECT DIS, V11, P742; FAY R. W., 1966, MOSQUITO NEWS, V26, P531; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303; GOH K T, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P295; GOMA LKH, 1966, MOSQUITOES; Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130; Guzman Maria G, 2004, Expert Rev Anti Infect Ther, V2, P895, DOI 10.1586/14789072.2.6.895; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Huang KJ, 2000, J GEN VIROL, V81, P2177, DOI 10.1099/0022-1317-81-9-2177; Hurd H, 2001, P ROY SOC B-BIOL SCI, V268, P1749, DOI 10.1098/rspb.2001.1729; Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2; KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Leisnham PT, 2008, J MED ENTOMOL, V45, P210, DOI 10.1603/0022-2585(2008)45[210:GVIASA]2.0.CO;2; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Makiya K., 1968, Japanese Journal of Sanitary Zoology, V19, P223; MCCRAE AWR, 1983, ANN TROP MED PARASIT, V77, P615, DOI 10.1080/00034983.1983.11811761; Mitchell C. J., 1995, Parassitologia (Rome), V37, P109; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; NAYAR JK, 1975, J INSECT PHYSIOL, V21, P1965, DOI 10.1016/0022-1910(75)90229-2; Nur AH, 2008, TROP BIOMED, V25, P117; Pang TK, 2003, CURR OPIN BIOTECH, V14, P332, DOI 10.1016/S0958-1669(03)00061-2; Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2; Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378; Preechaporn W., 2006, Dengue Bulletin, V30, P204; REISEN W K, 1989, Bulletin of the Society for Vector Ecology, V14, P67; Reisen WK, 2003, WAG UR FRON, V2, P25; REITER P, 1986, J AM MOSQUITO CONTR, V2, P219; Ritchie SA, 2003, J MED ENTOMOL, V40, P249, DOI 10.1603/0022-2585-40.3.249; RODRIGUEZFIGUEROA L, 1995, AM J TROP MED HYG, V52, P496, DOI 10.4269/ajtmh.1995.52.496; ROITBERG BD, 1993, NATURE, V364, P108, DOI 10.1038/364108a0; ROSEN L, 1987, AM J TROP MED HYG, V37, P398; ROSEN L, 1985, AM J TROP MED HYG, V34, P603, DOI 10.4269/ajtmh.1985.34.603; Rozilawati H, 2007, TROP BIOMED, V24, P83; RUDNICK A, 1965, BRIT MED J, V1, P1269, DOI 10.1136/bmj.1.5445.1269; Savage HM, 2008, J MED ENTOMOL, V45, P276, DOI 10.1603/0022-2585(2008)45[276:HHHAPA]2.0.CO;2; SOTA T, 1992, J MED ENTOMOL, V29, P296, DOI 10.1093/jmedent/29.2.296; *STAT SPSS INC, 2004, SYST 11 SOFTW; Sumanochitrapon W, 1998, AM J TROP MED HYG, V58, P283, DOI 10.4269/ajtmh.1998.58.283; Sumba Leunita A, 2004, J Circadian Rhythms, V2, P6, DOI 10.1186/1740-3391-2-6; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x; Thavara U, 2001, J VECTOR ECOL, V26, P172; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; WATERMAN SH, 1985, AM J TROP MED HYG, V34, P625, DOI 10.4269/ajtmh.1985.34.625; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P362; *WHO, 1999, WHO REG PUBL SEARO, V29; Woke PA, 1937, AM J HYG, V25, P372, DOI 10.1093/oxfordjournals.aje.a118313; 1992, WKLY EPIDEMIOL REC, V67, P99	68	66	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e11790	10.1371/journal.pone.0011790	http://dx.doi.org/10.1371/journal.pone.0011790			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668543	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000280371800004
J	Fonseca, MGP; Forsythe, S; Menezes, A; Vuthoori, S; Possas, C; Veloso, V; Lucena, FD; Stover, J				Fonseca, Maria Goretti P.; Forsythe, Steven; Menezes, Alexandre; Vuthoori, Shilpa; Possas, Cristina; Veloso, Valdilea; Lucena, Francisca de Fatima; Stover, John			Modeling HIV Vaccines in Brazil: Assessing the Impact of a Future HIV Vaccine on Reducing New Infections, Mortality and Number of People Receiving ARV	PLOS ONE			English	Article							RISK BEHAVIOR-CHANGE; TRANSMISSION; COUNTRIES; EPIDEMIC; EXAMPLE	Background: The AIDS epidemic in Brazil remains concentrated in populations with high vulnerability to HIV infection, and the development of an HIV vaccine could make an important contribution to prevention. This study modeled the HIV epidemic and estimated the potential impact of an HIV vaccine on the number of new infections, deaths due to AIDS and the number of people receiving ARV treatment, under various scenarios. Methods and Findings: The historical HIV prevalence was modeled using Spectrum and projections were made from 2010 to 2050 to study the impact of an HIV vaccine with 40% to 70% efficacy, and 80% coverage of adult population, specific groups such as MSM, IDU, commercial sex workers and their partners, and 15 year olds. The possibility of disinhibition after vaccination, neglecting medium-and high-risk groups, and a disease-modifying vaccine were also considered. The number of new infections and deaths were reduced by 73% and 30%, respectively, by 2050, when 80% of adult population aged 1549 was vaccinated with a 40% efficacy vaccine. Vaccinating medium-and high-risk groups reduced new infections by 52% and deaths by 21%. A vaccine with 70% efficacy produced a great decline in new infections and deaths. Neglecting medium-and high-risk population groups as well as disinhibition of vaccinated population reduced the impact or even increased the number of new infections. Disease-modifying vaccine also contributed to reducing AIDS deaths, the need for ART and new HIV infections. Conclusions: Even in a country with a concentrated epidemic and high levels of ARV coverage, such as Brazil, moderate efficacy vaccines as part of a comprehensive package of treatment and prevention could have a major impact on preventing new HIV infections and AIDS deaths, as well as reducing the number of people on ARV. Targeted vaccination strategies may be highly effective and cost-beneficial.	[Fonseca, Maria Goretti P.; Veloso, Valdilea] Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Forsythe, Steven; Stover, John] Futures Inst, Glastonbury, CT USA; [Menezes, Alexandre] Int AIDS Vaccine Initiat, New York, NY USA; [Vuthoori, Shilpa] Rabin Strateg Partners, New York, NY USA; [Possas, Cristina] Minist Saude, Dept DST AIDS & Hepatites Virais, Brasilia, DF, Brazil; [Lucena, Francisca de Fatima] Minist Desenvolvimento Social & Combate Fome, Brasilia, DF, Brazil	Fundacao Oswaldo Cruz; International AIDS Vaccine Initiative	Fonseca, MGP (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil.	gorettifonseca@fiocruz.br	Veloso, Valdilea Gonçalves/J-6189-2012; Forsythe, Steven/AAL-7558-2020; Possas, Cristina/AAJ-3840-2020	Forsythe, Steven/0000-0002-4409-5991; 	International AIDS Vaccine Initiative	International AIDS Vaccine Initiative	The authors acknowledge the International AIDS Vaccine Initiative for financially supporting this study as part of its Impact Modeling Project, which was made possible by the generous support of the American people through the United States for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. The funding sources had no involvement in the study design, in the collection, analysis, and interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.	Anderson R, 2005, J INFECT DIS, V191, pS85, DOI 10.1086/425267; Andersson KM, 2007, JAIDS-J ACQ IMM DEF, V46, P78; BARTHJONES DC, 2002, P INT C HLTH SCI SIM; BLOWER SM, 1994, SCIENCE, V265, P1451, DOI 10.1126/science.8073289; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; BLOWER SM, 2003, AID SCI, V3, P21; Bollinger LA, 2008, AIDS, V22, pS51, DOI 10.1097/01.aids.0000327623.31856.45; *BRAS MIN SAUD SEC, 2010, NUM PAC TER ANT REG; Chor Dóra, 2005, Cad. Saúde Pública, V21, P1586, DOI 10.1590/S0102-311X2005000500033; Edwards DM, 1998, INTERFACES, V28, P144, DOI 10.1287/inte.28.3.144; Fonseca MGP, 2007, CAD SAUDE PUBLICA, V23, pS333, DOI 10.1590/S0102-311X2007001500002; Gray RH, 2003, AIDS, V17, P1941, DOI 10.1097/00002030-200309050-00013; Hacker Mariana A., 2006, Cad. Saúde Pública, V22, P751, DOI 10.1590/S0102-311X2006000400014; *INT AIDS VACC IN, 2006, 8 INT AIDS VACC INT; *INT AIDS VACC IN, 2005, 5 INT AIDS VACC IN; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P197, DOI 10.1590/S1415-790X2002000200007; MELLO MB, 2008, ASSESSMENT RISK FACT; *MIN SAUD SECR POL, 2000, SER AV PN DST AIDS, V4; *MIN SAUD SECR POL, 2001, SER AV MIN SAUD, V8; *MIN SAUD SECR POL, 2001, SER AV MIN SAUD, V6; *MIN SAUD SECR POL, 2002, SER EST PESQ AV, V2; *MIN SAUD SECR POL, 2004, SER EST PESQ AV, V7; *MIN SAUD SECR VIG, 2005, PCAP PESQ CONH AT PR; *MIN SAUD SECR VIG, 2008, B EP AIDS DST V 01; *MIN SAUD SECR VIG, 2010, REC TER ANT AD INF P; *MIN SAUD SECR VIG, 2008, PLAN NAC ENFR EP AID; *MIN SAUD SECR VIG, 2007, REC PROF TRANSM VERT; Nagelkerke N, 2003, 2978 WORLD BANK; Osmanov S, 2005, AIDS, V19, pW1, DOI 10.1097/01.aids.0000181014.08127.a7; Owens DK, 1998, AIDS, V12, P1057, DOI 10.1097/00002030-199809000-00013; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P1; Smith RJ, 2004, LANCET INFECT DIS, V4, P636, DOI 10.1016/S1473-3099(04)01148-X; *SOC CIV BEMFAM, 1996, PROGR PESQ DEM SAUD; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; STOVER J, 2002, 2811 WORLD BANK; Stover J, 2007, HEALTH AFFAIR, V26, P1147, DOI 10.1377/hlthaff.26.4.1147; Szwarcwald Célia Landmann, 2005, Clinics, V60, P367, DOI 10.1590/S1807-59322005000500004; SZWARCWALD CL, 2006, B EPIDEMIOLOGICO AID; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; WELLER S, 2004, COCHRANE LIB	43	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11736	10.1371/journal.pone.0011736	http://dx.doi.org/10.1371/journal.pone.0011736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668523	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800011
J	Stieler, K; Fischer, N				Stieler, Kristin; Fischer, Nicole			Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; CHRONIC-FATIGUE-SYNDROME; PROSTATE-CANCER; CYTIDINE DEAMINASES; LTR-RETROTRANSPOSON; POTENT INHIBITORS; IN-VIVO; RETROVIRUS; REPLICATION; PROTEINS	Background: The human exogenous gammaretrovirus XMRV is thought to be implicated in prostate cancer and chronic fatigue syndrome. Besides pressing epidemiologic questions, the elucidation of the tissue and cell tropism of the virus, as well as its sensitivity to retroviral restriction factors is of fundamental importance. The Apobec3 (A3) proteins, a family of cytidine deaminases, are one important group of host proteins that control primary infection and efficient viral spread. Methodology/Principal Findings: Here we demonstrate that XMRV is resistant to human Apobec 3B, 3C and 3F, while being highly susceptible to the human A3G protein, a factor which is known to confer antiviral activity against most retroviruses. We show that XMRV as well as MoMLV virions package Apobec proteins independent of their specific restriction activity. hA3G was found to be a potent inhibitor of XMRV as well as of MoMLV infectivity. In contrast to MoMLV, XMRV infection can also be partially reduced by low concentrations of mA3. Interestingly, established prostate cancer cell lines, which are highly susceptible to XMRV infection, do not or only weakly express hA3G. Conclusions: Our findings confirm and extend recently published data that show restriction of XMRV infection by hA3G. The results will be of value to explore which cells are infected with XMRV and efficiently support viral spread in vivo. Furthermore, the observation that XMRV infection can be reduced by mA3 is of interest with regard to the current natural reservoir of XMRV infection.	[Stieler, Kristin; Fischer, Nicole] Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Stieler, K (corresponding author), Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.	nfischer@uke.de			Wilhelm Sander Stiftung [2005/166.1]	Wilhelm Sander Stiftung	This work was supported by the Wilhelm Sander Stiftung, grant 2005/166.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudu A, 2006, CURR BIOL, V16, P1565, DOI 10.1016/j.cub.2006.06.055; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Browne EP, 2008, J VIROL, V82, P1305, DOI 10.1128/JVI.01371-07; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Chiu YL, 2006, J BIOL CHEM, V281, P8309, DOI 10.1074/jbc.R500021200; Derse D, 2007, P NATL ACAD SCI USA, V104, P2915, DOI 10.1073/pnas.0609444104; Doehle BP, 2005, J VIROL, V79, P8201, DOI 10.1128/JVI.79.13.8201-8207.2005; Doehle BP, 2006, J VIROL, V80, P12102, DOI 10.1128/JVI.01600-06; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dutko JA, 2005, CURR BIOL, V15, P661, DOI 10.1016/j.cub.2005.02.051; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Groom HC, 2010, P NATL ACAD SCI US; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Jern P, 2008, CELL HOST MICROBE, V4, P196, DOI 10.1016/j.chom.2008.08.008; Kobayashi M, 2004, J VIROL, V78, P8238, DOI 10.1128/JVI.78.15.8238-8244.2004; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; LAKER C, 1987, P NATL ACAD SCI USA, V84, P8458, DOI 10.1073/pnas.84.23.8458; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Low A, 2009, VIROLOGY, V385, P455, DOI 10.1016/j.virol.2008.11.051; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Paprotka T, 2010, J VIROL, V84, P5719, DOI 10.1128/JVI.00134-10; Refsland E. W., 2010, NUCL ACIDS RES; RODRIGUEZ JJ, 2009, J VIROL; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Stieler KSC, 2010, VIROLOGY; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Takeda E, 2008, J VIROL, V82, P10998, DOI 10.1128/JVI.01311-08; Turelli P, 2005, SCIENCE, V307, P1061, DOI 10.1126/science.1105964; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; van Kuppeveld FJM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1018; Yu Q, 2004, J BIOL CHEM, V279, P53379, DOI 10.1074/jbc.M408802200; Zhang L, 2008, VIROLOGY, V378, P69, DOI 10.1016/j.virol.2008.05.006; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	49	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11738	10.1371/journal.pone.0011738	http://dx.doi.org/10.1371/journal.pone.0011738			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668529	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800012
J	Bridge, D; Theofiles, AG; Holler, RL; Marcinkevicius, E; Steele, RE; Martinez, DE				Bridge, Diane; Theofiles, Alexander G.; Holler, Rebecca L.; Marcinkevicius, Emily; Steele, Robert E.; Martinez, Daniel E.			FoxO and Stress Responses in the Cnidarian Hydra vulgaris	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TRANSCRIPTION FACTOR FOXO3A; PROTEIN-KINASE B; GENE-EXPRESSION; CELL-CYCLE; CAENORHABDITIS-ELEGANS; STEM-CELLS; LIFE-SPAN; NURSE CELLS; GROWTH	Background: In the face of changing environmental conditions, the mechanisms underlying stress responses in diverse organisms are of increasing interest. In vertebrates, Drosophila, and Caenorhabditis elegans, FoxO transcription factors mediate cellular responses to stress, including oxidative stress and dietary restriction. Although FoxO genes have been identified in early-arising animal lineages including sponges and cnidarians, little is known about their roles in these organisms. Methods/Principal Findings: We have examined the regulation of FoxO activity in members of the well-studied cnidarian genus Hydra. We find that Hydra FoxO is expressed at high levels in cells of the interstitial lineage, a cell lineage that includes multipotent stem cells that give rise to neurons, stinging cells, secretory cells and gametes. Using transgenic Hydra that express a FoxO-GFP fusion protein in cells of the interstitial lineage, we have determined that heat shock causes localization of the fusion protein to the nucleus. Our results also provide evidence that, as in bilaterian animals, Hydra FoxO activity is regulated by both Akt and JNK kinases. Conclusions: These findings imply that basic mechanisms of FoxO regulation arose before the evolution of bilaterians and raise the possibility that FoxO is involved in stress responses of other cnidarian species, including corals.	[Bridge, Diane; Theofiles, Alexander G.; Holler, Rebecca L.] Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA; [Marcinkevicius, Emily; Martinez, Daniel E.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Steele, Robert E.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Steele, Robert E.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA	Claremont Colleges; Pomona College; University of California System; University of California Irvine; University of California System; University of California Irvine	Bridge, D (corresponding author), Elizabethtown Coll, Dept Biol, Elizabethtown, PA 17022 USA.	bridged@etown.edu		Marcinkevicius, Emily/0000-0003-3454-3719	National Science Foundation [IBN-0316065]; Elizabethtown College	National Science Foundation(National Science Foundation (NSF)); Elizabethtown College	The research described was funded by National Science Foundation grant IBN-0316065 and by an Elizabethtown College faculty grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, FEBS LETT, V399, P333, DOI 10.1016/S0014-5793(96)01370-1; Alexandrova O, 2005, DEV BIOL, V281, P91, DOI 10.1016/j.ydbio.2005.02.015; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bode HR, 1996, J CELL SCI, V109, P1155; BODE HR, 1976, J CELL SCI, V20, P29; Bode HR, 1984, PATTERN FORMATION PR, V1, P213; Bottger A, 2007, SEMIN CANCER BIOL, V17, P134, DOI 10.1016/j.semcancer.2006.11.008; BOSCH TCG, 1987, DEV BIOL, V121, P182, DOI 10.1016/0012-1606(87)90151-5; BOSCH TCG, 1988, P NATL ACAD SCI USA, V85, P7927, DOI 10.1073/pnas.85.21.7927; BOSCH TCG, 1984, DEV BIOL, V104, P161, DOI 10.1016/0012-1606(84)90045-9; Brennecke T, 1998, EUR J BIOCHEM, V255, P703, DOI 10.1046/j.1432-1327.1998.2550703.x; BRIEN PAUL, 1950, ANN SOC ROY ZOOL BELGIQUE, V81, P33; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; CAMPBELL RD, 1973, J CELL SCI, V13, P651; CAMPBELL RD, 1967, J MORPHOL, V121, P19, DOI 10.1002/jmor.1051210103; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; Cikala M, 1999, CURR BIOL, V9, P959, DOI 10.1016/S0960-9822(99)80423-0; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; DAVID CN, 1977, DEV BIOL, V58, P372, DOI 10.1016/0012-1606(77)90098-7; DAVID CN, 1974, J CELL SCI, V16, P359; DAVID CN, 1973, ROUX ARCH DEV BIOL, V171, P259, DOI 10.1007/BF00577724; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DUBEL S, 1987, DIFFERENTIATION, V35, P181, DOI 10.1111/j.1432-0436.1987.tb00167.x; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Gaillard P, 2005, J MED CHEM, V48, P4596, DOI 10.1021/jm0310986; GELLNER K, 1992, EUR J BIOCHEM, V210, P683, DOI 10.1111/j.1432-1033.1992.tb17469.x; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Grens A, 1996, DEV BIOL, V180, P473, DOI 10.1006/dbio.1996.0321; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HONEGGER TG, 1989, TISSUE CELL, V21, P381, DOI 10.1016/0040-8166(89)90052-9; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jacobs FMJ, 2003, J BIOL CHEM, V278, P35959, DOI 10.1074/jbc.M302804200; Juhasz G, 2007, CELL DEATH DIFFER, V14, P1181, DOI 10.1038/sj.cdd.4402123; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Lasi M, 2010, APOPTOSIS, V15, P269, DOI 10.1007/s10495-009-0442-7; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MARCUM BA, 1978, J CELL SCI, V32, P233; Martinez DE, 1998, EXP GERONTOL, V33, P217, DOI 10.1016/S0531-5565(97)00113-7; Martinez DE, 1997, DEV BIOL, V192, P523, DOI 10.1006/dbio.1997.8715; Miller MA, 2000, DEV BIOL, V224, P286, DOI 10.1006/dbio.2000.9786; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; OTTO JJ, 1977, J CELL SCI, V28, P117; Philipp I, 2005, GENE EXPR PATTERNS, V5, P397, DOI 10.1016/j.modgep.2004.09.007; Philipp I, 2009, P NATL ACAD SCI USA, V106, P4290, DOI 10.1073/pnas.0812847106; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Reitzel AM, 2008, BIOL BULL-US, V214, P233, DOI 10.2307/25470666; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; SENECA FO, 2009, PATTERNS GENE EXPRES; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Steele RE, 1996, DEV GENES EVOL, V206, P247, DOI 10.1007/s004270050050; SUGIYAMA T, 1978, J CELL SCI, V32, P215; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Technau U, 2003, DEV BIOL, V260, P191, DOI 10.1016/S0012-1606(03)00241-0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Voolstra CR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-627; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Weis VM, 2009, SCIENCE, V324, P1153, DOI 10.1126/science.1172540; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	86	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11686	10.1371/journal.pone.0011686	http://dx.doi.org/10.1371/journal.pone.0011686			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657733	Green Published, gold			2022-12-27	WOS:000280197500025
J	Hurtado, LA; Mateos, M; Santamaria, CA				Hurtado, Luis A.; Mateos, Mariana; Santamaria, Carlos A.			Phylogeography of Supralittoral Rocky Intertidal Ligia Isopods in the Pacific Region from Central California to Central Mexico	PLOS ONE			English	Article							GULF-OF-CALIFORNIA; BAJA-CALIFORNIA; CRYPTIC VICARIANCE; EVOLUTION; PATTERNS; DIVERGENCE; HISTORY; DIVERSIFICATION; DIFFERENTIATION; BIOGEOGRAPHY	Background: Ligia isopods are widely distributed in the Pacific rocky intertidal shores from central California to central Mexico, including the Gulf of California. Yet, their biological characteristics restrict them to complete their life cycles in a very narrow range of the rocky intertidal supralittoral. Herein, we examine phylogeographic patterns of Ligia isopods from 122 localities between central California and central Mexico. We expect to find high levels of allopatric diversity. In addition, we expect the phylogeographic patterns to show signatures of past vicariant events that occurred in this geologically dynamic region. Methodology/Principal Findings: We sequenced two mitochondrial genes (Cytochrome Oxidase I and 16S ribosomal DNA). We conducted Maximum Likelihood and Bayesian phylogenetic analyses. We found many divergent clades that, in general, group according to geography. Some of the most striking features of the Ligia phylogeographic pattern include: (1) deep mid-peninsular phylogeographic breaks on the Pacific and Gulf sides of Baja peninsula; (2) within the Gulf lineages, the northern peninsula is most closely related to the northern mainland, while the southern peninsula is most closely related to the central-southern mainland; and, (3) the southernmost portion of the peninsula (Cape Region) is most closely related to the southernmost portion of mainland. Conclusions/Significance: Our results shed light on the phylogenetic relationships of Ligia populations in the study area. This study probably represents the finest-scale phylogeographic examination for any organism to date in this region. Presence of highly divergent lineages suggests multiple Ligia species exist in this region. The phylogeographic patterns of Ligia in the Gulf of California and Baja peninsula are incongruent with a widely accepted vicariant scenario among phylogeographers, but consistent with aspects of alternative geological hypotheses and phylo- and biogeographic patterns of several other taxa. Our findings contribute to the ongoing debate regarding the geological origin of this important biogeographic region.	[Hurtado, Luis A.; Mateos, Mariana; Santamaria, Carlos A.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Hurtado, LA (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	lhurtado@tamu.edu	Hurtado, Luis A/B-5953-2008; Santamaria, Carlos A/T-9447-2017; Mateos, Mariana/B-5235-2008	Hurtado, Luis A/0000-0002-9773-4996; Santamaria, Carlos A/0000-0001-8576-463X; Mateos, Mariana/0000-0001-5738-0145	National Science Foundation (NSF) [DEB 0743782]; Texas A&M University-Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT); Texas AM University; Sloan Minority PhD Program; Hispanic Leaders in Agriculture and the Environment Program; Division Of Environmental Biology [0743782] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Texas A&M University-Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Texas AM University; Sloan Minority PhD Program; Hispanic Leaders in Agriculture and the Environment Program; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation (NSF) grant DEB 0743782 to LAH and MM, by a Texas A&M University-Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACyT) grant to LAH, and by Texas A&M University. Partial support for CAS was provided by the Sloan Minority PhD Program and by the Hispanic Leaders in Agriculture and the Environment Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1993, EVOLUTIONARY BIOL LA; Bernardi G, 2003, EVOLUTION, V57, P1599; Boyer SL, 2007, J BIOGEOGR, V34, P2070, DOI 10.1111/j.1365-2699.2007.01755.x; Brusca R.C., 1980, COMMON INTERTIDAL IN, V2nd; BRUSCA RC, 2005, BIODIVERSITY ECOSYST; Calsbeek R, 2003, MOL ECOL, V12, P1021, DOI 10.1046/j.1365-294X.2003.01794.x; Carefoot Thomas H., 1995, Crustacean Issues, V9, P47; Carreno Ana Luisa, 2002, P14; Crews SC, 2006, MOL PHYLOGENET EVOL, V38, P470, DOI 10.1016/j.ympev.2005.11.010; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; Devitt TJ, 2006, MOL ECOL, V15, P4387, DOI 10.1111/j.1365-294X.2006.03015.x; DURHAM JW, 1960, SYST ZOOL, V9, P47, DOI 10.2307/2411859; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Grismer L. Lee, 2002, Herpetological Review, V33, P15; Grismer L. Lee, 1994, Herpetological Natural History, V2, P51; Helenes J, 2009, MAR MICROPALEONTOL, V72, P10, DOI 10.1016/j.marmicro.2009.02.003; Helenes J, 1999, J S AM EARTH SCI, V12, P589, DOI 10.1016/S0895-9811(99)00042-5; Holt JW, 2000, GEOL SOC AM BULL, V112, P540, DOI 10.1130/0016-7606(2000)112<540:AACOGO>2.0.CO;2; Huang D, 2001, MAR BIOL, V138, P421, DOI 10.1007/s002270000454; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Johnson M. E., 2009, ATLAS COASTAL ECOSYS; Jung J, 2008, MOL CELLS, V25, P523; KARIG DE, 1972, EARTH PLANET SC LETT, V17, P169, DOI 10.1016/0012-821X(72)90272-5; Keen A. M., 1971, SEA SHELLS TROPICAL, VSecond; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; LARSON RL, 1968, SCIENCE, V161, P781, DOI 10.1126/science.161.3843.781; Leache AD, 2007, MOL ECOL, V16, P5216, DOI 10.1111/j.1365-294X.2007.03556.x; Leache AD, 2007, BIOL LETTERS, V3, P646, DOI 10.1098/rsbl.2007.0368; Ledesma-Vasquez J, 2002, REV MEXICANA CIENCIA, V19, P145; Ledesma-Vazquez J., 2009, ATLAS COASTAL ECOSYS; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Lindell J, 2005, MOL PHYLOGENET EVOL, V36, P682, DOI 10.1016/j.ympev.2005.04.031; Lindell J, 2006, J BIOGEOGR, V33, P1327, DOI 10.1111/j.1365-2699.2006.01532.x; Lonsdale P., 1989, E PACIFIC OCEAN HAWA, VN, P499, DOI [DOI 10.1130/DNAG-GNA-N.499, 10.1130/DNAG-GNA-N.499]; LONSDALE P, 1991, GULF PENINSULAR PROV, V47, P87, DOI DOI 10.1306/M47542C7; Maddison D. R., 2003, MACCLADE 4 ANAL PHYL; Mateos M, 2005, J BIOGEOGR, V32, P775, DOI 10.1111/j.1365-2699.2005.01236.x; McGill T., 1978, THESIS U CALIFORNIA; MILLER WE, 1980, J PALEONTOL, V54, P762; Morris R.H., 1980, INTERTIDAL INVERTEBR; Murphy Robert W., 2002, P181; MURPHY RW, 1983, OCCAS PAP CALIF ACAD, V137, P1; Oskin M, 2003, GEOLOGY, V31, P23, DOI 10.1130/0091-7613(2003)031<0023:MISWPB>2.0.CO;2; Palumbi Stephen R., 1996, P205; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Riginos C, 2005, EVOLUTION, V59, P2678; Rocha-Olivares A, 2001, MOL BIOL EVOL, V18, P1088, DOI 10.1093/oxfordjournals.molbev.a003880; SCHMALFUSS H, 2003, WORLD CATALOG TERRES; SCHOENHERR AA, 1999, NATURAL HIST ISLANDS; Schotte M., 1995, WORLD LIST MARINE FR; Schultz M, 2005, BRYOLOGIST, V108, P520, DOI 10.1639/0007-2745(2005)108[0520:PAANLS]2.0.CO;2; Sinclair EA, 2004, AM NAT, V164, P396, DOI 10.1086/381404; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Upton DE, 1997, MOL PHYLOGENET EVOL, V8, P104, DOI 10.1006/mpev.1996.0392; Willett CS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-139; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Zwickl DJ., 2006, THESIS; [No title captured]; [No title captured]; [No title captured]; [No title captured]	67	67	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11633	10.1371/journal.pone.0011633	http://dx.doi.org/10.1371/journal.pone.0011633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657776	Green Published, gold, Green Submitted			2022-12-27	WOS:000280197500011
J	Rodrigues, LA; Henriques, G; Borges, ST; Hunt, P; Sanchez, CP; Martinelli, A; Cravo, P				Rodrigues, Louise A.; Henriques, Gisela; Borges, Sofia T.; Hunt, Paul; Sanchez, Cecilia P.; Martinelli, Axel; Cravo, Pedro			Experimental Evolution of Resistance to Artemisinin Combination Therapy Results in Amplification of the mdr1 Gene in a Rodent Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PFMDR1 GENE; MEFLOQUINE RESISTANCE; DRUG-RESISTANCE; HALOFANTRINE RESISTANCE; MULTIDRUG-RESISTANCE; NORTHWESTERN BORDER; P-GLYCOPROTEIN; LUMEFANTRINE; ARTEMETHER	Background: Lacking suitable alternatives, the control of malaria increasingly depends upon Artemisinin Combination Treatments (ACT): resistance to these drugs would therefore be disastrous. For ACTs, the biology of resistance to the individual components has been investigated, but experimentally induced resistance to component drugs in combination has not been generated. Methodology/Principal Findings: We have used the rodent malaria parasite Plasmodium chabaudi to select in vivo resistance to the artesunate (ATN) + mefloquine (MF) version of ACT, through prolonged exposure of parasites to both drugs over many generations. The selection procedure was carried out over twenty-seven consecutive sub-inoculations under increasing ATN + MF doses, after which a genetically stable resistant parasite, AS-ATNMF1, was cloned. AS-ATNMF1 showed increased resistance to ATN + MF treatment and to artesunate or mefloquine administered separately. Investigation of candidate genes revealed an mdr1 duplication in the resistant parasites and increased levels of mdr1 transcripts and protein. There were no point mutations in the atpase6 or ubp1genes. Conclusion: Resistance to ACTs may evolve even when the two drugs within the combination are taken simultaneously and amplification of the mdr1 gene may contribute to this phenotype. However, we propose that other gene(s), as yet unidentified, are likely to be involved.	[Rodrigues, Louise A.; Henriques, Gisela; Borges, Sofia T.; Martinelli, Axel; Cravo, Pedro] Ctr Malaria & Outras Doencas Trop IHMT UNL, UEI Biol Mol, UEI Malaria, Lisbon, Portugal; [Hunt, Paul] Univ Edinburgh, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh, Midlothian, Scotland; [Sanchez, Cecilia P.] Univ Klinikum Heidelberg, Abt Parasitol, Inst Hyg, Heidelberg, Germany	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; University of Edinburgh; Ruprecht Karls University Heidelberg	Rodrigues, LA (corresponding author), Ctr Malaria & Outras Doencas Trop IHMT UNL, UEI Biol Mol, UEI Malaria, Lisbon, Portugal.	pcravo@ihmt.unl.pt	Cravo, Pedro VL/G-3532-2012; Cravo, Pedro/AET-0639-2022	Cravo, Pedro VL/0000-0003-1675-4504; Cravo, Pedro/0000-0003-1675-4504; Rodrigues, Louise/0000-0002-8354-2686	FCT/MCTES of Portugal through FEDER [PTDC/SAL/MII/65028/2006]; MRC [G0400476] Funding Source: UKRI; Medical Research Council [G0400476] Funding Source: researchfish	FCT/MCTES of Portugal through FEDER(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by FCT/MCTES of Portugal (www.fct.mctes.pt), through FEDER, project ref. PTDC/SAL/MII/65028/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso A, 2006, ANTIMICROB AGENTS CH, V50, P480, DOI 10.1128/AAC.50.2.480-489.2006; Carlton JMR, 2001, TRENDS PARASITOL, V17, P236, DOI 10.1016/S1471-4922(01)01899-2; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; CHAVCHICH M, 2010, ANTIMICROB AGENTS CH, V29; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; COWMAN AF, 1994, P NATL ACAD SCI USA, V91, P1143, DOI 10.1073/pnas.91.3.1143; Cravo PVL, 2003, ANTIMICROB AGENTS CH, V47, P709, DOI 10.1128/AAC.47.2.709-718.2003; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Ferreira ID, 2004, MOL BIOCHEM PARASIT, V136, P43, DOI 10.1016/j.molbiopara.2004.02.008; Hayton K, 2002, ANTIMICROB AGENTS CH, V46, P2482, DOI 10.1128/AAC.46.8.2482-2489.2002; Hunt P, 2007, MOL MICROBIOL, V65, P27, DOI 10.1111/j.1365-2958.2007.05753.x; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Lim P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Noedl H, 2009, NEW ENGL J MED, V361, P540, DOI 10.1056/NEJMc0900231; PEEL SA, 1994, AM J TROP MED HYG, V51, P648, DOI 10.4269/ajtmh.1994.51.648; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 2006, CLIN INFECT DIS, V42, P1570, DOI 10.1086/503423; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; ROSARIO V, 1981, SCIENCE, V212, P1037, DOI 10.1126/science.7015505; Schlagenhauf P, 2009, EXPERT REV ANTI-INFE, V7, P1039, DOI 10.1586/ERI.09.85; Sidhu ABS, 2006, J INFECT DIS, V194, P528, DOI 10.1086/507115; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Uhlemann AC, 2005, NAT STRUCT MOL BIOL, V12, P628, DOI 10.1038/nsmb947; Uhlemann AC, 2007, J INFECT DIS, V195, P134, DOI 10.1086/509809; Vinayak S, 2010, J INFECT DIS, V201, P1551, DOI 10.1086/651949; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHITE NJ, 1991, ACT LEIDENS, V60, P141; WHO, 2006, WHO GUID TREATM MAL; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S; Wongsrichanalai Chansuda, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P41; Yeung S, 2005, TROP MED INT HEALTH, V10, P121, DOI 10.1111/j.1365-3156.2004.01364.x; Zhang ZG, 2004, MOL PHARMACOL, V66, P395, DOI 10.1124/mol.104.001966	38	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11593	10.1371/journal.pone.0011593	http://dx.doi.org/10.1371/journal.pone.0011593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657645	Green Published, gold, Green Submitted			2022-12-27	WOS:000279924500004
J	Marin, I				Marin, Ignacio			Diversification and Specialization of Plant RBR Ubiquitin Ligases	PLOS ONE			English	Article							LINEAGE-SPECIFIC EXPANSION; GENE FAMILY; COMPARATIVE GENOMICS; ARABIDOPSIS; EXPRESSION; RING; PROTEINS; COMPLEX; PARKIN; DESTRUCTION	Background: RBR ubiquitin ligases are components of the ubiquitin-proteasome system present in all eukaryotes. They are characterized by having the RBR (RING-IBR-RING) supradomain. In this study, the patterns of emergence of RBR genes in plants are described. Methodology/Principal Findings: Phylogenetic and structural data confirm that just four RBR subfamilies (Ariadne, ARA54, Plant I/Helicase and Plant II) exist in viridiplantae. All of them originated before the split that separated green algae from the rest of plants. Multiple genes of two of these subfamilies (Ariadne and Plant II) appeared in early plant evolution. It is deduced that the common ancestor of all plants contained at least five RBR genes and the available data suggest that this number has been increasing slowly along streptophyta evolution, although losses, especially of Helicase RBR genes, have also occurred in several lineages. Some higher plants (e. g. Arabidopsis thaliana, Oryza sativa) contain a very large number of RBR genes and many of them were recently generated by tandem duplications. Microarray data indicate that most of these new genes have low-level and sometimes specific expression patterns. On the contrary, and as occurs in animals, a small set of older genes are broadly expressed at higher levels. Conclusions/Significance: The available data suggests that the dynamics of appearance and conservation of RBR genes is quite different in plants from what has been described in animals. In animals, an abrupt emergence of many structurally diverse RBR subfamilies in early animal history, followed by losses of multiple genes in particular lineages, occurred. These patterns are not observed in plants. It is also shown that while both plants and animals contain a small, similar set of essential RBR genes, the rest evolves differently. The functional implications of these results are discussed.	CSIC, Inst Biomed Valencia, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Marin, I (corresponding author), CSIC, Inst Biomed Valencia, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009	Marin, Ignacio/0000-0002-1315-8961	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion. Spain [BIO2008-05067]	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion. Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grant BIO2008-05067 (Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion. Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascencio-Ibanez JT, 2008, PLANT PHYSIOL, V148, P436, DOI 10.1104/pp.108.121038; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Eisenhaber B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-209; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gingerich DJ, 2007, PLANT CELL, V19, P2329, DOI 10.1105/tpc.107.051300; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haerizadeh F, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-25; Hanada K, 2008, PLANT PHYSIOL, V148, P993, DOI 10.1104/pp.108.122457; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Kraft E, 2005, PLANT PHYSIOL, V139, P1597, DOI 10.1104/pp.105.067983; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Marin I, 2009, J MOL EVOL, V69, P54, DOI 10.1007/s00239-009-9252-3; Marrocco K, 2003, PLANT MOL BIOL, V52, P715, DOI 10.1023/A:1025056008926; Mladek C, 2003, PLANT PHYSIOL, V131, P27, DOI 10.1104/pp.012781; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Paterson AH, 2006, TRENDS GENET, V22, P597, DOI 10.1016/j.tig.2006.09.003; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Sokal R. R., 1981, BIOMETRY; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; SWOFFORD DL, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Xu GX, 2009, P NATL ACAD SCI USA, V106, P835, DOI 10.1073/pnas.0812043106; Yang XH, 2008, PLANT PHYSIOL, V148, P1189, DOI 10.1104/pp.108.121921; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	44	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11579	10.1371/journal.pone.0011579	http://dx.doi.org/10.1371/journal.pone.0011579			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644651	gold, Green Published			2022-12-27	WOS:000279884900018
J	Stachon, P; Missiou, A; Walter, C; Varo, N; Colberg, C; Wolf, D; Buchner, M; von zur Muhlen, C; Zirlik, K; Bode, C; Zirlik, A				Stachon, Peter; Missiou, Anna; Walter, Carina; Varo, Nerea; Colberg, Christian; Wolf, Dennis; Buchner, Maike; von zur Muehlen, Constantin; Zirlik, Katja; Bode, Christoph; Zirlik, Andreas			Tumor Necrosis Factor Receptor Associated Factor 6 Is Not Required for Atherogenesis in Mice and Does Not Associate with Atherosclerosis in Humans	PLOS ONE			English	Article							FACTOR-KAPPA-B; SIGNALING PATHWAY; APOLIPOPROTEIN-E; DEFICIENT MICE; CD40 LIGAND; DEFECTIVE INTERLEUKIN-1; REDUCES ATHEROSCLEROSIS; FACTORS TRAFS; ACTIVATION; CELLS	Background: Tumor necrosis factor receptor-associated factors (TRAFs) are important signaling molecules for a variety of pro-atherogenic cytokines including CD40L, TNF alpha, and IL1 beta. Several lines of evidence identified TRAF6 as a pro-inflammatory signaling molecule in vitro and we previously demonstrated overexpression of TRAF6 in human and Murine atherosclerotic plaques. This study investigated the role of TRAF6-deficiency in mice developing atherosclerosis, a chronic inflammatory disease. Methodology/Principal Findings: Lethally irradiated low density lipoprotein receptor-deficient mice (TRAF6(+/+)/LDLR(-/-)) were reconstituted with TRAF6-deficient fetal liver cells (FLC) and consumed high cholesterol diet for 18 weeks to assess the relevance of TRAF6 in hematopoietic cells for atherogenesis. Additionally, TRAF6(+/-)/LDLR(-/-) mice received TRAF6-deficient FLC to gain insight into the role of TRAF6 deficiency in resident cells. Surprisingly, atherosclerotic lesion size did not differ between the three groups in both aortic roots and abdominal aortas. Similarly, no significant differences in plaque composition could be observed as assessed by immunohistochemistry for macrophages, lipids, smooth muscle cells, T-cells, and collagen. In accord, in a small clinical study TRAF6/GAPDH total blood RNA ratios did not differ between groups of patients with stable coronary heart disease (0.034 +/- 0.0021, N = 178), acute coronary heart disease (0.029 +/- 0.0027, N = 70), and those without coronary heart disease (0.032 +/- 0.0016, N = 77) as assessed by angiography. Conclusion: Our study demonstrates that TRAF6 is not required for atherogenesis in mice and does not associate with clinical disease in humans. These data suggest that pro- and anti-inflammatory features of TRAF6 signaling outweigh each other in the context of atherosclerosis.	[Stachon, Peter; Missiou, Anna; Walter, Carina; Colberg, Christian; Wolf, Dennis; von zur Muehlen, Constantin; Bode, Christoph; Zirlik, Andreas] Univ Freiburg, Dept Cardiol, Freiburg, Germany; [Missiou, Anna; Zirlik, Andreas] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Missiou, Anna] Univ Freiburg, Fac Biol, Freiburg, Germany; [Varo, Nerea] Univ Navarra, Dept Clin Chem, E-31080 Pamplona, Spain; [Buchner, Maike; Zirlik, Katja] Univ Freiburg, Dept Hematol & Oncol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Navarra; University of Freiburg	Stachon, P (corresponding author), Univ Freiburg, Dept Cardiol, Freiburg, Germany.	andreas.zirlik@uniklinik-freiburg.de	Zirlik, Andreas/A-6400-2011; Wolf, Dennis/S-9217-2018; Wolf, Dennis/G-8299-2012; Varo, Nerea/AAB-3569-2019	Zirlik, Andreas/0000-0001-6290-3297; Wolf, Dennis/0000-0003-1525-4348; Varo, Nerea/0000-0002-2362-9472	German Research Foundation [DFG ZI743/3-1, 3-2, DFG GSC-4]	German Research Foundation(German Research Foundation (DFG))	This work was supported by research grants from the German Research Foundation to AZ (DFG ZI743/3-1 and 3-2). AM was partly funded by the Excellence Initiative of the German Research Foundation (DFG GSC-4, Spemann Graduate School). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2005, SCIENCE, V308, P248, DOI 10.1126/science.1105677; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bavendiek U, 2005, ARTERIOSCL THROM VAS, V25, P1244, DOI 10.1161/01.ATV.0000161420.55482.ef; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Branen L, 2004, ARTERIOSCL THROM VAS, V24, P2137, DOI 10.1161/01.ATV.0000143933.20616.1b; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Funakoshi-Tago M, 2008, CELL SIGNAL, V20, P1679, DOI 10.1016/j.cellsig.2008.05.013; Gohda J, 2004, J IMMUNOL, V173, P2913, DOI 10.4049/jimmunol.173.5.2913; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Kawai T, 2000, NAT MED, V6, P114, DOI 10.1038/72162; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Kobayashi N, 2001, EMBO J, V20, P1271, DOI 10.1093/emboj/20.6.1271; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lloyd-Jones D., CIRCULATION, V121, pe46; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; LUTGENS E, J EXP MED, V207, P391; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Miyahara T, 2004, CARDIOVASC RES, V64, P154, DOI 10.1016/j.cardiores.2004.06.014; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Schiller NK, 2001, ARTERIOSCL THROM VAS, V21, P1674, DOI 10.1161/hq1001.096724; Schonbeck U, 2000, P NATL ACAD SCI USA, V97, P7458, DOI 10.1073/pnas.97.13.7458; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; TANGIRALA RK, 1995, J LIPID RES, V36, P2320; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Xu LG, 2004, J BIOL CHEM, V279, P17278, DOI 10.1074/jbc.C400063200; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888; Zirlik A, 2007, ARTERIOSCL THROM VAS, V27, P1101, DOI 10.1161/ATVBAHA.107.140566; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	36	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11589	10.1371/journal.pone.0011589	http://dx.doi.org/10.1371/journal.pone.0011589			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644648	gold, Green Published, Green Submitted			2022-12-27	WOS:000279884900024
J	Kashiyama, T; Murayama, T; Suzuki, E; Allen, PD; Ogawa, Y				Kashiyama, Taku; Murayama, Takashi; Suzuki, Erika; Allen, Paul D.; Ogawa, Yasuo			Frog alpha- and beta-Ryanodine Receptors Provide Distinct Intracellular Ca2+ Signals in a Myogenic Cell Line	PLOS ONE			English	Article							CHICKEN SKELETAL-MUSCLE; INDUCED CALCIUM-RELEASE; MICE LACKING; SARCOPLASMIC-RETICULUM; PROTEIN ISOFORMS; SPARKS; EXPRESSION; CHANNELS; FIBERS; GENERATION	Background: In frog skeletal muscle, two ryanodine receptor (RyR) isoforms, alpha-RyR and beta-RyR, are expressed in nearly equal amounts. However, the roles and significance of the two isoforms in excitation-contraction (E-C) coupling remains to be elucidated. Methodology/Principal Findings: In this study, we expressed either or both alpha-RyR and beta-RyR in 1B5 RyR-deficient myotubes using the herpes simplex virus 1 helper-free amplicon system. Immunological characterizations revealed that alpha-RyR and beta-RyR are appropriately expressed and targeted at the junctions in 1B5 myotubes. In Ca2+ imaging studies, each isoform exhibited caffeine-induced Ca2+ transients, an indicative of Ca2+-induced Ca2+ release (CICR). However, the fashion of Ca2+ release events was fundamentally different: alpha-RyR mediated graded and sustained Ca2+ release observed uniformly throughout the cytoplasm, whereas beta-RyR supported all-or-none type regenerative Ca2+ oscillations and waves. alpha-RyR but not beta-RyR exhibited Ca2+ transients triggered by membrane depolarization with high [K+](o) that were nifedipine-sensitive, indicating that only alpha-RyR mediates depolarization-induced Ca2+ release. Myotubes co-expressing alpha-RyR and beta-RyR demonstrated high [K+](o)-induced Ca2+ transients which were indistinguishable from those with myotubes expressing alpha-RyR alone. Furthermore, procaine did not affect the peak height of high [K+](o)-induced Ca2+ transients, suggesting minor amplification of Ca2+ release by beta-RyR via CICR in 1B5 myotubes. Conclusions/Significance: These findings suggest that alpha-RyR and beta-RyR provide distinct intracellular Ca2+ signals in a myogenic cell line. These distinct properties may also occur in frog skeletal muscle and will be important for E-C coupling.	[Kashiyama, Taku; Murayama, Takashi; Suzuki, Erika; Ogawa, Yasuo] Juntendo Univ, Sch Med, Dept Pharmacol, Tokyo 113, Japan; [Allen, Paul D.] Brigham & Womens Hosp, Dept Anesthesia Perioperat & Pain Med, Boston, MA 02115 USA	Juntendo University; Harvard University; Brigham & Women's Hospital	Kashiyama, T (corresponding author), Juntendo Univ, Sch Med, Dept Pharmacol, Tokyo 113, Japan.	takashim@juntendo.ac.jp			Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science; National Institutes of Health (NIH) [R01 AR43140]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140] Funding Source: NIH RePORTER	Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by Grants-in-Aid for Scientific Research, Japan Society for Promotion of Science and National Institutes of Health (NIH) R01 AR43140 (PDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIREY JA, 1993, DEV DYNAM, V197, P189, DOI 10.1002/aja.1001970304; AIREY JA, 1990, J BIOL CHEM, V265, P14187; Brum G, 2003, BIOPHYS J, V85, P245, DOI 10.1016/S0006-3495(03)74470-1; Chawla S, 2001, J PHYSIOL-LONDON, V536, P351, DOI 10.1111/j.1469-7793.2001.0351c.xd; Cheng H, 1996, AM J PHYSIOL-CELL PH, V270, pC148; Cheng H, 1996, CELL CALCIUM, V20, P129, DOI 10.1016/S0143-4160(96)90102-5; Chugun A, 2003, AM J PHYSIOL-REG I, V285, pR601, DOI 10.1152/ajpregu.00419.2002; Conklin MW, 2000, BIOPHYS J, V78, P1777, DOI 10.1016/S0006-3495(00)76728-2; ENDO M, 1977, PHYSIOL REV, V57, P71, DOI 10.1152/physrev.1977.57.1.71; ENDO M, 1981, MECHANISM GATED CALC, P257; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; Felder E, 2002, P NATL ACAD SCI USA, V99, P1695, DOI 10.1073/pnas.032657599; Fessenden JD, 2000, BIOPHYS J, V79, P2509, DOI 10.1016/S0006-3495(00)76492-7; Franck JPC, 1998, AM J PHYSIOL-CELL PH, V275, pC401, DOI 10.1152/ajpcell.1998.275.2.C401; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gonzalez A, 2000, J GEN PHYSIOL, V115, P139, DOI 10.1085/jgp.115.2.139; HEISTRACHER P, 1969, J PHYSIOL-LONDON, V201, P627, DOI 10.1113/jphysiol.1969.sp008776; HODGKIN AL, 1960, J PHYSIOL-LONDON, V153, P386, DOI 10.1113/jphysiol.1960.sp006541; Kirsch WG, 2001, J PHYSIOL-LONDON, V537, P379, DOI 10.1111/j.1469-7793.2001.00379.x; KLEIN MG, 1992, J PHYSIOL-LONDON, V453, P341, DOI 10.1113/jphysiol.1992.sp019232; Kurebayashi N, 2003, BIOCHEM BIOPH RES CO, V310, P1266, DOI 10.1016/j.bbrc.2003.09.146; Legrand C, 2008, J PHYSIOL-LONDON, V586, P441, DOI 10.1113/jphysiol.2007.145862; LUTTGAU HC, 1968, J PHYSIOL-LONDON, V194, P51; LUTTGAU HC, 1979, J PHYSIOL-LONDON, V296, P411; Moore RA, 1998, J CELL BIOL, V140, P843, DOI 10.1083/jcb.140.4.843; Murayama T, 2000, BIOPHYS J, V78, P1810, DOI 10.1016/S0006-3495(00)76731-2; Murayama T, 2002, TRENDS CARDIOVAS MED, V12, P305, DOI 10.1016/S1050-1738(02)00179-2; Murayama T, 2001, J BIOL CHEM, V276, P2953, DOI 10.1074/jbc.M005809200; OBRIEN J, 1993, BIOPHYS J, V65, P2418, DOI 10.1016/S0006-3495(93)81303-1; Ogawa Y, 2002, FRONT BIOSCI-LANDMRK, V7, pD1184, DOI 10.2741/ogawa; OGAWA Y, 1994, CRIT REV BIOCHEM MOL, V29, P229, DOI 10.3109/10409239409083482; Ottini L, 1996, BIOCHEM J, V315, P207, DOI 10.1042/bj3150207; OYAMADA H, 1994, J BIOL CHEM, V269, P17206; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Protasi F, 1998, J CELL BIOL, V140, P831, DOI 10.1083/jcb.140.4.831; Rios E, 2004, BIOL RES, V37, P583; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Schneider MF, 1999, J GEN PHYSIOL, V113, P365, DOI 10.1085/jgp.113.3.365; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Shirokova N, 1998, J PHYSIOL-LONDON, V512, P377, DOI 10.1111/j.1469-7793.1998.377be.x; Shirokova N, 1999, J GEN PHYSIOL, V113, P377, DOI 10.1085/jgp.113.3.377; Sorrentino V, 1999, TRENDS CARDIOVAS MED, V9, P54, DOI 10.1016/S1050-1738(99)00003-1; Sorrentino V, 1995, Adv Pharmacol, V33, P67, DOI 10.1016/S1054-3589(08)60666-3; Sutko JL, 1996, PHYSIOL REV, V76, P1027, DOI 10.1152/physrev.1996.76.4.1027; TAKESHIMA H, 1995, EMBO J, V14, P2999, DOI 10.1002/j.1460-2075.1995.tb07302.x; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Takeshima H, 1996, J BIOL CHEM, V271, P19649, DOI 10.1074/jbc.271.33.19649; THORENS S, 1975, P JPN ACAD, V51, P473, DOI 10.2183/pjab1945.51.473; Wang Y, 2000, AM J PHYSIOL-CELL PH, V278, pC619, DOI 10.1152/ajpcell.2000.278.3.C619; Yang DM, 2001, J BIOL CHEM, V276, P40210, DOI 10.1074/jbc.M106944200; Zhou JS, 1998, J BIOL CHEM, V273, P25503, DOI 10.1074/jbc.273.39.25503	51	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11526	10.1371/journal.pone.0011526	http://dx.doi.org/10.1371/journal.pone.0011526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634947	Green Published, gold, Green Submitted			2022-12-27	WOS:000279781600011
J	Kerr, B; Silva, PA; Walz, K; Young, JI				Kerr, Bredford; Silva, Pamela A.; Walz, Katherina; Young, Juan I.			Unconventional Transcriptional Response to Environmental Enrichment in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; MECP2; MICE; EXPRESSION; DEFICIENCY; PHOSPHORYLATION; PHENOTYPE; BEHAVIOR; DISEASE	Background: Rett syndrome (RTT) is an X-linked postnatal neurodevelopmental disorder caused by mutations in the gene encoding methyl-CpG binding protein 2 (MeCP2) and one of the leading causes of mental retardation in females. RTT is characterized by psychomotor retardation, purposeless hand movements, autistic-like behavior and abnormal gait. We studied the effects of environmental enrichment (EE) on the phenotypic manifestations of a RTT mouse model that lacks MeCP2 (Mecp2(-/y)). Principal Findings: We found that EE delayed and attenuated some neurological alterations presented by Mecp2(-/y) mice and prevented the development of motor discoordination and anxiety-related abnormalities. To define the molecular correlate of this beneficial effect of EE, we analyzed the expression of several synaptic marker genes whose expression is increased by EE in several mouse models. Conclusions/Significance: We found that EE induced downregulation of several synaptic markers, suggesting that the partial prevention of RTT-associated phenotypes is achieved through a non-conventional transcriptional program.	[Kerr, Bredford; Silva, Pamela A.; Walz, Katherina; Young, Juan I.] Ctr Estudios Cient, Dept Biol, Valdivia, Chile; [Silva, Pamela A.; Walz, Katherina] Univ Austral Chile, Dept Biochem, Valdivia, Chile; [Walz, Katherina; Young, Juan I.] CIN Ctr Ingn Innovac CECS, Valdivia, Chile; [Walz, Katherina; Young, Juan I.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Dept Human Genet, Miami, FL 33136 USA	Universidad Austral de Chile; University of Miami	Kerr, B (corresponding author), Ctr Estudios Cient, Dept Biol, Valdivia, Chile.	Jyoung3@med.miami.edu		Kerr, Bredford/0000-0001-8714-8726	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT [1061067, 1051079, 11070237]; Chilean Government; Conicyt	Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Chilean Government; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico-FONDECYT (grants 1061067, 1051079 and 11070237). The Centro de Estudios Cientificos (CECS) is funded by the Chilean Government through the Millennium Science Initiative and the Centers of Excellence Base Financing Program of Conicyt. CECS is also supported by a group of private companies which at present includes Antofagasta Minerals, Arauco, Empresas CMPC, Indura, Naviera Ultragas and Telefonica del Sur. Centro de Ingenieria para la Innovacion-CIN is funded by Conicyt and the Gobierno Regional de Los Rios. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Saavedra M, 2007, HUM MOL GENET, V16, P2315, DOI 10.1093/hmg/ddm185; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Deng V, 2007, HUM MOL GENET, V16, P640, DOI 10.1093/hmg/ddm007; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Kondo M, 2008, EUR J NEUROSCI, V27, P3342, DOI 10.1111/j.1460-9568.2008.06305.x; Laurvick CL, 2006, J PEDIATR-US, V148, P347, DOI 10.1016/j.jpeds.2005.10.037; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Lewis MH, 2004, MENT RETARD DEV D R, V10, P91, DOI 10.1002/mrdd.20017; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McGill BE, 2006, P NATL ACAD SCI USA, V103, P18267, DOI 10.1073/pnas.0608702103; Miyano M, 2008, J CELL MOL MED, V12, P1188, DOI 10.1111/j.1582-4934.2008.00377.x; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Mount RH, 2002, J CHILD PSYCHOL PSYC, V43, P1099, DOI 10.1111/1469-7610.00236; Moy SS, 2007, BEHAV BRAIN RES, V176, P4, DOI 10.1016/j.bbr.2006.07.030; Nag N, 2009, BEHAV BRAIN RES, V196, P44, DOI 10.1016/j.bbr.2008.07.008; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; RETT A, 1986, AM J MED GENET, V24, P21; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van D.A., 2000, NATURE, V404, P721, DOI DOI 10.1038/35008142; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	37	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11534	10.1371/journal.pone.0011534	http://dx.doi.org/10.1371/journal.pone.0011534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634955	gold, Green Published, Green Submitted			2022-12-27	WOS:000279781600014
J	Rhea, CK; Rietdyk, S; Haddad, JM				Rhea, Christopher K.; Rietdyk, Shirley; Haddad, Jeffery M.			Locomotor Adaptation versus Perceptual Adaptation when Stepping Over an Obstacle with a Height Illusion	PLOS ONE			English	Article							REAL-TIME; AFFORDANCES; INFORMATION	Background: During locomotion, vision is used to perceive environmental obstacles that could potentially threaten stability; locomotor action is then modified to avoid these obstacles. Various factors such as lighting and texture can make these environmental obstacles appear larger or smaller than their actual size. It is unclear if gait is adapted based on the actual or perceived height of these environmental obstacles. The purposes of this study were to determine if visually guided action is scaled to visual perception, and to determine if task experience influenced how action is scaled to perception. Methodology/Principal Findings: Participants judged the height of two obstacles before and after stepping over each of them 50 times. An illusion made obstacle one appear larger than obstacle two, even though they were identical in size. The influence of task experience was examined by comparing the perception-action relationship during the first five obstacle crossings (1-5) with the last five obstacle crossings (46-50). In the first set of trials, obstacle one was perceived to be 2.0 cm larger than obstacle two and subjects stepped 2.7 cm higher over obstacle one. After walking over the obstacle 50 times, the toe elevation was not different between obstacles, but obstacle one was still perceived as 2.4 cm larger. Conclusions/Significance: There was evidence of locomotor adaptation, but no evidence of perceptual adaptation with experience. These findings add to research that demonstrates that while the motor system can be influenced by perception, it can also operate independent of perception.	[Rhea, Christopher K.; Rietdyk, Shirley; Haddad, Jeffery M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Rhea, CK (corresponding author), Brown Univ, Dept Cognit & Linguist Sci, Providence, RI 02912 USA.	christopher_rhea@brown.edu						AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Cornus S, 1999, ECOL PSYCHOL, V11, P249, DOI 10.1207/s15326969eco1104_1; Elliott DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004577; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Franz V, 2008, COGN NEUROPSYCHOL, V25, P920, DOI 10.1080/02643290701862449; Gibson J.J., 1986, ECOLOGICAL APPROACH; Glover S, 2004, EXP BRAIN RES, V154, P504, DOI 10.1007/s00221-003-1687-y; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Linden DEJ, 1999, PERCEPTION, V28, P469, DOI 10.1068/p2820; MARK LS, 1987, J EXP PSYCHOL HUMAN, V13, P361, DOI 10.1037/0096-1523.13.3.361; McCarville EM, 2006, EXP BRAIN RES, V171, P405, DOI 10.1007/s00221-005-0284-7; Mohagheghi AA, 2004, EXP BRAIN RES, V155, P459, DOI 10.1007/s00221-003-1751-7; Pavani F, 1999, EXP BRAIN RES, V127, P95, DOI 10.1007/s002210050777; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; Westwood DA, 2003, SPATIAL VISION, V16, P243, DOI 10.1163/156856803322467518	15	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11544	10.1371/journal.pone.0011544	http://dx.doi.org/10.1371/journal.pone.0011544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	623XV	20634962	Green Published, gold			2022-12-27	WOS:000279781600021
J	Zeller, SL; Kalinina, O; Brunner, S; Keller, B; Schmid, B				Zeller, Simon L.; Kalinina, Olena; Brunner, Susanne; Keller, Beat; Schmid, Bernhard			Transgene x Environment Interactions in Genetically Modified Wheat	PLOS ONE			English	Article							UBIQUITIN PROMOTER; RUST RESISTANCE; BREAD WHEAT; EXPRESSION; MARKER; TRANSFORMATION; PLASTICITY; SELECTION; ECOLOGY; CLONING	Background: The introduction of transgenes into plants may cause unintended phenotypic effects which could have an impact on the plant itself and the environment. Little is published in the scientific literature about the interrelation of environmental factors and possible unintended effects in genetically modified (GM) plants. Methods and Findings: We studied transgenic bread wheat Triticum aestivum lines expressing the wheat Pm3b gene against the fungus powdery mildew Blumeria graminis f.sp. tritici. Four independent offspring pairs, each consisting of a GM line and its corresponding non-GM control line, were grown under different soil nutrient conditions and with and without fungicide treatment in the glasshouse. Furthermore, we performed a field experiment with a similar design to validate our glasshouse results. The transgene increased the resistance to powdery mildew in all environments. However, GM plants reacted sensitive to fungicide spraying in the glasshouse. Without fungicide treatment, in the glasshouse GM lines had increased vegetative biomass and seed number and a twofold yield compared with control lines. In the field these results were reversed. Fertilization generally increased GM/control differences in the glasshouse but not in the field. Two of four GM lines showed up to 56% yield reduction and a 40-fold increase of infection with ergot disease Claviceps purpurea compared with their control lines in the field experiment; one GM line was very similar to its control. Conclusions: Our results demonstrate that, depending on the insertion event, a particular transgene can have large effects on the entire phenotype of a plant and that these effects can sometimes be reversed when plants are moved from the glasshouse to the field. However, it remains unclear which mechanisms underlie these effects and how they may affect concepts in molecular plant breeding and plant evolutionary ecology.	[Zeller, Simon L.; Kalinina, Olena; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Ecol & Environm Studies, Zurich, Switzerland; [Brunner, Susanne; Keller, Beat] Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland	University of Zurich; University of Zurich	Zeller, SL (corresponding author), Univ Zurich, Inst Evolutionary Ecol & Environm Studies, Zurich, Switzerland.	simon.zeller@ieu.uzh.ch; bkeller@botinst.uzh.ch	Keller, Beat/K-3093-2019; Brunner, Susanne/AAX-1457-2021; Kalinina, Olena/J-5986-2019; Schmid, Bernhard/C-8625-2009; Kalinina, Olena/H-6275-2011	Keller, Beat/0000-0003-2379-9225; Brunner, Susanne/0000-0002-4473-3199; Schmid, Bernhard/0000-0002-8430-3214; 	Swiss National Science Foundation [SNF 405940-115607]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation and is part of the wheat-cluster. ch, a sub-unit of the national research programme NRP 59 (SNF 405940-115607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; BAINBRIDGE A, 1974, PLANT PATHOL, V23, P160, DOI 10.1111/j.1365-3059.1974.tb01842.x; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; BERGELSON J, 1996, PLANT PATHOL, V148, P536; Brown JKM, 2002, CURR OPIN PLANT BIOL, V5, P339, DOI 10.1016/S1369-5266(02)00270-4; Cellini F, 2004, FOOD CHEM TOXICOL, V42, P1089, DOI 10.1016/j.fct.2004.02.003; Christensen AH, 1996, TRANSGENIC RES, V5, P213, DOI 10.1007/BF01969712; Coll A, 2009, TRANSGENIC RES, V18, P801, DOI 10.1007/s11248-009-9266-z; Conner AJ, 2003, PLANT J, V33, P19, DOI 10.1046/j.0960-7412.2002.001607.x; CONNER AJ, 1994, BIOCONTROL SCI TECHN, V4, P463, DOI 10.1080/09583159409355358; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; EFSA, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.99; Elmore RW, 2001, AGRON J, V93, P408, DOI 10.2134/agronj2001.932408x; Eyal Z., 1987, SEPTORIA DIS WHEAT C; Filipecki M, 2006, J APPL GENET, V47, P277, DOI 10.1007/BF03194637; GERTZ JM, 1999, P 1999 BRIGHT C WEED, V835, P340; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; GRIFFEY CA, 1986, CROP SCI, V26, P489, DOI 10.2135/cropsci1986.0011183X002600030010x; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; HENIKOFF S, 1979, GENETICS, V93, P105; Hill Ryan A., 2003, Environmental Biosafety Research, V2, P81, DOI 10.1051/ebr:2003004; Jones HD, 2005, J CEREAL SCI, V41, P137, DOI 10.1016/j.jcs.2004.08.009; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LARKIN PJ, 1981, THEOR APPL GENET, V60, P443; LAST FT, 1953, ANN APPL BIOL, V40, P312, DOI 10.1111/j.1744-7348.1953.tb01085.x; Masci S, 2003, MOL BREEDING, V12, P209, DOI 10.1023/A:1026346823301; McCullagh P., 1989, GENERALISED LINEAR M; Ortelli S, 1996, CROP SCI, V36, P1590, DOI 10.2135/cropsci1996.0011183X003600060030x; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; PETER M, 2010, PEDOBIOLOGI IN PRESS; PURRINGTON CB, 1995, TRENDS ECOL EVOL, V10, P340, DOI 10.1016/S0169-5347(00)89124-7; Reed J, 2001, IN VITRO CELL DEV-PL, V37, P127; Rooke L, 2000, ANN APPL BIOL, V136, P167, DOI 10.1111/j.1744-7348.2000.tb00022.x; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; SCHMID B, 1992, EVOL TREND PLANT, V6, P45; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Stam M, 1998, MOL CELL BIOL, V18, P6165, DOI 10.1128/MCB.18.11.6165; Stoger E, 1999, TRANSGENIC RES, V8, P73, DOI 10.1023/A:1008801929494; SULTAN SE, 1987, EVOL BIOL, V21, P127; SULTAN SE, 2001, PHENOTYPIC PLASTICIT; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Travella S, 2006, PLANT PHYSIOL, V142, P6, DOI 10.1104/pp.106.084517; von Burg S, 2010, BASIC APPL ECOL, V11, P257, DOI 10.1016/j.baae.2010.02.003; Waines JG, 2003, CROP SCI, V43, P451, DOI 10.2135/cropsci2003.0451; Wolfenbarger LL, 2000, SCIENCE, V290, P2088, DOI 10.1126/science.290.5499.2088; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Yu L, 2005, J INTEGR PLANT BIOL, V47, P214, DOI 10.1111/j.1744-7909.2005.00030.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	53	56	60	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11405	10.1371/journal.pone.0011405	http://dx.doi.org/10.1371/journal.pone.0011405			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635001	Green Published, gold			2022-12-27	WOS:000279781600001
J	Zhao, RY; Liang, D; Li, G; Larrimore, CW; Mirkin, BL				Zhao, Richard Y.; Liang, Dong; Li, Ge; Larrimore, Christopher W.; Mirkin, Bernard L.			Anti-Cancer Effect of HIV-1 Viral Protein R on Doxorubicin Resistant Neuroblastoma	PLOS ONE			English	Article							CELL-CYCLE; MULTIDRUG-RESISTANCE; NMR STRUCTURE; VPR ARRESTS; VIRUS; APOPTOSIS; P53; YEAST; EXPRESSION; LINES	Several unique biological features of HIV-1 Vpr make it a potentially powerful agent for anti-cancer therapy. First, Vpr inhibits cell proliferation by induction of cell cycle G2 arrest. Second, it induces apoptosis through multiple mechanisms, which could be significant as it may be able to overcome apoptotic resistance exhibited by many cancerous cells, and, finally, Vpr selectively kills fast growing cells in a p53-independent manner. To demonstrate the potential utility of Vpr as an anti-cancer agent, we carried out proof-of-concept studies in vitro and in vivo. Results of our preliminary studies demonstrated that Vpr induces cell cycle G2 arrest and apoptosis in a variety of cancer types. Moreover, the same Vpr effects could also be detected in some cancer cells that are resistant to anti-cancer drugs such as doxorubicin (DOX). To further illustrate the potential value of Vpr in tumor growth inhibition, we adopted a DOX-resistant neuroblastoma model by injecting SK-N-SH cells into C57BL/6N and C57BL/6J-scid/scid mice. We hypothesized that Vpr is able to block cell proliferation and induce apoptosis regardless of the drug resistance status of the tumors. Indeed, production of Vpr via adenoviral delivery to neuroblastoma cells caused G2 arrest and apoptosis in both drug naive and DOX-resistant cells. In addition, pre-infection or intratumoral injection of vpr-expressing adenoviral particles into neuroblastoma tumors in SCID mice markedly inhibited tumor growth. Therefore, Vpr could possibly be used as a supplemental viral therapeutic agent for selective inhibition of tumor growth in anti-cancer therapy especially when other therapies stop working.	[Zhao, Richard Y.; Liang, Dong; Li, Ge; Larrimore, Christopher W.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Microbiol Immunol, Baltimore, MD 21201 USA; [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Mirkin, Bernard L.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Childrens Mem Inst Educ & Res, Chicago, IL 60611 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine	Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.	rzhao@som.umaryland.edu		Zhao, Richard Y./0000-0003-3424-2852	Chicago Medical Research Council, Illinois Department of Public Aid and US Department of Human Health Services; University of Maryland Medical Center	Chicago Medical Research Council, Illinois Department of Public Aid and US Department of Human Health Services; University of Maryland Medical Center	This study was supported in part by the Chicago Medical Research Council, Illinois Department of Public Aid and US Department of Human Health Services and the University of Maryland Medical Center (to RYZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MR, 2008, CULT HEALTH SEX, V10, P1, DOI 10.1080/13691050701516363; Bartz SR, 1996, J VIROL, V70, P2324, DOI 10.1128/JVI.70.4.2324-2331.1996; Benko Z, 2004, J VIROL, V78, P11016, DOI 10.1128/JVI.78.20.11016-11029.2004; Bogenmann E, 1996, INT J CANCER, V67, P379, DOI 10.1002/(SICI)1097-0215(19960729)67:3<379::AID-IJC12>3.0.CO;2-3; Broberg EK, 2005, CURR GENE THER, V5, P523, DOI 10.2174/156652305774329267; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Elder RT, 2002, FRONT BIOSCI-LANDMRK, V7, pD349, DOI 10.2741/elder; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; ELDER RT, 2003, CANC CTR J NW U, V9, P26; EPSTEIN AL, 1978, CANCER, V42, P2379, DOI 10.1002/1097-0142(197811)42:5<2379::AID-CNCR2820420539>3.0.CO;2-4; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Heilman DW, 2005, CELL CYCLE, V4, P560; HELSON L, 1975, CANCER RES, V35, P2594; JOWETT JBM, 1995, J VIROL, V69, P6304, DOI 10.1128/JVI.69.10.6304-6313.1995; Karpinich NO, 2006, J CELL PHYSIOL, V208, P55, DOI 10.1002/jcp.20638; Li G, 2007, J BIOL CHEM, V282, P7287, DOI 10.1074/jbc.M607951200; Li G, 2009, CURR HIV RES, V7, P178, DOI 10.2174/157016209787581436; Liang D, 2007, MOL MED, V13, P229, DOI 10.2119/2007-00004.Liang; Lothstein L, 2001, DRUG RESIST UPDATE, V4, P169, DOI 10.1054/drup.2001.0201; LOUIE KG, 1985, CANCER RES, V45, P2110; Mahalingam S, 1997, DNA CELL BIOL, V16, P137, DOI 10.1089/dna.1997.16.137; MATLASHEWSKI G, 1986, EUR J BIOCHEM, V154, P665, DOI 10.1111/j.1432-1033.1986.tb09449.x; McCray AN, 2007, CANCER BIOL THER, V6, P1269; McCray AN, 2006, MOL THER, V14, P647, DOI 10.1016/j.ymthe.2006.06.010; Moon HS, 2006, MOL CELLS, V21, P7; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Muthumani K, 2002, ONCOGENE, V21, P4613, DOI 10.1038/sj.onc.1205549; Muthumani Karupplah, 2004, Current Drug Delivery, V1, P335, DOI 10.2174/1567201043334614; Ostrakhovitch EA, 2007, J CELL BIOCHEM, V102, P1571, DOI 10.1002/jcb.21381; Pang S, 2001, CLIN CANCER RES, V7, P3567; PONS G, 1982, CANCER RES, V42, P3719; Qian F, 2005, BIOMED PHARMACOTHER, V59, P64, DOI 10.1016/j.biopha.2005.01.002; RE F, 1995, J VIROL, V69, P6859, DOI 10.1128/JVI.69.11.6859-6864.1995; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Schuler W, 1999, J MOL BIOL, V285, P2105, DOI 10.1006/jmbi.1998.2381; Sherman MP, 2002, VIROLOGY, V302, P95, DOI 10.1006/viro.2002.1576; Smardova J, 2005, ONCOL REP, V14, P901; Smith PJ, 2002, AM J PHYSIOL-CELL PH, V283, pC609, DOI 10.1152/ajpcell.00439.2001; Suzuki K, 2003, INT J ONCOL, V23, P1263; Suzuki K, 2006, AUTOPHAGY, V2, P349; Tan M, 2002, BIOMETRICS, V58, P612, DOI 10.1111/j.0006-341X.2002.00612.x; Valentiner U, 2008, TUMOR BIOL, V29, P152, DOI 10.1159/000143401; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; WEI Q, 2006, CHINA J EXP DIAG, V10, P725; WEI Q, 2006, SHANGHAI MED PHARM J, V27, P308; Yeung MC, 1998, AIDS, V12, P349, DOI 10.1097/00002030-199804000-00002; Zelivianski S, 2006, APOPTOSIS, V11, P377, DOI 10.1007/s10495-006-4030-9; Zeman SM, 1998, P NATL ACAD SCI USA, V95, P11561, DOI 10.1073/pnas.95.20.11561; Zhang BR, 2001, J NANOSCI NANOTECHNO, V1, P263, DOI 10.1166/jnn.2001.047; Zhao RY, 2005, INDIAN J MED RES, V121, P270; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996; [No title captured]	53	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11466	10.1371/journal.pone.0011466	http://dx.doi.org/10.1371/journal.pone.0011466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628645	gold, Green Published, Green Submitted			2022-12-27	WOS:000279589300012
J	Subramanyam, MA; Ackerson, LK; Subramanian, SV				Subramanyam, Malavika A.; Ackerson, Leland K.; Subramanian, S. V.			Patterning in Birthweight in India: Analysis of Maternal Recall and Health Card Data	PLOS ONE			English	Article							POPULATION; PREGNANCY; NUTRITION; COHORT; WOMEN; SIZE; AGE	Background: National data on birthweight from birth certificates or medical records are not available in India. The third Indian National Family Health Survey included data on birthweight of children obtained from health cards and maternal recall. This study aims to describe the population that these data represent and compares the birthweight obtained from health cards with maternal recall data in terms of its socioeconomic patterning and as a risk factor for childhood growth failure. Methodology/Principal Findings: The analytic sample consisted of children aged 0 to 59 months with birthweight data obtained from health cards (n = 3227) and maternal recall (n = 16787). The difference between the card sample and the maternal recall sample in the distribution across household wealth, parental education, caste, religion, gender, and urban residence was compared using multilevel models. We also assessed the ability of birthweight to predict growth failure in infancy and childhood in the two groups. The survey contains birthweight data from a majority of household wealth categories (>5% in every category for recall), both genders, all age groups, all caste groups, all religion groups, and urban and rural dwellers. However, children from the lowest quintile of household wealth were under-represented (4.73% in card and 8.62% in recall samples). Comparison of data across health cards and maternal recall revealed similar social patterning of low birthweight and ability of birthweight to predict growth failure later in life. Children were less likely to be born with low birthweight if they had mothers with over 12 years of education compared to 1-5 years of education with relative risk (RR) of 0.79 (95% confidence interval [CI]: 0.52, 1.2) in the card sample and 0.70 (95% CI: 0.59, 0.84) in the recall sample. A 100 gram difference in a child's birthweight was associated with a decreased likelihood of underweight in both the card (RR: 0.95; 95% CI: 0.94, 0.96) and recall (RR: 0.96; 95% CI: 0.96, 0.97) samples. Conclusions: Our results suggest that in the absence of other sources, the data on birthweight in the third Indian National Family Health Survey is valuable for epidemiologic research.	[Subramanyam, Malavika A.] Univ Michigan, Sch Publ Hlth, Ctr Integrat Approaches Hlth Dispar, Ann Arbor, MI 48109 USA; [Ackerson, Leland K.] Univ Massachusetts Lowell, Dept Community Hlth & Sustainabil, Lowell, MA USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Lowell; Harvard University; Harvard T.H. Chan School of Public Health	Subramanyam, MA (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Integrat Approaches Hlth Dispar, Ann Arbor, MI 48109 USA.	svsubram@hsph.harvard.edu			National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct funding was available for this study. SVS is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri B, 2008, INDIAN J PEDIATR, V75, P111, DOI 10.1007/s12098-008-0066-x; Antonisamy B, 1994, Indian Pediatr, V31, P931; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Bisai S, 2007, ANN HUM BIOL, V34, P91, DOI 10.1080/03014460601080728; Blanc AK, 2005, B WORLD HEALTH ORGAN, V83, P178; Carmines E. G., 1979, RELIABILITY VALIDITY, DOI DOI 10.4135/9781412985642; CHITNIS S, 1997, POLITICS BACKWARDNES, P88; Deshmukh J S, 1998, Indian Pediatr, V35, P33; DHARMALINGAM A, 2009, MATERN CHILD HLTH J; Dwarkanath P, 2007, ASIA PAC J CLIN NUTR, V16, P704; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; George K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-5; Gupta PC, 2004, BMJ-BRIT MED J, V328, P1538, DOI 10.1136/bmj.38113.687882.EB; Hirve S S, 1994, Indian Pediatr, V31, P1221; IIPS and Macro International, 2007, NAT FAM HLTH SURV NF, V1; IIPS and ORC Macro, 2007, NAT FAM HLTH SURV 20; International Institute of Population Sciences (IIPS) & Macro International, 2007, NAT FAM HLTH SURV NF, VII; Kanade AN, 2008, J AM COLL NUTR, V27, P137, DOI 10.1080/07315724.2008.10719685; Kulkarni B, 2006, EUR J CLIN NUTR, V60, P1341, DOI 10.1038/sj.ejcn.1602461; MATHAI M, 1992, BRIT J OBSTET GYNAEC, V99, P342, DOI 10.1111/j.1471-0528.1992.tb13736.x; Misra M, 1995, J TROP PEDIATRICS, V41, P374, DOI 10.1093/tropej/41.6.374; Muthayya S, 2006, EUR J CLIN NUTR, V60, P791, DOI 10.1038/sj.ejcn.1602383; Muthayya S, 2006, PUBLIC HEALTH NUTR, V9, P896, DOI 10.1017/PHN2006943; Nair N. Sreekumaran, 2000, Indian Journal of Pediatrics, V67, P9, DOI 10.1007/BF02802625; Patel V, 2006, BRIT J PSYCHIAT, V188, P284, DOI 10.1192/bjp.bp.105.012096; Prasad K N, 1994, Indian Pediatr, V31, P836; Rao S, 2009, INT J EPIDEMIOL, V38, P1094, DOI 10.1093/ije/dyp223; Rehman AM, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-44; Sarkar N. C., 2000, Indian Journal of Pediatrics, V67, P419, DOI 10.1007/BF02859458; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1245, DOI 10.1093/ije/30.6.1245; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; World Health Organization (WHO), 2004, LOW BIRTH WEIGHT COU; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	34	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11424	10.1371/journal.pone.0011424	http://dx.doi.org/10.1371/journal.pone.0011424			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625399	gold, Green Published, Green Submitted			2022-12-27	WOS:000279465700011
J	Yao, W; Dai, WW; Shahnazari, M; Pham, A; Chen, ZQ; Chen, HY; Guan, M; Lane, NE				Yao, Wei; Dai, Weiwei; Shahnazari, Mohammad; Pham, Aaron; Chen, Zhiqiang; Chen, Haiyan; Guan, Min; Lane, Nancy E.			Inhibition of the Progesterone Nuclear Receptor during the Bone Linear Growth Phase Increases Peak Bone Mass in Female Mice	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; DEPOT MEDROXYPROGESTERONE ACETATE; GLUCOCORTICOID-TREATED MICE; ESTROGEN-DEFICIENT MICE; PROSTATE-CANCER CELLS; OSTEOBLAST-LIKE CELLS; KNOCKOUT PRKO MICE; OXIDATIVE STRESS; CALCIUM SUPPLEMENTATION; ANDROGEN RECEPTOR	Augmentation of the peak bone mass (PBM) may be one of the most effective interventions to reduce the risk of developing osteoporosis later in life; however treatments to augment PBM are currently limited. Our study evaluated whether a greater PBM could be achieved either in the progesterone nuclear receptor knockout mice (PRKO) or by using a nuclear progesterone receptor (nPR) antagonist, RU486 in mice. Compared to their wild type (WT) littermates the female PRKO mice developed significantly higher cancellous and cortical mass in the distal femurs, and this was associated with increased bone formation. The high bone mass phenotype was partially reproduced by administering RU486 in female WT mice from 1-3 months of age. Our results suggest that the inhibition of the nPR during the rapid bone growth period (1-3 months) increases osteogenesis, which results in acquisition of higher bone mass. Our findings suggest a crucial role for progesterone signaling in bone acquisition and inhibition of the nPR as a novel approach to augment bone mass, which may have the potential to reduce the burden of osteoporosis.	[Yao, Wei; Dai, Weiwei; Shahnazari, Mohammad; Pham, Aaron; Chen, Zhiqiang; Chen, Haiyan; Guan, Min; Lane, Nancy E.] Univ Calif Davis, Med Ctr, Dept Internal Med, Ctr Healthy Aging, Sacramento, CA 95817 USA	University of California System; University of California Davis	Yao, W (corresponding author), Univ Calif Davis, Med Ctr, Dept Internal Med, Ctr Healthy Aging, Sacramento, CA 95817 USA.	wei.yao@ucdmc.ucdavis.edu	Yao, Wei/O-8187-2019; Chen, Haiyan/HGB-6216-2022; yao, wei/GVS-3913-2022; Shahnazari, Mohammad Reza/AAU-8573-2020	Yao, Wei/0000-0002-1198-1161; yao, wei/0000-0002-1198-1161; Shahnazari, Mohammad Reza/0000-0001-8647-5426; Guan, Min/0000-0003-3851-8553	National Institute of Child Health and Human Development (NICHD) [NIAMS- 5R21AR057515, NIAMS- R01 AR043052-07, K24-AR-048841, 1K12HD05195801]; Office of Research on Women's Health (ORWH); Office of Dietary Supplements (ODS); National Institute of Aging (NIA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR057515, K24AR048841, R01AR043052] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of Research on Women's Health (ORWH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Office of Dietary Supplements (ODS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	NIAMS- 5R21AR057515 (to WY), NIAMS- R01 AR043052-07, K24-AR-048841 (to NEL), 1K12HD05195801 that is co-funded by National Institute of Child Health and Human Development (NICHD), the Office of Research on Women's Health (ORWH), the Office of Dietary Supplements (ODS) and the National Institute of Aging (NIA).	ABE T, 1992, BONE MINER, V19, P225, DOI 10.1016/0169-6009(92)90872-B; Abplanalp W, 2001, GYNECOL OBSTET INVES, V51, P81, DOI 10.1159/000052898; Azizi G, 2003, ENDOCR RES, V29, P133, DOI 10.1081/ERC-120022294; Bachrach LK, 2000, PEDIATRICS, V106, P1137, DOI 10.1542/peds.106.5.1137; BARENGOLTS EI, 1995, BONE, V17, P21, DOI 10.1016/8756-3282(95)00138-4; BARENGOLTS EI, 1990, J BONE MINER RES, V5, P1143; Bonjour JP, 2001, LANCET, V358, P1208, DOI 10.1016/S0140-6736(01)06342-5; Boonyaratanakornkit V, 2008, STEROIDS, V73, P922, DOI 10.1016/j.steroids.2008.01.010; Boonyaratanakornkit V, 2007, SEMIN REPROD MED, V25, P139, DOI 10.1055/s-2007-973427; Boonyaratanakornkit V, 2007, MOL ENDOCRINOL, V21, P359, DOI 10.1210/me.2006-0337; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brouwers JEM, 2007, J ORTHOP RES, V25, P1325, DOI 10.1002/jor.20439; Burger HG, 1998, CLIN ENDOCRINOL, V48, P809; Cao JJ, 2007, J BONE MINER RES, V22, P1271, DOI 10.1359/JBMR.070506; Chappell PE, 1999, ENDOCRINOLOGY, V140, P3653, DOI 10.1210/en.140.8.3653; Chappell PE, 1997, ENDOCRINOLOGY, V138, P4147, DOI 10.1210/en.138.10.4147; Chen L, 1997, J Tongji Med Univ, V17, P72; Conneely OM, 2001, MOL CELL ENDOCRINOL, V179, P97, DOI 10.1016/S0303-7207(01)00465-8; Courteix D, 2005, INT J SPORTS MED, V26, P332, DOI 10.1055/s-2004-821040; Crofton PM, 1997, CLIN ENDOCRINOL, V46, P109, DOI 10.1046/j.1365-2265.1997.d01-1744.x; Cromer BA, 2006, J ADOLESCENT HEALTH, V39, P296, DOI 10.1016/j.jadohealth.2006.03.011; Cundy T, 1997, AM J OBSTET GYNECOL, V176, P1116, DOI 10.1016/S0002-9378(97)70415-0; Cundy T, 1996, J CLIN ENDOCR METAB, V81, P1014, DOI 10.1210/jc.81.3.1014; Cundy T, 1998, OBSTET GYNECOL, V92, P569, DOI 10.1016/S0029-7844(98)00270-1; CUNDY T, 1991, BRIT MED J, V303, P13, DOI 10.1136/bmj.303.6793.13; Danilovich N, 2000, ENDOCRINOLOGY, V141, P4295, DOI 10.1210/en.141.11.4295; de Kretser DM, 2001, MOL CELL ENDOCRINOL, V180, P87, DOI 10.1016/S0303-7207(01)00502-0; de Kretser DM, 2000, MOL CELL ENDOCRINOL, V161, P43, DOI 10.1016/S0303-7207(99)00222-1; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fan WQ, 2007, J BIOL CHEM, V282, P7329, DOI 10.1074/jbc.M610447200; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Frye CA, 2006, PSYCHOPHARMACOLOGY, V185, P423, DOI 10.1007/s00213-005-0300-4; GALLAGHER JC, 1991, AM J MED, V90, P171; Gellersen B, 2009, HUM REPROD UPDATE, V15, P119, DOI 10.1093/humupd/dmn044; Grassi F, 2007, P NATL ACAD SCI USA, V104, P15087, DOI 10.1073/pnas.0703610104; Greer EL, 2008, ACTA PHYSIOL, V192, P19, DOI 10.1111/j.1748-1716.2007.01780.x; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grosse B, 2000, J CELL BIOCHEM, V79, P334, DOI 10.1002/1097-4644(20001101)79:2<334::AID-JCB160>3.3.CO;2-D; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; HOROWITZ M, 1993, CLIN ENDOCRINOL, V39, P649, DOI 10.1111/j.1365-2265.1993.tb02422.x; HSIAO EC, 2008, P NATL ACAD SCI US; Huang HJ, 2004, J BIOL CHEM, V279, P13866, DOI 10.1074/jbc.M314143200; Iqbal J, 2006, P NATL ACAD SCI USA, V103, P14925, DOI 10.1073/pnas.0606805103; Ishida Y, 1996, J BONE MINER RES, V11, P921; Ishida Y, 1997, BONE, V20, P17, DOI 10.1016/S8756-3282(96)00315-8; Ishida Y, 1997, OSTEOPOROSIS INT, V7, P323, DOI 10.1007/BF01623772; JOHNSTON CC, 1993, OSTEOPOROSIS INT, V3, pS54, DOI 10.1007/BF01621864; KALU DN, 1991, BONE MINER, V15, P109, DOI 10.1016/0169-6009(91)90002-H; Krum SA, 2008, EMBO J, V27, P535, DOI 10.1038/sj.emboj.7601984; Labied S, 2006, MOL ENDOCRINOL, V20, P35, DOI 10.1210/me.2005-0275; Lane NE, 2006, J BONE MINER RES, V21, P466, DOI 10.1359/JBMR.051103; Lane NE, 2005, J BONE MINER RES, V20, P58, DOI 10.1359/JBMR.041017; Le Mellay V, 2000, J CELL BIOCHEM, V79, P173, DOI 10.1002/1097-4644(20001101)79:2<173::AID-JCB10>3.0.CO;2-3; Lengyel F, 2007, STEROIDS, V72, P422, DOI 10.1016/j.steroids.2007.03.001; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Liang M, 2003, ENDOCR RES, V29, P483, DOI 10.1081/ERC-120026954; Liu JH, 2005, AM J OBSTET GYNECOL, V192, P1316, DOI 10.1016/j.ajog.2004.12.067; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MacNamara P, 1998, CALCIFIED TISSUE INT, V63, P39; MACNAMARA P, 1995, CALCIFIED TISSUE INT, V57, P436, DOI 10.1007/BF00301947; Manolagas SC, 2002, RECENT PROG HORM RES, V57, P385, DOI 10.1210/rp.57.1.385; Markovic V, 2005, AM J CLIN NUTR, V81, P175; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; Matsumoto M, 2005, CELL METAB, V1, P215, DOI 10.1016/j.cmet.2005.03.008; Meehan T, 2000, DEV BIOL, V220, P225, DOI 10.1006/dbio.2000.9625; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; PENSLER JM, 1990, J BONE MINER RES, V5, P797; Perrien DS, 2007, ENDOCRINOLOGY, V148, P1654, DOI 10.1210/en.2006-0848; Petitti DB, 2000, OBSTET GYNECOL, V95, P736, DOI 10.1016/S0029-7844(00)00782-1; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; PRIOR JC, 1994, AM J MED, V96, P521, DOI 10.1016/0002-9343(94)90092-2; Ramara A, 2007, BRAIN RES, V1176, P71, DOI 10.1016/j.brainres.2007.08.036; Reddy DS, 2005, NEUROPHARMACOLOGY, V48, P14, DOI 10.1016/j.neuropharm.2004.09.002; Rickard DJ, 2008, ENDOCRINOLOGY, V149, P2383, DOI 10.1210/en.2007-1247; Roemer SC, 2008, NUCLEIC ACIDS RES, V36, P3655, DOI 10.1093/nar/gkn249; Rohe HJ, 2009, PHARMACOL THERAPEUT, V121, P14, DOI 10.1016/j.pharmthera.2008.09.006; SANCHEZCRIADO JE, 1992, J ENDOCRINOL, V134, P51, DOI 10.1677/joe.0.1340051; SANCHEZCRIADO JE, 1992, J ENDOCRINOL, V134, P43, DOI 10.1677/joe.0.1340043; SCHEVEN BAA, 1992, BIOCHEM BIOPH RES CO, V186, P54, DOI 10.1016/S0006-291X(05)80774-0; Schneider JS, 2005, ENDOCRINOLOGY, V146, P4340, DOI 10.1210/en.2005-0490; Schneider JS, 2003, P NATL ACAD SCI USA, V100, P2951, DOI 10.1073/pnas.0130100100; SLOOTWEG MC, 1992, J ENDOCRINOL, V133, pR5, DOI 10.1677/joe.0.133R005; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Sudoh N, 2001, CIRCULATION, V103, P724; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Turgeon JL, 2001, ENDOCRINOLOGY, V142, P3108, DOI 10.1210/en.142.7.3108; WANG JD, 1994, CONTRACEPTION, V49, P245, DOI 10.1016/0010-7824(94)90042-6; Wang JP, 2008, J NANOELECTRON OPTOE, V3, P12, DOI 10.1166/jno.2008.006; Ward EC, 2008, ENDOCRINOLOGY, V149, P1942, DOI 10.1210/en.2007-0756; Ward KA, 2007, BONE, V41, P496, DOI 10.1016/j.bone.2007.06.007; WEI LL, 1993, BIOCHEM BIOPH RES CO, V195, P525, DOI 10.1006/bbrc.1993.2077; Welt CK, 1999, J CLIN ENDOCR METAB, V84, P105, DOI 10.1210/jc.84.1.105; Yao W, 2005, OSTEOPOROSIS INT, V16, P1939, DOI 10.1007/s00198-005-1969-2; Yao W, 2008, ARTHRITIS RHEUM, V58, P3485, DOI 10.1002/art.23954; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454	97	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11410	10.1371/journal.pone.0011410	http://dx.doi.org/10.1371/journal.pone.0011410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YF	20625385	Green Published, Green Submitted, gold			2022-12-27	WOS:000279465500003
J	Bergerot, B; Julliard, R; Baguette, M				Bergerot, Benjamin; Julliard, Romain; Baguette, Michel			Metacommunity Dynamics: Decline of Functional Relationship along a Habitat Fragmentation Gradient	PLOS ONE			English	Article							COTESIA-GLOMERATA; PARASITOID WASP; HOST; CONSERVATION; CATERPILLARS; COMMUNITIES; POPULATIONS; BUTTERFLIES; DISTANCES; BEHAVIOR	Background: The metacommunity framework is crucial to the study of functional relations along environmental gradients. Changes in resource grain associated with increasing habitat fragmentation should generate uncoupled responses of interacting species with contrasted dispersal abilities. Methodology/Principal Findings: Here we tested whether the intensity of parasitism was modified by increasing habitat fragmentation in the well know predator-prey system linking the parasitoid Cotesia glomerata (Hymenoptera: Braconidae) to its main host Pieris brassicae (Lepidoptera: Pieridae). We collected information on herbivorous abundance and parasitism rate along an urbanization gradient from the periphery to the centre of Paris. We showed that butterfly densities were not influenced by habitat fragmentation, whereas parasitism rate sharply decreased along this gradient. Conclusions/Significance: Our results provide novel insights into the mechanisms underlying the persistence of species in highly fragmented areas. They suggest that differential dispersal abilities could alter functional relationships between prey and predator, notably by a lack of natural predators.	[Bergerot, Benjamin; Julliard, Romain] UPMC, CNRS, MNHN, UMR CERSP 7204, Paris, France; [Baguette, Michel] MNHN, CNRS, UMR 7179, MAOAC, Brunoy, France; [Baguette, Michel] CNRS, USR 2936, Stn Ecol Expt, Moulis, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS)	Bergerot, B (corresponding author), UPMC, CNRS, MNHN, UMR CERSP 7204, Paris, France.	bergerot@mnhn.fr	Baguette, Michel/HHZ-3609-2022; bergerot, benjamin/AAD-4591-2021; Baguette, Michel/E-4754-2011	bergerot, benjamin/0000-0003-4313-4925	French National Museum of Natural History; Centre National de la Recherches Scientifiques (CNRS); ANR; SCALE (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales)	French National Museum of Natural History; Centre National de la Recherches Scientifiques (CNRS)(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); SCALE (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales)	The different field work projects of the authors were supported by the French National Museum of Natural History, the Centre National de la Recherches Scientifiques (CNRS), a grant from the ANR (ANR blanc DIAME Dispersal and MEtapopulation, 2008-2011) and the SCALE project (Securing the Conservation of biodiversity across Administrative Levels and spatial, temporal and Ecological Scales).	AKAIKE H, 1981, CC/ENG TECH APPL SCI, P22; Askew R.R., 1986, P225; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; COHEN JE, 1990, BIOMATHEMATICS BERLI, V20, P1; ECOMOS, 2003, EC SOIL OCC MOD; Elzinga JA, 2007, BASIC APPL ECOL, V8, P75, DOI 10.1016/j.baae.2006.04.003; Esch S, 2005, OECOLOGIA, V146, P218, DOI 10.1007/s00442-005-0214-1; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 1997, J WILDLIFE MANAGE, V61, P603, DOI 10.2307/3802168; FAHRIG L, 1994, CONSERV BIOL, V8, P50, DOI 10.1046/j.1523-1739.1994.08010050.x; Feltwell J., 1982, LARGE WHITE BUTTERFL; Geervliet JBF, 2000, OECOLOGIA, V124, P55, DOI 10.1007/s004420050024; Hanski I, 1999, METAPOPULATION DYNAM; Hardy PB, 1999, BIODIVERS CONSERV, V8, P1261, DOI 10.1023/A:1008984905413; Hill JK, 2006, BIOL LETTERS, V2, P152, DOI 10.1098/rsbl.2005.0401; Holt RD, 2002, ECOL RES, V17, P261, DOI 10.1046/j.1440-1703.2002.00485.x; Kolligs Detlef, 2000, Faunistisch-Oekologische Mitteilungen Supplement, V28, P1; Kozlov MV, 1996, ENTOMOL FENNICA, V7, P137, DOI 10.33338/ef.83902; Kruess A, 2003, ECOGRAPHY, V26, P283, DOI 10.1034/j.1600-0587.2003.03402.x; KRUESS A, 1994, SCIENCE, V264, P1581, DOI 10.1126/science.264.5165.1581; Marzluff JM, 2001, RESTOR ECOL, V9, P280, DOI 10.1046/j.1526-100x.2001.009003280.x; Moss JE, 1933, J ANIM ECOL, V2, P210, DOI 10.2307/959; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Muratet A, 2007, ECOSYSTEMS, V10, P661, DOI 10.1007/s10021-007-9047-6; OHSAKI N, 1990, ECOL ENTOMOL, V15, P169, DOI 10.1111/j.1365-2311.1990.tb00798.x; Poelman EH, 2009, FUNCT ECOL, V23, P951, DOI 10.1111/j.1365-2435.2009.01570.x; Rand TA, 2007, OIKOS, V116, P1353, DOI [10.1111/j.2007.0030-1299.15871.x, 10.1111/j.0030-1299.2007.15871.x]; Roland J, 1997, NATURE, V386, P710, DOI 10.1038/386710a0; TAKABAYASHI J, 1994, J CHEM ECOL, V20, P1329, DOI 10.1007/BF02059811; Tanaka S, 2006, ECOL RES, V21, P570, DOI 10.1007/s11284-006-0153-2; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Tscharntke T, 2002, ECOL APPL, V12, P354, DOI 10.1890/1051-0761(2002)012[0354:COSHFT]2.0.CO;2; van Nouhuys S, 2002, J ANIM ECOL, V71, P639, DOI 10.1046/j.1365-2656.2002.00627.x; van Nouhuys S, 2005, ANN ZOOL FENN, V42, P433; Vos M, 1998, J ANIM ECOL, V67, P774, DOI 10.1046/j.1365-2656.1998.00239.x; Wanner H, 2006, PHYSIOL ENTOMOL, V31, P127, DOI 10.1111/j.1365-3032.2006.00494.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Zabel J, 1998, OECOLOGIA, V116, P419, DOI 10.1007/s004420050605	43	23	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11294	10.1371/journal.pone.0011294	http://dx.doi.org/10.1371/journal.pone.0011294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613976	gold, Green Published, Green Submitted			2022-12-27	WOS:000279370000005
J	Najera, JL; Gomez, CE; Garcia-Arriaza, J; Sorzano, CO; Esteban, M				Luis Najera, Jose; Elena Gomez, Carmen; Garcia-Arriaza, Juan; Oscar Sorzano, Carlos; Esteban, Mariano			Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens	PLOS ONE			English	Article							CD8(+) T-CELL; POXVIRUS VECTORS MVA; IN-VITRO EXPRESSION; REPLICATION-COMPETENT; VIRAL VECTORS; DNA VACCINE; IMMUNOGENICITY; MEMORY; CANDIDATES; PROTEIN	Background: The highly attenuated vaccinia virus strain NYVAC expressing HIV-1 components has been evaluated as a vaccine candidate in preclinical and clinical trials with encouraging results. We have previously described that the presence of C7L in the NYVAC genome prevents the induction of apoptosis and renders the vector capable of replication in human and murine cell lines while maintaining an attenuated phenotype in mice. Methodology/Principal Findings: In an effort to improve the immunogenicity of NYVAC, we have developed a novel poxvirus vector by inserting the VACV host-range C7L gene into the genome of NYVAC-B, a recombinant virus that expresses four HIV-1 antigens from clade B (Env, Gag, Pol and Nef) (referred as NYVAC-B-C7L). In the present study, we have compared the in vitro and in vivo behavior of NYVAC-B and NYVAC-B-C7L. In cultured cells, NYVAC-B-C7L expresses higher levels of heterologous antigen than NYVAC-B as determined by Western blot and fluorescent-activated cell sorting to score Gag expressing cells. In a DNA prime/poxvirus boost approach with BALB/c mice, both recombinants elicited robust, broad and multifunctional antigen-specific T-cell responses to the HIV-1 immunogens expressed from the vectors. However, the use of NYVAC-B-C7L as booster significantly enhanced the magnitude of the T cell responses, and induced a more balanced cellular immune response to the HIV-1 antigens in comparison to that elicited in animals boosted with NYVAC-B. Conclusions/Significance: These findings demonstrate the possibility to enhance the immunogenicity of the highly attenuated NYVAC vector by the insertion of the host-range gene C7L and suggest the use of this modified vector as an improved vaccine candidate against HIV/AIDS.	[Luis Najera, Jose; Elena Gomez, Carmen; Garcia-Arriaza, Juan; Esteban, Mariano] CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Madrid, Spain; [Oscar Sorzano, Carlos] CSIC, Ctr Nacl Biotecnol, Biocomp Unit, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Najera, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Mol & Cellular Biol, Ciudad Univ Cantoblanco, Madrid, Spain.	mesteban@cnb.csic.es	NAJERA, Jose Luis/W-8177-2019; Sorzano, Carlos Oscar S S./F-2639-2016; S. Sorzano, Carlos Oscar/ABE-4884-2021; Gomez, Carmen Elena/K-1940-2014; GARCIA-ARRIAZA, JUAN/Q-6243-2017; Esteban, Mariano/ABG-5375-2020	Sorzano, Carlos Oscar S S./0000-0002-9473-283X; S. Sorzano, Carlos Oscar/0000-0002-9473-283X; Gomez, Carmen Elena/0000-0002-5414-7935; GARCIA-ARRIAZA, JUAN/0000-0002-5167-5724; Esteban, Mariano/0000-0003-0846-2827; Najera, jose Luis/0000-0001-7798-3330	Ministry of Science and Innovation [SAF2008-02036]; Foundation Botin of Spain;  [FIPSE-36551/06]	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Foundation Botin of Spain; 	This investigation was supported by grants from FIPSE-36551/06, the Ministry of Science and Innovation (SAF2008-02036) and Foundation Botin of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara RR, 2002, J VIROL, V76, P7625, DOI 10.1128/JVI.76.15.7625-7631.2002; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Bachmann MF, 2005, J IMMUNOL, V175, P4677, DOI 10.4049/jimmunol.175.7.4677; Backes S, 2010, J GEN VIROL, V91, P470, DOI 10.1099/vir.0.015347-0; Bartlett N, 2002, J GEN VIROL, V83, P1965, DOI 10.1099/0022-1317-83-8-1965; Brave A, 2007, MOL THER, V15, P1724, DOI 10.1038/sj.mt.6300235; Corbett M, 2008, P NATL ACAD SCI USA, V105, P2046, DOI 10.1073/pnas.0705191105; Critchfield JW, 2007, J VIROL, V81, P5460, DOI 10.1128/JVI.02535-06; Dai KF, 2008, VACCINE, V26, P5062, DOI 10.1016/j.vaccine.2008.06.011; Didierlaurent A, 2004, VACCINE, V22, P3395, DOI 10.1016/j.vaccine.2004.02.025; Gomez CE, 2007, VACCINE, V25, P1969, DOI 10.1016/j.vaccine.2006.11.051; Esteban M, 2009, HUM VACCINES, V5, P867, DOI 10.4161/hv.9693; Ferrier-Rembert A, 2008, VACCINE, V26, P1794, DOI 10.1016/j.vaccine.2007.12.059; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Gomez CE, 2008, CURR GENE THER, V8, P97, DOI 10.2174/156652308784049363; Gomez CE, 2007, J GEN VIROL, V88, P2473, DOI 10.1099/vir.0.83018-0; Gomez CE, 2007, VACCINE, V25, P2863, DOI 10.1016/j.vaccine.2006.09.090; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Hovav AH, 2007, J VIROL, V81, P12793, DOI 10.1128/JVI.01519-07; Huang XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004180; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Koff WC, 2008, BIOLOGICALS, V36, P277, DOI 10.1016/j.biologicals.2008.04.004; LEE MS, 1992, J VIROL, V66, P2617, DOI 10.1128/JVI.66.5.2617-2630.1992; Liniger M, 2007, EXPERT REV VACCINES, V6, P255, DOI 10.1586/14760584.6.2.255; Liu JY, 2007, VACCINE, V25, P2951, DOI 10.1016/j.vaccine.2006.05.081; Liu JY, 2006, VACCINE, V24, P3332, DOI 10.1016/j.vaccine.2006.01.017; Loffredo JT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001152; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola LR, 2000, AIDS, V14, pS167; Meng XZ, 2009, J VIROL, V83, P10627, DOI 10.1128/JVI.01260-09; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Mooij P, 2008, J VIROL, V82, P2975, DOI 10.1128/JVI.02216-07; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; Narayan S, 2007, EUR J IMMUNOL, V37, P406, DOI 10.1002/eji.200535688; OGUIURA N, 1993, J GEN VIROL, V74, P1409, DOI 10.1099/0022-1317-74-7-1409; Pantaleo G, 2004, NAT MED, V10, P806, DOI 10.1038/nm0804-806; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Precopio ML, 2007, J EXP MED, V204, P1405, DOI 10.1084/jem.20062363; Pulendran B, 2004, CURR BIOL, V14, pR30, DOI 10.1016/j.cub.2003.12.020; Radcliffe JN, 2006, J IMMUNOL, V177, P6626, DOI 10.4049/jimmunol.177.10.6626; Ramanathan VD, 2009, AIDS RES HUM RETROV, V25, P1107, DOI 10.1089/aid.2009.0096; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; RODRIGUEZ JF, 1988, P NATL ACAD SCI USA, V85, P1667, DOI 10.1073/pnas.85.5.1667; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rouder JN, 2005, PSYCHON B REV, V12, P573, DOI 10.3758/BF03196750; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; TARTAGLIA J, 1992, VIROLOGY, V188, P217, DOI 10.1016/0042-6822(92)90752-B; Vijaysri S, 2008, VACCINE, V26, P664, DOI 10.1016/j.vaccine.2007.11.045; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wherry EJ, 1999, J IMMUNOL, V163, P3735; Wherry EJ, 2002, J IMMUNOL, V168, P4455, DOI 10.4049/jimmunol.168.9.4455; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wyatt LS, 2008, VACCINE, V26, P486, DOI 10.1016/j.vaccine.2007.11.036; Zhang XG, 2007, J VIROL, V81, P7022, DOI 10.1128/JVI.02654-06; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102; zur Megede J, 2000, J VIROL, V74, P2628, DOI 10.1128/JVI.74.6.2628-2635.2000	65	53	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11406	10.1371/journal.pone.0011406	http://dx.doi.org/10.1371/journal.pone.0011406			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613977	Green Published, gold			2022-12-27	WOS:000279370000030
J	Gold, S; Monaghan, P; Mertens, P; Jackson, T				Gold, Sarah; Monaghan, Paul; Mertens, Peter; Jackson, Terry			A Clathrin Independent Macropinocytosis-Like Entry Mechanism Used by Bluetongue Virus-1 during Infection of BHK Cells	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; ENDOCYTIC PATHWAY; EPITHELIAL-CELLS; VACCINIA VIRUS; FUNCTIONAL-CHARACTERIZATION; MEDIATED ENDOCYTOSIS; CAVEOLAR ENDOCYTOSIS; ACTIN POLYMERIZATION; MEMBRANE DOMAINS; EARLY ENDOSOMES	Acid dependent infection of Hela and Vero cells by BTV-10 occurs from within early-endosomes following virus uptake by clathrin-mediated endocytosis (Forzan et al., 2007: J Virol 81: 4819-4827). Here we report that BTV-1 infection of BHK cells is also dependent on a low endosomal pH; however, virus entry and infection were not inhibited by dominant-negative mutants of Eps15, AP180 or the 'aa' splice variant of dynamin-2, which were shown to inhibit clathrin-mediated endocytosis. In addition, infection was not inhibited by depletion of cellular cholesterol, which suggests that virus entry is not mediated by a lipid-raft dependent process such as caveolae-mediated endocytosis. Although virus entry and infection were not inhibited by the dominant-negative dynamin-2 mutant, entry was inhibited by the general dynamin inhibitor, dynasore, indicating that virus entry is dynamin dependent. During entry, BTV-1 co-localised with LAMP-1 but not with transferrin, suggesting that virus is delivered to late-endosomal compartments without first passing through early-endosomes. BTV-1 entry and infection were inhibited by EIPA and cytochalasin-D, known macropinocytosis inhibitors, and during entry virus co-localised with dextran, a known marker for macropinocytosis/fluid-phase uptake. Our results extend earlier observations with BTV-10, and show that BTV-1 can infect BHK cells via an entry mechanism that is clathrin and cholesterol-independent, but requires dynamin, and shares certain characteristics in common with macropinocytosis.	[Gold, Sarah; Monaghan, Paul; Mertens, Peter; Jackson, Terry] AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute	Gold, S (corresponding author), AFRC, Inst Anim Hlth, Pirbright Lab, Woking GU24 0NF, Surrey, England.	terry.jackson@bbsrc.ac.uk	Monaghan, Paul/H-1973-2013	Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council [DTABB/B511951/1]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001442] Funding Source: researchfish; BBSRC [BBS/E/I/00001442] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Sarah Gold was supported by Biotechnology and Biological Sciences Research Council DTABB/B511951/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; BARRATTBOYES SM, 1992, J GEN VIROL, V73, P1953, DOI 10.1099/0022-1317-73-8-1953; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Benmerah A, 1999, J CELL SCI, V112, P1303; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; EATON BT, 1990, CURR TOP MICROBIOL, V162, P89; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Forzan M, 2004, P NATL ACAD SCI USA, V101, P2100, DOI 10.1073/pnas.0306448101; Forzan M, 2007, J VIROL, V81, P4819, DOI 10.1128/JVI.02284-06; Glebov OO, 2006, NAT CELL BIOL, V8, P46, DOI 10.1038/ncb1342; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; HEMATI B, 2009, J VIROL; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; Huang CY, 2008, J VIROL, V82, P7988, DOI 10.1128/JVI.00894-08; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; Huss M, 2009, J EXP BIOL, V212, P341, DOI 10.1242/jeb.024067; HYATT AD, 1993, VIROLOGY, V193, P592, DOI 10.1006/viro.1993.1167; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kalia M, 2006, MOL BIOL CELL, V17, P3689, DOI 10.1091/mbc.E05-10-0980; Karjalainen M, 2008, MOL BIOL CELL, V19, P2857, DOI 10.1091/mbc.E07-10-1094; Keller P, 1998, J CELL BIOL, V140, P1357, DOI 10.1083/jcb.140.6.1357; Kerr MC, 2009, TRAFFIC, V10, P364, DOI 10.1111/j.1600-0854.2009.00878.x; Khan AG, 2010, J VIROL, V84, P3984, DOI 10.1128/JVI.01693-09; Kumari S, 2008, NAT CELL BIOL, V10, P30, DOI 10.1038/ncb1666; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Liberali P, 2008, EMBO J, V27, P970, DOI 10.1038/emboj.2008.59; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Locker JK, 2000, MOL BIOL CELL, V11, P2497, DOI 10.1091/mbc.11.7.2497; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maclachlan NJ, 2009, J COMP PATHOL, V141, P1, DOI 10.1016/j.jcpa.2009.04.003; Marechal V, 2001, J VIROL, V75, P11166, DOI 10.1128/JVI.75.22.11166-11177.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin CSS, 2004, J VIROL, V78, P2310, DOI 10.1128/JVI.78.5.2310-2318.2004; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; Mertens PPC, 1996, VIROLOGY, V217, P582, DOI 10.1006/viro.1996.0153; MERTENS PPC, 1987, VIROLOGY, V157, P375, DOI 10.1016/0042-6822(87)90280-7; Misinzo G, 2009, VIRUS RES, V139, P1, DOI 10.1016/j.virusres.2008.09.005; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moriyama T, 2007, J VIROL, V81, P8552, DOI 10.1128/JVI.00924-07; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Nishi K, 2007, J BIOL CHEM, V282, P27503, DOI 10.1074/jbc.M703810200; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; O'Donnell V, 2008, J VIROL, V82, P9075, DOI 10.1128/JVI.00732-08; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Quirin K, 2008, VIROLOGY, V378, P21, DOI 10.1016/j.virol.2008.04.046; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; Raghu H, 2009, J VIROL, V83, P4895, DOI 10.1128/JVI.02498-08; Rojek JM, 2008, J VIROL, V82, P7677, DOI 10.1128/JVI.00560-08; Rojek JM, 2008, J VIROL, V82, P1505, DOI 10.1128/JVI.01331-07; Rust MJ, 2004, NAT STRUCT MOL BIOL, V11, P567, DOI 10.1038/nsmb769; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200; Smith JL, 2008, J VIROL, V82, P9505, DOI 10.1128/JVI.01014-08; Spoden G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003313; Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; Takamatsu H, 2003, J GEN VIROL, V84, P227, DOI 10.1099/vir.0.18705-0; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; Van Hamme E, 2008, J GEN VIROL, V89, P2147, DOI 10.1099/vir.0.2008/001602-0; Vidricaire G, 2007, J MOL BIOL, V368, P1267, DOI 10.1016/j.jmb.2007.03.003; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15	86	63	65	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11360	10.1371/journal.pone.0011360	http://dx.doi.org/10.1371/journal.pone.0011360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613878	Green Published, gold, Green Submitted			2022-12-27	WOS:000279369900009
J	Viswanath, K; Ackerson, LK; Sorensen, G; Gupta, PC				Viswanath, K.; Ackerson, Leland K.; Sorensen, Glorian; Gupta, Prakash C.			Movies and TV Influence Tobacco Use in India: Findings from a National Survey	PLOS ONE			English	Article							SMOKING; YOUTH; MORTALITY	Background: Exposure to mass media may impact the use of tobacco, a major source of illness and death in India. The objective is to test the association of self-reported tobacco smoking and chewing with frequency of use of four types of mass media: newspapers, radio, television, and movies. Methodology/Principal Findings: We analyzed data from a sex-stratified nationally-representative cross-sectional survey of 123,768 women and 74,068 men in India. All models controlled for wealth, education, caste, occupation, urbanicity, religion, marital status, and age. In fully-adjusted models, monthly cinema attendance is associated with increased smoking among women (relative risk [RR]: 1.55; 95% confidence interval [CI]: 1.04-2.31) and men (RR: 1.17; 95% CI: 1.12-1.23) and increased tobacco chewing among men (RR: 1.15; 95% CI: 1.11-1.20). Daily television and radio use is associated with higher likelihood of tobacco chewing among men and women, while daily newspaper use is related to lower likelihood of tobacco chewing among women. Conclusion/Significance: In India, exposure to visual mass media may contribute to increased tobacco consumption in men and women, while newspaper use may suppress the use of tobacco chewing in women. Future studies should investigate the role that different types of media content and media play in influencing other health behaviors.	[Viswanath, K.; Sorensen, Glorian] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Viswanath, K.; Sorensen, Glorian] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Ackerson, Leland K.] Univ Massachusetts Lowell, Dept Community Hlth & Sustainabil, Lowell, MA USA; [Gupta, Prakash C.] Healis Sekhsaria Inst Publ Hlth, Navi Mumbai, India	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; University of Massachusetts System; University of Massachusetts Lowell	Viswanath, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, 665 Huntington Ave, Boston, MA 02115 USA.	vish_viswanath@dfci.harvard.edu			American Legacy Foundation; National Cancer Institute	American Legacy Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K. Viswanath acknowledges the support of the Dana-Farber Harvard Cancer Center and the Tobacco Research Network on Disparities (TReND) funded by the American Legacy Foundation (http://www.legacyforhealth.org/) and the National Cancer Institute (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GLOBAL BURDEN DIS CO; Arora M, 2008, AM J HEALTH BEHAV, V32, P283; DiFranza JR, 2006, PEDIATRICS, V117, pE1237, DOI 10.1542/peds.2005-1817; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; FINNEGAN J, 2008, HLTH BEHAV HLTH ED T; Green MC, 2006, J COMMUN, V56, pS163, DOI 10.1111/j.1460-2466.2006.00288.x; Gupta PC, 2005, INT J EPIDEMIOL, V34, P1395, DOI 10.1093/ije/dyi196; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; GUPTA PC, 1986, LANCET, V1, P1235; GUPTA S, 2006, UICC HDB; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; National Cancer Institute, 2008, TOB CONTR MON, V19; Pednekar MS, 2007, PREV MED, V44, P496, DOI 10.1016/j.ypmed.2007.02.017; Reddy KS, 2004, REPORT TOBACCO CONTR; Sargent JD, 2007, PEDIATRICS, V119, pE1167, DOI 10.1542/peds.2006-2897; Sauvaget C, 2008, INT J EPIDEMIOL, V37, P1242, DOI 10.1093/ije/dyn097; Shah PB, 2008, ASIAN PAC J CANCER P, V9, P637; Smith KC, 2008, TOB CONTROL, V17, P17, DOI 10.1136/tc.2007.020495; Subramanian SV, 2006, AM J PUBLIC HEALTH, V96, P818, DOI 10.2105/AJPH.2004.060103; Thankappan KR, 2007, INDIAN J MED RES, V126, P300; Wakefield M, 2003, ADDICTION, V98, P79, DOI 10.1046/j.1360-0443.98.s1.6.x; Wakefield M, 2003, J HEALTH COMMUN, V8, P229, DOI 10.1080/10810730305686; Wellman RJ, 2006, ARCH PEDIAT ADOL MED, V160, P1285, DOI 10.1001/archpedi.160.12.1285; *WHO, 2007, TOB HLTH GLOB STAT R; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	28	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11365	10.1371/journal.pone.0011365	http://dx.doi.org/10.1371/journal.pone.0011365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618QD	20614005	gold, Green Submitted, Green Published			2022-12-27	WOS:000279369900014
J	Bianchi, MT; Cash, SS; Mietus, J; Peng, CK; Thomas, R				Bianchi, Matt T.; Cash, Sydney S.; Mietus, Joseph; Peng, Chung-Kang; Thomas, Robert			Obstructive Sleep Apnea Alters Sleep Stage Transition Dynamics	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; DAYTIME SLEEPINESS; HEART HEALTH; SCALE; FRAGMENTATION; NEUROBIOLOGY; WAKEFULNESS; DISORDERS; PATTERNS; MODEL	Introduction: Enhanced characterization of sleep architecture, compared with routine polysomnographic metrics such as stage percentages and sleep efficiency, may improve the predictive phenotyping of fragmented sleep. One approach involves using stage transition analysis to characterize sleep continuity. Methods and Principal Findings: We analyzed hypnograms from Sleep Heart Health Study (SHHS) participants using the following stage designations: wake after sleep onset (WASO), non-rapid eye movement (NREM) sleep, and REM sleep. We show that individual patient hypnograms contain insufficient number of bouts to adequately describe the transition kinetics, necessitating pooling of data. We compared a control group of individuals free of medications, obstructive sleep apnea (OSA), medical co-morbidities, or sleepiness (n = 374) with mild (n = 496) or severe OSA (n = 338). WASO, REM sleep, and NREM sleep bout durations exhibited multi-exponential temporal dynamics. The presence of OSA accelerated the "decay'' rate of NREM and REM sleep bouts, resulting in instability manifesting as shorter bouts and increased number of stage transitions. For WASO bouts, previously attributed to a power law process, a multi-exponential decay described the data well. Simulations demonstrated that a multi-exponential process can mimic a power law distribution. Conclusion and Significance: OSA alters sleep architecture dynamics by decreasing the temporal stability of NREM and REM sleep bouts. Multi-exponential fitting is superior to routine mono-exponential fitting, and may thus provide improved predictive metrics of sleep continuity. However, because a single night of sleep contains insufficient transitions to characterize these dynamics, extended monitoring of sleep, probably at home, would be necessary for individualized clinical application.	[Bianchi, Matt T.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Mietus, Joseph; Peng, Chung-Kang] Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02215 USA; [Thomas, Robert] Beth Israel Deaconess Med Ctr, Sleep Div, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Bianchi, MT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.	mtbianchi@partners.org	Thomas, Robert/AAC-9694-2021; Peng, Chung-Kang/N-1308-2019; Peng, Chung-Kang/E-1489-2011	Thomas, Robert/0000-0002-5575-3953; Peng, Chung-Kang/0000-0003-3666-9833; Peng, Chung-Kang/0000-0003-3666-9833	Department of Neurology, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology; Beth Israel Deaconess Medical Center; Pfizer, Inc.; Merck Co.;  [R21HL079248]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL079248] Funding Source: NIH RePORTER	Department of Neurology, Massachusetts General Hospital; Harvard/MIT Health Sciences and Technology; Beth Israel Deaconess Medical Center; Pfizer, Inc.(Pfizer); Merck Co.(Merck & Company); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Fudning: R21HL079248 (RJT); Department of Neurology, Massachusetts General Hospital, and the Clinical Investigator Training Program: Harvard/MIT Health Sciences and Technology, Beth Israel Deaconess Medical Center, in collaboration with Pfizer, Inc. and Merck & Co. (MTB). This paper represents the work of the authors and not the SHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Behn CGD, 2008, J NEUROPHYSIOL, V99, P3090, DOI 10.1152/jn.01243.2007; Benbadis SR, 1999, ANN INTERN MED, V130, P289, DOI 10.7326/0003-4819-130-4-199902160-00014; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Born J, 2006, NEUROSCIENTIST, V12, P410, DOI 10.1177/1073858406292647; CARSKADON MA, 1982, NEUROBIOL AGING, V3, P321, DOI 10.1016/0197-4580(82)90020-3; Chervin RD, 2005, AM J RESP CRIT CARE, V171, P652, DOI 10.1164/rccm.200408-1056OC; Chervin RD, 1999, NEUROLOGY, V52, P125, DOI 10.1212/WNL.52.1.125; Espana RA, 2004, SLEEP, V27, P811; Fuller PM, 2006, J BIOL RHYTHM, V21, P482, DOI 10.1177/0748730406294627; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x; Kaplan KA, 2009, SLEEP MED REV, V13, P275, DOI 10.1016/j.smrv.2008.09.001; KEMP B, 1986, SLEEP, V9, P405, DOI 10.1093/sleep/9.3.405; Kim JW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178104; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Klerman EB, 2004, SLEEP, V27, P793, DOI 10.1093/sleep/27.4.793; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lombardi C, 2008, J SLEEP RES, V17, P263, DOI 10.1111/j.1365-2869.2008.00659.x; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Mahowald MW, 2005, NATURE, V437, P1279, DOI 10.1038/nature04287; Mediano O, 2007, EUR RESPIR J, V30, P110, DOI 10.1183/09031936.00009506; Mochizuki T, 2004, J NEUROSCI, V24, P6291, DOI 10.1523/JNEUROSCI.0586-04.2004; Norman RG, 2006, SLEEP, V29, P1625, DOI 10.1093/sleep/29.12.1625; Ohayon MM, 2008, SLEEP MED REV, V12, P129, DOI 10.1016/j.smrv.2008.01.001; Quan SF, 1997, SLEEP, V20, P1077; Saper CB, 2005, J COMP NEUROL, V493, P92, DOI 10.1002/cne.20770; Siegel JM, 2009, NAT REV NEUROSCI, V10, P747, DOI 10.1038/nrn2697; Swihart BJ, 2008, J CLIN SLEEP MED, V4, P349; Togo F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2425; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Weaver EM, 2004, ARCH OTOLARYNGOL, V130, P453, DOI 10.1001/archotol.130.4.453; Wesensten NJ, 1999, J SLEEP RES, V8, P237, DOI 10.1046/j.1365-2869.1999.00161.x; YANG MCK, 1973, BIOMETRICS, V29, P667, DOI 10.2307/2529133	34	70	70	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11356	10.1371/journal.pone.0011356	http://dx.doi.org/10.1371/journal.pone.0011356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596541	Green Submitted, Green Published, gold			2022-12-27	WOS:000279259900024
J	Bernardo, BL; Wachtmann, TS; Cosgrove, PG; Kuhn, M; Opsahl, AC; Judkins, KM; Freeman, TB; Hadcock, JR; LeBrasseur, NK				Bernardo, Barbara L.; Wachtmann, Timothy S.; Cosgrove, Patricia G.; Kuhn, Max; Opsahl, Alan C.; Judkins, Kyle M.; Freeman, Thomas B.; Hadcock, John R.; LeBrasseur, Nathan K.			Postnatal PPAR delta Activation and Myostatin Inhibition Exert Distinct yet Complimentary Effects on the Metabolic Profile of Obese Insulin-Resistant Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; TRAINING IMPROVES; FAT MASS; GLUCOSE-HOMEOSTASIS; WEIGHT-LOSS; ADULT MICE; EXPRESSION; RECEPTOR; SENSITIVITY; EXERCISE	Background: Interventions for T2DM have in part aimed to mimic exercise. Here, we have compared the independent and combined effects of a PPAR delta agonist and endurance training mimetic (GW501516) and a myostatin antibody and resistance training mimetic (PF-879) on metabolic and performance outcomes in obese insulin resistant mice. Methodology/Principal Findings: Male ob/ob mice were treated for 6 weeks with vehicle, GW501516, PF-879, or GW501516 in combination with PF-879. The effects of the interventions on body composition, glucose homeostasis, glucose tolerance, energy expenditure, exercise capacity and metabolic gene expression were compared at the end of study. GW501516 attenuated body weight and fat mass accumulation and increased the expression of genes of oxidative metabolism. In contrast, PF-879 increased body weight by driving muscle growth and altered the expression of genes involved in insulin signaling and glucose metabolism. Despite their differences, both interventions alone improved glucose homeostasis. Moreover, GW501516 more effectively improved serum lipids, and PF-879 uniquely increased energy expenditure, exercise capacity and adiponectin levels. When combined the robust effects of GW501516 and/or PF-879 on body weight, adiposity, muscle mass, glycemia, serum lipids, energy expenditure and exercise capacity were highly conserved. Conclusions/Significance: The data, for the first time, demonstrate postnatal inhibition of myostatin not only promotes gains in muscle mass similar to resistance training, but improves metabolic homeostasis. In several instances, these effects were either distinct from or complimentary to those of GW501516. The data further suggest that strategies to increase muscle mass, and not necessarily oxidative capacity, may effectively counter insulin resistance and T2DM.	[Bernardo, Barbara L.; Wachtmann, Timothy S.; Cosgrove, Patricia G.; Judkins, Kyle M.; Freeman, Thomas B.; Hadcock, John R.; LeBrasseur, Nathan K.] Pfizer Global Res & Dev, Cardiovasc Metab & Endocrine Dis, Groton, CT USA; [Kuhn, Max] Pfizer Global Res & Dev, Preclin Stat, Groton, CT USA; [Opsahl, Alan C.] Pfizer Global Res & Dev, Investigat Pathol Lab, Groton, CT USA	Pfizer; Pfizer; Pfizer	Bernardo, BL (corresponding author), Pfizer Global Res & Dev, Cardiovasc Metab & Endocrine Dis, Groton, CT USA.	lebrasseur.nathan@mayo.edu	Bernardo, Barbara/N-7101-2019	LeBrasseur, Nathan/0000-0002-2002-0418	Pfizer, Inc	Pfizer, Inc(Pfizer)	This study was funded by Pfizer, Inc. All authors were employees of Pfizer, Inc. and were paid as such, therefore Pfizer had a role in the study design, data collection and analysis and decision to publish.	Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Dunstan DW, 2002, DIABETES CARE, V25, P1729, DOI 10.2337/diacare.25.10.1729; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fujii N, 2007, DIABETES RES CLIN PR, V77, pS92, DOI 10.1016/j.diabres.2007.01.040; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; HASSID WA, 1957, METHODS ENZYMOLOGY; Hittel DS, 2009, DIABETES, V58, P30, DOI 10.2337/db08-0943; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Honkola A, 1997, ACTA DIABETOL, V34, P245, DOI 10.1007/s005920050082; Ishii T, 1998, DIABETES CARE, V21, P1353, DOI 10.2337/diacare.21.8.1353; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; LEBRASSEUR NK, 2009, J GERONTOL A; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu LB, 2008, CELL METAB, V8, P310, DOI 10.1016/j.cmet.2008.07.008; Liu Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE657, DOI 10.1152/ajpendo.00186.2009; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Milan G, 2004, J CLIN ENDOCR METAB, V89, P2724, DOI 10.1210/jc.2003-032047; MURPHY KT, 2010, AM J PATHOL; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Park JJ, 2006, PHYSIOL GENOMICS, V27, P114, DOI 10.1152/physiolgenomics.00045.2006; Rockl KSC, 2007, DIABETES, V56, P2062, DOI 10.2337/db07-0255; Stolz LE, 2008, DIABETES OBES METAB, V10, P135, DOI 10.1111/j.1463-1326.2006.00672.x; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wilkes JJ, 2009, DIABETES, V58, P1133, DOI 10.2337/db08-0245; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	39	49	55	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11307	10.1371/journal.pone.0011307	http://dx.doi.org/10.1371/journal.pone.0011307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593012	gold, Green Published, Green Submitted			2022-12-27	WOS:000279140800009
J	Chantret, I; Fasseu, M; Zaoui, K; Le Bizec, C; Yaye, HS; Dupre, T; Moore, SEH				Chantret, Isabelle; Fasseu, Magali; Zaoui, Karim; Le Bizec, Christiane; Yaye, Hassane Sadou; Dupre, Thierry; Moore, Stuart E. H.			Identification of Roles for Peptide: N-Glycanase and Endo-beta-N-Acetylglucosaminidase (Engase1p) during Protein N-Glycosylation in Human HepG2 Cells	PLOS ONE			English	Article							POLYMANNOSE-TYPE OLIGOSACCHARIDES; NEWLY SYNTHESIZED GLYCOPROTEINS; RETICULUM-ASSOCIATED DEGRADATION; ALPHA-D-MANNOSIDASE; ENDOPLASMIC-RETICULUM; RAT-LIVER; SACCHAROMYCES-CEREVISIAE; LINKED OLIGOSACCHARIDES; CAENORHABDITIS-ELEGANS; CYTOSOL	Background: During mammalian protein N-glycosylation, 20% of all dolichol-linked oligosaccharides (LLO) appear as free oligosaccharides (fOS) bearing the di-N-acetylchitobiose (fOSGN2), or a single N-acetylglucosamine (fOSGN), moiety at their reducing termini. After sequential trimming by cytosolic endo beta-N-acetylglucosaminidase (ENGase) and Man2c1 mannosidase, cytosolic fOS are transported into lysosomes. Why mammalian cells generate such large quantities of fOS remains unexplored, but fOSGN2 could be liberated from LLO by oligosaccharyltransferase, or from glycoproteins by NGLY1-encoded Peptide-N-Glycanase (PNGase). Also, in addition to converting fOSGN2 to fOSGN, the ENGASE-encoded cytosolic ENGase of poorly defined function could potentially deglycosylate glycoproteins. Here, the roles of Ngly1p and Engase1p during fOS metabolism were investigated in HepG2 cells. Methods/Principal Findings: During metabolic radiolabeling and chase incubations, RNAi-mediated Engase1p down regulation delays fOSGN2-to-fOSGN conversion, and it is shown that Engase1p and Man2c1p are necessary for efficient clearance of cytosolic fOS into lysosomes. Saccharomyces cerevisiae does not possess ENGase activity and expression of human Engase1p in the png1D deletion mutant, in which fOS are reduced by over 98%, partially restored fOS generation. In metabolically radiolabeled HepG2 cells evidence was obtained for a small but significant Engase1p-mediated generation of fOS in 1 h chase but not 30 min pulse incubations. Ngly1p down regulation revealed an Ngly1p-independent fOSGN2 pool comprising mainly Man(8)GlcNAc(2), corresponding to similar to 70% of total fOS, and an Ngly1p-dependent fOSGN2 pool enriched in Glc(1)Man(9)GlcNAc(2) and Man(9)GlcNAc(2) that corresponds to similar to 30% of total fOS. Conclusions/Significance: As the generation of the bulk of fOS is unaffected by co-down regulation of Ngly1p and Engase1p, alternative quantitatively important mechanisms must underlie the liberation of these fOS from either LLO or glycoproteins during protein N-glycosylation. The fully mannosylated structures that occur in the Ngly1p-dependent fOSGN2 pool indicate an ERAD process that does not require N-glycan trimming.	[Chantret, Isabelle; Fasseu, Magali; Zaoui, Karim; Moore, Stuart E. H.] INSERM, U773, Ctr Rech Bichat Beaujon, Paris, France; [Chantret, Isabelle; Fasseu, Magali; Zaoui, Karim; Moore, Stuart E. H.] Univ Paris 07, Paris, France; [Le Bizec, Christiane; Yaye, Hassane Sadou; Dupre, Thierry] Hop Bichat Claude Bernard, AP HP, F-75877 Paris 18, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite	Chantret, I (corresponding author), INSERM, U773, Ctr Rech Bichat Beaujon, Paris, France.	isabelle.chantret@inserm.fr	Moore, Stuart/AAF-3920-2021; CHANTRET, Isabelle/AAF-7134-2021	Moore, Stuart/0000-0002-1020-2242; CHANTRET, Isabelle/0000-0002-0896-1274	Mizutani Foundation; GIS-Institut des maladies rares/INSERM; EUROGLYCANET [LSHM-CT-2005-512131]; INSERM	Mizutani Foundation; GIS-Institut des maladies rares/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); EUROGLYCANET; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Financial support was from The Mizutani Foundation; the GIS-Institut des maladies rares/INSERM funded French CDG Research Network; EUROGLYCANET (LSHM-CT-2005-512131), La Fondation pour la Recherche Medicale (FRM); institutional funding from INSERM. S. E. H. M. is the recipient of a Hospital/INSERM Interface Contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BISCHOFF J, 1990, J BIOL CHEM, V265, P17110; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Cacan R, 1996, BIOCHEM J, V313, P597, DOI 10.1042/bj3130597; Cacan R, 2001, J BIOL CHEM, V276, P22307, DOI 10.1074/jbc.M101077200; Cacan R, 1998, BIOCHIMIE, V80, P59, DOI 10.1016/S0300-9084(98)80057-6; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2008, GLYCOBIOLOGY, V18, P210, DOI 10.1093/glycob/cwn003; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Durrant C, 2002, BIOCHEM J, V365, P239, DOI 10.1042/BJ20011786; Duvet S, 1998, BIOCHEM J, V335, P389, DOI 10.1042/bj3350389; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; HALVORSON H, 1958, BIOCHIM BIOPHYS ACTA, V30, P28, DOI 10.1016/0006-3002(58)90237-3; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; JONES EW, 1977, GENETICS, V85, P23; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 1997, J BIOCHEM, V122, P1167, DOI 10.1093/oxfordjournals.jbchem.a021877; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Kawaguchi S, 2007, CELL, V129, P1230; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Moore SEH, 1999, TRENDS CELL BIOL, V9, P441, DOI 10.1016/S0962-8924(99)01648-7; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Moore SEH, 1998, GLYCOBIOLOGY, V8, P373, DOI 10.1093/glycob/8.4.373; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; Nothaft H, 2009, P NATL ACAD SCI USA, V106, P15019, DOI 10.1073/pnas.0903078106; OKU H, 1991, J BIOCHEM-TOKYO, V110, P982, DOI 10.1093/oxfordjournals.jbchem.a123700; Petracek ME, 2002, METHOD ENZYMOL, V350, P445, DOI 10.1016/S0076-6879(02)50978-2; PIERCE RJ, 1979, BIOCHEM J, V180, P673, DOI 10.1042/bj1800673; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Scott SV, 1995, J CELL BIOL, V131, P1727, DOI 10.1083/jcb.131.6.1727; SHOUP VA, 1976, J BIOL CHEM, V251, P3845; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; SUZUKI T, 1995, J BIOL CHEM, V270, P15181, DOI 10.1074/jbc.270.25.15181; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; VILLERS C, 1994, BIOCHEM J, V298, P135, DOI 10.1042/bj2980135; Xiao YT, 2008, INT J BIOCHEM CELL B, V40, P2002, DOI 10.1016/j.biocel.2007.08.006; Yanagida K, 2006, GLYCOBIOLOGY, V16, P294, DOI 10.1093/glycob/cwj074; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418; Zhou XK, 2006, P NATL ACAD SCI USA, V103, P17214, DOI 10.1073/pnas.0602954103	52	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11734	10.1371/journal.pone.0011734	http://dx.doi.org/10.1371/journal.pone.0011734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668520	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800010
J	Capparelli, R; Nocerino, N; Lanzetta, R; Silipo, A; Amoresano, A; Giangrande, C; Becker, K; Blaiotta, G; Evidente, A; Cimmino, A; Iannaccone, M; Parlato, M; Medaglia, C; Roperto, S; Roperto, F; Ramunno, L; Iannelli, D				Capparelli, Rosanna; Nocerino, Nunzia; Lanzetta, Rosa; Silipo, Alba; Amoresano, Angela; Giangrande, Chiara; Becker, Karsten; Blaiotta, Giuseppe; Evidente, Antonio; Cimmino, Alessio; Iannaccone, Marco; Parlato, Marianna; Medaglia, Chiara; Roperto, Sante; Roperto, Franco; Ramunno, Luigi; Iannelli, Domenico			Bacteriophage-Resistant Staphylococcus aureus Mutant Confers Broad Immunity against Staphylococcal Infection in Mice	PLOS ONE			English	Article							METHICILLIN-RESISTANT; TEICHOIC-ACID; CELL-WALL; PHAGE; VACCINE; PROTECTION; STRAINS; CARDIOTOXICITY; SENSITIVITY; DYNAMICS	In the presence of a bacteriophage (a bacteria-attacking virus) resistance is clearly beneficial to the bacteria. As expected in such conditions, resistant bacteria emerge rapidly. However, in the absence of the phage, resistant bacteria often display reduced fitness, compared to their sensitive counterparts. The present study explored the fitness cost associated with phage-resistance as an opportunity to isolate an attenuated strain of S. aureus. The phage-resistant strain A172 was isolated from the phage-sensitive strain A170 in the presence of the M-Sa phage. Acquisition of phage-resistance altered several properties of A172, causing reduced growth rate, under-expression of numerous genes and production of capsular polysaccharide. In vivo, A172 modulated the transcription of the TNF-alpha, IFN-gamma and Il-1 beta genes and, given intramuscularly, protected mice from a lethal dose of A170 (18/20). The heat-killed vaccine also afforded protection from heterologous methicillin-resistant S. aureus (MRSA) (8/10 mice) or vancomycin-intermediate S. aureus (VISA) (9/10 mice). The same vaccine was also effective when administered as an aerosol. Anti-A172 mouse antibodies, in the dose of 10 mu l/mouse, protected the animals (10/10, in two independent experiments) from a lethal dose of A170. Consisting predominantly of the sugars glucose and galactose, the capsular polysaccharide of A172, given in the dose of 25 mu g/mouse, also protected the mice (20/20) from a lethal dose of A170. The above results demonstrate that selection for phage-resistance can facilitate bacterial vaccine preparation.	[Capparelli, Rosanna; Nocerino, Nunzia; Iannaccone, Marco; Parlato, Marianna] Univ Naples Federico II, Fac Biotechnol, Naples, Italy; [Lanzetta, Rosa; Silipo, Alba; Amoresano, Angela; Giangrande, Chiara] Univ Naples Federico II, Dept Organ Chem & Biochem, Naples, Italy; [Becker, Karsten] Univ Klinikum Munster, Inst Med Mikrobiol, Munster, Germany; [Blaiotta, Giuseppe; Evidente, Antonio; Cimmino, Alessio; Medaglia, Chiara; Ramunno, Luigi; Iannelli, Domenico] Univ Naples Federico II, Sch Agr, Naples, Italy; [Roperto, Sante; Roperto, Franco] Univ Naples Federico II, Dept Pathol & Anim Hlth, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; University of Naples Federico II; University of Naples Federico II	Capparelli, R (corresponding author), Univ Naples Federico II, Fac Biotechnol, Naples, Italy.	iannelli@unina.it	Silipo, Alba/L-5929-2014; Parlato, Marianna/H-9467-2017; Cimmino, Alessio/I-2121-2012; Becker, Karsten/O-2302-2018; Iannaccone, Marco/K-7559-2016; Capparelli, Rosanna/Q-3144-2017; Evidente, Antonio/N-9357-2013	Cimmino, Alessio/0000-0002-1551-4237; Becker, Karsten/0000-0002-6391-1341; Iannaccone, Marco/0000-0002-2283-6613; Capparelli, Rosanna/0000-0001-8614-6251; Evidente, Antonio/0000-0001-9110-1656; Giangrande, Chiara/0000-0002-0287-9958; silipo, alba/0000-0002-5394-6532; LANZETTA, Rosa/0000-0002-1472-5825; roperto, sante/0000-0001-6210-5519; BLAIOTTA, Giuseppe/0000-0002-2174-8259; AMORESANO, Angela/0000-0002-8386-655X				Baggesen DL, 1997, J CLIN MICROBIOL, V35, P330, DOI 10.1128/JCM.35.1.330-333.1997; Blaiotta G, 2004, J APPL MICROBIOL, V97, P719, DOI 10.1111/j.1365-2672.2004.02349.x; Blaiotta G, 2001, J DAIRY RES, V68, P139, DOI 10.1017/S0022029900004672; Blaiotta G, 2006, APPL ENVIRON MICROB, V72, P6117, DOI 10.1128/AEM.00773-06; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; Boyce JM, 2005, LANCET INFECT DIS, V5, P653, DOI 10.1016/S1473-3099(05)70243-7; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Capparelli R, 2010, J INFECT DIS, V201, P52, DOI 10.1086/648478; Cimmino A, 2008, CARBOHYD RES, V343, P392, DOI 10.1016/j.carres.2007.10.023; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; COYETTE J, 1968, BIOCHEMISTRY-US, V7, P2385, DOI 10.1021/bi00846a048; Dinarello CA, 1996, CURR TOP MICROBIOL, V216, P133; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; GLASER L, 1966, BIOCHIM BIOPHYS ACTA, V124, P415, DOI 10.1016/0304-4165(66)90211-X; Goerke C, 2007, ENVIRON MICROBIOL, V9, P3134, DOI 10.1111/j.1462-2920.2007.01423.x; Goodner K, 1935, J EXP MED, V62, P359, DOI 10.1084/jem.62.3.359; HORMAECHE CE, 1991, MICROB PATHOGENESIS, V10, P149, DOI 10.1016/0882-4010(91)90075-L; Hu DL, 2003, J INFECT DIS, V188, P743, DOI 10.1086/377308; Jensen MA, 2006, P NATL ACAD SCI USA, V103, P4652, DOI 10.1073/pnas.0600166103; KORMAN RZ, 1975, J BACTERIOL, V124, P724, DOI 10.1128/JB.124.2.724-730.1975; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; LACHICA RVF, 1979, J CLIN MICROBIOL, V10, P752, DOI 10.1128/JCM.10.5.752-753.1979; Lederberg J, 1996, P NATL ACAD SCI USA, V93, P3167, DOI 10.1073/pnas.93.8.3167; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Luria SE, 1943, GENETICS, V28, P491; Marris E, 2005, NAT MED, V11, P461, DOI 10.1038/nm0505-461b; Mason WJ, 2001, J CLIN MICROBIOL, V39, P3332, DOI 10.1128/JCM.39.9.3332-3338.2001; McCallum N, 2006, ANTIMICROB AGENTS CH, V50, P2352, DOI 10.1128/AAC.00073-06; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Mellmann A, 2006, PLOS MED, V3, P348, DOI 10.1371/journal.pmed.0030033; Middelboe M, 2001, MICROBIAL ECOL, V42, P395, DOI 10.1007/s00248-001-0012-1; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Nilsson IM, 1998, J CLIN INVEST, V101, P2640, DOI 10.1172/JCI1823; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Sakoulas G, 2005, ANTIMICROB AGENTS CH, V49, P2687, DOI 10.1128/AAC.49.7.2687-2692.2005; SANDERSON AR, 1962, J BIOL CHEM, V237, P3603; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Sparano JA, 2000, LANCET, V356, P1947, DOI 10.1016/S0140-6736(00)03304-3; Taborda CP, 2003, J IMMUNOL, V170, P3621, DOI 10.4049/jimmunol.170.7.3621; Telford JL, 2008, CELL HOST MICROBE, V3, P408, DOI 10.1016/j.chom.2008.05.004; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Yeh ETH, 2006, ANNU REV MED, V57, P485, DOI 10.1146/annurev.med.57.121304.131240; YOUNG FE, 1967, P NATL ACAD SCI USA, V58, P2377, DOI 10.1073/pnas.58.6.2377; Zahid MSH, 2008, INFECT IMMUN, V76, P5266, DOI 10.1128/IAI.00578-08	48	65	68	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11720	10.1371/journal.pone.0011720	http://dx.doi.org/10.1371/journal.pone.0011720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661301	Green Submitted, gold, Green Published			2022-12-27	WOS:000280243300021
J	Marshall, RM; Robles, MD; Majka, DR; Haney, JA				Marshall, Robert M.; Robles, Marcos D.; Majka, Daniel R.; Haney, Jeanmarie A.			Sustainable Water Management in the Southwestern United States: Reality or Rhetoric?	PLOS ONE			English	Article						m	FLOW; ARIZONA; GROWTH; SYSTEM	Background: While freshwater sustainability is generally defined as the provisioning of water for both people and the environment, in practice it is largely focused only on supplying water to furnish human population growth. Symptomatic of this is the state of Arizona, where rapid growth outside of the metropolitan Phoenix-Tucson corridor relies on the same groundwater that supplies year-round flow in rivers. Using Arizona as a case study, we present the first study in the southwestern United States that evaluates the potential impact of future population growth and water demand on streamflow depletion across multiple watersheds. Methodology/Principal Findings: We modeled population growth and water demand through 2050 and used four scenarios to explore the potential effects of alternative growth and water management strategies on river flows. Under the base population projection, we found that rivers in seven of the 18 study watersheds could be dewatered due to municipal demand. Implementing alternative growth and water management strategies, however, could prevent four of these rivers from being dewatered. Conclusions/Significance: The window of opportunity to implement water management strategies is narrowing. Because impacts from groundwater extraction are cumulative and cannot be immediately reversed, proactive water management strategies should be implemented where groundwater will be used to support new municipal demand. Our approach provides a low-cost method to identify where alternative water and growth management strategies may have the most impact, and demonstrates that such strategies can maintain a continued water supply for both people and the environment.	[Marshall, Robert M.; Robles, Marcos D.; Majka, Daniel R.; Haney, Jeanmarie A.] Nat Conservancy Ctr Sci & Publ Policy, Tucson, AZ USA	Nature Conservancy	Marshall, RM (corresponding author), Nat Conservancy Ctr Sci & Publ Policy, Tucson, AZ USA.	rmarshall@tnc.org			Nature Conservancy	Nature Conservancy	This study was supported by general operating funds of The Nature Conservancy, a membership-supported organization. No other entity, beyond the study's authors, had a role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ADOC, 2006, 2006 2055 COMM POP P; *ADWR, 2009, AR WAT ATL IN PRESS; *AGFD HDMS, 2009, BIOT DAT VERS 4; Alley WM, 2007, GROUND WATER, V45, P251, DOI 10.1111/j.1745-6584.2006.00274.x; Alley WM, 1999, SUSTAINABILITY GROUN, V1186; Arthington AH, 2003, RIVER RES APPL, V19, P377, DOI 10.1002/rra.745; *AUSTR GOV NAT WAT, 2005, ENV WAT PROV; *AZ DEP WAT RES, 2009, WAT RERS ISS SE AR P; Barnett TP, 2009, P NATL ACAD SCI USA, V106, P7334, DOI 10.1073/pnas.0812762106; BLINN DW, 2005, RIVERS N AM, P482; CARLSON C A, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P220; Deacon JE, 2007, BIOSCIENCE, V57, P688, DOI 10.1641/B570809; Ellis AW, 2008, CLIM RES, V35, P227, DOI 10.3354/cr00727; Flint LE, 2007, 1703 US GEOL SURV; Gleick PH, 1998, ECOL APPL, V8, P571, DOI 10.1890/1051-0761(1998)008[0571:WICPTS]2.0.CO;2; Glennon Robert., 2009, UNQUENCHABLE AM WATE; Kalf FRP, 2005, HYDROGEOL J, V13, P295, DOI 10.1007/s10040-004-0401-x; King J, 2010, FRESHWATER BIOL, V55, P127, DOI 10.1111/j.1365-2427.2009.02316.x; LEENHOUTS JM, 2006, 20065163 US GEOL SUR; *MA DEP ENV PROT, 2005, 310 MASS DEP ENV PRO; *MAG, 2005, AR GROWTH MAPS ALG; MCLAUGHLIN SP, 2004, RIPARIAN AREAS SW US, P127; MILLER RR, 1989, FISHERIES, V14, P22, DOI 10.1577/1548-8446(1989)014<0022:EONAFD>2.0.CO;2; Minckley WL, 2002, COPEIA, P687, DOI 10.1643/0045-8511(2002)002[0687:TNPSCT]2.0.CO;2; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; POSTEL SL, 2007, J AM WATER RESOUR AS, V99, P2; Santhi C, 2008, J HYDROL, V351, P139, DOI 10.1016/j.jhydrol.2007.12.018; Serrat-Capdevila A, 2007, J HYDROL, V347, P48, DOI 10.1016/j.jhydrol.2007.08.028; SOPHOCLEOUS MA, 2000, NAT RESOUR RES, V9, P99; Tharme RE, 2003, RIVER RES APPL, V19, P397, DOI 10.1002/rra.736; Theobald DM, 2005, ECOL SOC, V10; Thomas BE, 2006, 1712 US GEOL SURV; Timmons D, 2006, PRESCOTT AMA GROUNDW; *TNC, 2008, EC ASS GEOD W N AM; Travis W. R., 2005, W FUTURES LOOK PATTE; Turner DS, 2007, AQUAT CONSERV, V17, P737, DOI 10.1002/aqc.802; *US BUR RECL, 2010, SIERR VIST WAT RECL; *US FISH WILDL SER, 2010, ENV CONS ONL SYST SP; *USFWS, 1998, 88 USFWS; Webb RH, 2007, RIBBON GREEN CHANGE	40	26	26	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11687	10.1371/journal.pone.0011687	http://dx.doi.org/10.1371/journal.pone.0011687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657735	Green Published, gold			2022-12-27	WOS:000280197500026
J	Bear, A; Simons, A; Westerman, E; Monteiro, A				Bear, Ashley; Simons, Ariel; Westerman, Erica; Monteiro, Antonia			The Genetic, Morphological, and Physiological Characterization of a Dark Larval Cuticle Mutation in the Butterfly, Bicyclus anynana	PLOS ONE			English	Article							JUVENILE-HORMONE; TOBACCO HORNWORM; CUTICULAR MELANIZATION; FEMALE REPRODUCTION; COMMON CUTWORM; MANDUCA-SEXTA; L LEPIDOPTERA; PIGMENTATION; INSECT; PYRIPROXYFEN	Studies on insect melanism have greatly contributed to our understanding of natural selection and the ultimate factors influencing the evolution of darkly pigmented phenotypes. Research on several species of melanic lepidopteran larvae have found that low levels of circulating juvenile hormone (JH) titers are associated with a melanic phenotype, suggesting that genetic changes in the JH biosynthetic pathway give rise to increased deposition of melanin granules in the cuticle in this group. But does melanism arise through different molecular mechanisms in different species? The present study reports on a Bicyclus anynana (Lepidoptera: Nymphalidae) dark larvae single locus mutation, in which larvae exhibit a darker cuticle relative to wild type. Unlike other lepidopteran melanic larvae mutations, this one is autosomal recessive and does not appear to involve a deficiency in JH titers. Unlike JH deficiency mutants, dark larvae mutants display similar growth rates and sexual behaviors as wild type, and topical application of a JH analogue failed to rescue the wild type cuticular coloration. Finally, transmission electron microscopy showed that sclerotization or deposition of diffuse melanin, rather than deposition of melanin granules, produces the dark coloration found in the cuticle of this species. We conclude that different molecular mechanisms underlie larval melanism in different species of Lepidoptera.	[Bear, Ashley; Simons, Ariel; Westerman, Erica; Monteiro, Antonia] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Bear, A (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	ashley.bear@yale.edu	Monteiro, Antonia/J-6452-2013	Monteiro, Antonia/0000-0001-9696-459X	National Science Foundation [IOB 0653399]; Yale University	National Science Foundation(National Science Foundation (NSF)); Yale University	This work was funded by National Science Foundation award IOB 0653399 (http://www.nsf.gov/) and by Yale University research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FESCEMYER HW, 1988, J INSECT PHYSIOL, V34, P29, DOI 10.1016/0022-1910(88)90037-6; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Geister TL, 2008, J EXP BIOL, V211, P1587, DOI 10.1242/jeb.016725; HIRUMA K, 1993, INT J INSECT MORPHOL, V22, P103, DOI 10.1016/0020-7322(93)90003-J; HIRUMA K, 1985, J COMP PHYSIOL B, V155, P659, DOI 10.1007/BF00694579; Hiruma K, 2009, INSECT BIOCHEM MOLEC, V39, P245, DOI 10.1016/j.ibmb.2009.01.008; HUBBARD J, 2010, CELL, V39, P231; IKEMOTO H, 1983, APPL ENTOMOL ZOOL, V18, P57, DOI 10.1303/aez.18.57; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; KAYSERWEGMANN I, 1976, CELL TISSUE RES, V171, P513; Llopart A, 2002, EVOLUTION, V56, P2262; Majerus M, 1998, MELANISM EVOLUTION A; Marcus JM, 2004, P ROY SOC B-BIOL SCI, V271, pS263, DOI 10.1098/rsbl.2004.0175; MORITA M, 1988, J INSECT PHYSIOL, V34, P751, DOI 10.1016/0022-1910(88)90148-5; Nijhout H.F., 1998, INSECT HORMONES, P280; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Rajpurohit Subhash, 2008, Entomological Research, V38, P49, DOI 10.1111/j.1748-5967.2008.00129.x; Saccheri IJ, 1996, EVOLUTION, V50, P2000, DOI 10.1111/j.1558-5646.1996.tb03587.x; SAFRANEK L, 1975, J INSECT PHYSIOL, V21, P1931, DOI 10.1016/0022-1910(75)90225-5; Steigenga MJ, 2006, ENTOMOL SCI, V9, P269, DOI 10.1111/j.1479-8298.2006.00173.x; Takahashi A, 2007, GENETICS, V177, P1233, DOI 10.1534/genetics.107.075283; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; TRUMAN JW, 1973, J INSECT PHYSIOL, V19, P195, DOI 10.1016/0022-1910(73)90232-1; Tsugehara T, 2007, COMP BIOCHEM PHYS B, V147, P358, DOI 10.1016/j.cbpb.2006.10.112; Westerlund SA, 2004, ANAL BIOANAL CHEM, V379, P540, DOI 10.1007/s00216-004-2598-x; Windig JJ, 1999, HEREDITY, V82, P57, DOI 10.1038/sj.hdy.6884510; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wu MC, 2008, ARCH INSECT BIOCHEM, V68, P232, DOI 10.1002/arch.20257; Zufelato MS, 2000, ARTHROPOD STRUCT DEV, V29, P111, DOI 10.1016/S1467-8039(00)00023-2	31	17	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11563	10.1371/journal.pone.0011563	http://dx.doi.org/10.1371/journal.pone.0011563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644735	gold, Green Published, Green Submitted			2022-12-27	WOS:000279884900011
J	Christoforou, N; Oskouei, BN; Esteso, P; Hill, CM; Zimmet, JM; Bian, WN; Bursac, N; Leong, KW; Hare, JM; Gearhart, JD				Christoforou, Nicolas; Oskouei, Behzad N.; Esteso, Paul; Hill, Christine M.; Zimmet, Jeffrey M.; Bian, Weining; Bursac, Nenad; Leong, Kam W.; Hare, Joshua M.; Gearhart, John D.			Implantation of Mouse Embryonic Stem Cell-Derived Cardiac Progenitor Cells Preserves Function of Infarcted Murine Hearts	PLOS ONE			English	Article							SMOOTH-MUSCLE; TERATOMA FORMATION; ES CELLS; CARDIOMYOCYTES; TRANSPLANTATION; MULTIPOTENT; MYOCARDIUM; HOST; DIFFERENTIATION; ENGRAFTMENT	Stem cell transplantation holds great promise for the treatment of myocardial infarction injury. We recently described the embryonic stem cell-derived cardiac progenitor cells (CPCs) capable of differentiating into cardiomyocytes, vascular endothelium, and smooth muscle. In this study, we hypothesized that transplanted CPCs will preserve function of the infarcted heart by participating in both muscle replacement and neovascularization. Differentiated CPCs formed functional electromechanical junctions with cardiomyocytes in vitro and conducted action potentials over cm-scale distances. When transplanted into infarcted mouse hearts, CPCs engrafted long-term in the infarct zone and surrounding myocardium without causing teratomas or arrhythmias. The grafted cells differentiated into cross-striated cardiomyocytes forming gap junctions with the host cells, while also contributing to neovascularization. Serial echocardiography and pressure-volume catheterization demonstrated attenuated ventricular dilatation and preserved left ventricular fractional shortening, systolic and diastolic function. Our results demonstrate that CPCs can engraft, differentiate, and preserve the functional output of the infarcted heart.	[Christoforou, Nicolas; Bian, Weining; Bursac, Nenad; Leong, Kam W.] Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA; [Oskouei, Behzad N.; Hare, Joshua M.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Esteso, Paul; Hill, Christine M.; Gearhart, John D.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Zimmet, Jeffrey M.] Univ Calif San Francisco, San Francisco, CA 94143 USA	Duke University; University of Miami; University of Pennsylvania; University of California System; University of California San Francisco	Christoforou, N (corresponding author), Duke Univ, Dept Biomed Engn, Pratt Sch Engn, Durham, NC 27706 USA.	nc28@duke.edu	Leong, Kam/O-9302-2019; Bursac, Nenad/AAU-5548-2021; Leong, Kam W/A-7270-2009; Zimmet, Jeffrey/AAI-7806-2020; Bian, Weining/G-3146-2011	Leong, Kam/0000-0002-8133-4955; Bursac, Nenad/0000-0002-5688-6061; Leong, Kam W/0000-0002-8133-4955; 	Institute for Cell Engineering at Johns Hopkins University; National Heart, Lung and Blood Institute [HL083342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL083342] Funding Source: NIH RePORTER	Institute for Cell Engineering at Johns Hopkins University; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded with resources from the Institute for Cell Engineering at Johns Hopkins University. National Heart, Lung and Blood Institute grant HL083342 to N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Behfar A, 2007, J EXP MED, V204, P405, DOI 10.1084/jem.20061916; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Bursac N, 2006, CARDIOVASC RES, V69, P381, DOI 10.1016/j.cardiores.2005.09.014; Bursac N, 2004, P NATL ACAD SCI USA, V101, P15530, DOI 10.1073/pnas.0400984101; Bursac N, 2002, CIRC RES, V91, pE45, DOI 10.1161/01.RES.0000047530.88338.EB; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Ferrarini M, 2006, CIRC RES, V98, P954, DOI 10.1161/01.RES.0000217342.83731.89; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Gude NA, 2008, CIRC RES, V102, P1025, DOI 10.1161/CIRCRESAHA.107.164749; Hayashi M, 2004, CELL TRANSPLANT, V13, P639, DOI 10.3727/000000004783983558; Iravanian S, 2003, AM J PHYSIOL-HEART C, V285, pH449, DOI 10.1152/ajpheart.00896.2002; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kolossov E, 2006, J EXP MED, V203, P2315, DOI 10.1084/jem.20061469; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lien CL, 1999, DEVELOPMENT, V126, P75; Menasche P, 2009, MOL THER, V17, P758, DOI 10.1038/mt.2009.40; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Min JY, 2003, J THORAC CARDIOV SUR, V125, P361, DOI 10.1067/mtc.2003.101; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Nelson TJ, 2006, ANAT REC PART A, V288A, P1216, DOI 10.1002/ar.a.20388; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Park KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1411, DOI 10.1152/ajpcell.00447.2005; Pouzet B, 2001, ANN THORAC SURG, V71, P844, DOI 10.1016/S0003-4975(00)01785-9; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Roell W, 2007, NATURE, V450, P819, DOI 10.1038/nature06321; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Rubart M, 2003, CIRC RES, V92, P1217, DOI 10.1161/01.RES.0000075089.39335.8C; Rubart M, 2007, NAT BIOTECHNOL, V25, P993, DOI 10.1038/nbt0907-993; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SOONPAA MH, 1994, SCIENCE, V264, P98, DOI 10.1126/science.8140423; Swijnenburg RJ, 2005, CIRCULATION, V112, pI166, DOI 10.1161/CIRCULATIONAHA.104.525824; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tambara K, 2003, CIRCULATION, V108, P259, DOI 10.1161/01.cir.0000087430.17543.b8; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yamanaka S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003896; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zuppinger C, 2000, Heart Fail Rev, V5, P251, DOI 10.1023/A:1009809520194	51	51	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11536	10.1371/journal.pone.0011536	http://dx.doi.org/10.1371/journal.pone.0011536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634944	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600016
J	Calboli, FCF; Tozzi, F; Galwey, NW; Antoniades, A; Mooser, V; Preisig, M; Vollenweider, P; Waterworth, D; Waeber, G; Johnson, MR; Muglia, P; Balding, DJ				Calboli, Federico C. F.; Tozzi, Federica; Galwey, Nicholas W.; Antoniades, Athos; Mooser, Vincent; Preisig, Martin; Vollenweider, Peter; Waterworth, Dawn; Waeber, Gerard; Johnson, Michael R.; Muglia, Pierandrea; Balding, David J.			A Genome-Wide Association Study of Neuroticism in a Population-Based Sample	PLOS ONE			English	Article							PERSONALITY-TRAIT NEUROTICISM; GENERALIZED ANXIETY DISORDER; CARDIOVASCULAR RISK-FACTORS; MAJOR DEPRESSION; LINKAGE ANALYSIS; ALZHEIMERS-DISEASE; 1ST ONSET; TWIN; HERITABILITY; GENES	Neuroticism is a moderately heritable personality trait considered to be a risk factor for developing major depression, anxiety disorders and dementia. We performed a genome-wide association study in 2,235 participants drawn from a population-based study of neuroticism, making this the largest association study for neuroticism to date. Neuroticism was measured by the Eysenck Personality Questionnaire. After Quality Control, we analysed 430,000 autosomal SNPs together with an additional 1.2 million SNPs imputed with high quality from the Hap Map CEU samples. We found a very small effect of population stratification, corrected using one principal component, and some cryptic kinship that required no correction. NKAIN2 showed suggestive evidence of association with neuroticism as a main effect (p<10(-6)) and GPC6 showed suggestive evidence for interaction with age (p approximate to 10(-7)). We found support for one previously-reported association (PDE4D), but failed to replicate other recent reports. These results suggest common SNP variation does not strongly influence neuroticism. Our study was powered to detect almost all SNPs explaining at least 2% of heritability, and so our results effectively exclude the existence of loci having a major effect on neuroticism.	[Calboli, Federico C. F.; Balding, David J.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Tozzi, Federica] GlaxoSmithKline R&D, Div Genet, Drug Discovery, Verona, Italy; [Galwey, Nicholas W.] GlaxoSmithKline, Discovery Biometr Resp, Greenford, Middx, England; [Antoniades, Athos] Univ Cyprus, Dept Comp Sci, Nicosia, Cyprus; [Mooser, Vincent; Waterworth, Dawn] GlaxoSmithKline R&D, Drug Discovery, Div Genet, Upper Merion, PA USA; [Preisig, Martin] Univ Hosp Ctr, Dept Psychiat, Lausanne, Switzerland; [Preisig, Martin; Vollenweider, Peter; Waeber, Gerard] Univ Lausanne, Lausanne, Switzerland; [Vollenweider, Peter; Waeber, Gerard] Univ Hosp Ctr, Dept Internal Med, Lausanne, Switzerland; [Johnson, Michael R.] Univ London Imperial Coll Sci Technol & Med, Dept Clin Neurosci, London, England; [Muglia, Pierandrea] GlaxoSmithKline R&D, Neurosci CEDD, Discovery Med, Verona, Italy; [Balding, David J.] UCL, Genet Inst, London, England	Imperial College London; GlaxoSmithKline; GlaxoSmithKline; University of Cyprus; GlaxoSmithKline; University of Lausanne; Imperial College London; GlaxoSmithKline; University of London; University College London	Calboli, FCF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England.	f.calboli@imperial.ac.uk	Tozzi, Federica/AAP-5462-2021; Muglia, Pierandrea/ABD-9235-2020; Balding, David/G-9898-2011; Colaus, PsyColaus/K-6607-2013	Tozzi, Federica/0000-0002-3536-2920; Muglia, Pierandrea/0000-0002-3973-8606; Balding, David/0000-0002-1480-6115; Antoniades, Athos/0000-0002-5789-5103; Preisig, Martin/0000-0001-5689-4259; Waeber, Gerard/0000-0003-4193-788X	Swiss National Science Foundation [3200B0-105993, 3200B0-118308, 33CSCO-122661]; GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, RD)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, RD)(GlaxoSmithKline)	The PsyCoLaus study was supported by grants from the Swiss National Science Foundation (#3200B0-105993, #3200B0-118308, 33CSCO-122661) and from GlaxoSmithKline (Psychiatry Center of Excellence for Drug Discovery and Genetics Division, Drug Discovery - Verona, R&D). F. Calboli was supported by a GSK grant to Imperial College London. GlaxoSmithKline had a role in study design, data analysis, decision to publish, and preparation of the manuscript: F. Tozzi, V. Mooser, D. Waterworth and N. W. Galwey are GlaxoSmithKline full-time employees. P. Muglia was a GlaxoSmithKline full-time employee at the time when this study was performed. M. Johnson was a GSK consultant at the time when the project was initiated.; The authors would like to express their gratitude to the Lausanne inhabitants who volunteered to participate in the PsyCoLaus study. We would also like to thank all the CoLaus investigators, and the PsyColaus investigators who have contributed to the recruitment, Marie-Louise Matthey, Christiane Shalofsky, Georgette Jungo, Stephane Rothen, Lajos Oros and Gioia Roccia, as well as many GSK employees who contributed to the execution of this study including Alun McCarthy, Paul Matthews, and especially Emiliangelo Ratti for supporting this work within GSK Drug Discovery. Special thanks also go to Allen Roses and Lefkos Middleton. Thanks to William Astle for providing code and assistance for the mixed-model analysis.	ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Beasley C, 2001, NEUROSCI LETT, V302, P117, DOI 10.1016/S0304-3940(01)01688-3; Birley AJ, 2006, PERS INDIV DIFFER, V40, P737, DOI 10.1016/j.paid.2005.09.005; Bocciardi R, 2005, HUM MUTAT, V26, P426, DOI 10.1002/humu.20235; Bouchard TJ, 2001, BEHAV GENET, V31, P243; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Christensen MV, 2006, NORD J PSYCHIAT, V60, P79, DOI 10.1080/08039480600600300; Cotton CH, 2009, NATURE, V458, pE6, DOI 10.1038/nature07927; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; Eaves L J, 1998, Twin Res, V1, P131, DOI 10.1375/twin.1.3.131; Eysenck H.J., 1975, MANUAL EYSENCK PERSO; Fanous A, 2002, PSYCHOL MED, V32, P719, DOI 10.1017/S003329170200541X; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; FLODERUSMYRHED B, 1980, BEHAV GENET, V10, P153, DOI 10.1007/BF01066265; FOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hettema JM, 2006, AM J PSYCHIAT, V163, P857, DOI 10.1176/appi.ajp.163.5.857; Hettema JM, 2004, AM J PSYCHIAT, V161, P1581, DOI 10.1176/appi.ajp.161.9.1581; HIRSCHFELD RMA, 1989, ARCH GEN PSYCHIAT, V46, P345; Huezo-Diaz Patricia, 2005, Curr Psychiatry Rep, V7, P117, DOI 10.1007/s11920-005-0008-5; Inestrosa NC, 2007, IUBMB LIFE, V59, P316, DOI 10.1080/15216540701242490; Ising M, 2004, ACTA PSYCHIAT SCAND, V109, P332, DOI 10.1111/j.1600-0447.2004.00309.x; Jang KL, 1996, J PERS, V64, P577, DOI 10.1111/j.1467-6494.1996.tb00522.x; JARDINE R, 1984, Genetic Epidemiology, V1, P89, DOI 10.1002/gepi.1370010202; JORM AF, 1987, AUST NZ J PSYCHIAT, V21, P501, DOI 10.3109/00048678709158917; Kendler KS, 2004, AM J PSYCHIAT, V161, P631, DOI 10.1176/appi.ajp.161.4.631; KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P853; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Kuo PH, 2007, AM J MED GENET B, V144B, P463, DOI 10.1002/ajmg.b.30478; Lake RIE, 2000, BEHAV GENET, V30, P223, DOI 10.1023/A:1001918408984; Li Meijuan, 2008, J Biomol Tech, V19, P122; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Martin N, 2000, Twin Res, V3, P310, DOI 10.1375/twin.3.4.310; Mathew SJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2080, DOI 10.1038/sj.npp.1301652; Nash MW, 2004, HUM MOL GENET, V13, P2173, DOI 10.1093/hmg/ddh239; Neale BM, 2005, AM J MED GENET B, V132B, P65, DOI 10.1002/ajmg.b.30095; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Preisig M, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shifman S, 2008, MOL PSYCHIATR, V13, P302, DOI 10.1038/sj.mp.4002048; van den Oord EJCG, 2008, ARCH GEN PSYCHIAT, V65, P1062, DOI 10.1001/archpsyc.65.9.1062; VIKEN RJ, 1994, J PERS SOC PSYCHOL, V66, P722, DOI 10.1037/0022-3514.66.4.722; Wang HX, 2009, NEUROLOGY, V72, P253, DOI 10.1212/01.wnl.0000339485.39246.87; Wilson RS, 2003, NEUROLOGY, V61, P1479, DOI 10.1212/01.WNL.0000096167.56734.59; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhou ZF, 2008, NATURE, V452, P997, DOI 10.1038/nature06858	49	60	63	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11504	10.1371/journal.pone.0011504	http://dx.doi.org/10.1371/journal.pone.0011504			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634892	Green Published, gold			2022-12-27	WOS:000279715300015
J	Marella, M; Seo, BB; Thomas, BB; Matsuno-Yagi, A; Yagi, T				Marella, Mathieu; Seo, Byoung Boo; Thomas, Biju B.; Matsuno-Yagi, Akemi; Yagi, Takao			Successful Amelioration of Mitochondrial Optic Neuropathy Using the Yeast NDI1 Gene in a Rat Animal Model	PLOS ONE			English	Article							NADH-QUINONE OXIDOREDUCTASE; COMPLEX-I DEFECTS; OPTIMIZED ALLOTOPIC EXPRESSION; SACCHAROMYCES-CEREVISIAE; DEHYDROGENASE NDI1; SUBUNIT; THERAPY; CELLS; DEATH; UBIQUINONE	Background: Leber's hereditary optic neuropathy (LHON) is a maternally inherited disorder with point mutations in mitochondrial DNA which result in loss of vision in young adults. The majority of mutations reported to date are within the genes encoding the subunits of the mitochondrial NADH-quinone oxidoreductase, complex I. Establishment of animal models of LHON should help elucidate mechanism of the disease and could be utilized for possible development of therapeutic strategies. Methodology/Principal Findings: We established a rat model which involves injection of rotenone-loaded microspheres into the optic layer of the rat superior colliculus. The animals exhibited the most common features of LHON. Visual loss was observed within 2 weeks of rotenone administration with no apparent effect on retinal ganglion cells. Death of retinal ganglion cells occurred at a later stage. Using our rat model, we investigated the effect of the yeast alternative NADH dehydrogenase, Ndi1. We were able to achieve efficient expression of the Ndi1 protein in the mitochondria of all regions of retinal ganglion cells and axons by delivering the NDI1 gene into the optical layer of the superior colliculus. Remarkably, even after the vision of the rats was severely impaired, treatment of the animals with the NDI1 gene led to a complete restoration of the vision to the normal level. Control groups that received either empty vector or the GFP gene had no effects. Conclusions/Significance: The present study reports successful manifestation of LHON-like symptoms in rats and demonstrates the potential of the NDI1 gene therapy on mitochondrial optic neuropathies. Our results indicate a window of opportunity for the gene therapy to be applied successfully after the onset of the disease symptoms.	[Marella, Mathieu; Seo, Byoung Boo; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Thomas, Biju B.] Univ So Calif, Keck Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA	Scripps Research Institute; Doheny Eye Institute; University of Southern California	Marella, M (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yagi@scripps.edu			U.S. Public Health Service [R01NS048441, R01DK053244]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048441] Funding Source: NIH RePORTER	U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. Public Health Service Grants R01NS048441 and R01DK053244 (to T.Y. and A.M.-Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahadorani S, 2010, AGING CELL, V9, P191, DOI 10.1111/j.1474-9726.2010.00546.x; Bai YD, 2001, J BIOL CHEM, V276, P38808, DOI 10.1074/jbc.M106363200; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Barber-Singh J, 2009, REJUV RES, V12, P259, DOI 10.1089/rej.2009.0854; Bonnet C, 2008, BBA-MOL CELL RES, V1783, P1707, DOI 10.1016/j.bbamcr.2008.04.018; Brandon MC, 2005, NUCLEIC ACIDS RES, V33, pD611; Carelli V, 2004, BBA-BIOENERGETICS, V1658, P172, DOI 10.1016/j.bbabio.2004.05.009; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; DeCorby A, 2007, BBA-BIOENERGETICS, V1767, P1157, DOI 10.1016/j.bbabio.2007.07.003; DiMauro S, 2009, BBA-MOL BASIS DIS, V1792, P1159, DOI 10.1016/j.bbadis.2008.10.015; Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; HART J, 1994, MICROCONTAMINATION, V12, P63; Howell N, 1997, VISION RES, V37, P3495, DOI 10.1016/S0042-6989(96)00167-8; Kelso GF, 2001, J BIOL CHEM, V276, P4588, DOI 10.1074/jbc.M009093200; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Levin LA, 2007, CAN J OPHTHALMOL, V42, P403, DOI 10.3129/i07-046; Ludtke H, 1999, GRAEF ARCH CLIN EXP, V237, P207, DOI 10.1007/s004170050220; MAAS MF, 2010, J MOL BIOL; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Marella M, 2009, J BIOENERG BIOMEMBR, V41, P493, DOI 10.1007/s10863-009-9249-z; Martin KRG, 2004, EYE, V18, P1049, DOI 10.1038/sj.eye.6701579; Nikoskelainen EK, 1996, OPHTHALMOLOGY, V103, P504; Park SH, 2007, IET OPTOELECTRON, V1, P42, DOI 10.1049/iet-opt:20060058; Perier C, 2005, P NATL ACAD SCI USA, V102, P19126, DOI 10.1073/pnas.0508215102; Pezzi PP, 1998, PEDIATR NEUROL, V19, P308, DOI 10.1016/S0887-8994(98)00060-5; Qi XP, 2003, ANN NEUROL, V53, P198, DOI 10.1002/ana.10426; Sanz A, 2010, P NATL ACAD SCI USA, V107, P9105, DOI 10.1073/pnas.0911539107; Seo BB, 1998, P NATL ACAD SCI USA, V95, P9167, DOI 10.1073/pnas.95.16.9167; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 1999, BBA-BIOENERGETICS, V1412, P56, DOI 10.1016/S0005-2728(99)00051-1; Seo BB, 2004, HUM GENE THER, V15, P887, DOI 10.1089/1043034041839217; Seo BB, 2002, MOL THER, V6, P336, DOI 10.1006/mthe.2002.0674; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; STONE EM, 1992, J CLIN NEURO-OPHTHAL, V12, P10; Thomas BB, 2004, J NEUROSCI METH, V138, P7, DOI 10.1016/j.jneumeth.2004.03.007; WAKAKURA M, 1995, BRIT J OPHTHALMOL, V79, P442, DOI 10.1136/bjo.79.5.442; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; Yagi T, 2006, BBA-BIOENERGETICS, V1757, P708, DOI 10.1016/j.bbabio.2006.01.011; Zanna C, 2005, APOPTOSIS, V10, P997, DOI 10.1007/s10495-005-0742-5; Zhang X, 2002, NEUROSCI LETT, V326, P97, DOI 10.1016/S0304-3940(02)00327-0	49	68	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11472	10.1371/journal.pone.0011472	http://dx.doi.org/10.1371/journal.pone.0011472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628600	Green Published, Green Submitted, gold			2022-12-27	WOS:000279637100005
J	Larsen, PE; Trivedi, G; Sreedasyam, A; Lu, V; Podila, GK; Collart, FR				Larsen, Peter E.; Trivedi, Geetika; Sreedasyam, Avinash; Lu, Vincent; Podila, Gopi K.; Collart, Frank R.			Using Deep RNA Sequencing for the Structural Annotation of the Laccaria Bicolor Mycorrhizal Transcriptome	PLOS ONE			English	Article							PROTEIN FUNCTION; ECTOMYCORRHIZAL SYMBIOSIS; DNA-SEQUENCES; GENOME; GENE; SEQ; PREDICTION; ACCURACY; FUNGI; TOOL	Background: Accurate structural annotation is important for prediction of function and required for in vitro approaches to characterize or validate the gene expression products. Despite significant efforts in the field, determination of the gene structure from genomic data alone is a challenging and inaccurate process. The ease of acquisition of transcriptomic sequence provides a direct route to identify expressed sequences and determine the correct gene structure. Methodology: We developed methods to utilize RNA-seq data to correct errors in the structural annotation and extend the boundaries of current gene models using assembly approaches. The methods were validated with a transcriptomic data set derived from the fungus Laccaria bicolor, which develops a mycorrhizal symbiotic association with the roots of many tree species. Our analysis focused on the subset of 1501 gene models that are differentially expressed in the free living vs. mycorrhizal transcriptome and are expected to be important elements related to carbon metabolism, membrane permeability and transport, and intracellular signaling. Of the set of 1501 gene models, 1439 (96%) successfully generated modified gene models in which all error flags were successfully resolved and the sequences aligned to the genomic sequence. The remaining 4% (62 gene models) either had deviations from transcriptomic data that could not be spanned or generated sequence that did not align to genomic sequence. The outcome of this process is a set of high confidence gene models that can be reliably used for experimental characterization of protein function. Conclusions: 69% of expressed mycorrhizal JGI "best'' gene models deviated from the transcript sequence derived by this method. The transcriptomic sequence enabled correction of a majority of the structural inconsistencies and resulted in a set of validated models for 96% of the mycorrhizal genes. The method described here can be applied to improve gene structural annotation in other species, provided that there is a sequenced genome and a set of gene models.	[Larsen, Peter E.; Lu, Vincent; Collart, Frank R.] Argonne Natl Lab, Biosci Div, Lemont, IL USA; [Trivedi, Geetika; Sreedasyam, Avinash; Podila, Gopi K.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Alabama System; University of Alabama Huntsville	Larsen, PE (corresponding author), Argonne Natl Lab, Biosci Div, Lemont, IL USA.	fcollart@anl.gov		Collart, Frank/0000-0001-6942-4483	US Department of Energy (DOE) Office of Biological and Environmental Research	US Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE))	The submitted manuscript has been created by UChicago Argonne, LLC, Operator of Argonne National Laboratory ("Argonne''). Argonne, a U.S. Department of Energy Office of Science laboratory, is operated under Contract No. DE-AC02-06CH11357. The authors have been supported by the US Department of Energy (DOE) Office of Biological and Environmental Research (http://www.sc.doe.gov/ober/ober_top.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brent MR, 2008, NAT REV GENET, V9, P62, DOI 10.1038/nrg2220; Cseke L.J., 2004, HDB MOL CELLULAR MET; Friedberg I, 2006, BRIEF BIOINFORM, V7, P225, DOI 10.1093/bib/bbl004; Guigo R, 2000, GENOME RES, V10, P1631, DOI 10.1101/gr.122800; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Harley J.L., 1983, MYCORRHIZAL SYMBIOSI; Ho EC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-334; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang XQ, 1997, GENOMICS, V46, P37, DOI 10.1006/geno.1997.4984; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Kim SJ, 1998, GENE, V222, P203, DOI 10.1016/S0378-1119(98)00483-1; Koide RT, 2008, NEW PHYTOL, V178, P230, DOI 10.1111/j.1469-8137.2008.02401.x; Kupfer DM, 2004, EUKARYOT CELL, V3, P1088, DOI 10.1128/EC.3.5.1088-1100.2004; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nehls U, 2008, J EXP BOT, V59, P1097, DOI 10.1093/jxb/erm334; Nehls U, 2007, PHYTOCHEMISTRY, V68, P82, DOI 10.1016/j.phytochem.2006.09.024; Raes J, 2007, CURR OPIN STRUC BIOL, V17, P362, DOI 10.1016/j.sbi.2007.05.010; Reese MG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s1; Sadowski MI, 2009, CURR OPIN STRUC BIOL, V19, P357, DOI 10.1016/j.sbi.2009.03.008; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; Stothard P, 2006, CURR OPIN MICROBIOL, V9, P505, DOI 10.1016/j.mib.2006.08.002; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valencia A, 2005, CURR OPIN STRUC BIOL, V15, P267, DOI 10.1016/j.sbi.2005.05.010; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WILHELM BT, 2009, METHODS	31	20	20	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e9780	10.1371/journal.pone.0009780	http://dx.doi.org/10.1371/journal.pone.0009780			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625404	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500001
J	Scheper, J; Guerra-Rebollo, M; Sanclimens, G; Moure, A; Masip, I; Gonzalez-Ruiz, D; Rubio, N; Crosas, B; Meca-Cortes, O; Loukili, N; Plans, V; Morreale, A; Blanco, J; Ortiz, AR; Messeguer, A; Thomson, TM				Scheper, Johanna; Guerra-Rebollo, Marta; Sanclimens, Gloria; Moure, Alejandra; Masip, Isabel; Gonzalez-Ruiz, Domingo; Rubio, Nuria; Crosas, Bernat; Meca-Cortes, Oscar; Loukili, Noureddine; Plans, Vanessa; Morreale, Antonio; Blanco, Jeronimo; Ortiz, Angel R.; Messeguer, Angel; Thomson, Timothy M.			Protein-Protein Interaction Antagonists as Novel Inhibitors of Non-Canonical Polyubiquitylation	PLOS ONE			English	Article							NF-KAPPA-B; UBIQUITIN-CONJUGATING ENZYME; PROSTATE-CANCER CELLS; RING FINGER PROTEIN; CHIRAL SIDE-CHAINS; DNA-REPAIR; LYSINE-63 POLYUBIQUITINATION; CRYSTAL-STRUCTURE; DRUG-RESISTANCE; ACTIVATION	Background: pathways that control cell survival under stress, namely RNF8-dependent DNA damage recognition and repair, PCNA-dependent DNA damage tolerance and activation of NF-kappa B by extrinsic signals, are regulated by the tagging of key proteins with lysine 63-based polyubiquitylated chains, catalyzed by the conserved ubiquitin conjugating heterodimeric enzyme Ubc13-Uev. Methodology/Principal Findings: By applying a selection based on in vivo protein-protein interaction assays of compounds from a combinatorial chemical library followed by virtual screening, we have developed small molecules that efficiently antagonize the Ubc13-Uev1 protein-protein interaction, inhibiting the enzymatic activity of the heterodimer. In mammalian cells, they inhibit lysine 63-type polyubiquitylation of PCNA, inhibit activation of NF-kappa B by TNF-alpha and sensitize tumor cells to chemotherapeutic agents. One of these compounds significantly inhibited invasiveness, clonogenicity and tumor growth of prostate cancer cells. Conclusions/Significance: This is the first development of pharmacological inhibitors of non-canonical polyubiquitylation that show that these compounds produce selective biological effects with potential therapeutic applications.	[Scheper, Johanna; Guerra-Rebollo, Marta; Crosas, Bernat; Meca-Cortes, Oscar; Loukili, Noureddine; Plans, Vanessa; Thomson, Timothy M.] CSIC, IBMB, Inst Mol Biol, Dept Cell Biol, Barcelona, Spain; [Sanclimens, Gloria; Moure, Alejandra; Masip, Isabel; Messeguer, Angel] CSIC, IQAC, Inst Adv Chem Catalonia, Dept Biol Organ Chem, Barcelona, Spain; [Gonzalez-Ruiz, Domingo; Morreale, Antonio; Ortiz, Angel R.] CSIC, UAM, CBM, Ctr Biol Mol Severo Ochoa,Bioinformat Unit, Madrid, Spain; [Rubio, Nuria; Blanco, Jeronimo] CSIC, CIC, Catalan Ctr Cardiovasc Res, Barcelona, Spain; [Rubio, Nuria; Blanco, Jeronimo] CIBER Bioingn Biomat & Nanomed, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN	Scheper, J (corresponding author), CSIC, IBMB, Inst Mol Biol, Dept Cell Biol, Barcelona, Spain.	titbmc@cid.csic.es	Blanco, Jeronimo/H-2764-2015; Thomson, Timothy/Z-6271-2019; Meca-Cortés, Oscar/H-3257-2015; Guerra-Rebollo, Marta/H-3199-2015; Rubio, Nuria/H-3156-2015	Blanco, Jeronimo/0000-0003-3765-0640; Thomson, Timothy/0000-0002-4670-9440; Meca-Cortés, Oscar/0000-0002-7389-9956; Guerra-Rebollo, Marta/0000-0002-3731-4527; Rubio, Nuria/0000-0003-2471-4684; Messeguer, Angel/0000-0002-8358-9425	Consejo Superior de Investigaciones Cientificas [PIF200580]; Ministerio de Educacion y Ciencia [SAF2005-05109-CO2-01, CTQ2005-00995, GEN2003-20642-C09-09, BIO2005-0576, GEN2003-206420-C09-08]; Comunidad de Madrid [GR/SAL/0306/2004, 200520M157]; Fundacion Ramon Areces; Ministerio de Educacion y Ciencia; Consejo Superior de Investigaciones Cientificas	Consejo Superior de Investigaciones Cientificas; Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Fundacion Ramon Areces; Ministerio de Educacion y Ciencia(Spanish Government); Consejo Superior de Investigaciones Cientificas	This work was funded by grants from the Consejo Superior de Investigaciones Cientificas (PIF200580 to T.M.T., A.R.O. and A. Messeguer), the Ministerio de Educacion y Ciencia (SAF2005-05109-CO2-01 to T.M.T.; CTQ2005-00995 and GEN2003-20642-C09-09 to A. Messeguer; BIO2005-0576, and GEN2003-206420-C09-08 to A.R.O.), the Comunidad de Madrid (GR/SAL/0306/2004 and 200520M157 to A.R.O.), and an institutional grant from the Fundacion Ramon Areces. J.S. and M. G. R. are receipients of fellowships from the Ministerio de Educacion y Ciencia, and A. Moure of a I3P fellowship from the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PL, 2005, J CELL BIOL, V170, P745, DOI 10.1083/jcb.200502113; Armand P, 1998, P NATL ACAD SCI USA, V95, P4309, DOI 10.1073/pnas.95.8.4309; Banerjee R, 2002, CHEMBIOCHEM, V3, P1263, DOI 10.1002/1439-7633(20021202)3:12<1263::AID-CBIC1263>3.0.CO;2-O; Bianchi K, 2009, MOL CELL, V36, P736, DOI 10.1016/j.molcel.2009.11.029; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiu RK, 2006, PLOS GENET, V2, P1070, DOI 10.1371/journal.pgen.0020116; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Fojo T, 2003, ONCOGENE, V22, P7512, DOI 10.1038/sj.onc.1206951; Fry DC, 2005, J MOL MED, V83, P955, DOI 10.1007/s00109-005-0705-x; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; Grunwald V, 2002, CANCER RES, V62, P6141; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Huang H, 2001, J BIOL CHEM, V276, P38830, DOI 10.1074/jbc.M103632200; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Jang HJ, 2005, ORG LETT, V7, P1951, DOI 10.1021/ol050371q; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lay JD, 2007, CANCER RES, V67, P3878, DOI 10.1158/0008-5472.CAN-06-3191; Linusson A, 1998, MOL DIVERS, V4, P103, DOI 10.1023/A:1026416430656; Masip I, 2005, BIOORGAN MED CHEM, V13, P1923, DOI 10.1016/j.bmc.2005.01.024; McKenna S, 2003, BIOCHEMISTRY-US, V42, P7922, DOI 10.1021/bi034480t; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; McKenna S, 2001, J BIOL CHEM, V276, P40120, DOI 10.1074/jbc.M102858200; Mondesire WH, 2004, CLIN CANCER RES, V10, P7031, DOI 10.1158/1078-0432.CCR-04-0361; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Pastushok L, 2005, J BIOL CHEM, V280, P17891, DOI 10.1074/jbc.M410469200; Perez C, 2001, J MED CHEM, V44, P3768, DOI 10.1021/jm010141r; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Rubio N, 1998, LAB INVEST, V78, P1315; Sanborn TJ, 2002, BIOPOLYMERS, V63, P12, DOI 10.1002/bip.1058; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Shukla S, 2004, CLIN CANCER RES, V10, P3169, DOI 10.1158/1078-0432.CCR-03-0586; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sun HY, 2004, J AM CHEM SOC, V126, P16686, DOI 10.1021/ja047438+; TAI KY, 2008, ONCOGENE; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; THOMSON TM, BIOCH SOC T, V38, P116; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Ulrich HD, 2007, BIOCHEM SOC T, V35, P1334, DOI 10.1042/BST0351334; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037	62	29	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11403	10.1371/journal.pone.0011403	http://dx.doi.org/10.1371/journal.pone.0011403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613989	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000028
J	Brown, ME; Rondon, E; Rajesh, D; Mack, A; Lewis, R; Feng, XZ; Zitur, LJ; Learish, RD; Nuwaysir, EF				Brown, Matthew E.; Rondon, Elizabeth; Rajesh, Deepika; Mack, Amanda; Lewis, Rachel; Feng, Xuezhu; Zitur, Laura Jo; Learish, Randall D.; Nuwaysir, Emile F.			Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes	PLOS ONE			English	Article							CANCER REGRESSION; GENERATION; DIFFERENTIATION; CULTURE	Induced pluripotent stem cells (iPSCs) hold enormous potential for the development of personalized in vitro disease models, genomic health analyses, and autologous cell therapy. Here we describe the generation of T lymphocyte-derived iPSCs from small, clinically advantageous volumes of non-mobilized peripheral blood. These T-cell derived iPSCs ("TiPS'') retain a normal karyotype and genetic identity to the donor. They share common characteristics with human embryonic stem cells (hESCs) with respect to morphology, pluripotency-associated marker expression and capacity to generate neurons, cardiomyocytes, and hematopoietic progenitor cells. Additionally, they retain their characteristic T-cell receptor (TCR) gene rearrangements, a property which could be exploited for iPSC clone tracking and T-cell development studies. Reprogramming T-cells procured in a minimally invasive manner can be used to characterize and expand donor specific iPSCs, and control their differentiation into specific lineages.	[Brown, Matthew E.; Rondon, Elizabeth; Rajesh, Deepika; Mack, Amanda; Lewis, Rachel; Feng, Xuezhu; Zitur, Laura Jo; Learish, Randall D.; Nuwaysir, Emile F.] Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA		Brown, ME (corresponding author), Cellular Dynam Int Inc, Dept Res & Dev, Madison, WI USA.	enuwaysir@cellulardynamics.com	feng, xuezhu/F-3223-2013	ZITUR, LAURA/0000-0002-1238-2726; Rajesh, Deepika/0000-0002-8820-4328	Cellular Dynamics International, Inc.	Cellular Dynamics International, Inc.	This study was supported by research funding from Cellular Dynamics International, Inc. to all authors. The funder had a role in the decision to publish the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Appelbaum F, 2009, THOMAS HEMATOPOIETIC; Berger C, 2003, BLOOD, V101, P476, DOI 10.1182/blood-2002-07-2142; Chatenoud L, 2005, CURR OPIN IMMUNOL, V17, P632, DOI 10.1016/j.coi.2005.09.011; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Johnson LA, 2009, BLOOD, V114, P535, DOI 10.1182/blood-2009-03-211714; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kleeberger CA, 1999, CLIN DIAGN LAB IMMUN, V6, P14, DOI 10.1128/CDLI.6.1.14-19.1999; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Lichtman M, 2006, WILLIAMS HEMATOLOGY, Vseventh; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Saito H, 2006, NAT PROTOC, V1, P2178, DOI 10.1038/nprot.2006.344; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Lent AU, 2007, J IMMUNOL, V179, P4959, DOI 10.4049/jimmunol.179.8.4959; YE Z, 2009, BLOOD; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	30	107	120	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11373	10.1371/journal.pone.0011373	http://dx.doi.org/10.1371/journal.pone.0011373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20617191	gold, Green Submitted, Green Published			2022-12-27	WOS:000279369900021
J	Sheppard Brennand, H; Soars, N; Dworjanyn, SA; Davis, AR; Byrne, M				Sheppard Brennand, Hannah; Soars, Natalie; Dworjanyn, Symon A.; Davis, Andrew R.; Byrne, Maria			Impact of Ocean Warming and Ocean Acidification on Larval Development and Calcification in the Sea Urchin Tripneustes gratilla	PLOS ONE			English	Article							PHENOTYPIC PLASTICITY; EMBRYONIC-DEVELOPMENT; CLIMATE-CHANGE; TEMPERATURE; FERTILIZATION; ECOLOGY; CARBON; CO2; ECHINODERMATA; SURVIVAL	Background: As the oceans simultaneously warm, acidify and increase in P-CO2, prospects for marine biota are of concern. Calcifying species may find it difficult to produce their skeleton because ocean acidification decreases calcium carbonate saturation and accompanying hypercapnia suppresses metabolism. However, this may be buffered by enhanced growth and metabolism due to warming. Methodology/Principal Findings: We examined the interactive effects of near-future ocean warming and increased acidification/P-CO2 on larval development in the tropical sea urchin Tripneustes gratilla. Larvae were reared in multifactorial experiments in flow-through conditions in all combinations of three temperature and three pH/P-CO2 treatments. Experiments were placed in the setting of projected near future conditions for SE Australia, a global change hot spot. Increased acidity/P-CO2 and decreased carbonate mineral saturation significantly reduced larval growth resulting in decreased skeletal length. Increased temperature (+3 degrees C) stimulated growth, producing significantly bigger larvae across all pH/P-CO2 treatments up to a thermal threshold (+6 degrees C). Increased acidity (-0.3-0.5 pH units) and hypercapnia significantly reduced larval calcification. A +3 degrees C warming diminished the negative effects of acidification and hypercapnia on larval growth. Conclusions and Significance: This study of the effects of ocean warming and CO2 driven acidification on development and calcification of marine invertebrate larvae reared in experimental conditions from the outset of development (fertilization) shows the positive and negative effects of these stressors. In simultaneous exposure to stressors the dwarfing effects of acidification were dominant. Reduction in size of sea urchin larvae in a high P-CO2 ocean would likely impair their performance with negative consequent effects for benthic adult populations.	[Sheppard Brennand, Hannah; Soars, Natalie; Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Dworjanyn, Symon A.] So Cross Univ, Natl Marine Sci Ctr, Coffs Harbour, NSW, Australia; [Davis, Andrew R.] Univ Wollongong, Inst Conservat Biol, Wollongong, NSW, Australia; [Byrne, Maria] Univ Sydney, Sch Med, Sydney, NSW 2006, Australia; [Byrne, Maria] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney; Southern Cross University; University of Wollongong; University of Sydney; University of Sydney	Sheppard Brennand, H (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia.	mbyrne@anatomy.usyd.edu.au	Dworjanyn, Symon A/O-5633-2017; Davis, Andy/H-3607-2011; Soars, Natalie A/M-7476-2013; Sheppard-Brennand, Hannah/N-7120-2013; Byrne, Maria/K-6355-2016	Dworjanyn, Symon A/0000-0002-6690-8033; Davis, Andy/0000-0002-8146-7424; Sheppard-Brennand, Hannah/0000-0002-2063-1905; Byrne, Maria/0000-0002-8902-9808	Australian Research Council	Australian Research Council(Australian Research Council)	The study was funded by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Contribution #, Institute for Conservation Biology and # from Sydney Institute of Marine Science.	Allen JD, 2008, BIOL BULL-US, V214, P42, DOI 10.2307/25066658; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Byrne M, 2008, FUNCT ECOL, V22, P643, DOI 10.1111/j.1365-2435.2008.01427.x; BYRNE M, 2010, DEEP SEA 2 IN PRESS; Byrne M, 2010, CLIMATE ALERT: CLIMATE CHANGE MONITORING AND STRATEGY, P169; Byrne M, 2010, MAR BIOL, V157, P2061, DOI 10.1007/s00227-010-1474-9; Byrne M, 2010, MAR ENVIRON RES, V69, P234, DOI 10.1016/j.marenvres.2009.10.014; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dubois P., 1989, Echinoderm Studies, V3, P109; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; Dupont S, 2008, MAR ECOL PROG SER, V373, P285, DOI 10.3354/meps07800; Dworjanyn SA, 2007, AQUACULTURE, V273, P624, DOI 10.1016/j.aquaculture.2007.08.023; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Findlay HS, 2010, MAR BIOL, V157, P725, DOI 10.1007/s00227-009-1356-1; FUJISAWA H, 1989, BIOL BULL, V176, P96, DOI 10.2307/1541576; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Juinio-Menez Marie Antonette, 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P393; KOIKE I, 1987, Ecological Research, V2, P19, DOI 10.1007/BF02348616; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lamare MD, 1999, MAR ECOL PROG SER, V180, P197, DOI 10.3354/meps180197; LAWRENCE JM, 2007, BIOL ECOLOGY EDIBLE, P499; Lawrence JM, 2007, DEV AQUAC FISH SCI, V37, P499; Marshall DJ, 2006, INTEGR COMP BIOL, V46, P643, DOI 10.1093/icb/icl013; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; Morse JW, 2007, CHEM REV, V107, P342, DOI 10.1021/cr050358j; Negri AP, 2007, CORAL REEFS, V26, P759, DOI 10.1007/s00338-007-0258-2; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Parker LM, 2009, GLOBAL CHANGE BIOL, V15, P2123, DOI 10.1111/j.1365-2486.2009.01895.x; Pierrot D., 2006, ORNLCDIAC105A US DEP; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Rahman S, 2009, BIOLOGIA, V64, P768, DOI 10.2478/s11756-009-0135-2; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2010, MAR ECOL-EVOL PERSP, V31, P447, DOI 10.1111/j.1439-0485.2009.00354.x; RUPP JH, 1973, MAR BIOL, V23, P183, DOI 10.1007/BF00389483; Sewell MA, 1999, J EXP MAR BIOL ECOL, V236, P291, DOI 10.1016/S0022-0981(98)00210-X; SHIRAYAMA Y, 2005, J GEOPHYS RES, pS908; Soars NA, 2009, MAR ECOL PROG SER, V383, P113, DOI 10.3354/meps07848; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Tyrrell T, 2008, J PLANKTON RES, V30, P141, DOI 10.1093/plankt/fbm105; Unsworth RKF, 2010, OCEAN COAST MANAGE, V53, P218, DOI 10.1016/j.ocecoaman.2010.04.002; Uthicke S, 2009, ECOL MONOGR, V79, P3, DOI 10.1890/07-2136.1; Whalan S, 2008, CORAL REEFS, V27, P783, DOI 10.1007/s00338-008-0400-9; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	57	177	179	3	245	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11372	10.1371/journal.pone.0011372	http://dx.doi.org/10.1371/journal.pone.0011372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613879	gold, Green Published, Green Submitted			2022-12-27	WOS:000279369900020
J	Darling, AE; Mau, B; Perna, NT				Darling, Aaron E.; Mau, Bob; Perna, Nicole T.			progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; TREE RECONSTRUCTION; LOCAL ALIGNMENT; EVOLUTION; HOMOLOGY; INVERSION; INFERENCE; REPEATS; VIEW	Background: Multiple genome alignment remains a challenging problem. Effects of recombination including rearrangement, segmental duplication, gain, and loss can create a mosaic pattern of homology even among closely related organisms. Methodology/Principal Findings: We describe a new method to align two or more genomes that have undergone rearrangements due to recombination and substantial amounts of segmental gain and loss ( flux). We demonstrate that the new method can accurately align regions conserved in some, but not all, of the genomes, an important case not handled by our previous work. The method uses a novel alignment objective score called a sum-of-pairs breakpoint score, which facilitates accurate detection of rearrangement breakpoints when genomes have unequal gene content. We also apply a probabilistic alignment filtering method to remove erroneous alignments of unrelated sequences, which are commonly observed in other genome alignment methods. We describe new metrics for quantifying genome alignment accuracy which measure the quality of rearrangement breakpoint predictions and indel predictions. The new genome alignment algorithm demonstrates high accuracy in situations where genomes have undergone biologically feasible amounts of genome rearrangement, segmental gain and loss. We apply the new algorithm to a set of 23 genomes from the genera Escherichia, Shigella, and Salmonella. Analysis of whole-genome multiple alignments allows us to extend the previously defined concepts of core- and pan-genomes to include not only annotated genes, but also non-coding regions with potential regulatory roles. The 23 enterobacteria have an estimated core- genome of 2.46Mbp conserved among all taxa and a pan-genome of 15.2Mbp. We document substantial population-level variability among these organisms driven by segmental gain and loss. Interestingly, much variability lies in intergenic regions, suggesting that the Enterobacteriacae may exhibit regulatory divergence. Conclusions: The multiple genome alignments generated by our software provide a platform for comparative genomic and population genomic studies. Free, open-source software implementing the described genome alignment approach is available from http://gel.ahabs.wisc.edu/mauve.	[Darling, Aaron E.; Perna, Nicole T.] Univ Wisconsin, Genome Ctr, Madison, WI USA; [Darling, Aaron E.] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Mau, Bob] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Mau, Bob] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Perna, Nicole T.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Darling, AE (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	aarondarling@ucdavis.edu	Weinstock, George M/C-6314-2013; Darling, Aaron/G-8119-2017	Weinstock, George M/0000-0002-2997-4592; Perna, Nicole/0000-0001-8208-0929; Darling, Aaron/0000-0003-2397-7925	National Institutes of Health (NIH) [R01-GM62994]; National Science Foundation (NSF) [DBI-0630765]; National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services [HHSN266200400040C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062994] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grant R01-GM62994 to N.T.P. and National Science Foundation (NSF) grant DBI-0630765 to A.E.D. This project has also been funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, NIH, Department of Health and Human Services, under Contract No. HHSN266200400040C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2003, GENETICS, V164, P1279; Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; Alekseyev MA, 2008, J COMPUT BIOL, V15, P1117, DOI 10.1089/cmb.2008.0080; Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Blanchette, 1997, Genome Inform Ser Workshop Genome Inform, V8, P25; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000392; Bray N, 2003, NUCLEIC ACIDS RES, V31, P3525, DOI 10.1093/nar/gkg623; Brudno M, 2004, NUCLEIC ACIDS RES, V32, pW41, DOI 10.1093/nar/gkh361; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Brudno M, 2003, BIOINFORMATICS, V19, pi54, DOI 10.1093/bioinformatics/btg1005; CHAO KM, 1995, COMPUT APPL BIOSCI, V11, P147; Chiaromonte F, 2002, Pac Symp Biocomput, P115; Darling AE, 2006, LECT NOTES COMPUT SC, V4175, P126; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darling AE, 2004, BIOINFORMATICS, V20, P122, DOI 10.1093/bioinformatics/btg378; DARLING AE, 2006, THESIS U WISCONSIN M; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Delcher AL, 2002, NUCLEIC ACIDS RES, V30, P2478, DOI 10.1093/nar/30.11.2478; DEWEY CN, 2006, HUM MOL GENET S1, V15; Dewey Colin N., 2007, V395, P221; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2009, GENOME RES, V19, P306, DOI 10.1101/gr.082263.108; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dubchak I, 2009, GENOME RES, V19, P682, DOI 10.1101/gr.081778.108; DURBIN R, 1998, BIOL SEQUENCE ANAL P, P80; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; Fu Z, 2007, J COMPUT BIOL, V14, P1160, DOI 10.1089/cmb.2007.0048; Hannenhalli S, 1995, AN S FDN CO, P581, DOI 10.1109/SFCS.1995.492588; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Hohl Michael, 2002, Bioinformatics, V18 Suppl 1, pS312; Hsiao WWL, 2005, PLOS GENET, V1, P540, DOI 10.1371/journal.pgen.0010062; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kucherov G, 2005, IEEE ACM T COMPUT BI, V2, P51, DOI 10.1109/TCBB.2005.12; Kumar S, 2007, GENOME RES, V17, P127, DOI 10.1101/gr.5232407; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Langille MGI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010071; Larget B, 2002, J R STAT SOC B, V64, P681, DOI 10.1111/1467-9868.00356; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LIPPERT RA, 2004, RECOMB, P233; LUNTER G, 2007, BIOINFORMATICS, V23; Lunter G, 2008, GENOME RES, V18, P298, DOI 10.1101/gr.6725608; Ma B, 2002, BIOINFORMATICS, V18, P440, DOI 10.1093/bioinformatics/18.3.440; Ma J, 2008, P NATL ACAD SCI USA, V105, P14254, DOI 10.1073/pnas.0805217105; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mau B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r44; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MILLER W, 2007, GENOME RES; Ogurtsov AY, 2002, BIOINFORMATICS, V18, P1703, DOI 10.1093/bioinformatics/18.12.1703; OPPENHEIM AB, 1993, MOL MICROBIOL, V10, P113, DOI 10.1111/j.1365-2958.1993.tb00908.x; Ovcharenko I, 2005, GENOME RES, V15, P184, DOI 10.1101/gr.3007205; Paten B, 2008, GENOME RES, V18, P1814, DOI 10.1101/gr.076554.108; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Phuong TM, 2006, NUCLEIC ACIDS RES, V34, P5932, DOI 10.1093/nar/gkl511; Prakash A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r124; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Raphael B, 2004, GENOME RES, V14, P2336, DOI 10.1101/gr.2657504; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Swidan F, 2006, PLOS COMPUT BIOL, V2, P870, DOI 10.1371/journal.pcbi.0020075; Swidan F, 2006, J COMPUT BIOL, V13, P1397, DOI 10.1089/cmb.2006.13.1397; Tang JJ, 2003, BIOINFORMATICS, V19, pi305, DOI 10.1093/bioinformatics/btg1042; Tannier E, 2004, LECT NOTES COMPUT SC, V3109, P1; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thompson JD, 1999, NUCLEIC ACIDS RES, V27, P2682, DOI 10.1093/nar/27.13.2682; Treangen TJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-433; Treangen TJ, 2009, IEEE ACM T COMPUT BI, V6, P180, DOI 10.1109/TCBB.2009.9; Vernikos GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r100; Vinh L., 2006, GENOME INFORM, V17, P141; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Yancopoulos S, 2005, BIOINFORMATICS, V21, P3340, DOI 10.1093/bioinformatics/bti535; Yang J, 2007, J MOL EVOL, V64, P71, DOI 10.1007/s00239-006-0052-8; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1285, DOI 10.1073/pnas.0409240102	75	2546	2567	6	195	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11147	10.1371/journal.pone.0011147	http://dx.doi.org/10.1371/journal.pone.0011147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593022	Green Published, gold, Green Submitted			2022-12-27	WOS:000279140800001
J	Panosa, A; Roca, I; Gibert, I				Panosa, Anais; Roca, Ignasi; Gibert, Isidre			Ribonucleotide Reductases of Salmonella Typhimurium: Transcriptional Regulation and Differential Role in Pathogenesis	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; NITRIC-OXIDE SYNTHASE; CELL-CYCLE REGULATION; COLI-NRD OPERON; ESCHERICHIA-COLI; EXPRESSION ANALYSIS; DIPHOSPHATE REDUCTASE; NATURAL-RESISTANCE; HYDROGEN-PEROXIDE; DNA-REPLICATION	Ribonucleotide reductases (RNRs) are essential enzymes that carry out the de novo synthesis of deoxyribonucleotides by reducing ribonucleotides. There are three different classes of RNRs (I, II and III), all having different oxygen dependency and biochemical characteristics. Salmonella enterica serovar Typhimurium (S. Typhimurium) harbors class Ia, class Ib and class III RNRs in its genome. We have studied the transcriptional regulation of these three RNR classes in S. Typhimurium as well as their differential function during infection of macrophage and epithelial cells. Deletion of both NrdR and Fur, two main transcriptional regulators, indicates that Fur specifically represses the class Ib enzyme and that NrdR acts as a global repressor of all three classes. A Fur recognition sequence within the nrdHIEF promoter has also been described and confirmed by electrophoretic mobility shift assays (EMSA). In order to elucidate the role of each RNR class during infection, S. Typhimurium single and double RNR mutants (as well as Fur and NrdR mutants) were used in infection assays with macrophage and epithelial cell lines. Our results indicate class Ia to be mainly responsible for deoxyribonucleotide production during invasion and proliferation inside macrophages and epithelial cells. Neither class Ib nor class III seem to be essential for growth under these conditions. However, class Ib is able to maintain certain growth in an nrdAB mutant during the first hours of macrophage infection. Our results suggest that, during the early stages of macrophage infection, class Ib may contribute to deoxyribonucleotide synthesis by means of both an NrdR and a Fur-dependent derepression of nrdHIEF due to hydrogen peroxide production and DNA damage associated with the oxidative burst, thus helping to overcome the host defenses.	Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Panosa, A (corresponding author), Hosp Arnau Vilanova, Labs Invest IRBLleida, Lleida, Spain.	IGROCA@clinic.ub.es; Isidre.Gibert@uab.cat	Panosa, Anais/A-1402-2013; Gibert, Isidre/L-9834-2014; Roca, Ignasi/M-4509-2014	Panosa, Anais/0000-0001-7686-9237; Gibert, Isidre/0000-0003-1442-2258; Roca, Ignasi/0000-0002-1800-1576	Ministerio de Educacion y Ciencia [BFU2004-03383]; (Generalitat de Catalunya), Spain [2005SGR-00956, 2009SGR-00108]; Universitat Autonoma de Barcelona	Ministerio de Educacion y Ciencia(Spanish Government); (Generalitat de Catalunya), Spain(Generalitat de Catalunya); Universitat Autonoma de Barcelona	This work was supported by grants BFU2004-03383 (Ministerio de Educacion y Ciencia), 2005SGR- 00956 and 2009SGR-00108 (Generalitat de Catalunya), Spain. A. P. was recipient of a fellowship from the Universitat Autonoma de Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2000, J MOL MICROB BIOTECH, V2, P191; AUGUSTIN LB, 1994, J BACTERIOL, V176, P378, DOI 10.1128/JB.176.2.378-387.1994; Borovok I, 2004, MOL MICROBIOL, V54, P1022, DOI 10.1111/j.1365-2958.2004.04325.x; Borovok I, 2002, MICROBIOL-SGM, V148, P391, DOI 10.1099/00221287-148-2-391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADLEY DJ, 1979, CLIN EXP IMMUNOL, V37, P7; BUCHMEIER NA, 1993, MOL MICROBIOL, V7, P933, DOI 10.1111/j.1365-2958.1993.tb01184.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeGroote MA, 1997, P NATL ACAD SCI USA, V94, P13997, DOI 10.1073/pnas.94.25.13997; DELORENZO V, 1988, EUR J BIOCHEM, V173, P537; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; FILPULA D, 1977, J BACTERIOL, V130, P107, DOI 10.1128/JB.130.1.107-113.1977; FILPULA D, 1978, J BACTERIOL, V135, P429, DOI 10.1128/JB.135.2.429-435.1978; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Govoni G, 1999, INFECT IMMUN, V67, P2225, DOI 10.1128/IAI.67.5.2225-2232.1999; Grinberg I, 2006, J BACTERIOL, V188, P7635, DOI 10.1128/JB.00903-06; GROS P, 1981, J IMMUNOL, V127, P2417; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Han JS, 1998, MOL GEN GENET, V259, P610, DOI 10.1007/s004380050854; HANTKE K, 1988, ARCH MICROBIOL, V149, P344, DOI 10.1007/BF00411654; Hautefort I, 2008, CELL MICROBIOL, V10, P958, DOI 10.1111/j.1462-5822.2007.01099.x; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Ikeda JS, 2005, J BACTERIOL, V187, P912, DOI 10.1128/JB.187.3.912-922.2005; Jacobson BA, 1998, MOL MICROBIOL, V28, P1307, DOI 10.1046/j.1365-2958.1998.00896.x; Janakiraman A, 2000, MOL MICROBIOL, V35, P1146, DOI 10.1046/j.1365-2958.2000.01783.x; Jang SJ, 2007, J BIOL CHEM, V282, P929, DOI 10.1074/jbc.M607646200; Jones BD, 1996, ANNU REV IMMUNOL, V14, P533, DOI 10.1146/annurev.immunol.14.1.533; JORDAN A, 1994, J BACTERIOL, V176, P3420, DOI 10.1128/jb.176.11.3420-3427.1994; Jordan A, 1996, MOL MICROBIOL, V19, P777, DOI 10.1046/j.1365-2958.1996.424950.x; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PLANT J, 1976, J INFECT DIS, V133, P72, DOI 10.1093/infdis/133.1.72; Roca I, 2008, INT MICROBIOL, V11, P49, DOI 10.2436/20.1501.01.44; Rodionov DA, 2005, TRENDS GENET, V21, P385, DOI 10.1016/j.tig.2005.05.011; Sambrook D.J., 1989, MOL CLONING LAB MANU; Smalley D, 2002, J BACTERIOL, V184, P895, DOI 10.1128/jb.184.4.895-903.2002; SUN L, 1994, J BACTERIOL, V176, P2415, DOI 10.1128/JB.176.8.2415-2426.1994; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; Torrents E, 2003, MICROBIOL-SGM, V149, P1011, DOI 10.1099/mic.0.26133-0; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Williams SM, 1998, FEMS MICROBIOL LETT, V163, P203, DOI 10.1111/j.1574-6968.1998.tb13046.x; Wyllie S, 2002, MICROBES INFECT, V4, P351, DOI 10.1016/S1286-4579(02)01548-4; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	55	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11328	10.1371/journal.pone.0011328	http://dx.doi.org/10.1371/journal.pone.0011328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593029	Green Published, gold, Green Submitted			2022-12-27	WOS:000279140800025
J	Neplioueva, V; Dobrikova, EY; Mukherjee, N; Keene, JD; Gromeier, M				Neplioueva, Valentina; Dobrikova, Elena Y.; Mukherjee, Neelanjan; Keene, Jack D.; Gromeier, Matthias			Tissue Type-Specific Expression of the dsRNA-Binding Protein 76 and Genome-Wide Elucidation of Its Target mRNAs	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; NUCLEAR FACTOR-90; RIBONUCLEOPROTEIN COMPLEXES; MITOCHONDRIAL BIOGENESIS; ILF3 GENE; NF90; CELLS; IDENTIFICATION; TRANSLATION; CANCER	Background: RNA-binding proteins accompany all steps in the life of mRNAs and provide dynamic gene regulatory functions for rapid adjustment to changing extra-or intracellular conditions. The association of RNA-binding proteins with their targets is regulated through changing subcellular distribution, post-translational modification or association with other proteins. Methodology: We demonstrate that the dsRNA binding protein 76 (DRBP76), synonymous with nuclear factor 90, displays inherently distinct tissue type-specific subcellular distribution in the normal human central nervous system and in malignant brain tumors of glial origin. Altered subcellular localization and isoform distribution in malignant glioma indicate that tumor-specific changes in DRBP76-related gene products and their regulatory functions may contribute to the formation and/or maintenance of these tumors. To identify endogenous mRNA targets of DRBP76, we performed RNA-immunoprecipitation and genome-wide microarray analyses in HEK293 cells, and identified specific classes of transcripts encoding critical functions in cellular metabolism. Significance: Our data suggest that physiologic DRBP76 expression, isoform distribution and subcellular localization are profoundly altered upon malignant transformation. Thus, the functional role of DRBP76 in co- or post-transcriptional gene regulation may contribute to the neoplastic phenotype.	[Neplioueva, Valentina; Dobrikova, Elena Y.; Gromeier, Matthias] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA; [Mukherjee, Neelanjan; Keene, Jack D.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University		grome001@mc.duke.edu		Mukherjee, Neelanjan/0000-0003-0017-1400	Public Health Service [CA124756]; Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE [R01CA124756] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Alex's Lemonade Stand Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Public Health Service grant CA124756 (M. G.) and a grant from Alex's Lemonade Stand Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic Y, 2004, BIOL CELL, V96, P479, DOI 10.1016/j.biolcel.2004.05.002; Buaas FW, 1999, MAMM GENOME, V10, P451, DOI 10.1007/s003359901022; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; Emmons J, 2008, RNA, V14, P888, DOI 10.1261/rna.748408; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Hieronymus H, 2004, GENE DEV, V18, P2845, DOI 10.1101/gad.1256904; KAO PN, 1994, J BIOL CHEM, V269, P20691; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Larcher JC, 2004, FASEB J, V18, P1761, DOI 10.1096/fj.04-1763fje; Liao HJ, 1998, P NATL ACAD SCI USA, V95, P8514, DOI 10.1073/pnas.95.15.8514; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Marzluff William F., 1992, Gene Expression, V2, P93; Merrill MK, 2006, J VIROL, V80, P6936, DOI 10.1128/JVI.00243-06; Merrill MK, 2006, J VIROL, V80, P3147, DOI 10.1128/JVI.80.7.3147-3156.2006; Merrill RA, 2002, P NATL ACAD SCI USA, V99, P3422, DOI 10.1073/pnas.052017399; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Parrott AM, 2005, J MOL BIOL, V348, P281, DOI 10.1016/j.jmb.2005.02.047; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Parrott AM, 2007, METHOD ENZYMOL, V429, P243, DOI 10.1016/S0076-6879(07)29012-3; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Reichman TW, 2003, CELL SIGNALING HDB, V3, P335; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Satoh M, 1999, J BIOL CHEM, V274, P34598, DOI 10.1074/jbc.274.49.34598; Saunders LR, 2001, J BIOL CHEM, V276, P32300, DOI 10.1074/jbc.M104207200; Schnell SA, 1999, J HISTOCHEM CYTOCHEM, V47, P719, DOI 10.1177/002215549904700601; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shi LF, 2005, J BIOL CHEM, V280, P18981, DOI 10.1074/jbc.M411034200; Shim J, 2002, MOL CELL, V10, P1331, DOI 10.1016/S1097-2765(02)00730-X; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Townley-Tilson WHD, 2006, RNA, V12, P1853, DOI 10.1261/rna.76006; Tran H, 2004, MOL CELL, V13, P101, DOI 10.1016/S1097-2765(03)00481-7; Viranaicken W, 2006, GENOMICS, V88, P622, DOI 10.1016/j.ygeno.2006.08.006; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Xu YH, 2005, MOL GENET METAB, V84, P252, DOI 10.1016/j.ymgme.2004.10.005; Xu YH, 1999, MOL GENET METAB, V68, P441, DOI 10.1006/mgme.1999.2934	51	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11710	10.1371/journal.pone.0011710	http://dx.doi.org/10.1371/journal.pone.0011710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668518	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243800005
J	To, S; Rodda, SJ; Rathjen, PD; Keough, RA				To, Sarah; Rodda, Stephen J.; Rathjen, Peter D.; Keough, Rebecca A.			Modulation of CP2 Family Transcriptional Activity by CRTR-1 and Sumoylation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; IN-VITRO; SUMO MODIFICATION; LBP PROTEINS; DNA-BINDING; MOUSE; GENE; CONJUGATION; INHIBITION; ACTIVATION	CRTR-1 is a member of the CP2 family of transcription factors. Unlike other members of the family which are widely expressed, CRTR-1 expression shows specific spatio-temporal regulation. Gene targeting demonstrates that CRTR-1 plays a central role in the maturation and function of the salivary glands and the kidney. CRTR-1 has also recently been identified as a component of the complex transcriptional network that maintains pluripotency in embryonic stem (ES) cells. CRTR-1 was previously shown to be a repressor of transcription. We examine the activity of CRTR-1 in ES and other cells and show that CRTR-1 is generally an activator of transcription and that it modulates the activity of other family members, CP2, NF2d9 and altNF2d9, in a cell specific manner. We also demonstrate that CRTR-1 activity is regulated by sumoylation at a single major site, residue K30. These findings imply that functional redundancy with other family members may mask important roles for CRTR-1 in other tissues, including the blastocyst stage embryo and embryonic stem cells.	[To, Sarah; Rodda, Stephen J.; Rathjen, Peter D.; Keough, Rebecca A.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [To, Sarah; Rodda, Stephen J.; Rathjen, Peter D.; Keough, Rebecca A.] Univ Adelaide, ARC Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia; [Rathjen, Peter D.] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia	University of Adelaide; University of Adelaide; University of Melbourne	To, S (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	rebecca.keough@adelaide.edu.au			University of Adelaide; Australian Research Council Special Centre for the Molecular Genetics of Development	University of Adelaide; Australian Research Council Special Centre for the Molecular Genetics of Development(Australian Research Council)	This work was funded by the University of Adelaide and the Australian Research Council Special Centre for the Molecular Genetics of Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409; Anckar J, 2006, MOL CELL BIOL, V26, P955, DOI 10.1128/MCB.26.3.955-964.2006; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Huang NW, 2005, MOL ENDOCRINOL, V19, P409, DOI 10.1210/me.2004-0086; Huang NW, 2000, J BIOL CHEM, V275, P2852, DOI 10.1074/jbc.275.4.2852; Kang HC, 2005, MOL CELL BIOL, V25, P6005, DOI 10.1128/MCB.25.14.6005-6020.2005; KANG T, 1993, J BIOL CHEM, V268, P9629; LIM LC, 1993, J BIOL CHEM, V268, P18008; Linke S, 2007, METHOD ENZYMOL, V435, P61, DOI 10.1016/S0076-6879(07)35004-0; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Long JY, 2004, BIOCHEM J, V379, P23, DOI 10.1042/BJ20031867; Lyst MJ, 2007, BIOCHEM SOC T, V35, P1389, DOI 10.1042/BST0351389; Murata T, 1998, GENES CELLS, V3, P443, DOI 10.1046/j.1365-2443.1998.00204.x; Pelton TA, 2002, J CELL SCI, V115, P329; Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; Rodda S, 2001, J BIOL CHEM, V276, P3324, DOI 10.1074/jbc.M008167200; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Shirra MK, 1998, J BIOL CHEM, V273, P19260, DOI 10.1074/jbc.273.30.19260; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Veljkovic J, 2004, GENE, V343, P23, DOI 10.1016/j.gene.2004.08.010; Yamaguchi Y, 2005, DEV DYNAM, V233, P484, DOI 10.1002/dvdy.20348; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; YOON JB, 1994, MOL CELL BIOL, V14, P1776, DOI 10.1128/MCB.14.3.1776	29	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11702	10.1371/journal.pone.0011702	http://dx.doi.org/10.1371/journal.pone.0011702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661472	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300008
J	Stollhoff, R; Jost, J; Elze, T; Kennerknecht, I				Stollhoff, Rainer; Jost, Juergen; Elze, Tobias; Kennerknecht, Ingo			The Early Time Course of Compensatory Face Processing in Congenital Prosopagnosia	PLOS ONE			English	Article							HUMAN NEURAL SYSTEM; DEVELOPMENTAL PROSOPAGNOSIA; PSYCHOMETRIC FUNCTION; DETAILED EXPLORATION; COVERT RECOGNITION; 1ST REPORT; AGNOSIA; PREVALENCE; PERCEPTION; STIMULI	Background: Prosopagnosia is a selective deficit in facial identification which can be either acquired, (e.g., after brain damage), or present from birth (congenital). The face recognition deficit in prosopagnosia is characterized by worse accuracy, longer reaction times, more dispersed gaze behavior and a strong reliance on featural processing. Methods/Principal Findings: We introduce a conceptual model of an apperceptive/associative type of congenital prosopagnosia where a deficit in holistic processing is compensated by a serial inspection of isolated, informative features. Based on the model proposed we investigated performance differences in different face and shoe identification tasks between a group of 16 participants with congenital prosopagnosia and a group of 36 age-matched controls. Given enough training and unlimited stimulus presentation prosopagnosics achieved normal face identification accuracy evincing longer reaction times. The latter increase was paralleled by an equally-sized increase in stimulus presentation times needed achieve an accuracy of 80%. When the inspection time of stimuli was limited (50ms to 750ms), prosopagnosics only showed worse accuracy but no difference in reaction time. Tested for the ability to generalize from frontal to rotated views, prosopagnosics performed worse than controls across all rotation angles but the magnitude of the deficit didn't change with increasing rotation. All group differences in accuracy, reaction or presentation times were selective to face stimuli and didn't extend to shoes. Conclusions/Significance: Our study provides a characterization of congenital prosopagnosia in terms of early processing differences. More specifically, compensatory processing in congenital prosopagnosia requires an inspection of faces that is sufficiently long to allow for sequential focusing on informative features. This characterization of dysfunctional processing in prosopagnosia further emphasizes fast and holistic information encoding as two defining characteristics of normal face processing.	[Stollhoff, Rainer; Jost, Juergen; Elze, Tobias] Max Planck Inst Math Sci, Leipzig, Germany; [Jost, Juergen] Santa Fe Inst, Santa Fe, NM 87501 USA; [Kennerknecht, Ingo] Univ Munster, Inst Human Genet, D-4400 Munster, Germany	Max Planck Society; The Santa Fe Institute; University of Munster	Stollhoff, R (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	rainer.stollhoff@mis.mpg.de		Elze, Tobias/0000-0002-2032-0496				Ariel R, 1996, CORTEX, V32, P221, DOI 10.1016/S0010-9452(96)80048-7; Avidan G, 2005, J COGNITIVE NEUROSCI, V17, P1150, DOI 10.1162/0898929054475145; Baayen R., 2008, J MEMORY LANGUAGE; Barton JJS, 2003, NEUROPSYCHOLOGIA, V41, P1703, DOI 10.1016/S0028-3932(03)00115-5; Barton JJS, 2001, NEUROLOGY, V57, P1161, DOI 10.1212/WNL.57.7.1161; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Bindemann M, 2008, PERCEPTION, V37, P33; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BURTON AM, 1991, COGNITION, V39, P129, DOI 10.1016/0010-0277(91)90041-2; Curby KM, 2009, J VISION, V9, DOI 10.1167/9.6.7; DAMASIO AR, 1990, ANNU REV NEUROSCI, V13, P89, DOI 10.1146/annurev.ne.13.030190.000513; Della Sala S, 2003, CORTEX, V39, P533; DERENZI E, 1991, CORTEX, V27, P213, DOI 10.1016/S0010-9452(13)80125-6; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine BC, 2004, NEUROLOGY, V62, P1219, DOI 10.1212/01.WNL.0000118297.03161.B3; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; Elze T, 2006, PERCEPTION, V35, P52; ELZE T, 2009, J VIS, V9, P58; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; FARAH MJ, 1993, PSYCHOL REV, V100, P571, DOI 10.1037/0033-295X.100.4.571; Faraway J.J., 2006, C&H TEXT STAT SCI, P59; Farkas L.G., 1981, ANTHROPOMETRY HEAD F; Faust C, 1947, NERVENARZT, V18, P294; Fox CJ, 2008, CORTEX, V44, P996, DOI 10.1016/j.cortex.2008.04.003; Gauthier I, 1999, J COGNITIVE NEUROSCI, V11, P349, DOI 10.1162/089892999563472; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; GRAND RL, 2006, BRAIN COGNITION, V61, P139; Grueter M, 2007, CORTEX, V43, P734, DOI 10.1016/S0010-9452(08)70502-1; Gruter T, 2009, NEUROSCI LETT, V453, P135, DOI 10.1016/j.neulet.2009.02.021; GRUTER M, 2004, THESIS MUNSTER U MD; Hadfield J., 2009, MCMC METHODS MULTIRE; Hasson U, 2003, J COGNITIVE NEUROSCI, V15, P419, DOI 10.1162/089892903321593135; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; HECAEN H, 1962, ARCH NEUROL-CHICAGO, V7, P92, DOI 10.1001/archneur.1962.04210020014002; Henderson JM, 2005, MEM COGNITION, V33, P98, DOI 10.3758/BF03195300; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennerknecht I, 2008, AM J MED GENET A, V146A, P2863, DOI 10.1002/ajmg.a.32552; Kennerknecht I, 2008, FRONT BIOSCI-LANDMRK, V13, P3150, DOI 10.2741/2916; Kennerknecht I, 2007, J HUM GENET, V52, P230, DOI 10.1007/s10038-006-0101-6; Kennerknecht I, 2006, AM J MED GENET A, V140A, P1617, DOI 10.1002/ajmg.a.31343; KESTEN H, 1958, ANN MATH STAT, V29, P41, DOI 10.1214/aoms/1177706705; Kress T, 2003, BEHAV NEUROL, V14, P109, DOI 10.1155/2003/520476; Lange J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007414; Lissauer H., 1890, ARCH PSYCHIAT NERVEN, V21, P22; MCCONACHIE HR, 1976, CORTEX, V12, P76, DOI 10.1016/S0010-9452(76)80033-0; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Palmeri TJ, 2004, TRENDS COGN SCI, V8, P378, DOI 10.1016/j.tics.2004.06.001; R Core Team, 2020, R LANG ENV STAT COMP; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RENZI ED, 1994, NEUROPSYCHOLOGIA, V32, P893; Riddoch JM, 1993, BORB BIRMINGHAM OBJE; Schmalzl L, 2008, J NEUROPSYCHOL, V2, P99, DOI 10.1348/174866407X256554; Schmalzl L, 2008, COGN NEUROPSYCHOL, V25, P704, DOI 10.1080/02643290802299350; Schwarzer G, 2007, PSYCHOL RES-PSYCH FO, V71, P583, DOI 10.1007/s00426-006-0068-0; Shepherd J.W., 1974, INT J PSYCHOL, V9, P205, DOI [10.1080/00207597408247104, DOI 10.1080/00207597408247104]; Tanaka JW, 2001, J EXP PSYCHOL GEN, V130, P534, DOI 10.1037/0096-3445.130.3.534; Thomas M, 2002, BEHAV BRAIN SCI, V25, P727, DOI 10.1017/S0140525X02000134; TREUTWEIN B, 1995, VISION RES, V35, P2503, DOI 10.1016/0042-6989(95)00016-X; Troje NF, 1996, VISION RES, V36, P1761, DOI 10.1016/0042-6989(95)00230-8; Tuerlinckx F, 2006, BRIT J MATH STAT PSY, V59, P225, DOI 10.1348/000711005x79857; ULLMAN S, 1997, HIGH LEVEL VISION OB, P432; Warrington EK., 1991, VISUAL OBJECT SPACE; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; WILBRAND H, 1892, DTSCH Z NERVENHEILKD, V2, P361, DOI DOI 10.1007/BF01667704	72	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11482	10.1371/journal.pone.0011482	http://dx.doi.org/10.1371/journal.pone.0011482			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657764	Green Submitted, Green Published, gold			2022-12-27	WOS:000280197500002
J	Borchert, GM; Holton, NW; Edwards, KA; Vogel, LA; Larson, ED				Borchert, Glen M.; Holton, Nathaniel W.; Edwards, Kevin A.; Vogel, Laura A.; Larson, Erik D.			Histone H2A and H2B Are Monoubiquitinated at AID-Targeted Loci	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; ACTIVATION-INDUCED DEAMINASE; CELL NUCLEAR ANTIGEN; SOMATIC HYPERMUTATION; GENE CONVERSION; MISMATCH; REPAIR; DNA; UBIQUITINATION	Background: Somatic hypermutation introduces base substitutions into the rearranged and expressed immunoglobulin (Ig) variable regions to promote immunity. This pathway requires and is initiated by the Activation Induced Deaminase (AID) protein, which deaminates cytidine to produce uracils and UG mismatches at the Ig genes. Subsequent processing of uracil by mismatch repair and base excision repair factors contributes to mutagenesis. While selective for certain genomic targets, the chromatin modifications which distinguish hypermutating from non-hypermutating loci are not defined. Methodology/Principal Findings: Here, we show that AID-targeted loci in mammalian B cells contain ubiquitinated chromatin. Chromatin immunoprecipitation (ChIP) analysis of a constitutively hypermutating Burkitt's B cell line, Ramos, revealed the presence of monoubiquitinated forms of both histone H2A and H2B at two AID-associated loci, but not at control loci which are expressed but not hypermutated. Similar analysis using LPS activated primary murine splenocytes showed enrichment of the expressed V(H) and S gamma 3 switch regions upon ChIP with antibody specific to AID and to monoubiquitinated H2A and H2B. In the mechanism of mammalian hypermutation, AID may interact with ubiquitinated chromatin because confocal immunofluorescence microscopy visualized AID colocalized with monoubiquitinated H2B within discrete nuclear foci. Conclusions/Significance: Our results indicate that monoubiquitinated histones accompany active somatic hypermutation, revealing part of the histone code marking AID-targeted loci. This expands the current view of the chromatin state during hypermutation by identifying a specific nucleosome architecture associated with somatic hypermutation.	[Borchert, Glen M.; Holton, Nathaniel W.; Edwards, Kevin A.; Vogel, Laura A.; Larson, Erik D.] Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA	Illinois State University	Borchert, GM (corresponding author), Illinois State Univ, Sch Biol Sci, Normal, IL 61761 USA.	elarson@ilstu.edu	Edwards, Kevin Andrew/GOE-3539-2022	Edwards, Kevin Andrew/0000-0003-4721-5626; Vogel, Laura/0000-0002-9305-175X; borchert, glen/0000-0002-6182-7154; Holton, Nate/0000-0001-7937-773X	National Institutes of Health [R15CA137608]; ISU School of Biological Sciences; NATIONAL CANCER INSTITUTE [R15CA137608] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ISU School of Biological Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health R15CA137608 to E.D.L. and the ISU School of Biological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa H, 2006, PLOS BIOL, V4, P1947, DOI 10.1371/journal.pbio.0040366; Bachl J, 2006, P NATL ACAD SCI USA, V103, P12081, DOI 10.1073/pnas.0605146103; Bemark M, 2000, ONCOGENE, V19, P3404, DOI 10.1038/sj.onc.1203686; Blaeser Anthony, 2008, Immun Ageing, V5, P15, DOI 10.1186/1742-4933-5-15; Cascalho M, 1999, Dev Immunol, V7, P43, DOI 10.1155/1999/24514; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Cascalho M, 1998, SCIENCE, V279, P1207, DOI 10.1126/science.279.5354.1207; Cattoretti G, 2006, BLOOD, V107, P3967, DOI 10.1182/blood-2005-10-4170; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Conticello SG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-229; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Game JC, 2009, DNA REPAIR, V8, P470, DOI 10.1016/j.dnarep.2009.01.007; Huen MSY, 2010, TRENDS BIOCHEM SCI, V35, P101, DOI 10.1016/j.tibs.2009.09.001; Kitao H, 2008, INT IMMUNOL, V20, P277, DOI 10.1093/intimm/dxm140; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Langerak P, 2009, PHILOS T R SOC B, V364, P621, DOI 10.1098/rstb.2008.0223; Larson ED, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-211; Larson ED, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-94; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Odegard VH, 2005, IMMUNITY, V23, P101, DOI 10.1016/j.immuni.2005.05.007; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; Pinato S, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-55; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; Shen HM, 2009, J EXP MED, V206, P1057, DOI 10.1084/jem.20082678; Simpson LJ, 2006, EMBO REP, V7, P927, DOI 10.1038/sj.embor.7400777; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van der Knaap JA, 2010, MOL CELL BIOL, V30, P736, DOI 10.1128/MCB.01121-09; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Woo CJ, 2003, IMMUNITY, V19, P479, DOI 10.1016/S1074-7613(03)00261-9; Yabuki M, 2005, NAT IMMUNOL, V6, P730, DOI 10.1038/ni1215; Yang GB, 2005, P NATL ACAD SCI USA, V102, P17083, DOI 10.1073/pnas.0501338102	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11641	10.1371/journal.pone.0011641	http://dx.doi.org/10.1371/journal.pone.0011641			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661291	Green Published, Green Submitted, gold			2022-12-27	WOS:000279980800023
J	Eshaghi, M; Lee, JH; Zhu, L; Poon, SY; Li, JT; Cho, KH; Chu, ZQ; Karuturi, RKM; Liu, J				Eshaghi, Majid; Lee, Jong Hoon; Zhu, Lei; Poon, Suk Yean; Li, Juntao; Cho, Kwang-Hyun; Chu, Zhaoqing; Karuturi, R. Krishna M.; Liu, Jianhua			Genomic Binding Profiling of the Fission Yeast Stress-Activated MAPK Sty1 and the bZIP Transcriptional Activator Atf1 in Response to H2O2	PLOS ONE			English	Article							RECOMBINATION HOT-SPOT; SCHIZOSACCHAROMYCES-POMBE; OXIDATIVE STRESS; MEIOTIC RECOMBINATION; PROTEIN-KINASE; CELL-CYCLE; REGULATED GENES; SPC1 KINASE; GROWTH-RATE; PHOSPHORYLATION	Background: The evolutionally conserved MAPK Sty1 and bZIP transcriptional activator Atf1 are known to play a pivotal role in response to the reactive oxygen species in S. pombe. However, it is unclear whether all of the H2O2-induced genes are directly regulated by the Sty1-Atf1 pathway and involved in growth fitness under H2O2-induced stress conditions. Methodology/Principal Findings: Here we present the study on ChIP-chip mapping of the genomic binding sites for Sty1, Atf1, and the Atf1's binding partner Pcr1; the genome-wide transcriptional profiling of the atf1 Delta and pcr1 Delta strains in response to H2O2; and the phenotypic assessment of similar to 90 Atf1/Pcr1-bound or unbound genes for growth fitness under H2O2 conditions. ChIP-chip analysis shows that Atf1 and Pcr1 binding sites are overlapped in the genome and constitutively present before H2O2 stress. On the other hand, Sty1 recruitment primarily occurs at the Atf1/Pcr1 binding sites and is induced by H2O2. We found that Atf1/Pcr1 is clearly responsible for the high-level transcriptional response to H2O2. Furthermore, phenotypic assessment indicates that among the H2O2-induced genes, Atf1/Pcr1-bound genes exhibit a higher likelihood of functional requirement for growth fitness under the stress condition than the Atf1/Pcr1-unbound genes do. Notably, we found that the Atf1/Pcr1-bound genes regardless of their responsiveness to H2O2 show a high probability of requirement for growth fitness. Conclusion/Significance: Together, our analyses on global mapping of protein binding sites, genome-wide transcriptional profiling, and phenotypic assessment provide insight into mechanisms for global transcriptional regulation by the Sty1-Atf1 pathway in response to H2O2-induced reactive oxygen species.	[Eshaghi, Majid; Zhu, Lei; Poon, Suk Yean; Li, Juntao; Chu, Zhaoqing; Karuturi, R. Krishna M.; Liu, Jianhua] Genome Inst Singapore, Singapore, Singapore; [Lee, Jong Hoon; Cho, Kwang-Hyun] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon, South Korea; [Liu, Jianhua] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Korea Advanced Institute of Science & Technology (KAIST); National University of Singapore	Eshaghi, M (corresponding author), Genome Inst Singapore, Singapore, Singapore.	liujh@gis.a-star.edu.sg	Cho, Kwang-Hyun/C-1684-2011	Liu, Jianhua/0000-0003-1165-9348; ?, ??/0000-0002-3982-9858	Korea Ministry of Education, Science & Technology (MEST) [2009-0086964, 2010-0017662]; GIS and Agency for Science, Technology and Research (A-STAR), Singapore [GIS/06-113401]	Korea Ministry of Education, Science & Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); GIS and Agency for Science, Technology and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was partly supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Ministry of Education, Science & Technology (MEST) through the grants (2009-0086964 and 2010-0017662) to KHC and by the GIS and Agency for Science, Technology and Research (A-STAR), Singapore (Grant GIS/06-113401) to J. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CLEVELAND WS, 1979, BIOL PSYCHIAT, V44, P775; DAVIDSON PW, 2004, J POLICY PRACT INTEL, V1, P2, DOI DOI 10.1111/J.1741-1130.2004.04001.X; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Gaits F, 1998, GENE DEV, V12, P1464, DOI 10.1101/gad.12.10.1464; Gao J, 2008, NUCLEIC ACIDS RES, V36, P2838, DOI 10.1093/nar/gkn037; Gao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005533; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harrison C, 2005, EMBO J, V24, P599, DOI 10.1038/sj.emboj.7600536; Kanoh J, 1996, GENES CELLS, V1, P391, DOI 10.1046/j.1365-2443.1996.d01-247.x; Kon N, 1998, MOL CELL BIOL, V18, P7575, DOI 10.1128/MCB.18.12.7575; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Lantermann AB, 2010, NAT STRUCT MOL BIOL, V17, P251, DOI 10.1038/nsmb.1741; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Ohmiya R, 1999, MOL GEN GENET, V261, P297, DOI 10.1007/s004380050970; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Regenberg B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r107; Reiter W, 2008, J BIOL CHEM, V283, P9945, DOI 10.1074/jbc.M710428200; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rodriguez-Gabriel MA, 2005, EUKARYOT CELL, V4, P1396, DOI 10.1128/EC.4.8.1396-1402.2005; Sanso M, 2008, EUKARYOT CELL, V7, P826, DOI 10.1128/EC.00465-07; SCHUCHERT P, 1991, EMBO J, V10, P2157, DOI 10.1002/j.1460-2075.1991.tb07750.x; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Takeda T, 1995, EMBO J, V14, P6193, DOI 10.1002/j.1460-2075.1995.tb00310.x; Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Toone WM, 2001, ONCOGENE, V20, P2336, DOI 10.1038/sj.onc.1204384; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Watanabe Y, 1996, MOL CELL BIOL, V16, P704; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	54	47	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11620	10.1371/journal.pone.0011620	http://dx.doi.org/10.1371/journal.pone.0011620			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661279	Green Submitted, Green Published, gold			2022-12-27	WOS:000279980800009
J	Chaste, P; Clement, N; Mercati, O; Guillaume, JL; Delorme, R; Botros, HG; Pagan, C; Perivier, S; Scheid, I; Nygren, G; Anckarsater, H; Rastam, M; Stahlberg, O; Gillberg, C; Serrano, E; Lemiere, N; Launay, JM; Mouren-Simeoni, MC; Leboyer, M; Gillberg, C; Jockers, R; Bourgeron, T				Chaste, Pauline; Clement, Nathalie; Mercati, Oriane; Guillaume, Jean-Luc; Delorme, Richard; Botros, Hany Goubran; Pagan, Cecile; Perivier, Samuel; Scheid, Isabelle; Nygren, Gudrun; Anckarsater, Henrik; Rastam, Maria; Stahlberg, Ola; Gillberg, Carina; Serrano, Emilie; Lemiere, Nathalie; Launay, Jean Marie; Mouren-Simeoni, Marie Christine; Leboyer, Marion; Gillberg, Christopher; Jockers, Ralf; Bourgeron, Thomas			Identification of Pathway-Biased and Deleterious Melatonin Receptor Mutants in Autism Spectrum Disorders and in the General Population	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; DIAGNOSTIC INTERVIEW; SLEEP PATTERNS; CHILDREN; GPR50; HETERODIMERIZATION; VARIANT; MTNR1B	Melatonin is a powerful antioxidant and a synchronizer of many physiological processes. Alteration of the melatonin pathway has been reported in circadian disorders, diabetes and autism spectrum disorders ( ASD). However, very little is known about the genetic variability of melatonin receptors in humans. Here, we sequenced the melatonin receptor MTNR1A and MTNR1B, genes coding for MT1 and MT2 receptors, respectively, in a large panel of 941 individuals including 295 patients with ASD, 362 controls and 284 individuals from different ethnic backgrounds. We also sequenced GPR50, coding for the orphan melatoninrelated receptor GPR50 in patients and controls. We identified six non-synonymous mutations for MTNR1A and ten for MTNR1B. The majority of these variations altered receptor function. Particularly interesting mutants are MT1-I49N, which is devoid of any melatonin binding and cell surface expression, and MT1-G166E and MT1-I212T, which showed severely impaired cell surface expression. Of note, several mutants possessed pathway-selective signaling properties, some preferentially inhibiting the adenylyl cyclase pathway, others preferentially activating the MAPK pathway. The prevalence of these deleterious mutations in cases and controls indicates that they do not represent major risk factor for ASD ( MTNR1A case 3.6% vs controls 4.4%; MTNR1B case 4.7% vs 3% controls). Concerning GPR50, we detected a significant association between ASD and two variations, D502-505 and T532A, in affected males, but it did not hold up after Bonferonni correction for multiple testing. Our results represent the first functional ascertainment of melatonin receptors in humans and constitute a basis for future structure-function studies and for interpreting genetic data on the melatonin pathway in patients.	[Chaste, Pauline; Mercati, Oriane; Delorme, Richard; Botros, Hany Goubran; Pagan, Cecile; Scheid, Isabelle; Serrano, Emilie; Lemiere, Nathalie; Bourgeron, Thomas] Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, Paris, France; [Delorme, Richard; Perivier, Samuel; Mouren-Simeoni, Marie Christine] Hop Robert Debre, AP HP, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France; [Clement, Nathalie; Guillaume, Jean-Luc; Jockers, Ralf] INSERM, U1016, Paris, France; [Nygren, Gudrun; Anckarsater, Henrik; Stahlberg, Ola; Gillberg, Carina] Gothenburg Univ, Dept Child & Adolescent Psychiat, Gothenburg, Sweden; [Anckarsater, Henrik] Lund Univ, Inst Clin Sci, Malmo, Sweden; [Rastam, Maria] Lund Univ, Dept Clin Sci Lund, Lund, Sweden; [Launay, Jean Marie] Hop Lariboisiere, AP HP, IFR 139, Serv Biochim,EA 3621, F-75475 Paris, France; [Leboyer, Marion] Univ Paris 12, INSERM, Inst Mondor Rech Biomed, U955, Creteil, France; [Leboyer, Marion; Bourgeron, Thomas] Fdn Fondamental, Creteil, France; [Gillberg, Christopher; Bourgeron, Thomas] St George Hosp, Sch Med, London, England; [Bourgeron, Thomas] Univ Paris 07, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Gothenburg; Lund University; Lund University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); St Georges University London; UDICE-French Research Universities; Universite Paris Cite	Chaste, P (corresponding author), Inst Pasteur, CNRS, URA Genes Synapses & Cognit 2182, Paris, France.	ralf.jockers@inserm.fr	Jockers, Ralf/Q-2100-2019; Jockers, Ralf/P-2272-2017; Leboyer, Marion/AAW-3648-2021	Jockers, Ralf/0000-0002-4354-1750; Jockers, Ralf/0000-0002-4354-1750; Leboyer, Marion/0000-0001-5473-3697; Bourgeron, Thomas/0000-0001-8164-9220; Delorme, Richard/0000-0002-5614-3663	Institut Pasteur; University Denis Diderot Paris 7; University Paris Descarte; INSERM; CNRS; Fondation pour la Recherche Medicale; Foundation Orange; Fondation de France; Foundation FondaMentale; Swedish Science Council	Institut Pasteur(European Commission); University Denis Diderot Paris 7; University Paris Descarte; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Foundation Orange; Fondation de France(Fondation de France); Foundation FondaMentale; Swedish Science Council	This work was supported by the Institut Pasteur, University Denis Diderot Paris 7, University Paris Descartes, INSERM, CNRS, Fondation pour la Recherche Medicale ("Equipe FRM'', RJ), Foundation Orange, Fondation de France, Foundation FondaMentale, and by the Swedish Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allik H, 2006, J AUTISM DEV DISORD, V36, P585, DOI 10.1007/s10803-006-0099-9; Andersen IM, 2008, J CHILD NEUROL, V23, P482, DOI 10.1177/0883073807309783; Arendt J, 2003, J NEUROENDOCRINOL, V15, P427, DOI 10.1046/j.1365-2826.2003.00987.x; Ayoub MA, 2002, J BIOL CHEM, V277, P21522, DOI 10.1074/jbc.M200729200; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Cann HM, 2002, SCIENCE, V296, P261; Garstang J, 2006, CHILD CARE HLTH DEV, V32, P585, DOI 10.1111/j.1365-2214.2006.00616.x; Gillberg C, 2001, AUTISM, V5, P57, DOI 10.1177/1362361301005001006; Grunewald E, 2009, MOL CELL NEUROSCI, V42, P363, DOI 10.1016/j.mcn.2009.08.007; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Hare DJ, 2006, AUTISM, V10, P565, DOI 10.1177/1362361306068509; Ishizaki Asayo, 1999, No To Hattatsu, V31, P428; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Jonsson L, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-10; Levoye A, 2006, EMBO J, V25, P3012, DOI 10.1038/sj.emboj.7601193; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Melke J, 2008, MOL PSYCHIATR, V13, P90, DOI 10.1038/sj.mp.4002016; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Paavonen EJ, 2003, J CHILD ADOL PSYCHOP, V13, P83, DOI 10.1089/104454603321666225; Patzold LM, 1998, J PAEDIATR CHILD H, V34, P528, DOI 10.1046/j.1440-1754.1998.00291.x; Petit L, 1999, BIOCHEM PHARMACOL, V58, P633, DOI 10.1016/S0006-2952(99)00134-3; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Simonneaux V, 2003, PHARMACOL REV, V55, P325, DOI 10.1124/pr.55.2.2; Taira M, 1998, PSYCHIAT CLIN NEUROS, V52, P182, DOI 10.1111/j.1440-1819.1998.tb01018.x; Tani P, 2004, NEUROPSYCHOBIOLOGY, V50, P147, DOI 10.1159/000079106; Thomson PA, 2005, MOL PSYCHIATR, V10, P470, DOI 10.1038/sj.mp.4001593; Wiggs L, 2004, DEV MED CHILD NEUROL, V46, P372; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Wirojanan J, 2009, J CLIN SLEEP MED, V5, P145	33	52	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11495	10.1371/journal.pone.0011495	http://dx.doi.org/10.1371/journal.pone.0011495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625VR	20657642	Green Published, Green Submitted, gold			2022-12-27	WOS:000279924500002
J	Wang, XL; Hang, SY; Prazak, L; Gergen, JP				Wang, Xiaoling; Hang, Saiyu; Prazak, Lisa; Gergen, J. Peter			NELF Potentiates Gene Transcription in the Drosophila Embryo	PLOS ONE			English	Article							POLYMERASE-II ELONGATION; RNA-POLYMERASE; FUSHI-TARAZU; CELL FATE; IN-VIVO; EXPRESSION; MELANOGASTER; SEGMENTATION; COFACTOR; PROMOTER	A hallmark of genes that are subject to developmental regulation of transcriptional elongation is association of the negative elongation factor NELF with the paused RNA polymerase complex. Here we use a combination of biochemical and genetic experiments to investigate the in vivo function of NELF in the Drosophila embryo. NELF associates with different gene promoter regions in correlation with the association of RNA polymerase II (Pol II) and the initial activation of gene expression during the early stages of embryogenesis. Genetic experiments reveal that maternally provided NELF is required for the activation, rather than the repression of reporter genes that emulate the expression of key developmental control genes. Furthermore, the relative requirement for NELF is dictated by attributes of the flanking cis-regulatory information. We propose that NELF-associated paused Pol II complexes provide a platform for high fidelity integration of the combinatorial spatial and temporal information that is central to the regulation of gene expression during animal development.	[Wang, Xiaoling; Hang, Saiyu; Gergen, J. Peter] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Wang, Xiaoling; Hang, Saiyu; Gergen, J. Peter] SUNY Stony Brook, Ctr Dev Genet, Grad Program Biochem & Struct Biol, Stony Brook, NY 11794 USA; [Prazak, Lisa] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, XL (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	pgergen@life.bio.sunysb.edu	Wang, Xiaoling/D-4208-2013		National Science Foundation [MCB 0344486, MCB 0721430]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation research grants MCB 0344486 and MCB 0721430 (JPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Amleh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005034; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Chopra VS, 2009, CURR BIOL, V19, P688, DOI 10.1016/j.cub.2009.02.055; Chou TB, 1996, GENETICS, V144, P1673; Crocker J, 2008, PLOS BIOL, V6, P2576, DOI 10.1371/journal.pbio.0060263; Fujioka M, 1999, DEVELOPMENT, V126, P2527; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; IBNSOUDA S, 1993, DEVELOPMENT, V119, P471; Janssens H, 2006, NAT GENET, V38, P1159, DOI 10.1038/ng1886; Kininis M, 2009, MOL CELL BIOL, V29, P1123, DOI 10.1128/MCB.00841-08; KLINGLER M, 1993, MECH DEVELOP, V43, P3, DOI 10.1016/0925-4773(93)90019-T; KRAUSE HM, 1988, GENE DEV, V2, P1021, DOI 10.1101/gad.2.8.1021; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; McChesney PA, 2006, CANCER RES, V66, P1346, DOI 10.1158/0008-5472.CAN-05-3593; Midorikawa Y, 2002, JPN J CANCER RES, V93, P636, DOI 10.1111/j.1349-7006.2002.tb01301.x; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Narita T, 2007, MOL CELL, V26, P349, DOI 10.1016/j.molcel.2007.04.011; NECHAEV S, SCIENCE, V327, P335; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Sullivan E, 2001, GENE DEV, V15, P173, DOI 10.1101/gad.862801; Sun JL, 2008, J CELL BIOCHEM, V103, P1798, DOI 10.1002/jcb.21568; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; THUMMEL CS, 1988, GENE, V74, P445, DOI 10.1016/0378-1119(88)90177-1; TSAI CC, 1994, DEVELOPMENT, V120, P1671; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; Wheeler JC, 2002, NAT GENET, V32, P206, DOI 10.1038/ng942; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; YUNG TM, 2009, EXP CELL RES; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	44	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11498	10.1371/journal.pone.0011498	http://dx.doi.org/10.1371/journal.pone.0011498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634899	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300011
J	Salgado-Luarte, C; Gianoli, E				Salgado-Luarte, Cristian; Gianoli, Ernesto			Herbivory on Temperate Rainforest Seedlings in Sun and Shade: Resistance, Tolerance and Habitat Distribution	PLOS ONE			English	Article							RESOURCE AVAILABILITY; SIMULATED HERBIVORY; INSECT HERBIVORY; TROPICAL FOREST; NATIVE CRUCIFER; CHILOE ISLAND; PLANT DEFENSE; GROWTH; LIGHT; TREE	Differential herbivory and/or differential plant resistance or tolerance in sun and shade environments may influence plant distribution along the light gradient. Embothrium coccineum is one of the few light-demanding tree species in the temperate rainforest of southern South America, and seedlings are frequently attacked by insects and snails. Herbivory may contribute to the exclusion of E. coccineum from the shade if 1) herbivory pressure is greater in the shade, which in turn can result from shade plants being less resistant or from habitat preferences of herbivores, and/or 2) consequences of damage are more detrimental in the shade, i.e., shade plants are less tolerant. We tested this in a field study with naturally established seedlings in treefall gaps (sun) and forest understory (shade) in a temperate rainforest of southern Chile. Seedlings growing in the sun sustained nearly 40% more herbivore damage and displayed half of the specific leaf area than those growing in the shade. A palatability test showed that a generalist snail consumed ten times more leaf area when fed on shade leaves compared to sun leaves, i.e., plant resistance was greater in sun-grown seedlings. Herbivore abundance (total biomass) was two-fold greater in treefall gaps compared to the forest understory. Undamaged seedlings survived better and showed a slightly higher growth rate in the sun. Whereas simulated herbivory in the shade decreased seedling survival and growth by 34% and 19%, respectively, damaged and undamaged seedlings showed similar survival and growth in the sun. Leaf tissue lost to herbivores in the shade appears to be too expensive to replace under the limiting light conditions of forest understory. Following evaluations of herbivore abundance and plant resistance and tolerance in contrasting light environments, we have shown how herbivory on a light-demanding tree species may contribute to its exclusion from shade sites. Thus, in the shaded forest understory, where the seedlings of some tree species are close to their physiological tolerance limit, herbivory could play an important role in plant establishment.	[Salgado-Luarte, Cristian; Gianoli, Ernesto] Univ Concepcion, Dept Bot, Concepcion, Chile; [Gianoli, Ernesto] Univ La Serena, Dept Biol, La Serena, Chile; [Gianoli, Ernesto] Pontificia Univ Catolica Chile, Ctr Adv Studies Ecol & Biodivers, Santiago, Chile	Universidad de Concepcion; Universidad de La Serena; Pontificia Universidad Catolica de Chile	Salgado-Luarte, C (corresponding author), Univ Concepcion, Dept Bot, Concepcion, Chile.	egianoli@userena.cl	Gianoli, Ernesto/A-7984-2015	Gianoli, Ernesto/0000-0003-4246-8640	FONDECYT [1070503]; CONICYT (Consejo Nacional de Investigacion Cientifica y Tecnologica) [21050805]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT (Consejo Nacional de Investigacion Cientifica y Tecnologica)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This study received partial financial support from FONDECYT (www.fondecyt.cl) grant 1070503. CS-L thanks CONICYT (Consejo Nacional de Investigacion Cientifica y Tecnologica) for doctoral fellowship 21050805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDE TM, 1990, ECOLOGY, V71, P1412, DOI 10.2307/1938278; [Anonymous], 2007, HDB FUNCTIONAL PLANT; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Baraza E, 2004, CAN J BOT, V82, P357, DOI [10.1139/b04-004, 10.1139/B04-004]; Bazzaz F. A., 1996, PLANTS CHANGING ENV; BAZZAZ FA, 1987, BIOSCIENCE, V37, P58, DOI 10.2307/1310178; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Calvo-Irabien LM, 1999, AM J BOT, V86, P1108, DOI 10.2307/2656973; Chacon P, 2006, OECOLOGIA, V146, P555, DOI 10.1007/s00442-005-0244-8; Choong MF, 1996, FUNCT ECOL, V10, P668, DOI 10.2307/2390178; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; COLEY PD, 1983, ECOLOGY, V64, P426, DOI 10.2307/1939960; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Collantes HG, 1998, PHYTOCHEMISTRY, V49, P1921, DOI 10.1016/S0031-9422(98)00444-0; COLLINGE SK, 1988, OECOLOGIA, V75, P559, DOI 10.1007/BF00776420; Crawley Michael J., 1997, P401; Crone EE, 1999, J CHEM ECOL, V25, P635, DOI 10.1023/A:1020966206840; Dalling JW, 2009, OECOLOGIA, V161, P361, DOI 10.1007/s00442-009-1385-y; DENSLOW JS, 1990, ECOLOGY, V71, P165, DOI 10.2307/1940257; DENSLOW JS, 1987, ANNU REV ECOL SYST, V18, P431, DOI 10.1146/annurev.es.18.110187.002243; Diaz MF, 2007, REV CHIL HIST NAT, V80, P13; Dirzo R, 1995, SEASONALLY DRY TROPI, P305; Dorsch K, 2003, THESIS L MAXIMILIANS; DUDT JF, 1994, ECOLOGY, V75, P86, DOI 10.2307/1939385; Elger A, 2009, OIKOS, V118, P767, DOI 10.1111/j.1600-0706.2009.17206.x; Figueroa JA, 2001, NEW PHYTOL, V152, P483, DOI 10.1046/j.0028-646X.2001.00282.x; Finzi AC, 2000, FOREST ECOL MANAG, V131, P153, DOI 10.1016/S0378-1127(99)00206-6; Gianoli E, 2010, J VEG SCI, V21, P66, DOI 10.1111/j.1654-1103.2009.01124.x; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; HARRISON S, 1987, OECOLOGIA, V72, P65, DOI 10.1007/BF00385046; Henriksson J, 2003, OIKOS, V103, P3, DOI 10.1034/j.1600-0706.2003.12306.x; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; JING SW, 1990, OIKOS, V58, P369, DOI 10.2307/3545228; KNAPP R, 1986, ECOLOGY, V67, P598, DOI 10.2307/1937683; LARSSON S, 1986, OIKOS, V47, P205, DOI 10.2307/3566047; LEI TT, 1990, OECOLOGIA, V84, P224, DOI 10.1007/BF00318275; Lentz KA, 1998, PLANT ECOL, V139, P125, DOI 10.1023/A:1009762603019; LINCOLN DE, 1984, OECOLOGIA, V64, P173, DOI 10.1007/BF00376867; Louda SM, 1996, J ECOL, V84, P229, DOI 10.2307/2261358; Lusk CH, 2006, OIKOS, V112, P131, DOI 10.1111/j.0030-1299.2006.13922.x; Lusk CH, 2002, OECOLOGIA, V132, P188, DOI 10.1007/s00442-002-0974-9; Lusk CH, 2002, AUSTRAL ECOL, V27, P173, DOI 10.1046/j.1442-9993.2002.01168.x; Lusk CH, 1999, J ECOL, V87, P973, DOI 10.1046/j.1365-2745.1999.00408.x; MACGARVIN M, 1986, OIKOS, V47, P135, DOI 10.2307/3566038; MAIORANA VC, 1981, BIOL J LINN SOC, V15, P151, DOI 10.1111/j.1095-8312.1981.tb00754.x; Marquis R. J., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P301; MCGRAW JB, 1990, TREE PHYSIOL, V7, P247, DOI 10.1093/treephys/7.1-2-3-4.247; Molina-Montenegro MA, 2006, ACTA OECOL, V30, P147, DOI 10.1016/j.actao.2006.02.008; Muth NZ, 2008, ECOSCIENCE, V15, P182, DOI 10.2980/15-2-3095; NICHOLSORIANS CM, 1991, OECOLOGIA, V86, P552, DOI 10.1007/BF00318322; NIESENBAUM RA, 1992, AM MIDL NAT, V128, P270, DOI 10.2307/2426460; Niesenbaum RA, 2006, ENVIRON ENTOMOL, V35, P600, DOI 10.1603/0046-225X-35.3.600; Norghauer JM, 2008, J ECOL, V96, P103, DOI 10.1111/j.1365-2745.2007.01325.x; NUNEZFARFAN J, 1988, OIKOS, V51, P274, DOI 10.2307/3565308; Onoda Y, 2008, ANN BOT-LONDON, V101, P727, DOI 10.1093/aob/mcn013; Pearson TRH, 2003, J ECOL, V91, P785, DOI 10.1046/j.1365-2745.2003.00803.x; PIERSON EA, 1990, OECOLOGIA, V84, P534, DOI 10.1007/BF00328171; Richards LA, 2007, J TROP ECOL, V23, P169, DOI 10.1017/S0266467406003907; Richards LA, 2007, OIKOS, V116, P31, DOI 10.1111/j.2006.0030-1299.15043.x; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Rogers WE, 2002, BASIC APPL ECOL, V3, P297, DOI 10.1078/1439-1791-00120; Rosenthal G. A, 1991, HERBIVORES THEIR INT; Sipura M, 2000, OIKOS, V91, P550, DOI 10.1034/j.1600-0706.2000.910317.x; Sousa WP, 2003, OECOLOGIA, V137, P436, DOI 10.1007/s00442-003-1350-0; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Yamasaki M, 2003, OECOLOGIA, V137, P226, DOI 10.1007/s00442-003-1337-x; ZANGERL AR, 1993, ECOLOGY, V74, P47, DOI 10.2307/1939500	70	42	43	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11460	10.1371/journal.pone.0011460	http://dx.doi.org/10.1371/journal.pone.0011460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628638	gold, Green Published, Green Submitted			2022-12-27	WOS:000279589300008
J	Hung, MS; Lin, YC; Mao, JH; Kim, IJ; Xu, ZD; Yang, CT; Jablons, DM; You, LA				Hung, Ming-Szu; Lin, Yu-Ching; Mao, Jian-Hua; Kim, Il-Jin; Xu, Zhidong; Yang, Cheng-Ta; Jablons, David M.; You, Liang			Functional Polymorphism of the CK2 alpha Intronless Gene Plays Oncogenic Roles in Lung Cancer	PLOS ONE			English	Article							PROTEIN-KINASE CK2; PML TUMOR-SUPPRESSOR; II SUBUNIT-ALPHA; PSEUDOGENE; IDENTIFICATION; TUMORIGENESIS; DEGRADATION; EXPRESSION; ORIGINS; GENOME	Protein kinase CK2 is frequently up-regulated in human cancers, although the mechanism of CK2 activation in cancer remains unknown. In this study, we investigated the role of the CK2 alpha intronless gene (CSNK2A1P, a presumed CK2 alpha pseudogene) in the pathogenesis of human cancers. We found evidence of amplification and over-expression of the CSNK2A1P gene in non-small cell lung cancer and leukemia cell lines and 25% of the lung cancer tissues studied. The mRNA expression levels correlated with the copy numbers of the CSNK2A1P gene. We also identified a novel polymorphic variant (398T/C, I133T) of the CSNK2A1P gene and showed that the 398T allele is selectively amplified over the 398C allele in 101 non-small cell lung cancer tissue samples compared to those in 48 normal controls (p = 0.013<0.05). We show for the first time CSNK2A1P protein expression in transfected human embryonic kidney 293T and mouse embryonic fibroblast NIH-3T3 cell lines. Both alleles are transforming in these cell lines, and the 398T allele appears to be more transforming than the 398C allele. Moreover, the 398T allele degrades PML tumor suppressor protein more efficiently than the 398C allele and shows a relatively stronger binding to PML. Knockdown of the CSNK2A1P gene expression with specific siRNA increased the PML protein level in lung cancer cells. We report, for the first time, that the CSNK2A1P gene is a functional proto-oncogene in human cancers and its functional polymorphism appears to degrade PML differentially in cancer cells. These results are consistent with an important role for the 398T allele of the CSNK2A1P in human lung cancer susceptibility.	[Hung, Ming-Szu; Kim, Il-Jin; Xu, Zhidong; Jablons, David M.; You, Liang] Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA; [Hung, Ming-Szu; Lin, Yu-Ching; Yang, Cheng-Ta] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Hung, Ming-Szu] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan; [Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Yang, Cheng-Ta] Chang Gung Univ, Coll Med, Dept Resp Care, Tao Yuan, Taiwan	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Chang Gung Memorial Hospital; Chang Gung University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Chang Gung University	Hung, MS (corresponding author), Univ Calif San Francisco, Dept Surg, Ctr Comprehens Canc, Thorac Oncol Lab, San Francisco, CA 94143 USA.	jablonsd@surgery.ucsf.edu; Liang.You@ucsfmedctr.org	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Yang, Cheng-Ta/0000-0003-1846-1027	National Institutes of Health [093708-01A3]; Larry Hall and Zygielbaum Memorial Trust; Kazan, McClain, Edises, Abrams, Fernandez, Lyons and Farrise Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry Hall and Zygielbaum Memorial Trust; Kazan, McClain, Edises, Abrams, Fernandez, Lyons and Farrise Foundation	This work was partially supported by the National Institutes of Health (093708-01A3) and the Larry Hall and Zygielbaum Memorial Trust, and the Kazan, McClain, Edises, Abrams, Fernandez, Lyons and Farrise Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATTISTUTTA R, 2009, CELL MOL LIFE SCI; Berger IR, 2005, CANCER GENET CYTOGEN, V159, P155, DOI 10.1016/j.cancergencyto.2004.10.010; Di Maira G, 2005, CELL DEATH DIFFER, V12, P668, DOI 10.1038/sj.cdd.4401604; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Harrison PM, 2002, GENOME RES, V12, P272, DOI 10.1101/gr.207102; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hwang SL, 2005, EUR SURG RES, V37, P100, DOI 10.1159/000084540; Jemal A, 2009, CA CANC J CLIN; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Landesman-Bollag E, 2001, MOL CELL BIOCHEM, V227, P153, DOI 10.1023/A:1013108822847; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; PINNA LA, 2009, CELL MOL LIFE SCI; Prudent R, 2009, CHEM BIOL, V16, P112, DOI 10.1016/j.chembiol.2009.01.004; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Scaglioni PP, 2008, MOL CELL BIOCHEM, V316, P149, DOI 10.1007/s11010-008-9812-7; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; Singh LS, 2002, BIOCHEMISTRY-US, V41, P8935, DOI 10.1021/bi025791r; Sun C, 2008, BIOCHEM BIOPH RES CO, V377, P215, DOI 10.1016/j.bbrc.2008.09.113; TREMBLEY JH, 2009, CELL MOL LIFE SCI; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; WIRKNER U, 1992, BIOCHIM BIOPHYS ACTA, V1131, P220, DOI 10.1016/0167-4781(92)90083-C; WIRKNER U, 1994, GENOMICS, V19, P257, DOI 10.1006/geno.1994.1056	31	21	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11418	10.1371/journal.pone.0011418	http://dx.doi.org/10.1371/journal.pone.0011418			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625391	gold, Green Submitted, Green Published			2022-12-27	WOS:000279465700006
J	Shah, P; Gilchrist, MA				Shah, Premal; Gilchrist, Michael A.			Is Thermosensing Property of RNA Thermometers Unique?	PLOS ONE			English	Article							MESSENGER-RNA; ESCHERICHIA-COLI; SECONDARY STRUCTURE; SIGMA(32); PREDICTION; INDUCTION	A large number of studies have been dedicated to identify the structural and sequence based features of RNA thermometers, mRNAs that regulate their translation initiation rate with temperature. It has been shown that the melting of the ribosome-binding site (RBS) plays a prominent role in this thermosensing process. However, little is known as to how widespread this melting phenomenon is as earlier studies on the subject have worked with a small sample of known RNA thermometers. We have developed a novel method of studying the melting of RNAs with temperature by computationally sampling the distribution of the RNA structures at various temperatures using the RNA folding software Vienna. In this study, we compared the thermosensing property of 100 randomly selected mRNAs and three well known thermometers rpoH, ibpA and agsA sequences from E. coli. We also compared the rpoH sequences from 81 mesophilic proteobacteria. Although both rpoH and ibpA show a higher rate of melting at their RBS compared with the mean of non-thermometers, contrary to our expectations these higher rates are not significant. Surprisingly, we also do not find any significant differences between rpoH thermometers from other gamma-proteobacteria and E. coli non-thermometers.	[Shah, Premal; Gilchrist, Michael A.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Shah, Premal; Gilchrist, Michael A.] Natl Inst Math & Biol Synth, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Shah, P (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	pshah1@utk.edu	Gilchrist, Michael A/A-8209-2008; Taylor, Graham/A-4027-2012	Gilchrist, Michael A/0000-0002-6936-0771; Shah, Premal/0000-0002-8424-4218	Department of Ecology and Evolutionary Biology at the University of Tennessee, Knoxville; National Institute for Mathematical and Biological Synthesis (NIMBioS)	Department of Ecology and Evolutionary Biology at the University of Tennessee, Knoxville; National Institute for Mathematical and Biological Synthesis (NIMBioS)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The funding was provided by the Department of Ecology and Evolutionary Biology at the University of Tennessee, Knoxville (http://eeb.bio.utk.edu/). P. S. was supported by the National Institute for Mathematical and Biological Synthesis (NIMBioS) Graduate Research Assistantship (http://nimbios.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avihoo A, 2005, IEEE COMP SYST BIOIN, P235; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; DESMIT MH, 1990, P NATL ACAD SCI USA, V87, P7668, DOI 10.1073/pnas.87.19.7668; Hambraeus G, 2003, MOL GENET GENOMICS, V269, P706, DOI 10.1007/s00438-003-0883-6; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hughes T A, 2006, Comput Math Methods Med, V7, P37, DOI 10.1080/10273660600906416; Huynen M, 1997, J MOL BIOL, V267, P1104, DOI 10.1006/jmbi.1997.0889; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Morita MT, 1999, GENE DEV, V13, P655, DOI 10.1101/gad.13.6.655; NAKAHIGASHI K, 1995, NUCLEIC ACIDS RES, V23, P4383; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; R Core Team, 2018, R LANG ENV STAT COMP; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shultzaberger RK, 2001, J MOL BIOL, V313, P215, DOI 10.1006/jmbi.2001.5040; Voss B, 2004, BIOINFORMATICS, V20, P1573, DOI 10.1093/bioinformatics/bth129; Waldminghaus T, 2005, BIOL CHEM, V386, P1279, DOI 10.1515/BC.2005.145; Waldminghaus T, 2007, MOL GENET GENOMICS, V278, P555, DOI 10.1007/s00438-007-0272-7; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; YUZAWA H, 1993, NUCLEIC ACIDS RES, V21, P5449, DOI 10.1093/nar/21.23.5449	24	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11308	10.1371/journal.pone.0011308	http://dx.doi.org/10.1371/journal.pone.0011308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625392	Green Submitted, Green Published, gold			2022-12-27	WOS:000279465700002
J	Yan, D; Ng, WL; Zhang, XM; Wang, P; Zhang, ZB; Mo, YY; Mao, H; Hao, CH; Olson, JJ; Curran, WJ; Wang, Y				Yan, Dan; Ng, Wooi Loon; Zhang, Xiangming; Wang, Ping; Zhang, Zhaobin; Mo, Yin-Yuan; Mao, Hui; Hao, Chunhai; Olson, Jeffrey J.; Curran, Walter J.; Wang, Ya			Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; STRAND BREAK REPAIR; MICRORNA-101; GLIOMA; RECOMBINATION; EXPRESSION; SUBUNIT; MIR-31	Background: Radiotherapy kills tumor-cells by inducing DNA double strand breaks (DSBs). However, the efficient repair of tumors frequently prevents successful treatment. Therefore, identifying new practical sensitizers is an essential step towards successful radiotherapy. In this study, we tested the new hypothesis: identifying the miRNAs to target DNA DSB repair genes could be a new way for sensitizing tumors to ionizing radiation. Principal Findings: Here, we chose two genes: DNA-PKcs (an essential factor for non-homologous end-joining repair) and ATM (an important checkpoint regulator for promoting homologous recombination repair) as the targets to search their regulating miRNAs. By combining the database search and the bench work, we picked out miR-101. We identified that miR-101 could efficiently target DNA-PKcs and ATM via binding to the 3'- UTR of DNA-PKcs or ATM mRNA. Up-regulating miR-101 efficiently reduced the protein levels of DNA-PKcs and ATM in these tumor cells and most importantly, sensitized the tumor cells to radiation in vitro and in vivo. Conclusions: These data demonstrate for the first time that miRNAs could be used to target DNA repair genes and thus sensitize tumors to radiation. These results provide a new way for improving tumor radiotherapy.	[Yan, Dan; Ng, Wooi Loon; Zhang, Xiangming; Wang, Ping; Curran, Walter J.; Wang, Ya] Emory Univ, Sch Med, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA; [Zhang, Zhaobin; Olson, Jeffrey J.] Emory Univ, Sch Med, Dept Neurosurg, Winship Canc Inst, Atlanta, GA USA; [Mo, Yin-Yuan] So Illinois Univ, Sch Med, Springfield, IL USA; [Mao, Hui] Emory Univ, Sch Med, Dept Radiol, Winship Canc Inst, Atlanta, GA 30322 USA; [Hao, Chunhai] Emory Univ, Sch Med, Dept Pathol & Lab Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University; Southern Illinois University System; Southern Illinois University; Emory University; Emory University	Yan, D (corresponding author), Emory Univ, Sch Med, Dept Radiat Oncol, Winship Canc Inst, Atlanta, GA 30322 USA.	ywang94@emory.edu	Yan, Dan/B-1793-2012; Mo, Yin-Yuan/R-8255-2019; Mo, Yin-Yuan/B-6141-2011	Yan, Dan/0000-0001-7531-5814; 	NIH [GM80771]; Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM80771 (to Y.W.) and an Emory University startup fund (to Y.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Golding SE, 2004, J BIOL CHEM, V279, P15402, DOI 10.1074/jbc.M314191200; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jackson SP, 1996, CANCER SURV, V28, P261; JEGGO PA, 1995, BIOESSAYS, V17, P949, DOI 10.1002/bies.950171108; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P927, DOI 10.1038/nrm2598; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li S, 2009, HEPATOLOGY, V49, P1194, DOI 10.1002/hep.22757; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Y L, 1989, Zhonghua Zhong Liu Za Zhi, V11, P1; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Wang FZ, 2008, J VIROL, V82, P9065, DOI 10.1128/JVI.00961-08; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858	28	182	198	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11397	10.1371/journal.pone.0011397	http://dx.doi.org/10.1371/journal.pone.0011397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YF	20617180	gold, Green Published, Green Submitted			2022-12-27	WOS:000279465500001
J	Fukuda, A; Cao, F; Morita, S; Yamada, K; Jincho, Y; Tane, S; Sotomaru, Y; Kono, T				Fukuda, Atsushi; Cao, Feng; Morita, Shinnosuke; Yamada, Kaori; Jincho, Yuko; Tane, Shouji; Sotomaru, Yusuke; Kono, Tomohiro			Identification of Inappropriately Reprogrammed Genes by Large-Scale Transcriptome Analysis of Individual Cloned Mouse Blastocysts	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR TRANSFER; EXPRESSION PROFILES; CHROMATIN-STRUCTURE; CYCLE REGULATION; X-CHROMOSOME; DONOR CELLS; MICE; EMBRYOS; METHYLATION	Although cloned embryos generated by somatic/embryonic stem cell nuclear transfer (SECNT) certainly give rise to viable individuals, they can often undergo embryonic arrest at any stage of embryogenesis, leading to diverse morphological abnormalities. In an effort to gain further insights into reprogramming and the properties of SECNT embryos, we performed a large-scale gene expression profiling of 87 single blastocysts using GeneChip microarrays. Sertoli cells, cumulus cells, and embryonic stem cells were used as donor cells. The gene expression profiles of 87 blastocysts were subjected to microarray analysis. Using principal component analysis and hierarchical clustering, the gene expression profiles were clearly classified into 3 clusters corresponding to the type of donor cell. The results revealed that each type of SECNT embryo had a unique gene expression profile that was strictly dependent upon the type of donor cells, although there was considerable variation among the individual profiles within each group. This suggests that the reprogramming process is distinct for embryos cloned from different types of donor cells. Furthermore, on the basis of the results of comparison analysis, we identified 35 genes that were inappropriately reprogrammed in most of the SECNT embryos; our findings demonstrated that some of these genes, such as Asz1, Xlr3a and App, were appropriately reprogrammed only in the embryos with a transcriptional profile that was the closest to that of the controls. Our findings provide a framework to further understand the reprogramming in SECNT embryos.	[Fukuda, Atsushi; Cao, Feng; Morita, Shinnosuke; Yamada, Kaori; Jincho, Yuko; Tane, Shouji; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan	Tokyo University of Agriculture; Hiroshima University	Fukuda, A (corresponding author), Tokyo Univ Agr, Dept Biosci, Tokyo, Japan.	tomohiro@nodai.ac.jp	Sotomaru, Yusuke/G-5508-2019	Tane, Shoji/0000-0002-0209-347X	Ministry of Education, Science, Sports and Culture of Japan [18208024]; Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan to T.K. (No. 18208024), and from the Ministry of Agriculture, Forestry and Fisheries of Japan (Development of stable production technology of cloned animals by somatic cell nuclear transfer) to T.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artus J, 2008, MOL CELL ENDOCRINOL, V282, P78, DOI 10.1016/j.mce.2007.11.008; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Beyhan Z, 2007, DEV BIOL, V305, P637, DOI 10.1016/j.ydbio.2007.01.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Chung YG, 2003, BIOL REPROD, V69, P146, DOI 10.1095/biolreprod.102.014076; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Egli D, 2007, NATURE, V447, P679, DOI 10.1038/nature05879; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Gurdon John, 2008, Cell Stem Cell, V2, P135, DOI 10.1016/j.stem.2008.01.009; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Iwamori N, 2002, FEBS LETT, V526, P119, DOI 10.1016/S0014-5793(02)03121-6; Jincho Y, 2008, BIOL REPROD, V78, P568, DOI 10.1095/biolreprod.107.064634; Kawahara M, 2008, NAT PROTOC, V3, P197, DOI 10.1038/nprot.2007.531; Kishigami S, 2006, NAT PROTOC, V1, P125, DOI 10.1038/nprot.2006.21; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Li XP, 2006, CLONING STEM CELLS, V8, P214, DOI 10.1089/clo.2006.8.214; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; Muller C, 2004, J BIOL CHEM, V279, P7353, DOI 10.1074/jbc.M312709200; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Ogawa H, 2003, REPRODUCTION, V126, P549, DOI 10.1530/rep.0.1260549; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Oishi M, 2006, MOL REPROD DEV, V73, P404, DOI 10.1002/mrd.20345; Ono Y, 2001, REPRODUCTION, V122, P731, DOI 10.1530/reprod/122.5.731; Ono Y, 2006, BIOL REPROD, V75, P210, DOI 10.1095/biolreprod.105.049171; PAI SR, 1994, ANTICANCER RES, V14, P2501; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shimozawa N, 2002, GENESIS, V34, P203, DOI 10.1002/gene.10143; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Somers J, 2006, REPRODUCTION, V131, P1073, DOI 10.1530/rep.1.00967; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Tong GQ, 2006, CELL TISSUE RES, V325, P231, DOI 10.1007/s00441-006-0189-1; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Waes JGV, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-156; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wee G, 2006, J BIOL CHEM, V281, P6048, DOI 10.1074/jbc.M511340200; Wee G, 2007, REPRODUCTION, V134, P781, DOI 10.1530/REP-07-0338; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yang XZ, 2007, NAT GENET, V39, P295, DOI 10.1038/ng1973; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang HS, 2001, ONCOGENE, V20, P3134, DOI 10.1038/sj.onc.1204338; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973	63	37	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11274	10.1371/journal.pone.0011274	http://dx.doi.org/10.1371/journal.pone.0011274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614022	gold, Green Submitted, Green Published			2022-12-27	WOS:000279370000004
J	Jonker, RM; Eichhorn, G; van Langevelde, F; Bauer, S				Jonker, Rudy M.; Eichhorn, Goetz; van Langevelde, Frank; Bauer, Silke			Predation Danger Can Explain Changes in Timing of Migration: The Case of the Barnacle Goose	PLOS ONE			English	Article							OPTIMAL AVIAN MIGRATION; HEART-RATE; OXYGEN-CONSUMPTION; SPRING MIGRATION; BRANTA-LEUCOPSIS; RANGE EXPANSION; CLIMATE-CHANGE; STOPOVER SITE; TRADE-OFF; GEESE	Understanding stopover decisions of long-distance migratory birds is crucial for conservation and management of these species along their migratory flyway. Recently, an increasing number of Barnacle geese breeding in the Russian Arctic have delayed their departure from their wintering site in the Netherlands by approximately one month and have reduced their staging duration at stopover sites in the Baltic accordingly. Consequently, this extended stay increases agricultural damage in the Netherlands. Using a dynamic state variable approach we explored three hypotheses about the underlying causes of these changes in migratory behavior, possibly related to changes in (i) onset of spring, (ii) potential intake rates and (iii) predation danger at wintering and stopover sites. Our simulations showed that the observed advance in onset of spring contradicts the observed delay of departure, whereas both increased predation danger and decreased intake rates in the Baltic can explain the delay. Decreased intake rates are expected as a result of increased competition for food in the growing Barnacle goose population. However, the effect of predation danger in the model was particularly strong, and we hypothesize that Barnacle geese avoid Baltic stopover sites as a response to the rapidly increasing number of avian predators in the area. Therefore, danger should be considered as an important factor influencing Barnacle goose migratory behavior, and receive more attention in empirical studies.	[Jonker, Rudy M.; van Langevelde, Frank] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Eichhorn, Goetz] Univ Strasbourg, DEPE, IPHC, Strasbourg, France; [Eichhorn, Goetz] CNRS, Strasbourg, France; [Jonker, Rudy M.; Bauer, Silke] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Maarssen, Netherlands; [Bauer, Silke] Swiss Ornithol Inst, Sempach, Switzerland	Wageningen University & Research; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Swiss Ornithological Institute	Jonker, RM (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.	rudy.jonker@wur.nl	Eichhorn, Götz/R-8136-2016; Bauer, Silke/C-3524-2008; Jonker, Rudy/I-3979-2012; Bauer, Silke/M-9811-2019	Eichhorn, Götz/0000-0003-2151-8856; Bauer, Silke/0000-0002-0844-164X; Bauer, Silke/0000-0002-0844-164X; Van Langevelde, Frank/0000-0001-8870-0797	Dutch Faunafonds; Koninklijke Nederlandse Jagersvereniging; ESF; 'Marianne und Dr. Fritz Walter-Fischer Stiftung', Germany; Groningen University; The Netherlands Organisation [816.01.007]	Dutch Faunafonds; Koninklijke Nederlandse Jagersvereniging; ESF(European Commission); 'Marianne und Dr. Fritz Walter-Fischer Stiftung', Germany; Groningen University; The Netherlands Organisation(Netherlands Organization for Scientific Research (NWO))	Rudy Jonker was funded by the Dutch Faunafonds and the Koninklijke Nederlandse Jagersvereniging. Gotz Eichhorn was supported by ESF travel grants and scholarships from the 'Marianne und Dr. Fritz Walter-Fischer Stiftung', Germany, and the 'Ubbo Emmius Programme' of Groningen University. Silke Bauer received support from The Netherlands Organisation for Scientific Research, Earth & Life Sciences (NWO-ALW) project grant 816.01.007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T., 1990, P331; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Bauer S, 2008, J ANIM ECOL, V77, P654, DOI 10.1111/j.1365-2656.2008.01381.x; Beekman JH, 2002, ARDEA, V90, P437; Both C, 2007, SCIENCE, V315, DOI 10.1126/science.1136148; Bruinzeel L.W., 1997, PATCHWORK PATCH USE, P111; Butler PJ, 2000, COMP BIOCHEM PHYS A, V126, P379, DOI 10.1016/S1095-6433(00)00221-X; Clark CW, 2000, OX ECOL EV; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Dierschke V, 2003, J AVIAN BIOL, V34, P24, DOI 10.1034/j.1600-048X.2003.03049.x; Eichhorn G., 2008, THESIS U GRONINGEN G; Eichhorn G, 2009, J ANIM ECOL, V78, P63, DOI 10.1111/j.1365-2656.2008.01485.x; Eichhorn G, 2006, ARDEA, V94, P667; *FAUN, 2009, DORDR AGR DAM BARN G; FORSLUND P, 1991, ARDEA, V79, P342; Fransson T, 1997, BEHAV ECOL SOCIOBIOL, V41, P75, DOI 10.1007/s002650050366; Ganter B., 1999, GOOSE POPULATIONS W, P270; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gordo O, 2007, CLIM RES, V35, P37, DOI 10.3354/cr00713; HELANDER B, 2000, P INT C BJORK SWED 1; HERMANN C, 2009, POPULATION DEV BALTI; Houston AI, 1998, J AVIAN BIOL, V29, P395, DOI 10.2307/3677158; Houston AI, 1999, MODELS ADAPTIVE BEHA; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Jonzen N, 2007, P ROY SOC B-BIOL SCI, V274, P269, DOI 10.1098/rspb.2006.3719; Klaassen M, 2006, J APPL ECOL, V43, P92, DOI 10.1111/j.1365-2664.2005.01109.x; Lank DB, 2003, OIKOS, V103, P303, DOI 10.1034/j.1600-0706.2003.12314.x; Lank DB, 2003, J AVIAN BIOL, V34, P225, DOI 10.1034/j.1600-048X.2003.03250.x; Leito Aivar, 1996, Estonia Maritima, V1, P1; Marra PP, 2005, OECOLOGIA, V142, P307, DOI 10.1007/s00442-004-1725-x; MCNAMARA JM, 1994, AM NAT, V144, P978, DOI 10.1086/285721; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; Pomeroy AC, 2006, BEHAV ECOL, V17, P1041, DOI 10.1093/beheco/arl043; Prins Herbert H. T., 2008, V195, P1; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; R Core Team, 2020, R LANG ENV STAT COMP; Roder Frank E., 2008, Takkeling, V16, P100; Stervander M, 2005, J AVIAN BIOL, V36, P210, DOI 10.1111/j.0908-8857.2005.03360.x; Sutherland WJ, 1998, J AVIAN BIOL, V29, P441, DOI 10.2307/3677163; Tombre IM, 2008, J AVIAN BIOL, V39, P691, DOI 10.1111/j.1600-048X.2008.04440.x; van der Graaf AJ, 2007, BASIC APPL ECOL, V8, P354, DOI 10.1016/j.baae.2006.07.001; van der Graaf SAJ, 2006, ARDEA, V94, P567; Van Der Jeugd HP, 2009, GLOBAL CHANGE BIOL, V15, P1057, DOI 10.1111/j.1365-2486.2008.01804.x; van der Jeugd HP, 2003, POLAR BIOL, V26, P700, DOI 10.1007/s00300-003-0535-7; VANDERGRAAF AJ, 2006, THESIS RIJKSUNIVERSI; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Ward S, 2002, J EXP BIOL, V205, P3347; Weber TP, 1998, EVOL ECOL, V12, P377, DOI 10.1023/A:1006560420310; YDENBERG RC, 1986, ADV STUD BEHAV, V16, P229, DOI 10.1016/S0065-3454(08)60192-8; YDENBERG RC, 1981, J APPL ECOL, V18, P443, DOI 10.2307/2402405; Ydenberg RC, 2007, J AVIAN BIOL, V38, P523, DOI 10.1111/j.2007.0908-8857.04202.x	54	46	47	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11369	10.1371/journal.pone.0011369	http://dx.doi.org/10.1371/journal.pone.0011369			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614027	Green Published, gold			2022-12-27	WOS:000279370000007
J	Kowarsch, A; Marr, C; Schmidl, D; Ruepp, A; Theis, FJ				Kowarsch, Andreas; Marr, Carsten; Schmidl, Daniel; Ruepp, Andreas; Theis, Fabian J.			Tissue-Specific Target Analysis of Disease-Associated MicroRNAs in Human Signaling Pathways	PLOS ONE			English	Article							REL/NF-KAPPA-B; MESSENGER-RNA; C-FOS; CANCER; GENE; IDENTIFICATION; EXPRESSION; GROWTH; CELLS; TRANSCRIPTION	MicroRNAs are a large class of post-transcriptional regulators that bind to the 39 untranslated region of messenger RNAs. They play a critical role in many cellular processes and have been linked to the control of signal transduction pathways. Recent studies indicate that microRNAs can function as tumor suppressors or even as oncogenes when aberrantly expressed. For more general insights of disease-associated microRNAs, we analyzed their impact on human signaling pathways from two perspectives. On a global scale, we found a core set of signaling pathways with enriched tissue-specific microRNA targets across diseases. The function of these pathways reflects the affinity of microRNAs to regulate cellular processes associated with apoptosis, proliferation or development. Comparing cancer and non-cancer related microRNAs, we found no significant differences between both groups. To unveil the interaction and regulation of microRNAs on signaling pathways locally, we analyzed the cellular location and process type of disease-associated microRNA targets and proteins. While disease-associated proteins are highly enriched in extracellular components of the pathway, microRNA targets are preferentially located in the nucleus. Moreover, targets of disease-associated microRNAs preferentially exhibit an inhibitory effect within the pathways in contrast to disease proteins. Our analysis provides systematic insights into the interaction of disease-associated microRNAs and signaling pathways and uncovers differences in cellular locations and process types of microRNA targets and disease-associated proteins.	[Kowarsch, Andreas; Marr, Carsten; Schmidl, Daniel; Ruepp, Andreas; Theis, Fabian J.] Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Schmidl, Daniel; Theis, Fabian J.] Tech Univ Munich, Inst Math Sci, D-8046 Garching, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Kowarsch, A (corresponding author), Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	andreas.kowarsch@helmholtz-muenchen.de; fabian.theis@helmholtz-muenchen.de	Marr, Carsten/B-3696-2013; Theis, Fabian J/ABD-5212-2021	Marr, Carsten/0000-0003-2154-4552; Theis, Fabian J/0000-0002-2419-1943	Federal Ministry of Education and Research (BMBF); MedSys initiative; Helmholtz Alliance on Systems Biology	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); MedSys initiative; Helmholtz Alliance on Systems Biology	This work was supported by the Federal Ministry of Education and Research (BMBF) and its MedSys initiative (project 'LungSys') and the Helmholtz Alliance on Systems Biology (project 'CoReNe'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chiao PJ, 2002, CANCER, V95, P1696, DOI 10.1002/cncr.10829; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; CUI Q, 2006, MOL SYSTEMS BIOL, P1; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Evangelisti C, 2009, FASEB J, V23, P4276, DOI 10.1096/fj.09-134965; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; George D, 2003, ADV EXP MED BIOL, V532, P141; Gerondakis S, 1999, ONCOGENE, V18, P6888, DOI 10.1038/sj.onc.1203236; Griffen TD, 2004, J INDO-EUR STUD, V32, P11; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; Hollams EM, 2002, NEUROCHEM RES, V27, P957, DOI 10.1023/A:1020992418511; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Klamt S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000385; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; LEGEWIE S, 2008, MOL SYSTEMS BIOL, P1; LEUCHT C, 2008, NAT NEUROSCI; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Lutter D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-224; Ricarte JCM, 2009, TRANSL ONCOL, V2, P236, DOI 10.1593/tlo.09151; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perrone G, 2007, MODERN PATHOL, V20, P344, DOI 10.1038/modpathol.3800743; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; SCHAEFER CF, 2008, NUCL ACIDS RES; Seigel GM, 2007, MOL VIS, V13, P823; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002; Wu EX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003794; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Yeilding NM, 1996, MOL CELL BIOL, V16, P3511; 2009, TARGETSPY	57	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11154	10.1371/journal.pone.0011154	http://dx.doi.org/10.1371/journal.pone.0011154			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614023	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000002
J	Oliva, AM; Salcedo, E; Hellier, JL; Ly, X; Koka, K; Tollin, DJ; Restrepo, D				Oliva, Anthony M.; Salcedo, Ernesto; Hellier, Jennifer L.; Ly, Xuan; Koka, Kanthaiah; Tollin, Daniel J.; Restrepo, Diego			Toward a Mouse Neuroethology in the Laboratory Environment	PLOS ONE			English	Article							PERIPHERAL OLFACTORY PROJECTIONS; NARIS CLOSURE; MUTANT MICE; BEHAVIOR; BULB; BRAIN; GLOMERULUS; SYSTEM; RATS; SIZE	In this report we demonstrate that differences in cage type brought unexpected effects on aggressive behavior and neuroanatomical features of the mouse olfactory bulb. A careful characterization of two cage types, including a comparison of the auditory and temperature environments, coupled with a demonstration that naris occlusion abolishes the neuroanatomical changes, lead us to conclude that a likely important factor mediating the phenotypic changes we find is the olfactory environment of the two cages. We infer that seemingly innocuous changes in cage environment can affect sensory input relevant to mice and elicit profound effects on neural output. Study of the neural mechanisms underlying animal behavior in the laboratory environment should be broadened to include neuroethological approaches to examine how the laboratory environment (beyond animal well-being and enrichment) influences neural systems and behavior.	[Oliva, Anthony M.; Salcedo, Ernesto; Hellier, Jennifer L.; Ly, Xuan; Restrepo, Diego] Univ Colorado, Dept Cell & Dev Biol, Sch Med, Aurora, CO USA; [Oliva, Anthony M.; Salcedo, Ernesto; Hellier, Jennifer L.; Ly, Xuan; Restrepo, Diego] Univ Colorado, Neurosci Program, Sch Med, Aurora, CO USA; [Oliva, Anthony M.; Salcedo, Ernesto; Hellier, Jennifer L.; Ly, Xuan; Koka, Kanthaiah; Tollin, Daniel J.; Restrepo, Diego] Univ Colorado, Rocky Mt Taste & Smell Ctr, Sch Med, Aurora, CO USA; [Koka, Kanthaiah; Tollin, Daniel J.] Univ Colorado, Dept Physiol & Biophys, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Oliva, AM (corresponding author), Univ Colorado, Dept Cell & Dev Biol, Sch Med, Aurora, CO USA.	Diego.Restrepo@ucdenver.edu	Koka, Kanthaiah/AAJ-1965-2020	, Daniel/0000-0001-6790-1290	National Institute of Deafness and Other Communication Disorders (National Institutes of Health, NIDCD) [DC00566, DC006070, DC04657, DC009137, DC00867]; NARSAD (National Alliance for Research in Schizophrenia and Depression); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F33DC009137, R01DC000566, P30DC004657, R01DC006070] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders (National Institutes of Health, NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NARSAD (National Alliance for Research in Schizophrenia and Depression)(NARSAD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institute of Deafness and Other Communication Disorders (National Institutes of Health, NIDCD) grants DC00566, DC006070 and DC04657 (DR), DC009137 (JT) and DC00867 (ES) and a NARSAD (National Alliance for Research in Schizophrenia and Depression) Essel Distinguished Investigator award (DR). NIDCD web site: http://www.nidcd.nih.gov/; NARSAD web site: http://www.narsad.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER H, 1993, BRAIN RES, V614, P109, DOI 10.1016/0006-8993(93)91023-L; Brennan PA, 2009, BEHAV BRAIN RES, V200, P287, DOI 10.1016/j.bbr.2008.10.045; BRUNJES PC, 1994, BRAIN RES REV, V19, P146; Castelhano-Carlos MJ, 2009, LAB ANIM-UK, V43, P311, DOI 10.1258/la.2009.0080098; Chesler EJ, 2002, NEUROSCI BIOBEHAV R, V26, P907, DOI 10.1016/S0149-7634(02)00103-3; Crabbe JC, 2003, SCIENCE, V299, P1313; Dotson CD, 2005, PHYSIOL BEHAV, V85, P655, DOI 10.1016/j.physbeh.2005.06.010; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Gonder JC, 2007, ILAR J, V48, P29, DOI 10.1093/ilar.48.1.29; Goymann W, 2002, GEN COMP ENDOCR, V129, P80, DOI 10.1016/S0016-6480(02)00520-8; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Hasen NS, 2009, GENES BRAIN BEHAV, V8, P639, DOI 10.1111/j.1601-183X.2009.00511.x; HEILIGENBERG W, 1991, ANNU REV NEUROSCI, V14, P247; HOYLE G, 1984, BEHAV BRAIN SCI, V7, P367, DOI 10.1017/S0140525X0001863X; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; *INC SASI, 2004, SAS STATR 9 1 US GUI, P8101; Izidio GS, 2005, GENES BRAIN BEHAV, V4, P412, DOI 10.1111/j.1601-183X.2005.00121.x; Kimchi T, 2007, NATURE, V448, P1009, DOI 10.1038/nature06089; Koay G, 2002, HEARING RES, V171, P111, DOI 10.1016/S0378-5955(02)00492-6; KRYTER KD, 1985, EFFECTS NOISE MAN, P8; Lewejohann L, 2006, GENES BRAIN BEHAV, V5, P64, DOI 10.1111/j.1601-183X.2005.00140.x; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Mandairon N, 2006, BEHAV NEUROSCI, V120, P173, DOI 10.1037/0735-7044.120.1.173; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Oliva AM, 2008, J COMP NEUROL, V510, P475, DOI 10.1002/cne.21800; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Restrepo D, 2006, TRENDS NEUROSCI, V29, P604, DOI 10.1016/j.tins.2006.08.001; Royal SJ, 1999, J NEUROSCI, V19, P9856; Schaefer ML, 2001, J COMP NEUROL, V436, P351; SEARLE SR, 1992, VARIANCE COMPONENTS, P1; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, P159; Takahashi A, 2006, BEHAV GENET, V36, P763, DOI 10.1007/s10519-005-9038-3; Tordoff MG, 2005, PHYSIOL BEHAV, V86, P480, DOI 10.1016/j.physbeh.2005.08.031; Vazquez-Palacios G, 2001, PHARMACOL BIOCHEM BE, V70, P305, DOI 10.1016/S0091-3057(01)00620-7; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Wahlsten D, 2006, P NATL ACAD SCI USA, V103, P16364, DOI 10.1073/pnas.0605342103; Watson KK, 2008, PHILOS T R SOC B, V363, P3825, DOI 10.1098/rstb.2008.0159; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	40	30	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11359	10.1371/journal.pone.0011359	http://dx.doi.org/10.1371/journal.pone.0011359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613876	Green Published, Green Submitted, gold			2022-12-27	WOS:000279369900008
J	Shi, YC; Lin, S; Wong, IPL; Baldock, PA; Aljanova, A; Enriquez, RF; Castillo, L; Mitchell, NF; Ye, JM; Zhang, L; Macia, L; Yulyaningsih, E; Nguyen, AD; Riepler, SJ; Herzog, H; Sainsbury, A				Shi, Yan-Chuan; Lin, Shu; Wong, Iris P. L.; Baldock, Paul A.; Aljanova, Aygul; Enriquez, Ronaldo F.; Castillo, Lesley; Mitchell, Natalie F.; Ye, Ji-Ming; Zhang, Lei; Macia, Laurence; Yulyaningsih, Ernie; Nguyen, Amy D.; Riepler, Sabrina J.; Herzog, Herbert; Sainsbury, Amanda			NPY Neuron-Specific Y2 Receptors Regulate Adipose Tissue and Trabecular Bone but Not Cortical Bone Homeostasis in Mice	PLOS ONE			English	Article							NEUROPEPTIDE-Y; BODY-WEIGHT; PEPTIDE-YY; PARAVENTRICULAR NUCLEUS; OBESITY SYNDROME; KNOCKOUT MICE; ZUCKER RATS; OB/OB MICE; LEPTIN; STRESS	Background: Y2 receptor signalling is known to be important in neuropeptide Y (NPY)-mediated effects on energy homeostasis and bone physiology. Y2 receptors are located post-synaptically as well as acting as auto receptors on NPY-expressing neurons, and the different roles of these two populations of Y2 receptors in the regulation of energy homeostasis and body composition are unclear. Methodology/Principal Findings: We thus generated two conditional knockout mouse models, Y2(lox/lox) and NPYCre/+;Y2(lox/lox), in which Y2 receptors can be selectively ablated either in the hypothalamus or specifically in hypothalamic NPY-producing neurons of adult mice. Specific deletion of hypothalamic Y2 receptors increases food intake and body weight compared to controls. Importantly, specific ablation of hypothalamic Y2 receptors on NPY-containing neurons results in a significantly greater adiposity in female but not male mice, accompanied by increased hepatic triglyceride levels, decreased expression of liver cartinine palmitoyltransferase (CPT1) and increased expression of muscle phosphorylated acetyl-CoA carboxylase (ACC). While food intake, body weight, femur length, bone mineral content, density and cortical bone volume and thickness are not significantly altered, trabecular bone volume and number were significantly increased by hypothalamic Y2 deletion on NPY-expressing neurons. Interestingly, in situ hybridisation reveals increased NPY and decreased proopiomelanocortin ( POMC) mRNA expression in the arcuate nucleus of mice with hypothalamus-specific deletion of Y2 receptors in NPY neurons, consistent with a negative feedback mechanism between NPY expression and Y2 receptors on NPY-ergic neurons. Conclusions/Significance: Taken together these data demonstrate the anti-obesogenic role of Y2 receptors in the brain, notably on NPY-ergic neurons, possibly via inhibition of NPY neurons and concomitant stimulation of POMC-expressing neurons in the arcuate nucleus of the hypothalamus, reducing lipogenic pathways in liver and/or skeletal muscle in females. These data also reveal as an anti-osteogenic effect of Y2 receptors on hypothalamic NPY-expressing neurons on trabecular but not on cortical bone.	[Shi, Yan-Chuan; Lin, Shu; Wong, Iris P. L.; Baldock, Paul A.; Aljanova, Aygul; Enriquez, Ronaldo F.; Castillo, Lesley; Mitchell, Natalie F.; Zhang, Lei; Macia, Laurence; Yulyaningsih, Ernie; Nguyen, Amy D.; Riepler, Sabrina J.; Herzog, Herbert; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia; [Ye, Ji-Ming] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Baldock, Paul A.; Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia	Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Shi, YC (corresponding author), Garvan Inst Med Res, Neurosci Res Program, Sydney, NSW, Australia.	a.sainsbury-salis@garvan.org.au	/E-2900-2010; Herzog, Herbert/B-8294-2008; /A-4361-2010; Nguyen, Amy D/K-2588-2019; Baldock, Paul/B-3840-2012; /B-6258-2012; Salis, Amanda/A-3187-2011; Macia, laurence/D-5983-2016; /A-6021-2011	Nguyen, Amy D/0000-0003-4603-564X; Salis, Amanda/0000-0001-9176-1574; Macia, laurence/0000-0003-0835-851X; /0000-0003-2110-2017; , Herbert/0000-0002-1713-1029; lin, shu/0000-0002-4239-2028	National Health and Medical Research Council (NHMRC) of Australia [427661, 427606]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council (NHMRC) of Australia grants # 427661 & # 427606, and AS, HH and PB are supported by NHMRC Fellowships (http://www.nhmrc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Goycolea C, 2005, J NEUROSCI, V25, P7406, DOI 10.1523/JNEUROSCI.1008-05.2005; Allison SJ, 2006, J BIOL CHEM, V281, P23436, DOI 10.1074/jbc.M604839200; Baldock PA, 2005, J BONE MINER RES, V20, P1851, DOI 10.1359/JBMR.050523; Baldock PA, 2002, J CLIN INVEST, V109, P915, DOI 10.1172/JCI14588; Baldock PA, 2006, J BONE MINER RES, V21, P1600, DOI 10.1359/JBMR.060705; Baldock PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008415; Baraban SC, 1998, REV NEUROSCIENCE, V9, P117; Baran K, 2002, DIABETES, V51, P152, DOI 10.2337/diabetes.51.1.152; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; BECK B, 1993, J NUTR, V123, P1168; BILLINGTON CJ, 1994, AM J PHYSIOL, V266, pR1765, DOI 10.1152/ajpregu.1994.266.6.R1765; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; Boey D, 2008, NEUROPEPTIDES, V42, P19, DOI 10.1016/j.npep.2007.11.003; Broberger C, 1997, NEUROENDOCRINOLOGY, V66, P393, DOI 10.1159/000127265; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Fetissov SO, 2004, J COMP NEUROL, V470, P256, DOI 10.1002/cne.11047; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Heilig M, 2004, NEUROPEPTIDES, V38, P213, DOI 10.1016/j.npep.2004.05.002; KALRA SP, 1991, P NATL ACAD SCI USA, V88, P10931, DOI 10.1073/pnas.88.23.10931; King PJ, 2000, EUR J PHARMACOL, V396, pR1, DOI 10.1016/S0014-2999(00)00230-2; Kotz CM, 1998, AM J PHYSIOL-REG I, V275, pR471, DOI 10.1152/ajpregu.1998.275.2.R471; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LEIBOWITZ SF, 1991, PEPTIDES, V12, P1251, DOI 10.1016/0196-9781(91)90203-2; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Lin S, 2007, ENDOCRINOLOGY, V148, P2056, DOI 10.1210/en.2006-1408; Marin MT, 2007, PHYSIOL BEHAV, V90, P29, DOI 10.1016/j.physbeh.2006.08.021; MCKIBBIN PE, 1991, DIABETES, V40, P1423, DOI 10.2337/diabetes.40.11.1423; McLean J., 1987, ANIMAL HUMAN CALORIM; Naveilhan P, 2002, PEPTIDES, V23, P1087, DOI 10.1016/S0196-9781(02)00042-6; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Pierroz DD, 1996, ENDOCRINOLOGY, V137, P3, DOI 10.1210/en.137.1.3; Playford RJ, 1996, TRENDS PHARMACOL SCI, V17, P436, DOI 10.1016/S0165-6147(96)01008-5; Pralong FP, 2002, FASEB J, V16, P712, DOI 10.1096/fj.01-0754fje; Redrobe JP, 2004, J MOL NEUROSCI, V22, P159, DOI 10.1385/JMN:22:3:159; Sainsbury A, 2006, DIABETES, V55, P19; Sainsbury A, 1997, DIABETES, V46, P209, DOI 10.2337/diabetes.46.2.209; Sainsbury A, 2003, MOL CELL BIOL, V23, P5225, DOI 10.1128/MCB.23.15.5225-5233.2003; Sainsbury A, 2002, P NATL ACAD SCI USA, V99, P8938, DOI 10.1073/pnas.132043299; Sainsbury A, 2002, DIABETES, V51, P3420, DOI 10.2337/diabetes.51.12.3420; STANLEY BG, 1989, PHYSIOL BEHAV, V46, P173, DOI 10.1016/0031-9384(89)90251-5; Tasan RO, 2010, J NEUROSCI, V30, P6282, DOI 10.1523/JNEUROSCI.0430-10.2010; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; WILLIAMS G, 1988, DIABETES, V37, P763, DOI 10.2337/diabetes.37.6.763; Ye JM, 2003, AM J PHYSIOL-ENDOC M, V284, pE531, DOI 10.1152/ajpendo.00299.2002; Zafar HM, 1997, BRAIN RES BULL, V44, P289, DOI 10.1016/S0361-9230(97)00140-8; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753	57	53	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11361	10.1371/journal.pone.0011361	http://dx.doi.org/10.1371/journal.pone.0011361			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613867	Green Published, gold			2022-12-27	WOS:000279369900010
J	Talwar, D; McConnachie, A; Welsh, P; Upton, M; O'Reilly, D; Smith, GD; Watt, G; Sattar, N				Talwar, Dinesh; McConnachie, Alex; Welsh, Paul; Upton, Mark; O'Reilly, Denis; Smith, George Davey; Watt, Graham; Sattar, Naveed			Which Circulating Antioxidant Vitamins Are Confounded by Socioeconomic Deprivation? The MIDSPAN Family Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; VEGETABLE INTAKE; ASCORBIC-ACID; BETA-CAROTENE; RISK; CANCER; HEALTH; WOMEN; HEART	Background: Antioxidant vitamins are often described as having "independent'' associations with risk of cancer, cardiovascular disease (CVD) and mortality. We aimed to compare to what extent a range of antioxidant vitamins and carotenoids are associated with adulthood and childhood markers of socioeconomic deprivation and to adverse lifestyle factors. Methods and Findings: Socioeconomic and lifestyle measures were available in 1040 men and 1298 women from the MIDSPAN Family Study (30-59 years at baseline) together with circulating levels of vitamins A, C, E, and carotenoids (alpha-carotene, beta-carotene, lutein and lycopene). Markers of socioeconomic deprivation in adulthood were consistently as strongly associated with lower vitamin C and carotenoid levels as markers of adverse lifestyle; the inverse association with overcrowding was particularly consistent (vitamin C and carotenoids range from 19.1% [95% CI 30.3-6.0] to 38.8% [49.9-25.3] lower among those in overcrowded residencies). These associations were consistent after adjusting for month, classical CVD risk factors, body mass index, physical activity, vitamin supplements, dietary fat and fibre intake. Similar, but weaker, associations were seen for childhood markers of deprivation. The association of vitamin A or E were strikingly different; several adult adverse lifestyle factors associated with higher levels of vitamin A and E, including high alcohol intake for vitamin A (9.5% [5.7-13.5]) and waist hip ratio for vitamin E (9.5% [4.8-14.4]), with the latter associations partially explained by classical risk factors, particularly cholesterol levels. Conclusions: Plasma vitamin C and carotenoids have strong inverse associations with adulthood markers of social deprivation, whereas vitamin A and E appear positively related to specific adverse lifestyle factors. These findings should help researchers better contextualize blood antioxidant vitamin levels by illustrating the potential	[Talwar, Dinesh; O'Reilly, Denis] Glasgow Royal Infirm, Dept Clin Biochem, Glasgow G4 0SF, Lanark, Scotland; [McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Welsh, Paul; Sattar, Naveed] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Upton, Mark] Woodlands Family Med Ctr, Stockton On Tees, England; [Smith, George Davey] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England	University of Glasgow; University of Glasgow; University of Glasgow; University of Bristol	Talwar, D (corresponding author), Glasgow Royal Infirm, Dept Clin Biochem, Glasgow G4 0SF, Lanark, Scotland.	nsattar@clinmed.gla.ac.uk	Davey Smith, George/A-7407-2013; Welsh, Paul/H-5249-2019	Davey Smith, George/0000-0002-1407-8314; Welsh, Paul/0000-0002-7970-3643; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; Upton, Mark/0000-0003-0839-1141	Wellcome Trust; NHS Cardiovascular Research and Development Programme; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); NHS Cardiovascular Research and Development Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge support from the Wellcome Trust and the NHS Cardiovascular Research and Development Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Rmeileh NME, 2008, OBESITY, V16, P1388, DOI 10.1038/oby.2008.211; Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Carstairs V., 1991, DEPRIVATION HLTH SCO; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; Dubowitz T, 2008, AM J CLIN NUTR, V87, P1883, DOI 10.1093/ajcn/87.6.1883; Haire-Joshu D, 2004, J NUTR EDUC BEHAV, V36, P309, DOI 10.1016/S1499-4046(06)60400-4; Hart C, 2008, INT J EPIDEMIOL, V37, P604, DOI 10.1093/ije/dyn052; Hart CL, 2009, ALCOHOL ALCOHOLISM, V44, P332, DOI 10.1093/alcalc/agn125; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jenab M, 2006, CARCINOGENESIS, V27, P2250, DOI 10.1093/carcin/bgl096; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Lawlor DA, 2005, HEART, V91, P1086, DOI 10.1136/hrt.2004.048934; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; MARGOLIS SA, 1988, CLIN CHEM, V34, P2217; Moats Caroline, 2007, Curr Atheroscler Rep, V9, P508, DOI 10.1007/s11883-007-0068-6; Morris CD, 2003, ANN INTERN MED, V139, P56, DOI 10.7326/0003-4819-139-1-200307010-00014; Sesso HD, 2008, JAMA-J AM MED ASSOC, V300, P2123, DOI 10.1001/jama.2008.600; Slatore CG, 2008, AM J RESP CRIT CARE, V177, P524, DOI 10.1164/rccm.200709-1398OC; SMITH GD, 2002, INT J EPIDEMIOL, V31, P710; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Upton MN, 2000, BMJ-BRIT MED J, V321, P88, DOI 10.1136/bmj.321.7253.88; Walsh Patrick C, 2005, J Urol, V174, P1823, DOI 10.1097/01.ju.0000183077.52404.ec; Wang XD, 2005, ALCOHOL, V35, P251, DOI 10.1016/j.alcohol.2005.04.006; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167; Wright ME, 2006, AM J CLIN NUTR, V84, P1200, DOI 10.1093/ajcn/84.5.1200	28	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11312	10.1371/journal.pone.0011312	http://dx.doi.org/10.1371/journal.pone.0011312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593021	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000279140800013
J	Kong, XX; Wang, R; Xue, Y; Liu, XJ; Zhang, HB; Chen, Y; Fang, F; Chang, YS				Kong, Xingxing; Wang, Rui; Xue, Yuan; Liu, Xiaojun; Zhang, Huabing; Chen, Yong; Fang, Fude; Chang, Yongsheng			Sirtuin 3, a New Target of PGC-1 alpha, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis	PLOS ONE			English	Article							ERR-ALPHA; RECEPTOR-ALPHA; SIR2 HOMOLOG; HEPATIC GLUCONEOGENESIS; ENERGY-METABOLISM; GENE-EXPRESSION; DEACETYLASE; GAMMA; IDENTIFICATION; COACTIVATORS	Background: Sirtuin 3 (SIRT3) is one of the seven mammalian sirtuins, which are homologs of the yeast Sir2 gene. SIRT3 is the only sirtuin with a reported association with the human life span. Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) plays important roles in adaptive thermogenesis, gluconeogenesis, mitochondrial biogenesis and respiration. PGC-1 alpha induces several key reactive oxygen species (ROS)-detoxifying enzymes, but the molecular mechanism underlying this is not well understood. Results: Here we show that PGC-1 alpha strongly stimulated mouse Sirt3 gene expression in muscle cells and hepatocytes. Knockdown of PGC-1 alpha led to decreased Sirt3 gene expression. PGC-1 alpha activated the mouse SIRT3 promoter, which was mediated by an estrogen-related receptor (ERR) binding element (ERRE) (-407/-399) mapped to the promoter region. Chromatin immunoprecipitation and electrophoretic mobility shift assays confirmed that ERR alpha bound to the identified ERRE and PGC-1 alpha co-localized with ERR alpha in the mSirt3 promoter. Knockdown of ERR alpha reduced the induction of Sirt3 by PGC-1 alpha in C2C12 myotubes. Furthermore, Sirt3 was essential for PGC-1 alpha-dependent induction of ROS-detoxifying enzymes and several components of the respiratory chain, including glutathione peroxidase-1, superoxide dismutase 2, ATP synthase 5c, and cytochrome c. Overexpression of SIRT3 or PGC-1 alpha in C2C12 myotubes decreased basal ROS level. In contrast, knockdown of mSIRT3 increased basal ROS level and blocked the inhibitory effect of PGC-1 alpha on cellular ROS production. Finally, SIRT3 stimulated mitochondrial biogenesis, and SIRT3 knockdown decreased the stimulatory effect of PGC-1 alpha on mitochondrial biogenesis in C2C12 myotubes. Conclusion: Our results indicate that Sirt3 functions as a downstream target gene of PGC-1 alpha and mediates the PGC-1 alpha effects on cellular ROS production and mitochondrial biogenesis. Thus, SIRT3 integrates cellular energy metabolism and ROS generation. The elucidation of the molecular mechanisms of SIRT3 regulation and its physiological functions may provide a novel target for treating ROS-related disease.	[Kong, Xingxing; Wang, Rui; Liu, Xiaojun; Zhang, Huabing; Fang, Fude; Chang, Yongsheng] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China; [Kong, Xingxing; Wang, Rui; Liu, Xiaojun; Zhang, Huabing; Fang, Fude; Chang, Yongsheng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Xue, Yuan; Chen, Yong] Hubei Prov Key Lab Biotechnol Chinese Tradit Med, Wuhan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Kong, XX (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100730, Peoples R China.	cy101610@npc.gov.cn; fangfd@vip.sina.com; changy@ibms.pumc.edu.cn	Wang, Rui/I-5643-2019	Wang, Rui/0000-0001-7015-0272	Major State Basic Research Development Program of China [2006CB503909]; National High Technology Research and Development Program of China [2006AA02Z192, 2006AA02A409]; National Natural Science Foundation of China [30700386, 30721063, 30800389, 90919019]; Natural Science Foundation of Beijing [7082056]	Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	This work was supported by collective grants from the Major State Basic Research Development Program of China (973 Program 2006CB503909), National High Technology Research and Development Program of China (863 Program 2006AA02Z192 and 2006AA02A409), the National Natural Science Foundation of China (Grant No. 30700386, No. 30721063, No. 30800389 and No. 90919019) and Natural Science Foundation of Beijing (Grant No. 7082056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzog B, 2006, J BIOL CHEM, V281, P99, DOI 10.1074/jbc.M509276200; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jacobs KM, 2008, INT J BIOL SCI, V4, P291; Jin L, 2009, PROTEIN SCI, V18, P514, DOI 10.1002/pro.50; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Kong XX, 2009, MOL PHARMACOL, V76, P854, DOI 10.1124/mol.109.056424; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Leong PHW, 2005, J STAT SOFTW, V12, P1; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; REMELS AH, 2009, MOL CELL ENDOCRINOL; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Slane BG, 2006, CANCER RES, V66, P7615, DOI 10.1158/0008-5472.CAN-06-0833; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wang YJ, 2004, WORLD J GASTROENTERO, V10, P699, DOI 10.3748/wjg.v10.i5.699; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YH, 2000, GENOMICS, V69, P355, DOI 10.1006/geno.2000.6360; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhao LJ, 2003, GENE, V316, P137, DOI 10.1016/S0378-1119(03)00750-9	56	523	540	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11707	10.1371/journal.pone.0011707	http://dx.doi.org/10.1371/journal.pone.0011707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661474	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243300011
J	Bull, JC; Bonsall, MB				Bull, James C.; Bonsall, Michael B.			Predators Reduce Extinction Risk in Noisy Metapopulations	PLOS ONE			English	Article							DEMOGRAPHIC STOCHASTICITY; APPARENT COMPETITION; ENVIRONMENTAL NOISE; SPATIAL SYNCHRONY; DYNAMICS; PERSISTENCE; DISPERSAL; STABILITY; MODELS; CYCLES	Background: Spatial structure across fragmented landscapes can enhance regional population persistence by promoting local "rescue effects.'' In small, vulnerable populations, where chance or random events between individuals may have disproportionately large effects on species interactions, such local processes are particularly important. However, existing theory often only describes the dynamics of metapopulations at regional scales, neglecting the role of multispecies population dynamics within habitat patches. Findings: By coupling analysis across spatial scales we quantified the interaction between local scale population regulation, regional dispersal and noise processes in the dynamics of experimental host-parasitoid metapopulations. We find that increasing community complexity increases negative correlation between local population dynamics. A potential mechanism underpinning this finding was explored using a simple population dynamic model. Conclusions: Our results suggest a paradox: parasitism, whilst clearly damaging to hosts at the individual level, reduces extinction risk at the population level.	[Bull, James C.] Univ Warwick, Dept Biol Sci, Populat & Dis Grp, Coventry CV4 7AL, W Midlands, England; [Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, Oxford OX1 3PS, England	University of Warwick; University of Oxford	Bull, JC (corresponding author), Univ Warwick, Dept Biol Sci, Populat & Dis Grp, Coventry CV4 7AL, W Midlands, England.	michael.bonsall@zoo.ox.ac.uk		Bull, James/0000-0002-4373-6830; Bonsall, Michael/0000-0003-0250-0423	Natural Environment Research Council [NER/A/S/2000/01288]; Natural Environment Research Council [NE/F010095/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by a grant from the Natural Environment Research Council to MBB (NER/A/S/2000/01288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allee W.C, 1931, ANIMAL AGGREGATION S; Amarasekare P, 1998, AM NAT, V152, P298, DOI 10.1086/286169; Benton TG, 2002, J ANIM ECOL, V71, P320, DOI 10.1046/j.1365-2656.2002.00601.x; Bjornstad ON, 1998, J ANIM ECOL, V67, P110, DOI 10.1046/j.1365-2656.1998.00168.x; Bonsall MB, 2005, P ROY SOC B-BIOL SCI, V272, P1465, DOI 10.1098/rspb.2005.3111; Bonsall MB, 1997, NATURE, V388, P371, DOI 10.1038/41084; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Bull JC, 2008, J ANIM ECOL, V77, P1296, DOI 10.1111/j.1365-2656.2008.01449.x; Bull JC, 2007, P ROY SOC B-BIOL SCI, V274, P87, DOI 10.1098/rspb.2006.3691; Bull JC, 2006, J ANIM ECOL, V75, P899, DOI 10.1111/j.1365-2656.2006.01107.x; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; COMINS HN, 1992, J ANIM ECOL, V61, P735, DOI 10.2307/5627; COMINS HN, 1987, THEOR POPUL BIOL, V31, P393, DOI 10.1016/0040-5809(87)90013-X; Comins HN, 1996, J THEOR BIOL, V183, P19, DOI 10.1006/jtbi.1996.0197; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; Earn DJD, 2000, SCIENCE, V290, P1360, DOI 10.1126/science.290.5495.1360; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; GURNEY WSC, 1998, ECOLOGICAL DYNAMICS; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P333; Holyoak M, 1996, J ANIM ECOL, V65, P640, DOI 10.2307/5743; Hudson PJ, 1998, SCIENCE, V282, P2256, DOI 10.1126/science.282.5397.2256; HUFFAKER C. B., 1958, HILGARDIA, V27, P343; Legendre P., 2012, NUMERICAL ECOLOGY; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; MAY RM, 1974, SCIENCE, V186, P645, DOI 10.1126/science.186.4164.645; Ranta E, 2000, P ROY SOC B-BIOL SCI, V267, P1851, DOI 10.1098/rspb.2000.1220; ROSENZWE.ML, 1971, SCIENCE, V171, P385, DOI 10.1126/science.171.3969.385; Royama T., 1992, ANAL POPULATION ECOL; Vogwill T, 2009, ECOL LETT, V12, P1194, DOI 10.1111/j.1461-0248.2009.01374.x; Wilson HB, 1997, P ROY SOC B-BIOL SCI, V264, P1189, DOI 10.1098/rspb.1997.0164; Zhou SR, 2004, MATH BIOSCI, V189, P103, DOI 10.1016/j.mbs.2003.06.001	36	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11635	10.1371/journal.pone.0011635	http://dx.doi.org/10.1371/journal.pone.0011635			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657767	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500012
J	Weiss, L; Piketty, C; Assoumou, L; Didier, C; Caccavelli, L; Donkova-Petrini, V; Levys, Y; Girard, PM; Burgard, M; Viard, JP; Rouzioux, C; Costagliola, D				Weiss, Laurence; Piketty, Christophe; Assoumou, Lambert; Didier, Celine; Caccavelli, Laure; Donkova-Petrini, Vladimira; Levys, Yves; Girard, Pierre-Marie; Burgard, Marianne; Viard, Jean-Paul; Rouzioux, Christine; Costagliola, Dominique		ANRS 116 SALTO Study Grp	Relationship between Regulatory T Cells and Immune Activation in Human Immunodeficiency Virus-Infected Patients Interrupting Antiretroviral Therapy	PLOS ONE			English	Article							DISEASE PROGRESSION; PERIPHERAL-BLOOD; HIV-INFECTION; LYMPHOCYTE-ACTIVATION; TYPE-1 INFECTION; SIV INFECTION; RNA LEVELS; CD4(+); RESPONSES; EXPRESSION	Persistent immune activation plays a central role in driving Human Immunodeficiency Virus (HIV) disease progression. Whether CD4+ CD25+ regulatory T cells (Tregs) are harmful by suppressing HIV-specific immune responses and/or beneficial through a decrease in immune activation remains debatable. We analysed the relationship between proportion and number of regulatory T cells (Tregs) and immune activation in HIV-infected patients interrupting an effective antiretroviral therapy (ART). Twenty-five patients were included in a substudy of a prospective multicenter trial of treatment interruption (TI) (ANRS 116). Proportions and numbers of Tregs and the proportion of activated CD4 and CD8 T cells were assessed at baseline and month 12 (M12) of TI. Specific anti-HIV CD4 and CD8 responses were investigated at baseline and M12. Non parametric univariate analyses and multivariate linear regression models were conducted. At baseline, the proportion of Tregs negatively correlated with the proportion of HLA-DR+ CD8(+) T cells (r = -0.519). Following TI, the proportion of Tregs increased from 6.3% to 7.2% (p = 0.029); absolute numbers of Tregs decreased. The increase in the proportion of HLA-DR+ CD38(+) CD8(+) T cells was significantly related to the increase in proportion of Tregs (p = 0.031). At M12, the proportion of Tregs did not negatively correlate with CD8 T-cell activation. Nevertheless, Tregs retain a suppressive function since depletion of Treg-containing CD4(+) CD25(+) cells led to an increase in lymphoproliferative responses in most patients studied. Our data suggest that Tregs are efficient in controlling residual immune activation in patients with ART-mediated viral suppression. However, the insufficient increase in the proportion and/or the decrease in the absolute number of Tregs result in a failure to control immune activation following TI.	[Weiss, Laurence; Rouzioux, Christine] Univ Paris 05, Fac Med, Paris, France; [Weiss, Laurence; Piketty, Christophe; Caccavelli, Laure; Donkova-Petrini, Vladimira] Hop Europe Georges Pompidou, AP HP, Paris, France; [Weiss, Laurence; Didier, Celine] Inst Pasteur, Unite Regulat Infect Retrovirales, Paris, France; [Assoumou, Lambert; Costagliola, Dominique] INSERM, U943, Paris, France; [Assoumou, Lambert; Costagliola, Dominique] Univ Paris 06, UMR S 943, Paris, France; [Levys, Yves] Univ Paris 12, INSERM, Unite U841, Creteil, France; [Levys, Yves] AP HP, Grp Henri Mondor Albert Chenevier, Creteil, France; [Girard, Pierre-Marie] Hop St Antoine, AP HP, F-75571 Paris, France; [Burgard, Marianne; Viard, Jean-Paul; Rouzioux, Christine] Hop Necker Paris, AP HP, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Weiss, L (corresponding author), Univ Paris 05, Fac Med, Paris, France.	laurence.weiss@egp.aphp.fr	WEISS, Laurence/B-1373-2012; Costagliola, Dominique/H-5849-2011; Caccavelli, Laure/H-8880-2017	Costagliola, Dominique/0000-0003-0765-0869; Caccavelli, Laure/0000-0001-6324-2304	French National Agency; Sidaction	French National Agency(French National Research Agency (ANR)); Sidaction	This study was funded by the French National Agency for Research on AIDS (ANRS). VDP was supported by Sidaction. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aandahl EM, 2004, J VIROL, V78, P2454, DOI 10.1128/JVI.78.5.2454-2459.2004; Akbar AN, 2007, NAT REV IMMUNOL, V7, P231, DOI 10.1038/nri2037; Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Apoil PA, 2005, JAIDS-J ACQ IMM DEF, V39, P381, DOI 10.1097/01.qai.0000169662.30783.2d; Avettand-Fenoel V, 2008, J CLIN VIROL, V42, P399, DOI 10.1016/j.jcv.2008.03.013; Banham AH, 2006, TRENDS IMMUNOL, V27, P541, DOI 10.1016/j.it.2006.10.002; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Bentwich Z, 1998, CLIN EXP IMMUNOL, V111, P1; Boasso A, 2007, J VIROL, V81, P11593, DOI 10.1128/JVI.00760-07; Buseyne F, 2005, AIDS RES HUM RETROV, V21, P719, DOI 10.1089/aid.2005.21.719; Carbonneil C, 2004, J IMMUNOL, V172, P7832, DOI 10.4049/jimmunol.172.12.7832; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Daucher M, 2008, J VIROL, V82, P4102, DOI 10.1128/JVI.02212-07; Deeks SG, 2002, J INFECT DIS, V185, P315, DOI 10.1086/338467; Eggena MP, 2005, J IMMUNOL, V174, P4407, DOI 10.4049/jimmunol.174.7.4407; Epple HJ, 2006, BLOOD, V108, P3072, DOI 10.1182/blood-2006-04-016923; Estes JD, 2006, J INFECT DIS, V193, P703, DOI 10.1086/500368; GIORGI JV, 1994, J INFECT DIS, V170, P775, DOI 10.1093/infdis/170.4.775; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Hartigan-O'Connor DJ, 2007, J IMMUNOL METHODS, V319, P41, DOI 10.1016/j.jim.2006.10.008; Kared H, 2008, AIDS, V22, P2451, DOI 10.1097/QAD.0b013e328319edc0; Kinter AL, 2004, J EXP MED, V200, P331, DOI 10.1084/jem.20032069; Kinter A, 2007, P NATL ACAD SCI USA, V104, P3390, DOI 10.1073/pnas.0611423104; Kornfeld C, 2005, J CLIN INVEST, V115, P1082, DOI 10.1172/JCI200523006; Lim A, 2007, AIDS, V21, P1525, DOI 10.1097/QAD.0b013e32825eab8b; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; MDEL MDB, 2010, J INFECT DIS, V201, P331; Ndhlovu LC, 2008, J LEUKOCYTE BIOL, V83, P254, DOI 10.1189/jlb.0507281; Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576; Orendi JM, 1998, J INFECT DIS, V178, P1279, DOI 10.1086/314451; Oxenius A, 2002, P NATL ACAD SCI USA, V99, P13747, DOI 10.1073/pnas.202372199; Pereira LE, 2007, J VIROL, V81, P4445, DOI 10.1128/JVI.00026-07; PIKETTY C, J MED VIROL IN PRESS; Raghavan S, 2005, FEMS IMMUNOL MED MIC, V44, P121, DOI 10.1016/j.femsim.2004.10.017; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Rouzioux C, 2005, J INFECT DIS, V192, P46, DOI 10.1086/430610; Samri A, 2006, CLIN VACCINE IMMUNOL, V13, P684, DOI 10.1128/CVI.00387-05; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7; Sousa AE, 2002, J IMMUNOL, V169, P3400, DOI 10.4049/jimmunol.169.6.3400; Speiser DE, 2001, EUR J IMMUNOL, V31, P459, DOI 10.1002/1521-4141(200102)31:2<459::AID-IMMU459>3.0.CO;2-Y; Tsunemi S, 2005, AIDS, V19, P879, DOI 10.1097/01.aids.0000171401.23243.56; Weiss L, 2004, BLOOD, V104, P3249, DOI 10.1182/blood-2004-01-0365	47	37	40	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11659	10.1371/journal.pone.0011659	http://dx.doi.org/10.1371/journal.pone.0011659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657770	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500015
J	McGill, BM; Sutton-Grier, AE; Wright, JP				McGill, Bonnie M.; Sutton-Grier, Ariana E.; Wright, Justin P.			Plant Trait Diversity Buffers Variability in Denitrification Potential over Changes in Season and Soil Conditions	PLOS ONE			English	Article							TEMPERATE FOREST SOILS; NITROUS-OXIDE; BIODIVERSITY; COMMUNITY; INTERFACE; CARBON; RATES; WATER	Background: Denitrification is an important ecosystem service that removes nitrogen (N) from N-polluted watersheds, buffering soil, stream, and river water quality from excess N by returning N to the atmosphere before it reaches lakes or oceans and leads to eutrophication. The denitrification enzyme activity (DEA) assay is widely used for measuring denitrification potential. Because DEA is a function of enzyme levels in soils, most ecologists studying denitrification have assumed that DEA is less sensitive to ambient levels of nitrate (NO3-) and soil carbon and thus, less variable over time than field measurements. In addition, plant diversity has been shown to have strong effects on microbial communities and belowground processes and could potentially alter the functional capacity of denitrifiers. Here, we examined three questions: (1) Does DEA vary through the growing season? (2) If so, can we predict DEA variability with environmental variables? (3) Does plant functional diversity affect DEA variability? Methodology/Principal Findings: The study site is a restored wetland in North Carolina, US with native wetland herbs planted in monocultures or mixes of four or eight species. We found that denitrification potentials for soils collected in July 2006 were significantly greater than for soils collected in May and late August 2006 (p<0.0001). Similarly, microbial biomass standardized DEA rates were significantly greater in July than May and August (p<0.0001). Of the soil variables measured soil moisture, organic matter, total inorganic nitrogen, and microbial biomass-none consistently explained the pattern observed in DEA through time. There was no significant relationship between DEA and plant species richness or functional diversity. However, the seasonal variance in microbial biomass standardized DEA rates was significantly inversely related to plant species functional diversity (p<0.01). Conclusions/Significance: These findings suggest that higher plant functional diversity may support a more constant level of DEA through time, buffering the ecosystem from changes in season and soil conditions.	[McGill, Bonnie M.; Sutton-Grier, Ariana E.; Wright, Justin P.] Duke Univ, Durham, NC 27706 USA	Duke University	McGill, BM (corresponding author), Duke Univ, Durham, NC 27706 USA.	bonniemcgill@gmail.com	McGill, Bonnie/AAT-7426-2020; Wright, Justin/AAG-6461-2019	McGill, Bonnie/0000-0002-5417-3519; Wright, Justin/0000-0002-9102-5347; Sutton-Grier, Ariana/0000-0002-1242-7728	National Science Foundation (NSF) [DEB0508763]; Association of University Women Educational Foundation; Society of Wetland Scientist; Duke Wetlands Center; USDA Natural Resources Conservation Service; Smithsonian Environmental Research Center	National Science Foundation (NSF)(National Science Foundation (NSF)); Association of University Women Educational Foundation; Society of Wetland Scientist; Duke Wetlands Center; USDA Natural Resources Conservation Service(United States Department of Agriculture (USDA)); Smithsonian Environmental Research Center(Smithsonian InstitutionSmithsonian Environmental Research Center)	This work was supported by National Science Foundation (NSF) Grant DEB0508763, an NSF Graduate Research Fellowship (http://www.nsfgrfp.org); an American Fellowship from the Association of University Women Educational Foundation (http://www.aauw.org/education/fga); a Society of Wetland Scientist Student Research Grant (http://www.sws.org/studentgrants); the Duke Wetlands Center Case Study Endowment (http://www.nicholas.duke.edu/wetland); and a grant from the USDA Natural Resources Conservation Service (http://www.nrcs.usda.gov). AS-G was also partially supported by a Smithsonian Fellowship from the Smithsonian Environmental Research Center (http://www.serc.si.edu/pro_training). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P831, DOI 10.1016/0038-0717(85)90143-9; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Dybzinski R, 2008, OECOLOGIA, V158, P85, DOI 10.1007/s00442-008-1123-x; Ettema CH, 1999, SOIL BIOL BIOCHEM, V31, P1609, DOI 10.1016/S0038-0717(99)00071-1; FORNARA DA, 2008, PLANT FUNCTIONAL COM, P314; GOODROAD LL, 1984, CAN J SOIL SCI, V64, P187, DOI 10.4141/cjss84-020; Groffman P., 1994, CURRENT TOPICS WETLA, V1, P15, DOI DOI 10.1016/J.GEOMORPH.2006.01.010; Groffman PM, 2009, BIOGEOCHEMISTRY, V93, P49, DOI 10.1007/s10533-008-9277-5; GROFFMAN PM, 1989, SOIL BIOL BIOCHEM, V21, P621, DOI 10.1016/0038-0717(89)90054-0; Groffman PM, 1999, LT EC RES NETWK SER, V2, P272; Groffman PM, 2003, J ENVIRON QUAL, V32, P1144, DOI 10.2134/jeq2003.1144; Hall K., 2003, RECOMMENDED NATIVE P; Hernandez ME, 2007, J ENVIRON QUAL, V36, P333, DOI 10.2134/jeq2006.0139; Hill AR, 2004, SOIL SCI SOC AM J, V68, P320, DOI 10.2136/sssaj2004.0320; Howarth RW, 2002, ESTUARIES, V25, P656, DOI 10.1007/BF02804898; JENSEN CR, 1969, AGRON J, V61, P474, DOI 10.2134/agronj1969.00021962006100030045x; Kirby R M, 1971, SOIL SURVEY DURHAM C; Kuzyakov Y, 2002, J PLANT NUTR SOIL SC, V165, P382, DOI 10.1002/1522-2624(200208)165:4<382::AID-JPLN382>3.0.CO;2-#; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Liang BC, 1997, CAN J SOIL SCI, V77, P21, DOI 10.4141/S96-018; Lowrance R, 2001, J ENVIRON QUAL, V30, P617, DOI 10.2134/jeq2001.302617x; Maynard DG, 1993, SOIL SAMPLING METHOD, P25; McClain ME, 2003, ECOSYSTEMS, V6, P301, DOI 10.1007/s10021-003-0161-9; MORAGHAN JT, 1977, SOIL SCI SOC AM J, V41, P1201, DOI 10.2136/sssaj1977.03615995004100060038x; MYROLD DD, 1988, SOIL SCI SOC AM J, V52, P412, DOI 10.2136/sssaj1988.03615995005200020019x; PARSONS LL, 1991, SOIL SCI SOC AM J, V55, P90, DOI 10.2136/sssaj1991.03615995005500010016x; Pelletier F, 1999, CAN J SOIL SCI, V79, P551, DOI 10.4141/S99-022; Petchey OL, 2004, ECOLOGY, V85, P847, DOI 10.1890/03-0226; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; REDDY KR, 1989, LIMNOL OCEANOGR, V34, P1004, DOI 10.4319/lo.1989.34.6.1004; Schimel J., 2001, GLOBAL BIOGEOCHEM CY, P177, DOI [10.1016/b978-012631260-7/50015-7, DOI 10.1016/B978-012631260-7/50015-7]; SCHIPPER LA, 1994, J ENVIRON QUAL, V23, P923, DOI 10.2134/jeq1994.00472425002300050012x; SCHMIDT J, 1988, J ATMOS CHEM, V6, P95, DOI 10.1007/BF00048334; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; STORER DA, 1984, COMMUN SOIL SCI PLAN, V15, P759, DOI 10.1080/00103628409367515; Strauss EA, 2006, J N AM BENTHOL SOC, V25, P596, DOI 10.1899/0887-3593(2006)25[596:VARODI]2.0.CO;2; SUTTONGRIER AE, 2008, THESIS DUKE U DURHAM; TIEDJE JM, 1989, PLANT SOIL, V115, P261, DOI 10.1007/BF02202594; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Voroney R.P., 1993, SOIL SAMPLING METHOD, P277; Wallenstein MD, 2006, ECOL APPL, V16, P2143, DOI 10.1890/1051-0761(2006)016[2143:ECODCA]2.0.CO;2; Wallenstein MD, 2006, ECOL APPL, V16, P2168, DOI 10.1890/1051-0761(2006)016[2168:NFEODA]2.0.CO;2; Wardle D., 2002, COMMUNITIES ECOSYSTE; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; WEIER KL, 1993, SOIL SCI SOC AM J, V57, P66, DOI 10.2136/sssaj1993.03615995005700010013x; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2	52	39	40	3	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11618	10.1371/journal.pone.0011618	http://dx.doi.org/10.1371/journal.pone.0011618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661464	Green Published, Green Submitted			2022-12-27	WOS:000279980800007
J	Anderson, MG; Ferree, CE				Anderson, Mark G.; Ferree, Charles E.			Conserving the Stage: Climate Change and the Geophysical Underpinnings of Species Diversity	PLOS ONE			English	Article							BIODIVERSITY; CONSERVATION; PATTERNS; HETEROGENEITY; AREA	Conservationists have proposed methods for adapting to climate change that assume species distributions are primarily explained by climate variables. The key idea is to use the understanding of species-climate relationships to map corridors and to identify regions of faunal stability or high species turnover. An alternative approach is to adopt an evolutionary timescale and ask ultimately what factors control total diversity, so that over the long run the major drivers of total species richness can be protected. Within a single climatic region, the temperate area encompassing all of the Northeastern U. S. and Maritime Canada, we hypothesized that geologic factors may take precedence over climate in explaining diversity patterns. If geophysical diversity does drive regional diversity, then conserving geophysical settings may offer an approach to conservation that protects diversity under both current and future climates. Here we tested how well geology predicts the species diversity of 14 US states and three Canadian provinces, using a comprehensive new spatial dataset. Results of linear regressions of species diversity on all possible combinations of 23 geophysical and climatic variables indicated that four geophysical factors; the number of geological classes, latitude, elevation range and the amount of calcareous bedrock, predicted species diversity with certainty (adj. R-2 = 0.94). To confirm the species-geology relationships we ran an independent test using 18,700 location points for 885 rare species and found that 40% of the species were restricted to a single geology. Moreover, each geology class supported 5-95 endemic species and chi-square tests confirmed that calcareous bedrock and extreme elevations had significantly more rare species than expected by chance (P<0.0001), strongly corroborating the regression model. Our results suggest that protecting geophysical settings will conserve the stage for current and future biodiversity and may be a robust alternative to species-level predictions.	[Anderson, Mark G.; Ferree, Charles E.] Nature Conservancy, Boston, MA USA	Nature Conservancy	Anderson, MG (corresponding author), Nature Conservancy, Boston, MA USA.	manderson@tnc.org						Anderson MG, 2008, SAVING BIOLOGICAL DIVERSITY: BALANCING PROTECTION OF ENDANGERED SPECIES AND ECOSYSTEMS, P119, DOI 10.1007/978-0-387-09565-3_10; ANDERSON MG, 1999, THESIS U NEW HAMPSHI; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Baldwin BG, 2005, EVOLUTION, V59, P2473; Begon M., 2009, ECOLOGY INDIVIDUALS; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; HARNER RF, 1976, ECOLOGY, V57, P1254, DOI 10.2307/1935049; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; Hutchinson G. E., 1965, ECOLOGICAL THEATER E; Ibanez I, 2006, ECOLOGY, V87, P1896, DOI 10.1890/0012-9658(2006)87[1896:PBCOTC]2.0.CO;2; Kintsch JA, 2002, CONSERV BIOL, V16, P936, DOI 10.1046/j.1523-1739.2002.00542.x; Kruckeberg A.R., 2002, GEOLOGY PLANT LIFE; KRUCKEBERG AR, 1986, SYST BOT, V11, P455, DOI 10.2307/2419082; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; *NATURESERVE EXPL, 2008, ONL ENC PLANTS AN EC; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; PACALA SW, 1993, BIOTIC INTERACTIONS, P53; Partel M, 2002, ECOLOGY, V83, P2361, DOI 10.1890/0012-9658(2002)083[2361:LPDPAE]2.0.CO;2; PLATT RB, 1951, ECOL MONOGR, V21, P269, DOI 10.2307/1948652; PURDY BG, 1994, AM J BOT, V81, P904, DOI 10.2307/2445771; Robinson G.R., 1997, 97154 US GEOL SURV; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rouget M, 2003, DIVERS DISTRIB, V9, P191, DOI 10.1046/j.1472-4642.2003.00025.x; Schauffler M, 2002, J ECOL, V90, P235, DOI 10.1046/j.1365-2745.2001.00656.x; Svenning JC, 2008, SCIENCE, V322, P206, DOI 10.1126/science.1164542; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; *WORLDCLIM, 2005, INT J CLIMATOLOGY, V25, P1965	34	185	188	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11554	10.1371/journal.pone.0011554	http://dx.doi.org/10.1371/journal.pone.0011554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644646	Green Published, gold			2022-12-27	WOS:000279884900010
J	Topp, SM; Chipukuma, JM; Giganti, M; Mwango, LK; Chiko, LM; Tambatamba-Chapula, B; Wamulume, CS; Reid, S				Topp, Stephanie M.; Chipukuma, Julien M.; Giganti, Mark; Mwango, Linah K.; Chiko, Like M.; Tambatamba-Chapula, Bushimbwa; Wamulume, Chibesa S.; Reid, Stewart			Strengthening Health Systems at Facility-Level: Feasibility of Integrating Antiretroviral Therapy into Primary Health Care Services in Lusaka, Zambia	PLOS ONE			English	Article							ALMA-ATA; IMPLEMENTATION; COUNTRIES; LESSONS; REBIRTH; TIME; COST	Introduction: HIV care and treatment services are primarily delivered in vertical antiretroviral (ART) clinics in sub-Saharan Africa but there have been concerns over the impact on existing primary health care services. This paper presents results from a feasibility study of a fully integrated model of HIV and non-HIV outpatient services in two urban Lusaka clinics. Methods: Integration involved three key modifications: i) amalgamation of space and patient flow; ii) standardization of medical records and iii) introduction of routine provider initiated testing and counseling (PITC). Assessment of feasibility included monitoring rates of HIV case-finding and referral to care, measuring median waiting and consultation times and assessing adherence to clinical care protocols for HIV and non-HIV outpatients. Qualitative data on patient/provider perceptions was also collected. Findings: Provider and patient interviews at both sites indicated broad acceptability of the model and highlighted a perceived reduction in stigma associated with integrated HIV services. Over six months in Clinic 1, PITC was provided to 2760 patients; 1485 (53%) accepted testing, 192 (13%) were HIV positive and 80 (42%) enrolled. Median OPD patient-provider contact time increased 55% (6.9 vs. 10.7 minutes; p<0.001) and decreased 1% for ART patients (27.9 vs. 27.7 minutes; p = 0.94). Median waiting times increased by 36 (p<0.001) and 23 minutes (p<0.001) for ART and OPD patients respectively. In Clinic 2, PITC was offered to 1510 patients, with 882 (58%) accepting testing, 208 (24%) HIV positive and 121 (58%) enrolled. Median OPD patient-provider contact time increased 110% (6.1 vs. 12.8 minutes; p<0.001) and decreased for ART patients by 23% (23 vs. 17.7 minutes; p<0.001). Median waiting times increased by 47 (p<0.001) and 34 minutes (p<0.001) for ART and OPD patients, respectively. Conclusions: Integrating vertical ART and OPD services is feasible in the low-resource and high HIV-prevalence setting of Lusaka, Zambia. Integration enabled shared use of space and staffing that resulted in increased HIV case finding, a reduction in stigma associated with vertical ART services but resulted in an overall increase in patient waiting times. Further research is urgently required to assess long-term clinical outcomes and cost effectiveness in order to evaluate scalability and generalizability.	[Topp, Stephanie M.; Chipukuma, Julien M.; Giganti, Mark; Mwango, Linah K.; Reid, Stewart] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Topp, Stephanie M.; Giganti, Mark; Reid, Stewart] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Topp, Stephanie M.; Giganti, Mark; Reid, Stewart] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35294 USA; [Chiko, Like M.; Wamulume, Chibesa S.] Lusaka Dist Hlth Management Team, Lusaka, Zambia; [Tambatamba-Chapula, Bushimbwa] Minist Hlth, Lusaka, Zambia	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Topp, SM (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	stephanie.topp@cidrz.org	Topp, Stephanie M/H-3923-2019	Topp, Stephanie M/0000-0002-3448-7983; Reid, Stewart/0000-0001-7779-4820	U.S. Centers for Disease Control and Prevention [U62/CCU12354]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The program described in this manuscript was supported by a multi-country grant to the Elizabeth Glaser Pediatric AIDS Foundation from the U.S. Centers for Disease Control and Prevention (U62/CCU12354); www.pedaids.org/www.cdc.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bleich SN, 2009, B WORLD HEALTH ORGAN, V87, P271, DOI 10.2471/BLT.07.050401; Bond V, 2006, J COMMUNITY APPL SOC, V16, P452, DOI 10.1002/casp.893; BRIGGS CJ, 2006, COCHRANE DATABASE SY, V2; Cahn P, 2008, LANCET, V372, P265, DOI 10.1016/S0140-6736(08)61085-5; Chi BH, 2005, JAIDS-J ACQ IMM DEF, V40, P350, DOI 10.1097/01.qai.0000162419.16114.39; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; England R, 2007, BRIT MED J, V335, P565, DOI 10.1136/bmj.39335.520463.94; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Fenton Kevin A, 2007, Top HIV Med, V15, P146; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Garrett L, 2007, FOREIGN AFF, V86, P14; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Hardon AP, 2007, AIDS CARE, V19, P658, DOI 10.1080/09540120701244943; Harris JB, 2008, INT J TUBERC LUNG D, V12, P773; Laurence J, 2007, AIDS READ, V17, P476; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Levine R, 2009, JAIDS-J ACQ IMM DEF, V52, pS3, DOI 10.1097/QAI.0b013e3181bbc807; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Oomman N., 2008, SEIZING OPPORTUNITY; Pfeiffer J, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-3; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Valdiserri RO, 2007, PLOS MED, V4, P975, DOI 10.1371/journal.pmed.0040200; Wanyenze RK, 2008, B WORLD HEALTH ORGAN, V86, P302, DOI 10.2471/BLT.07.042580; WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; *ZAMB CSO, 2009, ZAMB DEM HLTH SURV 2	30	58	59	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11522	10.1371/journal.pone.0011522	http://dx.doi.org/10.1371/journal.pone.0011522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	624MG	20644629	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000279822300005
J	Tao, B; Pietropaolo, M; Atkinson, M; Schatz, D; Taylor, D				Tao, Betty; Pietropaolo, Massimo; Atkinson, Mark; Schatz, Desmond; Taylor, David			Estimating the Cost of Type 1 Diabetes in the US: A Propensity Score Matching Method	PLOS ONE			English	Article							ECONOMIC CONSEQUENCES; MORTALITY; POPULATION; HEALTH; COMPLICATIONS; DIAGNOSIS; MELLITUS; SMOKING; DISEASE; ADULTS	Background: Diabetes costs represent a large burden to both patients and the health care system. However, few studies that examine the economic consequences of diabetes have distinguished between the two major forms, type 1 and type 2 diabetes, despite differences in underlying pathologies. Combining the two diseases implies that there is no difference between the costs of type 1 and type 2 diabetes to a patient. In this study, we examine the costs of type 1 diabetes, which is often overlooked due to the larger population of type 2 patients, and compare them to the estimated costs of diabetes reported in the literature. Methodology/Principal Findings: Using a nationally representative dataset, we estimate yearly and lifetime medical and indirect costs of type 1 diabetes by implementing a matching method to compare a patient with type 1 diabetes to a similar individual without the disease. We find that each year type 1 diabetes costs this country $14.4 billion (11.5-17.3) in medical costs and lost income. In terms of lost income, type 1 patients incur a disproportionate share of type 1 and type 2 costs. Further, if the disease were eliminated by therapeutic intervention, an estimated $10.6 billion (7.2-14.0) incurred by a new cohort and $422.9 billion (327.2-519.4) incurred by the existing number of type 1 diabetic patients over their lifetime would be avoided. Conclusions/Significance: We find that the costs attributed to type 1 diabetes are disproportionately higher than the number of type 1 patients compared with type 2 patients, suggesting that combining the two diseases when estimating costs is not appropriate. This study and another recent contribution provides a necessary first step in estimating the substantial costs of type 1 diabetes on the U.S.	[Tao, Betty] CNA, Ctr Hlth Res & Policy, Alexandria, VA USA; [Pietropaolo, Massimo] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pietropaolo, Massimo] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Atkinson, Mark] Univ Florida, Dept Pathol, Gainesville, FL 32611 USA; [Schatz, Desmond] Univ Florida, Dept Pediat, Gainesville, FL USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Tao, B (corresponding author), CNA, Ctr Hlth Res & Policy, Alexandria, VA USA.	betatao@gmail.com			University of Michigan [3000586513]; Brehm Coalition; University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053456] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); Brehm Coalition; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the University of Michigan (PO# 3000586513); portions of Pietropaolo's time, as well as Atkinson's and Schatz's on-going research efforts were funded by the Brehm Coalition. The University of Michigan provided financial support for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors are solely responsible for the design and conduct of the study; the collection, analysis, and interpretation of the data; and the preparation and review of the manuscript.	Akobundu E, 2006, PHARMACOECONOMICS, V24, P869, DOI 10.2165/00019053-200624090-00005; [Anonymous], 2000, Pediatrics, V105, P671; [Anonymous], NAT HLTH INT SURV NH; [Anonymous], 2010, REPORT EXPERT COMMIT; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Baser O, 2006, VALUE HEALTH, V9, P377, DOI 10.1111/j.1524-4733.2006.00130.x; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; *CDCP, 2005, NAT DIAB FACT SHEET; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Cusick M, 2005, DIABETES CARE, V28, P617, DOI 10.2337/diacare.28.3.617; Dahlquist G, 2005, DIABETES CARE, V28, P2384, DOI 10.2337/diacare.28.10.2384; Dall TM, 2009, POPUL HEALTH MANAG, V12, P103, DOI 10.1089/pop.2009.12203; DeVol R, 2007, UNHEALTHY AM EC BURD; DiLiberti JH, 2002, PEDIATRICS, V109, P479, DOI 10.1542/peds.109.3.479; Drummond MF, 2015, METHODS EC EVALUATIO; Fourlanos S, 2006, DIABETES CARE, V29, P970, DOI 10.2337/dc05-2101; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; HARRIS MI, 1995, DIABETES AM, V2, P95; Heckman JJ, 1997, REV ECON STUD, V64, P605, DOI 10.2307/2971733; HODGSON TA, 1992, MILBANK Q, V70, P81, DOI 10.2307/3350086; Huang ES, 2009, DIABETES CARE, V32, P2225, DOI 10.2337/dc09-0459; Icks A, 2007, EXP CLIN ENDOCR DIAB, V115, P448, DOI 10.1055/s-2007-981659; JANICE SD, 1995, RISK FACTORS INSULIN; Johnson JA, 2006, DIABETES CARE, V29, P2403, DOI 10.2337/dc06-0735; Juutilainen A, 2008, DIABETES CARE, V31, P714, DOI 10.2337/dc07-2124; Kahn ME, 1998, J LABOR ECON, V16, P878, DOI 10.1086/209909; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Landin-Olsson M, 2002, ANN NY ACAD SCI, V958, P112; LEU RE, 1983, SOC SCI MED, V17, P1907, DOI 10.1016/0277-9536(83)90168-5; MANNING WG, 1989, JAMA-J AM MED ASSOC, V261, P1604, DOI 10.1001/jama.261.11.1604; Miguel A, 2002, NEPHRON, V90, P290, DOI 10.1159/000049065; Milton B, 2006, DIABETIC MED, V23, P821, DOI 10.1111/j.1464-5491.2006.01796.x; Naik RG, 2003, REV ENDOCR METAB DIS, V4, P233, DOI 10.1023/A:1025148211587; Palmer Jerry P., 2004, Diabetes, V53, P250; Peng H, 2006, REV ENDOCR METAB DIS, V7, P149, DOI 10.1007/s11154-006-9024-y; Petersen M, 2003, DIABETES CARE, V26, P917; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Prando R, 1998, DIABETES CARE, V21, P1680, DOI 10.2337/diacare.21.10.1680; Prior M J, 1993, Ann Epidemiol, V3, P9; Rosenbaum, 2002, OBSERVATIONAL STUDIE; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Visalli N, 2003, ARCH DIS CHILD, V88, P695, DOI 10.1136/adc.88.8.695; WERNER BF, 1997, HEALTH ECON, V6, P253	47	123	124	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11501	10.1371/journal.pone.0011501	http://dx.doi.org/10.1371/journal.pone.0011501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	623CM	20634976	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300012
J	Valbuena, N; Moreno, S				Valbuena, Noelia; Moreno, Sergio			TOR and PKA Pathways Synergize at the Level of the Ste11 Transcription Factor to Prevent Mating and Meiosis in Fission Yeast	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; CELL-GROWTH; RAPAMYCIN; GENE; CAMP; MTOR	Background: In the fission yeast Schizosaccharomyces pombe, the TOR (target of rapamycin) and PKA (protein kinase A) signaling transduction pathways regulate the expression of genes required for cell growth and sexual differentiation in response to the nutritional environment. Inhibition of Tor2 signaling results in the induction of genes involved in sexual differentiation, and the cells undergo mating and meiosis, even under good nutritional conditions. The same phenotype is observed in mutants in which the PKA pathway is inactive. By contrast, Tor2 overexpression or mutations that hyperactivate PKA signaling impair sexual differentiation, even under poor nutritional conditions. Accordingly, a very important question is to understand the molecular mechanism by which these two pathways coordinately regulate gene expression in response to nutrients. Methodology/Principal Findings: Here we demonstrate that TOR and PKA pathways operate coordinately to negatively regulate sexual differentiation by inhibiting the nuclear accumulation of the Ste11 transcription factor. However, the Tor2 pathway is unable to block the nuclear localization of Ste11 under good nutritional conditions when the PKA pathway is inactive. Using microarray analyses, we found that both pathways inhibit sexual differentiation by blocking ste11-dependent gene expression. Conclusions/Significance: We conclude that both the PKA and the TOR pathways inhibit Ste11 nuclear accumulation to repress Ste11-dependent gene expression. However, the PKA pathway plays a quantitatively more important role than the TOR pathway in this process.	[Valbuena, Noelia; Moreno, Sergio] Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Valbuena, N (corresponding author), Univ Salamanca, Inst Biol Mol & Celular Canc, CSIC, E-37008 Salamanca, Spain.	smo@usal.es	Moreno, Sergio/K-3671-2014; IBSAL, Secretaría/H-3719-2011	Moreno, Sergio/0000-0002-8039-1413; 	Carlos III Institute, Ministerio de Sanidad; la Junta de Castilla y Leon [GR265]; Spanish Ministry of Science and Innovation [BFU2008-01808, CSD2007-00015]; Consolider [CSD2007-00015]; Junta de Castilla y Leon Grupo de Excelencia [GR 265]	Carlos III Institute, Ministerio de Sanidad(Instituto de Salud Carlos IIISpanish Government); la Junta de Castilla y Leon(Junta de Castilla y Leon); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Castilla y Leon Grupo de Excelencia(Junta de Castilla y Leon)	N.V. is supported by a postdoctoral grant from the Carlos III Institute, Ministerio de Sanidad. Our group is supported by grants from la Junta de Castilla y Leon (Grupo de Excelencia grant GR265) and the Spanish Ministry of Science and Innovation (BFU2008-01808 and Consolider Ingenio CSD2007-00015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs Keith Gull and Olaf Nielsen for the anti-tubulin and anti-ste11 antibodies, Alberto de Luis for the microarray analysis, and Nicholas Skinner for corrections to the manuscript. N.V. is supported by a postdoctoral grant from the Carlos III Institute, Ministerio de Sanidad. Our group is supported by grants BFU2008-01808, Consolider CSD2007-00015 and Junta de Castilla y Leon Grupo de Excelencia GR 265.	Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Daga RR, 2003, CURR BIOL, V13, P2015, DOI 10.1016/j.cub.2003.10.061; DEVOTI J, 1991, EMBO J, V10, P3759, DOI 10.1002/j.1460-2075.1991.tb04945.x; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; KAWAMUKAI M, 1991, CELL REGUL, V2, P155, DOI 10.1091/mbc.2.2.155; Kunitomo H, 2000, MOL BIOL CELL, V11, P3205, DOI 10.1091/mbc.11.9.3205; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; MAEDA T, 1994, J BIOL CHEM, V269, P9632; Mata J, 2006, P NATL ACAD SCI USA, V103, P15517, DOI 10.1073/pnas.0603403103; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Qin J, 2003, MOL CELL BIOL, V23, P3253, DOI 10.1128/MCB.23.9.3253-3264.2003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Smith FL, 1999, BRIT J PHARMACOL, V128, P220, DOI 10.1038/sj.bjp.0702771; SUGIMOTO A, 1991, GENE DEV, V5, P1990, DOI 10.1101/gad.5.11.1990; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Yamamoto M, 1996, CELL STRUCT FUNCT, V21, P431, DOI 10.1247/csf.21.431; YAMAWAKIKATAOKA Y, 1989, P NATL ACAD SCI USA, V86, P5693, DOI 10.1073/pnas.86.15.5693	29	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11514	10.1371/journal.pone.0011514	http://dx.doi.org/10.1371/journal.pone.0011514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634885	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300024
J	Planas, J; Serrat, JM				Planas, Jordi; Serrat, Josep M.			Gene Promoter Evolution Targets the Center of the Human Protein Interaction Network	PLOS ONE			English	Article							EXPRESSION LEVEL; STRUCTURAL DETERMINANTS; SUBSTITUTION RATES; POSITIVE SELECTION; TRANSCRIPTION; BINDING; CONSTRAINTS; INTENSITY; ALIGNMENT; REVEAL	Assessing the contribution of promoters and coding sequences to gene evolution is an important step toward discovering the major genetic determinants of human evolution. Many specific examples have revealed the evolutionary importance of cis-regulatory regions. However, the relative contribution of regulatory and coding regions to the evolutionary process and whether systemic factors differentially influence their evolution remains unclear. To address these questions, we carried out an analysis at the genome scale to identify signatures of positive selection in human proximal promoters. Next, we examined whether genes with positively selected promoters (Prom(+) genes) show systemic differences with respect to a set of genes with positively selected protein-coding regions (Cod(+) genes). We found that the number of genes in each set was not significantly different (8.1% and 8.5%, respectively). Furthermore, a functional analysis showed that, in both cases, positive selection affects almost all biological processes and only a few genes of each group are located in enriched categories, indicating that promoters and coding regions are not evolutionarily specialized with respect to gene function. On the other hand, we show that the topology of the human protein network has a different influence on the molecular evolution of proximal promoters and coding regions. Notably, Prom+ genes have an unexpectedly high centrality when compared with a reference distribution (P = 0.008, for Eigenvalue centrality). Moreover, the frequency of Prom+ genes increases from the periphery to the center of the protein network (P = 0.02, for the logistic regression coefficient). This means that gene centrality does not constrain the evolution of proximal promoters, unlike the case with coding regions, and further indicates that the evolution of proximal promoters is more efficient in the center of the protein network than in the periphery. These results show that proximal promoters have had a systemic contribution to human evolution by increasing the participation of central genes in the evolutionary process.	[Planas, Jordi; Serrat, Josep M.] Univ Vic, Dept Syst Biol, Bioinformat & Med Stat Grp, Vic, Spain	Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Planas, J (corresponding author), Univ Vic, Dept Syst Biol, Bioinformat & Med Stat Grp, Vic, Spain.	josepmaria.serrat@uvic.cat			Universitat de Vic; Generalitat de Catalunya [2009SGR-581]	Universitat de Vic; Generalitat de Catalunya(Generalitat de Catalunya)	This work has been supported with research funds of the Universitat de Vic, and with a research contract with the Generalitat de Catalunya (2009SGR-581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berglund J, 2009, PLOS BIOL, V7, P45, DOI 10.1371/journal.pbio.1000026; Bloom JD, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-14; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; BRANDES U, NETWORK ANAL; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Davidson EH, 2006, REG GEN GEN REG; Draghici S, 2003, GENOMICS, V81, P98, DOI 10.1016/S0888-7543(02)00021-6; Drummond DA, 2006, MOL BIOL EVOL, V23, P327, DOI 10.1093/molbev/msj038; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Franzosa EA, 2009, MOL BIOL EVOL, V26, P2387, DOI 10.1093/molbev/msp146; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Haygood R, 2007, NAT GENET, V39, P1140, DOI 10.1038/ng2104; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hoffman MM, 2010, GENOME RES, V20, P685, DOI 10.1101/gr.096719.109; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koudritsky M, 2008, NUCLEIC ACIDS RES, V36, P6795, DOI 10.1093/nar/gkn752; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Lemos B, 2004, NAT GENET, V36, P1059, DOI 10.1038/ng1427; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; PAGEL A, 2008, EVOLUTIONARY GENOMIC; Plotkin JB, 2007, MOL BIOL EVOL, V24, P1113, DOI 10.1093/molbev/msm044; R Core Team, 2020, R LANG ENV STAT COMP; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Subramanian S, 2004, GENETICS, V168, P373, DOI 10.1534/genetics.104.028944; Tabach Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000807; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; *UNIPROT CONS, 2010, NUCL ACIDS RES, V0038; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wolf JBW, 2009, GENOME BIOL EVOL, V1, P308, DOI 10.1093/gbe/evp030; Wolf MY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-40; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11476	10.1371/journal.pone.0011476	http://dx.doi.org/10.1371/journal.pone.0011476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628608	Green Published, gold, Green Submitted			2022-12-27	WOS:000279637100007
J	Nia, AM; Caglayan, E; Gassanov, N; Zimmermann, T; Aslan, O; Hellmich, M; Duru, F; Erdmann, E; Rosenkranz, S; Er, F				Nia, Amir M.; Caglayan, Evren; Gassanov, Natig; Zimmermann, Tom; Aslan, Orhan; Hellmich, Martin; Duru, Firat; Erdmann, Erland; Rosenkranz, Stephan; Er, Fikret			Beta(1)-Adrenoceptor Polymorphism Predicts Flecainide Action in Patients with Atrial Fibrillation	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; GENE POLYMORPHISM; SODIUM CURRENT; RECEPTOR GENE; BETA-BLOCKERS; CATECHOLAMINES; HYPERTENSION; ASSOCIATION; MECHANISM; ISOPROTERENOL	Background: Antiarrhythmic action of flecainide is based on sodium channel blockade. Beta(1)-adrenoceptor (beta(1)AR) activation induces sodium channel inhibition, too. The aim of the present study was to evaluate the impact of different beta(1)AR genotypes on antiarrhythmic action of flecainide in patients with structural heart disease and atrial fibrillation. Methodology/Principal Findings: In 145 subjects, 87 with atrial fibrillation, genotyping was performed to identify the individual beta(1)AR Arg389Gly and Ser49Gly polymorphism. Resting heart rate during atrial fibrillation and success of flecainide-induced cardioversion were correlated with beta(1)AR genotype. The overall cardioversion rate with flecainide was 39%. The Arg389Arg genotype was associated with the highest cardioversion rate (55.5%; OR 3.30; 95% CI; 1.34-8.13; p = 0.003) compared to patients with Arg389Gly (29.5%; OR 0.44; 95% CI; 0.18-1.06; p = 0.066) and Gly389Gly (14%; OR 0.24; 95% CI 0.03-2.07; p = 0.17) variants. The single Ser49Gly polymorphism did not influence the conversion rate. In combination, patients with Arg389Gly-Ser49Gly genotype displayed the lowest conversion rate with 20.8% (OR 0.31; 95% CI; 0.10-0.93; p = 0.03). In patients with Arg389Arg variants the heart rate during atrial fibrillation was significantly higher (110 +/- 2.7 bpm; p = 0.03 vs. other variants) compared to Arg389Gly (104.8 +/- 2.4 bpm) and Gly389Gly (96.9 +/- 5.8 bpm) carriers. The Arg389Gly-Ser49Gly genotype was more common in patients with atrial fibrillation compared to patients without atrial fibrillation (27.6% vs. 5.2%; HR 6.98; 95% CI; 1.99-24.46; p<0.001). Conclusions: The beta(1)AR Arg389Arg genotype is associated with increased flecainide potency and higher heart rate during atrial fibrillation. The Arg389Gly-Ser49Gly genotype might be of predictive value for atrial fibrillation.	[Nia, Amir M.; Caglayan, Evren; Gassanov, Natig; Zimmermann, Tom; Aslan, Orhan; Erdmann, Erland; Rosenkranz, Stephan; Er, Fikret] Univ Cologne, Dept Internal Med 3, Cologne, Germany; [Hellmich, Martin] Univ Cologne, Inst Med Stat Informat & Epidemiol, Cologne, Germany; [Duru, Firat] Univ Zurich Hosp, Clin Cardiol, CH-8091 Zurich, Switzerland	University of Cologne; University of Cologne; University of Zurich; University Zurich Hospital	Nia, AM (corresponding author), Univ Cologne, Dept Internal Med 3, Cologne, Germany.	Fikret.Er@uk-koeln.de	Caglayan, Evren/ABB-8674-2020; Duru, Firat/F-7161-2011	Duru, Firat/0000-0002-4748-0158; Hellmich, Martin/0000-0001-5174-928X				Alboni P, 2004, NEW ENGL J MED, V351, P2384, DOI 10.1056/NEJMoa041233; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Bengtsson K, 2001, CIRCULATION, V104, P187, DOI 10.1161/01.CIR.104.2.187; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Cragun KT, 1997, CIRCULATION, V96, P2701, DOI 10.1161/01.CIR.96.8.2701; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; ER F, 2010, CLIN RES CARDIOL; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Foody JM, 2002, JAMA-J AM MED ASSOC, V287, P883, DOI 10.1001/jama.287.7.883; Fu CY, 2008, CLIN BIOCHEM, V41, P773, DOI 10.1016/j.clinbiochem.2008.02.002; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Humma LM, 2001, AM J CARDIOL, V88, P1034, DOI 10.1016/S0002-9149(01)01986-5; Iwai C, 2003, AM HEART J, V146, P106, DOI 10.1016/S0002-8703(03)00110-8; Jalife J, 2002, CARDIOVASC RES, V54, P204, DOI 10.1016/S0008-6363(02)00223-7; JONES AS, 1963, NATURE, V198, P588, DOI 10.1038/198588a0; Joseph SS, 2004, BRIT J PHARMACOL, V142, P51, DOI 10.1038/sj.bjp.0705753; La Rosee K, 2004, PHARMACOGENETICS, V14, P711, DOI 10.1097/00008571-200411000-00001; Lalevee N, 2003, J CARDIOVASC ELECTR, V14, P885, DOI 10.1046/j.1540-8167.2003.03064.x; Leineweber K, 2009, BRIT J PHARMACOL, V158, P61, DOI 10.1111/j.1476-5381.2009.00187.x; Liggett SB, 2006, P NATL ACAD SCI USA, V103, P11288, DOI 10.1073/pnas.0509937103; Maqbool A, 1999, LANCET, V353, P897, DOI 10.1016/S0140-6736(99)00549-8; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; MIALET PJ, 2003, NAT MED, V9, P1300, DOI DOI 10.1038/NM930; Nicoulina S, 2010, GENET TEST MOL BIOMA, V14, P249, DOI 10.1089/gtmb.2009.0100; ONO K, 1989, AM J PHYSIOL, V256, pC1131, DOI 10.1152/ajpcell.1989.256.6.C1131; ONO K, 1993, CIRC RES, V72, P807, DOI 10.1161/01.RES.72.4.807; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Peters NS, 2002, LANCET, V359, P593, DOI 10.1016/S0140-6736(02)07748-6; RAAB W, 1960, AM J CARDIOL, V5, P571, DOI 10.1016/0002-9149(60)90121-1; Ranade K, 2002, AM J HUM GENET, V70, P935, DOI 10.1086/339621; RODEN DM, 1986, NEW ENGL J MED, V315, P36, DOI 10.1056/NEJM198607033150106; Roy D, 2008, CIRCULATION, V117, P1518, DOI 10.1161/CIRCULATIONAHA.107.723866; Sandilands A, 2004, PHARMACOGENETICS, V14, P343, DOI 10.1097/00008571-200406000-00003; SCHUBERT B, 1989, SCIENCE, V245, P516, DOI 10.1126/science.2547248; SCHUBERT B, 1990, AM J PHYSIOL, V258, pH977, DOI 10.1152/ajpheart.1990.258.4.H977; Shioji K, 2004, HYPERTENS RES, V27, P31, DOI 10.1291/hypres.27.31; Slavikova J, 2007, CLIN CARDIOL, V30, P326, DOI 10.1002/clc.20099; Tesson F, 1999, J MOL CELL CARDIOL, V31, P1025, DOI 10.1006/jmcc.1999.0947; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1	41	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11421	10.1371/journal.pone.0011421	http://dx.doi.org/10.1371/journal.pone.0011421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625396	Green Published, Green Submitted, gold			2022-12-27	WOS:000279465700008
J	Manez, KS; Ferse, SCA				Manez, Kathleen Schwerdtner; Ferse, Sebastian C. A.			The History of Makassan Trepang Fishing and Trade	PLOS ONE			English	Article							REEF; HOLOTHURIANS; COMMUNITY; BANDITS	The Malayan term trepang describes a variety of edible holothurians commonly known as sea cucumbers. Although found in temperate and tropical marine waters all over the world, the centre of species diversity and abundance are the shallow coastal waters of Island Southeast Asia. For at least 300 years, trepang has been a highly priced commodity in the Chinese market. Originally, its fishing and trade was a specialized business, centred on the town of Makassar in South Sulawesi (Indonesia). The rise of trepang fishing in the 17(th) century added valuable export merchandize to the rich shallow seas surrounding the islands of Southeast Asia. This enabled local communities to become part of large trading networks and greatly supported their economic development. In this article, we follow Makassan trepang fishing and trading from its beginning until the industrialization of the fishery and worldwide depletion of sea cucumbers in the 20(th) century. Thereby, we identify a number of characteristics which trepang fishing shares with the exploitation of other marine resources, including (1) a strong influence of international markets, (2) the role of patron-client relationships which heavily influence the resource selection, and (3) the roving-bandit-syndrome, where fishermen exploit local stocks of valuable resources until they are depleted, and then move to another area. We suggest that understanding the similarities and differences between historical and recent exploitation of marine resources is an important step towards effective management solutions.	[Manez, Kathleen Schwerdtner; Ferse, Sebastian C. A.] Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Manez, KS (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Bremen, Germany.	kathleen.schwerdtner@zmt-bremen.de	Ferse, Sebastian/AAH-8048-2021	Ferse, Sebastian/0000-0003-0930-5356	German Federal Ministry of Education and Research (BMBF) [03F0474A]; Indonesian Ministry of Marine Affairs and Fisheries (DKP); Ministry for Research and Technology (RISTEK)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Indonesian Ministry of Marine Affairs and Fisheries (DKP); Ministry for Research and Technology (RISTEK)	Sebastian Ferse was funded in the frame of the bilateral Indonesian-German research program SPICE II (Science for the Protection of Indonesian Coastal Ecosystems) supported by the German Federal Ministry of Education and Research (BMBF, Grant No. 03F0474A), the Indonesian Ministry of Marine Affairs and Fisheries (DKP) and the Ministry for Research and Technology (RISTEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkes F, 2006, SCIENCE, V311, P1557, DOI 10.1126/science.1122804; Bickmore A.S., 1868, TRAVELS E INDIAN ARC; Boomgaard P, 2005, MUDDIED WATERS HIST, P98; BOSSCHER C, 1855, TIJDSCHRIFT INDISCHE, V4; BURNINGHAM N, 1994, GREAT CIRCLE, V16, P139; Butcher John., 2004, CLOSING FRONTIER HIS; Cadigan Sean T., 2001, EXPLOITED SEAS NEW D, P31; Cense A.A., 1952, BIJDR TAAL-LAND-V, V108, P248, DOI [10.1163/22134379-90002431, DOI 10.1163/22134379-90002431]; CRAWFORD J, 1820, HIST INDIAN ARCHIPEL; DALRYMPLE A, 1771, J NOURSE T PAYNE; Earl George Windson, 1837, E SEAS VOYAGES ADVEN; EARL GW, 1850, J INDIAN ARCHIPELAGO, V4, P483; ERDMANN M, 1995, ICLARM Q, V2, P4; FERSE SCA, 2010, ENV CONS IN PRESS; Flinders M., 1814, VOYAGE TERRA AUSTRAL; Hamel JF, 2001, ADV MAR BIOL, V41, P129, DOI 10.1016/S0065-2881(01)41003-0; Hodgson G, 1999, MAR POLLUT BULL, V38, P345, DOI 10.1016/S0025-326X(99)00002-8; HOEKSEMA BW, 2004, CHALLENGING COASTS T, P49; Huitric M, 2005, ECOL SOC, V10; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; KELLY P, 1835, UNIVERSAL CAMBIST CO; KLAEHN, 1833, ALLGEMEINE ENCY WISS; Knaap Gerrit, 2004, MONSOON TRADERS SHIP; Kolff D. H., 1840, VOYAGES DUTCH BRIG W; KONINGSBERGER JC, 1904, TRIPANG TRIPANGVISSC; Leirissa R. Z., 1993, REV INDONESIAN MALAY, V27, P77; Lilley R., 2007, SPC LIVE REEF FISH I, V17, P11; LION HJ, 1855, TIJDSCHRIFT NIEDERLA, V17, P1; Lowe C., 2006, WILD PROFUSION BIODI; MacKnight C. C., 1976, VOYAGE MAREGE MACASS; MACKNIGHT CC, 1973, WORLD ARCHAEOL, V5, P198, DOI 10.1080/00438243.1973.9979566; MACKNIGHT CC, 1969, FARTHEST COAST; Massin C., 1982, P493; MASSIN C, 1999, THESIS LEIDEN; Meereboer M.T., 1998, LIVING HIST CULTURE, P249; Michio K, 2003, MAR POLLUT BULL, V47, P118, DOI 10.1016/S0025-326X(02)00411-3; Olson M, 2000, POWER PROSPERITY; OSSEWEIJER M, 2000, INDIGENOUS ENV KNOWL, P55; Pelras C, 2000, BIJDR TAAL-LAND-V, V156, P393, DOI 10.1163/22134379-90003833; POLUNIN NVC, 1983, OCEANOGR MAR BIOL, V21, P455; RADEMACHER JCM, 1786, VERHAND BATAV GENOOT, V4, P143; Reid Anthony M., 1999, CHARTING SHAPE EARLY; Riepen, 1995, ENV EC SOCIAL IMPLIC; Scales H, 2006, SCIENCE, V313, P612, DOI 10.1126/science.313.5787.612c; SEARCY A, 1909, AUSTRALIAN TROPICS; Sopher D.E, 1965, MEMOIRS NATL MUSEUM, V5; STIBBE DG, 1921, ENCY NEDERLANDSCH 4; Sutherland H, 2000, BIJDR TAAL-LAND-V, V156, P451, DOI 10.1163/22134379-90003835; Sutherland H., 2004, J SOUTHEAST ASIAN ST, V35, P133, DOI [10.1017/S0022463404000074, DOI 10.1017/S0022463404000074]; SUTHERLAND H, 2000, ARUNG SAMUDERA PERSE; SUTHERLAND H, 1988, RELIG DEV INTEGRATED, P146; Taylor Jean Gelman, 2003, INDONESIA PEOPLE HIS; Toral-Granda V., 2008, SEA CUCUMBERS GLOBAL; Uthicke S, 2004, CONSERV BIOL, V18, P1395, DOI 10.1111/j.1523-1739.2004.00309.x; Uthicke S, 1999, B MAR SCI, V64, P129; Uthicke S, 1998, MAR ECOL PROG SER, V169, P1, DOI 10.3354/meps169001; VOSMAER JN, 1839, VERH BATAV GENOOT KU, V17, P61; Wallace A., 1869, MALAY ARCHIPELAGO LA; Watson Andaya B., 2006, FLAMING WOMB REPOSIT; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; ZERNER C, 1994, LAW SOC REV, V28, P1079, DOI 10.2307/3054024; ZERNER C, 1998, NATURE ORIENT ENV HI, P535; [No title captured]; 1842, TAGBLATT KUNDE GEIST, V15, P367; 1882, TIJDSCHRIFT NIJVERHE, V26, P273; 1854, TIJDSCHRIFT NEDERLAN, V16, P345	66	50	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11346	10.1371/journal.pone.0011346	http://dx.doi.org/10.1371/journal.pone.0011346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613871	Green Published, gold, Green Submitted			2022-12-27	WOS:000279369900003
J	Monsellier, E; Ramazzotti, M; Taddei, N; Chiti, F				Monsellier, Elodie; Ramazzotti, Matteo; Taddei, Niccolo; Chiti, Fabrizio			A Computational Approach for Identifying the Chemical Factors Involved in the Glycosaminoglycans-Mediated Acceleration of Amyloid Fibril Formation	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; IN-VITRO; EXTRACELLULAR-MATRIX; PROTEIN INTERACTIONS; ALZHEIMERS-DISEASE; PRION PROTEIN; CONGO RED; BINDING; POLYPEPTIDE; AMYLOIDOGENESIS	Background: Amyloid fibril formation is the hallmark of many human diseases, including Alzheimer's disease, type II diabetes and amyloidosis. Amyloid fibrils deposit in the extracellular space and generally co-localize with the glycosaminoglycans ( GAGs) of the basement membrane. GAGs have been shown to accelerate the formation of amyloid fibrils in vitro for a number of protein systems. The high number of data accumulated so far has created the grounds for the construction of a database on the effects of a number of GAGs on different proteins. Methodology/Principal Findings: In this study, we have constructed such a database and have used a computational approach that uses a combination of single parameter and multivariate analyses to identify the main chemical factors that determine the GAG-induced acceleration of amyloid formation. We show that the GAG accelerating effect is mainly governed by three parameters that account for three-fourths of the observed experimental variability: the GAG sulfation state, the solute molarity, and the ratio of protein and GAG molar concentrations. We then combined these three parameters into a single equation that predicts, with reasonable accuracy, the acceleration provided by a given GAG in a given condition. Conclusions/Significance: In addition to shedding light on the chemical determinants of the protein: GAG interaction and to providing a novel mathematical predictive tool, our findings highlight the possibility that GAGs may not have such an accelerating effect on protein aggregation under the conditions existing in the basement membrane, given the values of salt molarity and protein: GAG molar ratio existing under such conditions.	[Monsellier, Elodie; Ramazzotti, Matteo; Taddei, Niccolo; Chiti, Fabrizio] Univ Florence, Dipartimento Sci Biochim, Florence, Italy; [Chiti, Fabrizio] Consorzio Interuniv Ist Nazl Biostrutture & Biosi, Rome, Italy	University of Florence	Monsellier, E (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	fabrizio.chiti@unifi.it	Monsellier, Elodie/GRF-5106-2022; Ramazzotti, Matteo/J-4866-2012	Ramazzotti, Matteo/0000-0002-6862-9409; Taddei, Niccolo/0000-0003-2513-1018; Monsellier, Elodie/0000-0001-7944-7531	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN 2007B57EAB, PRIN 20083ERXWS, FIRB RBNE03PX83]; European Union	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was partially supported by grants from the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (projects PRIN 2007B57EAB, PRIN 20083ERXWS and FIRB RBNE03PX83) and the European Union (Project EURAMY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu AT, 2005, PROTEIN SCI, V14, P1; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; Ancsin JB, 2003, AMYLOID, V10, P67, DOI 10.3109/13506120309041728; ARUGA E, 1993, LAB INVEST, V69, P223; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Bravo R, 2008, J BIOL CHEM, V283, P32471, DOI 10.1074/jbc.M709870200; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Castillo GM, 1998, DIABETES, V47, P612, DOI 10.2337/diabetes.47.4.612; Castillo GM, 1999, J NEUROCHEM, V72, P1681, DOI 10.1046/j.1471-4159.1999.721681.x; CAUGHEY B, 1994, J VIROL, V68, P2135, DOI 10.1128/JVI.68.4.2135-2141.1994; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Fraser PE, 2001, J BIOL CHEM, V276, P6412, DOI 10.1074/jbc.M008128200; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hull RL, 2007, AM J PHYSIOL-CELL PH, V293, pC1586, DOI 10.1152/ajpcell.00208.2007; Kisilevsky R, 2007, AMYLOID, V14, P21, DOI 10.1080/13506120601116419; Levine D. M., 2006, BUSINESS STAT 1 COUR; Lindahl B, 1999, J BIOL CHEM, V274, P30631, DOI 10.1074/jbc.274.43.30631; MAGNUS JH, 1989, ANN RHEUM DIS, V48, P215, DOI 10.1136/ard.48.3.215; MAGNUS JH, 1991, SCAND J IMMUNOL, V34, P63, DOI 10.1111/j.1365-3083.1991.tb01521.x; MCCUBBIN WD, 1988, BIOCHEM J, V256, P775, DOI 10.1042/bj2560775; McLaughlin RW, 2006, PROTEIN SCI, V15, P1710, DOI 10.1110/ps.051997606; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Meng F, 2007, BIOCHEMISTRY-US, V46, P12091, DOI 10.1021/bi7004834; Monsellier E, 2007, BIOPHYS J, V93, P4382, DOI 10.1529/biophysj.107.111336; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Park K, 2001, J BIOL CHEM, V276, P16611, DOI 10.1074/jbc.M008423200; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; SNOW AD, 1987, LAB INVEST, V57, P687; SNOW AD, 1988, AM J PATHOL, V133, P456; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Takase K, 1998, FEBS LETT, V441, P271, DOI 10.1016/S0014-5793(98)01563-4; Uversky VN, 2005, MOL BRAIN RES, V134, P84, DOI 10.1016/j.molbrainres.2004.11.014; VANDUINEN SG, 1995, LAB INVEST, V73, P183; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yamaguchi I, 2003, KIDNEY INT, V64, P1080, DOI 10.1046/j.1523-1755.2003.00167.x; Yamamoto S, 2004, J AM SOC NEPHROL, V15, P126, DOI 10.1097/01.ASN.0000103228.81623.C7; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210	44	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11363	10.1371/journal.pone.0011363	http://dx.doi.org/10.1371/journal.pone.0011363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613870	gold, Green Published			2022-12-27	WOS:000279369900012
J	Nougairede, A; Lagier, JC; Ninove, L; Sartor, C; Badiaga, S; Botelho, E; Brouqui, P; Zandotti, C; De Lamballerie, X; La Scola, B; Drancourt, M; Gould, EA; Charrel, RN; Raoult, D				Nougairede, Antoine; Lagier, Jean-Christophe; Ninove, Laetitia; Sartor, Catherine; Badiaga, Sekene; Botelho, Elizabeth; Brouqui, Philippe; Zandotti, Christine; De Lamballerie, Xavier; La Scola, Bernard; Drancourt, Michel; Gould, Ernest A.; Charrel, Remi N.; Raoult, Didier			Likely Correlation between Sources of Information and Acceptability of A/H1N1 Swine-Origin Influenza Virus Vaccine in Marseille, France	PLOS ONE			English	Article							HEALTH-CARE WORKERS; H5N1	Background: In France, there was a reluctance to accept vaccination against the A/H1N1 pandemic influenza virus despite government recommendation and investment in the vaccine programme. Methods and Findings: We examined the willingness of different populations to accept A/H1N1 vaccination (i) in a French hospital among 3315 employees immunized either by in-house medical personnel or mobile teams of MDs and (ii) in a shelter housing 250 homeless persons. Google was used to assess the volume of enquiries concerning incidence of influenza. We analyzed the information on vaccination provided by Google, the website of the major French newspapers, and PubMed. Two trust Surveys were used to assess public opinion on the trustworthiness of people in different professions. Paramedics were significantly more reluctant to accept immunisation than qualified medical staff. Acceptance was significantly increased when recommended directly by MDs. Anecdotal cases of directly observed severe infections were followed by enhanced acceptance of paramedical staff. Scientific literature was significantly more in favour of vaccination than Google and French newspaper websites. In the case of the newspaper websites, information correlated with their recognised political reputations, although they would presumably claim independence from political bias. The Trust Surveys showed that politicians were highly distrusted in contrast with doctors and pharmacists who were considered much more trustworthy. Conclusions: The low uptake of the vaccine could reflect failure to convey high quality medical information and advice relating to the benefits of being vaccinated. We believe that the media and internet contributed to this problem by raising concerns within the general population and that failure to involve GPs in the control programme may have been a mistake. GPs are highly regarded by the public and can provide face-to-face professional advice and information. The top-down strategy of vaccine programme management and information delivered by the Ministry of Health could have aggravated the problem, because the general population does not always trust politicians.	[Nougairede, Antoine; Ninove, Laetitia; Zandotti, Christine; De Lamballerie, Xavier; La Scola, Bernard; Drancourt, Michel; Charrel, Remi N.; Raoult, Didier] Hop Enfants La Timone, Assistance Publ Hop Marseille, Marseille, France; [Nougairede, Antoine; Ninove, Laetitia; De Lamballerie, Xavier; Gould, Ernest A.; Charrel, Remi N.] Univ Mediterranee, Inst Rech Dev, UMR Pathol Virales Emergentes 190, Marseille, France; [Lagier, Jean-Christophe; Badiaga, Sekene; Botelho, Elizabeth; Brouqui, Philippe; La Scola, Bernard; Drancourt, Michel; Raoult, Didier] Univ Mediterranee, CNRS, UMR 6236,IRD 3R198, Unite Rech Malad Infect & Trop Emergentes, Marseille, France; [Lagier, Jean-Christophe; Sartor, Catherine] Hop Conception, Assistance Publ Hop Marseille, Com Lutte Infect Nosocomiales, Marseille, France; [Badiaga, Sekene] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Accueil Urgences, Marseille, France; [Botelho, Elizabeth; Brouqui, Philippe] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Malad Infect & Trop, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Nougairede, A (corresponding author), Hop Enfants La Timone, Assistance Publ Hop Marseille, Marseille, France.	antoine.nougairede@yahoo.fr	LA SCOLA, Bernard/P-6477-2016; Badiaga, Sekene/P-5810-2016; Brouqui, Philippe/P-5771-2016; Lagier, Jean-Christophe/AAY-3837-2021; RAOULT, Didier/A-8434-2008	LA SCOLA, Bernard/0000-0001-8006-7704; Lagier, Jean-Christophe/0000-0003-0771-8245; RAOULT, Didier/0000-0002-0633-5974; Charrel, Remi/0000-0002-7675-8251	AP-HM Public Hospital	AP-HM Public Hospital	This study has been partly funded by AP-HM Public Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AG FRANC SEC SAN, 2010, SUIV PHARM VACC GRIP; [Anonymous], 2001, NATURE, V409, P269; Badiaga S, 2009, EUR J PUBLIC HEALTH, V19, P157, DOI 10.1093/eurpub/ckn142; Breman JG, 2003, NEW ENGL J MED, V348, P463, DOI 10.1056/NEJMp025175; Carneiro HA, 2009, CLIN INFECT DIS, V49, P1557, DOI 10.1086/630200; Chor JSY, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3391; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cousens SN, 1997, NATURE, V385, P197, DOI 10.1038/385197a0; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; Eastwood K, 2010, MED J AUSTRALIA, V192, P33, DOI 10.5694/j.1326-5377.2010.tb03399.x; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; *FRENCH MIN HLTH, 2009, GRIPP INF PROF; *FRENCH MIN HLTH, 2009, C PRESS GRIPP A H1N1; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; *HAUT CONS SANT PU, 2009, PAND GRIPP A H1N1 20; JONES JH, 2009, PLOS ONE, V8032, pN1; Kimura AC, 2007, AM J PUBLIC HEALTH, V97, P684, DOI 10.2105/AJPH.2005.082073; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; NICHOL KL, 1995, NEW ENGL J MED, V333, P889, DOI 10.1056/NEJM199510053331401; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; NOUGAIREDE A, 2009, PLOS CURRENTS INFLUE; Ofri D, 2009, NEW ENGL J MED, V361, P2594, DOI 10.1056/NEJMp0911047; PETIT G, 2009, NOUVEL OBSERVAT 1208; RACHIOTIS G, 2009, EURO SURVEILL, V15; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Sartor C, 2004, INFECT CONT HOSP EP, V25, P918, DOI 10.1086/502320; SCHWARZINGER M, PLOS ONE, V5; Schwarzinger M, 2010, VACCINE, V28, P2743, DOI 10.1016/j.vaccine.2010.01.027; Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; VANDEN B, 2009, EUR J PUBLIC HEALTH, V19, P370; World Health Organization (WHO), 2009, INFL LIK ILLN US MEX; Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552; 2009, MMWR MORB MORTAL WKL, V59, P357; 2009, READERS DIGEST; 2009, GOOGLE INSIGHTS SEAR	39	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11292	10.1371/journal.pone.0011292	http://dx.doi.org/10.1371/journal.pone.0011292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593024	gold, Green Submitted, Green Published			2022-12-27	WOS:000279140800005
J	Greene, CM; Bahri, P; Soto, D				Greene, Ciara M.; Bahri, Pooja; Soto, David			Interplay between Affect and Arousal in Recognition Memory	PLOS ONE			English	Article							CORTICAL COGNITIVE FUNCTION; SPATIAL WORKING-MEMORY; POSITIVE AFFECT; PREFRONTAL CORTEX; PLEASANT; STRESS; MUSIC; STIMULATION; PERFORMANCE; DOPAMINE	Background: Emotional states linked to arousal and mood are known to affect the efficiency of cognitive performance. However, the extent to which memory processes may be affected by arousal, mood or their interaction is poorly understood. Methodology/Principal Findings: Following a study phase of abstract shapes, we altered the emotional state of participants by means of exposure to music that varied in both mood and arousal dimensions, leading to four different emotional states: (i) positive mood-high arousal; (ii) positive mood-low arousal; (iii) negative mood-high arousal; (iv) negative mood-low arousal. Following the emotional induction, participants performed a memory recognition test. Critically, there was an interaction between mood and arousal on recognition performance. Memory was enhanced in the positive mood-high arousal and in the negative mood-low arousal states, relative to the other emotional conditions. Conclusions/Significance: Neither mood nor arousal alone but their interaction appears most critical to understanding the emotional enhancement of memory.	[Greene, Ciara M.; Bahri, Pooja; Soto, David] Univ London Imperial Coll Sci Technol & Med, Ctr Neurosci, London, England	Imperial College London	Greene, CM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Neurosci, London, England.	c.greene@imperial.ac.uk; d.soto@imperial.ac.uk	Soto, David/R-3711-2019	Soto, David/0000-0003-0205-7513; Greene, Ciara/0000-0002-8833-9046	British Academy [PDF/2007/501]; Medical Research Council [89631]; MRC [G0802212] Funding Source: UKRI; Medical Research Council [G0802212] Funding Source: researchfish	British Academy; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by grants from the British Academy (PDF/2007/501) and Medical Research Council (89631). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2006, P NATL ACAD SCI USA, V103, P1599, DOI 10.1073/pnas.0506308103; Arnsten AFT, 1999, BIOL PSYCHIAT, V45, P26, DOI 10.1016/S0006-3223(98)00296-0; Arnsten AFT, 1998, TRENDS COGN SCI, V2, P436, DOI 10.1016/S1364-6613(98)01240-6; Arnsten AFT, 1997, J PSYCHOPHARMACOL, V11, P151, DOI 10.1177/026988119701100208; Arnsten AFT, 2005, BIOL PSYCHIAT, V57, P1377, DOI 10.1016/j.biopsych.2004.08.019; Basso M R, 1996, J Int Neuropsychol Soc, V2, P249; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; DEKLOET ER, 1995, FRONT NEUROENDOCRIN, V16, P416, DOI 10.1006/frne.1995.1015; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Gold P E, 1975, Prog Brain Res, V42, P210; ISEN AM, 1985, J PERS SOC PSYCHOL, V48, P1413, DOI 10.1037/0022-3514.48.6.1413; ISEN AM, 1987, J PERS SOC PSYCHOL, V52, P1122, DOI 10.1037/0022-3514.52.6.1122; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; JUDDE S, 2010, NEUROBIOLOGY LEARNIN; Kensinger EA, 2004, P NATL ACAD SCI USA, V101, P3310, DOI 10.1073/pnas.0306408101; Liu DLJ, 2008, NEUROBIOL LEARN MEM, V89, P36, DOI 10.1016/j.nlm.2007.09.001; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; Mather M, 2007, PERSPECT PSYCHOL SCI, V2, P33, DOI 10.1111/j.1745-6916.2007.00028.x; Murphy BL, 1996, J NEUROSCI, V16, P7768; RAUSCHER FH, 1993, NATURE, V365, P611, DOI 10.1038/365611a0; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Southwick SM, 1999, BIOL PSYCHIAT, V46, P1192, DOI 10.1016/S0006-3223(99)00219-X; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; TULVING E, 1973, PSYCHOL REV, V80, P352, DOI 10.1037/h0020071; Zahrt J, 1997, J NEUROSCI, V17, P8528	26	20	21	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11739	10.1371/journal.pone.0011739	http://dx.doi.org/10.1371/journal.pone.0011739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	630AQ	20668532	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800013
J	Kuta, A; Deng, WH; El-Kadi, AM; Banks, GT; Hafezparast, M; Pfister, KK; Fisher, EMC				Kuta, Anna; Deng, Wenhan; El-Kadi, Ali Morsi; Banks, Gareth T.; Hafezparast, Majid; Pfister, K. Kevin; Fisher, Elizabeth M. C.			Mouse Cytoplasmic Dynein Intermediate Chains: Identification of New Isoforms, Alternative Splicing and Tissue Distribution of Transcripts	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; ARM DYNEIN; BINDS; SUBUNIT; PHOSPHORYLATION; MICROTUBULES; ORGANIZATION; TRANSPORT; DYNACTIN; DEFECTS	Background: Intracellular transport of cargoes including organelles, vesicles, signalling molecules, protein complexes, and RNAs, is essential for normal function of eukaryotic cells. The cytoplasmic dynein complex is an important motor that moves cargos along microtubule tracks within the cell. In mammals this multiprotein complex includes dynein intermediate chains 1 and 2 which are encoded by two genes, Dync1i1 and Dync1i2. These proteins are involved in dynein cargo binding and dynein complexes with different intermediate chains bind to specific cargoes, although the mechanisms to achieve this are not known. The DYNC1I1 and DYNC1I2 proteins are translated from different splice isoforms, and specific forms of each protein are essential for the function of different dynein complexes in neurons. Methodology/Principal Findings: Here we have undertaken a systematic survey of the dynein intermediate chain splice isoforms in mouse, basing our study on mRNA expression patterns in a range of tissues, and on bioinformatics analysis of mouse, rat and human genomic and cDNA sequences. We found a complex pattern of alternative splicing of both dynein intermediate chain genes, with maximum complexity in the embryonic and adult nervous system. We have found novel transcripts, including some with orthologues in human and rat, and a new promoter and alternative non-coding exon 1 for Dync1i2. Conclusions/Significance: These data, including the cloned isoforms will be essential for understanding the role of intermediate chains in the cytoplasmic dynein complex, particularly their role in cargo binding within individual tissues including different brain regions.	[Kuta, Anna; Banks, Gareth T.; Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London, England; [Deng, Wenhan; El-Kadi, Ali Morsi; Hafezparast, Majid] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England; [Pfister, K. Kevin] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA	University of London; University College London; University of Sussex; University of Virginia	Kuta, A (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London, England.	e.fisher@prion.ucl.ac.uk	Hafezparast, Majid/H-6728-2018; Fisher, Elizabeth MC/C-2168-2008; Hafezparast, Majid/N-8292-2019	Fisher, Elizabeth MC/0000-0003-2850-9936; Hafezparast, Majid/0000-0002-5262-7150; Banks, Gareth/0000-0002-8647-667X	Wellcome Trust; European Union; UK Medical Research Council; National Institute of General Medical Science (National Institutes of Health); BBSRC [BB/D012309/1] Funding Source: UKRI; MRC [G0300854] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D012309/1] Funding Source: researchfish; Medical Research Council [G0300854] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of General Medical Science (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These authors are supported by the Wellcome Trust, the ENDOCYTE Research and Training Network funded by the European Union and the UK Medical Research Council and the National Institute of General Medical Science (National Institutes of Health). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks GT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-214; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Crackower MA, 1999, GENOMICS, V55, P257, DOI 10.1006/geno.1998.5665; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guittot SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008454; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Hook P, 2006, J CELL SCI, V119, P4369, DOI 10.1242/jcs.03176; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Karki S, 1997, J BIOL CHEM, V272, P5887, DOI 10.1074/jbc.272.9.5887; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Levin M, 1997, MED HYPOTHESES, V49, P429, DOI 10.1016/S0306-9877(97)90092-X; Levy JR, 2006, INT J DEV NEUROSCI, V24, P103, DOI 10.1016/j.ijdevneu.2005.11.013; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; Ligon LA, 2001, NAT CELL BIOL, V3, P913, DOI 10.1038/ncb1001-913; Liu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009482; Lo KWH, 2007, J BIOL CHEM, V282, P36871, DOI 10.1074/jbc.M705991200; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Myers KR, 2007, J NEUROSCI RES, V85, P2640, DOI 10.1002/jnr.21213; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; PASCHAL BM, 1987, NATURE, V330, P672, DOI 10.1038/330672a0; PASCHAL BM, 1992, J CELL BIOL, V118, P1133, DOI 10.1083/jcb.118.5.1133; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Pfister KK, 1996, MOL BIOL CELL, V7, P331, DOI 10.1091/mbc.7.2.331; Pfister KK, 1996, J BIOL CHEM, V271, P1687, DOI 10.1074/jbc.271.3.1687; Salata MW, 2001, J NEUROSCI RES, V65, P408, DOI 10.1002/jnr.1168; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Towns WL, 2009, CELL MOTIL CYTOSKEL, V66, P80, DOI 10.1002/cm.20327; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Wagner OI, 2004, MOL BIOL CELL, V15, P5092, DOI 10.1091/mbc.E04-05-0401; Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901; Wang HZ, 2009, ENDOCRINOLOGY, V150, P3301, DOI 10.1210/en.2008-1812; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Yang PF, 1998, MOL BIOL CELL, V9, P3335, DOI 10.1091/mbc.9.12.3335	45	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11682	10.1371/journal.pone.0011682	http://dx.doi.org/10.1371/journal.pone.0011682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657784	Green Published, gold, Green Accepted			2022-12-27	WOS:000280197500023
J	Goller, CC; Seed, PC				Goller, Carlos C.; Seed, Patrick C.			High-Throughput Identification of Chemical Inhibitors of E. coli Group 2 Capsule Biogenesis as Anti-Virulence Agents	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; UROPATHOGENIC ESCHERICHIA-COLI; ACUTE UNCOMPLICATED CYSTITIS; INTRACELLULAR BACTERIAL COMMUNITIES; BLADDER EPITHELIAL-CELLS; ANTIMICROBIAL RESISTANCE; MULTIDRUG-RESISTANT; BACTERIOPHAGE K1F; POLYSACCHARIDE; WOMEN	Rising antibiotic resistance among Escherichia coli, the leading cause of urinary tract infections (UTIs), has placed a new focus on molecular pathogenesis studies, aiming to identify new therapeutic targets. Anti-virulence agents are attractive as chemotherapeutics to attenuate an organism during disease but not necessarily during benign commensalism, thus decreasing the stress on beneficial microbial communities and lessening the emergence of resistance. We and others have demonstrated that the K antigen capsule of E. coli is a preeminent virulence determinant during UTI and more invasive diseases. Components of assembly and export are highly conserved among the major K antigen capsular types associated with UTI-causing E. coli and are distinct from the capsule biogenesis machinery of many commensal E. coli, making these attractive therapeutic targets. We conducted a screen for anti-capsular small molecules and identified an agent designated "C7'' that blocks the production of K1 and K5 capsules, unrelated polysaccharide types among the Group 2-3 capsules. Herein lies proof-of-concept that this screen may be implemented with larger chemical libraries to identify second-generation small-molecule inhibitors of capsule biogenesis. These inhibitors will lead to a better understanding of capsule biogenesis and may represent a new class of therapeutics.	[Goller, Carlos C.; Seed, Patrick C.] Duke Univ, Dept Pediat, Ctr Microbial Pathogenesis, Durham, NC 27706 USA	Duke University	Goller, CC (corresponding author), Duke Univ, Dept Pediat, Ctr Microbial Pathogenesis, Durham, NC 27706 USA.	patrick.seed@duke.edu	Goller, Carlos C./AAJ-9924-2021	Goller, Carlos/0000-0002-2013-0334	National Institutes of Health (NIH) [K08DK074443]; NIH Office of Research on Women's Health SCOR [P50DK064540]; National Science Foundation (NSF); Duke Children's Miracle Network; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK064540, K08DK074443] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Office of Research on Women's Health SCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); National Science Foundation (NSF)(National Science Foundation (NSF)); Duke Children's Miracle Network; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	PCS received support from National Institutes of Health (NIH) grant K08DK074443 and NIH Office of Research on Women's Health SCOR P50DK064540. CCG received support from a National Science Foundation (NSF) Facilitating Academic Careers in Engineering and Science (FACES) fellowship award and a Duke Children's Miracle Network grant and currently is a postdoctoral fellow of the Hartwell Foundation (http://www.thehartwellfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali ASM, 2009, J UROLOGY, V182, P21, DOI 10.1016/j.juro.2009.02.124; ALLEN PZ, 1982, J CLIN MICROBIOL, V15, P324, DOI 10.1128/JCM.15.2.324-329.1982; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Anderson GG, 2004, MICROBES INFECT, V6, P1094, DOI 10.1016/j.micinf.2004.05.023; Anderson GG, 2010, INFECT IMMUN, V78, P963, DOI 10.1128/IAI.00925-09; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Blango MG, 2010, ANTIMICROB AGENTS CH, V54, P1855, DOI 10.1128/AAC.00014-10; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Clarke BR, 2000, J BACTERIOL, V182, P3761, DOI 10.1128/JB.182.13.3761-3766.2000; FINKE A, 1991, J BACTERIOL, V173, P4088, DOI 10.1128/jb.173.13.4088-4094.1991; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Gupta K, 2005, J ANTIMICROB CHEMOTH, V56, P243, DOI 10.1093/jac/dki169; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; Hames L, 2007, J AM COLL HEALTH, V56, P153, DOI 10.3200/JACH.56.2.153-158; Hang L, 1998, J UROLOGY, V159, P2185, DOI 10.1016/S0022-5347(01)63303-2; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; JOHNSON JR, 1991, CLIN MICROBIOL REV, V4, P80, DOI 10.1128/CMR.4.1.80-128.1991; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; Kahlmeter G, 2000, J ANTIMICROB CHEMOTH, V46, P15, DOI 10.1093/jac/46.suppl_1.15; Karlowsky JA, 2006, ANTIMICROB AGENTS CH, V50, P2251, DOI 10.1128/AAC.00123-06; Li K, 2008, MOL IMMUNOL, V45, P954, DOI 10.1016/j.molimm.2007.07.037; LITWIN MS, 2007, NIH PUBLICATION, P3; Llobet E, 2008, MICROBIOL-SGM, V154, P3877, DOI 10.1099/mic.0.2008/022301-0; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Manzi A, 2001, Curr Protoc Mol Biol, VChapter 17, DOI 10.1002/0471142727.mb1709s32; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Mushtaq N, 2005, J ANTIMICROB CHEMOTH, V56, P160, DOI 10.1093/jac/dki177; Olson RP, 2009, ANTIMICROB AGENTS CH, V53, P1285, DOI 10.1128/AAC.01188-08; PELKONEN S, 1988, J BACTERIOL, V170, P2646, DOI 10.1128/jb.170.6.2646-2653.1988; PETTER JG, 1993, J BACTERIOL, V175, P4354, DOI 10.1128/JB.175.14.4354-4363.1993; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; ROBERTS IS, 1995, MICROBIOL-SGM, V141, P2023, DOI 10.1099/13500872-141-9-2023; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Sambrook J., 2002, MOL CLONING LAB MANU; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; Schilling JD, 2001, J IMMUNOL, V166, P1148, DOI 10.4049/jimmunol.166.2.1148; Scholl D, 2005, J BACTERIOL, V187, P8499, DOI 10.1128/JB.187.24.8499-8503.2005; Scholl D, 2005, APPL ENVIRON MICROB, V71, P4872, DOI 10.1128/AEM.71.8.4872-4874.2005; SVANBORG C, 1993, ZBL BAKT-INT J MED M, V278, P359, DOI 10.1016/S0934-8840(11)80852-2; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583; Taylor CM, 2006, J BACTERIOL, V188, P1165, DOI 10.1128/JB.188.3.1165-1168.2006; Valore EV, 1998, J CLIN INVEST, V101, P1633, DOI 10.1172/JCI1861; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002; VIMR ER, 1992, J BACTERIOL, V174, P6191, DOI 10.1128/JB.174.19.6191-6197.1992; VIMR ER, 1985, J BACTERIOL, V164, P854, DOI 10.1128/JB.164.2.854-860.1985; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427; ZAPATA G, 1992, J BACTERIOL, V174, P315, DOI 10.1128/jb.174.1.315-319.1992; Zasloff M, 2007, J AM SOC NEPHROL, V18, P2810, DOI 10.1681/ASN.2007050611; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	53	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11642	10.1371/journal.pone.0011642	http://dx.doi.org/10.1371/journal.pone.0011642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657847	Green Published, gold, Green Submitted			2022-12-27	WOS:000280065600008
J	Thoren, LA; Norgaard, GA; Weischenfeldt, J; Waage, J; Jakobsen, JS; Damgaard, I; Bergstrom, FC; Blom, AM; Borup, R; Bisgaard, HC; Porse, BT				Thoren, Lina A.; Norgaard, Gitte A.; Weischenfeldt, Joachim; Waage, Johannes; Jakobsen, Janus S.; Damgaard, Inge; Bergstrom, Frida C.; Blom, Anna M.; Borup, Rehannah; Bisgaard, Hanne Cathrine; Porse, Bo T.			UPF2 Is a Critical Regulator of Liver Development, Function and Regeneration	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NONSENSE; EXPRESSION; PROTEINS; COMPLEX; CELLS; BINDING	Background: Nonsense-mediated mRNA decay (NMD) is a post-transcriptional RNA surveillance process that facilitates the recognition and destruction of mRNAs bearing premature terminations codons (PTCs). Such PTC-containing (PTC+) mRNAs may arise from different processes, including erroneous processing and expression of pseudogenes, but also from more regulated events such as alternative splicing coupled NMD (AS-NMD). Thus, the NMD pathway serves both as a silencer of genomic noise and a regulator of gene expression. Given the early embryonic lethality in NMD deficient mice, uncovering the full regulatory potential of the NMD pathway in mammals will require the functional assessment of NMD in different tissues. Methodology/Principal Findings: Here we use mouse genetics to address the role of UPF2, a core NMD component, in the development, function and regeneration of the liver. We find that loss of NMD during fetal liver development is incompatible with postnatal life due to failure of terminal differentiation. Moreover, deletion of Upf2 in the adult liver results in hepatosteatosis and disruption of liver homeostasis. Finally, NMD was found to be absolutely required for liver regeneration. Conclusion/Significance: Collectively, our data demonstrate the critical role of the NMD pathway in liver development, function and regeneration and highlights the importance of NMD for mammalian biology.	[Thoren, Lina A.; Norgaard, Gitte A.; Weischenfeldt, Joachim; Waage, Johannes; Jakobsen, Janus S.; Damgaard, Inge; Porse, Bo T.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Thoren, Lina A.; Norgaard, Gitte A.; Weischenfeldt, Joachim; Waage, Johannes; Jakobsen, Janus S.; Damgaard, Inge; Porse, Bo T.] Univ Copenhagen, Rigshosp, Sect Gene Therapy Res, DK-2100 Copenhagen, Denmark; [Jakobsen, Janus S.] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Bergstrom, Frida C.; Blom, Anna M.] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Malmo, Sweden; [Borup, Rehannah] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Bisgaard, Hanne Cathrine] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Lund University; Skane University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Thoren, LA (corresponding author), Univ Copenhagen, BRIC, Copenhagen, Denmark.	bo.porse@bric.dk	Porse, Bo/B-1332-2012; Blom, Anna/AFS-7369-2022; Weischenfeldt, Joachim/O-3681-2015; Blom, Anna/B-9607-2009; Jakobsen, Janus Schou/P-1679-2014	Weischenfeldt, Joachim/0000-0002-3917-5524; Blom, Anna/0000-0002-1348-1734; Jakobsen, Janus Schou/0000-0001-6135-5815; Waage, Johannes/0000-0002-0603-8822; Porse, Bo/0000-0001-6043-0844	Lundbeck Foundation; Alfred Benzon Foundation; Danish Natural Science Research Council; Novo Nordisk Foundation; Copenhagen Hospital Cooperation, Region H; Lundbeck Foundation [R5-2006-99] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Alfred Benzon Foundation; Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Copenhagen Hospital Cooperation, Region H; Lundbeck Foundation(Lundbeckfonden)	This work was supported by the Lundbeck Foundation, The Alfred Benzon Foundation (postdoctoral position to LAT), The Danish Natural Science Research Council, The Novo Nordisk Foundation and the Copenhagen Hospital Cooperation, Region H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Azzalin CM, 2006, CELL CYCLE, V5, P1496, DOI 10.4161/cc.5.14.3093; Azzalin CM, 2006, CURR BIOL, V16, P433, DOI 10.1016/j.cub.2006.01.018; Battle MA, 2006, P NATL ACAD SCI USA, V103, P8419, DOI 10.1073/pnas.0600246103; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brumbaugh KM, 2004, MOL CELL, V14, P585, DOI 10.1016/j.molcel.2004.05.005; Buhler M, 2005, MOL CELL, V18, P307, DOI 10.1016/j.molcel.2005.03.030; Buhler M, 2006, NAT STRUCT MOL BIOL, V13, P462, DOI 10.1038/nsmb1081; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Eberle AB, 2008, PLOS BIOL, V6, P849, DOI 10.1371/journal.pbio.0060092; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Hasemann MS, 2008, BLOOD, V111, P4309, DOI 10.1182/blood-2007-06-097790; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kiss T, 2006, COLD SPRING HARB SYM, V71, P407, DOI 10.1101/sqb.2006.71.025; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987; Lindqvist AKB, 2006, J IMMUNOL, V177, P3952, DOI 10.4049/jimmunol.177.6.3952; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel A, 2005, RNA, V11, P1530, DOI 10.1261/rna.2160905; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Sandmann T, 2006, NAT PROTOC, V1, P2839, DOI 10.1038/nprot.2006.383; Singh G, 2008, PLOS BIOL, V6, P860, DOI 10.1371/journal.pbio.0060111; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002; Weischenfeldt J, 2008, GENE DEV, V22, P1381, DOI 10.1101/gad.468808; Wittkopp N, 2009, MOL CELL BIOL, V29, P3517, DOI 10.1128/MCB.00177-09; Wittmann J, 2006, MOL CELL BIOL, V26, P1272, DOI 10.1128/MCB.26.4.1272-1287.2006; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83; Zhu J, 2001, NANO LETT, V1, P8, DOI 10.1021/nl005512q	42	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11650	10.1371/journal.pone.0011650	http://dx.doi.org/10.1371/journal.pone.0011650			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657840	gold, Green Submitted, Green Published			2022-12-27	WOS:000280065600014
J	Quijano, JC; Stinchfield, MJ; Zerlanko, B; Gibbens, YY; Takaesu, NT; Hyman-Walsh, C; Wotton, D; Newfeld, SJ				Quijano, Janine C.; Stinchfield, Michael J.; Zerlanko, Brad; Gibbens, Ying Y.; Takaesu, Norma T.; Hyman-Walsh, Cathy; Wotton, David; Newfeld, Stuart J.			The Sno Oncogene Antagonizes Wingless Signaling during Wing Development in Drosophila	PLOS ONE			English	Article							TGF-BETA; GENE-EXPRESSION; PROTEIN; GROWTH; ENCODES; ACHAETE; FAMILY; BLADE; TRUNCATIONS; ACTIVATION	The Sno oncogene (Snoo or dSno in Drosophila) is a highly conserved protein and a well-established antagonist of Transforming Growth Factor-beta signaling in overexpression assays. However, analyses of Sno mutants in flies and mice have proven enigmatic in revealing developmental roles for Sno proteins. Thus, to identify developmental roles for dSno we first reconciled conflicting data on the lethality of dSno mutations. Then we conducted analyses of wing development in dSno loss of function genotypes. These studies revealed ectopic margin bristles and ectopic campaniform sensilla in the anterior compartment of the wing blade suggesting that dSno functions to antagonize Wingless (Wg) signaling. A subsequent series of gain of function analyses yielded the opposite phenotype (loss of bristles and sensilla) and further suggested that dSno antagonizes Wg signal transduction in target cells. To date Sno family proteins have not been reported to influence the Wg pathway during development in any species. Overall our data suggest that dSno functions as a tissue-specific component of the Wg signaling pathway with modest antagonistic activity under normal conditions but capable of blocking significant levels of extraneous Wg, a role that may be conserved in vertebrates.	[Quijano, Janine C.; Stinchfield, Michael J.; Takaesu, Norma T.; Newfeld, Stuart J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Zerlanko, Brad; Hyman-Walsh, Cathy; Wotton, David] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Zerlanko, Brad; Hyman-Walsh, Cathy; Wotton, David] Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA; [Gibbens, Ying Y.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Arizona State University; Arizona State University-Tempe; University of Virginia; University of Virginia; University of Minnesota System; University of Minnesota Twin Cities	Quijano, JC (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	newfeld@asu.edu	Stinchfield, Michael/AAW-8983-2020	Gibbens, Ying/0000-0002-1125-7157; Wotton, David/0000-0002-4652-5350; Quijano, Janine/0000-0001-7755-3154	Inter Tribal Council of Arizona, Science Foundation Arizona; European Commission/ENFIN; N.I.H. [HD39926, CA109552, T32-HD007480]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039926, T32HD007480] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA109552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER	Inter Tribal Council of Arizona, Science Foundation Arizona; European Commission/ENFIN(European CommissionEuropean Commission Joint Research Centre); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Inter Tribal Council of Arizona, Science Foundation Arizona and the European Commission/ENFIN to S.J.N. and by N.I.H. grants to D.W. (HD39926) and S.J.N. (CA109552). Y.Y.G. thanks Mike O'Connor for support via N.I.H. training grant (T32-HD007480). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Barrio R, 2007, DEV BIOL, V306, P66, DOI 10.1016/j.ydbio.2007.02.039; Belenkaya TY, 2002, DEVELOPMENT, V129, P4089; BLAIR SS, 1992, DEV BIOL, V152, P263, DOI 10.1016/0012-1606(92)90134-3; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Chen DH, 2003, CANCER RES, V63, P6626; CHOU TB, 1992, GENETICS, V131, P643; Emerald BS, 2004, DEV BIOL, V267, P462, DOI 10.1016/j.ydbio.2003.12.006; FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0; GOMEZSKARMETA JL, 1995, GENE DEV, V9, P1869, DOI 10.1101/gad.9.15.1869; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; JACK J, 1991, DEVELOPMENT, V113, P735; Konikoff CE, 2008, J MOL EVOL, V67, P323, DOI 10.1007/s00239-008-9159-4; Marquez RM, 2001, GENETICS, V157, P1639; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Milan M, 1998, GENE DEV, V12, P2912, DOI 10.1101/gad.12.18.2912; Pai LM, 1997, DEVELOPMENT, V124, P2255; Parker DS, 2002, DEVELOPMENT, V129, P2565; Pearson-White S, 2003, MOL CELL BIOL, V23, P5446, DOI 10.1128/MCB.23.15.5446-5459.2003; Penton A, 2002, GENETICS, V161, P747; Peterson-Nedry W, 2008, DEV BIOL, V320, P226, DOI 10.1016/j.ydbio.2008.05.521; Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Ramel MC, 2007, MECH DEVELOP, V124, P304, DOI 10.1016/j.mod.2006.12.006; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RIPOLL P, 1988, DEVELOPMENT, V103, P757; Rousset R, 2001, GENE DEV, V15, P658, DOI 10.1101/gad.869201; RUEL L, 1993, EMBO J, V12, P1657, DOI 10.1002/j.1460-2075.1993.tb05811.x; Saller E, 2002, GENE DEV, V16, P1828, DOI 10.1101/gad.230002; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sarker KP, 2008, J BIOL CHEM, V283, P13269, DOI 10.1074/jbc.M708834200; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shravage BV, 2007, DEVELOPMENT, V134, P2261, DOI 10.1242/dev.02856; SIMPSON P, 1988, DEVELOPMENT, V103, P391; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Takaesu NT, 2006, GENETICS, V174, P1299, DOI 10.1534/genetics.106.064956; Takaesu NT, 2005, DEVELOPMENT, V132, P4883, DOI 10.1242/dev.02048; Treisman JE, 1997, GENE DEV, V11, P1949, DOI 10.1101/gad.11.15.1949; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Willert K, 1999, DEVELOPMENT, V126, P4165; Wrighton KH, 2007, J BIOL CHEM, V282, P6517, DOI 10.1074/jbc.M610206200; XU T, 1993, DEVELOPMENT, V117, P1223; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang F, 2003, CANCER RES, V63, P5005	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11619	10.1371/journal.pone.0011619	http://dx.doi.org/10.1371/journal.pone.0011619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661280	Green Submitted, Green Published, gold			2022-12-27	WOS:000279980800008
J	Guadalupe-Grau, A; Rodriguez-Gonzalez, FG; Ponce-Gonzalez, JG; Dorado, C; Olmedillas, H; Fuentes, T; Perez-Gomez, J; Sanchis-Moysi, J; Diaz-Chico, BN; Calbet, JAL				Guadalupe-Grau, Amelia; German Rodriguez-Gonzalez, Francisco; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Olmedillas, Hugo; Fuentes, Teresa; Perez-Gomez, Jorge; Sanchis-Moysi, Joaquin; Nicolas Diaz-Chico, Bonifacio; Calbet, Jose A. L.			Bone Mass and the CAG and GGN Androgen Receptor Polymorphisms in Young Men	PLOS ONE			English	Article							IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; REPEAT POLYMORPHISM; MINERAL DENSITY; GENETIC-DETERMINANTS; RANCHO-BERNARDO; SEX STEROIDS; WOMEN; OSTEOPOROSIS; METABOLISM; ADULTS	Background: To determine whether androgen receptor (AR) CAG (polyglutamine) and GGN (polyglycine) polymorphisms influence bone mineral density (BMD), osteocalcin and free serum testosterone concentration in young men. Methodology/Principal Findings: Whole body, lumbar spine and femoral bone mineral content (BMC) and BMD, Dual X-ray Absorptiometry (DXA), AR repeat polymorphisms (PCR), osteocalcin and free testosterone (ELISA) were determined in 282 healthy men (28.6 +/- 7.6 years). Individuals were grouped as CAG short (CAG(S)) if harboring repeat lengths of <= 21 or CAG long (CAG(L)) if CAG>21, and GGN was considered short (GGN(S)) or long (GGN(L)) if GGN <= 23 or >23. There was an inverse association between logarithm of CAG and GGN length and Ward's Triangle BMC (r = -0.15 and -0.15, P<0.05, age and height adjusted). No associations between CAG or GGN repeat length and regional BMC or BMD were observed after adjusting for age. Whole body and regional BMC and BMD values were similar in men harboring CAG(S), CAG(L), GGN(S) or GGN(L) AR repeat polymorphisms. Men harboring the combination CAG(L)+GGN(L) had 6.3 and 4.4% higher lumbar spine BMC and BMD than men with the haplotype CAG(S)+GGN(S) (both P<0.05). Femoral neck BMD was 4.8% higher in the CAG(S)+GGN(S) compared with the CAG(L)+GGN(S) men (P<0.05). CAG(S), CAG(L), GGN(S), GGN(L) men had similar osteocalcin concentration as well as the four CAG-GGN haplotypes studied. Conclusion: AR polymorphisms have an influence on BMC and BMD in healthy adult humans, which cannot be explained through effects in osteoblastic activity.	[Guadalupe-Grau, Amelia; Gustavo Ponce-Gonzalez, Jesus; Dorado, Cecilia; Olmedillas, Hugo; Fuentes, Teresa; Perez-Gomez, Jorge; Sanchis-Moysi, Joaquin; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Canary Islands, Spain; [German Rodriguez-Gonzalez, Francisco; Nicolas Diaz-Chico, Bonifacio] Univ Las Palmas Gran Canaria, Fac Hlth Sci, Dept Biochem & Physiol, Mol Endocrinol Grp, Las Palmas Gran Canaria, Canary Islands, Spain; [German Rodriguez-Gonzalez, Francisco; Nicolas Diaz-Chico, Bonifacio] Canary Isl Canc Res Inst ICIC, Las Palmas Gran Canaria, Canary Islands, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Guadalupe-Grau, A (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Canary Islands, Spain.	lopezcalbet@gmail.com	González, Jesús Gustavo Ponce/H-9500-2015; Dorado García, Cecilia/ABC-2792-2021; PONCE GONZALEZ, JESUS G/R-1836-2019; Gómez, Jorge Pérez/R-1334-2019; Sanchis-Moysi, Joaquin/B-5561-2012; Olmedillas, Hugo/F-4809-2015; Fuentes, Teresa/K-7227-2014; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Pérez-Gómez, Jorge/AAS-9254-2020; Cecilia, Dorado-Garcia/B-4586-2010; , Jorge/ABC-8629-2020; Calbet, Jose A L/H-6693-2015; Guadalupe-Grau, Amelia/H-4961-2016	González, Jesús Gustavo Ponce/0000-0002-5982-7761; PONCE GONZALEZ, JESUS G/0000-0002-5982-7761; Olmedillas, Hugo/0000-0003-4625-2759; Fuentes, Teresa/0000-0003-1286-8731; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Cecilia, Dorado-Garcia/0000-0001-6616-6810; , Jorge/0000-0002-4054-9132; Calbet, Jose A L/0000-0002-9215-6234; Guadalupe-Grau, Amelia/0000-0003-2573-4572; antunez, Ariel/0000-0002-2548-7885; Rodriguez Gonzalez, Francisco G/0000-0002-8509-0804; Diaz Chico, Bonifacio Nicolas/0000-0001-5633-6185	Ministerio de Educacion y Ciencia [DEP2006-56076-C06-04/ACTI]; FEDER; Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias [2006/179 0001]; Proyecto Interreg IIIB BIOPOLIS; Fundacion del Instituto Canario de Investigacion del Cancer (FICIC); Cabildo de Gran Canaria; Cabildo de Tenerife; La Caja de Canarias; Proyecto estructurante de la ULPGC [ULPAPD-08/01-4]	Ministerio de Educacion y Ciencia(Spanish Government); FEDER(European Commission); Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias; Proyecto Interreg IIIB BIOPOLIS; Fundacion del Instituto Canario de Investigacion del Cancer (FICIC); Cabildo de Gran Canaria; Cabildo de Tenerife; La Caja de Canarias; Proyecto estructurante de la ULPGC	The study was supported by Ministerio de Educacion y Ciencia (DEP2006-56076-C06-04/ACTI) and FEDER; Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias (2006/179 0001 and FEDER); Proyecto Interreg IIIB BIOPOLIS, Fundacion del Instituto Canario de Investigacion del Cancer (FICIC), Cabildo de Gran Canaria, Cabildo de Tenerife and La Caja de Canarias, and Proyecto estructurante de la ULPGC: ULPAPD-08/01-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu EO, 1997, J CLIN ENDOCR METAB, V82, P3493, DOI 10.1210/jc.82.10.3493; Ding DC, 2005, PROSTATE, V62, P133, DOI 10.1002/pros.20128; FINKELSTEIN JS, 1987, ANN INTERN MED, V106, P354, DOI 10.7326/0003-4819-106-3; FINKELSTEIN JS, 1989, J CLIN ENDOCR METAB, V69, P776, DOI 10.1210/jcem-69-4-776; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Guadalupe-Grau A, 2009, J APPL PHYSIOL, V106, P1100, DOI 10.1152/japplphysiol.91469.2008; Guadalupe-Grau A, 2011, BRIT J SPORT MED, V45, P95, DOI 10.1136/bjsm.2009.060285; Guerra B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003466; Krithivas K, 1999, J ENDOCRINOL, V162, P137, DOI 10.1677/joe.0.1620137; Langdahl BL, 2003, CALCIFIED TISSUE INT, V73, P237, DOI 10.1007/s00223-002-0019-8; Lee DK, 2003, J CLIN ENDOCR METAB, V88, P4043, DOI 10.1210/jc.2003-030261; Pederson L, 1999, P NATL ACAD SCI USA, V96, P505, DOI 10.1073/pnas.96.2.505; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Remes T, 2003, BONE, V32, P412, DOI 10.1016/S8756-3282(03)00032-2; Rodriguez G, 2006, INT J CANCER, V118, P1420, DOI 10.1002/ijc.21516; Salmen T, 2003, J BONE MINER RES, V18, P319, DOI 10.1359/jbmr.2003.18.2.319; Sanchis-Moysi J, 2010, SCAND J MED SCI SPOR, V20, P524, DOI 10.1111/j.1600-0838.2009.00969.x; Slemenda CW, 1997, J CLIN INVEST, V100, P1755, DOI 10.1172/JCI119701; SLEMENDA CW, 1991, J BONE MINER RES, V6, P561; SOROKO SB, 1994, J BONE MINER RES, V9, P761; STIGER F, 2008, CALCIF TISSUE INT; Valimaki VV, 2005, OSTEOPOROSIS INT, V16, P1633, DOI 10.1007/s00198-005-1889-1; Van Pottelbergh I, 2001, CLIN ENDOCRINOL, V55, P659, DOI 10.1046/j.1365-2265.2001.01403.x; Vicente-Rodriguez G, 2007, INT J SPORTS MED, V28, P386, DOI 10.1055/s-2006-924397; Zitzmann M, 2001, CLIN ENDOCRINOL, V55, P649, DOI 10.1046/j.1365-2265.2001.01391.x	25	17	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11529	10.1371/journal.pone.0011529	http://dx.doi.org/10.1371/journal.pone.0011529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634949	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600013
J	Holmes, K; Chapman, E; See, V; Cross, MJ				Holmes, Katherine; Chapman, Elinor; See, Violaine; Cross, Michael J.			VEGF Stimulates RCAN1.4 Expression in Endothelial Cells via a Pathway Requiring Ca2+/Calcineurin and Protein Kinase C-delta	PLOS ONE			English	Article							SYNDROME CRITICAL REGION; DOWN-SYNDROME; SELECTIVE INHIBITOR; GROWTH; CALCINEURIN; ANGIOGENESIS; PHOSPHORYLATION; ACTIVATION; DSCR1; GENE	Background: Vascular endothelial growth factor (VEGF) has previously been shown to upregulate the expression of the endogenous calcineurin inhibitor, regulator of calcineurin 1, variant 4 (RCAN1.4). The aim of this study was to determine the role and regulation of VEGF-mediated RCAN1.4 expression, using human dermal microvascular endothelial cells (HDMECs) as a model system. Methodology/Principal Findings: We show that VEGF is able to induce RCAN1.4 expression during cellular proliferation and differentiation, and that VEGF-mediated expression of RCAN1.4 was inhibited by the use of inhibitors to protein kinase C (PKC) and calcineurin. Further analysis revealed that siRNA silencing of PKC-delta expression partially inhibited VEGF-stimulated RCAN1.4 expression. Knockdown of RCAN1.4 with siRNA resulted in a decrease in cellular migration and disrupted tubular morphogenesis when HDMECs were either stimulated with VEGF in a collagen gel or in an endothelial/fibroblast co-culture model of angiogenesis. Analysis of intracellular signalling revealed that siRNA mediated silencing of RCAN1.4 resulted in increased expression of specific nuclear factor of activated T-cells (NFAT) regulated genes. Conclusions/Significance: Our data suggests that RCAN1.4 expression is induced by VEGFR-2 activation in a Ca2+ and PKC-delta dependent manner and that RCAN1.4 acts to regulate calcineurin activity and gene expression facilitating endothelial cell migration and tubular morphogenesis.	[Holmes, Katherine; Chapman, Elinor; Cross, Michael J.] Univ Liverpool, Dept Pharmacol & Therapeut, Sch Biomed Sci, Liverpool L69 3BX, Merseyside, England; [Chapman, Elinor] Bangor Univ, Sch Biol Sci, N W Canc Res Inst, Bangor, Gwynedd, Wales; [See, Violaine] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Bangor University; University of Liverpool	Holmes, K (corresponding author), Univ Liverpool, Dept Pharmacol & Therapeut, Sch Biomed Sci, Liverpool L69 3BX, Merseyside, England.	m.j.cross@liv.ac.uk	Chapman, Elinor A/F-6112-2010	Chapman, Elinor/0000-0002-4398-1705	North West Cancer Research Fund (NWCRF); BBSRC [BB/C520471/1]; Cancer Research Wales; Biotechnology and Biological Sciences Research Council [BB/C520471/1] Funding Source: researchfish	North West Cancer Research Fund (NWCRF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research Wales; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	K.H. and M.J.C. are supported by North West Cancer Research Fund (NWCRF). V.S. is a recipient of a BBSRC David Phillips Fellowship (BB/C520471/1). E.C. is funded by Cancer Research Wales. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CHAN B, 2005, P NATL ACAD SCI US; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Dayanir V, 2001, J BIOL CHEM, V276, P17686, DOI 10.1074/jbc.M009128200; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FOLKMAN J, 1986, CANCER RES, V46, P467; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gliki G, 2002, CELL BIOL INT, V26, P751, DOI 10.1016/S1065-6995(02)90926-1; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Holmes Katherine, 2010, BMC Res Notes, V3, P53, DOI 10.1186/1756-0500-3-53; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lee HJ, 2009, FEBS LETT, V583, P2557, DOI 10.1016/j.febslet.2009.07.023; Lindsey KQ, 2000, J INVEST DERM SYMP P, V5, P74, DOI 10.1046/j.1087-0024.2000.00013.x; Lorenzi O, 2008, J THROMB HAEMOST, V6, P1962, DOI 10.1111/j.1538-7836.2008.03138.x; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; OKANO Y, 1993, BIOCHEM BIOPH RES CO, V190, P842, DOI 10.1006/bbrc.1993.1125; PLEVIN R, 1990, BIOCHEM J, V268, P605, DOI 10.1042/bj2680605; QATSHA KA, 1993, P NATL ACAD SCI USA, V90, P4674, DOI 10.1073/pnas.90.10.4674; Qin LL, 2006, MOL CANCER RES, V4, P811, DOI 10.1158/1541-7786.MCR-06-0126; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Rahman I, 1998, THORAX, V53, P601, DOI 10.1136/thx.53.7.601; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sorrell JM, 2007, CELLS TISSUES ORGANS, V186, P157, DOI 10.1159/000106670; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Whittles CE, 2002, MICROCIRCULATION, V9, P513, DOI 10.1038/sj.mn.7800164; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yao YG, 2004, BIOCHEM BIOPH RES CO, V321, P648, DOI 10.1016/j.bbrc.2004.06.176; Zhao P, 2008, EXP BIOL MED, V233, P1289, DOI 10.3181/0803-RM-84	47	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11435	10.1371/journal.pone.0011435	http://dx.doi.org/10.1371/journal.pone.0011435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625401	Green Submitted, Green Published, gold			2022-12-27	WOS:000279522500006
J	Wanchanthuek, P; Bellgard, MI; La, T; Ryan, K; Moolhuijzen, P; Chapman, B; Black, M; Schibeci, D; Hunter, A; Barrero, R; Phillips, ND; Hampson, DJ				Wanchanthuek, Phatthanaphong; Bellgard, Matthew I.; La, Tom; Ryan, Karon; Moolhuijzen, Paula; Chapman, Brett; Black, Michael; Schibeci, David; Hunter, Adam; Barrero, Roberto; Phillips, Nyree D.; Hampson, David J.			The Complete Genome Sequence of the Pathogenic Intestinal Spirochete Brachyspira pilosicoli and Comparison with Other Brachyspira Genomes	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; SERPULINA-PILOSICOLI; HELICOBACTER-PYLORI; MOLECULAR EPIDEMIOLOGY; EASTERN HIGHLANDS; RISK-FACTORS; HYODYSENTERIAE; EXPRESSION; HUMANS; LIPOPOLYSACCHARIDE	Background: The anaerobic spirochete Brachyspira pilosicoli colonizes the large intestine of various species of birds and mammals, including humans. It causes "intestinal spirochetosis'', a condition characterized by mild colitis, diarrhea and reduced growth. This study aimed to sequence and analyse the bacterial genome to investigate the genetic basis of its specialized ecology and virulence. Methodology/Principal Findings: The genome of B. pilosicoli 95/1000 was sequenced, assembled and compared with that of the pathogenic Brachyspira hyodysenteriae and a near-complete sequence of Brachyspira murdochii. The B. pilosicoli genome was circular, composed of 2,586,443 bp with a 27.9 mol% G+C content, and encoded 2,338 genes. The three Brachyspira species shared 1,087 genes and showed evidence of extensive genome rearrangements. Despite minor differences in predicted protein functional groups, the species had many similar features including core metabolic pathways. Genes distinguishing B. pilosicoli from B. hyodysenteriae included those for a previously undescribed bacteriophage that may be useful for genetic manipulation, for a glycine reductase complex allowing use of glycine whilst protecting from oxidative stress, and for aconitase and related enzymes in the incomplete TCA cycle, allowing glutamate synthesis and function of the cycle during oxidative stress. B. pilosicoli had substantially fewer methyl-accepting chemotaxis genes than B. hyodysenteriae and hence these species are likely to have different chemotactic responses that may help to explain their different host range and colonization sites. B. pilosicoli lacked the gene for a new putative hemolysin identified in B. hyodysenteriae WA1. Both B. pilosicoli and B. murdochii lacked the rfbBADC gene cluster found on the B. hyodysenteriae plasmid, and hence were predicted to have different lipooligosaccharide structures. Overall, B. pilosicoli 95/1000 had a variety of genes potentially contributing to virulence. Conclusions/Significance: The availability of the complete genome sequence of B. pilosicoli 95/1000 will facilitate functional genomics studies aimed at elucidating host-pathogen interactions and virulence.	[Wanchanthuek, Phatthanaphong; Bellgard, Matthew I.; Ryan, Karon; Moolhuijzen, Paula; Chapman, Brett; Black, Michael; Schibeci, David; Hunter, Adam; Barrero, Roberto] Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia; [Wanchanthuek, Phatthanaphong] Mahasarakham Univ, Fac Informat, Maha Sarakham, Thailand; [La, Tom; Phillips, Nyree D.; Hampson, David J.] Murdoch Univ, Sch Vet & Biomed Sci, Anim Res Inst, Perth, WA, Australia	Murdoch University; Mahasarakham University; Murdoch University	Wanchanthuek, P (corresponding author), Murdoch Univ, Ctr Comparat Genom, Perth, WA, Australia.	d.hampson@murdoch.edu.au	Hampson, David/AAE-3666-2019; Black, Michael/H-7645-2016; Black, Michael/G-2684-2010; Hampson, David J/A-9464-2008	Black, Michael/0000-0002-7182-0714; Hampson, David J/0000-0002-7729-0427; Barrero, Roberto/0000-0002-7735-665X; Bellgard, Matthew/0000-0002-6303-9469	Australian Research Council; Novartis [LP0348441]; Western Australian Government; Mahasarakham University	Australian Research Council(Australian Research Council); Novartis(Novartis); Western Australian Government; Mahasarakham University	This study was supported by the Australian Research Council and Novartis Animal Vaccines through Linkage grant number LP0348441 for genomic sequencing and comparative genomic analysis for animal bacterial vaccine discovery, the Western Australian Government in establishment of the WA Centre of Excellence for Comparative Genomics and for support for this project, and the Mahasarakham University Research Affairs Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREESEN JR, 1994, ANTON LEEUW INT J G, V66, P223, DOI 10.1007/BF00871641; Bellgard MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004641; Boye M, 2001, VET MICROBIOL, V81, P33, DOI 10.1016/S0378-1135(01)00328-5; DALE MP, 1986, BIOCHEMISTRY-US, V25, P2522, DOI 10.1021/bi00357a036; Eckardt NA, 2001, PLANT CELL, V13, P723; FELLSTROM C, 1995, RES VET SCI, V59, P1, DOI 10.1016/0034-5288(95)90021-7; FUKUNAGA M, 1990, MICROBIOL IMMUNOL, V34, P565, DOI 10.1111/j.1348-0421.1990.tb01033.x; FUKUNAGA M, 1992, MICROBIOL IMMUNOL, V36, P161, DOI 10.1111/j.1348-0421.1992.tb01653.x; Graentzdoerffer A, 2001, ARCH MICROBIOL, V175, P8, DOI 10.1007/s002030000232; GREER JM, 1989, INFECT IMMUN, V57, P717, DOI 10.1128/IAI.57.3.717-723.1989; HALTER MR, 1988, INFECT IMMUN, V56, P3152, DOI 10.1128/IAI.56.12.3152-3156.1988; Hampson DJ, 2006, INT J SYST EVOL MICR, V56, P1009, DOI 10.1099/ijs.0.64004-0; Hampson DJ, 2006, EMERG INFECT DIS, V12, P869, DOI 10.3201/eid1205.051180; Hampson DJ, 1999, AUST VET J, V77, P48, DOI 10.1111/j.1751-0813.1999.tb12430.x; Hampson DJ, 2000, VET MICROBIOL, V73, P75, DOI 10.1016/S0378-1135(99)00200-X; Hellman J, 2002, J BIOL CHEM, V277, P14274, DOI 10.1074/jbc.M109696200; Hsu T, 2001, INFECT IMMUN, V69, P706, DOI 10.1128/IAI.69.2.706-711.2001; Humphrey SB, 1997, J BACTERIOL, V179, P323, DOI 10.1128/jb.179.2.323-329.1997; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; Jensen TK, 2010, VET PATHOL, V47, P334, DOI 10.1177/0300985809359054; JOENS LA, 1985, AM J VET RES, V46, P2369; Juliao PC, 2007, J BACTERIOL, V189, P4994, DOI 10.1128/JB.00146-07; KEENLEYSIDE WJ, 1994, MOL MICROBIOL, V11, P437, DOI 10.1111/j.1365-2958.1994.tb00325.x; Kilic AO, 2004, J BACTERIOL, V186, P4246, DOI 10.1128/JB.186.13.4246-4253.2004; KUNKLE RA, 1986, J CLIN MICROBIOL, V24, P669, DOI 10.1128/JCM.24.4.669-671.1986; Lee BJ, 1999, J MED MICROBIOL, V48, P411, DOI 10.1099/00222615-48-4-411; LEE JI, 1992, EPIDEMIOL INFECT, V109, P133; LEE JI, 1993, J CLIN MICROBIOL, V31, P16, DOI 10.1128/JCM.31.1.16-21.1993; Li CH, 2010, J BACTERIOL, V192, P2596, DOI 10.1128/JB.01502-09; Lichtensteiger CA, 1997, FEMS MICROBIOL LETT, V152, P269, DOI 10.1111/j.1574-6968.1997.tb10438.x; Little JW, 2005, PHAGES THEIR ROLES B, V1st, P37; Margawani KR, 2004, J MED MICROBIOL, V53, P325, DOI 10.1099/jmm.0.05415-0; Matson EG, 2007, ANAEROBE, V13, P89, DOI 10.1016/j.anaerobe.2007.04.004; McCaman MT, 2003, MICROBES INFECT, V5, P1, DOI 10.1016/S1286-4579(02)00048-5; Moeder W, 2007, PLANT MOL BIOL, V63, P273, DOI 10.1007/s11103-006-9087-x; Motro Y, 2008, MICROBIOL INSIGHTS, V1, P1; Motro Y, 2009, VET MICROBIOL, V134, P340, DOI 10.1016/j.vetmic.2008.09.051; Movahedi A, 2008, VET MICROBIOL, V131, P1, DOI 10.1016/j.vetmic.2008.02.011; Muniappa N, 1997, FEMS MICROBIOL LETT, V154, P159, DOI 10.1111/j.1574-6968.1997.tb12638.x; Munshi MA, 2004, EPIDEMIOL INFECT, V132, P137, DOI 10.1017/S095026880300116X; Naresh R, 2010, MICROBIOL-SGM, V156, P191, DOI 10.1099/mic.0.030262-0; Naresh R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008352; Nelson EJ, 2009, EMERG INFECT DIS, V15, P571, DOI 10.3201/eid1504.081214; NUESSEN ME, 1983, J IMMUNOL, V131, P997; Ochiai S, 1997, MICROBIOL IMMUNOL, V41, P445, DOI 10.1111/j.1348-0421.1997.tb01877.x; Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07; Oxberry SL, 1998, EPIDEMIOL INFECT, V121, P219, DOI 10.1017/S0950268898008863; PALMER RE, 1972, J BIOL CHEM, V247, P3420; Paster BJ, 2000, J MOL MICROB BIOTECH, V2, P341; Picardeau M, 1999, MOL MICROBIOL, V32, P437, DOI 10.1046/j.1365-2958.1999.01368.x; PIOTROWSKI J, 1991, BIOCHEM INT, V24, P749; Podkopaeva D. A., 2003, Mikrobiologiya, V72, P600; RodriguezHerva JJ, 1996, J BACTERIOL, V178, P1699, DOI 10.1128/jb.178.6.1699-1706.1996; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SCHWARTZ JJ, 1992, J BACTERIOL, V174, P3757, DOI 10.1128/JB.174.11.3757-3765.1992; Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998; Somerville G, 1999, J BACTERIOL, V181, P1072, DOI 10.1128/JB.181.4.1072-1078.1999; Somerville GA, 2002, INFECT IMMUN, V70, P6373, DOI 10.1128/IAI.70.11.6373-6382.2002; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920; Stanton TB, 1997, INT J SYST BACTERIOL, V47, P1007, DOI 10.1099/00207713-47-4-1007; Stanton TB, 2006, PROKARYOTES, V7, P330; Tamames J, 2001, GENOME BIOL, V2; TERHUURNE AAHM, 1995, VET MICROBIOL, V46, P347, DOI 10.1016/0378-1135(95)00049-G; Trivett-Moore NL, 1998, J CLIN MICROBIOL, V36, P261, DOI 10.1128/JCM.36.1.261-265.1998; Trott Darren J., 2001, Animal Health Research Reviews, V2, P19; Trott DJ, 1997, J CLIN MICROBIOL, V35, P482, DOI 10.1128/JCM.35.2.482-485.1997; Trott DJ, 1997, EPIDEMIOL INFECT, V119, P369, DOI 10.1017/S0950268897008194; Trott DJ, 1996, INFECT IMMUN, V64, P4648, DOI 10.1128/IAI.64.11.4648-4654.1996; Trott DJ, 1998, INT J SYST BACTERIOL, V48, P659, DOI 10.1099/00207713-48-3-659; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Wang G, 1999, MICROBIOL-SGM, V145, P3245, DOI 10.1099/00221287-145-11-3245; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang Y, 2008, GENETICS, V180, P391, DOI 10.1534/genetics.108.087981; Weissenbock H, 2005, VET MICROBIOL, V111, P67, DOI 10.1016/j.vetmic.2005.09.002; WHITFIELD C, 1995, TRENDS MICROBIOL, V3, P178, DOI 10.1016/S0966-842X(00)88917-9; Wildschutte H, 2004, P NATL ACAD SCI USA, V101, P10644, DOI 10.1073/pnas.0404028101; Wilson K, 1990, CURRENT PROTOCOLS MO, P241; Zuerner RL, 2004, ANAEROBE, V10, P229, DOI 10.1016/j.anaerobe.2004.05.002; ZUERNER RL, 1993, J BACTERIOL, V175, P5445, DOI 10.1128/JB.175.17.5445-5451.1993; ZUERNER RL, 1994, J BACTERIOL, V176, P1087, DOI 10.1128/JB.176.4.1087-1092.1994	82	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11455	10.1371/journal.pone.0011455	http://dx.doi.org/10.1371/journal.pone.0011455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625514	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500020
J	Gambino, F; Khelfaoui, M; Poulain, B; Bienvenu, T; Chelly, J; Humeau, Y				Gambino, Frederic; Khelfaoui, Malik; Poulain, Bernard; Bienvenu, Thierry; Chelly, Jamel; Humeau, Yann			Synaptic Maturation at Cortical Projections to the Lateral Amygdala in a Mouse Model of Rett Syndrome	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PYRAMIDAL NEURONS; CONDITIONED FEAR; PRESYNAPTIC LTP; MUTANT MICE; CYCLIC-AMP; MECP2; EXPRESSION; PLASTICITY; BRAIN	Rett syndrome (RTT) is a neuro-developmental disorder caused by loss of function of Mecp2 - methyl-CpG-binding protein 2 - an epigenetic factor controlling DNA transcription. In mice, removal of Mecp2 in the forebrain recapitulates most of behavioral deficits found in global Mecp2 deficient mice, including amygdala-related hyper-anxiety and lack of social interaction, pointing a role of Mecp2 in emotional learning. Yet very little is known about the establishment and maintenance of synaptic function in the adult amygdala and the role of Mecp2 in these processes. Here, we performed a longitudinal examination of synaptic properties at excitatory projections to principal cells of the lateral nucleus of the amygdala (LA) in Mecp2 mutant mice and their wild-type littermates. We first show that during animal life, Cortico-LA projections switch from a tonic to a phasic mode, whereas Thalamo-LA synapses are phasic at all ages. In parallel, we observed a specific elimination of Cortico-LA synapses and a decrease in their ability of generating presynaptic long term potentiation. In absence of Mecp2, both synaptic maturation and synaptic elimination were exaggerated albeit still specific to cortical projections. Surprisingly, associative LTP was unaffected at Mecp2 deficient synapses suggesting that synaptic maintenance rather than activity-dependent synaptic learning may be causal in RTT physiopathology. Finally, because the timing of synaptic evolution was preserved, we propose that some of the developmental effects of Mecp2 may be exerted within an endogenous program and restricted to synapses which maturate during animal life.	[Gambino, Frederic; Khelfaoui, Malik; Poulain, Bernard; Humeau, Yann] CNRS UPR 3212, Inst Neurosci Cellulaires & Integrat, Strasbourg, France; [Gambino, Frederic; Khelfaoui, Malik; Poulain, Bernard; Humeau, Yann] Univ Strasbourg, Strasbourg, France; [Khelfaoui, Malik; Bienvenu, Thierry; Chelly, Jamel] CHU Cochin, CNRS, UMR 8104, Inst Cochin,INSERM,U567, Paris, France; [Khelfaoui, Malik; Humeau, Yann] CNRS, UMR 5091, Bordeaux, France; [Khelfaoui, Malik; Humeau, Yann] Univ Bordeaux 2, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Gambino, F (corresponding author), CMU, Dept Neurosci Fondamentales, Geneva, Switzerland.	bodabour@gmail.com	Chelly, Jamel/J-7528-2015	Chelly, Jamel/0000-0002-0939-8719; gambino, frederic/0000-0002-2981-5030	Agence Nationale pour la Recherche; European Neuroscience Institutes Network; ATIP program	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Neuroscience Institutes Network(European Commission); ATIP program	This study was supported by grants from the Agence Nationale pour la Recherche (YH, JC), the European Neuroscience Institutes Network (YH) and the ATIP program (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2009, J NEUROSCI, V29, P4218, DOI 10.1523/JNEUROSCI.4225-08.2009; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Bauer EP, 2004, J NEUROSCI, V24, P9507, DOI 10.1523/JNEUROSCI.3567-04.2004; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Castro-Alamancos MA, 1999, J NEUROSCI, V19, P9090, DOI 10.1523/JNEUROSCI.19-20-09090.1999; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Dani VS, 2009, J NEUROSCI, V29, P11263, DOI 10.1523/JNEUROSCI.1019-09.2009; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Fourcaudot E, 2009, NAT NEUROSCI, V12, P1093, DOI 10.1038/nn.2378; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Frick A, 2007, J PHYSIOL-LONDON, V585, P103, DOI 10.1113/jphysiol.2007.141788; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Humeau Y, 2007, J NEUROSCI, V27, P10947, DOI 10.1523/JNEUROSCI.2603-07.2007; Ito W, 2009, LEARN MEMORY, V16, P187, DOI 10.1101/lm.1190809; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lopez de Armentia M, 2007, J PHYSIOL-LONDON, V581, P961, DOI 10.1113/jphysiol.2007.101822; Mahanty NK, 1999, EUR J NEUROSCI, V11, P1217, DOI 10.1046/j.1460-9568.1999.00528.x; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Monteggia LM, 2009, BIOL PSYCHIAT, V65, P204, DOI 10.1016/j.biopsych.2008.10.036; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Pan BX, 2009, BIOL PSYCHIAT, V66, P964, DOI 10.1016/j.biopsych.2009.07.006; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009; Sun YE, 2006, NEURON, V49, P321, DOI 10.1016/j.neuron.2006.01.014; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wang H, 2006, J NEUROSCI, V26, P10911, DOI 10.1523/JNEUROSCI.1810-06.2006; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701	50	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11399	10.1371/journal.pone.0011399	http://dx.doi.org/10.1371/journal.pone.0011399			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625482	Green Published, gold, Green Submitted			2022-12-27	WOS:000279465700003
J	Kantelhardt, SR; Caarls, W; de Vries, AHB; Hagen, GM; Jovin, TM; Schulz-Schaeffer, W; Rohde, V; Giese, A; Arndt-Jovin, DJ				Kantelhardt, Sven R.; Caarls, Wouter; de Vries, Anthony H. B.; Hagen, Guy M.; Jovin, Thomas M.; Schulz-Schaeffer, Walter; Rohde, Veit; Giese, Alf; Arndt-Jovin, Donna J.			Specific Visualization of Glioma Cells in Living Low-Grade Tumor Tissue	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MEDIATED SIGNAL-TRANSDUCTION; QUANTUM DOTS; GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; MALIGNANT GLIOMA; BRAIN-TUMORS; FLUORESCENCE; SURVIVAL; EXPRESSION	Background: The current therapy of malignant gliomas is based on surgical resection, radio-chemotherapy and chemotherapy. Recent retrospective case-series have highlighted the significance of the extent of resection as a prognostic factor predicting the course of the disease. Complete resection in low-grade gliomas that show no MRI-enhanced images are especially difficult. The aim in this study was to develop a robust, specific, new fluorescent probe for glioma cells that is easy to apply to live tumor biopsies and could identify tumor cells from normal brain cells at all levels of magnification. Methodology/Principal Findings: In this investigation we employed brightly fluorescent, photostable quantum dots (QDs) to specifically target epidermal growth factor receptor (EGFR) that is upregulated in many gliomas. Living glioma and normal cells or tissue biopsies were incubated with QDs coupled to EGF and/or monoclonal antibodies against EGFR for 30 minutes, washed and imaged. The data include results from cell-culture, animal model and ex vivo human tumor biopsies of both low-grade and high-grade gliomas and show high probe specificity. Tumor cells could be visualized from the macroscopic to single cell level with contrast ratios as high as 1000: 1 compared to normal brain tissue. Conclusions/Significance: The ability of the targeted probes to clearly distinguish tumor cells in low-grade tumor biopsies, where no enhanced MRI image was obtained, demonstrates the great potential of the method. We propose that future application of specifically targeted fluorescent particles during surgery could allow intraoperative guidance for the removal of residual tumor cells from the resection cavity and thus increase patient survival.	[Kantelhardt, Sven R.; Rohde, Veit; Giese, Alf] Univ Gottingen, Dept Neurosurg, Gottingen, Germany; [Caarls, Wouter; de Vries, Anthony H. B.; Hagen, Guy M.; Jovin, Thomas M.; Arndt-Jovin, Donna J.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany; [Schulz-Schaeffer, Walter] Univ Gottingen, Dept Neuropathol, Gottingen, Germany	University of Gottingen; Max Planck Society; University of Gottingen	Kantelhardt, SR (corresponding author), Univ Gottingen, Dept Neurosurg, Gottingen, Germany.	djovin@gwdg.de	Caarls, Wouter/N-9746-2018	Caarls, Wouter/0000-0001-9069-2378; Hagen, Guy/0000-0002-4802-9481	Head and Neck Cancer Research Foundation, Wiesbaden, Germany; EU [037465]; Novartis foundation for therapeutical research, Erlangen, Germany	Head and Neck Cancer Research Foundation, Wiesbaden, Germany; EU(European Commission); Novartis foundation for therapeutical research, Erlangen, Germany	This study was supported by the Head and Neck Cancer Research Foundation, Wiesbaden, Germany and the EU FP6 STREP FLUOROMAG project #037465. S.R.K. was the recipient of a stipend from the Novartis foundation for therapeutical research, Erlangen, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt-Jovin DJ, 2009, IEEE T NANOBIOSCI, V8, P65, DOI 10.1109/TNB.2009.2016548; ARNDTJOVIN DJ, 2006, P SPIE, V6096; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Cambi A, 2007, NANO LETT, V7, P970, DOI 10.1021/nl0700503; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Delamarre E, 2009, AM J PATHOL, V175, P844, DOI 10.2353/ajpath.2009.080920; Echarte MM, 2007, FEBS LETT, V581, P2905, DOI 10.1016/j.febslet.2007.05.041; Franco-Hernandez C, 2007, INT J ONCOL, V30, P209; HAGEN GM, 2007, P SPIE, V6441; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Heintzmann R, 2001, J MICROSC-OXFORD, V204, P119, DOI 10.1046/j.1365-2818.2001.00945.x; Huang PH, 2007, P NATL ACAD SCI USA, V104, P12867, DOI 10.1073/pnas.0705158104; Kantelhardt SR, 2008, LASER SURG MED, V40, P273, DOI 10.1002/lsm.20623; Lang FF, 2006, J CLIN ONCOL, V24, P1236, DOI 10.1200/JCO.2005.05.2399; Lidke DS, 2004, PHYSIOLOGY, V19, P322, DOI 10.1152/physiol.00030.2004; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Mariani L, 2001, J NEURO-ONCOL, V53, P161, DOI 10.1023/A:1012253317934; Mauro A, 1990, J Neurosurg Sci, V34, P171; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; MIYANAGA T, 2007, NEUROPATHOLOGY, V6, P6; Nakamura JL, 2007, EXPERT OPIN THER TAR, V11, P463, DOI 10.1517/14728222.11.4.463; Necesalova E, 2007, NEOPLASMA, V54, P212; Nguyen QT, 2010, P NATL ACAD SCI USA, V107, P4317, DOI 10.1073/pnas.0910261107; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Parsons DW, 2008, SCIENCE; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Rebetz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001936; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Smith AM, 2006, ANN BIOMED ENG, V34, P3, DOI 10.1007/s10439-005-9000-9; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2006, ONCOLOGIST, V11, P165, DOI 10.1634/theoncologist.11-2-165; Tang P, 1997, J NEURO-ONCOL, V35, P303, DOI 10.1023/A:1005824802617; Thorarinsdottir HK, 2008, CLIN CANCER RES, V14, P3386, DOI 10.1158/1078-0432.CCR-07-1616; WESTPHAL M, 1988, CANCER RES, V48, P731; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang XM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/9/095601	39	31	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11323	10.1371/journal.pone.0011323	http://dx.doi.org/10.1371/journal.pone.0011323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614029	gold, Green Published, Green Submitted			2022-12-27	WOS:000279370000006
J	Swant, J; Chirwa, S; Stanwood, G; Khoshbouei, H				Swant, Jarod; Chirwa, Sanika; Stanwood, Gregg; Khoshbouei, Habibeh			Methamphetamine Reduces LTP and Increases Baseline Synaptic Transmission in the CA1 Region of Mouse Hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; D-5 DOPAMINE-RECEPTORS; RAT HIPPOCAMPUS; IN-VITRO; INTRAVENOUS METHAMPHETAMINE; METABOLITE AMPHETAMINE; AREA CA1; SLICE PREPARATION; 5-HT1A RECEPTORS; SEEKING BEHAVIOR	Methamphetamine (METH) is an addictive psychostimulant whose societal impact is on the rise. Emerging evidence suggests that psychostimulants alter synaptic plasticity in the brain-which may partly account for their adverse effects. While it is known that METH increases the extracellular concentration of monoamines dopamine, serotonin, and norepinephrine, it is not clear how METH alters glutamatergic transmission. Within this context, the aim of the present study was to investigate the effects of acute and systemic METH on basal synaptic transmission and long-term potentiation (LTP; an activity-induced increase in synaptic efficacy) in CA1 sub-field in the hippocampus. Both the acute ex vivo application of METH to hippocampal slices and systemic administration of METH decreased LTP. Interestingly, the acute ex vivo application of METH at a concentration of 30 or 60 mu M increased baseline synaptic transmission as well as decreased LTP. Pretreatment with eticlopride (D2-like receptor antagonist) did not alter the effects of METH on synaptic transmission or LTP. In contrast, pretreatment with D1/D5 dopamine receptor antagonist SCH23390 or 5-HT1A receptor antagonist NAN-190 abrogated the effect of METH on synaptic transmission. Furthermore, METH did not increase baseline synaptic transmission in D1 dopamine receptor haploinsufficient mice. Our findings suggest that METH affects excitatory synaptic transmission via activation of dopamine and serotonin receptor systems in the hippocampus. This modulation may contribute to synaptic maladaption induced by METH addiction and/or METH-mediated cognitive dysfunction.	[Swant, Jarod; Chirwa, Sanika; Khoshbouei, Habibeh] Meharry Med Coll, Nashville, TN 37208 USA; [Swant, Jarod; Chirwa, Sanika; Stanwood, Gregg; Khoshbouei, Habibeh] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Stanwood, Gregg] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN USA	Meharry Medical College; Vanderbilt University; Vanderbilt University	Swant, J (corresponding author), Meharry Med Coll, Nashville, TN 37208 USA.	hkhoshbouei@mmc.edu		Stanwood, Gregg/0000-0001-6005-1203; Khoshbouei, Habibeh/0000-0002-1533-8771	National Science Foundation [IOS-0642188]; National Institutes of Health [DA026947, DA021471, T32 HL076133]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R24DA021471, R01DA026947] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Science Foundation (IOS-0642188), and the National Institutes of Health (DA026947, DA021471). Jarod Swant was supported by NIH training grant T32 HL076133. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen P, 1977, Ciba Found Symp, P87; Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brady AM, 2008, PSYCHOPHARMACOLOGY, V200, P205, DOI 10.1007/s00213-008-1195-7; BRIEN JF, 1978, RES COMMUN CHEM PATH, V22, P313; Brown PL, 2003, J NEUROSCI, V23, P3924; BURN JH, 1958, J PHYSIOL-LONDON, V144, P314, DOI 10.1113/jphysiol.1958.sp006104; Cadet JL, 2005, NEUROTOX RES, V8, P199, DOI 10.1007/BF03033973; Chambers RA, 2002, NEUROPSYCHOPHARMACOL, V27, P889, DOI 10.1016/S0893-133X(02)00365-2; Chirwa S, 2005, BRAIN RES BULL, V64, P433, DOI 10.1016/j.brainresbull.2004.09.012; Cho AK, 2001, SYNAPSE, V39, P161, DOI 10.1002/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COOK CE, 1993, DRUG METAB DISPOS, V21, P717; COOK CE, 1992, DRUG METAB DISPOS, V20, P856; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Cooper D., 2005, Morbidity and Mortality Weekly Report, V54, P356; Cragg SJ, 2004, TRENDS NEUROSCI, V27, P270, DOI 10.1016/j.tins.2004.03.011; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; Cruickshank CC, 2009, ADDICTION, V104, P1085, DOI 10.1111/j.1360-0443.2009.02564.x; Del Olmo N, 2006, ANN NY ACAD SCI, V1074, P427, DOI 10.1196/annals.1369.043; del Olmo N, 2006, BRAIN RES, V1116, P120, DOI 10.1016/j.brainres.2006.07.001; DRAGO J, 1994, P NATL ACAD SCI USA, V91, P12564, DOI 10.1073/pnas.91.26.12564; ECKERT R, 1977, P NATL ACAD SCI USA, V74, P1748, DOI 10.1073/pnas.74.4.1748; El-Ghundi M, 1998, EUR J PHARMACOL, V353, P149, DOI 10.1016/S0014-2999(98)00414-2; Foster T C, 1991, Hippocampus, V1, P79, DOI 10.1002/hipo.450010108; Fowler JS, 2008, NEUROIMAGE, V43, P756, DOI 10.1016/j.neuroimage.2008.07.020; FREY U, 1991, NEUROSCI LETT, V129, P111, DOI 10.1016/0304-3940(91)90732-9; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Guan X, 2009, NEUROSCIENCE, V161, P665, DOI 10.1016/j.neuroscience.2009.04.035; HERRON CE, 1985, NEUROSCI LETT, V60, P19, DOI 10.1016/0304-3940(85)90375-1; Hollon TR, 2002, J NEUROSCI, V22, P10801, DOI 10.1523/jneurosci.22-24-10801.2002; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; JAHNSEN H, 1980, BRAIN RES, V197, P83, DOI 10.1016/0006-8993(80)90436-9; KAIYA H, 1983, FOLIA PSYCHIAT NEU J, V37, P107; Kalueff AV, 2007, TRENDS PHARMACOL SCI, V28, P122, DOI 10.1016/j.tips.2007.01.002; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Kimura T, 2004, ANN NY ACAD SCI, V1025, P242, DOI 10.1196/annals.1316.030; Kojima T, 2003, BRAIN RES, V959, P165, DOI 10.1016/S0006-8993(02)03756-3; Lan KC, 1998, J FORMOS MED ASSOC, V97, P528; LOY R, 1980, J COMP NEUROL, V189, P699, DOI 10.1002/cne.901890406; MALENKA RC, 1991, NEURON, V6, P53, DOI 10.1016/0896-6273(91)90121-F; MELEGA WP, 1995, J PHARMACOL EXP THER, V274, P90; Mockett BG, 2004, BRAIN RES, V1021, P92, DOI 10.1016/j.brainres.2004.06.039; Montague DM, 2001, SYNAPSE, V39, P319, DOI 10.1002/1098-2396(20010315)39:4<319::AID-SYN1015>3.0.CO;2-1; Moriguchi S, 2002, EXP BRAIN RES, V144, P238, DOI 10.1007/s00221-002-1039-3; NASH JF, 1992, BRAIN RES, V581, P237, DOI 10.1016/0006-8993(92)90713-J; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Newton TF, 2005, PHARMACOL BIOCHEM BE, V82, P704, DOI 10.1016/j.pbb.2005.11.012; Nicola SM, 1996, J NEUROSCI, V16, P1591; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Nishioku T, 1999, NEUROSCI LETT, V268, P81, DOI 10.1016/S0304-3940(99)00386-9; O'Neil ML, 2006, SYNAPSE, V60, P465, DOI 10.1002/syn.20320; Onaivi ES, 2002, ANN NY ACAD SCI, V965, P28; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Pugliese AM, 1998, BRIT J PHARMACOL, V124, P93; Ricoy UM, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.047.2009; Riviere GJ, 1999, J PHARMACOL EXP THER, V291, P1220; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Rogers JL, 2007, NEUROBIOL LEARN MEM, V87, P688, DOI 10.1016/j.nlm.2007.01.003; SAMHSA, 2007, OAS SER S, V40; SCATTON B, 1980, NEUROSCI LETT, V18, P125, DOI 10.1016/0304-3940(80)90314-6; SCHMITZ D, 1995, J NEUROSCI, V15, P7217; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SCHOBER W, 1991, J HIRNFORSCH, V32, P409; SCHWARTZKROIN PA, 1975, BRAIN RES, V85, P423, DOI 10.1016/0006-8993(75)90817-3; SCHWARTZKROIN PA, 1977, BRAIN RES, V128, P53, DOI 10.1016/0006-8993(77)90235-9; SCHWARTZKROIN PA, 1975, BRAIN RES, V89, P107, DOI 10.1016/0006-8993(75)90138-9; Segal DS, 2005, PSYCHOPHARMACOLOGY, V180, P501, DOI 10.1007/s00213-005-2188-4; SEGAL M, 1980, J PHYSIOL-LONDON, V303, P423, DOI 10.1113/jphysiol.1980.sp013297; SHTARK MB, 1976, J NEUROBIOL, V7, P551, DOI 10.1002/neu.480070608; SMITH DA, 1993, BRAIN RES, V608, P259, DOI 10.1016/0006-8993(93)91466-6; Stanwood GD, 2005, J COMP NEUROL, V487, P270, DOI 10.1002/cne.20548; STEPHANS SE, 1994, SYNAPSE, V17, P203, DOI 10.1002/syn.890170310; Stramiello M, 2008, NEUROPHARMACOLOGY, V55, P871, DOI 10.1016/j.neuropharm.2008.06.053; STRINGER JL, 1983, BRAIN RES, V280, P127, DOI 10.1016/0006-8993(83)91180-0; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Sun WL, 2003, J NEUROSCI, V23, P10258; Swant J, 2006, LEARN MEMORY, V13, P161, DOI 10.1101/lm.63806; SWANT J, 2009, SOC NEUR M; Thompson AM, 2005, NEUROPHARMACOLOGY, V49, P185, DOI 10.1016/j.neuropharm.2005.03.005; Thompson AM, 2004, NEUROSCIENCE, V127, P177, DOI 10.1016/j.neuroscience.2004.05.001; Thompson AM, 2002, NEUROPHARMACOLOGY, V42, P1039, DOI 10.1016/S0028-3908(02)00059-X; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Williams S, 2006, NEUROSCI LETT, V402, P46, DOI 10.1016/j.neulet.2006.03.075; Zombeck JA, 2009, PSYCHOPHARMACOLOGY, V201, P589, DOI 10.1007/s00213-008-1327-0; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	92	41	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11382	10.1371/journal.pone.0011382	http://dx.doi.org/10.1371/journal.pone.0011382			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614033	Green Published, Green Submitted, gold			2022-12-27	WOS:000279370000012
J	Gregson, AL; Hoji, A; Palchevskiy, V; Hu, S; Weigt, SS; Liao, E; Derhovanessian, A; Saggar, R; Song, S; Elashoff, R; Yang, OO; Belperio, JA				Gregson, Aric L.; Hoji, Aki; Palchevskiy, Vyacheslav; Hu, Scott; Weigt, S. Samuel; Liao, Eileen; Derhovanessian, Ariss; Saggar, Rajeev; Song, Sophie; Elashoff, Robert; Yang, Otto O.; Belperio, John A.			Protection against Bronchiolitis Obliterans Syndrome Is Associated with Allograft CCR7(+)CD45RA(-) T Regulatory Cells	PLOS ONE			English	Article							MINIMAL ACUTE REJECTION; LUNG-TRANSPLANTATION; HEART-LUNG; RECEPTOR EXPRESSION; NAIVE-LIKE; MIGRATION; SURVIVAL; CCR4; DYSFUNCTION; RECIPIENTS	Bronchiolitis obliterans syndrome (BOS) is the major obstacle to long-term survival after lung transplantation, yet markers for early detection and intervention are currently lacking. Given the role of regulatory T cells (Treg) in modulation of immunity, we hypothesized that frequencies of Treg in bronchoalveolar lavage fluid (BALF) after lung transplantation would predict subsequent development of BOS. Seventy BALF specimens obtained from 47 lung transplant recipients were analyzed for Treg lymphocyte subsets by flow cytometry, in parallel with ELISA measurements of chemokines. Allograft biopsy tissue was stained for chemokines of interest. Treg were essentially all CD45RA(-), and total Treg frequency did not correlate to BOS outcome. The majority of Treg were CCR4(+) and CD103(-) and neither of these subsets correlated to risk for BOS. In contrast, higher percentages of CCR7(+) Treg correlated to reduced risk of BOS. Additionally, the CCR7 ligand CCL21 correlated with CCR7(+) Treg frequency and inversely with BOS. Higher frequencies of CCR7(+) CD3(+)CD4(+)CD25(hi)Foxp3(+)CD45RA(-) 2 lymphocytes in lung allografts is associated with protection against subsequent development of BOS, suggesting that this subset of putative Treg may down-modulate alloimmunity. CCL21 may be pivotal for the recruitment of this distinct subset to the lung allograft and thereby decrease the risk for chronic rejection.	[Gregson, Aric L.; Yang, Otto O.] Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA; [Hoji, Aki; Yang, Otto O.] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA USA; [Palchevskiy, Vyacheslav; Hu, Scott; Weigt, S. Samuel; Derhovanessian, Ariss; Saggar, Rajeev; Belperio, John A.] Univ Calif Los Angeles, Dept Med, Div Pulm & Crit Care, Los Angeles, CA 90024 USA; [Liao, Eileen; Elashoff, Robert] Univ Calif Los Angeles, Dept Med, Dept Biomath Biostat, Los Angeles, CA 90024 USA; [Song, Sophie] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Yang, Otto O.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Gregson, AL (corresponding author), Univ Calif Los Angeles, Dept Med, Div Infect Dis, Los Angeles, CA 90024 USA.	a.gregson@ucla.edu		Gregson, Aric/0000-0001-6806-0868	National Institutes of Health [HL080206, HL086491]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080206, K23HL102220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health grants HL080206 and HL086491 to JAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Githmi I, 2006, EUR J CARDIO-THORAC, V30, P846, DOI 10.1016/j.ejcts.2006.09.027; Allakhverdi Z, 2006, J ALLERGY CLIN IMMUN, V118, P1342, DOI 10.1016/j.jaci.2006.07.034; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Belperio JA, 2005, J CLIN INVEST, V115, P1150, DOI 10.1172/JCI200524233; Benghiat FS, 2005, TRANSPLANTATION, V79, P648, DOI 10.1097/01.TP.0000155179.61445.78; Bharat A, 2006, AM J TRANSPLANT, V6, P1799, DOI 10.1111/j.1600-6143.2006.01383.x; Bharat A, 2007, TRANSPLANTATION, V83, P150, DOI 10.1097/01.tp.0000250579.08042.b6; Burton CM, 2007, J HEART LUNG TRANSPL, V26, P681, DOI 10.1016/j.healun.2007.04.004; CERFBENSUSSAN N, 1987, EUR J IMMUNOL, V17, P1279, DOI 10.1002/eji.1830170910; Chalermskulrat W, 2003, CHEST, V123, P1825, DOI 10.1378/chest.123.6.1825; Christie JD, 2005, AM J RESP CRIT CARE, V171, P1312, DOI 10.1164/rccm.200409-1243OC; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Colovai AI, 2003, HUM IMMUNOL, V64, P31, DOI 10.1016/S0198-8859(02)00742-5; Daud SA, 2007, AM J RESP CRIT CARE, V175, P507, DOI 10.1164/rccm.200608-1079OC; ELLIS B, 2010, FLOWVIZ VISUALIZATIO; ELLIS B, 2010, FLOWCORE BASIC STRUC; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; Gregson AL, 2008, TRANSPLANTATION, V85, P1056, DOI 10.1097/TP.0b013e318169bd85; Hachem RR, 2005, TRANSPLANTATION, V80, P1406, DOI 10.1097/01.tp.0000181161.60638.fa; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Iellem A, 2003, EUR J IMMUNOL, V33, P1488, DOI 10.1002/eji.200323658; Jaramillo A, 2005, PEDIATR TRANSPLANT, V9, P84, DOI 10.1111/j.1399-3046.2004.00270.x; Kao J, 2003, CIRCULATION, V107, P1958, DOI 10.1161/01.CIR.0000069270.16498.75; Karim M, 2005, BLOOD, V105, P4871, DOI 10.1182/blood-2004-10-3888; Khalifah AP, 2005, AM J TRANSPLANT, V5, P2022, DOI 10.1111/j.1600-6143.2005.00953.x; Kilshaw PJ, 1999, J CLIN PATHOL-MOL PA, V52, P203, DOI 10.1136/mp.52.4.203; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Lee I, 2005, J EXP MED, V201, P1037, DOI 10.1084/jem.20041709; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Lim HW, 2006, J IMMUNOL, V177, P840, DOI 10.4049/jimmunol.177.2.840; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mizobucbi T, 2003, J IMMUNOL, V171, P1140, DOI 10.4049/jimmunol.171.3.1140; R Core Team, 2020, R LANG ENV STAT COMP; RAMSEY SD, 1995, CHEST, V108, P1594, DOI 10.1378/chest.108.6.1594; Rieger K, 2006, BLOOD, V107, P1717, DOI 10.1182/blood-2005-06-2529; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sarkar D., 2009, LATTICE LATTICE GRAP; Sharples LD, 1996, TRANSPLANTATION, V61, P560, DOI 10.1097/00007890-199602270-00008; Siegmund K, 2005, BLOOD, V106, P3097, DOI 10.1182/blood-2005-05-1864; SUNDARESAN S, 1995, ANN THORAC SURG, V60, P1341, DOI 10.1016/0003-4975(95)00751-6; Trulock EP, 2007, J HEART LUNG TRANSPL, V26, P782, DOI 10.1016/j.healun.2007.06.003; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016; Valentine VG, 1996, J HEART LUNG TRANSPL, V15, P371; Venken K, 2008, IMMUNOLOGY, V123, P79, DOI 10.1111/j.1365-2567.2007.02690.x; Vlad G, 2007, TRANSPL IMMUNOL, V18, P13, DOI 10.1016/j.trim.2007.03.001; Weigt SS, 2008, AM J TRANSPLANT, V8, P1512, DOI 10.1111/j.1600-6143.2008.02280.x; Wilkes DS, 2005, AM J RESP CRIT CARE, V172, P944, DOI 10.1164/rccm.200501-098WS; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022; 2009, HMISC HARRELL MISCEL	52	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11354	10.1371/journal.pone.0011354	http://dx.doi.org/10.1371/journal.pone.0011354			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613873	Green Published, gold, Green Submitted			2022-12-27	WOS:000279369900006
J	Xiao, SQ; Jia, JY; Mo, DL; Wang, QW; Qin, LM; He, ZY; Zhao, XA; Huang, YK; Li, AN; Yu, JW; Niu, YN; Liu, XH; Chen, YS				Xiao, Shuqi; Jia, Jianyu; Mo, Delin; Wang, Qiwei; Qin, Limei; He, Zuyong; Zhao, Xiao; Huang, Yuankai; Li, Anning; Yu, Jingwei; Niu, Yuna; Liu, Xiaohong; Chen, Yaosheng			Understanding PRRSV Infection in Porcine Lung Based on Genome-Wide Transcriptome Response Identified by Deep Sequencing	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; GENE-EXPRESSION ANALYSIS; INNATE IMMUNE-RESPONSES; INFLUENZA-A VIRUS; ALVEOLAR MACROPHAGES; UP-REGULATION; PROINFLAMMATORY CYTOKINES; SIGNALING PATHWAYS; DENDRITIC CELLS; IN-VIVO	Porcine reproductive and respiratory syndrome ( PRRS) has been one of the most economically important diseases affecting swine industry worldwide and causes great economic losses each year. PRRS virus ( PRRSV) replicates mainly in porcine alveolar macrophages (PAMs) and dendritic cells (DCs) and develops persistent infections, antibody-dependent enhancement (ADE), interstitial pneumonia and immunosuppression. But the molecular mechanisms of PRRSV infection still are poorly understood. Here we report on the first genome-wide host transcriptional responses to classical North American type PRRSV (N-PRRSV) strain CH 1a infection using Solexa/Illumina's digital gene expression (DGE) system, a tag-based high-throughput transcriptome sequencing method, and analyse systematically the relationship between pulmonary gene expression profiles after N-PRRSV infection and infection pathology. Our results suggest that N-PRRSV appeared to utilize multiple strategies for its replication and spread in infected pigs, including subverting host innate immune response, inducing an anti-apoptotic and anti-inflammatory state as well as developing ADE. Upregulation expression of virus-induced pro-inflammatory cytokines, chemokines, adhesion molecules and inflammatory enzymes and inflammatory cells, antibodies, complement activation were likely to result in the development of inflammatory responses during N-PRRSV infection processes. N-PRRSV-induced immunosuppression might be mediated by apoptosis of infected cells, which caused depletion of immune cells and induced an anti-inflammatory cytokine response in which they were unable to eradicate the primary infection. Our systems analysis will benefit for better understanding the molecular pathogenesis of N-PRRSV infection, developing novel antiviral therapies and identifying genetic components for swine resistance/susceptibility to PRRS.	[Xiao, Shuqi; Jia, Jianyu; Mo, Delin; Wang, Qiwei; Qin, Limei; He, Zuyong; Zhao, Xiao; Huang, Yuankai; Li, Anning; Yu, Jingwei; Niu, Yuna; Liu, Xiaohong; Chen, Yaosheng] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xiao, SQ (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	chyaosh@mail.sysu.edu.cn	He, Zuyong/AAU-9430-2021	Wang, Qiwei/0000-0003-3897-2529; Chen, Yaosheng/0000-0002-3871-7651; Li, Anning/0000-0001-7695-161X; Mo, Delin/0000-0002-8738-4486	National Natural Science Foundation of China [U0731003]; National Key Basic Research Plan (973 Project) [2006CB102101]; Ministry of National Agricultural Special Public Sector Research [nyhyzx07-034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Plan (973 Project)(National Basic Research Program of China); Ministry of National Agricultural Special Public Sector Research	This research was supported by National Natural Science Foundation of China (Grant No. U0731003) and National Key Basic Research Plan (973 Project) (Grant No. 2006CB102101) and the Ministry of National Agricultural Special Public Sector Research (Grant No. nyhyzx07-034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali T, 2007, VIRAL IMMUNOL, V20, P105, DOI 10.1089/vim.2006.0078; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Albert ML, 2004, NAT REV IMMUNOL, V4, P223, DOI 10.1038/nri11308; Albina E, 1998, J INTERF CYTOK RES, V18, P485, DOI 10.1089/jir.1998.18.485; Albina E, 1997, VET MICROBIOL, V55, P309, DOI 10.1016/S0378-1135(96)01322-3; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barman S, 2007, J VIROL, V81, P12169, DOI 10.1128/JVI.00835-07; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; BEURA LK, 2009, J VIROL; Bowie AG, 2004, J CELL BIOCHEM, V91, P1099, DOI 10.1002/jcb.20026; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Buddaert W, 1998, ADV EXP MED BIOL, V440, P461; Calvert JG, 2007, J VIROL, V81, P7371, DOI 10.1128/JVI.00513-07; CARLSSON U, 2009, TRANSBOUND EMERG DIS; Cavanagh D, 1997, ARCH VIROL, V142, P629; Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019; Chen NH, 2009, J VIROL METHODS, V161, P192, DOI 10.1016/j.jviromet.2009.06.007; Costers S, 2008, ARCH VIROL, V153, P1453, DOI 10.1007/s00705-008-0135-5; Costers S, 2006, J GEN VIROL, V87, P2341, DOI 10.1099/vir.0.81808-0; Dean GA, 2003, VET MICROBIOL, V97, P1, DOI 10.1016/j.vetmic.2003.08.010; Delputte PL, 2007, J INTERF CYTOK RES, V27, P757, DOI 10.1089/jir.2007.0001; Dinarello CA, 2004, J ENDOTOXIN RES, V10, P201, DOI 10.1179/096805104225006129; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Drew TW, 2000, VET RES, V31, P27, DOI 10.1051/vetres:2000055; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Flores-Mendoza L, 2008, CLIN VACCINE IMMUNOL, V15, P720, DOI 10.1128/CVI.00224-07; Frieman M, 2008, VIRUS RES, V133, P101, DOI 10.1016/j.virusres.2007.03.015; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Girard M, 2001, J GEN VIROL, V82, P1253, DOI 10.1099/0022-1317-82-6-1253; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo B., 1996, CHINESE J PREVENTIVE, V2, P1; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hossain H, 2006, CURR OPIN IMMUNOL, V18, P422, DOI 10.1016/j.coi.2006.05.018; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hu ZL, 2005, MAMM GENOME, V16, P792, DOI 10.1007/s00335-005-0060-9; Kash JC, 2006, J VIROL, V80, P3009, DOI 10.1128/JVI.80.6.3009-3020.2006; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Katze MG, 2008, NAT REV IMMUNOL, V8, P644, DOI 10.1038/nri2377; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lee CH, 2004, J IMMUNOL, V172, P7841, DOI 10.4049/jimmunol.172.12.7841; Lee SM, 2007, VIROLOGY, V365, P419, DOI 10.1016/j.virol.2007.04.001; Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Liu MT, 2000, J IMMUNOL, V165, P2327, DOI 10.4049/jimmunol.165.5.2327; Loving CL, 2007, IMMUNOLOGY, V120, P217, DOI 10.1111/j.1365-2567.2006.02493.x; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Masson F, 2010, CELL RES, V20, P1, DOI 10.1038/cr.2010.1; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; McFadden G, 2009, NAT REV IMMUNOL, V9, P645, DOI 10.1038/nri2623; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mi J, 2001, HUM GENE THER, V12, P1343, DOI 10.1089/104303401750270995; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Miller LC, 2008, DEV BIOLOGICALS, V132, P169, DOI 10.1159/000317157; Miller LD, 2002, CANCER CELL, V2, P353, DOI 10.1016/S1535-6108(02)00181-2; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Patton JB, 2009, VIRUS RES, V140, P161, DOI 10.1016/j.virusres.2008.12.002; Perlman S, 2005, NAT REV IMMUNOL, V5, P917, DOI 10.1038/nri1732; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Qiu HJ, 2005, VET IMMUNOL IMMUNOP, V106, P309, DOI 10.1016/j.vetimm.2005.03.008; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Suradhat S, 2003, J GEN VIROL, V84, P2755, DOI 10.1099/vir.0.19230-0; Suradhat S, 2003, J GEN VIROL, V84, P453, DOI 10.1099/vir.0.18698-0; SYED GH, 2009, TRENDS ENDOCRINOL ME; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Tsui PT, 2003, EMERG INFECT DIS, V9, P1064; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Van Gorp H, 2008, J GEN VIROL, V89, P2943, DOI 10.1099/vir.0.2008/005009-0; Van Reeth K, 1999, RES VET SCI, V67, P47, DOI 10.1053/rvsc.1998.0277; Velculescu VE, 2007, NAT BIOTECHNOL, V25, P878, DOI 10.1038/nbt0807-878; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wang X, 2007, ARCH VIROL, V152, P289, DOI 10.1007/s00705-006-0857-1; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007; Yuan SS, 2008, SCI CHINA SER C, V51, P271, DOI 10.1007/s11427-008-0023-y; Zhang XX, 1999, VIROLOGY, V262, P152, DOI 10.1006/viro.1999.9914; Zhou YJ, 2008, TRANSBOUND EMERG DIS, V55, P152, DOI 10.1111/j.1865-1682.2008.01020.x	89	106	117	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11377	10.1371/journal.pone.0011377	http://dx.doi.org/10.1371/journal.pone.0011377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614006	gold, Green Published, Green Submitted			2022-12-27	WOS:000279369900024
J	Kang, YB; Chen, BJ; DeOliveira, D; Mito, J; Chao, NJ				Kang, Yubin; Chen, Benny J.; DeOliveira, Divino; Mito, Jeffrey; Chao, Nelson J.			Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; STEM-CELLS; BONE-MARROW; PROGENITOR CELLS; REPOPULATING CAPACITY; RAPID MOBILIZATION; NOD/SCID MICE; CD34(+) CELLS; G-CSF; PHARMACOKINETICS	The interaction between stromal cell-derived factor-1 (SDF-1) with CXCR4 chemokine receptors plays an important role in hematopoiesis following hematopoietic stem cell transplantation. We examined the efficacy of post transplant administration of a specific CXCR4 antagonist (AMD3100) in improving animal survival and in enhancing donor hematopoietic cell engraftment using a congeneic mouse transplantation model. AMD3100 was administered subcutaneously at 5 mg/kg body weight 3 times a week beginning at day +2 post-transplant. Post-transplant administration of AMD3100 significantly improves animal survival. AMD3100 reduces pro-inflammatory cytokine/chemokine production. Furthermore, post transplant administration of AMD3100 selectively enhances donor cell engraftment and promotes recovery of all donor cell lineages (myeloid cells, T and B lymphocytes, erythrocytes and platelets). This enhancement results from a combined effect of increased marrow niche availability and greater cell division induced by AMD3100. Our studies shed new lights into the biological roles of SDF-1/CXCR4 interaction in hematopoietic stem cell engraftment following transplantation and in transplant-related mortality. Our results indicate that AMD3100 provides a novel approach for enhancing hematological recovery following transplantation, and will likely benefit patients undergoing transplantation.	[Kang, Yubin] Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA; [Kang, Yubin] Duke Univ, Med Ctr, Dept Med, Div Oncol, Durham, NC 27710 USA; [Kang, Yubin] Duke Univ, Med Ctr, Dept Med, Div Cellular Therapy, Durham, NC 27710 USA; [Chen, Benny J.; DeOliveira, Divino; Mito, Jeffrey; Chao, Nelson J.] Duke Univ, Med Ctr, Dept Med, Div Cellular Therapy Adult Bone Marrow Transplant, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Kang, YB (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Hematol, Durham, NC 27710 USA.	chao0002@mc.duke.edu			National Institutes of Health (NIH) [1U19 AI067798-01]; Genzyme Corp; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genzyme Corp(Sanofi-AventisGenzyme Corporation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by National Institutes of Health (NIH) grant 1U19 AI067798-01 (PI: NJC) and a research grant from Genzyme Corp (PI: NJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham M, 2009, LEUKEMIA, V23, P1378, DOI 10.1038/leu.2009.56; Battiwalla M, 2009, BONE MARROW TRANSPL, V43, P351, DOI 10.1038/bmt.2008.443; Beutler B, 2005, IMMUNOGENETICS, V57, P385, DOI 10.1007/s00251-005-0011-3; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Broxmeyer HE, 2007, ANN NY ACAD SCI, V1106, P1, DOI 10.1196/annals.1392.013; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Cashman J, 2002, J EXP MED, V196, P1141, DOI 10.1084/jem.20010916; Cashman J, 2002, BLOOD, V99, P792, DOI 10.1182/blood.V99.3.792; CHEN B, 2010, PLOS ONE IN PRESS; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Chen BJ, 2002, BLOOD, V99, P364, DOI 10.1182/blood.V99.1.364; Chen J, 2006, BLOOD, V107, P3764, DOI 10.1182/blood-2005-09-3593; Czechowicz A, 2007, SCIENCE, V318, P1296, DOI 10.1126/science.1149726; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; De Clercq E, 2003, NAT REV DRUG DISCOV, V2, P581, DOI 10.1038/nrd1134; De Klerck B, 2005, ARTHRITIS RES THER, V7, pR1208, DOI 10.1186/ar1806; Dekker A, 2006, J CLIN ONCOL, V24, P5207, DOI 10.1200/JCO.2006.06.1663; Devine SM, 2004, J CLIN ONCOL, V22, P1095, DOI 10.1200/JCO.2004.07.131; Devine SM, 2008, BLOOD, V112, P990, DOI 10.1182/blood-2007-12-130179; DiPersio JF, 2009, BLOOD, V113, P5720, DOI 10.1182/blood-2008-08-174946; DOMINICI M, 2009, BLOOD; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Fox N, 2002, J CLIN INVEST, V110, P389, DOI 10.1172/JCI200215430; Genzyme, 2009, PLER INJ INV BROCH V; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; KANG Y, 2009, HEMATOPOIETIC STEM C, P181; Kang YB, 2008, CURR OPIN HEMATOL, V15, P561, DOI 10.1097/MOH.0b013e32831366eb; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Larochelle A, 2006, BLOOD, V107, P3772, DOI 10.1182/blood-2005-09-3592; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Matthys P, 2001, J IMMUNOL, V167, P4686, DOI 10.4049/jimmunol.167.8.4686; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Plett PA, 2002, EXP HEMATOL, V30, P1061, DOI 10.1016/S0301-472X(02)00880-9; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Uchida N, 1998, J CLIN INVEST, V101, P961, DOI 10.1172/JCI1681; Verfaillie CM, 2002, J CLIN INVEST, V110, P303, DOI 10.1172/JCI200216376; Waskow C, 2009, NAT METHODS, V6, P267, DOI [10.1038/nmeth.1309, 10.1038/NMETH.1309]; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Xu JG, 2008, J HEART LUNG TRANSPL, V27, P1302, DOI 10.1016/j.healun.2008.08.010; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang WB, 2002, J BIOL CHEM, V277, P24515, DOI 10.1074/jbc.M200889200; Zhong JF, 2002, BLOOD, V100, P3521, DOI 10.1182/blood-2002-04-1256	53	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11316	10.1371/journal.pone.0011316	http://dx.doi.org/10.1371/journal.pone.0011316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596257	Green Published, Green Submitted, gold			2022-12-27	WOS:000279259900003
J	Laponogov, I; Pan, XS; Veselkov, DA; McAuley, KE; Fisher, LM; Sanderson, MR				Laponogov, Ivan; Pan, Xiao-Su; Veselkov, Dennis A.; McAuley, Katherine E.; Fisher, L. Mark; Sanderson, Mark R.			Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases	PLOS ONE			English	Article							NUCLEIC-ACID STRUCTURES; STREPTOCOCCUS-PNEUMONIAE; GYRASE; IV; SOFTWARE; CLEAVAGE; 3-AMINOQUINAZOLINEDIONES; VISUALIZATION; QUINOLONES; INHIBITORS	Type II DNA topoisomerases are ubiquitous enzymes with essential functions in DNA replication, recombination and transcription. They change DNA topology by forming a transient covalent cleavage complex with a gate-DNA duplex that allows transport of a second duplex though the gate. Despite its biological importance and targeting by anticancer and antibacterial drugs, cleavage complex formation and reversal is not understood for any type II enzyme. To address the mechanism, we have used X-ray crystallography to study sequential states in the formation and reversal of a DNA cleavage complex by topoisomerase IV from Streptococcus pneumoniae, the bacterial type II enzyme involved in chromosome segregation. A high resolution structure of the complex captured by a novel antibacterial dione reveals two drug molecules intercalated at a cleaved B-form DNA gate and anchored by drug-specific protein contacts. Dione release generated drug-free cleaved and resealed DNA complexes in which the DNA gate instead adopts an unusual A/B-form helical conformation with a Mg(2+) ion repositioned to coordinate each scissile phosphodiester group and promote reversible cleavage by active-site tyrosines. These structures, the first for putative reaction intermediates of a type II topoisomerase, suggest how a type II enzyme reseals DNA during its normal reaction cycle and illuminate aspects of drug arrest important for the development of new topoisomerase-targeting therapeutics.	[Laponogov, Ivan; Veselkov, Dennis A.; Sanderson, Mark R.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Laponogov, Ivan; Pan, Xiao-Su; Fisher, L. Mark] St Georges Univ London, Div Basic Med Sci, London, England; [McAuley, Katherine E.] Diamond Light Source, Didcot, Oxon, England	University of London; King's College London; St Georges University London; Diamond Light Source	Laponogov, I (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	lfisher@sgul.ac.uk; mark.sanderson@kcl.ac.uk		Fisher, Larry Mark/0000-0002-2172-3369; McAuley, Katherine/0000-0002-9545-072X	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BBH00405X1, BBD01882X1]; Biotechnology and Biological Sciences Research Council [BB/H00405X/1] Funding Source: researchfish; BBSRC [BB/H00405X/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnology and Biological Sciences Research Council (BBSRC). I. L. was supported by St George's and by BBSRC project grant BBH00405X1 (to L. M. F. and M. R. S). X. S. P. was funded by project grants BBH00405X1 and BBD01882X1 (to L. M. F.) from the BBSRC, and D. A. V. by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Deweese JE, 2008, NUCLEIC ACIDS RES, V36, P4883, DOI 10.1093/nar/gkn466; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Ellsworth EL, 2006, J MED CHEM, V49, P6435, DOI 10.1021/jm060505l; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huband MD, 2007, ANTIMICROB AGENTS CH, V51, P1191, DOI 10.1128/AAC.01321-06; Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leo E, 2005, J BIOL CHEM, V280, P14252, DOI 10.1074/jbc.M500156200; Lu XJ, 2008, NAT PROTOC, V3, P1213, DOI 10.1038/nprot.2008.104; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPherson A, 2006, J STRUCT BIOL, V156, P387, DOI 10.1016/j.jsb.2006.09.006; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan XS, 2009, ANTIMICROB AGENTS CH, V53, P3822, DOI 10.1128/AAC.00113-09; Pan XS, 1997, ANTIMICROB AGENTS CH, V41, P471, DOI 10.1128/AAC.41.2.471; Pan XS, 1996, ANTIMICROB AGENTS CH, V40, P2321, DOI 10.1128/AAC.40.10.2321; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Tran TP, 2007, BIOORG MED CHEM LETT, V17, P1312, DOI 10.1016/j.bmcl.2006.12.005; West KL, 2000, BIOCHEMISTRY-US, V39, P1223, DOI 10.1021/bi991328b	27	139	139	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11338	10.1371/journal.pone.0011338	http://dx.doi.org/10.1371/journal.pone.0011338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596531	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000279259900011
J	Yuan, J; Xu, BZ; Qi, ST; Tong, JS; Wei, LA; Li, M; Ouyang, YC; Hou, Y; Schatten, H; Sun, QY				Yuan, Ju; Xu, Bao-Zeng; Qi, Shu-Tao; Tong, Jing-Shan; Wei, Liang; Li, Mo; Ouyang, Ying-Chun; Hou, Yi; Schatten, Heide; Sun, Qing-Yuan			MAPK-Activated Protein Kinase 2 Is Required for Mouse Meiotic Spindle Assembly and Kinetochore-Microtubule Attachment	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; POLO-LIKE KINASE-1; AURORA-B; MITOTIC SPINDLE; CHROMOSOME SEGREGATION; SISTER CHROMATIDS; MAMMALIAN OOCYTES; MEIOSIS-I; MATURATION; P38	MAPK-activated protein kinase 2 (MK2), a direct substrate of p38 MAPK, plays key roles in multiple physiological functions in mitosis. Here, we show for the first time the unique distribution pattern of MK2 in meiosis. Phospho-MK2 was localized on bipolar spindle minus ends and along the interstitial axes of homologous chromosomes extending over centromere regions and arm regions at metaphase of first meiosis (MI stage) in mouse oocytes. At metaphase of second meiosis (MII stage), p-MK2 was localized on the bipolar spindle minus ends and at the inner centromere region of sister chromatids as dots. Knockdown or inhibition of MK2 resulted in spindle defects. Spindles were surrounded by irregular nondisjunction chromosomes, which were arranged in an amphitelic or syntelic/monotelic manner, or chromosomes detached from the spindles. Kinetochore-microtubule attachments were impaired in MK2-deficient oocytes because spindle microtubules became unstable in response to cold treatment. In addition, homologous chromosome segregation and meiosis progression were inhibited in these oocytes. Our data suggest that MK2 may be essential for functional meiotic bipolar spindle formation, chromosome segregation and proper kinetochore-microtubule attachments.	[Yuan, Ju; Xu, Bao-Zeng; Qi, Shu-Tao; Tong, Jing-Shan; Wei, Liang; Li, Mo; Ouyang, Ying-Chun; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Missouri System; University of Missouri Columbia	Yuan, J (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Wei, Liang/U-4349-2017	Qi, Shutao/0000-0002-4073-1161; Tong, Jingshan/0000-0003-1640-5769	National Natural Science Foundation of China [30570944]; National Basic Research Program of China [2006CB504004, 2006CB944001]; Chinese Academy of Sciences (CAS) [KSCX2-YW-R-52]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work was sponsored by the National Natural Science Foundation of China (30570944), National Basic Research Program of China (2006CB504004, 2006CB944001), and Knowledge Innovation Program of the Chinese Academy of Sciences (CAS) (KSCX2-YW-R-52) to QYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; BENLEVY R, 1995, EMBO J, V14, P5920, DOI 10.1002/j.1460-2075.1995.tb00280.x; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Brunet S, 1998, CURR BIOL, V8, P1231, DOI 10.1016/S0960-9822(07)00516-7; Bulavin DV, 2002, CURR OPIN GENET DEV, V12, P92, DOI 10.1016/S0959-437X(01)00270-2; Choi T, 1996, P NATL ACAD SCI USA, V93, P4730, DOI 10.1073/pnas.93.10.4730; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Davidson W, 2004, BIOCHEMISTRY-US, V43, P11658, DOI 10.1021/bi0495073; De La Fuente R, 2004, DEV BIOL, V272, P1, DOI 10.1016/j.ydbio.2003.12.012; DEBRABANDER M, 1981, P NATL ACAD SCI-BIOL, V78, P5608; Ducat D, 2004, EXP CELL RES, V301, P60, DOI 10.1016/j.yexcr.2004.08.016; Dumont J, 2007, J CELL BIOL, V176, P295, DOI 10.1083/jcb.200605199; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fearns C, 2000, J LEUKOCYTE BIOL, V67, P705, DOI 10.1002/jlb.67.5.705; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Gorbsky GJ, 2001, CURR BIOL, V11, pR1001, DOI 10.1016/S0960-9822(01)00609-1; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; Holt JE, 2009, MOL HUM REPROD, V15, P139, DOI 10.1093/molehr/gap007; Homer H, 2009, SCIENCE, V326, P991, DOI 10.1126/science.1175326; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Kaitna S, 2002, CURR BIOL, V12, P798, DOI 10.1016/S0960-9822(02)00820-5; Kapoor TM, 2004, CURR BIOL, V14, pR1011, DOI 10.1016/j.cub.2004.11.026; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Kudo NR, 2006, CELL, V126, P135, DOI 10.1016/j.cell.2006.05.033; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lee J, 2008, NAT CELL BIOL, V10, P42, DOI 10.1038/ncb1667; Lee J, 2006, CELL CYCLE, V5, P1448, DOI 10.4161/cc.5.13.2903; Lee JY, 2001, ANNU REV CELL DEV BI, V17, P753, DOI 10.1146/annurev.cellbio.17.1.753; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Maddox P, 2003, J CELL BIOL, V162, P377, DOI 10.1083/jcb.200301088; Maia AF, 2007, CELL CYCLE, V6, P1367, DOI 10.4161/cc.6.11.4271; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Mikhailov A, 2004, J CELL BIOL, V166, P517, DOI 10.1083/jcb.200405167; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Piehl M, 2004, P NATL ACAD SCI USA, V101, P1584, DOI 10.1073/pnas.0308205100; Polanski Z, 1997, ZYGOTE, V5, P105, DOI 10.1017/S0967199400003774; POLANSKI Z, 1986, J REPROD FERTIL, V78, P103, DOI 10.1530/jrf.0.0780103; Revenkova E, 2005, REPRODUCTION, V130, P783, DOI 10.1530/rep.1.00864; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Sun QY, 1999, REPROD FERT DEVELOP, V11, P443, DOI 10.1071/RD00014; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262; Terret ME, 2003, CURR BIOL, V13, P1797, DOI 10.1016/j.cub.2003.09.032; Tong C, 2002, BIOL REPROD, V67, P546, DOI 10.1095/biolreprod67.2.546; VERLHAC MH, 1993, DEV BIOL, V158, P330, DOI 10.1006/dbio.1993.1192; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Vician LJ, 2004, J NEUROSCI RES, V78, P315, DOI 10.1002/jnr.20251; Wang XZ, 2006, J BIOL CHEM, V281, P782, DOI 10.1074/jbc.M505822200; Wei L, 2010, CELL CYCLE, V9, P1112, DOI 10.4161/cc.9.6.10957; WEISENBERG RC, 1976, NATURE, V263, P792, DOI 10.1038/263792a0; Xiong B, 2008, CELL CYCLE, V7, P1804, DOI 10.4161/cc.7.12.6019; Yang JW, 2007, REPRODUCTION, V134, P731, DOI 10.1530/REP-07-0149; Yao LJ, 2004, BIOL REPROD, V70, P1392, DOI 10.1095/biolreprod.103.025155; Yu LZ, 2007, CELL CYCLE, V6, P330, DOI 10.4161/cc.6.3.3805; Yuan J, 2009, CELL CYCLE, V8, P3384, DOI 10.4161/cc.8.20.9885	71	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11247	10.1371/journal.pone.0011247	http://dx.doi.org/10.1371/journal.pone.0011247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596525	gold, Green Submitted, Green Published			2022-12-27	WOS:000279259900002
J	Jensen, JMB; Petersen, MS; Stegger, M; Ostergaard, LJ; Moller, BK				Jensen, Jens Magnus Bernth; Petersen, Mikkel Steen; Stegger, Marc; Ostergaard, Lars J.; Moller, Bjarne K.			Real-Time Relative qPCR without Reference to Control Samples and Estimation of Run-Specific PCR Parameters from Run-Internal Mini-Standard Curves	PLOS ONE			English	Article							QUANTITATIVE PCR; KINETIC PCR; QUANTIFICATION	Background: Real-Time quantitative PCR is an important tool in research and clinical settings. Here, we describe two new approaches that broaden the scope of real-time quantitative PCR; namely, run-internal mini standard curves (RIMS) and direct real-time relative quantitative PCR (drqPCR). RIMS are an efficient alternative to traditional standard curves and provide both run-specific and target-specific estimates of PCR parameters. The drqPCR enables direct estimation of target ratios without reference to conventional control samples. Methodology/Principal Findings: In this study, we compared RIMS-based drqPCR with classical quantifications based on external standard curves and the "comparative Ct method". Specifically, we used a raw real-time PCR dataset as the basis for more than two-and-a-half million simulated quantifications with various user-defined conditions. Compared with classical approaches, we found that RIMS-based drqPCR provided superior precision and comparable accuracy. Conclusions/Significance: The obviation of referencing to control samples is attractive whenever unpaired samples are quantified. This may be in clinical and research settings; for instance, studies on chimerism, TREC quantifications, copy number variations etc. Also, lab-to-lab comparability can be greatly simplified.	[Jensen, Jens Magnus Bernth; Petersen, Mikkel Steen; Moller, Bjarne K.] Aarhus Univ Hosp, Dept Clin Immunol, Skejby, Denmark; [Stegger, Marc; Ostergaard, Lars J.] Aarhus Univ Hosp, Dept Infect Dis, Skejby, Denmark	Aarhus University; Aarhus University	Jensen, JMB (corresponding author), Aarhus Univ Hosp, Dept Clin Immunol, Skejby, Denmark.	jejensen@rm.dk	Bernth-Jensen, Jens Magnus/H-6694-2019; Ostergaard, Lars/AAA-3020-2020	Ostergaard, Lars/0000-0003-2459-0511; Bernth Jensen, Jens Magnus/0000-0002-5004-7822; Ostergaard, Lars/0000-0002-7619-605X; Stegger, Marc/0000-0003-0321-1180				Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVAK KJ, 1997, PE APPL BIOSYST 1211; OVERHAUSER J, 1993, GENOMICS, V15, P387, DOI 10.1006/geno.1993.1072; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutledge RG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng093; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Weksberg R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-180; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	16	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11723	10.1371/journal.pone.0011723	http://dx.doi.org/10.1371/journal.pone.0011723			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661435	Green Submitted, Green Published, gold			2022-12-27	WOS:000280243300023
J	Delport, W; Scheffler, K; Gravenor, MB; Muse, SV; Pond, SK				Delport, Wayne; Scheffler, Konrad; Gravenor, Mike B.; Muse, Spencer V.; Pond, Sergei Kosakovsky			Benchmarking Multi-Rate Codon Models	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD APPROACH; SUBSTITUTION MODELS; SELECTIVE PRESSURES; SEQUENCE EVOLUTION; INDIVIDUAL SITES; PROTEIN; TREES	The single rate codon model of non-synonymous substitution is ubiquitous in phylogenetic modeling. Indeed, the use of a non-synonymous to synonymous substitution rate ratio parameter has facilitated the interpretation of selection pressure on genomes. Although the single rate model has achieved wide acceptance, we argue that the assumption of a single rate of non-synonymous substitution is biologically unreasonable, given observed differences in substitution rates evident from empirical amino acid models. Some have attempted to incorporate amino acid substitution biases into models of codon evolution and have shown improved model performance versus the single rate model. Here, we show that the single rate model of non-synonymous substitution is easily outperformed by a model with multiple non-synonymous rate classes, yet in which amino acid substitution pairs are assigned randomly to these classes. We argue that, since the single rate model is so easy to improve upon, new codon models should not be validated entirely on the basis of improved model fit over this model. Rather, we should strive to both improve on the single rate model and to approximate the general time-reversible model of codon substitution, with as few parameters as possible, so as to reduce model over-fitting. We hint at how this can be achieved with a Genetic Algorithm approach in which rate classes are assigned on the basis of sequence information content.	[Delport, Wayne] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Scheffler, Konrad] Univ Stellenbosch, Dept Math Sci, ZA-7600 Stellenbosch, South Africa; [Gravenor, Mike B.] Univ Swansea, Sch Med, Swansea, W Glam, Wales; [Muse, Spencer V.] N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; [Pond, Sergei Kosakovsky] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	University of California System; University of California San Diego; Stellenbosch University; Swansea University; University of North Carolina; North Carolina State University; University of California System; University of California San Diego	Delport, W (corresponding author), Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA.	wdelport@ucsd.edu	Delport, Wayne/C-1744-2008; Pond, Sergei LK/G-9830-2012	Pond, Sergei LK/0000-0003-4817-4029; Scheffler, Konrad/0000-0002-6041-8367	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative [NSF-0714991]; National Institutes of Health [AI47745]; University of California, San Diego Center for AIDS Research/National Institute of Allergy and Infectious Diseases (NIAID) [AI36214]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214, R01AI047745, R21AI047745] Funding Source: NIH RePORTER	Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, San Diego Center for AIDS Research/National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Joint Division of Mathematical Sciences/National Institute of General Medical Sciences Mathematical Biology Initiative through grant NSF-0714991, the National Institutes of Health (AI47745), and by a University of California, San Diego Center for AIDS Research/National Institute of Allergy and Infectious Diseases (NIAID) Developmental Award to W.D. and S.L.K.P (AI36214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimova M, 2009, MOL BIOL EVOL, V26, P255, DOI 10.1093/molbev/msn232; Conant GC, 2009, MOL BIOL EVOL, V26, P1155, DOI 10.1093/molbev/msp031; DAYHOFF MO, 1972, ATLAS PROTEIN SEQUEN, V5, P89; DELPORT W, 2010, PLOS COMP B IN PRESS; Delport W, 2009, BRIEF BIOINFORM, V10, P97, DOI 10.1093/bib/bbn049; Doron-Faigenboim A, 2007, MOL BIOL EVOL, V24, P388, DOI 10.1093/molbev/msl175; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; HASEGAWA M, 1985, MOL BIOL EVOL, V21, P160; Huelsenbeck JP, 2008, PHILOS T R SOC B, V363, P3941, DOI 10.1098/rstb.2008.0175; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; KOSAKOVSKY P, 2010, PLOS ONE IN PRESS; Kosiol C, 2007, MOL BIOL EVOL, V24, P1464, DOI 10.1093/molbev/msm064; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Pond SLK, 2005, MOL BIOL EVOL, V22, P223, DOI 10.1093/molbev/msi009; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; POND SLK, 2006, MOL BIOL EVOL MSL, V144; Sainudiin R, 2005, J MOL EVOL, V60, P315, DOI 10.1007/s00239-004-0153-1; Stanfel LE, 1996, J THEOR BIOL, V183, P195, DOI 10.1006/jtbi.1996.0213; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Whelan S, 2006, NUCLEIC ACIDS RES, V34, pD327, DOI 10.1093/nar/gkj087; Wong WSW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-148; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11587	10.1371/journal.pone.0011587	http://dx.doi.org/10.1371/journal.pone.0011587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657773	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500006
J	Lee, SH; Kim, PJ; Ahn, YY; Jeong, H				Lee, Sang Hoon; Kim, Pan-Jun; Ahn, Yong-Yeol; Jeong, Hawoong			Googling Social Interactions: Web Search Engine Based Social Network Construction	PLOS ONE			English	Article							COMMUNITY STRUCTURE; STATES	Social network analysis has long been an untiring topic of sociology. However, until the era of information technology, the availability of data, mainly collected by the traditional method of personal survey, was highly limited and prevented large-scale analysis. Recently, the exploding amount of automatically generated data has completely changed the pattern of research. For instance, the enormous amount of data from so-called high-throughput biological experiments has introduced a systematic or network viewpoint to traditional biology. Then, is "high-throughput'' sociological data generation possible? Google, which has become one of the most influential symbols of the new Internet paradigm within the last ten years, might provide torrents of data sources for such study in this (now and forthcoming) digital era. We investigate social networks between people by extracting information on the Web and introduce new tools of analysis of such networks in the context of statistical physics of complex systems or socio-physics. As a concrete and illustrative example, the members of the 109th United States Senate are analyzed and it is demonstrated that the methods of construction and analysis are applicable to various other weighted networks.	[Lee, Sang Hoon; Jeong, Hawoong] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Kim, Pan-Jun] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Ahn, Yong-Yeol] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Ahn, Yong-Yeol] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Ahn, Yong-Yeol] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Jeong, Hawoong] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); University of Illinois System; University of Illinois Urbana-Champaign; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Korea Advanced Institute of Science & Technology (KAIST)	Lee, SH (corresponding author), Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea.	hjeong@kaist.edu	Jeong, Hawoong/A-2469-2009; Ahn, Yong-Yeol/C-6334-2011; Jeong, Hawoong/C-1587-2011; Jeong, Hawoong/AAR-2524-2021; Lee, Sang Hoon/C-6327-2011	Jeong, Hawoong/0000-0002-2491-8620; Ahn, Yong-Yeol/0000-0002-4352-4301; Jeong, Hawoong/0000-0002-2491-8620; Kim, Pan-Jun/0000-0002-9329-4997	NAP of Korea Research Council of Fundamental Science Technology	NAP of Korea Research Council of Fundamental Science Technology	This work was supported by NAP of Korea Research Council of Fundamental Science & Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.228701; Barthelemy M, 2005, PHYSICA A, V346, P34, DOI 10.1016/j.physa.2004.08.047; Berners-Lee T, 2006, SCIENCE, V313, P769, DOI 10.1126/science.1126902; Cohen AM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-103; DERRIDA B, 1987, J PHYS A-MATH GEN, V20, P5273, DOI 10.1088/0305-4470/20/15/039; Dorogovtsev SN, 2002, ADV PHYS, V51, P1079, DOI 10.1080/00018730110112519; Ferret Olivier, 2004, COLING 2004 P 20 INT, P1326; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Henzinger M, 2004, P NATL ACAD SCI USA, V101, P5186, DOI 10.1073/pnas.0307528100; Henzinger M, 2007, SCIENCE, V317, P468, DOI 10.1126/science.1126557; *HERALDNET, 2008, BOEING HAS TENSE MCC; Kim DH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046126; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; PIPEK J, 1992, PHYS REV A, V46, P3148, DOI 10.1103/PhysRevA.46.3148; Porter MA, 2006, CHAOS, V16, DOI 10.1063/1.2390556; Porter MA, 2007, PHYSICA A, V386, P414, DOI 10.1016/j.physa.2007.07.039; RYAN A, 2006, KERRY SAYS HE BOTCHE; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Simkin MV, 2006, J MATH SOCIOL, V30, P33, DOI 10.1080/00222500500333258; Todd PM, 2007, P NATL ACAD SCI USA, V104, P15011, DOI 10.1073/pnas.0705290104; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang Y, 2008, PHYSICA A, V387, P1705, DOI 10.1016/j.physa.2007.11.004; ZHOU T, 2007, PHYS REV E, V76; Zyczkowski K, 2003, OPEN SYST INF DYN, V10, P297, DOI 10.1023/A:1025128024427; 2006, COOCCURRENCE PREDICT; 2007, FORTUNE 500; 2008, NATURE, V455, P1	35	40	42	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11233	10.1371/journal.pone.0011233	http://dx.doi.org/10.1371/journal.pone.0011233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657762	Green Submitted, Green Published, gold			2022-12-27	WOS:000280197500001
J	Milet, J; Nuel, G; Watier, L; Courtin, D; Slaoui, Y; Senghor, P; Migot-Nabias, F; Gaye, O; Garcia, A				Milet, Jacqueline; Nuel, Gregory; Watier, Laurence; Courtin, David; Slaoui, Yousri; Senghor, Paul; Migot-Nabias, Florence; Gaye, Oumar; Garcia, Andre			Genome Wide Linkage Study, Using a 250K SNP Map, of Plasmodium falciparum Infection and Mild Malaria Attack in a Senegalese Population	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; UBIQUITIN-CONJUGATING ENZYME; BLOOD-CELL POLYMORPHISMS; CEREBRAL MALARIA; CHROMOSOME 5Q31-Q33; GENETIC ASSOCIATION; GENERAL PEDIGREES; PROMOTER REGION; DENDRITIC CELLS	Multiple factors are involved in the variability of host's response to P. falciparum infection, like the intensity and seasonality of malaria transmission, the virulence of parasite and host characteristics like age or genetic make-up. Although admitted nowadays, the involvement of host genetic factors remains unclear. Discordant results exist, even concerning the best-known malaria resistance genes that determine the structure or function of red blood cells. Here we report on a genomewide linkage and association study for P. falciparum infection intensity and mild malaria attack among a Senegalese population of children and young adults from 2 to 18 years old. A high density single nucleotide polymorphisms (SNP) genome scan (Affimetrix GeneChip Human Mapping 250K-nsp) was performed for 626 individuals: i.e. 249 parents and 377 children out of the 504 ones included in the follow-up. The population belongs to a unique ethnic group and was closely followed-up during 3 years. Genome-wide linkage analyses were performed on four clinical and parasitological phenotypes and association analyses using the family based association tests (FBAT) method were carried out in regions previously linked to malaria phenotypes in literature and in the regions for which we identified a linkage peak. Analyses revealed three strongly suggestive evidences for linkage: between mild malaria attack and both the 6p25.1 and the 12q22 regions (empirical p-value = 5 x 10(-5) and 96 x 10(-5) respectively), and between the 20p11q11 region and the prevalence of parasite density in asymptomatic children (empirical p-value = 1.5 x 10(-4)). Family based association analysis pointed out one significant association between the intensity of plasmodial infection and a polymorphism located in ARHGAP26 gene in the 5q31-q33 region (p-value = 3.7 x 10(-5)). This study identified three candidate regions, two of them containing genes that could point out new pathways implicated in the response to malaria infection. Furthermore, we detected one gene associated with malaria infection in the 5q31-q33 region.	[Milet, Jacqueline; Courtin, David; Migot-Nabias, Florence; Garcia, Andre] IRD, UMR Mere & Enfant Face Infect Trop 216, Paris, France; [Milet, Jacqueline; Courtin, David; Migot-Nabias, Florence; Garcia, Andre] Univ Paris 05, Parasitol Lab, Paris, France; [Nuel, Gregory; Slaoui, Yousri] Univ Paris 05, CNRS, MAP5, UMR 8145, Paris, France; [Watier, Laurence] INSERM, U657, Garches, France; [Senghor, Paul; Gaye, Oumar] Univ Cheikh Anta Diop, Fac Med, Dept Biol & Explorat Fonct, Lab Parasitol & Mycol, Dakar, Senegal	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University Cheikh Anta Diop Dakar	Milet, J (corresponding author), IRD, UMR Mere & Enfant Face Infect Trop 216, Paris, France.	Andre.Garcia@ird.fr	Garcia, Andre/S-2959-2016; Garcia, Andre/ABA-1820-2020; , Watier/K-8213-2013; courtin, david/A-1584-2017	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; , Watier/0000-0002-4057-1102; courtin, david/0000-0002-5263-4430; Migot-Nabias, Florence/0000-0001-9982-594X; slaoui, yousri/0000-0001-5295-3311; MILET, Jacqueline/0000-0003-2710-1517	Ministere de la Recherche	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France)	1. Ministere de la Recherche; Programme PAL+ (suite de VIHPAL): Recherche sur le paludisme et les maladies transmissibles associees, pour les pays en developpement. http://www.enseignementsup-recherche.gouv.fr/. 2. Centre National du Genotypage; http://www.cng.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; [Anonymous], 2000, GLOB PARTN ROLL BACK; [Anonymous], 2004, STRATEGIC FRAMEWORK; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellenguez C, 2009, HUM HERED, V68, P87, DOI 10.1159/000212501; BOUGERET C, 1992, J IMMUNOL, V148, P318; Boyles AL, 2005, HUM HERED, V59, P220, DOI 10.1159/000087122; Briand V, 2005, AM J TROP MED HYG, V72, P702, DOI 10.4269/ajtmh.2005.72.702; Cabantous S, 2006, INFECT IMMUN, V74, P7040, DOI 10.1128/IAI.01581-05; Canal F, 2007, ARCH BIOCHEM BIOPHYS, V465, P282, DOI 10.1016/j.abb.2007.06.003; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Chima RI, 2003, HEALTH POLICY, V63, P17, DOI 10.1016/S0168-8510(02)00036-2; Clark TG, 2009, J INFECT DIS, V199, P569, DOI 10.1086/596320; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; COT M, 1991, ANN SOC BELG MED TR, V71, P17; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fillol F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-116; Fillol F, 2009, AM J TROP MED HYG, V80, P202, DOI 10.4269/ajtmh.2009.80.202; Flori L, 2003, HUM MOL GENET, V12, P375, DOI 10.1093/hmg/ddg033; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; Garcia A, 2004, MICROBES INFECT, V6, P68, DOI 10.1016/j.micinf.2003.09.021; Ghosh K, 2008, HUM IMMUNOL, V69, P856, DOI 10.1016/j.humimm.2008.08.294; Gyan B, 2009, AM J TROP MED HYG, V80, P541, DOI 10.4269/ajtmh.2009.80.541; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hommel M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S1; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jallow M, 2009, NAT GENET; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; Jeronimo SMB, 2007, GENES IMMUN, V8, P539, DOI 10.1038/sj.gene.6364422; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kim CC, 2008, INFECT IMMUN, V76, P5873, DOI 10.1128/IAI.00640-08; Knight JC, 1999, NAT GENET, V22, P145, DOI 10.1038/9649; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leu TH, 2006, MOL IMMUNOL, V43, P308, DOI 10.1016/j.molimm.2005.03.015; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Marquet S, 1996, NAT GENET, V14, P181, DOI 10.1038/ng1096-181; Mathanga DP., 2007, INT J EQUITY HLTH, V6, P22, DOI [10.1186/1475-9276-6-22, DOI 10.1186/1475-9276-6-22]; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; McGuire W, 1999, J INFECT DIS, V179, P287, DOI 10.1086/314533; MCGUIRE W, 1994, NATURE, V371, P508, DOI 10.1038/371508a0; McKenzie FE, 2005, J INFECT DIS, V192, P323, DOI 10.1086/431152; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Migot-Nabias F, 2006, MICROBES INFECT, V8, P2352, DOI 10.1016/j.micinf.2006.03.021; Minamoto S, 1997, BIOCHEM BIOPH RES CO, V237, P79, DOI 10.1006/bbrc.1997.7080; Mizui M, 2009, J CLIN IMMUNOL, V29, P1, DOI 10.1007/s10875-008-9263-7; MOLINEAUX L, 1980, AM J TROP MED HYG, V29, P725, DOI 10.4269/ajtmh.1980.29.725; Nacher M, 2001, AM J TROP MED HYG, V65, P834, DOI 10.4269/ajtmh.2001.65.834; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Peng X, 2007, ANN NY ACAD SCI, V1112, P339, DOI 10.1196/annals.1415.025; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Romani L, 2004, BLOOD, V103, P4232, DOI 10.1182/blood-2003-11-4036; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Sham PC, 2002, AM J HUM GENET, V71, P238, DOI 10.1086/341560; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Spiegel A, 2003, T ROY SOC TROP MED H, V97, P198, DOI 10.1016/S0035-9203(03)90117-9; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Thawan N, 2009, HAEMATOL-HEMATOL J, V94, P195, DOI 10.3324/haematol.13422; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; Valin N, 2006, PARASITE, V13, P79, DOI 10.1051/parasite/2006131079; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; Wattavidanage J, 1999, CLIN EXP IMMUNOL, V115, P350, DOI 10.1046/j.1365-2249.1999.00804.x; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Wilson JN, 2005, GENES IMMUN, V6, P462, DOI 10.1038/sj.gene.6364227; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhang P, 2005, EMBO REP, V6, P531, DOI 10.1038/sj.embor.7400433	83	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11616	10.1371/journal.pone.0011616	http://dx.doi.org/10.1371/journal.pone.0011616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657648	Green Published, gold, Green Submitted			2022-12-27	WOS:000279924500015
J	Haflidadottir, BS; Bergsteinsdottir, K; Praetorius, C; Steingrimsson, E				Haflidadottir, Benedikta S.; Bergsteinsdottir, Kristin; Praetorius, Christian; Steingrimsson, Eirikur			miR-148 Regulates Mitf in Melanoma Cells	PLOS ONE			English	Article							MICROPHTHALMIA TRANSCRIPTION FACTOR; MICRORNA EXPRESSION PROFILE; MALIGNANT-MELANOMA; LINEAGE SURVIVAL; MIRNA EXPRESSION; MESSENGER-RNA; GENE; MELANOCYTES; TARGET; CANCER	The Microphthalmia associated transcription factor (Mitf) is an important regulator in melanocyte development and has been shown to be involved in melanoma progression. The current model for the role of Mitf in melanoma assumes that the total activity of the protein is tightly regulated in order to secure cell proliferation. Previous research has shown that regulation of Mitf is complex and involves regulation of expression, splicing, protein stability and post-translational modifications. Here we show that microRNAs (miRNAs) are also involved in regulating Mitf in melanoma cells. Sequence analysis revealed conserved binding sites for several miRNAs in the Mitf 3'UTR sequence. Furthermore, miR-148 was shown to affect Mitf mRNA expression in melanoma cells through a conserved binding site in the 3'UTR sequence of mouse and human Mitf. In addition we confirm the previously reported effects of miR-137 on Mitf. Other miRNAs, miR-27a, miR-32 and miR-124 which all have conserved binding sites in the Mitf 3'UTR sequence did not have effects on Mitf. Our data show that miR-148 and miR-137 present an additional level of regulating Mitf expression in melanocytes and melanoma cells. Loss of this regulation, either by mutations or by shortening of the 3'UTR sequence, is therefore a likely factor in melanoma formation and/or progression.	[Haflidadottir, Benedikta S.; Bergsteinsdottir, Kristin; Praetorius, Christian; Steingrimsson, Eirikur] Univ Iceland, Dept Biochem & Mol Biol, Biomed Ctr, Fac Med, Reykjavik, Iceland	University of Iceland	Haflidadottir, BS (corresponding author), Univ Iceland, Dept Biochem & Mol Biol, Biomed Ctr, Fac Med, Reykjavik, Iceland.	eirikurs@hi.is		Praetorius, Christian/0000-0001-7514-5333; Steingrimsson, Eirikur/0000-0001-5826-7486	Icelandic Research Fund; University of Iceland Research Fund	Icelandic Research Fund; University of Iceland Research Fund	This work was supported by grants from the Icelandic Research Fund (www.rannis.is) and the University of Iceland Research Fund (www.hi.is/en/research_degrees). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2007, INVEST OPHTH VIS SCI, V48, P3962, DOI 10.1167/iovs.06-1221; BANDRES E, 2009, INT J CANC; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Bora N, 1998, DEV DYNAM, V213, P283, DOI 10.1002/(SICI)1097-0177(199811)213:3<283::AID-AJA5>3.0.CO;2-H; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Carreira S, 2000, J BIOL CHEM, V275, P21920, DOI 10.1074/jbc.M000035200; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; GOSWAMI S, 2010, J BIOL CHEM; Hallsson JH, 2007, PIGM CELL RES, V20, P185, DOI 10.1111/j.1600-0749.2007.00373.x; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Huang ZM, 2009, J DIGEST DIS, V10, P188, DOI 10.1111/j.1751-2980.2009.00384.x; HUGHES MJ, 1993, J BIOL CHEM, V268, P20687; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Katada T, 2009, INT J ONCOL, V34, P537, DOI 10.3892/ijo_00000179; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Mansky KC, 2002, J BIOL CHEM, V277, P11077, DOI 10.1074/jbc.M111696200; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McGill GG, 2006, J BIOL CHEM, V281, P10365, DOI 10.1074/jbc.M513094200; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Miller AJ, 2005, J BIOL CHEM, V280, P146, DOI 10.1074/jbc.M411757200; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3; Nguyen MTT, 2000, DEVELOPMENT, V127, P3581; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Saetrom P, 2007, NUCLEIC ACIDS RES, V35, P2333, DOI 10.1093/nar/gkm133; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Selzer E, 2002, CANCER RES, V62, P2098; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Takeda K, 2000, HUM MOL GENET, V9, P125, DOI 10.1093/hmg/9.1.125; Vachtenheim J, 1999, CELL MOL BIOL, V45, P1075; Vachtenheim J, 2001, J INVEST DERMATOL, V117, P1505, DOI 10.1046/j.0022-202x.2001.01563.x; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wellbrock C, 2005, J CELL BIOL, V170, P703, DOI 10.1083/jcb.200505059; Wren JD, 2000, AM J HUM GENET, V67, P345, DOI 10.1086/303013; Wu M, 2000, GENE DEV, V14, P301; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Xu WD, 2000, EXP CELL RES, V255, P135, DOI 10.1006/excr.2000.4803; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	62	84	90	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11574	10.1371/journal.pone.0011574	http://dx.doi.org/10.1371/journal.pone.0011574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644734	Green Submitted, Green Published, gold			2022-12-27	WOS:000279884900014
J	Bjork, JM; Smith, AR; Chen, G; Hommer, DW				Bjork, James M.; Smith, Ashley R.; Chen, Gang; Hommer, Daniel W.			Adolescents, Adults and Rewards: Comparing Motivational Neurocircuitry Recruitment Using fMRI	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EVENT-RELATED FMRI; ORBITOFRONTAL CORTEX; BRAIN ACTIVITY; RISK-TAKING; CHILDHOOD; CHILDREN; REGIONS; ANTICIPATION; NEUROSCIENCE	Background: Adolescent risk-taking, including behaviors resulting in injury or death, has been attributed in part to maturational differences in mesolimbic incentive-motivational neurocircuitry, including ostensible oversensitivity of the nucleus accumbens (NAcc) to rewards. Methodology/Principal Findings: To test whether adolescents showed increased NAcc activation by cues for rewards, or by delivery of rewards, we scanned 24 adolescents (age 12-17) and 24 adults age (22-42) with functional magnetic resonance imaging while they performed a monetary incentive delay (MID) task. The MID task was configured to temporally disentangle potential reward or potential loss anticipation-related brain signal from reward or loss notification-related signal. Subjects saw cues signaling opportunities to win or avoid losing $0, $.50, or $5 for responding quickly to a subsequent target. Subjects then viewed feedback of their trial success after a variable interval from cue presentation of between 6 to 17 s. Adolescents showed reduced NAcc recruitment by reward-predictive cues compared to adult controls in a linear contrast with non-incentive cues, and in a volume-of-interest analysis of signal change in the NAcc. In contrast, adolescents showed little difference in striatal and frontocortical responsiveness to reward deliveries compared to adults. Conclusions/Significance: In light of divergent developmental difference findings between neuroimaging incentive paradigms (as well as at different stages within the same task), these data suggest that maturational differences in incentive-motivational neurocircuitry: 1) may be sensitive to nuances of incentive tasks or stimuli, such as behavioral or learning contingencies, and 2) may be specific to the component of the instrumental behavior (such as anticipation versus notification).	[Bjork, James M.] NIDA, Div Clin Neurosci & Behav Res, NIH, Bethesda, MD 20892 USA; [Smith, Ashley R.; Hommer, Daniel W.] NIAAA, Lab Clin & Translat Studies, NIH, Bethesda, MD USA; [Chen, Gang] NIMH, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Bjork, JM (corresponding author), NIDA, Div Clin Neurosci & Behav Res, NIH, Bethesda, MD 20892 USA.	jbjork@mail.nih.gov	Smith, Ashley/GZB-0298-2022; Bjork, James/Q-5108-2019	Bjork, James/0000-0003-0593-3291; Lauwereyns, Jan/0000-0003-0551-2550	National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000081] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was sponsored by intramural research funds of the National Institute on Alcohol Abuse and Alcoholism (http://www.niaaa.nih.gov/ResearchInformation/IntramuralResearch/AboutDICBR/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjork JM, 2008, NEUROIMAGE, V42, P1609, DOI 10.1016/j.neuroimage.2008.06.035; Bjork JM, 2008, ADDICTION, V103, P1308, DOI 10.1111/j.1360-0443.2008.02250.x; Bjork JM, 2007, J NEUROSCI, V27, P4839, DOI 10.1523/JNEUROSCI.5469-06.2007; Bjork JM, 2007, BEHAV BRAIN RES, V177, P165, DOI 10.1016/j.bbr.2006.10.034; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; BJORK JM, 2009, J CHILD PSYCHOL PSYC; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dahl R E, 1996, Semin Pediatr Neurol, V3, P44, DOI 10.1016/S1071-9091(96)80028-3; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dillon DG, 2008, PSYCHOPHYSIOLOGY, V45, P36, DOI 10.1111/j.1469-8986.2007.00594.x; Durston S, 2001, J AM ACAD CHILD PSY, V40, P1012, DOI 10.1097/00004583-200109000-00009; Elliott R, 2004, NEUROIMAGE, V21, P984, DOI 10.1016/j.neuroimage.2003.10.010; Elliott R, 2003, J NEUROSCI, V23, P303; EPSTEIN R, 2007, MYTH TEEN BRAIN, P57; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Eshel N, 2007, NEUROPSYCHOLOGIA, V45, P1270, DOI 10.1016/j.neuropsychologia.2006.10.004; Fergusson DM, 2007, DRUG ALCOHOL DEPEN, V88, pS14, DOI 10.1016/j.drugalcdep.2006.12.011; FERGUSSON DM, 1995, J ABNORM CHILD PSYCH, V23, P183, DOI 10.1007/BF01447088; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; GARDNER W, 1991, ADOLESCENT RISK TAKI, P41; GEIER CF, 2009, CEREB CORTEX; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Guyer AE, 2006, J NEUROSCI, V26, P6399, DOI 10.1523/JNEUROSCI.0666-06.2006; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Holm SM, 2009, J ADOLESCENT HEALTH, V45, P326, DOI 10.1016/j.jadohealth.2009.04.001; Johnson SB, 2009, J ADOLESCENT HEALTH, V45, P216, DOI 10.1016/j.jadohealth.2009.05.016; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2005, CURR OPIN NEUROL, V18, P411, DOI 10.1097/01.wco.0000173463.24758.f6; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Pardini D, 2007, DRUG ALCOHOL DEPEN, V88, pS38, DOI 10.1016/j.drugalcdep.2006.12.014; Reich W, 2000, J AM ACAD CHILD PSY, V39, P59, DOI 10.1097/00004583-200001000-00017; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schultz W, 2007, TRENDS NEUROSCI, V30, P203, DOI 10.1016/j.tins.2007.03.007; SOMERVILLE LH, 2009, BRAIN COGN; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; STEINBERG L, 2009, BRAIN COGN; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; van Hell HH, 2010, EUR NEUROPSYCHOPHARM, V20, P153, DOI 10.1016/j.euroneuro.2009.11.010; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Van Leijenhorst L, 2010, CEREB CORTEX, V20, P61, DOI 10.1093/cercor/bhp078; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x	48	180	182	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11440	10.1371/journal.pone.0011440	http://dx.doi.org/10.1371/journal.pone.0011440			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625430	Green Published, Green Submitted, gold			2022-12-27	WOS:000279522500008
J	Galichet, C; Lovell-Badge, R; Rizzoti, K				Galichet, Christophe; Lovell-Badge, Robin; Rizzoti, Karine			Nestin-Cre Mice Are Affected by Hypopituitarism, Which Is Not Due to Significant Activity of the Transgene in the Pituitary Gland	PLOS ONE			English	Article							STEM-CELLS; MOUSE; GROWTH; GENE; RECOMBINATION; NEUROGENESIS; DEFICIENCY; ACTIVATION; EXPRESSION; HORMONE	Nestin-Cre mice express Cre recombinase under control of the rat nestin promoter and central nervous system (CNS) enhancer. While endogenous Nestin is expressed in some other tissues including the pituitary gland, Nestin-Cre mice induce recombination predominantly in the CNS. For this reason, they have been widely used to explore gene function or cell fate in the latter. Pituitary hormonal deficiencies, or hypopituitarism, are associated with a wide range of symptoms and with a significant morbidity. These can have a neural and/or a pituitary origin as the gland's secretions are controlled by the hypothalamus. We report here that Nestin-Cre mice themselves are affected by mild hypopituitarism. Hence, physiological consequences are expected, especially in combination with defects resulting from Cre mediated deletion of any gene under investigation. To further investigate the origin of this phenotype, we re-examined the activity of the transgene. We compared it with expression of Nestin itself in the context of the hypothalamo-pituitary axis, especially in the light of a recent report showing pituitary Nestin-Cre activity, which contrasts with previous data. Our results disagree with those of this recent study and do not support the claim that Nestin positive cells are present in the pituitary anlagen, the Rathke's pouch (RP). Moreover we did not observe any significant activity in the post-natal pituitary, in agreement with the initial report.	[Galichet, Christophe; Lovell-Badge, Robin; Rizzoti, Karine] MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London, England	MRC National Institute for Medical Research	Galichet, C (corresponding author), MRC Natl Inst Med Res, Div Stem Cell Biol & Dev Genet, London, England.	krizzot@nimr.mrc.ac.uk	Galichet, Christophe/AAJ-5678-2021; Rizzoti, Karine/AAW-1090-2021	Galichet, Christophe/0000-0003-0244-9381; Rizzoti, Karine/0000-0003-0711-5452; Lovell-Badge, Robin/0000-0001-9364-4179	Medical Research Council [U117512772]; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (U117512772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatzoglou KS, 2009, EARLY HUM DEV, V85, P705, DOI 10.1016/j.earlhumdev.2009.08.057; Chen JH, 2005, ENDOCRINOLOGY, V146, P3985, DOI 10.1210/en.2005-0185; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Gleiberman AS, 2008, P NATL ACAD SCI USA, V105, P6332, DOI 10.1073/pnas.0801644105; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Kelberman D, 2009, ENDOCR REV, V30, P790, DOI 10.1210/er.2009-0008; Krylyshkina O, 2005, ENDOCRINOLOGY, V146, P2376, DOI 10.1210/en.2004-1209; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li H, 1996, EMBO J, V15, P714, DOI 10.1002/j.1460-2075.1996.tb00407.x; Lichtenwalner RJ, 2006, J NEUROSCI RES, V83, P199, DOI 10.1002/jnr.20719; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; McGuinness L, 2003, ENDOCRINOLOGY, V144, P720, DOI 10.1210/en.2002-220847; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vankelecom H, 2007, SEMIN CELL DEV BIOL, V18, P559, DOI 10.1016/j.semcdb.2007.04.006; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; Young KM, 2010, GLIA, V58, P943, DOI 10.1002/glia.20976	25	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11443	10.1371/journal.pone.0011443	http://dx.doi.org/10.1371/journal.pone.0011443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625432	gold, Green Published, Green Submitted			2022-12-27	WOS:000279522500010
J	Zhang, JX; Yan, XD; Shi, JF; Gong, QY; Weng, XC; Liu, YJ				Zhang, Jiaxing; Yan, Xiaodan; Shi, Jinfu; Gong, Qiyong; Weng, Xuchu; Liu, Yijun			Structural Modifications of the Brain in Acclimatization to High-Altitude	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; VOXEL-BASED MORPHOMETRY; HYPOXIC VENTILATORY RESPONSIVENESS; MILD COGNITIVE IMPAIRMENT; ANTERIOR CINGULATE CORTEX; CHRONIC MOUNTAIN-SICKNESS; SUBJECT DIFFUSION DATA; FRACTIONAL ANISOTROPY; SPATIAL STATISTICS; PREFRONTAL CORTEX	Adaptive changes in respiratory and cardiovascular responses at high altitude (HA) have been well clarified. However, the central mechanisms underlying HA acclimatization remain unclear. Using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI) with fractional anisotropy (FA) calculation, we investigated 28 Han immigrant residents (17-22 yr) born and raised at HA of 2616-4200 m in Qinghai-Tibetan Plateau for at least 17 years and who currently attended college at sea-level (SL). Their family migrated from SL to HA 2-3 generations ago and has resided at HA ever since. Control subjects were matched SL residents. HA residents (vs. SL) showed decreased grey matter volume in the bilateral anterior insula, right anterior cingulate cortex, bilateral prefrontal cortex, left precentral cortex, and right lingual cortex. HA residents (vs. SL) had significantly higher FA mainly in the bilateral anterior limb of internal capsule, bilateral superior and inferior longitudinal fasciculus, corpus callosum, bilateral superior corona radiata, bilateral anterior external capsule, right posterior cingulum, and right corticospinal tract. Higher FA values in those regions were associated with decreased or unchanged radial diffusivity coinciding with no change of longitudinal diffusivity in HA vs. SL group. Conversely, HA residents had lower FA in the left optic radiation and left superior longitudinal fasciculus. Our data demonstrates that HA acclimatization is associated with brain structural modifications, including the loss of regional cortical grey matter accompanied by changes in the white matter, which may underlie the physiological adaptation of residents at HA.	[Zhang, Jiaxing; Shi, Jinfu; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Lab Higher Brain Funct, Beijing 100101, Peoples R China; [Zhang, Jiaxing] Xiamen Univ, Coll Med, Dept Physiol & Neurobiol, Xiamen, Peoples R China; [Yan, Xiaodan] NYU, Langone Med Ctr, New York, NY USA; [Gong, Qiyong] Sichuan Univ, W China Hosp, Huaxi Magnet Resonance Res Ctr, Chengdu 610064, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Xiamen University; New York University; NYU Langone Medical Center; Sichuan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Zhang, JX (corresponding author), Chinese Acad Sci, Inst Psychol, Lab Higher Brain Funct, Beijing 100101, Peoples R China.	xzhangj@163.com	Gong, Qiyong/W-3052-2019	Gong, Qiyong/0000-0002-5912-4871	National Science Foundation of China [30425008, 60628101]; Ministry of Science and Technology [2007CB512300]; China Postdoctoral Science Foundation [20060390129]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by National Science Foundation of China (Project No. 30425008, No. 60628101), Ministry of Science and Technology (Project No. 2007CB512300) and China Postdoctoral Science Foundation (Project No. 20060390129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beppu T, 2005, SURG NEUROL, V63, P56, DOI 10.1016/j.surneu.2004.02.034; Bernardi L, 1998, CLIN SCI, V95, P565, DOI 10.1042/cs0950565; Binks AP, 2008, J APPL PHYSIOL, V104, P212, DOI 10.1152/japplphysiol.00069.2007; Boero JA, 1999, J APPL PHYSIOL, V86, P1211, DOI 10.1152/jappl.1999.86.4.1211; Bookstein FL, 2001, NEUROIMAGE, V14, P1454, DOI 10.1006/nimg.2001.0770; Brutsaert TD, 1999, AM J HUM BIOL, V11, P383, DOI 10.1002/(SICI)1520-6300(1999)11:3<383::AID-AJHB9>3.0.CO;2-X; BURNS SM, 1985, BRAIN RES, V340, P71, DOI 10.1016/0006-8993(85)90774-7; Chang LD, 2008, J NEUROIMMUNE PHARM, V3, P265, DOI 10.1007/s11481-008-9120-8; Chua TC, 2008, CURR OPIN NEUROL, V21, P83, DOI 10.1097/WCO.0b013e3282f4594b; Claydon VE, 2008, STROKE, V39, P336, DOI 10.1161/STROKEAHA.107.491498; Concha L, 2005, ANN NEUROL, V57, P188, DOI 10.1002/ana.20334; Constantinidis Christos, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P444, DOI 10.3758/CABN.4.4.444; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Curran LS, 1997, J APPL PHYSIOL, V83, P2098, DOI 10.1152/jappl.1997.83.6.2098; Dani JA, 2007, NAT NEUROSCI, V10, P403, DOI 10.1038/nn0407-403; Davatzikos C, 2004, NEUROIMAGE, V23, P17, DOI 10.1016/j.neuroimage.2004.05.010; Davenport PW, 2009, RESP PHYSIOL NEUROBI, V167, P72, DOI 10.1016/j.resp.2008.10.001; FRISANCHO AR, 1975, SCIENCE, V187, P313, DOI 10.1126/science.1089311; FRISANCHO AR, 1977, INT J BIOMETEOROL, V21, P135, DOI 10.1007/BF01553707; FRISANCHO AR, 1973, J APPL PHYSIOL, V34, P176, DOI 10.1152/jappl.1973.34.2.176; Frisancho AR, 1999, AM J PHYS ANTHROPOL, V109, P295, DOI 10.1002/(SICI)1096-8644(199907)109:3<295::AID-AJPA2>3.0.CO;2-U; FRISANCHO AR, 1995, AM J PHYS ANTHROPOL, V96, P431, DOI 10.1002/ajpa.1330960408; Gao W, 2009, AM J NEURORADIOL, V30, P290, DOI 10.3174/ajnr.A1363; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Green AL, 2008, EXP PHYSIOL, V93, P1022, DOI 10.1113/expphysiol.2007.039461; Gulani V, 2006, J NEURO-OPHTHALMOL, V26, P51, DOI 10.1097/01.wno.0000205978.86281.3e; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Hogan AM, 2010, DEVELOPMENTAL SCI, V13, P533, DOI 10.1111/j.1467-7687.2009.00909.x; Huang BY, 2008, RADIOGRAPHICS, V28, P417, DOI 10.1148/rg.282075066; Hyafil A, 2009, J NEUROSCI, V29, P5135, DOI 10.1523/JNEUROSCI.2828-08.2009; Jansen GFA, 2007, J APPL PHYSIOL, V103, P518, DOI 10.1152/japplphysiol.01429.2006; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kanaan A, 2006, AM J PHYSIOL-REG I, V290, pR1105, DOI 10.1152/ajpregu.00535.2005; Kimmerly DS, 2007, AM J PHYSIOL-HEART C, V293, pH299, DOI 10.1152/ajpheart.00044.2007; LAMANNA JC, 1992, J APPL PHYSIOL, V72, P2238, DOI 10.1152/jappl.1992.72.6.2238; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Marconi C, 2004, J PHYSIOL-LONDON, V556, P661, DOI 10.1113/jphysiol.2003.059188; Moore LG, 2007, RESP PHYSIOL NEUROBI, V158, P180, DOI 10.1016/j.resp.2007.06.016; Morrell MJ, 2006, ADV EXP MED BIOL, V588, P75; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; PAPEZ JW, 1995, J NEUROPSYCH CLIN N, V7, P103; Paulus MP, 2009, NEUROSCI BIOBEHAV R, V33, P1080, DOI 10.1016/j.neubiorev.2009.05.003; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; PETERS J, 2009, NEUROSCIENC IN PRESS; Rivera-Ch M, 2003, J APPL PHYSIOL, V94, P1263, DOI 10.1152/japplphysiol.00857.2002; Schwartz ED, 2003, EXP NEUROL, V184, P570, DOI 10.1016/S0014-4886(03)00295-4; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Silton RL, 2010, NEUROIMAGE, V50, P1292, DOI 10.1016/j.neuroimage.2009.12.061; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Talairach I., 1988, COPLANAR STEREOTACTI; Thomalla G, 2004, NEUROIMAGE, V22, P1767, DOI 10.1016/j.neuroimage.2004.03.041; TRIPATHY V, 2006, HUM ECOL, V14, P77; Verberne AJM, 1998, PROG NEUROBIOL, V54, P149, DOI 10.1016/S0301-0082(97)00056-7; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; von Leupoldt A, 2005, CHEST, V128, P345, DOI 10.1378/chest.128.1.345; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wideroe M, 2009, NEUROIMAGE, V45, P880, DOI 10.1016/j.neuroimage.2008.12.007; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Wobrock T, 2008, BIOL PSYCHIAT, V63, P65, DOI 10.1016/j.biopsych.2007.02.026; Wu TY, 2006, HIGH ALT MED BIOL, V7, P193, DOI 10.1089/ham.2006.7.193; Zhang Y, 2007, NEUROLOGY, V68, P13, DOI 10.1212/01.wnl.0000250326.77323.01; ZHUANG J, 1993, J APPL PHYSIOL, V74, P303, DOI 10.1152/jappl.1993.74.1.303	74	35	40	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11449	10.1371/journal.pone.0011449	http://dx.doi.org/10.1371/journal.pone.0011449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625426	Green Submitted, Green Published, gold			2022-12-27	WOS:000279522500016
J	Kalhan, R; Tran, BT; Colangelo, LA; Rosenberg, SR; Liu, KA; Thyagarajan, B; Jacobs, DR; Smith, LJ				Kalhan, Ravi; Tran, Betty T.; Colangelo, Laura A.; Rosenberg, Sharon R.; Liu, Kiang; Thyagarajan, Bharat; Jacobs, David R., Jr.; Smith, Lewis J.			Systemic Inflammation in Young Adults Is Associated with Abnormal Lung Function in Middle Age	PLOS ONE			English	Article							C-REACTIVE PROTEIN; PULMONARY-FUNCTION; PLASMA-FIBRINOGEN; RISK DEVELOPMENT; DISEASE; COPD; POPULATION; MARKERS; HYPERTENSION; RECRUITMENT	Background: Systemic inflammation is associated with reduced lung function in both healthy individuals and those with chronic obstructive pulmonary disease (COPD). Whether systemic inflammation in healthy young adults is associated with future impairment in lung health is uncertain. Methodology/Principal Findings: We evaluated the association between plasma fibrinogen and C-reactive protein (CRP) in young adults and lung function in the Coronary Artery Risk Development in Young Adults cohort study. Higher year 7 fibrinogen was associated with greater loss of forced vital capacity (FVC) between years 5 and 20 (439 mL in quartile 4 vs. 398 mL in quartile 1, P<0.001) and forced expiratory volume in 1 second (FEV1) (487 mL in quartile 4 vs. 446 mL in quartile 1, P<0.001) independent of cigarette smoking, body habitus, baseline lung function and demographic factors. Higher year 7 CRP was also associated with both greater loss of FVC (455 mL in quartile 4 vs. 390 mL in quartile 1, P<0.001) and FEV1 (491 mL in quartile 4 vs. 442 mL in quartile 1, P = 0.001). Higher year 7 fibrinogen and CRP were associated with abnormal FVC at year 20 (odds ratio (OR) per standard deviation 1.51 (95% confidence interval (CI): 1.30-1.75) for fibrinogen and 1.35 (95% CI: 1.14-1.59) for CRP). Higher year 5 fibrinogen was additionally associated with abnormal FEV1. A positive interaction was observed between pack-years cigarette smoking and year 7 CRP for the COPD endpoint, and among participants with greater than 10 pack-years of cigarette exposure, year 7 CRP was associated with greater odds of COPD at year 20 (OR per standard deviation 1.53 (95% CI: 1.08-2.16). Conclusion/Significance: Systemic inflammation in young adults is associated with abnormal lung function in middle age. In particular, elevated CRP may identify vulnerability to COPD among individuals who smoke.	[Kalhan, Ravi; Rosenberg, Sharon R.; Smith, Lewis J.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Asthma Chron Obstruct Pulm Dis COPD, Chicago, IL 60611 USA; [Tran, Betty T.] Univ Washington, Div Pulm & Crit Care, Seattle, WA 98195 USA; [Colangelo, Laura A.; Liu, Kiang] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Thyagarajan, Bharat] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; Northwestern University; Feinberg School of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Kalhan, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care Med, Asthma Chron Obstruct Pulm Dis COPD, Chicago, IL 60611 USA.	r-kalhan@northwestern.edu	Fazli, Ghazal/AAE-8320-2022	Jacobs, David/0000-0002-7232-0543; Smith, Lewis J/0000-0002-4728-1562; Kalhan, Ravi/0000-0003-2443-0876	National Heart, Lung, and Blood Institute (NHLBI) [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095, N01-HC045134]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048050, N01HC095095, N01HC048047, N01HC045134, N01HC048048, N01HC048049] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053560, R01HL048049, R29HL048048, R01HL048048, R01HL048050] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The CARDIA study is funded by National Heart, Lung, and Blood Institute (NHLBI, www.nhlbi.nih.gov) contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers), N01-HC-95095 (CARDIA Coordinating Center), and N01-HC045134 Reading Center (CARDIA Pulmonary Reading Center). NHLBI had no role in the data analysis, interpretation, or writing of this report. This manuscript was reviewed and approved by CARDIA's independent Publications and Presentations and Steering Committees.	[Anonymous], 1979, AM REV RESPIR DIS, V119, P831; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; Aronson D, 2006, AM J RESP CRIT CARE, V174, P626, DOI 10.1164/rccm.200602-243OC; Engstrom G, 2009, THORAX, V64, P211, DOI 10.1136/thx.2008.102079; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Haffner SM, 2007, AM J MED, V120, P10, DOI 10.1016/j.amjmed.2007.06.006; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Lakoski SG, 2006, ARCH INTERN MED, V166, P345, DOI 10.1001/archinte.166.3.345; MacNee William, 2005, Proc Am Thorac Soc, V2, P50, DOI 10.1513/pats.200411-056SF; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; Reiner AP, 2006, J THROMB HAEMOST, V4, P1279, DOI 10.1111/j.1538-7836.2006.01907.x; Rossi A, 2008, INT J OBESITY, V32, P1423, DOI 10.1038/ijo.2008.103; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Sunyer J, 2008, EUR RESPIR J, V32, P92, DOI 10.1183/09031936.00052507; Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049; van Durme YMTA, 2009, AM J RESP CRIT CARE, V179, P375, DOI 10.1164/rccm.200810-1540OC; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Walter RE, 2008, CHEST, V133, P19, DOI 10.1378/chest.07-0058	29	70	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11431	10.1371/journal.pone.0011431	http://dx.doi.org/10.1371/journal.pone.0011431			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625390	Green Submitted, Green Published, gold			2022-12-27	WOS:000279465700013
J	Mogha, A; Fautrel, A; Mouchet, N; Guo, N; Corre, S; Adamski, H; Watier, E; Misery, L; Galibert, MD				Mogha, Ariane; Fautrel, Alain; Mouchet, Nicolas; Guo, Na; Corre, Sebastien; Adamski, Henri; Watier, Eric; Misery, Laurent; Galibert, Marie-Dominique			Merkel Cell Polyomavirus Small T Antigen mRNA Level Is Increased following In Vivo UV-Radiation	PLOS ONE			English	Article							SOLAR-SIMULATED RADIATION; CARCINOMA; SKIN; GENE; DNA; IDENTIFICATION; TRANSCRIPTION; EXPRESSION; PROTEIN; QUANTIFICATION	Merkel cell carcinoma (MCC) is a rare but aggressive skin cancer involving Merkel cells. Recently, a new human polyomavirus was implicated in MCC, being present in 80% of the samples analyzed. In virus-positive MCC, the Merkel cell polyomavirus (MCPyV) is clonally integrated into the patients DNA, and carries mutations in its large T antigen, leading to a truncated protein. In non-symptomatic tissue MCPyV can reside at very low levels. MCC is also associated with older age, immunosuppression and sun exposure. However, the link with solar exposure remains unknown, as the precise mechanism and steps involved between time of infection by MCPyV and the development of MCC. We thus investigated the potential impact of solar simulated radiation (SSR) on MCPyV transcriptional activity. We screened skin samples of 20 healthy patients enrolled in a photodermatological protocol based on in vivo-administered 2 and 4 J/cm(2) SSR. Two patients were infected with two new variants of MCPyV, present in their episomal form and RT-QPCR analyses on SSR-irradiated skin samples showed a specific and unique dose-dependent increase of MCPyV small t antigen transcript. A luciferase based in vitro assay confirmed that small t promoter is indeed UV-inducible. These findings demonstrate that solar radiation has an impact on MCPyV mRNA levels that may explain the association between MCC and solar exposure.	[Mogha, Ariane; Mouchet, Nicolas; Guo, Na; Corre, Sebastien; Galibert, Marie-Dominique] CNRS, Fac Med, Inst Genet & Dev Rennes, Equipe RTO,UMR 6061, Rennes, France; [Mogha, Ariane; Mouchet, Nicolas; Guo, Na; Corre, Sebastien; Galibert, Marie-Dominique] Univ Rennes 1, GFAS IFR140, Rennes, France; [Fautrel, Alain] Univ Rennes 1, Fac Med, Plateforme Histopathol BioGenouest IFR140 GFAS, Rennes, France; [Mouchet, Nicolas] PROCLAIM, St Gregoire, France; [Adamski, Henri] CHU Pontchaillou, Serv Dermatol, Rennes, France; [Watier, Eric] Hop Sud, Serv Chirurg Plast, Rennes, France; [Misery, Laurent] Univ Brest, EA Lab Neurobiol Cutanee 4326, Brest, France; [Galibert, Marie-Dominique] CHU Pontchaillou, Lab Genom Med, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Universite de Rennes; CHU Rennes; CHU Rennes; Universite de Bretagne Occidentale; CHU Rennes	Mogha, A (corresponding author), CNRS, Fac Med, Inst Genet & Dev Rennes, Equipe RTO,UMR 6061, Rennes, France.	mgaliber@univ-rennes1.fr	Fautrel, Alain/AAL-7391-2020; Mouchet, Nicolas/AAP-6126-2020; CORRE, Sebastien/B-7069-2018; Misery, Laurent/I-1186-2019	Mouchet, Nicolas/0000-0002-2849-9953; CORRE, Sebastien/0000-0003-1532-5660; FAUTREL, Alain/0000-0002-3449-0779	CNRS; Rennes University; Rennes CHU; LNCC Comite Departementaux du Grand Ouest; MRE;  [UMR6061-IGDR]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Rennes University; Rennes CHU; LNCC Comite Departementaux du Grand Ouest; MRE; 	The authors greatly thank the CNRS, the UMR6061-IGDR, Rennes University, and the Rennes CHU for their support. This work has been also supported in part by the LNCC Comite Departementaux du Grand Ouest, which the authors deeply acknowledge. Finally, Ariane Mogha was funded by the research ministry through a MRE-PhD-Fellowship. The funders, except for PROCLAIM company members, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The PROCLAIM collaborator had a role in data collection.	ANDRES C, 2009, J CUTAN PATHOL; Averbeck M, 2006, EXP DERMATOL, V15, P447, DOI 10.1111/j.0906-6705.2006.00429.x; Becker JC, 2009, J INVEST DERMATOL, V129, P248, DOI 10.1038/jid.2008.198; Boulais N, 2007, J AM ACAD DERMATOL, V57, P147, DOI 10.1016/j.jaad.2007.02.009; Carter JJ, 2009, JNCI-J NATL CANCER I, V101, P1510, DOI 10.1093/jnci/djp332; Cheng QZ, 2009, COMPOS PART A-APPL S, V40, P218, DOI 10.1016/j.compositesa.2008.11.009; Ciotti P, 2009, DIAGN MOL PATHOL, V18, P112, DOI 10.1097/PDM.0b013e3181831320; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; Corre S, 2006, J INVEST DERMATOL, V126, P916, DOI 10.1038/sj.jid.5700190; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Dalianis T, 2009, SEMIN CANCER BIOL, V19, P270, DOI 10.1016/j.semcancer.2009.04.001; Duncavage EJ, 2009, MODERN PATHOL, V22, P516, DOI 10.1038/modpathol.2009.3; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; Garcin G, 2009, PHOTOCHEM PHOTOBIOL, V85, P1440, DOI 10.1111/j.1751-1097.2009.00598.x; Garneski KM, 2009, J INVEST DERMATOL, V129, P246, DOI 10.1038/jid.2008.229; Kassem A, 2008, CANCER RES, V68, P5009, DOI 10.1158/0008-5472.CAN-08-0949; Katano H, 2009, J MED VIROL, V81, P1951, DOI 10.1002/jmv.21608; Khalili K, 2008, J CELL PHYSIOL, V215, P309, DOI 10.1002/jcp.21326; Kuhn M, 2006, ARCH DERMATOL RES, V297, P477, DOI 10.1007/s00403-006-0648-2; Kwun HJ, 2009, J VIROL, V83, P12118, DOI 10.1128/JVI.01336-09; Latonen L, 2010, PHOTODERMATOL PHOTO, V26, P70, DOI 10.1111/j.1600-0781.2010.00488.x; Lemos B, 2007, J INVEST DERMATOL, V127, P2100, DOI 10.1038/sj.jid.5700925; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Mestdagh P, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn725; Miller RW, 1999, CANCER EPIDEM BIOMAR, V8, P153; Moens U, 2007, CELL MOL LIFE SCI, V64, P1656, DOI 10.1007/s00018-007-7020-3; Mouchet N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010776; Purdie KJ, 1999, EMBO J, V18, P5359, DOI 10.1093/emboj/18.19.5359; RONAI ZA, 1990, CANCER RES, V50, P5374; RONAI ZA, 1988, J VIROL, V62, P1057, DOI 10.1128/JVI.62.3.1057-1060.1988; RUTBERG SE, 1992, NUCLEIC ACIDS RES, V20, P4305, DOI 10.1093/nar/20.16.4305; Sadowska B, 2003, J VIROL, V77, P665, DOI 10.1128/JVI.77.1.665-672.2003; Sastre-Garau X, 2009, J PATHOL, V218, P48, DOI 10.1002/path.2532; Seite S, 2004, PHOTOCHEM PHOTOBIOL, V79, P265, DOI 10.1562/YG-03-09.1; TOKER C, 1972, ARCH DERMATOL, V105, P107, DOI 10.1001/archderm.105.1.107; Tolstov YL, 2009, INT J CANCER, V125, P1250, DOI 10.1002/ijc.24509; Touze A, 2009, EMERG INFECT DIS, V15, P960, DOI 10.3201/eid1506.081463; Varga E, 2009, BRIT J DERMATOL, V161, P930, DOI 10.1111/j.1365-2133.2009.09221.x; Wieland U, 2009, EMERG INFECT DIS, V15, P1496, DOI 10.3201/eid1509.081575	43	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11423	10.1371/journal.pone.0011423	http://dx.doi.org/10.1371/journal.pone.0011423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625394	Green Published, gold, Green Submitted			2022-12-27	WOS:000279465700010
J	Brandley, MC; Wang, YZ; Guo, XG; de Oca, ANM; Ortiz, MF; Hikida, T; Ota, H				Brandley, Matthew C.; Wang, Yuezhao; Guo, Xianguang; Nieto Montes de Oca, Adrian; Feria Ortiz, Manuel; Hikida, Tsutomu; Ota, Hidetoshi			Bermuda as an Evolutionary Life Raft for an Ancient Lineage of Endangered Lizards	PLOS ONE			English	Article							LATE PLEISTOCENE; AVES; DIVERSIFICATION; STRATIGRAPHY; SPECIATION; TERRAPINS; RALLIDAE; POSITION; CHOICE	Oceanic islands are well known for harboring diverse species assemblages and are frequently the basis of research on adaptive radiation and neoendemism. However, a commonly overlooked role of some islands is their function in preserving ancient lineages that have become extinct everywhere else (paleoendemism). The island archipelago of Bermuda is home to a single species of extant terrestrial vertebrate, the endemic skink Plestiodon (formerly Eumeces) longirostris. The presence of this species is surprising because Bermuda is an isolated, relatively young oceanic island approximately 1000 km from the eastern United States. Here, we apply Bayesian phylogenetic analyses using a relaxed molecular clock to demonstrate that the island of Bermuda, although no older than two million years, is home to the only extant representative of one of the earliest mainland North American Plestiodon lineages, which diverged from its closest living relatives 11.5 to 19.8 million years ago. This implies that, within a short geological time frame, mainland North American ancestors of P. longirostris colonized the recently emergent Bermuda and the entire lineage subsequently vanished from the mainland. Thus, our analyses reveal that Bermuda is an example of a "life raft'' preserving millions of years of unique evolutionary history, now at the brink of extinction. Threats such as habitat destruction, littering, and non-native species have severely reduced the population size of this highly endangered lizard.	[Brandley, Matthew C.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Brandley, Matthew C.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wang, Yuezhao; Guo, Xianguang] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Nieto Montes de Oca, Adrian; Feria Ortiz, Manuel] Univ Nacl Autonoma Mexico, Fac Ciencias, Dept Biol Evolut, Mexico City 04510, DF, Mexico; [Hikida, Tsutomu] Kyoto Univ, Grad Sch Sci, Dept Zool, Kyoto, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Universidad Nacional Autonoma de Mexico; Kyoto University	Brandley, MC (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	matthew.brandley@yale.edu	Guo, Xianguang/C-3282-2013; NIETO-MONTES DE OCA, ADRIAN/GQP-4296-2022	Guo, Xianguang/0000-0001-7721-7388; 	National Natural Science Foundation of China [30700062]; National Science Foundation [OISE 0513295, OISE 0611646]; National Science Foundation Doctoral Dissertation Improvement [DEB 0709885]; Linnean Society Systematics Fund; Museum of Vertebrate Zoology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Doctoral Dissertation Improvement(National Science Foundation (NSF)); Linnean Society Systematics Fund; Museum of Vertebrate Zoology	This project was funded the National Natural Science Foundation of China (30700062) awarded to X. G.; and the the National Science Foundation East Asia and Pacific Program grants (OISE 0513295 and OISE 0611646, in conjunction with the National Natural Science Foundation of China and the Japan Society for the Promotion of Science), National Science Foundation Doctoral Dissertation Improvement grant (DEB 0709885), the Linnean Society Systematics Fund, and multiple grants from the Museum of Vertebrate Zoology awarded to M. C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BRANDLEY MC, 2010, SYST BIOL IN PRESS; Calsbeek R, 2003, NATURE, V426, P552, DOI 10.1038/nature02143; Censky EJ, 1998, NATURE, V395, P556, DOI 10.1038/26886; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Coughlan JP, 2004, MOL ECOL NOTES, V4, P678, DOI 10.1111/j.1471-8286.2004.00782.x; Davenport J, 2005, CHELONIAN CONSERV BI, V4, P956; Davenport J, 2001, ORYX, V35, P332, DOI 10.1046/j.1365-3008.2001.00200.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Evans SE, 1999, GEOBIOS-LYON, V32, P889, DOI 10.1016/S0016-6995(99)80871-7; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; GARMAN S, 1884, B US NAT HIST MUS, V25, P287; Gillespie RG, 2002, ANNU REV ENTOMOL, V47, P595, DOI 10.1146/annurev.ento.47.091201.145244; HEARTY PJ, 1992, GEOL SOC AM BULL, V104, P471, DOI 10.1130/0016-7606(1992)104<0471:AAAOPL>2.3.CO;2; Hearty PJ, 1999, GEOLOGY, V27, P375, DOI 10.1130/0091-7613(1999)027<0375:AMMPSL>2.3.CO;2; Hearty PJ, 2004, QUATERNARY SCI REV, V23, P1151, DOI 10.1016/j.quascirev.2003.09.008; Hearty PJ, 2002, SEDIMENT GEOL, V153, P1, DOI 10.1016/S0037-0738(02)00261-0; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; IUCN, 2008, 2008 IUCN RED LIST T; Jamieson IG, 2007, ANIM CONSERV, V10, P139, DOI 10.1111/j.1469-1795.2006.00095.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Meylan PA, 2000, ZOOL J LINN SOC-LOND, V128, P51, DOI 10.1006/zjls.1999.0199; Nydam RL, 2002, J VERTEBR PALEONTOL, V22, P276, DOI 10.1671/0272-4634(2002)022[0276:ANTLFT]2.0.CO;2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Olson SL, 2000, P BIOL SOC WASH, V113, P356; Olson SL, 2003, P NATL ACAD SCI USA, V100, P12825, DOI 10.1073/pnas.1934576100; Olson SL, 2001, P BIOL SOC WASH, V114, P509; Olson SL, 2008, P BIOL SOC WASH, V121, P130, DOI 10.2988/07-27.1; Olson SL, 2006, J HERPETOL, V40, P394, DOI 10.1670/0022-1511(2006)40[394:GCOEAS]2.0.CO;2; Olson Storrs L., 2005, Monografies de la Societat d'Historia Natural de les Balears, V12, P219; Parham JF, 2008, BIOL LETTERS, V4, P216, DOI 10.1098/rsbl.2007.0599; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith Hobart M., 2005, Journal of Kansas Herpetology, V14, P15; STEBBINS GL, 1965, ECOL MONOGR, V35, P1, DOI 10.2307/1942216; Sterrer W, 1998, B MAR SCI, V62, P809; TAYLOR EH, 1935, KANSAS U SCI B, V23, P1; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; VACHER HL, 1995, GEOLOGICAL SOC AM SP, V300, P269; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; WINGATE DAVID B., 1965, HERPETOLOGICA, V21, P202	45	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11375	10.1371/journal.pone.0011375	http://dx.doi.org/10.1371/journal.pone.0011375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614024	gold, Green Published			2022-12-27	WOS:000279370000008
J	Ghosh, M; Fahey, JV; Shen, Z; Lahey, T; Cu-Uvin, S; Wu, ZJ; Mayer, K; Wright, PF; Kappes, JC; Ochsenbauer, C; Wira, CR				Ghosh, Mimi; Fahey, John V.; Shen, Zheng; Lahey, Timothy; Cu-Uvin, Susan; Wu, Zhijin; Mayer, Kenneth; Wright, Peter F.; Kappes, John C.; Ochsenbauer, Christina; Wira, Charles R.			Anti-HIV Activity in Cervical-Vaginal Secretions from HIV-Positive and -Negative Women Correlate with Innate Antimicrobial Levels and IgG Antibodies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; FEMALE GENITAL-TRACT; LEUKOCYTE PROTEASE INHIBITOR; UTERINE EPITHELIAL-CELLS; HOST-DEFENSE; MENSTRUAL-CYCLE; CERVICOVAGINAL SECRETIONS; IMMUNE FACTORS; 1-INFECTED INDIVIDUALS; SEXUAL TRANSMISSION	Background: We investigated the impact of antimicrobials in cervicovaginal lavage (CVL) from HIV(+) and HIV(-) women on target cell infection with HIV. Since female reproductive tract (FRT) secretions contain a spectrum of antimicrobials, we hypothesized that CVL from healthy HIV(+) and (-) women inhibit HIV infection. Methodology/Principal Findings: CVL from 32 HIV(+) healthy women with high CD4 counts and 15 healthy HIV(-) women were collected by gently washing the cervicovaginal area with 10 ml of sterile normal saline. Following centrifugation, anti-HIV activity in CVL was determined by incubating CVL with HIV prior to addition to TZM-bl cells. Antimicrobials and anti-gp160 HIV IgG antibodies were measured by ELISA. When CXCR4 and CCR5 tropic HIV-1 were incubated with CVL from HIV(+) women prior to addition to TZM-bl cells, anti-HIV activity in CVL ranged from none to 100% inhibition depending on the viral strains used. CVL from HIV(-) controls showed comparable anti-HIV activity. Analysis of CH077.c (clone of an R5-tropic, mucosally-transmitted founder virus) viral inhibition by CVL was comparable to laboratory strains. Measurement of CVL for antimicrobials HBD2, trappin-2/elafin, SLPI and MIP3 alpha indicated that each was present in CVL from HIV(+) and HIV(-) women. HBD2 and MIP3 alpha correlated with anti-HIV activity as did anti-gp160 HIV IgG antibodies in CVL from HIV(+) women. Conclusions/Significance: These findings indicate that CVL from healthy HIV(+) and HIV(-) women contain innate and adaptive defense mechanisms that inhibit HIV infection. Our data suggest that innate endogenous antimicrobials and HIV-specific IgG in the FRT can act in concert to contribute toward the anti-HIV activity of the CVL and may play a role in inhibition of HIV transmission to women.	[Ghosh, Mimi; Fahey, John V.; Shen, Zheng; Wira, Charles R.] Dartmouth Med Sch, Dept Physiol, Lebanon, NH 03756 USA; [Lahey, Timothy] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH USA; [Lahey, Timothy] Dartmouth Med Sch, Dept Med, Lebanon, NH USA; [Cu-Uvin, Susan; Mayer, Kenneth] Brown Univ, Miriam Hosp, Ctr Immunol, Providence, RI USA; [Wu, Zhijin] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Wu, Zhijin] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; [Wright, Peter F.] Dartmouth Med Sch, Dept Pediat, Lebanon, NH USA; [Kappes, John C.; Ochsenbauer, Christina] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Kappes, John C.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA	Dartmouth College; Dartmouth College; Dartmouth College; Brown University; Lifespan Health Rhode Island; Miriam Hospital; Brown University; Brown University; Dartmouth College; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Ghosh, M (corresponding author), Dartmouth Med Sch, Dept Physiol, Lebanon, NH 03756 USA.	Charles.R.Wira@dartmouth.edu	wu, zhijin/J-4995-2016; wu, zhijin/J-2282-2014	wu, zhijin/0000-0002-9596-9134; 	National Institutes of Health Grants Allergy and Infectious Diseases [(AI)51877, AI13541, AI40350, AI066884, U01-AI067854]; Lifespan/Tufts/Brown Centers for AIDS Research (CFAR) [P30AI42853]; Centers for Disease Control (CDC) [106795]; University of Alabama CFAR [P30-AI27767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI066884, R37AI013541, R01AI013541, P30AI027767, R01AI040350, P30AI042853, P01AI051877, R03AI102837, R01AI071761, U01AI067854, R21AI040350, R55AI013541] Funding Source: NIH RePORTER	National Institutes of Health Grants Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Lifespan/Tufts/Brown Centers for AIDS Research (CFAR); Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Alabama CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants Allergy and Infectious Diseases (AI)51877 and AI13541 (CRW), AI40350 and AI066884, (SUC), U01-AI067854 (JCK and COJ); Lifespan/Tufts/Brown Centers for AIDS Research (CFAR) P30AI42853, Centers for Disease Control (CDC) 106795 (SUC and KM) and the Virology and Nucleotide Sequencing Cores of the University of Alabama CFAR (P30-AI27767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R, 2007, CURR HIV RES, V5, P588, DOI 10.2174/157016207782418452; Benki S, 2008, JAIDS-J ACQ IMM DEF, V47, P529, DOI 10.1097/QAI.0b013e318165b952; Berlier W, 2005, J MED VIROL, V77, P465, DOI 10.1002/jmv.20478; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Cannon G, 2008, J IMMUNOL, V181, P2065, DOI 10.4049/jimmunol.181.3.2065; *CDC, 2008, HIV AIDS WOM; Cole AM, 2006, CURR TOP MICROBIOL, V306, P199; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; Cu-Uvin S, 2006, JAIDS-J ACQ IMM DEF, V42, P584, DOI 10.1097/01.qai.0000229997.52246.95; Cummins JE, 2007, AIDS RES HUM RETROV, V23, P748, DOI 10.1089/aid.2006.0233; Cummins JE, 2006, AIDS RES HUM RETROV, V22, P788, DOI 10.1089/aid.2006.22.788; Cummins JE, 2003, J CLIN MICROBIOL, V41, P4081, DOI 10.1128/JCM.41.9.4081-4088.2003; El Messaoudi K, 1999, AIDS, V13, P333, DOI 10.1097/00002030-199902250-00005; El Messaoudi K, 2000, J VIROL, V74, P1004, DOI 10.1128/JVI.74.2.1004-1007.2000; Fahey JV, 2008, MUCOSAL IMMUNOL, V1, P317, DOI 10.1038/mi.2008.20; Fan SR, 2008, INT J GYNECOL OBSTET, V103, P50, DOI 10.1016/j.ijgo.2008.05.020; Fiore JR, 2000, MICROBIOLOGICA, V23, P85; Florese RH, 2009, J IMMUNOL, V182, P3718, DOI 10.4049/jimmunol.0803115; FOX CA, 1973, J REPROD FERTIL, V33, P69; Garzino-Demo A, 2007, CURR PHARM DESIGN, V13, P163, DOI 10.2174/138161207779313696; GHOSH M, 2009, IMMUNOLOGY IN PRESS; Ghosh M, 2008, FERTIL STERIL, V89, P1497, DOI 10.1016/j.fertnstert.2007.05.023; Ghosh M, 2009, AM J REPROD IMMUNOL, V62, P60, DOI 10.1111/j.1600-0897.2009.00713.x; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hasan L, 2006, J IMMUNOL, V176, P6512, DOI 10.4049/jimmunol.176.11.6512; Hashemi FB, 2001, AIDS, V15, P441, DOI 10.1097/00002030-200103090-00002; HENIN Y, 1993, J ACQ IMMUN DEF SYND, V6, P72; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Iqbal SM, 2008, AM J REPROD IMMUNOL, V59, P44; Iqbal SM, 2009, AIDS, V23, P1669, DOI 10.1097/QAD.0b013e32832ea643; Jokimaa V, 2001, MOL HUM REPROD, V7, P73, DOI 10.1093/molehr/7.1.73; Kang G, 2005, NATL MED J INDIA, V18, P15; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keller MJ, 2007, AIDS, V21, P467, DOI 10.1097/QAD.0b013e328013d9b5; King AE, 2003, J REPROD IMMUNOL, V59, P1, DOI 10.1016/S0165-0378(02)00083-9; Kovacs A, 1999, J ACQ IMMUN DEF SYND, V22, P124; KREISS J, 1994, J INFECT DIS, V170, P1597, DOI 10.1093/infdis/170.6.1597; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; Levinson P, 2009, AIDS, V23, P309, DOI 10.1097/QAD.0b013e328321809c; Lim JK, 2006, J LEUKOCYTE BIOL, V80, P1395, DOI 10.1189/jlb.0406290; Margolis L, 2006, NAT REV MICROBIOL, V4, P312, DOI 10.1038/nrmicro1387; McNeely TB, 1997, BLOOD, V90, P1141, DOI 10.1182/blood.V90.3.1141.1141_1141_1149; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; Mestecky H, 2007, J REPROD IMMUNOL, V73, P85, DOI 10.1016/j.jri.2007.01.005; Mestecky J, 2004, AIDS RES HUM RETROV, V20, P972, DOI 10.1089/aid.2004.20.972; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; MOSS GB, 1991, J INFECT DIS, V164, P588, DOI 10.1093/infdis/164.3.588; Nag P, 2004, J INFECT DIS, V190, P1970, DOI 10.1086/425582; Nardelli-Haefliger D, 2003, JNCI-J NATL CANCER I, V95, P1128, DOI 10.1093/jnci/djg018; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Oravecz T, 1997, J EXP MED, V186, P1865, DOI 10.1084/jem.186.11.1865; POLI G, 1990, J EXP MED, V172, P151, DOI 10.1084/jem.172.1.151; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Reichelderfer PS, 2000, AIDS, V14, P2101, DOI 10.1097/00002030-200009290-00005; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Ryckman C, 2002, J IMMUNOL, V169, P3307, DOI 10.4049/jimmunol.169.6.3307; Saidi H, 2007, VIROLOGY, V358, P55, DOI 10.1016/j.virol.2006.07.029; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Schaefer TM, 2005, J IMMUNOL, V174, P992, DOI 10.4049/jimmunol.174.2.992; SCHUMACHER G F B, 1973, P201; Sha BE, 1997, J ACQ IMMUN DEF SYND, V16, P161, DOI 10.1097/00042560-199711010-00004; Shaw JLV, 2008, BIOL CHEM, V389, P1513, DOI 10.1515/BC.2008.171; Shioda T, 1998, P NATL ACAD SCI USA, V95, P6331, DOI 10.1073/pnas.95.11.6331; Skott P, 2002, ORAL DIS, V8, P160, DOI 10.1034/j.1601-0825.2002.01807.x; Spear GT, 2008, AIDS RES HUM RETROV, V24, P973, DOI 10.1089/aid.2008.0004; Spear GT, 2008, J REPROD IMMUNOL, V78, P76, DOI 10.1016/j.jri.2007.11.001; Spear Gregory T, 2007, AIDS Res Ther, V4, P25, DOI 10.1186/1742-6405-4-25; Steinstraesser L, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-2; Stoddard E, 2007, J IMMUNOL, V179, P3126, DOI 10.4049/jimmunol.179.5.3126; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Taggart CC, 2003, J IMMUNOL, V171, P931, DOI 10.4049/jimmunol.171.2.931; TeviBenissan C, 1997, CLIN DIAGN LAB IMMUN, V4, P367; Venkataraman N, 2005, J IMMUNOL, V175, P7560, DOI 10.4049/jimmunol.175.11.7560; Villanueva JM, 2002, J INFECT DIS, V185, P170, DOI 10.1086/338447; VOGT MW, 1986, LANCET, V1, P525; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wira CR, 2008, AIDS, V22, P1909, DOI 10.1097/QAD.0b013e3283060ea4; Wright PF, 2002, AIDS RES HUM RETROV, V18, P1291, DOI 10.1089/088922202320886334; Yamasaki K, 2006, FASEB J, V20, P2068, DOI 10.1096/fj.06-6075com; Zhang SP, 2003, INFECT IMMUN, V71, P1, DOI 10.1128/IAI.71.1.1-12.2003	83	101	104	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11366	10.1371/journal.pone.0011366	http://dx.doi.org/10.1371/journal.pone.0011366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614007	Green Published, gold			2022-12-27	WOS:000279369900015
J	Blondel, CJ; Yang, HJ; Castro, B; Chiang, S; Toro, CS; Zaldivar, M; Contreras, I; Andrews-Polymenis, HL; Santiviago, CA				Blondel, Carlos J.; Yang, Hee-Jeong; Castro, Benjamin; Chiang, Sebastian; Toro, Cecilia S.; Zaldivar, Mercedes; Contreras, Ines; Andrews-Polymenis, Helene L.; Santiviago, Carlos A.			Contribution of the Type VI Secretion System Encoded in SPI-19 to Chicken Colonization by Salmonella enterica Serotypes Gallinarum and Enteritidis	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; AGROBACTERIUM-TUMEFACIENS; ANALYSIS UNCOVERS; FAMILY PROTEIN; TYPHIMURIUM; VIRULENCE; REQUIRES; CLONING; IDENTIFICATION	Salmonella Gallinarum is a pathogen with a host range specific to poultry, while Salmonella Enteritidis is a broad host range pathogen that colonizes poultry sub-clinically but is a leading cause of gastrointestinal salmonellosis in humans and many other species. Despite recent advances in our understanding of the complex interplay between Salmonella and their hosts, the molecular basis of host range restriction and unique pathobiology of Gallinarum remain largely unknown. Type VI Secretion System (T6SS) represents a new paradigm of protein secretion that is critical for the pathogenesis of many Gram-negative bacteria. We recently identified a putative T6SS in the Salmonella Pathogenicity Island 19 (SPI-19) of Gallinarum. In Enteritidis, SPI-19 is a degenerate element that has lost most of the T6SS functions encoded in the island. In this work, we studied the contribution of SPI-19 to the colonization of Salmonella Gallinarum strain 287/91 in chickens. Non-polar deletion mutants of SPI-19 and the clpV gene, an essential T6SS component, colonized the ileum, ceca, liver and spleen of White Leghorn chicks poorly compared to the wild-type strain after oral inoculation. Return of SPI-19 to the Delta SPI-19 mutant, using VEX-Capture, complemented this colonization defect. In contrast, transfer of SPI-19 from Gallinarum to Enteritidis resulted in transient increase in the colonization of the ileum, liver and spleen at day 1 post-infection, but at days 3 and 5 post-infection a strong colonization defect of the gut and internal organs of the experimentally infected chickens was observed. Our data indicate that SPI-19 and the T6SS encoded in this region contribute to the colonization of the gastrointestinal tract and internal organs of chickens by Salmonella Gallinarum and suggest that degradation of SPI-19 T6SS in Salmonella Enteritidis conferred an advantage in colonization of the avian host.	[Blondel, Carlos J.; Zaldivar, Mercedes; Contreras, Ines; Santiviago, Carlos A.] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Yang, Hee-Jeong; Andrews-Polymenis, Helene L.] Texas A&M Univ Syst Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, Coll Med, College Stn, TX USA; [Castro, Benjamin; Chiang, Sebastian; Toro, Cecilia S.] Univ Chile, Programa Microbiol & Micol, Inst Ciencias Biomed, Fac Med, Santiago, Chile	Universidad de Chile; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Universidad de Chile	Blondel, CJ (corresponding author), Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile.	csantiviago@ciq.uchile.cl; handrews@medicine.tamhsc.edu	Santiviago, Carlos/N-9991-2018; Blondel, Carlos/X-7380-2019; Blondel, Carlos J/B-1287-2010	Santiviago, Carlos/0000-0002-7043-7908; Blondel, Carlos/0000-0002-7099-6347; Blondel, Carlos J/0000-0002-7099-6347; Yang, Hee-Jeong/0000-0002-7351-8404	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) [ADI-08/2006, 21080373, AT-24091015]; World Bank; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1100092]; "Vicerrectoria de Asuntos Academicos" (Departamento de Postgrado y Postitulo, Universidad de Chile); National Institutes of Health (NIH) [R21AI083964, R01AI083646, R56AI077645]; United States Department of Agriculture (USDA) [2009-03579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083964, R01AI083646, R56AI077645] Funding Source: NIH RePORTER	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); World Bank(The World Bank India); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); "Vicerrectoria de Asuntos Academicos" (Departamento de Postgrado y Postitulo, Universidad de Chile); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grant ADI-08/2006 from Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) and The World Bank, and grant 1100092 from Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT). CJB was supported by fellowships from CONICYT (21080373 and AT-24091015), and from "Vicerrectoria de Asuntos Academicos" (Departamento de Postgrado y Postitulo, Universidad de Chile). HLAP is supported by grants R21AI083964, R01AI083646 and R56AI077645 from the National Institutes of Health (NIH), and grant 2009-03579 from the United States Department of Agriculture (USDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrow PA, 2000, AVIAN PATHOL, V29, P423, DOI 10.1080/030794500750047171; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Cascales E, 2008, EMBO REP, V9, P735, DOI 10.1038/embor.2008.131; Chappell L, 2009, VET IMMUNOL IMMUNOP, V128, P53, DOI 10.1016/j.vetimm.2008.10.295; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eswarappa SM, 2009, INFECT GENET EVOL, V9, P468, DOI 10.1016/j.meegid.2009.01.004; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Iqbal M, 2005, INFECT IMMUN, V73, P2344, DOI 10.1128/IAI.73.4.2344-2350.2005; Jeong JH, 2008, J BACTERIOL, V190, P6340, DOI 10.1128/JB.00385-08; Jones MA, 2001, INFECT IMMUN, V69, P5471, DOI 10.1128/IAI.69.9.5471-5476.2001; Leiman PG, 2009, P NATL ACAD SCI USA, V106, P4154, DOI 10.1073/pnas.0813360106; Lowry VK, 1999, INT J FOOD MICROBIOL, V48, P139, DOI 10.1016/S0168-1605(99)00036-7; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Ma AT, 2009, CELL HOST MICROBE, V5, P234, DOI 10.1016/j.chom.2009.02.005; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; McMeechan A, 2007, RES MICROBIOL, V158, P79, DOI 10.1016/j.resmic.2006.10.008; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Schlieker C, 2005, BIOL CHEM, V386, P1115, DOI 10.1515/BC.2005.128; Shivaprasad HL, 2000, REV SCI TECH OIE, V19, P405, DOI 10.20506/rst.19.2.1222; Sivula CP, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-182; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Wilson JW, 2007, APPL ENVIRON MICROB, V73, P5911, DOI 10.1128/AEM.00952-07; Wilson JW, 2006, J BIOTECHNOL, V122, P147, DOI 10.1016/j.jbiotec.2005.09.005; Wilson JW, 2004, J MICROBIOL METH, V57, P297, DOI 10.1016/j.mimet.2004.01.007; Wu HY, 2008, J BACTERIOL, V190, P2841, DOI 10.1128/JB.01775-07; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x	34	55	60	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11724	10.1371/journal.pone.0011724	http://dx.doi.org/10.1371/journal.pone.0011724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661437	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300024
J	Jin, SX; Feig, LA				Jin, Shan-xue; Feig, Larry A.			Long-Term Potentiation in the CA1 Hippocampus Induced by NR2A Subunit-Containing NMDA Glutamate Receptors Is Mediated by Ras-GRF2/Erk Map Kinase Signaling	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; DIFFERENTIAL ROLES; GENE-EXPRESSION; INDUCTION; SUBTYPES; MEMORY; RAS; CONSOLIDATION; DEPRESSION; SYSTEM	Background: NMDA-type glutamate receptors (NMDARs) are major contributors to long-term potentiation (LTP), a form of synaptic plasticity implicated in the process of learning and memory. These receptors consist of calcium-permeating NR1 and multiple regulatory NR2 subunits. A majority of studies show that both NR2A and NR2B-containing NMDARs can contribute to LTP, but their unique contributions to this form of synaptic plasticity remain poorly understood. Methodology/Principal Findings: In this study, we show that NR2A and NR2B-containing receptors promote LTP differently in the CA1 hippocampus of 1-month old mice, with the NR2A receptors functioning through Ras-GRF2 and its downstream effector, Erk Map kinase, and NR2B receptors functioning independently of these signaling molecules. Conclusions/Significance: This study demonstrates that NR2A-, but not NR2B, containing NMDA receptors induce LTP in pyramidal neurons of the CA1 hippocamus from 1 month old mice through Ras-GRF2 and Erk. This difference add new significance to the observation that the relative levels of these NMDAR subtypes is regulated in neurons, such that NR2A-containing receptors become more prominent late in postnatal development, after sensory experience and synaptic activity.	[Jin, Shan-xue; Feig, Larry A.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Tufts University	Jin, SX (corresponding author), Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA.	larry.feig@tufts.edu			NIH [02R01MH083324-2, P30-NS047243]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH 02R01MH083324-2, P30-NS047243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; Dumas TC, 2005, HIPPOCAMPUS, V15, P562, DOI 10.1002/hipo.20077; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Flint AC, 1997, J NEUROSCI, V17, P2469; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kohr G, 2003, J NEUROSCI, V23, P10791; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Lisman J., 2006, SCI STKE, V2006, pr; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu XB, 2004, J NEUROSCI, V24, P8885, DOI 10.1523/JNEUROSCI.2476-04.2004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; RUDY JW, 1994, BEHAV NEUROSCI, V108, P227, DOI 10.1037/0735-7044.108.2.227; Tian XJ, 2004, EMBO J, V23, P1567, DOI 10.1038/sj.emboj.7600151; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	23	60	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11732	10.1371/journal.pone.0011732	http://dx.doi.org/10.1371/journal.pone.0011732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661302	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300030
J	Kaler, P; Galea, V; Augenlicht, L; Klampfer, L				Kaler, Pawan; Galea, Vincent; Augenlicht, Leonard; Klampfer, Lidija			Tumor Associated Macrophages Protect Colon Cancer Cells from TRAIL-Induced Apoptosis through IL-1 beta-Dependent Stabilization of Snail in Tumor Cells (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRANSCRIPTION FACTOR SNAIL; BETA-CATENIN; COLORECTAL-CANCER; GENE-EXPRESSION; E-CADHERIN; CONFERS RESISTANCE; ANTITUMOR-ACTIVITY; DOWN-REGULATION	Background: We recently reported that colon tumor cells stimulate macrophages to release IL-1 beta, which in turn inactivates GSK3 beta and enhances Wnt signaling in colon cancer cells, generating a self-amplifying loop that promotes the growth of tumor cells. Principal Findings: Here we describe that macrophages protect HCT116 and Hke-3 colon cancer cells from TRAIL-induced apoptosis. Inactivation of IL-1 beta by neutralizing IL-1 beta antibody, or silencing of IL-1 beta in macrophages inhibited their ability to counter TRAIL-induced apoptosis. Accordingly, IL-1 beta was sufficient to inhibit TRAIL-induced apoptosis. TRAIL-induced collapse of the mitochondrial membrane potential (Delta psi) and activation of caspases were prevented by macrophages or by recombinant IL-1 beta. Pharmacological inhibition of IL-1 beta release from macrophages by vitamin D-3, a potent chemopreventive agent for colorectal cancer, restored the ability of TRAIL to induce apoptosis of tumor cells cultured with macrophages. Macrophages and IL-1 beta failed to inhibit TRAIL-induced apoptosis in HCT116 cells expressing dnI kappa B, dnAKT or dnTCF4, confirming that they oppose TRAIL-induced cell death through induction of Wnt signaling in tumor cells. We showed that macrophages and IL-1 beta stabilized Snail in tumor cells in an NF-kappa B/Wnt dependent manner and that Snail deficient tumor cells were not protected from TRAIL-induced apoptosis by macrophages or by IL-1 beta, demonstrating a crucial role of Snail in the resistance of tumor cells to TRAIL. Significance: We have identified a positive feedback loop between tumor cells and macrophages that propagates the growth and promotes the survival of colon cancer cells: tumor cells stimulate macrophages to secrete IL-1 beta, which in turn, promotes Wnt signaling and stabilizes Snail in tumor cells, conferring resistance to TRAIL. Vitamin D-3 halts this amplifying loop by interfering with the release of IL-1 beta from macrophages. Accordingly, vitamin D-3 sensitizes tumor cells to TRAIL-induced apoptosis, suggesting that the therapeutic efficacy of TRAIL could be augmented by this readily available chemopreventive agent.	[Kaler, Pawan; Galea, Vincent; Augenlicht, Leonard; Klampfer, Lidija] Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, New York, NY USA	Montefiore Medical Center; Yeshiva University	Kaler, P (corresponding author), Montefiore Med Ctr, Albert Einstein Canc Ctr, Dept Oncol, New York, NY USA.	lklampf@aecom.yu.edu	Galea, Vincent/AAA-8274-2020	Galea, Vincent/0000-0002-6255-9446	National Cancer Institute [CA 111361, U54 CA 100926, P30-13330]; NATIONAL CANCER INSTITUTE [R01CA111361, U54CA100926] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA 111361 (to LK), U54 CA 100926 (to LA) and P30-13330 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.\	Abdollahi T, 2005, APOPTOSIS, V10, P1383, DOI 10.1007/s10495-005-2139-x; Abdollahi T, 2003, CANCER RES, V63, P4521; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Cretney E, 2002, J IMMUNOL, V168, P1356, DOI 10.4049/jimmunol.168.3.1356; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Doubravska L, 2008, APOPTOSIS, V13, P573, DOI 10.1007/s10495-008-0191-z; El-Deiry WS, 2001, CELL DEATH DIFFER, V8, P1066, DOI 10.1038/sj.cdd.4400943; Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; John MAS, 2009, CLIN CANCER RES, V15, P6018, DOI 10.1158/1078-0432.CCR-09-0011; Kaler P, 2009, ONCOGENE, V28, P3892, DOI 10.1038/onc.2009.247; Kaler P, 2009, CANCER MICROENVIRON, V2, P69, DOI 10.1007/s12307-009-0030-y; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kothny-Wilkes G, 1998, J BIOL CHEM, V273, P29247, DOI 10.1074/jbc.273.44.29247; Kumagai T, 2003, J NATL CANCER I, V95, P896, DOI 10.1093/jnci/95.12.896; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Madhusudan S, 2005, J CLIN ONCOL, V23, P5950, DOI 10.1200/JCO.2005.04.127; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Oguma K, 2008, EMBO J, V27, P1671, DOI 10.1038/emboj.2008.105; Oshima M, 2002, CURR PHARM DESIGN, V8, P1021, DOI 10.2174/1381612023394953; Pai R, 2008, CANCER RES, V68, P5086, DOI 10.1158/0008-5472.CAN-07-2325; Perez LE, 2008, J IMMUNOL, V180, P1545, DOI 10.4049/jimmunol.180.3.1545; Poppelmann B, 2005, J BIOL CHEM, V280, P15635, DOI 10.1074/jbc.M413006200; Rasola A, 2007, ONCOGENE, V26, P1078, DOI 10.1038/sj.onc.1209859; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; Roy HK, 2004, MOL CANCER THER, V3, P1159; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Takeda K, 2002, J EXP MED, V195, P161, DOI 10.1084/jem.20011171; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Vega S, 2004, GENE DEV, V18, P1131, DOI 10.1101/gad.294104; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Yang LQ, 2006, CELL, V127, P139, DOI 10.1016/j.cell.2006.08.036; Zamai L, 1996, CYTOMETRY, V23, P303, DOI 10.1002/(SICI)1097-0320(19960401)23:4<303::AID-CYTO6>3.3.CO;2-B; Zhang L, 2010, NATURE, V464, P1058, DOI 10.1038/nature08871; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	59	64	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11700	10.1371/journal.pone.0011700	http://dx.doi.org/10.1371/journal.pone.0011700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661477	Green Submitted, gold, Green Published			2022-12-27	WOS:000280243300007
J	Larson, EM; Idnurm, A				Larson, Erica M.; Idnurm, Alexander			Two Origins for the Gene Encoding alpha-Isopropylmalate Synthase in Fungi	PLOS ONE			English	Article							PHYCOMYCES-BLAKESLEEANUS; MYCOBACTERIUM-TUBERCULOSIS; SACCHAROMYCES-CEREVISIAE; MUCOR-CIRCINELLOIDES; LEUCINE BIOSYNTHESIS; CRYSTAL-STRUCTURE; EVOLUTION; EXPRESSION; METABOLISM; SEQUENCE	Background: The biosynthesis of leucine is a biochemical pathway common to prokaryotes, plants and fungi, but absent from humans and animals. The pathway is a proposed target for antimicrobial therapy. Methodology/Principal Findings: Here we identified the leuA gene encoding alpha-isopropylmalate synthase in the zygomycete fungus Phycomyces blakesleeanus using a genetic mapping approach with crosses between wild type and leucine auxotrophic strains. To confirm the function of the gene, Phycomyces leuA was used to complement the auxotrophic phenotype exhibited by mutation of the leu3(+) gene of the ascomycete fungus Schizosaccharomyces pombe. Phylogenetic analysis revealed that the leuA gene in Phycomyces, other zygomycetes, and the chytrids is more closely related to homologs in plants and photosynthetic bacteria than ascomycetes or basidiomycetes, and suggests that the Dikarya have acquired the gene more recently. Conclusions/Significance: The identification of leuA in Phycomyces adds to the growing body of evidence that some primary metabolic pathways or parts of them have arisen multiple times during the evolution of fungi, probably through horizontal gene transfer events.	[Larson, Erica M.; Idnurm, Alexander] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	University of Missouri System; University of Missouri Kansas City	Larson, EM (corresponding author), Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA.	idnurma@umkc.edu	Idnurm, Alexander/AAC-9614-2019; Idnurm, Alexander/K-8558-2013; Idnurm, Alexander/GPX-9055-2022	Idnurm, Alexander/0000-0001-5995-7040; Idnurm, Alexander/0000-0001-5995-7040	University of Missouri-Kansas City (UMKC); US National Science Foundation [MCB-0920581]	University of Missouri-Kansas City (UMKC); US National Science Foundation(National Science Foundation (NSF))	This research was supported by a University of Missouri-Kansas City (UMKC) Faculty Research Grant and US National Science Foundation grant MCB-0920581. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALVAREZ MI, 1980, MOL GEN GENET, V179, P447, DOI 10.1007/BF00425475; Andersson JO, 2009, ANNU REV MICROBIOL, V63, P177, DOI 10.1146/annurev.micro.091208.073203; Arrach N, 2001, P NATL ACAD SCI USA, V98, P1687, DOI 10.1073/pnas.021555298; BACON GA, 1950, BRIT J EXP PATHOL, V31, P714; CAMPUZANO V, 1993, CURR GENET, V24, P515, DOI 10.1007/BF00351715; Cavalieri D, 1999, MOL GEN GENET, V261, P152, DOI 10.1007/s004380050952; Cerda-Olmedo E, 2001, FEMS MICROBIOL REV, V25, P503; Chayakulkeeree M, 2006, EUR J CLIN MICROBIOL, V25, P215, DOI 10.1007/s10096-006-0107-1; de Koning AP, 2004, EUKARYOT CELL, V3, P1198, DOI 10.1128/EC.3.5.1198-1205.2004; de Kraker JW, 2007, PLANT PHYSIOL, V143, P970, DOI 10.1104/pp.106.085555; DIAZMINGUEZ JM, 1990, MOL GEN GENET, V224, P269, DOI 10.1007/BF00271561; ESLAVA AP, 1975, P NATL ACAD SCI USA, V72, P4076, DOI 10.1073/pnas.72.10.4076; ESLAVA AP, 1975, GENETICS, V80, P445; Field B, 2006, PLANT MOL BIOL, V60, P717, DOI 10.1007/s11103-005-5547-y; Fondi M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S3; FORSBURG SL, 1993, NUCLEIC ACIDS RES, V21, P2955, DOI 10.1093/nar/21.12.2955; Goldstein AL, 2001, GENETICS, V159, P499; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Huisman FHA, 2010, BIOCHEM BIOPH RES CO, V393, P168, DOI 10.1016/j.bbrc.2010.01.114; Idnurm A, 2006, P NATL ACAD SCI USA, V103, P4546, DOI 10.1073/pnas.0600633103; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; ITURRIAGA EA, 1992, CURR GENET, V21, P215, DOI 10.1007/BF00336844; ITURRIAGA EA, 1990, NUCLEIC ACIDS RES, V18, P4612, DOI 10.1093/nar/18.15.4612; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Khaldi N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003036; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liautard JP, 2006, TRENDS MICROBIOL, V14, P109, DOI 10.1016/j.tim.2006.01.005; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Marcet-Houben M, 2010, TRENDS GENET, V26, P5, DOI 10.1016/j.tig.2009.11.007; MCADAM RA, 1995, INFECT IMMUN, V63, P1004, DOI 10.1128/IAI.63.3.1004-1012.1995; Mehta BJ, 2001, GENETICS, V158, P635; Miyazaki K, 2005, BIOCHEM BIOPH RES CO, V331, P341, DOI 10.1016/j.bbrc.2005.03.169; Oba T, 2005, BIOSCI BIOTECH BIOCH, V69, P1270, DOI 10.1271/bbb.69.1270; Obraztsova IN, 2004, FUNGAL GENET BIOL, V41, P168, DOI 10.1016/j.fgb.2003.09.007; OREJAS M, 1987, MOL GEN GENET, V210, P69, DOI 10.1007/BF00337760; PETERS MH, 1990, ARCH BIOCHEM BIOPHYS, V276, P294, DOI 10.1016/0003-9861(90)90041-V; REICHENBECHER VE, 1978, J BACTERIOL, V133, P794, DOI 10.1128/JB.133.2.794-801.1978; Ribichich KF, 2005, EUKARYOT CELL, V4, P455, DOI 10.1128/EC.4.2.455-464.2005; Richards TA, 2006, EUKARYOT CELL, V5, P1517, DOI 10.1128/EC.00106-06; Richards TA, 2006, CURR BIOL, V16, P1857, DOI 10.1016/j.cub.2006.07.052; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; RONCERO MIG, 1989, GENE, V84, P335, DOI 10.1016/0378-1119(89)90508-8; Sanz C, 2009, P NATL ACAD SCI USA, V106, P7095, DOI 10.1073/pnas.0900879106; Schmitt I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004437; Spellberg B, 2009, CLIN INFECT DIS, V48, P1743, DOI 10.1086/599105; Stajich JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r223; YAMASAKI Y, 1966, P JPN ACAD, V42, P946, DOI 10.2183/pjab1945.42.946; Yasutake Y, 2004, J MOL BIOL, V344, P325, DOI 10.1016/j.jmb.2004.09.035	56	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11605	10.1371/journal.pone.0011605	http://dx.doi.org/10.1371/journal.pone.0011605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657649	Green Published, gold, Green Submitted			2022-12-27	WOS:000279924500009
J	Frentz, D; Boucher, CAB; Assel, M; De Luca, A; Fabbiani, M; Incardona, F; Libin, P; Manca, N; Muller, V; Nuallain, BO; Paredes, R; Prosperi, M; Quiros-Roldan, E; Ruiz, L; Sloot, PMA; Torti, C; Vandamme, AM; Van Laethem, K; Zazzi, M; van de Vijver, DAMC				Frentz, Dineke; Boucher, Charles A. B.; Assel, Matthias; De Luca, Andrea; Fabbiani, Massimiliano; Incardona, Francesca; Libin, Pieter; Manca, Nino; Mueller, Viktor; Nuallain, Breanndan O.; Paredes, Roger; Prosperi, Mattia; Quiros-Roldan, Eugenia; Ruiz, Lidia; Sloot, Peter M. A.; Torti, Carlo; Vandamme, Anne-Mieke; Van Laethem, Kristel; Zazzi, Maurizio; van de Vijver, David A. M. C.			Comparison of HIV-1 Genotypic Resistance Test Interpretation Systems in Predicting Virological Outcomes Over Time	PLOS ONE			English	Article							DRUG-RESISTANCE; ANTIRETROVIRAL THERAPY; PROTEASE	Background: Several decision support systems have been developed to interpret HIV-1 drug resistance genotyping results. This study compares the ability of the most commonly used systems (ANRS, Rega, and Stanford's HIVdb) to predict virological outcome at 12, 24, and 48 weeks. Methodology/Principal Findings: Included were 3763 treatment-change episodes (TCEs) for which a HIV-1 genotype was available at the time of changing treatment with at least one follow-up viral load measurement. Genotypic susceptibility scores for the active regimens were calculated using scores defined by each interpretation system. Using logistic regression, we determined the association between the genotypic susceptibility score and proportion of TCEs having an undetectable viral load (<50 copies/ml) at 12 (8-16) weeks (2152 TCEs), 24 (16-32) weeks (2570 TCEs), and 48 (44-52) weeks (1083 TCEs). The Area under the ROC curve was calculated using a 10-fold cross-validation to compare the different interpretation systems regarding the sensitivity and specificity for predicting undetectable viral load. The mean genotypic susceptibility score of the systems was slightly smaller for HIVdb, with 1.92 +/- 1.17, compared to Rega and ANRS, with 2.22 +/- 1.09 and 2.23 +/- 1.05, respectively. However, similar odds ratio's were found for the association between each-unit increase in genotypic susceptibility score and undetectable viral load at week 12; 1.6 [95% confidence interval 1.5-1.7] for HIVdb, 1.7 [1.5-1.8] for ANRS, and 1.7 [1.9-1.6] for Rega. Odds ratio's increased over time, but remained comparable (odds ratio's ranging between 1.9-2.1 at 24 weeks and 1.9-2.2 at 48 weeks). The Area under the curve of the ROC did not differ between the systems at all time points; p = 0.60 at week 12, p = 0.71 at week 24, and p = 0.97 at week 48. Conclusions/Significance: Three commonly used HIV drug resistance interpretation systems ANRS, Rega and HIVdb predict virological response at 12, 24, and 48 weeks, after change of treatment to the same extent.	[Frentz, Dineke; Boucher, Charles A. B.; van de Vijver, David A. M. C.] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands; [Boucher, Charles A. B.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Assel, Matthias] Univ Stuttgart, High Performance Comp Ctr Stuttgart, Stuttgart, Germany; [De Luca, Andrea; Fabbiani, Massimiliano] Univ Cattolica Sacro Cuore, Inst Clin Infect Dis, I-00168 Rome, Italy; [De Luca, Andrea] Univ Hosp Siena, Infect Dis Unit 2, Siena, Italy; [Incardona, Francesca] Informa SrL, Rome, Italy; [Libin, Pieter] MyBioData, Rotselaar, Belgium; [Manca, Nino] Univ Brescia, Sch Med, Inst Microbiol, Brescia, Italy; [Mueller, Viktor] Eotvos Lorand Univ, Inst Biol, Budapest, Hungary; [Nuallain, Breanndan O.; Sloot, Peter M. A.] Univ Amsterdam, Amsterdam, Netherlands; [Paredes, Roger; Ruiz, Lidia] SIDA irsiCaixa, Inst Recerca, Badalona, Spain; [Prosperi, Mattia] Catholic Univ, Clin Infect Dis, Rome, Italy; [Quiros-Roldan, Eugenia; Torti, Carlo] Univ Brescia, Sch Med, Inst Infect & Trop Dis, Brescia, Italy; [Zazzi, Maurizio] Univ Siena, Dept Mol Biol, I-53100 Siena, Italy; [Van Laethem, Kristel] Katholieke Univ Leuven, Rega Inst, Leuven, Belgium	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; University of Stuttgart; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Siena; University Hospital of Siena; University of Brescia; Eotvos Lorand University; University of Amsterdam; Institut de Recerca de la Sida - IrsiCaixa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Brescia; University of Siena; KU Leuven	Frentz, D (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands.	d.vandevijver@erasmusmc.nl	Fabbiani, Massimiliano/K-8842-2016; Van Laethem, Kristel/R-6282-2016; ROLDAN, Maria Eugenia QUIROS/K-7586-2015; Ruiz, Lidia/ABF-9720-2021; De Luca, Andrea/G-8810-2011; Zazzi, Maurizio/K-3422-2018; Müller, Viktor/B-3493-2009; Vandamme, Anne-Mieke/I-4127-2012; Sloot, Peter/B-3078-2014	Fabbiani, Massimiliano/0000-0002-1343-812X; Van Laethem, Kristel/0000-0001-6036-2271; ROLDAN, Maria Eugenia QUIROS/0000-0003-1452-9100; De Luca, Andrea/0000-0002-9561-9193; Zazzi, Maurizio/0000-0002-0344-6281; Müller, Viktor/0000-0001-8212-4880; Vandamme, Anne-Mieke/0000-0002-6594-2766; van de Vijver, David/0000-0001-5877-8526; Sloot, Peter/0000-0002-3848-5395	EU [IST-027446]; EuResist project [IST-2004-027173]; IUAP [P6/41]; CHAIN 7FP [223131]; FWO [G.0611.09N]; Belgian Ministry of Social Affairs; Health Insurance System	EU(European Commission); EuResist project; IUAP; CHAIN 7FP; FWO(FWO); Belgian Ministry of Social Affairs; Health Insurance System	This work was supported by the EU-funded Virolab project (IST-027446), EuResist project (IST-2004-027173), IUAP P6/41, CHAIN 7FP (223131), FWO grant (G.0611.09N) and the AIDS Reference Laboratory of Leuven which receives support from the Belgian Ministry of Social Affairs through a fund within the Health Insurance System. Informa co-funded the project that gave origine to the EuResist DB, used in the paper, and it contributed to the project with coordination and implementation roles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brun-Vezinet F, 2004, ANTIVIR THER, V9, P465; Cingolani A, 2002, AIDS, V16, P369, DOI 10.1097/00002030-200202150-00008; De Luca A, 2003, J INFECT DIS, V187, P1934, DOI 10.1086/375355; Durant J, 1999, LANCET, V353, P2195, DOI 10.1016/S0140-6736(98)12291-2; Fox ZV, 2007, AIDS, V21, P2033, DOI 10.1097/QAD.0b013e32825a69e4; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Larder B, 2007, ANTIVIR THER, V12, P15; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Lorenzi P, 1999, AIDS, V13, pF17, DOI 10.1097/00002030-199902040-00001; Meynard JL, 2002, AIDS, V16, P727, DOI 10.1097/00002030-200203290-00008; Prosperi MCF, 2009, ANTIVIR THER, V14, P433; Ravela J, 2003, JAIDS-J ACQ IMM DEF, V33, P8, DOI 10.1097/00126334-200305010-00002; RHEE SY, 2009, J INFECT DIS; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Sloot PMA, 2009, PHILOS T R SOC A, V367, P2691, DOI 10.1098/rsta.2009.0043; Sloot P, 2008, STUD HEALTH TECHNOL, V138, P188; Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010; Van Laethem K, 2002, ANTIVIR THER, V7, P123; Zazzi M, 2009, J ANTIMICROB CHEMOTH, V64, P616, DOI 10.1093/jac/dkp252	20	50	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11505	10.1371/journal.pone.0011505	http://dx.doi.org/10.1371/journal.pone.0011505			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634893	Green Published, gold			2022-12-27	WOS:000279715300016
J	Vigil, A; Ortega, R; Jain, A; Nakajima-Sasaki, R; Tan, XL; Chomel, BB; Kasten, RW; Koehler, JE; Felgner, PL				Vigil, Adam; Ortega, Rocio; Jain, Aarti; Nakajima-Sasaki, Rie; Tan, Xiaolin; Chomel, Bruno B.; Kasten, Rickie W.; Koehler, Jane E.; Felgner, Philip L.			Identification of the Feline Humoral Immune Response to Bartonella henselae Infection by Protein Microarray	PLOS ONE			English	Article							GEL-ELECTROPHORESIS; ANTIBODY-RESPONSES; DOMESTIC CATS; EXPRESSION; PREDICTION; REVEALS; PREVALENCE; CHALLENGE; FRAMEWORK; PATHOGEN	Background: Bartonella henselae is the zoonotic agent of cat scratch disease and causes potentially fatal infections in immunocompromised patients. Understanding the complex interactions between the host's immune system and bacterial pathogens is central to the field of infectious diseases and to the development of effective diagnostics and vaccines. Methodology: We report the development of a microarray comprised of proteins expressed from 96% (1433/1493) of the predicted ORFs encoded by the genome of the zoonotic pathogen Bartonella henselae. The array was probed with a collection of 62 uninfected, 62 infected, and 8 "specific-pathogen free'' naive cat sera, to profile the antibody repertoire elicited during natural Bartonella henselae infection. Conclusions: We found that 7.3% of the B. henselae proteins on the microarray were seroreactive and that seroreactivity was not evenly distributed between predicted protein function or subcellular localization. Membrane proteins were significantly most likely to be seroreactive, although only 23% of the membrane proteins were reactive. Conversely, we found that proteins involved in amino acid transport and metabolism were significantly underrepresented and did not contain any seroreactive antigens. Of all seroreactive antigens, 52 were differentially reactive with sera from infected cats, and 53 were equally reactive with sera from infected and uninfected cats. Thirteen of the seroreactive antigens were found to be differentially seroreactive between B. henselae type I and type II. Based on these results, we developed a classifier algorithm that was capable of accurately discerning 93% of the infected animals using the microarray platform. The seroreactivity and diagnostic potential of these antigens was then validated on an immunostrip platform, which correctly identified 98% of the infected cats. Our protein microarray platform provides a high-throughput, comprehensive analysis of the feline humoral immune response to natural infection with the alpha-proteobacterium B. henselae at an antigen-specific, sera-specific, and genome-wide level. Furthermore, these results provide novel insight and utility in diagnostics, vaccine development, and understanding of host-pathogen interaction.	[Vigil, Adam; Ortega, Rocio; Jain, Aarti; Nakajima-Sasaki, Rie; Tan, Xiaolin; Felgner, Philip L.] Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA; [Chomel, Bruno B.; Kasten, Rickie W.] Univ Calif Irvine, Sch Vet Med, Dept Populat Hlth & Reprod, Irvine, CA 92717 USA; [Koehler, Jane E.] Univ Calif San Francisco, Dept Med, Div Infect Dis, San Francisco, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California San Francisco	Vigil, A (corresponding author), Univ Calif Irvine, Dept Med, Div Infect Dis, Irvine, CA 92717 USA.	vigila@uci.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [U01A1061363, U54065359, R01 AI52813]; California HIV/AIDS Research Program; Burroughs Wellcome Fund; Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052813, U54AI065359] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); California HIV/AIDS Research Program; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Center for Companion Animal Health, School of Veterinary Medicine, University of California, Davis(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases grants U01A1061363 (to P.L.F.), U54065359 (to P.L.F. and J.E.K.) and R01 AI52813 (to J.E.K.). J.E.K. received funding from a California HIV/AIDS Research Program Award and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research. The cat study was supported by a grant from the Center for Companion Animal Health (George and Phyllis Miller Feline Research Fund), School of Veterinary Medicine, University of California, Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BALDI P, 2001, BIOINFORMATICS MACHI, pR21; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; Chang CC, 2002, J INFECT DIS, V186, P1733, DOI 10.1086/345764; Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Doolan DL, 2008, PROTEOMICS, V8, P4680, DOI 10.1002/pmic.200800194; Eyles JE, 2007, PROTEOMICS, V7, P2172, DOI 10.1002/pmic.200600985; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; FELGNER PL, 2009, P NATL ACAD SCI US; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Greene CE, 1996, J CLIN MICROBIOL, V34, P1682, DOI 10.1128/JCM.34.7.1682-1685.1996; Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; JAMESON P, 1995, J INFECT DIS, V172, P1145, DOI 10.1093/infdis/172.4.1145; Kreil DP, 2004, BIOINFORMATICS, V20, P2026, DOI 10.1093/bioinformatics/bth193; Lindroos HL, 2005, J BACTERIOL, V187, P6155, DOI 10.1128/JB.187.17.6155-6165.2005; Long AD, 2001, J BIOL CHEM, V276, P19937, DOI 10.1074/jbc.M010192200; Marano N, 2007, REV SCI TECH OIE, V26, P203, DOI 10.20506/rst.26.1.1736; Molina DM, 2010, VACCINE, V28, P3014, DOI 10.1016/j.vaccine.2009.12.020; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Pamelard F, 2009, METHODS MOL BIOL, V570, P413, DOI 10.1007/978-1-60327-394-7_24; Regnery RL, 1996, AM J VET RES, V57, P1714; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Sundaresh S, 2007, BIOINFORMATICS, V23, pI508, DOI 10.1093/bioinformatics/btm207; Sundaresh S, 2006, BIOINFORMATICS, V22, P1760, DOI 10.1093/bioinformatics/btl162; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Vapnik V., 2013, NATURE STAT LAERNING; Vigil A, 2010, FUTURE MICROBIOL, V5, P241, DOI 10.2217/FMB.09.127; Yamamoto K, 2003, VET MICROBIOL, V92, P73, DOI 10.1016/S0378-1135(02)00347-4	37	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11447	10.1371/journal.pone.0011447	http://dx.doi.org/10.1371/journal.pone.0011447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625509	Green Published, gold			2022-12-27	WOS:000279522500014
J	Zuniga, JE; Hammill, JT; Drory, O; Nuss, JE; Burnett, JC; Gussio, R; Wipf, P; Bavari, S; Brunger, AT				Zuniga, Jorge E.; Hammill, Jared T.; Drory, Omri; Nuss, Jonathan E.; Burnett, James C.; Gussio, Rick; Wipf, Peter; Bavari, Sina; Brunger, Axel T.			Iterative Structure-Based Peptide-Like Inhibitor Design against the Botulinum Neurotoxin Serotype A	PLOS ONE			English	Article							TOXIN TYPE-A; SMALL-MOLECULE INHIBITORS; ALPHA-AMINO-ACIDS; CLOSTRIDIUM-BOTULINUM; SECONDARY STRUCTURE; LIGHT-CHAIN; NEUROTRANSMITTER RELEASE; CONFORMATIONAL-ANALYSIS; SUBSTRATE RECOGNITION; REMARKABLE RESISTANCE	The botulinum neurotoxin serotype A light chain (BoNT/A LC) protease is the catalytic component responsible for the neuroparalysis that is characteristic of the disease state botulism. Three related peptide-like molecules (PLMs) were designed using previous information from co-crystal structures, synthesized, and assayed for in vitro inhibition against BoNT/A LC. Our results indicate these PLMS are competitive inhibitors of the BoNT/A LC protease and their K(i) values are in the nM-range. A co-crystal structure for one of these inhibitors was determined and reveals that the PLM, in accord with the goals of our design strategy, simultaneously involves both ionic interactions via its P1 residue and hydrophobic contacts by means of an aromatic group in the P2' position. The PLM adopts a helical conformation similar to previously determined co-crystal structures of PLMs, although there are also major differences to these other structures such as contacts with specific BoNT/A LC residues. Our structure further demonstrates the remarkable plasticity of the substrate binding cleft of the BoNT/A LC protease and provides a paradigm for iterative structure-based design and development of BoNT/A LC inhibitors.	[Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Zuniga, Jorge E.; Drory, Omri; Brunger, Axel T.] Stanford Univ, Dept Photon Sci, Stanford, CA 94305 USA; [Hammill, Jared T.; Wipf, Peter] Univ Pittsburgh, Ctr Chem Methodol & Lib Dev, Pittsburgh, PA USA; [Nuss, Jonathan E.; Bavari, Sina] USA, Med Res Inst Infect Dis, Div Bacteriol, Dept Immunol Target Identificat & Translat Res, Frederick, MD USA; [Burnett, James C.] NCI, Target Struct Based Drug Discovery Grp, Frederick, MD 21701 USA; [Gussio, Rick] NCI, Informat Technol Branch, Dev Therapeut Program, Frederick, MD 21701 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zuniga, JE (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	pwipf@pitt.edu; brunger@stanford.edu	Hammill, Jared/AAW-7751-2020; Wipf, Peter/AAG-1771-2021; Bavari, Sina/L-3642-2019	Hammill, Jared/0000-0002-9463-0526; Wipf, Peter/0000-0001-7693-5863; Bavari, Sina/0000-0001-8424-5635; Brunger, Axel/0000-0001-5121-2036	Howard Hughes Medical Institute; Department of Defense	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Defense(United States Department of Defense)	This work was supported by the Howard Hughes Medical Institute and the Department of Defense (proposal number 3.10024_06_RD_B to A.T.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Albanese A, 1995, ALIMENT PHARM THERAP, V9, P599; Bachrach SM, 2008, J ORG CHEM, V73, P2466, DOI 10.1021/jo702665r; Bhidayasiri R, 2005, J NEUROL SCI, V235, P1, DOI 10.1016/j.jns.2005.04.017; Binz T, 2002, BIOCHEMISTRY-US, V41, P1717, DOI 10.1021/bi0157969; BINZ T, 1994, J BIOL CHEM, V269, P1617; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x; Breidenbach MA, 2005, TRENDS MOL MED, V11, P377, DOI 10.1016/j.molmed.2005.06.012; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Burnett JC, 2007, J MED CHEM, V50, P2127, DOI 10.1021/jm061446e; Burnett JC, 2007, J BIOL CHEM, V282, P5004, DOI 10.1074/jbc.M608166200; Burnett JC, 2003, BIOCHEM BIOPH RES CO, V310, P84, DOI 10.1016/j.bbrc.2003.08.112; Carter P, 2003, NUCLEIC ACIDS RES, V31, P3293, DOI 10.1093/nar/gkg626; Caya JG, 2004, ARCH PATHOL LAB MED, V128, P653; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Cheng CA, 2006, AM J HEALTH-SYST PH, V63, P225, DOI 10.2146/sp/06001; Cheng CA, 2006, AM J HEALTH-SYST PH, V63, P145, DOI 10.2146/ajhp050137; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster KA, 2005, DRUG DISCOV TODAY, V10, P563, DOI 10.1016/S1359-6446(05)03389-1; Foster KA, 2004, EXPERT OPIN INV DRUG, V13, P1437, DOI 10.1517/13543784.13.11.1437; Glogau RG, 1998, DERMATOL SURG, V24, P817, DOI 10.1111/j.1524-4725.1998.tb04257.x; Glogau RG, 2002, CLIN J PAIN, V18, pS191, DOI 10.1097/00002508-200211001-00012; Gui D, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.2003.01598.x; GUI D, 1994, LANCET, V344, P1127, DOI 10.1016/S0140-6736(94)90633-5; Hermone AR, 2008, CHEMMEDCHEM, V3, P1905, DOI 10.1002/cmdc.200800241; Keller JE, 2006, NEUROSCIENCE, V139, P629, DOI 10.1016/j.neuroscience.2005.12.029; KUMARAN D, 2008, J BIOL CHEM; Kumaran D, 2008, J BIOL CHEM, V283, P18883, DOI 10.1074/jbc.M801240200; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Li HT, 1999, ORG LETT, V1, P91, DOI 10.1021/ol990573k; Lipozencic Jasna, 2006, Acta Dermatovenerol Croat, V14, P60; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paddle BM, 2003, J APPL TOXICOL, V23, P139, DOI 10.1002/jat.903; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; SCHIAVO G, 1993, J BIOL CHEM, V268, P11516; SCHIAVO G, 1994, J BIOL CHEM, V269, P20213; Schmidt JJ, 1995, J PROTEIN CHEM, V14, P703, DOI 10.1007/BF01886909; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; Schmidt JJ, 2002, FEBS LETT, V532, P423, DOI 10.1016/S0014-5793(02)03738-9; Schmidt JJ, 1998, FEBS LETT, V435, P61, DOI 10.1016/S0014-5793(98)01041-2; Schmidt JJ, 2001, ANAL BIOCHEM, V296, P130, DOI 10.1006/abio.2001.5236; Schmidt JJ, 1997, J PROTEIN CHEM, V16, P19, DOI 10.1023/A:1026386710428; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Silvaggi NR, 2008, BIOCHEMISTRY-US, V47, P5736, DOI 10.1021/bi8001067; Silvaggi NR, 2007, CHEM BIOL, V14, P533, DOI 10.1016/j.chembiol.2007.03.014; Singh BR, 2000, NAT STRUCT BIOL, V7, P617, DOI 10.1038/77900; Sposito MMM, 2002, PLAST RECONSTR SURG, V110, P601, DOI 10.1097/00006534-200208000-00037; Sposito MMM, 2002, AESTHET PLAST SURG, V26, P89, DOI 10.1007/s00266-002-1491-2; Turton K, 2002, TRENDS BIOCHEM SCI, V27, P552, DOI 10.1016/S0968-0004(02)02177-1; Wang CB, 2009, HETEROCYCLES, V79, P487, DOI 10.3987/COM-08-S(D)8; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102; Willis B, 2008, ANGEW CHEM INT EDIT, V47, P8360, DOI 10.1002/anie.200705531; WIPF P, 1988, HELV CHIM ACTA, V71, P258, DOI 10.1002/hlca.19880710129; WIPF P, 1988, HELV CHIM ACTA, V71, P268, DOI 10.1002/hlca.19880710130; Wipf P, 2009, CHIMIA, V63, P764, DOI 10.2533/chimia.2009.764; Ye YH, 2005, BIOPOLYMERS, V80, P172, DOI 10.1002/bip.20201; Zuniga JE, 2008, STRUCTURE, V16, P1588, DOI 10.1016/j.str.2008.07.011	61	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11378	10.1371/journal.pone.0011378	http://dx.doi.org/10.1371/journal.pone.0011378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614028	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000279370000009
J	Guan, WJ; Jiang, HF; Guo, XX; Mancera, E; Xu, L; Li, YD; Steinmetz, L; Li, YQ; Gu, ZL				Guan, Wenjun; Jiang, Huifeng; Guo, Xiaoxian; Mancera, Eugenio; Xu, Lin; Li, Yudong; Steinmetz, Lars; Li, Yongquan; Gu, Zhenglong			Antagonistic Changes in Sensitivity to Antifungal Drugs by Mutations of an Important ABC Transporter Gene in a Fungal Pathogen	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; AMPHOTERICIN-B; ECOLOGICAL SPECIALIZATION; YEAST; PDR5; MECHANISMS; PATIENT; PROTEIN	Fungal pathogens can be lethal, especially among immunocompromised populations, such as patients with AIDS and recipients of tissue transplantation or chemotherapy. Prolonged usage of antifungal reagents can lead to drug resistance and treatment failure. Understanding mechanisms that underlie drug resistance by pathogenic microorganisms is thus vital for dealing with this emerging issue. In this study, we show that dramatic sequence changes in PDR5, an ABC (ATP-binding cassette) efflux transporter protein gene in an opportunistic fungal pathogen, caused the organism to become hypersensitive to azole, a widely used antifungal drug. Surprisingly, the same mutations conferred growth advantages to the organism on polyenes, which are also commonly used antimycotics. Our results indicate that Pdr5p might be important for ergosterol homeostasis. The observed remarkable sequence divergence in the PDR5 gene in yeast strain YJM789 may represent an interesting case of adaptive loss of gene function with significant clinical implications.	[Guan, Wenjun; Guo, Xiaoxian; Li, Yudong; Li, Yongquan] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Guan, Wenjun; Jiang, Huifeng; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Mancera, Eugenio; Steinmetz, Lars] European Mol Biol Lab, Heidelberg, Germany; [Xu, Lin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Zhejiang University; Cornell University; European Molecular Biology Laboratory (EMBL); Cornell University	Guan, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	lyq@zju.edu.cn; zg27@cornell.edu	li, Yu/HCI-9086-2022; Li, Yudong/GSN-4036-2022; li, yu/HGL-9518-2022; xu, lin/H-8560-2016; Mancera, Eugenio/M-6334-2016	Mancera, Eugenio/0000-0003-0146-8732; Steinmetz, Lars/0000-0002-3962-2865	Cornell University; Zhejiang University	Cornell University; Zhejiang University	The study was supported by the faculty startup funds from Cornell University awarded to Z.G. and the Future Academic Stars project of Zhejiang University to W.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminetzach YT, 2005, SCIENCE, V309, P764, DOI 10.1126/science.1112699; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; BALZI E, 1994, J BIOL CHEM, V269, P2206; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Chen XJ, 2001, J BACTERIOL, V183, P3939, DOI 10.1128/JB.183.13.3939-3948.2001; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Chu P, 2009, CURR MED RES OPIN, V25, P3011, DOI 10.1185/03007990903379077; Cooper VS, 2000, NATURE, V407, P736, DOI 10.1038/35037572; de Thozee CP, 2007, MOL MICROBIOL, V63, P811, DOI 10.1111/j.1365-2958.2006.05562.x; Decottignies A, 1998, J BIOL CHEM, V273, P12612, DOI 10.1074/jbc.273.20.12612; Decottignies A, 1997, NAT GENET, V15, P137, DOI 10.1038/ng0297-137; Dismukes WE, 2000, CLIN INFECT DIS, V30, P653, DOI 10.1086/313748; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Goffeau A, 2008, NATURE, V452, P541, DOI 10.1038/452541a; Golin J, 2007, BIOCHEM BIOPH RES CO, V356, P1, DOI 10.1016/j.bbrc.2007.02.011; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Groeschke J, 2006, J PHARMACEUT BIOMED, V42, P362, DOI 10.1016/j.jpba.2006.04.011; Groll AH, 2009, SEMIN HEMATOL, V46, P212, DOI 10.1053/j.seminhematol.2009.03.003; HINNEN A, 1978, P NATL ACAD SCI USA, V75, P1929, DOI 10.1073/pnas.75.4.1929; HIRATA D, 1994, CURR GENET, V26, P285, DOI 10.1007/BF00310491; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kontoyiannis DP, 2000, J ANTIMICROB CHEMOTH, V46, P199, DOI 10.1093/jac/46.2.199; LEPPERT G, 1990, GENETICS, V125, P13; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Li WH, 2005, NATURE, V437, P50, DOI 10.1038/437050a; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Mamnun YM, 2004, FEBS LETT, V559, P111, DOI 10.1016/S0014-5793(04)00046-8; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; MCCUSKER JH, 1994, INFECT IMMUN, V62, P5447, DOI 10.1128/IAI.62.12.5447-5455.1994; MCCUSKER JH, 1994, GENETICS, V136, P1261; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Mukhopadhyay K, 2004, ANTIMICROB AGENTS CH, V48, P1778, DOI 10.1128/AAC.48.5.1778-1787.2004; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Rose MD., 1990, METHODS YEAST GENETI; Ruhnke M, 2004, DRUGS, V64, P1163, DOI 10.2165/00003495-200464110-00002; Sambrook J., 2006, MOL CLONING LAB MANU, V3rd; Sanglard D, 2009, FEMS YEAST RES, V9, P1029, DOI 10.1111/j.1567-1364.2009.00578.x; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Seret ML, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-459; Shahi P, 2007, J BIOL CHEM, V282, P26822, DOI 10.1074/jbc.M704772200; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; STROUP JS, 2007, HOSP PHARM, V42, P532; Tamm M, 1999, RESPIRATION, V66, P199, DOI 10.1159/000029377; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tutulan-Cunita AC, 2005, GENES CELLS, V10, P409, DOI 10.1111/j.1365-2443.2005.00847.x; Vandeputte P, 2008, ANTIMICROB AGENTS CH, V52, P3701, DOI 10.1128/AAC.00423-08; Wang XX, 2006, PLOS BIOL, V4, P366, DOI 10.1371/journal.pbio.0040052; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; White KJ, 1998, J SOC CLIN PSYCHOL, V17, P11, DOI 10.1521/jscp.1998.17.1.11; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young LY, 2003, ANTIMICROB AGENTS CH, V47, P2717, DOI 10.1128/AAC.47.9.2717-2724.2003	60	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11309	10.1371/journal.pone.0011309	http://dx.doi.org/10.1371/journal.pone.0011309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593017	gold, Green Published, Green Submitted			2022-12-27	WOS:000279140800010
J	Guan, XH; Silk, BJ; Li, WK; Fleischauer, AT; Xing, XS; Jiang, XQ; Yu, HJ; Olsen, SJ; Cohen, AL				Guan, Xuhua; Silk, Benjamin J.; Li, Wenkai; Fleischauer, Aaron T.; Xing, Xuesen; Jiang, Xiaoqing; Yu, Hongjie; Olsen, Sonja J.; Cohen, Adam L.			Pneumonia Incidence and Mortality in Mainland China: Systematic Review of Chinese and English Literature, 1985-2008	PLOS ONE			English	Review							INFLUENZAE TYPE-B; CHILDREN YOUNGER; STREPTOCOCCUS-PNEUMONIAE; RESPIRATORY-INFECTIONS; DISEASE; BURDEN; RISK; IMPROVEMENT; XUANWEI; REFORM	Background: Pneumonia is a leading infectious disease killer worldwid, yet the burden in China is not well understood as much of the data is published in the non-English literature. Methodology/Principal Findings: We systematically reviewed the Chinese- and English-language literature for studies with primary data on pneumonia incidence and mortality in mainland China. Between 1985 and 2008, 37 studies met the inclusion criteria. The quality of the studies was highly variable. For children <5 years, incidence ranged from 0.06-0.27 episodes per person-year and mortality ranged from 184-1,223 deaths per 100,000 population. Overall incidence and mortality were stable or decreased over the study period and were higher in rural compared to urban areas. Conclusions/Significance: Pneumonia continues to be a major public health challenge in young children in China, and estimates of pneumonia incidence and mortality vary widely. Reliable surveillance data and new prevention efforts may be needed to achieve and document additional declines, especially in areas with higher incidence and mortality such as rural settings.	[Guan, Xuhua; Xing, Xuesen; Jiang, Xiaoqing] Hubei Ctr Dis Control & Prevent, Wuchang, Hubei, Peoples R China; [Silk, Benjamin J.; Cohen, Adam L.] Ctr Dis Control & Prevent, Resp Dis Branch, Div Bacterial Dis, Atlanta, GA USA; [Silk, Benjamin J.; Li, Wenkai; Fleischauer, Aaron T.; Olsen, Sonja J.] Ctr Dis Control & Prevent, Div Emerging Infect & Surveillance Serv, Atlanta, GA USA; [Yu, Hongjie] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chinese Center for Disease Control & Prevention	Guan, XH (corresponding author), Hubei Ctr Dis Control & Prevent, Wuchang, Hubei, Peoples R China.	dvj1@cdc.gov	Yu, Hongjie/GZK-5351-2022					[Anonymous], 2008, LANCET, V372, P1437, DOI 10.1016/S0140-6736(08)61601-3; Bai Qingrui, 2007, Wei Sheng Yan Jiu, V36, P510; Black RE, 2010, LANCET; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Center KJ, 2007, VACCINE, V25, P3085, DOI 10.1016/j.vaccine.2007.01.021; Chapman RS, 2005, BMJ-BRIT MED J, V331, P1050, DOI 10.1136/bmj.38628.676088.55; CHEN X, 2000, STRAIT J PREVENTIVE, V6, P22; DENG Y, 2008, CHINESE J BRIT HLTH, V16, P111; [邓至 Deng Zhi], 2003, [上海医学, Shanghai medical journal], V26, P876; Dherani M, 2008, B WORLD HEALTH ORGAN, V86, P390, DOI 10.2471/BLT.07.044529; Fung ICH, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-20; GAO J, 2004, MATERN CHILD HLTH J, V19, P13; *GDP, 2008, GDP GROWTH 1952 2007; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; [何礼贤 HE Li-xian], 2007, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V27, P110; HU B, 2002, CHINESE J INFECT CHE, V2, P74; HU H, 2009, EUR J CLIN MICROBIOL; Hu HL, 2008, PEDIATR INFECT DIS J, V27, P942, DOI 10.1097/INF.0b013e3181757b32; HU X, 2008, MATERN CHILD HLTH J, V23, P818; HUANG X, 2008, MATERN CHILD HLTH J, V23, P993; JIANG W, 2005, HLTH VOCATIONAL ED, V23, P42; JIANG Y, 2002, CHINESE J CHILD HLTH, V10, P266; Knoll MD, 2009, CLIN INFECT DIS, V48, pS37, DOI 10.1086/596480; Lan Q, 2002, J NATL CANCER I, V94, P826, DOI 10.1093/jnci/94.11.826; LAN X, 2008, STRAIT J PREVENTIVE, V14, P35; Lanata CF, 2004, INT J EPIDEMIOL, V33, P1362, DOI 10.1093/ije/dyh229; Levine OS, 2000, EMERG INFECT DIS, V6, P165, DOI 10.3201/eid0602.000209; LI X, 2001, CHINESE J CHILD HLTH, V9, P25; LIANG J, 2003, ANTHOLOGY MED, V22, P832; LIN L, 1990, CHINESE J EPIDEMIOLO, V11, P257; Liu Q, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-19; LIU Y, 1990, MATERNAL CHILD HLTH, V5; LIU Y, 1996, CHINESE J PEDIAT, V34, P365; LIU Y, 2008, MATERN CHILD HLTH J, V23, P3538; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Olsen SJ, 2010, EPIDEMIOL INFECT, V138, P1811, DOI 10.1017/S0950268810000646; *PEOPL REP CHIN NB, 2007, CHIN STAT YB 2007; *RESP DIS AC CHIN, 2002, MODERN PRACTICAL MED, V14, P160; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2004, B WORLD HEALTH ORGAN, V82, P895; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; SHEN Y, 2008, ZHEJIANG J PREVENTIV, V20, P58; Shimouchi A, 1995, CLIN INFECT DIS, V21, pS213, DOI 10.1093/clind/21.Supplement_3.S213; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; WANG H, 2003, MATERN CHILD HLTH CA, V18, P398; WANG L, 2008, MATERN CHILD HLTH J, V23, P1991; Wang LD, 2008, LANCET, V372, P1598, DOI 10.1016/S0140-6736(08)61365-3; WANG LZ, 1985, CHINESE MED J-PEKING, V98, P311; Wang Yan-ping, 2005, Zhonghua Yufang Yixue Zazhi, V39, P260; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4; *WHO, 2008, GLOB ACT PLAN PREV C; *WHO, 2008, WKLY EPIDEMIOL REC, V83, P61; *WHO MIN HLTH CHIN, 2006, JOINT REV MAT CHILD; WONG A, 2008, BRAVO HONG KONG TOTS; World Health Organization, 2018, TOP 10 CAUS DEATH; World Health Organization, 1991, TECHN BAS WHO REC MA; World Health Organization (WHO), WHO REC SURV STAND; Xia J, 2008, HEALTH INFO LIBR J, V25, P55, DOI 10.1111/j.1471-1842.2007.00734.x; XIAO Y, 2008, J SHANXI COLL TRADIT, V9, P39; [谢红梅 Xie Hongmei], 2003, [上海医学, Shanghai medical journal], V26, P880; XIE Y, 2003, HUBEI J PREVENTIVE M, V14, P17; XU G, 2000, CHINESE PRIMARY HLTH, V14, P36; Xue Xiao-yan, 2006, Beijing Da Xue Xue Bao Yi Xue Ban, V38, P276; YAN X, 2008, CHINESE J HLTH ED, V24, P57; YANG L, 2008, MATERN CHILD HLTH J, V23, P1176; YANG W, 2008, WORLD HLTH DIGEST ME, V5, P367; YE S, 2008, MATERN CHILD HLTH J, V22, P1667; Zeng D L, 1987, Zhonghua Yi Xue Za Zhi, V67, P437; Zhang DQ, 2008, LANCET, V372, P1865, DOI 10.1016/S0140-6736(08)61355-0; Zhang Z J, 1990, Zhonghua Liu Xing Bing Xue Za Zhi, V11, P145; ZHANG ZJ, 1986, CHINESE MED J-PEKING, V99, P561; Zhou Y, 2000, CHINESE J CHILD HLTH, V8, P35; 罗辉, 2008, [第四军医大学学报, Journal of the Fourth Military Medical University], V29, P959	74	41	45	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11721	10.1371/journal.pone.0011721	http://dx.doi.org/10.1371/journal.pone.0011721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668535	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800007
J	O'Hayre, M; Salanga, CL; Kipps, TJ; Messmer, D; Dorrestein, PC; Handel, TM				O'Hayre, Morgan; Salanga, Catherina L.; Kipps, Thomas J.; Messmer, Davorka; Dorrestein, Pieter C.; Handel, Tracy M.			Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; TUMOR-SUPPRESSOR PDCD4; FACTOR-I; B-CELLS; TRANSFORMATION SUPPRESSOR; BCR/ABL LEUKEMOGENESIS; ZAP-70 EXPRESSION; MASS-SPECTROMETRY; BINDING-PROTEIN; HNRNP A1	Background: Chronic Lymphocytic Leukemia (CLL) pathogenesis has been linked to the prolonged survival and/or apoptotic resistance of leukemic B cells in vivo, and is thought to be due to enhanced survival signaling responses to environmental factors that protect CLL cells from spontaneous and chemotherapy-induced death. Although normally associated with cell migration, the chemokine, CXCL12, is one of the factors known to support the survival of CLL cells. Thus, the signaling pathways activated by CXCL12 and its receptor, CXCR4, were investigated as components of these pathways and may represent targets that if inhibited, could render resistant CLL cells more susceptible to chemotherapy. Methodology/Principal Findings: To determine the downstream signaling targets that contribute to the survival effects of CXCL12 in CLL, we took a phosphoproteomics approach to identify and compare phosphopeptides in unstimulated and CXCL12-stimulated primary CLL cells. While some of the survival pathways activated by CXCL12 in CLL are known, including Akt and ERK1/2, this approach enabled the identification of additional signaling targets and novel phosphoproteins that could have implications in CLL disease and therapy. In addition to the phosphoproteomics results, we provide evidence from western blot validation that the tumor suppressor, programmed cell death factor 4 (PDCD4), is a previously unidentified phosphorylation target of CXCL12 signaling in all CLL cells probed. Additionally, heat shock protein 27 (HSP27), which mediates anti-apoptotic signaling and has previously been linked to chemotherapeutic resistance, was detected in a subset (similar to 25%) of CLL patients cells examined. Conclusions/Significance: Since PDCD4 and HSP27 have previously been associated with cancer and regulation of cell growth and apoptosis, these proteins may have novel implications in CLL cell survival and represent potential therapeutic targets. PDCD4 also represents a previously unknown signaling target of chemokine receptors; therefore, these observations increase our understanding of alternative pathways to migration that may be activated or inhibited by chemokines in the context of cancer cell survival.	[O'Hayre, Morgan; Salanga, Catherina L.; Dorrestein, Pieter C.; Handel, Tracy M.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Kipps, Thomas J.; Messmer, Davorka] Univ Calif San Diego, Rebecca & John Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	O'Hayre, M (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	thandel@ucsd.edu	Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012		California Breast Cancer Research Program [14GB-0147]; Ruth L. Kirschstein NIGMS [F31]; National Institutes of Health [RO1-AI37113]; Department of Defense [BC060331]; Lymphoma Research Foundation; V-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037113] Funding Source: NIH RePORTER	California Breast Cancer Research Program; Ruth L. Kirschstein NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Lymphoma Research Foundation; V-Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a California Breast Cancer Research Program Dissertation Award (14GB-0147) to MO (http://www.cbcrp.org), a Ruth L. Kirschstein NIGMS MARC Predoctoral Fellowship (F31) to CLS, and awards from the National Institutes of Health (RO1-AI37113), the Department of Defense (BC060331), and the Lymphoma Research Foundation (http://www.lymphoma.org) to TMH, TJK and DM and the V-Foundation Scholar Award (http://www.jimmyv.org) to PCD. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blees JS, 2010, J BIOMOL SCREEN, V15, P21, DOI 10.1177/1087057109351028; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Burger JA, 2000, BLOOD, V96, P2655; Burger JA, 2007, BRIT J HAEMATOL, V137, P288, DOI 10.1111/j.1365-2141.2007.06590.x; Castro JE, 2005, BLOOD, V106, P2506, DOI 10.1182/blood-2005-03-1099; Chauhan D, 2003, CANCER RES, V63, P6174; Cheng CH, 2006, MOL CELL BIOL, V26, P362, DOI 10.1128/MCB.26.1.362-370.2006; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; COLLINS RJ, 1989, BRIT J HAEMATOL, V71, P343; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Eiring AM, 2008, BLOOD, V111, P816, DOI 10.1182/blood-2007-05-090472; Favaro PMB, 2003, BIOCHEM BIOPH RES CO, V311, P365, DOI 10.1016/j.bbrc.2003.10.012; Fujita N, 2002, J BIOL CHEM, V277, P10346, DOI 10.1074/jbc.M106736200; Gabelloni ML, 2008, BRIT J HAEMATOL, V140, P117, DOI 10.1111/j.1365-2141.2007.06891.x; Garrido C, 2006, CELL CYCLE, V5, P2592, DOI 10.4161/cc.5.22.3448; Ghia P, 2005, CURR TOP MICROBIOL, V294, P135, DOI 10.1007/3-540-29933-5_8; Glockzin S, 2003, MOL CELL BIOL, V23, P8960, DOI 10.1128/MCB.23.24.8960-8969.2003; Huang MR, 1997, GENE THER, V4, P1093, DOI 10.1038/sj.gt.3300499; Iervolino A, 2002, MOL CELL BIOL, V22, P2255, DOI 10.1128/MCB.22.7.2255-2266.2002; Infantino S, 2006, J IMMUNOL, V176, P2197, DOI 10.4049/jimmunol.176.4.2197; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Lee JT, 2002, LEUKEMIA, V16, P486, DOI 10.1038/sj/leu/2402460; LIN CS, 1993, J BIOL CHEM, V268, P2781; Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606; Manceau V, 2006, FEBS J, V273, P577, DOI 10.1111/j.1742-4658.2005.05091.x; Matthiesen R, 2010, METHODS MOL BIOL, V593, P187, DOI 10.1007/978-1-60327-194-3_10; MELHEM RF, 1991, J BIOL CHEM, V266, P17747; Mohle R, 1999, LEUKEMIA, V13, P1954, DOI 10.1038/sj.leu.2401602; Montresor A, 2009, CANCER RES, V69, P9281, DOI 10.1158/0008-5472.CAN-09-2009; Morley SC, 2010, J IMMUNOL, V184, P3628, DOI 10.4049/jimmunol.0903851; Moser K, 2006, J PROTEOME RES, V5, P98, DOI 10.1021/pr0503073; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; O'Hayre M, 2009, METHOD ENZYMOL, V460, P331, DOI 10.1016/S0076-6879(09)05216-1; Obermann EC, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-162; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Parrado A, 2000, Hematol J, V1, P15, DOI 10.1038/sj.thj.6200012; Payne SH, 2008, J PROTEOME RES, V7, P3373, DOI 10.1021/pr800129m; Richardson SJ, 2006, BLOOD, V107, P3584, DOI 10.1182/blood-2005-04-1718; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Schorr RA, 2009, J MAMMAL, V90, P17, DOI 10.1644/07-MAMM-A-392.1; Scielzo C, 2005, J CLIN INVEST, V115, P1644, DOI 10.1172/JCI24276; Shitashige M, 2007, CANCER SCI, V98, P1862, DOI 10.1111/j.1349-7006.2007.00629.x; Shitashige M, 2007, GASTROENTEROLOGY, V132, P1039, DOI 10.1053/j.gastro.2007.01.007; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Till KJ, 2002, BLOOD, V99, P2977, DOI 10.1182/blood.V99.8.2977; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Want EJ, 2005, CHEMBIOCHEM, V6, P1941, DOI 10.1002/cbic.200500151; Wu Y, 2007, BIOCHEM BIOPH RES CO, V358, P170, DOI 10.1016/j.bbrc.2007.04.104; Yamazaki K, 2009, LAB INVEST, V89, P425, DOI 10.1038/labinvest.2009.5; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhu WH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840518; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	60	60	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11716	10.1371/journal.pone.0011716	http://dx.doi.org/10.1371/journal.pone.0011716			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661426	gold, Green Submitted, Green Published			2022-12-27	WOS:000280243300018
J	Johansson, F; Lederer, B; Lind, MI				Johansson, Frank; Lederer, Baptiste; Lind, Martin I.			Trait Performance Correlations across Life Stages under Environmental Stress Conditions in the Common Frog, Rana temporaria	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; POST-METAMORPHIC TRAITS; DEVELOPMENTAL PLASTICITY; LARVAL DEVELOPMENT; NATURAL-SELECTION; SPADEFOOT TOADS; HISTORY TRAITS; ANURAN LARVAE; BODY SHAPE; TREE FROG	If an organism's juvenile and adult life stages inhabit different environments, certain traits may need to be independently adapted to each environment. In many organisms, a move to a different environment during ontogeny is accompanied by metamorphosis. In such organisms phenotypic induction early in ontogeny can affect later phenotypes. In laboratory experiments we first investigated correlations between body morphology and the locomotor performance traits expressed in different life stages of the common frog, Rana temporaria: swimming speed and acceleration in tadpoles; and jump-distance in froglets. We then tested for correlations between these performances across life stages. We also subjected tadpoles to unchanging or decreasing water levels to explore whether decreasing water levels might induce any carry-over effects. Body morphology and performance were correlated in tadpoles; morphology and performance were correlated in froglets: hence body shape and morphology affect performance within each life stage. However, performance was decoupled across life stages, as there was no correlation between performance in tadpoles and performance in froglets. While size did not influence tadpole performance, it was correlated with performance of the metamorphosed froglets. Experiencing decreasing water levels accelerated development time, which resulted in smaller tadpoles and froglets, i.e., a carry-over effect. Interestingly, decreasing water levels positively affected the performance of tadpoles, but negatively affected froglet performance. Our results suggest that performance does not necessarily have to be correlated between life stages. However, froglet performance is size dependent and carried over from the tadpole stage, suggesting that some important size-dependent characters cannot be decoupled via metamorphosis.	[Johansson, Frank; Lederer, Baptiste; Lind, Martin I.] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden	Umea University	Johansson, F (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	frank.johansson@emg.umu.se	Lind, Martin/A-4189-2011	Lind, Martin/0000-0001-5602-1933	Swedish Research Council; Swedish Research Council FORMAS	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	Swedish Research Council and Swedish Research Council FORMAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altwegg R, 2003, EVOLUTION, V57, P872; BERVEN KA, 1990, ECOLOGY, V71, P1599, DOI 10.2307/1938295; BLEM CR, 1978, HERPETOLOGICA, V34, P288; BLOUIN MS, 1992, EVOLUTION, V46, P735, DOI 10.1111/j.1558-5646.1992.tb02079.x; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; CHEVERUD JM, 1988, EVOLUTION, V42, P958, DOI 10.1111/j.1558-5646.1988.tb02514.x; Dayton GH, 2005, OIKOS, V111, P582, DOI 10.1111/j.1600-0706.2005.14340.x; Emerson S.B., 1985, P58; EMERSON SB, 1978, EVOLUTION, V32, P551, DOI 10.1111/j.1558-5646.1978.tb04598.x; Ernande B, 2003, J EVOLUTION BIOL, V16, P399, DOI 10.1046/j.1420-9101.2003.00543.x; Ficetola GF, 2006, EVOL ECOL, V20, P143, DOI 10.1007/s10682-005-5508-6; Gasc J. P., 1997, ATLAS AMPHIBIANS REP, P496; Gomez-Mestre I, 2006, P NATL ACAD SCI USA, V103, P19021, DOI 10.1073/pnas.0603562103; Gosner K. L., 1960, Herpetologica, V16, P183; Hadfield JD, 2007, J EVOLUTION BIOL, V20, P549, DOI 10.1111/j.1420-9101.2006.01262.x; Henein J.T., 1997, AM MIDL NAT, V137, P136; Johansson F, 2005, EVOL ECOL RES, V7, P1025; JOHNALDER HB, 1990, COPEIA, P856, DOI 10.2307/1446453; Laugen AT, 2002, BIOL J LINN SOC, V76, P61, DOI 10.1046/j.1095-8312.2002.00048.x; Laurila A, 2002, EVOLUTION, V56, P617; Lind MI, 2007, J EVOLUTION BIOL, V20, P1288, DOI 10.1111/j.1420-9101.2007.01353.x; Lind MI, 2008, P ROY SOC LOND B BIO, V275, P1071; Liu H, 1996, J EXP BIOL, V199, P1245; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; Moran N. A., 1994, ANNU REV ECOL SYST, V25, P73; Morey SR, 2004, OIKOS, V104, P172, DOI 10.1111/j.0030-1299.2004.12623.x; Nauwelaerts S, 2007, J ANAT, V210, P304, DOI 10.1111/j.1469-7580.2007.00691.x; NEWMAN RA, 1988, EVOLUTION, V42, P774, DOI 10.1111/j.1558-5646.1988.tb02495.x; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Phillips PC, 1998, J EVOLUTION BIOL, V11, P453, DOI 10.1007/s000360050099; Plaistow SJ, 2004, P ROY SOC B-BIOL SCI, V271, P919, DOI 10.1098/rspb.2004.2682; Relyea RA, 2003, OECOLOGIA, V134, P596, DOI 10.1007/s00442-002-1161-8; Relyea RA, 2001, ECOLOGY, V82, P1947, DOI 10.1890/0012-9658(2001)082[1947:TLEOAP]2.0.CO;2; Richardson JML, 2002, EVOL ECOL RES, V4, P627; Richter-Boix A, 2006, EVOL ECOL RES, V8, P309; ROHLF FJ, 2007, TPS REGR VERSION 1 3; ROHLF FJ, 2003, TPS DIG VERSION 1 37; ROHLF FJ, 2003, TPS PLS VERSION 1 18; Savage R.M., 1961, ECOLOGY LIFE HIST CO; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; *SYSTAT SOFTW INC, 2007, SYST VERS 12 02; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Van Buskirk J, 2000, J EXP BIOL, V203, P2149; Van Buskirk J, 1999, OIKOS, V85, P31, DOI 10.2307/3546789; Van Buskirk J, 2000, J EVOLUTION BIOL, V13, P336; Van Buskirk J, 1997, EVOLUTION, V51, P1983, DOI 10.1111/j.1558-5646.1997.tb05119.x; Vences M, 2002, J ZOOL, V257, P155, DOI 10.1017/S0952836902000754; WASSERSUG RJ, 1985, J EXP BIOL, V119, P1; WASSERSUG RJ, 1977, ECOLOGY, V58, P830, DOI 10.2307/1936218; Watkins TB, 2001, EVOLUTION, V55, P1668	51	61	64	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11680	10.1371/journal.pone.0011680	http://dx.doi.org/10.1371/journal.pone.0011680			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657779	gold, Green Published, Green Submitted			2022-12-27	WOS:000280197500021
J	Pavie, J; Rachline, A; Loze, B; Niedbalski, L; Delaugerre, C; Laforgerie, E; Plantier, JC; Rozenbaum, W; Chevret, S; Molina, JM; Simon, F				Pavie, Juliette; Rachline, Anne; Loze, Benedicte; Niedbalski, Laurence; Delaugerre, Constance; Laforgerie, Eric; Plantier, Jean-Christophe; Rozenbaum, Willy; Chevret, Sylvie; Molina, Jean-Michel; Simon, Francois			Sensitivity of Five Rapid HIV Tests on Oral Fluid or Finger-Stick Whole Blood: A Real-Time Comparison in a Healthcare Setting	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; INFECTION; ANTIBODY; DIAGNOSIS; POPULATION; ANTIGEN; AFRICA; ACCESS; ASSAYS	Background: Health authorities in several countries recently recommended the expansion of human immunodeficiency virus (HIV) antibody testing, including the use of rapid tests. Several HIV rapid tests are now licensed in Europe but their sensitivity on total blood and/or oral fluid in routine healthcare settings is not known. Methods and Findings: 200 adults with documented HIV-1 (n = 194) or HIV-2 infection (n = 6) were prospectively screened with five HIV rapid tests using either oral fluid (OF) or finger-stick whole blood (FSB). The OraQuick Advance rapid HIV1/2(R) was first applied to OF and then to FSB, while the other tests were applied to FSB, in the following order: Vikia HIV 1/2(R), Determine HIV 1-2(R), Determine(R) HIV-1/2 Ag/Ab Combo(R) and INSTI HIV-1/HIV-2(R). Tests negative on FSB were repeated on paired serum samples. Twenty randomly selected HIV-seronegative subjects served as controls, and the results were read blindly. Most patients had HIV-1 subtype B infection (63.3%) and most were on antiretroviral therapy (68.5%). Sensitivity was 86.5%, 94.5%, 98.5%, 94.9%, 95.8% and 99% respectively, with OraQuick OF, OraQuick FSB, Vikia, Determine, Determine Ag/Ab Combo and INSTI (p<0.0001). OraQuick was less sensitive on OF than on FSB (p = 0.008). Among the six patients with three or more negative tests, two had recent HIV infection and four patients on antiretroviral therapy had undetectable plasma viral load. When patients positive in all the tests were compared with patients who had at least one negative test, only a plasma HIV RNA level <200 cp/ml was significantly associated with a false-negative result (p = 0.009). When the 33 rapid tests negative on FSB were repeated on serum, all but six (5 negative with OraQuick, 1 with INSTI) were positive. The sensitivity of OraQuick, Determine and Determine Ag/Ab Combo was significantly better on serum than on FSB (97.5%, p = 0.04; 100%, p = 0.004; and 100%, p = 0.02, respectively). Conclusion: When evaluated in a healthcare setting, rapid HIV tests were less sensitive on oral fluid than on finger-stick whole blood and less sensitive on finger-stick whole blood than on serum.	[Pavie, Juliette; Rachline, Anne; Loze, Benedicte; Niedbalski, Laurence; Rozenbaum, Willy; Molina, Jean-Michel] Univ Paris Diderot, Hop St Louis, Serv Malad Infect & Trop, Paris, France; [Delaugerre, Constance; Simon, Francois] Univ Paris Diderot, Hop St Louis, Microbiol Serv, Paris, France; [Laforgerie, Eric] Agence Francaise Secur Sanit & Prod Sante, St Denis, France; [Plantier, Jean-Christophe] CHU Charles Nicolle, Ctr Natl Reference VIH, Lab Associe, Rouen, France; [Chevret, Sylvie] Univ Paris Diderot, Hop St Louis, Dept Biostat & Informat Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Pavie, J (corresponding author), Univ Paris Diderot, Hop St Louis, Serv Malad Infect & Trop, Paris, France.	francois.simon@sls.aphp.fr		PLANTIER, Jean-Christophe/0000-0001-6417-4083; Rozenbaum, Willy/0000-0003-1975-3566; chevret, sylvie/0000-0001-6449-4730	"Agence Francaise pour la Securite Sanitaire et les Produits Sanguins" (AFSSAPS)	"Agence Francaise pour la Securite Sanitaire et les Produits Sanguins" (AFSSAPS)	The official national agency, "Agence Francaise pour la Securite Sanitaire et les Produits Sanguins'' (AFSSAPS), funded this study by buying all the tests and reagents and supporting the management. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. E. Laforgerie, coauthor from Afssaps, participated in the design of the study.	Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; APETREI C, 1996, AIDS, V10, P57; Barin F, 2007, AIDS, V21, P2351, DOI 10.1097/QAD.0b013e3282f15637; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; *CONS NAT SID, RAPP EV DISP DEP INF; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Delpierre C, 2006, AIDS PATIENT CARE ST, V20, P838, DOI 10.1089/apc.2006.20.838; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Everett DB, 2009, J CLIN MICROBIOL, V47, P1058, DOI 10.1128/JCM.01998-08; Facente SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008217; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Gautheret-Dejean A, 2008, CLIN INFECT DIS, V46, P1936, DOI 10.1086/588561; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; HOLGUI NA, 2009, J CLIN VIROL, V45, P150; *JOINT UN PROGR HI, 1997, WKLY EPIDEMIOL REC, V72, P81; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Laforgerie E, 2010, J VIROL METHODS, V165, P105, DOI 10.1016/j.jviromet.2009.12.007; Leung DHY, 2009, BIOSTATISTICS, V10, P436, DOI 10.1093/biostatistics/kxp002; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Ly TD, 2007, J VIROL METHODS, V143, P86, DOI 10.1016/j.jviromet.2007.02.013; Makuwa M, 2002, J VIROL METHODS, V103, P183, DOI 10.1016/S0166-0934(02)00026-5; SCHOCHETMAN G, 1992, AIDS TESTING METHODO; Scott LE, 2009, JAIDS-J ACQ IMM DEF, V51, P646, DOI 10.1097/QAI.0b013e3181a448ac; Simon F, 2001, AIDS RES HUM RETROV, V17, P937, DOI 10.1089/088922201750290050; Smith W, 1996, BIOMETRICS, V52, P1063, DOI 10.2307/2533067; SPIELBERG F, 1989, LANCET, V1, P580; Stekler J, 2007, ANN INTERN MED, V147, P147, DOI 10.7326/0003-4819-147-2-200707170-00022; Stekler JD, 2009, CLIN INFECT DIS, V49, P444, DOI 10.1086/600043; TARDY JC, 2009, JOURN NAT INFECTIOLO; VONSYDOW M, 1988, BMJ-BRIT MED J, V296, P238, DOI 10.1136/bmj.296.6617.238; Wesolowski LG, 2006, AIDS, V20, P1661, DOI 10.1097/01.aids.0000238413.13442.ed; Wesolowski LG, 2009, J CLIN MICROBIOL, V47, P3333, DOI 10.1128/JCM.01504-09; 2001, MMWR, V50, P1	34	120	120	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11581	10.1371/journal.pone.0011581	http://dx.doi.org/10.1371/journal.pone.0011581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657834	Green Submitted, Green Published, gold			2022-12-27	WOS:000280065600006
J	Yang, L; Xue, Z; He, Y; Sun, SY; Chen, H; Qi, L				Yang, Liu; Xue, Zhen; He, Yin; Sun, Shengyi; Chen, Hui; Qi, Ling			A Phos-Tag-Based Approach Reveals the Extent of Physiological Endoplasmic Reticulum Stress	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; TRANSMEMBRANE PROTEIN; CELL; ER; PANCREAS; KINASE; DEFICIENCY; INDUCTION; TRANSPORT; DISTINCT	Cellular response to endoplasmic reticulum (ER) stress or unfolded protein response (UPR) is a key defense mechanism associated with many human diseases. Despite its basic and clinical importance, the extent of ER stress inflicted by physiological and pathophysiological conditions remains difficult to quantitate, posing a huge obstacle that has hindered our further understanding of physiological UPR and its future therapeutic potential. Here we have optimized a Phos-tag-based system to detect the activation status of two proximal UPR sensors at the ER membrane. This method allowed for a quantitative assessment of the level of stress in the ER. Our data revealed quantitatively the extent of tissue-specific basal ER stress as well as ER stress caused by the accumulation of misfolded proteins and the fasting-refeeding cycle. Our study may pave the foundation for future studies on physiological UPR, aid in the diagnosis of ER-associated diseases and improve and facilitate therapeutic strategies targeting UPR in vivo.	[Yang, Liu; Sun, Shengyi; Qi, Ling] Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA; [Xue, Zhen; Qi, Ling] Cornell Univ, Grad Program Nutr, Ithaca, NY USA; [He, Yin; Qi, Ling] Cornell Univ, Grad Program Genet & Dev, Ithaca, NY USA; [Chen, Hui; Qi, Ling] Cornell Univ, Div Nutr Sci, Ithaca, NY USA	Cornell University; Cornell University; Cornell University; Cornell University	Yang, L (corresponding author), Cornell Univ, Grad Program Biochem Mol & Cell Biol, Ithaca, NY 14853 USA.	lq35@cornell.edu		Qi, Ling/0000-0001-8229-0184; Sun, Shengyi/0000-0002-1734-3902	Stip Olin Fellowship; NIH [5 T32 GM007617, R01DK082582]; Rosalinde and Arthur Foundation/AFAR; American Federation for Aging Research [RAG08061]; ADA Junior Faculty; American Diabetes Association [7-08-JF-47]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007617] Funding Source: NIH RePORTER	Stip Olin Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rosalinde and Arthur Foundation/AFAR; American Federation for Aging Research; ADA Junior Faculty; American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	L.Y. was supported in part by the Stip Olin Fellowship (to L.Y.) and Y.H. was supported in part by the NIH Predoctoral Training Grant in Genetics and Development (5 T32 GM007617). L. Q. is the recipient of the 2008 Rosalinde and Arthur Foundation/AFAR New Investigator Award in Alzheimer's Diseases and the ADA Junior Faculty Award. This study was supported in part by American Federation for Aging Research (RAG08061), American Diabetes Association (7-08-JF-47) and NIH R01DK082582 (to L.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SH, 2009, CELL METAB, V10, P13, DOI 10.1016/j.cmet.2009.06.002; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Brewer JW, 1997, EMBO J, V16, P7207, DOI 10.1093/emboj/16.23.7207; Chen H, 2010, BIOCHEM J, V429, P95, DOI 10.1042/BJ20100193; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Masaki T, 1999, BIOCHEM BIOPH RES CO, V261, P350, DOI 10.1006/bbrc.1999.0972; Miyata Y, 2008, BIOCHEM BIOPH RES CO, V365, P826, DOI 10.1016/j.bbrc.2007.11.045; MORI K, 1993, CELL, V74, P743; MORISSET JA, 1972, J CLIN INVEST, V51, P1, DOI 10.1172/JCI106779; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Reimold AM, 2000, GENE DEV, V14, P152; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sha HB, 2009, CELL METAB, V9, P556, DOI 10.1016/j.cmet.2009.04.009; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; SLOT JW, 1979, J CELL BIOL, V80, P692, DOI 10.1083/jcb.80.3.692; SLOT JW, 1979, J CELL BIOL, V80, P708, DOI 10.1083/jcb.80.3.708; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	32	52	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11621	10.1371/journal.pone.0011621	http://dx.doi.org/10.1371/journal.pone.0011621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661282	Green Submitted, Green Published, gold			2022-12-27	WOS:000279980800010
J	De Rosa, MC; Giardina, B; Bianchi, C; Carelli Alinovi, C; Pirolli, D; Ferraccioli, G; De Santis, M; Di Sante, G; Ria, F				De Rosa, Maria Cristina; Giardina, Bruno; Bianchi, Caterina; Carelli Alinovi, Cristiana; Pirolli, Davide; Ferraccioli, Gianfranco; De Santis, Maria; Di Sante, Gabriele; Ria, Francesco			Modeling the Ternary Complex TCR-V beta/CollagenII(261-273)/HLA-DR4 Associated with Rheumatoid Arthritis	PLOS ONE			English	Article							T-CELL RECOGNITION; PEPTIDE-MHC COMPLEXES; CLASS-II MOLECULE; HLA-DR4 DRA-ASTERISK-0101; RECEPTOR RECOGNITION; STRUCTURAL BASIS; SELF-PEPTIDE; COLLAGEN; BINDING; TCR	Background: It is known that genetic predisposition to rheumatoid arthritis (RA) is associated with the MHC class II allele HLA-DR4 and that residues 261-273 of type II collagen (huCollp261) represent an immunodominant T cell epitope restricted by the DR4 molecule. Despite recent advances in characterization of MHC and T cell receptor (TCR) contacts to this epitope, the atomic details of TCR/huCollp261/HLA-DR4 ternary complex are not known. Methodology/Principal Findings: Here we have used computational modeling to get insight into this interaction. A three-dimensional model of the TCR V beta domain from a DR4(+) patient affected by RA has been derived by homology modeling techniques. Subsequently, the structure of the TCR V beta domain in complex with huCollp261/HLA-DR4 was obtained from a docking approach in conjunction with a filtering procedure based on biochemical information. The best complex from the docking experiments was then refined by 20 ns of molecular dynamics simulation in explicit water. The predicted model is consistent with available experimental data. Our results indicate that residues 97-101 of CDR3 beta are critical for recognition of huCollp261/HLA-DR4 by TCR. We also show that TCR contacts on p/MHC surface affect the conformation of the shared epitope expressed by DR alleles associated with RA susceptibility. Conclusions/Significance: This work presents a three-dimensional model for the ternary complex TCR-V beta/collagenII(261-273)/HLA-DR4 associated with rheumatoid arthritis that can provide insights into the molecular mechanisms of self reactivity.	[De Rosa, Maria Cristina] CNR, Ist Chim Riconoscimento Mol, Rome, Italy; [Giardina, Bruno; Bianchi, Caterina; Carelli Alinovi, Cristiana; Pirolli, Davide] Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, Rome, Italy; [Ferraccioli, Gianfranco; De Santis, Maria] Univ Cattolica Sacro Cuore, Dipartimento Reumatol, Rome, Italy; [Di Sante, Gabriele; Ria, Francesco] Univ Cattolica Sacro Cuore, Ist Patol Gen, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	De Rosa, MC (corresponding author), CNR, Ist Chim Riconoscimento Mol, Rome, Italy.	mariacristina.derosa@icrm.cnr.it	Ria, Francesco/AAD-1174-2022; De Santis, Maria/K-2644-2018; Di Sante, Gabriele/K-8629-2016; De Rosa, Maria Cristina/K-3814-2014; carelli alinovi, cristiana/L-2212-2018; Di Sante, Gabriele/N-5280-2018; Di Sante, Gabriele/AHD-9850-2022; Di Sante, Gabriele/N-5294-2018	Ria, Francesco/0000-0001-7455-4290; De Santis, Maria/0000-0002-3196-1336; Di Sante, Gabriele/0000-0001-6608-3388; De Rosa, Maria Cristina/0000-0002-9611-2490; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Di Sante, Gabriele/0000-0001-6608-3388; Pirolli, Davide/0000-0003-2303-2577; Ferraccioli, Gianfranco/0000-0002-6884-4301	Consiglio Nazionale delle Ricerche (CNR)	Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	This work was supported by Consiglio Nazionale delle Ricerche (CNR). Computer simulations were performed at the Caspur Interuniversities Consortium for Supercomputing Applications (grant DPM@CASPUR 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Badou A, 2001, EUR J IMMUNOL, V31, P2487, DOI 10.1002/1521-4141(200108)31:8<2487::AID-IMMU2487>3.0.CO;2-L; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Collins EJ, 2008, IMMUNOL RES, V41, P267, DOI 10.1007/s12026-008-8040-2; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deng L, 2007, TRENDS BIOCHEM SCI, V32, P500, DOI 10.1016/j.tibs.2007.08.007; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Fridkis-Hareli M, 2000, HUM IMMUNOL, V61, P640, DOI 10.1016/S0198-8859(00)00126-9; FU XT, 1995, J EXP MED, V181, P915, DOI 10.1084/jem.181.3.915; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; Hausmann S, 1999, J IMMUNOL, V162, P338; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; HIRAIWA A, 1990, P NATL ACAD SCI USA, V87, P8051, DOI 10.1073/pnas.87.20.8051; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kjellen P, 1998, EUR J IMMUNOL, V28, P755, DOI 10.1002/(SICI)1521-4141(199802)28:02<755::AID-IMMU755>3.0.CO;2-2; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T, 2004, SCI STKE, V2004, P1; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; LONDEI M, 1989, P NATL ACAD SCI USA, V86, P636, DOI 10.1073/pnas.86.2.636; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; NEPOM GT, 1989, ARTHRITIS RHEUM, V32, P15, DOI 10.1002/anr.1780320104; Ria F., 2001, Current Molecular Medicine (Hilversum), V1, P297, DOI 10.2174/1566524013363690; Ria F, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2553; Rosloniec EF, 2002, J IMMUNOL, V168, P253, DOI 10.4049/jimmunol.168.1.253; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Russell AS, 2008, PHARMACOECONOMICS, V26, P831, DOI 10.2165/00019053-200826100-00004; Sakurai Y, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2043; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIGNORELLI KL, 1995, CELL IMMUNOL, V162, P217, DOI 10.1006/cimm.1995.1072; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stocker U, 2000, PROTEINS, V40, P145, DOI 10.1002/(SICI)1097-0134(20000701)40:1<145::AID-PROT160>3.0.CO;2-Y; WATSON WC, 1994, CLIN IMMUNOL IMMUNOP, V73, P27, DOI 10.1006/clin.1994.1166; Wilson DB, 1999, J IMMUNOL, V163, P6424; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920	42	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11550	10.1371/journal.pone.0011550	http://dx.doi.org/10.1371/journal.pone.0011550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644721	Green Published, gold			2022-12-27	WOS:000279884900008
J	Marg, S; Winkler, U; Sestu, M; Himmel, M; Schonherr, M; Bar, J; Mann, A; Moser, M; Mierke, CT; Rottner, K; Blessing, M; Hirrlinger, J; Ziegler, WH				Marg, Susanna; Winkler, Ulrike; Sestu, Marcello; Himmel, Mirko; Schoenherr, Madeleine; Baer, Janina; Mann, Amrit; Moser, Markus; Mierke, Claudia T.; Rottner, Klemens; Blessing, Manfred; Hirrlinger, Johannes; Ziegler, Wolfgang H.			The Vinculin-Delta In20/21 Mouse: Characteristics of a Constitutive, Actin-Binding Deficient Splice Variant of Vinculin	PLOS ONE			English	Article							FOCAL ADHESIONS; PROTEIN; TALIN; DYNAMICS; ACTIVATION; COOPERATE; SUGGESTS; SEQUENCE; SITES; CELLS	Background: The cytoskeletal adaptor protein vinculin plays a fundamental role in cell contact regulation and affects central aspects of cell motility, which are essential to both embryonal development and tissue homeostasis. Functional regulation of this evolutionarily conserved and ubiquitously expressed protein is dominated by a high-affinity, autoinhibitory head-to-tail interaction that spatially restricts ligand interactions to cell adhesion sites and, furthermore, limits the residency time of vinculin at these sites. To date, no mutants of the vinculin protein have been characterized in animal models. Methodology/Principal Findings: Here, we investigate vinculin-Delta Ex20, a splice variant of the protein lacking the 68 amino acids encoded by exon 20 of the vinculin gene VCL. Vinculin-Delta Ex20 was found to be expressed alongside with wild type protein in a knock-in mouse model with a deletion of introns 20 and 21 (VCL-Delta In20/21 allele) and shows defective head-to-tail interaction. Homozygous VCL-Delta In20/21 embryos die around embryonal day E12.5 showing cranial neural tube defects and exencephaly. In mouse embryonic fibroblasts and upon ectopic expression, vinculin-Delta Ex20 reveals characteristics of constitutive head binding activity. Interestingly, the impact of vinculin-Delta Ex20 on cell contact induction and stabilization, a hallmark of the vinculin head domain, is only moderate, thus allowing invasion and motility of cells in three-dimensional collagen matrices. Lacking both F-actin interaction sites of the tail, the vinculin-Delta Ex20 variant unveils vinculin's dynamic binding to cell adhesions independent of a cytoskeletal association, and thus differs from head-to-tail binding deficient mutants such as vinculin-T12, in which activated F-actin binding locks the protein variant to cell contact sites. Conclusions/Significance: Vinculin-Delta Ex20 is an active variant supporting adhesion site stabilization without an enhanced mechanical coupling. Its presence in a transgenic animal reveals the potential of splice variants in the vinculin gene to alter vinculin function in vivo. Correct control of vinculin is necessary for embryonic development.	[Marg, Susanna; Winkler, Ulrike; Sestu, Marcello; Himmel, Mirko; Schoenherr, Madeleine; Baer, Janina; Hirrlinger, Johannes; Ziegler, Wolfgang H.] Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany; [Winkler, Ulrike; Hirrlinger, Johannes] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, Leipzig, Germany; [Mann, Amrit; Blessing, Manfred] Univ Leipzig, Fac Vet Med, Ctr Biotechnol & Biomed, Leipzig, Germany; [Moser, Markus] Max Planck Inst Biochem, Dept Mol Med, D-82152 Martinsried, Germany; [Mierke, Claudia T.] Univ Erlangen Nurnberg, Ctr Med Phys & Technol, Erlangen, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, Braunschweig, Germany; [Ziegler, Wolfgang H.] Hannover Med Sch, Dept Nephrol, D-3000 Hannover, Germany	Leipzig University; Leipzig University; Leipzig University; Max Planck Society; University of Erlangen Nuremberg; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School	Marg, S (corresponding author), Univ Leipzig, Fac Med, Interdisciplinary Ctr Clin Res IZKF, Leipzig, Germany.	wolfgang.ziegler@medizin.uni-leipzig.de	Rottner, Klemens/AAE-5030-2020; Mierke, Claudia Tanja/L-5293-2018; Hirrlinger, Johannes/F-5984-2010	Mierke, Claudia Tanja/0000-0002-6622-335X; Ziegler, Wolfgang H./0000-0003-4529-1916; Rottner, Klemens/0000-0003-4244-4198; Himmel, Mirko/0000-0001-7872-8016	Deutsche Forschungsgemeinschaft [Zi545/4-1, Ro 2414/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft [Zi545/4-1 to WHZ and MB; Ro 2414/1-2 to KR] and the Interdisciplinary Centre for Clinical Research (IZKF) Leipzig at the Faculty of Medicine of the University of Leipzig [projects N04 to WHZ; N05 to JH; C34 to WHZ and JH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakolitsa C, 1999, CELL, V99, P603, DOI 10.1016/S0092-8674(00)81549-4; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; BARSTEAD RJ, 1991, J CELL BIOL, V114, P715, DOI 10.1083/jcb.114.4.715; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Cohen DM, 2005, J BIOL CHEM, V280, P17109, DOI 10.1074/jbc.M414704200; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Diez G, 2008, BIOCHEM BIOPH RES CO, V373, P69, DOI 10.1016/j.bbrc.2008.05.182; Diez G, 2009, BIOPHYS J, V97, P3105, DOI 10.1016/j.bpj.2009.09.039; FERNANDEZ JLR, 1992, J CELL BIOL, V119, P427, DOI 10.1083/jcb.119.2.427; FERNANDEZ JLR, 1993, J CELL BIOL, V122, P1285, DOI 10.1083/jcb.122.6.1285; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Himmel M, 2009, J BIOL CHEM, V284, P13832, DOI 10.1074/jbc.M900266200; Hirrlinger J, 2001, J NEUROCHEM, V76, P627, DOI 10.1046/j.1471-4159.2001.00101.x; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Janssen MEW, 2006, MOL CELL, V21, P271, DOI 10.1016/j.molcel.2005.11.020; Jousse C, 1998, BIOCHEM J, V334, P147, DOI 10.1042/bj3340147; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Maeda M, 1997, CIRCULATION, V95, P17, DOI 10.1161/01.CIR.95.1.17; Michael KE, 2009, MOL BIOL CELL, V20, P2508, DOI 10.1091/mbc.E08-01-0076; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Mohl CC, 2009, CELL MOTIL CYTOSKEL, V66, P350, DOI 10.1002/cm.20375; MOISEYEVA EP, 1993, J BIOL CHEM, V268, P4318; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Steimle PA, 1999, J BIOL CHEM, V274, P18414, DOI 10.1074/jbc.274.26.18414; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; Witt S, 2004, J BIOL CHEM, V279, P31533, DOI 10.1074/jbc.M314245200; Xu WM, 1998, DEVELOPMENT, V125, P327; Xu WM, 1998, J CELL SCI, V111, P1535; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zaidel-Bar R, 2009, J CELL BIOL, V186, P317, DOI 10.1083/jcb.200811067; Zemljic-Harpf AE, 2004, AM J PATHOL, V165, P1033, DOI 10.1016/S0002-9440(10)63364-0; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Ziegler WH, 2010, TRANSL RES BIOMED, V2, P136; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	39	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11530	10.1371/journal.pone.0011530	http://dx.doi.org/10.1371/journal.pone.0011530			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644727	Green Published, gold			2022-12-27	WOS:000279884900006
J	Bajenoff, M; Narni-Mancinelli, E; Brau, F; Lauvau, G				Bajenoff, Marc; Narni-Mancinelli, Emilie; Brau, Frederic; Lauvau, Gregoire			Visualizing Early Splenic Memory CD8(+) T Cells Reactivation against Intracellular Bacteria in the Mouse	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELL; LISTERIA-MONOCYTOGENES; LYMPH-NODE; DENDRITIC CELLS; PROTECTIVE IMMUNITY; PRECURSOR FREQUENCY; GAMMA-INTERFERON; WHITE PULP; IFN-GAMMA; IN-VIVO	Memory CD8(+) T cells represent an important effector arm of the immune response in maintaining long-lived protective immunity against viruses and some intracellular bacteria such as Listeria monocytogenes (L.m). Memory CD8(+) T cells are endowed with enhanced antimicrobial effector functions that perfectly tail them to rapidly eradicate invading pathogens. It is largely accepted that these functions are sufficient to explain how memory CD8(+) T cells can mediate rapid protection. However, it is important to point out that such improved functional features would be useless if memory cells were unable to rapidly find the pathogen loaded/infected cells within the infected organ. Growing evidences suggest that the anatomy of secondary lymphoid organs (SLOs) fosters the cellular interactions required to initiate naive adaptive immune responses. However, very little is known on how the SLOs structures regulate memory immune responses. Using Listeria monocytogenes (L.m) as a murine infection model and imaging techniques, we have investigated if and how the architecture of the spleen plays a role in the reactivation of memory CD8(+) T cells and the subsequent control of L. m growth. We observed that in the mouse, memory CD8(+) T cells start to control L. m burden 6 hours after the challenge infection. At this very early time point, L.m-specific and non-specific memory CD8(+) T cells localize in the splenic red pulp and form clusters around L. m infected cells while naive CD8(+) T cells remain in the white pulp. Within these clusters that only last few hours, memory CD8(+) T produce inflammatory cytokines such as IFN-gamma and CCL3 nearby infected myeloid cells known to be crucial for L.m killing. Altogether, we describe how memory CD8(+) T cells trafficking properties and the splenic microanatomy conjugate to create a spatio-temporal window during which memory CD8(+) T cells provide a local response by secreting effector molecules around infected cells.	[Bajenoff, Marc; Narni-Mancinelli, Emilie; Lauvau, Gregoire] INSERM, U924, Grp Avenir, Valbonne, France; [Bajenoff, Marc; Narni-Mancinelli, Emilie; Brau, Frederic; Lauvau, Gregoire] Univ Nice Sophia Antipolis, Nice, France; [Bajenoff, Marc] Ctr Immunol Marseille Luminy, INSERM, UMR S 631, Marseille, France; [Bajenoff, Marc; Brau, Frederic] CNRS, UMR 6102, Marseille, France; [Bajenoff, Marc] Univ Aix Marseille 2, UM 631, Marseille, France; [Bajenoff, Marc] CNRS, UMR6097, IPMC, F-06560 Valbonne, France; [Lauvau, Gregoire] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Yeshiva University	Bajenoff, M (corresponding author), INSERM, U924, Grp Avenir, Valbonne, France.	bajenoff@ciml.univ-mrs.fr; gregoire.lauvau@einstein.yu.edu	Narni-Mancinelli, Emilie/X-1888-2018	Narni-Mancinelli, Emilie/0000-0002-7001-1026	Institut National de la Sante et de la Recherche Medicale (INSERM-Avenir); Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR)-Maladies Infectieuses et leur Environnement (MIE) [ANR-08-JCJC-0134-01)]; Fondation pour la Recherche Medicale (FRM)	Institut National de la Sante et de la Recherche Medicale (INSERM-Avenir)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)-Maladies Infectieuses et leur Environnement (MIE)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This research was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM-Avenir), Centre National de la Recherche Scientifique (CNRS), Agence Nationale de la Recherche (ANR)-Maladies Infectieuses et leur Environnement (MIE) EMICIF-2008, ANR-08-JCJC-0134-01). E.N.M. was a recipient of a Fondation pour la Recherche Medicale (FRM) fellowship and an ANR-MIE Contrat Duree Determinee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele P, 2003, J IMMUNOL, V171, P1148, DOI 10.4049/jimmunol.171.3.1148; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Bajenoff M, 2007, TRENDS IMMUNOL, V28, P346, DOI 10.1016/j.it.2007.06.005; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bousso P, 1998, IMMUNITY, V9, P169, DOI 10.1016/S1074-7613(00)80599-3; Busch DH, 1999, IMMUNOL REV, V172, P163, DOI 10.1111/j.1600-065X.1999.tb01364.x; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Chtanova T, 2009, IMMUNITY, V31, P342, DOI 10.1016/j.immuni.2009.06.023; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; FAHEY TJ, 1992, J IMMUNOL, V148, P2764; Faust N, 2000, BLOOD, V96, P719; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Messingham KAN, 2007, J IMMUNOL, V179, P2457, DOI 10.4049/jimmunol.179.4.2457; Muraille E, 2007, CELL MICROBIOL, V9, P1445, DOI 10.1111/j.1462-5822.2007.00883.x; Narni-Mancinelli E, 2007, J EXP MED, V204, P2075, DOI 10.1084/jem.20070204; Pewe LL, 2004, J IMMUNOL, V172, P3151, DOI 10.4049/jimmunol.172.5.3151; PORTNOY DA, 1989, J EXP MED, V170, P2141, DOI 10.1084/jem.170.6.2141; Raue HP, 2004, J IMMUNOL, V173, P6873, DOI 10.4049/jimmunol.173.11.6873; Rocha B, 2006, IMMUNOL REV, V211, P182, DOI 10.1111/j.0105-2896.2006.00378.x; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smeltz RB, 2007, J IMMUNOL, V178, P4786, DOI 10.4049/jimmunol.178.8.4786; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Tvinnereim AR, 2000, INFECT IMMUN, V68, P2196, DOI 10.1128/IAI.68.4.2196-2204.2000; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Unsoeld H, 2004, J IMMUNOL, V173, P3013, DOI 10.4049/jimmunol.173.5.3013; Willard-Mack CL, 2006, TOXICOL PATHOL, V34, P409, DOI 10.1080/01926230600867727; Wong P, 2003, ANNU REV IMMUNOL, V21, P29, DOI 10.1146/annurev.immunol.21.120601.141114; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005	49	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11524	10.1371/journal.pone.0011524	http://dx.doi.org/10.1371/journal.pone.0011524			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634957	Green Published, gold			2022-12-27	WOS:000279781600009
J	Lorenzen, J; David, S; Bahlmann, FH; de Groot, K; Bahlmann, E; Kielstein, JT; Haller, H; Fliser, D				Lorenzen, Johan; David, Sascha; Bahlmann, Ferdinand H.; de Groot, Kirsten; Bahlmann, Elisabeth; Kielstein, Jan T.; Haller, Hermann; Fliser, Danilo			Endothelial Progenitor Cells and Cardiovascular Events in Patients with Chronic Kidney Disease - a Prospective Follow-Up Study	PLOS ONE			English	Article							ERYTHROPOIETIN; NUMBER	Background: Endothelial progenitor cells (EPCs) mediate vascular repair and regeneration. Their number in peripheral blood is related to cardiovascular events in individuals with normal renal function. Methods: We evaluated the association between functionally active EPCs (cell culture) and traditional cardiovascular risk factors in 265 patients with chronic kidney disease stage V receiving hemodialysis therapy. Thereafter, we prospectively assessed cardiovascular events, e. g. myocardial infarction, percutaneous transluminal coronary angioplasty (including stenting), aortocoronary bypass, stroke and angiographically verified stenosis of peripheral arteries, and cardiovascular death in this cohort. Results: In our patients EPCs were related only to age (r = 0.154; p = 0.01). During a median follow-up period of 36 months 109 (41%) patients experienced a cardiovascular event. In a multiple Cox regression analysis, we identified EPCs (p = 0.03) and patient age (p = 0.01) as the only independent variables associated with incident cardiovascular events. Moreover, a total of 70 patients died during follow-up, 45 of those due to cardiovascular causes. Log rank test confirmed statistical significance for EPCs concerning incident cardiovascular events (p = 0.02). Conclusions: We found a significant association between the number of functionally active EPCs and cardiovascular events in patients with chronic kidney disease. Thus, defective vascular repair and regeneration may be responsible, at least in part, for the enormous cardiovascular morbidity in this population.	[Lorenzen, Johan; David, Sascha; de Groot, Kirsten; Bahlmann, Elisabeth; Kielstein, Jan T.; Haller, Hermann] Hannover Med Sch, Dept Internal Med, Div Nephrol, D-3000 Hannover, Germany; [Bahlmann, Ferdinand H.; Fliser, Danilo] Univ Saarland, Med Ctr, Dept Internal Med 4, D-6650 Homburg, Germany	Hannover Medical School; Saarland University	Lorenzen, J (corresponding author), Hannover Med Sch, Dept Internal Med, Div Nephrol, D-3000 Hannover, Germany.	indfli@uks.eu	Kielstein, Jan T./I-2956-2019; David, Sascha/AAL-6909-2021	Kielstein, Jan T./0000-0001-8110-9064; Lorenzen, Johan/0000-0002-9132-948X	Else-Kroner-Fresenius Foundation, Germany	Else-Kroner-Fresenius Foundation, Germany	The study was supported by an unrestricted grant from Else-Kroner-Fresenius Foundation, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284; Bahlmann FH, 2003, KIDNEY INT, V64, P1648, DOI 10.1046/j.1523-1755.2003.00279.x; Chan CT, 2005, AM J PHYSIOL-RENAL, V289, pF679, DOI 10.1152/ajprenal.00127.2005; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; de Groot K, 2005, TRANSPLANTATION, V79, P941, DOI 10.1097/00007890-200504270-00012; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; FADINI GP, 2009, ATHEROSCLEROSIS 0405; Fliser D, 2004, NEPHROL DIAL TRANSPL, V19, P2952, DOI 10.1093/ndt/gfh577; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Gueler F, 2005, BLOOD PURIFICAT, V23, P196, DOI 10.1159/000083941; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Leri A, 2005, CIRC RES, V97, P299, DOI 10.1161/01.RES.0000179774.56498.d2; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Ritz E, 2004, BLOOD PURIFICAT, V22, P28, DOI 10.1159/000074921; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Steiner S, 2006, TRANSPLANTATION, V81, P599, DOI 10.1097/01.tp.0000198418.06383.e8; Steiner S, 2005, AM J KIDNEY DIS, V46, P520, DOI 10.1053/j.ajkd.2005.05.015; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P257, DOI 10.1161/01.ATV.0000198239.41189.5d; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814	26	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11477	10.1371/journal.pone.0011477	http://dx.doi.org/10.1371/journal.pone.0011477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628606	Green Submitted, gold, Green Published			2022-12-27	WOS:000279637100008
J	Schmid, CD; Bucher, P				Schmid, Christoph D.; Bucher, Philipp			MER41 Repeat Sequences Contain Inducible STAT1 Binding Sites	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; CHIP-SEQ EXPERIMENTS; DNA-BINDING; ELEMENTS; DATABASE; NETWORK; METHYLATION; ACTIVATION; VERTEBRATE; DISCOVERY	Chromatin immunoprecipitation combined with massively parallel sequencing methods (ChIP-seq) is becoming the standard approach to study interactions of transcription factors (TF) with genomic sequences. At the example of public STAT1 ChIP-seq data sets, we present novel approaches for the interpretation of ChIP-seq data. We compare recently developed approaches to determine STAT1 binding sites from ChIP-seq data. Assessing the content of the established consensus sequence for STAT1 binding sites, we find that the usage of "negative control'' ChIP-seq data fails to provide substantial advantages. We derive a single refined probabilistic model of STAT1 binding sequences from these ChIP-seq data. Contrary to previous claims, we find no evidence that STAT1 binds to multiple distinct motifs upon interferon-gamma stimulation in vivo. While a large majority of genomic sites with high ChIP-seq signal is associated with a nucleotide sequence ressembling a STAT1 binding site, only a very small subset of the over 5 million potential STAT1 binding sites in the human genome is covered by ChIP-seq data. Furthermore a surprisingly large fraction of the ChIP-seq signal (5%) is absorbed by a small family of repetitive sequences (MER41). The observation of the binding of activated STAT1 protein to a specific repetitive element bolsters similar reports concerning p53 and other TFs, and strengthens the notion of an involvement of repeats in gene regulation. Incidentally MER41 are specific to primates, consequently, regulatory mechanisms in the IFN-STAT pathway might fundamentally differ between primates and rodents. On a methodological aspect, the presence of large numbers of nearly identical binding sites in repetitive sequences may lead to wrong conclusions about intrinsic binding preferences of TF as illustrated by the spacing analysis STAT1 tandem motifs. Therefore, ChIP-seq data should be analyzed independently within repetitive and non-repetitive sequences.	[Schmid, Christoph D.; Bucher, Philipp] Swiss Inst Expt Canc Res GR BUCHER, SV ISREC, Ecole Polytech Fed Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland; [Schmid, Christoph D.] Swiss Trop & Publ Hlth Inst Swiss TPH, Basel, Switzerland; [Schmid, Christoph D.] Univ Basel, Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Institute of Bioinformatics; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Schmid, CD (corresponding author), Swiss Inst Expt Canc Res GR BUCHER, SV ISREC, Ecole Polytech Fed Lausanne, Swiss Inst Bioinformat, Lausanne, Switzerland.	Christoph.Schmid@unibas.ch			Swiss Government	Swiss Government	This work was done with support from the Swiss Government (direct funding to the Swiss Institute of Bioinformatics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann-Liebrich U, 2005, SOZ PRAVENTIV MED, V50, P245, DOI 10.1007/s00038-005-4075-5; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bourque G, 2008, GENOME RES, V18, P1752, DOI 10.1101/gr.080663.108; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Hu JJ, 2005, NUCLEIC ACIDS RES, V33, P4899, DOI 10.1093/nar/gki791; Iseli C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000579; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson R, 2009, MOL BIOL EVOL, V26, P1491, DOI 10.1093/molbev/msp058; Johnson R, 2006, NUCLEIC ACIDS RES, V34, P3862, DOI 10.1093/nar/gkl525; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Laperriere D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-23; Lecine P, 1996, MOL CELL BIOL, V16, P6829; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Li XX, 1998, BIOCHIMIE, V80, P703, DOI 10.1016/S0300-9084(99)80023-6; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Polak P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-133; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Schutz F, 2008, BIOINFORMATICS, V24, P1399, DOI 10.1093/bioinformatics/btn201; Sepp T, 1997, J VIROL, V71, P771, DOI 10.1128/JVI.71.1.771-777.1997; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Ward LD, 2008, BIOINFORMATICS, V24, pI165, DOI 10.1093/bioinformatics/btn154; Whitington T, 2009, NUCLEIC ACIDS RES, V37, P14, DOI 10.1093/nar/gkn866; Wormald S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-254; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	49	38	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11425	10.1371/journal.pone.0011425	http://dx.doi.org/10.1371/journal.pone.0011425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625510	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500005
J	Tarosso, LF; Sauer, MM; Sanabani, S; Giret, MT; Tomiyama, HI; Sidney, J; Piaskowski, SM; Diaz, RS; Sabino, EC; Sette, A; Kalil, J; Watkins, DI; Kallas, EG				Tarosso, Leandro F.; Sauer, Mariana M.; Sanabani, Sabri; Giret, Maria Teresa; Tomiyama, Helena I.; Sidney, John; Piaskowski, Shari M.; Diaz, Ricardo S.; Sabino, Ester C.; Sette, Alessandro; Kalil-Filho, Jorge; Watkins, David I.; Kallas, Esper G.			Unexpected Diversity of Cellular Immune Responses against Nef and Vif in HIV-1-Infected Patients Who Spontaneously Control Viral Replication	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HIV CONTROLLERS; INFECTION; PEPTIDE; GENE; CD8; REACTIVITY; ABSENCE; VIREMIA; CD4(+)	Background: HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using HIV-1 consensus B 15-mers that overlap by 11 amino acids. Unfortunately, this method may underestimate the real breadth of the cellular immune responses against the autologous sequence of the infecting virus. Methodology and Principal Findings: Here we compared cellular immune responses against nef and vif-encoded consensus B 15-mer peptides to responses against HLA class I-predicted minimal optimal epitopes from consensus B and autologous sequences in six patients who have controlled HIV-1 replication. Interestingly, our analysis revealed that three of our patients had broader cellular immune responses against HLA class I-predicted minimal optimal epitopes from either autologous viruses or from the HIV-1 consensus B sequence, when compared to responses against the 15-mer HIV-1 type B consensus peptides. Conclusion and Significance: This suggests that the cellular immune responses against HIV-1 in controller patients may be broader than we had previously anticipated.	[Tarosso, Leandro F.; Kalil-Filho, Jorge; Kallas, Esper G.] Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil; [Sauer, Mariana M.; Giret, Maria Teresa; Tomiyama, Helena I.; Diaz, Ricardo S.; Kallas, Esper G.] Univ Fed Sao Paulo, Div Infect Dis, Sao Paulo, Brazil; [Sanabani, Sabri; Sabino, Ester C.] Sao Paulo Blood Bank, Sao Paulo, Brazil; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Piaskowski, Shari M.; Watkins, David I.] Univ Wisconsin, Sch Med, Dept Pathol, Madison, WI 53706 USA	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); La Jolla Institute for Immunology; University of Wisconsin System; University of Wisconsin Madison	Tarosso, LF (corresponding author), Univ Sao Paulo, Clin Immunol & Allergy Div, Sao Paulo, Brazil.	esper.kallas@gmail.com	Diaz, Ricardo/K-3978-2012; Sette, Alessandro/AFO-8916-2022; Kallas, Esper G/C-9539-2012; Tarosso, Leandro F./H-6267-2012; Sanabani, Sabri Saeed/F-5600-2012; Sabino, Ester C/F-7750-2010; KALIL, JORGE/C-8029-2012	Sanabani, Sabri Saeed/0000-0002-8876-8262; Sabino, Ester C/0000-0003-2623-5126; KALIL, JORGE/0000-0001-8415-4274; Kallas, Esper/0000-0003-2026-6925	National Institutes of Health [R24 RR015371]; Ministry of Health [914/BRA/3014-UNESCO]; Sao Paulo City Health Department [2004-0.168.922-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/15856-9]; Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior (CAPES), Brazilian Ministry of Education; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073230] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Health; Sao Paulo City Health Department; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior (CAPES), Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the National Institutes of Health Grant R24 RR015371 (to D. I. W.), Brazilian Program for STD and AIDS - Ministry of Health Grant 914/BRA/3014-UNESCO and the Sao Paulo City Health Department Grant 2004-0.168.922-7 (to E. G. K.), and the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 04/15856-9 (to E. G. K., E. C. S., and R. S. D.). L. F. T., M. T. M. G., and M. M. S. were supported by the Coordenacao de Aperfeicoamento de Pessoal de Ni-vel Superior (CAPES), Brazilian Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The following reagents were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: complete HIV-1 Consensus subtype B peptide sets (15-mers overlapping by 11 acids) of Nef (Cat# 5189, Lot# 8) and Vif (Cat# 6446, Lot# 7).	Alexander L, 2000, J VIROL, V74, P4361, DOI 10.1128/JVI.74.9.4361-4376.2000; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2001, J VIROL, V75, P11983, DOI 10.1128/JVI.75.24.11983-11991.2001; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Chowdhury IH, 1996, J VIROL, V70, P5336, DOI 10.1128/JVI.70.8.5336-5345.1996; Coplan PM, 2005, J INFECT DIS, V191, P1427, DOI 10.1086/428450; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Draenert R, 2003, J IMMUNOL METHODS, V275, P19, DOI 10.1016/S0022-1759(02)00541-0; Emu B, 2008, J VIROL, V82, P5398, DOI 10.1128/JVI.02176-07; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Harrer T, 1996, J IMMUNOL, V156, P2616; Hassaine G, 2000, VIROLOGY, V276, P169, DOI 10.1006/viro.2000.0543; Kallas Esper Georges, 2004, Braz J Infect Dis, V8, P399, DOI 10.1590/S1413-86702004000600003; Kern F, 2000, EUR J IMMUNOL, V30, P1676, DOI 10.1002/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V; Kiecker F, 2004, HUM IMMUNOL, V65, P523, DOI 10.1016/j.humimm.2004.02.017; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; KORBER BTM, 2005, HIV MOL IMMUNOLOGY 2; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Liu BD, 2004, J VIROL, V78, P2072, DOI 10.1128/JVI.78.4.2072-2081.2004; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2008, J VIROL, V82, P8422, DOI 10.1128/JVI.00535-08; PANTALEO G, 1995, NEW ENGL J MED, V332, P209, DOI 10.1056/NEJM199501263320402; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Rhodes DI, 2000, J VIROL, V74, P10581, DOI 10.1128/JVI.74.22.10581-10588.2000; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Saez-Cirion A, 2007, TRENDS IMMUNOL, V28, P532, DOI 10.1016/j.it.2007.09.002; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Salvi R, 1998, J VIROL, V72, P3646, DOI 10.1128/JVI.72.5.3646-3657.1998; Sanabani S, 2006, AIDS RES HUM RETROV, V22, P171, DOI 10.1089/aid.2006.22.171; Simon JHM, 1999, J VIROL, V73, P2675, DOI 10.1128/JVI.73.4.2675-2681.1999; SOVA P, 1995, J VIROL, V69, P2557, DOI 10.1128/JVI.69.4.2557-2564.1995; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Walker Bruce D, 2007, Top HIV Med, V15, P134; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006; You LW, 2007, LECT NOTES COMPUT SC, V4774, P337; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	48	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11436	10.1371/journal.pone.0011436	http://dx.doi.org/10.1371/journal.pone.0011436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625436	Green Published, gold			2022-12-27	WOS:000279465700017
J	Rokah, OH; Shpilberg, O; Granot, G				Rokah, Oshrat Hershkovitz; Shpilberg, Ofer; Granot, Galit			NAD(P)H Quinone Oxidoreductase Protects TAp63 gamma from Proteasomal Degradation and Regulates TAp63 gamma-Dependent Growth Arrest	PLOS ONE			English	Article							P53 GENE FAMILY; P63 EXPRESSION; NAD(P)H-QUINONE-OXIDOREDUCTASE-1 NQO1; NAD(P)H-QUINONE OXIDOREDUCTASE-1; P53-DEPENDENT APOPTOSIS; GENOTOXIC STRESS; DNA-DAMAGE; BLADDER; CANCER; MECHANISM	Background: p63 is a member of the p53 transcription factor family. p63 is expressed from two promoters resulting in proteins with opposite functions: the transcriptionally active TAp63 and the dominant-negative Delta Np63. Similar to p53, the TAp63 isoforms induce cell cycle arrest and apoptosis. The Delta Np63 isoforms are dominant-negative variants opposing the activities of p53, TAp63 and TAp73. To avoid unnecessary cell death accompanied by proper response to stress, the expression of the p53 family members must be tightly regulated. NAD(P)H quinone oxidoreductase (NQO1) has recently been shown to interact with and inhibit the degradation of p53. Due to the structural similarities between p53 and p63, we were interested in studying the ability of wild-type and polymorphic, inactive NQO1 to interact with and stabilize p63. We focused on TAp63 gamma, as it is the most potent transcription activator and it is expected to have a role in tumor suppression. Principal Findings: We show that TAp63 gamma can be degraded by the 20S proteasomes. Wild-type but not polymorphic, inactive NQO1 physically interacts with TAp63 gamma, stabilizes it and protects it from this degradation. NQO1-mediated TAp63 gamma stabilization was especially prominent under stress. Accordingly, we found that downregulation of NQO1 inhibits TAp63 gamma-dependant p21 upregulation and TAp63 gamma-induced growth arrest stimulated by doxorubicin. Conclusions/Significance: Our report is the first to identify this new mechanism demonstrating a physical and functional relationship between NQO1 and the most potent p63 isoform, TAp63 gamma. These findings appoint a direct role for NQO1 in the regulation of TAp63 gamma expression, especially following stress and may therefore have clinical implications for tumor development and therapy.	[Rokah, Oshrat Hershkovitz; Shpilberg, Ofer; Granot, Galit] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Felsenstein Med Res Ctr, Petah Tiqwa, Israel; [Shpilberg, Ofer] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Rabin Med Ctr,Inst Hematol, Petah Tiqwa, Israel	Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Rokah, OH (corresponding author), Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	galitg@clalit.org.il	Hershkovitz-Rokah, Oshrat/GLR-2539-2022; Hershkovitz-Rokah, Oshrat/GVT-8614-2022	Hershkovitz-Rokah, Oshrat/0000-0003-4685-0679				Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bernassola F, 2005, ONCOGENE, V24, P6982, DOI 10.1038/sj.onc.1208843; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chao C, 2006, CANCER EPIDEM BIOMAR, V15, P979, DOI 10.1158/1055-9965.EPI-05-0899; Crook T, 2000, ONCOGENE, V19, P3439, DOI 10.1038/sj.onc.1203656; Cross JV, 1999, J BIOL CHEM, V274, P31150, DOI 10.1074/jbc.274.44.31150; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Katoh I, 2000, ONCOGENE, V19, P3126, DOI 10.1038/sj.onc.1203644; Koga F, 2003, CLIN CANCER RES, V9, P5501; Koutsodontis G, 2005, BIOCHEM J, V389, P443, DOI 10.1042/BJ20041980; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; Marchini S, 2008, ANN ONCOL, V19, P501, DOI 10.1093/annonc/mdm519; Massion PP, 2003, CANCER RES, V63, P7113; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moll UM, 2004, MOL CANCER RES, V2, P371; Okada Y, 2002, EXP CELL RES, V276, P194, DOI 10.1006/excr.2002.5535; Osada M, 2005, MOL CELL BIOL, V25, P6077, DOI 10.1128/MCB.25.14.6077-6089.2005; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Papoutsaki M, 2005, ONCOGENE, V24, P6970, DOI 10.1038/sj.onc.1208835; Park BJ, 2000, CANCER RES, V60, P3370; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Reigan P, 2007, BIOCHEMISTRY-US, V46, P5941, DOI 10.1021/bi700008y; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Sanyal S, 2007, SCAND J UROL NEPHROL, V41, P182, DOI 10.1080/00365590600991946; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Traver RD, 1997, BRIT J CANCER, V75, P69, DOI 10.1038/bjc.1997.11; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; VINDELOV LL, 1983, CYTOMETRY, V3, P323, DOI 10.1002/cyto.990030503; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zeng SX, 2002, EMBO J, V21, P5487, DOI 10.1093/emboj/cdf540	41	17	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11401	10.1371/journal.pone.0011401	http://dx.doi.org/10.1371/journal.pone.0011401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613985	Green Submitted, gold, Green Published			2022-12-27	WOS:000279370000026
J	Jefferson, A; Colella, S; Moralli, D; Wilson, N; Yusuf, M; Gimelli, G; Ragoussis, J; Volpi, EV				Jefferson, Andrew; Colella, Stefano; Moralli, Daniela; Wilson, Natalie; Yusuf, Mohammed; Gimelli, Giorgio; Ragoussis, Jiannis; Volpi, Emanuela V.			Altered Intra-Nuclear Organisation of Heterochromatin and Genes in ICF Syndrome	PLOS ONE			English	Article							DE-NOVO METHYLATION; CHROMOSOME INSTABILITY; DNA HYPOMETHYLATION; SATELLITE DNA; CHROMATIN-STRUCTURE; FACIAL ANOMALIES; DNMT3B MUTATIONS; CELL-NUCLEI; IMMUNODEFICIENCY; LOCALIZATION	The ICF syndrome is a rare autosomal recessive disorder, the most common symptoms of which are immunodeficiency, facial anomalies and cytogenetic defects involving decondensation and instability of chromosome 1, 9 and 16 centromeric regions. ICF is also characterised by significant hypomethylation of the classical satellite DNA, the major constituent of the juxtacentromeric heterochromatin. Here we report the first attempt at analysing some of the defining genetic and epigenetic changes of this syndrome from a nuclear architecture perspective. In particular, we have compared in ICF ( Type 1 and Type 2) and controls the large-scale organisation of chromosome 1 and 16 juxtacentromeric heterochromatic regions, their intra-nuclear positioning, and co-localisation with five specific genes (BTG2, CNN3, ID3, RGS1, F13A1), on which we have concurrently conducted expression and methylation analysis. Our investigations, carried out by a combination of molecular and cytological techniques, demonstrate the existence of specific and quantifiable differences in the genomic and nuclear organisation of the juxtacentromeric heterochromatin in ICF. DNA hypomethylation, previously reported to correlate with the decondensation of centromeric regions in metaphase described in these patients, appears also to correlate with the heterochromatin spatial configuration in interphase. Finally, our findings on the relative positioning of hypomethylated satellite sequences and abnormally expressed genes suggest a connection between disruption of long-range geneheterochromatin associations and some of the changes in gene expression in ICF. Beyond its relevance to the ICF syndrome, by addressing fundamental principles of chromosome functional organisation within the cell nucleus, this work aims to contribute to the current debate on the epigenetic impact of nuclear architecture in development and disease.	[Jefferson, Andrew; Colella, Stefano; Moralli, Daniela; Wilson, Natalie; Yusuf, Mohammed; Ragoussis, Jiannis; Volpi, Emanuela V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Gimelli, Giorgio] Ist Giannina Gaslini, Lab Citogenet, Genoa, Italy	University of Oxford; Wellcome Centre for Human Genetics; University of Genoa; IRCCS Istituto Giannina Gaslini	Jefferson, A (corresponding author), John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	emanuela.volpi@well.ox.ac.uk	Ragoussis, Ioannis/AAD-9790-2022; Colella, Stefano/A-7040-2008	Colella, Stefano/0000-0003-3139-6055; Ragoussis, Ioannis/0000-0002-8515-0934; Volpi, Emanuela/0000-0002-2422-9104	Wellcome Trust [075491/Z/04]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust {075491/Z/04}. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barki-Celli L, 2005, GENE CHROMOSOME CANC, V43, P339, DOI 10.1002/gcc.20179; Bartova E, 2002, J STRUCT BIOL, V139, P76, DOI 10.1016/S1047-8477(02)00560-9; Bickmore WA, 2003, HUM MOL GENET, V12, pR207, DOI 10.1093/hmg/ddg260; Blanco-Betancourt CE, 2004, BLOOD, V103, P2683, DOI 10.1182/blood-2003-08-2632; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cockell M, 1999, CURR OPIN GENET DEV, V9, P199, DOI 10.1016/S0959-437X(99)80030-6; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Dietzel S, 2004, J CELL SCI, V117, P4603, DOI 10.1242/jcs.01330; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Enukashvily NI, 2007, CYTOGENET GENOME RES, V118, P42, DOI 10.1159/000106440; Ferreira J, 1997, J CELL BIOL, V139, P1597, DOI 10.1083/jcb.139.7.1597; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; Gilbert N, 2007, J CELL BIOL, V177, P401, DOI 10.1083/jcb.200607133; Gisselsson D, 2005, CHROMOSOMA, V114, P118, DOI 10.1007/s00412-005-0343-7; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Hassan KMA, 2001, HUM GENET, V109, P452; Heidari M, 2006, LEUKEMIA, V20, P304, DOI 10.1038/sj.leu.2404071; Hepperger C, 2007, CHROMOSOMA, V116, P117, DOI 10.1007/s00412-006-0084-2; Hernandez R, 1997, CYTOGENET CELL GENET, V76, P196, DOI 10.1159/000134548; Hewitt SL, 2004, EUR J IMMUNOL, V34, P3604, DOI 10.1002/eji.200425469; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Ji WZ, 1997, MUTAT RES-FUND MOL M, V379, P33, DOI 10.1016/S0027-5107(97)00088-2; Jiang YL, 2005, HUM MUTAT, V25, P56, DOI 10.1002/humu.20113; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; KOKALJVOKAC N, 1993, CYTOGENET CELL GENET, V63, P11, DOI 10.1159/000133492; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kubota T, 2004, AM J MED GENET A, V129A, P290, DOI 10.1002/ajmg.a.30135; Luciani JJ, 2005, EUR J HUM GENET, V13, P41, DOI 10.1038/sj.ejhg.5201293; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; MARASCHIO P, 1988, J MED GENET, V25, P173, DOI 10.1136/jmg.25.3.173; MARASCHIO P, 1992, ANN HUM GENET, V56, P273, DOI 10.1111/j.1469-1809.1992.tb01152.x; Matarazzo MR, 2007, P NATL ACAD SCI USA, V104, P16546, DOI 10.1073/pnas.0702924104; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; Pezzolo A, 2002, HAEMATOLOGICA, V87, P329; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Sadoni N, 1999, J CELL BIOL, V146, P1211, DOI 10.1083/jcb.146.6.1211; Saurin AJ, 1998, J CELL BIOL, V142, P887, DOI 10.1083/jcb.142.4.887; SAWYER JR, 1995, AM J MED GENET, V56, P203, DOI 10.1002/ajmg.1320560218; Scheuermann MO, 2004, EXP CELL RES, V301, P266, DOI 10.1016/j.yexcr.2004.08.031; Schubeler D, 2000, GENE DEV, V14, P940; SCHUFFENHAUER S, 1995, HUM GENET, V96, P562, DOI 10.1007/BF00197412; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; STACEY M, 1995, J MED GENET, V32, P502, DOI 10.1136/jmg.32.7.502; Sumner AT, 1998, J MED GENET, V35, P833, DOI 10.1136/jmg.35.10.833; Tanabe H, 2002, P NATL ACAD SCI USA, V99, P4424, DOI 10.1073/pnas.072618599; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; TIEPOLO L, 1979, HUM GENET, V51, P127, DOI 10.1007/BF00287166; Tuck-Muller CM, 2000, CYTOGENET CELL GENET, V89, P121, DOI 10.1159/000015590; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Wijmenga C, 2000, HUM MUTAT, V16, P509, DOI 10.1002/1098-1004(200012)16:6<509::AID-HUMU8>3.3.CO;2-M; Wijmenga C, 1998, AM J HUM GENET, V63, P803, DOI 10.1086/302021; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	65	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11364	10.1371/journal.pone.0011364	http://dx.doi.org/10.1371/journal.pone.0011364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613881	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000279369900013
J	Ge, XH; Gebe, JA; Bollyky, PL; James, EA; Yang, JB; Stern, LJ; Kwok, WW				Ge, Xinhui; Gebe, John A.; Bollyky, Paul L.; James, Eddie A.; Yang, Junbao; Stern, Lawrence J.; Kwok, William W.			Peptide-MHC Cellular Microarray with Innovative Data Analysis System for Simultaneously Detecting Multiple CD4 T-Cell Responses	PLOS ONE			English	Article							CLASS-II TETRAMERS; INFLUENZA; AUTOANTIGEN; EPITOPES; ANTIGEN; IDENTIFICATION; PHENOTYPE; VIRUS	Background: Peptide: MHC cellular microarrays have been proposed to simultaneously characterize multiple Ag-specific populations of T cells. The practice of studying immune responses to complicated pathogens with this tool demands extensive knowledge of T cell epitopes and the availability of peptide: MHC complexes for array fabrication as well as a specialized data analysis approach for result interpretation. Methodology/Principal Findings: We co-immobilized peptide: DR0401 complexes, anti-CD28, anti-CD11a and cytokine capture antibodies on the surface of chamber slides to generate a functional array that was able to detect rare Ag-specific T cell populations from previously primed in vitro T cell cultures. A novel statistical methodology was also developed to facilitate batch processing of raw array-like data into standardized endpoint scores, which linearly correlated with total Ag-specific T cell inputs. Applying these methods to analyze Influenza A viral antigen-specific T cell responses, we not only revealed the most prominent viral epitopes, but also demonstrated the heterogeneity of anti-viral cellular responses in healthy individuals. Applying these methods to examine the insulin producing beta-cell autoantigen specific T cell responses, we observed little difference between autoimmune diabetic patients and healthy individuals, suggesting a more subtle association between diabetes status and peripheral autoreactive T cells. Conclusions/Significance: The data analysis system is reliable for T cell specificity and functional testing. Peptide: MHC cellular microarrays can be used to obtain multi-parametric results using limited blood samples in a variety of translational settings.	[Ge, Xinhui; Gebe, John A.; Bollyky, Paul L.; James, Eddie A.; Yang, Junbao; Kwok, William W.] Benaroya Res Inst Virginia Mason, Seattle, WA USA; [Stern, Lawrence J.] Univ Massachusetts, Sch Med, Dept Pathol, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	Benaroya Research Institute; Virginia Mason Medical Center; University of Massachusetts System; University of Massachusetts Worcester	Ge, XH (corresponding author), Benaroya Res Inst Virginia Mason, Seattle, WA USA.	bkwok@benaroyaresearch.org	James, Eddie/V-4929-2019	James, Eddie/0000-0002-7217-5729	W.K from American Diabetes Association [ADA 7-06-RA-75]; National Institutes of Health [R21 DK077525-02, HHSN272200900043C, U19 AI57319]; Juvenile Diabetes Research Foundation [3-2008-548]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077525] Funding Source: NIH RePORTER	W.K from American Diabetes Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants to W.K from American Diabetes Association (ADA 7-06-RA-75, www.diabetes.org) and National Institutes of Health (R21 DK077525-02; HHSN272200900043C, www.nih.gov), and a grant to LJ.S from National Institutes of Health (U19 AI57319, www.nih.gov). X. G is currently supported by Juvenile Diabetes Research Foundation International Postdoctoral Fellowship Award (3-2008-548, www.jdrf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, Nature, V419, P323; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Chen DS, 2006, CURR OPIN CHEM BIOL, V10, P28, DOI 10.1016/j.cbpa.2006.01.001; Chen DS, 2005, PLOS MED, V2, P1018, DOI 10.1371/journal.pmed.0020265; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Durinovic-Bello I, 2006, P NATL ACAD SCI USA, V103, P11683, DOI 10.1073/pnas.0603682103; Ge XH, 2010, J VIROL, V84, P3312, DOI 10.1128/JVI.02226-09; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kwong GA, 2009, J AM CHEM SOC, V131, P9695, DOI 10.1021/ja9006707; Nepom GT, 2001, P NATL ACAD SCI USA, V98, P1763, DOI 10.1073/pnas.98.4.1763; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Novak EJ, 1999, J CLIN INVEST, V104, pR63, DOI 10.1172/JCI8476; Peakman M, 1999, J CLIN INVEST, V104, P1449, DOI 10.1172/JCI7936; Soen Y, 2003, PLOS BIOL, V1, P429, DOI 10.1371/journal.pbio.0000065; Song Q, 2010, ANAL CHEM, V82, P473, DOI 10.1021/ac9024363; Stone JD, 2005, P NATL ACAD SCI USA, V102, P3744, DOI 10.1073/pnas.0407019102; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Wicker LS, 1996, J CLIN INVEST, V98, P2597, DOI 10.1172/JCI119079; Yang JB, 2006, J IMMUNOL, V176, P2781, DOI 10.4049/jimmunol.176.5.2781; Yang JB, 2006, CLIN IMMUNOL, V120, P21, DOI 10.1016/j.clim.2006.03.008; 2005, NATURE METHOD, V2, P321	21	14	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11355	10.1371/journal.pone.0011355	http://dx.doi.org/10.1371/journal.pone.0011355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20634998	Green Published, Green Submitted, gold			2022-12-27	WOS:000279259900023
J	Olsen, AK; Andreassen, A; Singh, R; Wiger, R; Duale, N; Farmer, PB; Brunborg, G				Olsen, Ann-Karin; Andreassen, Ashild; Singh, Rajinder; Wiger, Richard; Duale, Nur; Farmer, Peter B.; Brunborg, Gunnar			Environmental Exposure of the Mouse Germ Line: DNA Adducts in Spermatozoa and Formation of De Novo Mutations during Spermatogenesis	PLOS ONE			English	Article							SPERM CHROMATIN-STRUCTURE; POLYCYCLIC AROMATIC-HYDROCARBONS; NUCLEOTIDE EXCISION-REPAIR; IN-VITRO FERTILIZATION; CHILDHOOD BRAIN-TUMORS; DIOL EPOXIDE; STRUCTURE ASSAY; CIGARETTE-SMOKING; PREGNANCY RATES; TRANSGENIC MICE	Background: Spermatozoal DNA damage is associated with poor sperm quality, disturbed embryonic development and early embryonic loss, and some genetic diseases originate from paternal de novo mutations. We previously reported poor repair of bulky DNA-lesions in rodent testicular cells. Methodology/Principal Findings: We studied the fate of DNA lesions in the male germ line. B[a] PDE-N(2)-dG adducts were determined by liquid chromatography-tandem mass spectrometry, and de novo mutations were measured in the cll-transgene, in Big Blue (R) mice exposed to benzo[a] pyrene (B[a] P; 3x50 mg/kg bw, i.p.). Spermatozoa were harvested at various time-points following exposure, to study the consequences of exposure during the different stages of spermatogenesis. B[a] PDE-N(2)-dG adducts induced by exposure of spermatocytes or later stages of spermatogenesis persisted at high levels in the resulting spermatozoa. Spermatozoa originating from exposed spermatogonia did not contain DNA adducts; however de novo mutations had been induced (p = 0.029), specifically GC-TA transversions, characteristic of B[a] P mutagenesis. Moreover, a specific spectrum of spontaneous mutations was consistently observed in spermatozoa. Conclusions/Significance: A temporal pattern of genotoxic consequences following exposure was identified, with an initial increase in DNA adduct levels in spermatozoa, believed to influence fertility, followed by induction of germ line de novo mutations with possible consequences for the offspring.	[Olsen, Ann-Karin; Andreassen, Ashild; Wiger, Richard; Duale, Nur; Brunborg, Gunnar] Norwegian Inst Publ Hlth, Div Environm Med, Oslo, Norway; [Singh, Rajinder; Farmer, Peter B.] Univ Leicester, Dept Canc Studies & Mol Med, Leicester, Leics, England	Norwegian Institute of Public Health (NIPH); University of Leicester	Olsen, AK (corresponding author), Norwegian Inst Publ Hlth, Div Environm Med, Oslo, Norway.	ann.karin.olsen@fhi.no	Singh, Raj/HDN-1244-2022; Singh, Raj/A-5398-2011	Olsen, Ann-Karin/0000-0003-3982-5213	Research Council of Norway [148703]; Environmental Cancer Risk, Nutrition and Individual Susceptibility; European Union Network of Excellence [FOOD-CT-2005-513943]	Research Council of Norway(Research Council of Norway); Environmental Cancer Risk, Nutrition and Individual Susceptibility; European Union Network of Excellence(European Commission)	This work was supported by The Research Council of Norway [148703 to AKO], and by Environmental Cancer Risk, Nutrition and Individual Susceptibility, a European Union Network of Excellence (ECNIS, Contract No. FOOD-CT-2005-513943, to RS and PBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS WT, 1987, J MOL BIOL, V194, P391, DOI 10.1016/0022-2836(87)90669-3; Ahmadi A, 1999, J EXP ZOOL, V284, P696, DOI 10.1002/(SICI)1097-010X(19991101)284:6&lt;696::AID-JEZ11&gt;3.0.CO;2-E; Andersson AM, 2008, INT J ANDROL, V31, P74, DOI 10.1111/j.1365-2605.2007.00853.x; Andreassen A, 2006, MUTAT RES-GEN TOX EN, V604, P60, DOI 10.1016/j.mrgentox.2006.01.004; Andrew SE, 2000, CARCINOGENESIS, V21, P1291, DOI 10.1093/carcin/21.7.1291; Barber R, 2002, P NATL ACAD SCI USA, V99, P6877, DOI 10.1073/pnas.102015399; Borini A, 2006, HUM REPROD, V21, P2876, DOI 10.1093/humrep/del251; CAROTHERS AM, 1990, CARCINOGENESIS, V11, P189; Cordier S, 2004, AM J EPIDEMIOL, V159, P1109, DOI 10.1093/aje/kwh154; Cordier S, 1997, CANCER CAUSE CONTROL, V8, P688, DOI 10.1023/A:1018419118841; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DOUGLAS GR, 1994, MUTAGENESIS, V9, P451, DOI 10.1093/mutage/9.5.451; DUBROVA YE, 1993, NAT GENET, V5, P92, DOI 10.1038/ng0993-92; EVENSON DP, 1989, ENVIRON MOL MUTAGEN, V14, P79, DOI 10.1002/em.2850140203; EVENSON DP, 1993, ENVIRON MOL MUTAGEN, V21, P144, DOI 10.1002/em.2850210208; Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039; Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0; FRAGA CG, 1991, P NATL ACAD SCI USA, V88, P11003, DOI 10.1073/pnas.88.24.11003; Frydman N, 2008, FERTIL STERIL, V89, P92, DOI 10.1016/j.fertnstert.2007.02.022; GENEROSO WM, 1982, MUTAT RES, V94, P155, DOI 10.1016/0027-5107(82)90178-6; Harbach PR, 1999, ENVIRON MOL MUTAGEN, V33, P132, DOI 10.1002/(SICI)1098-2280(1999)33:2<132::AID-EM5>3.0.CO;2-2; Hassan MAM, 2004, FERTIL STERIL, V81, P384, DOI 10.1016/j.fertnstert.2003.06.027; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Hull MGR, 2000, FERTIL STERIL, V74, P725, DOI 10.1016/S0015-0282(00)01501-6; Irvine DS, 2000, J ANDROL, V21, P33; Jansen J, 2001, NUCLEIC ACIDS RES, V29, P1791, DOI 10.1093/nar/29.8.1791; KOHLER SW, 1991, ENVIRON MOL MUTAGEN, V18, P316, DOI 10.1002/em.2850180421; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; Lin MH, 2008, FERTIL STERIL, V90, P352, DOI 10.1016/j.fertnstert.2007.06.018; Loft S, 2003, HUM REPROD, V18, P1265, DOI 10.1093/humrep/deg202; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; MEISTRICH ML, 1986, BIOL REPROD, V34, P17, DOI 10.1095/biolreprod34.1.17; NELSON K, 1989, NEW ENGL J MED, V320, P19, DOI 10.1056/NEJM198901053200104; Ni ZY, 1997, MUTAT RES-FUND MOL M, V381, P77, DOI 10.1016/S0027-5107(97)00151-6; Olsen Ann-Karin, 2005, Toxicol Appl Pharmacol, V207, P521, DOI 10.1016/j.taap.2005.01.060; Oskam IC, 2005, REPRODUCTION, V130, P731, DOI 10.1530/rep.1.00690; Plichart M, 2008, EUR J CANCER PREV, V17, P376, DOI 10.1097/CEJ.0b013e3282f75e6f; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P188, DOI 10.1093/humrep/del364; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; Schmid TE, 2003, HUM REPROD, V18, P1474, DOI 10.1093/humrep/deg259; Shane BS, 2000, CARCINOGENESIS, V21, P715, DOI 10.1093/carcin/21.4.715; Shen HM, 2000, FREE RADICAL BIO MED, V28, P529, DOI 10.1016/S0891-5849(99)00234-8; Singh R, 2006, CHEM RES TOXICOL, V19, P868, DOI 10.1021/tx060011r; SIPINEN V, 2010, MUTAGENESIS; Sorahan T, 1997, BRIT J CANCER, V76, P1525, DOI 10.1038/bjc.1997.589; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Suter L, 1997, CYTOMETRY, V27, P161, DOI 10.1002/(SICI)1097-0320(19970201)27:2<161::AID-CYTO8>3.0.CO;2-J; VERHOFSTAD N, 2009, ENV MOL MUTAGEN; VOGEL F, 1975, ADV HUM GENET, V5, P223; Walter CA, 2004, DNA REPAIR, V3, P495, DOI 10.1016/j.dnarep.2004.01.005; Xu GG, 2005, BIOL REPROD, V73, P123, DOI 10.1095/biolreprod.104.039123; Yauk C, 2008, P NATL ACAD SCI USA, V105, P605, DOI 10.1073/pnas.0705896105; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; Yoon JH, 2004, CANCER RES, V64, P7321, DOI 10.1158/0008-5472.CAN-04-1094; Yoon JH, 2001, CANCER RES, V61, P7110; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; Zini A, 2008, HUM REPROD, V23, P2663, DOI 10.1093/humrep/den321; Zitzmann M, 2003, FERTIL STERIL, V79, P1550, DOI 10.1016/S0015-0282(03)00339-X	61	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11349	10.1371/journal.pone.0011349	http://dx.doi.org/10.1371/journal.pone.0011349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596530	Green Published, Green Submitted, gold			2022-12-27	WOS:000279259900020
J	Chan, TC; Hsiao, CK; Lee, CC; Chiang, PH; Kao, CL; Liu, CM; King, CC				Chan, Ta-Chien; Hsiao, Chuhsing Kate; Lee, Chang-Chun; Chiang, Po-Huang; Kao, Chuan-Liang; Liu, Chung-Ming; King, Chwan-Chuen			The Impact of Matching Vaccine Strains and Post-SARS Public Health Efforts on Reducing Influenza-Associated Mortality among the Elderly	PLOS ONE			English	Article							SURVEILLANCE SURVEILLANCE DATA; ACUTE RESPIRATORY SYNDROME; HEMAGGLUTINATION-INHIBITION; B VIRUS; EPIDEMIC	Public health administrators do not have effective models to predict excess influenza-associated mortality and monitor viral changes associated with it. This study evaluated the effect of matching/mismatching vaccine strains, type/subtype pattern changes in Taiwan's influenza viruses, and the impact of post-SARS (severe acute respiratory syndrome) public health efforts on excess influenza-associated mortalities among the elderly. A negative binomial model was developed to estimate Taiwan's monthly influenza-associated mortality among the elderly. We calculated three winter and annual excess influenza-associated mortalities [ pneumonia and influenza (P&I), respiratory and circulatory, and all-cause] from the 1999-2000 through the 2006-2007 influenza seasons. Obtaining influenza virus sequences from the months/years in which death from P&I was excessive, we investigated molecular variation in vaccine-mismatched influenza viruses by comparing hemagglutinin 1 (HA1) of the circulating and vaccine strains. We found that the higher the isolation rate of A (H3N2) and vaccine-mismatched influenza viruses, the greater the monthly P&I mortality. However, this significant positive association became negative for higher matching of A (H3N2) and public health efforts with post-SARS effect. Mean excess P&I mortality for winters was significantly higher before 2003 than after that year [mean +/- S.D.: 1.44 +/- 1.35 vs. 0.35 +/- 1.13, p = 0.04]. Further analysis revealed that vaccine-matched circulating influenza A viruses were significantly associated with lower excess P&I mortality during post-SARS winters (i.e., 2005-2007) than during pre-SARS winters [0.0360.06 vs. 1.5761.27, p = 0.01]. Stratification of these vaccine-matching and post-SARS effect showed substantial trends toward lower elderly excess P&I mortalities in winters with either mismatching vaccines during the post-SARS period or matching vaccines during the pre-SARS period. Importantly, all three excess mortalities were at their highest in May, 2003, when inter-hospital nosocomial infections were peaking. Furthermore, vaccine-mismatched H3N2 viruses circulating in the years with high excess P&I mortality exhibited both a lower amino acid identity percentage of HA1 between vaccine and circulating strains and a higher numbers of variations at epitope B. Our model can help future decision makers to estimate excess P&I mortality effectively, select and test virus strains for antigenic variation, and evaluate public health strategy effectiveness.	[Chan, Ta-Chien; Hsiao, Chuhsing Kate; Lee, Chang-Chun; Kao, Chuan-Liang; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan; [Chan, Ta-Chien; Chiang, Po-Huang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Hlth Policy Res, Zhunan, Taiwan; [Hsiao, Chuhsing Kate; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Kao, Chuan-Liang] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Liu, Chung-Ming] Natl Taiwan Univ, Global Change Res Ctr, Taipei 10764, Taiwan; [Liu, Chung-Ming] Natl Taiwan Univ, Coll Sci, Dept Atmospher Sci, Taipei 10764, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chan, TC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan.	chwanchuen@gmail.com	Chan, Ta-Chien/C-8992-2012; Chiang, Po-Huang/E-3996-2010	King, Chwan-Chuen/0000-0002-6078-2601; KAO, CHUAN-LIANG/0000-0002-1020-2605; hsiao, chuhsing kate/0000-0003-4905-8484	Taiwan's National Health Research Institute [98A1-PHSP09-018]; Taiwan-Centers for Disease Control [DOH95-DC-1021]; National Institutes of Health in the United States; Emory University [2U19AI05726606, HHSN266200700006C]	Taiwan's National Health Research Institute; Taiwan-Centers for Disease Control; National Institutes of Health in the United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University	This research was supported by four grants: #98A1-PHSP09-018 from Taiwan's National Health Research Institute, #DOH95-DC-1021 from Taiwan-Centers for Disease Control, and financial support from the National Institutes of Health in the United States and collaboration with Dr. Rafi Ahmed, Dr. C.L. Yang, and Dr. R. Compans at Emory University (grant #2U19AI05726606 and grant #HHSN266200700006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boni MF, 2008, VACCINE, V26, pC8, DOI 10.1016/j.vaccine.2008.04.011; Casella G., 2002, STAT INFERENCE, V2nd; Chambers TM, 2009, EQUINE VET J, V41, P87, DOI 10.2746/042516408X371937; Chen JM, 2007, ARCH VIROL, V152, P415, DOI 10.1007/s00705-006-0852-6; Chen JZ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-30; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Chu DC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-228; *CTR DIS CONTR, LAB VIR SURV REP; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Hai R, 2008, J VIROL, V82, P10580, DOI 10.1128/JVI.01213-08; Hsieh Yu-Chia, 2005, Journal of Microbiology Immunology and Infection, V38, P238; Jefferson TO, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub3; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; LONDI T, 2008, TAIWAN TODAY; Lu TH, 2007, HEALTH POLICY, V83, P375, DOI 10.1016/j.healthpol.2007.03.001; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; Pan K, 2009, VACCINE, V27, P5033, DOI 10.1016/j.vaccine.2009.05.068; Pechirra P, 2005, J MED VIROL, V77, P541, DOI 10.1002/jmv.20490; Rimmelzwaan GF, 2009, VACCINE, V27, P6363, DOI 10.1016/j.vaccine.2009.01.016; Rivetti D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004876.pub2; Rizzo C, 2006, VACCINE, V24, P6468, DOI 10.1016/j.vaccine.2006.06.052; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shaw K, 2006, PUBLIC HEALTH, V120, P8, DOI 10.1016/j.puhe.2005.10.002; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; *TAIW CDC, 2008, PROGR STAND ANT ANT; *TAIW CDC, 2010, INFL EXPR TAIW WEEK; Tan XD, 2004, HEALTH EDUC RES, V19, P576, DOI 10.1093/her/cyg074; Tang CSK, 2004, PREV MED, V39, P1187, DOI 10.1016/j.ypmed.2004.04.032; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tsai HP, 2006, J CLIN MICROBIOL, V44, P2705, DOI 10.1128/JCM.02694-05; *US BUR CENS, 2000, IT DAT BAS IDB; Wahl A, 2009, J VIROL, V83, P9206, DOI 10.1128/JVI.00932-09; Wang CS, 2007, VACCINE, V25, P1196, DOI 10.1016/j.vaccine.2006.10.015; *WHO, WHO REC INFL VACC CO; *WIK, 2009, 2009 FLU PAND COUNTR; Wong TW, 2005, AM J INFECT CONTROL, V33, P580, DOI 10.1016/j.ajic.2005.05.025; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Wung Cathy H Y, 2008, World Hosp Health Serv, V44, P14; Wung CH, 2008, WORLD HOSP HLTH SERV, V44, P18; Yen MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007962	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11317	10.1371/journal.pone.0011317	http://dx.doi.org/10.1371/journal.pone.0011317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615NA	20592764	Green Submitted, gold, Green Published			2022-12-27	WOS:000279140800017
J	Piron, F; Nicolai, M; Minoia, S; Piednoir, E; Moretti, A; Salgues, A; Zamir, D; Caranta, C; Bendahmane, A				Piron, Florence; Nicolai, Maryse; Minoia, Silvia; Piednoir, Elodie; Moretti, Andre; Salgues, Aurelie; Zamir, Dani; Caranta, Carole; Bendahmane, Abdelhafid			An Induced Mutation in Tomato eIF4E Leads to Immunity to Two Potyviruses	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTORS; INDUCED POINT MUTATIONS; REVERSE GENETICS TOOL; VENOUS-MOTTLE-VIRUS; ARABIDOPSIS-THALIANA; IN-SILICO; RECESSIVE RESISTANCE; FUNCTIONAL GENOMICS; MOLECULAR-BIOLOGY; FRUIT-DEVELOPMENT	Background: The characterization of natural recessive resistance genes and Arabidopsis virus-resistant mutants have implicated translation initiation factors of the eIF4E and eIF4G families as susceptibility factors required for virus infection and resistance function. Methodology/Principal Findings: To investigate further the role of translation initiation factors in virus resistance we set up a TILLING platform in tomato, cloned genes encoding for translation initiation factors eIF4E and eIF4G and screened for induced mutations that lead to virus resistance. A splicing mutant of the eukaryotic translation initiation factor, S.l_eIF4E1 G1485A, was identified and characterized with respect to cap binding activity and resistance spectrum. Molecular analysis of the transcript of the mutant form showed that both the second and the third exons were miss-spliced, leading to a truncated mRNA. The resulting truncated eIF4E1 protein is also impaired in cap-binding activity. The mutant line had no growth defect, likely because of functional redundancy with others eIF4E isoforms. When infected with different potyviruses, the mutant line was immune to two strains of Potato virus and Pepper mottle virus and susceptible to Tobacco each virus. Conclusions/Significance: Mutation analysis of translation initiation factors shows that translation initiation factors of the eIF4E family are determinants of plant susceptibility to RNA viruses and viruses have adopted strategies to use different isoforms. This work also demonstrates the effectiveness of TILLING as a reverse genetics tool to improve crop species. We have also developed a complete tool that can be used for both forward and reverse genetics in tomato, for both basic science and crop improvement. By opening it to the community, we hope to fulfill the and scientists who are using tomato as their model of study.	[Piron, Florence; Minoia, Silvia; Piednoir, Elodie; Bendahmane, Abdelhafid] Uni EVRY, CNRS, INRA, UMR,Unite Rech Genom Vegetale, Evry, France; [Nicolai, Maryse; Moretti, Andre; Salgues, Aurelie; Caranta, Carole] INRA, UR1052, Unite Genet & Ameliorat Fruits & Legumes, F-84143 Montfavet, France; [Zamir, Dani] Hebrew Univ Jerusalem, Fac Agr, Inst Plant Sci, IL-76100 Rehovot, Israel	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Hebrew University of Jerusalem	Piron, F (corresponding author), Uni EVRY, CNRS, INRA, UMR,Unite Rech Genom Vegetale, Evry, France.	bendahm@evry.inra.fr		Bendahmane, Abdelhafid/0000-0003-3246-868X; Piron Prunier, Florence/0000-0003-2652-5123	GENOPLANTE [GENOTILL 097-098, TRANSVIR GNP05003G]; EU-SOL; INRA	GENOPLANTE; EU-SOL; INRA	This work was supported by GENOPLANTE (GENOTILL 097-098 and TRANSVIR GNP05003G), EU-SOL and INRA Transfert. F.P., M.N. and E.P. were supported by fellowships from the same projects. The M82 TILLING platform was developed within the frame of the European EUSOL Integrated Project. The M82 TILLING platform is open to the scientific communities worldwide for collaborations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Albar L, 2006, PLANT J, V47, P417, DOI 10.1111/j.1365-313X.2006.02792.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bentley A, 2000, GENETICS, V156, P1169; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Caranta C, 1996, THEOR APPL GENET, V92, P15, DOI 10.1007/BF00222946; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Comai L, 2006, PLANT J, V45, P684, DOI 10.1111/j.1365-313X.2006.02670.x; Combe JP, 2005, PLANT MOL BIOL, V57, P749, DOI 10.1007/s11103-005-3098-x; D'Agostino N, 2007, NUCLEIC ACIDS RES, V35, pD901, DOI 10.1093/nar/gkl921; Dalmais M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r43; Doganlar S, 2002, GENOME, V45, P1189, DOI 10.1139/G02-091; Duprat A, 2002, PLANT J, V32, P927, DOI 10.1046/j.1365-313X.2002.01481.x; Fei ZJ, 2004, PLANT J, V40, P47, DOI 10.1111/j.1365-313X.2004.02188.x; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Greene EA, 2003, GENETICS, V164, P731; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Hwang J, 2009, MOL CELLS, V27, P329, DOI 10.1007/s10059-009-0042-y; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kang BC, 2005, PLANT J, V42, P392, DOI 10.1111/j.1365-313X.2005.02381.x; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Maule AJ, 2007, MOL PLANT PATHOL, V8, P223, DOI 10.1111/J.1364-3703.2007.00386.X; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Moco S, 2006, PLANT PHYSIOL, V141, P1205, DOI 10.1104/pp.106.078428; Moury B, 2004, MOL PLANT MICROBE IN, V17, P322, DOI 10.1094/MPMI.2004.17.3.322; Nicaise V, 2007, FEBS LETT, V581, P1041, DOI 10.1016/j.febslet.2007.02.007; OHYAMA A, 1995, PLANT CELL PHYSIOL, V36, P369, DOI 10.1093/oxfordjournals.pcp.a078769; Parrella G, 2002, THEOR APPL GENET, V105, P855, DOI 10.1007/s00122-002-1005-2; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Revers F, 1999, MOL PLANT MICROBE IN, V12, P367, DOI 10.1094/MPMI.1999.12.5.367; Rigola D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004761; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; ROBINSON NL, 1988, PLANT PHYSIOL, V87, P727, DOI 10.1104/pp.87.3.727; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruffel S, 2005, MOL GENET GENOMICS, V274, P346, DOI 10.1007/s00438-005-0003-x; Ruffel S, 2004, GENE, V338, P209, DOI 10.1016/j.gene.2004.05.010; Ruffel S, 2006, J GEN VIROL, V87, P2089, DOI 10.1099/vir.0.81817-0; Sambrook J., 2002, MOL CLONING LAB MANU; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Stack SM, 2009, CYTOGENET GENOME RES, V124, P339, DOI 10.1159/000218137; Till BJ, 2003, GENOME RES, V13, P524, DOI 10.1101/gr.977903; Triques K, 2007, PLANT J, V51, P1116, DOI 10.1111/j.1365-313X.2007.03201.x; VANCE VB, 1992, VIROLOGY, V191, P19, DOI 10.1016/0042-6822(92)90162-I; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILKINSON JQ, 1995, SCIENCE, V270, P1807, DOI 10.1126/science.270.5243.1807; Yeam I, 2007, PLANT CELL, V19, P2913, DOI 10.1105/tpc.107.050997	63	155	168	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11313	10.1371/journal.pone.0011313	http://dx.doi.org/10.1371/journal.pone.0011313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593023	gold, Green Published			2022-12-27	WOS:000279140800014
J	Gopinath, S; Malla, RR; Gondi, CS; Alapati, K; Fassett, D; Klopfenstein, JD; Dinh, DH; Gujrati, M; Rao, JS				Gopinath, Sreelatha; Malla, Rama Rao; Gondi, Christopher S.; Alapati, Kiranmai; Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Gujrati, Meena; Rao, Jasti S.			Co-Depletion of Cathepsin B and uPAR Induces G0/G1 Arrest in Glioma via FOXO3a Mediated p27(Kip1) Upregulation	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; FORKHEAD TRANSCRIPTION FACTORS; PROSTATE-CANCER CELLS; CDK INHIBITOR P27; DOWN-REGULATION; TUMOR-GROWTH; NUCLEAR IMPORT; HAIRPIN RNA; UROKINASE; CYCLE	Background: Cathepsin B and urokinase plasminogen activator receptor (uPAR) are both known to be overexpressed in gliomas. Our previous work and that of others strongly suggest a relationship between the infiltrative phenotype of glioma and the expression of cathepsin B and uPAR. Though their role in migration and adhesion are well studied the effect of these molecules on cell cycle progression has not been thoroughly examined. Methodology/Principal Findings: Cathespin B and uPAR single and bicistronic siRNA plasmids were used to downregulate these molecules in SNB19 and U251 glioma cells. FACS analysis and BrdU incorporation assay demonstrated G0/G1 arrest and decreased proliferation with the treatments, respectively. Immunoblot and immunocyto analysis demonstrated increased expression of p27(Kip1) and its nuclear localization with the knockdown of cathepsin B and uPAR. These effects could be mediated by alpha V beta 3/PI3K/AKT/FOXO pathway as observed by the decreased alpha V beta 3 expression, PI3K and AKT phosphorylation accompanied by elevated FOXO3a levels. These results were further confirmed with the increased expression of p27(Kip1) and FOXO3a when treated with Ly294002 (10 mu M) and increased luciferase expression with the siRNA and Ly294002 treatments when the FOXO binding promoter region of p27(Kip1) was used. Our treatment also reduced the expression of cyclin D1, cyclin D2, p-Rb and cyclin E while the expression of Cdk2 was unaffected. Of note, the Cdk2-cyclin E complex formation was reduced significantly. Conclusion/Significance: Our study indicates that cathepsin B and uPAR knockdown induces G0/G1 arrest by modulating the PI3K/AKT signaling pathway and further increases expression of p27(Kip1) accompanied by the binding of FOXO3a to its promoter. Taken together, our findings provide molecular mechanism for the G0/G1 arrest induced by the downregulation of cathepsin B and uPAR in SNB19 and U251 glioma cells.	[Gopinath, Sreelatha; Malla, Rama Rao; Gondi, Christopher S.; Alapati, Kiranmai; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Neurosurg, Peoria, IL 61656 USA; [Gujrati, Meena] Univ Illinois, Coll Med, Dept Pathol, Peoria, IL 61656 USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Gopinath, S (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu	Malla, Rama/E-2438-2019; Malla, Rama Rao/AAU-8455-2021; Alapati, Kiranmai/F-7171-2013	Malla, Rama/0000-0003-2448-1681; Malla, Rama Rao/0000-0003-2448-1681; Gondi, Christopher/0000-0002-3036-9920	National Institutes of Health [CA116708]; NATIONAL CANCER INSTITUTE [R01CA116708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a grant from National Institutes of Health, CA116708 (to J.S.R.) The contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkarain A, 2004, J MAMMARY GLAND BIOL, V9, P67, DOI 10.1023/B:JOMG.0000023589.00994.5e; Belletti B, 2005, CURR MED CHEM, V12, P1589, DOI 10.2174/0929867054367149; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Brownawell AM, 2001, MOL CELL BIOL, V21, P3534, DOI 10.1128/MCB.21.10.3534-3546.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cavallo-Medved D, 2005, J CELL SCI, V118, P1493, DOI 10.1242/jcs.02278; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; CLARK KL, 1993, NATURE, V364, P412, DOI 10.1038/364412a0; D'Alessio S, 2004, INT J CANCER, V110, P125, DOI 10.1002/ijc.20077; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Favrot M, 1998, GENE THER, V5, P728, DOI 10.1038/sj.gt.3300661; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GLADSON CL, 1995, AM J PATHOL, V146, P1150; Gondi CS, 2007, CLIN CANCER RES, V13, P4051, DOI 10.1158/1078-0432.CCR-06-3032; Gondi CS, 2004, NEURON GLIA BIOL, V1, P165, DOI 10.1017/S1740925X04000237; Gondi CS, 2006, MOL CANCER THER, V5, P3197, DOI 10.1158/1535-7163.MCT-05-0531; Gondi CS, 2004, ONCOGENE, V23, P8486, DOI 10.1038/sj.onc.1207879; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; HATAKEYAMA M, 1994, GENE DEV, V8, P1759, DOI 10.1101/gad.8.15.1759; Kops GJPL, 2000, J ANAT, V197, P571, DOI 10.1046/j.1469-7580.2000.19740571.x; Lakka SS, 2003, CANCER RES, V63, P2454; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lau CJ, 2009, CANCER RES, V69, P5433, DOI 10.1158/0008-5472.CAN-08-4540; Lawlor MA, 2001, J CELL SCI, V114, P2903; Li CJ, 2010, BIOCHEM PHARMACOL, V79, P926, DOI 10.1016/j.bcp.2009.10.019; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; LIN BTY, 1991, EMBO J, V10, P857, DOI 10.1002/j.1460-2075.1991.tb08018.x; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Mazzieri R, 2007, ONCOGENE, V26, P725, DOI 10.1038/sj.onc.1209833; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Mohan PM, 1999, CLIN EXP METASTAS, V17, P617, DOI 10.1023/A:1006779902978; Mohanam S, 1999, INT J ONCOL, V14, P169; Mohanam Sanjeeva, 1999, Frontiers in Bioscience, V4, pD178, DOI 10.2741/Mohanam; Moles A, 2009, HEPATOLOGY, V49, P1297, DOI 10.1002/hep.22753; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Obermajer N, 2008, CONNECT TISSUE RES, V49, P193, DOI 10.1080/03008200802143158; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; REMPEL SA, 1994, CANCER RES, V54, P6027; Rodriguez-Ubreva FJ, 2010, ONCOGENE, V29, P345, DOI 10.1038/onc.2009.329; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHI J, 2009, J NEUROONCOL; SIVAPARVATHI M, 1995, CLIN EXP METASTAS, V13, P49, DOI 10.1007/BF00144018; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Sue YM, 2009, AM J PHYSIOL-CELL PH, V297, pC321, DOI 10.1152/ajpcell.00069.2009; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Tralhao JG, 2003, FASEB J, V17, P464, DOI 10.1096/fj.02-0534fje; VAN BG, 2009, CANCER, V115, P3360; Vasiljeva O, 2008, ONCOGENE, V27, P4191, DOI 10.1038/onc.2008.59; Wei Q, 2003, MOL CELL BIOL, V23, P4035, DOI 10.1128/MCB.23.12.4035-4045.2003; Woltman AM, 2003, BLOOD, V101, P1439, DOI 10.1182/blood-2002-06-1688; Xu X, 1999, BIOCHEMISTRY-US, V38, P8713; YAMAMOTO M, 1994, CANCER RES, V54, P5016; YAMAMOTO M, 1994, J NEURO-ONCOL, V22, P139, DOI 10.1007/BF01052889; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yu W, 1997, J CELL BIOL, V137, P767, DOI 10.1083/jcb.137.3.767; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	71	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11668	10.1371/journal.pone.0011668	http://dx.doi.org/10.1371/journal.pone.0011668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661471	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243300004
J	Hayashi, T; Nakamichi, M; Naitou, H; Ohashi, N; Imai, Y; Miyake, M				Hayashi, Tsuyoshi; Nakamichi, Masahiro; Naitou, Hirotaka; Ohashi, Norio; Imai, Yasuyuki; Miyake, Masaki			Proteomic Analysis of Growth Phase-Dependent Expression of Legionella pneumophila Proteins Which Involves Regulation of Bacterial Virulence Traits	PLOS ONE			English	Article							FORMATION-MEDIATED EGRESS; LEGIONNAIRES-DISEASE; STATIONARY-PHASE; PORE FORMATION; TRANSMISSION PHENOTYPE; INTRACELLULAR GROWTH; SECRETION; MACROPHAGES; IDENTIFICATION; PHAGOSOME	Legionella pneumophila, which is a causative pathogen of Legionnaires' disease, expresses its virulent traits in response to growth conditions. In particular, it is known to become virulent at a post-exponential phase in vitro culture. In this study, we performed a proteomic analysis of differences in expression between the exponential phase and post-exponential phase to identify candidates associated with L. pneumophila virulence using 2-Dimentional Fluorescence Difference Gel Electrophoresis (2D-DIGE) combined with Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry (MALDI-TOF-MS). Of 68 identified proteins that significantly differed in expression between the two growth phases, 64 were up-regulated at a post-exponential phase. The up-regulated proteins included enzymes related to glycolysis, ketone body biogenesis and poly-3-hydroxybutyrate (PHB) biogenesis, suggesting that L. pneumophila may utilize sugars and lipids as energy sources, when amino acids become scarce. Proteins related to motility (flagella components and twitching motility-associated proteins) were also up-regulated, predicting that they enhance infectivity of the bacteria in host cells under certain conditions. Furthermore, 9 up-regulated proteins of unknown function were found. Two of them were identified as novel bacterial factors associated with hemolysis of sheep red blood cells (SRBCs). Another 2 were found to be translocated into macrophages via the Icm/Dot type IV secretion apparatus as effector candidates in a reporter assay with Bordetella pertussis adenylate cyclase. The study will be helpful for virulent analysis of L. pneumophila from the viewpoint of physiological or metabolic modulation dependent on growth phase.	[Hayashi, Tsuyoshi; Nakamichi, Masahiro; Imai, Yasuyuki; Miyake, Masaki] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Naitou, Hirotaka] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Shizuoka 4228526, Japan; [Ohashi, Norio] Univ Shizuoka, Microbiol Lab, Dept Food & Nutr Sci, Shizuoka 4228526, Japan; [Ohashi, Norio] Univ Shizuoka, Global COE, Shizuoka 4228526, Japan	University of Shizuoka; University of Shizuoka; University of Shizuoka; University of Shizuoka	Hayashi, T (corresponding author), Natl Agr & Food Res Org, NIAH, Res Team Zoonot Dis, Tsukuba, Ibaraki, Japan.	miyakem@ys7.u-shizuoka-ken.ac.jp	Hayashi, Tsuyoshi/GNW-6250-2022; Imai, Yasuyuki/E-8701-2010	Imai, Yasuyuki/0000-0002-8937-0221	Shizuoka Research Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan;  [16790258]	Shizuoka Research Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported in part by a grant from Shizuoka Research Institute, and a Grant-in-aid (16790258) and the COE Program in the 21st Century from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khodor S, 2008, MOL MICROBIOL, V70, P908, DOI 10.1111/j.1365-2958.2008.06453.x; Albers U, 2007, MICROBIOL-SGM, V153, P3817, DOI 10.1099/mic.0.2007/009829-0; Alli OAT, 2000, INFECT IMMUN, V68, P6431, DOI 10.1128/IAI.68.11.6431-6440.2000; Bachman MA, 2004, INFECT IMMUN, V72, P3284, DOI 10.1128/IAI.72.6.3284-3293.2004; Bachman MA, 2004, INFECT IMMUN, V72, P2468, DOI 10.1128/IAI.72.5.2468-2476.2004; Bachman MA, 2001, MOL MICROBIOL, V40, P1201, DOI 10.1046/j.1365-2958.2001.02465.x; Banga S, 2007, P NATL ACAD SCI USA, V104, P5121, DOI 10.1073/pnas.0611030104; Bardill JP, 2005, MOL MICROBIOL, V56, P90, DOI 10.1111/j.1365-2958.2005.04539.x; Benin AL, 2002, CLIN INFECT DIS, V35, P1039, DOI 10.1086/342903; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bozue JA, 1996, INFECT IMMUN, V64, P668, DOI 10.1128/IAI.64.2.668-673.1996; Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x; Buckles EL, 2006, MICROBIOL-SGM, V152, P153, DOI 10.1099/mic.0.28281-0; Burstein D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000508; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Cambronne ED, 2007, PLOS PATHOG, V3, P1837, DOI 10.1371/journal.ppat.0030188; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Coil DA, 2009, FEMS MICROBIOL LETT, V293, P271, DOI 10.1111/j.1574-6968.2009.01532.x; Dalebroux ZD, 2009, MOL MICROBIOL, V71, P640, DOI 10.1111/j.1365-2958.2008.06555.x; De Buck E, 2008, INT J MED MICROBIOL, V298, P449, DOI 10.1016/j.ijmm.2007.06.003; de Felipe KS, 2005, J BACTERIOL, V187, P7716, DOI 10.1128/JB.187.22.7716-7726.2005; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Dumenil G, 2004, J BIOL CHEM, V279, P4686, DOI 10.1074/jbc.M309908200; Edwards RL, 2009, MOL MICROBIOL, V71, P1190, DOI [10.1111/j.1365-2958.2009.06593.x, 10.1111/j.1365-2958.2008.06593.x]; Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004; Franco IS, 2009, CELL MICROBIOL, V11, P1435, DOI 10.1111/j.1462-5822.2009.01351.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Hammer BK, 1999, MOL MICROBIOL, V33, P721, DOI 10.1046/j.1365-2958.1999.01519.x; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Harb OS, 2000, ENVIRON MICROBIOL, V2, P251, DOI 10.1046/j.1462-2920.2000.00112.x; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P1319, DOI 10.1084/jem.158.4.1319; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Ibuki Y, 2005, PHOTOCHEM PHOTOBIOL, V81, P823, DOI 10.1562/2004-09-01-RA-297R1.1; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; James BW, 1999, APPL ENVIRON MICROB, V65, P822; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Katanasaka Y, 2007, BIOL PHARM BULL, V30, P2300, DOI 10.1248/bpb.30.2300; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x; Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103; Lebeau I, 2005, RES MICROBIOL, V156, P119, DOI 10.1016/j.resmic.2004.08.010; Liu YC, 2007, INFECT IMMUN, V75, P592, DOI 10.1128/IAI.01278-06; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Miyake M, 2005, INFECT IMMUN, V73, P6272, DOI 10.1128/IAI.73.10.6272-6282.2005; Molmeret M, 2002, MOL MICROBIOL, V43, P1139, DOI 10.1046/j.1365-2958.2002.02842.x; Molmeret M, 2002, INFECT IMMUN, V70, P69, DOI 10.1128/IAI.70.1.69-78.2002; Molofsky AB, 2005, INFECT IMMUN, V73, P5720, DOI 10.1128/IAI.73.9.5720-5734.2005; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Ninio S, 2007, TRENDS MICROBIOL, V15, P372, DOI 10.1016/j.tim.2007.06.006; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Price CT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000704; Rasis M, 2009, MOL MICROBIOL, V72, P995, DOI 10.1111/j.1365-2958.2009.06705.x; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; SADOSKY AB, 1993, INFECT IMMUN, V61, P5361, DOI 10.1128/IAI.61.12.5361-5373.1993; Sahr T, 2009, MOL MICROBIOL, V72, P741, DOI 10.1111/j.1365-2958.2009.06677.x; Shohdy N, 2005, P NATL ACAD SCI USA, V102, P4866, DOI 10.1073/pnas.0501315102; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stancik LM, 2002, J BACTERIOL, V184, P4246, DOI 10.1128/JB.184.15.4246-4258.2002; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Whitfield NN, 2010, INFECT IMMUN, V78, P423, DOI 10.1128/IAI.00070-09; WIATER LA, 1994, MOL MICROBIOL, V11, P641; Yerushalmi G, 2005, INFECT IMMUN, V73, P7578, DOI 10.1128/IAI.73.11.7578-7587.2005; YOUNG IG, 1971, J BACTERIOL, V105, P769, DOI 10.1128/JB.105.3.769-778.1971; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	77	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11718	10.1371/journal.pone.0011718	http://dx.doi.org/10.1371/journal.pone.0011718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661449	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300020
J	Seewald, AK; Cypser, J; Mendenhall, A; Johnson, T				Seewald, Alexander K.; Cypser, James; Mendenhall, Alexander; Johnson, Thomas			Quantifying Phenotypic Variation in Isogenic Caenorhabditis elegans Expressing Phsp-16.2::gfp by Clustering 2D Expression Patterns	PLOS ONE			English	Article							CELLULAR RESOLUTION; GENE-EXPRESSION	Isogenic populations of animals still show a surprisingly large amount of phenotypic variation between individuals. Using a GFP reporter that has been shown to predict longevity and resistance to stress in isogenic populations of the nematode Caenorhabditis elegans, we examined residual variation in expression of this GFP reporter. We found that when we separated the populations into brightest 3% and dimmest 3% we also saw variation in relative expression patterns that distinguished the bright and dim worms. Using a novel image processing method which is capable of directly analyzing worm images, we found that bright worms (after normalization to remove variation between bright and dim worms) had expression patterns that correlated with other bright worms but that dim worms fell into two distinct expression patterns. We have analysed a small set of worms with confocal microscopy to validate these findings, and found that the activity loci in these clusters are caused by extremely bright intestine cells. We also found that the vast majority of the fluorescent signal for all worms came from intestinal cells as well, which may indicate that the activity of intestinal cells is responsible for the observed patterns. Phenotypic variation in C. elegans is still not well understood but our proposed novel method to analyze complex expression patterns offers a way to enable a better understanding.	[Seewald, Alexander K.] Seewald Solut, Vienna, Austria; [Cypser, James; Mendenhall, Alexander; Johnson, Thomas] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Seewald, AK (corresponding author), Seewald Solut, Vienna, Austria.	alex@seewald.at		CYPSER, JAMES/0000-0001-8436-6437	United States National Institute on Aging	United States National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research is a collaboration between the University of Colorado at Boulder and Seewald Solutions. Neither the University of Colorado nor Seewald Solutions provided financial support. Seewald Solutions developed the image processing methods, and the University of Colorado provided the experimental design and setup, and the images themselves. This research was partially supported by the United States National Institute on Aging on a grant which is no longer active. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; GENG W, 2004, THESIS U CALIFORNIA; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; HEINDL A, 2009, 5 PHD S YOUNG SCI AS; LECESSIE S, 1992, APPL STAT-J ROY ST C, V41, P191; LONG F, 2009, NAT METH, P667; Long FH, 2008, LECT N BIOINFORMAT, V4955, P128; Luengo Hendriks CL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r123; Murray JI, 2008, NAT METHODS, V5, P703, DOI 10.1038/nmeth.1228; Ning F, 2005, IEEE T IMAGE PROCESS, V14, P1360, DOI 10.1109/TIP.2005.852470; Peng HC, 2008, BIOINFORMATICS, V24, P234, DOI 10.1093/bioinformatics/btm569; R Core Team, 2020, R LANG ENV STAT COMP; Rea SL, 2005, NAT GENET, V37, P894, DOI 10.1038/ng1608; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; SUZUKI R, 2004, 15 INT C GEN INF 200	17	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11426	10.1371/journal.pone.0011426	http://dx.doi.org/10.1371/journal.pone.0011426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657830	gold, Green Published, Green Submitted			2022-12-27	WOS:000280065600001
J	Mburu, P; Romero, MR; Hilton, H; Parker, A; Townsend, S; Kikkawa, Y; Brown, SDM				Mburu, Philomena; Romero, Maria Rosario; Hilton, Helen; Parker, Andrew; Townsend, Stuart; Kikkawa, Yoshiaki; Brown, Steve D. M.			Gelsolin Plays a Role in the Actin Polymerization Complex of Hair Cell Stereocilia	PLOS ONE			English	Article							MYOSIN-XVA; INNER-EAR; WHIRLIN; MOUSE; INTERACTS; FILAMENTS; DEAFNESS; COCHLEA; PROTEIN; BUNDLE	A complex of proteins scaffolded by the PDZ protein, whirlin, reside at the stereocilia tip and are critical for stereocilia development and elongation. We have shown that in outer hair cells (OHCs) whirlin is part of a larger complex involving the MAGUK protein, p55, and protein 4.1R. Whirlin interacts with p55 which is expressed exclusively in outer hair cells (OHC) in both the long stereocilia that make up the stereocilia bundle proper as well as surrounding shorter microvilli that will eventually regress. In erythrocytes, p55 forms a tripartite complex with protein 4.1R and glycophorin C promoting the assembly of actin filaments and the interaction of whirlin with p55 indicates that it plays a similar role in OHC stereocilia. However, the components directly involved in actin filament regulation in stereocilia are unknown. We have investigated additional components of the whirlin interactome by identifying interacting partners to p55. We show that the actin capping and severing protein, gelsolin, is a part of the whirlin complex. Gelsolin is detected in OHC where it localizes to the tips of the shorter rows but not to the longest row of stereocilia and the pattern of localisation at the apical hair cell surface is strikingly similar to p55. Like p55, gelsolin is ablated in the whirler and shaker2 mutants. Moreover, in a gelsolin mutant, stereocilia in the apex of the cochlea become long and straggly indicating defects in the regulation of stereocilia elongation. The identification of gelsolin provides for the first time a link between the whirlin scaffolding protein complex involved in stereocilia elongation and a known actin regulatory molecule.	[Mburu, Philomena; Romero, Maria Rosario; Hilton, Helen; Parker, Andrew; Townsend, Stuart; Brown, Steve D. M.] MRC, Mammalian Genet Unit, Oxford, England; [Kikkawa, Yoshiaki] Tokyo Univ Agr, Dept Bioprod, Abashiri, Japan	Tokyo University of Agriculture	Mburu, P (corresponding author), MRC, Mammalian Genet Unit, Harwell Sci & Innovat Campus, Oxford, England.	s.brown@har.mrc.ac.uk	Kikkawa, Yoshiaki/AAI-7229-2020	Kikkawa, Yoshiaki/0000-0001-8859-4998	MRC; FP6 Integrated Project EUROHEAR [LSHG-CT-2004-512063]; Medical Research Council [MC_U142684172, MC_U142684175] Funding Source: researchfish; MRC [MC_U142684172, MC_U142684175] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FP6 Integrated Project EUROHEAR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the MRC and FP6 Integrated Project EUROHEAR, LSHG-CT-2004-512063. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNIKO M, 1983, ANAT EMBRYOL, V166, P355, DOI 10.1007/BF00305923; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Forge A, 1997, SEMIN CELL DEV BIOL, V8, P225, DOI 10.1006/scdb.1997.0147; FURNESS DN, 1989, HEARING RES, V38, P95, DOI 10.1016/0378-5955(89)90131-7; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Kikkawa Y, 2005, HUM MOL GENET, V14, P391, DOI 10.1093/hmg/ddi035; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; MARFATIA SM, 1995, J BIOL CHEM, V270, P715, DOI 10.1074/jbc.270.2.715; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Mogensen MM, 2007, CELL MOTIL CYTOSKEL, V64, P496, DOI 10.1002/cm.20199; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Peng AW, 2009, J NEUROSCI, V29, P15083, DOI 10.1523/JNEUROSCI.2782-09.2009; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Rzadzinska AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007097; Spinardi L., 2007, V45, P55; TILNEY LG, 1988, J CELL BIOL, V106, P355, DOI 10.1083/jcb.106.2.355; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Yap CC, 2003, J NEUROCHEM, V85, P123, DOI 10.1046/j.1471-4159.2003.01647.x	24	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11627	10.1371/journal.pone.0011627	http://dx.doi.org/10.1371/journal.pone.0011627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661277	gold, Green Published, Green Submitted			2022-12-27	WOS:000279980800015
J	Slocombe, KE; Kaller, T; Call, J; Zuberbuhler, K				Slocombe, Katie E.; Kaller, Tanja; Call, Josep; Zuberbuehler, Klaus			Chimpanzees Extract Social Information from Agonistic Screams	PLOS ONE			English	Article							WILD CHIMPANZEES; COMMUNICATION; RECRUITMENT; RESPONSES; SIZE	Chimpanzee (Pan troglodytes) agonistic screams are graded vocal signals that are produced in a context-specific manner. Screams given by aggressors and victims can be discriminated based on their acoustic structure but the mechanisms of listener comprehension of these calls are currently unknown. In this study, we show that chimpanzees extract social information from these vocal signals that, combined with their more general social knowledge, enables them to understand the nature of out-of-sight social interactions. In playback experiments, we broadcast congruent and incongruent sequences of agonistic calls and monitored the response of bystanders. Congruent sequences were in accordance with existing social dominance relations; incongruent ones violated them. Subjects looked significantly longer at incongruent sequences, despite them being acoustically less salient (fewer call types from fewer individuals) than congruent ones. We concluded that chimpanzees categorised an apparently simple acoustic signal into victim and aggressor screams and used pragmatics to form inferences about third-party interactions they could not see.	[Slocombe, Katie E.; Kaller, Tanja] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Call, Josep] Max Planck Inst Evolutionary Anthropol, Dept Dev & Comparat Psychol, Leipzig, Germany; [Zuberbuehler, Klaus] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland	University of York - UK; Max Planck Society; University of St Andrews	Slocombe, KE (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	ks553@york.ac.uk	Slocombe, Katie E/B-8788-2016; Zuberbühler, Klaus/A-9053-2011	Slocombe, Katie E/0000-0002-7310-1887; Zuberbühler, Klaus/0000-0001-8378-088X	Biotechnology and Biological Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council to KZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2008, BEHAVIOUR, V145, P1065, DOI 10.1163/156853908784474498; Barlow KE, 1997, ANIM BEHAV, V53, P991, DOI 10.1006/anbe.1996.0398; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; CHENEY DL, 1995, J COMP PSYCHOL, V109, P134, DOI 10.1037/0735-7036.109.2.134; Corballis MC, 2002, HAND MOUTH ORIGINS L; Farago T, 2010, ANIM BEHAV, V79, P917, DOI 10.1016/j.anbehav.2010.01.005; Goodall J., 1986, CHIMPANZEES GOMBE PA; GOUZOULES S, 1984, ANIM BEHAV, V32, P182, DOI 10.1016/S0003-3472(84)80336-X; HANEY M, 1993, J COMP PSYCHOL, V107, P373, DOI 10.1037/0735-7036.107.4.373; Herbinger I, 2009, ANIM BEHAV, V78, P1389, DOI 10.1016/j.anbehav.2009.09.010; Kojima S, 2003, PRIMATES, V44, P225, DOI 10.1007/s10329-002-0014-8; MCGREGOR PK, 1992, PLAYBACK STUDIES ANI, V228, P1; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Newton-Fisher NE, 2004, PRIMATES, V45, P81, DOI 10.1007/s10329-003-0064-6; Onishi KH, 2007, ACTA PSYCHOL, V124, P106, DOI 10.1016/j.actpsy.2006.09.009; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Seyfarth RM, 2005, TRENDS COGN SCI, V9, P264, DOI 10.1016/j.tics.2005.04.001; Slocombe KE, 2007, P NATL ACAD SCI USA, V104, P17228, DOI 10.1073/pnas.0706741104; Slocombe KE, 2009, ANIM COGN, V12, P441, DOI 10.1007/s10071-008-0204-x; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; Slocombe KE, 2005, J COMP PSYCHOL, V119, P67, DOI 10.1037/0735-7036.119.1.67; SLOCOMBE KE, ANIMAL BEHA IN PRESS; Taylor AM, 2010, ANIM BEHAV, V79, P205, DOI 10.1016/j.anbehav.2009.10.030; Tomasello M, 2008, JEAN NICOD LECT, P1; Vasconcelos RO, 2010, ETHOLOGY, V116, P155, DOI 10.1111/j.1439-0310.2009.01722.x; Zuberbuhler K, 1999, J COMP PSYCHOL, V113, P33, DOI 10.1037/0735-7036.113.1.33	26	47	47	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11473	10.1371/journal.pone.0011473	http://dx.doi.org/10.1371/journal.pone.0011473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644722	gold, Green Published, Green Submitted			2022-12-27	WOS:000279884900004
J	Wang, CG; Wang, Z; Luo, JT; Li, Q; Li, Y; Ahn, K; Prows, DR; Wu, RL				Wang, Chenguang; Wang, Zhong; Luo, Jiangtao; Li, Qin; Li, Yao; Ahn, Kwangmi; Prows, Daniel R.; Wu, Rongling			A Model for Transgenerational Imprinting Variation in Complex Traits	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; DNA METHYLATION; PLANTS; GENE; GENOME; GROWTH; ALLELE; LOCI	Despite the fact that genetic imprinting, i.e., differential expression of the same allele due to its different parental origins, plays a pivotal role in controlling complex traits or diseases, the origin, action and transmission mode of imprinted genes have still remained largely unexplored. We present a new strategy for studying these properties of genetic imprinting with a two-stage reciprocal F-2 mating design, initiated with two contrasting inbred lines. This strategy maps quantitative trait loci that are imprinted (i.e., iQTLs) based on their segregation and transmission across different generations. By incorporating the allelic configuration of an iQTL genotype into a mixture model framework, this strategy provides a path to trace the parental origin of alleles from previous generations. The imprinting effects of iQTLs and their interactions with other traditionally defined genetic effects, expressed in different generations, are estimated and tested by implementing the EM algorithm. The strategy was used to map iQTLs responsible for survival time with four reciprocal F-2 populations and test whether and how the detected iQTLs inherit their imprinting effects into the next generation. The new strategy will provide a tool for quantifying the role of imprinting effects in the creation and maintenance of phenotypic diversity and elucidating a comprehensive picture of the genetic architecture of complex traits and diseases.	[Wang, Chenguang; Li, Qin] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Wang, Zhong; Luo, Jiangtao; Ahn, Kwangmi; Wu, Rongling] Penn State Univ, Ctr Stat Genet, Hershey, PA USA; [Li, Yao] W Virginia Univ, Dept Stat, Morgantown, WV 26506 USA; [Prows, Daniel R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	State University System of Florida; University of Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; West Virginia University; University System of Ohio; University of Cincinnati	Wang, CG (corresponding author), Univ Florida, Dept Stat, Gainesville, FL 32611 USA.	rwu@hes.hmc.psu.edu	Ahn, Kwangmi/GLV-4077-2022; Wang, Zhong/C-3737-2014		National Science Foundation (NSF) [DMS/NIGMS-0540745]; Changjiang Scholarship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075562] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); Changjiang Scholarship Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Science Foundation (NSF) grant DMS/NIGMS-0540745 and Changjiang Scholarship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anholt RRH, 2004, NAT REV GENET, V5, P838, DOI 10.1038/nrg1472; Cheng Y, 2009, METHODS MOL BIOL, V573, P189, DOI 10.1007/978-1-60761-247-6_11; Cheverud JM, 2008, P NATL ACAD SCI USA, V105, P4253, DOI 10.1073/pnas.0706562105; CHURCHILL GA, 1994, GENETICS, V138, P963; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cropley JE, 2006, P NATL ACAD SCI USA, V103, P17308, DOI 10.1073/pnas.0607090103; Cui YH, 2007, J THEOR BIOL, V244, P115, DOI 10.1016/j.jtbi.2006.07.009; Dolinoy DC, 2006, ENVIRON HEALTH PERSP, V114, P567, DOI 10.1289/ehp.8700; Isles AR, 2000, TRENDS COGN SCI, V4, P309, DOI 10.1016/S1364-6613(00)01504-7; Itier JM, 1998, NATURE, V393, P125, DOI 10.1038/30120; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kahn A, 2009, J GERONTOL A-BIOL, V64, P195, DOI 10.1093/gerona/gln064; Kakutani T, 2002, PLANT CELL PHYSIOL, V43, P1106, DOI 10.1093/pcp/pcf131; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; LANDER ES, 1989, GENETICS, V121, P185; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Li YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003131; Liu T, 2007, GENOMICS, V90, P276, DOI 10.1016/j.ygeno.2007.04.004; Ma CX, 2002, GENETICS, V161, P1751; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MCGRATH J, 1984, SCIENCE, V226, P1317, DOI 10.1126/science.6542249; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Paterson AH, 2006, NAT REV GENET, V7, P174, DOI 10.1038/nrg1806; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Prows DR, 2007, PHYSIOL GENOMICS, V30, P271, DOI 10.1152/physiolgenomics.00038.2007; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHALKWYK L, 2010, J HUM GENET, V86, P196; Sha K, 2008, ANNU REV GENOM HUM G, V9, P197, DOI 10.1146/annurev.genom.122007.110031; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wen S, 2009, ALGORITHM MOL BIOL, V4, DOI 10.1186/1748-7188-4-11; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wolf JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000091; Wu R., 2007, STAT GENETICS QUANTI; Xu SZ, 2003, GENETICS, V163, P789; Yang RQ, 2010, BIOINFORMATICS, V26, P235, DOI 10.1093/bioinformatics/btp620; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445; ZENG ZB, 1994, GENETICS, V136, P1457	51	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11396	10.1371/journal.pone.0011396	http://dx.doi.org/10.1371/journal.pone.0011396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644725	gold, Green Submitted, Green Published			2022-12-27	WOS:000279884900001
J	Benakanakere, MR; Zhao, JW; Galicia, JC; Martin, M; Kinane, DF				Benakanakere, Manjunatha R.; Zhao, Jiawei; Galicia, Johnah C.; Martin, Michael; Kinane, Denis F.			Sphingosine Kinase-1 Is Required for Toll Mediated beta-Defensin 2 Induction in Human Oral Keratinocytes	PLOS ONE			English	Article							GINGIVAL EPITHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3; ANTIMICROBIAL PEPTIDES; PORPHYROMONAS-GINGIVALIS; HUMAN BETA-DEFENSIN-2; IN-VITRO; CYTOKINE PRODUCTION; GENE-EXPRESSION; UP-REGULATION; HOST-DEFENSE	Background: Host defense against invading pathogens is triggered by various receptors including toll-like receptors (TLRs). Activation of TLRs is a pivotal step in the initiation of innate, inflammatory, and antimicrobial defense mechanisms. Human beta-defensin 2 (HBD-2) is a cationic antimicrobial peptide secreted upon Gram-negative bacterial perturbation in many cells. Stimulation of various TLRs has been shown to induce HBD-2 in oral keratinocytes, yet the underlying cellular mechanisms of this induction are poorly understood. Principal Findings: Here we demonstrate that HBD-2 induction is mediated by the Sphingosine kinase-1 (Sphk-1) and augmented by the inhibition of Glycogen Synthase Kinase-3 beta (GSK-3 beta) via the Phosphoinositide 3-kinase (PI3K) dependent pathway. HBD-2 secretion was dose dependently inhibited by a pharmacological inhibitor of Sphk-1. Interestingly, inhibition of GSK-3 beta by SB 216763 or by RNA interference, augmented HBD-2 induction. Overexpression of Sphk-1 with concomitant inhibition of GSK-3 beta enhanced the induction of beta-defensin-2 in oral keratinocytes. Ectopic expression of constitutively active GSK-3 beta (S9A) abrogated HBD-2 whereas kinase inactive GSK-3 beta (R85A) induced higher amounts of HBD-2. Conclusions/Significance: These data implicate Sphk-1 in HBD-2 regulation in oral keratinocytes which also involves the activation of PI3K, AKT, GSK-3 beta and ERK 1/2. Thus we reveal the intricate relationship and pathways of toll-signaling molecules regulating HBD-2 which may have therapeutic potential.	[Benakanakere, Manjunatha R.; Zhao, Jiawei; Galicia, Johnah C.; Kinane, Denis F.] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Martin, Michael] Univ Louisville, Sch Dent, Oral Hlth & Syst Dis Ctr, Louisville, KY 40292 USA	University of Pennsylvania; University of Louisville	Benakanakere, MR (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	dfkinane@dental.upenn.edu		Galicia, Johnah/0000-0003-1908-5801	United States Public Health Service; National Institutes of Health; NIDCR [DE017384]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017384] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by United States Public Health Service, National Institutes of Health, NIDCR grant DE017384 to DFK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arimura Y, 2004, ANTICANCER RES, V24, P4051; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Biragyn A, 2002, SCIENCE, V298, P1025, DOI 10.1126/science.1075565; Burns E, 2006, J IMMUNOL, V177, P8296, DOI 10.4049/jimmunol.177.12.8296; Burns E, 2010, J IMMUNOL, V184, P1455, DOI 10.4049/jimmunol.0900378; Carretero M, 2008, J INVEST DERMATOL, V128, P223, DOI 10.1038/sj.jid.5701043; Chong KT, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-75; Danai Pajman, 2005, Curr Infect Dis Rep, V7, P329, DOI 10.1007/s11908-005-0005-1; Danai PA, 2007, CRIT CARE MED, V35, P410, DOI 10.1097/01.CCM.0000253405.17038.43; Diamond G, 2000, INFECT IMMUN, V68, P113, DOI 10.1128/IAI.68.1.113-119.2000; Donnarumma G, 2007, PEPTIDES, V28, P2286, DOI 10.1016/j.peptides.2007.09.009; EldarFinkelman H, 1996, P NATL ACAD SCI USA, V93, P10228, DOI 10.1073/pnas.93.19.10228; Eskan MA, 2008, EUR J IMMUNOL, V38, P1138, DOI 10.1002/eji.200737898; Eskan MA, 2007, INFECT IMMUN, V75, P892, DOI 10.1128/IAI.01604-06; Falco A, 2008, MOL IMMUNOL, V45, P757, DOI 10.1016/j.molimm.2007.06.358; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Ganz T, 2002, J CLIN INVEST, V109, P693, DOI 10.1172/JCI200215218; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Ganz T, 2004, CR BIOL, V327, P539, DOI 10.1016/j.crvi.2003.12.007; Garcia CA, 2009, J IMMUNOL, V183, P4475, DOI 10.4049/jimmunol.0901283; Garcia CA, 2008, J IMMUNOL, V181, P8363, DOI 10.4049/jimmunol.181.12.8363; Garg SK, 2006, CLIN IMMUNOL, V121, P23, DOI 10.1016/j.clim.2006.06.003; Garg SK, 2006, CLIN IMMUNOL, V121, P260, DOI 10.1016/j.clim.2006.09.002; Garg SK, 2004, J INFECT DIS, V189, P2129, DOI 10.1086/386286; Gould I M, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS2, DOI 10.1016/S0924-8579(09)70549-7; Haider AS, 2006, J INVEST DERMATOL, V126, P869, DOI 10.1038/sj.jid.5700157; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hajishengallis G, 2009, J IMMUNOL, V182, P6690, DOI 10.4049/jimmunol.0900524; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jang BC, 2004, BIOCHEM BIOPH RES CO, V320, P1026, DOI 10.1016/j.bbrc.2004.06.049; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Kaiser V, 2000, J LEUKOCYTE BIOL, V68, P779; Karliner JS, 2009, J CARDIOVASC PHARM, V53, P189, DOI 10.1097/FJC.0b013e3181926706; Kennedy S, 2009, CURR OPIN PHARMACOL, V9, P194, DOI 10.1016/j.coph.2008.11.002; Kinane DF, 2006, GENES IMMUN, V7, P190, DOI 10.1038/sj.gene.6364282; Kota S, 2008, J BIOL CHEM, V283, P22417, DOI 10.1074/jbc.M710415200; Krisanaprakornkit S, 2002, J IMMUNOL, V168, P316, DOI 10.4049/jimmunol.168.1.316; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Liu LD, 2003, J IMMUNOL, V170, P575, DOI 10.4049/jimmunol.170.1.575; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Markeeva N, 2005, EXP ONCOL, V27, P308; Markeeva N, 2005, EXP ONCOL, V27, P130; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Mizukawa N, 2000, ANTICANCER RES, V20, P2005; Nakayama K, 2001, J IMMUNOL, V167, P1145, DOI 10.4049/jimmunol.167.3.1145; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Quinones-Mateu ME, 2003, AIDS, V17, pF39, DOI [10.1097/00002030-200311070-00001, 10.1097/01.aids.0000096878.73209.4f]; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Scott MG, 2000, CRIT REV IMMUNOL, V20, P407; Shiba H, 2005, J PERIODONTAL RES, V40, P153, DOI 10.1111/j.1600-0765.2005.00781.x; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2002, J BIOL CHEM, V277, P25851, DOI 10.1074/jbc.R200007200; Travis SM, 2001, CURR OPIN IMMUNOL, V13, P89, DOI 10.1016/S0952-7915(00)00187-4; Vora P, 2004, J IMMUNOL, V173, P5398, DOI 10.4049/jimmunol.173.9.5398; Wang YM, 2006, J INFRARED MILLIM W, V25, P50; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; Yamane D, 2009, J BIOL CHEM, V284, P13648, DOI 10.1074/jbc.M807498200; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yoshida A, 2009, ANTICANCER RES, V29, P907; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhi L, 2006, J CELL PHYSIOL, V208, P109, DOI 10.1002/jcp.20646	79	10	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11512	10.1371/journal.pone.0011512	http://dx.doi.org/10.1371/journal.pone.0011512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634980	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300023
J	Zhang, XW; Bearer, EL; Boulat, B; Hall, FS; Uhl, GR; Jacobs, RE				Zhang, Xiaowei; Bearer, Elaine L.; Boulat, Benoit; Hall, F. Scott; Uhl, George R.; Jacobs, Russell E.			Altered Neurocircuitry in the Dopamine Transporter Knockout Mouse Brain	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; PREPULSE INHIBITION DEFICITS; VIVO H-1-NMR SPECTROSCOPY; MEDIAL PREFRONTAL CORTEX; VENTRAL TEGMENTAL AREA; IN-VIVO; MICE LACKING; ALZHEIMERS-DISEASE; NEURAL CIRCUITS; COCAINE REWARD	The plasma membrane transporters for the monoamine neurotransmitters dopamine, serotonin, and norepinephrine modulate the dynamics of these monoamine neurotransmitters. Thus, activity of these transporters has significant consequences for monoamine activity throughout the brain and for a number of neurological and psychiatric disorders. Gene knockout (KO) mice that reduce or eliminate expression of each of these monoamine transporters have provided a wealth of new information about the function of these proteins at molecular, physiological and behavioral levels. In the present work we use the unique properties of magnetic resonance imaging (MRI) to probe the effects of altered dopaminergic dynamics on meso-scale neuronal circuitry and overall brain morphology, since changes at these levels of organization might help to account for some of the extensive pharmacological and behavioral differences observed in dopamine transporter (DAT) KO mice. Despite the smaller size of these animals, voxel-wise statistical comparison of high resolution structural MR images indicated little morphological change as a consequence of DAT KO. Likewise, proton magnetic resonance spectra recorded in the striatum indicated no significant changes in detectable metabolite concentrations between DAT KO and wild-type (WT) mice. In contrast, alterations in the circuitry from the prefrontal cortex to the mesocortical limbic system, an important brain component intimately tied to function of mesolimbic/mesocortical dopamine reward pathways, were revealed by manganese-enhanced MRI (MEMRI). Analysis of co-registered MEMRI images taken over the 26 hours after introduction of Mn2+ into the prefrontal cortex indicated that DAT KO mice have a truncated Mn2+ distribution within this circuitry with little accumulation beyond the thalamus or contralateral to the injection site. By contrast, WT littermates exhibit Mn2+ transport into more posterior midbrain nuclei and contralateral mesolimbic structures at 26 hr post-injection. Thus, DAT KO mice appear, at this level of anatomic resolution, to have preserved cortico-striatal-thalamic connectivity but diminished robustness of reward-modulating circuitry distal to the thalamus. This is in contradistinction to the state of this circuitry in serotonin transporter KO mice where we observed more robust connectivity in more posterior brain regions using methods identical to those employed here.	[Zhang, Xiaowei; Bearer, Elaine L.; Boulat, Benoit; Jacobs, Russell E.] CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; [Bearer, Elaine L.] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Hall, F. Scott; Uhl, George R.] Natl Inst Drug Abuse, Intramural Res Program, Mol Neurobiol Branch, Baltimore, MD USA	California Institute of Technology; University of New Mexico; University of New Mexico's Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Zhang, XW (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA.	rjacobs@caltech.edu	Hall, F. Scott/C-3036-2013; Jacobs, Russell/H-1087-2011	Hall, F. Scott/0000-0002-0822-4063; Jacobs, Russell/0000-0002-1382-8486	Beckman Institute; NINDS [RO1 NS062184, RO1 NS046810]; NIDA [R01DA18184]; NCRR [U24 RR021760]; National Institute on Drug Abuse, Intramural Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062184, R01NS046810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000165, R01DA018184] Funding Source: NIH RePORTER	Beckman Institute; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Drug Abuse, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The project was funded in part by the Beckman Institute, NINDS RO1 NS062184 and RO1 NS046810 (E.L.B.), NIDA R01DA18184, and NCRR U24 RR021760 Mouse BIRN (R.E.J.) and, in part, by the National Institute on Drug Abuse, Intramural Research Program (G.R.U. and F.S.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Aoki I, 2002, MAGNET RESON MED, V48, P927, DOI 10.1002/mrm.10320; Ariano MA, 1998, DEV NEUROSCI-BASEL, V20, P237, DOI 10.1159/000017317; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Bearer EL, 2007, NEUROIMAGE, V37, P230, DOI 10.1016/j.neuroimage.2007.05.010; Bearer EL, 2009, NEUROIMAGE, V46, P1091, DOI 10.1016/j.neuroimage.2009.03.026; Bonci A, 2003, TRENDS PHARMACOL SCI, V24, P172, DOI 10.1016/S0165-6147(03)00068-3; Bosse R, 1997, NEURON, V19, P127, DOI 10.1016/S0896-6273(00)80353-0; BOTTOMLEY PA, 1987, ANN NY ACAD SCI, V508, P333, DOI 10.1111/j.1749-6632.1987.tb32915.x; Brenhouse HC, 2008, J NEUROSCI, V28, P2375, DOI 10.1523/JNEUROSCI.5064-07.2008; BROMAN J, 2004, RAT NERVOUS SYSTEM, P1269; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Canals S, 2008, NEUROIMAGE, V40, P458, DOI 10.1016/j.neuroimage.2007.12.007; Caron MG, 1996, AM J PSYCHIAT, V153, P1515; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Carson RP, 2002, J PHARMACOL EXP THER, V301, P410, DOI 10.1124/jpet.301.2.410; Chan KC, 2008, NEUROIMAGE, V40, P1166, DOI 10.1016/j.neuroimage.2008.01.002; Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024; Chen L, 2003, ANN NEUROL, V54, pS91, DOI 10.1002/ana.10655; Comings DE, 2000, PROG BRAIN RES, V126, P325; Cyr M, 2005, NEUROIMAGE, V26, P83, DOI 10.1016/j.neuroimage.2005.01.039; Dedeoglu A, 2004, BRAIN RES, V1012, P60, DOI 10.1016/j.brainres.2004.02.079; Dong H.W., 2008, ALLEN REFERENCE ATLA; Drago J, 1998, DEV NEUROSCI-BASEL, V20, P188, DOI 10.1159/000017313; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Drobyshevsky A, 2005, J NEUROSCI, V25, P5988, DOI 10.1523/JNEUROSCI.4983-04.2005; ELLURU RG, 1995, MOL BIOL CELL, V6, P21, DOI 10.1091/mbc.6.1.21; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Floresco SB, 2007, J NEUROSCI, V27, P2045, DOI 10.1523/JNEUROSCI.5474-06.2007; Franken IHA, 2005, EUR J PHARMACOL, V526, P199, DOI 10.1016/j.ejphar.2005.09.025; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Gainetdinov RR, 2008, N-S ARCH PHARMACOL, V377, P301, DOI 10.1007/s00210-007-0216-0; Gainetdinov RR, 2002, TRENDS PHARMACOL SCI, V23, P367, DOI 10.1016/S0165-6147(02)02044-8; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; Gainetdinov RR, 2001, J AM ACAD CHILD PSY, V40, P380, DOI 10.1097/00004583-200103000-00020; Gerfen C.R., 2004, RAT NERVOUS SYSTEM, P455, DOI DOI 10.1016/B978-012547638-6/50019-5; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goncalves L, 2009, BRAIN RES BULL, V78, P240, DOI 10.1016/j.brainresbull.2008.11.012; Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hasan KM, 2001, J MAGN RESON, V152, P41, DOI 10.1006/jmre.2001.2400; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Hetherington HP, 1997, NMR BIOMED, V10, P360, DOI 10.1002/(SICI)1099-1492(199712)10:8<360::AID-NBM477>3.0.CO;2-8; Hof PR., 2000, COMP CYTOARCHITECTON; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; John CE, 2006, NEUROCHEM INT, V49, P737, DOI 10.1016/j.neuint.2006.06.004; Jones S, 2005, CURR OPIN PHARMACOL, V5, P20, DOI 10.1016/j.coph.2004.08.011; Kalisch R, 2004, NEUROIMAGE, V23, P382, DOI 10.1016/j.neuroimage.2004.06.012; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kassubek J, 2004, J NEUROL NEUROSUR PS, V75, P213; KIDA S, 1993, NEUROPATH APPL NEURO, V19, P480, DOI 10.1111/j.1365-2990.1993.tb00476.x; Kochunov P, 2001, J COMPUT ASSIST TOMO, V25, P805, DOI 10.1097/00004728-200109000-00023; Koob GF, 2010, NEUROPSYCHOPHARMACOL, V35, P217, DOI 10.1038/npp.2009.110; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; Lau JC, 2008, NEUROIMAGE, V42, P19, DOI 10.1016/j.neuroimage.2008.04.252; LeBihan D, 1995, NMR BIOMED, V8, P375, DOI 10.1002/nbm.1940080711; Lee EF, 2005, ANAT EMBRYOL, V210, P245, DOI 10.1007/s00429-005-0048-y; Lepore N, 2008, IEEE T MED IMAGING, V27, P129, DOI 10.1109/TMI.2007.906091; Lyoo IK, 2002, BIOL PSYCHIAT, V51, P195, DOI 10.1016/S0006-3223(01)01313-0; Ma Y, 2005, NEUROSCIENCE, V135, P1203, DOI 10.1016/j.neuroscience.2005.07.014; Madabhushi A, 2005, IEEE T MED IMAGING, V24, P561, DOI 10.1109/TMI.2004.843256; Marjanska M, 2005, P NATL ACAD SCI USA, V102, P11906, DOI 10.1073/pnas.0505513102; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Mori S, 2001, MAGN RESON MED, V46, P18, DOI 10.1002/mrm.1155; Morris PG, 1999, J PSYCHOPHARMACOL, V13, P330, DOI 10.1177/026988119901300403; Mundorf ML, 2001, J NEUROCHEM, V79, P130, DOI 10.1046/j.1471-4159.2001.00554.x; Murayama Y, 2006, MAGN RESON IMAGING, V24, P349, DOI 10.1016/j.mri.2005.12.031; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Papadakis NG, 1999, MAGN RESON IMAGING, V17, P881, DOI 10.1016/S0730-725X(99)00029-6; Pautler RG, 2003, MAGNET RESON MED, V50, P33, DOI 10.1002/mrm.10498; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Paxinos G., 2004, RAT NERVOUS SYSTEM, V3rd; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pouwels PJW, 1998, MAGN RESON MED, V39, P53, DOI 10.1002/mrm.1910390110; Ralph RJ, 2001, J NEUROSCI, V21, P305, DOI 10.1523/JNEUROSCI.21-01-00305.2001; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Robbins TW, 2002, NEUROBIOL LEARN MEM, V78, P625, DOI 10.1006/nlme.2002.4103; Rodriguiz RM, 2004, BEHAV BRAIN RES, V148, P185, DOI 10.1016/S0166-4328(03)00187-6; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Ross B, 2001, ANAT RECORD, V265, P54, DOI 10.1002/ar.1058; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; RUDIN M, 1995, EUR J PHARM SCI, V3, P255, DOI 10.1016/0928-0987(95)00012-3; Sanacora G, 1999, NEUROSCIENTIST, V5, P192, DOI 10.1177/107385849900500316; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Shattuck DW, 2001, IEEE T MED IMAGING, V20, P1167, DOI 10.1109/42.963819; Shen HW, 2004, NEUROPSYCHOPHARMACOL, V29, P1790, DOI 10.1038/sj.npp.1300476; SHINONAGA Y, 1994, NEUROSCIENCE, V58, P389, DOI 10.1016/0306-4522(94)90045-0; SIDHU A, 2003, DOPAMINE RECEPTORS T; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sora I, 2001, P NATL ACAD SCI USA, V98, P5300, DOI 10.1073/pnas.091039298; Sora I, 1998, P NATL ACAD SCI USA, V95, P7699, DOI 10.1073/pnas.95.13.7699; Spanagel R, 2003, CLIN NEUROSCI RES, V3, P325, DOI 10.1016/S1566-2772(03)00094-X; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Thanos PK, 2008, SYNAPSE, V62, P319, DOI 10.1002/syn.20503; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Toga A.W., 2002, BRAIN MAPPING METHOD; Trinh JV, 2003, NEUROSCIENCE, V118, P297, DOI 10.1016/S0306-4522(03)00165-9; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Uhl GR, 2003, MOVEMENT DISORD, V18, pS71, DOI 10.1002/mds.10578; Van der Linden A, 2007, NMR BIOMED, V20, P522, DOI 10.1002/nbm.1131; van Eden CG, 2000, PROG BRAIN RES, V126, P49; vanDoorn A, 1996, EUR J MORPHOL, V34, P325, DOI 10.1076/ejom.34.4.325.13041; VanDoorn A, 1996, EUR J MORPHOL, V34, P5, DOI 10.1076/ejom.34.1.5.13156; Verma R, 2005, P NATL ACAD SCI USA, V102, P6978, DOI 10.1073/pnas.0407828102; Volkow ND, 2004, MOL PSYCHIATR, V9, P557, DOI 10.1038/sj.mp.4001507; Watanabe T, 2001, MAGNET RESON MED, V46, P424, DOI 10.1002/mrm.1209; Wieshmann UC, 1999, MAGN RESON IMAGING, V17, P1269, DOI 10.1016/S0730-725X(99)00082-X; Wong JYF, 2003, EUR J PHARMACOL, V472, P39, DOI 10.1016/S0014-2999(03)01862-4; Yamashita M, 2006, NEUROPSYCHOPHARMACOL, V31, P2132, DOI 10.1038/sj.npp.1301009; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	129	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11506	10.1371/journal.pone.0011506	http://dx.doi.org/10.1371/journal.pone.0011506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634895	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000279715300017
J	Re, M; Pampillo, M; Savard, M; Dubuc, C; McArdle, CA; Millar, RP; Conn, PM; Gobeil, F; Bhattacharya, M; Babwah, AV				Re, Michelle; Pampillo, Macarena; Savard, Martin; Dubuc, Celena; McArdle, Craig A.; Millar, Robert P.; Conn, P. Michael; Gobeil, Fernand, Jr.; Bhattacharya, Moshmi; Babwah, Andy V.			The Human Gonadotropin Releasing Hormone Type I Receptor Is a Functional Intracellular GPCR Expressed on the Nuclear Membrane	PLOS ONE			English	Article							C-TERMINAL TAIL; PROSTAGLANDIN E-2 RECEPTORS; CELL-SURFACE EXPRESSION; HYPOGONADOTROPIC HYPOGONADISM; PHARMACOLOGICAL CHAPERONES; BETA-2-ADRENERGIC RECEPTOR; PROTEIN-KINASE; BREAST-CANCER; GNRH RECEPTOR; LOCALIZATION	The mammalian type I gonadotropin releasing hormone receptor (GnRH-R) is a structurally unique G protein-coupled receptor (GPCR) that lacks cytoplasmic tail sequences and displays inefficient plasma membrane expression (PME). Compared to its murine counterparts, the primate type I receptor is inefficiently folded and retained in the endoplasmic reticulum (ER) leading to a further reduction in PME. The decrease in PME and concomitant increase in intracellular localization of the mammalian GnRH-RI led us to characterize the spatial distribution of the human and mouse GnRH receptors in two human cell lines, HEK 293 and HTR-8/SVneo. In both human cell lines we found the receptors were expressed in the cytoplasm and were associated with the ER and nuclear membrane. A molecular analysis of the receptor protein sequence led us to identify a putative monopartite nuclear localization sequence (NLS) in the first intracellular loop of GnRH-RI. Surprisingly, however, neither the deletion of the NLS nor the addition of the Xenopus GnRH-R cytoplasmic tail sequences to the human receptor altered its spatial distribution. Finally, we demonstrate that GnRH treatment of nuclei isolated from HEK 293 cells expressing exogenous GnRH-RI triggers a significant increase in the acetylation and phosphorylation of histone H3, thereby revealing that the nuclear-localized receptor is functional. Based on our findings, we conclude that the mammalian GnRH-RI is an intracellular GPCR that is expressed on the nuclear membrane. This major and novel discovery causes us to reassess the signaling potential of this physiologically and clinically important receptor.	[Re, Michelle; Pampillo, Macarena; Babwah, Andy V.] Childrens Hlth Res Inst, London, ON, Canada; [Re, Michelle; Pampillo, Macarena; Babwah, Andy V.] Lawson Hlth Res Inst, London, ON, Canada; [Re, Michelle; Pampillo, Macarena; Babwah, Andy V.] Univ Western Ontario, Dept Obstet & Gynaecol, London, ON, Canada; [Re, Michelle; Bhattacharya, Moshmi; Babwah, Andy V.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Savard, Martin; Dubuc, Celena; Gobeil, Fernand, Jr.] Univ Sherbrooke, Dept Pharmacol, Sherbrooke, PQ J1K 2R1, Canada; [McArdle, Craig A.] Univ Bristol, Dept Clin Sci S Bristol, Labs Integrated Neurosci & Endocrinol, Bristol, Avon, England; [Millar, Robert P.] Queens Med Res Inst, MRC Human Reprod Sci Unit, Edinburgh, Midlothian, Scotland; [Conn, P. Michael] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Sherbrooke; University of Bristol; University of Edinburgh; Oregon Health & Science University; Oregon National Primate Research Center	Re, M (corresponding author), Childrens Hlth Res Inst, London, ON, Canada.	Fernand.Gobeil@usherbrooke.ca; ababwah@uwo.ca	Millar, Robert P/A-4853-2012; McArdle, Craig/AAQ-5660-2021	McArdle, Craig/0000-0003-4836-5351; Millar, Robert P/0000-0003-3606-2708	Natural Sciences and Engineering Research Council of Canada (NSERC) [327334-2006]; Canadian Institute of Health Research (CIHR) [89832]; National Institutes of Health [HD-19899, RR-00163, HD-18185]; CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council; NSERC University Faculty; Department of Obstetrics and Gynaecology, University of Western Ontario; Fonds de la recherche en sante du Quebec (FRSQ); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD018185, R37HD019899, R01HD019899, P30HD018185] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council(Canadian Institutes of Health Research (CIHR)); NSERC University Faculty(Natural Sciences and Engineering Research Council of Canada (NSERC)); Department of Obstetrics and Gynaecology, University of Western Ontario; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Research reported in this study was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca) 327334-2006 (AVB), the Canadian Institute of Health Research (CIHR, http://www.cihr-irsc.gc.ca) MOP# 89832 (FG) and the National Institutes of Health (http://www.nih.gov) Grants HD-19899, RR-00163, and HD-18185 (PMC). The following are recipients of a salary award and studentships: Andy Babwah: CIHR/CIHR's Institute of Gender and Health/Ontario Women's Health Council New Investigator Award, Moshmi Bhattacharya: NSERC University Faculty Award and Michelle Re: Department of Obstetrics and Gynaecology, University of Western Ontario, Studentships. Martin Savard was supported by a fellowship award from the Fonds de la recherche en sante du Quebec (FRSQ, http://www.frsq.gouv.qc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA KK, 1995, J BIOL CHEM, V270, P22820, DOI 10.1074/jbc.270.39.22820; Babwah AV, 2003, J BIOL CHEM, V278, P5419, DOI 10.1074/jbc.M211053200; Bhattacharya M, 1998, P NATL ACAD SCI USA, V95, P15792, DOI 10.1073/pnas.95.26.15792; Bhattacharya M, 1999, J BIOL CHEM, V274, P15719, DOI 10.1074/jbc.274.22.15719; Bhattacharya M, 2004, J NEUROSCI, V24, P8752, DOI 10.1523/JNEUROSCI.3155-04.2004; Boivin B, 2003, J BIOL CHEM, V278, P29153, DOI 10.1074/jbc.M301738200; Brothers SP, 2006, J MOL ENDOCRINOL, V37, P479, DOI 10.1677/jme.1.02142; Brothers SP, 2003, J CLIN ENDOCR METAB, V88, P6107, DOI 10.1210/jc.2003-031047; Cao TT, 2005, MOL PHARMACOL, V67, P288, DOI 10.1124/mol.104.003608; Cavanagh PC, 2009, AM J PHYSIOL-CELL PH, V297, pC17, DOI 10.1152/ajpcell.00013.2009; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Chen R, 2000, AM J PHYSIOL-RENAL, V279, pF440, DOI 10.1152/ajprenal.2000.279.3.F440; Cheng KW, 2000, ENDOCRINOLOGY, V141, P2340, DOI 10.1210/en.141.7.2340; Chou CS, 2004, J CLIN ENDOCR METAB, V89, P1459, DOI 10.1210/jc.2003-031636; Cornea A, 2001, J BIOL CHEM, V276, P2153, DOI 10.1074/jbc.M007850200; EGGENA P, 1993, HYPERTENSION, V22, P496, DOI 10.1161/01.HYP.22.4.496; Finch AR, 2008, J ENDOCRINOL, V196, P353, DOI 10.1677/JOE-07-0471; Gardner LA, 2006, J BIOL CHEM, V281, P33537, DOI 10.1074/jbc.M601809200; Gobeil F, 2002, CIRC RES, V90, P682, DOI 10.1161/01.RES.0000013303.17964.7A; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Janovick JA, 2006, J BIOL CHEM, V281, P8417, DOI 10.1074/jbc.M510601200; Janovick JA, 2003, ENDOCRINE, V22, P317, DOI 10.1385/ENDO:22:3:317; Janovick JA, 2003, J PHARMACOL EXP THER, V305, P608, DOI 10.1124/jpet.102.048454; Janovick JA, 2007, MOL CELL ENDOCRINOL, V272, P77, DOI 10.1016/j.mce.2007.04.012; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Jong YJI, 2007, J NEUROCHEM, V101, P458, DOI 10.1111/j.1471-4159.2006.04382.x; KAISER UB, 1994, GENOMICS, V20, P506, DOI 10.1006/geno.1994.1211; KAKAR SS, 1992, BIOCHEM BIOPH RES CO, V189, P289, DOI 10.1016/0006-291X(92)91556-6; Knollman PE, 2008, ARCH BIOCHEM BIOPHYS, V477, P92, DOI 10.1016/j.abb.2008.05.011; Leanos-Miranda A, 2005, J CLIN ENDOCR METAB, V90, P3001, DOI 10.1210/jc.2004-2071; Leanos-Miranda A, 2002, J CLIN ENDOCR METAB, V87, P4825, DOI 10.1210/jc.2002-020961; Lee DK, 2004, J BIOL CHEM, V279, P7901, DOI 10.1074/jbc.M306377200; Lu D, 1998, ENDOCRINOLOGY, V139, P365, DOI 10.1210/en.139.1.365; Mangia A, 2002, ONCOL REP, V9, P1127; Maudsley S, 2004, CANCER RES, V64, P7533, DOI 10.1158/0008-5472.CAN-04-1360; Maya-Nunez G, 2000, ENDOCRINE, V13, P401, DOI 10.1385/ENDO:13:3:401; Meethal SV, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-103; MILLAR RP, 1983, FEBS LETT, V153, P382, DOI 10.1016/0014-5793(83)80648-6; MOREL G, 1987, CELL TISSUE RES, V248, P541, DOI 10.1007/BF00216482; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Petrovska R, 2005, BRIT J PHARMACOL, V144, P651, DOI 10.1038/sj.bjp.0706087; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Savard M, 2008, J CELL PHYSIOL, V216, P234, DOI 10.1002/jcp.21398; Sedgley KR, 2006, J ENDOCRINOL, V191, P625, DOI 10.1677/joe.1.07067; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; SZENDE B, 1994, RECEPTOR, V4, P201; Tetsuka M, 2004, ENDOCRINOLOGY, V145, P3712, DOI 10.1210/en.2003-1638; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Venkatesan S, 2001, J BIOL CHEM, V276, P40133, DOI 10.1074/jbc.M105722200; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Watson PH, 2000, J BONE MINER RES, V15, P1033, DOI 10.1359/jbmr.2000.15.6.1033; Watson PH, 2000, BONE, V26, P221, DOI 10.1016/S8756-3282(99)00264-1	59	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11489	10.1371/journal.pone.0011489	http://dx.doi.org/10.1371/journal.pone.0011489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628612	gold, Green Submitted, Green Published			2022-12-27	WOS:000279637100014
J	Nair, AK; Sugunan, D; Kumar, H; Anilkumar, G				Nair, Anup Kumar; Sugunan, Divya; Kumar, Harish; Anilkumar, Gopalakrishnapillai			Case-Control Analysis of SNPs in GLUT4, RBP4 and STRA6: Association of SNPs in STRA6 with Type 2 Diabetes in a South Indian Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRANSCRIPTION-FACTOR-7-LIKE-2 TCF7L2 GENE; INSULIN-RESISTANCE; SERUM RETINOL; RISK LOCI; SUSCEPTIBILITY; POLYMORPHISMS; VARIANTS; RETINOL-BINDING-PROTEIN-4; REPLICATION	Background: The inverse relationship between GLUT4 and RBP4 expression is known to play a role in the pathogenesis of type 2 diabetes. Elevated levels of RBP4 were shown to cause insulin resistance in muscles and liver. Identification of STRA6 as a cell surface receptor for RBP4 provides further link in this axis and hence we analyzed SNPs in these three genes for association with type 2 diabetes in a South Indian population. Methodology/Principal Findings: Selected SNPs in the three genes were analyzed in a total of 2002 individuals belonging to Dravidian ethnicity, South India, by Tetra Primer ARMS PCR or RFLP PCR. Allele frequencies and genotype distribution were calculated in cases and controls and were analyzed for association by Chi-squared test and Logistic regression. Haplotype analysis was carried out for each gene by including all the markers in a single block. We observed a significant association of three SNPs, rs974456, rs736118, and rs4886578 in STRA6 with type 2 diabetes (P = 0.001, OR 0.79[0.69-0.91], P = 0.003, OR 0.81[0.71-0.93], and P = 0.001, OR 0.74[0.62-0.89] respectively). None of the SNPs in RBP4 and GLUT4 showed any association with type 2 diabetes. Haplotype analysis revealed that two common haplotypes H1 (111, P = 0.001, OR 1.23[1.08-1.40]) and H2 (222, P = 0.002 OR 0.73[0.59-0.89]) in STRA6, H6 (2121, P = 0.006, OR 1.69[1.51-2.48]) in RBP4 and H4 (2121, P = 0.01 OR 1.41[1.07-1.85]) in GLUT4 were associated with type 2 diabetes. Conclusion: SNPs in STRA6, gene coding the cell surface receptor for RBP4, were significantly associated with type 2 diabetes and further genetic and functional studies are required to understand and ascertain its role in the manifestation of type 2 diabetes.	[Nair, Anup Kumar; Sugunan, Divya; Anilkumar, Gopalakrishnapillai] Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India; [Kumar, Harish] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, Kochi, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri; Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Kochi	Nair, AK (corresponding author), Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India.	ammasanil@am.amrita.edu	gopala, Anilkumar/AAG-2713-2021; Nair, Anup K/AAE-5957-2021	Nair, Anup/0000-0002-0424-1616; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X	Department of Science and Technology, Govt. of India [SR/SO/HS-0008/2008]; CSIR	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	Department of Science and Technology, Govt. of India, with a funding number SR/SO/HS-0008/2008. CSIR fellowship to AKN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Aeberli I, 2007, J CLIN ENDOCR METAB, V92, P4359, DOI 10.1210/jc.2007-0468; BARONI MG, 1992, HUM GENET, V88, P557, DOI 10.1007/BF00219344; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; CHOI WH, 1991, DIABETES, V40, P1712, DOI 10.2337/diabetes.40.12.1712; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hu C, 2008, DIABETIC MED, V25, P11, DOI 10.1111/j.1464-5491.2007.02314.x; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kovacs P, 2007, DIABETES, V56, P3095, DOI 10.2337/db06-1647; Li ZZ, 2010, J INT MED RES, V38, P95, DOI 10.1177/147323001003800111; Ma DH, 2007, J BIOL CHEM, V282, P5781, DOI 10.1074/jbc.M608776200; MATSUTANI A, 1990, DIABETES, V39, P1534, DOI 10.2337/diabetes.39.12.1534; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mohan V, 2007, INDIAN J MED RES, V125, P217; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; ORAHILLY S, 1992, DIABETOLOGIA, V35, P486, DOI 10.1007/BF02342449; Pontiroli AE, 1996, ACTA DIABETOL, V33, P193; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; SHEA JL, 2009, OBESITY SIL IN PRESS; Szeto W, 2001, CANCER RES, V61, P4197; Takebayashi K, 2007, J CLIN ENDOCR METAB, V92, P2712, DOI 10.1210/jc.2006-1249; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wang GJ, 2006, PHARMACOGENOMICS, V7, P203, DOI 10.2217/14622416.7.2.203; White T, 2008, MOL VIS, V14, P2458; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Ye S, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.17.e88; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	41	39	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11444	10.1371/journal.pone.0011444	http://dx.doi.org/10.1371/journal.pone.0011444			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625434	Green Published, Green Submitted, gold			2022-12-27	WOS:000279522500011
J	Schreiber, HA; Hulseberg, PD; Lee, J; Prechl, J; Barta, P; Szlavik, N; Harding, JS; Fabry, Z; Sandor, M				Schreiber, Heidi A.; Hulseberg, Paul D.; Lee, JangEun; Prechl, Jozsef; Barta, Peter; Szlavik, Nora; Harding, Jeffrey S.; Fabry, Zsuzsanna; Sandor, Matyas			Dendritic Cells in Chronic Mycobacterial Granulomas Restrict Local Anti-Bacterial T Cell Response in a Murine Model	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; TUBERCULOSIS SECRETORY ANTIGEN; PROGRAMMED DEATH-1 LIGANDS; INDUCED LIVER GRANULOMAS; CYTOKINE PRODUCTION; INTERFERON-GAMMA; IMMUNE-RESPONSE; IN-VITRO; INTRACELLULAR SURVIVAL; PULMONARY GRANULOMA	Background: Mycobacterium-induced granulomas are the interface between bacteria and host immune response. During acute infection dendritic cells (DCs) are critical for mycobacterial dissemination and activation of protective T cells. However, their role during chronic infection in the granuloma is poorly understood. Methodology/Principal Findings: We report that an inflammatory subset of murine DCs are present in granulomas induced by Mycobacteria bovis strain Bacillus Calmette-guerin (BCG), and both their location in granulomas and costimulatory molecule expression changes throughout infection. By flow cytometric analysis, we found that CD11c(+) cells in chronic granulomas had lower expression of MHCII and co-stimulatory molecules CD40, CD80 and CD86, and higher expression of inhibitory molecules PD-L1 and PD-L2 compared to CD11c(+) cells from acute granulomas. As a consequence of their phenotype, CD11c(+) cells from chronic lesions were unable to support the reactivation of newly-recruited, antigen 85B-specific CD4(+)IFN gamma T+ cells or induce an IFN gamma response from naive T cells in vivo and ex vivo. The mechanism of this inhibition involves the PD-1:PD-L signaling pathway, as ex vivo blockade of PD-L1 and PD-L2 restored the ability of isolated CD11c(+) cells from chronic lesions to stimulate a protective IFN gamma T cell response. Conclusions/Significance: Our data suggest that DCs in chronic lesions may facilitate latent infection by down-regulating protective T cell responses, ultimately acting as a shield that promotes mycobacterium survival. This DC shield may explain why mycobacteria are adapted for long-term survival in granulomatous lesions.	[Schreiber, Heidi A.; Hulseberg, Paul D.; Lee, JangEun; Prechl, Jozsef; Harding, Jeffrey S.; Fabry, Zsuzsanna; Sandor, Matyas] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Schreiber, Heidi A.; Hulseberg, Paul D.; Harding, Jeffrey S.; Fabry, Zsuzsanna; Sandor, Matyas] Univ Wisconsin, Cellular & Mol Pathol Training Program, Madison, WI USA; [Barta, Peter] Semmelweis Univ, Dept Pulmonol, H-1085 Budapest, Hungary; [Szlavik, Nora] Hosp Bajcsy Zsilinszky, Budapest, Hungary	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Semmelweis University	Schreiber, HA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI 53706 USA.	msandor@wisc.edu	Prechl, József/B-2094-2009	Prechl, József/0000-0003-3859-4353	National Institutes of Health [R01-A1048087, R21-A1072638]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS037570, R01NS037570] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health funding R01-A1048087 and R21-A1072638 (M. Sandor). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderson KL, 2008, J IMMUNOL, V180, P2981, DOI 10.4049/jimmunol.180.5.2981; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; Cai GF, 2004, CELL IMMUNOL, V230, P89, DOI 10.1016/j.cellimm.2004.09.004; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Cheadle EJ, 2003, IMMUNOLOGY, V108, P79, DOI 10.1046/j.1365-2567.2003.01543.x; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chiu BC, 2004, AM J PATHOL, V164, P1021, DOI 10.1016/S0002-9440(10)63189-6; Co DO, 2004, CLIN IMMUNOL, V113, P130, DOI 10.1016/j.clim.2004.08.012; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; Ernst JD, 2007, J CLIN INVEST, V117, P1738, DOI 10.1172/JCI31810; ETCHECHOURY I, 2009, ZOONOSES PUBLIC HLTH; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Fortsch D, 2000, J IMMUNOL, V165, P978, DOI 10.4049/jimmunol.165.2.978; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gonzalez-Juarrero M, 2001, INFECT IMMUN, V69, P1127, DOI 10.1128/IAI.69.2.1127-1133.2001; GRANGE JM, 1994, EUR RESPIR J, V7, P1564, DOI 10.1183/09031936.94.07091564; Gu T, 2008, CELL MOL IMMUNOL, V5, P33, DOI 10.1038/cmi.2008.4; Hanekom WA, 2003, J INFECT DIS, V188, P257, DOI 10.1086/376451; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Heninger E, 2006, J IMMUNOL, V177, P3303, DOI 10.4049/jimmunol.177.5.3303; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Hingley-Wilson SM, 2003, NAT IMMUNOL, V4, P949, DOI 10.1038/ni981; Hlavsa MC, 2008, CLIN INFECT DIS, V47, P168, DOI 10.1086/589240; Hogan LH, 2001, J IMMUNOL, V166, P6367, DOI 10.4049/jimmunol.166.10.6367; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Inman BA, 2007, CANCER-AM CANCER SOC, V109, P1499, DOI 10.1002/cncr.22588; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Jurado JO, 2008, J IMMUNOL, V181, P116, DOI 10.4049/jimmunol.181.1.116; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Lagranderie M, 2003, IMMUNOLOGY, V108, P352, DOI 10.1046/j.1365-2567.2003.01609.x; Larsen JM, 2007, IMMUNOLOGY, V121, P276, DOI 10.1111/j.1365-2567.2007.02575.x; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Ling CY, 2006, J NEUROSCI, V26, P731, DOI 10.1523/JNEUROSCI.3502-05.2006; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Loke P, 2003, P NATL ACAD SCI USA, V100, P5336, DOI 10.1073/pnas.0931259100; Mariotti S, 2002, EUR J IMMUNOL, V32, P3050, DOI 10.1002/1521-4141(200211)32:11<3050::AID-IMMU3050>3.0.CO;2-K; Martino A, 2004, J LEUKOCYTE BIOL, V76, P827, DOI 10.1189/jlb.0703313; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Mohagheghpour N, 2000, INFECT IMMUN, V68, P5824, DOI 10.1128/IAI.68.10.5824-5829.2000; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Natarajan K, 2003, J INFECT DIS, V187, P914, DOI 10.1086/368173; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; Ojo O, 2008, EMERG INFECT DIS, V14, P1931, DOI 10.3201/eid1412.071135; ORME IM, 1987, J IMMUNOL, V138, P293; Popov A, 2008, J MOL MED, V86, P145, DOI 10.1007/s00109-007-0262-6; Rejic R, 2005, TUBERCULOSIS, V85, P81, DOI 10.1016/j.tube.2004.09.006; Rhoades ER, 1997, TUBERCLE LUNG DIS, V78, P57, DOI 10.1016/S0962-8479(97)90016-2; ROCHE PW, 1995, TRENDS MICROBIOL, V3, P397, DOI 10.1016/S0966-842X(00)88986-6; Rodwell TC, 2008, EMERG INFECT DIS, V14, P909, DOI 10.3201/eid1406.071485; Sacco Randy E., 1996, Methods (Orlando), V9, P215, DOI 10.1006/meth.1996.0028; Salam N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002869; SANDOR M, 1995, J IMMUNOL, V155, P275; Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027; Saunders PA, 2005, EUR J IMMUNOL, V35, P3561, DOI 10.1002/eji.200526347; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; SCHREIBER HA, 2009, IMMUNOL LETT; Sinha A, 2006, J IMMUNOL, V177, P468, DOI 10.4049/jimmunol.177.1.468; Sunder S, 2009, J CLIN MICROBIOL, V47, P1249, DOI 10.1128/JCM.02042-08; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Toussirot E, 2004, EXPERT OPIN PHARMACO, V5, P581, DOI 10.1517/14656566.5.3.581; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Tsuchiya T, 2002, AM J RESP CRIT CARE, V165, P1640, DOI 10.1164/rccm.2110086; Uehira K, 2002, CLIN IMMUNOL, V105, P296, DOI 10.1006/clim.2002.5287; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538	84	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11453	10.1371/journal.pone.0011453	http://dx.doi.org/10.1371/journal.pone.0011453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625513	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500019
J	Sindhava, V; Woodman, ME; Stevenson, B; Bondada, S				Sindhava, Vishal; Woodman, Michael E.; Stevenson, Brian; Bondada, Subbarao			Interleukin-10 Mediated Autoregulation of Murine B-1 B-Cells and Its Role in Borrelia hermsii Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; FACTOR-KAPPA-B; IMMUNE-RESPONSES; MARGINAL ZONE; T-CELLS; IL-10; PROLIFERATION; EXPRESSION; ANTIGEN; IGM	B cells are typically characterized as positive regulators of the immune response, primarily by producing antibodies. However, recent studies indicate that various subsets of B cells can perform regulatory functions mainly through IL-10 secretion. Here we discovered that peritoneal B-1 (B-1P) cells produce high levels of IL-10 upon stimulation with several Toll-like receptor (TLR) ligands. High levels of IL-10 suppressed B-1P cell proliferation and differentiation response to all TLR ligands studied in an autocrine manner in vitro and in vivo. IL-10 that accumulated in cultures inhibited B-1P cells at second and subsequent cell divisions mainly at the G1/S interphase. IL-10 inhibits TLR induced B-1P cell activation by blocking the classical NF-kappa B pathway. Co-stimulation with CD40 or BAFF abrogated the IL-10 inhibitory effect on B-1P cells during TLR stimulation. Finally, B-1P cells adoptively transferred from the peritoneal cavity of IL-10(-/-) mice showed better clearance of Borrelia hermsii than wild-type B-1P cells. This study described a novel autoregulatory property of B-1P cells mediated by B-1P cell derived IL-10, which may affect the function of B-1P cells in infection and autoimmunity.	[Sindhava, Vishal; Woodman, Michael E.; Stevenson, Brian; Bondada, Subbarao] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA; [Sindhava, Vishal; Bondada, Subbarao] Univ Kentucky, Coll Med, Markey Canc Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky	Sindhava, V (corresponding author), Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40536 USA.	bondada@uky.edu			National Institutes of Health (NIH) [CA09357, AI076956]; University of Kentucky College of Medicine; University of Kentucky; NATIONAL CANCER INSTITUTE [T32CA009357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076956] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kentucky College of Medicine; University of Kentucky; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by National Institutes of Health (NIH) grants CA09357, AI076956 and funds from the vice president for research at the University of Kentucky to S. Bondada and exploratory funds from the University of Kentucky College of Medicine to Brian Stevenson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2007, J IMMUNOL, V178, P3740, DOI 10.4049/jimmunol.178.6.3740; Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Amano M, 1998, J IMMUNOL, V161, P1710; ARNOLD LW, 1994, J EXP MED, V179, P1585, DOI 10.1084/jem.179.5.1585; Baumann M, 2000, MACROMOL MATER ENG, V280, P1, DOI 10.1002/1439-2054(20000801)280:1<1::AID-MAME1>3.0.CO;2-U; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Blenman KRM, 2006, LAB INVEST, V86, P1136, DOI 10.1038/labinvest.3700468; Bolz DD, 2006, INFECT IMMUN, V74, P6750, DOI 10.1128/IAI.01160-06; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Chumley MJ, 2002, J IMMUNOL, V169, P1735, DOI 10.4049/jimmunol.169.4.1735; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Dasu T, 2009, MOL IMMUNOL, V46, P2655, DOI 10.1016/j.molimm.2009.04.015; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Fischer Helene, 2001, BMC Physiology, V1, P1, DOI 10.1186/1472-6793-1-1; GarciaMonco JC, 1997, J INFECT DIS, V175, P1243, DOI 10.1086/593681; Gavin AL, 2006, SCIENCE, V314, P1936, DOI 10.1126/science.1135299; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Goodnow CC, 2007, CELL, V130, P25, DOI 10.1016/j.cell.2007.06.033; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Gururajan M, 2008, J IMMUNOL, V181, P4590, DOI 10.4049/jimmunol.181.7.4590; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HARDY RR, 1987, SCIENCE, V236, P81, DOI 10.1126/science.3105057; Lazarus JJ, 2006, J IMMUNOL, V177, P7076, DOI 10.4049/jimmunol.177.10.7076; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; LIN TZ, 1992, CLIN IMMUNOL IMMUNOP, V65, P10, DOI 10.1016/0090-1229(92)90242-G; Lyons AB, 2000, J IMMUNOL METHODS, V243, P147, DOI 10.1016/S0022-1759(00)00231-3; Marcelletti JF, 1996, J IMMUNOL, V157, P3323; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Montecino-Rodriguez E, 2006, TRENDS IMMUNOL, V27, P428, DOI 10.1016/j.it.2006.07.005; Moon BG, 2004, J IMMUNOL, V172, P6020, DOI 10.4049/jimmunol.172.10.6020; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Neumann M, 1996, J IMMUNOL, V157, P4862; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; PALM NW, 2009, P NATL ACAD SCI US; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Perrin GQ, 1999, BLOOD, V93, P208, DOI 10.1182/blood.V93.1.208.401k06_208_216; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Rosado MM, 2009, MUCOSAL IMMUNOL, V2, P351, DOI 10.1038/mi.2009.15; ROTHSTEIN TL, 1988, J IMMUNOL, V140, P2880; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schottelius AJG, 1999, J BIOL CHEM, V274, P31868, DOI 10.1074/jbc.274.45.31868; Sen G, 2002, MOL IMMUNOL, V39, P57, DOI 10.1016/S0161-5890(02)00047-0; Shames BD, 1998, SHOCK, V10, P389, DOI 10.1097/00024382-199812000-00002; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Siebenlist U, 2005, NAT REV IMMUNOL, V5, P435, DOI 10.1038/nri1629; Stoermann B, 2007, EUR J IMMUNOL, V37, P1613, DOI 10.1002/eji.200636640; Tangye SG, 1998, LEUKEMIA LYMPHOMA, V31, P121, DOI 10.3109/10428199809057592; Wolf SD, 1996, J EXP MED, V184, P2271, DOI 10.1084/jem.184.6.2271; Wong SC, 2002, J BIOL CHEM, V277, P30707, DOI 10.1074/jbc.M202460200; Woodman ME, 2009, J LEUKOCYTE BIOL, V86, P727, DOI 10.1189/jlb.0309169; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	58	39	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11445	10.1371/journal.pone.0011445	http://dx.doi.org/10.1371/journal.pone.0011445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625435	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500012
J	Guendel, I; Carpio, L; Pedati, C; Schwartz, A; Teal, C; Kashanchi, F; Kehn-Hall, K				Guendel, Irene; Carpio, Lawrence; Pedati, Caitlin; Schwartz, Arnold; Teal, Christine; Kashanchi, Fatah; Kehn-Hall, Kylene			Methylation of the Tumor Suppressor Protein, BRCA1, Influences Its Transcriptional Cofactor Function	PLOS ONE			English	Article							RNA-POLYMERASE-II; DNA-DAMAGE RESPONSE; BREAST-CANCER CELLS; ARGININE METHYLATION; IN-VIVO; SACCHAROMYCES-CEREVISIAE; SIGNAL TRANSDUCER; GENE-EXPRESSION; NUCLEAR EXPORT; PRMT1	Background: Approximately half of hereditary breast cancers have mutations in either BRCA1 or BRCA2. BRCA1 is a multifaceted tumor suppressor protein that has implications in processes such as cell cycle, transcription, DNA damage response and chromatin remodeling. This multifunctional nature of BRCA1 is achieved by exerting its many effects through modulation of transcription. Many cellular events are dictated by covalent modification of proteins, an important mechanism in regulating protein and genome function; of which protein methylation is an important posttranslational modification with activating or repressive effects. Methods/Principal Findings: Here we demonstrate for the first time that BRCA1 is methylated both in breast cancer cell lines and breast cancer tumor samples at arginine and lysine residues through immunoprecipitation and western blot analysis. Arginine methylation by PRMT1 was observed in vitro and the region of BRCA1 504-802 shown to be highly methylated. PRMT1 was detected in complex with BRCA1 504-802 through in vitro binding assays and co-immunoprecipitated with BRCA1. Inhibition of methylation resulted in decreased BRCA1 methylation and alteration of BRCA1 binding to promoters in vivo as shown through chromatin immunoprecipitation assays. Knockdown of PRMT1 also resulted in increased BRCA1 binding to particular promoters in vivo. Finally, following methylation inhibition, Sp1 was found to preferentially associate with hypo-methylated BRCA1 and STAT1 was found to preferentially associate with hyper-methylated BRCA1. Conclusions/Significance: These results suggest that methylation may influence either the ability of BRCA1 to bind to specific promoters or protein-protein interactions which alters the recruitment of BRCA1 to these promoters. Thus, given the importance of BRCA1 to genomic stability, methylation of BRCA1 may ultimately affect the tumor suppressor ability of BRCA1.	[Guendel, Irene; Carpio, Lawrence; Pedati, Caitlin; Kashanchi, Fatah] George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Schwartz, Arnold] George Washington Univ, Med Ctr, Dept Pathol, Washington, DC 20037 USA; [Teal, Christine] George Washington Univ, Med Ctr, Breast Care Ctr, Washington, DC 20037 USA; [Guendel, Irene; Carpio, Lawrence; Kashanchi, Fatah; Kehn-Hall, Kylene] George Mason Univ, Dept Mol & Microbiol, Natl Ctr Biodef & Infect Dis, Manassas, VA USA	George Washington University; George Washington University; George Washington University; George Mason University	Guendel, I (corresponding author), George Washington Univ, Med Ctr, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	kkehnhal@gmu.edu	Kehn-Hall, Kylene/I-5752-2013	Kehn-Hall, Kylene/0000-0001-8036-7213	George Washington University's Cancer Institute	George Washington University's Cancer Institute	This work was supported by an American Cancer Society Seed Grant from The George Washington University's Cancer Institute to KKH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch S, 2003, FEBS LETT, V541, P149, DOI 10.1016/S0014-5793(03)00315-6; AKIYAMA K, 1994, BBA-GENE STRUCT EXPR, V1219, P15, DOI 10.1016/0167-4781(94)90241-0; Altiok S, 1999, J BIOL CHEM, V274, P32274, DOI 10.1074/jbc.274.45.32274; Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; ARTEAGA CL, 1993, J CELL BIOCHEM, P187; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bedford MT, 2000, J BIOL CHEM, V275, P16030, DOI 10.1074/jbc.M909368199; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Boisvert FM, 2005, GENE DEV, V19, P671, DOI 10.1101/gad.1279805; Boisvert FM, 2005, CELL CYCLE, V4, P1834, DOI 10.4161/cc.4.12.2250; Cable PL, 2003, MOL CARCINOGEN, V38, P85, DOI 10.1002/mc.10148; Chen CF, 1996, J BIOL CHEM, V271, P32863, DOI 10.1074/jbc.271.51.32863; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Cuthbert GL, 2004, CELL, V118, P545, DOI 10.1016/j.cell.2004.08.020; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Feng ZH, 2004, J BIOL CHEM, V279, P28574, DOI 10.1074/jbc.M404137200; Fung H, 2001, J BIOL CHEM, V276, P42011, DOI 10.1074/jbc.M106423200; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gatei M, 2000, CANCER RES, V60, P3299; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Herrmann F, 2005, J BIOL CHEM, V280, P38005, DOI 10.1074/jbc.M502458200; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Herrmann F, 2009, GENES CELLS, V14, P309, DOI 10.1111/j.1365-2443.2008.01266.x; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Ikeda S, 2002, BIOCHEM BIOPH RES CO, V296, P785, DOI 10.1016/S0006-291X(02)00939-7; Jin SQ, 2000, ONCOGENE, V19, P4050, DOI 10.1038/sj.onc.1203759; KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751; KAKIMOTO Y, 1971, BIOCHIM BIOPHYS ACTA, V243, P31, DOI 10.1016/0005-2795(71)90033-X; Kehn K, 2007, ONCOGENE, V26, P5060, DOI 10.1038/sj.onc.1210319; Krum SA, 2003, J BIOL CHEM, V278, P52012, DOI 10.1074/jbc.M308418200; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc; Le Romancer M, 2008, MOL CELL, V31, P212, DOI 10.1016/j.molcel.2008.05.025; Lee HM, 2000, EUR J BIOCHEM, V267, P591, DOI 10.1046/j.1432-1327.2000.01043.x; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Man S, 2007, CANCER METAST REV, V26, P737, DOI 10.1007/s10555-007-9087-6; Maor S, 2007, HORM METAB RES, V39, P179, DOI 10.1055/s-2007-970415; Maor SB, 2000, MOL GENET METAB, V69, P130, DOI 10.1006/mgme.1999.2958; Maor S, 2007, CANCER LETT, V257, P236, DOI 10.1016/j.canlet.2007.07.019; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; McBride AE, 2001, CELL, V106, P5, DOI 10.1016/S0092-8674(01)00423-8; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Pahlich S, 2005, PROTEINS, V61, P164, DOI 10.1002/prot.20579; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Parvin JD, 2009, ENVIRON MOL MUTAGEN, V50, P649, DOI 10.1002/em.20475; Paull TT, 2001, P NATL ACAD SCI USA, V98, P6086, DOI 10.1073/pnas.111125998; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rodriguez JA, 2000, J BIOL CHEM, V275, P38589, DOI 10.1074/jbc.M003851200; Rosen EM, 2003, J CELL PHYSIOL, V196, P19, DOI 10.1002/jcp.10257; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang Y, 2004, SCIENCE, V306, P279, DOI 10.1126/science.1101400; Williamson EA, 2002, ONCOGENE, V21, P3199, DOI 10.1038/sj.onc.1205461; Wilson CA, 1997, ONCOGENE, V14, P1, DOI 10.1038/sj.onc.1200924; Wilson DM, 1997, P NATL ACAD SCI USA, V94, P12754, DOI 10.1073/pnas.94.24.12754; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yun CY, 2000, J CELL BIOL, V150, P707, DOI 10.1083/jcb.150.4.707; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	76	58	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11379	10.1371/journal.pone.0011379	http://dx.doi.org/10.1371/journal.pone.0011379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614009	Green Submitted, Green Published, gold			2022-12-27	WOS:000279369900025
J	Park, KS; Choi, KH; Kim, YS; Hong, BS; Kim, OY; Kim, JH; Yoon, CM; Koh, GY; Kim, YK; Gho, YS				Park, Kyong-Su; Choi, Kyoung-Ho; Kim, You-Sun; Hong, Bok Sil; Kim, Oh Youn; Kim, Ji Hyun; Yoon, Chang Min; Koh, Gou-Young; Kim, Yoon-Keun; Gho, Yong Song			Outer Membrane Vesicles Derived from Escherichia coli Induce Systemic Inflammatory Response Syndrome	PLOS ONE			English	Article							ZEA-MAYS L; NEISSERIA-MENINGITIDIS; PERIPLASMIC PROTEINS; CYTOKINE PRODUCTION; SEVERE SEPSIS; SEPTIC SHOCK; LIPOPOLYSACCHARIDE; ASSOCIATION; BACTERIA; ORGAN	Sepsis, characterized by a systemic inflammatory state that is usually related to Gram-negative bacterial infection, is a leading cause of death worldwide. Although the annual incidence of sepsis is still rising, the exact cause of Gram-negative bacteria-associated sepsis is not clear. Outer membrane vesicles (OMVs), constitutively secreted from Gram-negative bacteria, are nano-sized spherical bilayered proteolipids. Using a mouse model, we showed that intraperitoneal injection of OMVs derived from intestinal Escherichia coli induced lethality. Furthermore, OMVs induced host responses which resemble a clinically relevant condition like sepsis that was characterized by piloerection, eye exudates, hypothermia, tachypnea, leukopenia, disseminated intravascular coagulation, dysfunction of the lungs, hypotension, and systemic induction of tumor necrosis factor-alpha and interleukin-6. Our study revealed a previously unidentified causative microbial signal in the pathogenesis of sepsis, suggesting OMVs as a new therapeutic target to prevent and/or treat severe sepsis caused by Gram-negative bacterial infection.	[Park, Kyong-Su; Kim, You-Sun; Hong, Bok Sil; Kim, Oh Youn; Kim, Ji Hyun; Yoon, Chang Min; Kim, Yoon-Keun; Gho, Yong Song] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Choi, Kyoung-Ho] Catholic Univ Korea, Coll Med, Dept Emergency Med, Seoul, South Korea; [Koh, Gou-Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Pohang University of Science & Technology (POSTECH); Catholic University of Korea; Korea Advanced Institute of Science & Technology (KAIST)	Park, KS (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	juinea@postech.ac.kr; ysgho@postech.ac.kr	Koh, Gou Young/C-1615-2011; Hong, Bok Sil/GYQ-5150-2022	Kyoung ho, Choi/0000-0003-2301-2250; Hong, Bok Sil/0000-0002-2710-7727	Korean Ministry of Education, Science and Technology [FPR08B1-240]	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Korean Ministry of Education, Science and Technology, FPR08B1-240 of the 21C Frontier Functional Proteomics Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BAKER CC, 1983, SURGERY, V94, P331; Beveridge TJ, 1996, MICROB DRUG RESIST, V2, P1, DOI 10.1089/mdr.1996.2.1; Blackwell TS, 1996, BRIT J ANAESTH, V77, P110, DOI 10.1093/bja/77.1.110; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chelius MK, 2000, APPL ENVIRON MICROB, V66, P783, DOI 10.1128/AEM.66.2.783-787.2000; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; COSTERTON JW, 1974, BACTERIOL REV, V38, P87, DOI 10.1128/MMBR.38.1.87-110.1974; da Silva FP, 2007, NAT MED, V13, P1368, DOI 10.1038/nm1665; DINARELLO CA, 1997, CHEST S, V112, P321, DOI DOI 10.1378/CHEST.112.6_SUPPLEMENT.321S; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Kesty NC, 2004, J BIOL CHEM, V279, P2069, DOI 10.1074/jbc.M307628200; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Klinzing S, 2000, RES EXP MED, V200, P27; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee EY, 2008, MASS SPECTROM REV, V27, P535, DOI 10.1002/mas.20175; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee EY, 2009, PROTEOMICS, V9, P5425, DOI 10.1002/pmic.200900338; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; Mirlashari MR, 2001, CYTOKINE, V13, P91, DOI 10.1006/cyto.2000.0803; Namork E, 2002, LANCET, V360, P1741, DOI 10.1016/S0140-6736(02)11721-1; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Oftung F, 1999, FEMS IMMUNOL MED MIC, V26, P75, DOI 10.1016/S0928-8244(99)00125-X; Opal SM, 2007, INT J MED MICROBIOL, V297, P365, DOI 10.1016/j.ijmm.2007.03.006; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Rice TW, 2005, ANNU REV MED, V56, P225, DOI 10.1146/annurev.med.56.082103.104356; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Schild S, 2009, INFECT IMMUN, V77, P472, DOI 10.1128/IAI.01139-08; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang HW, 1997, J IMMUNOL, V159, P4868	45	112	117	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11334	10.1371/journal.pone.0011334	http://dx.doi.org/10.1371/journal.pone.0011334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596524	gold, Green Published, Green Submitted			2022-12-27	WOS:000279259900007
J	Dejean, A; Leroy, C; Corbara, B; Roux, O; Cereghino, R; Orivel, J; Boulay, R				Dejean, Alain; Leroy, Celine; Corbara, Bruno; Roux, Olivier; Cereghino, Regis; Orivel, Jerome; Boulay, Raphael			Arboreal Ants Use the "Velcro (R) Principle'' to Capture Very Large Prey	PLOS ONE			English	Article							AURITA GROUP; FOOD BODIES; DOLICHODERINAE; BLOCHMANNIA; FORMICIDAE; BEHAVIOR; PLANTS	Plant-ants live in a mutualistic association with host plants known as "myrmecophytes'' that provide them with a nesting place and sometimes with extra-floral nectar (EFN) and/or food bodies (FBs); the ants can also attend sap-sucking Hemiptera for their honeydew. In return, plant-ants, like most other arboreal ants, protect their host plants from defoliators. To satisfy their nitrogen requirements, however, some have optimized their ability to capture prey in the restricted environment represented by the crowns of trees by using elaborate hunting techniques. In this study, we investigated the predatory behavior of the ant Azteca andreae which is associated with the myrmecophyte Cecropia obtusa. We noted that up to 8350 ant workers per tree hide side-by-side beneath the leaf margins of their host plant with their mandibles open, waiting for insects to alight. The latter are immediately seized by their extremities, and then spread-eagled; nestmates are recruited to help stretch, carve up and transport prey. This group ambush hunting technique is particularly effective when the underside of the leaves is downy, as is the case for C. obtusa. In this case, the hook-shaped claws of the A. andreae workers and the velvet-like structure of the underside of the leaves combine to act like natural Velcro (R) that is reinforced by the group ambush strategy of the workers, allowing them to capture prey of up to 13,350 times the mean weight of a single worker.	[Dejean, Alain; Leroy, Celine; Roux, Olivier; Orivel, Jerome] CNRS, Ecol Forets Guyane UMR CNRS 8172, Kourou, France; [Corbara, Bruno] Univ Clermont Ferrand, Clermont Univ, Clermont Ferrand, France; [Corbara, Bruno] CNRS, UMR 6023, Lab Microorganismes Genome & Environm, Aubiere, France; [Cereghino, Regis] CNRS, EcoLab, Lab Ecol Fonct, Toulouse, France; [Cereghino, Regis] Univ Toulouse, UPS, INPT, EcoLab, Toulouse, France; [Boulay, Raphael] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Boulay, Raphael] Univ Granada, Fac Ciencias, Dept Biol Anim, Granada, Spain	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Granada	Dejean, A (corresponding author), CNRS, Ecol Forets Guyane UMR CNRS 8172, Campus Agron, Kourou, France.	alain.dejean@wanadoo.fr	Leroy, Celine/I-4857-2016; Roux, Olivier/A-1181-2011; Orivel, Jerome/C-4034-2011; CEREGHINO, Regis/G-9500-2011; Boulay, Raphael/I-3735-2015; Roux, Olivier/I-5675-2016	Leroy, Celine/0000-0003-4859-8040; Orivel, Jerome/0000-0002-5636-3228; Boulay, Raphael/0000-0002-0138-0856; Cereghino, Regis/0000-0003-3981-3159; CORBARA, Bruno/0000-0003-4232-8234; Roux, Olivier/0000-0001-5440-0219; Dejean, Alain/0000-0002-3561-2248	French Centre National de la Recherche Scientifique [2ID]; European Community	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	This study was funded by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davidson DW, 2005, OECOLOGIA, V142, P221, DOI 10.1007/s00442-004-1722-0; Davidson DW., 2005, FLORA NEOTROPICA MON, P214; de Souza DJ, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-29; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Dejean A., 2007, FUNCT ECOSYST COMMUN, V1, P105, DOI DOI 10.1515/CCLM.2008.220; DEJEAN A, 2009, AZTECA NATURWISSENSC, V96, P57; Dejean A, 2008, BIOL J LINN SOC, V93, P63, DOI 10.1111/j.1095-8312.2007.00927.x; Federle W, 2004, J EXP BIOL, V207, P67, DOI 10.1242/jeb.00716; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Fischer RC, 2002, OECOLOGIA, V133, P186, DOI 10.1007/s00442-002-1000-y; Guerrero RJ, 2010, J HYMENOPT RES, V19, P51; Heil M, 2004, CHEMOECOLOGY, V14, P45, DOI 10.1007/s00049-003-0257-x; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Longino JT, 2007, ZOOTAXA, P1; MORAIS HC, 1994, INSECT SOC, V41, P339, DOI 10.1007/BF01242307; MORAIS HC, 1998, AZTECA CF LANUGINOSA; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Whitney HM, 2009, CURR BIOL, V19, P948, DOI 10.1016/j.cub.2009.04.051; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P7411, DOI 10.1073/pnas.0502264102; Wojtusiak J, 1995, TROP ZOOL, V8, P309, DOI 10.1080/03946975.1995.10539287	23	31	33	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11331	10.1371/journal.pone.0011331	http://dx.doi.org/10.1371/journal.pone.0011331			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593032	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000279140800028
J	Thalhauser, CJ; Komarova, NL				Thalhauser, Craig J.; Komarova, Natalia L.			Signal Response Sensitivity in the Yeast Mitogen-Activated Protein Kinase Cascade	PLOS ONE			English	Article							MAP KINASE; SCAFFOLD PROTEINS; SPECIFICITY; DYNAMICS; PATHWAY	The yeast pheromone response pathway is a canonical three-step mitogen activated protein kinase (MAPK) cascade which requires a scaffold protein for proper signal transduction. Recent experimental studies into the role the scaffold plays in modulating the character of the transduced signal, show that the presence of the scaffold increases the biphasic nature of the signal response. This runs contrary to prior theoretical investigations into how scaffolds function. We describe a mathematical model of the yeast MAPK cascade specifically designed to capture the experimental conditions and results of these empirical studies. We demonstrate how the system can exhibit either graded or ultrasensitive (biphasic) response dynamics based on the binding kinetics of enzymes to the scaffold. At the basis of our theory is an analytical result that weak interactions make the response biphasic while tight interactions lead to a graded response. We then show via an analysis of the kinetic binding rate constants how the results of experimental manipulations, modeled as changes to certain of these binding constants, lead to predictions of pathway output consistent with experimental observations. We demonstrate how the results of these experimental manipulations are consistent within the framework of our theoretical treatment of this scaffold-dependent MAPK cascades, and how future efforts in this style of systems biology can be used to interpret the results of other signal transduction observations.	[Thalhauser, Craig J.; Komarova, Natalia L.] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA	University of California System; University of California Irvine	Thalhauser, CJ (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu			National Institutes of Health/National Science Foundation [GM75309]; NIH/National Institute of General Medical Sciences [1P50GM076516-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075309, P50GM076516] Funding Source: NIH RePORTER	National Institutes of Health/National Science Foundation(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health/National Science Foundation joint initiative on Mathematical Biology through NIH grant GM75309 and NIH/National Institute of General Medical Sciences grant 1P50GM076516-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Bardwell L, 2007, BIOPHYS J, V92, P3425, DOI 10.1529/biophysj.106.090084; Behar M, 2007, P NATL ACAD SCI USA, V104, P16146, DOI 10.1073/pnas.0703894104; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; Briggs GE, 1925, BIOCHEM J, V19, P338, DOI 10.1042/bj0190338; DOHLMAN H, 2008, SCI STKE, V42, pPE46; FERRELL J, 2000, SCI STKE, V52, pPE1; Flatauer LJ, 2005, MOL CELL BIOL, V25, P1793, DOI 10.1128/MCB.25.5.1793-1803.2005; Good M, 2009, CELL, V136, P1085, DOI 10.1016/j.cell.2009.01.049; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Kofahl B, 2004, YEAST, V21, P831, DOI 10.1002/yea.1122; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komarova NL, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100031; LAMSON R, 2006, CURR BIOL, V61, P618; Levchenko A., 2004, Systems Biology, V1, P139, DOI 10.1049/sb:20045014; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Shao DY, 2006, BIOPHYS J, V91, P3986, DOI 10.1529/biophysj.106.081661; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; THALHAUSER C, 2009, BIOPHYSICAL IN PRESS, V66; Zou XF, 2008, J THEOR BIOL, V250, P139, DOI 10.1016/j.jtbi.2007.09.024	25	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11568	10.1371/journal.pone.0011568	http://dx.doi.org/10.1371/journal.pone.0011568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668519	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800001
J	Uva, P; Lahm, A; Sbardellati, A; Grigoriadis, A; Tutt, A; de Rinaldis, E				Uva, Paolo; Lahm, Armin; Sbardellati, Andrea; Grigoriadis, Anita; Tutt, Andrew; de Rinaldis, Emanuele			Comparative Membranome Expression Analysis in Primary Tumors and Derived Cell Lines	PLOS ONE			English	Article							GENE-EXPRESSION; CLASSIFICATION; SIGNATURE; BREAST; OLIGONUCLEOTIDE; PATTERNS; IDENTIFICATION; CARCINOMAS; MUTATIONS; PROFILES	Despite the wide use of cell lines in cancer research, the extent to which their surface properties correspond to those of primary tumors is poorly characterized. The present study addresses this problem from a transcriptional standpoint, analyzing the expression of membrane protein genes - the Membranome - in primary tumors and immortalized in-vitro cultured tumor cells. 409 human samples, deriving from ten independent studies, were analyzed. These comprise normal tissues, primary tumors and tumor derived cell lines deriving from eight different tissues: brain, breast, colon, kidney, leukemia, lung, melanoma, and ovary. We demonstrated that the Membranome has greater power than the remainder of the transcriptome when used as input for the automatic classification of tumor samples. This feature is maintained in tumor derived cell lines. In most cases primary tumors show maximal similarity in Membranome expression with cell lines of same tissue origin. Differences in Membranome expression between tumors and cell lines were analyzed also at the pathway level and biological themes were identified that were differentially regulated in the two settings. Moreover, by including normal samples in the analysis, we quantified the degree to which cell lines retain the Membranome up-and down-regulations observed in primary tumors with respect to their normal counterparts. We showed that most of the Membranome up-regulations observed in primary tumors are lost in the in-vitro cultured cells. Conversely, the majority of Membranome genes down-regulated upon tumor transformation maintain lower expression levels also in the cell lines. This study points towards a central role of Membranome genes in the definition of the tumor phenotype. The comparative analysis of primary tumors and cell lines identifies the limits of cell lines as a model for the study of cancer-related processes mediated by the cell surface. Results presented allow for a more rational use of the cell lines as a model of cancer.	[Uva, Paolo; Sbardellati, Andrea] Parco Sci & Tecnol POLARIS, CRS4 Bioinformat Lab, Cagliari, Italy; [Lahm, Armin] IRBM, Rome, Italy; [Grigoriadis, Anita; Tutt, Andrew; de Rinaldis, Emanuele] Kings Coll London, Sch Med, Guys Hosp, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England	Merck & Company; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Uva, P (corresponding author), Parco Sci & Tecnol POLARIS, CRS4 Bioinformat Lab, Cagliari, Italy.	emanuele.de_rinaldis@kcl.ac.uk	Uva, Paolo/A-2877-2011	Uva, Paolo/0000-0002-9524-8492; Grigoriadis, Anita/0000-0003-3434-201X; Tutt, Andrew/0000-0001-8715-2901	Breakthrough Breast Cancer Research, United Kingdom	Breakthrough Breast Cancer Research, United Kingdom	This work was supported by Breakthrough Breast Cancer Research, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R PROJECT STAT COMPU; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dai HY, 2005, CANCER RES, V65, P4059, DOI 10.1158/0008-5472.CAN-04-3953; Ellison G, 2002, J CLIN PATHOL-MOL PA, V55, P294, DOI 10.1136/mp.55.5.294; Ertel A, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-55; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jacks T, 2002, CELL, V111, P923, DOI 10.1016/S0092-8674(02)01229-1; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Josic D, 2008, CURR OPIN MOL THER, V10, P116; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karman J, 2004, J IMMUNOL, V173, P2353, DOI 10.4049/jimmunol.173.4.2353; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Le XF, 2005, J BIOL CHEM, V280, P2092, DOI 10.1074/jbc.M403080200; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Loo DT, 2008, CURR OPIN PHARMACOL, V8, P627, DOI 10.1016/j.coph.2008.08.011; Mah N, 2004, PHYSIOL GENOMICS, V16, P361, DOI 10.1152/physiolgenomics.00080.2003; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Monaci P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001508; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Nutt CL, 2003, CANCER RES, V63, P1602; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Roschke AV, 2003, CANCER RES, V63, P8634; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Samoylova T. I., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P9, DOI 10.2174/187152006774755492; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Sandberg R, 2005, P NATL ACAD SCI USA, V102, P2052, DOI 10.1073/pnas.0408105102; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal NH, 2003, J CLIN ONCOL, V21, P1775, DOI 10.1200/JCO.2003.10.108; Shmueli O, 2003, CR BIOL, V326, P1067, DOI 10.1016/j.crvi.2003.09.012; Stein WD, 2004, CANCER RES, V64, P2805, DOI 10.1158/0008-5472.CAN-03-3383; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2001, CANCER RES, V61, P7388; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tan S, 2008, PROTEOMICS, V8, P3924, DOI 10.1002/pmic.200800597; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Virtanen C, 2002, P NATL ACAD SCI USA, V99, P12357, DOI 10.1073/pnas.192240599; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Wang Huixia, 2006, BMC Genomics, V7, P166; WHITESIDE T, 2006, LINK INFLAMMATION CA; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xing-Dong Feng, 2007, Genomics Proteomics & Bioinformatics, V5, P15, DOI 10.1016/S1672-0229(07)60010-2; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	61	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11742	10.1371/journal.pone.0011742	http://dx.doi.org/10.1371/journal.pone.0011742			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668533	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800016
J	Seoighe, C; Gehring, C				Seoighe, Cathal; Gehring, Chris			Heritability in the Efficiency of Nonsense-Mediated mRNA Decay in Humans	PLOS ONE			English	Article							GENOME-WIDE SURVEY; GENE-EXPRESSION; SURVEILLANCE; VARIANTS; IDENTIFICATION; MUTATIONS; COMPONENT; COMPLEX; EXONS	Background: In eukaryotes mRNA transcripts of protein-coding genes in which an intron has been retained in the coding region normally result in premature stop codons and are therefore degraded through the nonsense-mediated mRNA decay (NMD) pathway. There is evidence in the form of selective pressure for in-frame stop codons in introns and a depletion of length three introns that this is an important and conserved quality-control mechanism. Yet recent reports have revealed that the efficiency of NMD varies across tissues and between individuals, with important clinical consequences. Principal Findings: Using previously published Affymetrix exon microarray data from cell lines genotyped as part of the International HapMap project, we investigated whether there are heritable, inter-individual differences in the abundance of intron-containing transcripts, potentially reflecting differences in the efficiency of NMD. We identified intronic probesets using EST data and report evidence of heritability in the extent of intron expression in 56 HapMap trios. We also used a genome-wide association approach to identify genetic markers associated with intron expression. Among the top candidates was a SNP in the DCP1A gene, which forms part of the decapping complex, involved in NMD. Conclusions: While we caution that some of the apparent inter-individual difference in intron expression may be attributable to different handling or treatments of cell lines, we hypothesize that there is significant polymorphism in the process of NMD, resulting in heritable differences in the abundance of intronic mRNA. Part of this phenotype is likely to be due to a polymorphism in a decapping enzyme on human chromosome 3.	[Seoighe, Cathal] Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland; [Seoighe, Cathal] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Gehring, Chris] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia	Ollscoil na Gaillimhe-University of Galway; University of Cape Town; King Abdullah University of Science & Technology	Seoighe, C (corresponding author), Natl Univ Ireland Galway, Sch Math Stat & Appl Math, Galway, Ireland.	Cathal.Seoighe@nuigalway.ie		Gehring, Christoph/0000-0003-4355-4591	Science Foundation Ireland [07/SK/M1211b]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was funded by Science Foundation Ireland (Grant number 07/SK/M1211b; http://www.sfi.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; AULCHENKO Y, 2009, GENABEL GENOME WIDE; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Chaix R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000184; Cheung VG, 2009, NAT REV GENET, V10, P595, DOI 10.1038/nrg2630; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Couttet P, 2004, NUCLEIC ACIDS RES, V32, P488, DOI 10.1093/nar/gkh218; Dabney A, 2009, QVALUE Q VALUE ESTIM; ElSharawy A, 2006, HUM MUTAT, V27, P1129, DOI 10.1002/humu.20377; ElSharawy A, 2009, HUM MUTAT, V30, P625, DOI 10.1002/humu.20906; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedel CC, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp542; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; HERRICK D, 1990, MOL CELL BIOL, V10, P2269, DOI 10.1128/MCB.10.5.2269; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Linde L, 2007, EUR J HUM GENET, V15, P1156, DOI 10.1038/sj.ejhg.5201889; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Lykke-Andersen J, 2002, MOL CELL BIOL, V22, P8114, DOI 10.1128/MCB.22.23.8114-8121.2002; Mitrovich QM, 2005, CURR BIOL, V15, P963, DOI 10.1016/j.cub.2005.04.055; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nembaware V, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-265; Pagani F, 2004, NAT REV GENET, V5, P389, DOI 10.1038/nrg1327; Seko Y, 2006, AUTOIMMUN REV, V5, P299, DOI 10.1016/j.autrev.2005.10.013; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Viegas MH, 2007, NUCLEIC ACIDS RES, V35, P4542, DOI 10.1093/nar/gkm461; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Zetoune AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-83	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11657	10.1371/journal.pone.0011657	http://dx.doi.org/10.1371/journal.pone.0011657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657766	gold, Green Published, Green Submitted			2022-12-27	WOS:000280197500014
J	Brugger, SD; Frey, P; Aebi, S; Hinds, J; Muhlemann, K				Brugger, Silvio D.; Frey, Pascal; Aebi, Suzanne; Hinds, Jason; Muehlemann, Kathrin			Multiple Colonization with S. pneumoniae before and after Introduction of the Seven-Valent Conjugated Pneumococcal Polysaccharide Vaccine	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; NASOPHARYNGEAL COLONIZATION; UNITED-STATES; SEROTYPE 19A; CHILDREN; DISEASE; CARRIAGE; PCR; POPULATION	Background: Simultaneous carriage of more than one strain of Streptococcus pneumoniae promotes horizontal gene transfer events and may lead to capsule switch and acquisition of antibiotic resistance. We studied the epidemiology of cocolonization with S. pneumoniae before and after introduction of the seven-valent conjugated pneumococcal vaccine (PCV7). Methodology: Nasopharyngeal swabs (n 1120) were collected from outpatients between 2004 and 2009 within an ongoing nationwide surveillance program. Cocolonization was detected directly from swabs by restriction fragment length polymorphism (RFLP) analysis. Serotypes were identified by agglutination, multiplex PCR and microarray. Principal Findings: Rate of multiple colonization remained stable up to three years after PCV7 introduction. Cocolonization was associated with serotypes of low carriage prevalence in the prevaccine era. Pneumococcal colonization density was higher in cocolonized samples and cocolonizing strains were present in a balanced ratio (median 1.38). Other characteristics of cocolonization were a higher frequency at young age, but no association with recurrent acute otitis media, recent antibiotic exposure, day care usage and PCV7 vaccination status. Conclusions: Pneumococcal cocolonization is dominated by serotypes of low carriage prevalence in the prevaccine era, which coexist in the nasopharynx. Emergence of such previously rare serotypes under vaccine selection pressure may promote cocolonization in the future.	[Brugger, Silvio D.; Frey, Pascal; Aebi, Suzanne; Muehlemann, Kathrin] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Hinds, Jason] Univ London, Div Cellular & Mol Med, London, England; [Muehlemann, Kathrin] Univ Hosp Bern, Dept Infect Dis, CH-3010 Bern, Switzerland	University of Bern; University of London; University of Bern; University Hospital of Bern	Brugger, SD (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	kathrin.muehlemann@ifik.unibe.ch	Kummer, Juerg/B-3322-2011; Brugger, Silvio Daniel/AAY-7090-2020	Brugger, Silvio Daniel/0000-0001-9492-9088; Hinds, Jason/0000-0002-2739-1908; Frey, Pascal/0000-0001-6161-0919	Swiss National Science Foundation [320000-113912, 323500-119214]; Wellcome Trust; Pfizer AG	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Pfizer AG	The authors acknowledge the Swiss National Science Foundation ( research grant 320000-113912 to K. M.; MD-PhD scholarship 323500-119214 to S. B.), the Wellcome Trust for funding B mu G@S (Bacterial Microarray Group at St George's, University of London), and Pfizer AG for partial support of the pneumococcal surveillance system. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2007, J CLIN MICROBIOL, V45, P3408, DOI 10.1128/JCM.01393-07; AURANEN K, AM J EPIDEMIOL, V171, P169; Billal DS, 2008, EUR J PEDIATR, V167, P401, DOI 10.1007/s00431-007-0510-3; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bronsdon MA, 2004, J CLIN MICROBIOL, V42, P1596, DOI 10.1128/JCM.42.4.1596-1600.2004; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2007, PLOS PATHOG, V3, P1628, DOI 10.1371/journal.ppat.0030168; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; Hare KM, 2008, PEDIATR INFECT DIS J, V27, P178, DOI 10.1097/INF.0b013e31815bb6c5; Hathaway LJ, 2007, J CLIN MICROBIOL, V45, P803, DOI 10.1128/JCM.02169-06; Hill PC, 2008, CLIN INFECT DIS, V46, P807, DOI 10.1086/528688; Huebner RE, 2000, PEDIATR INFECT DIS J, V19, P1017, DOI 10.1097/00006454-200010000-00019; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; Kronenberg A, 2006, J CLIN MICROBIOL, V44, P2032, DOI 10.1128/JCM.00275-06; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Madhi SA, 2007, J INFECT DIS, V196, P1662, DOI 10.1086/522164; MARGOLIS E, BMC MICROBIOL, V10, P59; Meier PS, 2003, ANTIMICROB AGENTS CH, V47, P863, DOI 10.1128/AAC.47.3.863-868.2003; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Morrison KE, 2000, J CLIN MICROBIOL, V38, P434; Muhlemann K, 2003, J INFECT DIS, V187, P589, DOI 10.1086/367994; O'Brien KL, 2007, J INFECT DIS, V196, P1211, DOI 10.1086/521833; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Poehling KA, 2006, JAMA-J AM MED ASSOC, V295, P1668, DOI 10.1001/jama.295.14.1668; Regev-Yochay G, 2008, CLIN INFECT DIS, V47, P289, DOI 10.1086/589573; Rivera-Olivero IA, 2009, J MED MICROBIOL, V58, P584, DOI 10.1099/jmm.0.006726-0; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Temime L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003244; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	34	74	74	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11638	10.1371/journal.pone.0011638	http://dx.doi.org/10.1371/journal.pone.0011638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661289	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000279980800022
J	Okumu, FO; Govella, NJ; Moore, SJ; Chitnis, N; Killeen, GF				Okumu, Fredros O.; Govella, Nicodem J.; Moore, Sarah J.; Chitnis, Nakul; Killeen, Gerry F.			Potential Benefits, Limitations and Target Product-Profiles of Odor-Baited Mosquito Traps for Malaria Control in Africa	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; ENTOMOLOGIC INOCULATION RATES; GLOSSINA-MORSITANS-CENTRALIS; EXPERIMENTAL HUT TRIALS; HUMAN SKIN EMANATIONS; ANOPHELES-GAMBIAE; PLASMODIUM-FALCIPARUM; VECTOR-CONTROL; BED NETS; FIELD-EVALUATION	Background: Traps baited with synthetic human odors have been proposed as suitable technologies for controlling malaria and other mosquito-borne diseases. We investigated the potential benefits of such traps for preventing malaria transmission in Africa and the essential characteristics that they should possess so as to be effective. Methods and Principal Findings: An existing mathematical model was reformulated to distinguish availability of hosts for attack by mosquitoes from availability of blood per se. This adaptation allowed the effects of pseudo-hosts such as odor-baited mosquito traps, which do not yield blood but which can nonetheless be attacked by the mosquitoes, to be simulated considering communities consisting of users and non-users of insecticide-treated nets (ITNs), currently the primary malaria prevention method. We determined that malaria transmission declines as trap coverage (proportion of total availability of all hosts and pseudo hosts that traps constitute) increases. If the traps are more attractive than humans and are located in areas where mosquitoes are most abundant, 20-130 traps per 1000 people would be sufficient to match the impact of 50% community-wide ITN coverage. If such traps are used to complement ITNs, malaria transmission can be reduced by 99% or more in most scenarios representative of Africa. However, to match cost-effectiveness of ITNs, the traps delivery, operation and maintenance would have to cost a maximum of US$4.25 to 27.61 per unit per year. Conclusions and Significance: Odor-baited mosquito traps might potentially be effective and affordable tools for malaria control in Africa, particularly if they are used to complement, rather than replace, existing methods. We recommend that developers should focus on super-attractive baits and cheaper traps to enhance cost-effectiveness, and that the most appropriate way to deploy such technologies is through vertical delivery mechanisms.	[Okumu, Fredros O.; Govella, Nicodem J.; Moore, Sarah J.; Killeen, Gerry F.] Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania; [Okumu, Fredros O.; Moore, Sarah J.] London Sch Hyg & Trop Med, Publ Hlth Entomol Grp, Dept Infect Dis, London WC1, England; [Govella, Nicodem J.; Killeen, Gerry F.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Chitnis, Nakul] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland	Ifakara Health Institute; University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool; University of Basel; Swiss Tropical & Public Health Institute	Okumu, FO (corresponding author), Ifakara Hlth Inst, Biomed & Environm Sci Themat Grp, Ifakara, Tanzania.	fredros@ihi.or.tz	Chitnis, Nakul/B-3105-2013; Moore, Sarah J/HGE-7143-2022	Moore, Sarah J/0000-0002-0938-6654; Chitnis, Nakul/0000-0002-1103-9141	Bill & Melinda Gates Foundation [51431, 45114]; President's Malaria Initiative (USAID) [621-A-00-08-0007-00]; London School of Hygiene and Tropical Medicine [RCA-3125]; Wellcome Trust [076806]; PATH-MACEPA; Malaria Transmission Consortium (MTC)	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); President's Malaria Initiative (USAID)(United States Agency for International Development (USAID)President's Malaria Initiative (PMI)); London School of Hygiene and Tropical Medicine; Wellcome Trust(Wellcome TrustEuropean Commission); PATH-MACEPA; Malaria Transmission Consortium (MTC)	This work was supported with funds from the Bill & Melinda Gates Foundation provided through research grants from the Global Health Discovery Program (Grand Challenges Explorations Grant No. 53214) and direct award numbers 51431 and 45114) as well as the President's Malaria Initiative (USAID award No. 621-A-00-08-0007-00). Personal support was provided to FOO through a PhD studentship at the London School of Hygiene and Tropical Medicine (Grant No. RCA-3125) and to GFK through a Wellcome Trust Research Career Development Fellowship (Award No. 076806). NC was supported by a postdoctoral fellowship from PATH-MACEPA and a grant from the Malaria Transmission Consortium (MTC), a project funded by the Bill & Melinda Gates Foundation (BMGF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, Trans R Soc Trop Med Hyg, V86, P499; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2005, ROLL BACK MAL GLOB S; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], 2007, INS TREAT NETS POS S; Ansell J, 2002, T ROY SOC TROP MED H, V96, P113, DOI 10.1016/S0035-9203(02)90271-3; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Beier JC, 1998, ANNU REV ENTOMOL, V43, P519, DOI 10.1146/annurev.ento.43.1.519; Bernier UR, 2002, J AM MOSQUITO CONTR, V18, P186; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Bernier UR, 2007, INSECT REPELLENTS PR, P77; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; BRAIMAH N, 2005, INT J TROP INSECT SC, P1; Cairncross S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P771; Charlwood JD, 1997, B ENTOMOL RES, V87, P445, DOI 10.1017/S0007485300041304; Chitnis Nakul, 2008, Journal of Biological Dynamics, V2, P259, DOI 10.1080/17513750701769857; Clements A. N., 1992, BIOL MOSQUITOES, V1; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Costantini C., 1993, Parassitologia (Rome), V35, P5; DAY JF, 1994, AM J TROP MED HYG, V50, P126, DOI 10.4269/ajtmh.1994.50.126; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; FEACHEM RG, 1980, PROC R SOC SER B-BIO, V209, P15, DOI 10.1098/rspb.1980.0068; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699; Garrett-Jones C, 1975, WHOMAL75851; Gillies M, 1987, ANOPHELINAE AFRICA S; GILLIES MT, 1972, B ENTOMOL RES, V61, P389, DOI 10.1017/S0007485300047295; Govella NJ, 2010, AM J TROP MED HYG, V82, P415, DOI 10.4269/ajtmh.2010.09-0579; Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716; Gu WD, 2003, T ROY SOC TROP MED H, V97, P43, DOI 10.1016/S0035-9203(03)90018-6; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; HADI A, 2000, PARTICIPATORY APPROA, P332; Hanson K, 2003, B WORLD HEALTH ORGAN, V81, P269; Hawley WA, 2003, AM J TROP MED HYG, V68, P168, DOI 10.4269/ajtmh.2003.68.168; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hutchinson RA, 2007, B ENTOMOL RES, V97, P591, DOI 10.1017/S0007485307005263; Ito T, 2006, DEV OLYSET NET TOOL; Kauman PE, 2008, J AM MOSQUITO CONTR, V24, P528; Kawada H, 2005, J VECTOR ECOL, V30, P181; Kelly DW, 2000, PARASITOLOGY, V120, P319, DOI 10.1017/S0031182099005442; Khan ZR, 2000, PEST MANAG SCI, V56, P957, DOI 10.1002/1526-4998(200011)56:11<957::AID-PS236>3.0.CO;2-T; Killeen GF, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-121; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Killeen GF, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-161; Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022; Killeen GF, 2004, AM J TROP MED HYG, V71, P87, DOI 10.4269/ajtmh.2004.71.2_suppl.0700087; Killeen GF, 2003, LANCET INFECT DIS, V3, P297, DOI 10.1016/S1473-3099(03)00611-X; Killeen GF, 2001, T ROY SOC TROP MED H, V95, P469, DOI 10.1016/S0035-9203(01)90005-7; Killeen GF, 2000, AM J TROP MED HYG, V62, P545, DOI 10.4269/ajtmh.2000.62.545; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Kline DL, 1999, J AM MOSQUITO CONTR, V15, P276; Kline DL, 2002, J VECTOR ECOL, V27, P1; KNOLS BGJ, 1993, MED VET ENTOMOL, V7, P161, DOI 10.1111/j.1365-2915.1993.tb00670.x; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; KUSNETSOV RL, 1977, TROPICAL DOCTOR, V7, P81; Lacroix R, 2005, PLOS BIOL, V3, P1590, DOI 10.1371/journal.pbio.0030298; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Le Menach A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-10; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; LINDSAY SW, 1995, MED VET ENTOMOL, V9, P50, DOI 10.1111/j.1365-2915.1995.tb00116.x; LINDSAY SW, 1993, J MED ENTOMOL, V30, P368, DOI 10.1093/jmedent/30.2.368; LINDSAY SW, 1991, MED VET ENTOMOL, V5, P477, DOI 10.1111/j.1365-2915.1991.tb00576.x; LINES JD, 1987, MED VET ENTOMOL, V1, P37, DOI 10.1111/j.1365-2915.1987.tb00321.x; Logan JG, 2007, PEST MANAG SCI, V63, P647, DOI 10.1002/ps.1408; Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18; MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P613; Magesa SM, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-34; Mathenge EM, 2002, MED VET ENTOMOL, V16, P67, DOI 10.1046/j.0269-283x.2002.00350.x; Mathenge EM, 2004, AM J TROP MED HYG, V70, P33, DOI 10.4269/ajtmh.2004.70.33; Maxwell C. A., 2006, Journal of Vector Borne Diseases, V43, P1; Miller JR, 2010, P NATL ACAD SCI USA, V107, P22, DOI 10.1073/pnas.0908453107; MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x; Mukabana W. R., 2002, DIFFERENTIAL ATTRACT; N'Guessan R, 2001, MED VET ENTOMOL, V15, P97, DOI 10.1046/j.1365-2915.2001.00284.x; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; Okumu FO, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-12; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; OKUMU OF, 2008, OPEN TROPICAL MED J, V1, P68; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pickett JA, 1997, AGR ECOSYST ENVIRON, V64, P149, DOI 10.1016/S0167-8809(97)00033-9; Qiu YT, 2006, MED VET ENTOMOL, V20, P280, DOI 10.1111/j.1365-2915.2006.00627.x; Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Roitberg BD, 2003, BEHAV ECOL, V14, P736, DOI 10.1093/beheco/arg055; Ross A, 2006, AM J TROP MED HYG, V75, P32, DOI 10.4269/ajtmh.2006.75.32; SAUL AJ, 1990, J APPL ECOL, V27, P123, DOI 10.2307/2403572; Sauli V, 2003, J HIGH ENERGY PHYS; Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230; Service MW, 1997, J MED ENTOMOL, V34, P579, DOI 10.1093/jmedent/34.6.579; SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Shililu J, 2003, AM J TROP MED HYG, V69, P295, DOI 10.4269/ajtmh.2003.69.295; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; SMITH T, 1995, ACTA TROP, V59, P1, DOI 10.1016/0001-706X(94)00082-C; Soremekun S, 2004, TROP MED INT HEALTH, V9, P664, DOI 10.1111/j.1365-3156.2004.01250.x; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Takken W, 2009, TRENDS PARASITOL, V25, P101, DOI 10.1016/j.pt.2008.12.002; Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19; Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Tumwine JK, 2003, INT J ENVIRON HEAL R, V13, P107, DOI 10.1080/0960312031000098035; VALE GA, 1988, B ENTOMOL RES, V78, P31, DOI 10.1017/S0007485300016059; *WHO, 2009, WHO PEST EV SCHEM SP; WHO, 2009, GLOB MAL ACT PLAN; WILLEMSE L, 1991, B ENTOMOL RES, V81, P351, DOI 10.1017/S0007485300033630; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	116	53	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11573	10.1371/journal.pone.0011573	http://dx.doi.org/10.1371/journal.pone.0011573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644731	gold, Green Published, Green Submitted			2022-12-27	WOS:000279884900013
J	Hu, J; Doucette, K; Hartling, L; Tjosvold, L; Robinson, J				Hu, Jia; Doucette, Karen; Hartling, Lisa; Tjosvold, Lisa; Robinson, Joan			Treatment of Hepatitis C in Children: A Systematic Review	PLOS ONE			English	Review							RIBAVIRIN COMBINATION THERAPY; INTERFERON-ALPHA TREATMENT; PLUS RIBAVIRIN; VIRUS-INFECTION; PEGINTERFERON ALPHA-2B; PEGYLATED INTERFERON-ALPHA-2B; VIROLOGICAL RESPONSE; NATURAL-HISTORY; ADOLESCENTS; EFFICACY	Background: Current guidelines recommend children be treated for hepatitis C virus (HCV) using the same principles applied in adults. There are however few published studies which assess the efficacy and safety of HCV therapy in children. Methodology/Principal Findings: A systematic review of the literature was completed for studies of any design that evaluated HCV therapy in children. The primary outcome was sustained virologic response (SVR), with sub-group analysis of response rates by genotype. There were 4 randomized controlled trials (RCTs) and 31 non-randomized studies, all involving interferon, pegylated interferon (PEG-IFN), or combinations of these drugs with ribavirin. The SVR rate could not be directly compared as the populations and interventions differed across studies. Genotype was not reported or differed substantially from study to study. The overall SVR rate for PEG-IFN and ribavirin ranged from 30 to 100% which is comparable to the rate in adults. Similar to adults, the SVR rates were significantly higher in children with genotype 2 or 3 compared to genotype 1. Adverse effects were primarily flu-like symptoms and neutropenia. There were insufficient data to assess the applicability of the week 12 stop rule (stopping therapy at week 12 if there is less than a 2 log drop in HCV RNA) or the efficacy of shortening therapy to 24 weeks in children with genotype 2 and 3. Conclusions/Significance: Current guidelines for the treatment of HCV in children are based on limited data. Further research is needed to define the optimal therapy for HCV in children.	[Hu, Jia; Hartling, Lisa; Tjosvold, Lisa; Robinson, Joan] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Doucette, Karen] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Hartling, Lisa; Tjosvold, Lisa] Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Hu, J (corresponding author), Univ Alberta, Dept Pediat, Edmonton, AB, Canada.	jh11@ualberta.ca; jr3@ualberta.ca		Doucette, Karen/0000-0002-1660-9166; Tjosvold, Lisa/0000-0002-5667-6312				Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Baker RD, 2007, J CLIN GASTROENTEROL, V41, P111, DOI 10.1097/MCG.0b013e31802dd2f6; Barshes NR, 2006, LIVER TRANSPLANT, V12, P1119, DOI 10.1002/lt.20793; Bortolotti F, 1995, HEPATOLOGY, V22, P1623, DOI 10.1002/hep.1840220602; Christensson B, 2000, CLIN INFECT DIS, V30, P585, DOI 10.1086/313709; CLEMENTE MG, 1994, J PEDIATR-US, V125, P123, DOI 10.1016/S0022-3476(94)70138-5; Conjeevaram HS, 2006, GASTROENTEROLOGY, V131, P470, DOI 10.1053/j.gastro.2006.06.008; Czerwionka-Szaflarska M, 2000, Med Sci Monit, V6, P964; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Figlerowicz M, 2004, EUR J PEDIATR, V163, P265, DOI 10.1007/s00431-004-1418-9; Fried MW, 2002, HEPATOLOGY, V36, P967, DOI 10.1053/jhep.2002.35529; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; FUJISAWA T, 1995, J PEDIATR-US, V127, P660, DOI 10.1016/S0022-3476(95)70135-4; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gessoni G, 1993, Eur J Med, V2, P79; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gonzalez-Peralta RP, 2005, HEPATOLOGY, V42, P1010, DOI 10.1002/hep.20884; Goodman ZD, 2008, HEPATOLOGY, V47, P836, DOI 10.1002/hep.22094; Guido M, 2003, AM J GASTROENTEROL, V98, P660, DOI [10.1016/S0002-9270(02)06015-X, 10.1111/j.1572-0241.2003.07293.x]; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hasan F, 2006, GASTROENTEROLOGY, V130, pA840; Iorio R, 2005, CLIN INFECT DIS, V41, P1431, DOI 10.1086/497141; Iorio R, 1995, J HEPATOL, V23, P761, DOI 10.1016/0168-8278(95)80047-6; Jacobson KR, 2002, J PEDIATR GASTR NUTR, V34, P52, DOI 10.1097/00005176-200201000-00013; Jara P, 2003, CLIN INFECT DIS, V36, P275, DOI 10.1086/345908; Jara P, 2008, PEDIATR INFECT DIS J, V27, P142, DOI 10.1097/INF.0b013e318159836c; Jonas MM, 1998, PEDIATR INFECT DIS J, V17, P241, DOI 10.1097/00006454-199803000-00013; Jonas MM, 1996, PEDIATRICS, V98, P211; KATZ JA, 1988, INVEST NEW DRUG, V6, P115; Ko JS, 2001, J PEDIATR GASTR NUTR, V32, P41, DOI 10.1097/00005176-200101000-00013; Komatsu H, 1996, BLOOD, V87, P4072, DOI 10.1182/blood.V87.10.4072.bloodjournal87104072; KWO P, 2009, HCV SPRINT 1 FINAL R; Majda-Stanislawska E, 2000, Med Sci Monit, V6, P1142; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Matsuoka S, 1997, EUR J PEDIATR, V156, P704, DOI 10.1007/s004310050694; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MOHAN N, J PEDIAT GASTROENTER, V50, P123; MOLLESTON JP, 2009, J PEDIAT GASTROEN S1, V49, pE73; Moy L.C., 2009, CHRONIC HEPATITIS C; Mozer-Lisewska I, 2003, EUR J PEDIATR, V162, P755, DOI 10.1007/s00431-002-1147-x; Nakashima E, 2003, J GASTROEN HEPATOL, V18, P411, DOI 10.1046/j.1440-1746.2003.03010.x; NARKEWICZ M, 2008, OPHTHALMOLOGIC COMPL; NGATCHU T, 1992, J TROP MED HYG, V95, P57; PAWLOWSKA M, 2009, PEGYLATED INTERFERON; Pensati P, 1999, J HEPATOL, V31, P604, DOI 10.1016/S0168-8278(99)80338-9; Puetz J, 2004, HAEMOPHILIA, V10, P87, DOI 10.1046/j.1365-2516.2003.00843.x; RUIZMORENO M, 1992, HEPATOLOGY, V16, P882, DOI 10.1002/hep.1840160405; Sawada A, 1998, J HEPATOL, V28, P184, DOI 10.1016/0168-8278(88)80003-5; Schwarz KB, 2006, J PEDIATR GASTR NUTR, V43, P499, DOI 10.1097/01.mpg.0000235974.67496.e6; Schwarz KB, 2008, HEPATOLOGY, V48, p418A; Sokal EM, 2010, J HEPATOL, V52, P827, DOI 10.1016/j.jhep.2010.01.028; Spiliopoulou I, 1999, EUR J CLIN MICROBIOL, V18, P709, DOI 10.1007/s100960050383; Stephenne X, 2002, ACTA GASTRO-ENT BELG, V65, P95; Suoglu OD, 2002, J PEDIATR GASTR NUTR, V34, P199, DOI 10.1097/00005176-200202000-00018; TANAKA E, 1992, AM J TROP MED HYG, V46, P460, DOI 10.4269/ajtmh.1992.46.460; Tovo PA, 2000, J INFECT DIS, V181, P419, DOI 10.1086/315264; Wirth S, 2005, HEPATOLOGY, V41, P1013, DOI 10.1002/hep.20661; Wirth S, 2002, HEPATOLOGY, V36, P1280, DOI 10.1053/jhep.2002.36495; ZHANG H, 2009, ANN GEN M AM ASS STU; Zwiener RJ, 1996, PEDIATR INFECT DIS J, V15, P906, DOI 10.1097/00006454-199610000-00015; 2009, ASSESSMENT SAFETY EF	62	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11542	10.1371/journal.pone.0011542	http://dx.doi.org/10.1371/journal.pone.0011542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644626	Green Published, Green Submitted, gold			2022-12-27	WOS:000279822300008
J	Ueyama, M; Akimoto, Y; Ichimiya, T; Ueda, R; Kawakami, H; Aigaki, T; Nishihara, S				Ueyama, Morio; Akimoto, Yoshihiro; Ichimiya, Tomomi; Ueda, Ryu; Kawakami, Hayato; Aigaki, Toshiro; Nishihara, Shoko			Increased Apoptosis of Myoblasts in Drosophila Model for the Walker-Warburg Syndrome	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; O-MANNOSYLTRANSFERASE ACTIVITY; EYE-BRAIN DISEASE; ALPHA-DYSTROGLYCAN; POMT1 GENE; MUTATIONS; MUSCLE; LAMININ; DISRUPTION; IDENTIFICATION	Walker-Warburg syndrome, a progressive muscular dystrophy, is a severe disease with various kinds of symptoms such as muscle weakness and occasional seizures. The genes of protein O-mannosyltransferases 1 and 2 (POMT1 and POMT2), fukutin, and fukutin-related protein are responsible for this syndrome. In our previous study, we cloned Drosophila orthologs of human POMT1 and POMT2 and identified their activity. However, the mechanism of onset of this syndrome is not well understood. Furthermore, little is known about the behavioral properties of the Drosophila POMT1 and POMT2 mutants, which are called rotated abdomen (rt) and twisted (tw), respectively. First, we performed various kinds of behavioral tests and described in detail the muscle structures by using these mutants. The mutant flies exhibited abnormalities in heavy exercises such as climbing or flight but not in light movements such as locomotion. Defective motor function in mutants appeared immediately after eclosion and was exaggerated with aging. Along with motor function, muscle ultrastructure in the tw mutant was altered, as seen in human patients. We demonstrated that expression of RNA interference (RNAi) for the rt gene and the tw mutant was almost completely lethal and semi-lethal, respectively. Flies expressing RNAi had reduced lifespans. These findings clearly demonstrate that Drosophila POMT mutants are models for human muscular dystrophy. We then observed a high density of myoblasts with an enhanced degree of apoptosis in the tw mutant, which completely lost enzymatic activity. In this paper, we propose a novel mechanism for the development of muscular dystrophy: POMT mutation causes high myoblast density and position derangement, which result in apoptosis, muscle disorganization, and muscle cell defects.	[Ueyama, Morio; Ichimiya, Tomomi; Nishihara, Shoko] Soka Univ, Dept Bioinformat, Tokyo, Japan; [Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Sch Med, Dept Anat, Tokyo, Japan; [Ueda, Ryu] Natl Inst Genet, Invertebrate Genet Lab, Shizuoka, Japan; [Aigaki, Toshiro] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan	Soka University; Kyorin University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tokyo Metropolitan University	Ueyama, M (corresponding author), Soka Univ, Dept Bioinformat, Tokyo, Japan.	shoko@t.soka.ac.jp		Ueyama, Morio/0000-0002-2950-7361; Nishihara, Shoko/0000-0002-1668-2603	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Matching Fund for Private Universities [S0901015]; NICHD	Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Matching Fund for Private Universities; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by funds from the Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST), and from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Matching Fund for Private Universities, S0901015, 2009-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. T. Maqbool, Dr. D. Yamamoto, Bloomington stock center, and Szeged stock center for providing fly stocks, Dr. M. Umeda for providing anti- Dg antibody, Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa for providing other 1st antibodies, C. Ohkura for data handling of locomotion assay, M. Fukuda, and S. Matubara for technical assistance of electron microscopy, Dr. T. J. Fuwa for suggesting the experimental methods, Dr. S. Yamamura for discussion about muscular dystrophies, Dr. T. Matsuo, Dr. D. Yamamoto, and Dr. Y. Fuyama for comments on the manuscript, and anonymous reviewers for constructive comments.	Akasaka-Manya K, 2004, BIOCHEM BIOPH RES CO, V325, P75, DOI 10.1016/j.bbrc.2004.10.001; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Bouchet C, 2007, MOL GENET METAB, V90, P93, DOI 10.1016/j.ymgme.2006.09.005; BROWN NH, 1994, DEVELOPMENT, V120, P1221; Burton EA, 2002, CELL, V108, P5, DOI 10.1016/S0092-8674(01)00626-2; Chiba A, 1997, J BIOL CHEM, V272, P2156; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Cormand B, 2001, NEUROLOGY, V56, P1059, DOI 10.1212/WNL.56.8.1059; CULLEN MJ, 1975, J NEUROL SCI, V24, P179, DOI 10.1016/0022-510X(75)90232-4; Currier SC, 2005, AM J MED GENET A, V133A, P53, DOI 10.1002/ajmg.a.30487; DAVIS BK, 1980, DROSOPH INF SERV, V55, P31; de Bernabe DBV, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013870; de Bernabe DBV, 2003, J MED GENET, V40, P845; Deng WM, 2003, DEVELOPMENT, V130, P173, DOI 10.1242/dev.00199; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; DWAYNE GS, 2004, NATURE CELL BIO, V6, P388; Emery AEH, 2002, NEUROMUSCULAR DISORD, V12, P343, DOI 10.1016/S0960-8966(01)00303-0; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Henry MD, 1998, CELL, V95, P859, DOI 10.1016/S0092-8674(00)81708-0; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Kaneuchi T, 2003, BIOGERONTOLOGY, V4, P157, DOI 10.1023/A:1024145822785; Lyalin D, 2006, GENETICS, V172, P343, DOI 10.1534/genetics.105.049650; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2002, J BIOL CHEM, V277, P35503, DOI 10.1074/jbc.M206033200; Martin D, 1999, J CELL BIOL, V145, P191, DOI 10.1083/jcb.145.1.191; MartinBlanco E, 1996, P NATL ACAD SCI USA, V93, P6048, DOI 10.1073/pnas.93.12.6048; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mostacciuolo ML, 1996, HUM GENET, V97, P277, DOI 10.1007/BF02185752; Muntoni F, 2004, NAT MED, V10, P676, DOI 10.1038/nm0704-676; Neuman S, 2001, GENE, V263, P17, DOI 10.1016/S0378-1119(00)00584-9; Poulton JS, 2006, P NATL ACAD SCI USA, V103, P12775, DOI 10.1073/pnas.0603817103; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; Roy S, 1999, BIOESSAYS, V21, P486, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;486::AID-BIES5&gt;3.0.CO;2-M; Schneider M, 2006, DEVELOPMENT, V133, P3805, DOI 10.1242/dev.02549; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; Soler C, 2004, DEVELOPMENT, V131, P6041, DOI 10.1242/dev.01527; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; Takeuchi K, 2009, SCIENCE, V323, P1740, DOI 10.1126/science.1165712; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; VOIT T, 2004, MYOLOGY, P1203; Wairkar YP, 2008, J NEUROSCI, V28, P3781, DOI 10.1523/JNEUROSCI.0478-08.2008; Walker AE, 1942, ARCH NEUROL PSYCHIAT, V48, P13; WARBURG M, 1976, HUM HERED, V26, P137, DOI 10.1159/000152795; WARBURG M, 1978, AM J OPHTHALMOL, V85, P88, DOI 10.1016/S0002-9394(14)76671-1; Willer T, 2004, P NATL ACAD SCI USA, V101, P14126, DOI 10.1073/pnas.0405899101; Williams ST, 2003, APOPTOSIS, V8, P353, DOI 10.1023/A:1024168901003; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yanagisawa A, 2007, NEUROLOGY, V69, P1254, DOI 10.1212/01.wnl.0000268489.60809.c4; YARNITZKY T, 1995, DEV BIOL, V169, P609, DOI 10.1006/dbio.1995.1173	55	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11557	10.1371/journal.pone.0011557	http://dx.doi.org/10.1371/journal.pone.0011557			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644630	Green Published, gold, Green Submitted			2022-12-27	WOS:000279822300011
J	Volkow, ND; Wang, GJ; Tomasi, D; Telang, F; Fowler, JS; Pradhan, K; Jayne, M; Logan, J; Goldstein, RZ; Alia-Klein, N; Wong, C				Volkow, Nora D.; Wang, Gene-Jack; Tomasi, Dardo; Telang, Frank; Fowler, Joanna S.; Pradhan, Kith; Jayne, Millard; Logan, Jean; Goldstein, Rita Z.; Alia-Klein, Nelly; Wong, Christopher			Methylphenidate Attenuates Limbic Brain Inhibition after Cocaine-Cues Exposure in Cocaine Abusers	PLOS ONE			English	Article							DOPAMINE SYSTEM REGULATION; NUCLEUS-ACCUMBENS; SEEKING BEHAVIOR; EXTRACELLULAR DOPAMINE; INTRAVENOUS COCAINE; GLUCOSE-UTILIZATION; ADDICTION; DEPENDENCE; STRIATUM; RATS	Dopamine (phasic release) is implicated in conditioned responses. Imaging studies in cocaine abusers show decreases in striatal dopamine levels, which we hypothesize may enhance conditioned responses since tonic dopamine levels modulate phasic dopamine release. To test this we assessed the effects of increasing tonic dopamine levels (using oral methylphenidate) on brain activation induced by cocaine-cues in cocaine abusers. Brain metabolism (marker of brain function) was measured with PET and (18)FDG in 24 active cocaine abusers tested four times; twice watching a Neutral video (nature scenes) and twice watching a Cocaine-cues video; each video was preceded once by placebo and once by methylphenidate (20 mg). The Cocaine-cues video increased craving to the same extent with placebo (68%) and with methylphenidate (64%). In contrast, SPM analysis of metabolic images revealed that differences between Neutral versus Cocaine-cues conditions were greater with placebo than methylphenidate; whereas with placebo the Cocaine-cues decreased metabolism (p<0.005) in left limbic regions (insula, orbitofrontal, accumbens) and right parahippocampus, with methylphenidate it only decreased in auditory and visual regions, which also occurred with placebo. Decreases in metabolism in these regions were not associated with craving; in contrast the voxel-wise SPM analysis identified significant correlations with craving in anterior orbitofrontal cortex (p<0.005), amygdala, striatum and middle insula (p<0.05). This suggests that methylphenidate's attenuation of brain reactivity to Cocaine-cues is distinct from that involved in craving. Cocaine-cues decreased metabolism in limbic regions (reflects activity over 30 minutes), which contrasts with activations reported by fMRI studies (reflects activity over 2-5 minutes) that may reflect long-lasting limbic inhibition following activation. Studies to evaluate the clinical significance of methylphenidate's blunting of cue-induced limbic inhibition may help identify potential benefits of this medication in cocaine addiction.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD USA; [Volkow, Nora D.; Tomasi, Dardo; Telang, Frank; Jayne, Millard] NIAAA, Lab Neuroimaging, Bethesda, MD USA; [Wang, Gene-Jack; Fowler, Joanna S.; Pradhan, Kith; Logan, Jean; Goldstein, Rita Z.; Alia-Klein, Nelly; Wong, Christopher] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Bethesda, MD USA.	nvolkow@nida.nih.gov	Tomasi, Dardo/J-2127-2015; Alia-Klein, Nelly/C-3154-2013	Logan, Jean/0000-0002-6993-9994	National Institutes of Health; Department of Energy (DOE) [DE-AC01-76CH00016]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy (DOE)(United States Department of Energy (DOE)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Research was supported by the National Institutes of Health Intramural Research Program (NIAAA) and by the Department of Energy (DOE) (DE-AC01-76CH00016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALSTER RL, 1973, J EXP ANAL BEHAV, V20, P119, DOI 10.1901/jeab.1973.20-119; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Castells X, 2007, ADDICTION, V102, P1871, DOI 10.1111/j.1360-0443.2007.01943.x; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Collins SL, 2006, DRUG ALCOHOL DEPEN, V82, P158, DOI 10.1016/j.drugalcdep.2005.09.003; Di Ciano P, 2004, J NEUROSCI, V24, P7167, DOI 10.1523/JNEUROSCI.1581-04.2004; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dols M, 2000, ADDICT BEHAV, V25, P103, DOI 10.1016/S0306-4603(98)00115-4; Duncan E, 2007, AM J ADDICTION, V16, P174, DOI 10.1080/10550490701375285; Ferrario CR, 2008, BRAIN RES, V1209, P151, DOI 10.1016/j.brainres.2008.02.081; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Grace AA, 2000, ADDICTION, V95, pS119; GRACE AA, 1995, DRUG ALCOHOL DEPEN, V37, P111, DOI 10.1016/0376-8716(94)01066-T; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Kampman KM, 2002, ADDICT BEHAV, V27, P251, DOI 10.1016/S0306-4603(01)00171-X; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Kiyatkin EA, 1996, NEUROSCI LETT, V211, P73, DOI 10.1016/0304-3940(96)12731-2; Knapp CM, 2002, BRAIN RES, V950, P119, DOI 10.1016/S0006-8993(02)03011-1; KOOB GF, 1988, SCIENCE, V242, P715, DOI 10.1126/science.2903550; Martinez D, 2009, AM J PSYCHIAT, V166, P1170, DOI 10.1176/appi.ajp.2009.08121801; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Moeller SJ, 2010, BRAIN, V133, P1484, DOI 10.1093/brain/awq066; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Stuber GD, 2005, NEUROPSYCHOPHARMACOL, V30, P853, DOI 10.1038/sj.npp.1300619; TIFFANY ST, 1993, DRUG ALCOHOL DEPEN, V34, P19, DOI 10.1016/0376-8716(93)90042-O; Vadhan NP, 2007, AM J DRUG ALCOHOL AB, V33, P727, DOI 10.1080/00952990701523722; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volkow ND, 1999, AM J PSYCHIAT, V156, P19, DOI 10.1176/ajp.156.1.19; Volkow ND, 1999, J PHARMACOL EXP THER, V291, P409; Volkow ND, 2003, AM J PSYCHIAT, V160, P1909, DOI 10.1176/appi.ajp.160.11.1909; Volkow ND, 2008, NEUROIMAGE, V39, P1266, DOI 10.1016/j.neuroimage.2007.09.059; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Volkow ND, 2010, NEUROIMAGE, V49, P2536, DOI 10.1016/j.neuroimage.2009.10.088; Volkow ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002017; Wanat Matthew J, 2009, Curr Drug Abuse Rev, V2, P195; Wang GJ, 1999, LIFE SCI, V64, P775, DOI 10.1016/S0024-3205(98)00619-5; WANG GJ, 1993, RADIOLOGY, V186, P59, DOI 10.1148/radiology.186.1.8416587; Weiss F, 2000, P NATL ACAD SCI USA, V97, P4321, DOI 10.1073/pnas.97.8.4321; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wong DF, 2006, NEUROPSYCHOPHARMACOL, V31, P2716, DOI 10.1038/sj.npp.1301194	46	40	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11509	10.1371/journal.pone.0011509	http://dx.doi.org/10.1371/journal.pone.0011509			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634975	Green Submitted, gold, Green Published			2022-12-27	WOS:000279715300020
J	Plager, DA; Kahl, JC; Asmann, YW; Nilson, AE; Pallanch, JF; Friedman, O; Kita, H				Plager, Douglas A.; Kahl, Jane C.; Asmann, Yan W.; Nilson, Allan E.; Pallanch, John F.; Friedman, Oren; Kita, Hirohito			Gene Transcription Changes in Asthmatic Chronic Rhinosinusitis with Nasal Polyps and Comparison to Those in Atopic Dermatitis	PLOS ONE			English	Article							INCREASED EXPRESSION; ALLERGIC RHINITIS; CYTOKINE; CELLS; DIFFERENTIATION; INFLAMMATION; EOSINOPHILS; RECRUITMENT; HEALTH; IL-33	Background: Asthmatic chronic rhinosinusitis with nasal polyps (aCRSwNP) is a common disruptive eosinophilic disease without effective medical treatment. Therefore, we sought to identify gene expression changes, particularly those occurring early, in aCRSwNP. To highlight expression changes associated with eosinophilic epithelial inflammation, we further compared the changes in aCRSwNP with those in a second eosinophilic epithelial disease, atopic dermatitis (AD), which is also closely related to asthma. Methods/Principal Findings: Genome-wide mRNA levels measured by exon array in both nasosinus inflamed mucosa and adjacent polyp from 11 aCRSwNP patients were compared to those in nasosinus tissue from 17 normal or rhinitis subjects without polyps. Differential expression of selected genes was confirmed by qRT-PCR or immunoassay, and transcription changes common to AD were identified. Comparison of aCRSwNP inflamed mucosa and polyp to normal/rhinitis tissue identified 447 differentially transcribed genes at $2 fold-change and adjusted p-value, 0.05. These included increased transcription of chemokines localized to chromosome 17q11.2 (CCL13, CCL2, CCL8, and CCL11) that favor eosinophil and monocyte chemotaxis and chemokines (CCL18, CCL22, and CXCL13) that alternatively-activated monocyte-derived cells have been shown to produce. Additional transcription changes likely associated with Th2-like eosinophilic inflammation were prominent and included increased IL1RL1 (IL33 receptor) and EMR1&3 and decreased CRISP2&3. A down-regulated PDGFB-centric network involving several smooth muscle-associated genes was also implicated. Genes at 17q11.2, genes associated with alternative activation or smooth muscle, and the IL1RL1 gene were also differentially transcribed in AD. Conclusions/Significance: Our data implicate several genes or gene sets in aCRSwNP and eosinophilic epithelial inflammation, some that likely act in the earlier stages of inflammation. The identified gene expression changes provide additional diagnostic and therapeutic targets for aCRSwNP and other eosinophilic epithelial diseases.	[Plager, Douglas A.; Nilson, Allan E.; Kita, Hirohito] Mayo Clin, Allerg Dis Res Lab, Rochester, MN 55905 USA; [Kahl, Jane C.; Asmann, Yan W.] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN USA; [Pallanch, John F.; Friedman, Oren] Mayo Clin, Dept Otorhinolaryngol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Plager, DA (corresponding author), Mayo Clin, Allerg Dis Res Lab, Rochester, MN 55905 USA.	plager.douglas@mayo.edu			National Institutes of Health [AI 58208, AI 49235]; Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058208, R01AI049235, R56AI049235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI 58208 and AI 49235 and by the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson LM, 2009, J SEP SCI, V32, P44, DOI 10.1002/jssc.200800474; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Blanchard C, 2008, MUCOSAL IMMUNOL, V1, P289, DOI 10.1038/mi.2008.15; Cherry WB, 2008, J ALLERGY CLIN IMMUN, V121, P1484, DOI 10.1016/j.jaci.2008.04.005; Collins J G, 1997, Vital Health Stat 10, P1; Fritz SB, 2003, J ALLERGY CLIN IMMUN, V112, P1057, DOI 10.1016/j.jaci.2003.09.042; Goetzel RZ, 2003, J OCCUP ENVIRON MED, V45, P5, DOI 10.1097/00043764-200301000-00007; Gros E, 2009, J ALLERGY CLIN IMMUN, V124, P753, DOI 10.1016/j.jaci.2009.07.004; Hamann J, 2007, EUR J IMMUNOL, V37, P2797, DOI 10.1002/eji.200737553; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Huvenne W, 2009, CURR ALLERGY ASTHM R, V9, P213, DOI 10.1007/s11882-009-0031-4; Jacobsen EA, 2008, J EXP MED, V205, P699, DOI 10.1084/jem.20071840; Johnson-Huang LM, 2009, J CLIN IMMUNOL, V29, P247, DOI 10.1007/s10875-009-9278-8; Kin HB, 2009, CHEST, V135, P295, DOI 10.1378/chest.08-0962; KITA H, 2003, BIOL EOSINOPHILS ALL, P305; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Liu Z, 2004, J ALLERGY CLIN IMMUN, V114, P783, DOI 10.1016/j.jaci.2004.04.052; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Plager DA, 2007, EXP DERMATOL, V16, P28, DOI 10.1111/j.1600-0625.2006.00504.x; Pushparaj PN, 2009, P NATL ACAD SCI USA, V106, P9773, DOI 10.1073/pnas.0901206106; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Richer SL, 2008, AM J RHINOL, V22, P228, DOI 10.2500/ajr.2008.22.3162; Rostkowska-Nadolska Beata, 2008, Otolaryngol Pol, V62, P261, DOI 10.1016/S0030-6657(08)70251-8; Saaf AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004017; Smith DE, 2010, CLIN EXP ALLERGY, V40, P200, DOI 10.1111/j.1365-2222.2009.03384.x; Stankovic KM, 2008, LARYNGOSCOPE, V118, P881, DOI 10.1097/MLG.0b013e31816b4b6f; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Taha RA, 2000, J ALLERGY CLIN IMMUN, V105, P1002, DOI 10.1067/mai.2000.106483; Tieu DD, 2009, J ALLERGY CLIN IMMUN, V124, P37, DOI 10.1016/j.jaci.2009.04.045; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Werfel T, 2009, J INVEST DERMATOL, V129, P1878, DOI 10.1038/jid.2009.71; Zou J, 2002, GENOME BIOL, V3	37	58	60	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11450	10.1371/journal.pone.0011450	http://dx.doi.org/10.1371/journal.pone.0011450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625511	Green Submitted, Green Published, gold			2022-12-27	WOS:000279522500017
J	Khatib, AM; Lahlil, R; Scamuffa, N; Akimenko, MA; Ernest, S; Lomri, A; Lalou, C; Seidah, NG; Villoutreix, BO; Calvo, F; Siegfried, G				Khatib, Abdel-Majid; Lahlil, Rachid; Scamuffa, Nathalie; Akimenko, Marie-Andree; Ernest, Sylvain; Lomri, Abdderahim; Lalou, Claude; Seidah, Nabil G.; Villoutreix, Bruno O.; Calvo, Fabien; Siegfried, Geraldine			Zebrafish ProVEGF-C Expression, Proteolytic Processing and Inhibitory Effect of Unprocessed ProVEGF-C during Fin Regeneration	PLOS ONE			English	Article							PROPROTEIN CONVERTASES FURIN; GROWTH-FACTOR; VEGF-C; VASCULAR DEVELOPMENT; CELLS; RECEPTORS; PACE4; PC5	Background: In zebrafish, vascular endothelial growth factor-C precursor (proVEGF-C) processing occurs within the dibasic motif HSIIRR214 suggesting the involvement of one or more basic amino acid-specific proprotein convertases (PCs) in this process. In the present study, we examined zebrafish proVEGF-C expression and processing and the effect of unprocessed proVEGF-C on caudal fin regeneration. Methodology/Principal Findings: Cell transfection assays revealed that the cleavage of proVEGF-C, mainly mediated by the proprotein convertases Furin and PC5 and to a less degree by PACE4 and PC7, is abolished by PCs inhibitors or by mutation of its cleavage site (HSIIRR214 into HSIISS214). In vitro, unprocessed proVEGF-C failed to activate its signaling proteins Akt and ERK and to induce cell proliferation. In vivo, following caudal fin amputation, the induction of VEGF-C, Furin and PC5 expression occurs as early as 2 days post-amputation (dpa) with a maximum levels at 4-7 dpa. Using immunofluorescence staining we localized high expression of VEGF-C and the convertases Furin and PC5 surrounding the apical growth zone of the regenerating fin. While expression of wild-type proVEGF-C in this area had no effect, unprocessed proVEGF-C inhibited fin regeneration. Conclusions/Significances: Taken together, these data indicate that zebrafish fin regeneration is associated with upregulation of VEGF-C and the convertases Furin and PC5 and highlight the inhibitory effect of unprocessed proVEGF-C on fin regeneration.	[Khatib, Abdel-Majid; Lahlil, Rachid; Scamuffa, Nathalie; Lalou, Claude; Calvo, Fabien] Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,UMRS940,Equipe Avenir, Paris, France; [Lahlil, Rachid; Siegfried, Geraldine] INSERM, U770, Le Kremlin Bicetre, France; [Akimenko, Marie-Andree] Ottawa Hlth Res Inst, Ottawa, ON, Canada; [Ernest, Sylvain] Ecole Normale Super, INSERM, U784, F-75231 Paris, France; [Lomri, Abdderahim] Univ Paris 07, Lariboisiere Hosp, INSERM, U606, Paris, France; [Seidah, Nabil G.] IRCM, Clin Res Inst Montreal, Montreal, PQ, Canada; [Villoutreix, Bruno O.] Univ Paris 05, INSERM, U648, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Ottawa; Ottawa Hospital Research Institute; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Khatib, AM (corresponding author), Univ Paris 07, Hop St Louis, Inst Genet Mol, INSERM,UMRS940,Equipe Avenir, Paris, France.	geraldine.siegfried@inserm.fr	Villoutreix, Bruno/I-4565-2015; Lahlil, Rachid/AAK-1654-2020; Seidah, Nabil/I-3596-2013; Siegfried, Géraldine/N-6017-2018; KHATIB, Abdel-Majid/A-9948-2015; Ernest, Sylvain/C-5513-2011	Villoutreix, Bruno/0000-0002-6456-7730; Seidah, Nabil/0000-0001-6503-9342; KHATIB, Abdel-Majid/0000-0001-6957-0384; Ernest, Sylvain/0000-0001-5382-5338; siegfried, geraldine/0000-0002-6346-5206; calvo, fabien/0000-0002-0298-7633; LALOU, Claude/0000-0002-5271-7439; Lahlil, Rachid/0000-0003-2966-6386; Lomri, Abderrahim/0000-0001-9847-026X	Institut national du cancer (INCA)	Institut national du cancer (INCA)(Institut National du Cancer (INCA) France)	This work was supported by Institut national du cancer (INCA) to AMK, BV and GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimenko MA, 2003, DEV DYNAM, V226, P190, DOI 10.1002/dvdy.10248; Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; BASAK A, NOVEL ENEDIYNYL PEPT; Bergeron E, 2003, BIOCHEM J, V373, P475, DOI 10.1042/BJ20021630; Bontemps Y, 2007, MED RES REV, V27, P631, DOI 10.1002/med.20072; Cao J, 2005, J BIOL CHEM, V280, P10974, DOI 10.1074/jbc.M412370200; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; DRIEVER W, 1993, IN VITRO CELL DEV-AN, V29, P749; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Eyries M, 2008, CIRC RES, V103, P432, DOI 10.1161/CIRCRESAHA.108.179333; Fukumoto S, 2005, THER APHER DIAL, V9, P319, DOI 10.1111/j.1744-9987.2005.00289.x; Huang HY, 2001, LAB INVEST, V81, P1729, DOI 10.1038/labinvest.3780386; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Jin WJ, 2005, J BIOL CHEM, V280, P36551, DOI 10.1074/jbc.M502264200; Johnson SL, 1999, METHOD CELL BIOL, V59, P301; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Karkkainen MJ, 2002, NAT CELL BIOL, V4, pE2, DOI 10.1038/ncb0102-e2; Khatib AM, 2001, J BIOL CHEM, V276, P30686, DOI 10.1074/jbc.M101725200; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lalou C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009992; Lapierre M, 2007, CANCER RES, V67, P9030, DOI 10.1158/0008-5472.CAN-07-0807; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lymboussaki A, 1999, CIRC RES, V85, P992; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Pepper MS, 1998, J CELL PHYSIOL, V177, P439, DOI 10.1002/(SICI)1097-4652(199812)177:3<439::AID-JCP7>3.0.CO;2-2; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Raya A, 2004, CLONING STEM CELLS, V6, P345, DOI 10.1089/clo.2004.6.345; Scamuffa N, 2008, GUT, V57, P1573, DOI 10.1136/gut.2007.141812; Scamuffa N, 2008, J CLIN INVEST, V118, P352, DOI 10.1172/JCI32040; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; TAKAHASHI S, 1993, BIOCHEM BIOPH RES CO, V195, P1019, DOI 10.1006/bbrc.1993.2146; ZHENG M, 1994, J NEUROSCI, V14, P4656	39	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11438	10.1371/journal.pone.0011438	http://dx.doi.org/10.1371/journal.pone.0011438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625388	Green Published, Green Submitted, gold			2022-12-27	WOS:000279465700018
J	Wu, B; Zhou, D; Fu, F; Luo, QJ; Wang, L; Traulsen, A				Wu, Bin; Zhou, Da; Fu, Feng; Luo, Qingjun; Wang, Long; Traulsen, Arne			Evolution of Cooperation on Stochastic Dynamical Networks	PLOS ONE			English	Article							DIRECT RECIPROCITY; PRISONERS-DILEMMA; GAMES; INDIVIDUALS; BEHAVIOR	Cooperative behavior that increases the fitness of others at a cost to oneself can be promoted by natural selection only in the presence of an additional mechanism. One such mechanism is based on population structure, which can lead to clustering of cooperating agents. Recently, the focus has turned to complex dynamical population structures such as social networks, where the nodes represent individuals and links represent social relationships. We investigate how the dynamics of a social network can change the level of cooperation in the network. Individuals either update their strategies by imitating their partners or adjust their social ties. For the dynamics of the network structure, a random link is selected and breaks with a probability determined by the adjacent individuals. Once it is broken, a new one is established. This linking dynamics can be conveniently characterized by a Markov chain in the configuration space of an ever-changing network of interacting agents. Our model can be analytically solved provided the dynamics of links proceeds much faster than the dynamics of strategies. This leads to a simple rule for the evolution of cooperation: The more fragile links between cooperating players and non-cooperating players are (or the more robust links between cooperators are), the more likely cooperation prevails. Our approach may pave the way for analytically investigating coevolution of strategy and structure.	[Wu, Bin; Wang, Long] Peking Univ, Ctr Syst & Control, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China; [Wu, Bin; Traulsen, Arne] Max Planck Inst Evolutionary Biol, Emmy Noether Grp Evolutionary Dynam, Plon, Germany; [Zhou, Da] Peking Univ, Sch Math Sci, Beijing 100871, Peoples R China; [Fu, Feng] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Luo, Qingjun] Peking Univ, Sch Elect Engn & Comp Sci, Beijing 100871, Peoples R China	Peking University; Max Planck Society; Peking University; Harvard University; Peking University	Wu, B (corresponding author), Peking Univ, Ctr Syst & Control, State Key Lab Turbulence & Complex Syst, Coll Engn, Beijing 100871, Peoples R China.	bin.wu@evolbio.mpg.de	Wang, Long/A-7798-2010; Traulsen, Arne/A-4955-2009; Gao, Y./GWZ-3665-2022; Fu, Feng/R-3686-2017; Fu, Feng/A-3376-2009	Wang, Long/0000-0001-5600-8157; Traulsen, Arne/0000-0002-0669-5267; Fu, Feng/0000-0001-8252-1990; Fu, Feng/0000-0001-8252-1990; Zhou, Da/0000-0002-0272-6644	China Scholarship Council [2009601286]; Natural Science Foundation of China [10625101]; 973 Fund [2006CB805900]; National Natural Science Foundation of China [10972002, 60736022]; Deutsche Forschungsgemeinschaft	China Scholarship Council(China Scholarship Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Fund(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	B.W. gratefully acknowledges the financial support from China Scholarship Council (2009601286). D.Z. acknowledges support by the Natural Science Foundation of China (10625101) and 973 Fund (2006CB805900). L.W. acknowledges support by the National Natural Science Foundation of China (10972002 and 60736022). A.T. acknowledges support by the Emmy-Noether program of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Biely C, 2007, PHYSICA D, V228, P40, DOI 10.1016/j.physd.2007.02.004; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Bshary R, 2005, BIOL LETTERS, V1, P396, DOI 10.1098/rsbl.2005.0344; Chen XJ, 2008, PHYSICA A, V387, P5609, DOI 10.1016/j.physa.2008.05.043; DO AL, 2009, NEW J PHYS IN PRESS; EBEL H, 2002, CONDMAT0211666; Fu F, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.016104; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hanaki N, 2007, MANAGE SCI, V53, P1036, DOI 10.1287/mnsc.1060.0625; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Karlin S., 1975, 1 COURSE STOCHASTIC, V2; Levin SA, 2009, SPRINGER SER GAME TH, P1, DOI 10.1007/978-3-540-85436-4; LINDGREN K, 1994, PHYSICA D, V75, P292, DOI 10.1016/0167-2789(94)90289-5; Maynard Smith J., 1982, pi; NASH JF, 1950, P NATL ACAD SCI USA, V36, P48, DOI 10.1073/pnas.36.1.48; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2010, PHILOS T R SOC B, V365, P19, DOI 10.1098/rstb.2009.0215; Ohtsuki H, 2007, J THEOR BIOL, V247, P462, DOI 10.1016/j.jtbi.2007.03.018; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2008, J THEOR BIOL, V250, P723, DOI 10.1016/j.jtbi.2007.10.040; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Pacheco JM, 2006, J THEOR BIOL, V243, P437, DOI 10.1016/j.jtbi.2006.06.027; Perc M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022101; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; SEGBROECK SV, 2009, PHYS REV LETT, V102; Sigmund K., 2010, CALCULUS SELFISHNESS; Skyrms B, 2000, P NATL ACAD SCI USA, V97, P9340, DOI 10.1073/pnas.97.16.9340; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Taylor C, 2007, EVOLUTION, V61, P2281, DOI 10.1111/j.1558-5646.2007.00196.x; Tomassini M, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016132; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2010, EVOLUTION, V64, P316, DOI 10.1111/j.1558-5646.2009.00899.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Segbroeck S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-287; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143; Zimmermann MG, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056118; ZSCHALER G, 2009, ARXIV09100940	52	135	140	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11187	10.1371/journal.pone.0011187	http://dx.doi.org/10.1371/journal.pone.0011187			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614025	gold, Green Published, Green Submitted			2022-12-27	WOS:000279370000003
J	Nonaka, E; Ebel, GD; Wearing, HJ				Nonaka, Etsuko; Ebel, Gregory D.; Wearing, Helen J.			Persistence of Pathogens with Short Infectious Periods in Seasonal Tick Populations: The Relative Importance of Three Transmission Routes	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; LYME-DISEASE SPIROCHETE; CO-FEEDING TRANSMISSION; IXODES-SCAPULARIS; POWASSAN VIRUS; UNITED-STATES; DEER TICKS; DYNAMICS; ECOLOGY; HOST	Background: The flaviviruses causing tick-borne encephalitis (TBE) persist at low but consistent levels in tick populations, despite short infectious periods in their mammalian hosts and transmission periods constrained by distinctly seasonal tick life cycles. In addition to systemic and vertical transmission, cofeeding transmission has been proposed as an important route for the persistence of TBE-causing viruses. Because cofeeding transmission requires ticks to feed simultaneously, the timing of tick activity may be critical to pathogen persistence. Existing models of tick-borne diseases do not incorporate all transmission routes and tick seasonality. Our aim is to evaluate the influence of seasonality on the relative importance of different transmission routes by using a comprehensive mathematical model. Methodology/Principal Findings: We developed a stage-structured population model that includes tick seasonality and evaluated the relative importance of the transmission routes for pathogens with short infectious periods, in particular Powassan virus (POWV) and the related "deer tick virus,'' emergent encephalitis-causing flaviviruses in North America. We used the next generation matrix method to calculate the basic reproductive ratio and performed elasticity analyses. We confirmed that cofeeding transmission is critically important for such pathogens to persist in seasonal tick populations over the reasonable range of parameter values. At higher but still plausible rates of vertical transmission, our model suggests that vertical transmission can strongly enhance pathogen prevalence when it operates in combination with cofeeding transmission. Conclusions/Significance: Our results demonstrate that the consistent prevalence of POWV observed in tick populations could be maintained by a combination of low vertical, intermediate cofeeding and high systemic transmission rates. When vertical transmission is weak, nymphal ticks support integral parts of the transmission cycle that are critical for maintaining the pathogen. We also extended the model to pathogens that cause chronic infections in hosts and found that cofeeding transmission could contribute to elevating prevalence even in these systems. Therefore, the common assumption that cofeeding transmission is not relevant in models of chronic host infection, such as Lyme disease, could lead to underestimating pathogen prevalence.	[Nonaka, Etsuko; Wearing, Helen J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Nonaka, Etsuko; Wearing, Helen J.] Univ New Mexico, Dept Math & Stat, Albuquerque, NM 87131 USA; [Ebel, Gregory D.] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico; University of New Mexico	Nonaka, E (corresponding author), Umea Univ, IceLab, Umea, Sweden.	enonaka@unm.edu	Ebel, Gregory/ABG-1052-2021; Ebel, Gregory/D-8324-2017; Nonaka, Etsuko/J-7395-2019	Nonaka, Etsuko/0000-0001-6563-2840; Wearing, Helen/0000-0002-9837-9797	University of New Mexico; National Institute of Allergy and Infectious Disease, National Institutes of Health [AI067380]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067380] Funding Source: NIH RePORTER	University of New Mexico; National Institute of Allergy and Infectious Disease, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the University of New Mexico Graduate Assistantship to EN and facilitated by start-up funds from the University of New Mexico to HJW. GDE contributions to this work were supported in part by funds from the National Institute of Allergy and Infectious Disease, National Institutes of Health, under grant AI067380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTSOB H, 1989, ARBOVIRUSES EPIDEMIO, V4, P29; Brackney DE, 2008, AM J TROP MED HYG, V79, P971, DOI 10.4269/ajtmh.2008.79.971; Caswell H., 2006, MATRIX POPULATION MO; Costero A, 1996, AM J TROP MED HYG, V55, P536, DOI 10.4269/ajtmh.1996.55.536; Danielova V, 2002, FOLIA PARASIT, V49, P323, DOI 10.14411/fp.2002.060; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195; Ebel GD, 2004, AM J TROP MED HYG, V71, P268, DOI 10.4269/ajtmh.2004.71.3.0700268; Ebel GD, 1999, EMERG INFECT DIS, V5, P570, DOI 10.3201/eid0504.990423; Ebel GD, 2010, ANNU REV ENTOMOL, V55, P95, DOI 10.1146/annurev-ento-112408-085446; Fukunaga M, 2000, J PARASITOL, V86, P38, DOI 10.1645/0022-3395(2000)086[0038:MPAOIT]2.0.CO;2; Goodwin BJ, 2001, VECTOR-BORNE ZOONOT, V1, P129, DOI 10.1089/153036601316977732; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Hartemink NA, 2008, AM NAT, V171, P743, DOI 10.1086/587530; Hinten SR, 2008, VECTOR-BORNE ZOONOT, V8, P733, DOI 10.1089/vbz.2008.0022; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; Kaiser R, 2008, INFECT DIS CLIN N AM, V22, P561, DOI 10.1016/j.idc.2008.03.013; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Lewellen RH, 1998, ECOL MONOGR, V68, P571, DOI 10.1890/0012-9615(1998)068[0571:TEODDA]2.0.CO;2; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Matser A, 2009, ECOL LETT, V12, P1298, DOI 10.1111/j.1461-0248.2009.01378.x; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden NH, 1997, PARASITOLOGY, V115, P591, DOI 10.1017/S0031182097001868; Ostfeld RS, 1996, J MAMMAL, V77, P266, DOI 10.2307/1382727; Ostfeld RS, 1996, J MED ENTOMOL, V33, P90, DOI 10.1093/jmedent/33.1.90; Ostfeld RS, 2000, CONSERV BIOL, V14, P722, DOI 10.1046/j.1523-1739.2000.99014.x; PIESMAN J, 1979, J MED ENTOMOL, V15, P537, DOI 10.1093/jmedent/15.5-6.537; PROCO TC, 1999, IMA J MATH APPL MED, V261, P296; Randolph S, 2003, EMERG INFECT DIS, V9, P893; Randolph S, 2002, INT J MED MICROBIOL, V291, P6, DOI 10.1016/S1438-4221(02)80002-9; Randolph S.E., 2002, P119; RANDOLPH SE, 1995, J MED ENTOMOL, V32, P765, DOI 10.1093/jmedent/32.6.765; Randolph SE, 2002, INT J PARASITOL, V32, P979, DOI 10.1016/S0020-7519(02)00030-9; Randolph SE, 1996, PARASITOL TODAY, V12, P472, DOI 10.1016/S0169-4758(96)10072-7; Randolph SE, 2004, PARASITOLOGY, V129, pS37, DOI 10.1017/S0031182004004925; Randolph SE, 2000, PARASITOLOGY, V121, P15, DOI 10.1017/S0031182099006083; Randolph SE, 2000, P ROY SOC B-BIOL SCI, V267, P1741, DOI 10.1098/rspb.2000.1204; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Richter D, 2003, EMERG INFECT DIS, V9, P895; Richter D, 2002, EMERG INFECT DIS, V8, P1421, DOI 10.3201/eid0812.010519; Rosa R, 2003, J THEOR BIOL, V224, P359, DOI 10.1016/S0022-5193(03)00173-5; Rosa R, 2007, MATH BIOSCI, V208, P216, DOI 10.1016/j.mbs.2006.10.002; SANDBERG S, 1992, J THEOR BIOL, V157, P203, DOI 10.1016/S0022-5193(05)80621-6; Schauber EM, 2002, ECOL APPL, V12, P1142, DOI 10.1890/1051-0761(2002)012[1142:MTEORC]2.0.CO;2; Sumilo D, 2008, REV MED VIROL, V18, P81, DOI 10.1002/rmv.566; Suss J, 2008, EUROSURVEILLANCE, V13, P1; Tavakoli NP, 2009, NEW ENGL J MED, V360, P2099, DOI 10.1056/NEJMoa0806326; TELFORD SR, 1988, AM J TROP MED HYG, V39, P105, DOI 10.4269/ajtmh.1988.39.105; Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209	50	29	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11745	10.1371/journal.pone.0011745	http://dx.doi.org/10.1371/journal.pone.0011745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668521	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243800018
J	Ilc, G; Giachin, G; Jaremko, M; Jaremko, L; Benetti, F; Plavec, J; Zhukov, I; Legname, G				Ilc, Gregor; Giachin, Gabriele; Jaremko, Mariusz; Jaremko, Lukasz; Benetti, Federico; Plavec, Janez; Zhukov, Igor; Legname, Giuseppe			NMR Structure of the Human Prion Protein with the Pathological Q212P Mutation Reveals Unique Structural Features	PLOS ONE			English	Article							STRAUSSLER-SCHEINKER-DISEASE; RESIDUAL DIPOLAR COUPLINGS; TORSION ANGLE DYNAMICS; TRANSGENIC MICE; THERMODYNAMIC STABILITY; PRP; SYSTEM; NEURODEGENERATION; CRYSTALLOGRAPHY; CONVERSION	Prion diseases are fatal neurodegenerative disorders caused by an aberrant accumulation of the misfolded cellular prion protein (PrPC) conformer, denoted as infectious scrapie isoform or PrPSc. In inherited human prion diseases, mutations in the open reading frame of the PrP gene (PRNP) are hypothesized to favor spontaneous generation of PrPSc in specific brain regions leading to neuronal cell degeneration and death. Here, we describe the NMR solution structure of the truncated recombinant human PrP from residue 90 to 231 carrying the Q212P mutation, which is believed to cause Gerstmann-Straussler-Scheinker (GSS) syndrome, a familial prion disease. The secondary structure of the Q212P mutant consists of a flexible disordered tail (residues 90-124) and a globular domain (residues 125-231). The substitution of a glutamine by a proline at the position 212 introduces novel structural differences in comparison to the known wild-type PrP structures. The most remarkable differences involve the C-terminal end of the protein and the beta(2)-alpha(2) loop region. This structure might provide new insights into the early events of conformational transition of PrPC into PrPSc. Indeed, the spontaneous formation of prions in familial cases might be due to the disruptions of the hydrophobic core consisting of beta(2)-alpha(2) loop and alpha(3) helix.	[Ilc, Gregor; Plavec, Janez; Zhukov, Igor] Natl Inst Chem, Slovenian NMR Ctr, Ljubljana, Slovenia; [Giachin, Gabriele; Benetti, Federico; Legname, Giuseppe] SISSA, Lab Prion Biol, Neurobiol Sect, Trieste, Italy; [Jaremko, Mariusz; Jaremko, Lukasz; Zhukov, Igor] Polish Acad Sci, Inst Biochem & Biophys, Lab Biol NMR, Warsaw, Poland; [Jaremko, Lukasz] Warsaw Univ, Fac Chem, Warsaw, Poland; [Benetti, Federico; Legname, Giuseppe] Italian Inst Technol, SISSA Unit, Trieste, Italy; [Plavec, Janez] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana, Slovenia; [Legname, Giuseppe] Sincrotrone Trieste SCpA, ELETTRA Lab, Trieste, Italy	National Institute of Chemistry - Slovenia; International School for Advanced Studies (SISSA); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT; University of Ljubljana; Elettra Sincrotrone Trieste	Ilc, G (corresponding author), Natl Inst Chem, Slovenian NMR Ctr, Ljubljana, Slovenia.	janez.plavec@ki.si; legname@sissa.it	Jaremko, Lukasz/A-3101-2009; Legname, Giuseppe/C-1723-2012; Giachin, Gabriele/AAE-2348-2020; Jaremko, Lukasz/GQB-5017-2022; Zhukov, Igor/J-4069-2015	Jaremko, Lukasz/0000-0001-7684-9359; Legname, Giuseppe/0000-0003-0716-4393; Giachin, Gabriele/0000-0001-7550-0307; Jaremko, Mariusz/0000-0002-0787-702X; Benetti, Federico/0000-0001-6491-4715; Zhukov, Igor/0000-0002-9912-1018	European Community [222887]	European Community(European Commission)	The research leading to presented results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n. 222887 - the PRIORITY project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dossena S, 2008, NEURON, V60, P598, DOI 10.1016/j.neuron.2008.09.008; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; Goddard T. D., SPARKY 3; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hornemann S, 2009, J BIOL CHEM, V284, P22713, DOI 10.1074/jbc.M109.000430; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HSIAO KK, 1990, SCIENCE, V250, P1587, DOI 10.1126/science.1980379; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Keller R., 2004, COMPUTER AIDED RESON, V1; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee S, 2010, EMBO J, V29, P251, DOI 10.1038/emboj.2009.333; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P140; Liberski Pawel P, 2004, Folia Neuropathol, V42 Suppl B, P120; Liemann S, 1999, BIOCHEMISTRY-US, V38, P3258, DOI 10.1021/bi982714g; Lipsitz RS, 2004, ANNU REV BIOPH BIOM, V33, P387, DOI 10.1146/annurev.biophys.33.110502.140306; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; Mishra RS, 2003, J ALZHEIMERS DIS, V5, P15, DOI 10.3233/JAD-2003-5103; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piccardo P, 1998, J NEUROPATH EXP NEUR, V57, P979, DOI 10.1097/00005072-199810000-00010; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Swietnicki W, 1998, J BIOL CHEM, V273, P31048, DOI 10.1074/jbc.273.47.31048; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Vanik DL, 2002, J BIOL CHEM, V277, P49065, DOI 10.1074/jbc.M207511200; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wopfner F, 1999, J MOL BIOL, V289, P1163, DOI 10.1006/jmbi.1999.2831; Yao LS, 2009, J BIOMOL NMR, V43, P161, DOI 10.1007/s10858-009-9299-x; Young K, 1998, J NEUROPATH EXP NEUR, V57, P518, DOI 10.1097/00005072-199805000-00213; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	59	62	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11715	10.1371/journal.pone.0011715	http://dx.doi.org/10.1371/journal.pone.0011715			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661422	Green Submitted, gold, Green Published			2022-12-27	WOS:000280243300017
J	Yang, RL; Su, B				Yang, Ruolin; Su, Bing			Characterization and Comparison of the Tissue-Related Modules in Human and Mouse	PLOS ONE			English	Article							GENE-EXPRESSION DATA; EVOLUTIONARY RATE; SACCHAROMYCES-CEREVISIAE; ULTRACONSERVED ELEMENTS; MOLECULAR EVOLUTION; METABOLIC NETWORK; TRANSCRIPTION; PATTERNS; RATES; ORGANIZATION	Background: Due to the advances of high throughput technology and data-collection approaches, we are now in an unprecedented position to understand the evolution of organisms. Great efforts have characterized many individual genes responsible for the interspecies divergence, yet little is known about the genome-wide divergence at a higher level. Modules, serving as the building blocks and operational units of biological systems, provide more information than individual genes. Hence, the comparative analysis between species at the module level would shed more light on the mechanisms underlying the evolution of organisms than the traditional comparative genomics approaches. Results: We systematically identified the tissue-related modules using the iterative signature algorithm (ISA), and we detected 52 and 65 modules in the human and mouse genomes, respectively. The gene expression patterns indicate that all of these predicted modules have a high possibility of serving as real biological modules. In addition, we defined a novel quantity, "total constraint intensity,'' a proxy of multiple constraints (of co-regulated genes and tissues where the co-regulation occurs) on the evolution of genes in module context. We demonstrate that the evolutionary rate of a gene is negatively correlated with its total constraint intensity. Furthermore, there are modules coding the same essential biological processes, while their gene contents have diverged extensively between human and mouse. Conclusions: Our results suggest that unlike the composition of module, which exhibits a great difference between human and mouse, the functional organization of the corresponding modules may evolve in a more conservative manner. Most importantly, our findings imply that similar biological processes can be carried out by different sets of genes from human and mouse, therefore, the functional data of individual genes from mouse may not apply to human in certain occasions.	[Yang, Ruolin; Su, Bing] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Yang, Ruolin; Su, Bing] Chinese Acad Sci, Kunming Primate Res Ctr, Kunming, Peoples R China; [Yang, Ruolin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, RL (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	sub@mail.kiz.ac.cn		Yang, Ruolin/0000-0001-6241-6317	National 973 project of China [2007CB947701, 2007CB815705]; Chinese Academy of Sciences [KSCX1-YW-R-34]; National Natural Science Foundation of China [30700445, 30630013, 30771181]; Natural Science Foundation of Yunnan Province of China [2009CD107065]	National 973 project of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province of China(Natural Science Foundation of Yunnan Province)	This study was supported by grants from the National 973 project of China (2007CB947701, 2007CB815705), the Chinese Academy of Sciences (KSCX1-YW-R-34, Westlight Doctoral Program), the National Natural Science Foundation of China (30700445, 30630013 and 30771181), and the Natural Science Foundation of Yunnan Province of China (2009CD107065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; CHARTRAND G, 2005, INTRO GRAPH THEORY, pR12; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P859; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fraser HB, 2005, NAT GENET, V37, P351, DOI 10.1038/ng1530; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Glasner ME, 2002, BIOCHEMISTRY-US, V41, P8103, DOI 10.1021/bi012179b; Glazov EA, 2005, GENOME RES, V15, P800, DOI 10.1101/gr.3545105; Guan YF, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000165; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Liao BY, 2006, MOL BIOL EVOL, V23, P1119, DOI 10.1093/molbev/msj119; Liao BY, 2006, MOL BIOL EVOL, V23, P2072, DOI 10.1093/molbev/msl076; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; PAMILO P, 1993, MOL BIOL EVOL, V10, P271; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Ramsay H, 2009, MOL BIOL EVOL, V26, P1045, DOI 10.1093/molbev/msp021; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsaparas P, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-70; Wang YQ, 2004, HUM MOL GENET, V13, P1131, DOI 10.1093/hmg/ddh127; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; YANG ZH, 1995, GENETICS, V141, P1641; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	54	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11730	10.1371/journal.pone.0011730	http://dx.doi.org/10.1371/journal.pone.0011730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661448	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243300028
J	Beby, F; Housset, M; Fossat, N; Le Greneur, C; Flamant, F; Godement, P; Lamonerie, T				Beby, Francis; Housset, Michael; Fossat, Nicolas; Le Greneur, Coralie; Flamant, Frederic; Godement, Pierre; Lamonerie, Thomas			Otx2 Gene Deletion in Adult Mouse Retina Induces Rapid RPE Dystrophy and Slow Photoreceptor Degeneration	PLOS ONE			English	Article							PIGMENT-EPITHELIUM; TRANSCRIPTION FACTOR; EXPRESSION; MICE; MIDBRAIN; REVEALS; PROTEIN; CELLS; RETINOBLASTOMA; KNOCKOUT	Background: Many developmental genes are still active in specific tissues after development is completed. This is the case for the homeobox gene Otx2, an essential actor of forebrain and head development. In adult mouse, Otx2 is strongly expressed in the retina. Mutations of this gene in humans have been linked to severe ocular malformation and retinal diseases. It is, therefore, important to explore its post-developmental functions. In the mature retina, Otx2 is expressed in three cell types: bipolar and photoreceptor cells that belong to the neural retina and retinal pigment epithelium (RPE), a neighbour structure that forms a tightly interdependent functional unit together with photoreceptor cells. Methodology/Principal Findings: Conditional self-knockout was used to address the late functions of Otx2 gene in adult mice. This strategy is based on the combination of a knock-in CreERT2 allele and a floxed allele at the Otx2 locus. Time-controlled injection of tamoxifen activates the recombinase only in Otx2 expressing cells, resulting in selective ablation of the gene in its entire domain of expression. In the adult retina, loss of Otx2 protein causes slow degeneration of photoreceptor cells. By contrast, dramatic changes of RPE activity rapidly occur, which may represent a primary cause of photoreceptor disease. Conclusions: Our novel mouse model uncovers new Otx2 functions in adult retina. We show that this transcription factor is necessary for long-term maintenance of photoreceptors, likely through the control of specific activities of the RPE.	[Beby, Francis; Le Greneur, Coralie; Flamant, Frederic; Godement, Pierre; Lamonerie, Thomas] Univ Lyon, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,Inst Natl Rech Agron, Lyon, France; [Housset, Michael; Le Greneur, Coralie; Lamonerie, Thomas] Univ Nice Sophia Antipolis, CNRS, Inst Biol Dev & Canc, Nice, France; [Fossat, Nicolas] Univ Sydney, Sydney Med Sch, Childrens Med Res Inst, Embryol Unit, Wentworthville, Australia	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Children's Medical Research Institute - Australia; University of Sydney	Beby, F (corresponding author), Univ Lyon, CNRS, Ecole Normale Super Lyon, Inst Genom Fonct Lyon,Inst Natl Rech Agron, Lyon, France.	lamonerie@unice.fr		Lamonerie, Thomas/0000-0003-2371-2708	Centre National de la Recherche Scientifique; Retina France	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Retina France	This work was supported by a Centre National de la Recherche Scientifique grant to FF and TL and a Retina France grant to TL. NF was supported by a fellowship from Retina France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3; Bok D, 2007, ARCH OPHTHALMOL-CHIC, V125, P160, DOI 10.1001/archopht.125.2.160; Bonilha VL, 2006, EXP EYE RES, V82, P720, DOI 10.1016/j.exer.2005.09.013; Boulton M, 2001, EYE, V15, P384, DOI 10.1038/eye.2001.141; Chatelain G, 2006, J MOL MED, V84, P604, DOI 10.1007/s00109-006-0048-2; CHELSKY D, 1989, MOL CELL BIOL, V9, P2487, DOI 10.1128/MCB.9.6.2487; Courtois V, 2003, J NEUROCHEM, V84, P840, DOI 10.1046/j.1471-4159.2003.01583.x; EISENFELD AJ, 1984, INVEST OPHTH VIS SCI, V25, P1321; Fong SL, 1999, CURR EYE RES, V18, P283, DOI 10.1076/ceyr.18.4.283.5360; Fossat N, 2005, DEV DYNAM, V233, P154, DOI 10.1002/dvdy.20287; Fossat N, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-122; Fossat N, 2006, EMBO REP, V7, P824, DOI 10.1038/sj.embor.7400751; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Glubrecht DD, 2009, J NEUROCHEM, V111, P250, DOI 10.1111/j.1471-4159.2009.06322.x; Kim DS, 2008, J NEUROSCI, V28, P7748, DOI 10.1523/JNEUROSCI.0397-08.2008; Koike C, 2007, MOL CELL BIOL, V27, P8318, DOI 10.1128/MCB.01209-07; Kurokawa D, 2004, DEVELOPMENT, V131, P3319, DOI 10.1242/dev.01220; Kurokawa D, 2004, DEVELOPMENT, V131, P3307, DOI 10.1242/dev.01219; Lavado A, 2006, FRONT BIOSCI-LANDMRK, V11, P743, DOI 10.2741/1832; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200; Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Nishida Akihiro, 2005, Nippon Ganka Gakkai Zasshi, V109, P708; Puelles E, 2004, DEVELOPMENT, V131, P2037, DOI 10.1242/dev.01107; Puelles E, 2003, NAT NEUROSCI, V6, P453, DOI 10.1038/nn1037; Ragge NK, 2005, AM J HUM GENET, V76, P1008, DOI 10.1086/430721; Sgado P, 2006, P NATL ACAD SCI USA, V103, P15242, DOI 10.1073/pnas.0602116103; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Tajima T, 2009, J CLIN ENDOCR METAB, V94, P314, DOI 10.1210/jc.2008-1219; Takeda K, 2003, BIOCHEM BIOPH RES CO, V300, P908, DOI 10.1016/S0006-291X(02)02934-0; Valamanesh F, 2007, MOL VIS, V13, P1746; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	35	37	37	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11673	10.1371/journal.pone.0011673	http://dx.doi.org/10.1371/journal.pone.0011673			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657788	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500018
J	Cole, CL; Hansen, SU; Barath, M; Rushton, G; Gardiner, JM; Avizienyte, E; Jayson, GC				Cole, Claire L.; Hansen, Steen U.; Barath, Marek; Rushton, Graham; Gardiner, John M.; Avizienyte, Egle; Jayson, Gordon C.			Synthetic Heparan Sulfate Oligosaccharides Inhibit Endothelial Cell Functions Essential for Angiogenesis	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; FOCAL ADHESION KINASE; MITOGENIC ACTIVITY; IN-VIVO; ACTIVATION; MIGRATION; PROTEOGLYCANS; CAPACITY; BINDING	Background: Heparan sulfate (HS) is an important regulator of the assembly and activity of various angiogenic signalling complexes. However, the significance of precisely defined HS structures in regulating cytokine-dependent angiogenic cellular functions and signalling through receptors regulating angiogenic responses remains unclear. Understanding such structure-activity relationships is important for the rational design of HS fragments that inhibit HS-dependent angiogenic signalling complexes. Methodology/Principal Findings: We synthesized a series of HS oligosaccharides ranging from 7 to 12 saccharide residues that contained a repeating disaccharide unit consisting of iduronate 2-O-sulfate linked to glucosamine with or without N-sulfate. The ability of oligosaccharides to compete with HS for FGF2 and VEGF(165) binding significantly increased with oligosaccharide length and sulfation. Correspondingly, the inhibitory potential of oligosaccharides against FGF2- and VEGF(165)-induced endothelial cell responses was greater in longer oligosaccharide species that were comprised of disaccharides bearing both 2-O- and N-sulfation (2SNS). FGF2- and VEGF(165)-induced endothelial cell migration were inhibited by longer 2SNS oligosaccharide species with 2SNS dodecasaccharide activity being comparable to that of receptor tyrosine kinase inhibitors targeting FGFR or VEGFR-2. Moreover, the 2SNS dodecasaccharide ablated FGF2- or VEGF(165)-induced phosphorylation of FAK and assembly of F-actin in peripheral lamellipodia-like structures. In contrast, FGF2-induced endothelial cell proliferation was only moderately inhibited by longer 2SNS oligosaccharides. Inhibition of FGF2- and VEGF(165)-dependent endothelial tube formation strongly correlated with oligosaccharide length and sulfation with 10-mer and 12-mer 2SNS oligosaccharides being the most potent species. FGF2- and VEGF(165)-induced activation of MAPK pathway was inhibited by biologically active oligosaccharides correlating with the specific phosphorylation events in FRS2 and VEGFR-2, respectively. Conclusion/Significance: These results demonstrate structure-function relationships for synthetic HS saccharides that suppress endothelial cell migration, tube formation and signalling induced by key angiogenic cytokines.	[Cole, Claire L.; Rushton, Graham; Avizienyte, Egle; Jayson, Gordon C.] Univ Manchester, Sch Canc & Enabling Sci, Manchester, Lancs, England; [Hansen, Steen U.; Gardiner, John M.] Univ Manchester, Sch Chem, Manchester, Lancs, England; [Barath, Marek] Slovak Acad Sci, Inst Chem, Ctr Glyc, Bratislava, Slovakia; [Hansen, Steen U.; Gardiner, John M.] Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	University of Manchester; University of Manchester; Slovak Academy of Sciences; University of Manchester	Cole, CL (corresponding author), Univ Manchester, Sch Canc & Enabling Sci, Manchester, Lancs, England.	Eavizienyte@picr.man.ac.uk	Gardiner, John M/Q-7268-2017; Baráth, Marek/AAR-3869-2021; Jayson, Gordon C/O-8224-2015	Gardiner, John M/0000-0003-1827-6817; Baráth, Marek/0000-0003-2200-9623; Jayson, Gordon C/0000-0002-8515-8944	Medical Research Council [G0601746]; Cancer Research UK - Discovery Committee [C2075/A9106]; Jean Martin Gynaecological Cancer Research; MRC [G0902173, G0601746] Funding Source: UKRI; Medical Research Council [G0902173] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK - Discovery Committee; Jean Martin Gynaecological Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Milstein fund from the Medical Research Council (G0601746), a grant from Cancer Research UK - Discovery Committee (C2075/A9106) and Jean Martin Gynaecological Cancer Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Baleux F, 2009, NAT CHEM BIOL, V5, P743, DOI 10.1038/nchembio.207; Bhattacharya R, 2009, J CELL SCI, V122, P1025, DOI 10.1242/jcs.041913; Boilly B, 2000, CYTOKINE GROWTH F R, V11, P295, DOI 10.1016/S1359-6101(00)00014-9; de Paz JL, 2001, CHEMBIOCHEM, V2, P673, DOI 10.1002/1439-7633(20010903)2:9<673::AID-CBIC673>3.0.CO;2-7; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Faham S, 1996, SCIENCE, V271, P1116, DOI 10.1126/science.271.5252.1116; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Hansen SU, 2009, ORG LETT, V11, P4528, DOI 10.1021/ol901723m; HANSEN SU, 2009, Patent No. 2009098449; Hasan J, 2005, CLIN CANCER RES, V11, P8172, DOI 10.1158/1078-0432.CCR-05-0452; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; IAGHER JT, 2006, BIOCHEM SOC T, V34, P438; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Leali D, 2001, J BIOL CHEM, V276, P37900; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Ludwig RJ, 2006, THROMB HAEMOSTASIS, V95, P535, DOI 10.1160/TH05-07-0515; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Norrby K, 2006, APMIS, V114, P79, DOI 10.1111/j.1600-0463.2006.apm_235.x; Noti C, 2006, CHEM-EUR J, V12, P8664, DOI 10.1002/chem.200601103; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Soker S, 1996, J BIOL CHEM, V271, P5761, DOI 10.1074/jbc.271.10.5761; Stringer SE, 2006, BIOCHEM SOC T, V34, P451, DOI 10.1042/BST0340451; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Zhang FM, 2009, BIOCHEMISTRY-US, V48, P8379, DOI 10.1021/bi9006379	32	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11644	10.1371/journal.pone.0011644	http://dx.doi.org/10.1371/journal.pone.0011644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657775	gold, Green Published, Green Submitted			2022-12-27	WOS:000280197500013
J	Schlicht, EJ; Shimojo, S; Camerer, CF; Battaglia, P; Nakayama, K				Schlicht, Erik J.; Shimojo, Shinsuke; Camerer, Colin F.; Battaglia, Peter; Nakayama, Ken			Human Wagering Behavior Depends on Opponents' Faces	PLOS ONE			English	Article							CINGULATE CORTEX; NEURAL SYSTEMS; TRUST; TRUSTWORTHINESS; RECIPROCITY; RESPONSES; REPUTATION	Research in competitive games has exclusively focused on how opponent models are developed through previous outcomes and how peoples' decisions relate to normative predictions. Little is known about how rapid impressions of opponents operate and influence behavior in competitive economic situations, although such subjective impressions have been shown to influence cooperative decision-making. This study investigates whether an opponent's face influences players' wagering decisions in a zero-sum game with hidden information. Participants made risky choices in a simplified poker task while being presented opponents whose faces differentially correlated with subjective impressions of trust. Surprisingly, we find that threatening face information has little influence on wagering behavior, but faces relaying positive emotional characteristics impact peoples' decisions. Thus, people took significantly longer and made more mistakes against emotionally positive opponents. Differences in reaction times and percent correct were greatest around the optimal decision boundary, indicating that face information is predominantly used when making decisions during medium-value gambles. Mistakes against emotionally positive opponents resulted from increased folding rates, suggesting that participants may have believed that these opponents were betting with hands of greater value than other opponents. According to these results, the best "poker face'' for bluffing may not be a neutral face, but rather a face that contains emotional correlates of trustworthiness. Moreover, it suggests that rapid impressions of an opponent play an important role in competitive games, especially when people have little or no experience with an opponent.	[Schlicht, Erik J.; Nakayama, Ken] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Schlicht, Erik J.; Shimojo, Shinsuke] CALTECH, Dept Biol, Pasadena, CA 91125 USA; [Camerer, Colin F.] CALTECH, Dept Econ, Pasadena, CA 91125 USA; [Battaglia, Peter] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Harvard University; California Institute of Technology; California Institute of Technology; Massachusetts Institute of Technology (MIT)	Schlicht, EJ (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	schlicht@wjh.harvard.edu		Schlicht, Erik J/0000-0001-5711-8227	Japan Science and Technology Agency (JST) Exploratory Research; National Eye Institute (NEI) [R01 EY01362]	Japan Science and Technology Agency (JST) Exploratory Research(Japan Science & Technology Agency (JST)); National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by a Japan Science and Technology Agency (JST) Exploratory Research for Advanced Technology (ERATO) grant (to S.S.) and partially supported by National Eye Institute (NEI) grant R01 EY01362 (to K.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACUNA D, 2008, C NEUR INF PROC SYST; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Battaglia PW, 2005, ACM INT C P SERIES, V95, P145, DOI DOI 10.1145/1080402.1080430; BELLMAN R, 1949, P NATL ACAD SCI USA, V35, P600, DOI 10.1073/pnas.35.10.600; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chiu PH, 2008, NEURON, V57, P463, DOI 10.1016/j.neuron.2007.12.020; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; *FACEGEN, FACEGEN 3 1 SOFTW; Fang F, 2005, NAT NEUROSCI, V8, P1380, DOI 10.1038/nn1537; Ferguson C, 2003, GAME THEORY AND APPLICATIONS, VOL IX, P17; Hancock PJB, 2003, BEHAV BRAIN SCI, V26, P162; Jiang Y, 2009, NEUROIMAGE, V44, P1171, DOI 10.1016/j.neuroimage.2008.09.038; KARLIN S, 1957, CONTRIB THEOR GAMES, V39, P337; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; KNILL DC, 1991, NATURE, V351, P228, DOI 10.1038/351228a0; Lerner JS, 2007, BIOL PSYCHIAT, V61, P253, DOI 10.1016/j.biopsych.2006.08.016; Levine DK, 1998, REV ECON DYNAM, V1, P593; Maloney LT, 2002, J VISION, V2, DOI 10.1167/2.6.6; Mamassian P, 2002, NEU INF PRO, P13; McCabe KA, 1998, GAME ECON BEHAV, V24, P10, DOI 10.1006/game.1998.0638; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; PONSSARD JP, 1975, MANAGE SCI, V21, P794, DOI 10.1287/mnsc.21.7.794; Schlicht EJ, 2007, J NEUROPHYSIOL, V97, P4203, DOI 10.1152/jn.00160.2007; *SHARKSC, 2009, SHARKSC LEAD BOARD A; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; SORIN S, 1980, INT J GAME THEORY, V9, P99; Todorov A, 2008, COGN NEUROPSYCHOL, V25, P395, DOI 10.1080/02643290802044996; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	40	27	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11663	10.1371/journal.pone.0011663	http://dx.doi.org/10.1371/journal.pone.0011663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657772	Green Published, gold, Green Accepted			2022-12-27	WOS:000280197500016
J	Zhang, HM; Robinson, N; Wu, CY; Wang, WL; Harrington, MA				Zhang, Hongmei; Robinson, Natallia; Wu, Chiayen; Wang, Wenlan; Harrington, Melissa A.			Electrophysiological Properties of Motor Neurons in a Mouse Model of Severe Spinal Muscular Atrophy: In Vitro versus In Vivo Development	PLOS ONE			English	Article							NEUROMUSCULAR-JUNCTIONS; GENE; PROTEIN; SMA; DEFECTS	We examined the electrophysiological activity of motor neurons from the mouse model of severe spinal muscular atrophy (SMA) using two different methods: whole cell patch clamp of neurons cultured from day 13 embryos; and multi-electrode recording of ventral horns in spinal cord slices from pups on post-natal days 5 and 6. We used the MED64 multi-electrode array to record electrophysiological activity from motor neurons in slices from the lumbar spinal cord of SMA pups and their unaffected littermates. Recording simultaneously from up to 32 sites across the ventral horn, we observed a significant decrease in the number of active neurons in 5-6 day-old SMA pups compared to littermates. Ventral horn activity in control pups is significantly activated by serotonin and depressed by GABA, while these agents had much less effect on SMA slices. In contrast to the large differences observed in spinal cord, neurons cultured from SMA embryos for up to 21 days showed no significant differences in electrophysiological activity compared to littermates. No differences were observed in membrane potential, frequency of spiking and synaptic activity in cells from SMA embryos compared to controls. In addition, we observed no difference in cell survival between cells from SMA embryos and their unaffected littermates. Our results represent the first report on the electrophysiology of SMN-deficient motor neurons, and suggest that motor neuron development in vitro follows a different path than in vivo development, a path in which loss of SMN expression has little effect on motor neuron function and survival.	[Zhang, Hongmei; Robinson, Natallia; Harrington, Melissa A.] Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA; [Wu, Chiayen; Wang, Wenlan] Alfred I DuPont Hosp Children, Wilmington, DE USA	Delaware State University; Nemours Alfred I. duPont Hospital for Children	Zhang, HM (corresponding author), Delaware State Univ, Dept Biol Sci, Dover, DE 19901 USA.	mharrington@desu.edu			NIH [5S06GM073765-01A2, 5P20RR016472-05]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM073765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH Grants 5S06GM073765-01A2 and 5P20RR016472-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaydin E., 2004, INTRO MACHINE LEARNI; Bendat J.S., 2000, RANDOM DATA ANAL MEA; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Iannaccone Susan T, 2004, Curr Neurol Neurosci Rep, V4, P74, DOI 10.1007/s11910-004-0016-6; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; LORSON CL, 1999, NAT GENET, V19, P63; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; NOAKES PG, 1993, DEV BIOL, V155, P275, DOI 10.1006/dbio.1993.1025; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Smith SW, 2002, DIGIT SIGNAL PROCESS; Swash M, 2000, AMYOTROPH LATERAL SC, V1, P105; Swoboda KJ, 2005, ANN NEUROL, V57, P704, DOI 10.1002/ana.20473; Talbot K, 2001, SEMIN NEUROL, V21, P189, DOI 10.1055/s-2001-15264; Ting CH, 2007, HUM MOL GENET, V16, P499, DOI 10.1093/hmg/ddl482; ZHANG H, 2009, NEUROREPORT, V20, P854	26	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11696	10.1371/journal.pone.0011696	http://dx.doi.org/10.1371/journal.pone.0011696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657731	Green Published, gold, Green Submitted			2022-12-27	WOS:000280197500033
J	Liberloo, M; Luyssaert, S; Bellassen, V; Djomo, SN; Lukac, M; Calfapietra, C; Janssens, IA; Hoosbeek, MR; Viovy, N; Churkina, G; Scarascia-Mugnozza, G; Ceulemans, R				Liberloo, Marion; Luyssaert, Sebastiaan; Bellassen, Valentin; Djomo, Sylvestre Njakou; Lukac, Martin; Calfapietra, Carlo; Janssens, Ivan A.; Hoosbeek, Marcel R.; Viovy, Nicolas; Churkina, Galina; Scarascia-Mugnozza, Giuseppe; Ceulemans, Reinhart			Bio-Energy Retains Its Mitigation Potential Under Elevated CO2	PLOS ONE			English	Article							CARBON SEQUESTRATION; PLANTATION INCREASES; CONIFEROUS FORESTS; BIOMASS PRODUCTION; GREENHOUSE GASES; POPLAR; ROTATION; SOIL; BIOFUELS; FERTILIZATION	Background: If biofuels are to be a viable substitute for fossil fuels, it is essential that they retain their potential to mitigate climate change under future atmospheric conditions. Elevated atmospheric CO2 concentration [CO2] stimulates plant biomass production; however, the beneficial effects of increased production may be offset by higher energy costs in crop management. Methodology/Main Findings: We maintained full size poplar short rotation coppice (SRC) systems under both current ambient and future elevated [CO2] (550 ppm) and estimated their net energy and greenhouse gas balance. We show that a poplar SRC system is energy efficient and produces more energy than required for coppice management. Even more, elevated [CO2] will increase the net energy production and greenhouse gas balance of a SRC system with 18%. Managing the trees in shorter rotation cycles (i.e., 2 year cycles instead of 3 year cycles) will further enhance the benefits from elevated [CO2] on both the net energy and greenhouse gas balance. Conclusions/Significance: Adapting coppice management to the future atmospheric [CO2] is necessary to fully benefit from the climate mitigation potential of bio-energy systems. Further, a future increase in potential biomass production due to elevated [CO2] outweighs the increased production costs resulting in a northward extension of the area where SRC is greenhouse gas neutral. Currently, the main part of the European terrestrial carbon sink is found in forest biomass and attributed to harvesting less than the annual growth in wood. Because SRC is intensively managed, with a higher turnover in wood production than conventional forest, northward expansion of SRC is likely to erode the European terrestrial carbon sink.	[Liberloo, Marion; Djomo, Sylvestre Njakou; Janssens, Ivan A.; Ceulemans, Reinhart] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Luyssaert, Sebastiaan; Bellassen, Valentin; Viovy, Nicolas] CEA, CNRS, Commissariat Energie Atom & Energies Alternat, LSCE,UM, F-91198 Gif Sur Yvette, France; [Luyssaert, Sebastiaan; Bellassen, Valentin; Viovy, Nicolas] Univ Versailles St Quentin Yvelines UVSQ, Gif Sur Yvette, France; [Lukac, Martin] Imperial Coll London, Ctr Populat Biol, NERC, Ascot, Berks, England; [Calfapietra, Carlo; Scarascia-Mugnozza, Giuseppe] CNR, Inst Agroenvironm & Forest Biol IBAF, Monterotondo, Italy; [Hoosbeek, Marcel R.] Wageningen Univ, Dept Environm Sci, Wageningen, Netherlands; [Churkina, Galina] Leibniz Ctr Agr Landscape Res ZALF, Muencheberg, Germany	University of Antwerp; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Agroambientale e Forestale (IBAF-CNR); Wageningen University & Research; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF)	Liberloo, M (corresponding author), Univ Antwerp, Dept Biol, Antwerp, Belgium.	sebastiaan.luyssaert@lsce.ipsl.fr	Lukac, Martin/A-4379-2013; Janssens, Ivan A/P-1331-2014; Calfapietra, Carlo/E-2269-2015; Ceulemans, Reinhart J M/F-2109-2016; Viovy, Nicolas/S-2631-2018; Njakou Djomo, Sylvestre/E-5330-2015; Luyssaert, Sebastiaan/F-6684-2011	Lukac, Martin/0000-0002-8535-6334; Janssens, Ivan A/0000-0002-5705-1787; Ceulemans, Reinhart J M/0000-0003-4773-9358; Viovy, Nicolas/0000-0002-9197-6417; Njakou Djomo, Sylvestre/0000-0003-1828-0015; Luyssaert, Sebastiaan/0000-0003-1121-1869; Hoosbeek, Marcel/0000-0003-0617-0089; Bellassen, Valentin/0000-0001-8581-2814; Churkina, Galina/0000-0002-5895-7425	EC [EVR1-CT-2002-40027]; Italian Ministry of University and Research (MIUR); Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen); Research Centre of Excellence ECO (UA-Methusalem); ERC [242564]; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	EC(European CommissionEuropean Commission Joint Research Centre); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen)(FWO); Research Centre of Excellence ECO (UA-Methusalem); ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided for MLi, MLu, CC, MRH, GSM and RC by the EC Fifth Framework Program, Environment and Climate RTD Program, research contract EVR1-CT-2002-40027 (EUROFACE) and by the Centre of Excellence "Forest and Climate'' of the Italian Ministry of University and Research (MIUR). MLi received a post-doctoral fellowship from the Fund for Scientific Research-Flanders (F.W.O.-Vlaanderen) and SL from the Research Centre of Excellence ECO (UA-Methusalem) and ERC Starting Grant 242564. IAJ, SND, NV, GC, VB received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HDB GROW SHORT ROTAT; Calfapietra C, 2005, ENVIRON POLLUT, V137, P525, DOI 10.1016/j.envpol.2005.01.038; Calfapietra C, 2003, NEW PHYTOL, V160, P305, DOI 10.1046/j.1469-8137.2003.00899.x; Calfapietra C, 2003, TREE PHYSIOL, V23, P805, DOI 10.1093/treephys/23.12.805; Churkina G, 2000, CLIMATIC CHANGE, V47, P167, DOI 10.1023/A:1005620808273; Churkina G, 2003, ECOSYSTEMS, V6, P168, DOI 10.1007/s10021-002-0197-2; Ciais P, 2008, NAT GEOSCI, V1, P425, DOI 10.1038/ngeo233; *COMM COTE, 2008, 20080016COD COMM COT; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gasol CM, 2009, BIOMASS BIOENERG, V33, P119, DOI 10.1016/j.biombioe.2008.04.020; Gerbens-Leenes W, 2009, P NATL ACAD SCI USA, V106, P10219, DOI 10.1073/pnas.0812619106; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hoosbeek MR, 2006, PLANT SOIL, V281, P247, DOI 10.1007/s11104-005-4293-x; Hoosbeek MR, 2009, ECOSYSTEMS, V12, P220, DOI 10.1007/s10021-008-9219-z; Hoosbeek MR, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002127; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; Liberloo M, 2005, TREE PHYSIOL, V25, P179, DOI 10.1093/treephys/25.2.179; Liberloo M, 2006, GLOBAL CHANGE BIOL, V12, P1094, DOI 10.1111/j.1365-2486.2006.01118.x; Liberloo M, 2009, NEW PHYTOL, V182, P331, DOI 10.1111/j.1469-8137.2008.02754.x; Lukac M, 2003, GLOBAL CHANGE BIOL, V9, P838, DOI 10.1046/j.1365-2486.2003.00582.x; NAKICENOVIC N, 2000, REPORT EMISSION SCEN; Norby RJ, 2005, P NATL ACAD SCI USA, V102, P18052, DOI 10.1073/pnas.0509478102; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pontailler JY, 1999, FORESTRY, V72, P157; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schulze ED, 2009, NAT GEOSCI, V2, P842, DOI 10.1038/ngeo686; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Sims REH, 2006, GLOBAL CHANGE BIOL, V12, P2054, DOI 10.1111/j.1365-2486.2006.01163.x; Thornton P., 1998, REGIONAL ECOSYSTEM S; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Tricker PJ, 2009, BIOMASS BIOENERG, V33, P200, DOI 10.1016/j.biombioe.2008.05.009; Vetter M, 2005, GLOBAL CHANGE BIOL, V11, P810, DOI 10.1111/j.1365-2486.2005.00932.x; *WRI, 2005, EARTHTR	37	16	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11648	10.1371/journal.pone.0011648	http://dx.doi.org/10.1371/journal.pone.0011648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657833	Green Published, gold, Green Submitted			2022-12-27	WOS:000280065600012
J	Pang, XLL; Preiksaitis, JK; Wong, S; Li, V; Lee, BE				Pang, Xiaoli L.; Preiksaitis, Jutta K.; Wong, Sallene; Li, Vincent; Lee, Bonita E.			Influence of Novel Norovirus GII.4 Variants on Gastroenteritis Outbreak Dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008	PLOS ONE			English	Article							NORWALK-LIKE VIRUSES; REVERSE TRANSCRIPTION-PCR; ROUND-STRUCTURED VIRUSES; VIRAL GASTROENTERITIS; EPOCHAL EVOLUTION; UNITED-STATES; P2 DOMAIN; STRAIN; CHILDREN; SPREAD	Background: Norovirus GII.4 is the predominant genotype circulating worldwide over the last decade causing 80% of all norovirus outbreaks with new GII.4 variants reported in parallel with periodic epidemic waves of norovirus outbreaks. The circulating new GII.4 variants and the epidemiology of norovirus outbreaks in Alberta, Canada have not been described. Our hypothesis is that the periodic epidemic norovirus outbreak activity in Alberta was driven by new GII.4 variants evolving by genetic drift. Methodology/Principal Findings: The Alberta Provincial Public Health Laboratory performed norovirus testing using RTPCR for suspected norovirus outbreaks in the province and the northern Territories between 2000 and 2008. At least one norovirus strain from 707 out of 1,057 (66.9%) confirmed norovirus outbreaks were successfully sequenced. Phylogenetic analysis was performed using BioNumerics and 617 (91.1%) outbreaks were characterized as caused by GII.4 with 598 assigned as novel variants including: GII.4-1996, GII.4-2002, GII.4-2004, GII.4-2006a, GII.4-2006b, GII.4-2008a and GII.4-2008b. Defining July to June of the following year as the yearly observation period, there was clear biannual pattern of low and high outbreak activity in Alberta. Within this biannual pattern, high outbreak activity followed the emergence of novel GII.4 variants. The two variants that emerged in 2006 had wider geographic distribution and resulted in higher outbreak activity compared to other variants. The outbreak settings were analyzed. Community-based group residence was the most common for both GII.4 variants and non-GII.4 variants. GII.4 variants were more commonly associated with outbreaks in acute care hospitals while outbreaks associated non-GII.4 variants were more commonly seen in school and community social events settings (p < 0.01). Conclusions/Significance: The emergence of new norovirus GII.4 variants resulted in an increased norovirus outbreak activity in the following season in a unique biannual pattern in Alberta over an eight year period. The association between antigenic drift of GII.4 strains and epidemic norovirus outbreak activity could be due to changes in host immunity, viral receptor binding efficiency or virulence factors in the new variants. Early detection of novel GII.4 variants provides vital information that could be used to forecast the norovirus outbreak burden, enhance public health preparedness and allocate appropriate resources for outbreak management.	[Pang, Xiaoli L.; Preiksaitis, Jutta K.; Wong, Sallene; Li, Vincent; Lee, Bonita E.] Prov Lab Publ Hlth, Edmonton, AB, Canada; [Pang, Xiaoli L.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Lee, Bonita E.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Preiksaitis, Jutta K.] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Pang, XLL (corresponding author), Prov Lab Publ Hlth, Edmonton, AB, Canada.	x.pang@provlab.ab.ca			Alberta Health and Wellness	Alberta Health and Wellness	The study was funded by Alberta Health and Wellness. The funders had no role in the study design, data analysis, preparation of the manuscript and the decision to publish.	ANDO T, 1995, J CLIN MICROBIOL, V33, P64, DOI 10.1128/JCM.33.1.64-71.1995; Ando T, 2000, J INFECT DIS, V181, pS336, DOI 10.1086/315589; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Buesa J, 2008, J MED VIROL, V80, P1288, DOI 10.1002/jmv.21182; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Dolin R, 2007, NEW ENGL J MED, V357, P1072, DOI 10.1056/NEJMp078050; Doultree JC, 1999, J HOSP INFECT, V41, P51, DOI 10.1016/S0195-6701(99)90037-3; Fankhauser RL, 2002, J INFECT DIS, V186, P1, DOI 10.1086/341085; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Ho ECM, 2006, J MED VIROL, V78, P1473, DOI 10.1002/jmv.20721; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koopmans M, 2002, FEMS MICROBIOL REV, V26, P187, DOI 10.1016/S0168-6445(02)00096-7; Kroneman A., 2006, EUROSURVEILLANCE, V11; Lee BE, 2008, J MED VIROL, V80, P330, DOI 10.1002/jmv.21061; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lochridge VP, 2005, J GEN VIROL, V86, P2799, DOI 10.1099/vir.0.81134-0; Lopman B, 2004, LANCET, V363, P682, DOI 10.1016/S0140-6736(04)15641-9; Marks PJ, 2003, EPIDEMIOL INFECT, V131, P727, DOI 10.1017/S0950268803008689; Medici MC, 2006, J MED VIROL, V78, P1486, DOI 10.1002/jmv.20723; Noel JS, 1999, J INFECT DIS, V179, P1334, DOI 10.1086/314783; O'Reilly CE, 2007, CLIN INFECT DIS, V44, P506, DOI 10.1086/511043; Okada M, 2007, ARCH VIROL, V152, P2249, DOI 10.1007/s00705-007-1028-8; Pang XL, 2004, J CLIN MICROBIOL, V42, P4679, DOI 10.1128/JCM.42.10.4679-4685.2004; Pang XLL, 2005, J CLIN VIROL, V33, P168, DOI 10.1016/j.jcv.2004.12.014; PARRINO TA, 1977, NEW ENGL J MED, V297, P86, DOI 10.1056/NEJM197707142970204; Phan TG, 2006, J MED VIROL, V78, P971, DOI 10.1002/jmv.20649; Siebenga JJ, 2007, J VIROL, V81, P9932, DOI 10.1128/JVI.00674-07; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Siebenga JJ, 2009, J INFECT DIS, V200, P802, DOI 10.1086/605127; Tan M, 2003, J VIROL, V77, P12562, DOI 10.1128/JVI.77.23.12562-12571.2003; Tan M, 2008, J MED VIROL, V80, P1296, DOI 10.1002/jmv.21200; Tu ETV, 2008, J CLIN MICROBIOL, V46, P2119, DOI 10.1128/JCM.02198-07; Tu ETV, 2008, CLIN INFECT DIS, V46, P413, DOI 10.1086/525259; Vinje J, 1997, J INFECT DIS, V176, P1374, DOI 10.1086/517325; Webby RJ, 2007, CLIN INFECT DIS, V44, P1026, DOI 10.1086/512807; White P, 2002, J MED VIROL, V68, P113, DOI 10.1002/jmv.10177; Widdowson MA, 2004, J INFECT DIS, V190, P27, DOI 10.1086/420888; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015; 2006, MMWR MORB MORTAL WKL, V56, P842	42	50	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11599	10.1371/journal.pone.0011599	http://dx.doi.org/10.1371/journal.pone.0011599			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661286	Green Published, gold, Green Submitted			2022-12-27	WOS:000279980800005
J	Carey, MA; Bradbury, JA; Rebolloso, YD; Graves, JP; Zeldin, DC; Germolec, DR				Carey, Michelle A.; Bradbury, J. Alyce; Rebolloso, Yvette D.; Graves, Joan P.; Zeldin, Darryl C.; Germolec, Dori R.			Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; G-CSF; ALLERGIC INFLAMMATION; IMMUNE-RESPONSE; DEFICIENT MICE; VIRUS; HYPOTHERMIA; CYCLOOXYGENASES; PROSTAGLANDINS; GRANULOCYTE	Background: We previously demonstrated that cyclooxygenase (COX)-1 deficiency results in greater morbidity and inflammation, whereas COX-2 deficiency leads to reduced morbidity, inflammation and mortality in influenza infected mice. Methodology/Principal Findings: We investigated the effects of COX-1 and COX-2 inhibitors in influenza A viral infection. Mice were given a COX-1 inhibitor (SC-560), a COX-2 inhibitor (celecoxib) or no inhibitor beginning 2 weeks prior to influenza A viral infection (200 PFU) and throughout the course of the experiment. Body weight and temperature were measured daily as indicators of morbidity. Animals were sacrificed on days 1 and 4 post-infection and bronchoalveolar lavage (BAL) fluid was collected or daily mortality was recorded up to 2 weeks post-infection. Treatment with SC-560 significantly increased mortality and was associated with profound hypothermia and greater weight loss compared to celecoxib or control groups. On day 4 of infection, BAL fluid cells were modestly elevated in celecoxib treated mice compared to SC-560 or control groups. Viral titres were similar between treatment groups. Levels of TNF-alpha and G-CSF were significantly attenuated in the SC-560 and celecoxib groups versus control and IL-6 levels were significantly lower in BAL fluid of celecoxib treated mice versus control and versus the SC-560 group. The chemokine KC was significantly lower in SC-560 group versus control. Conclusions/Significance: Treatment with a COX-1 inhibitor during influenza A viral infection is detrimental to the host whereas inhibition of COX-2 does not significantly modulate disease severity. COX-1 plays a critical role in controlling the thermoregulatory response to influenza A viral infection in mice.	[Carey, Michelle A.; Bradbury, J. Alyce; Rebolloso, Yvette D.; Graves, Joan P.; Zeldin, Darryl C.; Germolec, Dori R.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Carey, MA (corresponding author), NIEHS, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307	National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025043] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu ES, 2007, AM J PHYSIOL-REG I, V292, pR1846, DOI 10.1152/ajpregu.00786.2006; Basu S, 2000, BLOOD, V95, P3725; Carey MA, 2005, J IMMUNOL, V175, P6878, DOI 10.4049/jimmunol.175.10.6878; Carey MA, 2003, PROSTAG LEUKOTR ESS, V69, P157, DOI 10.1016/S0952-3278(03)00076-0; Carey MA, 2003, AM J RESP CRIT CARE, V167, P1509, DOI 10.1164/rccm.200211-1383OC; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Chen JZ, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-30; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fedson DS, 2008, LANCET INFECT DIS, V8, P571, DOI 10.1016/S1473-3099(08)70070-7; Fedson DS, 2009, INFLUENZA OTHER RESP, V3, P129, DOI 10.1111/j.1750-2659.2009.00090.x; Gregory AD, 2007, BLOOD, V109, P3235, DOI 10.1182/blood-2005-01-015081; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6; Leon LR, 2004, FRONT BIOSCI, V9, P1877, DOI 10.2741/1381; LIESCHKE GJ, 1994, BLOOD, V84, P1737; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; MILTON AS, 1989, ANN NY ACAD SCI, V559, P392; Mossad SB, 2009, CLEV CLIN J MED, V76, P337, DOI 10.3949/ccjm.76a.09047; Narko K, 2005, PROSTAG OTH LIPID M, V76, P86, DOI 10.1016/j.prostaglandins.2005.01.002; Oka T, 2003, J PHYSIOL-LONDON, V551, P945, DOI 10.1113/jphysiol.2003.048140; Peebles RS, 2002, AM J RESP CRIT CARE, V165, P1154, DOI 10.1164/rccm.2106025; Rainsford K. D., 2006, Inflammopharmacology, V14, P2, DOI 10.1007/s10787-006-0002-5; REED LJ, 1938, AM J HYG, V27; Rocca B, 1999, J CLIN INVEST, V103, P1469, DOI 10.1172/JCI6400; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Saito H, 2003, MECH AGEING DEV, V124, P1047, DOI 10.1016/j.mad.2003.08.002; Scammell TE, 1998, AM J PHYSIOL-REG I, V274, pR783, DOI 10.1152/ajpregu.1998.274.3.R783; Schonthal AH, 2007, BRIT J CANCER, V97, P1465, DOI 10.1038/sj.bjc.6604049; Steiner AA, 2009, AM J PHYSIOL-REG I, V297, pR485, DOI 10.1152/ajpregu.91026.2008; Tegeder I, 2001, FASEB J, V15, P2057, DOI 10.1096/fj.01-0390rev; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Traynor TR, 2007, BRAIN BEHAV IMMUN, V21, P311, DOI 10.1016/j.bbi.2006.09.007; Ushikubi F, 1998, NATURE, V395, P281, DOI 10.1038/26233; Warn PA, 2003, LAB ANIM-UK, V37, P126, DOI 10.1258/00236770360563769; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Wong JP, 1997, LAB ANIM SCI, V47, P143; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhang XW, 2003, DIAM RELAT MATER, V12, P1, DOI 10.1016/S0925-9635(02)00246-7	40	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11610	10.1371/journal.pone.0011610	http://dx.doi.org/10.1371/journal.pone.0011610			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657653	Green Published, gold, Green Submitted			2022-12-27	WOS:000279924500012
J	Aldecoa, R; Marin, I				Aldecoa, Rodrigo; Marin, Ignacio			Jerarca: Efficient Analysis of Complex Networks Using Hierarchical Clustering	PLOS ONE			English	Article							FUNCTIONAL MODULES; PROTEIN COMPLEXES; PREDICTION; INTERACTOME	Background: How to extract useful information from complex biological networks is a major goal in many fields, especially in genomics and proteomics. We have shown in several works that iterative hierarchical clustering, as implemented in the UVCluster program, is a powerful tool to analyze many of those networks. However, the amount of computation time required to perform UVCluster analyses imposed significant limitations to its use. Methodology/Principal Findings: We describe the suite Jerarca, designed to efficiently convert networks of interacting units into dendrograms by means of iterative hierarchical clustering. Jerarca is divided into three main sections. First, weighted distances among units are computed using up to three different approaches: a more efficient version of UVCluster and two new, related algorithms called RCluster and SCluster. Second, Jerarca builds dendrograms based on those distances, using well-known phylogenetic algorithms, such as UPGMA or Neighbor-Joining. Finally, Jerarca provides optimal partitions of the trees using statistical criteria based on the distribution of intra- and intercluster connections. Outputs compatible with the phylogenetic software MEGA and the Cytoscape package are generated, allowing the results to be easily visualized. Conclusions/Significance: The four main advantages of Jerarca in respect to UVCluster are: 1) Improved speed of a novel UVCluster algorithm; 2) Additional, alternative strategies to perform iterative hierarchical clustering; 3) Automatic evaluation of the hierarchical trees to obtain optimal partitions; and, 4) Outputs compatible with popular software such as MEGA and Cytoscape.	[Aldecoa, Rodrigo; Marin, Ignacio] CSIC, IBV, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV)	Aldecoa, R (corresponding author), CSIC, IBV, Valencia, Spain.	imarin@ibv.csic.es	Marin, Ignacio/A-9524-2009; Aldecoa, Rodrigo/I-3569-2012	Marin, Ignacio/0000-0002-1315-8961; Aldecoa, Rodrigo/0000-0002-8041-3416	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion, Spain [BIO2008-05067]	Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was supported by grant BIO2008-05067 (Programa Nacional de Biotecnologia; Ministerio de Ciencia e Innovacion, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aittokallio T, 2006, BRIEF BIOINFORM, V7, P243, DOI 10.1093/bib/bbl022; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Brun C, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-95; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; King AD, 2004, BIOINFORMATICS, V20, P3013, DOI 10.1093/bioinformatics/bth351; Lu HC, 2004, NUCLEIC ACIDS RES, V32, P4804, DOI 10.1093/nar/gkh814; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Marco A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-69; Marco A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-442; Nei M., 2000, MOL EVOLUTION PHYLOG; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pereira-Leal JB, 2004, PROTEINS, V54, P49, DOI 10.1002/prot.10505; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sokal R., 1958, U KANSAS SCI B, V38, P1409; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Yip AM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-22	28	32	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11585	10.1371/journal.pone.0011585	http://dx.doi.org/10.1371/journal.pone.0011585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644733	Green Published, Green Submitted, gold			2022-12-27	WOS:000279884900021
J	Caesar, R; Manieri, M; Kelder, T; Boekschoten, M; Evelo, C; Muller, M; Kooistra, T; Cinti, S; Kleemann, R; Drevon, CA				Caesar, Robert; Manieri, Monia; Kelder, Thomas; Boekschoten, Mark; Evelo, Chris; Mueller, Michael; Kooistra, Teake; Cinti, Saverio; Kleemann, Robert; Drevon, Christian A.			A Combined Transcriptomics and Lipidomics Analysis of Subcutaneous, Epididymal and Mesenteric Adipose Tissue Reveals Marked Functional Differences	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MESSENGER-RNA EXPRESSION; FATTY-ACID-COMPOSITION; GENE-EXPRESSION; LYMPHOID-CELLS; INSULIN SENSITIVITY; HUMAN PREADIPOCYTES; GLUCOSE-METABOLISM; OBESE SUBJECTS; IN-VITRO	Depot-dependent differences in adipose tissue physiology may reflect specialized functions and local interactions between adipocytes and surrounding tissues. We combined time-resolved microarray analyses of mesenteric- (MWAT), subcutaneous- (SWAT) and epididymal adipose tissue (EWAT) during high-fat feeding of male transgenic ApoE3Leiden mice with histology, targeted lipidomics and biochemical analyses of metabolic pathways to identify differentially regulated processes and site-specific functions. EWAT was found to exhibit physiological zonation. De novo lipogenesis in fat proximal to epididymis was stably low, whereas de novo lipogenesis distal to epididymis and at other locations was down-regulated in response to high-fat diet. The contents of linoleic acid and alpha-linolenic acid in EWAT were increased compared to other depots. Expression of the androgen receptor (Ar) was higher in EWAT than in MWAT and SWAT. We suggest that Ar may mediate depot-dependent differences in de novo lipogenesis rate and propose that accumulation of linoleic acid and alpha-linolenic acid in EWAT is favored by testosterone-mediated inhibition of de novo lipogenesis and may promote further elongation and desaturation of these polyunsaturated fatty acids during spermatogenesis.	[Caesar, Robert; Drevon, Christian A.] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway; [Caesar, Robert] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden; [Manieri, Monia; Cinti, Saverio] Univ Ancona, Sch Med, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Kelder, Thomas; Evelo, Chris] Maastricht Univ, Dept Bioinformat, BiGCaT, Maastricht, Netherlands; [Boekschoten, Mark; Mueller, Michael] TI Food & Nutr, Nutrigenom Consortium, Wageningen, Netherlands; [Boekschoten, Mark; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Kooistra, Teake; Kleemann, Robert] TNO Qual Life, BioSci, Leiden, Netherlands	University of Oslo; University of Gothenburg; Marche Polytechnic University; Maastricht University; Top Institute Food & Nutrition; Wageningen University & Research; Netherlands Organization Applied Science Research	Caesar, R (corresponding author), Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Nutr, Oslo, Norway.	Robert.Caesar@wlab.gu.se	Boekschoten, Mark V/A-2458-2011; Muller, Michael/B-5795-2008; Boekschoten, Mark/AAS-4597-2021; Evelo, Chris TA/D-2914-2009; Caesar, Robert/AAX-3205-2020; Muller, Michael/M-5724-2019	Boekschoten, Mark V/0000-0002-2139-0795; Muller, Michael/0000-0002-5930-9905; Boekschoten, Mark/0000-0002-2139-0795; Evelo, Chris TA/0000-0002-5301-3142; Muller, Michael/0000-0002-5930-9905; CINTI, Saverio/0000-0003-0362-5017	Nutrigenomics Organisation; EC-funded Network of Excellence [FOOD-2004-506360]; Johan Throne Holst Foundation for Nutrition Research; Freia Medical Research Fund	Nutrigenomics Organisation; EC-funded Network of Excellence; Johan Throne Holst Foundation for Nutrition Research; Freia Medical Research Fund	This project was funded by the Nutrigenomics Organisation (www.nugo.org/), EC-funded Network of Excellence, grant number FOOD-2004-506360. Financial support was also obtained from the Johan Throne Holst Foundation for Nutrition Research and the Freia Medical Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER P, 1990, J CLIN INVEST, V86, P1595, DOI 10.1172/JCI114880; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baccini M, 2008, GENES NUTR, V3, P147, DOI 10.1007/s12263-008-0102-5; Bastelica D, 2002, ARTERIOSCL THROM VAS, V22, P173, DOI 10.1161/hq0102.101552; Caserta F, 2001, AM J PHYSIOL-ENDOC M, V280, pE238, DOI 10.1152/ajpendo.2001.280.2.E238; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; DREVON CA, 1993, OMEGA 3 FATTY ACIDS, P1; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; EINERJENSEN N, 1974, J REPROD FERTIL, V37, P145; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FAUST IM, 1976, AM J PHYSIOL, V231, P538, DOI 10.1152/ajplegacy.1976.231.2.538; Ferre P, 1999, P NUTR SOC, V58, P621, DOI 10.1017/S0029665199000816; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foretz M, 1999, MOL CELL BIOL, V19, P3760; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; He ZB, 2004, AM J PHYSIOL-ENDOC M, V287, pE424, DOI 10.1152/ajpendo.00568.2003; HELLMER J, 1992, J CLIN ENDOCR METAB, V75, P15, DOI 10.1210/jc.75.1.15; Iizuka K, 2008, ENDOCR J, V55, P617, DOI 10.1507/endocrj.K07E-110; Joyner J, 2002, HORM METAB RES, V34, P223, DOI 10.1055/s-2002-32144; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kleemann R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r200; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Letexier D, 2005, DIABETES METAB, V31, P558, DOI 10.1016/S1262-3636(07)70231-8; LIN DS, 1993, J LIPID RES, V34, P491; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Macotela Y, 2009, DIABETES, V58, P803, DOI 10.2337/db08-1054; Mattacks CA, 1997, BRIT J NUTR, V77, P621, DOI 10.1079/BJN19970061; Mattacks Christine A, 2004, Lymphat Res Biol, V2, P107, DOI 10.1089/lrb.2004.2.107; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Montague CT, 1997, DIABETES, V46, P342, DOI 10.2337/diabetes.46.3.342; Motoshima H, 2002, J CLIN ENDOCR METAB, V87, P5662, DOI 10.1210/JC.2002-020635; NISSEN HP, 1981, ANDROLOGIA, V13, P444; NISSEN HP, 1983, ANDROLOGIA, V15, P264; POND CM, 1995, J LIPID RES, V36, P2219; Pond CM, 1998, IMMUNOL LETT, V63, P159, DOI 10.1016/S0165-2478(98)00074-1; Pond CM, 2005, PROSTAG LEUKOTR ESS, V73, P17, DOI 10.1016/j.plefa.2005.04.005; Pond CM, 2003, BRIT J NUTR, V89, P375, DOI 10.1079/BJN2002784; POULOS A, 1973, COMP BIOCHEM PHYSIOL, V46, P541, DOI 10.1016/0305-0491(73)90094-1; REBUFFESCRIVE M, 1990, J CLIN ENDOCR METAB, V71, P1215, DOI 10.1210/jcem-71-5-1215; Reynisdottir S, 1997, J CLIN ENDOCR METAB, V82, P4162, DOI 10.1210/jc.82.12.4162; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Saether T, 2003, BIOL REPROD, V69, P117, DOI 10.1095/biolreprod.102.014035; Saether T, 2007, REPRODUCTION, V133, P467, DOI 10.1530/REP-06-00294; Scott T W, 1973, J Reprod Fertil Suppl, V18, P65; SRINIVASAN V, 1986, INDIAN J EXP BIOL, V24, P487; Stewart TM, 2009, HUM REPROD, V24, P1561, DOI 10.1093/humrep/dep075; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Towle HC, 2001, P NATL ACAD SCI USA, V98, P13476, DOI 10.1073/pnas.251530798; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; Zalata AA, 1998, MOL HUM REPROD, V4, P111, DOI 10.1093/molehr/4.2.111	60	74	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11525	10.1371/journal.pone.0011525	http://dx.doi.org/10.1371/journal.pone.0011525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634946	gold, Green Published, Green Submitted			2022-12-27	WOS:000279781600010
J	Salvi, N; Guellich, A; Michelet, P; Demoule, A; Le Guen, M; Renou, L; Bonne, G; Riou, B; Langeron, O; Coirault, C				Salvi, Nadege; Guellich, Aziz; Michelet, Pierre; Demoule, Alexandre; Le Guen, Morgan; Renou, Laure; Bonne, Gisele; Riou, Bruno; Langeron, Olivier; Coirault, Catherine			Upregulation of PPAR beta/delta Is Associated with Structural and Functional Changes in the Type I Diabetes Rat Diaphragm	PLOS ONE			English	Article							CONTRACTILE CHARACTERISTICS; MYOSIN PHENOTYPE; GENE-EXPRESSION; MUSCLE; CARDIOMYOPATHY; RELAXATION; SKELETAL; STIMULATION; METFORMIN; KINETICS	Background: Diabetes mellitus is associated with alterations in peripheral striated muscles and cardiomyopathy. We examined diaphragmatic function and fiber composition and identified the role of peroxisome proliferator-activated receptors (PPAR alpha and beta/delta) as a factor involved in diaphragm muscle plasticity in response to type I diabetes. Methodology/Principal Findings: Streptozotocin-treated rats were studied after 8 weeks and compared with their controls. Diaphragmatic strips were stimulated in vitro and mechanical and energetic variables were measured, cross bridge kinetics assessed, and the effects of fatigue and hypoxia evaluated. Morphometry, myosin heavy chain isoforms, PPAR alpha and beta/delta gene and protein expression were also assessed. Diabetes induced a decrease in maximum velocity of shortening (-14%, P<0.05) associated with a decrease in myosin ATPase activity (-49%, P<0.05), and an increase in force (+20%, P<0.05) associated with an increase in the number of cross bridges (+14%, P<0.05). These modifications were in agreement with a shift towards slow myosin heavy chain fibers and were associated with an upregulation of PPAR beta/delta (+314% increase in gene and +190% increase in protein expression, P<0.05). In addition, greater resistances to fatigue and hypoxia were observed in diabetic rats. Conclusions/Significance: Type I diabetes induced complex mechanical and energetic changes in the rat diaphragm and was associated with an up-regulation of PPAR beta/delta that could improve resistance to fatigue and hypoxia and favour the shift towards slow myosin heavy chain isoforms.	[Salvi, Nadege; Michelet, Pierre; Le Guen, Morgan; Riou, Bruno; Langeron, Olivier] Univ Paris 06, INSERM, UMRS 956, Inst Myol,IFR14, Paris, France; [Guellich, Aziz; Demoule, Alexandre; Bonne, Gisele; Coirault, Catherine] Univ Paris 06, INSERM, UMRS 974, Inst Myol,IFR14, Paris, France; [Renou, Laure; Bonne, Gisele; Coirault, Catherine] Univ Paris 06, CNRS, UMR 7215, Inst Myol,IFR14, Paris, France; [Riou, Bruno] Grp Hosp Pitie Salpetriere, AP HP, Dept Emergency Med & Surg, F-75634 Paris, France; [Le Guen, Morgan; Langeron, Olivier] Grp Hosp Pitie Salpetriere, AP HP, Dept Anesthesiol & Crit Care, F-75634 Paris, France; [Demoule, Alexandre] Grp Hosp Pitie Salpetriere, AP HP, Dept Pneumol, F-75634 Paris, France; [Bonne, Gisele] Grp Hosp Pitie Salpetriere, AP HP, Dept Metab Biochem, F-75634 Paris, France; [Coirault, Catherine] Hop Bicetre, AP HP, Dept Physiol, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Salvi, N (corresponding author), Univ Paris 06, INSERM, UMRS 956, Inst Myol,IFR14, Paris, France.	bruno.riou@psl.aphp.fr	Coirault, Catherine/I-2979-2016; Coirault, Catherine/S-2454-2019; Bonne, Gisèle/G-3121-2013; Demoule, Alexandre/ABG-4915-2021	Coirault, Catherine/0000-0002-5594-1057; Bonne, Gisèle/0000-0002-2516-3258; Demoule, Alexandre/0000-0002-0432-7217				Amour J, 2008, ANESTH ANALG, V107, P1130, DOI 10.1213/ane.0b013e3181806903; Amour J, 2007, ANESTHESIOLOGY, V107, P452, DOI 10.1097/01.anes.0000278909.40408.24; BEATTY CH, 1959, J BIOL CHEM, V234, P11; BELOFFCH.A, 1968, BIOCHEM J, V110, P529, DOI 10.1042/bj1100529; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Clanton TL, 2001, J APPL PHYSIOL, V90, P2508, DOI 10.1152/jappl.2001.90.6.2508; Coirault C, 1999, AM J PHYSIOL-CELL PH, V277, pC1170, DOI 10.1152/ajpcell.1999.277.6.C1170; COIRAULT C, 1995, AM J RESP CRIT CARE, V152, P1275, DOI 10.1164/ajrccm.152.4.7551382; COIRAULT C, 1993, J APPL PHYSIOL, V75, P2265, DOI 10.1152/jappl.1993.75.5.2265; COIRAULT C, 1994, J APPL PHYSIOL, V76, P1468, DOI 10.1152/jappl.1994.76.4.1468; Escher P, 2001, ENDOCRINOLOGY, V142, P4195, DOI 10.1210/en.142.10.4195; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Hida W, 1996, AM J RESP CRIT CARE, V153, P1875, DOI 10.1164/ajrccm.153.6.8665049; HILL AV, 1964, PROC R SOC SER B-BIO, V159, P319, DOI 10.1098/rspb.1964.0005; Howlett RA, 2007, EXP PHYSIOL, V92, P887, DOI 10.1113/expphysiol.2007.037291; Huang CJ, 2007, PULM PHARMACOL THER, V20, P69, DOI 10.1016/j.pupt.2005.11.012; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; Lecarpentier Y, 2008, J THEOR BIOL, V250, P92, DOI 10.1016/j.jtbi.2007.09.022; Lecarpentier Y, 1998, FASEB J, V12, P981, DOI 10.1096/fasebj.12.11.981; LECARPENTIER YC, 1979, AM J PHYSIOL, V237, pH455, DOI 10.1152/ajpheart.1979.237.4.H455; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Mancini M, 1999, CHEST, V115, P1553, DOI 10.1378/chest.115.6.1553; McGuire M, 1998, EXP PHYSIOL, V83, P481, DOI 10.1113/expphysiol.1998.sp004131; McGuire M, 1999, EXP PHYSIOL, V84, P1051, DOI 10.1111/j.1469-445X.1999.01916.x; METZGER JM, 1985, J APPL PHYSIOL, V58, P1085, DOI 10.1152/jappl.1985.58.4.1085; Muoio DM, 2010, BBA-MOL CELL BIOL L, V1801, P281, DOI 10.1016/j.bbalip.2009.11.007; PARADISE NF, 1981, AM J PHYSIOL, V241, pH348, DOI 10.1152/ajpheart.1981.241.3.H348; Scano G, 2000, CHEST, V117, P960, DOI 10.1378/chest.117.4.960; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Sieck GC, 1998, COMP BIOCHEM PHYS B, V119, P435, DOI 10.1016/S0305-0491(98)00005-4; Sieck GC, 1996, J APPL PHYSIOL, V80, P2179, DOI 10.1152/jappl.1996.80.6.2179; STEARNS SB, 1979, J LIPID RES, V20, P654; van Lunteren E, 2003, RESP PHYSIOL NEUROBI, V135, P9, DOI 10.1016/S1569-9048(03)00038-7; van Lunteren E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007832; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; WANKE T, 1992, RESPIRATION, V59, P233; WANKE T, 1991, AM REV RESPIR DIS, V143, P97, DOI 10.1164/ajrccm/143.1.97; WATCHKO JF, 1993, J APPL PHYSIOL, V75, P1341, DOI 10.1152/jappl.1993.75.3.1341; WHITE JES, 1992, DIABETIC MED, V9, P954, DOI 10.1111/j.1464-5491.1992.tb01739.x; Yu BC, 2008, CARDIOVASC RES, V80, P78, DOI 10.1093/cvr/cvn172	42	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11494	10.1371/journal.pone.0011494	http://dx.doi.org/10.1371/journal.pone.0011494			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628611	Green Published, Green Submitted, gold			2022-12-27	WOS:000279637100016
J	Hiona, A; Sanz, A; Kujoth, GC; Pamplona, R; Seo, AY; Hofer, T; Someya, S; Miyakawa, T; Nakayama, C; Samhan-Arias, AK; Servais, S; Barger, JL; Portero-Otin, M; Tanokura, M; Prolla, TA; Leeuwenburgh, C				Hiona, Asimina; Sanz, Alberto; Kujoth, Gregory C.; Pamplona, Reinald; Seo, Arnold Y.; Hofer, Tim; Someya, Shinichi; Miyakawa, Takuya; Nakayama, Chie; Samhan-Arias, Alejandro K.; Servais, Stephane; Barger, Jamie L.; Portero-Otin, Manuel; Tanokura, Masaru; Prolla, Tomas A.; Leeuwenburgh, Christiaan			Mitochondrial DNA Mutations Induce Mitochondrial Dysfunction, Apoptosis and Sarcopenia in Skeletal Muscle of Mitochondrial DNA Mutator Mice	PLOS ONE			English	Article							OXIDATIVE STRESS; DELETION MUTATIONS; POINT MUTATIONS; CALORIC RESTRICTION; ELECTRON-TRANSPORT; HYDROGEN-PEROXIDE; CELL-DEATH; CAUSAL ROLE; LIFE-SPAN; AGE	Background: Aging results in a progressive loss of skeletal muscle, a condition known as sarcopenia. Mitochondrial DNA (mtDNA) mutations accumulate with aging in skeletal muscle and correlate with muscle loss, although no causal relationship has been established. Methodology/Principal Findings: We investigated the relationship between mtDNA mutations and sarcopenia at the gene expression and biochemical levels using a mouse model that expresses a proofreading-deficient version (D257A) of the mitochondrial DNA Polymerase c, resulting in increased spontaneous mtDNA mutation rates. Gene expression profiling of D257A mice followed by Parametric Analysis of Gene Set Enrichment (PAGE) indicates that the D257A mutation is associated with a profound downregulation of gene sets associated with mitochondrial function. At the biochemical level, sarcopenia in D257A mice is associated with a marked reduction (35-50%) in the content of electron transport chain (ETC) complexes I, III and IV, all of which are partly encoded by mtDNA. D257A mice display impaired mitochondrial bioenergetics associated with compromised state-3 respiration, lower ATP content and a resulting decrease in mitochondrial membrane potential (Delta psi(m)). Surprisingly, mitochondrial dysfunction was not accompanied by an increase in mitochondrial reactive oxygen species (ROS) production or oxidative damage. Conclusions/Significance: These findings demonstrate that mutations in mtDNA can be causal in sarcopenia by affecting the assembly of functional ETC complexes, the lack of which provokes a decrease in oxidative phosphorylation, without an increase in oxidative stress, and ultimately, skeletal muscle apoptosis and sarcopenia.	[Hiona, Asimina; Seo, Arnold Y.; Hofer, Tim; Servais, Stephane; Leeuwenburgh, Christiaan] Univ Florida, Coll Med, Inst Aging, Dept Aging & Geriatr Res,Div Biol Aging, Gainesville, FL USA; [Sanz, Alberto] Univ Tampere, Inst Med Technol, Mitochondrial Gene Express & Dis Grp, FIN-33101 Tampere, Finland; [Sanz, Alberto] Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; [Kujoth, Gregory C.; Someya, Shinichi; Prolla, Tomas A.] Univ Wisconsin, Dept Genet & Med Genet, Madison, WI USA; [Pamplona, Reinald; Portero-Otin, Manuel] Univ Lleida, Inst Recerca Biomed Lleida, Dept Expt Med, Lleida, Spain; [Someya, Shinichi; Miyakawa, Takuya; Nakayama, Chie; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo, Japan; [Samhan-Arias, Alejandro K.] Univ Extremadura, Fac Sci, Dept Biochem & Mol Biol, Badajoz, Spain; [Barger, Jamie L.] LifeGen Technol LLC, Madison, WI USA	State University System of Florida; University of Florida; Tampere University; Tampere University; Tampere University Hospital; University of Wisconsin System; University of Wisconsin Madison; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University of Tokyo; Universidad de Extremadura	Hiona, A (corresponding author), Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens, Greece.	taprolla@wisc.edu; cleeuwen@aging.ufl.edu	Portero-Otin, Manuel/B-7122-2009; Pamplona, Reinald/A-7359-2010; Sanz, Alberto/O-2329-2015; Servais, Stephane/Q-6057-2017; Samhan-Arias, Alejandro/J-3593-2014; SANZ, ALBERTO/F-8432-2011	Portero-Otin, Manuel/0000-0002-1823-0299; Pamplona, Reinald/0000-0003-4337-6107; Sanz, Alberto/0000-0003-2149-1753; Servais, Stephane/0000-0002-3127-9679; Samhan-Arias, Alejandro/0000-0001-9602-4848; Barger, Jamie/0000-0001-8694-0068; Tanokura, Masaru/0000-0001-5072-2480; Kujoth, Gregory/0000-0002-6636-2800; Leeuwenburgh, Christiaan/0000-0003-0826-4257	National Institute on Aging [AG17994, AG21042]; National Institutes of Health [AG021905]; American Heart Predoctoral Fellowship [0415166B, 0525346B, 0615256B]; Academy of Finland; University of Florida Institute on Aging; Spanish Ministry of Education and Science [BFU2006-14495/BFI]; Spanish Ministry of Health (ISCIII, Red de Envejecimiento y Fragilidad) [RD06/0013/0012, PI081843]; Autonomous Government of Catalonia [2005SGR00101]; Ministry of Education, Culture, Sports, Science, and Technologies of Japan; Claude D. Pepper Older Americans Independence Center Genomics and Biomarker Core [1 P30 AG028740]; NATIONAL INSTITUTE ON AGING [R01AG017994, P30AG028740, R01AG021042, R01AG021905] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Predoctoral Fellowship; Academy of Finland(Academy of Finland); University of Florida Institute on Aging; Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Health (ISCIII, Red de Envejecimiento y Fragilidad)(Spanish Government); Autonomous Government of Catalonia(Generalitat de Catalunya); Ministry of Education, Culture, Sports, Science, and Technologies of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Claude D. Pepper Older Americans Independence Center Genomics and Biomarker Core; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National Institute on Aging (AG17994 and AG21042) to CL, National Institutes of Health (AG021905) to TAP, an American Heart Predoctoral Fellowship to AH (0415166B), an American Heart Postdoctoral Fellowship to TH (0525346B), a grant from the Academy of Finland to AS, and an American Heart Predoctoral Fellowship to AYS (0615256B). Oxidative stress analysis was supported by the University of Florida Institute on Aging and Claude D. Pepper Older Americans Independence Center (1 P30 AG028740) Genomics and Biomarker Core. This research was also supported in part by I+D grants from the Spanish Ministry of Education and Science (BFU2006-14495/BFI), the Spanish Ministry of Health (ISCIII, Red de Envejecimiento y Fragilidad, RD06/0013/0012, and PI081843), and the Autonomous Government of Catalonia (2005SGR00101) to RP and MPO. Additional support was provided to MT by the National Projects on Protein Structural and Functional Analyses from the Ministry of Education, Culture, Sports, Science, and Technologies of Japan. Dr. Barger of LifeGen Technologies was involved with analysis of gene expression data from microarray experiments. No other funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemi M, 2007, FREE RADICAL BIO MED, V42, P32, DOI 10.1016/j.freeradbiomed.2006.09.014; Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148; BANDY B, 1990, FREE RADICAL BIO MED, V8, P523, DOI 10.1016/0891-5849(90)90152-9; Barja G, 2000, FASEB J, V14, P312, DOI 10.1096/fasebj.14.2.312; Barja G, 2002, J BIOENERG BIOMEMBR, V34, P227, DOI 10.1023/A:1016039604958; BEYER RE, 1984, MECH AGEING DEV, V24, P309, DOI 10.1016/0047-6374(84)90116-7; Bohr VA, 1999, BIOCHIMIE, V81, P155, DOI 10.1016/S0300-9084(99)80048-0; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brierley EJ, 1998, ANN NEUROL, V43, P217, DOI 10.1002/ana.410430212; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Cao ZJ, 2001, NUCLEIC ACIDS RES, V29, P4502, DOI 10.1093/nar/29.21.4502; Chabi B, 2005, BIOCHEM BIOPH RES CO, V332, P542, DOI 10.1016/j.bbrc.2005.04.153; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Cheadle Chris, 2003, Appl Bioinformatics, V2, P209; CHUNG SS, 1994, AGING-CLIN EXP RES, V6, P193, DOI 10.1007/BF03324239; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567; Desai VG, 1996, ARCH BIOCHEM BIOPHYS, V333, P145, DOI 10.1006/abbi.1996.0375; Dirks A, 2002, AM J PHYSIOL-REG I, V282, pR519, DOI 10.1152/ajpregu.00458.2001; Dirks AJ, 2004, FREE RADICAL BIO MED, V36, P27, DOI 10.1016/j.freeradbiomed.2003.10.003; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Drew B, 2003, AM J PHYSIOL-REG I, V284, pR474, DOI 10.1152/ajpregu.00455.2002; DUBESSAY P, 2007, BIOCHIMIE; Edgar D, 2009, CELL METAB, V10, P131, DOI 10.1016/j.cmet.2009.06.010; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Fayet G, 2002, NEUROMUSCULAR DISORD, V12, P484, DOI 10.1016/S0960-8966(01)00332-7; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; FLEMING JE, 1982, GERONTOLOGY, V28, P44, DOI 10.1159/000212510; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; HARMAN D, 1972, AM J CLIN NUTR, V25, P839; Harper ME, 1998, AM J PHYSIOL-ENDOC M, V275, pE197, DOI 10.1152/ajpendo.1998.275.2.E197; Herbst A, 2007, J GERONTOL A-BIOL, V62, P235, DOI 10.1093/gerona/62.3.235; Herrero A, 1999, AGING-CLIN EXP RES, V11, P294, DOI 10.1007/BF03339803; Hiona A, 2008, EXP GERONTOL, V43, P24, DOI 10.1016/j.exger.2007.10.001; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; KATAYAMA M, 1991, BIOCHEM INT, V25, P47; Kerner J, 2001, AM J PHYSIOL-ENDOC M, V281, pE1054; Khaidakov M, 2003, MUTAT RES-FUND MOL M, V526, P1, DOI 10.1016/S0027-5107(03)00010-1; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; LATORRE A, 1986, P NATL ACAD SCI USA, V83, P8649, DOI 10.1073/pnas.83.22.8649; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; LEE CM, 1993, J GERONTOL, V48, pB201, DOI 10.1093/geronj/48.6.B201; LINNANE AW, 1990, BIOCHEM INT, V22, P1067; Mansouri A, 2006, MECH AGEING DEV, V127, P298, DOI 10.1016/j.mad.2005.11.004; Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911; Marcinek DJ, 2005, J PHYSIOL-LONDON, V569, P467, DOI 10.1113/jphysiol.2005.097782; McKenzie D, 2002, EUR J BIOCHEM, V269, P2010, DOI 10.1046/j.1432-1033.2002.02867.x; McKiernan S, 2004, FASEB J, V18, P580, DOI 10.1096/fj.03-0667fje; MELOV S, 1994, NUCLEIC ACIDS RES, V22, P1075, DOI 10.1093/nar/22.6.1075; Miyoshi N, 2006, P NATL ACAD SCI USA, V103, P1727, DOI 10.1073/pnas.0510346103; Mott JL, 2001, MUTAT RES-FUND MOL M, V474, P35, DOI 10.1016/S0027-5107(00)00159-7; MULLERHOCKER J, 1993, VIRCHOWS ARCH A, V422, P7, DOI 10.1007/BF01605127; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; PIERI C, 1993, MECH AGEING DEV, V70, P201, DOI 10.1016/0047-6374(93)90048-V; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; PROCTOR DN, 1995, J APPL PHYSIOL, V78, P2033, DOI 10.1152/jappl.1995.78.6.2033; Roubenoff R, 2000, EUR J CLIN NUTR, V54, pS40, DOI 10.1038/sj.ejcn.1601024; Sanz A, 2005, BIOGERONTOLOGY, V6, P15, DOI 10.1007/s10522-004-7380-0; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Someya S, 2007, BRAIN RES, V1182, P26, DOI 10.1016/j.brainres.2007.08.090; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TROYER DL, 1990, ANAT HISTOL EMBRYOL, V19, P154, DOI 10.1111/j.1439-0264.1990.tb00899.x; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wanagat J, 2001, FASEB J, V15, P322, DOI 10.1096/fj.00-0320com; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017	87	186	193	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11468	10.1371/journal.pone.0011468	http://dx.doi.org/10.1371/journal.pone.0011468			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628647	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000279589300013
J	van Boven, M; Donker, T; van der Lubben, M; van Gageldonk-Lafeber, RB; Beest, DET; Koopmans, M; Meijer, A; Timen, A; Swaan, C; Dalhuijsen, A; Hahne, S; van den Hoek, A; Teunis, P; van der Sande, MAB; Wallinga, J				van Boven, Michiel; Donker, Tjibbe; van der Lubben, Mariken; van Gageldonk-Lafeber, Rianne B.; Beest, Dennis E. Te; Koopmans, Marion; Meijer, Adam; Timen, Aura; Swaan, Corien; Dalhuijsen, Anton; Hahne, Susan; van den Hoek, Anneke; Teunis, Peter; van der Sande, Marianne A. B.; Wallinga, Jacco			Transmission of Novel Influenza A(H1N1) in Households with Post-Exposure Antiviral Prophylaxis	PLOS ONE			English	Article							PANDEMIC INFLUENZA; DISEASE; OSELTAMIVIR; VIRUS; PATHOGENESIS; PARAMETERS; INFECTION; CONTACTS	Background: Despite impressive advances in our understanding of the biology of novel influenza A(H1N1) virus, little is as yet known about its transmission efficiency in close contact places such as households, schools, and workplaces. These are widely believed to be key in supporting propagating spread, and it is therefore of importance to assess the transmission levels of the virus in such settings. Methodology/Principal Findings: We estimate the transmissibility of novel influenza A(H1N1) in 47 households in the Netherlands using stochastic epidemic models. All households contained a laboratory confirmed index case, and antiviral drugs (oseltamivir) were given to both the index case and other households members within 24 hours after detection of the index case. Among the 109 household contacts there were 9 secondary infections in 7 households. The overall estimated secondary attack rate is low (0.075, 95% CI: 0.037-0.13). There is statistical evidence indicating that older persons are less susceptible to infection than younger persons (relative susceptibility of older persons: 0.11, 95% CI: 0.024-0.43. Notably, the secondary attack rate from an older to a younger person is 0.35 (95% CI: 0.14-0.61) when using an age classification of <= 12 versus.12 years, and 0.28 (95% CI: 0.12-0.50) when using an age classification of <= 18 versus >18 years. Conclusions/Significance: Our results indicate that the overall household transmission levels of novel influenza A(H1N1) in antiviral-treated households were low in the early stage of the epidemic. The relatively high rate of adult-to-child transmission indicates that control measures focused on this transmission route will be most effective in minimizing the total number of infections.	[van Boven, Michiel; Donker, Tjibbe; van der Lubben, Mariken; van Gageldonk-Lafeber, Rianne B.; Beest, Dennis E. Te; Koopmans, Marion; Meijer, Adam; Timen, Aura; Swaan, Corien; Hahne, Susan; Teunis, Peter; van der Sande, Marianne A. B.; Wallinga, Jacco] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [Beest, Dennis E. Te] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands; [Dalhuijsen, Anton] Publ Hlth Serv Hollands Midden, Unit Infect Dis Control, Leiden, Netherlands; [van den Hoek, Anneke] Publ Hlth Serv, Dept Infect Dis, Amsterdam, Netherlands; [van der Sande, Marianne A. B.; Wallinga, Jacco] Univ Med Ctr Utrecht, Julius Ctr Hlth Res & Primary Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Utrecht University; Public Health Service Amsterdam; Utrecht University; Utrecht University Medical Center	van Boven, M (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	michiel.van.boven@rivm.nl	Wallinga, Jacco/C-4382-2018; Timen, Aura/GLV-4130-2022	Wallinga, Jacco/0000-0003-1725-5627; van der Sande, Marianne AB/0000-0002-4778-6739; Donker, Tjibbe/0000-0001-9022-4240; Koopmans, Marion/0000-0002-5204-2312; te Beest, Dennis E./0000-0001-5265-9008	Dutch Ministry of Health, Welfare and Sport	Dutch Ministry of Health, Welfare and Sport	This study was funded by the Dutch Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDY CL, 1991, BIOMETRICS, V47, P961, DOI 10.2307/2532652; Ball F, 1999, J APPL PROBAB, V36, P473, DOI 10.1017/S0021900200017265; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Ghani AC, 2009, PLOS CURR INFLUENZA, V1, DOI [10.1371/currents.RRN1130, DOI 10.1371/CURRENTS.RRN1130]; Glass K, 2009, J R SOC INTERFACE, V6, P695, DOI 10.1098/rsif.2008.0404; HAHNE S, 2009, EURO SURVEILLANCE, V14; Halloran ME, 2007, AM J EPIDEMIOL, V165, P212, DOI 10.1093/aje/kwj362; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P845, DOI 10.1093/oxfordjournals.aje.a115038; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Meijer A, 2009, J CLIN VIROL, V45, P179, DOI 10.1016/j.jcv.2009.06.003; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; O'Neill PD, 2009, BIOSTATISTICS, V10, P779, DOI 10.1093/biostatistics/kxp031; Odaira F, 2009, EUROSURVEILLANCE, V14, P2; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; van Boven M, 2007, PLOS COMPUT BIOL, V3, P1394, DOI 10.1371/journal.pcbi.0030145; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	36	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11442	10.1371/journal.pone.0011442	http://dx.doi.org/10.1371/journal.pone.0011442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628642	Green Published, Green Submitted, gold			2022-12-27	WOS:000279589300003
J	Guo, L; Lu, ZH				Guo, Li; Lu, Zuhong			The Fate of miRNA* Strand through Evolutionary Analysis: Implication for Degradation As Merely Carrier Strand or Potential Regulatory Molecule?	PLOS ONE			English	Article							SMALL RNAS; MICRORNA; EXPRESSION; IDENTIFICATION; GENES; CELL; BIOGENESIS; MECHANISMS; ASYMMETRY; SIRNAS	Background: During typical microRNA (miRNA) biogenesis, one strand of a similar to 22 nt RNA duplex is preferentially selected for entry into a silencing complex, whereas the other strand, known as the passenger strand or miRNA* strand, is degraded. Recently, some miRNA* sequences were reported as guide miRNAs with abundant expression. Here, we intended to discover evolutionary implication of the fate of miRNA* strand by analyzing miRNA/miRNA* sequences across vertebrates. Principal Findings: Mature miRNAs based on gene families were well conserved especially for their seed sequences across vertebrates, while their passenger strands always showed various divergence patterns. The divergence mainly resulted from divergence of different animal species, homologous miRNA genes and multicopy miRNA hairpin precursors. Some miRNA* sequences were phylogenetically conserved in seed and anchor sequences similar to mature miRNAs, while others revealed high levels of nucleotide divergence despite some of their partners were highly conserved. Most of those miRNA precursors that could generate abundant miRNAs from both strands always were well conserved in sequences of miR-#-5p and miR-#-3p, especially for their seed sequences. Conclusions: The final fate of miRNA* strand, either degraded as merely carrier strand or expressed abundantly as potential functional guide miRNA, may be destined across evolution. Well-conserved miRNA* strands, particularly conservation in seed sequences, maybe afford potential opportunities for contributing to regulation network. The study will broaden our understanding of potential functional miRNA* species.	[Guo, Li; Lu, Zuhong] Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China; [Lu, Zuhong] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing, Peoples R China	Southeast University - China; Southeast University - China	Guo, L (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, State Key Lab Bioelect, Nanjing, Peoples R China.	zhlu@seu.edu.cn	Lu, Zuhong/A-5448-2013	Lu, Zuhong/0000-0003-3332-2615	National Natural Science Foundation of China [30871393]; Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation	The work is supported by the project 30871393 from National Natural Science Foundation of China and funded by Tsinghua National Laboratory for Information Science and Technology (TNList) Cross-discipline Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bompfunewerer AF, 2005, THEOR BIOSCI, V123, P301, DOI 10.1016/j.thbio.2005.01.002; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; GUO L, 2010, ANAL ISOMIR IN PRESS; Guo L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007944; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; O'Toole AS, 2006, NUCLEIC ACIDS RES, V34, P3338, DOI 10.1093/nar/gkl428; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P354, DOI 10.1038/nsmb.1409; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schwarz DS, 2007, CELL, V131, P30, DOI 10.1016/S0092-8674(03)00759-1; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x	48	173	179	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11387	10.1371/journal.pone.0011387	http://dx.doi.org/10.1371/journal.pone.0011387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613982	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000016
J	Hostager, BS; Fox, DK; Whitten, D; Wilkerson, CG; Eipper, BA; Francone, VP; Rothman, PB; Colgan, JD				Hostager, Bruce S.; Fox, Daniel K.; Whitten, Douglas; Wilkerson, Curtis G.; Eipper, Betty A.; Francone, Victor P.; Rothman, Paul B.; Colgan, John D.			HOIL-1L Interacting Protein (HOIP) as an NF-kappa B Regulating Component of the CD40 Signaling Complex	PLOS ONE			English	Article							SERINE-PROTEASE; APOPTOSIS; IDENTIFICATION; TRAF2; CELLS; LYMPHOCYTES; RECRUITMENT; ACTIVATION; MECHANISM; ROLES	The tumor necrosis factor receptor (TNFR) superfamily mediates signals critical for regulation of the immune system. One family member, CD40, is important for the efficient activation of antibody-producing B cells and other antigen-presenting cells. The molecules and mechanisms that mediate CD40 signaling are only partially characterized. Proteins known to interact with the cytoplasmic domain of CD40 include members of the TNF receptor-associated factor (TRAF) family, which regulate signaling and serve as links to other signaling molecules. To identify additional proteins important for CD40 signaling, we used a combined stimulation/immunoprecipitation procedure to isolate CD40 signaling complexes from B cells and characterized the associated proteins by mass spectrometry. In addition to known CD40-interacting proteins, we detected SMAC/DIABLO, HTRA2/Omi, and HOIP/RNF31/PAUL/ZIBRA. We found that these previously unknown CD40-interacting partners were recruited in a TRAF2-dependent manner. HOIP is a ubiquitin ligase capable of mediating NF-kappa B activation through the ubiquitin-dependent activation of IKK gamma. We found that a mutant HOIP molecule engineered to lack ubiquitin ligase activity inhibited the CD40-mediated activation of NF-kappa B. Together, our results demonstrate a powerful approach for the identification of signaling molecules associated with cell surface receptors and indicate an important role for the ubiquitin ligase activity of HOIP in proximal CD40 signaling.	[Hostager, Bruce S.; Rothman, Paul B.; Colgan, John D.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Fox, Daniel K.] Univ Iowa, Med Scientist Training Program, Iowa City, IA USA; [Whitten, Douglas; Wilkerson, Curtis G.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Whitten, Douglas; Wilkerson, Curtis G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Eipper, Betty A.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT USA; [Francone, Victor P.] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA	University of Iowa; University of Iowa; Michigan State University; Michigan State University; University of Connecticut; Geisinger Commonwealth School of Medicine	Hostager, BS (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	bruce-hostager@uiowa.edu		Colgan, John/0000-0001-9273-2644	Carver Trust; American Cancer Society/Holden Comprehensive Cancer Center; National Institutes of Health (NIH) [DK32948, R01AI054821, R01AI077516]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077516, R01AI067489, R01AI054821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK032948, R01DK032948, R37DK032948] Funding Source: NIH RePORTER	Carver Trust; American Cancer Society/Holden Comprehensive Cancer Center(American Cancer Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a Carver Trust Medical Research Initiative Grant (BSH), an American Cancer Society/Holden Comprehensive Cancer Center grant (BSH), and National Institutes of Health (NIH) (www.nih.gov) grants DK32948 (BAE), R01AI054821 (PBR) and R01AI077516 ( PBR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson RJ, 2006, EUR J IMMUNOL, V36, P2535, DOI 10.1002/eji.200535483; Bishop GA, 2007, ADV EXP MED BIOL, V597, P131; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Ehrlund A, 2009, MOL CELL BIOL, V29, P2230, DOI 10.1128/MCB.00743-08; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; HEATH AW, 1994, EUR J IMMUNOL, V24, P1828, DOI 10.1002/eji.1830240816; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hollmann CA, 2002, EXP CELL RES, V280, P201, DOI 10.1006/excr.2002.5640; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; Hostager BS, 1996, J IMMUNOL, V157, P1047; Hostager BS, 2000, J BIOL CHEM, V275, P15392, DOI 10.1074/jbc.M909520199; Jin SK, 2003, GENE DEV, V17, P359, DOI 10.1101/gad.1047003; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kuai J, 2003, J BIOL CHEM, V278, P14363, DOI 10.1074/jbc.M208672200; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; MCKEAN DJ, 1983, J IMMUNOL, V131, P2726; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pineda G, 2007, ADV EXP MED BIOL, V597, P80; Rowland SL, 2007, J IMMUNOL, V179, P4645, DOI 10.4049/jimmunol.179.7.4645; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Thompson HGR, 2004, EXP CELL RES, V295, P448, DOI 10.1016/j.yexcr.2004.01.019; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vidalain PO, 2000, EMBO J, V19, P3304, DOI 10.1093/emboj/19.13.3304; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Xie P, 2008, CYTOKINE GROWTH F R, V19, P199, DOI 10.1016/j.cytogfr.2008.04.002	28	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11380	10.1371/journal.pone.0011380	http://dx.doi.org/10.1371/journal.pone.0011380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614026	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000010
J	Lee, SH; Cho, SY; Shannon, MF; Fan, J; Rangasamy, D				Lee, Sung-Hun; Cho, Soo-Young; Shannon, M. Frances; Fan, Jun; Rangasamy, Danny			The Impact of CpG Island on Defining Transcriptional Activation of the Mouse L1 Retrotransposable Elements	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; LINE-1 RETROTRANSPOSONS; EPIGENETIC REGULATION; MAMMALIAN GENOMES; BINDING-SITES; SUBFAMILY; GENES; DNA; AMPLIFICATION; INTERFERENCE	Background: L1 retrotransposable elements are potent insertional mutagens responsible for the generation of genomic variation and diversification of mammalian genomes, but reliable estimates of the numbers of actively transposing L1 elements are mostly nonexistent. While the human and mouse genomes contain comparable numbers of L1 elements, several phylogenetic and L1Xplore analyses in the mouse genome suggest that 1,500-3,000 active L1 elements currently exist and that they are still expanding in the genome. Conversely, the human genome contains only 150 active L1 elements. In addition, there is a discrepancy among the nature and number of mouse L1 elements in L1Xplore and the mouse genome browser at the UCSC and in the literature. To date, the reason why a high copy number of active L1 elements exist in the mouse genome but not in the human genome is unknown, as are the potential mechanisms that are responsible for transcriptional activation of mouse L1 elements. Methodology/Principal Findings: We analyzed the promoter sequences of the 1,501 potentially active mouse L1 elements retrieved from the GenBank and L1Xplore databases and evaluated their transcription factors binding sites and CpG content. To this end, we found that a substantial number of mouse L1 elements contain altered transcription factor YY1 binding sites on their promoter sequences that are required for transcriptional initiation, suggesting that only a half of L1 elements are capable of being transcriptionally active. Furthermore, we present experimental evidence that previously unreported CpG islands exist in the promoters of the most active T(F) family of mouse L1 elements. The presence of sequence variations and polymorphisms in CpG islands of L1 promoters that arise from transition mutations indicates that CpG methylation could play a significant role in determining the activity of L1 elements in the mouse genome. Conclusions: A comprehensive analysis of mouse L1 promoters suggests that the number of transcriptionally active elements is significantly lower than the total number of full-length copies from the three active mouse L1 families. Like human L1 elements, the CpG islands and potentially the transcription factor YY1 binding sites are likely to be required for transcriptional initiation of mouse L1 elements.	[Lee, Sung-Hun; Shannon, M. Frances; Fan, Jun; Rangasamy, Danny] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Cho, Soo-Young] Hanyang Univ, Div Mol & Life Sci, Ansan, South Korea	Australian National University; John Curtin School of Medical Research; Hanyang University	Lee, SH (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia.	Danny.Rangasamy@anu.edu.au						Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Chen JM, 2005, HUM GENET, V117, P411, DOI 10.1007/s00439-005-1321-0; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; DeBerardinis RJ, 1998, NAT GENET, V20, P288, DOI 10.1038/3104; Dmitriev SE, 2007, MOL CELL BIOL, V27, P4685, DOI 10.1128/MCB.02138-06; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Fontanillas P, 2007, PLOS GENET, V3, P2256, DOI 10.1371/journal.pgen.0030210; FURANO AV, 1988, NUCLEIC ACIDS RES, V16, P9215, DOI 10.1093/nar/16.19.9215; Furano AV, 2000, PROG NUCLEIC ACID RE, V64, P255, DOI 10.1016/S0079-6603(00)64007-2; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Graham T, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/75327; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Huda A, 2009, ANN NY ACAD SCI, V1178, P276, DOI 10.1111/j.1749-6632.2009.05007.x; Huda A, 2009, GENE, V436, P12, DOI 10.1016/j.gene.2009.01.013; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Khatib H, 2007, MAMM GENOME, V18, P538, DOI 10.1007/s00335-007-9039-z; Kinoshita Y, 2007, PLANT J, V49, P38, DOI 10.1111/j.1365-313X.2006.02936.x; Ko CY, 2008, J BIOL CHEM, V283, P30919, DOI 10.1074/jbc.M804029200; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SH, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-53; Lu KP, 2003, J BIOL CHEM, V278, P28201, DOI 10.1074/jbc.M303888200; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; Montoya-Durango DE, 2009, MUTAT RES-FUND MOL M, V665, P20, DOI 10.1016/j.mrfmmm.2009.02.011; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; Schones DE, 2005, BIOINFORMATICS, V21, P307, DOI 10.1093/bioinformatics/bth480; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheelan SJ, 2005, GENOME RES, V15, P1073, DOI 10.1101/gr.3688905; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663	46	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11353	10.1371/journal.pone.0011353	http://dx.doi.org/10.1371/journal.pone.0011353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613872	Green Published, Green Submitted, gold			2022-12-27	WOS:000279369900005
J	del Rincon, SV; Rogers, J; Widschwendter, M; Sun, DH; Sieburg, HB; Spruck, C				del Rincon, Sonia V.; Rogers, Jeff; Widschwendter, Martin; Sun, Dahui; Sieburg, Hans B.; Spruck, Charles			Development and Validation of a Method for Profiling Post-Translational Modification Activities Using Protein Microarrays	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; SACCHAROMYCES-CEREVISIAE; SUMOYLATED PROTEINS; PROLACTIN RECEPTOR; MASS-SPECTROMETRY; LIGASE; IDENTIFICATION; PROTEOMICS; CANCER; PHOSPHORYLATION	Background: Post-translational modifications (PTMs) impact on the stability, cellular location, and function of a protein thereby achieving a greater functional diversity of the proteome. To fully appreciate how PTMs modulate signaling networks, proteome-wide studies are necessary. However, the evaluation of PTMs on a proteome-wide scale has proven to be technically difficult. To facilitate these analyses we have developed a protein microarray-based assay that is capable of profiling PTM activities in complex biological mixtures such as whole-cell extracts and pathological specimens. Methodology/Principal Findings: In our assay, protein microarrays serve as a substrate platform for in vitro enzymatic reactions in which a recombinant ligase, or extracts prepared from whole cells or a pathological specimen is overlaid. The reactions include labeled modifiers (e. g., ubiquitin, SUMO1, or NEDD8), ATP regenerating system, and other required components (depending on the assay) that support the conjugation of the modifier. In this report, we apply this methodology to profile three molecularly complex PTMs (ubiquitylation, SUMOylation, and NEDDylation) using purified ligase enzymes and extracts prepared from cultured cell lines and pathological specimens. We further validate this approach by confirming the in vivo modification of several novel PTM substrates identified by our assay. Conclusions/Significance: This methodology offers several advantages over currently used PTM detection methods including ease of use, rapidity, scale, and sample source diversity. Furthermore, by allowing for the intrinsic enzymatic activities of cell populations or pathological states to be directly compared, this methodology could have widespread applications for the study of PTMs in human diseases and has the potential to be directly applied to most, if not all, basic PTM research.	[del Rincon, Sonia V.; Sun, Dahui; Sieburg, Hans B.; Spruck, Charles] Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA; [Rogers, Jeff] Life Technol Corp, Carlsbad, CA USA; [Widschwendter, Martin] UCL, Dept Gynaecol Oncol, London, England	Sanford Burnham Prebys Medical Discovery Institute; Thermo Fisher Scientific; University of London; University College London	del Rincon, SV (corresponding author), Sanford Burnham Med Res Inst, Signal Transduct Program, La Jolla, CA USA.	cspruck@burnham.org		Widschwendter, Martin/0000-0002-7778-8380	Department of Defense Breast Cancer Research Program [W81XWH-07-1-0628]; DOD BCRP [W81XWH-06-1-0544]; California Breast Cancer Research Program [CBCRP, 15IB-0130]	Department of Defense Breast Cancer Research Program(United States Department of Defense); DOD BCRP(United States Department of Defense); California Breast Cancer Research Program	This work was supported by a grant from the Department of Defense Breast Cancer Research Program (DOD BCRP, W81XWH-07-1-0628) to CS. SVdR was supported by a postdoctoral fellowship from the DOD BCRP (W81XWH-06-1-0544) and an IDEA award from the California Breast Cancer Research Program (CBCRP, 15IB-0130). Materials and salary support for JR were provided by Life Technologies Corp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2000, FEBS LETT, V475, P31, DOI 10.1016/S0014-5793(00)01621-5; Ali S, 2003, J BIOL CHEM, V278, P52021, DOI 10.1074/jbc.M306758200; Bartek J, 2010, CANCER CELL, V17, P9, DOI 10.1016/j.ccr.2009.12.030; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertone P, 2005, PLANT PHYSIOL, V138, P560, DOI 10.1104/pp.104.900154; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; Burger AM, 2005, CANCER RES, V65, P10401, DOI 10.1158/0008-5472.CAN-05-2103; CAHOREAU C, 1994, FEBS LETT, V350, P230, DOI 10.1016/0014-5793(94)00772-1; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Dantuma NP, 2009, DNA REPAIR, V8, P449, DOI 10.1016/j.dnarep.2009.01.005; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Gresko E, 2005, BIOCHEM BIOPH RES CO, V329, P1293, DOI 10.1016/j.bbrc.2005.02.113; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Gupta R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100159; Hancock WS, 2002, PROTEOMICS, V2, P352, DOI 10.1002/1615-9861(200204)2:4<352::AID-PROT352>3.0.CO;2-U; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Jeon HB, 2007, BIOCHEM BIOPH RES CO, V357, P731, DOI 10.1016/j.bbrc.2007.04.015; Johnson FM, 2007, ANTI-CANCER AGENT ME, V7, P651, DOI 10.2174/187152007784111278; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kobayashi S, 2004, FASEB J, V18, P929, DOI 10.1096/fj.03-0767fje; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Langereis MA, 2007, J VIROL METHODS, V139, P189, DOI 10.1016/j.jviromet.2006.09.019; Li TW, 2006, ARCH BIOCHEM BIOPHYS, V453, P70, DOI 10.1016/j.abb.2006.03.002; Lu Z, 2007, J CELL BIOL, V177, P1077, DOI 10.1083/jcb.200610060; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Merbl Y, 2009, P NATL ACAD SCI USA, V106, P2543, DOI 10.1073/pnas.0812892106; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Norman JA, 2006, BIOCHEMISTRY-US, V45, P3014, DOI 10.1021/bi052435a; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pedrioli PGA, 2006, NAT METHODS, V3, P533, DOI 10.1038/NMETH891; Pereira C.A.d.B., 1999, ENTROPY-SWITZ, V1, P99, DOI [10.3390/e1040099, DOI 10.3390/E1040099]; Pereira CAD, 2008, BAYESIAN ANAL, V3, P79; Pfleger CM, 2000, GENE DEV, V14, P655; Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Raymond FL, 2006, J MED GENET, V43, P193, DOI 10.1136/jmg.2005.033043; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Team RDC, 2019, R LANG ENV STAT COMP; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700	53	22	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11332	10.1371/journal.pone.0011332	http://dx.doi.org/10.1371/journal.pone.0011332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596523	Green Published, gold, Green Submitted			2022-12-27	WOS:000279259900006
J	Nowak, M; Arredouani, MS; Tun-Kyi, A; Schmidt-Wolf, I; Sanda, MG; Balk, SP; Exley, MA				Nowak, Michael; Arredouani, Mohammed S.; Tun-Kyi, Adrian; Schmidt-Wolf, Ingo; Sanda, Martin G.; Balk, Steven P.; Exley, Mark A.			Defective NKT Cell Activation by CD1d+TRAMP Prostate Tumor Cells Is Corrected by Interleukin-12 with alpha-Galactosylceramide	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; KILLER T-CELLS; DENDRITIC CELLS; IFN-GAMMA; RECEPTOR EXPRESSION; IMMUNE-RESPONSES; CD1 MOLECULES; MURINE CD1; MOUSE; CANCER	Numerical and functional defects of invariant natural killer T cells (iNKT) have been documented in human and mouse cancers, resulting in a defect in IFN production in several malignancies. iNKT cells recognize glycolipids presented on CD1d molecules by dendritic and related cells, leading to their activation and thereby regulating immune reactions. Activated iNKT cells cytokine secretion and cytotoxicity can inhibit existing and spontaneous tumor growth, progression, and metastasis. We have identified functional iNKT cell defects in the murine TRAMP prostate cancer model. We found that iNKT cells show the ability to migrate into TRAMP prostate tumors. This infiltration was mediated through CCL2: CCR5 chemokine: receptor interaction. Prostate tumor cells expressing CD1d partially activated iNKT cells, as appreciated by up-regulation of CD25, PD-1 and the IL-12R. However, despite inducing up-regulation of these activation markers and, hence, delivering positive signals, prostate tumor cells inhibited the IL-12-induced STAT4 phosphorylation in a cell-cell contact dependent but CD1d-independent manner. Consequently, tumor cells did not induce secretion of IFN gamma by iNKT cells. Blocking the inhibitory Ly49 receptor on iNKT cells in the presence of alpha-GalCer restored their IFN gamma production in vivo and in vitro. However, Ly49 blockade alone was not sufficient. Importantly, this defect could be also be reversed into vigorous secretion of IFN gamma by the addition of both IL-12 and the exogenous CD1d ligand alpha-galactosylceramide, but not by IL-12 alone, both in vivo and in vitro. These data underscore the potential to optimize iNKT-based therapeutic approaches.	[Nowak, Michael; Tun-Kyi, Adrian; Balk, Steven P.; Exley, Mark A.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Dept Med, Boston, MA 02215 USA; [Nowak, Michael; Schmidt-Wolf, Ingo] Univ Bonn, Dept Hematol & Oncol, D-5300 Bonn, Germany; [Arredouani, Mohammed S.; Sanda, Martin G.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Surg,Div Urol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Bonn; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nowak, M (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol,Dept Med, Boston, MA 02215 USA.	michael.nowak@ukb.uni-bonn.de	Sanda, Martin G/A-6202-2013; Sanda, Martin G/B-2023-2015	Exley, Mark/0000-0002-5088-1032	NIH [R01 DK 066917]; Prostate Cancer Foundation; DOD [W81XWH-09-1-0156]; NATIONAL CANCER INSTITUTE [R21CA143748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066917] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DF/HCC Prostate Cancer SPORE Development Award (MAE), NIH R01 DK 066917 (MAE), Prostate Cancer Foundation Competitive Award (MAE) and DOD Prostate Cancer Development Award W81XWH-09-1-0156 (SPB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beldi G, 2008, HEPATOLOGY, V48, P841, DOI 10.1002/hep.22401; Bellone M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008646; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; BLEICHER PA, 1990, SCIENCE, V250, P679, DOI 10.1126/science.1700477; Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; BRUTKIEWICZ RR, 1995, J EXP MED, V182, P1913, DOI 10.1084/jem.182.6.1913; Chang WS, 2008, J IMMUNOL, V181, P6707, DOI 10.4049/jimmunol.181.10.6707; Cocco C, 2009, CURR MOL MED, V9, P459, DOI 10.2174/156652409788167140; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Fais F, 2004, INT J CANCER, V109, P402, DOI 10.1002/ijc.11723; Fasso M, 2008, P NATL ACAD SCI USA, V105, P3509, DOI 10.1073/pnas.0712269105; Fujii S, 2002, NAT IMMUNOL, V3, P867, DOI 10.1038/ni827; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Hayakawa Y, 2001, J IMMUNOL, V166, P6012, DOI 10.4049/jimmunol.166.10.6012; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kim CH, 2002, BLOOD, V100, P11, DOI 10.1182/blood-2001-12-0196; Kitamura H, 1999, J EXP MED, V189, P1121, DOI 10.1084/jem.189.7.1121; Lu Y, 2006, PROSTATE, V66, P1311, DOI 10.1002/pros.20464; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Mandal M, 1998, MOL IMMUNOL, V35, P525, DOI 10.1016/S0161-5890(98)00055-8; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Matsuda JL, 2008, CURR OPIN IMMUNOL, V20, P358, DOI 10.1016/j.coi.2008.03.018; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Mazzucchelli L, 1996, AM J PATHOL, V149, P501; Metelitsa LS, 2004, J EXP MED, V199, P1213, DOI 10.1084/jem.20031462; Metelitsa LS, 2003, LEUKEMIA, V17, P1068, DOI 10.1038/sj.leu.2402943; Molling JW, 2005, INT J CANCER, V116, P87, DOI 10.1002/ijc.20998; Moodycliffe AM, 2000, NAT IMMUNOL, V1, P521, DOI 10.1038/82782; Motohashi S, 2008, CANCER SCI, V99, P638, DOI 10.1111/j.1349-7006.2008.00730.x; Nowak M, 2007, INT REV IMMUNOL, V26, P95, DOI 10.1080/08830180601070195; Ortaldo JR, 2005, MOL IMMUNOL, V42, P445, DOI 10.1016/j.molimm.2004.07.024; Parekh VV, 2009, J IMMUNOL, V182, P2816, DOI 10.4049/jimmunol.0803648; Parekh VV, 2005, CRIT REV IMMUNOL, V25, P183, DOI 10.1615/CritRevImmunol.v25.i3.20; Park SH, 1998, J IMMUNOL, V160, P3128; Reddy M, 2005, CELL IMMUNOL, V236, P123, DOI 10.1016/j.cellimm.2005.08.018; Roark JH, 1998, J IMMUNOL, V160, P3121; Shi MQ, 2005, EXP ONCOL, V27, P125; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; Thomas SY, 2003, J IMMUNOL, V171, P2571, DOI 10.4049/jimmunol.171.5.2571; van der Vliet HJJ, 2008, J IMMUNOL, V180, P7287, DOI 10.4049/jimmunol.180.11.7287; VANDERVLIER HJ, 2003, CANCER RES, V53, P4101; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Yang YF, 2000, INT IMMUNOL, V12, P1669, DOI 10.1093/intimm/12.12.1669	46	47	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11311	10.1371/journal.pone.0011311	http://dx.doi.org/10.1371/journal.pone.0011311			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593019	Green Submitted, Green Published, gold			2022-12-27	WOS:000279140800012
J	Wiens, KM; Lee, HL; Shimada, H; Metcalf, AE; Chao, MY; Lien, CL				Wiens, Katie M.; Lee, Hyuna L.; Shimada, Hiroyuki; Metcalf, Anthony E.; Chao, Michael Y.; Lien, Ching-Ling			Platelet-Derived Growth Factor Receptor beta Is Critical for Zebrafish Intersegmental Vessel Formation	PLOS ONE			English	Article							PDGF-B; GENE-EXPRESSION; PERICYTE LOSS; DEFICIENT; CELLS	Background: Platelet-derived growth factor receptor beta (PDGFR beta) is a tyrosine kinase receptor known to affect vascular development. The zebrafish is an excellent model to study specific regulators of vascular development, yet the role of PDGF signaling has not been determined in early zebrafish embryos. Furthermore, vascular mural cells, in which PDGFR beta functions cell autonomously in other systems, have not been identified in zebrafish embryos younger than 72 hours post fertilization. Methodology/Principal Findings: In order to investigate the role of PDGFR beta in zebrafish vascular development, we cloned the highly conserved zebrafish homolog of PDGFR beta. We found that pdgfr beta is expressed in the hypochord, a developmental structure that is immediately dorsal to the dorsal aorta and potentially regulates blood vessel development in the zebrafish. Using a PDGFR tyrosine kinase inhibitor, a morpholino oligonucleotide specific to PDGFR beta, and a dominant negative PDGFR beta transgenic line, we found that PDGFR beta is necessary for angiogenesis of the intersegmental vessels. Significance/Conclusion: Our data provide the first evidence that PDGFR beta signaling is required for zebrafish angiogenesis. We propose a novel mechanism for zebrafish PDGFR beta signaling that regulates vascular angiogenesis in the absence of mural cells.	[Wiens, Katie M.; Lee, Hyuna L.; Lien, Ching-Ling] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Wiens, Katie M.; Lee, Hyuna L.; Shimada, Hiroyuki; Lien, Ching-Ling] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Shimada, Hiroyuki] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Metcalf, Anthony E.; Chao, Michael Y.] Calif State Univ San Bernardino, Dept Biol, San Bernardino, CA 92407 USA	University of Southern California; Children's Hospital Los Angeles; University of Southern California; California State University System; California State University San Bernardino	Wiens, KM (corresponding author), Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA.	clien@chla.usc.edu			National Institute of Heart, Lung and Blood [HL096121]; American Heart Association [0730214N]; Wright Foundation; Saban Research Institute; California Institute of Regenerative Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096121] Funding Source: NIH RePORTER	National Institute of Heart, Lung and Blood(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Wright Foundation; Saban Research Institute; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institute of Heart, Lung and Blood (HL096121, www.nhlbi.nih.gov), the American Heart Association (0730214N, www.americanheart.org), the Wright Foundation (www.wrightfoundation.com), the Research Career Development Award from the Saban Research Institute to C-L.L., and a California Institute of Regenerative Medicine training fellowship (www.cirm.ca.gov) to K.M.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Betsholtz C, 2004, CYTOKINE GROWTH F R, V15, P215, DOI 10.1016/j.cytogfr.2004.03.005; Bjarnegard M, 2004, DEVELOPMENT, V131, P1847, DOI 10.1242/dev.01080; Chan J, 2001, DEV BIOL, V234, P470, DOI 10.1006/dbio.2001.0281; Childs S, 2002, DEVELOPMENT, V129, P973; Cleaver O, 2000, DEVELOPMENT, V127, P869; Covassin LD, 2006, P NATL ACAD SCI USA, V103, P6554, DOI 10.1073/pnas.0506886103; Drake Christopher J., 2003, Birth Defects Research, V69, P73, DOI 10.1002/bdrc.10003; Halpern ME, 2008, ZEBRAFISH, V5, P97, DOI 10.1089/zeb.2008.0530; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lien CL, 2006, PLOS BIOL, V4, P1386, DOI 10.1371/journal.pbio.0040260; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Liu LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002850; Nishioka C, 2008, BLOOD, V111, P5086, DOI 10.1182/blood-2007-06-098079; NUSSLEINVOLHARD.RD, 2002, ZEBRAFISH; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santoro MM, 2009, MECH DEVELOP, V126, P638, DOI 10.1016/j.mod.2009.06.1080; Scheer N, 2002, MECH DEVELOP, V112, P9, DOI 10.1016/S0925-4773(01)00621-9; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Tallquist MD, 2003, PLOS BIOL, V1, P288, DOI 10.1371/journal.pbio.0000052; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00	36	37	38	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11324	10.1371/journal.pone.0011324	http://dx.doi.org/10.1371/journal.pone.0011324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593033	Green Published, gold, Green Submitted			2022-12-27	WOS:000279140800021
J	Narantuya, D; Nagai, A; Sheikh, AM; Masuda, J; Kobayashi, S; Yamaguchi, S; Kim, SU				Narantuya, Dashdemberel; Nagai, Atsushi; Sheikh, Abdullah Md; Masuda, Junichi; Kobayashi, Shotai; Yamaguchi, Shuhei; Kim, Seung U.			Human Microglia Transplanted in Rat Focal Ischemia Brain Induce Neuroprotection and Behavioral Improvement	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; MESSENGER-RNA; STROKE MODEL; GLIAL-CELLS; EXPRESSION; INJURY	Backgrond and Purpose: Microglia are resident immunocompenent and phagocytic cells of central nervous system (CNS), which produce various cytokines and growth factors in response to injury and thereby regulate disease pathology. The purpose of this study is to investigate the effects of microglial transplantation on focal cerebral ischemia model in rat. Methods: Transient middle cerebral artery occlusion (MCAO) in rats was induced by the intraluminal filament technique. HMO6 cells, human microglial cell line, were transplanted intravenously at 48 hours after MCAO. Functional tests were performed and the infarct volume was measured at 7 and 14 days after MCAO. Migration and cell survival of transplanted microglial cells and host glial reaction in the brain were studied by immunohistochemistry. Gene expression of neurotrophic factors, cytokines and chemokines in transplanted cells and host rat glial cells was determined by laser capture microdissection (LCM) and quantitative real time-PCR. Results: HMO6 human microglial cells transplantion group demonstrated significant functional recovery compared with control group. At 7 and 14 days after MCAO, infarct volume was significantly reduced in the HMO group. In the HMO6 group, number of apoptotic cells was time-dependently reduced in the infarct core and penumbra. In addition, number of host rat microglia/macrophages and reactive astrocytes was significantly decreased at 7 and 14 days after MCAO in the penumbra. Gene expression of various neurotrophic factors (GDNF, BDNF, VEGF and BMP7) and anti-inflammatory cytokines (IL4 and IL5) was up-regulated in transplanted HMO6 cells of brain tissue compared with those in culture. The expression of GDNF and VEGF in astrocytes in penumbra was significantly up-regulated in the HMO6 group. Conclusions: Our results indicate that transplantation of HMO6 human microglial cells reduces ischemic deficits and apoptotic events in stroke animals. The results were mediated by modulation of gliosis and neuroinflammation, and neuroprotection provided by neurotrophic factors of endogenous and transplanted cells-origin.	[Narantuya, Dashdemberel; Yamaguchi, Shuhei] Shimane Univ, Sch Med, Dept Neurol, Izumo, Shimane, Japan; [Nagai, Atsushi; Sheikh, Abdullah Md; Masuda, Junichi] Shimane Univ, Sch Med, Dept Lab Med, Izumo, Shimane, Japan; [Kobayashi, Shotai] Shimane Univ, Sch Med, Shimane Univ Hosp, Izumo, Shimane, Japan; [Kim, Seung U.] Univ British Columbia, Dept Med, Div Neurol, UBC Hosp, Vancouver, BC V6T 1W5, Canada; [Kim, Seung U.] Chung Ang Univ, Coll Med, Med Res Inst, Seoul 156756, South Korea	Shimane University; Shimane University; Shimane University; University of British Columbia; Chung Ang University; Chung Ang University Hospital	Narantuya, D (corresponding author), Shimane Univ, Sch Med, Dept Neurol, Izumo, Shimane, Japan.	anagai@med.shimane-u.ac.jp; sukim@interchange.ubc.ca		Nagai, Atsushi/0000-0002-9280-8044	Canadian Myelin Research Initiative	Canadian Myelin Research Initiative	This study was supported by grants from the Canadian Myelin Research Initiative (SUK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Block F, 2000, NEUROREPORT, V11, P963, DOI 10.1097/00001756-200004070-00013; Bruce-Keller AJ, 1999, J NEUROSCI RES, V58, P191, DOI 10.1002/(SICI)1097-4547(19991001)58:1<191::AID-JNR17>3.0.CO;2-E; Buttini M, 1996, NEUROSCIENCE, V71, P1, DOI 10.1016/0306-4522(95)00414-9; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; CHEN H, 1992, J CEREBR BLOOD F MET, V12, P621, DOI 10.1038/jcbfm.1992.86; Chen HL, 2003, BRAIN RES, V994, P81, DOI 10.1016/j.brainres.2003.09.020; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chou J, 2006, J NEUROL SCI, V240, P21, DOI 10.1016/j.jns.2005.08.015; Clausen BH, 2005, NEUROSCIENCE, V132, P879, DOI 10.1016/j.neuroscience.2005.01.031; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Elkabes S, 1996, J NEUROSCI, V16, P2508; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Jin KL, 2005, NEUROBIOL DIS, V18, P366, DOI 10.1016/j.nbd.2004.10.010; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lee HJ, 2009, GENE THER, V16, P1066, DOI 10.1038/gt.2009.51; Lee HJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000156; Lee HJ, 2007, STEM CELLS, V25, P1204, DOI 10.1634/stemcells.2006-0409; Lee YB, 2002, J NEUROSCI RES, V69, P94, DOI 10.1002/jnr.10253; Li Y, 2000, J CEREBR BLOOD F MET, V20, P1311, DOI 10.1097/00004647-200009000-00006; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Minami M, 2003, LIFE SCI, V74, P321, DOI 10.1016/j.lfs.2003.09.019; Miwa T, 1997, J NEUROSCI RES, V50, P1023; Miyamoto Y, 1999, J NEUROSCI RES, V55, P245, DOI 10.1002/(SICI)1097-4547(19990115)55:2<245::AID-JNR12>3.0.CO;2-Q; Nagai A, 2005, J NEUROSCI RES, V81, P342, DOI 10.1002/jnr.20478; Nagai A, 2001, NEUROBIOL DIS, V8, P1057, DOI 10.1006/nbdi.2001.0437; Nagai A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001272; NAKAJIMA K, 1993, NEUROSCI RES, V17, P187, DOI 10.1016/0168-0102(93)90047-T; Okazaki T, 2008, NEUROSCI LETT, V430, P109, DOI 10.1016/j.neulet.2007.10.046; Panickar KS, 2005, GLIA, V50, P287, DOI 10.1002/glia.20181; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Rupalla K, 1998, ACTA NEUROPATHOL, V96, P172, DOI 10.1007/s004010050878; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Takami S, 1997, NEUROSCI LETT, V227, P173, DOI 10.1016/S0304-3940(97)00338-8; Tomimoto H, 1996, ACTA NEUROPATHOL, V92, P281, DOI 10.1007/s004010050519; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Wang W, 2008, J CLIN NEUROSCI, V15, P278, DOI 10.1016/j.jocn.2007.02.004; Xu XH, 2006, LIFE SCI, V78, P704, DOI 10.1016/j.lfs.2005.05.080; Zawadzka M, 2005, GLIA, V49, P36, DOI 10.1002/glia.20092; Zhang ZG, 1997, BRAIN RES, V744, P189, DOI 10.1016/S0006-8993(96)01085-2; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	49	86	93	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11746	10.1371/journal.pone.0011746	http://dx.doi.org/10.1371/journal.pone.0011746			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668522	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800019
J	Guenard, B; Dunn, RR				Guenard, Benoit; Dunn, Robert R.			A New (Old), Invasive Ant in the Hardwood Forests of Eastern North America and Its Potentially Widespread Impacts	PLOS ONE			English	Article							IMPORTED FIRE ANT; PACHYCONDYLA-CHINENSIS; PHEIDOLE-MEGACEPHALA; SOLENOPSIS-INVICTA; ARGENTINE ANTS; NATIVE ANTS; LINEPITHEMA HUMILE; SEED DISPERSAL; INTRODUCED ANT; ECONOMIC COSTS	Biological invasions represent a serious threat for the conservation of biodiversity in many ecosystems. While many social insect species and in particular ant species have been introduced outside their native ranges, few species have been successful at invading temperate forests. In this study, we document for the first time the relationship between the abundance of the introduced ant, Pachycondyla chinensis, in mature forests of North Carolina and the composition, abundance and diversity of native ant species using both a matched pair approach and generalized linear models. Where present, P. chinensis was more abundant than all native species combined. The diversity and abundance of native ants in general and many individual species were negatively associated with the presence and abundance of P. chinensis. These patterns held regardless of our statistical approach and across spatial scales. Interestingly, while the majority of ant species was strongly and negatively correlated with the abundance and presence of P. chinensis, a small subset of ant species larger than P. chinensis was either as abundant or even more abundant in invaded than in uninvaded sites. The large geographic range of this ant species combined with its apparent impact on native species make it likely to have cascading consequences on eastern forests in years to come, effects mediated by the specifics of its life history which is very different from those of other invasive ants. The apparent ecological impacts of P. chinensis are in addition to public health concerns associated with this species due to its sometimes, deadly sting.	[Guenard, Benoit; Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Guenard, Benoit; Dunn, Robert R.] N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Guenard, B (corresponding author), N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA.	bsguenar@ncsu.edu	Dunn, Robert/B-1360-2013	/0000-0001-6782-917X; Guenard, Benoit/0000-0002-7144-1175; Dunn, Robert/0000-0002-6030-4837	Department of Energy - National Institute for Climate Change Research, DOE-NICCR; Department of Energy [DE-FG02-08ER64510]; NASA [NNX09AK22G]; administration of Historic Yates Mill County Park; Hemlock Bluff Nature Preserve; Schenck Forest	Department of Energy - National Institute for Climate Change Research, DOE-NICCR(United States Department of Energy (DOE)); Department of Energy(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); administration of Historic Yates Mill County Park; Hemlock Bluff Nature Preserve; Schenck Forest	Department of Energy - National Institute for Climate Change Research, DOE-NICCR grant, http://niccr.nau.edu/. Department of Energy - Program for Ecosystem Research, DOE-PER grant DE-FG02-08ER64510, http://www.energy.gov/ NASA award NNX09AK22G, http://www.nasa.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank: Matthew Hamilton, David Bednar, Szabolcs Lengyel and Chris Hirsch for their help in the field and to sort specimens. We also would like to thank the administration of Historic Yates Mill County Park, Hemlock Bluff Nature Preserve, and Schenck Forest for their hospitality and support during our projects. Michael D. Weiser and Sean Menke for valuable discussion and insight. We would like to thank Nathan J. Sanders and Andrew V. Suarez for their valuable comments on the manuscript. Finally, we would like to thank the three anonymous reviewers for their valuable comments and suggestions on this manuscript.	Allen CR, 2004, AM MIDL NAT, V152, P88, DOI 10.1674/0003-0031(2004)152[0088:RIFAIO]2.0.CO;2; Bae GR., 1999, KOREAN J PREVENTIVE, V32, P421; BARONIURBANI C, 1974, ENVIRON ENTOMOL, V3, P755; BEATTIE AJ, 1981, ECOLOGY, V62, P107, DOI 10.2307/1936674; Bestelmeyer Brandon T., 2000, P122; Boer Peter, 2008, Entomologische Berichten (Amsterdam), V68, P121; Carter W. G., 1962, Journal Mitchell Scientific Society Chapel Hill, V78, P150; CARTER WILLIAM G., 1962, JOUR ELISHA MITCHELL SCI SOC, V78, P1; Cho YS, 2002, J ALLERGY CLIN IMMUN, V110, P54, DOI 10.1067/mai.2002.124890; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; CULVER DC, 1978, J ECOL, V66, P53, DOI 10.2307/2259181; Davidson DW, 1998, ECOL ENTOMOL, V23, P484, DOI 10.1046/j.1365-2311.1998.00145.x; Deheer CJ, 2004, MOL ECOL, V13, P431, DOI 10.1046/j.1365-294X.2003.2065.x; DUFFY DC, 1992, CONSERV BIOL, V6, P196, DOI 10.1046/j.1523-1739.1992.620196.x; Fowler Harold G., 1992, Ciencia e Cultura (Sao Paulo), V44, P345; Graham JH, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.30; Graham JH, 2008, SOUTHEAST NAT, V7, P429, DOI 10.1656/1528-7092-7.3.429; Grover CD, 2007, P ROY SOC B-BIOL SCI, V274, P2951, DOI 10.1098/rspb.2007.1065; HANDEL SN, 1981, B TORREY BOT CLUB, V108, P430, DOI 10.2307/2484443; Helms KR, 2002, ECOLOGY, V83, P2425, DOI 10.1890/0012-9658(2002)083[2425:WAOTIA]2.0.CO;2; Helms KR, 2001, SOUTHWEST NAT, V46, P396, DOI 10.2307/3672443; Heterick B, 1997, AUST J ECOL, V22, P218, DOI 10.1111/j.1442-9993.1997.tb00661.x; Hoffmann BD, 1999, OECOLOGIA, V120, P595, DOI 10.1007/PL00008824; Hoffmann BD, 2008, BIOL INVASIONS, V10, P1171, DOI 10.1007/s10530-007-9194-x; Holldobler B., 1990, pi; Holway DA, 1998, OECOLOGIA, V116, P252, DOI 10.1007/s004420050586; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Holway DA, 2005, BIOL CONSERV, V121, P561, DOI 10.1016/j.biocon.2004.06.005; Holway DA, 1998, OECOLOGIA, V115, P206, DOI 10.1007/s004420050509; HOWARD RW, 1982, ENVIRON ENTOMOL, V11, P1290, DOI 10.1093/ee/11.6.1290; Human KG, 1997, CONSERV BIOL, V11, P1242, DOI 10.1046/j.1523-1739.1997.96264.x; Ivanov K, 2009, ENVIRON ENTOMOL, V38, P1724, DOI 10.1603/022.038.0626; Kennedy TA, 1998, AM MIDL NAT, V140, P343, DOI 10.1674/0003-0031(1998)140[0343:POAIBA]2.0.CO;2; Kim SS, 2001, J ALLERGY CLIN IMMUN, V107, P1095, DOI 10.1067/mai.2001.114341; King JR, 2006, J ANIM ECOL, V75, P1370, DOI 10.1111/j.1365-2656.2006.01161.x; King JR, 2008, P NATL ACAD SCI USA, V105, P20339, DOI 10.1073/pnas.0809423105; Lach L, 2003, ANN MO BOT GARD, V90, P91, DOI 10.2307/3298529; Lach L, 2008, AUST J ENTOMOL, V47, P275, DOI 10.1111/j.1440-6055.2008.00659.x; Le Breton J, 2003, AUSTRAL ECOL, V28, P204, DOI 10.1046/j.1442-9993.2003.01266.x; Leath TM, 2006, J ALLERGY CLIN IMMUN, V117, pS129, DOI 10.1016/j.jaci.2005.12.517; Lee EK, 2009, CLIN EXP ALLERGY, V39, P602, DOI 10.1111/j.1365-2222.2008.03181.x; Lester PJ, 2005, DIVERS DISTRIB, V11, P279, DOI 10.1111/j.1366-9516.2005.00169.x; Lockwood J, 2005, CONSERV BIOL SER, V8, P365; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; MAC MJ, 1998, STATUES TRENDS NATIO; MacGown J.A., 2009, Midsouth Entomologist, V2, P88; Matsuura K, 2002, BEHAV ECOL SOCIOBIOL, V51, P172, DOI 10.1007/s00265-001-0426-2; McGlynn TP, 1999, J BIOGEOGR, V26, P535, DOI 10.1046/j.1365-2699.1999.00310.x; Mitchell CE, 2002, ECOL APPL, V12, P1364, DOI 10.2307/3099977; Moller H, 1996, BIOL CONSERV, V78, P125, DOI 10.1016/0006-3207(96)00022-5; Morrison LW, 2003, ENVIRON ENTOMOL, V32, P548, DOI 10.1603/0046-225X-32.3.548; Morrison LW, 2002, ECOLOGY, V83, P2337, DOI 10.1890/0012-9658(2002)083[2337:LTIOAA]2.0.CO;2; Nelder MP, 2006, J MED ENTOMOL, V43, P1094, DOI 10.1603/0022-2585(2006)43[1094:EOTIAP]2.0.CO;2; Ness JH, 2009, OIKOS, V118, P1793, DOI 10.1111/j.1600-0706.2009.17430.x; Ness JH, 2004, BIOL INVASIONS, V6, P445, DOI 10.1023/B:BINV.0000041556.88920.dd; NUHN TP, 1979, AM MIDL NAT, V102, P353, DOI 10.2307/2424662; Ohnishi Y, 2008, ECOL RES, V23, P299, DOI 10.1007/s11284-007-0378-8; Oliva Matthew S., 2005, International Ophthalmology Clinics, V45, P1; Oliver TH, 2008, INSECT CONSERV DIVER, V1, P208, DOI 10.1111/j.1752-4598.2008.00026.x; Orivel J, 2001, ANN ENTOMOL SOC AM, V94, P449, DOI 10.1603/0013-8746(2001)094[0449:RBPMAA]2.0.CO;2; Peck SL, 1998, ENVIRON ENTOMOL, V27, P1102, DOI 10.1093/ee/27.5.1102; Peeters Christian, 1997, P372; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; PORTER SD, 1990, ECOLOGY, V71, P2095, DOI 10.2307/1938623; Rowles AD, 2009, OECOLOGIA, V161, P161, DOI 10.1007/s00442-009-1368-z; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sanders NJ, 2001, OECOLOGIA, V127, P123, DOI 10.1007/s004420000572; SANDERS NJ, 2004, SW NAT, V49, P247; Sarty M, 2007, INSECT SOC, V54, P166, DOI 10.1007/s00040-007-0927-8; Smith M. R., 1934, Annals of the Entomological Society of America, V27, P557; SMITH MR, 1947, AM MIDL NAT, V37, P521, DOI 10.2307/2421469; STRUIK GJ, 1965, ECOLOGY, V46, P401, DOI 10.2307/1934873; Stuble KL, 2009, ECOL ENTOMOL, V34, P520, DOI 10.1111/j.1365-2311.2009.01098.x; Suarez AV, 2010, ANT ECOLOGY, P233; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Suarez AV, 2005, P NATL ACAD SCI USA, V102, P17032, DOI 10.1073/pnas.0506119102; Teranishi Y., 1929, ZOOL MAG, V41, P312; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833; Tillberg CV, 2007, P NATL ACAD SCI USA, V104, P20856, DOI 10.1073/pnas.0706903105; Ward Philip S., 2000, P99; WARD PS, 1987, HILGARDIA, V55, P1; YASHIRO T, EVOLUTION S IN PRESS; Yun YY, 1999, J ALLERGY CLIN IMMUN, V104, P879, DOI 10.1016/S0091-6749(99)70302-7; Zelikova TJ, 2008, ACTA OECOL, V34, P155, DOI 10.1016/j.actao.2008.05.002	86	50	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11614	10.1371/journal.pone.0011614	http://dx.doi.org/10.1371/journal.pone.0011614			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657769	Green Published, gold			2022-12-27	WOS:000280197500009
J	Jung, HS; Okegawa, Y; Shih, PM; Kellogg, E; Abdel-Ghany, SE; Pilon, M; Sjolander, K; Shikanai, T; Niyogi, KK				Jung, Hou-Sung; Okegawa, Yuki; Shih, Patrick M.; Kellogg, Elizabeth; Abdel-Ghany, Salah E.; Pilon, Marinus; Sjoelander, Kimmen; Shikanai, Toshiharu; Niyogi, Krishna K.			Arabidopsis thaliana PGR7 Encodes a Conserved Chloroplast Protein That Is Necessary for Efficient Photosynthetic Electron Transport	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHOTOSYSTEM-I; ARABIDOPSIS-THALIANA; XANTHOPHYLL CYCLE; PHYLOGENOMIC INFERENCE; ABSORBENCY CHANGES; LIGHT; FLUORESCENCE; FLOW; PHOTOPROTECTION	A significant fraction of a plant's nuclear genome encodes chloroplast-targeted proteins, many of which are devoted to the assembly and function of the photosynthetic apparatus. Using digital video imaging of chlorophyll fluorescence, we isolated proton gradient regulation 7 (pgr7) as an Arabidopsis thaliana mutant with low nonphotochemical quenching of chlorophyll fluorescence (NPQ). In pgr7, the xanthophyll cycle and the PSBS gene product, previously identified NPQ factors, were still functional, but the efficiency of photosynthetic electron transport was lower than in the wild type. The pgr7 mutant was also smaller in size and had lower chlorophyll content than the wild type in optimal growth conditions. Positional cloning located the pgr7 mutation in the At3g21200 (PGR7) gene, which was predicted to encode a chloroplast protein of unknown function. Chloroplast targeting of PGR7 was confirmed by transient expression of a GFP fusion protein and by stable expression and subcellular localization of an epitope-tagged version of PGR7. Bioinformatic analyses revealed that the PGR7 protein has two domains that are conserved in plants, algae, and bacteria, and the N-terminal domain is predicted to bind a cofactor such as FMN. Thus, we identified PGR7 as a novel, conserved nuclear gene that is necessary for efficient photosynthetic electron transport in chloroplasts of Arabidopsis.	[Jung, Hou-Sung; Shih, Patrick M.; Sjoelander, Kimmen; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Okegawa, Yuki] Kyushu Univ, Grad Sch Agr, Fukuoka 812, Japan; [Okegawa, Yuki; Shikanai, Toshiharu] Kyoto Univ, Dept Bot, Grad Sch Sci, Kyoto, Japan; [Kellogg, Elizabeth; Sjoelander, Kimmen] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Abdel-Ghany, Salah E.; Pilon, Marinus] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Niyogi, Krishna K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Kyushu University; Kyoto University; University of California System; University of California Berkeley; Colorado State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jung, HS (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	niyogi@nature.berkeley.edu	Shikanai, Toshiharu/AAK-9112-2020	Okegawa, Yuki/0000-0001-7712-021X	U.S. Department of Agriculture National Research Initiative [98-35306-6600]; Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy [449A449B]; U.S. National Science Foundation [IBN-0418993, IOS-0847442, 0732065]; JSPS [19-8015, 17GS0316]	U.S. Department of Agriculture National Research Initiative(United States Department of Agriculture (USDA)); Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the U.S. Department of Agriculture National Research Initiative (grant number 98-35306-6600 to K.K.N.) and the Chemical Sciences, Geosciences and Biosciences Division, Office of Basic Energy Sciences, Office of Science, U.S. Department of Energy (FWP number 449A449B to K.K.N.), and by the U.S. National Science Foundation (grants IBN-0418993 and IOS-0847442 to M. P. and 0732065 to K. S.) Y.O. and T. S. were supported by a grant-in-aid from JSPS (19-8015 and 17GS0316, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Archibald JM, 2002, TRENDS GENET, V18, P577, DOI 10.1016/S0168-9525(02)02777-4; BILGER W, 1990, PHOTOSYNTH RES, V25, P173, DOI 10.1007/BF00033159; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Brown DP, 2007, PLOS COMPUT BIOL, V3, P1526, DOI 10.1371/journal.pcbi.0030160; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DalCorso G, 2008, CELL, V132, P273, DOI 10.1016/j.cell.2007.12.028; DemmigAdams B, 1996, PLANTA, V198, P460, DOI 10.1007/BF00620064; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Dytham C, 2003, CHOOSING USING STAT; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; GILMORE AM, 1993, PHOTOSYNTH RES, V35, P67, DOI 10.1007/BF02185412; Glanville JG, 2007, NUCLEIC ACIDS RES, V35, pW27, DOI 10.1093/nar/gkm325; Haldrup A, 2003, J BIOL CHEM, V278, P33276, DOI 10.1074/jbc.M305106200; Haldrup A, 2000, J BIOL CHEM, V275, P31211, DOI 10.1074/jbc.M002933200; Hashimoto M, 2003, PLANT J, V36, P541, DOI 10.1046/j.1365-313X.2003.01900.x; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KLIMYUK VI, 1993, PLANT J, V3, P493, DOI 10.1046/j.1365-313X.1993.t01-26-00999.x; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Krishnamurthy N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S12; Krishnamurthy N, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r83; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; LI XP, 2004, J BIOL CHEM; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Muller-Moule P, 2002, PLANT PHYSIOL, V128, P970, DOI 10.1104/pp.010924; Munekaga Y, 2004, NATURE, V429, P579, DOI 10.1038/nature02598; Munekage Y, 2002, CELL, V110, P361, DOI 10.1016/S0092-8674(02)00867-X; Munekage Y, 2001, PLANT J, V28, P351, DOI 10.1046/j.1365-313X.2001.01178.x; Murakami R, 2002, FEBS LETT, V523, P138, DOI 10.1016/S0014-5793(02)02963-0; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHREIBER U, 1988, Z NATURFORSCH C, V43, P686; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Shikanai T, 2007, ANNU REV PLANT BIOL, V58, P199, DOI 10.1146/annurev.arplant.58.091406.110525; Sjolander K, 2004, BIOINFORMATICS, V20, P170, DOI 10.1093/bioinformatics/bth021; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Varotto C, 2000, PLANT J, V22, P115, DOI 10.1046/j.1365-313x.2000.00717.x; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200; YAMAMOTO HY, 1962, ARCH BIOCHEM BIOPHYS, V97, P168, DOI 10.1016/0003-9861(62)90060-7; Yamazaki H, 2004, PLANT J, V38, P152, DOI 10.1111/j.1365-313X.2004.02035.x	50	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11688	10.1371/journal.pone.0011688	http://dx.doi.org/10.1371/journal.pone.0011688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657737	Green Submitted, Green Published, gold			2022-12-27	WOS:000280197500027
J	Morais, DAD; Harrison, PM				Morais, David A. de Lima; Harrison, Paul M.			Large-Scale Evidence for Conservation of NMD Candidature Across Mammals	PLOS ONE			English	Article							MESSENGER-RNA DECAY; NONSENSE-MEDIATED DECAY; INTRON RETENTION EVENTS; PROTEIN; EXPRESSION; GENOME; GENES; SURVEILLANCE; MUTATIONS; APOPTOSIS	Background: Alternatively-spliced (AS) forms can vary protein function, intracellular localization and post-translational modifications. AS coupled with mRNA nonsense-mediated decay (NMD) can also control the transcript abundance. Here, we have investigated the genome-scale conservation of alternatively-spliced NMD candidates (AS-NMD candidates), in mammals. Methodology/Principal Findings: We mapped >12 million cDNA/EST library transcripts, comprising pooled data from both older and next-generation sequencing techniques, against genomic sequences to annotate AS-NMD candidates generated by in-frame premature termination codons (PTCs), in the human, mouse, rat and cow genomes. In these genomes, we found populations of genes that harbour AS-NMD candidates, varying in number from, similar to 149 to 2,051 genes. We discovered that a highly-significant proportion (27%-35%) of AS-NMD candidate genes in mouse, rat and cow, also have human orthologs targeted for NMD. Intron retention was the most abundant type of AS-NMD, ranging from 43% to 67% of genes harbouring an AS-NMD candidate. Groupings of AS-NMD candidate genes either with or without intron retentions also have highly significant AS-NMD conservation, indicating that the trend is not due primarily to conservation of intron retentions. As a subset, the AS-NMD intron retentions are distinguished from non-retained introns by higher GC content, and codon usage similar to the usage in protein-coding sequences. This indicates that most of these alternatively spliced sequences have coded for proteins in the recent evolutionary past. In general, the AS-NMD candidate genes showed a similar pattern of Gene Ontology functional category enrichments in all four species. Genes linked to nucleic-acid interaction and apoptosis, and involved in pathways linked with cancer, were the most common. Finally, we mapped the AS-NMD candidates to mass spectrometry-derived proteomics data, and gathered evidence of truncated polypeptides for at least 10% of all human AS-NMD candidate transcripts. Conclusions/Significance: In summary, our analysis provides strong statistical evidence for conservation of functional AS-NMD candidature across Mammalia for a large subset of genes. However, because codon usage of AS-NMD intron retentions is similar to the usage in exons, it is difficult to de-couple conservation of AS-NMD-based regulation from conservation for protein-coding ability, for intron retentions.	[Morais, David A. de Lima; Harrison, Paul M.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Morais, DAD (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	paul.harrison@mcgill.ca			National Science and Engineering Research Council of Canada; Les Fonds du Quebec de la Recherche and des Technologies	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds du Quebec de la Recherche and des Technologies	This work was funded by the National Science and Engineering Research Council of Canada, and by Les Fonds du Quebec de la Recherche and des Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth C, 2005, NATURE, V438, P726, DOI 10.1038/438726a; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Fewell SW, 1999, MOL CELL BIOL, V19, P826; Galante PAF, 2004, RNA, V10, P757, DOI 10.1261/rna.5123504; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayes GM, 2006, CANCER RES, V66, P3819, DOI 10.1158/0008-5472.CAN-05-4065; Hiller M, 2005, NUCLEIC ACIDS RES, V33, P5611, DOI 10.1093/nar/gki870; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KANEHISA M, 2009, NUCL ACIDS RES; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; Kuenen B C, 2003, Ned Tijdschr Geneeskd, V147, P2044; Kurmangaliyev YZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-13; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Malygin AA, 2007, NUCLEIC ACIDS RES, V35, P6414, DOI 10.1093/nar/gkm701; Mercatante D, 2000, PHARMACOL THERAPEUT, V85, P237, DOI 10.1016/S0163-7258(99)00067-4; Merdzhanova G, 2008, CELL DEATH DIFFER, V15, P1815, DOI 10.1038/cdd.2008.135; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Morais DD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-309; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Saltzman AL, 2008, MOL CELL BIOL, V28, P4320, DOI 10.1128/MCB.00361-08; Shi YQ, 2004, EXP CELL RES, V296, P337, DOI 10.1016/j.yexcr.2004.02.009; Silva AL, 2009, FEBS LETT, V583, P499, DOI 10.1016/j.febslet.2008.12.058; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stephenson LS, 1996, BIOCHIMIE, V78, P1043, DOI 10.1016/S0300-9084(97)86728-4; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; VIZCAINO JA, NUCL ACIDS RES, V38, pD736; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911; Zavolan M, 2002, GENOME RES, V12, P1377, DOI 10.1101/gr.191702; Zhang ZG, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-23	44	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11695	10.1371/journal.pone.0011695	http://dx.doi.org/10.1371/journal.pone.0011695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657786	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500032
J	O'Grady, SP; Wende, AR; Remien, CH; Valenzuela, LO; Enright, LE; Chesson, LA; Abel, ED; Cerling, TE; Ehleringer, JR				O'Grady, Shannon P.; Wende, Adam R.; Remien, Christopher H.; Valenzuela, Luciano O.; Enright, Lindsey E.; Chesson, Lesley A.; Abel, E. Dale; Cerling, Thure E.; Ehleringer, James R.			Aberrant Water Homeostasis Detected by Stable Isotope Analysis	PLOS ONE			English	Article							HYDROGEN ISOTOPES; OXYGEN ISOTOPES; BODY-WATER; FRACTIONATION; RATIOS; HAIR; PRECIPITATION; ADAPTATION; PHOSPHATE; TURNOVER	While isotopes are frequently used as tracers in investigations of disease physiology (i.e., (14)C labeled glucose), few studies have examined the impact that disease, and disease-related alterations in metabolism, may have on stable isotope ratios at natural abundance levels. The isotopic composition of body water is heavily influenced by water metabolism and dietary patterns and may provide a platform for disease detection. By utilizing a model of streptozotocin (STZ)-induced diabetes as an index case of aberrant water homeostasis, we demonstrate that untreated diabetes mellitus results in distinct combinations, or signatures, of the hydrogen (delta(2)H) and oxygen (delta(18)O) isotope ratios in body water. Additionally, we show that the delta(2)H and delta(18)O values of body water are correlated with increased water flux, suggesting altered blood osmolality, due to hyperglycemia, as the mechanism behind this correlation. Further, we present a mathematical model describing the impact of water flux on the isotopic composition of body water and compare model predicted values with actual values. These data highlight the importance of factors such as water flux and energy expenditure on predictive models of body water and additionally provide a framework for using naturally occurring stable isotope ratios to monitor diseases that impact water homeostasis.	[O'Grady, Shannon P.; Valenzuela, Luciano O.; Enright, Lindsey E.; Chesson, Lesley A.; Cerling, Thure E.; Ehleringer, James R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Wende, Adam R.; Abel, E. Dale] Div Endocrinol Diabet & Metab, Salt Lake City, UT USA; [Remien, Christopher H.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Valenzuela, Luciano O.; Chesson, Lesley A.; Cerling, Thure E.; Ehleringer, James R.] IsoForensics Inc, Salt Lake City, UT USA; [Cerling, Thure E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	O'Grady, SP (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	ogrady@biology.utah.edu	Wende, Adam/AFG-8878-2022; Ehleringer, James/G-1780-2010	Wende, Adam/0000-0002-5536-4675; Abel, E. Dale/0000-0001-5290-0738; Cerling, Thure/0000-0002-3590-294X; Valenzuela, Luciano/0000-0002-5024-6581	Intelligence Community; Juvenile Diabetes Research Foundation; IsoForensics, Inc.;  [U01HL087947]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087947] Funding Source: NIH RePORTER	Intelligence Community; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); IsoForensics, Inc.; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.P.O. is funded by an Intelligence Community Postdoctoral Fellowship, A. R. W. is funded by a Juvenile Diabetes Research Foundation Advanced Postdoctoral Fellowship, and E. D. A. by U01HL087947. L.O.V., L. A. C., T. E. C. and J.R.E. are partially funded by IsoForensics, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AMDCC CONS, 2003, AMDCC PROT, P1; Bowen GJ, 2009, AM J PHYS ANTHROPOL, V139, P494, DOI 10.1002/ajpa.21008; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Chesson LA, 2010, J AGR FOOD CHEM, V58, P2358, DOI 10.1021/jf904151c; Cheung MC, 2009, J SURG RES, V153, P326, DOI 10.1016/j.jss.2008.05.002; Clementz MT, 2008, PALAIOS, V23, P574, DOI 10.2110/palo.2007.p07-054r; DANSGAARD W, 1964, TELLUS, V16, P436; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Gretebeck RJ, 1997, J APPL PHYSIOL, V82, P563, DOI 10.1152/jappl.1997.82.2.563; Hobson KA, 2009, J GEOCHEM EXPLOR, V102, P167, DOI 10.1016/j.gexplo.2009.02.007; HORITA J, 1994, GEOCHIM COSMOCHIM AC, V58, P3425, DOI 10.1016/0016-7037(94)90096-5; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Longinelli A., 1980, EUR J MASS SPECTROM, V1, P135; Lu WT, 1998, TRANSPLANT P, V30, P609, DOI 10.1016/S0041-1345(97)01425-5; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Meier-Augenstein W, 2008, SCI JUSTICE, V48, P153, DOI 10.1016/j.scijus.2007.10.010; Pflug K.P., 1979, STABLE ISOTOPES, P553; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Polotsky VY, 2001, AM J RESP CRIT CARE, V163, P624, DOI 10.1164/ajrccm.163.3.2007120; Raman A, 2004, AM J PHYSIOL-RENAL, V286, pF394, DOI 10.1152/ajprenal.00295.2003; Rodrigues B, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-38; Schoeller D.A., 1986, AM J PHYSIOL, V240, P823; Schrier RW, 1997, DIS KIDNEY	26	31	33	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11699	10.1371/journal.pone.0011699	http://dx.doi.org/10.1371/journal.pone.0011699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657736	Green Submitted, Green Published, gold			2022-12-27	WOS:000280197500036
J	Dai, JX; Hatzakis, E; Hurley, LH; Yang, DZ				Dai, Jixun; Hatzakis, Emmanuel; Hurley, Laurence H.; Yang, Danzhou			I-Motif Structures Formed in the Human c-MYC Promoter Are Highly Dynamic-Insights into Sequence Redundancy and I-Motif Stability	PLOS ONE			English	Article							G-QUADRUPLEX STRUCTURE; NUCLEASE HYPERSENSITIVE ELEMENT; HUMAN TELOMERIC SEQUENCE; RELEVANT G-QUADRUPLEX; POTASSIUM SOLUTION; BURKITT-LYMPHOMA; GENE-EXPRESSION; BREAST-CANCER; CELL-GROWTH; SPIN-ECHO	The GC-rich nuclease hypersensitivity element III1 (NHE III1) of the c-MYC promoter largely controls the transcriptional activity of the c-MYC oncogene. The C-rich strand in this region can form I-motif DNA secondary structures. We determined the folding pattern of the major I-motif formed in the NHE III1, which can be formed at near-neutral pH. While we find that the I-motif formed in the four 3' consecutive runs of cytosines appears to be the most favored, our results demonstrate that the C-rich strand of the c-MYC NHE III1 exhibits a high degree of dynamic equilibration. Using a trisubstituted oligomer of this region, we determined the formation of two equilibrating loop isomers, one of which contains a flipped-out cytosine. Our results indicate that the intercalative cytosine(+)-cytosine base pairs are not always necessary for an intramolecular I-motif. The dynamic character of the c-MYC I-motif is intrinsic to the NHE III1 sequence and appears to provide stability to the c-MYC I-motif.	[Dai, Jixun; Hatzakis, Emmanuel; Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA; [Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA; [Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85721 USA; [Hurley, Laurence H.; Yang, Danzhou] Univ Arizona, Dept Chem, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; Arizona Center Cancer Care; University of Arizona; University of Arizona	Dai, JX (corresponding author), Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA.	yang@pharmacy.arizona.edu	Dai, Jixun/C-8275-2011; YANG, Dan/HHD-2733-2022; Yang, Danzhou/B-6228-2012	Yang, Danzhou/0000-0001-7489-7111	National Institutes of Health [1S10 RR16659, CA122952]; NATIONAL CANCER INSTITUTE [R01CA122952] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by the National Institutes of Health (1S10 RR16659, CA122952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus A, 2005, BIOCHEMISTRY-US, V44, P2048, DOI 10.1021/bi048242p; Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; BERNS EMJJ, 1992, CANCER RES, V52, P1107; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P2440, DOI 10.1093/nar/gkm009; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2009, J AM CHEM SOC, V131, P6102, DOI 10.1021/ja900967r; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dang CV, 1999, MOL CELL BIOL, V19, P1; Freier K, 2003, CANCER RES, V63, P1179; Gallego J, 1997, J MOL BIOL, V273, P840, DOI 10.1006/jmbi.1997.1361; GEHRING K, 1993, NATURE, V363, P561, DOI 10.1038/363561a0; Grand CL, 2002, MOL CANCER THER, V1, P565; Gueron M, 2000, CURR OPIN STRUC BIOL, V10, P326, DOI 10.1016/S0959-440X(00)00091-9; Han XG, 1998, J MOL BIOL, V278, P949, DOI 10.1006/jmbi.1998.1740; Harris CP, 2003, GENE CHROMOSOME CANC, V36, P233, DOI 10.1002/gcc.10158; Hurley LH, 2006, SEMIN ONCOL, V33, P498, DOI 10.1053/j.seminoncol.2006.04.012; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; Lavelle C, 2008, NAT STRUCT MOL BIOL, V15, P123, DOI 10.1038/nsmb0208-123; LEROY JL, 1995, STRUCTURE, V3, P101, DOI 10.1016/S0969-2126(01)00138-1; Leroy JL, 2003, J MOL BIOL, V333, P125, DOI 10.1016/S0022-2836(03)00945-8; Magrath I, 1990, Adv Cancer Res, V55, P133, DOI 10.1016/S0065-230X(08)60470-4; MARCU KB, 1992, ANNU REV BIOCHEM, V61, P809, DOI 10.1146/annurev.bi.61.070192.004113; Marcu KB, 1997, CURR TOP MICROBIOL, V224, P47; MICHELOTTI EF, 1995, J BIOL CHEM, V270, P9494, DOI 10.1074/jbc.270.16.9494; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; NOWELL P, 1983, NATURE, V306, P494, DOI 10.1038/306494a0; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Ou TM, 2007, J MED CHEM, V50, P1465, DOI 10.1021/jm0610088; Pelengaris S, 2003, EXPERT OPIN THER TAR, V7, P623, DOI 10.1517/eott.7.5.623.22524; Pelengaris S, 2000, CURR OPIN GENET DEV, V10, P100, DOI 10.1016/S0959-437X(99)00046-5; PERTSCHUK LP, 1993, CANCER, V71, P162, DOI 10.1002/1097-0142(19930101)71:1<162::AID-CNCR2820710126>3.0.CO;2-1; Phan AT, 2000, J MOL BIOL, V299, P123, DOI 10.1006/jmbi.2000.3613; Phan AT, 2004, J AM CHEM SOC, V126, P8710, DOI 10.1021/ja048805k; Schlagbauer-Wadl H, 1999, J INVEST DERMATOL, V112, P332, DOI 10.1046/j.1523-1747.1999.00506.x; Seenisamy J, 2004, J AM CHEM SOC, V126, P8702, DOI 10.1021/ja040022b; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Simonsson T, 2000, BIOCHEM BIOPH RES CO, V278, P158, DOI 10.1006/bbrc.2000.3783; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; SPENCER CA, 1991, ADV CANCER RES, V56, P1; Sun D, 2009, J MED CHEM, V52, P2863, DOI 10.1021/jm900055s; SZEWCZAK AA, 1993, FEBS LETT, V327, P261, DOI 10.1016/0014-5793(93)81000-P; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	50	53	54	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11647	10.1371/journal.pone.0011647	http://dx.doi.org/10.1371/journal.pone.0011647			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657837	Green Published, gold, Green Submitted			2022-12-27	WOS:000280065600011
J	Imaizumi, K; Priebe, NJ; Sharpee, TO; Cheung, SW; Schreiner, CE				Imaizumi, Kazuo; Priebe, Nicholas J.; Sharpee, Tatyana O.; Cheung, Steven W.; Schreiner, Christoph E.			Encoding of Temporal Information by Timing, Rate, and Place in Cat Auditory Cortex	PLOS ONE			English	Article							AMPLITUDE-MODULATED SOUNDS; SPECIES-SPECIFIC CALLS; INTERSPIKE INTERVALS; ODOR REPRESENTATIONS; RECEPTIVE-FIELDS; CORTICAL FIELDS; SPIKE PATTERNS; NEURAL CODE; PERIODICITY; SPEECH	A central goal in auditory neuroscience is to understand the neural coding of species-specific communication and human speech sounds. Low-rate repetitive sounds are elemental features of communication sounds, and core auditory cortical regions have been implicated in processing these information-bearing elements. Repetitive sounds could be encoded by at least three neural response properties: 1) the event-locked spike-timing precision, 2) the mean firing rate, and 3) the interspike interval (ISI). To determine how well these response aspects capture information about the repetition rate stimulus, we measured local group responses of cortical neurons in cat anterior auditory field (AAF) to click trains and calculated their mutual information based on these different codes. ISIs of the multiunit responses carried substantially higher information about low repetition rates than either spike-timing precision or firing rate. Combining firing rate and ISI codes was synergistic and captured modestly more repetition information. Spatial distribution analyses showed distinct local clustering properties for each encoding scheme for repetition information indicative of a place code. Diversity in local processing emphasis and distribution of different repetition rate codes across AAF may give rise to concurrent feed-forward processing streams that contribute differently to higher-order sound analysis.	[Imaizumi, Kazuo; Cheung, Steven W.; Schreiner, Christoph E.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, WM Keck Ctr Integrat Neurosci, Coleman Mem Lab, San Francisco, CA 94143 USA; [Imaizumi, Kazuo] Louisiana State Univ Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA USA; [Priebe, Nicholas J.] Univ Texas Austin, Sch Biol Sci, Neurobiol Sect, Austin, TX 78712 USA; [Sharpee, Tatyana O.; Schreiner, Christoph E.] Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; [Sharpee, Tatyana O.] Salk Inst Biol Studies, Computat Neurobiol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Francisco; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas Austin; University of California System; University of California San Francisco; Salk Institute	Imaizumi, K (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, WM Keck Ctr Integrat Neurosci, Coleman Mem Lab, San Francisco, CA 94143 USA.	kimaiz@lsuhsc.edu; chris@phy.ucsf.edu	Sharpee, Tatyana/E-8663-2010; Imaizumi, Kazuo/U-8586-2019; Imaizumi, Kazuo/R-3892-2019	Imaizumi, Kazuo/0000-0001-7165-9978; Sharpee, Tatyana/0000-0002-7483-5081; Schreiner, Christoph/0000-0002-4571-4328	National Institutes of Health (NIH) [DC-02260, MH-077970, EY019288, MH068904, EY019493]; Veterans Affairs; Hearing Research Inc.; Coleman Memorial Fund; Pew Charitable Trust; Alfred P. Sloan Fellowship; Searle Funds; National Science Foundation (NSF) [IIS-0712852]; McKnight Scholarship; Keck and Ray Thomas Edwards Foundations; Center for Theoretical Biological Physics (NSF) [PHY-0822283]; NATIONAL EYE INSTITUTE [R01EY019288, R01EY019493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077970, K25MH068904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Hearing Research Inc.; Coleman Memorial Fund; Pew Charitable Trust; Alfred P. Sloan Fellowship(Alfred P. Sloan Foundation); Searle Funds; National Science Foundation (NSF)(National Science Foundation (NSF)); McKnight Scholarship; Keck and Ray Thomas Edwards Foundations; Center for Theoretical Biological Physics (NSF); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) grants DC-02260 and MH-077970 to C.E.S., Veterans Affairs Merit Review to S.W.C., as well as Hearing Research Inc., and the Coleman Memorial Fund. N.J.P. was supported by NIH grant EY019288 and the Pew Charitable Trust. T.O.P. was supported by the Alfred P. Sloan Fellowship, the Searle Funds, NIH grants MH068904 and EY019493, National Science Foundation (NSF) grant IIS-0712852, the McKnight Scholarship, the Keck and Ray Thomas Edwards Foundations, and the Center for Theoretical Biological Physics (NSF PHY-0822283). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SW, 2004, NAT NEUROSCI, V7, P974, DOI 10.1038/nn1293; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; Bieser A, 1996, EXP BRAIN RES, V108, P273; Bizley JK, 2010, J NEUROSCI, V30, P5078, DOI 10.1523/JNEUROSCI.5475-09.2010; Cariani P, 1999, NEURAL PLAST, V6, P147, DOI 10.1155/NP.1999.147; Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Cliff A, 1973, SPATIAL AUTOCORRELAT; DEAR SP, 1993, NATURE, V364, P620, DOI 10.1038/364620a0; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; Eggermont JJ, 1998, J NEUROPHYSIOL, V80, P2743, DOI 10.1152/jn.1998.80.5.2743; Eggermont JJ, 1996, AUDIT NEUROSCI, V2, P309; Eggermont JJ, 2001, HEARING RES, V157, P1, DOI 10.1016/S0378-5955(01)00259-3; EGGERMONT JJ, 1993, HEARING RES, V65, P175, DOI 10.1016/0378-5955(93)90212-J; Escabi MA, 2005, J NEUROSCI, V25, P9524, DOI 10.1523/JNEUROSCI.1804-05.2005; Fitch RH, 1997, ANNU REV NEUROSCI, V20, P331, DOI 10.1146/annurev.neuro.20.1.331; Gehr DD, 2000, HEARING RES, V150, P27, DOI 10.1016/S0378-5955(00)00170-2; GOLDBERG JM, 1968, J NEUROPHYSIOL, V31, P539, DOI 10.1152/jn.1968.31.4.639; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hauser M. D., 2003, DESIGN ANIMAL COMMUN; HEFFNER HE, 1984, SCIENCE, V226, P75, DOI 10.1126/science.6474192; Heil P, 1997, J NEUROPHYSIOL, V77, P2616, DOI 10.1152/jn.1997.77.5.2616; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Imaizumi K, 2005, AUDITORY CORTEX: SYNTHESIS OF HUMAN AND ANIMAL RESEARCH, P95; Imaizumi K, 2004, J NEUROPHYSIOL, V92, P444, DOI 10.1152/jn.01173.2003; Imaizumi K, 2007, J NEUROPHYSIOL, V98, P2933, DOI 10.1152/jn.00511.2007; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Kayser C, 2009, NEURON, V61, P597, DOI 10.1016/j.neuron.2009.01.008; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Krebs B, 2008, J NEUROPHYSIOL, V100, P1602, DOI 10.1152/jn.90374.2008; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; Lee CC, 2004, CEREB CORTEX, V14, P441, DOI 10.1093/cercor/bhh006; Linden JF, 2003, J NEUROPHYSIOL, V90, P2660, DOI 10.1152/jn.00751.2002; Liu RC, 2003, J ACOUST SOC AM, V114, P3412, DOI 10.1121/1.1623787; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Luna R, 2005, NAT NEUROSCI, V8, P1210, DOI 10.1038/nn1513; Lundstrom BN, 2006, J NEUROSCI, V26, P9030, DOI 10.1523/JNEUROSCI.0225-06.2006; Malhotra S, 2004, J NEUROPHYSIOL, V92, P1625, DOI 10.1152/jn.01205.2003; Malone BJ, 2007, J NEUROPHYSIOL, V98, P1451, DOI 10.1152/jn.01203.2006; Metzner W, 1998, J NEUROSCI, V18, P2283; MOREL A, 1987, J COMP NEUROL, V265, P119, DOI 10.1002/cne.902650109; Nagarajan SS, 2002, J NEUROPHYSIOL, V87, P1723, DOI 10.1152/jn.00632.2001; Nelken I, 2008, CURR OPIN NEUROBIOL, V18, P413, DOI 10.1016/j.conb.2008.08.014; Nelson ME, 2002, J PHYSIOL-PARIS, V96, P507, DOI 10.1016/S0928-4257(03)00006-8; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Petkov CI, 2008, NAT NEUROSCI, V11, P367, DOI 10.1038/nn2043; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Poremba A, 2004, NATURE, V427, P448, DOI 10.1038/nature02268; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; REALE RA, 1980, J COMP NEUROL, V192, P265, DOI 10.1002/cne.901920207; Reich DS, 2000, J NEUROSCI, V20, P1964; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; SCHREINER CE, 1986, HEARING RES, V21, P227, DOI 10.1016/0378-5955(86)90221-2; SCHREINER CE, 1988, HEARING RES, V32, P49, DOI 10.1016/0378-5955(88)90146-3; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Sincich LC, 2009, J NEUROSCI, V29, P6207, DOI 10.1523/JNEUROSCI.3701-08.2009; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tan Z.h., 2001, P 7 EUR C SPEECH COM, P473; Theunissen FE, 1998, J NEUROSCI, V18, P3786; TIAN B, 1994, J NEUROPHYSIOL, V71, P1959, DOI 10.1152/jn.1994.71.5.1959; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; Wang XQ, 2003, SPEECH COMMUN, V41, P107, DOI 10.1016/S0167-6393(02)00097-3; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wong SW, 2003, SPEECH COMMUN, V41, P93, DOI 10.1016/S0167-6393(02)00096-1; Zheng Y, 2008, J NEUROSCI, V28, P14230, DOI 10.1523/JNEUROSCI.2882-08.2008	77	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11531	10.1371/journal.pone.0011531	http://dx.doi.org/10.1371/journal.pone.0011531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657832	Green Published, Green Submitted, gold			2022-12-27	WOS:000280065600002
J	Betancur-R, R; Arturo, AP; Duque-Caro, H; Santos, SR				Betancur-R, Ricardo; Arturo, Acero P.; Duque-Caro, Hermann; Santos, Scott R.			Phylogenetic and Morphologic Analyses of a Coastal Fish Reveals a Marine Biogeographic Break of Terrestrial Origin in the Southern Caribbean	PLOS ONE			English	Article							REEF FISHES; COMPARATIVE PHYLOGEOGRAPHY; GENETIC-DIVERGENCE; SEA CATFISHES; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; NICHE CONSERVATISM; BAJA-CALIFORNIA; MIXED MODELS; SPECIATION	Background: Marine allopatric speciation involves interplay between intrinsic organismal properties and extrinsic factors. However, the relative contribution of each depends on the taxon under study and its geographic context. Utilizing sea catfishes in the Cathorops mapale species group, this study tests the hypothesis that both reproductive strategies conferring limited dispersal opportunities and an apparent geomorphologic barrier in the Southern Caribbean have promoted speciation in this group from a little studied area of the world. Methodology/Principal Findings: Mitochondrial gene sequences were obtained from representatives of the Cathorops mapale species group across its distributional range from Colombia to Venezuela. Morphometric and meristic analyses were also done to assess morphologic variation. Along a similar to 2000 km transect, two major lineages, Cathorops sp. and C. mapale, were identified by levels of genetic differentiation, phylogenetic reconstructions, and morphological analyses. The lineages are separated by similar to 150 km at the Santa Marta Massif (SMM) in Colombia. The northward displacement of the SMM into the Caribbean in the early Pleistocene altered the geomorphology of the continental margin, ultimately disrupting the natural habitat of C. mapale. The estimated similar to 0.86 my divergence of the lineages from a common ancestor coincides with the timing of the SMM displacement at similar to 0.78 my. Main Conclusions/Significance: Results presented here support the hypothesis that organismal properties as well as extrinsic factors lead to diversification of the Cathorops mapale group along the northern coast of South America. While a lack of pelagic larval stages and ecological specialization are forces impacting this process, the identification of the SMM as contributing to allopatric speciation in marine organisms adds to the list of recognized barriers in the Caribbean. Comparative examination of additional Southern Caribbean taxa, particularly those with varying life history traits and dispersal capabilities, will determine the extent by which the SMM has influenced marine phylogeography in the region.	[Betancur-R, Ricardo; Santos, Scott R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Betancur-R, Ricardo; Arturo, Acero P.] Univ Nacl Colombia, CECIMAR INVEMAR, Santa Marta, Colombia; [Duque-Caro, Hermann] Duque Caro & Cia Ltda, Bogota, Colombia	Auburn University System; Auburn University; Universidad Nacional de Colombia	Betancur-R, R (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	betanri@gmail.com	Santos, Scott R/A-7472-2009	Acero P., Arturo/0000-0002-6637-9901	National Science Foundation [DEB-0315963]; COLCIENCIAS, Colombia [1101-09-138-98, 117-09-12459]; Duque Caro y Cia. Ltda, Bogota D.C., Colombia	National Science Foundation(National Science Foundation (NSF)); COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Duque Caro y Cia. Ltda, Bogota D.C., Colombia	The study was funded by: 1) The All Catfish Species Inventory project supported by the National Science Foundation DEB-0315963 (http://www.nsf.gov/). 2) COLCIENCIAS 1101-09-138-98, 117-09-12459, Colombia (http://www.colciencias.gov.co). 3) Duque Caro y Cia. Ltda, Bogota D.C., Colombia. The only role of this agency in the study was to support the salary of the third author (H. Duque-Caro). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acero P.A., 2005, MEMORIA FUNDACION SA, V163, P37; ACERO PA, 1985, ZOOLOGICAL IMPLICATI, P433; AVISE JC, 1987, EVOLUTION, V41, P991, DOI 10.1111/j.1558-5646.1987.tb05872.x; Barandica Juan Carlos Narvaez, 2008, Boletin de Investigaciones Marinas y Costeras, V37, P163; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; BERGGREN WA, 1995, SEPM SPEC PUBL, V54, P212; Bermingham Eldredge, 1997, P113, DOI 10.1016/B978-012417540-2/50009-9; Bernardi G, 2005, MOL ECOL, V14, P4085, DOI 10.1111/j.1365-294X.2005.02729.x; Bernardi G, 2003, EVOLUTION, V57, P1599; Bernardi G, 2004, MAR BIOL, V145, P803, DOI 10.1007/s00227-004-1355-1; Betancur-R R, 2005, ZOOTAXA, P45; Betancur-R R, 2007, MOL PHYLOGENET EVOL, V45, P339, DOI 10.1016/j.ympev.2007.02.022; Betancur-R R, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-175; Betancur R, 2009, EVOLUTION, V63, P1232, DOI 10.1111/j.1558-5646.2009.00640.x; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 2007, DIVERS DISTRIB, V13, P544, DOI 10.1111/j.1472-4642.2007.00362.x; BULA G, 1977, AN I INV MAR PUNTA B, V9, P45; CAMPBELL CJ, 1968, PORT SPAIN TRINIDAD, P247; Carlin JL, 2003, MAR BIOL, V143, P1057, DOI 10.1007/s00227-003-1151-3; Cervigon F., 1991, PECES MARINOS VENEZU; Coates Anthony G., 1996, P21; COLIN PL, 1995, B MAR SCI, V56, P48; COSEL RV, 1976, MITTEILUNGEN I COLOM, V8, P83; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Dawson MN, 2001, EVOLUTION, V55, P1167; Diaz Juan M., 1995, Caribbean Journal of Science, V31, P104; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Duque-Caro H, 1979, GEOLOGICAL GEOPHYS I, V29, P329, DOI DOI 10.1016/j.ympev.2017.04.003; DUQUECARO H, 1990, PALAEOGEOGR PALAEOCL, V77, P203, DOI 10.1016/0031-0182(90)90178-A; FitzSimmons NN, 1997, GENETICS, V147, P1843; Hellberg ME, 2002, B MAR SCI, V70, P273; Hickerson MJ, 2001, MAR BIOL, V138, P407, DOI 10.1007/s002270000465; *INVEMAR, 2003, INF EST AMB MAR COST; IRVING EM, 1975, US GEOLOGICAL SURVEY, V846, P1; Jennings RM, 2009, J HERED, V100, P86, DOI 10.1093/jhered/esn067; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Knowlton N, 2000, HYDROBIOLOGIA, V420, P73, DOI 10.1023/A:1003933603879; Landau B, 2008, PALAEOGEOGR PALAEOCL, V257, P445, DOI 10.1016/j.palaeo.2007.10.019; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marceniuk AP, 2008, NEOTROP ICHTHYOL, V6, P25, DOI 10.1590/S1679-62252008000100004; McCune AR, 1998, ENDLESS FORMS, P172; Mendoza-Carranza Manuel, 2005, Hidrobiológica, V15, P275; MENDOZACARRANZA M, 2003, HIDROBIOLOGICA, V12, P119; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Pelc RA, 2009, J BIOGEOGR, V36, P1881, DOI 10.1111/j.1365-2699.2009.02138.x; Planes S, 2001, EVOLUTION, V55, P2263; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Richards VP, 2007, MOL ECOL, V16, P139, DOI 10.1111/j.1365-294X.2006.03145.x; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Roberts MA, 2004, GENETICS, V166, P1857, DOI 10.1534/genetics.166.4.1857; Rocha LA, 2003, J BIOGEOGR, V30, P1161, DOI 10.1046/j.1365-2699.2003.00900.x; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson M.J., 2004, R8S VERSION 1 70 USE; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; TSCHANZ CM, 1974, GEOL SOC AM BULL, V85, P273, DOI 10.1130/0016-7606(1974)85<273:GEOTSN>2.0.CO;2; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; WOODRING WP, 1974, GESELLSCHAFT BASEL, V84, P209; YANEZARANCIBIA A, 1988, MAR ECOL PROG SER, V49, P215, DOI 10.3354/meps049215; Zwickl DJ., 2006, THESIS	71	18	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11566	10.1371/journal.pone.0011566	http://dx.doi.org/10.1371/journal.pone.0011566			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644638	gold, Green Submitted, Green Published			2022-12-27	WOS:000279822300017
J	Nielsen, UN; Osler, GHR; Campbell, CD; Neilson, R; Burslem, DFRP; van der Wal, R				Nielsen, Uffe N.; Osler, Graham H. R.; Campbell, Colin D.; Neilson, Roy; Burslem, David F. R. P.; van der Wal, Rene			The Enigma of Soil Animal Species Diversity Revisited: The Role of Small-Scale Heterogeneity	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; ORIBATID MITES ACARI; MICROBIAL DIVERSITY; HEATHER MOORLAND; HABITAT; BIODIVERSITY; COMPLEXITY; COMMUNITY; BIRCH; CRYPTOSTIGMATA	Background: "The enigma of soil animal species diversity'' was the title of a popular article by J. M. Anderson published in 1975. In that paper, Anderson provided insights on the great richness of species found in soils, but emphasized that the mechanisms contributing to the high species richness belowground were largely unknown. Yet, exploration of the mechanisms driving species richness has focused, almost exclusively, on above-ground plant and animal communities, and nearly 35 years later we have several new hypotheses but are not much closer to revealing why soils are so rich in species. One persistent but untested hypothesis is that species richness is promoted by small-scale environmental heterogeneity. Methodology/Principal Findings: To test this hypothesis we manipulated small-scale heterogeneity in soil properties in a one-year field experiment and investigated the impacts on the richness of soil fauna and evenness of the microbial communities. We found that heterogeneity substantially increased the species richness of oribatid mites, collembolans and nematodes, whereas heterogeneity had no direct influence on the evenness of either the fungal, bacterial or archaeal communities or on species richness of the large and mobile mesostigmatid mites. These results suggest that the heterogeneity-species richness relationship is scale dependent. Conclusions: Our results provide direct evidence for the hypothesis that small-scale heterogeneity in soils increase species richness of intermediate-sized soil fauna. The concordance of mechanisms between above and belowground communities suggests that the relationship between environmental heterogeneity and species richness may be a general property of ecological communities.	[Nielsen, Uffe N.; Osler, Graham H. R.; Campbell, Colin D.] Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland; [Nielsen, Uffe N.; Burslem, David F. R. P.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland; [Nielsen, Uffe N.; van der Wal, Rene] Univ Aberdeen, Aberdeen Ctr Environm Sustainabil, Aberdeen, Scotland; [Campbell, Colin D.] Swedish Univ Agr Sci, Dept Soil & Environm, Uppsala, Sweden; [Neilson, Roy] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	James Hutton Institute; University of Aberdeen; University of Aberdeen; Swedish University of Agricultural Sciences; James Hutton Institute	Nielsen, UN (corresponding author), Macaulay Land Use Res Inst, Aberdeen AB9 2QJ, Scotland.	uffe@nrel.colostate.edu	Campbell, Colin D/B-3944-2010; van der Wal, Rene/F-3177-2010; Neilson, Roy/Q-1206-2019; Burslem, David FRP/F-1204-2019	Campbell, Colin D/0000-0002-5163-7656; Burslem, David FRP/0000-0001-6033-0990; Nielsen, Uffe N/0000-0003-2400-7453; Neilson, Roy/0000-0003-4544-2227	Aberdeen Centre for Environmental Sustainability; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	Aberdeen Centre for Environmental Sustainability; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD)	UNN acknowledges funding from the Aberdeen Centre for Environmental Sustainability; GO, CDC and RN acknowledge funding from the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson J.M., 1975, P51; ANDERSON JM, 1978, SOIL BIOL BIOCHEM, V10, P77, DOI 10.1016/0038-0717(78)90014-7; ANDERSON JM, 1978, OECOLOGIA, V32, P341, DOI 10.1007/BF00345112; Bardgett RD, 2002, ZOOLOGY, V105, P367, DOI 10.1078/0944-2006-00072; Blackwood CB, 2007, APPL ENVIRON MICROB, V73, P5276, DOI 10.1128/AEM.00514-07; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; Burnett MR, 1998, CONSERV BIOL, V12, P363, DOI 10.1046/j.1523-1739.1998.96238.x; Chust G, 2003, CONSERV BIOL, V17, P1712, DOI 10.1111/j.1523-1739.2003.00564.x; Downes BJ, 1998, ECOL MONOGR, V68, P237, DOI 10.1890/0012-9615(1998)068[0237:HSAROL]2.0.CO;2; Ducarme X, 2004, PEDOBIOLOGIA, V48, P139, DOI 10.1016/j.pedobi.2003.10.002; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Farley RA, 1999, J ECOL, V87, P688, DOI 10.1046/j.1365-2745.1999.00390.x; Gans J, 2005, SCIENCE, V309, P1387, DOI 10.1126/science.1112665; GILL R W, 1969, Ecology (Washington D C), V50, P805, DOI 10.2307/1933694; Hansen RA, 1998, APPL SOIL ECOL, V9, P17, DOI 10.1016/S0929-1393(98)00048-1; Hansen RA, 2000, ECOLOGY, V81, P1120, DOI 10.1890/0012-9658(2000)081[1120:EOHCAC]2.0.CO;2; Hopkin S.P., 2007, KEY COLLEMBOLA SPRIN; Huston M.A., 1994, BIOL DIVERSITY; JEFFRIES M, 1993, OIKOS, V67, P142, DOI 10.2307/3545104; Keith AM, 2006, SOIL BIOL BIOCHEM, V38, P3421, DOI 10.1016/j.soilbio.2006.05.013; MACFADYEN A., 1962, ADVANCES ECOL RES, V1, P1, DOI 10.1016/S0065-2504(08)60299-8; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MITCHELL MJ, 1978, ECOLOGY, V59, P516, DOI 10.2307/1936582; Mitchell RJ, 2007, J ECOL, V95, P540, DOI 10.1111/j.1365-2745.2007.01227.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; Osler GHR, 2006, PEDOBIOLOGIA, V50, P323, DOI 10.1016/j.pedobi.2006.05.001; Robson BJ, 1999, AUST J ECOL, V24, P599, DOI 10.1046/j.1442-9993.1999.01007.x; Ruf A, 2005, ECOTOX ENVIRON SAFE, V62, P290, DOI 10.1016/j.ecoenv.2005.03.029; Singh BK, 2006, APPL ENVIRON MICROB, V72, P7278, DOI 10.1128/AEM.00510-06; SMILES DE, 1988, BIOL FERT SOILS, V6, P204, DOI 10.1007/BF00260817; STANTON NL, 1979, ECOLOGY, V60, P295, DOI 10.2307/1937658; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Treves DS, 2003, MICROB ECOL, V45, P20, DOI 10.1007/s00248-002-1044-x; Wardle D.A, 2002, MG POP BIOL, V34, P1, DOI 10.1515/9781400847297; Wardle DA, 1996, SOIL BIOL BIOCHEM, V28, P1549, DOI 10.1016/S0038-0717(96)00293-3; WAUTHY G, 1982, ACTA OECOL-OEC GEN, V3, P469; Xia BC, 2001, PROG NAT SCI, V11, P818; Young IM, 1998, GLOBAL CHANGE BIOL, V4, P703, DOI 10.1046/j.1365-2486.1998.00194.x; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	43	79	83	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11567	10.1371/journal.pone.0011567	http://dx.doi.org/10.1371/journal.pone.0011567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644639	gold, Green Published, Green Submitted			2022-12-27	WOS:000279822300018
J	Zouk, H; Marchand, L; Polychronakos, C				Zouk, Hana; Marchand, Luc; Polychronakos, Constantin			Study of Transcriptional Effects in Cis at the IFIH1 Locus	PLOS ONE			English	Article							ACTING REGULATORY VARIATION; GENOME-WIDE ASSOCIATION; HUMAN GENE-EXPRESSION; SINGLE NUCLEOTIDE; PRIMER EXTENSION; DNA POOLS; RIG-I; HELICASE; PROTEIN; CELL	Background: The Thr allele at the non-synonymous single-nucleotide polymorphism (nsSNP) Thr946Ala in the IFIH1 gene confers risk for Type 1 diabetes (T1D). The SNP is embedded in a 236 kb linkage disequilibrium (LD) block that includes four genes: IFIH1, GCA, FAP and KCNH7. The absence of common nsSNPs in the other genes makes the IFIH1 SNP the strongest functional candidate, but it could be merely a marker of association, due to LD with a variant regulating expression levels of IFIH1 or neighboring genes. Methodology/Principal Findings: We investigated the effect of the T1D-associated variation on mRNA transcript expression of these genes. Heterozygous mRNA from lymphoblastoid cell lines (LCLs), pancreas and thymus was examined by allelic expression imbalance, to detect effects in cis on mRNA expression. Using single-nucleotide primer extension, we found no difference between mRNA transcripts in 9 LCLs, 6 pancreas and 13 thymus samples, suggesting that GCA and FAP are not involved. On the other hand, KCNH7 was not expressed at a detectable level in all tissues examined. Moreover, the association of the Thr946Ala SNP with T1D is not due to modulation of IFIH1 expression in organs involved in the disease, pointing to the IFIH1 nsSNP as the causal variant. Conclusions/Significance: The mechanism of the association of the nsSNP with T1D remains to be determined, but does not involve mRNA modulation. It becomes necessary to study differential function of the IFIH1 protein alleles at Thr946Ala to confirm that it is responsible for the disease association.	[Zouk, Hana; Marchand, Luc; Polychronakos, Constantin] McGill Univ, Montreal Childrens Hosp, Res Inst, Endocrine Genet Lab,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Zouk, Hana; Polychronakos, Constantin] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Polychronakos, Constantin] McGill Univ, Ctr Hlth, Dept Paediat, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University; McGill University	Zouk, H (corresponding author), McGill Univ, Montreal Childrens Hosp, Res Inst, Endocrine Genet Lab,Hlth Ctr, Montreal, PQ H3H 1P3, Canada.	constantin.polychronakos@mcgill.ca		Zouk, Hana/0000-0001-6492-6118; Polychronakos, Constantin/0000-0002-7624-6635	Juvenile Diabetes Research Foundation International; Fonds de Recherche en Sante du Quebec	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was funded by the Juvenile Diabetes Research Foundation International. HZ is supported by a doctoral scholarship from the Fonds de Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjos SM, 2005, GENES IMMUN, V6, P305, DOI 10.1038/sj.gene.6364211; BOYHAN A, 1992, J BIOL CHEM, V267, P2928; Bray NJ, 2006, PSYCHIAT GENET, V16, P173, DOI 10.1097/01.ypg.0000218612.35139.84; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Buckland PR, 2004, HUM MOL GENET, V13, pR255, DOI 10.1093/hmg/ddh227; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fassnacht M, 2005, CLIN CANCER RES, V11, P5566, DOI 10.1158/1078-0432.CCR-05-0699; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Hyoty H, 2002, DIABETOLOGIA, V45, P1353, DOI 10.1007/s00125-002-0852-3; Kang DC, 2004, ONCOGENE, V23, P1789, DOI 10.1038/sj.onc.1207300; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Marchand L, 2007, DIABETES, V56, P709, DOI 10.2337/db06-0402; Marinou I, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2179; McCann JA, 2001, BIOCHEM BIOPH RES CO, V286, P943, DOI 10.1006/bbrc.2001.5500; Muhlbauer E, 2007, CELL MOL LIFE SCI, V64, P768, DOI 10.1007/s00018-007-6478-3; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Norton N, 2002, HUM GENET, V110, P471, DOI 10.1007/s00439-002-0706-6; Pastinen T, 2005, HUM MOL GENET, V14, P3963, DOI 10.1093/hmg/ddi420; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Qu HQ, 2008, DIABETOLOGIA, V51, P473, DOI 10.1007/s00125-007-0895-6; Roivainen M, 2006, INT J BIOCHEM CELL B, V38, P721, DOI 10.1016/j.biocel.2005.08.019; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Singer-Sam J, 1992, PCR Methods Appl, V1, P160; SINGERSAM J, 1992, P NATL ACAD SCI USA, V89, P10469, DOI 10.1073/pnas.89.21.10469; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; van der Werf N, 2007, DIABETES-METAB RES, V23, P169, DOI 10.1002/dmrr.695; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	36	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11564	10.1371/journal.pone.0011564	http://dx.doi.org/10.1371/journal.pone.0011564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644636	Green Published, Green Submitted, gold			2022-12-27	WOS:000279822300015
J	Meadows, SK; Dressman, HK; Daher, P; Himburg, H; Russell, JL; Doan, P; Chao, NJ; Lucas, J; Nevins, JR; Chute, JP				Meadows, Sarah K.; Dressman, Holly K.; Daher, Pamela; Himburg, Heather; Russell, J. Lauren; Doan, Phuong; Chao, Nelson J.; Lucas, Joseph; Nevins, Joseph R.; Chute, John P.			Diagnosis of Partial Body Radiation Exposure in Mice Using Peripheral Blood Gene Expression Profiles	PLOS ONE			English	Article							SIGNATURES; BIOMARKERS; LEUKEMIA; PREDICT; CANCER; RISK; PROGENITOR; MANAGEMENT; WORKERS; HEALTH	In the event of a terrorist-mediated attack in the United States using radiological or improvised nuclear weapons, it is expected that hundreds of thousands of people could be exposed to life-threatening levels of ionizing radiation. We have recently shown that genome-wide expression analysis of the peripheral blood (PB) can generate gene expression profiles that can predict radiation exposure and distinguish the dose level of exposure following total body irradiation (TBI). However, in the event a radiation-mass casualty scenario, many victims will have heterogeneous exposure due to partial shielding and it is unknown whether PB gene expression profiles would be useful in predicting the status of partially irradiated individuals. Here, we identified gene expression profiles in the PB that were characteristic of anterior hemibody-, posterior hemibody- and single limb-irradiation at 0.5 Gy, 2 Gy and 10 Gy in C57Bl6 mice. These PB signatures predicted the radiation status of partially irradiated mice with a high level of accuracy (range 79-100%) compared to non-irradiated mice. Interestingly, PB signatures of partial body irradiation were poorly predictive of radiation status by site of injury (range 16-43%), suggesting that the PB molecular response to partial body irradiation was anatomic site specific. Importantly, PB gene signatures generated from TBI-treated mice failed completely to predict the radiation status of partially irradiated animals or non-irradiated controls. These data demonstrate that partial body irradiation, even to a single limb, generates a characteristic PB signature of radiation injury and thus may necessitate the use of multiple signatures, both partial body and total body, to accurately assess the status of an individual exposed to radiation.	[Meadows, Sarah K.; Daher, Pamela; Himburg, Heather; Russell, J. Lauren; Doan, Phuong; Chao, Nelson J.; Chute, John P.] Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC 27706 USA; [Dressman, Holly K.; Lucas, Joseph; Nevins, Joseph R.; Chute, John P.] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Chute, John P.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University	Meadows, SK (corresponding author), Duke Univ, Dept Med, Div Cellular Therapy, Durham, NC 27706 USA.	john.chute@duke.edu	Doan, Phuong L./Q-2093-2019	Doan, Phuong L./0000-0003-1361-2068	National Institute for Allergy and Infectious Diseases (JPC) [AI-067798-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER	National Institute for Allergy and Infectious Diseases (JPC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grant AI-067798-01 from the National Institute for Allergy and Infectious Diseases (JPC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2004, CANCER RES, V64, P6368, DOI 10.1158/0008-5472.CAN-04-1883; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Bader JL, 2008, PREHOSP EMERG CARE, V12, P1, DOI 10.1080/10903120701710595; Baird AE, 2007, STROKE, V38, P694, DOI 10.1161/01.STR.0000250431.99687.7b; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blakely WF, 2005, HEALTH PHYS, V89, P494, DOI 10.1097/01.HP.0000175913.36594.a4; Brengues M, 2010, HEALTH PHYS, V98, P179, DOI 10.1097/01.HP.0000346706.44253.5c; BUDDEMEIER B, 2009, RAD EVENT MED MA AUG; Coleman CN, 2009, ANN EMERG MED, V53, P213, DOI 10.1016/j.annemergmed.2007.12.021; Dainiak N, 2007, EXP HEMATOL, V35, P17, DOI 10.1016/j.exphem.2007.01.007; *DEP EN, MANH PROJ OFF HIST H; DiCarlo AL, 2008, RADIAT RES, V169, P712, DOI 10.1667/RR1295.1; Dressman HK, 2007, PLOS MED, V4, P690, DOI 10.1371/journal.pmed.0040106; Fliedner TM, 2009, STEM CELLS, V27, P1205, DOI 10.1002/stem.16; Grace MB, 2002, INT J RADIAT BIOL, V78, P1011, DOI 10.1080/09553000210158056; Grande T, 2006, INT J RADIAT ONCOL, V64, P612, DOI 10.1016/j.ijrobp.2005.09.036; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LUCAS JE, 2009, SPARSE STAT MODELING, P155; Lucas J, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1436; Lucas JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004523; Mandel M, 2006, LUPUS, V15, P451, DOI 10.1191/0961203306lu2332oa; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; MILLER SW, 1985, AM J CARDIOL, V55, P171, DOI 10.1016/0002-9149(85)90322-4; Ossetrova NI, 2009, INT J RADIAT BIOL, V85, P837, DOI 10.3109/09553000903154799; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Prasanna Pataje G S, 2010, Radiat Res, V173, P245, DOI 10.1667/RR1993.1; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Schubauer-Berigan MK, 2007, RADIAT RES, V167, P222, DOI 10.1667/RR0724.1; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Thompson LJ, 2009, P NATL ACAD SCI USA, V106, P22433, DOI 10.1073/pnas.0912386106; Tyburski JB, 2008, RADIAT RES, V170, P1, DOI 10.1667/RR1265.1; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; WANG Q, 2007, B INT SOC BAYESIAN A, V14, P4; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weinstock DM, 2008, BLOOD, V111, P5440, DOI 10.1182/blood-2008-01-134817; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; WONG O, 1995, OCCUP ENVIRON MED, V52, P380, DOI 10.1136/oem.52.6.380; Yoshinaga S, 2004, RADIOLOGY, V233, P313, DOI 10.1148/radiol.2332031119; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	43	41	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11535	10.1371/journal.pone.0011535	http://dx.doi.org/10.1371/journal.pone.0011535			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634956	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600015
J	Lesur, I; Textoris, J; Loriod, B; Courbon, C; Garcia, S; Leone, M; Nguyen, C				Lesur, Isabelle; Textoris, Julien; Loriod, Beatrice; Courbon, Cecile; Garcia, Stephane; Leone, Marc; Nguyen, Catherine			Gene Expression Profiles Characterize Inflammation Stages in the Acute Lung Injury in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ANGIOTENSIN-CONVERTING ENZYME; LIPID-METABOLISM; OLEIC-ACID; DNA MICROARRAYS; MOUSE MODEL; SEPSIS; INTERLEUKIN-6; STIMULATION; ACTIVATION	Acute Lung Injury (ALI) carries about 50 percent mortality and is frequently associated with an infection (sepsis). Life-support treatment with mechanical ventilation rescues many patients, although superimposed infection or multiple organ failure can result in death. The outcome of a patient developing sepsis depends on two factors: the infection and the preexisting inflammation. In this study, we described each stage of the inflammation process using a transcriptional approach and an animal model. Female C57BL6/J mice received an intravenous oleic acid injection to induce an acute lung injury (ALI). Lung expression patterns were analyzed using a 9900 cDNA mouse microarray (MUSV29K). Our gene-expression analysis revealed marked changes in the immune and inflammatory response metabolic pathways, notably lipid metabolism and transcription. The early stage (1 hour-1.5 hours) is characterized by a pro-inflammatory immune response. Later (3 hours-4 hours), the immune cells migrate into inflamed tissues through interaction with vascular endothelial cells. Finally, at late stages of lung inflammation (18 hours-24 hours), metabolism is deeply disturbed. Highly expressed proinflammatory cytokines activate transcription of many genes and lipid metabolism. In this study, we described a global overview of critical events occurring during lung inflammation which is essential to understand infectious pathologies such as sepsis where inflammation and infection are intertwined. Based on these data, it becomes possible to isolate the impact of a pathogen at the transcriptional level from the global gene expression modifications resulting from the infection associated with the inflammation.	[Lesur, Isabelle; Textoris, Julien; Loriod, Beatrice; Nguyen, Catherine] Univ Mediterranee, TAGC, INSERM, U928, Marseille, France; [Textoris, Julien; Leone, Marc] Univ Mediterranee, Hop Nord, AP HM, Serv Anesthesie & Reanimat, Marseille, France; [Courbon, Cecile] Univ Mediterranee, Hop LaTimone, AP HM, Serv Anesthesie & Reanimat, Marseille, France; [Garcia, Stephane] Univ Mediterranee, Fac Med, Secteur Nord, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Lesur, I (corresponding author), Univ Mediterranee, TAGC, INSERM, U928, Parc Sci Luminy, Marseille, France.	nguyen@tagc.univ-mrs.fr	Nguyen, Catherine/M-4119-2016; Leone, Marc/P-4835-2016; Textoris, Julien/H-3317-2019; loriod, beatrice bl/L-2948-2016	Nguyen, Catherine/0000-0001-9376-6360; Leone, Marc/0000-0002-3097-758X; Textoris, Julien/0000-0002-3821-9337; loriod, beatrice bl/0000-0001-5801-2264	Conseil Regional Provence Alpes Cote d'Azur; Societe Francaise d'Anesthesie et de Reanimation; Ministere de la sante	Conseil Regional Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'AzurRegion Auvergne-Rhone-Alpes); Societe Francaise d'Anesthesie et de Reanimation; Ministere de la sante	This work was supported by grants from Conseil Regional Provence Alpes Cote d'Azur, Societe Francaise d'Anesthesie et de Reanimation, and le Ministere de la sante (Programme Hospitalier de Recherche Clinique, PHRC 2005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 1996, BRIT J ANAESTH, V77, P17, DOI 10.1093/bja/77.1.17; AKIRA S, 1993, ADV IMMUNOL, V54, P1, DOI 10.1016/S0065-2776(08)60532-5; ARGILES JM, 1989, BIOCHEM J, V259, P673, DOI 10.1042/bj2590673; Armstrong L, 1997, THORAX, V52, P442, DOI 10.1136/thx.52.5.442; BAUMANN H, 1989, ANN NY ACAD SCI, V557, P280; Bein K, 2009, AM J RESP CELL MOL, V41, P226, DOI 10.1165/rcmb.2008-0317OC; Bem RA, 2009, AM J PHYSIOL-LUNG C, V296, pL46, DOI 10.1152/ajplung.00467.2007; Bhatia M, 2004, J PATHOL, V202, P145, DOI 10.1002/path.1491; BIRCH HE, 1986, J BIOL CHEM, V261, P8077; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bulfone-Paus S, 1999, FASEB J, V13, P1575, DOI 10.1096/fasebj.13.12.1575; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; CASEY L, 1981, CRIT CARE MED, V9, P651, DOI 10.1097/00003246-198109000-00008; CAVAILLON J, 1998, PATHOPHYSIOLOGICAL R, P127; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; CHINNAIYAN AM, 2001, MOL SIGNATURES SEPSI; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; CROWL RM, 1991, J BIOL CHEM, V266, P2647; DERKS CM, 1977, AM J PATHOL, V87, P143; Diehl F, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf078; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FEINGOLD KR, 1992, J LIPID RES, V33, P1765; Giannoudis PV, 1998, BRIT J SURG, V85, P986; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GRANJEAUD S, MIQC; GRUNFELD C, 1991, CANCER RES, V51, P2803; Hardardottir I, 1995, BIOCHEM SOC T, V23, P1013, DOI 10.1042/bst0231013; Hotchkiss RS, 2009, NAT MED, V15, P496, DOI 10.1038/nm0509-496; HOWARD M, 1992, IMMUNOL TODAY, V13, P198, DOI 10.1016/0167-5699(92)90153-X; Huang HW, 2007, J BIOMED SCI, V14, P169, DOI 10.1007/s11373-006-9135-1; Johnson Pauline, 2009, Inflammation & Allergy Drug Targets, V8, P208; Johnson SB, 2007, ANN SURG, V245, P611, DOI 10.1097/01.sla.0000251619.10648.32; KASAMA T, 1994, J IMMUNOL, V152, P3559; Kopterides P, 2009, CLIN MICROBIOL INFEC, V15, P325, DOI 10.1111/j.1469-0691.2009.02750.x; Leone M, 2003, ANN FR ANESTH, V22, P721, DOI 10.1016/S0750-7658(03)00327-7; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; Loureiro RMB, 2008, BRIT J HAEMATOL, V141, P739, DOI 10.1111/j.1365-2141.2008.07105.x; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Muller WA, 2009, CIRC RES, V105, P223, DOI 10.1161/CIRCRESAHA.109.200717; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; NIJSTEN MWN, 1991, SURGERY, V109, P761; Olman MA, 2004, J IMMUNOL, V172, P2668, DOI 10.4049/jimmunol.172.4.2668; Opdenakker G, 2001, Verh K Acad Geneeskd Belg, V63, P531; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puthier D, 2004, J IMMUNOL, V173, P6109, DOI 10.4049/jimmunol.173.10.6109; PUTHIER D, NYLONARRAY; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Saban MR, 2001, PHYSIOL GENOMICS, V5, P147, DOI 10.1152/physiolgenomics.2001.5.3.147; SCHUSTER DP, 1994, AM J RESP CRIT CARE, V149, P245, DOI 10.1164/ajrccm.149.1.8111590; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002; Tanaka TS, 2000, P NATL ACAD SCI USA, V97, P9127, DOI 10.1073/pnas.97.16.9127; TEVELDE AA, 1990, BLOOD, V76, P1392; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Villar J, 2008, INTENS CARE MED, V34, P488, DOI 10.1007/s00134-007-0937-z; Wang ZX, 2008, AM J RESP CELL MOL, V38, P724, DOI 10.1165/rcmb.2007-0354OC; Woerndle RH, 2008, J AM OSTEOPATH ASSOC, V108, P486; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Worgall TS, 2009, CURR OPIN CLIN NUTR, V12, P105, DOI 10.1097/MCO.0b013e32832595b7; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Zhou ZH, 2005, AM J RESP CRIT CARE, V172, P344, DOI 10.1164/rccm.200503-343OC	65	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11485	10.1371/journal.pone.0011485	http://dx.doi.org/10.1371/journal.pone.0011485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628605	Green Published, gold, Green Submitted			2022-12-27	WOS:000279637100012
J	Kurz, A; Double, KL; Lastres-Becker, I; Tozzi, A; Tantucci, M; Bockhart, V; Bonin, M; Garcia-Arencibia, M; Nuber, S; Schlaudraff, F; Liss, B; Fernandez-Ruiz, J; Gerlach, M; Wullner, U; Luddens, H; Calabresi, P; Auburger, G; Gispert, S				Kurz, Alexander; Double, Kay L.; Lastres-Becker, Isabel; Tozzi, Alessandro; Tantucci, Michela; Bockhart, Vanessa; Bonin, Michael; Garcia-Arencibia, Moises; Nuber, Silke; Schlaudraff, Falk; Liss, Birgit; Fernandez-Ruiz, Javier; Gerlach, Manfred; Wuellner, Ullrich; Lueddens, Hartmut; Calabresi, Paolo; Auburger, Georg; Gispert, Suzana			A53T-Alpha-Synuclein Overexpression Impairs Dopamine Signaling and Striatal Synaptic Plasticity in Old Mice	PLOS ONE			English	Article							HUMAN ALPHA-SYNUCLEIN; RECEPTOR MESSENGER-RNA; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; NEURONAL DYSFUNCTION; GLOBUS-PALLIDUS; GENE-EXPRESSION; RAT-BRAIN; STIMULATION; ACTIVATION	Background: Parkinson's disease (PD), the second most frequent neurodegenerative disorder at old age, can be caused by elevated expression or the A53T missense mutation of the presynaptic protein alpha-synuclein (SNCA). PD is characterized pathologically by the preferential vulnerability of the dopaminergic nigrostriatal projection neurons. Methodology/Principal Findings: Here, we used two mouse lines overexpressing human A53T-SNCA and studied striatal dysfunction in the absence of neurodegeneration to understand early disease mechanisms. To characterize the progression, we employed young adult as well as old mice. Analysis of striatal neurotransmitter content demonstrated that dopamine (DA) levels correlated directly with the level of expression of SNCA, an observation also made in SNCA-deficient (knockout, KO) mice. However, the elevated DA levels in the striatum of old A53T-SNCA overexpressing mice may not be transmitted appropriately, in view of three observations. First, a transcriptional downregulation of the extraneural DA degradation enzyme catechol-ortho-methytransferase (COMT) was found. Second, an upregulation of DA receptors was detected by immunoblots and autoradiography. Third, extensive transcriptome studies via microarrays and quantitative real-time RTPCR (qPCR) of altered transcript levels of the DA-inducible genes Atf2, Cb1, Freq, Homer1 and Pde7b indicated a progressive and genotype-dependent reduction in the postsynaptic DA response. As a functional consequence, long term depression (LTD) was absent in corticostriatal slices from old transgenic mice. Conclusions/Significance: Taken together, the dysfunctional neurotransmission and impaired synaptic plasticity seen in the A53T-SNCA overexpressing mice reflect early changes within the basal ganglia prior to frank neurodegeneration. As a model of preclinical stages of PD, such insights may help to develop neuroprotective therapeutic approaches.	[Kurz, Alexander; Lastres-Becker, Isabel; Auburger, Georg; Gispert, Suzana] Goethe Univ Frankfurt, Sch Med, Dept Neurol, Frankfurt, Germany; [Double, Kay L.] Neurosci Res Australia, Sydney, NSW, Australia; [Double, Kay L.] Univ New S Wales, Sydney, NSW, Australia; [Tozzi, Alessandro; Tantucci, Michela; Calabresi, Paolo] Univ Perugia, Osped S Maria Misericordia, Neurol Clin, I-06100 Perugia, Italy; [Bockhart, Vanessa; Lueddens, Hartmut] Johannes Gutenberg Univ Mainz, Dept Psychiat, D-6500 Mainz, Germany; [Bonin, Michael] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Garcia-Arencibia, Moises; Fernandez-Ruiz, Javier] Univ Complutense, Dept Biochem & Mol Biol, E-28040 Madrid, Spain; [Garcia-Arencibia, Moises; Fernandez-Ruiz, Javier] Univ Complutense, Fac Med, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-28040 Madrid, Spain; [Nuber, Silke] Univ Tubingen, Dept Med Genet, Tubingen, Germany; [Schlaudraff, Falk; Liss, Birgit] Univ Ulm, Inst Gen Physiol, Ulm, Germany; [Gerlach, Manfred] Univ Wurzburg, Dept Child & Adolescent Psychiat Psychosomat & Ps, Lab Clin Neurochem, Wurzburg, Germany; [Wuellner, Ullrich] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany; [Tozzi, Alessandro; Calabresi, Paolo] European Brain Res Inst, Fdn Santa Lucia IRCCS CERC, Rome, Italy	Goethe University Frankfurt; Neuroscience Research Australia; University of New South Wales Sydney; Hospital Santa Maria della Misericordia; University of Perugia; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Complutense University of Madrid; CIBERNED; Complutense University of Madrid; Eberhard Karls University of Tubingen; Ulm University; University of Wurzburg; University of Bonn; IRCCS Santa Lucia	Kurz, A (corresponding author), Goethe Univ Frankfurt, Sch Med, Dept Neurol, Frankfurt, Germany.	gispert-sanchez@em.uni-frankfurt.de	Wüllner, Ullrich/R-6790-2019; Double, Kay/AAX-7902-2021; Cao, Pengxiu/I-5378-2012; Tozzi, Alessandro/AAB-8707-2022; Becker, Isabel Lastres/AAB-6788-2019; Garcia-Arencibia, Moises/B-5538-2012; Garcia-Arencibia, Moises/K-9920-2013; Tozzi, Alessandro/G-7254-2011; Lastres-Becker, Isabel/R-3403-2018; Calabresi, Paolo/G-8496-2011; FERNANDEZ RUIZ, JOSE JAVIER/S-3875-2018	Double, Kay/0000-0001-8712-7781; Becker, Isabel Lastres/0000-0002-4968-2175; Garcia-Arencibia, Moises/0000-0002-1618-4487; Lastres-Becker, Isabel/0000-0002-4968-2175; Calabresi, Paolo/0000-0003-0326-5509; FERNANDEZ RUIZ, JOSE JAVIER/0000-0002-4490-0604; Tozzi, Alessandro/0000-0003-3153-2424; liss, Birgit/0000-0002-6733-9207	Deutsche Forschungsgemeinschaft [GI 342/3-1]; Bundesministerium fuer Forschung und Technologie [8.2.7]; National Health and Medical Research Council of Australia; Comunidad de Madrid [S-SAL-0261/2006]; CIBERNED [CB06/05/0089]; European Community [HEALTH-2007-22918]; Ministero della Salute; BMBF (NGFN-Net); Gemeinnuetzige Hertiestiftung; Alfried Krupp Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fuer Forschung und Technologie; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Comunidad de Madrid(Comunidad de Madrid); CIBERNED(Instituto de Salud Carlos III); European Community(European Commission); Ministero della Salute(Ministry of Health, Italy); BMBF (NGFN-Net)(Federal Ministry of Education & Research (BMBF)); Gemeinnuetzige Hertiestiftung; Alfried Krupp Foundation	This work was supported by the Deutsche Forschungsgemeinschaft [GI 342/3-1], the Bundesministerium fuer Forschung und Technologie [NGFN2 and NGFNplus Parkinson Net, Project 8.2.7], the National Health and Medical Research Council of Australia; Comunidad de Madrid [S-SAL-0261/2006], the CIBERNED [CB06/05/0089]; the European Community [HEALTH-2007-22918, REPLACES to P.C.], the Ministero della Salute [Progetto Strategico 2007 to P.C.]. I.L.-B. was a fellow of the Alexander von Humboldt Foundation. K.L.D. was a Fellow of the National Health and Medical Research Council of Australia, S.N. had a Stipendium of the Deutschen Parkinson Gesellschaft. This work was supported by the BMBF (NGFN-Net), the Gemeinnuetzige Hertiestiftung (B.L.), and the Alfried Krupp Foundation (B.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; ALWANDI A, 2008, NEUROBIOL AGING; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Cabin DE, 2002, J NEUROSCI, V22, P8797; Calabresi P, 2001, J NEUROSCI, V21, P5110, DOI 10.1523/JNEUROSCI.21-14-05110.2001; Calabresi P, 1997, J NEUROSCI, V17, P1940; CALABRESI P, 1990, J NEUROPHYSIOL, V63, P663, DOI 10.1152/jn.1990.63.4.663; Calabresi P, 2000, TRENDS NEUROSCI, V23, pS57, DOI 10.1016/S1471-1931(00)00017-3; Calabresi P, 2007, TRENDS NEUROSCI, V30, P211, DOI 10.1016/j.tins.2007.03.001; Calabresi P, 2009, BRAIN, V132, P285, DOI 10.1093/brain/awn340; CAO P, PLOS ONE, V5, pE9312; Cenci MA, 2006, J NEUROCHEM, V99, P381, DOI 10.1111/j.1471-4159.2006.04124.x; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Costa C, 2008, J NEUROSCI, V28, P8040, DOI 10.1523/JNEUROSCI.1947-08.2008; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; Gispert S, 2003, MOL CELL NEUROSCI, V24, P419, DOI 10.1016/S1044-7431(03)00198-2; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Henning J, 2007, EUR J NEUROSCI, V25, P239, DOI 10.1111/j.1460-9568.2006.05264.x; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Itier JM, 2003, HUM MOL GENET, V12, P2277, DOI 10.1093/hmg/ddg239; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; KITA H, 1994, BRAIN RES, V636, P308, DOI 10.1016/0006-8993(94)91030-8; Kitada T, 2009, J NEUROCHEM, V111, P696, DOI 10.1111/j.1471-4159.2009.06350.x; Krasnova IN, 2007, NEUROTOX RES, V11, P107, DOI 10.1007/BF03033390; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kuwajima M, 2007, J NEUROSCI, V27, P6249, DOI 10.1523/JNEUROSCI.3819-06.2007; Lastres-Becker I, 2002, BRAIN RES, V929, P236, DOI 10.1016/S0006-8993(01)03403-5; LEHMANN A, 1974, ATLAS STEREOTAXIQUE; Liu SM, 2004, EMBO J, V23, P4506, DOI 10.1038/sj.emboj.7600451; Lotharius J, 2002, HUM MOL GENET, V11, P2395, DOI 10.1093/hmg/11.20.2395; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mosharov EV, 2006, J NEUROSCI, V26, P9304, DOI 10.1523/JNEUROSCI.0519-06.2006; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Pearson AG, 2005, NEUROSCIENCE, V133, P437, DOI 10.1016/j.neuroscience.2005.02.029; Picconi B, 2003, NAT NEUROSCI, V6, P501, DOI 10.1038/nn1040; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Richfield EK, 2002, EXP NEUROL, V175, P35, DOI 10.1006/exnr.2002.7882; ROMERO J, 1995, BRAIN RES, V694, P223, DOI 10.1016/0006-8993(95)00835-E; RUBINO T, 1994, NEUROREPORT, V5, P2493, DOI 10.1097/00001756-199412000-00022; Sasaki T, 2004, J NEUROCHEM, V89, P474, DOI 10.1111/j.1471-4159.2004.02354.x; SEEMAN P, 1990, FASEB J, V4, P2737, DOI 10.1096/fasebj.4.10.2197154; Seidel K, 2010, ANN NEUROL, V67, P684, DOI 10.1002/ana.21966; Senior SL, 2008, EUR J NEUROSCI, V27, P947, DOI 10.1111/j.1460-9568.2008.06055.x; Sidhu A, 2004, FEBS LETT, V565, P1, DOI 10.1016/j.febslet.2004.03.063; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tappe A, 2006, P NATL ACAD SCI USA, V103, P774, DOI 10.1073/pnas.0505900103; Thomas U, 2002, J NEUROCHEM, V81, P407, DOI 10.1046/j.1471-4159.2002.00869.x; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Wersinger C, 2005, BIOCHEMISTRY-US, V44, P13612, DOI 10.1021/bi050402p; Winter C, 2000, NEUROSCIENCE, V95, P753; Yamada H, 2007, BRAIN RES, V1131, P88, DOI 10.1016/j.brainres.2006.11.011; Zeng BY, 1999, NEUROSCI LETT, V276, P71, DOI 10.1016/S0304-3940(99)00762-4	57	88	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11464	10.1371/journal.pone.0011464	http://dx.doi.org/10.1371/journal.pone.0011464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628651	Green Published, gold			2022-12-27	WOS:000279589300011
J	Adam, V; Petrlova, J; Wang, J; Eckschlager, T; Trnkova, L; Kizek, R				Adam, Vojtech; Petrlova, Jitka; Wang, Joseph; Eckschlager, Tomas; Trnkova, Libuse; Kizek, Rene			Zeptomole Electrochemical Detection of Metallothioneins	PLOS ONE			English	Article							SPECIATION; PROTEINS; LEVEL	Background: Thiol-rich peptides and proteins possess a large number of biological activities and may serve as markers for numerous health problems including cancer. Metallothionein (MT), a small molecular mass protein rich in cysteine, may be considered as one of the promising tumour markers. The aim of this paper was to employ chronopotentiometric stripping analysis (CPSA) for highly sensitive detection of MT. Methodology/Principal Findings: In this study, we used adsorptive transfer stripping technique coupled with CPSA for detection of cysteine, glutathione oxidized and reduced, phytochelatin, bovine serum albumin, and metallothionein. Under the optimal conditions, we were able to estimate detection limits down to tens of fg per ml. Further, this method was applied to detect metallothioneins in blood serum obtained from patients with breast cancer and in neuroblastoma cells resistant and sensitive to cisplatin in order to show the possible role of metallothioneins in carcinogenesis. It was found that MT level in blood serum was almost twice higher as compared to the level determined in healthy individuals. Conclusions/Significance: This paper brings unique results on the application of ultra-sensitive electroanalytical method for metallothionein detection. The detection limit and other analytical parameters are the best among the parameters of other techniques. In spite of the fact that the paper is mainly focused on metallothionein, it is worth mentioning that successful detection of other biologically important molecules is possible by this method. Coupling of this method with simple isolation methods such as antibody-modified paramagnetic particles may be implemented to lab-on-chip instrument.	[Adam, Vojtech; Petrlova, Jitka; Kizek, Rene] Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Brno, Czech Republic; [Wang, Joseph] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Eckschlager, Tomas] Charles Univ Prague, Fac Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Trnkova, Libuse] Masaryk Univ, Fac Sci, Dept Chem, CS-61137 Brno, Czech Republic	Mendel University in Brno; University of California System; University of California San Diego; Charles University Prague; Masaryk University Brno	Adam, V (corresponding author), Mendel Univ Brno, Fac Agron, Dept Chem & Biochem, Brno, Czech Republic.	kizek@sci.muni.cz	Adam, Vojtech/D-7686-2012; Kizek, Rene/D-7748-2012; Wang, Joseph/C-6175-2011	Adam, Vojtech/0000-0002-8527-286X; Kizek, Rene/0000-0002-0467-6169	GAAV [IAA40199071]	GAAV(Grant Agency of the Czech Republic)	Financial support from GAAV IAA40199071 is highly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM V, 2010, TRAC TRENDS IN PRESS, P158; Adam V, 2008, SENSORS-BASEL, V8, P2293, DOI 10.3390/s8042293; DIEZEL W, 1972, ANAL BIOCHEM, V48, P617, DOI 10.1016/0003-2697(72)90117-0; Eckschlager T, 2009, CURR PROTEIN PEPT SC, V10, P360, DOI 10.2174/138920309788922243; Fabrik I, 2008, ELECTROANAL, V20, P1521, DOI 10.1002/elan.200704215; Fagerholm R, 2008, NAT GENET, V40, P844, DOI 10.1038/ng.155; Ferrarello CN, 2000, ANAL CHEM, V72, P5874, DOI 10.1021/ac0004411; Harrington CF, 2005, ANAL CHEM, V77, P4034, DOI 10.1021/ac050256t; Kizek R, 2001, ANAL CHEM, V73, P4801, DOI 10.1021/ac010126u; Knipp M, 2007, J MED CHEM, V50, P4075, DOI 10.1021/jm070271l; Kondo T, 2006, NAT PROTOC, V1, P2940, DOI 10.1038/nprot.2006.421; Kulasingam V, 2008, NAT CLIN PRACT ONCOL, V5, P588, DOI 10.1038/ncponc1187; LONG GL, 1983, ANAL CHEM, V55, pA712, DOI 10.1021/ac00258a001; Luo DB, 2003, ANAL CHEM, V75, P6346, DOI 10.1021/ac0300643; MARGOSHES M, 1957, J AM CHEM SOC, V79, P4813, DOI 10.1021/ja01574a064; Murphy BJ, 2008, MOL CANCER RES, V6, P483, DOI 10.1158/1541-7786.MCR-07-0341; Petrlova J, 2006, ELECTROCHIM ACTA, V51, P5112, DOI 10.1016/j.electacta.2006.03.078; Poulsen CB, 2006, BLOOD, V108, P3514, DOI 10.1182/blood-2006-04-015305; Strouhal M, 2003, BIOELECTROCHEMISTRY, V60, P29, DOI 10.1016/S1567-5394(03)00043-4; Szpunar J, 2005, ANALYST, V130, P442, DOI 10.1039/b418265k; Trnkova L, 2002, BIOELECTROCHEMISTRY, V56, P57, DOI 10.1016/S1567-5394(02)00048-8; Wang ZX, 2002, ANAL CHEM, V74, P626, DOI 10.1021/ac010862y; Wei H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-7; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	24	63	64	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11441	10.1371/journal.pone.0011441	http://dx.doi.org/10.1371/journal.pone.0011441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625429	gold, Green Published			2022-12-27	WOS:000279522500009
J	Roepke, TK; Purtell, K; King, EC; La Perle, KMD; Lerner, DJ; Abbott, GW				Roepke, Torsten K.; Purtell, Kerry; King, Elizabeth C.; La Perle, Krista M. D.; Lerner, Daniel J.; Abbott, Geoffrey W.			Targeted Deletion of Kcne2 Causes Gastritis Cystica Profunda and Gastric Neoplasia	PLOS ONE			English	Article							BECKWITH-WIEDEMANN-SYNDROME; POTASSIUM CHANNELS; CANCER-CELLS; HELICOBACTER-PYLORI; MONGOLIAN GERBILS; OXYNTIC ATROPHY; PARIETAL-CELLS; ACID-SECRETION; MUTANT MICE; K+ CHANNEL	Gastric cancer is the second leading cause of cancer death worldwide. Predisposing factors include achlorhydria, Helicobacter pylori infection, oxyntic atrophy and TFF2-expressing metaplasia. In parietal cells, apical potassium channels comprising the KCNQ1 alpha subunit and the KCNE2 beta subunit provide a K+ efflux current to facilitate gastric acid secretion by the apical H(+)K(+)ATPase. Accordingly, genetic deletion of murine Kcnq1 or Kcne2 impairs gastric acid secretion. Other evidence has suggested a role for KCNE2 in human gastric cancer cell proliferation, independent of its role in gastric acidification. Here, we demonstrate that 1-year-old Kcne2(-/-) mice in a pathogen-free environment all exhibit a severe gastric preneoplastic phenotype comprising gastritis cystica profunda, 6-fold increased stomach mass, increased Ki67 and nuclear Cyclin D1 expression, and TFF2- and cytokeratin 7-expressing metaplasia. Some Kcne2(-/-) mice also exhibited pyloric polypoid adenomas extending into the duodenum, and neoplastic invasion of thin walled vessels in the sub-mucosa. Finally, analysis of human gastric cancer tissue indicated reduced parietal cell KCNE2 expression. Together with previous findings, the results suggest KCNE2 disruption as a possible risk factor for gastric neoplasia.	[Roepke, Torsten K.; Purtell, Kerry; King, Elizabeth C.; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Roepke, Torsten K.; Lerner, Daniel J.; Abbott, Geoffrey W.] Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA; [La Perle, Krista M. D.] Ohio State Univ, Coll Vet Med, Dept Vet Biosci, Columbus, OH 43210 USA	Cornell University; Cornell University; University System of Ohio; Ohio State University	Roepke, TK (corresponding author), Charite, Clin Cardiol & Angiol, D-13353 Berlin, Germany.	gwa2001@med.cornell.edu	La Perle, Krista Marie DuBray/B-3099-2015	Abbott, Geoffrey/0000-0003-4552-496X	National Heart, Lung and Blood Institute, National Institutes of Health [R01 HL079275]; American Heart Association [0855756D]; Irma T. Hirschl Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Irma T. Hirschl Career Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	G.W.A. is supported by the National Heart, Lung and Blood Institute, National Institutes of Health (R01 HL079275), the American Heart Association (Grant-In-Aid 0855756D), and an Irma T. Hirschl Career Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Arcangeli A, 1999, J NEUROBIOL, V40, P214; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BEAUCHAMP RD, 1989, J CLIN INVEST, V84, P1017, DOI 10.1172/JCI114223; BECHADE D, 2007, ENDOSCOPY; Bianchi L, 1998, CANCER RES, V58, P815; Boivin GP, 1996, LAB INVEST, V74, P513; Chen SZ, 2005, CANCER CHEMOTH PHARM, V56, P212, DOI 10.1007/s00280-004-0960-5; Cherubini A, 2000, BRIT J CANCER, V83, P1722, DOI 10.1054/bjoc.2000.1497; Conti DJ, 2004, AM J TRANSPLANT, V4, P166; De Falco M, 2004, J ANAT, V205, P405, DOI 10.1111/j.0021-8782.2004.00347.x; Diaz-Meyer N, 2003, J MED GENET, V40, P797, DOI 10.1136/jmg.40.11.797; Elso CM, 2004, HUM MOL GENET, V13, P2813, DOI 10.1093/hmg/ddh307; FITZPATRICK GV, 2002, NAT GENET; FONDE EC, 1986, AM J GASTROENTEROL, V81, P459; Fujita A, 2002, J PHYSIOL-LONDON, V540, P85, DOI 10.1113/jphysiol.2001.013439; Gao P, 2004, WORLD J GASTROENTERO, V10, P2936; Geibel JP, 2005, WORLD J GASTROENTERO, V11, P5259, DOI 10.3748/wjg.v11.i34.5259; Giraud AS, 2007, GASTROENTEROLOGY, V132, P2053, DOI 10.1053/j.gastro.2007.03.074; Goldenring JR, 2006, AM J PHYSIOL-GASTR L, V291, pG999, DOI 10.1152/ajpgi.00187.2006; Itoi T, 2000, J GASTROENTEROL, V35, P142, DOI 10.1007/s005350050027; JIANG W, 1992, CANCER RES, V52, P2980; Kurland J, 2006, GASTROINTEST ENDOSC, V63, P716, DOI 10.1016/j.gie.2005.11.027; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Malinowska DH, 2004, AM J PHYSIOL-CELL PH, V286, pC495, DOI 10.1152/ajpcell.00386.2003; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Mitomi H, 1998, SCAND J GASTROENTERO, V33, P1226; Mohammed IA, 2002, MODERN PATHOL, V15, P611, DOI 10.1038/modpathol.3880574; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; Ogawa M, 2006, AM J PHYSIOL-GASTR L, V290, pG793, DOI 10.1152/ajpgi.00309.2005; OZENC AM, 1988, ARCH SURG-CHICAGO, V123, P372; Pan YL, 2007, CANCER LETT, V246, P129, DOI 10.1016/j.canlet.2006.02.010; Park KH, 2001, NEUROSCI LETT, V298, P29, DOI 10.1016/S0304-3940(00)01710-9; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmidt PH, 1999, LAB INVEST, V79, P639; SHAO X, 2005, CANC BIOL THER, V4; Stepan V, 2005, J BIOL CHEM, V280, P15700, DOI 10.1074/jbc.M413037200; Suzuki T, 2004, INT J ONCOL, V25, P153; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989; Yamashita M, 2002, APMIS, V110, P717, DOI 10.1034/j.1600-0463.2002.1101005.x; Yoshizawa N, 2007, LAB INVEST, V87, P1265, DOI 10.1038/labinvest.3700682; Zavros Y, 2005, ONCOGENE, V24, P2354, DOI 10.1038/sj.onc.1208407; Zhai Y, 2002, AM J PATHOL, V160, P1229, DOI 10.1016/S0002-9440(10)62550-3; Zheng Q, 2004, J GASTROEN HEPATOL, V19, P1192, DOI 10.1111/j.1440-1746.2004.03469.x	48	56	62	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11451	10.1371/journal.pone.0011451	http://dx.doi.org/10.1371/journal.pone.0011451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625512	Green Published, gold, Green Accepted			2022-12-27	WOS:000279522500018
J	Bae, JS; Cheong, HS; Park, BL; Kim, LH; Han, CS; Park, TJ; Kim, JY; Pasaje, CFA; Lee, JS; Shin, HD				Bae, Joon Seol; Cheong, Hyun Sub; Park, Byung Lae; Kim, Lyoung Hyo; Han, Chang Soo; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Shin, Hyoung Doo			Genome-Wide Profiling of Structural Genomic Variations in Korean HapMap Individuals	PLOS ONE			English	Article							COPY NUMBER VARIATION; IDENTIFICATION; ABERRATIONS; FREQUENCY; VARIANTS; SEQUENCE; DISEASE; RISK	Background: Structural genomic variation study, along with microarray technology development has provided many genomic resources related with architecture of human genome, and led to the fact that human genome structure is a lot more complicated than previously thought. Methodology/Principal Findings: In the case of International HapMap Project, Epstein-Barr various immortalized cell lines were preferably used over blood in order to get a larger number of genomic DNA. However, genomic aberration stemming from immortalization process, biased representation of the donor tissue, and culture process may influence the accuracy of SNP genotypes. In order to identify chromosome aberrations including loss of heterozygosity (LOH), large-scale and small-scale copy number variations, we used Illumina HumanHap500 BeadChip (555,352 markers) on Korean HapMap individuals (n = 90) to obtain Log R ratio and B allele frequency information, and then utilized the data with various programs including Illumina ChromoZone, cnvParition and PennCNV. As a result, we identified 28 LOHs (>3 mb) and 35 large-scale CNVs (>1 mb), with 4 samples having completely duplicated chromosome. In addition, after checking the sample quality (standard deviation of log R ratio <0.30), we selected 79 samples and used both signal intensity and B allele frequency simultaneously for identification of small-scale CNVs (<1 mb) to discover 4,989 small-scale CNVs. Identified CNVs in this study were successfully validated using visual examination of the genoplot images, overlapping analysis with previously reported CNVs in DGV, and quantitative PCR. Conclusion/Significance: In this study, we describe the result of the identified chromosome aberrations in Korean HapMap individuals, and expect that these findings will provide more meaningful information on the human genome.	[Bae, Joon Seol; Park, Tae Joon; Kim, Jason Yongha; Pasaje, Charisse Flerida A.; Lee, Jin Sol; Shin, Hyoung Doo] Sogang Univ, Dept Life Sci, Lab Genom Divers, Seoul, South Korea; [Cheong, Hyun Sub; Park, Byung Lae; Kim, Lyoung Hyo; Han, Chang Soo; Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul, South Korea	Sogang University; SNP Genetics	Bae, JS (corresponding author), Sogang Univ, Dept Life Sci, Lab Genom Divers, Seoul, South Korea.	hdshin@sogang.ac.kr	Pasaje, Charisse Flerida A./J-7990-2014; Pasaje, Charisse Flerida A./AAY-8793-2020	Pasaje, Charisse Flerida A./0000-0002-9780-3680; Pasaje, Charisse Flerida A./0000-0002-9780-3680	Korean government (MEST) [2009-0080157, 2010-0011206]	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the Korea Science and Engineering Foundation (KOSEF) funded by the Korean government (MEST) (No. 2009-0080157 and 2010-0011206). SNP Genetics, Inc. provided the Beadstation500 scanner instrument and BeadStudio 3.2 software used in the research; they also were involved in the design, data collection and analysis, decision to publish, and preparation of the manuscript.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Bae JS, 2008, BIOCHEM BIOPH RES CO, V373, P593, DOI 10.1016/j.bbrc.2008.06.083; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Beissbarth T, 2006, METHOD ENZYMOL, V411, P340, DOI 10.1016/S0076-6879(06)11018-6; Bonassi S, 2008, CARCINOGENESIS, V29, P1178, DOI 10.1093/carcin/bgn075; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cusco I, 2009, HUM MOL GENET, V18, P1795, DOI 10.1093/hmg/ddp092; Erdogan F, 2008, EUR J MED GENET, V51, P81, DOI 10.1016/j.ejmg.2007.09.007; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; He M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004684; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeon JP, 2007, CANCER GENET CYTOGEN, V173, P122, DOI 10.1016/j.cancergencyto.2006.10.010; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Kim KJ, 2006, GENOMICS, V88, P535, DOI 10.1016/j.ygeno.2006.03.003; Koolen DA, 2009, HUM MUTAT, V30, P283, DOI 10.1002/humu.20883; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Middeldorp A, 2008, J PATHOL, V216, P25, DOI 10.1002/path.2375; Patterson D, 2009, HUM GENET, V126, P195, DOI 10.1007/s00439-009-0696-8; Pedersen RK, 1999, CANCER GENET CYTOGEN, V110, P128, DOI 10.1016/S0165-4608(98)00204-0; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; VANHEMEL JO, 1992, HUM GENET, V88, P661, DOI 10.1007/BF02265294; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	31	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11417	10.1371/journal.pone.0011417	http://dx.doi.org/10.1371/journal.pone.0011417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625389	Green Published, gold, Green Submitted			2022-12-27	WOS:000279465700005
J	Schweizer, ML; Furuno, JP; Harris, AD; Johnson, JK; Shardell, MD; McGregor, JC; Thom, KA; Sakoulas, G; Perencevich, EN				Schweizer, Marin L.; Furuno, Jon P.; Harris, Anthony D.; Johnson, J. Kristie; Shardell, Michelle D.; McGregor, Jessina C.; Thom, Kerri A.; Sakoulas, George; Perencevich, Eli N.			Empiric Antibiotic Therapy for Staphylococcus aureus Bacteremia May Not Reduce In-Hospital Mortality: A Retrospective Cohort Study	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ANTIMICROBIAL TREATMENT; PATIENT OUTCOMES; IMPACT; COMORBIDITY; INFECTIONS; RISK; PREDICTORS; VANCOMYCIN; USA300	Background: Appropriate empiric therapy, antibiotic therapy with in vitro activity to the infecting organism given prior to confirmed culture results, may improve Staphylococcus aureus outcomes. We aimed to measure the clinical impact of appropriate empiric antibiotic therapy on mortality, while statistically adjusting for comorbidities, severity of illness and presence of virulence factors in the infecting strain. Methodology: We conducted a retrospective cohort study of adult patients admitted to a tertiary-care facility from January 1, 2003 to June 30, 2007, who had S. aureus bacteremia. Time to appropriate therapy was measured from blood culture collection to the receipt of antibiotics with in vitro activity to the infecting organism. Cox proportional hazard models were used to measure the association between receipt of appropriate empiric therapy and in-hospital mortality, statistically adjusting for patient and pathogen characteristics. Principal Findings: Among 814 admissions, 537 (66%) received appropriate empiric therapy. Those who received appropriate empiric therapy had a higher hazard of 30-day in-hospital mortality (Hazard Ratio (HR): 1.52; 95% confidence interval (CI): 0.99, 2.34). A longer time to appropriate therapy was protective against mortality (HR: 0.79; 95% CI: 0.60, 1.03) except among the healthiest quartile of patients (HR: 1.44; 95% CI: 0.66, 3.15). Conclusions/Significance: Appropriate empiric therapy was not associated with decreased mortality in patients with S. aureus bacteremia except in the least ill patients. Initial broad antibiotic selection may not be widely beneficial.	[Schweizer, Marin L.; Furuno, Jon P.; Harris, Anthony D.; Shardell, Michelle D.; Thom, Kerri A.] Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; [Schweizer, Marin L.; Perencevich, Eli N.] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA; [Johnson, J. Kristie] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [McGregor, Jessina C.] Oregon Hlth & Sci Univ, Coll Pharm, Dept Pharm, Portland, OR 97201 USA; [Sakoulas, George] Sharp Mem Hosp & Rehabil Ctr, San Diego, CA USA; [Perencevich, Eli N.] Iowa City VA Med Ctr, Iowa City, IA USA	University System of Maryland; University of Maryland Baltimore; University of Iowa; University System of Maryland; University of Maryland Baltimore; Oregon Health & Science University; Sharp Memorial Hospital Rehabilitation & Physical Therapy; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Schweizer, ML (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA.	marin-schweizer@uiowa.edu	McGregor, Jessina C/A-7625-2008	Schweizer, Marin/0000-0002-3604-0093; McGregor, Jessina/0000-0002-6093-5444; Perencevich, Eli/0000-0002-3721-3355	Pfizer, Inc [IIR GA5951BG]; National Institutes of Health [1R01A160859-01A1, 1K24AI079040 - 01A1, 1K01AI071015-02, 1K12RR02350-03, KL2RR024141, K12HD043489]; US Department of Veterans Affairs Health Services Research and Develop [RCD-02-026-2, IIR-05-123-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043489] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002350, KL2RR024141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI079040, K01AI071015] Funding Source: NIH RePORTER	Pfizer, Inc(Pfizer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs Health Services Research and Develop(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by an investigator-initiated research grant from Pfizer, Inc (IIR GA5951BG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AD Harris is supported by the National Institutes of Health grants 1R01A160859-01A1 and 1K24AI079040 - 01A1. JP Furuno is supported by National Institutes of Health grant 1K01AI071015-02. JK Johnson is supported by National Institutes of Health grant 1K12RR02350-03. JC McGregor is supported by National Institutes of Health grant KL2RR024141. EN Perencevich was supported by US Department of Veterans Affairs Health Services Research and Develop grants RCD-02-026-2 and IIR-05-123-1. MD Shardell is supported by National Institutes of Health grant K12HD043489.	Ammerlaan H, 2009, CLIN INFECT DIS, V49, P997, DOI 10.1086/605555; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Chang FY, 2003, MEDICINE, V82, P333, DOI 10.1097/01.md.0000091184.93122.09; Clinical and Laboratory Standards Institute, 2008, M100S19 CLSI; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Forrest GN, 2006, J ANTIMICROB CHEMOTH, V58, P154, DOI 10.1093/jac/dkl146; Furuno JP, 2007, INFECT CONT HOSP EP, V28, P666, DOI 10.1086/518348; Furuno JP, 2005, EMERG INFECT DIS, V11, P1539, DOI 10.3201/eid1110.050508; Gomez J, 2007, EUR J CLIN MICROBIOL, V26, P239, DOI 10.1007/s10096-007-0272-x; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Johnson JK, 2007, EMERG INFECT DIS, V13, P1195, DOI 10.3201/eid1308.061575; Khatib R, 2006, EUR J CLIN MICROBIOL, V25, P181, DOI 10.1007/s10096-006-0096-0; Kim PW, 2005, AM J RESP CRIT CARE, V171, P616, DOI 10.1164/rccm.200407-916OC; Kim SH, 2006, CLIN MICROBIOL INFEC, V12, P13, DOI 10.1111/j.1469-0691.2005.01294.x; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; Leibovici L, 1998, J INTERN MED, V244, P379; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Lin MY, 2008, ANTIMICROB AGENTS CH, V52, P3188, DOI 10.1128/AAC.01553-07; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lodise Thomas P., 2003, Clinical Infectious Diseases, V36, P1418, DOI 10.1086/375057; McGregor JC, 2005, AM J EPIDEMIOL, V161, P483, DOI 10.1093/aje/kwi068; McGregor JC, 2007, CLIN INFECT DIS, V45, P329, DOI 10.1086/519283; McGregor JC, 2006, J CLIN EPIDEMIOL, V59, P1266, DOI 10.1016/j.jclinepi.2006.01.016; Mylotte JM, 2000, CLIN INFECT DIS, V31, P1170, DOI 10.1086/317421; Osih RB, 2007, ANTIMICROB AGENTS CH, V51, P839, DOI 10.1128/AAC.00901-06; Robinson JO, 2009, EUR J CLIN MICROBIOL, V28, P353, DOI 10.1007/s10096-008-0632-1; Roghmann MC, 2000, ARCH INTERN MED, V160, P1001, DOI 10.1001/archinte.160.7.1001; RomeroVivas J, 1995, CLIN INFECT DIS, V21, P1417, DOI 10.1093/clinids/21.6.1417; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Schramm GE, 2006, CRIT CARE MED, V34, P2069, DOI 10.1097/01.CCM.0000227655.41566.3E; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Shorr AF, 2008, CRIT CARE MED, V36, P2335, DOI 10.1097/CCM.0b013e31818103ea; Soriano A, 2000, CLIN INFECT DIS, V30, P368, DOI 10.1086/313650; Stryjewski ME, 2007, CLIN INFECT DIS, V44, P190, DOI 10.1086/510386; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tam VH, 2007, J INFECT DIS, V195, P1818, DOI 10.1086/518003	39	35	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11432	10.1371/journal.pone.0011432	http://dx.doi.org/10.1371/journal.pone.0011432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625395	Green Submitted, Green Published, gold			2022-12-27	WOS:000279465700014
J	Dash, PK; Orsi, SA; Zhang, M; Grill, RJ; Pati, S; Zhao, J; Moore, AN				Dash, Pramod K.; Orsi, Sara A.; Zhang, Min; Grill, Raymond J.; Pati, Shibani; Zhao, Jing; Moore, Anthony N.			Valproate Administered after Traumatic Brain Injury Provides Neuroprotection and Improves Cognitive Function in Rats	PLOS ONE			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITION; CONTROLLED CORTICAL IMPACT; SPATIAL MEMORY DEFICITS; CLOSED-HEAD INJURY; CELLS IN-VITRO; MOOD STABILIZER; MEDIATED NEUROPROTECTION; GENE-EXPRESSION; H3 ACETYLATION	Background: Traumatic brain injury (TBI) initiates a complex series of neurochemical and signaling changes that lead to pathological events including neuronal hyperactivity, excessive glutamate release, inflammation, increased blood-brain barrier (BBB) permeability and cerebral edema, altered gene expression, and neuronal dysfunction. It is believed that a drug combination, or a single drug acting on multiple targets, may be an effective strategy to treat TBI. Valproate, a widely used antiepileptic drug, has a number of targets including GABA transaminase, voltage-gated sodium channels, glycogen synthase kinase (GSK)-3, and histone deacetylases (HDACs), and therefore may attenuate a number of TBI-associated pathologies. Methodology/Principal Findings: Using a rodent model of TBI, we tested if post-injury administration of valproate can decrease BBB permeability, reduce neural damage and improve cognitive outcome. Dose-response studies revealed that systemic administration of 400 mg/kg (i.p.), but not 15, 30, 60 or 100 mg/kg, increases histone H3 and H4 acetylation, and reduces GSK-3 activity, in the hippocampus. Thirty min post-injury administration of 400 mg/kg valproate improved BBB integrity as indicated by a reduction in Evans Blue dye extravasation. Consistent with its dose response to inhibit GSK-3 and HDACs, valproate at 400 mg/kg, but not 100 mg/kg, reduced TBI-associated hippocampal dendritic damage, lessened cortical contusion volume, and improved motor function and spatial memory. These behavioral improvements were not observed when SAHA (suberoylanilide hydroxamic acid), a selective HDAC inhibitor, was administered. Conclusion/Significance: Our findings indicate that valproate given soon after TBI can be neuroprotective. As clinically proven interventions that can be used to minimize the damage following TBI are not currently available, the findings from this report support the further testing of valproate as an acute therapeutic strategy.	[Dash, Pramod K.; Orsi, Sara A.; Zhang, Min; Zhao, Jing; Moore, Anthony N.] Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA; [Dash, Pramod K.; Orsi, Sara A.; Zhang, Min; Zhao, Jing; Moore, Anthony N.] Univ Texas Hlth Sci Ctr Houston, Dept Neurosurg, Houston, TX USA; [Grill, Raymond J.] Univ Texas Hlth Sci Ctr Houston, Dept Integrated Biol & Pharmacol, Houston, TX USA; [Pati, Shibani] Univ Texas Hlth Sci Ctr Houston, Ctr Translat Injury Res, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Dash, PK (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Neurobiol & Anat, Houston, TX USA.	P.Dash@uth.tmc.edu		Dash, Pramod/0000-0001-6746-1002	Department of Defense [W81XWH-08-2-0134]; National Institutes of Health (NIH) [5T32HD049350]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD049350] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was made possible by funding support from the Department of Defense (W81XWH-08-2-0134) and a training grant from National Institutes of Health (NIH) (5T32HD049350). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam HB, 2009, SURGERY, V146, P325, DOI 10.1016/j.surg.2009.04.007; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bramlett HM, 2007, PROG BRAIN RES, V161, P125, DOI 10.1016/S0079-6123(06)61009-1; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Butler LM, 2000, CANCER RES, V60, P5165; Chen G, 1999, J NEUROCHEM, V72, P1327, DOI 10.1046/j.1471-4159.2000.0721327.x; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dash RR, 2009, J HAZARD MATER, V163, P1, DOI 10.1016/j.jhazmat.2008.06.051; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Eleuteri S, 2009, NEUROTOX RES, V15, P127, DOI 10.1007/s12640-009-9013-5; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Gao WM, 2006, BRAIN RES, V1070, P31, DOI 10.1016/j.brainres.2005.11.038; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Gonzales E, 2006, SHOCK, V25, P395, DOI 10.1097/01.shk.0000209522.28120.c8; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hao YL, 2004, J NEUROSCI, V24, P6590, DOI 10.1523/JNEUROSCI.5747-03.2004; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Jallon P, 2001, DRUG SAFETY, V24, P969, DOI 10.2165/00002018-200124130-00004; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Kanai H, 2004, PHARMACOGENOMICS J, V4, P336, DOI 10.1038/sj.tpj.6500269; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Li YQ, 2010, J SURG RES, V159, P474, DOI 10.1016/j.jss.2009.04.011; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI 10.1089/neu.2008-0794; Mattson MP, 2002, PHYSIOL REV, V82, P637, DOI 10.1152/physrev.00004.2002; McDonald HY, 2005, NEUROSCI LETT, V385, P70, DOI 10.1016/j.neulet.2005.05.022; MEANEY DF, 1994, J NEUROTRAUM, V11, P599, DOI 10.1089/neu.1994.11.599; Miller JS, 2009, NEUROPHARMACOLOGY, V56, P1116, DOI 10.1016/j.neuropharm.2009.03.006; Miller Laura C, 2008, Expert Rev Neurother, V8, P1817, DOI 10.1586/14737175.8.12.1817; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; O'Dell DM, 2000, BRAIN RES, V861, P325, DOI 10.1016/S0006-8993(00)02055-2; Ooba S, 2008, NEUROSCI RES, V62, P195, DOI 10.1016/j.neures.2008.08.005; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Roberge MC, 2008, NEUROSCIENCE, V156, P11, DOI 10.1016/j.neuroscience.2008.05.062; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; SHAPIRA Y, 1993, ANESTH ANALG, V77, P141; Sharma S, 2005, BRAIN RES BULL, V67, P482, DOI 10.1016/j.brainresbull.2005.07.015; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; SHOHAMI E, 1993, J NEUROTRAUM, V10, P109, DOI 10.1089/neu.1993.10.109; Sinn DI, 2007, NEUROBIOL DIS, V26, P464, DOI 10.1016/j.nbd.2007.02.006; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Wada A, 2009, J PHARMACOL SCI, V110, P14, DOI 10.1254/jphs.09R02CR; Wada A, 2009, FRONT BIOSCI-LANDMRK, V14, P1558, DOI 10.2741/3324; Watterson JM, 2002, BRAIN RES, V934, P69, DOI 10.1016/S0006-8993(02)02362-4; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047; Yin D, 2007, CLIN CANCER RES, V13, P1045, DOI 10.1158/1078-0432.CCR-06-1261; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950; Zhang Z, 2008, CELL MOL LIFE SCI, V65, P4055, DOI 10.1007/s00018-008-8521-4; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	72	148	156	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11383	10.1371/journal.pone.0011383	http://dx.doi.org/10.1371/journal.pone.0011383			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614021	Green Published, Green Submitted, gold			2022-12-27	WOS:000279370000013
J	Dunne, DW; Shaw, A; Bockenstedt, LK; Allore, HG; Chen, S; Malawista, SE; Leng, L; Mizue, Y; Piecychna, M; Zhang, L; Towle, V; Bucala, R; Montgomery, RR; Fikrig, E				Dunne, Dana W.; Shaw, Albert; Bockenstedt, Linda K.; Allore, Heather G.; Chen, Shu; Malawista, Stephen E.; Leng, Lin; Mizue, Yuka; Piecychna, Marta; Zhang, Lin; Towle, Virginia; Bucala, Richard; Montgomery, Ruth R.; Fikrig, Erol			Increased TLR4 Expression and Downstream Cytokine Production in Immunosuppressed Adults Compared to Non-Immunosuppressed Adults	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; TOLL-LIKE RECEPTOR-4; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSES; MACROPHAGE; ACTIVATION; LUPUS; GENE; RECOGNITION; INTERFERON	Background: An increasing number of patients have medical conditions with altered host immunity or that require immunosuppressive medications. While immunosuppression is associated with increased risk of infection, the precise effect of immunosuppression on innate immunity is not well understood. We studied monocyte Toll-like receptor (TLR) expression and cytokine production in 137 patients with autoimmune diseases who were maintained on immunosuppressive medications and 419 non-immunosuppressed individuals. Methodology/Principal Findings: Human peripheral blood monocytes were assessed for surface expression of TLRs 1, 2, and 4. After incubation with TLR agonists, in vitro production of the cytokines IL-8, TNF alpha, and MIF were measured by ELISA as a measure of TLR signaling efficiency and downstream effector responsiveness. Immunosuppressed patients had significantly higher TLR4 surface expression when compared to non-immunosuppressed adults (TLR4 %-positive 70.12 +/- 2.28 vs. 61.72 +/- 2.05, p = 0.0008). IL-8 and TNF-alpha baseline levels did not differ, but were significantly higher in the autoimmune disease group following TLR stimulation. By contrast, baseline MIF levels were elevated in monocytes from immunosuppressed individuals. By multivariable analyses, IL-8 and TNF alpha, but not MIF levels, were associated with the diagnosis of an underlying autoimmune disease. However, only MIF levels were significantly associated with the use of immunosuppressive medications. Conclusions/Significance: Our results reveal that an enhanced innate immune response is a feature of patients with autoimmune diseases treated with immunosuppressive agents. The increased risk for infection evident in this patient group may reflect a dysregulation rather than a simple suppression of innate immunity.	[Dunne, Dana W.; Shaw, Albert; Bockenstedt, Linda K.; Allore, Heather G.; Chen, Shu; Malawista, Stephen E.; Leng, Lin; Piecychna, Marta; Zhang, Lin; Towle, Virginia; Bucala, Richard; Montgomery, Ruth R.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Mizue, Yuka] Sapporo Immuno Diagnost Lab, Sapporo, Hokkaido, Japan; [Fikrig, Erol] Howard Hughes Med Inst, Chevy Chase, MD USA	Yale University; Howard Hughes Medical Institute	Dunne, DW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	dana.dunne@yale.edu	Shaw, Albert/AAD-2567-2021	Shaw, Albert/0000-0003-4970-7640; Allore, Heather/0000-0001-7685-8175; Montgomery, Ruth/0000-0002-8661-4454; Leng, Lin/0000-0002-0605-358X; Mizue, Yuka/0000-0002-2208-0772	National Institutes of Health [N01-AI-50031, R37-AI-049200-09S1]; Yale Claude D. Pepper Older Americans Independence Center [P30AG21342]; NCRR/GCRC Program [M01-RR00125, AR050498, AR049610]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI049200, N01AI050031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050498, R01AR049610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Claude D. Pepper Older Americans Independence Center; NCRR/GCRC Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant support was provided by the National Institutes of Health (N01-AI-50031, R37-AI-049200-09S1, Yale Claude D. Pepper Older Americans Independence Center P30AG21342, the NCRR/GCRC Program M01-RR00125, AR050498, and AR049610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Berdeli G, 2006, RHEUMATOL INT, V26, P726, DOI 10.1007/s00296-005-0062-7; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Franklin J, 2007, ANN RHEUM DIS, V66, P308, DOI 10.1136/ard.2006.057265; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Kang I, 2003, CURR OPIN RHEUMATOL, V15, P528, DOI 10.1097/00002281-200309000-00002; Kim HR, 2007, J RHEUMATOL, V34, P927; Kong KF, 2008, J VIROL, V82, P7613, DOI 10.1128/JVI.00618-08; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165; Lovgren T, 2004, ARTHRITIS RHEUM-US, V50, P1861, DOI 10.1002/art.20254; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martinez A, 2007, HUM IMMUNOL, V68, P744, DOI 10.1016/j.humimm.2007.06.007; McCullagh P, 1989, GEN LINEAR MODELS; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morand EF, 2002, RHEUMATOLOGY, V41, P558, DOI 10.1093/rheumatology/41.5.558; Onodera S, 2000, J BIOL CHEM, V275, P444, DOI 10.1074/jbc.275.1.444; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Roger T, 2003, J ENDOTOXIN RES, V9, P119, DOI 10.1179/096805103125001513; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sacre SM, 2008, J IMMUNOL, V181, P8002, DOI 10.4049/jimmunol.181.11.8002; Sampey AV, 2001, ARTHRITIS RHEUM-US, V44, P1273, DOI 10.1002/1529-0131(200106)44:6<1273::AID-ART219>3.0.CO;2-8; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; VERBEKE G, 1997, SAS ORIENTED APPROAC	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11343	10.1371/journal.pone.0011343	http://dx.doi.org/10.1371/journal.pone.0011343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596538	gold, Green Published, Green Submitted			2022-12-27	WOS:000279259900016
J	Sahu, N; Morales, JL; Fowell, D; August, A				Sahu, Nisebita; Morales, J. Luis; Fowell, Deborah; August, Avery			Modeling Susceptibility versus Resistance in Allergic Airway Disease Reveals Regulation by Tec Kinase Itk	PLOS ONE			English	Article							CD4(+) T-CELLS; MICE LACKING; HOUSE-DUST; MURINE MODEL; TYROSINE KINASE; ASTHMA; ANTIGEN; EXPOSURE; RESPONSES; INFLAMMATION	Murine models of allergic asthma have been used to understand the mechanisms of development and pathology in this disease. In addition, knockout mice have contributed significantly to our understanding of the roles of specific molecules and cytokines in these models. However, results can vary significantly depending on the mouse strain used in the model, and in particularly in understanding the effect of specific knockouts. For example, it can be equivocal as to whether specific gene knockouts affect the susceptibility of the mice to developing the disease, or lead to resistance. Here we used a house dust mite model of allergic airway inflammation to examine the response of two strains of mice (C57BL/6 and BALB/c) which differ in their responses in allergic airway inflammation. We demonstrate an algorithm that can facilitate the understanding of the behavior of these models with regards to susceptibility (to allergic airway inflammation) (Saai) or resistance (Raai) in this model. We verify that both C57BL/6 and BALB/c develop disease, but BALB/c mice have higher Saai for development. We then use this approach to show that the absence of the Tec family kinase Itk, which regulates the production of Th2 cytokines, leads to Raai in the C57BL/6 background, but decreases Saai on the BALB/c background. We suggest that the use of such approaches could clarify the behavior of various knockout mice in modeling allergic asthma.	[Sahu, Nisebita; Morales, J. Luis; August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Sahu, Nisebita; Morales, J. Luis; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Sahu, Nisebita] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Fowell, Deborah] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Rochester	Sahu, N (corresponding author), Harvard Univ, Sch Med, Ctr Canc, Massachusetts Gen Hosp,Dept Med, Charlestown, MA USA.	averyaugust@cornell.edu			National Institutes of Health [AI051626, AI065566, AI073955]; American Academy of Allergy Asthma and Immunology Strategic Training in Allergy Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI065566, R01AI073955, R01AI050201, R01AI065566, R01AI051626, R56AI073955] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Academy of Allergy Asthma and Immunology Strategic Training in Allergy Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants AI051626, AI065566 and AI073955 to AA. NS was the recipient of an American Academy of Allergy Asthma and Immunology Strategic Training in Allergy Research (ST*AR) Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung BB, 2006, J IMMUNOL, V176, P3895, DOI 10.4049/jimmunol.176.7.3895; Cates EC, 2004, J IMMUNOL, V173, P6384, DOI 10.4049/jimmunol.173.10.6384; CORRY D, 1997, J EXP MED, V1185, P1715; Corry DB, 1996, J EXP MED, V183, P109, DOI 10.1084/jem.183.1.109; EWART S, 1995, J APPL PHYSIOL, V79, P560, DOI 10.1152/jappl.1995.79.2.560; Ferrara TJ, 2006, J ALLERGY CLIN IMMUN, V117, P780, DOI 10.1016/j.jaci.2005.12.1330; Finkelman FD, 2008, J ALLERGY CLIN IMMUN, V121, P603, DOI 10.1016/j.jaci.2008.01.008; Finotto S, 2002, SCIENCE, V295, P336, DOI 10.1126/science.1065544; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Fujiwara M, 2007, J ALLERGY CLIN IMMUN, V119, P662, DOI 10.1016/j.jaci.2006.12.643; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; HOLT PG, 1981, IMMUNOLOGY, V42, P409; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; KUNG TT, 1994, INT ARCH ALLERGY IMM, V105, P83, DOI 10.1159/000236807; Liao XC, 1995, IMMUNITY, V3, P757, DOI 10.1016/1074-7613(95)90065-9; Miller AT, 2004, IMMUNITY, V21, P67, DOI 10.1016/j.immuni.2004.06.009; MIYAMOTO T, 1968, J ALLERGY, V42, P14, DOI 10.1016/0021-8707(68)90128-7; Mueller C, 2003, J IMMUNOL, V170, P5056, DOI 10.4049/jimmunol.170.10.5056; Neeno T, 1996, J IMMUNOL, V156, P3191; OBRIEN RM, 1992, J ALLERGY CLIN IMMUN, V89, P1021, DOI 10.1016/0091-6749(92)90225-Q; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; SAHU N, 2008, J IMMUNOL, V3180; Sahu N, 2008, J IMMUNOL, V181, P6125, DOI 10.4049/jimmunol.181.9.6125; Sahu N, 2008, J IMMUNOL, V180, P3833, DOI 10.4049/jimmunol.180.6.3833; Sakai K, 1999, CLIN EXP IMMUNOL, V118, P9; Schaeffer EM, 2001, NAT IMMUNOL, V2, P1183, DOI 10.1038/ni734; Schramm CM, 2004, AM J PATHOL, V164, P295, DOI 10.1016/S0002-9440(10)63119-7; Swirski FK, 2002, CLIN EXP ALLERGY, V32, P411, DOI 10.1046/j.1365-2222.2002.01291.x; Swirski FK, 2002, J IMMUNOL, V169, P3499, DOI 10.4049/jimmunol.169.7.3499; Walsh ER, 2008, J EXP MED, V205, P1285, DOI 10.1084/jem.20071836; Whitehead GS, 2003, AM J PHYSIOL-LUNG C, V285, pL32, DOI 10.1152/ajplung.00390.2002; Zhu WY, 2009, IMMUNOGENETICS, V61, P199, DOI 10.1007/s00251-008-0353-8	34	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11348	10.1371/journal.pone.0011348	http://dx.doi.org/10.1371/journal.pone.0011348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596543	Green Published, Green Submitted, gold			2022-12-27	WOS:000279259900019
J	McMillan, DJ; Bessen, DE; Pinho, M; Ford, C; Hall, GS; Melo-Cristino, J; Ramirez, M				McMillan, David J.; Bessen, Debra E.; Pinho, Marcos; Ford, Candace; Hall, Gerod S.; Melo-Cristino, Jose; Ramirez, Mario			Population Genetics of Streptococcus dysgalactiae Subspecies equisimilis Reveals Widely Dispersed Clones and Extensive Recombination	PLOS ONE			English	Article							GROUP-A; GROUP-C; HORIZONTAL TRANSFER; PYOGENES; EMM; EVOLUTION; STRAINS; DISEASE; PROTEIN; EBURST	Background: Streptococcus dysgalactiae subspecies equisimilis (SDSE) is an emerging global pathogen that can colonize and infect humans. Although most SDSE isolates possess the Lancefield group G carbohydrate, a significant minority have the group C carbohydrate. Isolates are further sub-typed on the basis of differences within the emm gene. To gain a better understanding of their molecular epidemiology and evolutionary relationships, multilocus sequence typing (MLST) analysis was performed on SDSE isolates collected from Australia, Europe and North America. Methodology/Principal Findings: The 178 SDSE isolates, representing 37 emm types, segregate into 80 distinct sequence types (STs) that form 17 clonal complexes (CCs). Eight STs recovered from all three continents account for >50% of the isolates. Thus, a small number of STs are highly prevalent and have a wide geographic distribution. Both ST and CC strongly correlate with group carbohydrate. In contrast, eleven STs were associated with >1 emm type, suggestive of recombinational replacements involving the emm gene; furthermore, 35% of the emm types are associated with genetically distant STs. Data also reveal a history of extensive inter-and intra-species recombination involving the housekeeping genes used for MLST. Sequence analysis of single locus variants identified through goeBURST indicates that genetic change mediated by recombination occurred similar to 4.4 times more frequently than by point mutation. Conclusions/Significance: A few genetic lineages with an intercontinental distribution dominate among SDSE causing infections in humans. The distinction between group C and G isolates reflects recent evolution, and no long-term genetic isolation between them was found. Lateral gene transfer and recombination involving housekeeping genes and the emm gene are important mechanisms driving genetic variability in the SDSE population.	[McMillan, David J.] Queensland Inst Med Res, Bacterial Pathogenesis Lab, Herston, Qld 4006, Australia; [McMillan, David J.] Griffith Med Res Coll, Herston, Qld, Australia; [Bessen, Debra E.; Ford, Candace; Hall, Gerod S.] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA; [Pinho, Marcos; Melo-Cristino, Jose; Ramirez, Mario] Univ Lisbon, Inst Microbiol, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal	QIMR Berghofer Medical Research Institute; Griffith University; New York Medical College; Universidade de Lisboa	McMillan, DJ (corresponding author), Queensland Inst Med Res, Bacterial Pathogenesis Lab, Bramston Terrace, Herston, Qld 4006, Australia.	debra_bessen@nymc.edu	Melo-Cristino, Jose A G/H-3726-2013; McMillan, David/P-5582-2016; Ramirez, Mario/B-4993-2008; Pinho, Marcos D/E-5834-2019	Melo-Cristino, Jose A G/0000-0001-8643-1722; McMillan, David/0000-0002-9339-0639; Ramirez, Mario/0000-0002-4084-6233; Pinho, Marcos D/0000-0002-4298-0014	Australian Government; National Institutes of Health [AI-065572, GM-060793]; Fundao para a Cincia e a Tecnologia [PTDC/SAU-ESA/72321/2006]; Fundao Calouste Gulbenkian, Portugal; Glaxo Smithkline, Portugal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060793] Funding Source: NIH RePORTER	Australian Government(Australian GovernmentCGIAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundao para a Cincia e a Tecnologia; Fundao Calouste Gulbenkian, Portugal; Glaxo Smithkline, Portugal(GlaxoSmithKline); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	DM is supported by an Australian Government NHMRC Program grant and NHMRC Project grant. DEB received support from the National Institutes of Health (AI-065572; GM-060793). Work conducted by MR was supported in part by Fundao para a Cincia e a Tecnologia (PTDC/SAU-ESA/72321/2006), Fundao Calouste Gulbenkian, Portugal and from an unrestricted grant from Glaxo Smithkline, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, J CLIN MICROBIOL, V47, P2046, DOI 10.1128/JCM.00246-09; Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; BENNASR A, 1994, EUR J BIOCHEM, V222, P267, DOI 10.1111/j.1432-1033.1994.tb18865.x; Bessen DE, 2005, J BACTERIOL, V187, P4163, DOI 10.1128/JB.187.12.4163-4172.2005; BESSEN DE, 2010, FUTURE MICR IN PRESS; Bessen DE, 2009, INFECT GENET EVOL, V9, P581, DOI 10.1016/j.meegid.2009.03.002; Bramhachari PV, 2010, J MED MICROBIOL, V59, P220, DOI 10.1099/jmm.0.015644-0; Broyles LN, 2009, CLIN INFECT DIS, V48, P706, DOI 10.1086/597035; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chhatwal G. S., 2006, Gram-positive pathogens, P213; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Davies MR, 2007, CLIN INFECT DIS, V44, P1442, DOI 10.1086/516780; Efstratiou A, 1997, J APPL MICROBIOL, V83, pS72, DOI 10.1046/j.1365-2672.83.s1.8.x; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Facklam R, 2002, CLIN MICROBIOL REV, V15, P613, DOI 10.1128/CMR.15.4.613-630.2002; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2000, RES MICROBIOL, V151, P465, DOI 10.1016/S0923-2508(00)00168-6; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Hashikawa S, 2004, J CLIN MICROBIOL, V42, P186, DOI 10.1128/JCM.42.1.186-192.2004; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Igwe EI, 2003, FEMS MICROBIOL LETT, V229, P259, DOI 10.1016/S0378-1097(03)00842-5; Ikebe T, 2004, EPIDEMIOL INFECT, V132, P145, DOI 10.1017/S0950268803001262; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Kilian M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002683; Korman TM, 2004, J CLIN MICROBIOL, V42, P2866, DOI 10.1128/JCM.42.6.2866-2869.2004; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martin DP, 2009, METHODS MOL BIOL, V537, P185, DOI 10.1007/978-1-59745-251-9_9; McDonald M, 2007, EMERG INFECT DIS, V13, P1694, DOI 10.3201/eid1311.061258; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Panchaud A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-198; Pinho MD, 2006, J CLIN MICROBIOL, V44, P841, DOI 10.1128/JCM.44.3.841-846.2006; PINHO MD, ANTIMICROB IN PRESS; Sakota V, 2006, J CLIN MICROBIOL, V44, P2160, DOI 10.1128/JCM.02456-05; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; SIMPSON WJ, 1992, INFECT IMMUN, V60, P1890, DOI 10.1128/IAI.60.5.1890-1893.1992; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka D, 2008, J CLIN MICROBIOL, V46, P1526, DOI 10.1128/JCM.02188-07; Towers RJ, 2004, J CLIN MICROBIOL, V42, P5357, DOI 10.1128/JCM.42.11.5357-5361.2004; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Woo PCY, 2001, J CLIN MICROBIOL, V39, P3147, DOI 10.1128/JCM.39.9.3147-3155.2001	46	41	42	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11741	10.1371/journal.pone.0011741	http://dx.doi.org/10.1371/journal.pone.0011741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668530	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800015
J	Ritter, JG; Veith, R; Veenendaal, A; Siebrasse, JP; Kubitscheck, U				Ritter, Joerg Gerhard; Veith, Roman; Veenendaal, Andreas; Siebrasse, Jan Peter; Kubitscheck, Ulrich			Light Sheet Microscopy for Single Molecule Tracking in Living Tissue	PLOS ONE			English	Article							PROTEIN MOLECULES; ULTRAMICROSCOPY; VISUALIZATION; RESOLUTION; TRANSPORT; MOVEMENT; DYNAMICS; RNA	Single molecule observation in cells and tissue allows the analysis of physiological processes with molecular detail, but it still represents a major methodological challenge. Here we introduce a microscopic technique that combines light sheet optical sectioning microscopy and ultra sensitive high-speed imaging. By this approach it is possible to observe single fluorescent biomolecules in solution, living cells and even tissue with an unprecedented speed and signal-to-noise ratio deep within the sample. Thereby we could directly observe and track small and large tracer molecules in aqueous solution. Furthermore, we demonstrated the feasibility to visualize the dynamics of single tracer molecules and native messenger ribonucleoprotein particles (mRNPs) in salivary gland cell nuclei of Chironomus tentans larvae up to 200 mm within the specimen with an excellent signal quality. Thus single molecule light sheet based fluorescence microscopy allows analyzing molecular diffusion and interactions in complex biological systems.	[Ritter, Joerg Gerhard; Veith, Roman; Veenendaal, Andreas; Siebrasse, Jan Peter; Kubitscheck, Ulrich] Univ Bonn, Inst Phys & Theoret Chem, D-5300 Bonn, Germany	University of Bonn	Ritter, JG (corresponding author), Univ Bonn, Inst Phys & Theoret Chem, Wegelerstr 12, D-5300 Bonn, Germany.	u.kubitscheck@uni-bonn.de	Kubitscheck, Ulrich/GPS-8017-2022	Kubitscheck, Ulrich/0000-0003-3750-5355	German Research Foundation [Ku 2474/7-1]; German Federal Ministry of Economics and Technology (AiF) [KF2297601AK9]	German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Economics and Technology (AiF)(Federal Ministry for Economic Affairs and Energy (BMWi))	This work was supported by grants of the German Research Foundation (grant Ku 2474/7-1) and the German Federal Ministry of Economics and Technology (AiF grant KF2297601AK9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KM, 1998, Z KRISTALLOGR, V213, P369, DOI 10.1524/zkri.1998.213.7-8.369; AXELROD D, 1981, J CELL BIOL, V89, P141, DOI 10.1083/jcb.89.1.141; Berg, 2018, RANDOM WALKS BIOL; Buytaert JAN, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2671712; Buytaert JAN, 2009, APPL OPTICS, V48, P941, DOI 10.1364/AO.48.000941; CASE ST, 1978, J MOL BIOL, V124, P223, DOI 10.1016/0022-2836(78)90157-2; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; Daneholt B, 2001, CHROMOSOMA, V110, P173, DOI 10.1007/s004120000127; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Ermolayev V, 2009, BIOPHYS J, V96, P3390, DOI 10.1016/j.bpj.2009.01.032; Friedrich M, 2009, BIOCHEM BIOPH RES CO, V390, P722, DOI 10.1016/j.bbrc.2009.10.036; Gorisch SM, 2005, J CELL SCI, V118, P5825, DOI 10.1242/jcs.02689; Grunwald D, 2006, CHEMPHYSCHEM, V7, P812, DOI 10.1002/cphc.200500632; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Huisken J, 2009, DEVELOPMENT, V136, P1963, DOI 10.1242/dev.022426; Jahrling N, 2009, ORGANOGENESIS, V5, P227, DOI 10.4161/org.5.4.10403; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Konopka CA, 2008, PLANT J, V53, P186, DOI 10.1111/j.1365-313X.2007.03306.x; Kues T, 2001, BIOPHYS J, V80, P2954, DOI 10.1016/S0006-3495(01)76261-3; Kues T, 2001, P NATL ACAD SCI USA, V98, P12021, DOI 10.1073/pnas.211250098; Leischner U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005785; Lord SJ, 2010, ANAL CHEM, V82, P2192, DOI 10.1021/ac9024889; Muller CB, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46001; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Ritter JG, 2008, OPT EXPRESS, V16, P7142, DOI 10.1364/OE.16.007142; Schaaf MJM, 2009, BIOPHYS J, V97, P1206, DOI 10.1016/j.bpj.2009.05.044; Scherz PJ, 2008, DEVELOPMENT, V135, P1179, DOI 10.1242/dev.010694; Siebrasse JP, 2008, P NATL ACAD SCI USA, V105, P20291, DOI 10.1073/pnas.0810692105; SIEDENTOPF H, 1903, ANN PHYS, V4, P1; Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vermot J, 2008, HFSP J, V2, P143, DOI 10.2976/1.2907579; Visa N, 1996, CELL, V84, P253, DOI 10.1016/S0092-8674(00)80980-0; VOIE AH, 1993, J MICROSC-OXFORD, V170, P229, DOI 10.1111/j.1365-2818.1993.tb03346.x; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WIESLANDER L, 1994, PROG NUCLEIC ACID RE, V48, P275, DOI 10.1016/S0079-6603(08)60858-2; Wurtz T, 1996, MOL CELL BIOL, V16, P1425	40	118	120	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11639	10.1371/journal.pone.0011639	http://dx.doi.org/10.1371/journal.pone.0011639			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668517	Green Submitted, gold, Green Published			2022-12-27	WOS:000280243800002
J	Aguilar-Yanes, JM; Portillo-Lara, R; Mendoza-Ochoa, GI; Garcia-Echauri, SA; Lopes-Pacheco, F; Bulnes-Abundis, D; Salgado-Gallegos, J; Lara-Mayorga, IM; Webb-Vargas, Y; Leon-Angel, FO; Rivero-Aranda, RE; Oropeza-Almazan, Y; Ruiz-Palacios, GM; Zertuche-Guerra, MI; DuBois, RM; White, SW; Schultz-Cherry, S; Russell, CJ; Alvarez, MM				Aguilar-Yanes, Jose M.; Portillo-Lara, Roberto; Mendoza-Ochoa, Gonzalo I.; Garcia-Echauri, Sergio A.; Lopes-Pacheco, Felipe; Bulnes-Abundis, David; Salgado-Gallegos, Johari; Lara-Mayorga, Itzel M.; Webb-Vargas, Yenny; Leon-Angel, Felipe O.; Rivero-Aranda, Ramon E.; Oropeza-Almazan, Yuriana; Ruiz-Palacios, Guillermo M.; Zertuche-Guerra, Manuel I.; DuBois, Rebecca M.; White, Stephen W.; Schultz-Cherry, Stacey; Russell, Charles J.; Alvarez, Mario M.			An Influenza A/H1N1/2009 Hemagglutinin Vaccine Produced in Escherichia coli	PLOS ONE			English	Article							SIZE-DISTRIBUTION ANALYSIS; VIRUS HEMAGGLUTININ; ANTIGENIC STRUCTURE; RECEPTOR-BINDING; CELL CULTURE; H5N1 VIRUS; PROTEINS; PATHOGENESIS; EXPRESSION; ANTIBODY	Background: The A/H1N1/2009 influenza pandemic made evident the need for faster and higher-yield methods for the production of influenza vaccines. Platforms based on virus culture in mammalian or insect cells are currently under investigation. Alternatively, expression of fragments of the hemagglutinin (HA) protein in prokaryotic systems can potentially be the most efficacious strategy for the manufacture of large quantities of influenza vaccine in a short period of time. Despite experimental evidence on the immunogenic potential of HA protein constructs expressed in bacteria, it is still generally accepted that glycosylation should be a requirement for vaccine efficacy. Methodology/Principal Findings: We expressed the globular HA receptor binding domain, referred to here as HA(63-286)-RBD, of the influenza A/H1N1/2009 virus in Escherichia coli using a simple, robust and scalable process. The recombinant protein was refolded and purified from the insoluble fraction of the cellular lysate as a single species. Recombinant HA(63-286)-RBD appears to be properly folded, as shown by analytical ultracentrifugation and bio-recognition assays. It binds specifically to serum antibodies from influenza A/H1N1/2009 patients and was found to be immunogenic, to be capable of triggering the production of neutralizing antibodies, and to have protective activity in the ferret model. Conclusions/Significance: Projections based on our production/purification data indicate that this strategy could yield up to half a billion doses of vaccine per month in a medium-scale pharmaceutical production facility equipped for bacterial culture. Also, our findings demonstrate that glycosylation is not a mandatory requirement for influenza vaccine efficacy.	[Aguilar-Yanes, Jose M.; Portillo-Lara, Roberto; Mendoza-Ochoa, Gonzalo I.; Garcia-Echauri, Sergio A.; Lopes-Pacheco, Felipe; Bulnes-Abundis, David; Salgado-Gallegos, Johari; Lara-Mayorga, Itzel M.; Webb-Vargas, Yenny; Leon-Angel, Felipe O.; Rivero-Aranda, Ramon E.; Oropeza-Almazan, Yuriana; Ruiz-Palacios, Guillermo M.; Zertuche-Guerra, Manuel I.; Alvarez, Mario M.] Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Mexico; [DuBois, Rebecca M.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Schultz-Cherry, Stacey; Russell, Charles J.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN USA	Tecnologico de Monterrey; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Aguilar-Yanes, JM (corresponding author), Tecnol Monterrey, Ctr Biotecnol FEMSA, Monterrey, Mexico.	mario.alvarez@itesm.mx	Schultz-Cherry, Stacey/N-2506-2018; Oropeza-Almazan, Yuriana/AAS-5240-2021; Russell, Charles/K-4824-2013; Russell, Charles/AAU-6006-2020; White, Stephen W/N-8164-2018; Portillo-Lara, Roberto/AAX-5002-2020; Ruiz-Palacios, Guillermo/GYQ-5462-2022	Russell, Charles/0000-0001-5683-3990; Russell, Charles/0000-0001-5683-3990; Portillo-Lara, Roberto/0000-0002-1781-3126; Aguilar-Yanez, Jose M/0000-0002-8590-9111; Mendoza-Ochoa, Gonzalo I/0000-0002-7361-8915; Lara Mayorga, Itzel Montserrat/0000-0001-5444-5177; Alvarez, Mario Moises/0000-0002-9131-5344; DuBois, Rebecca/0000-0003-4185-5673; Garcia, Sergio/0000-0001-8738-7356; Oropeza-Almazan, Yuriana/0000-0003-0387-3686	Zambrano-Hellion family; FEMSA; Tecnologico de Monterrey [CAT-122]; National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; Cancer Center [CA21765]; American Lebanese Syrian Associated Charities (ALSAC); Childrens Infection Defense Center (CIDC) at St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER	Zambrano-Hellion family; FEMSA; Tecnologico de Monterrey; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Center; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Childrens Infection Defense Center (CIDC) at St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Zambrano-Hellion family, FEMSA, and Tecnologico de Monterrey (seed fund CAT-122). This work was also funded by the National Institutes of Health, National Institute of Allergy and Infectious Diseases, under contract number HHSN266200700005C, Cancer Center core grant CA21765, the American Lebanese Syrian Associated Charities (ALSAC), and the Childrens Infection Defense Center (CIDC) at St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010176; BALBO A, 2007, CURR PROTOC IMMUNOL, V18, P1; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Berhanu A, 2008, J VIROL, V82, P3517, DOI 10.1128/JVI.01854-07; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; Bright RA, 2003, VIROLOGY, V308, P270, DOI 10.1016/S0042-6822(03)00008-4; CATON AJ, 1982, CELL, V31, P417, DOI 10.1016/0092-8674(82)90135-0; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; Chowell G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008164; Chu C, 2009, P NATL ACAD SCI USA, V106, P14802, DOI 10.1073/pnas.0905912106; DAVIS AR, 1981, P NATL ACAD SCI-BIOL, V78, P5376, DOI 10.1073/pnas.78.9.5376; Dumon-Seignovert L, 2004, PROTEIN EXPRES PURIF, V37, P203, DOI 10.1016/j.pep.2004.04.025; Fang M, 2006, VIROLOGY, V345, P231, DOI 10.1016/j.virol.2005.09.056; Fedson DS, 2008, BIOLOGICALS, V36, P346, DOI 10.1016/j.biologicals.2008.07.001; GERHARD W, 1981, NATURE, V290, P713, DOI 10.1038/290713a0; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; HIDAYATULLAH TA, 2009, INT J INTEGRATIVE BI, V6, P137; Igarashi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008553; King JC, 2009, VACCINE, V27, P6589, DOI 10.1016/j.vaccine.2009.08.032; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LIU J, 2008, Patent No. 20080286850; Liu J, 2009, VACCINE, V27, P6460, DOI 10.1016/j.vaccine.2009.06.024; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Paal M, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-7; Panda AK, 2003, ADV BIOCHEM ENG BIOT, V85, P43; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwahn AB, 2009, J IMMUNOASS IMMUNOCH, V30, P245, DOI 10.1080/15321810903084350; Schwarzer J, 2009, VACCINE, V27, P4325, DOI 10.1016/j.vaccine.2009.04.076; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; SKEHEL JJ, 1984, P NATL ACAD SCI-BIOL, V81, P1779, DOI 10.1073/pnas.81.6.1779; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Stevens J, 2004, SCIENCE, V303, P1866, DOI 10.1126/science.1093373; Szymczakiewicz-Multanowska A, 2009, J INFECT DIS, V200, P841, DOI 10.1086/605505; Wang CC, 2009, P NATL ACAD SCI USA, V106, P18137, DOI 10.1073/pnas.0909696106; Wang K, 2006, VACCINE, V24, P2176, DOI 10.1016/j.vaccine.2005.11.005; WILEY DC, 1987, ANNU REV BIOCHEM, V56, P365, DOI 10.1146/annurev.bi.56.070187.002053; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; World Health Organization, 2009, CDC PROT REALT RTPCR; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yoshida R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000350	51	39	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11694	10.1371/journal.pone.0011694	http://dx.doi.org/10.1371/journal.pone.0011694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661476	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243300006
J	Jahan, I; Pan, N; Kersigo, J; Fritzsch, B				Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Fritzsch, Bernd			Neurod1 Suppresses Hair Cell Differentiation in Ear Ganglia and Regulates Hair Cell Subtype Development in the Cochlea	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SENSORY EPITHELIA; NULL MICE; AUDITORY NEURONS; MATH1; GENE; SPECIFICATION; INNERVATION; FATE; SOX2	Background: At least five bHLH genes regulate cell fate determination and differentiation of sensory neurons, hair cells and supporting cells in the mammalian inner ear. Cross-regulation of Atoh1 and Neurog1 results in hair cell changes in Neurog1 null mice although the nature and mechanism of the cross-regulation has not yet been determined. Neurod1, regulated by both Neurog1 and Atoh1, could be the mediator of this cross-regulation. Methodology/Principal Findings: We used Tg(Pax2-Cre) to conditionally delete Neurod1 in the inner ear. Our data demonstrate for the first time that the absence of Neurod1 results in formation of hair cells within the inner ear sensory ganglia. Three cell types, neural crest derived Schwann cells and mesenchyme derived fibroblasts (neither expresses Neurod1) and inner ear derived neurons (which express Neurod1) constitute inner ear ganglia. The most parsimonious explanation is that Neurod1 suppresses the alternative fate of sensory neurons to develop as hair cells. In the absence of Neurod1, Atoh1 is expressed and differentiates cells within the ganglion into hair cells. We followed up on this effect in ganglia by demonstrating that Neurod1 also regulates differentiation of subtypes of hair cells in the organ of Corti. We show that in Neurod1 conditional null mice there is a premature expression of several genes in the apex of the developing cochlea and outer hair cells are transformed into inner hair cells. Conclusions/Significance: Our data suggest that the long noted cross-regulation of Atoh1 expression by Neurog1 might actually be mediated in large part by Neurod1. We suggest that Neurod1 is regulated by both Neurog1 and Atoh1 and provides a negative feedback for either gene. Through this and other feedback, Neurod1 suppresses alternate fates of neurons to differentiate as hair cells and regulates hair cell subtypes.	[Jahan, Israt; Pan, Ning; Kersigo, Jennifer; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA	University of Iowa	Jahan, I (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Fritzsch, Bernd/0000-0002-4882-8398	NIH [R01 DC 005590]; CLAS; OVPR of the University of Iowa; Roy. J. Carver foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005590, P30DC010362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLAS; OVPR of the University of Iowa; Roy. J. Carver foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a NIH grant (R01 DC 005590) to B. F. The support of CLAS and OVPR of the University of Iowa is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We like to thank Drs. K.-A. Nave and S. Goebbels, Max-Planck-Institute of Experimental Medicine, for providing the floxed Neurod1 mice used for this study and Drs. T. Ohyama and A. Groves for providing the Pax2-Cre line. The Leica TCS SP5 confocal microscope was purchased in part with a grant from the Roy. J. Carver foundation. We thank CLAS and the Office of the Vice President for Research (OVPR) for support. We wish to thank the following people for providing plasmids for in situ hybridization: Atoh1; Dr. Zoghbi; Neurog1, Dr. Ma; Fgf8, Dr. Pirvola; Pou4f3, Dr. Xiang; Nhlh1 and Nhlh2, Dr. Braun; Sox2, Dr. Cheah.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Alvarez Y, 2003, DEVELOPMENT, V130, P6329, DOI 10.1242/dev.00881; Beisel K, 2008, CELL TISSUE RES, V333, P373, DOI 10.1007/s00441-008-0639-z; Bell D, 2008, DEV BIOL, V322, P109, DOI 10.1016/j.ydbio.2008.07.011; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Bermingham-McDonogh O, 2006, J COMP NEUROL, V496, P172, DOI 10.1002/cne.20944; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Chen P, 2002, DEVELOPMENT, V129, P2495; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Dabdoub A, 2008, P NATL ACAD SCI USA, V105, P18396, DOI 10.1073/pnas.0808175105; DELCERRO M, 1980, MICROSC ACTA, V83, P117; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Fritzsch B, 2000, NEUROREPORT, V11, pR35, DOI 10.1097/00001756-200011270-00013; Fritzsch B, 2005, DEV DYNAM, V233, P570, DOI 10.1002/dvdy.20370; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; FRITZSCH B, 2010, CMLSE IN PRESS; Fritzsch B., 2006, INT J COMP PSYCHOL, V19, P1; Fritzsch B, 2006, BIOESSAYS, V28, P1181, DOI 10.1002/bies.20502; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Goebbels S, 2005, GENESIS, V42, P247, DOI 10.1002/gene.20138; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Groves AK, 2010, EXP BIOL MED, V235, P434, DOI 10.1258/ebm.2009.009281; Hayashi T, 2008, J NEUROSCI, V28, P5991, DOI 10.1523/JNEUROSCI.1690-08.2008; Hayashi T, 2010, DEV DYNAM, V239, P1019, DOI 10.1002/dvdy.22236; Huang EJ, 2001, DEVELOPMENT, V128, P2421; JAHAN I, 2010, CELL TISSUE IN PRESS; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kawauchi S, 2004, DEV NEUROSCI-BASEL, V26, P166, DOI 10.1159/000082135; Keithley EM, 1999, HEARING RES, V134, P71, DOI 10.1016/S0378-5955(99)00070-2; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kelly M, 2007, INT J DEV BIOL, V51, P535, DOI 10.1387/ijdb.072344mk; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Kim WY, 2001, DEVELOPMENT, V128, P417; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Kruger M, 2006, EUR J NEUROSCI, V24, P1581, DOI 10.1111/j.1460-9568.2006.05051.x; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Ma QF, 2000, JARO-J ASSOC RES OTO, V1, P129, DOI 10.1007/s101620010017; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Matei VA, 2006, BRAIN RES BULL, V70, P33, DOI 10.1016/j.brainresbull.2005.11.007; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Ohyama T, 2007, INT J DEV BIOL, V51, P463, DOI 10.1387/ijdb.072320to; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Pan N, 2009, CELL TISSUE RES, V337, P407, DOI 10.1007/s00441-009-0826-6; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Puligilla C, 2007, DEV DYNAM, V236, P1905, DOI 10.1002/dvdy.21192; Puligilla C, 2010, J NEUROSCI, V30, P714, DOI 10.1523/JNEUROSCI.3852-09.2010; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Ray SK, 2007, MOL CELL BIOL, V27, P7839, DOI 10.1128/MCB.00438-07; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ryan AF, 2009, ADV OTO-RHINO-LARYNG, V66, P99, DOI 10.1159/000218210; Satoh T, 2005, DEVELOPMENT, V132, P1687, DOI 10.1242/dev.01730; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Sekerkova G, 2008, J COMP NEUROL, V509, P661, DOI 10.1002/cne.21755; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wright TJ, 2003, DEVELOPMENT, V130, P3379, DOI 10.1242/dev.00555; Xia AP, 2007, JARO-J ASSOC RES OTO, V8, P447, DOI 10.1007/s10162-007-0092-9; Xiang MQ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-2; Xiang MQ, 1997, P NATL ACAD SCI USA, V94, P9445, DOI 10.1073/pnas.94.17.9445; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718	76	98	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11661	10.1371/journal.pone.0011661	http://dx.doi.org/10.1371/journal.pone.0011661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661473	gold, Green Submitted, Green Published			2022-12-27	WOS:000280243300003
J	Szajnik, M; Czystowska, M; Szczepanski, MJ; Mandapathil, M; Whiteside, TL				Szajnik, Marta; Czystowska, Malgorzata; Szczepanski, Miroslaw J.; Mandapathil, Magis; Whiteside, Theresa L.			Tumor-Derived Microvesicles Induce, Expand and Up-Regulate Biological Activities of Human Regulatory T Cells (Treg)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; OVARIAN-CANCER; NECK-CANCER; ENDOTHELIAL-CELLS; MEMBRANE-VESICLES; FAS LIGAND; EXOSOMES; HEAD; APOPTOSIS; MICROENVIRONMENT	Background: Tumor-derived microvesicles (TMV) or exosomes are present in body fluids of patients with cancer and might be involved in tumor progression. The frequency and suppressor functions of peripheral blood CD4(+)CD25(high)FOXP3(+) Treg are higher in patients with cancer than normal controls. The hypothesis is tested that TMV contribute to induction/expansion/and activation of human Treg. Methodology/Principal Findings: TMV isolated from supernatants of tumor cells but not normal cells induced the generation and enhanced expansion of human Treg. TMV also mediated conversion of CD4(+)CD25(neg) T cells into CD4(+)CD25(high)FOXP3(+) Treg. Upon co-incubation with TMV, Treg showed an increased FasL, IL-10, TGF-beta 1, CTLA-4, granzyme B and perforin expression (p < 0.05) and mediated stronger suppression of responder cell (RC) proliferation (p < 0.01). Purified Treg were resistant to TMV-mediated apoptosis relative to other T cells. TMV also increased phospho-SMAD2/3 and phospho-STAT3 expression in Treg. Neutralizing Abs specific for TGF-beta 1 and/or IL-10 significantly inhibited TMV ability to expand Treg. Conclusions/Significance: This study suggests that TMV have immunoregulatory properties. They induce Treg, promote Treg expansion, up-regulate Treg suppressor function and enhance Treg resistance to apoptosis. Interactions of TMV with Treg represent a newly-defined mechanism that might be involved in regulating peripheral tolerance by tumors and in supporting immune evasion of human cancers.	[Szajnik, Marta; Czystowska, Malgorzata; Szczepanski, Miroslaw J.; Mandapathil, Magis; Whiteside, Theresa L.] Univ Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA; [Whiteside, Theresa L.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whiteside, TL (corresponding author), Univ Pittsburgh Canc Inst, Pittsburgh, PA 15260 USA.	whitesidetl@upmc.edu	Czystowska-Kuźmicz, Małgorzata/ABH-3220-2020; Czystowska-Kuźmicz, Małgorzata/U-7933-2018; Mandapathil, Magis/AFL-3260-2022; Czystowska-Kuzmicz, Malgorzata/AAC-6989-2020	Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; 	National Institutes of Health [PO1 CA109688]; Heidi L. Browning Ovarian Cancer Research Fund; National Heart Lung Blood Institute [NO1-HB37165]; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heidi L. Browning Ovarian Cancer Research Fund; National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the National Institutes of Health grant PO1 CA109688 (TLW) and Heidi L. Browning Ovarian Cancer Research Fund. Dr. Szajnik was supported by the National Heart Lung Blood Institute grant NO1-HB37165 (TLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2003, CANCER RES, V63, P5573; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andreola G, 2002, J EXP MED, V195, P1303, DOI 10.1084/jem.20011624; Barry OP, 1997, J CLIN INVEST, V99, P2118, DOI 10.1172/JCI119385; Bergmann C, 2008, CLIN CANCER RES, V14, P3706, DOI 10.1158/1078-0432.CCR-07-5126; Bergmann C, 2009, HEAD NECK-J SCI SPEC, V31, P371, DOI 10.1002/hed.20968; Castellana D, 2009, CANCER RES, V69, P785, DOI 10.1158/0008-5472.CAN-08-1946; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Czystowska M, 2009, CELL DEATH DIFFER, V16, P708, DOI 10.1038/cdd.2008.197; CZYSTOWSKA M, 2010, J MOL MED IN PRESS; Dolo V, 2000, BBA-MOL CELL BIOL L, V1486, P265, DOI 10.1016/S1388-1981(00)00063-9; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Hwang IY, 2003, P NATL ACAD SCI USA, V100, P6670, DOI 10.1073/pnas.1131852100; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Kim JW, 2005, CLIN CANCER RES, V11, P1010; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Mandapathil M, 2009, CLIN CANCER RES, V15, P6348, DOI 10.1158/1078-0432.CCR-09-1143; Millimaggi D, 2007, NEOPLASIA, V9, P349, DOI 10.1593/neo.07133; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Sabapatha A, 2006, AM J REPROD IMMUNOL, V56, P345, DOI 10.1111/j.1600-0897.2006.00435.x; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, CLIN CANCER RES, V13, P4345, DOI 10.1158/1078-0432.CCR-07-0472; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Taylor DD, 2006, J IMMUNOL, V176, P1534, DOI 10.4049/jimmunol.176.3.1534; Taylor DD, 2005, BRIT J CANCER, V92, P305, DOI 10.1038/sj.bjc.6602316; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2006, CANCER RES, V66, P9290, DOI 10.1158/0008-5472.CAN-06-1819; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Wang GJ, 2008, J IMMUNOL, V181, P5242, DOI 10.4049/jimmunol.181.8.5242; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Whiteside TL, 2005, CANCER METAST REV, V24, P95, DOI 10.1007/s10555-005-5050-6; Whiteside TL, 2006, SEMIN CANCER BIOL, V16, P3, DOI 10.1016/j.semcancer.2005.07.008; WHITESIDE TL, 2007, REV CANC BIOL THERAP, P89; Wieckowski EU, 2009, J IMMUNOL, V183, P3720, DOI 10.4049/jimmunol.0900970; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Woo EY, 2001, CANCER RES, V61, P4766	46	311	327	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11469	10.1371/journal.pone.0011469	http://dx.doi.org/10.1371/journal.pone.0011469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661468	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000280243300001
J	Kraft, P; Schwarz, T; Meijers, JCM; Stoll, G; Kleinschnitz, C				Kraft, Peter; Schwarz, Tobias; Meijers, Joost C. M.; Stoll, Guido; Kleinschnitz, Christoph			Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficient Mice Are Susceptible to Intracerebral Thrombosis and Ischemic Stroke	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; CARBOXYPEPTIDASE-B; MYOCARDIAL-INFARCTION; PROCARBOXYPEPTIDASE-U; INCREASED RISK; INFLAMMATION; GENE; IDENTIFICATION; POLYMORPHISMS; THROMBOLYSIS	Background: Thrombus formation is a key step in the pathophysiology of acute ischemic stroke and results from the activation of the coagulation cascade. Thrombin plays a central role in this coagulation system and contributes to thrombus stability via activation of thrombin-activatable fibrinolysis inhibitor (TAFIa). TAFIa counteracts endogenous fibrinolysis at different stages and elevated TAFI levels are a risk factor for thrombotic events including ischemic stroke. Although substantial in vitro data on the influence of TAFI on the coagulation-fibrinolysis-system exist, investigations on the consequences of TAFI inhibition in animal models of cerebral ischemia are still lacking. In the present study we analyzed stroke development and post stroke functional outcome in TAFI(-/-) mice. Methodology/Principal Findings: TAFI(-/-) mice and wild-type controls were subjected to 60 min transient middle cerebral artery occlusion (tMCAO) using the intraluminal filament method. After 24 hours, functional outcome scores were assessed and infarct volumes were measured from 2,3,5- Triphenyltetrazoliumchloride (TTC)-stained brain slices. Hematoxylin and eosin (H&E) staining was used to estimate the extent of neuronal cell damage. Thrombus formation within the infarcted brain areas was analyzed by immunoblot. Infarct volumes and functional outcomes did not significantly differ between TAFI(-/-) mice and controls (p>0.05). Histology revealed extensive ischemic neuronal damage regularly including the cortex and the basal ganglia in both groups. TAFI deficiency also had no influence on intracerebral fibrin(ogen) formation after tMCAO. Conclusion: Our study shows that TAFI does not play a major role for thrombus formation and neuronal degeneration after ischemic brain challenge.	[Kraft, Peter; Schwarz, Tobias; Stoll, Guido; Kleinschnitz, Christoph] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Meijers, Joost C. M.] Univ Amsterdam, Acad Med Ctr, Dept Expt Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Wurzburg; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kraft, P (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.	christoph.kleinschnitz@mail.uni-wuerzburg.de	Meijers, J.C.M./S-5981-2019	Meijers, J.C.M./0000-0002-4198-6780	Deutsche Forschungsgemeinschaft [SFB 688]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB 688 (TP B1 to GS and A13 to CK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; Boffa MB, 2007, CLIN BIOCHEM, V40, P431, DOI 10.1016/j.clinbiochem.2006.10.020; Bouckaert M, 2009, NAT REV NEUROL, V5, P477, DOI 10.1038/nrneurol.2009.116; Bouma BN, 2003, J THROMB HAEMOST, V1, P1566, DOI 10.1046/j.1538-7836.2003.00329.x; Brouns R, 2010, J THROMB HAEMOST, V8, P75, DOI 10.1111/j.1538-7836.2009.03663.x; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P165, DOI 10.1016/j.clineuro.2008.09.002; Colucci M, 2010, J THROMB HAEMOST, V8, P50; Colucci M, 2001, THROMB HAEMOSTASIS, V85, P661; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; DAVIE EW, 1964, SCIENCE, V145, P1310, DOI 10.1126/science.145.3638.1310; de Bruijne ELE, 2009, J THROMB HAEMOST, V7, P919, DOI 10.1111/j.1538-7836.2009.03350.x; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Edwards MT, 1999, AM J NEURORADIOL, V20, P1682; EIKELBOOM JW, 2010, J THROMB HA IN PRESS; Franco RF, 2001, HAEMATOLOGICA, V86, P510; Hankey GJ, 2010, LANCET NEUROL, V9, P273, DOI 10.1016/S1474-4422(10)70038-7; Henry M, 2001, BLOOD, V97, P2053, DOI 10.1182/blood.V97.7.2053; Juhan-Vague I, 2002, ARTERIOSCL THROM VAS, V22, P867, DOI 10.1161/01.ATV.0000015445.22243.F4; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kozian DH, 2010, THROMB HAEMOSTASIS, V103, P976, DOI 10.1160/TH09-10-0682; Leebeek FWG, 2005, J THROMB HAEMOST, V3, P2211, DOI 10.1111/j.1538-7836.2005.01484.x; Leung LLK, 2008, ADV EXP MED BIOL, V632, P61, DOI 10.1007/978-0-387-78952-1_5; MACFARLANE RG, 1964, NATURE, V202, P498, DOI 10.1038/202498a0; Mao SS, 2005, BLOOD COAGUL FIBRIN, V16, P407, DOI 10.1097/01.mbc.0000181175.62437.2a; Marti-Fabregas J, 2009, CEREBROVASC DIS, V27, P111, DOI 10.1159/000200448; Meltzer ME, 2009, HAEMATOL-HEMATOL J, V94, P811, DOI 10.3324/haematol.2008.002386; Montaner J, 2003, STROKE, V34, P1038, DOI 10.1161/01.STR.0000063139.06585.45; MORAN PM, 1995, P NATL ACAD SCI USA, V92, P5341, DOI 10.1073/pnas.92.12.5341; MORSER J, 2010, J THROMB HA IN PRESS; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Myles T, 2003, J BIOL CHEM, V278, P51059, DOI 10.1074/jbc.M306977200; Nagashima M, 2002, J CLIN INVEST, V109, P101, DOI 10.1172/JCI12119; Rooth E, 2007, BLOOD COAGUL FIBRIN, V18, P365, DOI 10.1097/MBC.0b013e3281139c34; Santamaria A, 2003, STROKE, V34, P2387, DOI 10.1161/01.STR.0000088642.07691.15; Silveira A, 2000, THROMB HAEMOSTASIS, V84, P364; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Swaisgood CM, 2002, J CLIN INVEST, V110, P1275, DOI 10.1172/JCI200215082; van den Berg JSP, 2009, ACTA NEUROL SCAND, V120, P157, DOI 10.1111/j.1600-0404.2008.01140.x; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; van Tilburg NH, 2000, BLOOD, V95, P2855, DOI 10.1182/blood.V95.9.2855.009k02_2855_2859; Velde EAT, 2003, J THROMB HAEMOST, V1, P2087, DOI 10.1046/j.1538-7836.2003.00404.x	46	28	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11658	10.1371/journal.pone.0011658	http://dx.doi.org/10.1371/journal.pone.0011658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657835	Green Published, Green Submitted, gold			2022-12-27	WOS:000280065600019
J	Faustova, M; Sacherova, V; Sheets, HD; Svensson, JE; Taylor, DJ				Faustova, Marketa; Sacherova, Veronika; Sheets, H. David; Svensson, Jan-Erik; Taylor, Derek J.			Coexisting Cyclic Parthenogens Comprise a Holocene Species Flock in Eubosmina	PLOS ONE			English	Article							LONGISPINA LEYDIG CRUSTACEA; MORPHOLOGICAL VARIATION; CLADOCERA; HISTORY; POPULATIONS; DAPHNIA; EVOLUTION; RADIATION; COMPLEX; SEE	Background: Mixed breeding systems with extended clonal phases and weak sexual recruitment are widespread in nature but often thought to impede the formation of discrete evolutionary clusters. Thus, cyclic parthenogens, such as cladocerans and rotifers, could be predisposed to "species problems'' and a lack of discrete species. However, species flocks have been proposed for one cladoceran group, Eubosmina, where putative species are sympatric, and there is a detailed paleolimnological record indicating a Holocene age. These factors make the Eubosmina system suitable for testing the hypotheses that extended clonal phases and weak sexual recruitment inhibit speciation. Although common garden experiments have revealed a genetic component to the morphotypic variation, the evolutionary significance of the morphotypes remains controversial. Methodology/Principal Findings: In the present study, we tested the hypothesis of a single polymorphic species (i.e., mixing occurs but selection maintains genes for morphology) in four northern European lakes where the morphotypes coexist. Our evidence is based on nuclear DNA sequence, mitochondrial DNA sequence, and morphometric analysis of coexisting morphotypes. We found significant genetic differentiation, genealogical exclusivity, and morphometric differentiation for coexisting morphotypes. Conclusions: We conclude that the studied morphotypes represent a group of young species undergoing speciation with apparent reproductive barriers despite coexistence in the freshwater pelagic zone.	[Faustova, Marketa; Taylor, Derek J.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Faustova, Marketa; Sacherova, Veronika] Charles Univ Prague, Dept Ecol, Prague, Czech Republic; [Sheets, H. David] Canisius Coll, Dept Phys, Buffalo, NY 14208 USA; [Svensson, Jan-Erik] Univ Coll Boras, Sch Engn, Boras, Sweden; [Svensson, Jan-Erik] Medins Biol AB, Molnlycke, Sweden	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Charles University Prague; University of Boras	Faustova, M (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	marfaustova@hotmail.com	Sacherová, Veronika/AAE-7237-2019; Sacherova, Veronika/M-4805-2017	Sacherova, Veronika/0000-0003-2311-8346	National Science Foundation [0331095]; Czech Ministry of Education [MSM0021620828]; Swedish Environmental Protection Agency [dnr 3094664-06 Nv]	National Science Foundation(National Science Foundation (NSF)); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Swedish Environmental Protection Agency	Major research funding was provided by the National Science Foundation (DEB grant 0331095 to DJT). Additional research funding was provided by the Czech Ministry of Education (project MSM0021620828) to VS and MF and the Swedish Environmental Protection Agency (dnr 3094664-06 Nv) to J-ES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz SJ, 2004, ZOOL J LINN SOC-LOND, V140, P171, DOI 10.1111/j.1096-3642.2003.00089.x; Adamowicz SJ, 2002, MOL ECOL, V11, P1209, DOI 10.1046/j.1365-294X.2002.01517.x; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Barraclough TG, 2003, EVOLUTION, V57, P2166; Bell Graham, 2009, P46; Belyaeva M, 2009, MOL PHYLOGENET EVOL, V50, P534, DOI 10.1016/j.ympev.2008.11.007; Bookstein F., 1996, IMAGE FUSION SHAPE V, P79; Bookstein FL, 1997, MED IMAGE ANAL, V1, P225, DOI DOI 10.1016/S1361-8415(97)85012-8; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyne J.A., 2004, SPECIATION; Cristescu MEA, 2002, J EVOLUTION BIOL, V15, P838, DOI 10.1046/j.1420-9101.2002.00466.x; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Elmer KR, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-60; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisk DL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-22; Flossner D, 1972, CRUSTACEA, P1; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Fontaneto D, 2009, MOL PHYLOGENET EVOL, V53, P182, DOI 10.1016/j.ympev.2009.04.011; Frey D. G., 1958, Archiv fuer Hydrobiologie, V54, P209; FREY DG, 1960, ECOLOGY, V41, P684, DOI 10.2307/1931802; FREY DG, 1962, J PALEONTOL, V36, P1133; FREY DG, 1962, JAPAN SOC LIMNOLOGY, V23, P145; FUTUYMA DJ, 2008, EVOLUTION, V62, P2446; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Goulden C. E., 1964, Archiv fuer Hydrobiologie, V60, P1; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUNTHER J, 1993, INT REV GES HYDROBIO, V78, P1, DOI 10.1002/iroh.19930780102; Haney RA, 2003, J EVOLUTION BIOL, V16, P871, DOI 10.1046/j.1420-9101.2003.00594.x; Hellsten M, 1999, OECOLOGIA, V118, P23, DOI 10.1007/s004420050699; HELLSTEN ME, 1995, HYDROBIOLOGIA, V312, P1, DOI 10.1007/BF00018881; Hellsten ME, 2000, HYDROBIOLOGIA, V421, P157, DOI 10.1023/A:1003975203884; HOFMANN W, 1991, HYDROBIOLOGIA, V225, P81, DOI 10.1007/BF00028387; HOFMANN W, 1986, HYDROBIOLOGIA, V143, P119, DOI 10.1007/BF00026653; HOFMANN W, 1984, Z ZOOL SYST EVOL, V22, P294; HOFMANN W, 1987, HYDROBIOLOGIA, V145, P315, DOI 10.1007/BF02530293; HOFMANN W, 1977, ARCH HYDROBIOL, V80, P349; HOFMANN W, 1984, SCHWEIZ Z HYDROL, V46, P139, DOI 10.1007/BF02538104; HOFMANN W, 1978, Polskie Archiwum Hydrobiologii, V25, P167; HOFMANN W, 1987, J PLANKTON RES, V9, P381, DOI 10.1093/plankt/9.2.381; Hofmann Wolfgang, 1993, Lecture Notes in Earth Sciences, V49, P393; Hofmann Wolfgang, 1994, Faunistisch-Oekologische Mitteilungen, V6, P479; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; JOHNSEN GH, 1987, J PLANKTON RES, V9, P297, DOI 10.1093/plankt/9.2.297; Kerfoot WC, 2006, ARCH HYDROBIOL, V167, P147, DOI 10.1127/0003-9136/2006/0167-0147; KERFOOT WC, 1981, ECOLOGY, V62, P216, DOI 10.2307/1936683; Lagergren R, 2000, FUNCT ECOL, V14, P380, DOI 10.1046/j.1365-2435.2000.00433.x; Lagergren R, 2000, J PLANKTON RES, V22, P1213, DOI 10.1093/plankt/22.6.1213; LIEDER U, 1996, SUSSWASSERFAUNA MITT, V8, P1; Lilljeborg W., 1901, N A REG SOC SCI UPSA, V19, P1; Little TJ, 1997, P ROY SOC B-BIOL SCI, V264, P1363, DOI 10.1098/rspb.1997.0189; LYNCH M, 1984, EVOLUTION, V38, P465, DOI 10.1111/j.1558-5646.1984.tb00312.x; Lynch M., 1985, Internationale Vereinigung fuer Theoretische und Angewandte Limnologie Verhandlungen, V22, P3116; Maemets A, 1996, HYDROBIOLOGIA, V338, P105, DOI 10.1007/BF00031714; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Mayr E., 1963, ANIMAL SPECIES EVOLU; McCormack JE, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-28; MORRAN L, 2009, NATURE, V462, P294; NAUWERCK A, 1978, ARCH HYDROBIOL, V82, P387; NAUWERCK A, 1991, HYDROBIOLOGIA, V225, P87, DOI 10.1007/BF00028388; NILSSEN JP, 1980, INT REV GES HYDROBIO, V65, P507, DOI 10.1002/iroh.19800650408; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Ritz MS, 2008, MOL PHYLOGENET EVOL, V49, P292, DOI 10.1016/j.ympev.2008.07.014; ROHLF F, 2004, TPSDIG 2 0; Sampson PD, 1996, NATO ADV SCI INST SE, V284, P211; Shaffer HB, 2007, SYST BIOL, V56, P896, DOI 10.1080/10635150701772563; Shan R. K.c., 1969, Hydrobiologia, V34, P513; SHEETS HD, 2005, IMP SERIES SOFTWARE; Stoeck T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-72; TAYLOR DJ, 1992, LIMNOL OCEANOGR, V37, P658, DOI 10.4319/lo.1992.37.3.0658; Taylor DJ, 1999, P ROY SOC B-BIOL SCI, V266, P791, DOI 10.1098/rspb.1999.0707; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR; Zink RM, 2002, AUK, V119, P864, DOI 10.1642/0004-8038(2002)119[0864:ANPOTE]2.0.CO;2	75	15	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11623	10.1371/journal.pone.0011623	http://dx.doi.org/10.1371/journal.pone.0011623			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661283	Green Published, Green Submitted, gold			2022-12-27	WOS:000279980800012
J	Straud, S; Zubovych, I; de Brabander, JK; Roth, MG				Straud, Sarah; Zubovych, Iryna; de Brabander, Jef K.; Roth, Michael G.			Inhibition of Iron Uptake Is Responsible for Differential Sensitivity to V-ATPase Inhibitors in Several Cancer Cell Lines	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; ENDOPLASMIC-RETICULUM STRESS; CHOLESTEROL-METABOLISM; PROTON PUMP; PATHWAY; ALDOLASE; RECEPTOR; DISTINCT; PH; CHEMORESISTANCE	Many cell lines derived from tumors as well as transformed cell lines are far more sensitive to V-ATPase inhibitors than normal counterparts. The molecular mechanisms underlying these differences in sensitivity are not known. Using global gene expression data, we show that the most sensitive responses to HeLa cells to low doses of V-ATPase inhibitors involve genes responsive to decreasing intracellular iron or decreasing cholesterol and that sensitivity to iron uptake is an important determinant of V-ATPase sensitivity in several cancer cell lines. One of the most sensitive cell lines, melanoma derived SK-Mel-5, over-expresses the iron efflux transporter ferroportin and has decreased expression of proteins involved in iron uptake, suggesting that it actively suppresses cytoplasmic iron. SK-Mel-5 cells have increased production of reactive oxygen species and may be seeking to limit additional production of ROS by iron.	[Straud, Sarah; Zubovych, Iryna; de Brabander, Jef K.; Roth, Michael G.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Straud, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	michael.roth@utsouthwestern.edu		Roth, Michael/0000-0002-9056-332X	National Cancer Institute (NCI) [CA095471, CA09349]; National Institutes of Health (NIH) [5P30 AR41940]; Robert A. Welch Foundation [I-1422]; National Center for Research Resources (NCRR) [C06-RR15437]; NATIONAL CANCER INSTITUTE [P01CA095471, F32CA009349] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041940] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants CA095471 and CA09349 from the National Cancer Institute (NCI), 5P30 AR41940 from the National Institutes of Health (NIH) and grant I-1422 from the Robert A. Welch Foundation. The research was conducted in a facility constructed with support from Research Facilities Improvement Program Grants C06-RR15437 from the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman EJ, 2005, J BIOENERG BIOMEMBR, V37, P431, DOI 10.1007/s10863-005-9485-9; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruick RK, 2002, SCIENCE, V295, P807, DOI 10.1126/science.1069825; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gu F, 2000, J BIOL CHEM, V275, P8154, DOI 10.1074/jbc.275.11.8154; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Jean JC, 2006, AM J PHYSIOL-LUNG C, V291, pL950, DOI 10.1152/ajplung.00087.2006; Kida Y, 2001, HISTOCHEM CELL BIOL, V115, P189; Kim JW, 1999, J ORG CHEM, V64, P153, DOI 10.1021/jo9814997; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Lebreton S, 2008, BIOORG MED CHEM LETT, V18, P5879, DOI 10.1016/j.bmcl.2008.07.003; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Nguyen AD, 2007, J BIOL CHEM, V282, P27436, DOI 10.1074/jbc.M704976200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Porciuncula LO, 2003, NEUROREPORT, V14, P577, DOI 10.1097/01.wnr.0000060833.03650.f7; ROUILLE Y, 1995, FRONT NEUROENDOCRIN, V16, P322, DOI 10.1006/frne.1995.1012; Saroussi S, 2009, PFLUG ARCH EUR J PHY, V457, P581, DOI 10.1007/s00424-008-0458-9; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; Scheel AA, 1996, BIOCHEMISTRY-US, V35, P10203, DOI 10.1021/bi960807x; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Yamada S, 2006, BIOCHEM BIOPH RES CO, V343, P1079, DOI 10.1016/j.bbrc.2006.03.051; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023	35	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11629	10.1371/journal.pone.0011629	http://dx.doi.org/10.1371/journal.pone.0011629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661293	Green Published, Green Submitted, gold			2022-12-27	WOS:000279980800017
J	van Gaal, S; Lamme, VAF; Ridderinkhof, KR				van Gaal, Simon; Lamme, Victor A. F.; Ridderinkhof, K. Richard			Unconsciously Triggered Conflict Adaptation	PLOS ONE			English	Article							SEQUENTIAL MODULATIONS; VISUAL-PERCEPTION; ACTIVATION; MOTOR; MECHANISMS; ABSENCE; TASK	In conflict tasks such as the Stroop, the Eriksen flanker or the Simon task, it is generally observed that the detection of conflict in the current trial reduces the impact of conflicting information in the subsequent trial; a phenomenon termed conflict adaptation. This higher-order cognitive control function has been assumed to be restricted to cases where conflict is experienced consciously. In the present experiment we manipulated the awareness of conflict-inducing stimuli in a metacontrast masking paradigm to directly test this assumption. Conflicting response tendencies were elicited either consciously (through primes that were weakly masked) or unconsciously (strongly masked primes). We demonstrate trial-by-trial conflict adaptation effects after conscious as well as unconscious conflict, which could not be explained by direct stimulus/response repetitions. These findings show that unconscious information can have a longer-lasting influence on our behavior than previously thought and further stretch the functional boundaries of unconscious cognition.	[van Gaal, Simon; Lamme, Victor A. F.] Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands; [van Gaal, Simon; Ridderinkhof, K. Richard] Univ Amsterdam, Dept Psychol, Amsterdam Ctr Study Adapt Control Brain & Behav, Amsterdam, Netherlands; [Lamme, Victor A. F.; Ridderinkhof, K. Richard] Univ Amsterdam, Ctr Cognit Sci, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; University of Amsterdam	van Gaal, S (corresponding author), Univ Amsterdam, Dept Psychol, Cognit Neurosci Grp, Amsterdam, Netherlands.	s.vangaal@uva.nl			European Research Council; Netherlands Organization of Scientific Research (NWO)	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by an advanced investigator grant from the European Research Council to VAFL and a VICI grant from the Netherlands Organization of Scientific Research (NWO) to KRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Breitmeyer B., 2006, VISUAL MASKING; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Cohen MX, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.054.2009; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dupoux E, 2008, COGNITION, V109, P267, DOI 10.1016/j.cognition.2008.06.012; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Elliott R, 1998, J NEUROSCI, V18, P4697; Frings C, 2008, ACTA PSYCHOL, V128, P318, DOI 10.1016/j.actpsy.2008.03.004; Gaillard R, 2007, NEUROREPORT, V18, P1527, DOI 10.1097/WNR.0b013e3282f0b6cd; Gaillard R, 2009, PLOS BIOL, V7, P472, DOI 10.1371/journal.pbio.1000061; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Hommel B, 2004, TRENDS COGN SCI, V8, P494, DOI 10.1016/j.tics.2004.08.007; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Klotz W, 1999, J EXP PSYCHOL HUMAN, V25, P976, DOI 10.1037/0096-1523.25.4.976; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kunde W, 2003, PSYCHON B REV, V10, P198, DOI 10.3758/BF03196485; Kunde W, 2006, MEM COGNITION, V34, P356, DOI 10.3758/BF03193413; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; Mattler U, 2005, PERCEPT PSYCHOPHYS, V67, P285, DOI 10.3758/BF03206492; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Pavone EF, 2009, EUR J NEUROSCI, V30, P1424, DOI 10.1111/j.1460-9568.2009.06908.x; Rossetti Y, 1998, CONSCIOUS COGN, V7, P520, DOI 10.1006/ccog.1998.0370; Sumner P, 2006, P NATL ACAD SCI USA, V103, P10520, DOI 10.1073/pnas.0601974103; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; van Gaal S, 2008, J NEUROSCI, V28, P8053, DOI 10.1523/JNEUROSCI.1278-08.2008; van Gaal S, 2010, J NEUROSCI, V30, P4143, DOI 10.1523/JNEUROSCI.2992-09.2010; VANGAAL S, J COGN NEUR IN PRESS; Vorberg D, 2003, P NATL ACAD SCI USA, V100, P6275, DOI 10.1073/pnas.0931489100	36	86	86	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11508	10.1371/journal.pone.0011508	http://dx.doi.org/10.1371/journal.pone.0011508			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	623CM	20634898	Green Published, gold			2022-12-27	WOS:000279715300019
J	Nogueira, C; Buckup, PA; Menezes, NA; Oyakawa, OT; Kasecker, TP; Neto, MBR; da Silva, JMC				Nogueira, Cristiano; Buckup, Paulo A.; Menezes, Naercio A.; Oyakawa, Osvaldo T.; Kasecker, Thais P.; Ramos Neto, Mario B.; da Silva, Jose Maria C.			Restricted-Range Fishes and the Conservation of Brazilian Freshwaters	PLOS ONE			English	Article							BIODIVERSITY HOTSPOTS; PROTECTED AREAS; STRATEGIES; PRIORITIES; PATTERNS; THREATS; AMAZON; RIVER; UNITS; DAMS	Background: Freshwaters are the most threatened ecosystems on earth. Although recent assessments provide data on global priority regions for freshwater conservation, local scale priorities remain unknown. Refining the scale of global biodiversity assessments (both at terrestrial and freshwater realms) and translating these into conservation priorities on the ground remains a major challenge to biodiversity science, and depends directly on species occurrence data of high taxonomic and geographic resolution. Brazil harbors the richest freshwater ichthyofauna in the world, but knowledge on endemic areas and conservation in Brazilian rivers is still scarce. Methodology/Principal Findings: Using data on environmental threats and revised species distribution data we detect and delineate 540 small watershed areas harboring 819 restricted-range fishes in Brazil. Many of these areas are already highly threatened, as 159 (29%) watersheds have lost more than 70% of their original vegetation cover, and only 141 (26%) show significant overlap with formally protected areas or indigenous lands. We detected 220 (40%) critical watersheds overlapping hydroelectric dams or showing both poor formal protection and widespread habitat loss; these sites harbor 344 endemic fish species that may face extinction if no conservation action is in place in the near future. Conclusions/Significance: We provide the first analysis of site-scale conservation priorities in the richest freshwater ecosystems of the globe. Our results corroborate the hypothesis that freshwater biodiversity has been neglected in former conservation assessments. The study provides a simple and straightforward method for detecting freshwater priority areas based on endemism and threat, and represents a starting point for integrating freshwater and terrestrial conservation in representative and biogeographically consistent site-scale conservation strategies, that may be scaled-up following naturally linked drainage systems. Proper management (e. g. forestry code enforcement, landscape planning) and conservation (e. g. formal protection) of the 540 watersheds detected herein will be decisive in avoiding species extinction in the richest aquatic ecosystems on the planet.	[Nogueira, Cristiano; Ramos Neto, Mario B.] Conservacao Int Brasil, Programa Cerrado Pantanal, Brasilia, DF, Brazil; [Buckup, Paulo A.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, Brazil; [Menezes, Naercio A.; Oyakawa, Osvaldo T.] Univ Sao Paulo, Museu Zool, Secao Ictiol, Sao Paulo, Brazil; [Kasecker, Thais P.; da Silva, Jose Maria C.] Conservacao Int Brasil, Programa Amazonia, Belem, Para, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo	Nogueira, C (corresponding author), Univ Brasilia, Dept Zool, Brasilia, DF, Brazil.	cnogueira@unb.br	Buckup, Paulo Andreas/H-6729-2013; da Silva, José Maria Cardoso/K-3479-2016; Menezes, Naercio A./K-8763-2013; Nogueira, Cristiano de C. de Campos/I-5100-2012	Buckup, Paulo Andreas/0000-0002-1156-3226; da Silva, José Maria Cardoso/0000-0002-7229-6694; Menezes, Naercio A./0000-0002-9634-6051; Nogueira, Cristiano de C. de Campos/0000-0003-1835-6761	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Gordon and Betty Moore Foundation	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided research grants and fellowships. The Gordon and Betty Moore Foundation provided research funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Agostinho AA, 2004, REV FISH BIOL FISHER, V14, P11, DOI 10.1007/s11160-004-3551-y; Amis MA, 2009, BIOL CONSERV, V142, P2217, DOI 10.1016/j.biocon.2009.04.021; *ANA, 2006, OTT NIV 6 VERS 07 12; ANA, 2006, TOP HIDR MET CONSTR; *ANA, 2007, GEO BRAS REC HIDR RE; *ANA, 2007, MAN CONSTR BAS HIDR; *ANA, 2006, REG HIDR SUP GEST IN; Anderson EP, 2006, AQUAT CONSERV, V16, P679, DOI 10.1002/aqc.806; Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; BARTHEM RB, 1991, BIOL CONSERV, V55, P339, DOI 10.1016/0006-3207(91)90037-A; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Chapman AD, 2006, GLOBAL BIODIVERSITY; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Duellman W. E., 1986, BIOL AMPHIBIANS; Eken G, 2004, BIOSCIENCE, V54, P1110, DOI 10.1641/0006-3568(2004)054[1110:KBAASC]2.0.CO;2; FabrU N.N., 2005, MANEJO PESCA GRANDES; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Ghazzi MS., 2007, CATALOGO ESPECIES PE; Hausdorf B, 2002, SYST BIOL, V51, P648, DOI 10.1080/10635150290102320; HIJMANS RJ, 2004, 5 0 GEOGRAPHIC INFOR; *IBGE, 2004, MAP BIOM BRAS RIO JA; *ISA, 2009, ARE IND BRAS MAP; IUCN, 2007, IUCN RED LIST THREAT; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; *IUCN, 2009, WILDL CHANG WORLD AN; Lamoreux JF, 2006, NATURE, V440, P212, DOI 10.1038/nature04291; Langeani F., 2009, ESTADO ARTE PERSPECT, V1, P211; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Loyola RD, 2007, DIVERS DISTRIB, V13, P389, DOI 10.1111/j.1472-4642.2007.00345.x; Magurran AE, 2009, SCIENCE, V325, P1215, DOI 10.1126/science.1177215; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; MINISTERIO DO MEIO AMBIENTE - MMA, 2003, LIST ESP FAUN BRAS A; Mittermeier RA, 1997, MEGADIVERSITY EARTHS; *MMA, 2006, MAP AR PRIOR CONS US; MMA, 2007, MAP COB VEG BIOM BRA; *MMA, 2009, UNID CONSERV PROT IN; *MME, 2009, SIPOT SIST INF POT H; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 2003, BIOSCIENCE, V53, P916; Paynter Jr R. A., 1991, ORNITHOLOGICAL GAZET; PETRERE M, 1996, FISHERIES LARGE TROP, V2, P111; Quinn CH, 2005, BIODIVERS CONSERV, V14, P297, DOI 10.1007/s10531-004-5048-3; Regnier C, 2009, CONSERV BIOL, V23, P1214, DOI 10.1111/j.1523-1739.2009.01245.x; REINTHAL PN, 1991, CONSERV BIOL, V5, P231, DOI 10.1111/j.1523-1739.1991.tb00128.x; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Rosenfield JA, 2002, GLOBAL ECOL BIOGEOGR, V11, P323, DOI 10.1046/j.1466-822X.2002.00287.x; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Stattersfield Alison J., 1998, Birdlife Conservation Series, V7, P1; Vanzolini PE., 1992, SUPPLEMENT ORNITHOLO; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x	55	97	103	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11390	10.1371/journal.pone.0011390	http://dx.doi.org/10.1371/journal.pone.0011390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613986	Green Published, Green Submitted, gold			2022-12-27	WOS:000279370000019
J	Nishikawa, M; Shibata, T				Nishikawa, Masatoshi; Shibata, Tatsuo			Nonadaptive Fluctuation in an Adaptive Sensory System: Bacterial Chemoreceptor	PLOS ONE			English	Article							STATE-DEPENDENT INACTIVATION; ESCHERICHIA-COLI; BEHAVIORAL VARIABILITY; STOCHASTIC SIMULATION; COVALENT MODIFICATION; CHEMOTACTIC RESPONSE; SIGNAL-TRANSDUCTION; FLAGELLAR MOTORS; ADAPTATION; AMPLIFICATION	Background: Sensory systems often exhibit an adaptation or desensitization after a transient response, making the system ready to receive a new signal over a wide range of backgrounds. Because of the strong influence of thermal stochastic fluctuations on the biomolecules responsible for the adaptation, such as many membrane receptors and channels, their response is inherently noisy, and the adaptive property is achieved as a statistical average. Methodology/Principal Findings: Here, we study a simple kinetic model characterizing the essential aspects of these adaptive molecular systems and show theoretically that, while such an adaptive sensory system exhibits a perfect adaptation property on average, its temporal stochastic fluctuations are able to be sensitive to the environmental conditions. Among the adaptive sensory systems, an extensively studied model system is the bacterial receptor responsible for chemotaxis. The model exhibits a nonadaptive fluctuation sensitive to the environmental ligand concentration, while perfect adaptation is achieved on average. Furthermore, we found that such nonadaptive fluctuation makes the bacterial behavior dependent on the environmental chemoattractant concentrations, which enhances the chemotactic performance. Conclusions/Significance: This result indicates that adaptive sensory systems can make use of such stochastic fluctuation to carry environmental information, which is not possible by means of the average, while keeping responsive to the changing stimulus.	[Nishikawa, Masatoshi; Shibata, Tatsuo] Hiroshima Univ, Dept Math & Life Sci, Hiroshima, Japan; [Nishikawa, Masatoshi; Shibata, Tatsuo] Japan Sci & Technol Agcy, CREST, Osaka, Japan; [Shibata, Tatsuo] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Hiroshima University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Nishikawa, M (corresponding author), Hiroshima Univ, Dept Math & Life Sci, Hiroshima, Japan.	shibata@hiroshima-u.ac.jp	Shibata, Tatsuo/A-8119-2012	Shibata, Tatsuo/0000-0002-9294-9998	Japan Science and Technology Agency (JST); Core Research of Evolutional Science and Technology (CREST); JST Precursory Research for Embryonic Science and Technology (PRESTO)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Core Research of Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); JST Precursory Research for Embryonic Science and Technology (PRESTO)	This work was supported by funding from the Japan Science and Technology Agency (JST), Core Research of Evolutional Science and Technology (CREST) (www.sysbio.jst.go.jp) and JST Precursory Research for Embryonic Science and Technology (PRESTO) (www.model.jst.go.jp). There are no numbers for these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA S, 1984, J MOL BIOL, V176, P349, DOI 10.1016/0022-2836(84)90494-7; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Barkai N, 2001, CR ACAD SCI IV-PHYS, V2, P871, DOI 10.1016/S1296-2147(01)01230-6; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; BLOCK SM, 1982, CELL, V31, P215, DOI 10.1016/0092-8674(82)90421-4; BORKOVICH KA, 1992, P NATL ACAD SCI USA, V89, P6756, DOI 10.1073/pnas.89.15.6756; Clark DA, 2005, P NATL ACAD SCI USA, V102, P9150, DOI 10.1073/pnas.0407659102; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; de Gennes PG, 2004, EUR BIOPHYS J BIOPHY, V33, P691, DOI 10.1007/s00249-004-0426-z; Emonet T, 2008, P NATL ACAD SCI USA, V105, P3304, DOI 10.1073/pnas.0705463105; Ferguson SSG, 1998, SEMIN CELL DEV BIOL, V9, P119, DOI 10.1006/scdb.1997.0216; Friedlander T, 2009, P NATL ACAD SCI USA, V106, P22558, DOI 10.1073/pnas.0902146106; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; KHAN S, 1980, J MOL BIOL, V138, P563, DOI 10.1016/S0022-2836(80)80018-0; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MAROM S, 1994, BIOPHYS J, V67, P579, DOI 10.1016/S0006-3495(94)80517-X; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Tostevin F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.218101; Tu YH, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.208101; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11224	10.1371/journal.pone.0011224	http://dx.doi.org/10.1371/journal.pone.0011224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613875	Green Published, gold, Green Submitted			2022-12-27	WOS:000279369900001
J	Bergstedt, W; Tingskov, PN; Thierry-Carstensen, B; Hoff, ST; Aggerbeck, H; Thomsen, VO; Andersen, P; Andersen, AB				Bergstedt, Winnie; Tingskov, Pernille N.; Thierry-Carstensen, Birgit; Hoff, Soren T.; Aggerbeck, Henrik; Thomsen, Vibeke O.; Andersen, Peter; Andersen, Aase B.			First-in-Man Open Clinical Trial of a Combined rdESAT-6 and rCFP-10 Tuberculosis Specific Skin Test Reagent	PLOS ONE			English	Article							DIAGNOSIS; INFECTION; ESAT-6; ANTIGENS	Background: Tuberculin is still the only available skin test reagent for the diagnosis of mycobacterial infection. The product has a remarkable sensitivity, but poor specificity. Previous studies, including two human phase I clinical trials, have indicated that rdESAT-6 has a potential as an improved skin test reagent. Animal studies have shown that the sensitivity may be increased by inclusion of the genetically related CFP-10 antigen in the preparation without loosing specificity. Methodology: In this study a Lactococcus fermented, recombinant skin test reagent consisting of a 1:1 wt/wt of rdESAT-6 and CFP-10 was manufactured according to GMP standards and tested for the first time in 42 healthy adult volunteers. The two doses of 0.01 mu g or 0.1 mu g were injected intradermally by the Mantoux technique with 6 or 12 weeks interval. No serious adverse events and only mild adverse reactions were reported. The reagent elicited a positive skin test reaction after the first injection in one participant, who most likely was latently infected with M. tuberculosis as indicated by an appreciable IFN gamma response just below the Quantiferon (R) cut-off level at the screening visit. None of the remaining participants in the four groups had any skin test reactions and sensitisation by the reagent could therefore be excluded. Conclusion: The investigational skin test reagent rdESAT-6 and CFP-10 appeared safe and non-sensitising in this first-in-man clinical trial in human volunteers and can now be tested in larger clinical trials involving individuals with latent M. tuberculosis infection or active TB disease.	[Bergstedt, Winnie; Andersen, Aase B.] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Tingskov, Pernille N.; Thierry-Carstensen, Birgit; Aggerbeck, Henrik] Statens Serum Inst, Dept Vaccine Dev, DK-2300 Copenhagen, Denmark; [Hoff, Soren T.; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Thomsen, Vibeke O.] Statens Serum Inst, Natl Ctr Antimicrobials & Infect Control, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Statens Serum Institut; Statens Serum Institut; Statens Serum Institut	Bergstedt, W (corresponding author), Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark.	bengaard@rh.dk	Thomsen, Vibeke Østergaard/H-9370-2013	Andersen, Aase Bengaard/0000-0003-4779-7603; Andersen, Peter/0000-0002-5869-2551; Thomsen, Vibeke Ostergaard/0000-0002-1653-6294	SSI, Copenhagen, DK [2008-001489-96]	SSI, Copenhagen, DK	The study was sponsored by SSI, Copenhagen, DK (Trial code TESEC-01, EudraCT no.: 2008-001489-96). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerbeck H, 2006, TUBERCULOSIS, V86, P363, DOI 10.1016/j.tube.2005.08.020; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Arend SM, 2008, TUBERCULOSIS, V88, P249, DOI 10.1016/j.tube.2007.11.004; Arend SM, 2002, J INFECT DIS, V186, P1797, DOI 10.1086/345760; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Lillebaek T, 2009, TUBERCULOSIS, V89, P158, DOI 10.1016/j.tube.2008.09.007; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; SNIDER DE, 1982, AM REV RESPIR DIS, V125, P108; THOMPSON NJ, 1979, AM REV RESPIR DIS, V119, P587; van Pinxteren LAH, 2000, CLIN DIAGN LAB IMMUN, V7, P155, DOI 10.1128/CDLI.7.2.155-160.2000	14	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11277	10.1371/journal.pone.0011277	http://dx.doi.org/10.1371/journal.pone.0011277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593018	Green Published, gold, Green Submitted			2022-12-27	WOS:000279140800003
J	Boye, SE; Boye, SL; Pang, JJ; Ryals, R; Everhart, D; Umino, Y; Neeley, AW; Besharse, J; Barlow, R; Hauswirth, WW				Boye, Shannon E.; Boye, Sanford L.; Pang, Jijing; Ryals, Renee; Everhart, Drew; Umino, Yumiko; Neeley, Andy W.; Besharse, Joseph; Barlow, Robert; Hauswirth, William W.			Functional and Behavioral Restoration of Vision by Gene Therapy in the Guanylate Cyclase-1 (GC1) Knockout Mouse	PLOS ONE			English	Article							LEBER CONGENITAL AMAUROSIS; ADENOASSOCIATED VIRUS; RETINAL DEGENERATION; PHOTORECEPTOR CELLS; RESTORES VISION; CONE VISION; EXPRESSION; ROD; TRANSDUCTION; MUTATIONS	Background: Recessive mutations in guanylate cyclase-1 (Gucy2d) are associated with severe, early onset Leber congenital amaurosis-1(LCA1). Gucy2d encodes guanylate cyclase (GC1) is expressed in photoreceptor outer segment membranes and produces cGMP in these cells. LCA1 patients present in infancy with severely impaired vision and extinguished electroretinogram (ERG) but retain some photoreceptors in both their macular and peripheral retina for years. Like LCA1 patients, loss of cone function in the GC1 knockout (GC1KO) mouse precedes cone degeneration. The purpose of this study was to test whether delivery of functional GC1 to cone cells of the postnatal GC1KO mouse could restore function to these cells. Methodology/Principal Findings: Serotype 5 AAV vectors containing either a photoreceptor-specific, rhodopsin kinase (hGRK1) or ubiquitous (smCBA) promoter driving expression of wild type murine GC1 were subretinally delivered to one eye of P14 GC1KO mice. Visual function (ERG) was analyzed in treated and untreated eyes until 3 months post injection. AAV-treated, isogenic wild type and uninjected control mice were evaluated for restoration of visual behavior using optomotor testing. At 3 months post injection, all animals were sacrificed, and their treated and untreated retinas assayed for expression of GC1 and localization of cone arrestin. Cone-mediated function was restored to treated eyes of GC1KO mice (ERG amplitudes were similar to 45% of normal). Treatment effect was stable for at least 3 months. Robust improvements in cone-mediated visual behavior were also observed, with responses of treated mice being similar or identical to that of wild type mice. AAV-vectored GC1 expression was found in photoreceptors and cone cells were preserved in treated retinas. Conclusions/Significance: This is the first demonstration of gene-based restoration of both visual function/vision-elicited behavior and cone preservation in a mammalian model of GC1 deficiency. Importantly, results were obtained using a well characterized, clinically relevant AAV vector. These results lay the ground work for the development of an AAV-based gene therapy vector for the treatment of LCA1.	[Boye, Shannon E.; Boye, Sanford L.; Pang, Jijing; Ryals, Renee; Neeley, Andy W.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Everhart, Drew; Umino, Yumiko; Barlow, Robert] SUNY Upstate Med Univ, Coll Med, Dept Ophthalmol, Syracuse, NY USA; [Besharse, Joseph] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	State University System of Florida; University of Florida; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Medical College of Wisconsin	Boye, SE (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	shaire@ufl.edu		Boye, Shannon/0000-0002-7312-3197; hauswirth, william/0000-0002-3244-4947	National Institutes of Health (NIH) [EY13729, EY11123, EY08571]; Macular Vision Research Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [P30EY008571, U10EY013729, R01EY011123] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health (NIH) grants EY13729, EY11123, and EY08571, and by grants from the Macular Vision Research Foundation (www.mvrg.org), the Foundation Fighting Blindness (www.blindness.org), Hope for Vision (www.hopeforvision.org), and Research to Prevent Blindness, Inc. (www.rpbusa.org). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; BELTRAN W, 2010, GENE THERAP IN PRESS; Bereta G, 2010, J BIOL CHEM, V285, P1899, DOI 10.1074/jbc.M109.061713; Bhowmick R, 2009, TRAFFIC, V10, P648, DOI 10.1111/j.1600-0854.2009.00896.x; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chung DC, 2009, J AAPOS, V13, P587, DOI 10.1016/j.jaapos.2009.10.004; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Coleman JE, 2004, INVEST OPHTH VIS SCI, V45, P3397, DOI 10.1167/iovs.04-0392; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Glushakova LG, 2006, MOL VIS, V12, P298; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Huang YJ, 1998, INVEST OPHTH VIS SCI, V39, P2405; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Karan S, 2010, MOL CELL BIOCHEM, V334, P141, DOI 10.1007/s11010-009-0322-z; Khani SC, 2007, INVEST OPHTH VIS SCI, V48, P3954, DOI 10.1167/iovs.07-0257; KOMAROMY AM, 2010, HUM MOL GENET   0421; Li WS, 2009, MOL VIS, V15, P267; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; Lotery AJ, 2003, HUM GENE THER, V14, P1663, DOI 10.1089/104303403322542301; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Milam AH, 2003, OPHTHALMOLOGY, V110, P549, DOI 10.1016/S0161-6420(02)01757-8; Natkunarajah M, 2008, GENE THER, V15, P463, DOI 10.1038/sj.gt.3303074; OttoBruc A, 1997, BIOCHEMISTRY-US, V36, P4295, DOI 10.1021/bi963000d; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PANG J, 2010, GENE THER       0318; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; PASADHIKA S, 2009, INVEST OPHTHALMOL VI; PAWLYK BS, 2010, HUM GENE THER   0412; Perrault I, 1999, MOL GENET METAB, V68, P200, DOI 10.1006/mgme.1999.2906; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Perrault I, 2000, EUR J HUM GENET, V8, P578, DOI 10.1038/sj.ejhg.5200503; Semple-Rowland SL, 1998, P NATL ACAD SCI USA, V95, P1271, DOI 10.1073/pnas.95.3.1271; Simonelli F, 2007, INVEST OPHTH VIS SCI, V48, P4284, DOI 10.1167/iovs.07-0068; Stephen R, 2007, STRUCTURE, V15, P1392, DOI 10.1016/j.str.2007.09.013; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; Sun X, 2010, GENE THER, V17, P117, DOI 10.1038/gt.2009.104; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Timmers A, 2001, MOL VIS, V7, P131; ULSHAFER RJ, 1984, EXP EYE RES, V39, P125, DOI 10.1016/0014-4835(84)90003-4; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Weiss ER, 2001, J NEUROSCI, V21, P9175, DOI 10.1523/JNEUROSCI.21-23-09175.2001; Williams GA, 2007, VISION RES, V47, P2037, DOI 10.1016/j.visres.2007.03.023; Williams ML, 2006, PLOS MED, V3, P904, DOI 10.1371/journal.pmed.0030201; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; Yang RB, 1997, J BIOL CHEM, V272, P13738, DOI 10.1074/jbc.272.21.13738; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	55	78	82	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11306	10.1371/journal.pone.0011306	http://dx.doi.org/10.1371/journal.pone.0011306			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593011	Green Submitted, Green Published, gold			2022-12-27	WOS:000279140800008
J	Nunes, MC; Okada, M; Scheidig-Benatar, C; Cooke, BM; Scherf, A				Nunes, Marta C.; Okada, Mami; Scheidig-Benatar, Christine; Cooke, Brian M.; Scherf, Artur			Plasmodium falciparum FIKK Kinase Members Target Distinct Components of the Erythrocyte Membrane	PLOS ONE			English	Article							RED-BLOOD-CELLS; PHOSPHOPROTEIN GEL STAIN; INFECTED ERYTHROCYTES; CHONDROITIN SULFATE; MALARIA PARASITES; HOST-CELL; PROTEIN; PHOSPHORYLATION; FAMILY; CYTOSKELETON	Background: Modulation of infected host cells by intracellular pathogens is a prerequisite for successful establishment of infection. In the human malaria parasite Plasmodium falciparum, potential candidates for erythrocyte remodelling include the apicomplexan-specific FIKK kinase family (20 members), several of which have been demonstrated to be transported into the erythrocyte cytoplasm via Maurer's clefts. Methodology: In the current work, we have knocked out two members of this gene family (Pf fikk7.1 and Pf fikk12), whose products are localized at the inner face of the erythrocyte membrane. Both mutant parasite lines were viable and erythrocytes infected with these parasites showed no detectable alteration in their ability to adhere in vitro to endothelial receptors such as chondroitin sulfate A and CD36. However, we observed sizeable decreases in the rigidity of infected erythrocytes in both knockout lines. Mutant parasites were further analyzed using a phospho-proteomic approach, which revealed distinct phosphorylation profiles in ghost preparations of infected erythrocytes. Knockout parasites showed a significant reduction in the level of phosphorylation of a protein of approximately 80 kDa for FIKK12-KO in trophozoite stage and a large protein of about 300 kDa for FIKK7.1-KO in schizont stage. Conclusions: Our results suggest that FIKK members phosphorylate different membrane skeleton proteins of the infected erythrocyte in a stage-specific manner, inducing alterations in the mechanical properties of the parasite-infected red blood cell. This suggests that these host cell modifications may contribute to the parasites' survival in the circulation of the human host.	[Nunes, Marta C.; Okada, Mami; Scheidig-Benatar, Christine; Scherf, Artur] Inst Pasteur, CNRS, UR2581, Unite Biol Interact Hote Parasite, Paris, France; [Cooke, Brian M.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Monash University	Nunes, MC (corresponding author), Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa.	nunesm@rmpru.co.za; ascherf@pasteur.fr	Scherf, Artur/A-9674-2014	Nunes, Marta/0000-0003-3788-878X; Scherf, Artur/0000-0003-2411-3328	Fond Dedier; Human Frontiers Science Program; NHMRC	Fond Dedier; Human Frontiers Science Program(Human Frontier Science Program); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work has been supported by the Fond Dedier, including a post doctoral fellowship to M.O., and BioMalPar. M.C.N. had financial support from the Human Frontiers Science Program. Brian Cooke is an Australian National Health and Medical Research Council Senior Research Fellow and is supported by grants from the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruch DI, 1997, BLOOD, V90, P3766, DOI 10.1182/blood.V90.9.3766; Blisnick T, 2000, MOL BIOCHEM PARASIT, V111, P107, DOI 10.1016/S0166-6851(00)00301-7; Buffet PA, 1999, P NATL ACAD SCI USA, V96, P12743, DOI 10.1073/pnas.96.22.12743; CHISHTI AH, 1994, BLOOD, V83, P3339; COHEN CM, 1992, SEMIN HEMATOL, V29, P244; CONBOY JG, 1993, SEMIN HEMATOL, V30, P58; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; EDER PS, 1986, BIOCHEMISTRY-US, V25, P1764, DOI 10.1021/bi00355a047; Fujioka H, 2002, CHEM IMMUNOL, V80, P1; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hora R, 2009, J BIOL CHEM, V284, P6260, DOI 10.1074/jbc.M809756200; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; LEECH JH, 1984, J CELL BIOL, V98, P1256, DOI 10.1083/jcb.98.4.1256; LU PW, 1985, J BIOL CHEM, V260, P4958; LUSTIGMAN S, 1990, MOL BIOCHEM PARASIT, V38, P261, DOI 10.1016/0166-6851(90)90029-L; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; MANNO S, 1995, J BIOL CHEM, V270, P5659, DOI 10.1074/jbc.270.10.5659; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Murray J, 2004, ELECTROPHORESIS, V25, P2520, DOI 10.1002/elps.200406006; MURRAY MC, 1989, MOL BIOCHEM PARASIT, V34, P229, DOI 10.1016/0166-6851(89)90051-0; Noviyanti R, 2001, MOL BIOCHEM PARASIT, V114, P227, DOI 10.1016/S0166-6851(01)00266-3; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; RANGACHARI K, 1986, NATURE, V324, P364, DOI 10.1038/324364a0; Schneider AG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-30; Schulenberg B, 2004, ELECTROPHORESIS, V25, P2526, DOI 10.1002/elps.200406007; Staines HM, 2007, INT J PARASITOL, V37, P475, DOI 10.1016/j.ijpara.2006.12.013; Steinberg TH, 2003, PROTEOMICS, V3, P1128, DOI 10.1002/pmic.200300434; TAKAKUWA Y, 1986, J CLIN INVEST, V78, P80, DOI 10.1172/JCI112577; Takakuwa Y, 2000, INT J HEMATOL, V72, P298; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Ooij C, 2007, CELL MICROBIOL, V9, P573, DOI 10.1111/j.1462-5822.2006.00875.x; Viebig NK, 2006, EXP PARASITOL, V112, P121, DOI 10.1016/j.exppara.2005.09.007; Viebig NK, 2005, EMBO REP, V6, P775, DOI 10.1038/sj.embor.7400466; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WASSERMAN M, 1990, PARASITOL RES, V76, P681, DOI 10.1007/BF00931087; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Wu Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-105; ZHUO S, 1993, J BIOL CHEM, V268, P17754	42	53	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11747	10.1371/journal.pone.0011747	http://dx.doi.org/10.1371/journal.pone.0011747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668526	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800020
J	Bryant, CM; Albertus, DL; Kim, S; Chen, G; Brambilla, C; Guedj, M; Arima, C; Travis, WD; Yatabe, Y; Takahashi, T; Brambilla, E; Beer, DG				Bryant, Christopher M.; Albertus, Daniel L.; Kim, Sinae; Chen, Guoan; Brambilla, Christian; Guedj, Mickael; Arima, Chinatsu; Travis, William D.; Yatabe, Yasushi; Takahashi, Takashi; Brambilla, Elisabeth; Beer, David G.			Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER; SURVIVAL; CLASSIFICATION; MUTATIONS; NATION; GENOME	Lung adenocarcinoma (AD) represents a predominant type of lung cancer demonstrating significant morphologic and molecular heterogeneity. We sought to understand this heterogeneity by utilizing gene expression analyses of 432 AD samples and examining associations between 27 known cancer-related pathways and the AD subtype, clinical characteristics and patient survival. Unsupervised clustering of AD and gene expression enrichment analysis reveals that cell proliferation is the most important pathway separating tumors into subgroups. Further, AD with increased cell proliferation demonstrate significantly poorer outcome and an increased solid AD subtype component. Additionally, we find that tumors with any solid component have decreased survival as compared to tumors without a solid component. These results lead to the potential to use a relatively simple pathological examination of a tumor in order to determine its aggressiveness and the patient's prognosis. Additional results suggest the ability to use a similar approach to determine a patient's sensitivity to targeted treatment. We then demonstrated the consistency of these findings using two independent AD cohorts from Asia (N = 87) and Europe (N = 89) using the identical analytic procedures.	[Bryant, Christopher M.; Albertus, Daniel L.; Chen, Guoan; Beer, David G.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Beer, David G.] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI USA; [Kim, Sinae] Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI USA; [Brambilla, Christian; Guedj, Mickael] Univ Grenoble 1, Programme Cartes Identite Tumeurs, Grenoble, France; [Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Yatabe, Yasushi] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan; [Arima, Chinatsu; Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc, Nagoya, Aichi 4648601, Japan; [Brambilla, Elisabeth] Univ Grenoble 1, Dept Anat & Cytol Pathol, Grenoble, France	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Memorial Sloan Kettering Cancer Center; Aichi Cancer Center; Nagoya University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bryant, CM (corresponding author), Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA.	dgbeer@umich.edu	YATABE, Yasushi/J-6461-2014; Brambilla, Elisabeth MP/L-8796-2013; Chen, Guoan/J-9140-2018; Takahashi, Takashi/I-7262-2014	YATABE, Yasushi/0000-0003-1788-559X; Chen, Guoan/0000-0001-5608-6761; Takahashi, Takashi/0000-0003-0615-7001				Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ebi H, 2009, CANCER RES, V69, P4027, DOI 10.1158/0008-5472.CAN-08-3403; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Jemal A, 2004, CANCER-AM CANCER SOC, V101, P3, DOI 10.1002/cncr.20288; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Motoi N, 2008, AM J SURG PATHOL, V32A, P810, DOI 10.1097/PAS.0b013e31815cb162; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358	14	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11712	10.1371/journal.pone.0011712	http://dx.doi.org/10.1371/journal.pone.0011712			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661423	Green Submitted, Green Published, gold			2022-12-27	WOS:000280243300015
J	Lou, PH; Yang, GQ; Huang, L; Cui, YX; Pourbahrami, T; Radda, GK; Li, C; Han, WP				Lou, Phing-How; Yang, Guoqing; Huang, Lu; Cui, Yunxia; Pourbahrami, Tiffany; Radda, George K.; Li, Cai; Han, Weiping			Reduced Body Weight and Increased Energy Expenditure in Transgenic Mice Over-Expressing Soluble Leptin Receptor	PLOS ONE			English	Article							BOUND LEPTIN; MOUSE; PROTEIN; OBESITY; GENE; IDENTIFICATION; GENERATION; ADIPOSITY; CLONING; PLASMA	Background: Soluble leptin receptor (OBRe), one of several leptin receptor isoforms, is the only bona fide leptin binding protein in plasma. Our earlier studies demonstrated that OBRe modulates leptin levels in circulation. Both clinical and in vitro studies have shown that OBRe expression is inversely correlated to body weight and leptin levels. However, it is not clear whether OBRe plays an active role, either in collaboration with leptin or independently, in the maintenance of body weight. Methodology/Principal Findings: To investigate the function of OBRe in the regulation of energy homeostasis, we generated transgenic mice that express OBRe under the control of human serum amyloid P (hSAP) component gene promoter. The transgene led to approximately doubling of OBRe in circulation in the transgenic mice than in wild type control mice. Transgenic mice exhibited lower body weight at 4 weeks of age, and slower rate of weight gain when compared with control mice. Furthermore, transgenic mice had lower body fat content. Indirect calorimetry revealed that transgenic mice had reduced food intake, increased basal metabolic rate, and increased lipid oxidation, which could account for the differences in body weight and body fat content. Transgenic mice also showed higher total circulating leptin, with the majority of it being in the bound form, while the amount of free leptin is comparable between transgenic and control mice. Conclusions: These results are consistent with the role of OBRe as a leptin binding protein in regulating leptin's bioavailability and activity.	[Lou, Phing-How; Yang, Guoqing; Radda, George K.; Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Huang, Lu; Cui, Yunxia; Pourbahrami, Tiffany; Li, Cai] Univ Texas SW Med Ctr Dallas, Touchstone Ctr Diabet Res, Dept Physiol, Dallas, TX 75390 USA; [Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); University of Texas System; University of Texas Southwestern Medical Center Dallas; National University of Singapore	Lou, PH (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.	cai_li@merck.com; weiping_han@sbic.a-star.edu.sg			American Heart Association, Texas Affiliate [0255737Y]; Welch Foundation [I-1470]; National Institutes of Health [DK 60137]; A*STAR Biomedical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060137] Funding Source: NIH RePORTER	American Heart Association, Texas Affiliate(American Heart Association); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by grants from the American Heart Association, Texas Affiliate (0255737Y, C. L.), the Welch Foundation (I-1470, C. L.), National Institutes of Health (DK 60137, C. L.) and A*STAR Biomedical Research Council (W. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brabant G, 2000, DIABETOLOGIA, V43, P438, DOI 10.1007/s001250051326; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; Chan JL, 2002, DIABETES, V51, P2105, DOI 10.2337/diabetes.51.7.2105; Chehab FE, 1996, NAT GENET, V12, P318, DOI 10.1038/ng0396-318; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cohen SE, 2007, J BIOL CHEM, V282, P23672, DOI 10.1074/jbc.M704053200; Doring H, 1998, INT J OBESITY, V22, P83, DOI 10.1038/sj.ijo.0800547; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gavrilova O, 1997, J BIOL CHEM, V272, P30546, DOI 10.1074/jbc.272.48.30546; Ge HF, 2002, J BIOL CHEM, V277, P45898, DOI 10.1074/jbc.M205825200; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Harper JA, 2002, BIOCHEM J, V361, P49, DOI 10.1042/0264-6021:3610049; Hileman SM, 2002, ENDOCRINOLOGY, V143, P775, DOI 10.1210/en.143.3.775; Huang L, 2001, J BIOL CHEM, V276, P6343, DOI 10.1074/jbc.M009795200; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Lewandowski K, 1999, J CLIN ENDOCR METAB, V84, P300, DOI 10.1210/jc.84.1.300; Li C, 1998, J BIOL CHEM, V273, P10078, DOI 10.1074/jbc.273.16.10078; Licinio J, 2004, P NATL ACAD SCI USA, V101, P4531, DOI 10.1073/pnas.0308767101; Liu CL, 1997, ENDOCRINOLOGY, V138, P3548, DOI 10.1210/en.138.8.3548; Maamra M, 2001, ENDOCRINOLOGY, V142, P4389, DOI 10.1210/en.142.10.4389; Matsuda J, 1998, JPN J CANCER RES, V89, P150, DOI 10.1111/j.1349-7006.1998.tb00543.x; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ogier V, 2002, INT J OBESITY, V26, P496, DOI 10.1038/sj.ijo.0801951; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Shimizu H, 2002, NUTRITION, V18, P309, DOI 10.1016/S0899-9007(01)00787-0; Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913; Stuart JA, 2001, J BIOL CHEM, V276, P18633, DOI 10.1074/jbc.M011566200; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tu H, 2008, J CELL PHYSIOL, V214, P301, DOI 10.1002/jcp.21195; Tu H, 2007, J CELL PHYSIOL, V212, P215, DOI 10.1002/jcp.21020; Yoshimoto T, 1998, J IMMUNOL, V160, P588; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZHAO X, 1992, J BIOCHEM-TOKYO, V111, P736, DOI 10.1093/oxfordjournals.jbchem.a123828	38	39	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11669	10.1371/journal.pone.0011669	http://dx.doi.org/10.1371/journal.pone.0011669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652026	Green Submitted, gold, Green Published			2022-12-27	WOS:000280109700004
J	Haase, T; Haase, N; Kraehling, JR; Behrends, S				Haase, Tobias; Haase, Nadine; Kraehling, Jan Robert; Behrends, Soenke			Fluorescent Fusion Proteins of Soluble Guanylyl Cyclase Indicate Proximity of the Heme Nitric Oxide Domain and Catalytic Domain	PLOS ONE			English	Article							ENERGY-TRANSFER MICROSCOPY; CRYSTAL-STRUCTURE; SIGNALING PROTEINS; BETA-1 SUBUNIT; LIVING CELLS; IN-VIVO; DIMERIZATION; EXPRESSION; BINDING; HELIX	Background: To examine the structural organisation of heterodimeric soluble guanylyl cyclase (sGC) Forster resonance energy transfer (FRET) was measured between fluorescent proteins fused to the amino-and carboxy-terminal ends of the sGC beta(1) and alpha subunits. Methodology/Principal Findings: Cyan fluorescent protein (CFP) was used as FRET donor and yellow fluorescent protein (YFP) as FRET acceptor. After generation of recombinant baculovirus, fluorescent-tagged sGC subunits were co-expressed in Sf9 cells. Fluorescent variants of sGC were analyzed in vitro in cytosolic fractions by sensitized emission FRET. Co-expression of the amino-terminally tagged alpha subunits with the carboxy-terminally tagged beta(1) subunit resulted in an enzyme complex that showed a FRET efficiency of 10% similar to fluorescent proteins separated by a helix of only 48 amino acids. Because these findings indicated that the amino-terminus of the alpha subunits is close to the carboxy-terminus of the beta(1) subunit we constructed fusion proteins where both subunits are connected by a fluorescent protein. The resulting constructs were not only fluorescent, they also showed preserved enzyme activity and regulation by NO. Conclusions/Significance: Based on the ability of an amino-terminal fragment of the beta(1) subunit to inhibit activity of an heterodimer consisting only of the catalytic domains (alpha(cat)beta(cat)), Winger and Marletta (Biochemistry 2005, 44: 4083-90) have proposed a direct interaction of the amino-terminal region of beta(1) with the catalytic domains. In support of such a concept of "trans'' regulation of sGC activity by the H-NOX domains our results indicate that the domains within sGC are organized in a way that allows for direct interaction of the amino-terminal regulatory domains with the carboxy-terminal catalytic region. In addition, we constructed "fluorescent-conjoined'' sGC's by fusion of the alpha amino-terminus to the beta(1) carboxy-terminus leading to a monomeric, fluorescent and functional enzyme complex. To our knowledge this represents the first example where a fluorescent protein links two different subunits of a higher ordered complex to yield a stoichometrically fixed functionally active monomer.	[Haase, Tobias; Haase, Nadine; Kraehling, Jan Robert; Behrends, Soenke] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmakol Toxikol & Klin Pharm, Braunschweig, Germany	Braunschweig University of Technology	Haase, T (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmakol Toxikol & Klin Pharm, Braunschweig, Germany.	s.behrends@tu-braunschweig.de	Haase, Tobias/A-4297-2010; Behrends, Sönke/A-2551-2010	Behrends, Sönke/0000-0002-9068-0729; Kraehling, Jan R./0000-0002-0979-2900; Haase, Tobias/0000-0002-7220-602X; Haase, Nadine/0000-0003-0727-1738	VolkswagenStiftung; Deutsche Forschungsgemeinschaft [INST 188/286-1]	VolkswagenStiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the VolkswagenStiftung and the Deutsche Forschungsgemeinschaft (INST 188/286-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-25; Bamberger AM, 2001, J CLIN ENDOCR METAB, V86, P909, DOI 10.1210/jc.86.2.909; Boon EM, 2006, J BIOL CHEM, V281, P21892, DOI 10.1074/jbc.M600557200; Efendiev R, 2006, FEBS LETT, V580, P5067, DOI 10.1016/j.febslet.2006.08.035; Elangovan M, 2003, METHODS, V29, P58, DOI 10.1016/S1046-2023(02)00283-9; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; HAASE N, BEHRENDS S DIR UNPUB; Iyer LM, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-5; Karow DS, 2004, BIOCHEMISTRY-US, V43, P10203, DOI 10.1021/bi049374l; Kerppola TK, 2006, NAT METHODS, V3, P969, DOI 10.1038/nmeth1206-969; Koglin M, 2003, J BIOL CHEM, V278, P12590, DOI 10.1074/jbc.M212740200; Koglin M, 2002, BIOCHEM BIOPH RES CO, V292, P1057, DOI 10.1006/bbrc.2002.6764; Kolossov VL, 2008, EXP BIOL MED, V233, P238, DOI 10.3181/0707-RM-192; Lee YC, 2000, P NATL ACAD SCI USA, V97, P10763, DOI 10.1073/pnas.190333697; Lembo A, 2010, GASTROENTEROLOGY, V138, pS53, DOI 10.1053/j.gastro.2009.12.050; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; Ma XL, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-2; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Rothkegel C, 2007, MOL PHARMACOL, V72, P1181, DOI 10.1124/mol.107.036368; Schmidt H.H., 2009, HDB EXP PHARM, V191, pv; Schmidt Harald H. H. W., 2009, V191, P309, DOI 10.1007/978-3-540-68964-5_14; Schultz G., 1984, METHOD ENZYMAT AN, P379; Shiga T, 2005, ZOOL SCI, V22, P735, DOI 10.2108/zsj.22.735; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; WEDEL B, 1994, P NATL ACAD SCI USA, V91, P2592, DOI 10.1073/pnas.91.7.2592; Winger JA, 2005, BIOCHEMISTRY-US, V44, P4083, DOI 10.1021/bi047601d; Winger JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-42; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zabel U, 1999, J BIOL CHEM, V274, P18149, DOI 10.1074/jbc.274.26.18149; Zhao Y, 1997, BIOCHEMISTRY-US, V36, P15959, DOI 10.1021/bi971825x; Zhao Y, 1998, BIOCHEMISTRY-US, V37, P4502, DOI 10.1021/bi972686m	41	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11617	10.1371/journal.pone.0011617	http://dx.doi.org/10.1371/journal.pone.0011617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657650	gold, Green Submitted, Green Published			2022-12-27	WOS:000279924500016
J	Rohwer, S; Wang, LK				Rohwer, Sievert; Wang, Luan-Keng			A Quantitative Analysis of Flight Feather Replacement in the Moustached Tree Swift Hemiprocne mystacea, a Tropical Aerial Forager	PLOS ONE			English	Article							LIFE-HISTORY IMPLICATIONS; PRIMARY MOLT; PATTERNS; PTILOCHRONOLOGY; PERFORMANCE; BIRDS	The functional life span of feathers is always much less than the potential life span of birds, so feathers must be renewed regularly. But feather renewal entails important energetic, time and performance costs that must be integrated into the annual cycle. Across species the time required to replace flight feather increases disproportionately with body size, resulting in complex, multiple waves of feather replacement in the primaries of many large birds. We describe the rules of flight feather replacement for Hemiprocne mystacea, a small, 60g tree swift from the New Guinea region. This species breeds and molts in all months of the year, and flight feather molt occurs during breeding in some individuals. H. mystacea is one to be the smallest species for which stepwise replacement of the primaries and secondaries has been documented; yet, primary replacement is extremely slow in this aerial forager, requiring more than 300 days if molt is not interrupted. We used growth bands to show that primaries grow at an average rate of 2.86 mm/d. The 10 primaries are a single molt series, while the 11 secondaries and five rectrices are each broken into two molt series. In large birds stepwise replacement of the primaries serves to increase the rate of primary replacement while minimizing gaps in the wing. But stepwise replacement of the wing quills in H. mystacea proceeds so slowly that it may be a consequence of the ontogeny of stepwise molting, rather than an adaptation, because the average number of growing primaries is probably lower than 1.14 feathers per wing.	[Rohwer, Sievert] Univ Washington, Burke Museum, Seattle, WA 98195 USA; Univ Washington, Dept Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rohwer, S (corresponding author), Univ Washington, Burke Museum, Seattle, WA 98195 USA.	rohwer@u.washington.edu			Hugh Ferguson; Burke Endowment; AMNH; Lady McNeice; Loke Cheng Kim Foundation; Burke Museum	Hugh Ferguson; Burke Endowment; AMNH; Lady McNeice; Loke Cheng Kim Foundation; Burke Museum	Burke expeditions to the Solomon Islands were supported by Hugh Ferguson and the Burke Endowment for Ornithology. LKW was awarded a study grant from the AMNH, and was supported by Lady McNeice, the Loke Cheng Kim Foundation, and by Eddy Fellowships from the Burke Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHMOLE NP, 1968, CONDOR, V70, P35, DOI 10.2307/1366507; Bridge Eli S., 2006, Marine Ornithology, V34, P7; BRODIN A, 1993, ORNIS SCAND, V24, P167, DOI 10.2307/3676732; Chai P, 1997, J EXP BIOL, V200, P1527; EDELSTAM C, 1984, ANN ZOOL FENN, V21, P271; Edwards AE, 2005, CONDOR, V107, P835, DOI 10.1650/7533.1; Filardi CE, 2001, CONDOR, V103, P555, DOI 10.1650/0010-5422(2001)103[0555:LHIOCA]2.0.CO;2; Forshaw J. M., 1977, PARROTS WORLD, Vsecond; Ginn H. B., 1983, MOULT BIRDS BTO GUID; Jenni L., 1994, BIOL MOULT BIRDS; LANGSTON NE, 1995, CONDOR, V97, P1, DOI 10.2307/1368978; Langston NE, 1996, OIKOS, V76, P498, DOI 10.2307/3546343; Lind J, 2001, FUNCT ECOL, V15, P29; LINDSTROM A, 1993, PHYSIOL ZOOL, V66, P490, DOI 10.1086/physzool.66.4.30163805; MICHENER HAROLD, 1938, CONDOR, V40, P149, DOI 10.2307/1363421; MILLER ALDEN H., 1941, CONDOR, V43, P113, DOI 10.2307/1364415; MURPHY ME, 1991, AUK, V108, P695, DOI 10.2307/4088109; MURPHY ME, 1995, COMP BIOCHEM PHYS A, V111, P385, DOI 10.1016/0300-9629(95)00039-A; POTTS GR, 1971, IBIS, V113, P298, DOI 10.1111/j.1474-919X.1971.tb05159.x; Pyle P, 2005, CONDOR, V107, P823, DOI 10.1650/7598.1; RASMUSSEN PC, 1988, CONDOR, V90, P220, DOI 10.2307/1368451; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Rohwer S, 2008, CONDOR, V110, P799, DOI 10.1525/cond.2008.8320; Rohwer VG, 2009, ORNITOL NEOTROP, V20, P565; Shugart GW, 1996, CONDOR, V98, P222, DOI 10.2307/1369140; Slagsvold T, 1996, ECOLOGY, V77, P461, DOI 10.2307/2265622; STRESEMANN ERWIN, 1966, J ORNITHOL, V107, P1; Stresemann V., 1960, Journal fuer Ornithologie, V101, P373, DOI 10.1007/BF01671228; Swaddle JP, 1996, J AVIAN BIOL, V27, P103, DOI 10.2307/3677139; TUCKER VA, 1991, AUK, V108, P108; WOOD HAROLD B., 1950, AUK, V67, P486; Yuri T, 1997, AUK, V114, P249, DOI 10.2307/4089166; [No title captured]	33	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11586	10.1371/journal.pone.0011586	http://dx.doi.org/10.1371/journal.pone.0011586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644642	gold, Green Published, Green Submitted			2022-12-27	WOS:000279884900022
J	Balasubramanian, S; Mani, SK; Kasiganesan, H; Baicu, CC; Kuppuswamy, D				Balasubramanian, Sundaravadivel; Mani, Santhosh K.; Kasiganesan, Harinath; Baicu, Catalin C.; Kuppuswamy, Dhandapani			Hypertrophic Stimulation Increases beta-actin Dynamics in Adult Feline Cardiomyocytes	PLOS ONE			English	Article							OVERLOAD CARDIAC-HYPERTROPHY; CYTOPLASMIC GAMMA-ACTIN; FOCAL COMPLEX-FORMATION; PRESSURE-OVERLOAD; C-SRC; INTEGRIN; EXPRESSION; MUSCLE; ACTIVATION; ADHESION	The myocardium responds to hemodynamic stress through cellular growth and organ hypertrophy. The impact of cytoskeletal elements on this process, however, is not fully understood. While alpha-actin in cardiomyocytes governs muscle contraction in combination with the myosin motor, the exact role of beta-actin has not been established. We hypothesized that in adult cardiomyocytes, as in non-myocytes, beta-actin can facilitate cytoskeletal rearrangement within cytoskeletal structures such as Z-discs. Using a feline right ventricular pressure overload (RVPO) model, we measured the level and distribution of beta-actin in normal and pressure overloaded myocardium. Resulting data demonstrated enriched levels of beta-actin and enhanced translocation to the Triton-insoluble cytoskeletal and membrane skeletal complexes. In addition, RVPO in vivo and in vitro hypertrophic stimulation with endothelin (ET) or insulin in isolated adult cardiomyocytes enhanced the content of polymerized fraction (F-actin) of beta-actin. To determine the localization and dynamics of beta-actin, we adenovirally expressed GFP-tagged beta-actin in isolated adult cardiomyocytes. The ectopically expressed beta-actin-GFP localized to the Z-discs, costameres, and cell termini. Fluorescence recovery after photobleaching (FRAP) measurements of beta-actin dynamics revealed that beta-actin at the Z-discs is constantly being exchanged with beta-actin from cytoplasmic pools and that this exchange is faster upon hypertrophic stimulation with ET or insulin. In addition, in electrically stimulated isolated adult cardiomyocytes, while beta-actin overexpression improved cardiomyocyte contractility, immunoneutralization of beta-actin resulted in a reduced contractility suggesting that beta-actin could be important for the contractile function of adult cardiomyocytes. These studies demonstrate the presence and dynamics of beta-actin in the adult cardiomyocyte and reinforce its usefulness in measuring cardiac cytoskeletal rearrangement during hypertrophic stimulation.	[Balasubramanian, Sundaravadivel; Mani, Santhosh K.; Kasiganesan, Harinath; Baicu, Catalin C.; Kuppuswamy, Dhandapani] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Kuppuswamy, Dhandapani] Vet Affairs Med Ctr, Ralph H Johnson Dept, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Balasubramanian, S (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA.	balasubr@musc.edu			National Institutes of Health (NIH) [RHL092124A]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092124] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institutes of Health (NIH) grant RHL092124A (to D.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2003, J BIOL CHEM, V278, P42214, DOI 10.1074/jbc.M303428200; Balasubramanian S, 2006, J MOL CELL CARDIOL, V41, P669, DOI 10.1016/j.yjmcc.2006.04.022; Balasubramanian Sundaravadivel, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P52; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; Brancaccio M, 2006, CARDIOVASC RES, V70, P422, DOI 10.1016/j.cardiores.2005.12.015; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Carson JA, 2000, J APPL PHYSIOL, V88, P337, DOI 10.1152/jappl.2000.88.1.337; CHERNIN MI, 1990, CLIN EXP HYPERTENS A, V12, P617, DOI 10.3109/10641969009073488; COOPER G, 1974, J APPL PHYSIOL, V37, P762, DOI 10.1152/jappl.1974.37.5.762; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Hanft LM, 2007, NEUROMUSCULAR DISORD, V17, P569, DOI 10.1016/j.nmd.2007.03.004; Harborth J, 2001, J CELL SCI, V114, P4557; HILENSKI LL, 1991, CELL TISSUE RES, V264, P577, DOI 10.1007/BF00319047; Hsueh WA, 1998, HYPERTENSION, V31, P176, DOI 10.1161/01.HYP.31.1.176; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kaneda Y, 2002, MOL THER, V6, P219, DOI 10.1006/mthe.2002.0647; Kee AJ, 2009, J MUSCLE RES CELL M, V30, P187, DOI 10.1007/s10974-009-9193-x; Khaitlina SY, 2001, INT REV CYTOL, V202, P35, DOI 10.1016/S0074-7696(01)02003-4; Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23; Kuppuswamy D, 1997, J BIOL CHEM, V272, P4500, DOI 10.1074/jbc.272.7.4500; Laser M, 2000, J BIOL CHEM, V275, P35624, DOI 10.1074/jbc.M006124200; Liew CC, 2004, NAT REV GENET, V5, P811, DOI 10.1038/nrg1470; Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517; MANN DL, 1989, CIRC RES, V64, P1079, DOI 10.1161/01.RES.64.6.1079; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Nagai T, 1999, AM J CARDIOL, V83, p38H; Rao JY, 2004, CURR CANCER DRUG TAR, V4, P345, DOI 10.2174/1568009043332998; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Renley BA, 1998, CELL MOTIL CYTOSKEL, V41, P264, DOI 10.1002/(SICI)1097-0169(1998)41:3<264::AID-CM7>3.3.CO;2-Q; RHEE D, 1994, CELL MOTIL CYTOSKEL, V28, P1, DOI 10.1002/cm.970280102; Rybakova IN, 2000, J CELL BIOL, V150, P1209, DOI 10.1083/jcb.150.5.1209; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Satoh M, 2006, P NATL ACAD SCI USA, V103, P7432, DOI 10.1073/pnas.0510444103; Shimada Y, 1997, CELL STRUCT FUNCT, V22, P59, DOI 10.1247/csf.22.59; SIMPSON DG, 1993, J CELL BIOL, V123, P323, DOI 10.1083/jcb.123.2.323; Skwarek-Maruszewska A, 2009, J CELL SCI, V122, P2119, DOI 10.1242/jcs.046805; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Stilli D, 2006, EXP PHYSIOL, V91, P571, DOI 10.1113/expphysiol.2005.032607; Sussman MA, 2000, J CLIN INVEST, V105, P875, DOI 10.1172/JCI8497; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; TERRACIO L, 1991, CIRC RES, V68, P734, DOI 10.1161/01.RES.68.3.734; Tuxworth WJ, 2008, BASIC RES CARDIOL, V103, P41, DOI 10.1007/s00395-007-0682-z; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; vonArx P, 1995, J CELL BIOL, V131, P1759, DOI 10.1083/jcb.131.6.1759; Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063; Willey CD, 2003, J MOL CELL CARDIOL, V35, P671, DOI 10.1016/S0022-2828(03)00112-3; Wu X, 2010, AM J PHYSIOL-HEART C, V298, pH2071, DOI 10.1152/ajpheart.01156.2009; Xu L, 2006, J BIOL CHEM, V281, P34430, DOI 10.1074/jbc.M607446200; Yu JG, 2005, J HISTOCHEM CYTOCHEM, V53, P839, DOI 10.1369/jhc.4A6608.2005	50	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11470	10.1371/journal.pone.0011470	http://dx.doi.org/10.1371/journal.pone.0011470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635003	Green Submitted, Green Published, gold			2022-12-27	WOS:000279781600003
J	Hong, SL; Beck, MR				Hong, S. Lee; Beck, Melissa R.			Uncertainty Compensation in Human Attention: Evidence from Response Times and Fixation Durations	PLOS ONE			English	Article							VISUAL INFORMATION; ORIENTING ATTENTION; VARIABILITY; COMPONENTS; MODULATION; GAIN	Background: Uncertainty and predictability have remained at the center of the study of human attention. Yet, studies have only examined whether response times (RT) or fixations were longer or shorter under levels of stimulus uncertainty. To date, no study has examined patterns of stimuli and responses through a unifying framework of uncertainty. Methodology/Principal Findings: We asked 29 college students to generate repeated responses to a continuous series of visual stimuli presented on a computer monitor. Subjects produced these responses by pressing on a keypad as soon a target was detected (regardless of position) while the durations of their visual fixations were recorded. We manipulated the level of stimulus uncertainty in space and time by changing the number of potential stimulus locations and time intervals between stimulus presentations. To allow the analyses to be conducted using uncertainty as common description of stimulus and response we calculated the entropy of the RT and fixation durations. We tested the hypothesis of uncertainty compensation across space and time by fitting the RT and fixation duration entropy values to a quadratic surface. The quadratic surface accounted for 80% of the variance in the entropy values of both RT and fixation durations. RT entropy increased as a function of spatial and temporal uncertainty of the stimulus, alongside a symmetric, compensatory decrease in the entropy of fixation durations as the level of spatial and temporal uncertainty of the stimuli was increased. Conclusions/Significance: Our results demonstrate that greater uncertainty in the stimulus leads to greater uncertainty in the response, and that the effects of spatial and temporal uncertainties are compensatory. We also observed compensatory relationship across the entropies of fixation duration and RT, suggesting that a more predictable visual search strategy leads to more uncertain response patterns and vice versa.	[Hong, S. Lee] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Beck, Melissa R.] Louisiana State Univ, Dept Psychol, Baton Rouge, LA 70803 USA	Indiana University System; Indiana University Bloomington; Louisiana State University System; Louisiana State University	Hong, SL (corresponding author), Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA.	slhong@indiana.edu	Hong, S./B-2390-2008; Beck, Melissa/F-4811-2010	Hong, S./0000-0001-6044-2482; 	Louisiana State University Faculty	Louisiana State University Faculty	This work was supported by a 2008-2009 Louisiana State University Faculty Research Grant awarded to Drs. Advokat, Beck, Gouvier, Ikuma, and Wolenski. http://www.research.lsu.edu/frg_ext.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aks D.J., 2002, NONLINEAR DYNAMICS P, V6, P1, DOI 10.1023/A:1012222601935; Ash R.B., 1965, INFORM THEORY; Boot WR, 2006, HUM FACTORS, V48, P759, DOI 10.1518/001872006779166424; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Coull JT, 1998, J NEUROSCI, V18, P7426; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DONDERS FC, 1969, ACTA PSYCHOL, V30, P412, DOI 10.1016/0001-6918(69)90065-1; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Fitts PM., 1967, HUM PERFORM; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Griffin IC, 2002, NEUROPSYCHOLOGIA, V40, P2325, DOI 10.1016/S0028-3932(02)00087-8; Griffin IC, 2001, FRONT BIOSCI-LANDMRK, V6, pD660, DOI 10.2741/Griffin; Hancock P.A., 1985, MOTOR BEHAV PROGRAMM, P153, DOI [10.1007/978-3-642-69749-4_5, DOI 10.1007/978-3-642-69749-4_5]; HEATHCOTE A, 1991, PSYCHOL BULL, V109, P340, DOI 10.1037/0033-2909.109.2.340; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hong SL, 2008, PERCEPT PSYCHOPHYS, V70, P306, DOI 10.3758/PP.70.2.306; Hong S Lee, 2008, Nonlinear Dynamics Psychol Life Sci, V12, P163; Hong SL, 2008, EXP BRAIN RES, V189, P61, DOI 10.1007/s00221-008-1403-z; Hong SL, 2008, CHAOS, V18, DOI 10.1063/1.2979695; Hong SL, 2008, CHAOS, V18, DOI 10.1063/1.2838854; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; JUOLA JF, 1991, J EXP PSYCHOL HUMAN, V17, P125, DOI 10.1037/0096-1523.17.1.125; KLEMMER ET, 1957, J EXP PSYCHOL, V54, P195, DOI 10.1037/h0046227; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Mandell AJ, 1997, CHAOS, V7, P67, DOI 10.1063/1.166241; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Neuringer A, 2004, AM PSYCHOL, V59, P891, DOI 10.1037/0003-066X.59.9.891; Newell K. M., 2005, COGNITIVE PROCESSING, V6, P37, DOI [10.1007/s10339-004-0047-6, DOI 10.1007/S10339-004-0047-6]; Newell KM, 2009, HUM MOVEMENT SCI, V28, P655, DOI 10.1016/j.humov.2009.07.001; Nobre AC, 2001, NEUROPSYCHOLOGIA, V39, P1317; Peterson MS, 2004, PERCEPT PSYCHOPHYS, V66, P398, DOI 10.3758/BF03194888; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Slifkin AB, 2000, J NEUROPHYSIOL, V84, P1708, DOI 10.1152/jn.2000.84.4.1708; Sosnoff JJ, 2006, NEUROSCI LETT, V392, P165, DOI 10.1016/j.neulet.2005.09.010; Sosnoff JJ, 2005, EXP BRAIN RES, V167, P76, DOI 10.1007/s00221-005-0009-y; Sosnoff JJ, 2005, PERCEPT PSYCHOPHYS, V67, P335, DOI 10.3758/BF03206496; STERNBERG S, 1969, AM SCI, V57, P421; Van Orden GC, 2005, J EXP PSYCHOL GEN, V134, P117, DOI 10.1037/0096-3445.134.1.117	43	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11461	10.1371/journal.pone.0011461	http://dx.doi.org/10.1371/journal.pone.0011461			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621OQ	20628640	gold, Green Published, Green Submitted			2022-12-27	WOS:000279589300009
J	Kranjec, A; Lehet, M; Bromberger, B; Chatterjee, A				Kranjec, Alexander; Lehet, Matthew; Bromberger, Bianca; Chatterjee, Anjan			A Sinister Bias for Calling Fouls in Soccer	PLOS ONE			English	Article								Distinguishing between a fair and unfair tackle in soccer can be difficult. For referees, choosing to call a foul often requires a decision despite some level of ambiguity. We were interested in whether a well documented perceptual-motor bias associated with reading direction influenced foul judgments. Prior studies have shown that readers of left-to-right languages tend to think of prototypical events as unfolding concordantly, from left-to-right in space. It follows that events moving from right-to-left should be perceived as atypical and relatively debased. In an experiment using a go/no-go task and photographs taken from real games, participants made more foul calls for pictures depicting left-moving events compared to pictures depicting right-moving events. These data suggest that two referees watching the same play from distinct vantage points may be differentially predisposed to call a foul.	[Kranjec, Alexander] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Ctr Cognit Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Kranjec, A (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	akranjec@mail.med.upenn.edu			NIH [RO1 HD050199, RO1 DC008779]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008779] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The study was supported by NIH grants RO1 HD050199 and RO1 DC008779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHATTERJEE A, 1995, NEUROPSYCHOLOGIA, V33, P643, DOI 10.1016/0028-3932(94)00134-B; Chatterjee A, 2001, TRENDS COGN SCI, V5, P55, DOI 10.1016/S1364-6613(00)01598-9; Coppola Francis Ford, 1979, APOCALYPSE NOW; Dobel C, 2007, PSYCHOL SCI, V18, P487, DOI 10.1111/j.1467-9280.2007.01926.x; *FIFA, 2001, OFF LAWS GAM; Foer F., 2004, SOCCER EXPLAINS WORL; Hagemann N, 2008, PSYCHOL SCI, V19, P769, DOI 10.1111/j.1467-9280.2008.02155.x; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Maass A, 2003, PSYCHOL SCI, V14, P296, DOI 10.1111/1467-9280.14421; Maass A, 2007, SOC COGNITION, V25, P833, DOI 10.1521/soco.2007.25.6.833; TVERSKY B, 1991, COGNITIVE PSYCHOL, V23, P515, DOI 10.1016/0010-0285(91)90005-9; Van Sijll J., 2005, CINEMATIC STORYTELLI; Winawer J, 2008, PSYCHOL SCI, V19, P276, DOI 10.1111/j.1467-9280.2008.02080.x	13	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11667	10.1371/journal.pone.0011667	http://dx.doi.org/10.1371/journal.pone.0011667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621OQ	20628648	Green Published, Green Submitted, gold			2022-12-27	WOS:000279589300014
J	Hwang, J; Graves, PM; Jima, D; Reithinger, R; Kachur, SP				Hwang, Jimee; Graves, Patricia M.; Jima, Daddi; Reithinger, Richard; Kachur, S. Patrick		Ethiopia MIS Working Grp	Knowledge of Malaria and Its Association with Malaria-Related Behaviors-Results from the Malaria Indicator Survey, Ethiopia, 2007	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; CHILDHOOD FEBRILE ILLNESSES; RANDOMIZED CONTROLLED-TRIAL; PREGNANT-WOMEN; BED NETS; TREATMENT SEEKING; RURAL ETHIOPIA; WESTERN KENYA; CHILDREN; OWNERSHIP	Background: In 2005, the Ministry of Health in Ethiopia launched a major effort to distribute over 20 million long-lasting insecticidal nets, provide universal access to artemisinin-based combination therapy (ACTs), and train 30,000 village-based health extension workers. Methods and Findings: A cross-sectional, nationally representative Malaria Indicator Survey was conducted during the malaria transmission season in 2007. Multivariate logistic regression analyses were performed to assess the effect of women's malaria knowledge on household ITN ownership and women's ITN use. In addition, we investigated the effect of mothers' malaria knowledge on their children under 5 years of age's (U5) ITN use and their access to fever treatment on behalf of their child U5. Malaria knowledge was based on a composite index about the causes, symptoms, danger signs and prevention of malaria. Approximately 67% of women (n = 5,949) and mothers of children U5 (n = 3,447) reported some knowledge of malaria. Women's knowledge of malaria was significantly associated with household ITN ownership (adjusted Odds Ratio [aOR] = 2.1; 95% confidence interval [CI] 1.6-2.7) and with increased ITN use for themselves (aOR = 1.8; 95% CI 1.3-2.5). Knowledge of malaria amongst mothers of children U5 was associated with ITN use for their children U5 (aOR = 1.6; 95% CI 1.1-2.4), but not significantly associated with their children U5 seeking care for a fever. School attendance was a significant factor in women's ITN use (aOR = 2.0; 95% CI 1.1-3.9), their children U5's ITN use (aOR = 4.4; 95% CI 1.6-12.1), and their children U5 having sought treatment for a fever (aOR = 6.5; 95% CI 1.9-22.9). Conclusions: Along with mass free distribution of ITNs and universal access to ACTs, delivery of targeted malaria educational information to women could improve ITN ownership and use. Efforts to control malaria could be influenced by progress towards broader goals of improving access to education, especially for women.	[Hwang, Jimee; Kachur, S. Patrick] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Hwang, Jimee] UCSF Global Hlth Sci, Global Hlth Grp, San Francisco, CA USA; [Graves, Patricia M.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Jima, Daddi] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia; [Reithinger, Richard] US Agcy Int Dev, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco; Emory University; Ethiopian Health & Nutrition Research Institute; United States Agency for International Development (USAID)	Hwang, J (corresponding author), US Ctr Dis Control & Prevent, Atlanta, GA USA.	jhwang@cdc.gov	Kachur, Patrick/ABE-7220-2021; Graves, Patricia M/J-8691-2014	Graves, Patricia M/0000-0002-5215-3901; Ngondi, Jeremiah/0000-0003-4357-4816	United States Agency for International Development; Carter Center; Malaria Control and Evaluation Partnership in Africa (MACEPA) at PATH	United States Agency for International Development(United States Agency for International Development (USAID)); Carter Center; Malaria Control and Evaluation Partnership in Africa (MACEPA) at PATH	The Ethiopian Federal Ministry of Health received funding for this national survey from the United States Agency for International Development, The Carter Center, and The Malaria Control and Evaluation Partnership in Africa (MACEPA) at PATH. Although the above funding partners provided technical assistance in the study design, data collection and analysis and preparation of the manuscript, all decisions to publish were made by the Ministry of Health. Centers for Disease Control and Prevention also provided technical assistance in the study design, data collection and analysis, and preparation of the manuscript, but did not provide funding for this evaluation. The opinions expressed in this paper are those of the authors and may not reflect the position of their employing organizations nor of the sources of funding.	Alaii JA, 2003, AM J TROP MED HYG, V68, P128, DOI 10.4269/ajtmh.2003.68.128; Alaii JA, 2003, AM J TROP MED HYG, V68, P137, DOI 10.4269/ajtmh.2003.68.137; [Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], GLOB MAL ACT PLAN; Belay M, 2008, TROP MED INT HEALTH, V13, P1303, DOI 10.1111/j.1365-3156.2008.02159.x; *CENTR STAT AG MAC, 2006, ETH DEM HLTH SURV 20; Chirdan OO, 2008, ANN AFR MED, V7, P112, DOI 10.4103/1596-3519.55667; De La Cruz N, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-61; Deressa W, 2003, B WORLD HEALTH ORGAN, V81, P261; DERESSA W, 2007, MALAR J, V6; Deressa W, 2007, T ROY SOC TROP MED H, V101, P939, DOI 10.1016/j.trstmh.2007.04.018; Deressa W, 2007, ACTA TROP, V102, P1, DOI 10.1016/j.actatropica.2007.02.009; Deribew A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-121; Eisele TP, 2009, AM J TROP MED HYG, V80, P209, DOI 10.4269/ajtmh.2009.80.209; Eng JLV, 2007, AM J TROP MED HYG, V77, P393, DOI 10.4269/ajtmh.2007.77.393; *ETH FED MIN HLTH, 2006, NAT 5 YEAR STRAT PLA; *ETH FED MIN HLTH, 2008, ETH NAT MAL IND SURV; *ETH FED MIN HLTH, 2008, HLTH HLTH REL IND RE; *ETH MIN HLTH FED, 2009, NAT STRAT PLAN MAL P; Fernando SD, 2008, T ROY SOC TROP MED H, V102, P1081, DOI 10.1016/j.trstmh.2008.06.007; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; *GOV REP ZAMB MIN, 2009, ZAMB NAT MAL IND SUR; Graves PM, 2009, T ROY SOC TROP MED H, V103, P1211, DOI 10.1016/j.trstmh.2008.11.016; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jima D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-58; Kazembe LN, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-40; Kleinbaum D. G., 2005, LOGISTIC REGRESSION; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; KYAWT SK, 2004, AM J TROP MED PUBLIC, V35, P53; LYNCH C, 2006, KABP SURVEY ITN UTIL; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; McCombie SC, 1996, SOC SCI MED, V43, P933, DOI 10.1016/0277-9536(95)00446-7; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; NOOR A, 2009, DJIB NAT MAL IND SUR; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-5; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Pettifor A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-331; *PRES MAL IN, 2010, LANT HYD US GOV MAL; Rhee M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-35; Romaniuk J., 2006, J TARGETING MEASUREM, V15, P3; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Shargie EB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-321; SLUTSKER L, 1994, TROP MED PARASITOL, V45, P61; Thwing J, 2008, TROP MED INT HEALTH, V13, P827, DOI 10.1111/j.1365-3156.2008.02070.x; *UN SECR GEN BAN K, 2008, SECR GEN ANN ROLL BA; Waller J, 2004, BRIT J PSYCHOL, V95, P219, DOI 10.1348/000712604773952430; Wiseman V, 2007, AM J TROP MED HYG, V76, P830, DOI 10.4269/ajtmh.2007.76.830; YENENEH H, 1993, B WORLD HEALTH ORGAN, V71, P763	50	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11692	10.1371/journal.pone.0011692	http://dx.doi.org/10.1371/journal.pone.0011692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657782	Green Published, Green Accepted, gold			2022-12-27	WOS:000280197500030
J	Eronen, VP; Linden, RO; Lindroos, A; Kanerva, M; Aittokallio, T				Eronen, Ville-Pekka; Linden, Rolf O.; Lindroos, Anna; Kanerva, Mirella; Aittokallio, Tero			Genome-Wide Scoring of Positive and Negative Epistasis through Decomposition of Quantitative Genetic Interaction Fitness Matrices	PLOS ONE			English	Article							SYNTHETIC-LETHALITY ANALYSIS; INTERACTION NETWORKS; BUDDING YEAST; PATHWAY; ORGANIZATION; DATABASE; SPINDLE; COMPLEX; BIOLOGY; ACTIN	Recent technological developments in genetic screening approaches have offered the means to start exploring quantitative genotype-phenotype relationships on a large-scale. What remains unclear is the extent to which the quantitative genetic interaction datasets can distinguish the broad spectrum of interaction classes, as compared to existing information on mutation pairs associated with both positive and negative interactions, and whether the scoring of varying degrees of such epistatic effects could be improved by computational means. To address these questions, we introduce here a computational approach for improving the quantitative discrimination power encoded in the genetic interaction screening data. Our matrix approximation model decomposes the original double-mutant fitness matrix into separate components, representing variability across the array and query mutants, which can be utilized for estimating and correcting the single-mutant fitness effects, respectively. When applied to three large-scale quantitative interaction datasets in yeast, we could improve the accuracy of scoring various interaction classes beyond that obtained with the original fitness data, especially in synthetic genetic array (SGA) and in genetic interaction mapping (GIM) datasets. In addition to the known pairs of interactions used in the evaluation of the computational approach, a number of novel interaction pairs were also predicted, along with underlying biological mechanisms, which remained undetected by the original datasets. It was shown that the optimal choice of the scoring function depends heavily on the screening approach and on the interaction class under analysis. Moreover, a simple preprocessing of the fitness matrix could further enhance the discrimination power of the epistatic miniarray profiling (E-MAP) dataset. These systematic evaluation results provide in-depth information on the optimal analysis of the future, large-scale screening experiments. In general, the modeling framework, enabling accurate identification and classification of genetic interactions, provides a solid basis for completing and mining the genetic interaction networks in yeast and other organisms.	[Eronen, Ville-Pekka; Linden, Rolf O.; Aittokallio, Tero] Univ Turku, Dept Math, Biomath Res Grp, SF-20500 Turku, Finland; [Linden, Rolf O.; Aittokallio, Tero] Univ Turku, Data Min & Modeling Grp, Turku Ctr Biotechnol, SF-20500 Turku, Finland; [Lindroos, Anna; Kanerva, Mirella] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland	University of Turku; University of Turku; University of Turku	Eronen, VP (corresponding author), Univ Turku, Dept Math, Biomath Res Grp, SF-20500 Turku, Finland.	tero.aittokallio@utu.fi	Aittokallio, Tero/B-6583-2009	Aittokallio, Tero/0000-0002-0886-9769	Academy of Finland [120569, 133227]	Academy of Finland(Academy of Finland)	This work was supported by the Academy of Finland (grants 120569 and 133227; http://www.aka.fi/en-gb/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Breker M, 2009, MOL BIOSYST, V5, P1473, DOI 10.1039/b907076c; Carter GW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000347; Casey FP, 2008, BIOINFORMATICS, V24, P2733, DOI 10.1093/bioinformatics/btn472; Chipman KC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-17; CLEVES AE, 1989, J CELL BIOL, V109, P2939, DOI 10.1083/jcb.109.6.2939; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Costanzo M, 2009, METHODS MOL BIOL, V548, P37, DOI 10.1007/978-1-59745-540-4_3; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Decourty L, 2008, P NATL ACAD SCI USA, V105, P5821, DOI 10.1073/pnas.0710533105; DELEEUW J, 2006, 2006041602 DEP STAT; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Dror O, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-69; Fawcett T., 2004, ROC GRAPHS NOTES PRA; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Golub G. H., 1989, MATRIX COMPUTATIONS; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Jarvinen AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003284; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Kahana JA, 1998, MOL BIOL CELL, V9, P1741, DOI 10.1091/mbc.9.7.1741; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Koh JLY, 2010, NUCLEIC ACIDS RES, V38, pD502, DOI 10.1093/nar/gkp820; Le Meur N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r135; Lehner B, 2007, J EXP BIOL, V210, P1559, DOI 10.1242/jeb.002311; Liu L, 2003, P NATL ACAD SCI USA, V100, P13167, DOI 10.1073/pnas.1733249100; Ma XT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001922; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Meluh Pamela B., 2008, V416, P221, DOI 10.1007/978-1-59745-321-9_15; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Paladugu SR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-426; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Pu SY, 2008, BIOINFORMATICS, V24, P2376, DOI 10.1093/bioinformatics/btn440; Qi Y, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-288; Qi Y, 2008, GENOME RES, V18, P1991, DOI 10.1101/gr.077693.108; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Smialowski P, 2010, NUCLEIC ACIDS RES, V38, pD540, DOI 10.1093/nar/gkp1026; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Thompson DA, 1999, GENETICS, V153, P621; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tukey JW, 1977, EXPLORATORY DATA ANA; Ulitsky I, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100144; Ulitsky I, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r140; Ulitsky I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.42; Wang XQ, 1996, NUCLEIC ACIDS RES, V24, P4791, DOI 10.1093/nar/24.23.4791; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Ye P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-270; Ye P, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100034; Zhai C, 2008, BIOCHEM J, V415, P455, DOI 10.1042/BJ20080209; Zhang Lan V, 2005, J Biol, V4, P6, DOI 10.1186/jbiol23	62	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11611	10.1371/journal.pone.0011611	http://dx.doi.org/10.1371/journal.pone.0011611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657656	Green Submitted, Green Published, gold			2022-12-27	WOS:000279924500013
J	Veeravalli, KK; Chetty, C; Ponnala, S; Gondi, CS; Lakka, SS; Fassett, D; Klopfenstein, JD; Dinh, DH; Gujrati, M; Rao, JS				Veeravalli, Krishna Kumar; Chetty, Chandramu; Ponnala, Shivani; Gondi, Christopher S.; Lakka, Sajani S.; Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Gujrati, Meena; Rao, Jasti S.			MMP-9, uPAR and Cathepsin B Silencing Downregulate Integrins in Human Glioma Xenograft Cells In Vitro and In Vivo in Nude Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; FOCAL ADHESION KINASE; HUMAN BRAIN-TUMORS; MATRIX METALLOPROTEINASES; UROKINASE RECEPTOR; GENE-EXPRESSION; GLIOBLASTOMA-MULTIFORME; EXTRACELLULAR-MATRIX; CYTOPLASMIC DOMAIN; ANTISENSE UPA	Background: Involvement of MMP-9, uPAR and cathepsin B in adhesion, migration, invasion, proliferation, metastasis and tumor growth has been well established. In the present study, MMP-9, uPAR and cathepsin B genes were downregulated in glioma xenograft cells using shRNA plasmid constructs and we evaluated the involvement of integrins and changes in their adhesion, migration and invasive potential. Methodology/Principal Findings: MMP-9, uPAR and cathepsin B single shRNA plasmid constructs were used to downregulate these molecules in xenograft cells. We also used MMP-9/uPAR and MMP-9/cathepsin B bicistronic constructs to evaluate the cumulative effects. MMP-9, uPAR and cathepsin B downregulation significantly inhibits xenograft cell adhesion to several extracellular matrix proteins. Treatment with MMP-9, uPAR and cathepsin B shRNA of xenografts led to the downregulation of several alpha and beta integrins. In all the assays, we noticed more prominent effects with the bicistronic plasmid constructs when compared to the single plasmid shRNA constructs. FACS analysis demonstrated the expression of alpha V beta 3, alpha 6 beta 1 and alpha 9 beta 1 integrins in xenograft cells. Treatment with bicistronic constructs reduced alpha V beta 3, alpha 6 beta 1 and alpha 9 beta 1 integrin expressions in xenograft injected nude mice. Migration and invasion were also inhibited by MMP-9, uPAR and cathepsin B shRNA treatments as assessed by spheroid migration, wound healing, and Matrigel invasion assays. As expected, bicistronic constructs further inhibited the adhesion, migration and invasive potential of the xenograft cells as compared to individual treatments. Conclusions/Significance: Downregulation of MMP-9, uPAR and cathespin B alone and in combination inhibits adhesion, migration and invasive potential of glioma xenografts by downregulating integrins and associated signaling molecules. Considering the existence of integrin inhibitor-resistant cancer cells, our study provides a novel and effective approach to inhibiting integrins by downregulating MMP-9, uPAR and cathepsin B in the treatment of glioma.	[Veeravalli, Krishna Kumar; Chetty, Chandramu; Ponnala, Shivani; Gondi, Christopher S.; Lakka, Sajani S.; Rao, Jasti S.] Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA; [Fassett, Daniel; Klopfenstein, Jeffrey D.; Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA; [Gujrati, Meena] Univ Illinois, Coll Med Peoria, Dept Pathol, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Veeravalli, KK (corresponding author), Univ Illinois, Coll Med, Dept Canc Biol & Pharmacol, Peoria, IL 61656 USA.	jsrao@uic.edu		Veeravalli, Krishna Kumar/0000-0002-2243-004X; Gondi, Christopher/0000-0002-3036-9920	National Institute of Neurological Disorders and Stroke (NINDS) [NS047699]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047699] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS NS047699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBELDA SM, 1990, FASEB J, V4, P2868, DOI 10.1096/fasebj.4.11.2199285; Bass R, 2005, J BIOL CHEM, V280, P14811, DOI 10.1074/jbc.M414189200; BERQUIN IM, 1995, GENE, V159, P143, DOI 10.1016/0378-1119(95)00072-E; Brown MC, 2008, NEURO-ONCOLOGY, V10, P968, DOI 10.1215/15228517-2008-047; Chaurasia P, 2006, J BIOL CHEM, V281, P14852, DOI 10.1074/jbc.M512311200; Crowe DL, 1999, HISTOL HISTOPATHOL, V14, P665, DOI 10.14670/HH-14.665; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345; Ghiso JAA, 2002, ONCOGENE, V21, P2513, DOI 10.1038/sj/onc/1205342; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Giese A, 1996, NEUROSURGERY, V39, P235, DOI 10.1097/00006123-199608000-00001; GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q; Goldbrunner RH, 1998, MICROSC RES TECHNIQ, V43, P250, DOI 10.1002/(SICI)1097-0029(19981101)43:3<250::AID-JEMT7>3.0.CO;2-C; Gondi CS, 2008, INT J ONCOL, V33, P783, DOI 10.3892/ijo_00000065; Gondi CS, 2006, MOL CANCER THER, V5, P3197, DOI 10.1158/1535-7163.MCT-05-0531; Gondi Christopher S., 2009, V487, P267, DOI 10.1007/978-1-60327-547-7_13; Gondi CS, 2003, ONCOGENE, V22, P5967, DOI 10.1038/sj.onc.1206535; GRONDAHLHANSEN J, 1993, CANCER RES, V53, P2513; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Gupta SK, 2010, CELL ADHES MIGR, V4, P194, DOI 10.4161/cam.4.2.10900; Gupta SK, 2009, J CELL SCI, V122, P2043, DOI 10.1242/jcs.041632; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kachra Z, 1999, CLIN EXP METASTAS, V17, P555, DOI 10.1023/A:1006760632766; Lakka SS, 2005, BRAIN PATHOL, V15, P327; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Liu SC, 2001, J BIOL CHEM, V276, P37086, DOI 10.1074/jbc.M105114200; Mahesparan R, 2003, ACTA NEUROPATHOL, V105, P49, DOI 10.1007/s00401-002-0610-0; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mohanam S, 1997, ONCOGENE, V14, P1351, DOI 10.1038/sj.onc.1200963; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Raithatha SA, 2000, NEURO-ONCOLOGY, V2, P145, DOI 10.1093/neuonc/2.3.145; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; RAO JS, 1993, CANCER RES, V53, P2208; RAO NK, 1995, J CLIN INVEST, V96, P465, DOI 10.1172/JCI118057; REMPEL SA, 1994, CANCER RES, V54, P6027; Rolli M, 2003, P NATL ACAD SCI USA, V100, P9482, DOI 10.1073/pnas.1633689100; Rooprai HK, 1998, INT J ONCOL, V13, P1153; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; SCHALLER MD, 1994, CURR OPIN CELL BIOL, V6, P705, DOI 10.1016/0955-0674(94)90097-3; Shattil SJ, 1991, CURR OPIN CELL BIOL, V3, P869, DOI 10.1016/0955-0674(91)90062-4; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Vlahakis NE, 2007, J BIOL CHEM, V282, P15187, DOI 10.1074/jbc.M609323200; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Young BA, 2001, MOL BIOL CELL, V12, P3214, DOI 10.1091/mbc.12.10.3214; ZACHARY I, 1992, CELL, V71, P891, DOI 10.1016/0092-8674(92)90385-P	52	37	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11583	10.1371/journal.pone.0011583	http://dx.doi.org/10.1371/journal.pone.0011583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657647	gold, Green Published, Green Submitted			2022-12-27	WOS:000279924500003
J	Snellman, G; Melhus, H; Gedeborg, R; Byberg, L; Berglund, L; Wernroth, L; Michaelsson, K				Snellman, Greta; Melhus, Hakan; Gedeborg, Rolf; Byberg, Liisa; Berglund, Lars; Wernroth, Lisa; Michaelsson, Karl			Determining Vitamin D Status: A Comparison between Commercially Available Assays	PLOS ONE			English	Article							BONE-MINERAL DENSITY; 25-HYDROXYVITAMIN-D; RISK; AGREEMENT; CAPACITY; EXPOSURE; WOMEN; HPLC; SKIN	Background: Vitamin D is not only important for bone health but can also affect the development of several non-bone diseases. The definition of vitamin D insufficiency by serum levels of 25-hydroxyvitamin D depends on the clinical outcome but might also be a consequence of analytical methods used for the definition. Although numerous 25-hydroxyvitamin D assays are available, their comparability is uncertain. We therefore aim to investigate the precision, accuracy and clinical consequences of differences in performance between three common commercially available assays. Methodology/Principal Findings: Serum 25-hydroxyvitamin D levels from 204 twins from the Swedish Twin Registry were determined with high-pressure liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry (HPLCAPCI-MS), a radioimmunoassay (RIA) and a chemiluminescent immunoassay (CLIA). High inter-assay disagreement was found. Mean 25-hydroxyvitamin D levels were highest for the HPLC-APCI-MS technique (85 nmol/L, 95% CI 81-89), intermediate for RIA (70 nmol/L, 95% CI 66-74) and lowest with CLIA (60 nmol/L, 95% CI 56-64). Using a 50-nmol/L cut-off, 8% of the subjects were insufficient using HPLC-APCI-MS, 22% with RIA and 43% by CLIA. Because of the heritable component of 25-hydroxyvitamin D status, the accuracy of each method could indirectly be assessed by comparison of within-twin pair correlations. The strongest correlation was found for HPLC-APCI-MS (r = 0.7), intermediate for RIA (r = 0.5) and lowest for CLIA (r = 0.4). Regression analyses between the methods revealed a non-uniform variance (p<0.0001) depending on level of 25-hydroxyvitamin D. Conclusions/Significance: There are substantial inter-assay differences in performance. The most valid method was HPLCAPCI-MS. Calibration between 25-hydroxyvitamin D assays is intricate.	[Snellman, Greta; Byberg, Liisa; Michaelsson, Karl] Univ Uppsala Hosp, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden; [Melhus, Hakan] Univ Uppsala Hosp, Dept Med Sci, Clin Pharmacol Sect, Uppsala, Sweden; [Melhus, Hakan; Gedeborg, Rolf; Byberg, Liisa; Berglund, Lars; Wernroth, Lisa; Michaelsson, Karl] Univ Uppsala Hosp, Uppsala Clin Res Ctr, Uppsala, Sweden; [Gedeborg, Rolf] Univ Uppsala Hosp, Dept Surg Sci, Sect Anaesthesiol & Intens Care, Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Snellman, G (corresponding author), Univ Uppsala Hosp, Dept Surg Sci, Sect Orthopaed, Uppsala, Sweden.	greta.snellman@surgsci.uu.se	Berglund, Lars/AAA-3188-2019; Gedeborg, Rolf/AAV-6702-2020; Michaelsson, Karl/AAM-9094-2021; Berglund, Lars/AAD-3856-2019	Gedeborg, Rolf/0000-0002-8850-7863; Berglund, Lars/0000-0002-7437-9047; Michaelsson, Karl/0000-0003-2815-1217	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkley N, 2008, J CLIN ENDOCR METAB, V93, P1804, DOI 10.1210/jc.2007-2340; Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Bischoff-Ferrari HA, 2004, AM J MED, V116, P634, DOI 10.1016/j.amjmed.2003.12.029; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Burgaz A, 2007, AM J CLIN NUTR, V86, P1399, DOI 10.1093/ajcn/86.5.1399; Carter GD, 2004, CLIN CHEM, V50, P2195, DOI 10.1373/clinchem.2004.040683; Carter GD, 2009, CLIN CHEM, V55, P1300, DOI 10.1373/clinchem.2009.125906; Chapuy MC, 1997, OSTEOPOROSIS INT, V7, P439, DOI 10.1007/s001980050030; CLEMENS TL, 1982, LANCET, V1, P74; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Forman JP, 2005, HYPERTENSION, V46, P676, DOI 10.1161/01.HYP.0000182662.82666.37; Glendenning P, 2006, ANN CLIN BIOCHEM, V43, P23, DOI 10.1258/000456306775141650; Hogstrom M, 2006, CALCIFIED TISSUE INT, V79, P95, DOI 10.1007/s00223-006-0049-8; Holick MF, 2005, J NUTR, V135, p2739S, DOI 10.1093/jn/135.11.2739S; Holick MF, 2004, AM J CLIN NUTR, V79, P362; HOLICK MF, 1995, AM J CLIN NUTR, V61, p638S, DOI 10.1093/ajcn/61.3.638S; Hunter D, 2001, J BONE MINER RES, V16, P371, DOI 10.1359/jbmr.2001.16.2.371; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Lensmeyer GL, 2006, CLIN CHEM, V52, P1120, DOI 10.1373/clinchem.2005.064956; Lichtenstein P, 2002, J INTERN MED, V252, P184, DOI 10.1046/j.1365-2796.2002.01032.x; Lips P, 2004, J STEROID BIOCHEM, V89-90, P611, DOI 10.1016/j.jsbmb.2004.03.040; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 1999, OSTEOPOROSIS INT, V9, P394, DOI 10.1007/s001980050162; Macdonald HM, 2008, BONE, V42, P996, DOI 10.1016/j.bone.2008.01.011; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; PERSSON T, 2000, SHMI REPORTS METEORO, V89; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Snellman G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007747; Tsugawa N, 2005, ANAL CHEM, V77, P3001, DOI 10.1021/ac048249c; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; DEQAS VITAMIN D EXTE	35	180	180	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11555	10.1371/journal.pone.0011555	http://dx.doi.org/10.1371/journal.pone.0011555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644628	Green Published, Green Submitted, gold			2022-12-27	WOS:000279822300010
J	Kotchoni, SO; Jimenez-Lopez, JC; Gao, DY; Edwards, V; Gachomo, EW; Margam, VM; Seufferheld, MJ				Kotchoni, Simeon O.; Jimenez-Lopez, Jose C.; Gao, Dongying; Edwards, Vincent; Gachomo, Emma W.; Margam, Venu M.; Seufferheld, Manfredo J.			Modeling-Dependent Protein Characterization of the Rice Aldehyde Dehydrogenase (ALDH) Superfamily Reveals Distinct Functional and Structural Features	PLOS ONE			English	Article							GENE SUPERFAMILY; ARABIDOPSIS-THALIANA; CRYSTAL-STRUCTURE; VIBRIO-HARVEYI; SALT TOLERANCE; EXPRESSION; PLANTS; STRESS; SPECIFICITY; EVOLUTION	The completion of the rice genome sequence has made it possible to identify and characterize new genes and to perform comparative genomics studies across taxa. The aldehyde dehydrogenase (ALDH) gene superfamily encoding for NAD(P)(+)-dependent enzymes is found in all major plant and animal taxa. However, the characterization of plant ALDHs has lagged behind their animal-and prokaryotic-ALDH homologs. In plants, ALDHs are involved in abiotic stress tolerance, male sterility restoration, embryo development and seed viability and maturation. However, there is still no structural property-dependent functional characterization of ALDH protein superfamily in plants. In this paper, we identify members of the rice ALDH gene superfamily and use the evolutionary nesting events of retrotransposons and protein-modeling-based structural reconstitution to report the genetic and molecular and structural features of each member of the rice ALDH superfamily in abiotic/biotic stress responses and developmental processes. Our results indicate that rice-ALDHs are the most expanded plant ALDHs ever characterized. This work represents the first report of specific structural features mediating functionality of the whole families of ALDHs in an organism ever characterized.	[Kotchoni, Simeon O.; Gao, Dongying; Edwards, Vincent] Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA; [Jimenez-Lopez, Jose C.] CSIC, Estn Expt Zaidin, Dept Biochem Cell & Mol Biol Plants, Granada, Spain; [Gachomo, Emma W.] S Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Margam, Venu M.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Seufferheld, Manfredo J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); South Dakota State University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Illinois System; University of Illinois Urbana-Champaign	Kotchoni, SO (corresponding author), Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA.	skotchon@purdue.edu	Jimenez-Lopez, Jose C./H-5896-2011; Margam, Venu M/E-5876-2010	Jimenez-Lopez, Jose C./0000-0002-1470-360X; Margam, Venu/0000-0001-6510-4618				Ahvazi B, 2000, BIOCHEM J, V349, P853, DOI 10.1042/bj3490853; ALTSHUL SF, 1997, NUCLEIC ACIDS RES, V25, P402; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bartels D, 2001, TRENDS PLANT SCI, V6, P284, DOI 10.1016/S1360-1385(01)01983-5; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; Di Costanzo L, 2007, J MOL BIOL, V366, P481, DOI 10.1016/j.jmb.2006.11.023; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Estey T, 2007, EXP EYE RES, V84, P3, DOI 10.1016/j.exer.2006.04.010; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; Gao CX, 2009, GENE, V431, P86, DOI 10.1016/j.gene.2008.11.010; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hempel J, 2001, CHEM-BIOL INTERACT, V130, P39, DOI 10.1016/S0009-2797(00)00220-9; Igarashi Y, 1997, PLANT MOL BIOL, V33, P857, DOI 10.1023/A:1005702408601; Jiang N, 2004, CURR OPIN PLANT BIOL, V7, P115, DOI 10.1016/j.pbi.2004.01.004; Kahraman A, 2007, J MOL BIOL, V368, P283, DOI 10.1016/j.jmb.2007.01.086; Khoury GA, 2009, PROTEIN SCI, V18, P2125, DOI 10.1002/pro.227; Kim S, 2005, INDOOR AIR, V15, P317, DOI 10.1111/j.1600-0668.2005.00368.x; Kirch HH, 2005, PLANT MOL BIOL, V57, P315, DOI 10.1007/s11103-004-7796-6; Kirch HH, 2004, TRENDS PLANT SCI, V9, P371, DOI 10.1016/j.tplants.2004.06.004; Kirch HH, 2001, PLANT J, V28, P555, DOI 10.1046/j.1365-313X.2001.01176.x; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kotchoni S, 2003, BULG J PLANT PHYSL S, V2003, P37; Kotchoni SO, 2006, PLANT CELL ENVIRON, V29, P1033, DOI 10.1111/j.1365-3040.2005.01458.x; KOTCHONI SO, 2004, THESIS U BONN GERMAN; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Liu F, 2002, PLANT PHYSIOL, V130, P1657, DOI 10.1104/pp.012336; Liu F, 2001, PLANT CELL, V13, P1063, DOI 10.1105/tpc.13.5.1063; Livesay DR, 2005, PROTEIN SCI, V14, P1158, DOI 10.1110/ps.041221105; Livesay DR, 2003, BIOCHEMISTRY-US, V42, P3464, DOI 10.1021/bi026918f; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; MARINO M, 1995, PROTEIN ENG, V8, P551, DOI 10.1093/protein/8.6.551; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Munoz-Clares RA, 2010, ARCH BIOCHEM BIOPHYS, V493, P71, DOI 10.1016/j.abb.2009.09.006; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Perozich J, 2001, CHEM-BIOL INTERACT, V130, P115, DOI 10.1016/S0009-2797(00)00227-1; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; Rodrigues SM, 2006, J EXP BOT, V57, P1909, DOI 10.1093/jxb/erj132; Rodriguez-Zavala J, 2001, CHEM-BIOL INTERACT, V130, P151, DOI 10.1016/S0009-2797(00)00230-1; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; Shin JH, 2009, PLANT PHYSIOL, V149, P905, DOI 10.1104/pp.108.130716; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; STROEHER VL, 1995, PLANT MOL BIOL, V27, P541, DOI 10.1007/BF00019320; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Tsuji H, 2003, FEBS LETT, V546, P369, DOI 10.1016/S0014-5793(03)00631-8; VANGUNSTEREN WF, 1996, BIOMOLECULAR SIMULAT, P96; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Vasiliou Vasilis, 2005, Human Genomics, V2, P138; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Wood AJ, 2009, BRYOLOGIST, V112, P1, DOI 10.1639/0007-2745-112.1.1; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; Zhang L, 1999, BIOCHEMISTRY-US, V38, P11440, DOI 10.1021/bi991101g; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	69	38	40	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11516	10.1371/journal.pone.0011516	http://dx.doi.org/10.1371/journal.pone.0011516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634950	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600005
J	Park, B; Ying, HY; Shen, XA; Park, JS; Qiu, Y; Shyam, R; Yue, BYJT				Park, BumChan; Ying, Hongyu; Shen, Xiang; Park, Jeong-Seok; Qiu, Ye; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.			Impairment of Protein Trafficking upon Overexpression and Mutation of Optineurin	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; NF-KAPPA-B; CELL-DEATH; MOLECULAR-CLONING; PLASMA-MEMBRANE; GOLGI-APPARATUS; MYOSIN-VI; WILD-TYPE; MUTANT; RECEPTOR	Background: Glaucoma is a major blinding disease characterized by progressive loss of retinal ganglion cells (RGCs) and axons. Optineurin is one of the candidate genes identified so far. A mutation of Glu(50) to Lys (E50K) has been reported to be associated with a more progressive and severe disease. Optineurin, known to interact with Rab8, myosin VI and transferrin receptor (TfR), was speculated to have a role in protein trafficking. Here we determined whether, and how optineurin overexpression and E50K mutation affect the internalization of transferrin (Tf), widely used as a marker for receptor-mediated endocytosis. Methodology/Principal Findings: Human retinal pigment epithelial (RPE) and rat RGC5 cells transfected to overexpress wild type optineurin were incubated with Texas Red-Tf to evaluate Tf uptake. Granular structures or dots referred to as foci formed in perinuclear regions after transfection. An impairment of the Tf uptake was in addition observed in transfected cells. Compared to overexpression of the wild type, E50K mutation yielded an increased foci formation and a more pronounced defect in Tf uptake. Co-transfection with TfR, but not Rab8 or myosin VI, construct rescued the optineurin inhibitory effect, suggesting that TfR was the factor involved in the trafficking phenotype. Forced expression of both wild type and E50K optineurin rendered TfR to colocalize with the foci. Surface biotinylation experiments showed that the surface level of TfR was also reduced, leading presumably to an impeded Tf uptake. A non-consequential Leu(157) to Ala (L157A) mutation that displayed much reduced foci formation and TfR binding had normal TfR distribution, normal surface TfR level and normal Tf internalization. Conclusions/Significance: The present study demonstrates that overexpression of wild type optineurin results in impairment of the Tf uptake in RPE and RGC5 cells. The phenotype is related to the optineurin interaction with TfR. Our results further indicate that E50K induces more dramatic effects than the wild type optineurin, and is thus a gain-of-function mutation. The defective protein trafficking may be one of the underlying bases why glaucoma pathology develops in patients with E50K mutation.	[Park, BumChan; Ying, Hongyu; Shen, Xiang; Park, Jeong-Seok; Qiu, Ye; Shyam, Rajalekshmy; Yue, Beatrice Y. J. T.] Univ Illinois, Chicago Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Park, B (corresponding author), Univ Illinois, Chicago Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60680 USA.	beatyue@uic.edu		Shyam, Rajalekshmy/0000-0003-2154-4173	National Eye Institute, National Institutes of Health, Bethesda, Maryland [EY01792]; American Health Assistance Foundation, Clarksburg, Maryland;  [EY018828];  [EY005628];  [EY003890]; NATIONAL EYE INSTITUTE [R01EY003890, R01EY005628, R01EY018828, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); American Health Assistance Foundation, Clarksburg, Maryland; ; ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants EY018828, EY005628, and EY003890 (to B.Y.J.T.Y.) and Core Grant EY01792 from the National Eye Institute, National Institutes of Health, Bethesda, Maryland; and by a grant from the American Health Assistance Foundation, Clarksburg, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Anborgh PH, 2005, J BIOL CHEM, V280, P34840, DOI 10.1074/jbc.M504508200; Aung T, 2005, INVEST OPHTH VIS SCI, V46, P2816, DOI 10.1167/iovs.04-1133; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Buss F, 2004, ANNU REV CELL DEV BI, V20, P649, DOI 10.1146/annurev.cellbio.20.012103.094243; Chalasani ML, 2008, EXP EYE RES, V87, P1, DOI 10.1016/j.exer.2007.10.021; Chalasani ML, 2007, INVEST OPHTH VIS SCI, V48, P1607, DOI 10.1167/iovs.06-0834; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Chibalina MV, 2008, METHOD ENZYMOL, V438, P11, DOI 10.1016/S0076-6879(07)38002-6; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; De Marco N, 2006, J BIOL CHEM, V281, P16147, DOI 10.1074/jbc.M601467200; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Fan BJ, 2006, CLIN BIOCHEM, V39, P231, DOI 10.1016/j.clinbiochem.2005.11.010; Fernandez-Sanchez E, 2008, BIOCHEM J, V409, P669, DOI 10.1042/BJ20070533; Gonatas NK, 2006, J NEUROL SCI, V246, P21, DOI 10.1016/j.jns.2006.01.019; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hattula K, 2000, CURR BIOL, V10, P1603, DOI 10.1016/S0960-9822(00)00864-2; Hauser MA, 2006, J GLAUCOMA, V15, P358, DOI 10.1097/01.ijg.0000212255.17950.42; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Kroeber M, 2006, EXP EYE RES, V82, P1075, DOI 10.1016/j.exer.2005.11.004; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Laifenfeld D, 2007, J NEUROSCI, V27, P7141, DOI 10.1523/JNEUROSCI.4599-06.2007; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Li YG, 1998, MOL CELL BIOL, V18, P1601, DOI 10.1128/MCB.18.3.1601; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Moreland RJ, 2000, NUCLEIC ACIDS RES, V28, P1986, DOI 10.1093/nar/28.9.1986; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Nagabhushana A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-4; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Park SY, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-43; Perret E, 2005, CURR OPIN CELL BIOL, V17, P423, DOI 10.1016/j.ceb.2005.06.008; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ramjeesingh M, 2003, BIOCHEM J, V374, P793, DOI 10.1042/BJ20030683; Rezaie T, 2005, INVEST OPHTH VIS SCI, V46, P2404, DOI 10.1167/iovs.04-1243; Rezaie T, 2005, GENOMICS, V85, P131, DOI 10.1016/j.ygeno.2004.10.011; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schwamborn K, 2000, J BIOL CHEM, V275, P22780, DOI 10.1074/jbc.M001500200; Shen X, 2008, J BIOL CHEM, V283, P603, DOI 10.1074/jbc.M708250200; Strick DJ, 2005, MOL BIOL CELL, V16, P5699, DOI 10.1091/mbc.E05-03-0204; Sudhakar C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005114; Tezel G, 2008, PROG BRAIN RES, V173, P409, DOI 10.1016/S0079-6123(08)01128-X; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Velier J, 1998, EXP NEUROL, V152, P34, DOI 10.1006/exnr.1998.6832; Vittitow JL, 2002, BIOCHEM BIOPH RES CO, V298, P67, DOI 10.1016/S0006-291X(02)02395-1; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041	54	47	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11547	10.1371/journal.pone.0011547	http://dx.doi.org/10.1371/journal.pone.0011547			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634958	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600024
J	Kahsai, L; Kapan, N; Dircksen, H; Winther, AME; Nassel, DR				Kahsai, Lily; Kapan, Neval; Dircksen, Heinrich; Winther, Asa M. E.; Nassel, Dick R.			Metabolic Stress Responses in Drosophila Are Modulated by Brain Neurosecretory Cells That Produce Multiple Neuropeptides	PLOS ONE			English	Article							TACHYKININ-RELATED PEPTIDES; ION-TRANSPORT PEPTIDE; CENTRAL-NERVOUS-SYSTEM; INSULIN-LIKE PEPTIDES; RETROCEREBRAL COMPLEX; FUNCTIONAL-CHARACTERIZATION; ADIPOKINETIC HORMONE; LOCUSTATACHYKININ-I; MALPIGHIAN TUBULES; FLUID SECRETION	In Drosophila, neurosecretory cells that release peptide hormones play a prominent role in the regulation of development, growth, metabolism, and reproduction. Several types of peptidergic neurosecretory cells have been identified in the brain of Drosophila with release sites in the corpora cardiaca and anterior aorta. We show here that in adult flies the products of three neuropeptide precursors are colocalized in five pairs of large protocerebral neurosecretory cells in two clusters (designated ipc-1 and ipc-2a): Drosophila tachykinin (DTK), short neuropeptide F (sNPF) and ion transport peptide (ITP). These peptides were detected by immunocytochemistry in combination with GFP expression driven by the enhancer trap Gal4 lines c929 and Kurs-6, both of which are expressed in ipc-1 and 2a cells. This mix of colocalized peptides with seemingly unrelated functions is intriguing and prompted us to initiate analysis of the function of the ten neurosecretory cells. We investigated the role of peptide signaling from large ipc-1 and 2a cells in stress responses by monitoring the effect of starvation and desiccation in flies with levels of DTK or sNPF diminished by RNA interference. Using the Gal4-UAS system we targeted the peptide knockdown specifically to ipc-1 and 2a cells with the c929 and Kurs-6 drivers. Flies with reduced DTK or sNPF levels in these cells displayed decreased survival time at desiccation and starvation, as well as increased water loss at desiccation. Our data suggest that homeostasis during metabolic stress requires intact peptide signaling by ipc-1 and 2a neurosecretory cells.	[Kahsai, Lily; Kapan, Neval; Dircksen, Heinrich; Winther, Asa M. E.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden	Stockholm University	Kahsai, L (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se	Dircksen, Heinrich/C-7704-2013; Winther, Åsa/E-8842-2010	Dircksen, Heinrich/0000-0001-7815-4868; 	Swedish Research Council [621- 2007-6500]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by the Swedish Research Council (VR, Grant 621- 2007-6500; http://www.vr.se/) to D. R. Nassel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUDSLEY N, 1992, J EXP BIOL, V173, P261; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Birse RT, 2006, J NEUROBIOL, V66, P33, DOI 10.1002/neu.20189; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; BROWN MR, 1994, J INSECT PHYSIOL, V40, P399, DOI 10.1016/0022-1910(94)90158-9; Cabrero P, 2002, J EXP BIOL, V205, P3799; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choi MY, 2001, CELL TISSUE RES, V306, P459, DOI 10.1007/s00441-001-0467-x; Choi YJ, 2005, J COMP NEUROL, V482, P372, DOI 10.1002/cne.20419; Coast GM, 2002, ADV INSECT PHYSIOL, V29, P279, DOI 10.1016/S0065-2806(02)29004-9; Dircksen H, 2008, J COMP NEUROL, V509, P23, DOI 10.1002/cne.21715; Dircksen H, 2009, J EXP BIOL, V212, P401, DOI 10.1242/jeb.026112; Ewer J, 2005, HORM BEHAV, V48, P418, DOI 10.1016/j.yhbeh.2005.05.018; Feng GP, 2003, EUR J NEUROSCI, V18, P227, DOI 10.1046/j.1460-9568.2003.02719.x; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Glantz RM, 2000, J NEUROSCI, V20, P1780; Hamanaka Y, 2004, CELL TISSUE RES, V318, P403, DOI 10.1007/s00441-004-0935-1; Hamanaka Y, 2007, CELL TISSUE RES, V329, P581, DOI 10.1007/s00441-007-0433-3; Hartenstein V, 2006, J ENDOCRINOL, V190, P555, DOI 10.1677/joe.1.06964; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; HOMBERG U, 1991, J COMP NEUROL, V303, P35, DOI 10.1002/cne.903030105; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Isabel G, 2005, AM J PHYSIOL-REG I, V288, pR531, DOI 10.1152/ajpregu.00158.2004; Johard HAD, 2003, PEPTIDES, V24, P1571, DOI 10.1016/j.peptides.2003.08.012; Johard HAD, 2008, J COMP NEUROL, V507, P1479, DOI 10.1002/cne.21636; Johard HAD, 2009, J COMP NEUROL, V516, P59, DOI 10.1002/cne.22099; JOHNSON EC, 2006, INVERTEBRATE NEUROPE, P1; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lange AB, 2001, PEPTIDES, V22, P229, DOI 10.1016/S0196-9781(00)00386-7; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; LEE KS, 2008, NAT CELL BIOL; Lee KS, 2009, FEBS LETT, V583, P2573, DOI 10.1016/j.febslet.2009.07.024; MATSUMOTO S, 1989, INSECT BIOCHEM, V19, P277, DOI 10.1016/0020-1790(89)90073-5; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Mertens I, 2002, BIOCHEM BIOPH RES CO, V297, P1140, DOI 10.1016/S0006-291X(02)02351-3; Nassel DR, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-90; NASSEL DR, 1995, REGUL PEPTIDES, V57, P297, DOI 10.1016/0167-0115(95)00043-B; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Nassel DR, 1999, PEPTIDES, V20, P141, DOI 10.1016/S0196-9781(98)00142-9; Nichols R, 2003, ANNU REV ENTOMOL, V48, P485, DOI 10.1146/annurev.ento.48.091801.112525; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; POELS J, 2008, PEPTIDES; Predel R, 2004, J COMP NEUROL, V474, P379, DOI 10.1002/cne.20145; Raabe M, 1989, RECENT DEV INSECT NE; Radford JC, 2002, J BIOL CHEM, V277, P38810, DOI 10.1074/jbc.M203694200; Reale V, 2004, EUR J NEUROSCI, V19, P570, DOI 10.1111/j.0953-816X.2003.03141.x; Ring M, 1998, INSECT BIOCHEM MOLEC, V28, P51, DOI 10.1016/S0965-1748(97)00096-9; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Siviter RJ, 2000, J BIOL CHEM, V275, P23273, DOI 10.1074/jbc.M002875200; Skaer NJV, 2002, J EXP BIOL, V205, P1869; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Veenstra JA, 2009, INSECT BIOCHEM MOLEC, V39, P755, DOI 10.1016/j.ibmb.2009.09.008; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Winther AME, 2003, J COMP NEUROL, V464, P180, DOI 10.1002/cne.10790; Winther AME, 2001, J EXP BIOL, V204, P1269; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102	68	67	67	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11480	10.1371/journal.pone.0011480	http://dx.doi.org/10.1371/journal.pone.0011480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628603	Green Published, Green Submitted, gold			2022-12-27	WOS:000279637100010
J	Noben-Trauth, K; Latoche, JR; Neely, HR; Bennett, B				Noben-Trauth, Konrad; Latoche, Joseph R.; Neely, Harold R.; Bennett, Beth			Phenotype and Genetics of Progressive Sensorineural Hearing Loss (Snhl1) in the LXS Set of Recombinant Inbred Strains of Mice	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; MOUSE; IMPAIRMENT; INHERITANCE	Progressive sensorineural hearing loss is the most common form of acquired hearing impairment in the human population. It is also highly prevalent in inbred strains of mice, providing an experimental avenue to systematically map genetic risk factors and to dissect the molecular pathways that orchestrate hearing in peripheral sensory hair cells. Therefore, we ascertained hearing function in the inbred long sleep (ILS) and inbred short sleep (ISS) strains. Using auditory-evoked brain stem response (ABR) and distortion product otoacoustic emission (DPOAE) measurements, we found that ISS mice developed a high-frequency hearing loss at twelve weeks of age that progressed to lower frequencies by 26 weeks of age in the presence of normal endocochlear potentials and unremarkable inner ear histology. ILS mice exhibited milder hearing loss, showing elevated thresholds and reduced DPOAEs at the higher frequencies by 26 weeks of age. To map the genetic variants that underlie this hearing loss we computed ABR thresholds of 63 recombinant inbred stains derived from the ISS and ILS founder strains. A single locus was linked to markers associated with ISS alleles on chromosome 10 with a highly significant logarithm of odds (LOD) score of 15.8. The 2-LOD confidence interval spans,4 Megabases located at position 54-60 Mb. This locus, termed sensorineural hearing loss 1 (Snhl1), accounts for approximately 82% of the phenotypic variation. In summary, this study identifies a novel hearing loss locus on chromosome 10 and attests to the prevalence and genetic heterogeneity of progressive hearing loss in common mouse strains.	[Noben-Trauth, Konrad; Latoche, Joseph R.; Neely, Harold R.] Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, Mol Biol Lab, NIH, Rockville, MD USA; [Bennett, Beth] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Colorado System; University of Colorado Boulder	Noben-Trauth, K (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurogenet Sect, Mol Biol Lab, NIH, Rockville, MD USA.	nobentk@nidcd.nih.gov			National Institutes of Health (NIH) [RO1AA08940]; University of Colorado; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA008940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000056] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Intramural Research Program at the National Institutes of Health (NIH) (KNT), by funds from the University of Colorado and grants from the NIH (RO1AA08940, BB) www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown SDM, 2008, NAT REV GENET, V9, P277, DOI 10.1038/nrg2309; Drayton M, 2006, HEARING RES, V212, P128, DOI 10.1016/j.heares.2005.11.006; Friedman RA, 2009, HUM MOL GENET, V18, P785, DOI 10.1093/hmg/ddn402; Hendrickx JJ, 2007, B-ENT, P51; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; Konings A, 2009, EAR HEARING, V30, P151, DOI 10.1097/AUD.0b013e3181987080; Leibovici M, 2008, CURR TOP DEV BIOL, V84, P385, DOI 10.1016/S0070-2153(08)00608-X; Liu XZ, 2007, J PATHOL, V211, P188, DOI 10.1002/path.2102; Martin GK, 2007, HEARING RES, V234, P59, DOI 10.1016/j.heares.2007.09.002; Mashimo T, 2006, MAMM GENOME, V17, P841, DOI 10.1007/s00335-004-2438-5; MCCLEARN GE, 1970, ANNU REV GENET, V4, P437, DOI 10.1146/annurev.ge.04.120170.002253; Nemoto M, 2004, BIOCHEM BIOPH RES CO, V324, P1283, DOI 10.1016/j.bbrc.2004.09.186; *NIDCD, 2010, STAT EP; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Noben-Trauth K, 2009, BRAIN RES, V1277, P42, DOI 10.1016/j.brainres.2009.02.012; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; Williams RW, 2004, MAMM GENOME, V15, P637, DOI 10.1007/s00335-004-2380-6; Witmer PD, 2003, GENOME RES, V13, P485, DOI 10.1101/gr.717903; Zheng QY, 2009, NEUROBIOL AGING, V30, P1693, DOI 10.1016/j.neurobiolaging.2007.12.011; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	21	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11459	10.1371/journal.pone.0011459	http://dx.doi.org/10.1371/journal.pone.0011459			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628639	Green Published, gold, Green Submitted			2022-12-27	WOS:000279589300007
J	Epeldegui, M; Thapa, DR; De La Cruz, J; Kitchen, S; Zack, JA; Martinez-Maza, O				Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Kitchen, Scott; Zack, Jerome A.; Martinez-Maza, Otoniel			CD40 Ligand (CD154) Incorporated into HIV Virions Induces Activation-Induced Cytidine Deaminase (AID) Expression in Human B Lymphocytes	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; CLASS SWITCH RECOMBINATION; BLOOD MONONUCLEAR-CELLS; NON-HODGKINS-LYMPHOMA; CD4(+) T-CELLS; VIRUS INFECTION; HOMOSEXUAL MEN; SERUM-LEVELS; IMMUNOGLOBULIN	Most AIDS-associated non-Hodgkin's lymphoma (AIDS-NHL) arises fromerrors in immunoglobulin heavy-chain gene (IgH) class switch recombination (CSR) or somatic hypermutation (SHM), events that occur in germinal center (GC) B cells and require the activity of activation induced cytidine deaminase (AID). Several oncogenic viruses (EBV, HCV, HPV) can induce AID gene (AID) expression, and elevated AID expression is seen in circulating lymphocytes prior to AIDS-NHL diagnosis. Here, we report that HIV produced in peripheral blood mononuclear cells (PBMC) induced AID expression in normal human B cells. Since HIV produced in PBMC contains host cell CD40 ligand (CD40L) incorporated into the viral membrane, and CD40L is known to induce AID expression in human B cells, the role of virion-associated CD40L in HIV-induced AID expression was examined. Only viruses expressing functional CD40L were seen to induce AID expression; CD40L-negative HIV did not induce AID expression. The induction of AID expression by CD40L+ HIV was abrogated by addition of blocking anti-CD40L antibody. AID protein was detected in B cells exposed to CD40L+ HIV using intracellular multicolor flow cytometry, with most AID producing B cells expressing the CD71 activation marker on their surface. Therefore, HIV virions that express CD40L induce AID expression in B cells, and this induction appears to be due to a direct interaction between CD40L on these viruses and CD40 on B cells. These findings are consistent with a role for HIV in the direct stimulation of B cells, potentially leading to the accumulation of molecular lesions that have the potential to contribute to the development of NHL.	[Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA; [Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Immunol, Los Angeles, CA 90095 USA; [Epeldegui, Marta; Thapa, Dharma R.; De La Cruz, Justin; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol Genet, Los Angeles, CA 90095 USA; [Kitchen, Scott; Zack, Jerome A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Kitchen, Scott; Zack, Jerome A.; Martinez-Maza, Otoniel] Univ Calif Los Angeles, AIDS Inst, Los Angeles, CA 90095 USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Zack, Jerome A.; Martinez-Maza, Otoniel] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA; [Martinez-Maza, Otoniel] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Epeldegui, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA.	omartinez@mednet.ucla.edu	Martinez-Maza, Otoniel/B-2667-2009; Thapa, Dharma/C-2854-2012	Martinez-Maza, Otoniel/0000-0003-1364-0675; 	NIH [R01-CA57152, P50-CA96888, U01-AI35040, T32-CA009120]; University of California [D04-LA-403, ID05-LA-047]; UCLA Center for AIDS Research (CFAR) NIH/NIAID [AI028697]; NATIONAL CANCER INSTITUTE [R01CA057152, P50CA096888, T32CA009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, P30AI028697] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California(University of California System); UCLA Center for AIDS Research (CFAR) NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by NIH grants R01-CA57152, P50-CA96888, U01-AI35040 and T32-CA009120, as well as by grants from the University-wide AIDS Research Program of the University of California (D04-LA-403 and ID05-LA-047). UCLA AIDS Institute core facilities used in this study were supported by an NIH grant: UCLA Center for AIDS Research (CFAR) NIH/NIAID AI028697. This work was carried out in the facilities of the UCLA AIDS Institute, which were supported, in part, by funds from the James B. Pendleton Charitable Trust and the McCarthy Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMADORI A, 1991, AIDS, V5, P821, DOI 10.1097/00002030-199107000-00005; AMADORI A, 1990, IMMUNOL TODAY, V11, P374, DOI 10.1016/0167-5699(90)90144-X; Baenziger S, 2009, BLOOD, V113, P377, DOI 10.1182/blood-2008-04-151712; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; BIRX DL, 1990, BLOOD, V76, P2303; Bonnet F, 2006, CLIN INFECT DIS, V42, P411, DOI 10.1086/499054; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Breen EC, 2006, TUMOR BIOL, V27, P187, DOI 10.1159/000093022; Breen EC, 2005, AIDS, V19, P1711, DOI 10.1097/01.aids.0000184924.04983.7c; Breen EC, 2003, CLIN IMMUNOL, V109, P119, DOI 10.1016/S1521-6616(03)00214-6; BREEN EC, 1990, J IMMUNOL, V144, P480; Dorsett Y, 2007, J EXP MED, V204, P2225, DOI 10.1084/jem.20070884; Epeldegui M, 2007, AIDS, V21, P2265, DOI 10.1097/QAD.0b013e3282ef9f59; Epeldegui M, 2007, MOL IMMUNOL, V44, P934, DOI 10.1016/j.molimm.2006.03.018; Epeldegui M, 2006, CURR OPIN ONCOL, V18, P444, DOI 10.1097/01.cco.0000239882.23839.e5; He B, 2003, J IMMUNOL, V171, P5215, DOI 10.4049/jimmunol.171.10.5215; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Malaspina A, 2006, P NATL ACAD SCI USA, V103, P2262, DOI 10.1073/pnas.0511094103; Martin G, 2004, CLIN IMMUNOL, V111, P275, DOI 10.1016/j.clim.2004.02.004; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Martinez-Maza O, 2002, CURR OPIN ONCOL, V14, P528, DOI 10.1097/00001622-200209000-00009; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; MARTINEZMAZA O, 1992, RES IMMUNOL, V143, P764, DOI 10.1016/0923-2494(92)80020-L; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; MIZUMA H, 1988, CLIN EXP IMMUNOL, V71, P410; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; PAHWA SG, 1984, ANN INTERN MED, V101, P757, DOI 10.7326/0003-4819-101-6-757; Pasqualucci L, 2008, NAT GENET, V40, P108, DOI 10.1038/ng.2007.35; PLUDA JM, 1993, J CLIN ONCOL, V11, P1099, DOI 10.1200/JCO.1993.11.6.1099; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Rosina J, 2007, PHYSIOL RES, V56, pS93, DOI 10.33549/physiolres.931306; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; SCHROFF RW, 1983, CLIN IMMUNOL IMMUNOP, V27, P300, DOI 10.1016/0090-1229(83)90083-1; Swingler S, 2008, CELL HOST MICROBE, V4, P63, DOI 10.1016/j.chom.2008.05.015; Vatakis DN, 2007, J VIROL, V81, P3574, DOI 10.1128/JVI.02569-06; YAWETZ S, 1995, BLOOD, V85, P1843, DOI 10.1182/blood.V85.7.1843.bloodjournal8571843	39	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11448	10.1371/journal.pone.0011448	http://dx.doi.org/10.1371/journal.pone.0011448			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625427	Green Submitted, Green Published, gold			2022-12-27	WOS:000279522500015
J	McKinnon, LR; Kimani, M; Wachihi, C; Nagelkerke, NJ; Muriuki, FK; Kariri, A; Lester, RT; Gelmon, L; Ball, TB; Plummer, FA; Kaul, R; Kimani, J				McKinnon, Lyle R.; Kimani, Makobu; Wachihi, Charles; Nagelkerke, Nico J.; Muriuki, Festus K.; Kariri, Anthony; Lester, Richard T.; Gelmon, Lawrence; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert; Kimani, Joshua			Effect of Baseline HIV Disease Parameters on CD4+T Cell Recovery After Antiretroviral Therapy Initiation in Kenyan Women	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; INFECTED PATIENTS; IMMUNODEFICIENCY; ACTIVATION; RECONSTITUTION; COHORT; RISK	Background: Antiretroviral therapy (ART) for HIV infection reconstitutes the immune system and improves survival. However, the rate and extent of CD4+ T cell recovery varies widely. We assessed the impact of several factors on immune reconstitution in a large Kenyan cohort. Methodology/Principal Findings: HIV-infected female sex workers from a longitudinal cohort, with at least 1 year of pre-ART and 6 months of post-ART follow-up (n = 79), were enrolled in the current study. The median pre-ART follow-up was 4,040 days. CD4 counts were measured biannually and viral loads where available. The median CD4 count at ART initiation was 180 cells/ul, which increased to 339 cells/ul at the most recent study visit. The rate of CD4+ T cell increase on ART was 7.91 cells/month (mean = 13, range -25.92 to 169.4). LTNP status prior to ART initiation did not associate with the rate of CD4 recovery on ART. In univariate analyses, associations were observed for CD4 recovery rate and duration of pre-ART immunosuppression (r = -0.326, p = 0.004) and CD4 nadir (r = 0.284, p = 0.012). In multivariate analysis including age, CD4 nadir, duration of HIV infection, duration of pre-ART immunosuppression, and baseline viral load, only CD4 nadir (p = 0.007) and not duration of immunosupression (p = 0.87) remained significantly associated with the rate of CD4 recovery. Conclusions/Significance: These data suggest that prior duration of immune suppression does not predict subsequent recovery once ART is initiated and confirm the previous observation that the degree of CD4 depletion prior to ART initiation is the most important determinant of subsequent immune reconstitution.	[McKinnon, Lyle R.; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [McKinnon, Lyle R.; Kimani, Makobu; Wachihi, Charles; Muriuki, Festus K.; Kariri, Anthony; Lester, Richard T.; Gelmon, Lawrence; Plummer, Francis A.; Kaul, Rupert; Kimani, Joshua] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Nagelkerke, Nico J.] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates; [Lester, Richard T.; Gelmon, Lawrence; Ball, T. Blake; Plummer, Francis A.; Kimani, Joshua] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Ball, T. Blake] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada; [Ball, T. Blake] Publ Hlth Agcy Canada, Lab HIV Immunol, Winnipeg, MB, Canada; [Plummer, Francis A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of Toronto; University of Nairobi; United Arab Emirates University; University of Manitoba; University of Manitoba; Public Health Agency of Canada; Public Health Agency of Canada	McKinnon, LR (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	sijuisijali@gmail.com	Kimani, Makobu/V-6369-2019	Kimani, Makobu/0000-0001-9275-4018; McKinnon, Lyle/0000-0002-7157-0700; Kaul, Rupert/0000-0002-1586-4093	United States President's Plan for AIDS Relief (PEPFAR) [U62/CCU024510-05]; National Institutes of Health [R01 AI56980 A1]; Canadian Institutes of Health Research (CIHR) through the Grand Challenges in Global Health Initiative [HOP-43135, MOP-89983]; Bill and Melinda Gates FoundationCanada Research Chair; International Infectious Diseases and Global Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056980] Funding Source: NIH RePORTER	United States President's Plan for AIDS Relief (PEPFAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR) through the Grand Challenges in Global Health Initiative(Canadian Institutes of Health Research (CIHR)); Bill and Melinda Gates FoundationCanada Research Chair; International Infectious Diseases and Global Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for these studies was provided by the United States President's Plan for AIDS Relief (PEPFAR) Grant no. U62/CCU024510-05, as well as grants from the National Institutes of Health (R01 AI56980 A1), the Canadian Institutes of Health Research (HOP-43135), the Bill and Melinda Gates Foundation, and the Canadian Institutes of Health Research (CIHR) through the Grand Challenges in Global Health Initiative to FP, and Canadian Institutes of Health Research (CIHR) (MOP-89983) to RK. Salary support for FP and RK is provided by the Canada Research Chair program, and for LM by a CIHR Biomedical/Clinical HIV/AIDS Research Fellowship and the International Infectious Diseases and Global Health Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KB, 2003, JAIDS-J ACQ IMM DEF, V33, P125, DOI 10.1097/00126334-200306010-00002; Benito DM, 2005, JAIDS-J ACQ IMM DEF, V38, P373, DOI 10.1097/01.qai.0000153105.42455.c2; Benveniste O, 2005, J INFECT DIS, V191, P1670, DOI 10.1086/429670; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Delobel P, 2006, J VIROL, V80, P10229, DOI 10.1128/JVI.00965-06; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Goicoechea M, 2006, J INFECT DIS, V194, P29, DOI 10.1086/504718; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Micheloud D, 2008, J INFECTION, V56, P130, DOI 10.1016/j.jinf.2007.12.001; Miro JM, 2006, CLIN INFECT DIS, V43, P79, DOI 10.1086/504872; Okulicz JF, 2010, CLIN INFECT DIS, V50, P1187, DOI 10.1086/651421; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Siddique MA, 2006, J INFECT DIS, V194, P661, DOI 10.1086/505913; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7	18	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11434	10.1371/journal.pone.0011434	http://dx.doi.org/10.1371/journal.pone.0011434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625393	Green Published, Green Submitted, gold			2022-12-27	WOS:000279465700016
J	Christensen, A; Svensson, K; Thelin, L; Zhang, WJ; Tintor, N; Prins, D; Funke, N; Michalak, M; Schulze-Lefert, P; Saijo, Y; Sommarin, M; Widell, S; Persson, S				Christensen, Anna; Svensson, Karin; Thelin, Lisa; Zhang, Wenjing; Tintor, Nico; Prins, Daniel; Funke, Norma; Michalak, Marek; Schulze-Lefert, Paul; Saijo, Yusuke; Sommarin, Marianne; Widell, Susanne; Persson, Staffan			Higher Plant Calreticulins Have Acquired Specialized Functions in Arabidopsis	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; EXPRESSION; PROTEIN; IDENTIFICATION; CALCIUM; GENE; CHAPERONE; RECEPTOR; CALNEXIN	Background: Calreticulin (CRT) is a ubiquitous ER protein involved in multiple cellular processes in animals, such as protein folding and calcium homeostasis. Like in animals, plants have evolved divergent CRTs, but their physiological functions are less understood. Arabidopsis contains three CRT proteins, where the two CRTs AtCRT1a and CRT1b represent one subgroup, and AtCRT3 a divergent member. Methodology/Principal Findings: Through expression of single Arabidopsis family members in CRT-deficient mouse fibroblasts we show that both subgroups have retained basic CRT functions, including ER Ca2+-holding potential and putative chaperone capabilities. However, other more general cellular defects due to the absence of CRT in the fibroblasts, such as cell adhesion deficiencies, were not fully restored. Furthermore, in planta expression, protein localization and mutant analyses revealed that the three Arabidopsis CRTs have acquired specialized functions. The AtCRT1a and CRT1b family members appear to be components of a general ER chaperone network. In contrast, and as recently shown, AtCRT3 is associated with immune responses, and is essential for responsiveness to the bacterial Pathogen-Associated Molecular Pattern (PAMP) elf18, derived from elongation factor (EF)-Tu. Whereas constitutively expressed AtCRT1a fully complemented Atcrt1b mutants, AtCRT3 did not. Conclusions/Significance: We conclude that the physiological functions of the two CRT subgroups in Arabidopsis have diverged, resulting in a role for AtCRT3 in PAMP associated responses, and possibly more general chaperone functions for AtCRT1a and CRT1b.	[Christensen, Anna; Thelin, Lisa; Sommarin, Marianne] Lund Univ, Dept Biochem, Ctr Chem & Chem Engn, Lund, Sweden; [Christensen, Anna; Sommarin, Marianne] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Svensson, Karin; Zhang, Wenjing; Widell, Susanne] Lund Univ, Dept Cell & Organism Biol, Lund, Sweden; [Tintor, Nico; Schulze-Lefert, Paul; Saijo, Yusuke] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Cologne, Germany; [Prins, Daniel; Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Persson, Staffan] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Lund University; Umea University; Lund University; Max Planck Society; University of Alberta; Max Planck Society	Christensen, A (corresponding author), Lund Univ, Dept Biochem, Ctr Chem & Chem Engn, Lund, Sweden.	persson@mpimp-golm.mpg.de	Persson, Staffan/S-8399-2016; Schulze-Lefert, Paul/B-6707-2011	Persson, Staffan/0000-0002-6377-5132; 	Max-Planck Gesellschaft; Canadian Institute of Health Research [MOP-15291]; Alberta Heritage for Medical; Swedish Research Council; Swedish Foundation for Strategic Research; Swedish Research Council Formas; Carl Tryggers Foundation	Max-Planck Gesellschaft(Max Planck Society); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage for Medical; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Carl Tryggers Foundation	NF and SP were funded through the Max-Planck Gesellschaft. MM is supported by the Canadian Institute of Health Research (MOP-15291), and DP was supported by an Alberta Heritage for Medical Research Summer Student Award. MS was supported by the Swedish Research Council, Swedish Foundation for Strategic Research, and The Swedish Research Council Formas. SW was supported by the Carl Tryggers Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson A, 2005, PHYSIOL PLANTARUM, V123, P92, DOI 10.1111/j.1399-3054.2004.00434.x; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Baluska F, 1999, PLANT J, V19, P481, DOI 10.1046/j.1365-313X.1999.00530.x; BECHTOLD N, 1994, GENE TRANSFER PLANTS, P19; Bedard K, 2005, INT REV CYTOL, V245, P91, DOI 10.1016/S0074-7696(05)45004-4; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Borisjuk N, 1998, PLANTA, V206, P504, DOI 10.1007/s004250050427; CHEN FQ, 1994, PLANT CELL, V6, P835, DOI 10.1105/tpc.6.6.835; Christensen A, 2008, PLANT CELL PHYSIOL, V49, P912, DOI 10.1093/pcp/pcn065; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; Coughlan SJ, 1997, PLANT MOL BIOL, V34, P897, DOI 10.1023/A:1005822327479; Crofts AJ, 1998, TRENDS PLANT SCI, V3, P396, DOI 10.1016/S1360-1385(98)01312-0; Day B, 2006, PLANT CELL, V18, P2782, DOI 10.1105/tpc.106.044693; DENECKE J, 1995, PLANT CELL, V7, P391, DOI 10.1105/tpc.7.4.391; Ellgaard L, 2003, CELL BIOCHEM BIOPHYS, V39, P223, DOI 10.1385/CBB:39:3:223; Fadel MP, 2001, J BIOL CHEM, V276, P27083, DOI 10.1074/jbc.M101676200; Jia XY, 2008, J EXP BOT, V59, P739, DOI 10.1093/jxb/erm369; Jia XY, 2009, PHYSIOL PLANTARUM, V136, P127, DOI [10.1111/j.1399-3054.2009.1223.x, 10.1111/j.1399-3054.2009.01223.x]; Jin H, 2009, P NATL ACAD SCI USA, V106, P13612, DOI 10.1073/pnas.0906144106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeClere S, 2001, PLANT MOL BIOL, V46, P695, DOI 10.1023/A:1011699722052; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Li ZG, 2008, PROG NAT SCI, V18, P1219, DOI 10.1016/j.pnsc.2008.02.013; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Meyers BC, 2002, PLANT J, V32, P77, DOI 10.1046/j.1365-313X.2002.01404.x; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2010, PLANT PHYSIOL, V152, P29, DOI 10.1104/pp.109.145318; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NAPIER RM, 1995, J EXP BOT, V46, P1603, DOI 10.1093/jxb/46.10.1603; Navazio L, 2002, BIOCHEMISTRY-US, V41, P14141, DOI 10.1021/bi0204701; Nelson DE, 1997, PLANT PHYSIOL, V114, P29, DOI 10.1104/pp.114.1.29; Opas M, 1996, J CELL BIOL, V135, P1913, DOI 10.1083/jcb.135.6.1913; Opas M, 1996, PROTOPLASMA, V191, P164, DOI 10.1007/BF01281814; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Persson S, 2003, PLANT PHYSIOL, V133, P1385, DOI 10.1104/pp.103.024943; Persson S, 2002, GENE, V297, P151, DOI 10.1016/S0378-1119(02)00880-6; Persson S, 2001, PLANT PHYSIOL, V126, P1092, DOI 10.1104/pp.126.3.1092; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROBERTSON D, 1992, J MICROSC-OXFORD, V168, P85, DOI 10.1111/j.1365-2818.1992.tb03253.x; Saijo Y, 2009, EMBO J, V28, P3439, DOI 10.1038/emboj.2009.263; Schwessinger B, 2008, CURR OPIN PLANT BIOL, V11, P389, DOI 10.1016/j.pbi.2008.06.001; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Williams CM, 1997, SEX PLANT REPROD, V10, P83, DOI 10.1007/s004970050071; Wyatt SE, 2002, TRANSGENIC RES, V11, P1, DOI 10.1023/A:1013917701701	51	57	59	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11342	10.1371/journal.pone.0011342	http://dx.doi.org/10.1371/journal.pone.0011342			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596537	Green Published, gold			2022-12-27	WOS:000279259900015
J	Costa, MD; Bajanca, F; Rodrigues, AJ; Tome, RJ; Corthals, G; Macedo-Ribeiro, S; Paulson, HL; Logarinho, E; Maciel, P				Costa, Maria do Carmo; Bajanca, Fernanda; Rodrigues, Ana-Joao; Tome, Ricardo J.; Corthals, Garry; Macedo-Ribeiro, Sandra; Paulson, Henry L.; Logarinho, Elsa; Maciel, Patricia			Ataxin-3 Plays a Role in Mouse Myogenic Differentiation through Regulation of Integrin Subunit Levels	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; DEVELOPMENTAL EXPRESSION; DEUBIQUITINATING ENZYMES; C-ELEGANS; PROTEIN; GENE; UBIQUITINATION; BINDING; DEGRADATION; PROTEASOME	Background: During myogenesis several transcription factors and regulators of protein synthesis and assembly are rapidly degraded by the ubiquitin-proteasome system (UPS). Given the potential role of the deubiquitinating enzyme (DUB) ataxin3 in the UPS, and the high expression of the murine ataxin-3 homolog in muscle during embryogenesis, we sought to define its role in muscle differentiation. Methodology/Principal Findings: Using immunofluorescence analysis, we found murine ataxin-3 (mATX3) to be highly expressed in the differentiated myotome of E9.5 mouse embryos. C2C12 myoblasts depleted of mATX3 by RNA interference exhibited a round morphology, cell misalignment, and a delay in differentiation following myogenesis induction. Interestingly, these cells showed a down-regulation of alpha 5 and alpha 7 integrin subunit levels both by immunoblotting and immunofluorescence. Mouse ATX3 was found to interact with a5 integrin subunit and to stabilize this protein by repressing its degradation through the UPS. Proteomic analysis of mATX3-depleted C2C12 cells revealed alteration of the levels of several proteins related to integrin signaling. Conclusions: Ataxin-3 is important for myogenesis through regulation of integrin subunit levels.	[Costa, Maria do Carmo; Bajanca, Fernanda; Rodrigues, Ana-Joao; Logarinho, Elsa; Maciel, Patricia] Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal; [Costa, Maria do Carmo; Paulson, Henry L.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Tome, Ricardo J.; Macedo-Ribeiro, Sandra; Logarinho, Elsa] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Corthals, Garry] Turku Ctr Biotechnol, Turku, Finland	Universidade do Minho; University of Michigan System; University of Michigan; Universidade do Porto; University of Turku	Costa, MD (corresponding author), Univ Minho, Life & Hlth Sci Res Inst ICVS, Sch Hlth Sci, Braga, Portugal.	pmaciel@ecsaude.uminho.pt	Maciel, Patrícia/B-5989-2009; Corthals, Garry/G-9417-2016; Rodrigues, Ana/GYQ-6273-2022; Macedo-Ribeiro, Sandra/D-9258-2011; Maciel, Patricia/AAH-2102-2020; Rodrigues, Ana João/D-3782-2012; Logarinho, Elsa/I-5616-2013	Maciel, Patrícia/0000-0002-0920-6350; Corthals, Garry/0000-0001-9423-5596; Macedo-Ribeiro, Sandra/0000-0002-7698-1170; Maciel, Patricia/0000-0002-0920-6350; Rodrigues, Ana João/0000-0003-1968-7968; Logarinho, Elsa/0000-0002-8741-0744; Pereira da Costa, Maria do Carmo/0000-0001-8466-4864; Bajanca, Fernanda/0000-0001-8846-6611	Fundacao para a Ciencia e a Tecnologia (FCT) [POCI/SAU-MMO/60412/2002, SFRH/BD/9759/2003, SFRH/BPD/28560/2006, SFRH/BPD/17368/2004, SFRH/BD/17066/2004, SFRH/BD/29947/2006]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [RO1 NS038712]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038712] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was financed by the Fundacao para a Ciencia e a Tecnologia (FCT) (POCI/SAU-MMO/60412/2002) and by National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) grant RO1 NS038712 to HLP. MCC, FB, AJR, and RJT were supported by the FCT fellowships (SFRH/BD/9759/2003 and SFRH/BPD/28560/2006), (SFRH/BPD/17368/2004), (SFRH/BD/17066/2004), (SFRH/BD/29947/2006), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajanca F, 2004, DEV DYNAM, V231, P402, DOI 10.1002/dvdy.20136; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Cachaco AS, 2005, DEV DYNAM, V232, P1069, DOI 10.1002/dvdy.20280; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chow MKM, 2004, BIOCHEM BIOPH RES CO, V322, P387, DOI 10.1016/j.bbrc.2004.07.131; Costa MD, 2004, GENOMICS, V84, P361, DOI 10.1016/j.ygeno.2004.02.012; COUTINHO P, 1978, NEUROLOGY, V28, P703, DOI 10.1212/WNL.28.7.703; Doss-Pepe EW, 2003, MOL CELL BIOL, V23, P6469, DOI 10.1128/MCB.23.18.6469-6483.2003; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Ferro A, 2007, BBA-MOL CELL RES, V1773, P1619, DOI 10.1016/j.bbamcr.2007.07.012; Fukushige T, 2006, GENE DEV, V20, P3395, DOI 10.1101/gad.1481706; Gales L, 2005, J MOL BIOL, V353, P642, DOI 10.1016/j.jmb.2005.08.061; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Gu YF, 2006, I C FIELD PROG LOGIC, P21, DOI 10.1109/FPL.2006.311190; GULLBERG D, 1998, FRONT BIOSCI, V3, P1039; Hynes RO, 1996, DEV BIOL, V180, P402, DOI 10.1006/dbio.1996.0314; Kaabeche K, 2005, J CELL SCI, V118, P1223, DOI 10.1242/jcs.01679; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Lee HJ, 2006, GENE EXPR PATTERNS, V6, P277, DOI 10.1016/j.modgep.2005.07.007; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; NAKANO KK, 1972, NEUROLOGY, V22, P49, DOI 10.1212/WNL.22.1.49; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Noren NK, 2004, CELL SIGNAL, V16, P655, DOI 10.1016/j.cellsig.2003.10.006; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Rodrigues AJ, 2007, FASEB J, V21, P1126, DOI 10.1096/fj.06-7002com; Rodrigues AJ, 2009, BIOCHEM BIOPH RES CO, V386, P575, DOI 10.1016/j.bbrc.2009.06.092; ROSENBERG RN, 1976, NEUROLOGY, V26, P703, DOI 10.1212/WNL.26.8.703; RUDNICKI MA, 1995, BIOESSAYS, V17, P203, DOI 10.1002/bies.950170306; Schmitt I, 2007, BIOCHEM BIOPH RES CO, V362, P734, DOI 10.1016/j.bbrc.2007.08.062; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Shen Lu, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P40; Shiraishi S, 2007, J BIOL CHEM, V282, P9017, DOI 10.1074/jbc.M611513200; Sporle R, 2001, DEV GENES EVOL, V211, P198, DOI 10.1007/s004270100139; Spurny R, 2007, J BIOL CHEM, V282, P8175, DOI 10.1074/jbc.M608473200; Sun JJ, 2004, J BIOL CHEM, V279, P42936, DOI 10.1074/jbc.M406493200; Todi SV, 2009, EMBO J, V28, P372, DOI 10.1038/emboj.2008.289; Tomczak KK, 2003, FASEB J, V17, P403, DOI 10.1096/f.03-0568fje; Tzvetkov N, 2007, BIOL CHEM, V388, P973, DOI 10.1515/BC.2007.107; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; WANG H, 2007, J NEUROCHEM; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Webb DJ, 2007, J BIOL CHEM, V282, P6929, DOI 10.1074/jbc.M610981200; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164	60	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11728	10.1371/journal.pone.0011728	http://dx.doi.org/10.1371/journal.pone.0011728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668528	gold, Green Submitted, Green Published			2022-12-27	WOS:000280243800008
J	Gawlik, KI; Akerlund, M; Carmignac, V; Elamaa, H; Durbeej, M				Gawlik, Kinga I.; Akerlund, Mikael; Carmignac, Virginie; Elamaa, Harri; Durbeej, Madeleine			Distinct Roles for Laminin Globular Domains in Laminin alpha 1 Chain Mediated Rescue of Murine Laminin alpha 2 Chain Deficiency	PLOS ONE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; BASEMENT-MEMBRANE; SKELETAL-MUSCLE; SCHWANN-CELLS; LAMININ-ALPHA-1 CHAIN; PERIPHERAL NEUROPATHY; INTEGRIN ALPHA-7-BETA-1; REGENERATIVE CAPACITY; DYSTROGLYCAN BINDING; SULFATIDE BINDING	Background: Laminin alpha 2 chain mutations cause congenital muscular dystrophy with dysmyelination neuropathy (MDC1A). Previously, we demonstrated that laminin alpha 1 chain ameliorates the disease in mice. Dystroglycan and integrins are major laminin receptors. Unlike laminin alpha 2 chain, alpha 1 chain binds the receptors by separate domains; laminin globular (LG) domains 4 and LG1-3, respectively. Thus, the laminin alpha 1 chain is an excellent tool to distinguish between the roles of dystroglycan and integrins in the neuromuscular system. Methodology/Principal Findings: Here, we provide insights into the functions of laminin alpha 1LG domains and the division of their roles in MDC1A pathogenesis and rescue. Overexpression of laminin alpha 1 chain that lacks the dystroglycan binding LG4-5 domains in alpha 2 chain deficient mice resulted in prolonged lifespan and improved health. Importantly, diaphragm and heart muscles were corrected, whereas limb muscles were dystrophic, indicating that different muscles have different requirements for LG4-5 domains. Furthermore, the regenerative capacity of the skeletal muscle did not depend on laminin alpha 1LG4-5. However, this domain was crucial for preventing apoptosis in limb muscles, essential for myelination in peripheral nerve and important for basement membrane assembly. Conclusions/Significance: These results show that laminin alpha 1LG domains and consequently their receptors have disparate functions in the neuromuscular system. Understanding these interactions could contribute to design and optimization of future medical treatment for MDC1A patients.	[Gawlik, Kinga I.; Akerlund, Mikael; Carmignac, Virginie; Elamaa, Harri; Durbeej, Madeleine] Lund Univ, Muscle Biol Unit, Dept Expt Med Sci, Lund, Sweden	Lund University	Gawlik, KI (corresponding author), Lund Univ, Muscle Biol Unit, Dept Expt Med Sci, Lund, Sweden.	madeleine.durbeej-hjalt@med.lu.se		Durbeej Hjalt, Madeleine/0000-0002-5491-2457	Association Francaise contre les Myopathies; Muscular Dystrophy Association; Anna-Greta Crafoord Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Muscular Dystrophy Association(Muscular Dystrophy Association); Anna-Greta Crafoord Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Funded by Association Francaise contre les Myopathies, Muscular Dystrophy Association, Anna-Greta Crafoord Foundation for Rheumatological Research, Greta and Johan Kock Foundation and Alfred Osterlund Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Allikian MJ, 2004, J CELL SCI, V117, P3821, DOI 10.1242/jcs.01234; Andac Z, 1999, J MOL BIOL, V287, P253, DOI 10.1006/jmbi.1999.2606; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207; Cohn RD, 1999, J NEUROL SCI, V163, P140, DOI 10.1016/S0022-510X(99)00012-X; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Dupree JL, 1998, J NEUROCYTOL, V27, P649, DOI 10.1023/A:1006908013972; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190; Gawlik KI, 2006, FEBS LETT, V580, P1759, DOI 10.1016/j.febslet.2006.02.027; GAWLIK KI, 2010, MUSCLE NERV IN PRESS; Gawlik KI, 2006, HUM MOL GENET, V15, P2690, DOI 10.1093/hmg/ddl201; Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928; Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523; Goutebroze L, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-29; Guo C, 2006, HUM MOL GENET, V15, P989, DOI 10.1093/hmg/ddl018; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; Han R, 2009, P NATL ACAD SCI USA, V106, P12573, DOI 10.1073/pnas.0906545106; Harrison D, 2007, J BIOL CHEM, V282, P11573, DOI 10.1074/jbc.M610657200; Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; JAROS E, 1979, NEUROPATH APPL NEURO, V5, P133, DOI 10.1111/j.1365-2990.1979.tb00666.x; Jimenez-Mallebrera C, 2009, BRAIN PATHOL, V19, P596, DOI 10.1111/j.1750-3639.2008.00198.x; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; LEE EC, 1992, J CELL BIOL, V117, P671, DOI 10.1083/jcb.117.3.671; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098; Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986; Marcus J, 2006, GLIA, V53, P372, DOI 10.1002/glia.20292; Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200; Mckee KK, 2007, J BIOL CHEM, V282, P21437, DOI 10.1074/jbc.M702963200; Mckee KK, 2009, J BIOL CHEM, V284, P8984, DOI 10.1074/jbc.M809719200; Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152; Miner JH, 2008, MICROSC RES TECHNIQ, V71, P349, DOI 10.1002/jemt.20563; MIRSKY R, 1990, DEVELOPMENT, V109, P105; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Mukasa T, 1999, BIOCHEM BIOPH RES CO, V260, P139, DOI 10.1006/bbrc.1999.0829; Nakagawa M, 2001, GLIA, V35, P101, DOI 10.1002/glia.1075; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nodari A, 2008, J NEUROSCI, V28, P6714, DOI 10.1523/JNEUROSCI.0326-08.2008; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Previtali SC, 2003, MOL CELL NEUROSCI, V23, P210, DOI 10.1016/S1044-7431(03)00014-9; Previtali SC, 2003, J NEUROSCI, V23, P5520; Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102; Quijano-Roy S, 2004, MUSCLE NERVE, V29, P292, DOI 10.1002/mus.10544; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; Rooney JE, 2009, AM J PATHOL, V174, P256, DOI 10.2353/ajpath.2009.080522; Saito F, 2003, NEURON, V38, P747, DOI 10.1016/S0896-6273(03)00301-5; Sander S, 2000, J NEUROL NEUROSUR PS, V68, P483, DOI 10.1136/jnnp.68.4.483; Satz JS, 2008, J NEUROSCI, V28, P10567, DOI 10.1523/JNEUROSCI.2457-08.2008; Scheele S, 2005, P NATL ACAD SCI USA, V102, P1502, DOI 10.1073/pnas.0405095102; Sciandra F, 2007, TRENDS BIOTECHNOL, V25, P262, DOI 10.1016/j.tibtech.2007.04.002; SHORER Z, 1995, J CHILD NEUROL, V10, P472, DOI 10.1177/088307389501000610; Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200; SOROKIN L, 1990, J CELL BIOL, V111, P1265, DOI 10.1083/jcb.111.3.1265; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; SUNADA Y, 1995, HUM MOL GENET, V4, P1055, DOI 10.1093/hmg/4.6.1055; Suzuki N, 2003, BIOCHEMISTRY-US, V42, P12625, DOI 10.1021/bi030014s; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432; Tsiper MV, 2002, J CELL SCI, V115, P1005; Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716; VOIT T, 2004, MYOLOGY, P1203; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; von der Mark H, 2007, J MOL BIOL, V371, P1188, DOI 10.1016/j.jmb.2007.05.074; WILLIAMS RW, 1986, J COMP NEUROL, V246, P32, DOI 10.1002/cne.902460104; Wizemann H, 2003, J MOL BIOL, V332, P635, DOI 10.1016/S0022-2836(03)00848-9; XU H, 1994, P NATL ACAD SCI USA, V91, P5572, DOI 10.1073/pnas.91.12.5572; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158; Yurchenco PD, 2004, J CELL SCI, V117, P735, DOI 10.1242/jcs.00911	79	32	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11549	10.1371/journal.pone.0011549	http://dx.doi.org/10.1371/journal.pone.0011549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657839	Green Published, gold, Green Submitted			2022-12-27	WOS:000280065600003
J	Hunter, MJ; Treharne, KJ; Winter, AK; Cassidy, DM; Land, S; Mehta, A				Hunter, Mairi J.; Treharne, Kate J.; Winter, Alexandra K.; Cassidy, Diane M.; Land, Stephen; Mehta, Anil			Expression of Wild-Type CFTR Suppresses NF-kappa B-Driven Inflammatory Signalling	PLOS ONE			English	Article							CYSTIC-FIBROSIS GENE; PROTEIN-KINASE CK2; TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; UP-REGULATION; CL-CHANNEL; IDENTIFICATION; ACTIVATION; INHIBITION	Background: Mutation of the cystic fibrosis transmembrane-conductance regulator (CFTR) causes cystic fibrosis (CF) but not all CF aspects can easily be explained by deficient ion transport. CF-inflammation provides one example but its pathogenesis remains controversial. Here, we tested the simple but fundamental hypothesis that wild-type CFTR is needed to suppress NF-kappa B activity. Methodology/Principal Findings: In lung epithelial (H441) and engineered (H57) cell lines; we report that inflammatory markers are significantly suppressed by wild-type CFTR. Transient-transfection of wild-type CFTR into CFTR-naive H441 cells, dose-dependently down-regulates both basal and Tumour Necrosis Factor-alpha evoked NF-kappa B activity when compared to transfection with empty vector alone (p < 0.01, n > 5). This effect was also observed in CFTR-naive H57-HeLa cells which stably express a reporter of NF-kappa B activity, confirming that the CFTR-mediated repression of inflammation was not due to variable reporter gene transfection efficiency. In contrast, H57 cells transfected with a control cyano-fluorescent protein show a significantly elevated basal level of NF-kappa B activity above control. Initial cell seeding density may be a critical factor in mediating the suppressive effects of CFTR on inflammation as only at a certain density (1 x 10(5) cells/well) did we observe the reduction in NF-kappa B activity. CFTR channel activity may be necessary for this suppression because the CFTR specific inhibitor CFTRinh172 significantly stimulates NF-kappa B activity by similar to 30% in CFTR expressing 16HBE14o- cells whereas pharmacological elevation of cyclic-AMP depresses activity by similar to 25% below baseline. Conclusions/Significance: These data indicate that CFTR has inherent anti-inflammatory properties. We propose that the hyper-inflammation found in CF may arise as a consequence of disrupted repression of NF-kappa B signalling which is normally mediated by CFTR. Our data therefore concur with in vivo and in vitro data from Vij and colleagues which highlights CFTR as a suppressor of basal inflammation acting through NF-kappa B, a central hub in inflammatory signalling.	[Hunter, Mairi J.; Treharne, Kate J.; Winter, Alexandra K.; Cassidy, Diane M.; Land, Stephen; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland	University of Dundee	Hunter, MJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Med Sci, Dundee DD1 9SY, Scotland.	a.mehta@dundee.ac.uk		Land, Stephen/0000-0001-9216-5969	CF [Trust-PJ538]; Wellcome Trust [075237]; Chest Research-Education Fund	CF; Wellcome Trust(Wellcome TrustEuropean Commission); Chest Research-Education Fund	CF Trust-PJ538 (MJH) www.cftrust.org.uk, Wellcome Trust (075237) (KJT/DC) www.wellcome.ac.uk and the Chest Research-Education Fund (AW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachhuber T, 2008, J BIOL CHEM, V283, P13225, DOI 10.1074/jbc.M704532200; Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003; Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; Carrabino S, 2006, J CYST FIBROS, V5, P113, DOI 10.1016/j.jcf.2005.12.003; Comer DM, 2009, QJM-INT J MED, V102, P793, DOI 10.1093/qjmed/hcp120; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dechecchi MC, 2007, AM J RESP CELL MOL, V36, P615, DOI 10.1165/rcmb.2006-0200OC; DECHECCHI MC, 2008, J CYST FIBROS; DiMango E, 1998, J CLIN INVEST, V101, P2598, DOI 10.1172/JCI2865; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; Eidelman O, 2001, MOL MED, V7, P523, DOI 10.1007/BF03401858; Hallows KR, 2006, J BIOL CHEM, V281, P4231, DOI 10.1074/jbc.M511029200; Kalin N, 1999, J CLIN INVEST, V103, P1379, DOI 10.1172/JCI5731; Kelly M, 2010, J PHARMACOL EXP THER, V333, P60, DOI 10.1124/jpet.109.162032; Kerbiriou M, 2007, BBA-MOL BASIS DIS, V1772, P1236, DOI 10.1016/j.bbadis.2007.10.004; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kongsuphol P, 2009, J BIOL CHEM, V284, P5645, DOI 10.1074/jbc.M806780200; Kramer BW, 2009, SEMIN FETAL NEONAT M, V14, P2, DOI 10.1016/j.siny.2008.08.011; Land SC, 2004, AM J PHYSIOL-LUNG C, V286, pL473, DOI 10.1152/ajplung.00401.2002; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Marcorelles P, 2007, PEDIATR PULM, V42, P1032, DOI 10.1002/ppul.20690; Muhlebach MS, 1999, AM J RESP CRIT CARE, V160, P186, DOI 10.1164/ajrccm.160.1.9808096; Muselet-Charlier C, 2007, BIOCHEM BIOPH RES CO, V357, P402, DOI 10.1016/j.bbrc.2007.03.141; Nagayama S, 1999, FEBS LETT, V455, P215, DOI 10.1016/S0014-5793(99)00880-7; Noah TL, 1997, J INFECT DIS, V175, P638, DOI 10.1093/infdis/175.3.638; Pagano MA, 2008, BIOCHEMISTRY-US, V47, P7925, DOI 10.1021/bi800316z; Pagano MA, 2010, BIOCHEM J, V426, P19, DOI 10.1042/BJ20090813; Perez A, 2007, AM J PHYSIOL-LUNG C, V292, pL383, DOI 10.1152/ajplung.00403.2005; Perez Aura, 2004, Journal of Structural and Functional Genomics, V5, P179, DOI 10.1023/B:JSFG.0000028982.59273.bd; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rae C, 2006, BIOCHEM BIOPH RES CO, V349, P416, DOI 10.1016/j.bbrc.2006.08.067; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Schwiebert LM, 1999, AM J PHYSIOL-CELL PH, V276, pC700, DOI 10.1152/ajpcell.1999.276.3.C700; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Singh NN, 2008, J MOL MED, V86, P887, DOI 10.1007/s00109-008-0352-0; Srivastava M, 1999, MOL MED, V5, P753, DOI 10.1007/BF03402099; Stanke F, 2006, HUM GENET, V119, P331, DOI 10.1007/s00439-006-0140-2; Tabary O, 1998, AM J PATHOL, V153, P921, DOI 10.1016/S0002-9440(10)65633-7; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Treharne KJ, 2009, MOL CELL BIOCHEM, V329, P107, DOI 10.1007/s11010-009-0118-1; TREZISE AEO, 1993, HUM MOL GENET, V2, P213, DOI 10.1093/hmg/2.3.213; Venkatakrishnan A, 2000, AM J RESP CELL MOL, V23, P396, DOI 10.1165/ajrcmb.23.3.3949; Verhaeghe C, 2007, J CYST FIBROS, V6, P304, DOI 10.1016/j.jcf.2006.12.001; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Weber AJ, 2001, AM J PHYSIOL-LUNG C, V281, pL71, DOI 10.1152/ajplung.2001.281.1.L71; Welsh M., 2001, SCRIVER, P5121	51	52	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11598	10.1371/journal.pone.0011598	http://dx.doi.org/10.1371/journal.pone.0011598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644644	Green Published, Green Submitted, gold			2022-12-27	WOS:000279884900028
J	Hesling, I; Dilharreguy, B; Peppe, S; Amirault, M; Bouvard, M; Allard, M				Hesling, Isabelle; Dilharreguy, Bixente; Peppe, Sue; Amirault, Marion; Bouvard, Manuel; Allard, Michele			The Integration of Prosodic Speech in High Functioning Autism: A Preliminary fMRI Study	PLOS ONE			English	Article							LISTENING PREFERENCES; EMOTIONAL PROSODY; RIGHT-HEMISPHERE; DEFAULT MODE; CHILDREN; BRAIN; COMPREHENSION; PERCEPTION; NETWORKS; PITCH	Background: Autism is a neurodevelopmental disorder characterized by a specific triad of symptoms such as abnormalities in social interaction, abnormalities in communication and restricted activities and interests. While verbal autistic subjects may present a correct mastery of the formal aspects of speech, they have difficulties in prosody (music of speech), leading to communication disorders. Few behavioural studies have revealed a prosodic impairment in children with autism, and among the few fMRI studies aiming at assessing the neural network involved in language, none has specifically studied prosodic speech. The aim of the present study was to characterize specific prosodic components such as linguistic prosody (intonation, rhythm and emphasis) and emotional prosody and to correlate them with the neural network underlying them. Methodology/Principal Findings: We used a behavioural test (Profiling Elements of the Prosodic System, PEPS) and fMRI to characterize prosodic deficits and investigate the neural network underlying prosodic processing. Results revealed the existence of a link between perceptive and productive prosodic deficits for some prosodic components (rhythm, emphasis and affect) in HFA and also revealed that the neural network involved in prosodic speech perception exhibits abnormal activation in the left SMG as compared to controls (activation positively correlated with intonation and emphasis) and an absence of deactivation patterns in regions involved in the default mode. Conclusions/Significance: These prosodic impairments could not only result from activation patterns abnormalities but also from an inability to adequately use the strategy of the default network inhibition, both mechanisms that have to be considered for decreasing task performance in High Functioning Autism.	[Hesling, Isabelle; Dilharreguy, Bixente; Amirault, Marion; Bouvard, Manuel; Allard, Michele] Univ Victor Segalen, Lab Imagerie Mol & Fonctionnelle, CNRS, UMR 5231, Bordeaux, France; [Peppe, Sue] Queen Margaret Univ Coll, Edinburgh, Midlothian, Scotland; [Bouvard, Manuel] CHRS, Bordeaux, France; [Allard, Michele] EPHE, F-75006 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Queen Margaret University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Hesling, I (corresponding author), Univ Victor Segalen, Lab Imagerie Mol & Fonctionnelle, CNRS, UMR 5231, Bordeaux, France.	isabelle.hesling@wanadoo.fr	ALLARD, Michèle/D-8538-2014	dilharreguy, bixente/0000-0002-7771-1383; Hesling, Isabelle/0000-0002-3719-983X	Fondation de France Recherche Autisme [2006 012484]	Fondation de France Recherche Autisme	This study was supported by the Fondation de France Recherche Autisme 2006 012484. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*APA, 1994, DSM 4 DIAGN STAT MAN; Baddeley AD, 1992, SPEED CAPACITY LANGU; BALTAXE CSJ, 1985, PROSODIC DEV NORMAL, P95; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Bonnel A, 2003, J COGNITIVE NEUROSCI, V15, P226, DOI 10.1162/089892903321208169; Breitenstein C, 1998, BRAIN LANG, V65, P243; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Buchanan L, 2000, BRAIN COGNITION, V43, P65; Burack J., 2001, DEV AUTISM PERSPECTI; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Fay W.H., 1980, EMERGING LANGUAGE AU; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; George MS, 1996, ARCH NEUROL-CHICAGO, V53, P665, DOI 10.1001/archneur.1996.00550070103017; Gervais H, 2004, NAT NEUROSCI, V7, P801, DOI 10.1038/nn1291; Grady CL, 2010, CEREB CORTEX, V20, P1432, DOI 10.1093/cercor/bhp207; Groen WB, 2009, J AUTISM DEV DISORD, V39, P742, DOI 10.1007/s10803-008-0682-3; Guberina P, 1981, VERBOTONAL METHOD RE; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Heaton P, 2008, AUTISM, V12, P203, DOI 10.1177/1362361307085270; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Imaizumi S, 1997, NEUROREPORT, V8, P2809, DOI 10.1097/00001756-199708180-00031; Jarvinen-Pasley A, 2008, DEVELOPMENTAL SCI, V11, P109, DOI 10.1111/j.1467-7687.2007.00644.x; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; KLIN A, 1991, J AUTISM DEV DISORD, V21, P29, DOI 10.1007/BF02206995; KLIN A, 1992, J CHILD PSYCHOL PSYC, V33, P763, DOI 10.1111/j.1469-7610.1992.tb00911.x; Korpilahti P, 2007, J AUTISM DEV DISORD, V37, P1539, DOI 10.1007/s10803-006-0271-2; Kuhl PK, 2005, DEVELOPMENTAL SCI, V8, pF1, DOI 10.1111/j.1467-7687.2004.00384.x; Kujala T, 2005, NEUROSCI LETT, V383, P260, DOI 10.1016/j.neulet.2005.04.048; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; Lepisto T, 2008, BIOL PSYCHOL, V77, P25, DOI 10.1016/j.biopsycho.2007.08.010; Luna B, 2002, NEUROLOGY, V59, P834, DOI 10.1212/WNL.59.6.834; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Muller RA, 1997, NEUROREPORT, V8, P3767; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Paul R, 2005, J AUTISM DEV DISORD, V35, P861, DOI 10.1007/s10803-005-0031-8; Paul R, 2005, J AUTISM DEV DISORD, V35, P205, DOI 10.1007/s10803-004-1999-1; Peppe S, 2003, CLIN LINGUIST PHONET, V17, P345, DOI 10.1080/0269920031000079994; Peppe S, 2006, J PRAGMATICS, V38, P1776, DOI 10.1016/j.pragma.2005.07.004; Peppe S, 2007, J SPEECH LANG HEAR R, V50, P1015, DOI 10.1044/1092-4388(2007/071); Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; Pierce K, 2004, BRAIN, V127, P2703, DOI 10.1093/brain/awh289; Plante E, 2006, BRAIN LANG, V97, P332, DOI 10.1016/j.bandl.2005.12.004; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Ross ED, 1997, BRAIN LANG, V56, P27, DOI 10.1006/brln.1997.1731; Russo NM, 2008, CLIN NEUROPHYSIOL, V119, P1720, DOI 10.1016/j.clinph.2008.01.108; Samson F, 2006, J AUTISM DEV DISORD, V36, P65, DOI 10.1007/s10803-005-0043-4; SAUSSURE FD, 1976, COURS LINGUISTIQUE G; Schlosser MJ, 1998, HUM BRAIN MAPP, V6, P1, DOI 10.1002/(SICI)1097-0193(1998)6:1<1::AID-HBM1>3.0.CO;2-7; Shriberg LD, 2001, J SPEECH LANG HEAR R, V44, P1097, DOI 10.1044/1092-4388(2001/087); Shriberg LD., 1990, PROSODY VOICE SCREEN; TAGERFLUSBERG H, 1981, J AUTISM DEV DISORD, V11, P45, DOI 10.1007/BF01531340; Tesink CMJY, 2009, BRAIN, V132, P1941, DOI 10.1093/brain/awp103; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Young EC, 2005, LANG SPEECH HEAR SER, V36, P62, DOI 10.1044/0161-1461(2005/006); ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29	66	37	38	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11571	10.1371/journal.pone.0011571	http://dx.doi.org/10.1371/journal.pone.0011571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644633	Green Published, Green Submitted, gold			2022-12-27	WOS:000279822300021
J	Kalushkova, A; Fryknas, M; Lemaire, M; Fristedt, C; Agarwal, P; Eriksson, M; Deleu, S; Atadja, P; Osterborg, A; Nilsson, K; Vanderkerken, K; Oberg, F; Jernberg-Wiklund, H				Kalushkova, Antonia; Fryknas, Marten; Lemaire, Miguel; Fristedt, Charlotte; Agarwal, Prasoon; Eriksson, Maria; Deleu, Sarah; Atadja, Peter; Osterborg, Anders; Nilsson, Kenneth; Vanderkerken, Karin; Oberg, Fredrik; Jernberg-Wiklund, Helena			Polycomb Target Genes Are Silenced in Multiple Myeloma	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; MONOCLONAL GAMMOPATHY; DNA METHYLATION; UNDETERMINED SIGNIFICANCE; EXPRESSION SIGNATURE; CANCER-CELLS; LONG-TERM; EZH2; MECHANISMS; MUTATIONS	Multiple myeloma (MM) is a genetically heterogeneous disease, which to date remains fatal. Finding a common mechanism for initiation and progression of MM continues to be challenging. By means of integrative genomics, we identified an underexpressed gene signature in MM patient cells compared to normal counterpart plasma cells. This profile was enriched for previously defined H3K27-tri-methylated genes, targets of the Polycomb group (PcG) proteins in human embryonic fibroblasts. Additionally, the silenced gene signature was more pronounced in ISS stage III MM compared to stage I and II. Using chromatin immunoprecipitation (ChIP) assay on purified CD138+ cells from four MM patients and on two MM cell lines, we found enrichment of H3K27me3 at genes selected from the profile. As the data implied that the Polycomb-targeted gene profile would be highly relevant for pharmacological treatment of MM, we used two compounds to chemically revert the H3K27-tri-methylation mediated gene silencing. The S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin (DZNep) and the histone deacetylase inhibitor LBH589 (Panobinostat), reactivated the expression of genes repressed by H3K27me3, depleted cells from the PRC2 component EZH2 and induced apoptosis in human MM cell lines. In the immunocompetent 5T33MM in vivo model for MM, treatment with LBH589 resulted in gene upregulation, reduced tumor load and increased overall survival. Taken together, our results reveal a common gene signature in MM, mediated by gene silencing via the Polycomb repressor complex. The importance of the underexpressed gene profile in MM tumor initiation and progression should be subjected to further studies.	[Kalushkova, Antonia; Fryknas, Marten; Fristedt, Charlotte; Agarwal, Prasoon; Eriksson, Maria; Nilsson, Kenneth; Oberg, Fredrik; Jernberg-Wiklund, Helena] Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden; [Lemaire, Miguel; Deleu, Sarah; Vanderkerken, Karin] Vrije Univ Brussel, Dept Hematol & Immunol, Brussels, Belgium; [Atadja, Peter] Novartis Inst Biomed Res, Cambridge, MA USA; [Osterborg, Anders] Karolinska Univ Hosp Solna, Dept Hematol, Stockholm, Sweden	Uppsala University; Vrije Universiteit Brussel; Novartis; Karolinska Institutet; Karolinska University Hospital	Kalushkova, A (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, Uppsala, Sweden.	Helena.Jernberg_Wiklund@genpat.uu.se	Agarwal, Prasoon/H-8101-2019; Vanderkerken, Karin/I-3513-2013; Agarwal, Prasoon/D-7303-2016	Agarwal, Prasoon/0000-0003-1813-7606; Agarwal, Prasoon/0000-0003-1813-7606; Kalushkova, Antonia/0000-0003-4535-506X; Vanderkerken, Karin/0000-0002-2137-7179; Jernberg Wiklund, Helena/0000-0002-9319-7986	Swedish Cancer Society; Swedish Research Council; Multiple Myeloma Research Foundation; VonKantzows stiftelse; Stichting tegen Kanker; FWO-Vlaanderen; GOA-Vrije Universiteit Brussel	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Multiple Myeloma Research Foundation; VonKantzows stiftelse; Stichting tegen Kanker; FWO-Vlaanderen(FWO); GOA-Vrije Universiteit Brussel	This work was supported by grants from The Swedish Cancer Society, The Swedish Research Council, The Multiple Myeloma Research Foundation, VonKantzows stiftelse, Stichting tegen Kanker, FWO-Vlaanderen and GOA-Vrije Universiteit Brussel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli L, 2007, BRIT J HAEMATOL, V136, P565, DOI 10.1111/j.1365-2141.2006.06467.x; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buttitta LA, 2007, CURR OPIN CELL BIOL, V19, P697, DOI 10.1016/j.ceb.2007.10.004; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Croonquist PA, 2005, ONCOGENE, V24, P6269, DOI 10.1038/sj.onc.1208771; Fiskus W, 2006, MOL CANCER THER, V5, P3096, DOI 10.1158/1535-7163.MCT-06-0418; Fiskus W, 2009, BLOOD, V114, P2733, DOI 10.1182/blood-2009-03-213496; Ghosh N, 2001, J BIOL CHEM, V276, P15264, DOI 10.1074/jbc.M100862200; Hallek M, 1998, BLOOD, V91, P3, DOI 10.1182/blood.V91.1.3.3_3_21; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Holling TM, 2007, J IMMUNOL, V179, P5317, DOI 10.4049/jimmunol.179.8.5317; JERNBERGWIKLUND H, 1992, LEUKEMIA, V6, P310; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kondo Y, 2008, NAT GENET, V40, P741, DOI 10.1038/ng.159; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Maiso P, 2006, CANCER RES, V66, P5781, DOI 10.1158/0008-5472.CAN-05-4186; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; Mattioli M, 2005, ONCOGENE, V24, P2461, DOI 10.1038/sj.onc.1208447; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; RADL J, 1979, J IMMUNOL, V122, P609; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shaughnessy JD, 2007, BLOOD, V109, P2276, DOI 10.1182/blood-2006-07-038430; SIEGEL DD, 2008, ASH ANN M, P2781; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Tshuikina M, 2008, EXP HEMATOL, V36, P1673, DOI 10.1016/j.exphem.2008.08.001; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Vanderkerken K, 2003, IMMUNOL REV, V194, P196, DOI 10.1034/j.1600-065X.2003.00035.x; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yu J, 2007, CANCER RES, V67, P10657, DOI 10.1158/0008-5472.CAN-07-2498; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	52	75	80	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11483	10.1371/journal.pone.0011483	http://dx.doi.org/10.1371/journal.pone.0011483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634887	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300003
J	Palacios, G; Lovoll, M; Tengs, T; Hornig, M; Hutchison, S; Hui, J; Kongtorp, RT; Savji, N; Bussetti, AV; Solovyov, A; Kristoffersen, AB; Celone, C; Street, C; Trifonov, V; Hirschberg, DL; Rabadan, R; Egholm, M; Rimstad, E; Lipkin, WI				Palacios, Gustavo; Lovoll, Marie; Tengs, Torstein; Hornig, Mady; Hutchison, Stephen; Hui, Jeffrey; Kongtorp, Ruth-Torill; Savji, Nazir; Bussetti, Ana V.; Solovyov, Alexander; Kristoffersen, Anja B.; Celone, Christopher; Street, Craig; Trifonov, Vladimir; Hirschberg, David L.; Rabadan, Raul; Egholm, Michael; Rimstad, Espen; Lipkin, W. Ian			Heart and Skeletal Muscle Inflammation of Farmed Salmon Is Associated with Infection with a Novel Reovirus	PLOS ONE			English	Article							ATLANTIC SALMON; OUTBREAK	Atlantic salmon (Salmo salar L.) mariculture has been associated with epidemics of infectious diseases that threaten not only local production, but also wild fish coming into close proximity to marine pens and fish escaping from them. Heart and skeletal muscle inflammation (HSMI) is a frequently fatal disease of farmed Atlantic salmon. First recognized in one farm in Norway in 1999[1], HSMI was subsequently implicated in outbreaks in other farms in Norway and the United Kingdom[2]. Although pathology and disease transmission studies indicated an infectious basis, efforts to identify an agent were unsuccessful. Here we provide evidence that HSMI is associated with infection with piscine reovirus (PRV). PRV is a novel reovirus identified by unbiased high throughput DNA sequencing and a bioinformatics program focused on nucleotide frequency as well as sequence alignment and motif analyses. Formal implication of PRV in HSMI will require isolation in cell culture and fulfillment of Koch's postulates, or prevention or modification of disease through use of specific drugs or vaccines. Nonetheless, as our data indicate that a causal relationship is plausible, measures must be taken to control PRV not only because it threatens domestic salmon production but also due to the potential for transmission to wild salmon populations.	[Palacios, Gustavo; Hornig, Mady; Hui, Jeffrey; Savji, Nazir; Bussetti, Ana V.; Solovyov, Alexander; Street, Craig; Hirschberg, David L.; Lipkin, W. Ian] Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA; [Lovoll, Marie; Tengs, Torstein; Kristoffersen, Anja B.] Natl Vet Inst, Oslo, Norway; [Kongtorp, Ruth-Torill] Minist Fisheries & Coastal Affairs, Oslo, Norway; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY USA; [Trifonov, Vladimir; Rabadan, Raul] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY USA; [Rimstad, Espen] Norwegian Sch Vet Sci, Oslo, Norway	Columbia University; Norwegian Veterinary Institute; Columbia University; Columbia University; Norwegian University of Life Sciences	Palacios, G (corresponding author), Columbia Univ, Ctr Infect & Immun, New York, NY 10027 USA.	espen.rimstad@nvh.no; wil2001@columbia.edu	Hornig, Mady/AAE-8431-2020; Rabadan, Raul/AAZ-7367-2020; Palacios, Gustavo/I-7773-2015; Lipkin, W. Ian/ABE-6216-2020	Hornig, Mady/0000-0001-7572-3092; Palacios, Gustavo/0000-0001-5062-1938; Lipkin, W. Ian/0000-0002-8768-9386; Rabadan, Raul/0000-0001-7946-9255	National Institutes of Health [AI57158]; Google.org; Norwegian Research Council [186907, 178950]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Google.org(Google Incorporated); Norwegian Research Council(Research Council of NorwayEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI57158), Google.org and the Norwegian Research Council (Grant 186907 and 178950). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; Kongtorp RT, 2009, J FISH DIS, V32, P253, DOI 10.1111/j.1365-2761.2008.00983.x; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MERTENS P, 2005, FAMILY REOVIRIDAE FA; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas O, 1902, P ZOOL SOC LOND, V1902, P2; TRIFONOV V, MBIO UNPUB; Watanabe K, 2006, DIS AQUAT ORGAN, V70, P183, DOI 10.3354/dao070183	22	175	187	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11487	10.1371/journal.pone.0011487	http://dx.doi.org/10.1371/journal.pone.0011487			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634888	Green Published, gold			2022-12-27	WOS:000279715300004
J	Bernard, E; Solignat, M; Gay, B; Chazal, N; Higgs, S; Devaux, C; Briant, L				Bernard, Eric; Solignat, Maxime; Gay, Bernard; Chazal, Nathalie; Higgs, Stephen; Devaux, Christian; Briant, Laurence			Endocytosis of Chikungunya Virus into Mammalian Cells: Role of Clathrin and Early Endosomal Compartments	PLOS ONE			English	Article							MOSQUITO CELLS; LOW PH; ENTRY; INFECTION; EPIDEMIC; CHOLESTEROL; OUTBREAK; RAB5; ALPHAVIRUSES; CYTOSKELETON	Background: The replicative cycle of chikungunya virus (CHIKV), an alphavirus that recently re-emerged in India and in Indian Ocean area, remains mostly unknown. The aim of the present study was to investigate the intracellular trafficking pathway(s) hijacked by CHIKV to enter mammalian cells. Methodology/Principal Findings: Entry pathways were investigated using a variety of pharmacological inhibitors or overexpression of dominant negative forms of proteins perturbating cellular endocytosis. We found that CHIKV infection of HEK293T mammalian cells is independent of clathrin heavy chain and-dependent of functional Eps15, and requires integrity of Rab5-, but not Rab7-positive endosomal compartment. Cytoskeleton integrity is crucial as cytochalasin D and nocodazole significantly reduced infection of the cells. Finally, both methyl beta-cyclodextrin and lysomotropic agents impaired CHIKV infection, supporting that a cholesterol-, pH-dependent step is required to achieve productive infection. Interestingly, differential sensitivity to lysomotropic agents was observed between the prototypal 37997 African strain of CHIKV and the LR-OPY1 virus isolated from the recent outbreak in Reunion Island. Conclusions: Together our data indicate that CHIKV entry in its target cells is essentially mediated by clathrin-independent, Eps15-dependent endocytosis. Despite that this property is shared by the prototypal 37997 African strain of CHIKV and the LR-OPY1 virus isolated from the recent outbreak in La Reunion Island, differential sensitivity to lysomotropic agents may support that the LR-OPY1 strain has acquired specific entry mechanisms.	[Bernard, Eric; Solignat, Maxime; Gay, Bernard; Chazal, Nathalie; Devaux, Christian; Briant, Laurence] Univ Montpellier I, CNRS, UMR5236, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France; [Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Higgs, Stephen] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bernard, E (corresponding author), Univ Montpellier I, CNRS, UMR5236, Ctr Etud Agents Pathogenes & Biotechnol Sante CPB, Montpellier, France.	Laurence.briant@univ-montp1.fr	Chazal, Nathalie/AAH-2937-2021; Briant, Laurence/AAB-9281-2021	Chazal, Nathalie/0000-0002-1528-9607; Briant, Laurence/0000-0002-1995-3501	Centre National de la Recherche Scientifique (CNRS) and University of Montpellier; French ANR; National Institutes of Health (NIH) [AI R21 AI073389]; Centre National de la Recherche Scientifique-Delegation Generale pour l'Armement (CNRS-DGA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073389] Funding Source: NIH RePORTER	Centre National de la Recherche Scientifique (CNRS) and University of Montpellier(Centre National de la Recherche Scientifique (CNRS)); French ANR(French National Research Agency (ANR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique-Delegation Generale pour l'Armement (CNRS-DGA)(Centre National de la Recherche Scientifique (CNRS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by institutional funds from the Centre National de la Recherche Scientifique (CNRS) and University of Montpellier and a grant from the French ANR. SH was supported in part by funding from the National Institutes of Health (NIH) AI R21 AI073389. MS is supported by a Centre National de la Recherche Scientifique-Delegation Generale pour l'Armement (CNRS-DGA) PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Ashok A, 2003, J VIROL, V77, P1347, DOI 10.1128/JVI.77.2.1347-1356.2003; Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161; Benmerah A, 1999, J CELL SCI, V112, P1303; Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; *CAREC, 2006, CHIK MART FRENCH GUY, V26, P17; Chastel Claude, 2005, Bull Acad Natl Med, V189, P1827; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; DEPOORTERE E, 2006, EUROSURVEILLANCE, V11, P2; Durrbach A, 1996, J CELL SCI, V109, P457; FAN DP, 1978, CELL, V15, P985, DOI 10.1016/0092-8674(78)90282-9; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; GREISERWILKE I, 1989, J GEN VIROL, V70, P743, DOI 10.1099/0022-1317-70-3-743; HAMMON WM, 1960, T ASSOC AM PHYSICIAN, V73, P140; Hernandez R, 2001, J VIROL, V75, P2010, DOI 10.1128/JVI.75.4.2010-2013.2001; HIGASHI N, 1967, VIROLOGY, V33, P55, DOI 10.1016/0042-6822(67)90093-1; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Hunter AW, 2000, J CELL SCI, V113, P4379; *INVS, 2006, EP CHIK REUN POINT S; Karabatsos N., 1985, INT CATALOGUE ARBOVI; KIELIAN M, 1990, MOL BIOL MED, V7, P17; KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6; Kolokoltsov AA, 2006, VIROLOGY, V347, P333, DOI 10.1016/j.virol.2005.11.051; Kumar NP, 2008, J GEN VIROL, V89, P1945, DOI 10.1099/vir.0.83628-0; Lamaze C, 1997, J BIOL CHEM, V272, P20332, DOI 10.1074/jbc.272.33.20332; Laras K, 2005, T ROY SOC TROP MED H, V99, P128, DOI 10.1016/j.trstmh.2004.03.013; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARSH M, 1984, BIOCHEM SOC T, V12, P981, DOI 10.1042/bst0120981; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; MCCRAE AWR, 1971, T ROY SOC TROP MED H, V65, P152, DOI 10.1016/0035-9203(71)90212-4; MIRANDA AF, 1974, J CELL BIOL, V62, P406, DOI 10.1083/jcb.62.2.406; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; PADBIDRI VS, 1979, J HYG EPID MICROB IM, V23, P445; Paredes AM, 2004, VIROLOGY, V324, P373, DOI 10.1016/j.virol.2004.03.046; Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Rao T R, 1966, J Indian Med Assoc, V46, P248; Ravi V, 2006, Indian J Med Microbiol, V24, P83; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROSS R. W., 1956, JOUR HYG, V54, P177; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Rulli NE, 2007, ANN NY ACAD SCI, V1102, P96, DOI 10.1196/annals.1408.007; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; SHAH KV, 1964, INDIAN J MED RES, V52, P676; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; SIMIZU B, 1984, J VIROL, V51, P254, DOI 10.1128/JVI.51.1.254-258.1984; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; SOURISSEAU M, 2007, P NATL ACAD SCI USA, V102, P2760; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Warner E., 2006, Morbidity and Mortality Weekly Report, V55, P1040	64	116	119	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11479	10.1371/journal.pone.0011479	http://dx.doi.org/10.1371/journal.pone.0011479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628602	Green Published, Green Submitted, gold			2022-12-27	WOS:000279637100009
J	Balakumaran, A; Pawelczyk, E; Ren, JQ; Sworder, B; Chaudhry, A; Sabatino, M; Stroncek, D; Frank, JA; Robey, PG				Balakumaran, Arun; Pawelczyk, Edyta; Ren, Jiaqiang; Sworder, Brian; Chaudhry, Aneeka; Sabatino, Marianna; Stroncek, David; Frank, Joseph A.; Robey, Pamela G.			Superparamagnetic Iron Oxide Nanoparticles Labeling of Bone Marrow Stromal (Mesenchymal) Cells Does Not Affect Their "Stemness''	PLOS ONE			English	Article							IN-VIVO; FERUMOXIDES; TRACKING; OSTEOGENESIS; TRAFFICKING; FIBROBLASTS; EXPRESSION; MOUSE; MRI	Superparamagnetic iron oxide nanoparticles (SPION) are increasingly used to label human bone marrow stromal cells (BMSCs, also called "mesenchymal stem cells'') to monitor their fate by in vivo MRI, and by histology after Prussian blue (PB) staining. SPION-labeling appears to be safe as assessed by in vitro differentiation of BMSCs, however, we chose to resolve the question of the effect of labeling on maintaining the "stemness'' of cells within the BMSC population in vivo. Assays performed include colony forming efficiency, CD146 expression, gene expression profiling, and the "gold standard'' of evaluating bone and myelosupportive stroma formation in vivo in immuncompromised recipients. SPION-labeling did not alter these assays. Comparable abundant bone with adjoining host hematopoietic cells were seen in cohorts of mice that were implanted with SPION-labeled or unlabeled BMSCs. PB+ adipocytes were noted, demonstrating their donor origin, as well as PB+ pericytes, indicative of self-renewal of the stem cell in the BMSC population. This study confirms that SPION labeling does not alter the differentiation potential of the subset of stem cells within BMSCs.	[Balakumaran, Arun; Sworder, Brian; Robey, Pamela G.] Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA; [Pawelczyk, Edyta; Chaudhry, Aneeka; Frank, Joseph A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Ren, Jiaqiang; Sabatino, Marianna; Stroncek, David] NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA; [Frank, Joseph A.] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	Balakumaran, A (corresponding author), Natl Inst Dent & Craniofacial Res, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD USA.	balakumarana@nidcr.nih.gov	Robey, Pamela Gehron/H-1429-2011; Frank, Joseph/W-2021-2019	Robey, Pamela Gehron/0000-0002-5316-5576; Sworder, Brian/0000-0002-5902-5507	National Institute of Dental and Craniofacial Research; Clinical Center, IRP, NIH, Department of Health and Human Services; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000380] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL002120, ZIACL090007] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Clinical Center, IRP, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); CLINICAL CENTER	This study was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research and the Clinical Center, IRP, NIH, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 2005, BLOOD, V105, P420, DOI 10.1182/blood-2004-06-2222; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2005, NMR BIOMED, V18, P553, DOI 10.1002/nbm.991; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Arbab AS, 2004, HUM GENE THER, V15, P351, DOI 10.1089/104303404322959506; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2006, METHOD ENZYMOL, V419, P117, DOI 10.1016/S0076-6879(06)19006-0; de Vries IJM, 2005, NAT BIOTECHNOL, V23, P1407, DOI 10.1038/nbt1154; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frank JA, 2004, CYTOTHERAPY, V6, P621, DOI 10.1080/14653240410005267-1; Kostura L, 2004, NMR BIOMED, V17, P513, DOI 10.1002/nbm.925; Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee ESM, 2009, STEM CELLS, V27, P1921, DOI 10.1002/stem.112; Mankani MH, 2004, RADIOLOGY, V230, P369, DOI 10.1148/radiol.2302011529; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pawelczyk E, 2006, NMR BIOMED, V19, P581, DOI 10.1002/nbm.1038; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Shapiro EM, 2004, P NATL ACAD SCI USA, V101, P10901, DOI 10.1073/pnas.0403918101; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Stroncek DF, 2009, MOL DIAGN THER, V13, P181, DOI 10.2165/01250444-200913030-00003; Wang E, 2000, NAT BIOTECHNOL, V18, P457, DOI 10.1038/74546; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; WESTEN H, 1979, J EXP MED, V150, P919, DOI 10.1084/jem.150.4.919; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304	25	85	87	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11462	10.1371/journal.pone.0011462	http://dx.doi.org/10.1371/journal.pone.0011462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628641	Green Submitted, Green Published, gold			2022-12-27	WOS:000279589300010
J	Parker, LA; Saez, NG; Lumbreras, B; Porta, M; Hernandez-Aguado, I				Parker, Lucy A.; Gomez Saez, Noemi; Lumbreras, Blanca; Porta, Miquel; Hernandez-Aguado, Ildefonso			Methodological Deficits in Diagnostic Research Using '-Omics' Technologies: Evaluation of the QUADOMICS Tool and Quality of Recently Published Studies	PLOS ONE			English	Article							BLOOD-EXTRACTION; TUMOR-TISSUE; CANCER; ACCURACY; SERUM; BIAS; VALIDATION; BIOMARKERS; REPRODUCIBILITY; IDENTIFICATION	Background: QUADOMICS is an adaptation of QUADAS (a quality assessment tool for use in systematic reviews of diagnostic accuracy studies), which takes into account the particular challenges presented by '-omics' based technologies. Our primary objective was to evaluate the applicability and consistency of QUADOMICS. Subsequently we evaluated and describe the methodological quality of a sample of recently published studies using the tool. Methodology/Principal Findings: 45'-omics'-based diagnostic studies were identified by systematic search of Pubmed using suitable MeSH terms ("Genomics", "Sensitivity and specificity", "Diagnosis"). Three investigators independently assessed the quality of the articles using QUADOMICS and met to compare observations and generate a consensus. Consistency and applicability was assessed by comparing each reviewer's original rating with the consensus. Methodological quality was described using the consensus rating. Agreement was above 80% for all three reviewers. Four items presented difficulties with application, mostly due to the lack of a clearly defined gold standard. Methodological quality of our sample was poor; studies met roughly half of the applied criteria (mean +/- 6 sd, 54.7 +/- 18.4%). Few studies were carried out in a population that mirrored the clinical situation in which the test would be used in practice, (6, 13.3%); none described patient recruitment sufficiently; and less than half described clinical and physiological factors that might influence the biomarker profile (20, 44.4%). Conclusions: The QUADOMICS tool can consistently be applied to diagnostic '-omics' studies presently published in biomedical journals. A substantial proportion of reports in this research field fail to address design issues that are fundamental to make inferences relevant for patient care.	[Parker, Lucy A.; Gomez Saez, Noemi; Lumbreras, Blanca; Hernandez-Aguado, Ildefonso] Univ Miguel Hernandez, Dept Salud Publ, Alicante, Spain; [Parker, Lucy A.; Lumbreras, Blanca; Porta, Miquel; Hernandez-Aguado, Ildefonso] CIBERESP, Barcelona, Spain; [Porta, Miquel] Univ Autonoma Barcelona, Fac Med, Inst Municipal Invest Med, E-08193 Barcelona, Spain	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Autonomous University of Barcelona; University of Barcelona	Parker, LA (corresponding author), Univ Miguel Hernandez, Dept Salud Publ, Alicante, Spain.	lparker@umh.es	Porta, Miquel/AAD-5371-2020; Hernández-Aguado, Ildefonso/I-2634-2015; Porta, Miquel/B-5787-2008; Parker, Lucy Anne/R-3622-2017	Porta, Miquel/0000-0003-1684-7428; Hernández-Aguado, Ildefonso/0000-0003-1911-5759; Porta, Miquel/0000-0003-1684-7428; Lumbreras, Blanca/0000-0003-1665-0860; Parker, Lucy Anne/0000-0002-2362-4057	Spanish Agency for Health Technology Assessment [Exp PI06/90311]; Instituto de Salud Carlos III; CIBER en Epidemiologi-a y Salud Publica (CIBERESP) in Spain	Spanish Agency for Health Technology Assessment; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CIBER en Epidemiologi-a y Salud Publica (CIBERESP) in Spain	This work was supported by the Spanish Agency for Health Technology Assessment, Exp PI06/90311, Instituto de Salud Carlos III and CIBER en Epidemiologi-a y Salud Publica (CIBERESP) in Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NAT METHODS, V6, P237, DOI 10.1038/nmeth0409-237; Armitage P., 2002, STAT METHODS MED RES; Baggerly KA, 2005, JNCI-J NATL CANCER I, V97, P307, DOI 10.1093/jnci/dji008; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Belluco C, 2007, ANN SURG ONCOL, V14, P2470, DOI 10.1245/s10434-007-9354-3; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Check E, 2004, NATURE, V429, P496, DOI 10.1038/429496a; Diamandis EP, 2007, CLIN CHEM, V53, P1004, DOI 10.1373/clinchem.2006.082552; Feinstein AR, 1985, CLIN EPIDEMIOLOGY AR; Finn WG, 2007, J MOL DIAGN, V9, P431, DOI 10.2353/jmoldx.2007.070023; Fontela PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007753; Ghosh D, 2009, GENOMICS, V93, P13, DOI 10.1016/j.ygeno.2008.07.006; Haynes RB, 2006, CLIN EPIDEMIOLOGY DO; Hoppin JA, 2002, ANN EPIDEMIOL, V12, P1, DOI 10.1016/S1047-2797(01)00250-2; Ioannidis JPA, 2007, ONCOLOGIST, V12, P301, DOI 10.1634/theoncologist.12-3-301; IRWIG L, 1994, ANN INTERN MED, V120, P667, DOI 10.7326/0003-4819-120-8-199404150-00008; Kleinbaum DG, 1998, APPL REGRESSION ANAL; Lantz CA, 1996, J CLIN EPIDEMIOL, V49, P431, DOI 10.1016/0895-4356(95)00571-4; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lumbreras B, 2008, CLIN BIOCHEM, V41, P1316, DOI 10.1016/j.clinbiochem.2008.06.018; Lumbreras B, 2009, PROTEOM CLIN APPL, V3, P173, DOI 10.1002/prca.200800092; Lumbreras B, 2009, CLIN CHEM, V55, P786, DOI 10.1373/clinchem.2008.121517; Monzon FA, 2009, J CLIN ONCOL, V27, P2503, DOI 10.1200/JCO.2008.17.9762; Negm RS, 2002, TRENDS MOL MED, V8, P288, DOI 10.1016/S1471-4914(02)02353-5; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Petri AL, 2009, ACTA OBSTET GYN SCAN, V88, P18, DOI 10.1080/00016340802443830; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; PORTA M, 2008, DICT EPIDEMIOLOGY, P69; Porta M, 2008, J CLIN EPIDEMIOL, V61, P695, DOI 10.1016/j.jclinepi.2007.08.013; Porta M, 2007, EUR J EPIDEMIOL, V22, P577, DOI 10.1007/s10654-007-9149-7; Porta M, 2009, CANCER CAUSE CONTROL, V20, P1893, DOI 10.1007/s10552-009-9383-2; Ransohoff DF, 2007, J CLIN EPIDEMIOL, V60, P1205, DOI 10.1016/j.jclinepi.2007.04.020; Ransohoff DF, 2005, NAT REV CANCER, V5, P142, DOI 10.1038/nrc1550; RUTJES AWS, CMAJ, V176, P469; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Smidt N, 2006, NEUROLOGY, V67, P792, DOI 10.1212/01.wnl.0000238386.41398.30; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Tatsioni A, 2005, ANN INTERN MED, V142, P1048, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00004; Taylor JMG, 2008, CLIN CANCER RES, V14, P5977, DOI 10.1158/1078-0432.CCR-07-4534; Thomas DC, 2006, EPIDEMIOLOGY, V17, P490, DOI 10.1097/01.ede.0000229950.29674.68; Wagner L, 2004, J NATL CANCER I, V96, P500, DOI 10.1093/jnci/96.7.500; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whiting Penny F, 2006, BMC Med Res Methodol, V6, P9, DOI 10.1186/1471-2288-6-9	47	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11419	10.1371/journal.pone.0011419	http://dx.doi.org/10.1371/journal.pone.0011419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625481	gold, Green Submitted, Green Published			2022-12-27	WOS:000279465700007
J	Rocha, GM; Teixeira, DE; Miranda, K; Weissmuller, G; Bisch, PM; de Souza, W				Rocha, Gustavo Miranda; Teixeira, Dirceu Esdras; Miranda, Kildare; Weissmueller, Gilberto; Bisch, Paulo Mascarello; de Souza, Wanderley			Structural Changes of the Paraflagellar Rod during Flagellar Beating in Trypanosoma cruzi	PLOS ONE			English	Article							KINETOPLASTID PARASITES; CELL-SURFACE; ORGANIZATION; COMPONENTS; BRUCEI; MOTILITY; CHARGE; GENE	Background: Trypanosoma cruzi, the agent of Chagas disease, is a protozoan member of the Kinetoplastidae family characterized for the presence of specific and unique structures that are involved in different cell activities. One of them is the paraflagellar rod (PFR), a complex array of filaments connected to the flagellar axoneme. Although the function played by the PFR is not well established, it has been shown that silencing of the synthesis of its major proteins by either knockout of RNAi impairs and/or modifies the flagellar motility. Methodology/Principal Findings: Here, we present results obtained by atomic force microscopy (AFM) and transmission electron microscopy (TEM) of replicas of quick-frozen, freeze-fractured, deep-etched and rotary-replicated cells to obtain detailed information of the PFR structures in regions of the flagellum in straight and in bent state. The images obtained show that the PFR is not a fixed and static structure. The pattern of organization of the PFR filament network differs between regions of the flagellum in a straight state and those in a bent state. Measurements of the distances between the PFR filaments and the filaments that connect the PFR to the axoneme as well as of the angles between the intercrossed filaments supported this idea. Conclusions/Significance: Graphic computation based on the information obtained allowed the proposal of an animated model for the PFR structure during flagellar beating and provided a new way of observing PFR filaments during flagellar beating.	[Rocha, Gustavo Miranda; Teixeira, Dirceu Esdras; Miranda, Kildare; de Souza, Wanderley] Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Rio De Janeiro, Brazil; [Rocha, Gustavo Miranda; Miranda, Kildare; Weissmueller, Gilberto; Bisch, Paulo Mascarello; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estruct & Bioimag, Rio De Janeiro, Brazil; [Rocha, Gustavo Miranda; Miranda, Kildare; de Souza, Wanderley] Inst Nacl Metrol Normalizacao & Qualidade Ind, Rio De Janeiro, Brazil; [Weissmueller, Gilberto; Bisch, Paulo Mascarello] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Fis Biol, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Instituto Nacional de Metrologia, Qualidade e Tecnologia (INMETRO); Universidade Federal do Rio de Janeiro	Rocha, GM (corresponding author), Univ Fed Rio de Janeiro, Lab Ultraestrutura Celular Hertha Meyer, Cidade Univ, Rio De Janeiro, Brazil.	wsouza@biof.ufrj.br	Teixeira, Dirceu Esdras/ABB-3196-2020; Mascarello Bisch, Paulo/GRF-5572-2022	Teixeira, Dirceu Esdras/0000-0002-8305-8261; Weissmuller, Gilberto/0000-0002-0345-7335	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio (FUJB)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio (FUJB)	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) and Fundacao Universitaria Jose Bonifacio (FUJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdille MH, 2008, EXP PARASITOL, V118, P614, DOI 10.1016/j.exppara.2007.11.011; Akaki M, 2001, PARASITOL RES, V87, P193, DOI 10.1007/PL00008574; Bastin P, 1999, MOL CELL BIOL, V19, P8191; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; BOVEE EC, 1972, J THEOR BIOL, V35, P259, DOI 10.1016/0022-5193(72)90038-0; de Souza W, 2008, CURR PHARM DESIGN, V14, P822, DOI 10.2174/138161208784041123; de Souza W, 2009, MEM I OSWALDO CRUZ, V104, P89, DOI 10.1590/S0074-02762009000900014; DESOUZA W, 1978, J CELL SCI, V33, P285; Dvorak JA, 2000, J ELECTRON MICROSC, V49, P429, DOI 10.1093/oxfordjournals.jmicro.a023825; FARINA M, 1986, J PROTOZOOL, V33, P552, DOI 10.1111/j.1550-7408.1986.tb05661.x; Gadelha C, 2004, MOL BIOCHEM PARASIT, V136, P113, DOI 10.1016/j.molbiopara.2004.03.006; GOODENOUGH UW, 1982, J CELL BIOL, V95, P798, DOI 10.1083/jcb.95.3.798; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; Hunger-Glaser I, 1997, MOL BIOCHEM PARASIT, V90, P347, DOI 10.1016/S0166-6851(97)00139-4; Katta SS, 2009, MOL BIOCHEM PARASIT, V164, P105, DOI 10.1016/j.molbiopara.2008.12.002; Moreira-Leite FF, 1999, MOL BIOCHEM PARASIT, V104, P131, DOI 10.1016/S0166-6851(99)00143-7; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Ralston KS, 2008, INT J PARASITOL, V38, P869, DOI 10.1016/j.ijpara.2008.03.003; Rocha GM, 2008, MICROSC RES TECHNIQ, V71, P133, DOI 10.1002/jemt.20535; Rusconi F, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-6; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; SCHLIWA M, 1981, J CELL BIOL, V90, P222, DOI 10.1083/jcb.90.1.222; SOUTOPADRON T, 1984, ACTA TROP, V41, P215; TETLEY L, 1985, J CELL SCI, V74, P1; Tuxhorn J, 1998, CELL MOTIL CYTOSKEL, V40, P133, DOI 10.1016/j.semcdb.2008.07.005; VICKERMAN K, 1973, J PROTOZOOL, V20, P394, DOI 10.1111/j.1550-7408.1973.tb00909.x; WALTERS LL, 1987, AM J TROP MED HYG, V36, P294, DOI 10.4269/ajtmh.1987.36.294	27	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11407	10.1371/journal.pone.0011407	http://dx.doi.org/10.1371/journal.pone.0011407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613980	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000031
J	Yuede, CM; Wozniak, DF; Creeley, CE; Taylor, GT; Olney, JW; Farber, NB				Yuede, Carla M.; Wozniak, David F.; Creeley, Catherine E.; Taylor, George T.; Olney, John W.; Farber, Nuri B.			Behavioral Consequences of NMDA Antagonist-Induced Neuroapoptosis in the Infant Mouse Brain	PLOS ONE			English	Article							METHYL-D-ASPARTATE; APOPTOTIC NEURODEGENERATION; WORKING-MEMORY; EARLY EXPOSURE; DEFICITS; MICE; ETHANOL; COMBINATION; KETAMINE	Background: Exposure to NMDA glutamate antagonists during the brain growth spurt period causes widespread neuroapoptosis in the rodent brain. This period in rodents occurs during the first two weeks after birth, and corresponds to the third trimester of pregnancy and several years after birth in humans. The developing human brain may be exposed to NMDA antagonists through drug-abusing mothers or through anesthesia. Methodology/Principal Findings: We evaluated the long-term neurobehavioral effects of mice exposed to a single dose of the NMDA antagonist, phencyclidine (PCP), or saline, on postnatal day 2 (P2) or P7, or on both P2 and P7. PCP treatment on P2 + P7 caused more severe cognitive impairments than either single treatment. Histological examination of acute neuroapoptosis resulting from exposure to PCP indicated that the regional pattern of degeneration induced by PCP in P2 pups was different from that in P7 pups. The extent of damage when evaluated quantitatively on P7 was greater for pups previously treated on P2 compared to pups treated only on P7. Conclusions: These findings signify that PCP induces different patterns of neuroapoptosis depending on the developmental age at the time of exposure, and that exposure at two separate developmental ages causes more severe neuropathological and neurobehavioral consequences than a single treatment.	[Yuede, Carla M.; Wozniak, David F.; Creeley, Catherine E.; Olney, John W.; Farber, Nuri B.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Yuede, Carla M.; Taylor, George T.] Univ Missouri, Dept Psychol, St Louis, MO 63121 USA	Washington University (WUSTL); University of Missouri System; University of Missouri Saint Louis	Yuede, CM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.	yuedec@psychiatry.wustl.edu		FARBER, NURI/0000-0003-3178-1877	National Institute on Drug Abuse [T32DA002761, DA05072]; MERIT [HD37100]; NBF [ES01244304]; Bantly Foundation (NBF); NIH [P30 NS057105]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD037100, R01HD037100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MERIT; NBF; Bantly Foundation (NBF); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by T32DA002761 and DA05072 (JWO) from the National Institute on Drug Abuse, MERIT award HD37100 (JWO), Research grant ES01244304 (NBF), The Bantly Foundation (NBF), and NIH Neuroscience Blueprint Interdisciplinary Center Core Grant P30 NS057105 to Washington University (DFW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Boctor SY, 2010, NEUROTOXICOLOGY, V31, P42, DOI 10.1016/j.neuro.2009.10.007; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Cheng ZW, 2005, J NEUROSCI RES, V81, P284, DOI 10.1002/jnr.20559; DiMaggio C, 2009, J NEUROSURG ANESTH, V21, P286, DOI 10.1097/ANA.0b013e3181a71f11; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Fredriksson A, 2004, NEUROTOX RES, V6, P435, DOI 10.1007/BF03033280; Fredriksson A, 2004, BEHAV BRAIN RES, V153, P367, DOI 10.1016/j.bbr.2003.12.026; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Gallitano-Mendel A, 2007, NEUROSCIENCE, V148, P633, DOI 10.1016/j.neuroscience.2007.05.050; Hartman RE, 2001, EXP NEUROL, V170, P326, DOI 10.1006/exnr.2001.7715; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Johnson SA, 2008, J NEUROSURG ANESTH, V20, P21, DOI 10.1097/ANA.0b013e3181271850; Kalkman CJ, 2009, ANESTHESIOLOGY, V110, P805, DOI 10.1097/ALN.0b013e31819c7124; Khuchua Z, 2003, NEUROSCIENCE, V119, P101, DOI 10.1016/S0306-4522(03)00094-0; Mitchell AS, 2002, J NEUROSCI, V22, P1922, DOI 10.1523/JNEUROSCI.22-05-01922.2002; Nakatani-Pawlak A, 2009, BIOL PHARM BULL, V32, P1576, DOI 10.1248/bpb.32.1576; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; Wang C, 2001, NEUROSCIENCE, V107, P535, DOI 10.1016/S0306-4522(01)00384-0; Wilder RT, 2009, ANESTHESIOLOGY, V110, P796, DOI 10.1097/01.anes.0000344728.34332.5d; Wiley JL, 2003, PSYCHOPHARMACOLOGY, V165, P378, DOI 10.1007/s00213-002-1297-6; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014; Young C, 2005, BRIT J PHARMACOL, V146, P189, DOI 10.1038/sj.bjp.0706301; Zou XJ, 2009, INT J DEV NEUROSCI, V27, P727, DOI 10.1016/j.ijdevneu.2009.06.010	31	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11374	10.1371/journal.pone.0011374	http://dx.doi.org/10.1371/journal.pone.0011374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613880	Green Published, Green Submitted, gold			2022-12-27	WOS:000279369900022
J	Maher-Laporte, M; Berthiaume, F; Moreau, M; Julien, LA; Lapointe, G; Mourez, M; DesGroseillers, L				Maher-Laporte, Marjolaine; Berthiaume, Frederic; Moreau, Mireille; Julien, Louis-Andre; Lapointe, Gabriel; Mourez, Michael; DesGroseillers, Luc			Molecular Composition of Staufen2-Containing Ribonucleoproteins in Embryonic Rat Brain	PLOS ONE			English	Article							BINDING PROTEIN STAUFEN2; MESSENGER-RNA TRANSPORT; POLY(A)-BINDING PROTEIN; NUCLEAR EXPORT; TRANSLATION; YB-1; COMPLEXES; GRANULES; KINESIN; DOMAIN	Messenger ribonucleoprotein particles (mRNPs) are used to transport mRNAs along neuronal dendrites to their site of translation. Numerous mRNA-binding and regulatory proteins within mRNPs finely regulate the fate of bound-mRNAs. Their specific combination defines different types of mRNPs that in turn are related to specific synaptic functions. One of these mRNA-binding proteins, Staufen2 (Stau2), was shown to transport dendritic mRNAs along microtubules. Its knockdown expression in neurons was shown to change spine morphology and synaptic functions. To further understand the molecular mechanisms by which Stau2 modulates synaptic function in neurons, it is important to identify and characterize protein cofactors that regulate the fate of Stau2-containing mRNPs. To this end, a proteomic approach was used to identify co-immunoprecipitated proteins in Staufen2-containing mRNPs isolated from embryonic rat brains. The proteomic approach identified mRNA-binding proteins (PABPC1, hnRNP H1, YB1 and hsc70), proteins of the cytoskeleton (alpha- and beta-tubulin) and RUFY3 a poorly characterized protein. While PABPC1 and YB1 associate with Stau2-containing mRNPs through RNAs, hsc70 is directly bound to Stau2 and this interaction is regulated by ATP. PABPC1 and YB1 proteins formed puncta in dendrites of embryonic rat hippocampal neurons. However, they poorly co-localized with Stau2 in the large dendritic complexes suggesting that they are rather components of Stau2-containing mRNA particles. All together, these results represent a further step in the characterization of Stau2-containing mRNPs in neurons and provide new tools to study and understand how Stau2-containing mRNPs are transported, translationally silenced during transport and/or locally expressed according to cell needs.	[Maher-Laporte, Marjolaine; Moreau, Mireille; Julien, Louis-Andre; Lapointe, Gabriel; DesGroseillers, Luc] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Universite de Montreal	Maher-Laporte, M (corresponding author), Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.	luc.desgroseillers@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP 62751, MGC-57079]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by operating [MOP 62751] and group [MGC-57079] grants from the Canadian Institutes of Health Research (CIHR-www.cihr-irsc.gc.ca/) to LDG. MML and LAJ were supported by a postgraduate scholarship and an undergraduate student research award, respectively, from the Natural Sciences and Engineering Research Council of Canada (NSERC-www.nserc-crsng.gc.ca/). MM held a Canada Research Chair on Bacterial Animal Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angenstein F, 2005, J BIOL CHEM, V280, P6496, DOI 10.1074/jbc.M412742200; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; Bannai H, 2004, J BIOL CHEM, V279, P53427, DOI 10.1074/jbc.M409732200; Bassell GJ, 1999, FASEB J, V13, P447, DOI 10.1096/fasebj.13.3.447; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; Chernov Konstantin G., 2008, BMC Biochemistry, V9, P23, DOI 10.1186/1471-2091-9-23; Duchaine TF, 2002, J CELL SCI, V115, P3285; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Elvira G, 2006, J NEUROCHEM, V96, P105, DOI 10.1111/j.1471-4159.2005.03523.x; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2006, CELL CYCLE, V5, P1143, DOI 10.4161/cc.5.11.2784; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; Henics T, 1999, J BIOL CHEM, V274, P17318, DOI 10.1074/jbc.274.24.17318; Jeong JH, 2007, J NEUROCHEM, V102, P2073, DOI 10.1111/j.1471-4159.2007.04697.x; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; Keene JD, 2005, CHROMOSOME RES, V13, P327, DOI 10.1007/s10577-005-0848-1; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim KC, 2006, NEUROSCI LETT, V397, P48, DOI 10.1016/j.neulet.2005.11.047; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kose S, 2005, J CELL BIOL, V171, P19, DOI 10.1083/jcb.200506074; Lebeau G, 2008, MOL CELL BIOL, V28, P2896, DOI 10.1128/MCB.01844-07; LEWIS SA, 1990, NATURE, V345, P674, DOI 10.1038/345674a0; Macchi P, 2004, J BIOL CHEM, V279, P31440, DOI 10.1074/jbc.C400226200; Maher-Laporte M, 2010, BMB REP, V43, P344, DOI 10.5483/BMBRep.2010.43.5.344; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mazumder B, 2001, MOL CELL BIOL, V21, P6440, DOI 10.1128/MCB.21.19.6440-6449.2001; Miki T, 2004, J BIOL CHEM, V279, P47473, DOI 10.1074/jbc.M407883200; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Mohr E, 2001, P NATL ACAD SCI USA, V98, P7072, DOI 10.1073/pnas.111146598; Monshausen M, 2004, NEUROMOL MED, V6, P127, DOI 10.1385/NMM:6:2-3:127; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Patel GP, 2005, NUCLEIC ACIDS RES, V33, P7074, DOI 10.1093/nar/gki1014; Sanchez-Carbente MD, 2008, PROG BRAIN RES, V169, P41, DOI 10.1016/S0079-6123(07)00003-9; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; SHI YG, 1992, MOL CELL BIOL, V12, P2186, DOI 10.1128/MCB.12.5.2186; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Stratford AL, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2202; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tsai MY, 2000, MOL BIOL CELL, V11, P2161, DOI 10.1091/mbc.11.6.2161; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552	57	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11350	10.1371/journal.pone.0011350	http://dx.doi.org/10.1371/journal.pone.0011350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596529	Green Published, Green Submitted, gold			2022-12-27	WOS:000279259900021
J	Alais, D; Cass, J				Alais, David; Cass, John			Multisensory Perceptual Learning of Temporal Order: Audiovisual Learning Transfers to Vision but Not Audition	PLOS ONE			English	Article							SHORT-TIME-INTERVALS; NEURAL MECHANISMS; DISCRIMINATION; OFFSET; PLASTICITY; DURATION; STIMULI; NEURONS; HUMANS; CORTEX	Background: An outstanding question in sensory neuroscience is whether the perceived timing of events is mediated by a central supra-modal timing mechanism, or multiple modality-specific systems. We use a perceptual learning paradigm to address this question. Methodology/Principal Findings: Three groups were trained daily for 10 sessions on an auditory, a visual or a combined audiovisual temporal order judgment (TOJ). Groups were pre-tested on a range TOJ tasks within and between their group modality prior to learning so that transfer of any learning from the trained task could be measured by post-testing other tasks. Robust TOJ learning (reduced temporal order discrimination thresholds) occurred for all groups, although auditory learning (dichotic 500/2000 Hz tones) was slightly weaker than visual learning (lateralised grating patches). Crossmodal TOJs also displayed robust learning. Post-testing revealed that improvements in temporal resolution acquired during visual learning transferred within modality to other retinotopic locations and orientations, but not to auditory or crossmodal tasks. Auditory learning did not transfer to visual or crossmodal tasks, and neither did it transfer within audition to another frequency pair. In an interesting asymmetry, crossmodal learning transferred to all visual tasks but not to auditory tasks. Finally, in all conditions, learning to make TOJs for stimulus onsets did not transfer at all to discriminating temporal offsets. These data present a complex picture of timing processes. Conclusions/Significance: The lack of transfer between unimodal groups indicates no central supramodal timing process for this task; however, the audiovisual-to-visual transfer cannot be explained without some form of sensory interaction. We propose that auditory learning occurred in frequency-tuned processes in the periphery, precluding interactions with more central visual and audiovisual timing processes. Functionally the patterns of featural transfer suggest that perceptual learning of temporal order may be optimised to object-centered rather than viewer-centered constraints.	[Alais, David] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia; [Cass, John] Univ Western Sydney, Sch Psychol, Milperra, Australia; [Cass, John] Univ Western Sydney, MARCS Auditory Labs, Milperra, Australia	University of Sydney; Western Sydney University; Western Sydney University	Alais, D (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	j.cass@uws.edu.au	Cass, John/AAC-7505-2021		Australian Research Council [DP0774697, DP0770299]	Australian Research Council(Australian Research Council)	This research was supported by Discovery Projects awarded by the Australian Research Council (JC: DP0774697; DA: DP0770299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2010, SEEING PERCEIVING, V23, P3, DOI 10.1163/187847510X488603; ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bair W, 2004, VISUAL NEUROSCI, V21, P671, DOI 10.1017/S0952523804215012; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bregman A.S., 1990, AUDITORY SCENE ANAL; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Burr D, 2007, NAT NEUROSCI, V10, P423, DOI 10.1038/nn1874; CARLILE S, 1996, VIRTUAL AUDITORY SPA; Coulombe JL, 2008, STUD AM INDIAN LIT, V20, P1, DOI 10.1353/ail.0.0039; DIVENYI PL, 1978, PERCEPT PSYCHOPHYS, V24, P429, DOI 10.3758/BF03199740; Edwards CJ, 2002, NAT NEUROSCI, V5, P934, DOI 10.1038/nn916; EFRON R, 1970, PERCEPT PSYCHOPHYS, V8, P231, DOI 10.3758/BF03210211; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fahle M, 2002, PERCEPTUAL LEARNING; Folta K, 2003, VISION RES, V43, P1177, DOI 10.1016/S0042-6989(03)00041-5; Fujino K, 2003, P NATL ACAD SCI USA, V100, P265, DOI 10.1073/pnas.0135345100; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Grondin S, 1998, PSYCHOL RES-PSYCH FO, V61, P261, DOI 10.1007/s004260050030; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Kim RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001532; King B, 2007, J RES READ, V30, P443, DOI 10.1111/j.1467-9817.2007.00346.x; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Majewska AK, 2006, TRENDS NEUROSCI, V29, P323, DOI 10.1016/j.tins.2006.04.002; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; Michon J. A., 1985, TIME MIND BEHAV, P21; Moore B, 1986, FREQUENCY SELECTIVIT; Morgan MJ, 2008, J VISION, V8, DOI 10.1167/8.2.14; Mossbridge JA, 2008, LEARN MEMORY, V15, P13, DOI 10.1101/lm.573608; Mossbridge JA, 2006, J NEUROSCI, V26, P12708, DOI 10.1523/JNEUROSCI.2254-06.2006; Nagarajan SS, 1998, J NEUROSCI, V18, P1559; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; PARKER DM, 1980, PERCEPT PSYCHOPHYS, V28, P365, DOI 10.3758/BF03204396; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PATTERSON RD, 1976, J ACOUST SOC AM, V59, P640, DOI 10.1121/1.380914; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAMMSAYER T, 1998, PSYCHOL BEITR, V40, P387; RAMMSAYER TH, 1992, NEUROPSYCHOBIOLOGY, V26, P71, DOI 10.1159/000118899; ROUSSEAU R, 1983, PERCEPT PSYCHOPHYS, V34, P541, DOI 10.3758/BF03205907; Schirmer A, 2004, COGNITIVE BRAIN RES, V21, P269, DOI 10.1016/j.cogbrainres.2004.04.003; Seitz AR, 2006, CURR BIOL, V16, P1422, DOI 10.1016/j.cub.2006.05.048; SERVIERE J, 1977, VISION RES, V17, P65, DOI 10.1016/0042-6989(77)90202-4; SONG JH, 2008, J COGN NEUROSCI; Sowden PT, 2002, VISION RES, V42, P1249, DOI 10.1016/S0042-6989(02)00019-6; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Virsu V, 2008, EXP BRAIN RES, V186, P525, DOI 10.1007/s00221-007-1254-z; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Westheimer G, 1999, EXP BRAIN RES, V129, P121, DOI 10.1007/s002210050942; Wright BA, 1997, J NEUROSCI, V17, P3956	56	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 23	2010	5	6							e11283	10.1371/journal.pone.0011283	http://dx.doi.org/10.1371/journal.pone.0011283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615KY	20585664	Green Submitted, gold, Green Published			2022-12-27	WOS:000279135400025
J	Deere, JD; Higgins, J; Cannavo, E; Villalobos, A; Adamson, L; Fromentin, E; Schinazi, RF; Luciw, PA; North, TW				Deere, Jesse D.; Higgins, Joanne; Cannavo, Elda; Villalobos, Andradi; Adamson, Lourdes; Fromentin, Emilie; Schinazi, Raymond F.; Luciw, Paul A.; North, Thomas W.			Viral Decay Kinetics in the Highly Active Antiretroviral Therapy-Treated Rhesus Macaque Model of AIDS	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; REVERSE-TRANSCRIPTASE GENE; CD4(+) T-CELLS; INFECTED INDIVIDUALS; HIV-1; VIREMIA; REPLICATION; SUPPRESSION; PERSISTENCE; LYMPHOCYTES	To prevent progression to AIDS, persons infected with human immunodeficiency virus type 1 (HIV-1) must remain on highly active antiretroviral therapy (HAART) indefinitely since this modality does not eradicate the virus. The mechanisms involved in viral persistence during HAART are poorly understood, but an animal model of HAART could help elucidate these mechanisms and enable studies of HIV-1 eradication strategies. Due to the specificity of non-nucleoside reverse transcriptase (RT) inhibitors (NNRTIs) for HIV-1, we have used RT-SHIV, a chimeric virus of simian immunodeficiency virus with RT from HIV-1. This virus is susceptible to NNRTIs and causes an AIDS-like disease in rhesus macaques. In this study, two groups of HAART-treated, RT-SHIV-infected macaques were analyzed to determine viral decay kinetics. In the first group, viral loads were monitored with a standard TaqMan RT-PCR assay with a limit of detection of 50 viral RNA copies per mL. Upon initiation of HAART, viremia decayed in a bi-phasic manner with half-lives of 1.7 and 8.5 days, respectively. A third phase was observed with little further decay. In the second group, the macaques were followed longitudinally with a more sensitive assay utilizing ultracentrifugation to concentrate virus from plasma. Bi-phasic decay of viral RNA was also observed in these animals with half-lives of 1.8 and 5.8 days. Viral loads in these animals during a third phase ranged from 2-58 RNA copies/mL, with little decay over time. The viral decay kinetics observed in these macaques are similar to those reported for HIV-1 infected humans. These results demonstrate that low-level viremia persists in RT-SHIV-infected macaques despite a HAART regimen commonly used in humans.	[Deere, Jesse D.; Higgins, Joanne; Cannavo, Elda; Villalobos, Andradi; Adamson, Lourdes; Luciw, Paul A.; North, Thomas W.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Luciw, Paul A.] Univ Calif Davis, Dept Pathol, Sch Med, Davis, CA 95616 USA; [North, Thomas W.] Univ Calif Davis, Dept Vet Mol Biosci, Davis, CA 95616 USA; [Fromentin, Emilie; Schinazi, Raymond F.] Emory Univ, Sch Med, Biochem Pharmacol Lab, Ctr AIDS Res,Dept Pediat,Vet Affairs Med Ctr, Decatur, GA 30033 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Deere, JD (corresponding author), Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA.	twnorth@ucdavis.edu	Deere, Jesse Dee/ABH-7940-2020; Schinazi, Raymond F/B-6777-2017	Deere, Jesse/0000-0002-2539-0338	NIH [P01-AI058708, T32-AI60555, 1R01-RR025996]; Department of Veterans Affairs; NIH CFAR [2P30-AI-050409]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060555, P30AI050409, P01AI058708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NIH CFAR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH program project grant P01-AI058708. J. D. Deere was supported by NIH training grant T32-AI60555 as well as NIH grant 1R01-RR025996 (TWN and RFS). RFS is also supported by NIH CFAR grant 2P30-AI-050409 and the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose Z, 2007, J VIROL, V81, P12145, DOI 10.1128/JVI.01301-07; BALZARINI J, 1995, BIOCHEM BIOPH RES CO, V211, P850, DOI 10.1006/bbrc.1995.1890; Balzarini J, 1997, J ACQ IMMUN DEF SYND, V15, P1, DOI 10.1097/00042560-199705010-00001; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1999, P NATL ACAD SCI USA, V96, P10958, DOI 10.1073/pnas.96.20.10958; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cline AN, 2005, J MED PRIMATOL, V34, P303; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Deeks SG, 2001, NEW ENGL J MED, V344, P472, DOI 10.1056/NEJM200102153440702; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; GARDNER MB, 1989, FASEB J, V3, P2593, DOI 10.1096/fasebj.3.14.2556312; GARDNER MB, 2004, AIDS OTHER MANIFESTA, P195; Gavegnano Christina, 2009, Antiviral Chemistry & Chemotherapy, V20, P63, DOI 10.3851/IMP1374; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; Giuffre AC, 2003, ANTIMICROB AGENTS CH, V47, P1756, DOI 10.1128/AAC.47.5.1756-1759.2003; GRANT CK, 1977, J IMMUNOL, V119, P401; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hammer SM, 1997, NEW ENGL J MED, V337, P725, DOI 10.1056/NEJM199709113371101; Harrigan PR, 1999, AIDS, V13, pF59, DOI 10.1097/00002030-199905280-00001; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hofman MJ, 2004, ANTIMICROB AGENTS CH, V48, P3483, DOI 10.1128/AAC.48.9.3483-3490.2004; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Leutenegger CM, 2001, AIDS RES HUM RETROV, V17, P243, DOI 10.1089/088922201750063160; Lewin SR, 1999, J VIROL, V73, P6099, DOI 10.1128/JVI.73.7.6099-6103.1999; LUCIW PA, 1995, P NATL ACAD SCI USA, V92, P7490, DOI 10.1073/pnas.92.16.7490; Lundgren JD, 2008, J INFECT DIS, V197, P1145, DOI 10.1086/529523; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; North TW, 2010, J VIROL, V84, P2913, DOI 10.1128/JVI.02356-09; North TW, 2005, J VIROL, V79, P7349, DOI 10.1128/JVI.79.12.7349-7354.2005; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Perelson AS, 1997, AIDS, V11, pS17; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Shen AD, 2003, J VIROL, V77, P4938, DOI 10.1128/JVI.77.8.4938-4949.2003; Soderberg K, 2002, J VIROL, V76, P5803, DOI 10.1128/JVI.76.11.5803-5806.2002; Tandon R, 2005, J VIROL METHODS, V130, P124, DOI 10.1016/j.jviromet.2005.06.017; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; UBERLA K, 1995, P NATL ACAD SCI USA, V92, P8210, DOI 10.1073/pnas.92.18.8210; Van Rompay KKA, 2004, ANTIMICROB AGENTS CH, V48, P1469, DOI 10.1128/AAC.48.5.1469-1487.2004; Van Rompay KKA, 2002, J VIROL, V76, P6083, DOI 10.1128/JVI.76.12.6083-6092.2002; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	53	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11640	10.1371/journal.pone.0011640	http://dx.doi.org/10.1371/journal.pone.0011640			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668516	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243800003
J	Peric, D; Durrant-Arico, C; Delenda, C; Dupre, T; De Lonlay, P; de Baulny, HO; Pelatan, C; Bader-Meunier, B; Danos, O; Chantret, I; Moore, SEH				Peric, Delphine; Durrant-Arico, Christelle; Delenda, Christophe; Dupre, Thierry; De Lonlay, Pascale; de Baulny, Helene Ogier; Pelatan, Cecile; Bader-Meunier, Brigitte; Danos, Olivier; Chantret, Isabelle; Moore, Stuart E. H.			The Compartmentalisation of Phosphorylated Free Oligosaccharides in Cells from a CDG Ig Patient Reveals a Novel ER-to-Cytosol Translocation Process	PLOS ONE			English	Article							POLYMANNOSE-TYPE OLIGOSACCHARIDES; LIPID-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; CONGENITAL DISORDERS; GLYCOPEPTIDE EXPORT; GLYCOPROTEIN-BIOSYNTHESIS; DIPHOSPHATE OLIGOSACCHARIDES; SACCHAROMYCES-CEREVISIAE; TRANSBILAYER MOVEMENT; HEPG2 CELLS	Background: Biosynthesis of the dolichol linked oligosaccharide (DLO) required for protein N-glycosylation starts on the cytoplasmic face of the ER to give Man(5)GlcNAc(2)-PP-dolichol, which then flips into the ER for further glycosylation yielding mature DLO (Glc(3)Man(9)GlcNAc(2)-PP-dolichol). After transfer of Glc(3)Man(9)GlcNAc(2) onto protein, dolichol-PP is recycled to dolichol-P and reused for DLO biosynthesis. Because de novo dolichol synthesis is slow, dolichol recycling is rate limiting for protein glycosylation. Immature DLO intermediates may also be recycled by pyrophosphatase-mediated cleavage to yield dolichol-P and phosphorylated oligosaccharides (fOSGN2-P). Here, we examine fOSGN2-P generation in cells from patients with type I Congenital Disorders of Glycosylation (CDG I) in which defects in the dolichol cycle cause accumulation of immature DLO intermediates and protein hypoglycosylation. Methods and Principal Findings: In EBV-transformed lymphoblastoid cells from CDG I patients and normal subjects a correlation exists between the quantities of metabolically radiolabeled fOSGN2-P and truncated DLO intermediates only when these two classes of compounds possess 7 or less hexose residues. Larger fOSGN2-P were difficult to detect despite an abundance of more fully mannosylated and glucosylated DLO. When CDG Ig cells, which accumulate Man(7)GlcNAc(2)-PP-dolichol, are permeabilised so that vesicular transport and protein synthesis are abolished, the DLO pool required for Man(7)GlcNAc(2)-P generation could be depleted by adding exogenous glycosylation acceptor peptide. Under conditions where a glycotripeptide and neutral free oligosaccharides remain predominantly in the lumen of the ER, Man(7)GlcNAc(2)-P appears in the cytosol without detectable generation of ER luminal Man(7)GlcNAc(2)-P. Conclusions and Significance: The DLO pools required for N-glycosylation and fOSGN2-P generation are functionally linked and this substantiates the hypothesis that pyrophosphatase-mediated cleavage of DLO intermediates yields recyclable dolichol-P. The kinetics of cytosolic fOSGN2-P generation from a luminally-generated DLO intermediate demonstrate the presence of a previously undetected ER-to-cytosol translocation process for either fOSGN2-P or DLO.	[Peric, Delphine; Durrant-Arico, Christelle; Dupre, Thierry; Chantret, Isabelle; Moore, Stuart E. H.] INSERM, CRB3 U773, Paris, France; [Peric, Delphine; Dupre, Thierry; Chantret, Isabelle; Moore, Stuart E. H.] Univ Paris 07, Paris, France; [Durrant-Arico, Christelle] Univ Paris 05, Paris, France; [Delenda, Christophe; Danos, Olivier] Genethon, Evry, France; [Dupre, Thierry] Hop Bichat Claude Bernard, AP HP, F-75877 Paris 18, France; [De Lonlay, Pascale] Hop Necker Enfants Malad, Dept Pediat, Paris, France; [de Baulny, Helene Ogier] Hop Robert Debre, APHP, F-75019 Paris, France; [Pelatan, Cecile] Ctr Hosp, Serv Pediat, Le Mans, France; [Bader-Meunier, Brigitte] Hop Bicetre, APHP, Serv Hematol Biol, Paris, France; [Danos, Olivier] Hop Necker Enfants Malad, INSERM, U781, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Le Mans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Peric, D (corresponding author), CEA, DSV, iRCM, Lab Genet Radiosensibil, Fontenay Aux Roses, France.	Stuart.moore@inserm.fr	Moore, Stuart/AAF-3920-2021; CHANTRET, Isabelle/AAF-7134-2021	Moore, Stuart/0000-0002-1020-2242; CHANTRET, Isabelle/0000-0002-0896-1274; bader-meunier, brigitte/0000-0001-8476-8196	INSERM; Vaincre les Maladies Lysosomales (VLM); La Fondation pour la Recherche Medicale (FRM); European Community [LSHM-CT-2005-512131]; Mizutani Foundation; GIS - Institut des Maladies Rares/INSERM; Hospital/INSERM Contrat d'Interface; Association Francaise Contre les Myopathies (AFM)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Vaincre les Maladies Lysosomales (VLM); La Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Community(European Commission); Mizutani Foundation; GIS - Institut des Maladies Rares/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Hospital/INSERM Contrat d'Interface; Association Francaise Contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	This work was supported by institutional funding from INSERM. Additional funding was obtained from: Vaincre les Maladies Lysosomales (VLM), La Fondation pour la Recherche Medicale (FRM), EUROGLYCANET: a European Community Coordination Action (LSHM-CT-2005-512131), the Mizutani Foundation, the GIS - Institut des Maladies Rares/INSERM funded French CDG Research Network. SM is funded by a Hospital/INSERM Contrat d'Interface. Apart from Genethon (Gene Vector Production Network, Genethon, Evry, France), which is funded by the Association Francaise Contre les Myopathies (AFM), who financed and designed the recombinant lentiviral vectors used in this study, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Ali BRS, 2000, J BIOL CHEM, V275, P33222, DOI 10.1074/jbc.M003845200; Ali BRS, 2000, GLYCOBIOLOGY, V10, P383, DOI 10.1093/glycob/10.4.383; ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BELARD M, 1988, BIOCHEM J, V255, P235; BHAKDI S, 1993, MED MICROBIOL IMMUN, V182, P167; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; CACAN R, 1992, GLYCOBIOLOGY, V2, P127, DOI 10.1093/glycob/2.2.127; CACAN R, 1987, EUR J BIOCHEM, V166, P469, DOI 10.1111/j.1432-1033.1987.tb13539.x; CACAN R, 1980, EUR J BIOCHEM, V106, P473, DOI 10.1111/j.1432-1033.1980.tb04594.x; Cacan R, 1997, TRENDS GLYCOSCI GLYC, V9, P365, DOI 10.4052/tigg.9.365; Chantret I, 2003, J BIOL CHEM, V278, P9962, DOI 10.1074/jbc.M211950200; Chantret I, 2002, J BIOL CHEM, V277, P25815, DOI 10.1074/jbc.M203285200; CHAPMAN A, 1979, CELL, V17, P509, DOI 10.1016/0092-8674(79)90259-9; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Dancourt J, 2006, PEDIATR RES, V59, P835, DOI 10.1203/01.pdr.0000219430.52532.8e; Gao NG, 2005, J BIOL CHEM, V280, P17901, DOI 10.1074/jbc.M500510200; Gao NG, 2002, J BIOL CHEM, V277, P39425, DOI 10.1074/jbc.M205195200; HANOVER JA, 1981, ARCH BIOCHEM BIOPHYS, V211, P1, DOI 10.1016/0003-9861(81)90423-9; HASE S, 1984, J BIOCHEM-TOKYO, V95, P197, DOI 10.1093/oxfordjournals.jbchem.a134585; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; HOFLACK B, 1981, EUR J BIOCHEM, V117, P285, DOI 10.1111/j.1432-1033.1981.tb06335.x; HSU AF, 1974, P NATL ACAD SCI USA, V71, P2391, DOI 10.1073/pnas.71.6.2391; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; MILLER SG, 1991, J CELL BIOL, V112, P39, DOI 10.1083/jcb.112.1.39; Moore SEH, 1998, GLYCOBIOLOGY, V8, P373, DOI 10.1093/glycob/8.4.373; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; OLIVER GJA, 1975, BIOCHEM SOC T, V3, P666, DOI 10.1042/bst0030666; Oriol R, 2002, MOL BIOL EVOL, V19, P1451, DOI 10.1093/oxfordjournals.molbev.a004208; ROMISCH K, 1992, P NATL ACAD SCI USA, V89, P7227, DOI 10.1073/pnas.89.15.7227; Romisch K, 1997, P NATL ACAD SCI USA, V94, P6730, DOI 10.1073/pnas.94.13.6730; ROSENWALD AG, 1990, J BIOL CHEM, V265, P14544; Rush JS, 2008, J BIOL CHEM, V283, P4087, DOI 10.1074/jbc.M707067200; Rush JS, 2009, J BIOL CHEM, V284, P19835, DOI 10.1074/jbc.M109.000893; Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Sanyal S, 2009, P NATL ACAD SCI USA, V106, P767, DOI 10.1073/pnas.0810225106; SCHENK B, 2001, GLYCOBIOLOGY, V11, P61; SPIRO MJ, 1991, J BIOL CHEM, V266, P5311; SPIRO RG, 1983, J BIOL CHEM, V258, P9469; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V304, P326, DOI 10.1016/S0006-291X(03)00600-4; TROWBRIDGE IS, 1978, CELL, V14, P21, DOI 10.1016/0092-8674(78)90297-0; VARKI A, 1983, J BIOL CHEM, V258, P2808; Vuillaumier-Barrot S, 2000, J MED GENET, V37, P579, DOI 10.1136/jmg.37.8.579; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8	47	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11675	10.1371/journal.pone.0011675	http://dx.doi.org/10.1371/journal.pone.0011675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652024	Green Submitted, Green Published, gold			2022-12-27	WOS:000280109700008
J	Isgren, CM; Upjohn, MM; Fernandez-Fuente, M; Massey, C; Pollott, G; Verheyen, KLP; Piercy, RJ				Isgren, Cajsa M.; Upjohn, Melissa M.; Fernandez-Fuente, Marta; Massey, Claire; Pollott, Geoff; Verheyen, Kristien L. P.; Piercy, Richard J.			Epidemiology of Exertional Rhabdomyolysis Susceptibility in Standardbred Horses Reveals Associated Risk Factors and Underlying Enhanced Performance	PLOS ONE			English	Article							POLYSACCHARIDE STORAGE MYOPATHY; CREATINE-KINASE ACTIVITY; SKELETAL-MUSCLE; THOROUGHBRED RACEHORSES; UNITED-KINGDOM; QUARTER HORSES; GYS1 MUTATION; EXERCISE; RESPONSES; HERITABILITY	Background: Exertional rhabdomyolysis syndrome is recognised in many athletic horse breeds and in recent years specific forms of the syndrome have been identified. However, although Standardbred horses are used worldwide for racing, there is a paucity of information about the epidemiological and performance-related aspects of the syndrome in this breed. The objectives of this study therefore were to determine the incidence, risk factors and performance effects of exertional rhabdomyolysis syndrome in Standardbred trotters and to compare the epidemiology and genetics of the syndrome with that in other breeds. Methodology/Principal Findings: A questionnaire-based case-control study (with analysis of online race records) was conducted following identification of horses that were determined susceptible to exertional rhabdomyolysis (based on serum biochemistry) from a total of 683 horses in 22 yards. Thirty six exertional rhabdomyolysis-susceptible horses were subsequently genotyped for the skeletal muscle glycogen synthase (GYS1) mutation responsible for type 1 polysaccharide storage myopathy. A total of 44 susceptible horses was reported, resulting in an annual incidence of 6.4 (95% CI 4.6-8.2%) per 100 horses. Female horses were at significantly greater risk than males (odds ratio 7.1; 95% CI 2.1-23.4; p = 0.001) and nervous horses were at a greater risk than horses with calm or average temperaments (odds ratio 7.9; 95% CI 2.3-27.0; p = 0.001). Rhabdomyolysis-susceptible cases performed better from standstill starts (p = 0.04) than controls and had a higher percentage of wins (p = 0.006). All exertional rhabdomyolysis-susceptible horses tested were negative for the R309H GYS1 mutation. Conclusions/Significance: Exertional rhabdomyolysis syndrome in Standardbred horses has a similar incidence and risk factors to the syndrome in Thoroughbred horses. If the disorder has a genetic basis in Standardbreds, improved performance in susceptible animals may be responsible for maintenance of the disorder in the population.	[Isgren, Cajsa M.; Upjohn, Melissa M.; Fernandez-Fuente, Marta; Massey, Claire; Pollott, Geoff; Verheyen, Kristien L. P.; Piercy, Richard J.] Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England; [Pollott, Geoff] Univ London Royal Vet Coll, Dept Vet Basic Sci, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Isgren, CM (corresponding author), Univ London Royal Vet Coll, Dept Vet Clin Sci, London, England.	rpiercy@rvc.ac.uk	Verheyen, Kristien/I-3300-2014; Fernandez-Fuente, Marta/A-1761-2014	Verheyen, Kristien/0000-0002-5077-224X; 				BEECH J, 1993, RES VET SCI, V54, P110, DOI 10.1016/0034-5288(93)90019-C; Collinder E, 1997, EQUINE VET J, V29, P117, DOI 10.1111/j.2042-3306.1997.tb01652.x; Dranchak PK, 2005, JAVMA-J AM VET MED A, V227, P762, DOI 10.2460/javma.2005.227.762; DRANCHAK PK, 2004, ANAL RECURRENT EXERT; Firshman AM, 2003, AM J VET RES, V64, P1319, DOI 10.2460/ajvr.2003.64.1319; FRAUENFELDER HC, 1986, EQUINE VET J, V18, P371, DOI 10.1111/j.2042-3306.1986.tb03657.x; HARRIS PA, 1991, BRIT VET J, V147, P373, DOI 10.1016/0007-1935(91)90011-B; Hunt LM, 2008, EQUINE VET J, V40, P171, DOI 10.2746/042516408X244262; JEFFCOTT LB, 1982, EQUINE VET J, V14, P185, DOI 10.1111/j.2042-3306.1982.tb02389.x; Lentz LR, 1999, AM J VET RES, V60, P992; Lentz LR, 1999, AM J VET RES, V60, P684; LINDHOLM A, 1974, ACTA VET SCAND, V15, P325; MacLeay JM, 1999, AM J VET RES, V60, P250; MacLeay JM, 1999, AM J VET RES, V60, P1562; MacLeay JM, 2000, AM J VET RES, V61, P1390, DOI 10.2460/ajvr.2000.61.1390; Martin BB, 2000, J AM VET MED ASSOC, V216, P554, DOI 10.2460/javma.2000.216.554; McCue ME, 2008, J VET INTERN MED, V22, P1228, DOI 10.1111/j.1939-1676.2008.0167.x; McCue M E, 2006, Equine Vet J Suppl, P340; McCue ME, 2009, VET PATHOL, V46, P1281, DOI 10.1354/vp.08-VP-0177-M-FL; Mccue ME, 2008, GENOMICS, V91, P458, DOI 10.1016/j.ygeno.2008.01.011; McGowan CM, 2002, VET REC, V151, P623, DOI 10.1136/vr.151.21.623; McGowan CM, 2002, VET REC, V150, P535, DOI 10.1136/vr.150.17.535; McKenzie EC, 2004, AM J VET RES, V65, P74, DOI 10.2460/ajvr.2004.65.74; McKenzie EC, 2003, J VET INTERN MED, V17, P693, DOI 10.1892/0891-6640(2003)017&lt;0693:EODSFA&gt;2.3.CO;2; Oki H, 2007, J ANIM BREED GENET, V124, P185, DOI 10.1111/j.1439-0388.2007.00659.x; ROSSDALE PD, 1985, VET REC, V116, P66, DOI 10.1136/vr.116.3.66; RUDOLPH JA, 1992, NAT GENET, V2, P144, DOI 10.1038/ng1092-144; Singer ER, 2008, VET J, V175, P76, DOI 10.1016/j.tvjl.2006.11.009; Stanley RL, 2009, EQUINE VET J, V41, P597, DOI 10.2746/042516409X407611; Upjohn MM, 2005, VET REC, V156, P763, DOI 10.1136/vr.156.24.763; VALBERG S, 1993, EQUINE VET J, V25, P11, DOI 10.1111/j.2042-3306.1993.tb02893.x; Valberg S J, 1999, Equine Vet J Suppl, P533; Valentine BA, 2000, VET PATHOL, V37, P193, DOI 10.1354/vp.37-2-193; Wilsher S, 2006, EQUINE VET J, V38, P113, DOI 10.2746/042516406776563305	34	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11594	10.1371/journal.pone.0011594	http://dx.doi.org/10.1371/journal.pone.0011594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644724	Green Published, gold, Green Submitted			2022-12-27	WOS:000279884900025
J	Romaguera, D; Angquist, L; Du, HD; Jakobsen, MU; Forouhi, NG; Halkjaer, J; Feskens, EJM; van der A, DL; Masala, G; Steffen, A; Palli, D; Wareham, NJ; Overvad, K; Tjonneland, A; Boeing, H; Riboli, E; Sorensen, TIA				Romaguera, Dora; Aengquist, Lars; Du, Huaidong; Jakobsen, Marianne Uhre; Forouhi, Nita G.; Halkjaer, Jytte; Feskens, Edith J. M.; van der A, Daphne L.; Masala, Giovanna; Steffen, Annika; Palli, Domenico; Wareham, Nicholas J.; Overvad, Kim; Tjonneland, Anne; Boeing, Heiner; Riboli, Elio; Sorensen, Thorkild I. A.			Dietary Determinants of Changes in Waist Circumference Adjusted for Body Mass Index - a Proxy Measure of Visceral Adiposity	PLOS ONE			English	Article							EPIC-OXFORD PARTICIPANTS; MIDDLE-AGED MEN; GLYCEMIC INDEX; ABDOMINAL ADIPOSITY; SUBSEQUENT CHANGES; EUROPEAN MEN; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; INSULIN-RESISTANCE; ENERGY DENSITY	Background: Given the recognized health effects of visceral fat, the understanding of how diet can modulate changes in the phenotype "waist circumference for a given body mass index (WCBMI)'', a proxy measure of visceral adiposity, is deemed necessary. Hence, the objective of the present study was to assess the association between dietary factors and prospective changes in visceral adiposity as measured by changes in the phenotype WCBMI. Methods and Findings: We analyzed data from 48,631 men and women from 5 countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Anthropometric measurements were obtained at baseline and after a median follow-up time of 5.5 years. WCBMI was defined as the residuals of waist circumference regressed on body mass index, and annual change in WCBMI (Delta WCBMI, cm/y) was defined as the difference between residuals at follow-up and baseline, divided by follow-up time. The association between energy, energy density (ED), macronutrients, alcohol, glycemic index (GI), glycemic load (GL), fibre and Delta WCBMI was modelled using centre-specific adjusted linear regression, and random-effects meta-analyses to obtain pooled estimates. Men and women with higher ED and GI diets showed significant increases in their WCBMI, compared to those with lower ED and GI [1 kcal/g greater ED predicted a Delta WCBMI of 0.09 cm (95% CI 0.05 to 0.13) in men and 0.15 cm (95% CI 0.09 to 0.21) in women; 10 units greater GI predicted a Delta WCBMI of 0.07 cm (95% CI 0.03 to 0.12) in men and 0.06 cm (95% CI 0.03 to 0.10) in women]. Among women, lower fibre intake, higher GL, and higher alcohol consumption also predicted a higher Delta WCBMI. Conclusions: Results of this study suggest that a diet with low GI and ED may prevent visceral adiposity, defined as the prospective changes in WCBMI. Additional effects may be obtained among women of low alcohol, low GL, and high fibre intake.	[Romaguera, Dora; Riboli, Elio] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England; [Aengquist, Lars; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Du, Huaidong; van der A, Daphne L.] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands; [Du, Huaidong] Nutr & Toxicol Res Inst Maastricht, Dept Human Biol, Maastricht, Netherlands; [Jakobsen, Marianne Uhre] Aarhus Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Forouhi, Nita G.; Wareham, Nicholas J.] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Halkjaer, Jytte; Tjonneland, Anne] Inst Canc Epidemiol, Danish Canc Soc, Copenhagen, Denmark; [Feskens, Edith J. M.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands; [Masala, Giovanna; Palli, Domenico] ISPO Canc Res & Prevent Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; [Steffen, Annika; Boeing, Heiner] German Inst Human Nutr, Dept Epidemiol, Potsdam, Nuthetal, Germany; [Overvad, Kim] Aarhus Univ, Dept Epidemiol, Sch Publ Hlth, Aarhus, Denmark; [Overvad, Kim] Aarhus Univ Hosp, Dept Cardiol, Aalborg Hosp, Aalborg, Denmark	Imperial College London; University of Copenhagen; Netherlands National Institute for Public Health & the Environment; Maastricht University; Maastricht University Medical Centre (MUMC); Aarhus University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Danish Cancer Society; Wageningen University & Research; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Romaguera, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London, England.	d.romaguera-bosch@imperial.ac.uk	Jakobsen, Marianne Uhre/I-8550-2018; Feskens, Edith JM/A-3757-2012; Romaguera, Dora/ABE-7004-2020; Feskens, Edith/ABI-1446-2020; Steffen, Annika/H-7709-2018; Steffen, Annika/E-8540-2016; Romaguera, Dora/AAB-2852-2020; Masala, Giovanna/AAC-5474-2022	Jakobsen, Marianne Uhre/0000-0001-6518-4136; Romaguera, Dora/0000-0002-5762-8558; Feskens, Edith/0000-0001-5819-2488; Steffen, Annika/0000-0003-4072-9245; Steffen, Annika/0000-0003-4072-9245; Masala, Giovanna/0000-0002-5758-9069; PALLI, Domenico/0000-0002-5558-2437; Angquist, Lars/0000-0002-9516-4424; Riboli, Elio/0000-0001-6795-6080; Du, Huaidong/0000-0002-9814-0049; Forouhi, Nita/0000-0002-5041-248X; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; tumino, rosario/0000-0003-2666-414X	European Union [FOOD-CT-2005-513946]; Medical Research Council [MC_UP_A100_1003, MC_U106179471] Funding Source: researchfish; MRC [MC_UP_A100_1003] Funding Source: UKRI	European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DiOGenes is the acronym of the project "Diet, Obesity and Genes'' supported by the European Union (Contract no. FOOD-CT-2005-513946). The parties of the project are listed on the web-site of the project (http://www.diogenes-eu.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bigaard J, 2003, OBES RES, V11, P895, DOI 10.1038/oby.2003.123; Chaston TB, 2008, INT J OBESITY, V32, P619, DOI 10.1038/sj.ijo.0803761; Dallongeville J, 1998, INT J OBESITY, V22, P1178, DOI 10.1038/sj/ijo/0800744; Deharveng G, 1999, EUR J CLIN NUTR, V53, P60, DOI 10.1038/sj.ejcn.1600677; Du H, 2009, INT J OBESITY, V33, P1280, DOI 10.1038/ijo.2009.163; Du HD, 2010, AM J CLIN NUTR, V91, P329, DOI 10.3945/ajcn.2009.28191; Du HD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005339; Feldeisen SE, 2007, APPL PHYSIOL NUTR ME, V32, P46, DOI [10.1139/H06-101, 10.1139/h06-101]; Forouhi NG, 2009, AM J CLIN NUTR, V90, P1632, DOI 10.3945/ajcn.2009.27828; Freemantle N, 2008, INT J CLIN PRACT, V62, P1391, DOI 10.1111/j.1742-1241.2008.01805.x; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Haftenberger M, 2002, PUBLIC HEALTH NUTR, V5, P1147, DOI 10.1079/PHN2002396; Halkjaer J, 2004, BRIT J NUTR, V92, P735, DOI 10.1079/BJN20041246; Halkjaer J, 2006, AM J CLIN NUTR, V84, P789, DOI 10.1093/ajcn/84.4.789; Han TS, 1998, INT J EPIDEMIOL, V27, P422, DOI 10.1093/ije/27.3.422; Howard BV, 2006, JAMA-J AM MED ASSOC, V295, P39, DOI 10.1001/jama.295.1.39; Janssen I, 2005, J AM GERIATR SOC, V53, P2112, DOI 10.1111/j.1532-5415.2005.00505.x; Janssen I, 2002, AM J CLIN NUTR, V75, P683, DOI 10.1093/ajcn/75.4.683; Kaaks R, 1997, INT J EPIDEMIOL, V26, pS15, DOI 10.1093/ije/26.suppl_1.S15; Kahn HS, 1997, AM J PUBLIC HEALTH, V87, P747, DOI 10.2105/AJPH.87.5.747; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719, DOI 10.1093/ajcn/78.4.719; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Lau C, 2005, DIABETES CARE, V28, P1397, DOI 10.2337/diacare.28.6.1397; Lee K, 2008, NUTRITION, V24, P625, DOI 10.1016/j.nut.2008.03.004; Liese AD, 2005, DIABETES CARE, V28, P2832, DOI 10.2337/diacare.28.12.2832; Mendez MA, 2009, AM J CLIN NUTR, V89, P316, DOI 10.3945/ajcn.2008.26444; Okosun IS, 2001, J HUM HYPERTENS, V15, P307, DOI 10.1038/sj.jhh.1001179; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Romaguera D, 2009, J NUTR, V139, P1728, DOI 10.3945/jn.109.108902; Schuetze M, 2009, EUR J CLIN NUTR, V63, P1143, DOI 10.1038/ejcn.2009.39; Spencer EA, 2004, PUBLIC HEALTH NUTR, V7, P723, DOI 10.1079/PHN2004600; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Summerbell CD, 2009, INT J OBESITY, V33, pS1, DOI 10.1038/ijo.2009.80; Tolstrup JS, 2008, AM J CLIN NUTR, V87, P957, DOI 10.1093/ajcn/87.4.957; Vadstrup ES, 2003, INT J OBESITY, V27, P238, DOI 10.1038/sj.ijo.802203; van Bakel MME, 2009, EUR J CLIN NUTR, V63, pS188, DOI 10.1038/ejcn.2009.81; van Bakel MME, 2009, J NUTR, V139, P568, DOI 10.3945/jn.108.097121; Vergnaud AC, 2009, BRIT J NUTR, V102, P302, DOI 10.1017/S0007114508162109; Wareham NJ, 2003, PUBLIC HEALTH NUTR, V6, P407, DOI 10.1079/PHN2002439; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366	44	76	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11588	10.1371/journal.pone.0011588	http://dx.doi.org/10.1371/journal.pone.0011588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644647	Green Published, gold, Green Submitted			2022-12-27	WOS:000279884900023
J	Durkin, MS; Maenner, MJ; Meaney, FJ; Levy, SE; DiGuiseppi, C; Nicholas, JS; Kirby, RS; Pinto-Martin, JA; Schieve, LA				Durkin, Maureen S.; Maenner, Matthew J.; Meaney, F. John; Levy, Susan E.; DiGuiseppi, Carolyn; Nicholas, Joyce S.; Kirby, Russell S.; Pinto-Martin, Jennifer A.; Schieve, Laura A.			Socioeconomic Inequality in the Prevalence of Autism Spectrum Disorder: Evidence from a US Cross-Sectional Study	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; SOCIAL-CLASS; INFANTILE-AUTISM; RISK-FACTORS; CHILDREN; EPIDEMIOLOGY; HEALTH	Background: This study was designed to evaluate the hypothesis that the prevalence of autism spectrum disorder (ASD) among children in the United States is positively associated with socioeconomic status (SES). Methods: A cross-sectional study was implemented with data from the Autism and Developmental Disabilities Monitoring Network, a multiple source surveillance system that incorporates data from educational and health care sources to determine the number of 8-year-old children with ASD among defined populations. For the years 2002 and 2004, there were 3,680 children with ASD among a population of 557 689 8-year-old children. Area-level census SES indicators were used to compute ASD prevalence by SES tertiles of the population. Results: Prevalence increased with increasing SES in a dose-response manner, with prevalence ratios relative to medium SES of 0.70 (95% confidence interval [CI] 0.64, 0.76) for low SES, and of 1.25 (95% CI 1.16, 1.35) for high SES, (P<0.001). Significant SES gradients were observed for children with and without a pre-existing ASD diagnosis, and in analyses stratified by gender, race/ethnicity, and surveillance data source. The SES gradient was significantly stronger in children with a pre-existing diagnosis than in those meeting criteria for ASD but with no previous record of an ASD diagnosis (p<0.001), and was not present in children with co-occurring ASD and intellectual disability. Conclusions: The stronger SES gradient in ASD prevalence in children with versus without a pre-existing ASD diagnosis points to potential ascertainment or diagnostic bias and to the possibility of SES disparity in access to services for children with autism. Further research is needed to confirm and understand the sources of this disparity so that policy implications can be drawn. Consideration should also be given to the possibility that there may be causal mechanisms or confounding factors associated with both high SES and vulnerability to ASD.	[Durkin, Maureen S.; Maenner, Matthew J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53706 USA; [Durkin, Maureen S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI USA; [Durkin, Maureen S.; Maenner, Matthew J.] Univ Wisconsin, Waisman Ctr, Madison, WI USA; [Meaney, F. John] Univ Arizona, Hlth Sci Ctr, Dept Pediat, Tucson, AZ 85721 USA; [Levy, Susan E.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [DiGuiseppi, Carolyn] Univ Colorado Denver, Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Nicholas, Joyce S.] Med Univ S Carolina, Dept Neurosci, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Nicholas, Joyce S.] Med Univ S Carolina, Dept Med, Div Biostat & Epidemiol, Charleston, SC 29425 USA; [Kirby, Russell S.] Univ S Florida, Dept Community & Family Hlth, Tampa, FL USA; [Pinto-Martin, Jennifer A.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Pinto-Martin, Jennifer A.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Schieve, Laura A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Arizona; University of Arizona Health Sciences; University of Pennsylvania; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Medical University of South Carolina; Medical University of South Carolina; State University System of Florida; University of South Florida; University of Pennsylvania; University of Pennsylvania; Centers for Disease Control & Prevention - USA	Durkin, MS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53706 USA.	mdurkin@wisc.edu	DiGuiseppi, Carolyn/AAU-1341-2020; Kirby, Russell/E-8113-2018; Romanova, Raisa/O-5724-2018; Durkin, Maureen/B-7834-2015	DiGuiseppi, Carolyn/0000-0002-6440-7817; Kirby, Russell/0000-0002-3489-401X; 	Centers for Disease Control and Prevention [UR3/CCU523235, UR3/DD000078]; University of Wisconsin; CENTERS FOR DISEASE CONTROL AND PREVENTION [UR3DD000078] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); University of Wisconsin; CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by the Centers for Disease Control and Prevention (www.cdc.gov), Cooperative Agreements UR3/CCU523235 and UR3/DD000078. Additional funding for graduate student support for data analysis was provided by the University of Wisconsin (www.wisc.edu). Scientists employed by the funding agency participated in the study design and data collection and one of these scientists, Dr. Laura Schieve, participated in the analysis, decision to publish, and preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bhasin TK, 2007, J AUTISM DEV DISORD, V37, P667, DOI 10.1007/s10803-006-0194-y; BRASK BH, 1972, NORDIC S CARE PSYCHO; Burd L, 1999, J PERINAT MED, V27, P441, DOI 10.1515/JPM.1999.059; CIALDELLA P, 1989, J CHILD PSYCHOL PSYC, V30, P165, DOI 10.1111/j.1469-7610.1989.tb00775.x; COX A, 1975, BRIT J PSYCHIAT, V126, P146, DOI 10.1192/bjp.126.2.146; Croen LA, 2002, J AUTISM DEV DISORD, V32, P217, DOI 10.1023/A:1015405914950; Cryan E, 1996, J AUTISM DEV DISORD, V26, P453, DOI 10.1007/BF02172829; Cuccaro ML, 1996, J AUTISM DEV DISORD, V26, P461, DOI 10.1007/BF02172830; Durkin M.S., 2007, PUBLIC HLTH PREVENTI, V15th, P1173; Durkin MS, 2008, AM J EPIDEMIOL, V168, P1268, DOI 10.1093/aje/kwn250; EISENBERG L, 1956, AM J ORTHOPSYCHIAT, V26, P556, DOI 10.1111/j.1939-0025.1956.tb06202.x; FINEGAN JA, 1979, J CHILD PSYCHOL PSYC, V20, P119, DOI 10.1111/j.1469-7610.1979.tb00492.x; Fombonne E, 2001, J AM ACAD CHILD PSY, V40, P820, DOI 10.1097/00004583-200107000-00017; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; GILLBERG C, 1982, J AUTISM DEV DISORD, V12, P223, DOI 10.1007/BF01531368; HOSHINO Y, 1982, FOLIA PSYCHIAT NEU J, V36, P115; Kanner L, 1943, NERV CHILD, V2, P217; Krieger N, 2003, J EPIDEMIOL COMMUN H, V57, P186, DOI 10.1136/jech.57.3.186; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lotter V., 1967, SOCIAL PSYCHIATRY, V1, P163, DOI [DOI 10.1007/BF00578950, 10.1002/mrdd.1002910.1007/bf00584048]; Maenner M. J., 2009, WISC MED J, V108, P37; Mandell DS, 2009, AM J PUBLIC HEALTH, V99, P493, DOI 10.2105/AJPH.2007.131243; MCCARTHY P, 1979, J CHILD PSYCHOL PSYC, V20, P119; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Palmer RF, 2010, AM J PUBLIC HEALTH, V100, P270, DOI 10.2105/AJPH.2008.150565; Palmer RF, 2005, AM J PUBLIC HEALTH, V95, P125, DOI 10.2105/AJPH.2003.023077; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Rice CE, 2007, PAEDIATR PERINAT EP, V21, P179, DOI 10.1111/j.1365-3016.2007.00801.x; RITVO ER, 1971, J AUTISM CHILD SCHIZ, V1, P297; Rook GAW, 2007, T ROY SOC TROP MED H, V101, P1072, DOI 10.1016/j.trstmh.2007.05.014; SCHOPLER E, 1979, J AUTISM DEV DISORD, V9, P139, DOI 10.1007/BF01531530; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; STEFFENBURG S, 1986, BRIT J PSYCHIAT, V149, P81, DOI 10.1192/bjp.149.1.81; Susser MW, 1985, SOCIOLOGY MED; TREFFERT DA, 1970, ARCH GEN PSYCHIAT, V22, P431; TSAI L, 1982, J AUTISM DEV DISORD, V12, P211, DOI 10.1007/BF01531367; U.S. Census Bureau, 2000, US CENS 2000; U S Census Bureau, POV AR; Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7; Williams E, 2008, DEV MED CHILD NEUROL, V50, P672, DOI 10.1111/j.1469-8749.2008.03042.x; WING L, 1980, BRIT J PSYCHIAT, V137, P410, DOI 10.1192/bjp.137.5.410	42	261	276	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11551	10.1371/journal.pone.0011551	http://dx.doi.org/10.1371/journal.pone.0011551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	623XV	20634960	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600026
J	Sharma, P; Ignatchenko, V; Grace, K; Ursprung, C; Kislinger, T; Gramolini, AO				Sharma, Parveen; Ignatchenko, Vladimir; Grace, Kevin; Ursprung, Claudia; Kislinger, Thomas; Gramolini, Anthony O.			Endoplasmic Reticulum Protein Targeting of Phospholamban: A Common Role for an N-Terminal Di-Arginine Motif in ER Retention?	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; SARCOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; CARDIAC CONTRACTILITY; POTASSIUM CHANNELS; SKELETAL-MUSCLE; BINDING-SITES; BETA-SUBUNIT; GOLGI; SARCOLIPIN	Background: Phospholamban (PLN) is an effective inhibitor of the sarco(endo) plasmic reticulum Ca(2+)-ATPase, which transports Ca(2+) into the SR lumen, leading to muscle relaxation. A mutation of PLN in which one of the di-arginine residues at positions 13 and 14 was deleted led to a severe, early onset dilated cardiomyopathy. Here we were interested in determining the cellular mechanisms involved in this disease-causing mutation. Methodology/Principal Finding: Mutations deleting codons for either or both Arg13 or Arg14 resulted in the mislocalization of PLN from the ER. Our data show that PLN is recycled via the retrograde Golgi to ER membrane traffic pathway involving COP-I vesicles, since co-immunoprecipitation assays determined that COP I interactions are dependent on an intact di-arginine motif as PLN R Delta 14 did not co-precipitate with COP I containing vesicles. Bioinformatic analysis determined that the di-arginine motif is present in the first 25 residues in a large number of all ER/SR Gene Ontology (GO) annotated proteins. Mutations in the di-arginine motif of the Sigma 1-type opioid receptor, the beta-subunit of the signal recognition particle receptor, and Sterol-O-acyltransferase, three proteins identified in our bioinformatic screen also caused mislocalization of these known ER-resident proteins. Conclusion: We conclude that PLN is enriched in the ER due to COP I-mediated transport that is dependent on its intact diarginine motif and that the N-terminal di-arginine motif may act as a general ER retrieval sequence.	[Sharma, Parveen; Grace, Kevin; Ursprung, Claudia; Gramolini, Anthony O.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Ignatchenko, Vladimir; Kislinger, Thomas] Univ Hlth Network, Ontario Canc Inst, Toronto, ON, Canada; [Kislinger, Thomas] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Gramolini, Anthony O.] Toronto Gen Res Inst, Div Cellular & Mol Biol, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Sharma, P (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	anthony.gramolini@utoronto.ca	Kislinger, Thomas/A-5934-2008	Kislinger, Thomas/0000-0003-3525-5540; Sharma, Parveen/0000-0002-5534-2417; Grace, Kevin/0000-0003-4746-6353	Heart and Stroke Foundation of Ontario [T-6281]; Canadian Institutes of Health Research [MOP-84267]; Canadian Foundation for Innovation; Connaught Foundation; Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Connaught Foundation(University of Toronto); Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence	This study was supported by the Heart and Stroke Foundation of Ontario (#T-6281) http://www.heartandstroke.ca/, Canadian Institutes of Health Research (MOP-84267) http://www.cihr-irsc.gc.ca/, Canadian Foundation for Innovation, Connaught Foundation, and the Heart and Stroke/Richard Lewar Centre of Cardiovascular Excellence. AOG is a Canada Research Chair and a New Investigator of the Heart and Stroke Foundation of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Asahi M, 2003, P NATL ACAD SCI USA, V100, P5040, DOI 10.1073/pnas.0330962100; Asahi M, 2002, J BIOL CHEM, V277, P26725, DOI 10.1074/jbc.C200269200; Bord S, 2001, J CLIN ENDOCR METAB, V86, P2309, DOI 10.1210/jc.86.5.2309; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Dolinski K, 2007, ANNU REV GENET, V41, P465, DOI 10.1146/annurev.genet.40.110405.090439; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Elschenbroich S, 2009, J PROTEOME RES, V8, P4860, DOI 10.1021/pr900318k; Girod A, 1999, NAT CELL BIOL, V1, P423, DOI 10.1038/15658; Gramolini AO, 2004, P NATL ACAD SCI USA, V101, P16807, DOI 10.1073/pnas.0407815101; Gu S, 2007, J BIOL CHEM, V282, P33064, DOI 10.1074/jbc.M702685200; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Harter C, 1996, P NATL ACAD SCI USA, V93, P1902, DOI 10.1073/pnas.93.5.1902; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kim KH, 2008, J PHARMACOL EXP THER, V324, P160, DOI 10.1124/jpet.107.125773; Kimura Y, 1997, J BIOL CHEM, V272, P15061, DOI 10.1074/jbc.272.24.15061; Kimura Y, 1998, J BIOL CHEM, V273, P14238, DOI 10.1074/jbc.273.23.14238; Kraev A, 1996, GENOMICS, V37, P105, DOI 10.1006/geno.1996.0526; Leach MR, 2002, J BIOL CHEM, V277, P29686, DOI 10.1074/jbc.M202405200; Legate KR, 2003, J BIOL CHEM, V278, P27712, DOI 10.1074/jbc.M302158200; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; MacLennan DH, 2003, ANN NY ACAD SCI, V986, P472, DOI 10.1111/j.1749-6632.2003.tb07231.x; MacLennan DH, 2003, NAT REV MOL CELL BIO, V4, P566, DOI 10.1038/nrm1151; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; MARTIN FC, 1983, EUR J CLIN INVEST, V13, P49, DOI 10.1111/j.1365-2362.1983.tb00064.x; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Odermatt A, 1997, GENOMICS, V45, P541, DOI 10.1006/geno.1997.4967; Odermatt A, 1998, J BIOL CHEM, V273, P12360, DOI 10.1074/jbc.273.20.12360; PELHAM HRB, 1990, TRENDS BIOCHEM SCI, V15, P483, DOI 10.1016/0968-0004(90)90303-S; Ponting CP, 2002, ANNU REV BIOPH BIOM, V31, P45, DOI 10.1146/annurev.biophys.31.082901.134314; Simmerman HKB, 1998, PHYSIOL REV, V78, P921, DOI 10.1152/physrev.1998.78.4.921; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stenoien DL, 2007, AM J PHYSIOL-CELL PH, V292, pC2084, DOI 10.1152/ajpcell.00523.2006; Stephens DJ, 2000, J CELL SCI, V113, P2177; TADA M, 1982, ANNU REV PHYSIOL, V44, P401, DOI 10.1146/annurev.ph.44.030182.002153; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Vangheluwe P, 2005, CELL CALCIUM, V38, P291, DOI 10.1016/j.ceca.2005.06.033; Wilke RA, 1999, J BIOL CHEM, V274, P18387, DOI 10.1074/jbc.274.26.18387; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang JY, 2003, J BIOL CHEM, V278, P7459, DOI 10.1074/jbc.M207976200; Zvaritch E, 2000, J BIOL CHEM, V275, P14985, DOI 10.1074/jbc.275.20.14985	51	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11496	10.1371/journal.pone.0011496	http://dx.doi.org/10.1371/journal.pone.0011496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634894	gold, Green Submitted, Green Published			2022-12-27	WOS:000279715300009
J	Barbosa, VC				Barbosa, Valmir C.			Network Conduciveness with Application to the Graph-Coloring and Independent-Set Optimization Transitions	PLOS ONE			English	Article							ACYCLIC ORIENTATIONS; PHASE-TRANSITIONS	Background: Given an undirected graph, we consider the two problems of combinatorial optimization, which ask that its chromatic and independence numbers be found. Although both problems are NP-hard, when either one is solved on the incrementally denser graphs of a random sequence, at certain critical values of the number of edges, it happens that the transition to the next value causes optimal solutions to be obtainable substantially more easily than right before it. Methodology/Principal Findings: We introduce the notion of a network's conduciveness, a probabilistically interpretable measure of how the network's structure allows it to be conducive to roaming agents, in certain conditions, from one portion of the network to another. We demonstrate that the performance jumps of graph coloring and independent sets at the critical-value transitions in the number of edges can be understood by resorting to the network that represents the solution space of the problems for each graph and examining its conduciveness between the non-optimal solutions and the optimal ones. Right past each transition, this network becomes strikingly more conducive in the direction of the optimal solutions than it was just before it, while at the same time becoming less conducive in the opposite direction. Conclusions/Significance: Network conduciveness provides a useful conceptual framework for explaining the performance jumps associated with graph coloring and independent sets. We believe it may also become instrumental in helping clarify further issues related to NP-hardness that remain poorly understood. Additionally, it may become useful also in other areas in which network theory has a role to play.	Univ Fed Rio de Janeiro, COPPE, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Programa Engn Sistemas & Computacao, BR-21945 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Barbosa, VC (corresponding author), Univ Fed Rio de Janeiro, COPPE, Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, Programa Engn Sistemas & Computacao, BR-21945 Rio De Janeiro, Brazil.	valmir@cos.ufrj.br		Carneiro Barbosa, Valmir/0000-0003-1010-7170	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was partially supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and a Cientista do Nosso Estado grant from Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa V.C., 2000, ATLAS EDGE REVERSAL; Barbosa VC, 2004, J COMB OPTIM, V8, P419, DOI 10.1007/s10878-004-4835-9; Barbosa VC, 2004, PHYSICA A, V343, P401, DOI 10.1016/j.physa.2004.05.055; Barbosa VC, 1999, INFORM PROCESS LETT, V72, P71, DOI 10.1016/S0020-0190(99)00120-9; Barbosa VC, 2004, J COMB OPTIM, V8, P41, DOI 10.1023/B:JOCO.0000021937.26468.b2; BOLLOBA B, 2009, HDB LARGE SCALE RAND; Bondy J.A., 2008, GRAPH THEORY; Bornholdt S, 2003, HDB GRAPHS NETWORKS; BRELAZ D, 1979, COMMUN ACM, V22, P251, DOI 10.1145/359094.359101; CARRAGHAN R, 1990, OPER RES LETT, V9, P375, DOI 10.1016/0167-6377(90)90057-C; CHEESEMAN P, 1991, P 12 INT JOINT C ART, P331; Culberson J, 2001, THEOR COMPUT SCI, V265, P227, DOI 10.1016/S0304-3975(01)00164-5; DEMING RW, 1979, J COMB THEORY B, V26, P101, DOI 10.1016/0095-8956(79)90048-0; Garey M.R., 1979, COMPUTERS INTRACTABI; Giordana A, 2000, MACH LEARN, V41, P217, DOI 10.1023/A:1007620705405; Johnson David S., 1990, HDB THEORETICAL COMP, VA, P67; JOHNSON DS, 1993, DFMAX C SEMIEXHAUSTI; Latham PE, 2009, SCHOLARPEDIA, V4, P1658, DOI [10.4249/scholarpedia.1658, DOI 10.4249/SCHOLARPEDIA.1658]; MITCHELL D, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P459; Newman MEJ., 2006, STRUCTURE DYNAMICS N; SLANEY J, 2001, P 17 INT JOINT C ART, P254; Stanley R. P., 1973, Discrete Mathematics, V5, P171, DOI 10.1016/0012-365X(73)90108-8; TRICK MA, 1994, COLOR C EASY CODE GR	24	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11232	10.1371/journal.pone.0011232	http://dx.doi.org/10.1371/journal.pone.0011232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628597	Green Published, Green Submitted, gold			2022-12-27	WOS:000279637100001
J	Wilbanks, EG; Facciotti, MT				Wilbanks, Elizabeth G.; Facciotti, Marc T.			Evaluation of Algorithm Performance in ChIP-Seq Peak Detection	PLOS ONE			English	Article							FACTOR-BINDING SITES; GENOME-WIDE IDENTIFICATION; CHROMATIN-IMMUNOPRECIPITATION; MODEL; DECONVOLUTION; PROFILES; NETWORK; TOOL; MAP	Next-generation DNA sequencing coupled with chromatin immunoprecipitation (ChIP-seq) is revolutionizing our ability to interrogate whole genome protein-DNA interactions. Identification of protein binding sites from ChIP-seq data has required novel computational tools, distinct from those used for the analysis of ChIP-Chip experiments. The growing popularity of ChIP-seq spurred the development of many different analytical programs (at last count, we noted 31 open source methods), each with some purported advantage. Given that the literature is dense and empirical benchmarking challenging, selecting an appropriate method for ChIP-seq analysis has become a daunting task. Herein we compare the performance of eleven different peak calling programs on common empirical, transcription factor datasets and measure their sensitivity, accuracy and usability. Our analysis provides an unbiased critical assessment of available technologies, and should assist researchers in choosing a suitable tool for handling ChIP-seq data.	[Wilbanks, Elizabeth G.; Facciotti, Marc T.] Univ Calif Davis, Grad Grp Microbiol, Davis, CA 95616 USA; [Facciotti, Marc T.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Wilbanks, Elizabeth G.; Facciotti, Marc T.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Wilbanks, EG (corresponding author), Univ Calif Davis, Grad Grp Microbiol, Davis, CA 95616 USA.	mtfacciotti@ucdavis.edu	Facciotti, Marc/AAF-9227-2020	Facciotti, Marc/0000-0003-4453-3274	National Science Foundation; UC Davis	National Science Foundation(National Science Foundation (NSF)); UC Davis	This work was supported by a National Science Foundation Graduate Research Fellowship to EGW and MTF's start-up funds from UC Davis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BARSKI A, 2009, J CELL BIOCH; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BLAHNIK K, 2009, NUCL ACIDS RES; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Collins PJ, 2007, PLOS GENET, V3, P2247, DOI 10.1371/journal.pgen.0030208; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng WX, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S23; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johannes F, 2010, BIOINFORMATICS, V26, P1000, DOI 10.1093/bioinformatics/btq087; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; KHARCHENKO PV, 2008, NAT BIOTECHNOL; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lun DS, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r142; McPherson JD, 2009, NAT METHODS, V6, pS2, DOI [10.1038/NMETH.F.268, 10.1038/nmeth.f.268]; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; QIN S, 2009, HMM BASED ALGORITHM; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reiss DJ, 2008, BIOINFORMATICS, V24, P396, DOI 10.1093/bioinformatics/btm592; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; ROSENBLOOM KR, 2009, NUCL ACIDS RES  1117; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Spyrou C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-299; Taslim C, 2009, BIOINFORMATICS, V25, P2334, DOI 10.1093/bioinformatics/btp384; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Vega VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005241; Wang CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-81; Wilder S, 2010, SWEMBL GENERIC PEAK; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu H, 2008, BIOINFORMATICS, V24, P2344, DOI 10.1093/bioinformatics/btn402; Xu H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-436; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158	50	196	203	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11471	10.1371/journal.pone.0011471	http://dx.doi.org/10.1371/journal.pone.0011471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628599	Green Published, Green Submitted, gold			2022-12-27	WOS:000279637100004
J	Das, D; Luo, X; Singh, A; Gu, YP; Ghosh, S; Mukhopadhyay, CK; Chen, SG; Sy, MS; Kong, QZ; Singh, N				Das, Dola; Luo, Xiu; Singh, Ajay; Gu, Yaping; Ghosh, Soumya; Mukhopadhyay, Chinmay K.; Chen, Shu G.; Sy, Man-Sun; Kong, Qingzhong; Singh, Neena			Paradoxical Role of Prion Protein Aggregates in Redox-Iron Induced Toxicity	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; DEPENDENT GENERATION; REPEAT REGION; COPPER; DISEASE; METALS; PATHOGENESIS; CONVERSION; REDUCTION; AUTOPHAGY	Background: Imbalance of iron homeostasis has been reported in sporadic Creutzfeldt-Jakob-disease (sCJD) affected human and scrapie infected animal brains, but the contribution of this phenotype to disease associated neurotoxicity is unclear. Methodology/Principal Findings: Using cell models of familial prion disorders, we demonstrate that exposure of cells expressing normal prion protein (PrPC) or mutant PrP forms to a source of redox-iron induces aggregation of PrPC and specific mutant PrP forms. Initially this response is cytoprotective, but becomes increasingly toxic with time due to accumulation of PrP-ferritin aggregates. Mutant PrP forms that do not aggregate are not cytoprotective, and cells show signs of acute toxicity. Intracellular PrP-ferritin aggregates induce the expression of LC3-II, indicating stimulation of autophagy in these cells. Similar observations are noted in sCJD and scrapie infected hamster brains, lending credence to these results. Furthermore, phagocytosis of PrP-ferritin aggregates by astrocytes is cytoprotective, while culture in astrocyte conditioned medium (CM) shows no measurable effect. Exposure to H2O2, on the other hand, does not cause aggregation of PrP, and cells show acute toxicity that is alleviated by CM. Conclusions/Significance: These observations suggest that aggregation of PrP in response to redox-iron is cytoprotective. However, subsequent co-aggregation of PrP with ferritin induces intracellular toxicity unless the aggregates are degraded by autophagosomes or phagocytosed by adjacent scavenger cells. H2O2, on the other hand, does not cause aggregation of PrP, and induces toxicity through extra-cellular free radicals. Together with previous observations demonstrating imbalance of iron homeostasis in prion disease affected brains, these observations provide insight into the mechanism of neurotoxicity by redox-iron, and the role of PrP in this process.	[Das, Dola; Luo, Xiu; Singh, Ajay; Gu, Yaping; Ghosh, Soumya; Chen, Shu G.; Sy, Man-Sun; Kong, Qingzhong; Singh, Neena] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Mukhopadhyay, Chinmay K.] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	Case Western Reserve University; Jawaharlal Nehru University, New Delhi	Das, D (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	ajay.singh2@case.edu; neena.singh@case.edu	Chen, Shu G./O-4750-2014; Das, Dola/I-1802-2014; Chen, Shu G./AAK-7301-2021; Chen, Shu/Z-2943-2019	Chen, Shu G./0000-0001-7180-3001; Chen, Shu G./0000-0001-7180-3001; 	National Institutes of Health [R21AG033423, R01NS044209]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG033423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants R21AG033423 and R01NS044209 (to NS) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Allsop D, 2008, BIOCHEM SOC T, V36, P1293, DOI 10.1042/BST0361293; Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Basu S, 2007, MOL BIOL CELL, V18, P3302, DOI 10.1091/mbc.E07-04-0317; Brown DR, 1999, J NEUROSCI RES, V58, P717; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chinta SJ, 2008, BBA-GEN SUBJECTS, V1780, P1362, DOI 10.1016/j.bbagen.2008.02.005; Choi CJ, 2006, NEUROTOXICOLOGY, V27, P777, DOI 10.1016/j.neuro.2006.06.004; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gimenez-Xavier P, 2009, NEUROTOXICOLOGY, V30, P658, DOI 10.1016/j.neuro.2009.04.007; Gregory A, 2005, FOLIA NEUROPATHOL, V43, P286, DOI 10.1016/B978-0-444-63233-3.00019-1; Gu YP, 2003, J NEUROCHEM, V84, P10, DOI 10.1046/j.1471-4159.2003.01255.x; Harris DA, 2006, NEURON, V50, P353, DOI 10.1016/j.neuron.2006.04.020; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kawano T, 2007, INT J BIOL SCI, V3, P57; Kim BH, 2007, NEUROSCI LETT, V422, P158, DOI 10.1016/j.neulet.2007.05.061; Kim NH, 2005, FASEB J, V19, P783, DOI 10.1096/fj.04-2117fje; Kim NH, 2000, BRAIN RES, V884, P98, DOI 10.1016/S0006-8993(00)02907-3; Koiri RK, 2008, BIOMETALS, V21, P117, DOI 10.1007/s10534-007-9098-3; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Lehmann S, 2002, CURR OPIN CHEM BIOL, V6, P187, DOI 10.1016/S1367-5931(02)00295-8; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mishra RS, 2002, J BIOL CHEM, V277, P24554, DOI 10.1074/jbc.M200213200; Miura T, 2005, BIOCHEMISTRY-US, V44, P8712, DOI 10.1021/bi0501784; Molina-Holgado F, 2007, BIOMETALS, V20, P639, DOI 10.1007/s10534-006-9033-z; Oh JM, 2008, MOL CELL NEUROSCI, V39, P238, DOI 10.1016/j.mcn.2008.07.003; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Petersen RB, 2005, ACTA NEUROPATHOL, V110, P232, DOI 10.1007/s00401-005-1034-4; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2004, PRION BIOL DIS; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Ruiz FH, 2000, BIOCHEM BIOPH RES CO, V269, P491, DOI 10.1006/bbrc.2000.2270; Shearer J, 2007, INORG CHEM, V46, P710, DOI 10.1021/ic061236s; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Singh N, 1997, J BIOL CHEM, V272, P28461, DOI 10.1074/jbc.272.45.28461; Tabner BJ, 2005, BIOCHEM SOC T, V33, P548, DOI 10.1042/BST0330548; Turnbull S, 2003, NEUROSCI LETT, V336, P159, DOI 10.1016/S0304-3940(02)01254-5; Turnbull S, 2003, BIOCHEMISTRY-US, V42, P7675, DOI 10.1021/bi030036e; Varela-Nallar L, 2006, BIOL RES, V39, P39, DOI 10.4067/S0716-97602006000100005; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	49	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11420	10.1371/journal.pone.0011420	http://dx.doi.org/10.1371/journal.pone.0011420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625431	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500004
J	Meeran, SM; Patel, SN; Tollefsbol, TO				Meeran, Syed M.; Patel, Shweta N.; Tollefsbol, Trygve O.			Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; TELOMERASE REVERSE-TRANSCRIPTASE; GENE-EXPRESSION; DNA METHYLATION; APOPTOSIS; PROMOTER; GROWTH; TRICHOSTATIN; ACETYLATION; MODULATION	Background: Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is a common dietary component that has histone deacetylase inhibition activity and exciting potential in cancer prevention. The mechanisms by which SFN imparts its chemopreventive properties are of considerable interest and little is known of its preventive potential for breast cancer. Principal Findings: We found that SFN significantly inhibits the viability and proliferation of breast cancer cells in vitro while it has negligible effects on normal breast cells. Inhibition of telomerase has received considerable attention because of its high expression in cancer cells and extremely low level of expression in normal cells. SFN treatment dose-and time-dependently inhibited human telomerase reverse transcriptase (hTERT), the catalytic regulatory subunit of telomerase, in both MCF-7 and MDA-MB-231 human breast cancer cells. DNA methyltransferases (DNMTs), especially DNMT1 and DNMT3a, were also decreased in SFN-treated breast cancer cells suggesting that SFN may repress hTERT by impacting epigenetic pathways. Down-regulation of DNMTs in response to SFN induced site-specific CpG demethylation occurring primarily in the first exon of the hTERT gene thereby facilitating CTCF binding associated with hTERT repression. Chromatin immunoprecipitation (ChIP) analysis of the hTERT promoter revealed that SFN increased the level of active chromatin markers acetyl-H3, acetyl-H3K9 and acetyl-H4, whereas the trimethyl-H3K9 and trimethyl-H3K27 inactive chromatin markers were decreased in a dose-dependent manner. SFN-induced hyperacetylation facilitated the binding of many hTERT repressor proteins such as MAD1 and CTCF to the hTERT regulatory region. Depletion of CTCF using siRNA reduced the SFN-induced down-regulation of hTERT mRNA transcription in these breast cancer cells. In addition, down-regulation of hTERT expression facilitated the induction of cellular apoptosis in human breast cancer cells. Significance: Collectively, our results provide novel insights into SFN-mediated epigenetic down-regulation of telomerase in breast cancer prevention and may open new avenues for approaches to SFN-mediated cancer prevention.	[Meeran, Syed M.; Patel, Shweta N.; Tollefsbol, Trygve O.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Tollefsbol, Trygve O.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Meeran, SM (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	trygve@uab.edu	Meeran, Syed Musthapa/AAG-2157-2020	Meeran, Syed Musthapa/0000-0003-3859-146X; Tollefsbol, Trygve/0000-0002-0284-1511	National Cancer Institute [R01 CA129415]; NATIONAL CANCER INSTITUTE [R01CA129415] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R01 CA129415 National Cancer Institute (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2003, J ANTI-AGING MED, V6, P315, DOI 10.1089/109454503323028911; Anderson CJ, 2006, ONCOGENE, V25, P61, DOI 10.1038/sj.onc.1209011; Berletch JB, 2008, J CELL BIOCHEM, V103, P509, DOI 10.1002/jcb.21417; Bhamre S, 2009, PROSTATE, V69, P181, DOI 10.1002/pros.20869; Choi JH, 2010, BIOCHEM BIOPH RES CO, V391, P449, DOI 10.1016/j.bbrc.2009.11.078; Choi KC, 2009, CANCER RES, V69, P583, DOI 10.1158/0008-5472.CAN-08-2442; Chu WF, 2009, ORAL ONCOL, V45, P998, DOI 10.1016/j.oraloncology.2009.05.641; Ciftci K, 2003, J PHARM PHARMACOL, V55, P1135, DOI 10.1211/002235703322277177; Cornblatt BS, 2007, CARCINOGENESIS, V28, P1485, DOI 10.1093/carcin/bgm049; Dashwood RH, 2008, NUTR REV, V66, pS36, DOI 10.1111/j.1753-4887.2008.00065.x; Fahey JW, 1997, P NATL ACAD SCI USA, V94, P10367, DOI 10.1073/pnas.94.19.10367; Golubovskaya VM, 2008, MOL CARCINOGEN, V47, P222, DOI 10.1002/mc.20380; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Ho E, 2009, J NUTR, V139, P2393, DOI 10.3945/jn.109.113332; Hou M, 2002, EXP CELL RES, V274, P25, DOI 10.1006/excr.2001.5462; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Jew S, 2009, J MED FOOD, V12, P925, DOI 10.1089/jmf.2008.0268; Kyo S, 2008, CANCER SCI, V99, P1528, DOI 10.1111/j.1349-7006.2008.00878.x; Li YY, 2009, INT J CANCER, V125, P286, DOI 10.1002/ijc.24398; Liu L, 2004, GENE, V340, P1, DOI 10.1016/j.gene.2004.06.011; Liu L, 2004, MOL CANCER THER, V3, P1003; Meeran SM, 2007, EXP DERMATOL, V16, P405, DOI 10.1111/j.1600-0625.2007.00542.x; Munster P, 2009, CLIN CANCER RES, V15, P2488, DOI 10.1158/1078-0432.CCR-08-1930; Murakami J, 2005, CANCER CHEMOTH PHARM, V56, P22, DOI 10.1007/s00280-004-0976-x; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; Myzak MC, 2007, EXP BIOL MED, V232, P227; Naasani I, 2003, CANCER RES, V63, P824; Nian H, 2009, ENVIRON MOL MUTAGEN, V50, P213, DOI 10.1002/em.20454; Patil BS, 2009, J AGR FOOD CHEM, V57, P8142, DOI 10.1021/jf9000132; Pledgie-Tracy A, 2007, MOL CANCER THER, V6, P1013, DOI 10.1158/1535-7163.MCT-06-0494; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Renaud S, 2005, NUCLEIC ACIDS RES, V33, P6850, DOI 10.1093/nar/gki989; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Shun MC, 2004, NUTR CANCER, V48, P95, DOI 10.1207/s15327914nc4801_13; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Suenaga M, 2002, INT J CANCER, V97, P621, DOI 10.1002/ijc.10082; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Telang U, 2009, EXP BIOL MED, V234, P287, DOI 10.3181/0808-RM-241; Wei N, 2009, FASEB J, V23; Woo HJ, 2007, EXP MOL PATHOL, V82, P77, DOI 10.1016/j.yexmp.2006.02.004; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu DW, 2001, P NATL ACAD SCI USA, V98, P3826, DOI 10.1073/pnas.071043198; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	44	253	260	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11457	10.1371/journal.pone.0011457	http://dx.doi.org/10.1371/journal.pone.0011457			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625516	Green Submitted, Green Published, gold			2022-12-27	WOS:000279522500022
J	Hosking, MP; Tirotta, E; Ransohoff, RM; Lane, TE				Hosking, Martin P.; Tirotta, Emanuele; Ransohoff, Richard M.; Lane, Thomas E.			CXCR2 Signaling Protects Oligodendrocytes and Restricts Demyelination in a Mouse Model of Viral-Induced Demyelination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; HEPATITIS-VIRUS; CHEMOKINE RECEPTORS; MURINE CORONAVIRUS; IFN-GAMMA; MEDIATED DEMYELINATION; MICE LACKING; SPINAL-CORD; JHM STRAIN; T-CELLS	Background: The functional role of ELR-positive CXC chemokines during viral - induced demyelination was assessed. Inoculation of the neuroattenuated JHM strain of mouse hepatitis virus (JHMV) into the CNS of susceptible mice results in an acute encephalomyelitis that evolves into a chronic demyelinating disease, modeling white matter pathology observed in the human demyelinating disease Multiple Sclerosis. Methodology/Principal Findings: JHMV infection induced the rapid and sustained expression of transcripts specific for the ELR (+) chemokine ligands CXCL1 and CXCL2, as well as their binding receptor CXCR2, which was enriched within the spinal cord during chronic infection. Inhibiting CXCR2 signaling with neutralizing antiserum significantly (p < 0.03) delayed clinical recovery. Moreover, CXCR2 neutralization was associated with an increase in the severity of demyelination that was independent of viral recrudescence or modulation of neuroinflammation. Rather, blocking CXCR2 was associated with increased numbers of apoptotic cells primarily within white matter tracts, suggesting that oligodendrocytes were affected. JHMV infection of enriched oligodendrocyte progenitor cell (OPC) cultures revealed that apoptosis was associated with elevated expression of cleaved caspase 3 and muted Bcl-2 expression. Inclusion of CXCL1 within JHMV infected cultures restricted caspase 3 cleavage and increased Bcl-2 expression that was associated with a significant (p < 0.001) decrease in apoptosis. CXCR2 deficient oligodendrocytes were refractory to CXCL1 mediated protection from JHMV - induced apoptosis, readily activating caspase 3 and down regulating Bcl-2. Conclusion/Significance: These findings highlight a previously unappreciated role for CXCR2 signaling in protecting oligodendrocyte lineage cells from apoptosis during inflammatory demyelination initiated by viral infection of the CNS.	[Hosking, Martin P.; Tirotta, Emanuele; Lane, Thomas E.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [Lane, Thomas E.] Univ Calif Irvine, Inst Immunol, Irvine, CA 92717 USA; [Lane, Thomas E.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA 92717 USA; [Ransohoff, Richard M.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Neuroinflammat Res Ctr, Cleveland, OH 44106 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Cleveland Clinic Foundation	Hosking, MP (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.	tlane@uci.edu			National Institutes of Health (NIH) [NS41249, T32 AI-060573]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041249] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health (NIH) grants NS41249 to T. E. L. supported this work. M. P. H. was supported by NIH T32 AI-060573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajetto A, 2001, FRONT NEUROENDOCRIN, V22, P147, DOI 10.1006/frne.2001.0214; Balabanov R, 2006, J NEUROSCI, V26, P5143, DOI 10.1523/JNEUROSCI.0737-06.2006; Ben-Hur T, 1998, J NEUROSCI, V18, P5777, DOI 10.1523/jneurosci.18-15-05777.1998; Bergmann CC, 1996, J GEN VIROL, V77, P315, DOI 10.1099/0022-1317-77-2-315; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Carollo M, 2001, BRIT J PHARMACOL, V134, P1166, DOI 10.1038/sj.bjp.0704371; CHEEVER FS, 1949, J EXP MED, V90, P181, DOI 10.1084/jem.90.3.181; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Dorf ME, 2000, J NEUROIMMUNOL, V111, P109, DOI 10.1016/S0165-5728(00)00371-4; DSouza SD, 1996, J EXP MED, V184, P2361, DOI 10.1084/jem.184.6.2361; Glabinski AR, 1997, AM J PATHOL, V150, P617; Gonzalez JM, 2006, AM J PATHOL, V168, P796, DOI 10.2353/ajpath.2006.050496; Gonzalez JM, 2005, GLIA, V51, P22, DOI 10.1002/glia.20182; HIRANO N, 1978, JPN J EXP MED, V48, P71; Horuk R, 1997, J IMMUNOL, V158, P2882; Hosking MP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000648; Hovelmeyer N, 2005, J IMMUNOL, V175, P5875, DOI 10.4049/jimmunol.175.9.5875; KERSTETTER AE, 2009, EXP NEUROL; Kielian T, 2000, AM J PATHOL, V157, P647, DOI 10.1016/S0002-9440(10)64575-0; Kuhlmann T, 1999, GLIA, V28, P34, DOI 10.1002/(SICI)1098-1136(199910)28:1<34::AID-GLIA4>3.0.CO;2-8; Lane TE, 1998, J IMMUNOL, V160, P970; Lin MT, 1997, J VIROL, V71, P383, DOI 10.1128/JVI.71.1.383-391.1997; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Liu MT, 2001, J IMMUNOL, V167, P4091, DOI 10.4049/jimmunol.167.7.4091; Liu Y, 2006, J VIROL, V80, P395, DOI 10.1128/JVI.80.1.395-403.2006; Liu Y, 2005, J VIROL, V79, P47, DOI 10.1128/JVI.79.1.47-56.2005; Liu Y, 2003, J VIROL, V77, P11952, DOI 10.1128/JVI.77.22.11952-11963.2003; Liu Y, 2007, VIROLOGY, V360, P364, DOI 10.1016/j.virol.2006.10.044; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; Lucchinetti C, 1999, BRAIN, V122, P2279, DOI 10.1093/brain/122.12.2279; Mehrad B, 1999, J IMMUNOL, V163, P6086; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; OKA A, 1993, J NEUROSCI, V13, P1441; Omari KM, 2009, AM J PATHOL, V174, P164, DOI 10.2353/ajpath.2009.080350; Omari KM, 2006, GLIA, V53, P24, DOI 10.1002/glia.20246; Omari KM, 2005, BRAIN, V128, P1003, DOI 10.1093/brain/awh479; Padovani-Claudio DA, 2006, GLIA, V54, P471, DOI 10.1002/glia.20383; Parra B, 1999, J IMMUNOL, V162, P1641; Parra B, 1997, VIROLOGY, V233, P260, DOI 10.1006/viro.1997.8613; Perlman S, 2000, EFFECTS OF MICROBES ON THE IMMUNE SYSTEM, P331; Pewe L, 2002, J IMMUNOL, V168, P1547, DOI 10.4049/jimmunol.168.4.1547; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Popivanova BK, 2003, BRAIN RES, V970, P195, DOI 10.1016/S0006-8993(03)02343-6; Pouly S, 2000, J NEUROPATH EXP NEUR, V59, P280, DOI 10.1093/jnen/59.4.280; Robinson S, 1998, J NEUROSCI, V18, P10457; Rubio N, 2007, VIROLOGY, V358, P98, DOI 10.1016/j.virol.2006.08.003; Rubio N, 2006, CELL IMMUNOL, V239, P31, DOI 10.1016/j.cellimm.2006.03.003; Schwartz T, 2002, J NEUROVIROL, V8, P392, DOI 10.1080/13550280260422695; SELMAJ KW, 1988, ANN NEUROL, V23, P339, DOI 10.1002/ana.410230405; Stiles LN, 2006, EUR J IMMUNOL, V36, P613, DOI 10.1002/eji.200535509; STOHLMAN SA, 1981, NEUROLOGY, V31, P38, DOI 10.1212/WNL.31.1.38; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Totoiu MO, 2004, EXP NEUROL, V187, P254, DOI 10.1016/j.expneurol.2004.01.028; Trifilo MJ, 2004, VIROLOGY, V327, P8, DOI 10.1016/j.virol.2004.06.027; Tsai HH, 2002, CELL, V110, P373, DOI 10.1016/S0092-8674(02)00838-3; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; Valles A, 2006, NEUROBIOL DIS, V22, P312, DOI 10.1016/j.nbd.2005.11.015; Walsh KB, 2008, J VIROL, V82, P3031, DOI 10.1128/JVI.02033-07; WANG FI, 1992, LAB INVEST, V66, P744; Wang ZY, 2003, VIROLOGY, V312, P60, DOI 10.1016/S0042-6822(03)00181-8; Wu GF, 1999, J VIROL, V73, P8771, DOI 10.1128/JVI.73.10.8771-8780.1999; XUE SR, 1995, VIROLOGY, V208, P173, DOI 10.1006/viro.1995.1140; Yu N, 1998, P NATL ACAD SCI USA, V95, P2624, DOI 10.1073/pnas.95.5.2624	68	41	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11340	10.1371/journal.pone.0011340	http://dx.doi.org/10.1371/journal.pone.0011340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596532	gold, Green Published			2022-12-27	WOS:000279259900013
J	Jahn, A; Floyd, S; McGrath, N; Crampin, AC; Kachiwanda, L; Mwinuka, V; Zaba, B; Fine, PEM; Glynn, JR				Jahn, Andreas; Floyd, Sian; McGrath, Nuala; Crampin, Amelia C.; Kachiwanda, Lackson; Mwinuka, Venance; Zaba, Basia; Fine, Paul E. M.; Glynn, Judith R.			Child Mortality in Rural Malawi: HIV Closes the Survival Gap between the Socio-Economic Strata	PLOS ONE			English	Article							NORTHERN MALAWI; VERBAL AUTOPSY; INFECTION; DISTRICT; KARONGA; AFRICA; TRENDS; RISK	Background: As HIV-related deaths increase in a population the usual association between low socioeconomic status and child mortality may change, particularly as death rates from other causes decline. Methods/Principal Findings: As part of a demographic surveillance system in northern Malawi in 2002-6, covering a population of 32,000, information was collected on socio-economic status of the households. Deaths were classified as HIV/AIDS-related or not by verbal autopsy. Poisson regression models were used to assess the association of socio-economic indicators with all-cause mortality, AIDS-mortality and non-AIDS mortality among children. There were 195 deaths in infants, 109 in children aged 1-4 years, and 38 in children aged 5-15. All-cause child mortality in infants and 1-4 year olds was similar in households with higher and lower socio-economic status. In infants 13% of deaths were attributed to AIDS, and there were no clear trends with socio-economic status for AIDS or non-AIDS causes. For 1-4 year olds 27% of deaths were attributed to AIDS. AIDS mortality was higher among those with better built houses, and lowest in those with income from farming and fishing, whereas non-AIDS mortality was higher in those with worse built houses, lowest in those with income from employment, and decreased with increasing household assets. Conclusions/Significance: In this population, since HIV infection among adults was initially more common among the less poor, childhood mortality patterns have changed. The usual gap in survival between the poor and the less poor has been lost, but because the less poor have been disproportionately affected by HIV, rather than because of relative improvement in the survival of the poorest.	[Jahn, Andreas; Floyd, Sian; McGrath, Nuala; Crampin, Amelia C.; Zaba, Basia; Fine, Paul E. M.; Glynn, Judith R.] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [McGrath, Nuala] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Kachiwanda, Lackson; Mwinuka, Venance] Karonga Prevent Study, Chilumba, Karonga, Malawi	University of London; London School of Hygiene & Tropical Medicine; University of Kwazulu Natal; Malawi Epidemiology and Intervention Research Unit	Jahn, A (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	Judith.glynn@lshtm.ac.uk	Jahn, Andreas/ABB-7796-2020	Jahn, Andreas/0000-0003-4645-1600; Crampin, Amelia/0000-0002-1513-4330; McGrath, Nuala/0000-0002-1039-0159	Wellcome Trust; Government of the Republic of Malawi; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Government of the Republic of Malawi; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Karonga Prevention Study is funded primarily by the Wellcome Trust (www.wellcome.ac.uk), with contributions from LEPRA (The British Leprosy Relief Association, www.lepra.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Government of the Republic of Malawi for their interest in and support of the Project and the National Health Sciences Research Committee of Malawi for permission to publish the paper.	[Anonymous], REP GLOB AIDS EP 200; Banerjee A, 1997, T ROY SOC TROP MED H, V91, P707, DOI 10.1016/S0035-9203(97)90533-2; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; Crampin AC, 2003, AIDS, V17, P389, DOI 10.1097/00002030-200302140-00013; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; *INDEPTH NETW, 2003, INDEPTH STAND VERB A; JAHN A, B WHO IN PRESS; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Marston M, 2005, JAIDS-J ACQ IMM DEF, V38, P219, DOI 10.1097/00126334-200502010-00015; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; Mishra V, 2007, DHS WORKING PAPERS, V31; MWALE MW, 2005, MALAWI DEMOGRAPHIC H, P123; Nykanen M, 1995, E AFR MED J, V72, P731; Over M, 1993, DIS CONTROL PRIORITI, P455; Razzell P, 2005, INT J EPIDEMIOL, V34, P477, DOI 10.1093/ije/dyi035; TODD JE, 1994, ANN TROP PAEDIATR, V14, P31, DOI 10.1080/02724936.1994.11747689; van Rossum CTM, 2000, J EPIDEMIOL COMMUN H, V54, P178, DOI 10.1136/jech.54.3.178; Wojcicki JM, 2005, J BIOSOC SCI, V37, P1, DOI 10.1017/S0021932004006534	22	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11320	10.1371/journal.pone.0011320	http://dx.doi.org/10.1371/journal.pone.0011320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	617DB	20596521	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000279259900005
J	van Buul, JD; van Rijssel, J; van Alphen, FPJ; Hoogenboezem, M; Tol, S; Hoeben, KA; van Marle, J; Mul, EPJ; Hordijk, PL				van Buul, Jaap D.; van Rijssel, Jos; van Alphen, Floris P. J.; Hoogenboezem, Mark; Tol, Simon; Hoeben, Kees A.; van Marle, Jan; Mul, Erik P. J.; Hordijk, Peter L.			Inside-Out Regulation of ICAM-1 Dynamics in TNF-alpha-Activated Endothelium	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; LEUKOCYTE TRANSENDOTHELIAL MIGRATION; INTRACELLULAR DOMAIN; SIGNALING PATHWAY; CELLS; RHO; TRANSMIGRATION; PHOSPHORYLATION; RECRUITMENT; DIAPEDESIS	Background: During transendothelial migration, leukocytes use adhesion molecules, such as ICAM-1, to adhere to the endothelium. ICAM-1 is a dynamic molecule that is localized in the apical membrane of the endothelium and clusters upon binding to leukocytes. However, not much is known about the regulation of ICAM-1 clustering and whether membrane dynamics are linked to the ability of ICAM-1 to cluster and bind leukocyte integrins. Therefore, we studied the dynamics of endothelial ICAM-1 under non-clustered and clustered conditions. Principal Findings: Detailed scanning electron and fluorescent microscopy showed that the apical surface of endothelial cells constitutively forms small filopodia-like protrusions that are positive for ICAM-1 and freely move within the lateral plane of the membrane. Clustering of ICAM-1, using anti-ICAM-1 antibody-coated beads, efficiently and rapidly recruits ICAM-1. Using fluorescence recovery after photo-bleaching (FRAP), we found that clustering increased the immobile fraction of ICAM-1, compared to non-clustered ICAM-1. This shift required the intracellular portion of ICAM-1. Moreover, biochemical assays showed that ICAM-1 clustering recruited beta-actin and filamin. Cytochalasin B, which interferes with actin polymerization, delayed the clustering of ICAM-1. In addition, we could show that cytochalasin B decreased the immobile fraction of clustered ICAM-1-GFP, but had no effect on non-clustered ICAM-1. Also, the motor protein myosin-II is recruited to ICAM-1 adhesion sites and its inhibition increased the immobile fraction of both non-clustered and clustered ICAM-1. Finally, blocking Rac1 activation, the formation of lipid rafts, myosin-II activity or actin polymerization, but not Src, reduced the adhesive function of ICAM-1, tested under physiological flow conditions. Conclusions: Together, these findings indicate that ICAM-1 clustering is regulated in an inside-out fashion through the actin cytoskeleton. Overall, these data indicate that signaling events within the endothelium are required for efficient ICAM-1-mediated leukocyte adhesion.	[van Buul, Jaap D.; van Rijssel, Jos; van Alphen, Floris P. J.; Hoogenboezem, Mark; Tol, Simon; Mul, Erik P. J.; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Hoeben, Kees A.; van Marle, Jan] Univ Amsterdam, Acad Med Ctr, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Buul, JD (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Mol Cell Biol, Sanquin Res & Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.vanbuul@sanquin.nl	van Buul, Jaap D/AAJ-4371-2021	van Buul, Jaap D/0000-0003-0054-7949; van Rijssel, Jos/0000-0001-8077-1371; Hordijk, Peter/0000-0002-3348-078X; Mul, FPJ/0000-0002-8234-9972	Dutch Heart Foundation [2005T039]; NWO (The Netherlands Organisation for Scientific Research)-ZonMW (the Netherlands Organisation for Health Research and Development) [916.76.053]	Dutch Heart Foundation(Netherlands Heart Foundation); NWO (The Netherlands Organisation for Scientific Research)-ZonMW (the Netherlands Organisation for Health Research and Development)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work has been funded by the Dutch Heart Foundation (grant no. 2005T039) and NWO (The Netherlands Organisation for Scientific Research)-ZonMW (the Netherlands Organisation for Health Research and Development) Veni grant 916.76.053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that	Alcaide P, 2009, MICROCIRCULATION, V16, P43, DOI 10.1080/10739680802273892; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; BACK AL, 1992, J IMMUNOL, V148, P710; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Bouquier N, 2009, CHEM BIOL, V16, P657, DOI 10.1016/j.chembiol.2009.04.012; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Carman CV, 2003, J IMMUNOL, V171, P6135, DOI 10.4049/jimmunol.171.11.6135; Celli L, 2006, J IMMUNOL, V177, P4113, DOI 10.4049/jimmunol.177.6.4113; Chen XH, 2007, P NATL ACAD SCI USA, V104, P15358, DOI 10.1073/pnas.0707406104; DURIEUTRAUTMANN O, 1994, J BIOL CHEM, V269, P1; Etienne S, 1998, J IMMUNOL, V161, P5755; Greenwood J, 2003, J IMMUNOL, V171, P2099, DOI 10.4049/jimmunol.171.4.2099; Heiska L, 1998, J BIOL CHEM, V273, P21893, DOI 10.1074/jbc.273.34.21893; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Kluger Martin S, 2004, Adv Dermatol, V20, P163; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Oh HM, 2007, MOL BIOL CELL, V18, P2322, DOI 10.1091/mbc.E06-08-0744; Saito H, 2002, J LEUKOCYTE BIOL, V72, P829; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Thompson PW, 2002, J IMMUNOL, V169, P1007, DOI 10.4049/jimmunol.169.2.1007; Tilghman RW, 2002, FEBS LETT, V525, P83, DOI 10.1016/S0014-5793(02)03070-3; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; van Buul JD, 2007, ARTERIOSCL THROM VAS, V27, P1870, DOI 10.1161/ATVBAHA.107.145821; van Buul JD, 2007, J CELL BIOL, V178, P1279, DOI 10.1083/jcb.200612053; van Buul JD, 2009, THROMB HAEMOSTASIS, V101, P649, DOI 10.1160/TH08-11-0714; van Buul JD, 2002, J IMMUNOL, V168, P588, DOI 10.4049/jimmunol.168.2.588; van Hennik PB, 2003, J BIOL CHEM, V278, P39166, DOI 10.1074/jbc.M307001200; Vestweber D, 2007, Ernst Schering Found Symp Proc, P151; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wojciak-Stothard B, 1999, J CELL BIOL, V145, P1293, DOI 10.1083/jcb.145.6.1293; Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440	39	45	46	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11336	10.1371/journal.pone.0011336	http://dx.doi.org/10.1371/journal.pone.0011336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596527	gold, Green Published, Green Submitted			2022-12-27	WOS:000279259900009
J	Curlin, ME; Huang, ML; Lu, XY; Celum, CL; Sanchez, J; Selke, S; Baeten, JM; Zuckerman, RA; Erdman, DD; Corey, L				Curlin, Marcel E.; Huang, Meei-Li; Lu, Xiaoyan; Celum, Connie L.; Sanchez, Jorge; Selke, Stacy; Baeten, Jared M.; Zuckerman, Richard A.; Erdman, Dean D.; Corey, Lawrence			Frequent Detection of Human Adenovirus from the Lower Gastrointestinal Tract in Men Who Have Sex with Men	PLOS ONE			English	Article							ENTERIC VIRUSES; T-CELL; VACCINE VECTORS; HOMOSEXUAL-MEN; HIV-1 VACCINE; DOUBLE-BLIND; PREVALENCE; INFECTION; AIDS; ROTAVIRUS	Background: The association between baseline seropositivity to human adenovirus (HAdV) type 5 and increased HIV acquisition in the Step HIV Vaccine Study has raised questions concerning frequency of acquired and/or persistent Adenovirus infections among adults at high risk of HIV-1 infection. Methodology: To evaluate the frequency and pattern of HAdV shedding from the lower GI tract, we retrospectively tested rectal swabs for HAdVs in a cohort of 20 HSV-2 positive HIV-positive Peruvian men who have sex with men (MSM) undergoing rectal swabbing three times/week for 18 consecutive weeks, in a prospective study of HSV-2 suppression in HIV infection. Viral DNA was extracted and amplified using a sensitive multiplex PCR assay that detects all currently recognized HAdV types. Molecular typing of viruses was performed on selected samples by hexon gene sequencing. Baseline neutralizing antibody titers to HAdVs 25, 226, 235 and 248 were also assessed. Principal Findings: 15/20 individuals had HAdV detected during follow up. The median frequency of HAdV detection was 30% of samples (range 2.0% to 64.7%). HAdV shedding typically occurred on consecutive days in clustered episodes lasting a median of 4 days (range 1 to 9 days) separated by periods without shedding, suggesting frequent new infections or reactivation of latent infections over time. 8 of the 15 shedders had more than one type detected in follow-up. 20 HAdV types from species B, C, and D were identified, including HAdV-5, 226 and 248, HAdV types under development as potential vaccine candidates. 14/20 subjects were seropositive for HAdV-5; 15/20 for HAdV-26; 3/20 for HAdV-35; and 2/20 for HAdV-48. HAdV shedding did not correlate with CD4 count, plasma HIV-1 viral load, or titers to HAdV-5 or HAdV-35. The sole individual with HAdV-5 shedding was HAdV-5 seropositive. Conclusions: HAdV shedding was highly prevalent and diverse, including types presently under consideration as HIV vaccine vectors. Subclinical HAdV infection of the GI tract is common among MSM in Peru; the prevalence of HAdV in the enteric tract should be evaluated in other populations. The association between ongoing recent enteric HAdV and the immune response to recombinant HAdV vaccines should be evaluated.	[Curlin, Marcel E.; Corey, Lawrence] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Curlin, Marcel E.; Huang, Meei-Li; Celum, Connie L.; Selke, Stacy; Baeten, Jared M.; Corey, Lawrence] Univ Washington, Dept Med, Seattle, WA USA; [Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Celum, Connie L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Celum, Connie L.; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Sanchez, Jorge] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Zuckerman, Richard A.] Dartmouth Hitchcock Med Ctr, Div Infect Dis, Lebanon, NH 03766 USA; [Lu, Xiaoyan; Erdman, Dean D.] Ctr Dis Control & Prevent, Atlanta, GA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Dartmouth College; Centers for Disease Control & Prevention - USA	Curlin, ME (corresponding author), Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA.	cemarcel@u.washington.edu	Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	GlaxoSmithKline; NIH CFAR Clinical Research and Laboratory Core [AI-27757, AI-38858, R37 AI-42528]; NIAID [AI-30731]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, U01AI038858, R37AI042528, P30AI027757] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NIH CFAR Clinical Research and Laboratory Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a research grant from GlaxoSmithKline and NIH CFAR Clinical Research and Laboratory Core Grants AI-27757 & AI-38858, R37 AI-42528 and NIAID Grant AI-30731. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; ALBRECHT H, 1993, SCAND J GASTROENTERO, V28, P307, DOI 10.3109/00365529309090246; Baden LR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-O36; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; BUIMOVICIKLEIN E, 1988, J MED VIROL, V25, P371, DOI 10.1002/jmv.1890250402; Cinek O, 2006, J CLIN VIROL, V35, P33, DOI 10.1016/j.jcv.2005.03.007; CUNNINGHAM AL, 1988, J INFECT DIS, V158, P386, DOI 10.1093/infdis/158.2.386; DUREPAIRE N, 1995, J MED VIROL, V45, P56, DOI 10.1002/jmv.1890450111; Ebner K, 2005, J VIROL, V79, P12635, DOI 10.1128/JVI.79.20.12635-12642.2005; Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07; EVANS AS, 1958, AM J HYG, V67, P256, DOI 10.1093/oxfordjournals.aje.a119932; Gonzalez GG, 1998, J MED VIROL, V55, P288, DOI 10.1002/(SICI)1096-9071(199808)55:4&lt;288::AID-JMV6&gt;3.0.CO;2-X; Gray GC, 2007, CLIN INFECT DIS, V45, P1120, DOI 10.1086/522188; GRAY JR, 1989, AM J GASTROENTEROL, V84, P1521; GROHMANN GS, 1993, NEW ENGL J MED, V329, P14, DOI 10.1056/NEJM199307013290103; GUARINO A, 1993, AIDS, V7, P1435; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HIERHOLZER JC, 1988, J INFECT DIS, V158, P804, DOI 10.1093/infdis/158.4.804; HIERHOLZER JC, 1978, J CLIN MICROBIOL, V7, P499; HIERHOLZER JC, 1992, CLIN MICROBIOL REV, V5, P262, DOI 10.1128/CMR.5.3.262-274.1992; HILLIS WD, 1973, INDIAN J MED RES, V61, P980; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; HORVATH J, 1986, J VIROL, V59, P189, DOI 10.1128/JVI.59.1.189-192.1986; HORWITZ MS, 1984, ANN NY ACAD SCI, V437, P161, DOI 10.1111/j.1749-6632.1984.tb37132.x; Huang ML, 2008, DIAGN MICR INFEC DIS, V62, P263, DOI 10.1016/j.diagmicrobio.2008.06.009; KALJOT KT, 1989, GASTROENTEROLOGY, V97, P1031, DOI 10.1016/0016-5085(89)91516-3; Kaye SB, 2005, J MED VIROL, V77, P227, DOI 10.1002/jmv.20440; KHOO SH, 1995, J INFECT DIS, V172, P629, DOI 10.1093/infdis/172.3.629; Kurosaki Kunikazu, 2004, Antiviral Chemistry & Chemotherapy, V15, P281; LAUGHON BE, 1988, GASTROENTEROLOGY, V94, P984, DOI 10.1016/0016-5085(88)90557-4; Leen AM, 2004, BLOOD, V104, P2432, DOI 10.1182/blood-2004-02-0646; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; LEW JF, 1991, J INFECT DIS, V164, P673, DOI 10.1093/infdis/164.4.673; Lu X, 2006, ARCH VIROL, V151, P1587, DOI 10.1007/s00705-005-0722-7; MAST TC, 2009, VACCINE; Naesens L, 2005, ANTIMICROB AGENTS CH, V49, P1010, DOI 10.1128/AAC.49.3.1010-1016.2005; Perreau M, 2008, J EXP MED, V205, P2717, DOI 10.1084/jem.20081786; Radosevic K, 2007, INFECT IMMUN, V75, P4105, DOI 10.1128/IAI.00004-07; Robb ML, 2008, LANCET, V372, P1857, DOI 10.1016/S0140-6736(08)61593-7; Rodriguez A, 2008, INFECT IMMUN, V76, P1709, DOI 10.1128/IAI.01614-07; Rodriguez-Baez N, 2002, J PEDIATR GASTR NUTR, V35, P64, DOI 10.1097/00005176-200207000-00014; Roy S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000503; SAULSBURY FT, 1980, J PEDIATR-US, V97, P61, DOI 10.1016/S0022-3476(80)80131-4; Schmidt W, 1996, J ACQ IMMUN DEF SYND, V13, P33, DOI 10.1097/00042560-199609000-00006; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THEA DM, 1993, T ROY SOC TROP MED H, V87, P263, DOI 10.1016/0035-9203(93)90119-B; Thomas P D, 1999, HIV Med, V1, P19, DOI 10.1046/j.1468-1293.1999.00004.x; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Vogels R, 2003, J VIROL, V77, P8263, DOI 10.1128/JVI.77.15.8263-8271.2003; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Zuckerman RA, 2007, J INFECT DIS, V196, P1500, DOI 10.1086/522523	52	10	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11321	10.1371/journal.pone.0011321	http://dx.doi.org/10.1371/journal.pone.0011321			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593015	Green Published, Green Submitted, gold			2022-12-27	WOS:000279140800019
J	Oliveira, RF; Terrin, A; Di Benedetto, G; Cannon, RC; Koh, W; Kim, M; Zaccolo, M; Blackwell, KT				Oliveira, Rodrigo F.; Terrin, Anna; Di Benedetto, Giulietta; Cannon, Robert C.; Koh, Wonryull; Kim, MyungSook; Zaccolo, Manuela; Blackwell, Kim T.			The Role of Type 4 Phosphodiesterases in Generating Microdomains of cAMP: Large Scale Stochastic Simulations	PLOS ONE			English	Article							PROTEIN-KINASE-A; MAMMALIAN ADENYLYL-CYCLASE; RESONANCE ENERGY-TRANSFER; SMALL SUBCELLULAR VOLUMES; CYCLIC-AMP; CARDIAC MYOCYTES; BETA(2)-ADRENERGIC RECEPTOR; MEDIATED PHOSPHORYLATION; DIFFUSION-COEFFICIENTS; SIGNALING PATHWAYS	Cyclic AMP (cAMP) and its main effector Protein Kinase A (PKA) are critical for several aspects of neuronal function including synaptic plasticity. Specificity of synaptic plasticity requires that cAMP activates PKA in a highly localized manner despite the speed with which cAMP diffuses. Two mechanisms have been proposed to produce localized elevations in cAMP, known as microdomains: impeded diffusion, and high phosphodiesterase (PDE) activity. This paper investigates the mechanism of localized cAMP signaling using a computational model of the biochemical network in the HEK293 cell, which is a subset of pathways involved in PKA-dependent synaptic plasticity. This biochemical network includes cAMP production, PKA activation, and cAMP degradation by PDE activity. The model is implemented in NeuroRD: novel, computationally efficient, stochastic reaction-diffusion software, and is constrained by intracellular cAMP dynamics that were determined experimentally by real-time imaging using an Epac-based FRET sensor (H30). The model reproduces the high concentration cAMP microdomain in the submembrane region, distinct from the lower concentration of cAMP in the cytosol. Simulations further demonstrate that generation of the cAMP microdomain requires a pool of PDE4D anchored in the cytosol and also requires PKA-mediated phosphorylation of PDE4D which increases its activity. The microdomain does not require impeded diffusion of cAMP, confirming that barriers are not required for microdomains. The simulations reported here further demonstrate the utility of the new stochastic reaction-diffusion algorithm for exploring signaling pathways in spatially complex structures such as neurons.	[Oliveira, Rodrigo F.; Koh, Wonryull; Kim, MyungSook; Blackwell, Kim T.] George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA; [Terrin, Anna; Zaccolo, Manuela] Univ Glasgow, Fac Biomed & Life Sci, Glasgow, Lanark, Scotland; [Di Benedetto, Giulietta] Venetian Inst Mol Med, Padua, Veneto, Italy; [Cannon, Robert C.] Textensor Ltd, Edinburgh, Midlothian, Scotland	George Mason University; University of Glasgow; Veneto Institute Molecular Medicine	Oliveira, RF (corresponding author), George Mason Univ, Krasnow Inst Adv Study, Fairfax, VA 22030 USA.	kblackw1@gmu.edu	Oliveira, Rodrigo Freire/Q-7155-2018; Di Benedetto, Giulietta/L-9842-2019; Zaccolo, Manuela/AAP-6706-2020; Zaccolo, Manuela/B-3802-2011	Oliveira, Rodrigo Freire/0000-0003-0312-1839; Di Benedetto, Giulietta/0000-0002-1489-3896; Zaccolo, Manuela/0000-0002-0934-3662; Oliveira, Rodrigo/0000-0002-3414-3339	HFSP; NSF-NIH [R01 AA16022]; Foundation Leducq [O6 CVD 02]; British Heart Foundation [PG/07/091/23698]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA016022] Funding Source: NIH RePORTER	HFSP(Human Frontier Science Program); NSF-NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Leducq(Leducq Foundation); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	An HFSP program grant (K. B. and M.Z.), the joint NSF-NIH CRCNS program through NIH grant R01 AA16022 (K. B.), Foundation Leducq (O6 CVD 02 to M.Z.) and the British Heart Foundation (PG/07/091/23698 to M.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SS, 2004, PHYS BIOL, V1, P137, DOI 10.1088/1478-3967/1/3/001; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Blackwell KT, 2006, J NEUROSCI METH, V157, P142, DOI 10.1016/j.jneumeth.2006.04.003; Blackwell KT, 2004, J COMPUT NEUROSCI, V17, P81, DOI 10.1023/B:JCNS.0000023866.88225.03; BODE DC, 1988, MOL CELL BIOCHEM, V82, P13; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; Cannon RC, 2007, NEUROINFORMATICS, V5, P127, DOI 10.1007/s12021-007-0004-5; Chen CH, 1999, BIOPHYS J, V76, P2861, DOI 10.1016/S0006-3495(99)77440-0; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Crook S, 2007, NEUROINFORMATICS, V5, P96, DOI 10.1007/s12021-007-0003-6; Dessauer CW, 1997, J BIOL CHEM, V272, P27787, DOI 10.1074/jbc.272.44.27787; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Gervasi N, 2007, J NEUROSCI, V27, P2744, DOI 10.1523/JNEUROSCI.5352-06.2007; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HABERMAN R, 1997, ELEMENTARY APPL PART; Hattne J, 2005, BIOINFORMATICS, V21, P2923, DOI 10.1093/bioinformatics/bti431; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Herman SB, 2000, MOL PHARMACOL, V57, P991; HUANG RC, 1991, J GEN PHYSIOL, V98, P835, DOI 10.1085/jgp.98.4.835; HUBLEY MJ, 1995, NMR BIOMED, V8, P72, DOI 10.1002/nbm.1940080205; Kerr RA, 2008, SIAM J SCI COMPUT, V30, P3126, DOI 10.1137/070692017; KIM M, 2009, 13521C31 SOC NEUR; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; MacKenzie SJ, 2002, BRIT J PHARMACOL, V136, P421, DOI 10.1038/sj.bjp.0704743; Martin ACL, 2006, BIOCHEM SOC T, V34, P480, DOI 10.1042/BST0340480; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; OGREID D, 1981, FEBS LETT, V129, P282, DOI 10.1016/0014-5793(81)80184-6; OLIVEIRA RF, 2009, 13520C30 SOC NEUR; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Rich TC, 2001, P NATL ACAD SCI USA, V98, P13049, DOI 10.1073/pnas.221381398; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; SIEGEL RM, 2000, SCI STKE, pPL1; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Sunahara RK, 1997, J BIOL CHEM, V272, P22265, DOI 10.1074/jbc.272.35.22265; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tardito D, 2006, PHARMACOL REV, V58, P115, DOI 10.1124/pr.58.1.7; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xin WK, 2008, J GEN PHYSIOL, V131, P349, DOI 10.1085/jgp.200709881; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; Zaccolo M, 2004, CIRC RES, V94, P866, DOI 10.1161/01.RES.0000123825.83803.CD; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200	64	86	86	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11725	10.1371/journal.pone.0011725	http://dx.doi.org/10.1371/journal.pone.0011725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661441	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000280243300025
J	Schneider, BS; Soong, L; Coffey, LL; Stevenson, HL; Mcgee, CE; Higgs, S				Schneider, Bradley S.; Soong, Lynn; Coffey, Lark L.; Stevenson, Heather L.; McGee, Charles E.; Higgs, Stephen			Aedes aegypti Saliva Alters Leukocyte Recruitment and Cytokine Signaling by Antigen-Presenting Cells during West Nile Virus Infection	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS-VIRUS; HOST IMMUNE-RESPONSE; NITRIC-OXIDE; IN-VITRO; GLAND EXTRACTS; T-CELLS; LYMPHOCYTE-PROLIFERATION; NONVIREMIC TRANSMISSION; INFLAMMATORY RESPONSE; MOUSE MACROPHAGES	West Nile virus (WNV) is transmitted during mosquito bloodfeeding. Consequently, the first vertebrate cells to contact WNV are cells in the skin, followed by those in the draining lymph node. Macrophages and dendritic cells are critical early responders in host defense against WNV infection, not just because of their role in orchestrating the immune response, but also because of their importance as sites of early peripheral viral replication. Antigen-presenting cell (APC) signals have a profound effect on host antiviral responses and disease severity. During transmission, WNV is intimately associated with mosquito saliva. Due to the ability of mosquito saliva to affect inflammation and immune responses, and the importance of understanding early events in WNV infection, we investigated whether mosquito saliva alters APC signaling during arbovirus infection, and if alterations in cell recruitment occur when WNV infection is initiated with mosquito saliva. Accordingly, experiments were performed with cultured dendritic cells and macrophages, flow cytometry was used to characterize infiltrating cell types in the skin and lymph nodes during early infection, and real-time RT-PCR was employed to evaluate virus and cytokine levels. Our in vitro results suggest that mosquito saliva significantly decreases the expression of interferon-beta and inducible nitric oxide synthase in macrophages (by as much as 50 and 70%, respectively), whilst transiently enhancing interleukin-10 (IL-10) expression. In vivo results indicate that the predominate effect of mosquito feeding is to significantly reduce the recruitment of T cells, leading the inoculation site of mice exposed to WNV alone to have up to 2.8 fold more t cells as mice infected in the presence of mosquito saliva. These shifts in cell population are associated with significantly elevated IL-10 and WNV (up to 4.0 and 10 fold, respectively) in the skin and draining lymph nodes. These results suggest that mosquito saliva dysregulates APC antiviral signaling, and reveal a possible mechanism for the observed enhancement of WNV disease mediated by mosquito saliva via a reduction of T lymphocyte and antiviral activity at the inoculation site, an elevated abundance of susceptible cell types, and a concomitant increase in immunoregulatory activity of IL-10.	[Schneider, Bradley S.; Soong, Lynn; Stevenson, Heather L.; McGee, Charles E.; Higgs, Stephen] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX USA; [Soong, Lynn] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [Coffey, Lark L.] Inst Pasteur, Dept Virol, Viral Populat & Pathogenesis Grp, Paris, France	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Schneider, BS (corresponding author), GVFI, San Francisco, CA USA.	sthiggs@UTMB.EDU		Coffey, Lark/0000-0002-0718-5146; Stevenson, Heather/0000-0002-0645-7621; Schneider, Bradley S/0000-0001-7642-0018	Centers for Disease Control Fellowship in Vector-Borne Infectious Diseases [T01/CCT622892]; National Institutes of Health [R01AI47246, AI47246]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047246] Funding Source: NIH RePORTER	Centers for Disease Control Fellowship in Vector-Borne Infectious Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BSS, CEM, and HLS were supported by the Centers for Disease Control Fellowship in Vector-Borne Infectious Diseases T01/CCT622892. This research was supported by the National Institutes of Health grant number R01AI47246 and, in part, by the National Institutes of Health grant number AI47246 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrati C, 2001, MOL MED, V7, P11, DOI 10.1007/BF03401834; Agrati C, 2001, AIDS RES HUM RETROV, V17, P1357, DOI 10.1089/08892220152596614; ANJILI CO, 1995, ACTA TROP, V60, P97, DOI 10.1016/0001-706X(95)00112-R; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; BenNathan D, 1996, ARCH VIROL, V141, P459, DOI 10.1007/BF01718310; Bishop JV, 2006, AM J TROP MED HYG, V75, P532, DOI 10.4269/ajtmh.2006.75.532; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Byrne SN, 2001, J INVEST DERMATOL, V117, P702, DOI 10.1046/j.0022-202x.2001.01454.x; CHAMBERS TJ, 2003, FLAVIVIRUSES PATHOGE; Chaturvedi UC, 1999, J MED VIROL, V59, P335, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;335::AID-JMV13&gt;3.0.CO;2-E; Daffis S, 2008, J VIROL, V82, P8465, DOI 10.1128/JVI.00918-08; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Demeure CE, 2005, J IMMUNOL, V174, P3932, DOI 10.4049/jimmunol.174.7.3932; Depinay N, 2006, J IMMUNOL, V176, P4141, DOI 10.4049/jimmunol.176.7.4141; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Grisham MB, 1998, FREE RADICAL BIO MED, V25, P404, DOI 10.1016/S0891-5849(98)00094-X; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; HAAHR S, 1971, ARCH GES VIRUSFORSCH, V35, P1, DOI 10.1007/BF01249747; Hajnicka V, 2000, PARASITE IMMUNOL, V22, P201, DOI 10.1046/j.1365-3024.2000.00296.x; Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102; Johnston LJ, 2000, J INVEST DERMATOL, V114, P560, DOI 10.1046/j.1523-1747.2000.00904.x; Kenneth KR, 1998, J BIOL CHEM, V273, P20802, DOI 10.1074/jbc.273.33.20802; Kopecky J, 1999, PARASITE IMMUNOL, V21, P351, DOI 10.1046/j.1365-3024.1999.00233.x; Kuthejlova M, 2001, INFECT IMMUN, V69, P575, DOI 10.1128/IAI.69.1.575-578.2001; Limesand KH, 2003, J MED ENTOMOL, V40, P199, DOI 10.1603/0022-2585-40.2.199; Lin YL, 1997, J VIROL, V71, P5227, DOI 10.1128/JVI.71.7.5227-5235.1997; Lobigs M, 2003, VACCINE, V21, P1572, DOI 10.1016/S0264-410X(02)00743-0; Macaluso KR, 2001, ANN TROP MED PARASIT, V95, P413, DOI 10.1080/00034980120059081; MARLETTA MA, 1994, J MED CHEM, V37, P1899, DOI 10.1021/jm00039a001; Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008; Maxwell SS, 2005, ANN TROP MED PARASIT, V99, P661, DOI 10.1179/136485905X51490; McGee CE, 2007, AM J TROP MED HYG, V76, P424, DOI 10.4269/ajtmh.2007.76.424; Montgomery RR, 2004, INFECT IMMUN, V72, P2989, DOI 10.1128/IAI.72.5.2989-2994.2004; OFLAHERTY JT, 1994, LAB INVEST, V70, P816; Owhashi M, 2001, PARASITOL RES, V87, P376, DOI 10.1007/s004360000355; Pacsa AS, 2000, FEMS IMMUNOL MED MIC, V28, P151, DOI 10.1111/j.1574-695X.2000.tb01470.x; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Rakasz E, 1999, IMMUNOL LETT, V70, P89, DOI 10.1016/S0165-2478(99)00132-7; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Sanabria MXH, 2008, INFECT IMMUN, V76, P5100, DOI 10.1128/IAI.00438-08; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001171; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Schneider BS, 2004, VIRAL IMMUNOL, V17, P565, DOI 10.1089/vim.2004.17.565; Shrestha B, 2004, J VIROL, V78, P8312, DOI [10.1128/JVI.78.15.8312-8321.2004, 10.1128/jvi.78.15.8312-8321.2004]; Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07; Sitati EM, 2006, J VIROL, V80, P12060, DOI 10.1128/JVI.01650-06; Soares MBP, 1998, J IMMUNOL, V160, P1811; Styer LM, 2006, AM J TROP MED HYG, V75, P337, DOI 10.4269/ajtmh.2006.75.337; Takhampunya R, 2006, J GEN VIROL, V87, P3003, DOI 10.1099/vir.0.81880-0; TAYLOR JL, 1980, J INFECT DIS, V142, P394, DOI 10.1093/infdis/142.3.394; THEODOS CM, 1993, PARASITE IMMUNOL, V15, P481, DOI 10.1111/j.1365-3024.1993.tb00634.x; Thomson SA, 1998, J IMMUNOL, V160, P1717; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; VARGIN VV, 1977, ACTA VIROL, V21, P114; Waitumbi J, 1998, INFECT IMMUN, V66, P1534, DOI 10.1128/IAI.66.4.1534-1537.1998; Wanasen N, 2004, MED VET ENTOMOL, V18, P191, DOI 10.1111/j.1365-2915.2004.00498.x; WANG L-Y, 1975, Chinese Journal of Microbiology, V8, P274; Wang T, 2003, J IMMUNOL, V171, P2524, DOI 10.4049/jimmunol.171.5.2524; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Wasserman HA, 2004, PARASITE IMMUNOL, V26, P295, DOI 10.1111/j.0141-9838.2004.00712.x; Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	64	61	61	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11704	10.1371/journal.pone.0011704	http://dx.doi.org/10.1371/journal.pone.0011704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661470	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243300010
J	Schulke, JP; Wochnik, GM; Lang-Rollin, I; Gassen, NC; Knapp, RT; Berning, B; Yassouridis, A; Rein, T				Schuelke, Jan-Philip; Wochnik, Gabriela Monika; Lang-Rollin, Isabelle; Gassen, Nils Christian; Knapp, Regina Theresia; Berning, Barbara; Yassouridis, Alexander; Rein, Theo			Differential Impact of Tetratricopeptide Repeat Proteins on the Steroid Hormone Receptors	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; FK506-BINDING IMMUNOPHILIN FKBP51; GLUCOCORTICOID-RECEPTOR; MOLECULAR CHAPERONES; NEGATIVE REGULATOR; SQUIRREL-MONKEY; CYCLOSPORINE-A; TPR DOMAINS; HSP90; BINDING	Background: Tetratricopeptide repeat (TPR) motif containing co-chaperones of the chaperone Hsp90 are considered control modules that govern activity and specificity of this central folding platform. Steroid receptors are paradigm clients of Hsp90. The influence of some TPR proteins on selected receptors has been described, but a comprehensive analysis of the effects of TPR proteins on all steroid receptors has not been accomplished yet. Methodology and Principal Findings: We compared the influence of the TPR proteins FK506 binding proteins 51 and 52, protein phosphatase-5, C-terminus of Hsp70 interacting protein, cyclophillin 40, hepatitis-virus-B X-associated protein-2, and tetratricopeptide repeat protein-2 on all six steroid hormone receptors in a homogeneous mammalian cell system. To be able to assess each cofactor's effect on the transcriptional activity of on each steroid receptor we employed transient transfection in a reporter gene assay. In addition, we evaluated the interactions of the TPR proteins with the receptors and components of the Hsp90 chaperone heterocomplex by coimmunoprecipitation. In the functional assays, corticosteroid and progesterone receptors displayed the most sensitive and distinct reaction to the TPR proteins. Androgen receptor's activity was moderately impaired by most cofactors, whereas the Estrogen receptors' activity was impaired by most cofactors only to a minor degree. Second, interaction studies revealed that the strongly receptor-interacting co-chaperones were all among the inhibitory proteins. Intriguingly, the TPR-proteins also differentially coprecipitated the heterochaperone complex components Hsp90, Hsp70, and p23, pointing to differences in their modes of action. Conclusion and Significance: The results of this comprehensive study provide important insight into chaperoning of diverse client proteins via the combinatorial action of (co)-chaperones. The differential effects of the TPR proteins on steroid receptors bear on all physiological processes related to steroid hormone activity.	[Schuelke, Jan-Philip; Wochnik, Gabriela Monika; Lang-Rollin, Isabelle; Gassen, Nils Christian; Knapp, Regina Theresia; Berning, Barbara; Rein, Theo] Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany; [Yassouridis, Alexander] Max Planck Inst Psychiat, Biostat Grp, D-80804 Munich, Germany	Max Planck Society; Max Planck Society	Schulke, JP (corresponding author), Max Planck Inst Psychiat, Chaperone Res Grp, Munich, Germany.	theorein@mpipsykl.mpg.de		Rein, Theo/0000-0003-2850-4289	Max Planck Institute of Psychiatry	Max Planck Institute of Psychiatry(Max Planck Society)	The research was financed by the Max Planck Institute of Psychiatry. Therefore, no funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2002, MOL ENDOCRINOL, V16, P1352, DOI 10.1210/me.16.6.1352; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; BINART N, 1995, BIOCHEM J, V311, P797, DOI 10.1042/bj3110797; Binder EB, 2004, NAT GENET, V36, P1319, DOI 10.1038/ng1479; Binder EB, 2008, JAMA-J AM MED ASSOC, V299, P1291, DOI 10.1001/jama.299.11.1291; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Carver LA, 1998, J BIOL CHEM, V273, P33580, DOI 10.1074/jbc.273.50.33580; Chadli A, 2008, BIOCHEMISTRY-US, V47, P2850, DOI 10.1021/bi7023332; Chen MS, 1996, J BIOL CHEM, V271, P32315, DOI 10.1074/jbc.271.50.32315; Cheung-Flynn J, 2005, MOL ENDOCRINOL, V19, P1654, DOI 10.1210/me.2005-0071; Clark CB, 2009, FREE RADICAL BIO MED, V47, P1440, DOI 10.1016/j.freeradbiomed.2009.08.012; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; CZAR MJ, 1995, MOL ENDOCRINOL, V9, P1549, DOI 10.1210/me.9.11.1549; Davies TH, 2005, BIOCHEMISTRY-US, V44, P2030, DOI 10.1021/bi048503v; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Duina AA, 1996, SCIENCE, V274, P1713, DOI 10.1126/science.274.5293.1713; Elbi C, 2004, P NATL ACAD SCI USA, V101, P2876, DOI 10.1073/pnas.0400116101; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Fliss AE, 2000, J STEROID BIOCHEM, V72, P223, DOI 10.1016/S0960-0760(00)00037-6; Froidevaux MSC, 2006, EMBO REP, V7, P1035, DOI 10.1038/sj.embor.7400778; Fukuyo Y, 2008, CANCER RES, V68, P6324, DOI 10.1158/0008-5472.CAN-07-6602; Gallo LI, 2007, BIOCHEMISTRY-US, V46, P14044, DOI 10.1021/bi701372c; Gougelet A, 2005, J STEROID BIOCHEM, V94, P71, DOI 10.1016/j.jsbmb.2005.01.018; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; He B, 2004, J BIOL CHEM, V279, P30643, DOI 10.1074/jbc.M403117200; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Herr AS, 2000, MOL PHARMACOL, V57, P732, DOI 10.1124/mol.57.4.732; Hinds TD, 2008, INT J BIOCHEM CELL B, V40, P2358, DOI 10.1016/j.biocel.2007.08.010; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; Hubler TR, 2003, ENDOCRINOLOGY, V144, P2380, DOI 10.1210/en.2003-0092; Ikeda K, 2004, MOL ENDOCRINOL, V18, P1131, DOI 10.1210/me.2003-0308; Ising M, 2008, EUR J NEUROSCI, V28, P389, DOI 10.1111/j.1460-9568.2008.06332.x; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Karin M, 1998, CELL, V93, P487, DOI 10.1016/S0092-8674(00)81177-0; Katzenellenbogen JA, 1996, MOL ENDOCRINOL, V10, P119, DOI 10.1210/me.10.2.119; Kazlauskas A, 2000, J BIOL CHEM, V275, P41317, DOI 10.1074/jbc.M007765200; Kirchheiner J, 2008, PHARMACOGENOMICS, V9, P841, DOI 10.2217/14622416.9.7.841; Koenen KC, 2005, MOL PSYCHIATR, V10, P1058, DOI 10.1038/sj.mp.4001727; Laenger A, 2009, FEBS LETT, V583, P1493, DOI 10.1016/j.febslet.2009.03.072; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lekman M, 2008, BIOL PSYCHIAT, V63, P1103, DOI 10.1016/j.biopsych.2007.10.026; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Meyer BK, 1998, MOL CELL BIOL, V18, P978, DOI 10.1128/MCB.18.2.978; Moffatt NSC, 2008, BIOCHEMISTRY-US, V47, P8203, DOI 10.1021/bi800770g; Moosmann B, 1999, P NATL ACAD SCI USA, V96, P8867, DOI 10.1073/pnas.96.16.8867; Ni L, 2010, MOL CELL BIOL, V30, P1243, DOI 10.1128/MCB.01891-08; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Periyasamy S, 2010, ONCOGENE, V29, P1691, DOI 10.1038/onc.2009.458; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; PICARD D, 1990, NATURE, V348, P166, DOI 10.1038/348166a0; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; RENOIR JM, 1995, P NATL ACAD SCI USA, V92, P4977, DOI 10.1073/pnas.92.11.4977; Reynolds PD, 1999, J CLIN ENDOCR METAB, V84, P663, DOI 10.1210/jc.84.2.663; Riggs DL, 2007, MOL CELL BIOL, V27, P8658, DOI 10.1128/MCB.00985-07; Riggs DL, 2003, EMBO J, V22, P1158, DOI 10.1093/emboj/cdg108; Rosenhagen MC, 2003, MOL ENDOCRINOL, V17, P1991, DOI 10.1210/me.2003-0141; Rosenhagen MC, 2001, BIOL CHEM, V382, P499, DOI 10.1515/BC.2001.063; Ruegg J, 2004, MOL CELL BIOL, V24, P9371, DOI 10.1128/MCB.24.21.9371-9382.2004; Samuni Y, 2010, FREE RADICAL BIO MED, V48, P1559, DOI 10.1016/j.freeradbiomed.2010.03.001; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Segnitz B, 1997, J BIOL CHEM, V272, P18694, DOI 10.1074/jbc.272.30.18694; Silverstein AM, 1999, J BIOL CHEM, V274, P36980, DOI 10.1074/jbc.274.52.36980; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200; Suuronen T, 2008, NEUROCHEM RES, V33, P1768, DOI 10.1007/s11064-008-9622-z; Tatro ET, 2009, J NEUROIMMUNE PHARM, V4, P218, DOI 10.1007/s11481-009-9146-6; Tranguch S, 2005, P NATL ACAD SCI USA, V102, P14326, DOI 10.1073/pnas.0505775102; Wandinger SK, 2006, EMBO J, V25, P367, DOI 10.1038/sj.emboj.7600930; Wang Z, 2007, MOL ENDOCRINOL, V21, P625, DOI 10.1210/me.2005-0338; Warth R, 1997, BIOL CHEM, V378, P381, DOI 10.1515/bchm.1997.378.5.381; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; WILLOUR VL, 2008, MOL PSYCHIAT; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wochnik GM, 2004, FEBS LETT, V560, P35, DOI 10.1016/S0014-5793(04)00066-3; Wolf IM, 2009, J STEROID BIOCHEM, V113, P36, DOI 10.1016/j.jsbmb.2008.11.006; Yang ZC, 2006, MOL ENDOCRINOL, V20, P2682, DOI 10.1210/me.2006-0024; Yehuda R, 2009, BIOL PSYCHIAT, V66, P708, DOI 10.1016/j.biopsych.2009.02.034; Yong WD, 2007, J BIOL CHEM, V282, P5026, DOI 10.1074/jbc.M609360200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e	94	77	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11717	10.1371/journal.pone.0011717	http://dx.doi.org/10.1371/journal.pone.0011717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661446	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300019
J	Bekeredjian, R; Walton, CB; MacCannell, KA; Ecker, J; Kruse, F; Outten, JT; Sutcliffe, D; Gerard, RD; Bruick, RK; Shohet, RV				Bekeredjian, Raffi; Walton, Chad B.; MacCannell, Keith A.; Ecker, Jennifer; Kruse, Fred; Outten, Joel T.; Sutcliffe, David; Gerard, Robert D.; Bruick, Richard K.; Shohet, Ralph V.			Conditional HIF-1 alpha Expression Produces a Reversible Cardiomyopathy	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; LACTATE-DEHYDROGENASE; PROLYL HYDROXYLATION; TRANSCRIPTION FACTOR; STRUCTURAL BASIS; BINDING-SITES; HIF-ALPHA; COMPLEX	Background: The response to hypoxia in tissues is regulated by the heterodimeric transcription factor Hypoxia Inducible Factor-1 (HIF-1). Methodology/Principal Findings: We have created a strain of mice with inducible cardiomyocyte-specific expression of a mutated, oxygen-stable, form of HIF-1 alpha. Cardiac function steadily decreased with transgene expression, but recovered after the transgene was turned off. Using long-oligo microarrays, we identified 162 transcripts more than 3-fold dysregulated in these hearts after transgene expression. Among the down-regulated genes the transcript for SERCA was reduced 46% and the protein 92%. This led us to an evaluation of calcium flux that showed diminished reuptake of cytoplasmic calcium in myocytes from these hearts, suggesting a mechanism for cardiac dysfunction. Conclusions/Significance: These results provide a deeper understanding of transcriptional activity of HIF in the heart, and show that enhanced HIF-1 activity is sufficient to cause contractile dysfunction in the adult heart. HIF is stabilized in the myocardium of patients with ischemic cardiomyopathy, and our results suggest that HIF could be contributing directly to the contractile dysfunction in this disease.	[Walton, Chad B.; MacCannell, Keith A.; Ecker, Jennifer; Outten, Joel T.; Shohet, Ralph V.] Univ Hawaii, Dept Med, Honolulu, HI 96822 USA; [Bekeredjian, Raffi] Univ Heidelberg, Dept Cardiol, D-6900 Heidelberg, Germany; [Kruse, Fred; Sutcliffe, David; Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA	University of Hawaii System; Ruprecht Karls University Heidelberg; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bekeredjian, R (corresponding author), Univ Heidelberg, Dept Cardiol, Bergheimer Str 58, D-6900 Heidelberg, Germany.	shohet@hawaii.edu			National Heart, Lung and Blood Institute [HL080532, HL073449]; National Center for Research Resources [RR16453]; American Heart Association; Bundesministerium Bildung und Forschung, Germany; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080532, UH1HL073449] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); Bundesministerium Bildung und Forschung, Germany; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant support has included: National Heart, Lung and Blood Institute HL080532, National Heart, Lung and Blood Institute HL073449, National Center for Research Resources RR16453, and an American Heart Association National Grant-in Aid Award (to RVS). Dr. Raffi Bekeredijan was funded by a Postdoctoral Research Fellowship Grant of the American Heart Association and is presently funded by the BioFuture grant of the Bundesministerium Bildung und Forschung, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bos R, 2003, ONCOGENE, V22, P8948, DOI 10.1038/sj.onc.1206995; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chi NC, 2004, CARDIOVASC RES, V61, P437, DOI 10.1016/j.cardiores.2003.11.033; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; FIRTH JD, 1994, P NATL ACAD SCI USA, V91, P6496, DOI 10.1073/pnas.91.14.6496; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Hernandez-Pampaloni M, 2005, EUR J NUCL MED MOL I, V32, P314, DOI 10.1007/s00259-004-1682-y; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kido M, 2005, J AM COLL CARDIOL, V46, P2116, DOI 10.1016/j.jacc.2005.08.045; Kureishy N, 2002, BIOESSAYS, V24, P350, DOI 10.1002/bies.10070; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Le Cras TD, 2004, AM J PHYSIOL-LUNG C, V287, pL134, DOI 10.1152/ajplung.00050.2004; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MEYER M, 1995, CIRCULATION, V92, P778, DOI 10.1161/01.CIR.92.4.778; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; Tsuji T, 2009, AM J PHYSIOL-HEART C, V296, pH310, DOI 10.1152/ajpheart.00975.2008; Vahlhaus C, 2005, J CARDIAC SURG, V20, P412, DOI 10.1111/j.1540-8191.2005.2004107.x; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	38	94	99	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11693	10.1371/journal.pone.0011693	http://dx.doi.org/10.1371/journal.pone.0011693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657781	Green Published, gold, Green Submitted			2022-12-27	WOS:000280197500031
J	Xue, Q; Jenkins, SA; Gu, CF; Smeds, E; Liu, Q; Vasan, R; Russell, BH; Xu, Y				Xue, Qiong; Jenkins, Sarah A.; Gu, Chunfang; Smeds, Emanuel; Liu, Qing; Vasan, Ranga; Russell, Brooke H.; Xu, Yi			Bacillus anthracis Spore Entry into Epithelial Cells Is an Actin-Dependent Process Requiring c-Src and PI3K	PLOS ONE			English	Article							INTERNALIZATION; PROTEIN; MACROPHAGES; INHIBITION; FATE	Dissemination of Bacillus anthracis from the respiratory mucosa is a critical step in the establishment of inhalational anthrax. Recent in vitro and in vivo studies indicated that this organism was able to penetrate the lung epithelium by directly entering into epithelial cells of the lung; however the molecular details of B. anthracis breaching the epithelium were lacking. Here, using a combination of pharmacological inhibitors, dominant negative mutants, and colocalization experiments, we demonstrated that internalization of spores by epithelial cells was actin-dependent and was mediated by the Rho-family GTPase Cdc42 but not RhoA or Rac1. Phosphatidylinositol 3-kinase (PI3K) activity was also required as indicated by the inhibitory effects of PI3K inhibitors, wortmannin and LY294002, and a PI3K dominant negative (DN) mutant Delta p85 alpha. In addition, spore entry into epithelial cells (but not into macrophages) required the activity of Src as indicated by the inhibitory effect of Src family kinase (SFK) inhibitors, PP2 and SU6656, and specific siRNA knockdown of Src. Enrichment of PI3K and F-actin around spore attachment sites was observed and was significantly reduced by treatment with SFK and PI3K inhibitors, respectively. Moreover, B. anthracis translocation through cultured lung epithelial cells was significantly impaired by SFK inhibitors, suggesting that this signaling pathway is important for bacterial dissemination. The effect of the inhibitor on dissemination in vivo was then evaluated. SU6656 treatment of mice significantly reduced B. anthracis dissemination from the lung to distal organs and prolonged the median survival time of mice compared to the untreated control group. Together these results described a signaling pathway specifically required for spore entry into epithelial cells and provided evidence suggesting that this pathway is important for dissemination and virulence in vivo.	[Xue, Qiong; Gu, Chunfang; Smeds, Emanuel; Vasan, Ranga; Russell, Brooke H.; Xu, Yi] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX USA; [Jenkins, Sarah A.] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA; [Liu, Qing] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center	Xue, Q (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Infect & Inflammatory Dis, Houston, TX USA.	yxu@ibt.tamhsc.edu			National Institutes of Health (NIH) [AI061555, AI082306]; Region VI center for Biodefense and Emerging Infections [U54 AI057156]; Texas A&M Health Science Center (TAMHSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI082306, R21AI061555, U54AI057156] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region VI center for Biodefense and Emerging Infections; Texas A&M Health Science Center (TAMHSC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants AI061555 and AI082306 (http://www.niaid.nih.gov) to Y. Xu, a career development award from Region VI center for Biodefense and Emerging Infections (U54 AI057156 to D. Walker)(http://www.niaid.nih.gov), and start-up funds from Texas A&M Health Science Center (TAMHSC) (http://www.tamhsc.edu) to Y. Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett EG, 1998, AM J PHYSIOL-LUNG C, V275, pL1110, DOI 10.1152/ajplung.1998.275.6.L1110; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Chakrabarty K, 2007, INFECT IMMUN, V75, P3729, DOI 10.1128/IAI.00046-07; Cleret A, 2007, J IMMUNOL, V178, P7994, DOI 10.4049/jimmunol.178.12.7994; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Dixon TC, 2000, CELL MICROBIOL, V2, P453, DOI 10.1046/j.1462-5822.2000.00067.x; Evans SE, 2010, AM J RESP CELL MOL, V42, P40, DOI 10.1165/rcmb.2008-0260OC; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; GLASSMAN HN, 1966, BACTERIOL REV, V30, P657, DOI 10.1128/MMBR.30.3.657-659.1966; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Guidi-Rontani C, 2002, TRENDS MICROBIOL, V10, P405, DOI 10.1016/S0966-842X(02)02422-8; Guidi-Rontani C, 2001, MOL MICROBIOL, V42, P931, DOI 10.1046/j.1365-2958.2001.02695.x; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; HENDERSON D. W., 1956, JOUR HYG, V54, P28; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jewett TJ, 2006, P NATL ACAD SCI USA, V103, P15599, DOI 10.1073/pnas.0603044103; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; Oliva C, 2009, P NATL ACAD SCI USA, V106, P13957, DOI 10.1073/pnas.0902392106; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; Russell BH, 2008, INFECT IMMUN, V76, P3975, DOI 10.1128/IAI.00282-08; Russell BH, 2008, CELL MICROBIOL, V10, P945, DOI 10.1111/j.1462-5822.2007.01098.x; Russell BH, 2007, CELL MICROBIOL, V9, P1262, DOI 10.1111/j.1462-5822.2006.00869.x; Severgnini M, 2005, AM J RESP CRIT CARE, V171, P858, DOI 10.1164/rccm.200407-981OC; Tanaka M, 1999, BIOCHEM BIOPH RES CO, V255, P169, DOI 10.1006/bbrc.1999.0162; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Vanhaesebroeck B, 1999, EXP CELL RES, V253, P239, DOI 10.1006/excr.1999.4701; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Vietri NJ, 2006, P NATL ACAD SCI USA, V103, P7813, DOI 10.1073/pnas.0602748103; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Welkos S, 2002, J MED MICROBIOL, V51, P821, DOI 10.1099/0022-1317-51-10-821; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11665	10.1371/journal.pone.0011665	http://dx.doi.org/10.1371/journal.pone.0011665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652027	Green Published, Green Submitted, gold			2022-12-27	WOS:000280109700003
J	Shan, B; Hagood, JS; Zhuo, Y; Nguyen, HT; MacEwen, M; Morris, GF; Lasky, JA				Shan, Bin; Hagood, James S.; Zhuo, Ying; Nguyen, Hong T.; MacEwen, Mark; Morris, Gilbert F.; Lasky, Joseph A.			Thy-1 Attenuates TNF-alpha-Activated Gene Expression in Mouse Embryonic Fibroblasts via Src Family Kinase	PLOS ONE			English	Article							NECROSIS FACTOR-ALPHA; LUNG FIBROBLASTS; GROWTH-FACTOR; DIFFERENTIAL EXPRESSION; TYROSINE PHOSPHORYLATION; EPITHELIAL-CELLS; ADHESION; SUBPOPULATIONS; MIGRATION; BINDING	Heterogeneous surface expression of Thy-1 in fibroblasts modulates inflammation and may thereby modulate injury and repair. As a paradigm, patients with idiopathic pulmonary fibrosis, a disease with pathologic features of chronic inflammation, demonstrate an absence of Thy-1 immunoreactivity within areas of fibrotic activity (fibroblast foci) in contrast to the predominant Thy-1 expressing fibroblasts in the normal lung. Likewise, Thy-1 deficient mice display more severe lung fibrosis in response to an inflammatory injury than wildtype littermates. We investigated the role of Thy-1 in the response of fibroblasts to the pro-inflammatory cytokine TNF-alpha. Our study demonstrates distinct profiles of TNF-alpha-activated gene expression in Thy-1 positive (Thy-1+) and negative (Thy-12) subsets of mouse embryonic fibroblasts (MEF). TNF-alpha induced a robust activation of MMP-9, ICAM-1, and the IL-8 promoter driven reporter in Thy-12 MEFs, in contrast to only a modest increase in Thy-1+ counterparts. Consistently, ectopic expression of Thy-1 in Thy-12 MEFs significantly attenuated TNF-alpha-activated gene expression. Mechanistically, TNF-alpha activated Src family kinase (SFK) only in Thy-12 MEFs. Blockade of SFK activation abrogated TNF-alpha-activated gene expression in Thy-12 MEFs, whereas restoration of SFK activation rescued the TNF-alpha response in Thy-1+ MEFs. Our findings suggest that Thy-1 down-regulates TNF-alpha-activated gene expression via interfering with SFK-and NF-kappa B-mediated transactivation. The current study provides a novel mechanistic insight to the distinct roles of fibroblast Thy-1 subsets in inflammation.	[Shan, Bin; Zhuo, Ying; Nguyen, Hong T.; Lasky, Joseph A.] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Hagood, James S.; MacEwen, Mark] Univ Alabama, Sch Med, Dept Pediat, Birmingham, AL USA; [Morris, Gilbert F.] Tulane Univ, Dept Pathol, Hlth Sci Ctr, New Orleans, LA 70118 USA	Tulane University; University of Alabama System; University of Alabama Birmingham; Tulane University	Shan, B (corresponding author), Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA.	jlasky@tulane.edu		Shan, Bin/0000-0002-6869-2678	National Institutes of Health (NIH) [ES010046, HL063778, HL083480, HL065348, T32HL007973]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065348, R01HL083480, T32HL007973, R01HL082818, R01HL063778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010046] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by National Institutes of Health (NIH) grants ES010046, HL063778, and HL083480 awarded to J. A. L., and by HL065348, to J. S. H.; B. S. was supported by an NIH postdoctoral training grant T32HL007973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker TH, 2004, J BIOL CHEM, V279, P23510, DOI 10.1074/jbc.M402169200; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Borrello MA, 1996, CELL IMMUNOL, V173, P198, DOI 10.1006/cimm.1996.0268; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Fiedler MA, 1998, AM J RESP CELL MOL, V19, P259, DOI 10.1165/ajrcmb.19.2.3149; Hagood JS, 2005, AM J PATHOL, V167, P365, DOI 10.1016/S0002-9440(10)62982-3; Hagood JS, 2002, AM J RESP CELL MOL, V26, P702, DOI 10.1165/ajrcmb.26.6.4547; Hagood JS, 2001, CHEST, V120, p64S, DOI 10.1378/chest.120.1_suppl.S64; Hagood JS, 1999, AM J PHYSIOL-LUNG C, V277, pL218, DOI 10.1152/ajplung.1999.277.1.L218; HE HT, 1991, J EXP MED, V173, P515, DOI 10.1084/jem.173.2.515; Huang WC, 2003, J IMMUNOL, V170, P4767, DOI 10.4049/jimmunol.170.9.4767; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Hueber AO, 1997, CURR BIOL, V7, P705, DOI 10.1016/S0960-9822(06)00300-9; Koumas L, 2002, AM J PHYSIOL-CELL PH, V283, pC599, DOI 10.1152/ajpcell.00065.2002; Koumas L, 2002, EUR J IMMUNOL, V32, P477, DOI 10.1002/1521-4141(200202)32:2<477::AID-IMMU477>3.0.CO;2-U; MCINTOSH JC, 1994, EUR RESPIR J, V7, P2131, DOI 10.1183/09031936.94.07122131; PHIPPS RP, 1990, EUR J IMMUNOL, V20, P1723, DOI 10.1002/eji.1830200815; Phipps RP, 1997, J PERIODONTAL RES, V32, P159, DOI 10.1111/j.1600-0765.1997.tb01398.x; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; Rege TA, 2006, EXP CELL RES, V312, P3752, DOI 10.1016/j.yexcr.2006.07.029; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Saouaf SJ, 1997, BIOCHEM BIOPH RES CO, V234, P325, DOI 10.1006/bbrc.1997.6638; Shan B, 2005, J BIOL CHEM, V280, P1103, DOI 10.1074/jbc.M406293200; Shan B, 2005, EXP CELL RES, V305, P10, DOI 10.1016/j.yexcr.2004.09.033; Shan B, 2007, J MOL CELL CARDIOL, V42, P517, DOI 10.1016/j.yjmcc.2006.08.004; Smith TJ, 1997, ENDOCRINOLOGY, V138, P5576, DOI 10.1210/en.138.12.5576; Sumida A, 2008, ARCH MED RES, V39, P503, DOI 10.1016/j.arcmed.2008.02.005; Surviladze Z, 2001, EUR J IMMUNOL, V31, P1, DOI 10.1002/1521-4141(200101)31:1<1::AID-IMMU1>3.0.CO;2-W; Tagoe CE, 2008, J IMMUNOL, V181, P2813, DOI 10.4049/jimmunol.181.4.2813; Wu GD, 1997, J BIOL CHEM, V272, P2396; Wu SS, 2005, CELL SIGNAL, V17, P93, DOI 10.1016/j.cellsig.2004.06.001; Zhou Y, 2004, AM J PATHOL, V165, P659, DOI 10.1016/S0002-9440(10)63330-5	35	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11662	10.1371/journal.pone.0011662	http://dx.doi.org/10.1371/journal.pone.0011662			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657842	gold, Green Submitted, Green Published			2022-12-27	WOS:000280065600020
J	Sherrid, AM; Rustad, TR; Cangelosi, GA; Sherman, DR				Sherrid, Ashley M.; Rustad, Tige R.; Cangelosi, Gerard A.; Sherman, David R.			Characterization of a Clp Protease Gene Regulator and the Reaeration Response in Mycobacterium tuberculosis	PLOS ONE			English	Article							LOW-OXYGEN TENSION; HYPOXIC RESPONSE; TRANSCRIPTIONAL-ACTIVATOR; SWISS-MODEL; EXPRESSION; CLGR; RESUSCITATION; BIOSYNTHESIS; MACROPHAGES; ADAPTATION	Mycobacterium tuberculosis (MTB) enters a non-replicating state when exposed to low oxygen tension, a condition the bacillus encounters in granulomas during infection. Determining how mycobacteria enter and maintain this state is a major focus of research. However, from a public health standpoint the importance of latent TB is its ability to reactivate. The mechanism by which mycobacteria return to a replicating state upon re-exposure to favorable conditions is not understood. In this study, we utilized reaeration from a defined hypoxia model to characterize the adaptive response of MTB following a return to favorable growth conditions. Global transcriptional analysis identified the similar to 100 gene Reaeration Response, induced relative to both log-phase and hypoxic MTB. This response includes chaperones and proteases, as well as the transcription factor Rv2745c, which we characterize as a Clp protease gene regulator (ClgR) orthologue. During reaeration, genes repressed during hypoxia are also upregulated in a wave of transcription that includes genes crucial to transcription, translation and oxidative phosphorylation and culminates in bacterial replication. In sum, this study defines a new transcriptional response of MTB with potential relevance to disease, and implicates ClgR as a regulator involved in resumption of replication following hypoxia.	[Sherrid, Ashley M.; Rustad, Tige R.; Cangelosi, Gerard A.; Sherman, David R.] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sherrid, Ashley M.] Univ Washington, Mol & Cellular Grad Program, Seattle, WA 98195 USA; [Cangelosi, Gerard A.; Sherman, David R.] Univ Washington, Pathobiol Program, Seattle, WA 98195 USA; [Cangelosi, Gerard A.; Sherman, David R.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sherrid, AM (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	david.sherman@seattlebiomed.org			Paul G. Allen Family Foundation [8999]; Akibene Foundation	Paul G. Allen Family Foundation; Akibene Foundation	This work was supported by funding from the Paul G. Allen Family Foundation (grant #8999) and the Akibene Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bellier A, 2006, MICROBIOL-SGM, V152, P1021, DOI 10.1099/mic.0.28564-0; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; Boshoff HIM, 2008, J BIOL CHEM, V283, P19329, DOI 10.1074/jbc.M800694200; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; CRECYLAGARD V, 1999, MOL MICROBIOL, V32, P505; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Dawes SS, 2003, INFECT IMMUN, V71, P6124, DOI 10.1128/IAI.71.11.6124-6131.2003; Downing KJ, 2005, INFECT IMMUN, V73, P3038, DOI 10.1128/IAI.73.5.3038-3043.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Engels S, 2005, MOL MICROBIOL, V57, P576, DOI 10.1111/j.1365-2958.2005.04710.x; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; GEDDEDAHL T, 1952, AM J HYG, V56, P139, DOI 10.1093/oxfordjournals.aje.a119547; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; HAAPANEN JH, 1959, AM REV RESPIR DIS, V80, P1; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Kana BD, 2008, MOL MICROBIOL, V67, P672, DOI 10.1111/j.1365-2958.2007.06078.x; Lin G, 2009, NATURE, V461, P621, DOI 10.1038/nature08357; Low KL, 2009, J BACTERIOL, V191, P5037, DOI 10.1128/JB.00530-09; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Marks GB, 2000, AM J RESP CRIT CARE, V162, P1851, DOI 10.1164/ajrccm.162.5.2004154; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Moss AR, 2000, AM J RESP CRIT CARE, V162, P460, DOI 10.1164/ajrccm.162.2.9910055; Mukamolova GV, 2002, MOL MICROBIOL, V46, P623, DOI 10.1046/j.1365-2958.2002.03184.x; Novy FG, 1925, J INFECT DIS, V36, P168, DOI 10.1093/infdis/36.2.168; Pai M, 2010, CURR OPIN PULM MED, V16, P271, DOI 10.1097/MCP.0b013e328338094f; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; Rich AR, 1942, B JOHNS HOPKINS HOSP, V71, P345; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Russo S, 2009, J BIOL CHEM, V284, P5208, DOI 10.1074/jbc.M806591200; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Tufariello JM, 2006, INFECT IMMUN, V74, P2985, DOI 10.1128/IAI.74.5.2985-2995.2006; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ventura M, 2005, J BACTERIOL, V187, P8411, DOI 10.1128/JB.187.24.8411-8426.2005; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Wayne L. G., 1998, Tubercle and Lung Disease, V79, P127, DOI 10.1054/tuld.1998.0015; WAYNE LG, 1977, INFECT IMMUN, V17, P528, DOI 10.1128/IAI.17.3.528-530.1977; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; World Health Organization, 2009, GLOB TUB CONTR EP ST	56	54	57	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11622	10.1371/journal.pone.0011622	http://dx.doi.org/10.1371/journal.pone.0011622			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661284	Green Published, gold, Green Submitted			2022-12-27	WOS:000279980800011
J	Cinar, HN; Kothary, M; Datta, AR; Tall, BD; Sprando, R; Bilecen, K; Yildiz, F; McCardell, B				Cinar, Hediye Nese; Kothary, Mahendra; Datta, Atin R.; Tall, Ben D.; Sprando, Robert; Bilecen, Kivanc; Yildiz, Fitnat; McCardell, Barbara			Vibrio cholerae Hemolysin Is Required for Lethality, Developmental Delay, and Intestinal Vacuolation in Caenorhabditis elegans	PLOS ONE			English	Article							PORE-FORMING TOXINS; HOST-PATHOGEN INTERACTIONS; LIVE ORAL VACCINE; EL-TOR HEMOLYSIN; CELL VACUOLATION; BACTERIAL PATHOGENESIS; VIRULENCE FACTORS; CYTOLYSIN; O1; PROTEASE	Background: Cholera toxin (CT) and toxin-co-regulated pili (TCP) are the major virulence factors of Vibrio cholerae O1 and O139 strains that contribute to the pathogenesis of disease during devastating cholera pandemics. However, CT and TCP negative V. cholerae strains are still able to cause severe diarrheal disease in humans through mechanisms that are not well understood. Methodology/Principal Findings: To determine the role of other virulence factors in V. cholerae pathogenesis, we used a CT and TCP independent infection model in the nematode Caenorhabditis elegans and identified the hemolysin A (hlyA) gene as a factor responsible for animal death and developmental delay. We demonstrated a correlation between the severity of infection in the nematode and the level of hemolytic activity in the V. cholerae biotypes. At the cellular level, V. cholerae infection induces formation of vacuoles in the intestinal cells in a hlyA dependent manner, consistent with the previous in vitro observations. Conclusions/Significance: Our data strongly suggest that HlyA is a virulence factor in C. elegans infection leading to lethality and developmental delay presumably through intestinal cytopathic changes.	[Cinar, Hediye Nese; Kothary, Mahendra; Datta, Atin R.; Tall, Ben D.; McCardell, Barbara] US FDA, Div Virulence Assessment, Laurel, MD USA; [Bilecen, Kivanc; Yildiz, Fitnat] Univ Calif Santa Cruz, Dept Environm Toxicol, Santa Cruz, CA 95064 USA; [Sprando, Robert] US FDA, Div Toxicol, Laurel, MD USA	US Food & Drug Administration (FDA); University of California System; University of California Santa Cruz; US Food & Drug Administration (FDA)	Cinar, HN (corresponding author), US FDA, Div Virulence Assessment, Laurel, MD USA.	hediye.cinar@fda.hhs.gov	Bilecen, Kivanc/E-3308-2019	Bilecen, Kivanc/0000-0002-6254-3516; Tall, Ben/0000-0003-0399-3629	Food and Drug Administration	Food and Drug Administration(United States Department of Health & Human Services)	This study was funded by Food and Drug Administration intramural funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aballay A, 2002, CURR OPIN MICROBIOL, V5, P97, DOI 10.1016/S1369-5274(02)00293-X; ALM RA, 1991, J CLIN MICROBIOL, V29, P2438, DOI 10.1128/JCM.29.11.2438-2445.1991; Alouf J., 2005, COMPREHENSIVE SOURCE; Aroian R, 2007, CURR OPIN MICROBIOL, V10, P57, DOI 10.1016/j.mib.2006.12.008; Bae T, 2004, P NATL ACAD SCI USA, V101, P12312, DOI 10.1073/pnas.0404728101; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Beyhan S, 2006, INFECT IMMUN, V74, P3633, DOI 10.1128/IAI.01750-05; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; DATTA AR, 1984, J BACTERIOL, V160, P808, DOI 10.1128/JB.160.2.808-811.1984; Faruque SM, 2004, P NATL ACAD SCI USA, V101, P2123, DOI 10.1073/pnas.0308485100; Figueroa-Arredondo P, 2001, INFECT IMMUN, V69, P1613, DOI 10.1128/IAI.69.3.1613-1624.2001; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gutierrez MG, 2007, P NATL ACAD SCI USA, V104, P1829, DOI 10.1073/pnas.0601437104; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; Ikigai H, 1996, INFECT IMMUN, V64, P2968, DOI 10.1128/IAI.64.8.2968-2973.1996; Kurz CL, 2007, CURR OPIN MICROBIOL, V10, P10, DOI 10.1016/j.mib.2006.12.001; Kurz CL, 2003, NAT REV GENET, V4, P380, DOI 10.1038/nrg1067; Kurz CL, 2000, TRENDS MICROBIOL, V8, P142, DOI 10.1016/S0966-842X(99)01691-1; Kurz CL, 2003, EMBO J, V22, P1451, DOI 10.1093/emboj/cdg159; LEVINE M M, 1988, Lancet, V2, P467; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; Marroquin LD, 2000, GENETICS, V155, P1693; MICHALSKI J, 1993, INFECT IMMUN, V61, P4462, DOI 10.1128/IAI.61.10.4462-4468.1993; Mitra R, 2000, INFECT IMMUN, V68, P1928, DOI 10.1128/IAI.68.4.1928-1933.2000; Moschioni M, 2002, CELL MICROBIOL, V4, P397, DOI 10.1046/j.1462-5822.2002.00199.x; Nass R., 2007, CURR PROTOC TOXICOL, V31, P1, DOI [10.1002/0471140856.tx0109s31, DOI 10.1002/0471140856.TX0109S31]; Ogierman MA, 1997, J BACTERIOL, V179, P7072, DOI 10.1128/jb.179.22.7072-7080.1997; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Ottaviani D, 2009, INT J FOOD MICROBIOL, V132, P47, DOI 10.1016/j.ijfoodmicro.2009.03.014; Ou GW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007806; Pulak Rock, 2006, V351, P275; RADER AE, 1988, INFECT IMMUN, V56, P1414, DOI 10.1128/IAI.56.6.1414-1419.1988; RICHARDSON K, 1986, INFECT IMMUN, V54, P415, DOI 10.1128/IAI.54.2.415-420.1986; Saka HA, 2007, AUTOPHAGY, V3, P363, DOI 10.4161/auto.4159; SATCHELL KJF, 2003, MICROB PATHOGENESIS, P481; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Sprando RL, 2009, FOOD CHEM TOXICOL, V47, P722, DOI 10.1016/j.fct.2009.01.007; Sulston JHJ, 1988, NEMATODE CAENORHABDI; Tacket CO, 1997, AM J TROP MED HYG, V56, P533, DOI 10.4269/ajtmh.1997.56.533; TACKET CO, 1993, J INFECT DIS, V168, P1536, DOI 10.1093/infdis/168.6.1536; TACKET CO, 1995, J INFECT DIS, V172, P883, DOI 10.1093/infdis/172.3.883; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Vaitkevicius K, 2006, P NATL ACAD SCI USA, V103, P9280, DOI 10.1073/pnas.0601754103; Wood WB, 1988, NEMATODE CAENORHABDI; Zitzer A, 1997, EUR J BIOCHEM, V247, P209, DOI 10.1111/j.1432-1033.1997.00209.x	49	37	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11558	10.1371/journal.pone.0011558	http://dx.doi.org/10.1371/journal.pone.0011558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644623	gold, Green Published, Green Submitted			2022-12-27	WOS:000279822300012
J	Razidlo, DF; Whitney, TJ; Casper, ME; McGee-Lawrence, ME; Stensgard, BA; Li, XD; Secreto, FJ; Knutson, SK; Hiebert, SW; Westendorf, JJ				Razidlo, David F.; Whitney, Tiffany J.; Casper, Michelle E.; McGee-Lawrence, Meghan E.; Stensgard, Bridget A.; Li, Xiaodong; Secreto, Frank J.; Knutson, Sarah K.; Hiebert, Scott W.; Westendorf, Jennifer J.			Histone Deacetylase 3 Depletion in Osteo/Chondroprogenitor Cells Decreases Bone Density and Increases Marrow Fat	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; PPAR-GAMMA; RUNX2; ROLES; INHIBITOR; COMPLEX; HDAC3; CBFA1; SMRT	Histone deacetylase (Hdac)3 is a nuclear enzyme that contributes to epigenetic programming and is required for embryonic development. To determine the role of Hdac3 in bone formation, we crossed mice harboring loxP sites around exon 7 of Hdac3 with mice expressing Cre recombinase under the control of the osterix promoter. The resulting Hdac3 conditional knockout (CKO) mice were runted and had severe deficits in intramembranous and endochondral bone formation. Calvarial bones were significantly thinner and trabecular bone volume in the distal femur was decreased 75% in the Hdac3 CKO mice due to a substantial reduction in trabecular number. Hdac3-CKO mice had fewer osteoblasts and more bone marrow adipocytes as a proportion of tissue area than their wildtype or heterozygous littermates. Bone formation rates were depressed in both the cortical and trabecular regions of Hdac3 CKO femurs. Microarray analyses revealed that numerous developmental signaling pathways were affected by Hdac3-deficiency. Thus, Hdac3 depletion in osterix-expressing progenitor cells interferes with bone formation and promotes bone marrow adipocyte differentiation. These results demonstrate that Hdac3 inhibition is detrimental to skeletal health.	[Razidlo, David F.; Whitney, Tiffany J.; Casper, Michelle E.; McGee-Lawrence, Meghan E.; Stensgard, Bridget A.; Li, Xiaodong; Secreto, Frank J.; Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Razidlo, David F.; Whitney, Tiffany J.; Casper, Michelle E.; McGee-Lawrence, Meghan E.; Stensgard, Bridget A.; Li, Xiaodong; Secreto, Frank J.; Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA; [Knutson, Sarah K.; Hiebert, Scott W.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Mayo Clinic; Mayo Clinic; Vanderbilt University	Razidlo, DF (corresponding author), Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA.	westendorf.jennifer@mayo.edu		McGee-Lawrence, Meghan/0000-0002-2728-5849; Casper Taylor, Michelle/0000-0003-1707-6645	National Institutes of Health [R01-AR048147, T32-AR056950]; Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE [R01CA141071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950, R01AR048147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The National Institutes of Health (R01-AR048147 and T32-AR056950) and the Mayo Clinic Foundation supported this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat T, 2008, NATURE, V456, P997, DOI 10.1038/nature07541; Bellosta P, 2003, J BONE MINER RES, V18, P818, DOI 10.1359/jbmr.2003.18.5.818; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; BOER JD, 2006, TISSUE ENG; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; CHOO MK, 2009, BONE; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Enomoto H, 2004, J CELL SCI, V117, P417, DOI 10.1242/jcs.00866; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; GALLAY SH, 1994, J ORTHOPAED RES, V12, P515, DOI 10.1002/jor.1100120408; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Han JW, 2000, CANCER RES, V60, P6068; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; IWAMI K, 1993, INT J BIOCHEM, V25, P1631, DOI 10.1016/0020-711X(93)90522-G; Iwaniec Urszula T., 2008, V447, P325, DOI 10.1007/978-1-59745-242-7_21; Jensen ED, 2008, J BONE MINER RES, V23, P361, DOI 10.1359/JBMR.071104; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Kawase T, 2009, CELL, V136, P535, DOI 10.1016/j.cell.2008.12.002; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kim KH, 2007, FEBS LETT, V581, P3303, DOI 10.1016/j.febslet.2007.06.012; Knutson SK, 2008, EMBO J, V27, P1017, DOI 10.1038/emboj.2008.51; Kobayashi H, 2000, BIOCHEM BIOPH RES CO, V273, P630, DOI 10.1006/bbrc.2000.2981; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lamour V, 2007, J BIOL CHEM, V282, P36240, DOI 10.1074/jbc.M705833200; Lee HW, 2006, MOL ENDOCRINOL, V20, P2432, DOI 10.1210/me.2006-0061; Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025; Marks PA, 2007, ONCOGENE, V26, P1351, DOI 10.1038/sj.onc.1210204; McGee-Lawrence ME, 2009, J BIOMECH, V42, P1378, DOI 10.1016/j.jbiomech.2008.11.039; Montgomery RL, 2008, J CLIN INVEST, V118, P3588, DOI 10.1172/JCI35847; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Petit M. A., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P213; PRATAP J, 2008, J BONE MINERAL RE S1, V23; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Reinholz GG, 2009, OSTEOARTHR CARTILAGE, V17, P723, DOI 10.1016/j.joca.2008.10.011; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Rosen CJ, 2009, CRIT REV EUKAR GENE, V19, P109, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.20; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Schroeder TM, 2005, J BONE MINER RES, V20, P2254, DOI 10.1359/JBMR.050813; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; WESTENDORF JJ, 2007, J CELL BIOCH; Wiech NL, 2009, CURR TOP MED CHEM, V9, P257, DOI 10.2174/156802609788085241; Wise LD, 2007, BIRTH DEFECTS RES B, V80, P57, DOI 10.1002/bdrb.20104; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zupkovitz G, 2006, MOL CELL BIOL, V26, P7913, DOI 10.1128/MCB.01220-06	62	88	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11492	10.1371/journal.pone.0011492	http://dx.doi.org/10.1371/journal.pone.0011492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20628553	Green Published, Green Submitted, gold			2022-12-27	WOS:000279715300007
J	Aumeunier, A; Grela, F; Ramadan, A; Van, LP; Bardel, E; Alcala, AG; Jeannin, P; Akira, S; Bach, JF; Thieblemont, N				Aumeunier, Aude; Grela, Francoise; Ramadan, Abdulraouf; Linh Pham Van; Bardel, Emilie; Alcala, Alejandro Gomez; Jeannin, Pascale; Akira, Shizuo; Bach, Jean-Francois; Thieblemont, Nathalie			Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice	PLOS ONE			English	Article								Background: Infections may be associated with exacerbation of allergic and autoimmune diseases. Paradoxically, epidemiological and experimental data have shown that some microorganisms can also prevent these pathologies. This observation is at the origin of the hygiene hypothesis according to which the decline of infections in western countries is at the origin of the increased incidence of both Th1-mediated autoimmune diseases and Th2-mediated allergic diseases over the last decades. We have tested whether Toll-like receptor (TLR) stimulation can recapitulate the protective effect of infectious agents on allergy and autoimmunity. Methods and Findings: Here, we performed a systematic study of the disease-modifying effects of a set of natural or synthetic TLR agonists using two experimental models, ovalbumin (OVA)-induced asthma and spontaneous autoimmune diabetes, presenting the same genetic background of the non obese diabetic mouse (NOD) that is highly susceptible to both pathologies. In the same models, we also investigated the effect of probiotics. Additionally, we examined the effect of the genetic invalidation of MyD88 on the development of allergic asthma and spontaneous diabetes. We demonstrate that multiple TLR agonists prevent from both allergy and autoimmunity when administered parenterally. Probiotics which stimulate TLRs also protect from these two diseases. The physiological relevance of these findings is further suggested by the major acceleration of OVA-induced asthma in MyD88 invalidated mice. Our results strongly indicate that the TLR-mediated effects involve immunoregulatory cytokines such as interleukin (IL)-10 and transforming growth factor (TGF)-beta and different subsets of regulatory T cells, notably CD4(+)CD25(+)FoxP3(+) T cells for TLR4 agonists and NKT cells for TLR3 agonists. Conclusions/Significance: These observations demonstrate that systemic administration of TLR ligands can suppress both allergic and autoimmune responses. They provide a plausible explanation for the hygiene hypothesis. They also open new therapeutic perspectives for the prevention of these pathologies.	[Aumeunier, Aude; Grela, Francoise; Ramadan, Abdulraouf; Linh Pham Van; Bardel, Emilie; Alcala, Alejandro Gomez; Bach, Jean-Francois; Thieblemont, Nathalie] Univ Paris 05, Paris, France; [Aumeunier, Aude; Grela, Francoise; Ramadan, Abdulraouf; Linh Pham Van; Bardel, Emilie; Alcala, Alejandro Gomez; Thieblemont, Nathalie] CNRS, UMR8147, Paris, France; [Jeannin, Pascale] INSERM, U564, Angers, France; [Akira, Shizuo] Osaka Univ, Dept Host Def, Osaka, Japan; [Bach, Jean-Francois] INSERM, U1013, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Osaka University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Thieblemont, N (corresponding author), Univ Paris 05, Paris, France.	nathalie.thieblemont@parisdescartes.fr	JEANNIN, Pascale/K-8656-2015; Thieblemont, Nathalie/P-1329-2017	Thieblemont, Nathalie/0000-0002-8898-9217; JEANNIN, Pascale/0000-0002-3666-3856; Pham Van, Linh/0000-0001-7107-1496	Juvenile Diabetes Research Foundation (JDRF); Fondation pour la Recherche Medicale [DAL20041203162]; Chancellerie des Universites de Paris (Legs Poix); Association Francaise des Diabetiques (AFD); Fondation Day-Solvay	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Chancellerie des Universites de Paris (Legs Poix); Association Francaise des Diabetiques (AFD); Fondation Day-Solvay	This work was supported by grants from the Juvenile Diabetes Research Foundation (JDRF), Fondation pour la Recherche Medicale (#DAL20041203162), Chancellerie des Universites de Paris (Legs Poix); Association Francaise des Diabetiques (AFD); Fondation Day-Solvay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 2003, EUR J IMMUNOL, V33, P2717, DOI 10.1002/eji.200323329; Alyanakian MA, 2006, DIABETES, V55, P179, DOI 10.2337/diabetes.55.1.179; Anders HJ, 2004, FASEB J, V18, P534, DOI 10.1096/fj.03-0646fje; Araujo LM, 2004, EUR J IMMUNOL, V34, P327, DOI 10.1002/eji.200324151; BACH JF, 1994, ENDOCR REV, V15, P516, DOI 10.1210/er.15.4.516; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Camateros P, 2007, AM J RESP CRIT CARE, V175, P1241, DOI 10.1164/rccm.200701-054OC; Caramalho I, 2003, J EXP MED, V197, P403, DOI 10.1084/jem.20021633; Cohen SJ, 2010, J IMMUNOL, V184, P212, DOI 10.4049/jimmunol.0900296; Conrad ML, 2009, J EXP MED, V206, P2869, DOI 10.1084/jem.20090845; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hollingsworth JW, 2006, J IMMUNOL, V176, P5856, DOI 10.4049/jimmunol.176.10.5856; Jeannin P, 2005, IMMUNITY, V22, P551, DOI 10.1016/j.immuni.2005.03.008; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kimzey SL, 2004, J IMMUNOL, V173, P632, DOI 10.4049/jimmunol.173.1.632; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lenschow DJ, 1996, IMMUNITY, V5, P285, DOI 10.1016/S1074-7613(00)80323-4; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Marty RR, 2006, CIRCULATION, V113, P258, DOI 10.1161/CIRCULATIONAHA.105.564294; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Moisan J, 2006, AM J PHYSIOL-LUNG C, V290, pL987, DOI 10.1152/ajplung.00440.2005; Murakami D, 2007, CLIN EXP ALLERGY, V37, P339, DOI 10.1111/j.1365-2222.2006.02633.x; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Nyirenda Mukanthu H., 2009, Inflammation & Allergy Drug Targets, V8, P124; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Okada H, 2010, CLIN EXP IMMUNOL, V160, P1, DOI 10.1111/j.1365-2249.2010.04139.x; Paget C, 2007, IMMUNITY, V27, P597, DOI 10.1016/j.immuni.2007.08.017; Pasare C, 2003, SCIENCE, V299, P1033, DOI 10.1126/science.1078231; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Quintana FJ, 2000, J IMMUNOL, V165, P6148, DOI 10.4049/jimmunol.165.11.6148; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Sel S, 2007, J IMMUNOL, V178, P7805, DOI 10.4049/jimmunol.178.12.7805; SERREZE DV, 1989, J AUTOIMMUN, V2, P759, DOI 10.1016/0896-8411(89)90003-6; Shah Uzma, 2002, Adv Pediatr, V49, P299; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; TAKEI I, 1992, J AUTOIMMUN, V5, P665, DOI 10.1016/0896-8411(92)90184-R; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Zaccone P, 2004, EUR J IMMUNOL, V34, P3246, DOI 10.1002/eji.200425285	60	98	104	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11484	10.1371/journal.pone.0011484	http://dx.doi.org/10.1371/journal.pone.0011484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V28NK	20628601	Green Published, Green Submitted, gold			2022-12-27	WOS:000208687300001
J	Hervouet, E; Lalier, L; Debien, E; Cheray, M; Geairon, A; Rogniaux, H; Loussouarn, D; Martin, SA; Vallette, FM; Cartron, PF				Hervouet, Eric; Lalier, Lisenn; Debien, Emilie; Cheray, Mathilde; Geairon, Audrey; Rogniaux, Helene; Loussouarn, Delphine; Martin, Stephane A.; Vallette, Francois M.; Cartron, Pierre-Francois			Disruption of Dnmt1/PCNA/UHRF1 Interactions Promotes Tumorigenesis from Human and Mice Glial Cells	PLOS ONE			English	Article							HEMI-METHYLATED DNA; NEURAL PROGENITORS; SRA DOMAIN; DNMT1; HYPOMETHYLATION; TUMORS; HYPERMETHYLATION; 5-METHYLCYTOSINE; RECOGNITION; COMPLEX	Global DNA hypomethylation is a hallmark of cancer cells, but its molecular mechanisms have not been elucidated. Here, we show that the disruption of Dnmt1/PCNA/UHRF1 interactions promotes a global DNA hypomethylation in human gliomas. We then demonstrate that the Dnmt1 phosphorylations by Akt and/or PKC abrogate the interactions of Dnmt1 with PCNA and UHRF1 in cellular and acelluar studies including mass spectrometric analyses and the use of primary cultured patient-derived glioma. By using methylated DNA immunoprecipitation, methylation and CGH arrays, we show that global DNA hypomethylation is associated with genes hypomethylation, hypomethylation of DNA repeat element and chromosomal instability. Our results reveal that the disruption of Dnmt1/PCNA/UHRF1 interactions acts as an oncogenic event and that one of its signatures (i.e. the low level of mMTase activity) is a molecular biomarker associated with a poor prognosis in GBM patients. We identify the genetic and epigenetic alterations which collectively promote the acquisition of tumor/glioma traits by human astrocytes and glial progenitor cells as that promoting high proliferation and apoptosis evasion.	[Hervouet, Eric; Lalier, Lisenn; Debien, Emilie; Cheray, Mathilde; Loussouarn, Delphine; Martin, Stephane A.; Vallette, Francois M.; Cartron, Pierre-Francois] Equipe Labellisee Ligue Natl Canc, INSERM, Ctr Rech Cancerol Nantes Angers,U892, Equipe Aspect Mecanist & Physiopathol Act Prot Fa, Nantes, France; [Hervouet, Eric; Lalier, Lisenn; Debien, Emilie; Cheray, Mathilde; Vallette, Francois M.; Cartron, Pierre-Francois] Univ Nantes, Fac Med, Dept Rech Cancerol, IFR26, Nantes, France; [Geairon, Audrey; Rogniaux, Helene] INRA, Biopolymere Interact Assemblages UR1268, Plate Forme BIBS, F-44026 Nantes, France; [Loussouarn, Delphine] CHU Nantes, HGRL, Serv Anat Pathol, F-44035 Nantes 01, France; [Martin, Stephane A.] CHU Nantes, Hop G&R Laennec, Serv Neurochirurg, F-44035 Nantes 01, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; INRAE; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Hervouet, E (corresponding author), Equipe Labellisee Ligue Natl Canc, INSERM, Ctr Rech Cancerol Nantes Angers,U892, Equipe Aspect Mecanist & Physiopathol Act Prot Fa, Nantes, France.	pierre-francois.cartron@univ-nantes.fr	Hervouet, Eric/U-5784-2019; Cartron, Pierre Francois/K-9802-2015; Vallette, Francois M/K-9047-2015; Lalier, Lisenn/K-9230-2015; Vallette, Francois/N-2361-2018	Vallette, Francois M/0000-0002-3296-8572; Cartron, Pierre-Francois/0000-0002-3393-784X; Vallette, Francois/0000-0003-0802-0519; Cheray, Mathilde/0000-0002-7551-6357	Association pour la Recherche contre le Cancer (ARC) [1020, 3907]; INCa (Region Grand Ouest); En avant la vie	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); INCa (Region Grand Ouest)(Institut National du Cancer (INCA) France); En avant la vie	This work was supported by grants from the Association pour la Recherche contre le Cancer (ARC#1020 and #3907). E. H. was supported by a fellowship from INCa (Region Grand Ouest). E. D. was supported by a fellowship from "En avant la vie''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; BOSTICK M, 2007, SCIENCE, V27, P2187; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Chuang LSH, 1997, SCIENCE, V277, P1996, DOI 10.1126/science.277.5334.1996; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Easwaran HP, 2004, EMBO REP, V5, P1181, DOI 10.1038/sj.embor.7400295; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Ehrlich M, 2002, ONCOGENE, V21, P6694, DOI 10.1038/sj.onc.1205890; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Fuks F, 2000, NAT GENET, V24, P88, DOI 10.1038/71750; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; ROBERTSON KD, 2000, DNMT1 FORMS COMPLEX, V25, P338; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schermelleh L, 2007, NUCLEIC ACIDS RES, V35, P4301, DOI 10.1093/nar/gkm432; Sehgal A, 1998, SEMIN SURG ONCOL, V14, P3; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Tran Y, 1998, ONCOGENE, V17, P3499, DOI 10.1038/sj.onc.1202258; Vertino PM, 2002, CELL CYCLE, V1, P416, DOI 10.4161/cc.1.6.270; Yokochi Tomoki, 2004, Methods Mol Biol, V287, P285	33	99	107	31	223	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11333	10.1371/journal.pone.0011333	http://dx.doi.org/10.1371/journal.pone.0011333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613874	Green Published, Green Submitted, gold			2022-12-27	WOS:000279369900002
J	Kharraz, Y; Salmand, PA; Camus, A; Auriol, J; Gueydan, C; Kruys, V; Morello, D				Kharraz, Yacine; Salmand, Pierre-Adrien; Camus, Anne; Auriol, Jacques; Gueydan, Cyril; Kruys, Veronique; Morello, Dominique			Impaired Embryonic Development in Mice Overexpressing the RNA-Binding Protein TIAR	PLOS ONE			English	Article							AU-RICH ELEMENT; MESSENGER-RNA; STRESS GRANULES; POSTTRANSCRIPTIONAL REGULATION; EXPRESSION; CULTURE; TRANSLATION; DEPHOSPHORYLATION; IDENTIFICATION; GASTRULATION	Background: TIA-1-related (TIAR) protein is a shuttling RNA-binding protein involved in several steps of RNA metabolism. While in the nucleus TIAR participates to alternative splicing events, in the cytoplasm TIAR acts as a translational repressor on specific transcripts such as those containing AU-Rich Elements (AREs). Due to its ability to assemble abortive pre-initiation complexes coalescing into cytoplasmic granules called stress granules, TIAR is also involved in the general translational arrest observed in cells exposed to environmental stress. However, the in vivo role of this protein has not been studied so far mainly due to severe embryonic lethality upon tiar invalidation. Methodology/Principal Findings: To examine potential TIAR tissue-specificity in various cellular contexts, either embryonic or adult, we constructed a TIAR transgenic allele (loxPGFPloxPTIAR) allowing the conditional expression of TIAR protein upon Cre recombinase activity. Here, we report the role of TIAR during mouse embryogenesis. We observed that early TIAR overexpression led to low transgene transmission associated with embryonic lethality starting at early post-implantation stages. Interestingly, while pre-implantation steps evolved correctly in utero, in vitro cultured embryos were very sensitive to culture medium. Control and transgenic embryos developed equally well in the G2 medium, whereas culture in M16 medium led to the phosphorylation of eIF2 alpha that accumulated in cytoplasmic granules precluding transgenic blastocyst hatching. Our results thus reveal a differential TIAR-mediated embryonic response following artificial or natural growth environment. Conclusions/Significance: This study reports the importance of the tightly balanced expression of the RNA-binding protein TIAR for normal embryonic development, thereby emphasizing the role of post-transcriptional regulations in early embryonic programming.	[Kharraz, Yacine; Gueydan, Cyril; Kruys, Veronique] Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, Gosselies, Belgium; [Salmand, Pierre-Adrien; Auriol, Jacques; Morello, Dominique] Univ Toulouse, CBD, CNRS, UMR5547, Toulouse, France; [Camus, Anne] Univ Paris Diderot Paris 7, CNRS, Lab Specificat Destins Cellulaires Chez Souris, Inst Jacques Monod,UMR 7592, Paris, France; [Kruys, Veronique] Ctr Microscopy & Mol Imaging, Gosselies, Belgium	Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Kharraz, Y (corresponding author), Univ Libre Bruxelles, Fac Sci, Lab Biol Mol Gene, Gosselies, Belgium.	vkruys@ulb.ac.be	Camus, Anne/P-1515-2014; Kharraz, Yacine/I-1202-2015; Kruys, Veronique I/N-6613-2018	Kharraz, Yacine/0000-0001-9172-7624; Gueydan, Cyril/0000-0003-3097-7667; Kruys, Veronique/0000-0002-3144-5403; Camus, Anne/0000-0002-8820-0407	Direction Generale des Technologies, de la Recherche et de l'Energie; Medical Scientific Research [2.4.511.00.F]; Actions de Recherches Concertees [00-05/250, AV.06/11-345]; Association pour la Recherche sur le Cancer [3823]; Alliance des Recherches sur le Cancer network Pole proteomique et Cancer; Conseil Regional Cibles therapeutiques et recherche de nouveaux marqueurs diagnostics et pronostics dans les cancers and La Ligue Contre le Cancer; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture/Fonds National de la Recherche Scientifique; Fonds Van Buren (Belgium)	Direction Generale des Technologies, de la Recherche et de l'Energie; Medical Scientific Research; Actions de Recherches Concertees; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Alliance des Recherches sur le Cancer network Pole proteomique et Cancer; Conseil Regional Cibles therapeutiques et recherche de nouveaux marqueurs diagnostics et pronostics dans les cancers and La Ligue Contre le Cancer; Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture/Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds Van Buren (Belgium)	This work was funded by the Direction Generale des Technologies, de la Recherche et de l'Energie (region Wallonne), the Fund for Medical Scientific Research (Belgium, grant 2.4.511.00.F), and the Actions de Recherches Concertees (grants 00-05/250 and AV.06/11-345), the Association pour la Recherche sur le Cancer #3823, Alliance des Recherches sur le Cancer network Pole proteomique et Cancer, Conseil Regional Cibles therapeutiques et recherche de nouveaux marqueurs diagnostics et pronostics dans les cancers and La Ligue Contre le Cancer. YK was supported by a Ph.D. fellowship from the Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture/Fonds National de la Recherche Scientifique and by a grant from the Fonds Van Buren (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2004, J LEUKOCYTE BIOL, V76, P42, DOI 10.1189/jlb.1103536; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Ang SL, 2004, SEMIN CELL DEV BIOL, V15, P555, DOI 10.1016/j.semcdb.2004.04.009; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Beck ARP, 1998, P NATL ACAD SCI USA, V95, P2331, DOI 10.1073/pnas.95.5.2331; Bell CE, 2008, MOL HUM REPROD, V14, P691, DOI 10.1093/molehr/gan063; Boiani M, 2005, STEM CELLS, V23, P1089, DOI 10.1634/stemcells.2004-0352; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chou CF, 2006, MOL CELL BIOL, V26, P3695, DOI 10.1128/MCB.26.10.3695-3706.2006; DelGatto F, 1997, MOL CELL BIOL, V17, P5106, DOI 10.1128/MCB.17.9.5106; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gardner DK, 1998, FERTIL STERIL, V69, P84, DOI 10.1016/S0015-0282(97)00438-X; Gouble A, 2002, CANCER RES, V62, P1489; Gueydan C, 1999, J BIOL CHEM, V274, P2322, DOI 10.1074/jbc.274.4.2322; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hamatani Toshio, 2006, Hum Cell, V19, P98; Harding HP, 2009, P NATL ACAD SCI USA, V106, P1832, DOI 10.1073/pnas.0809632106; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Jones GM, 1998, HUM REPROD, V13, P169, DOI 10.1093/humrep/13.1.169; Jousse C, 2003, J CELL BIOL, V163, P767, DOI 10.1083/jcb.200308075; Kandasamy K, 2005, J BIOL CHEM, V280, P1931, DOI 10.1074/jbc.M405937200; KAUFMAN, 1992, ATLAS MOUSE DEV; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Liao BS, 2007, NAT STRUCT MOL BIOL, V14, P511, DOI 10.1038/nsmb1249; Linker K, 2005, NUCLEIC ACIDS RES, V33, P4813, DOI 10.1093/nar/gki797; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; MCKEE AE, 2005, BMC DEV BIOL, V20, P5; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Perea-Gomez A, 2004, CURR BIOL, V14, P197, DOI 10.1016/j.cub.2004.01.030; Pfister S, 2007, GENE EXPR PATTERNS, V7, P558, DOI 10.1016/j.modgep.2007.01.005; Piecyk M, 2000, EMBO J, V19, P4154, DOI 10.1093/emboj/19.15.4154; Rivera-Perez JA, 2003, DEV BIOL, V261, P470, DOI 10.1016/S0012-1606(03)00302-6; Ron D, 2007, TRANSLATIONAL CONTRO, P345; Vidal F, 1998, MOL REPROD DEV, V51, P274, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;274::AID-MRD6&gt;3.0.CO;2-M; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025; Yu Q, 2003, J BIOL CHEM, V278, P1579, DOI 10.1074/jbc.M203526200; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang T, 2005, J CELL SCI, V118, P5453, DOI 10.1242/jcs.02669; Zhu H, 2003, MOL CELL BIOL, V23, P5959, DOI 10.1128/MCB.23.17.5959-5971.2003	46	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11352	10.1371/journal.pone.0011352	http://dx.doi.org/10.1371/journal.pone.0011352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596534	gold, Green Published, Green Submitted			2022-12-27	WOS:000279259900022
J	Xin, YR; Chanrion, B; Liu, MM; Galfalvy, H; Costa, R; Ilievski, B; Rosoklija, G; Arango, V; Dwork, AJ; Mann, JJ; Tycko, B; Haghighi, F				Xin, Yurong; Chanrion, Benjamin; Liu, Meng-Min; Galfalvy, Hanga; Costa, Ramiro; Ilievski, Boro; Rosoklija, Gorazd; Arango, Victoria; Dwork, Andrew J.; Mann, J. John; Tycko, Benjamin; Haghighi, Fatemeh			Genome-Wide Divergence of DNA Methylation Marks in Cerebral and Cerebellar Cortices	PLOS ONE			English	Article							CHROMATIN REPEAT LENGTH; EXPRESSION; CORTEX; SIGNATURES; TISSUE	Background: Emerging evidence suggests that DNA methylation plays an expansive role in the central nervous system (CNS). Large-scale whole genome DNA methylation profiling of the normal human brain offers tremendous potential in understanding the role of DNA methylation in brain development and function. Methodology/Significant Findings: Using methylation-sensitive SNP chip analysis (MSNP), we performed whole genome DNA methylation profiling of the prefrontal, occipital, and temporal regions of cerebral cortex, as well as cerebellum. These data provide an unbiased representation of CpG sites comprising 377,509 CpG dinucleotides within both the genic and intergenic euchromatic region of the genome. Our large-scale genome DNA methylation profiling reveals that the prefrontal, occipital, and temporal regions of the cerebral cortex compared to cerebellum have markedly different DNA methylation signatures, with the cerebral cortex being hypermethylated and cerebellum being hypomethylated. Such differences were observed in distinct genomic regions, including genes involved in CNS function. The MSNP data were validated for a subset of these genes, by performing bisulfite cloning and sequencing and confirming that prefrontal, occipital, and temporal cortices are significantly more methylated as compared to the cerebellum. Conclusions: These findings are consistent with known developmental differences in nucleosome repeat lengths in cerebral and cerebellar cortices, with cerebrum exhibiting shorter repeat lengths than cerebellum. Our observed differences in DNA methylation profiles in these regions underscores the potential role of DNA methylation in chromatin structure and organization in CNS, reflecting functional specialization within cortical regions.	[Xin, Yurong; Chanrion, Benjamin; Galfalvy, Hanga; Costa, Ramiro; Ilievski, Boro; Rosoklija, Gorazd; Arango, Victoria; Dwork, Andrew J.; Mann, J. John; Haghighi, Fatemeh] Columbia Univ, Dept Psychiat, New York, NY 10027 USA; [Xin, Yurong; Chanrion, Benjamin; Galfalvy, Hanga; Costa, Ramiro; Ilievski, Boro; Rosoklija, Gorazd; Arango, Victoria; Dwork, Andrew J.; Mann, J. John; Haghighi, Fatemeh] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Liu, Meng-Min; Dwork, Andrew J.; Tycko, Benjamin] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Liu, Meng-Min; Tycko, Benjamin] Columbia Univ Coll Phys & Surg, Taub Inst Res Aging Brain, New York, NY 10032 USA; [Ilievski, Boro; Rosoklija, Gorazd; Dwork, Andrew J.; Mann, J. John] Univ Ss Cyril & Methodius, Sch Med, Skopje, North Macedonia; [Rosoklija, Gorazd] Univ Ss Cyril & Methodius, Macedonian Acad Sci & Arts, Skopje, North Macedonia	Columbia University; New York State Psychiatry Institute; Columbia University; Columbia University; Saints Cyril & Methodius University of Skopje; Saints Cyril & Methodius University of Skopje	Xin, YR (corresponding author), Columbia Univ, Dept Psychiat, New York, NY 10027 USA.	fgh3@columbia.edu	Galfalvy, Hanga/AAI-5492-2020; Arango, Victoria/K-9377-2015	Galfalvy, Hanga/0000-0001-7156-6106; Arango, Victoria/0000-0001-8811-400X	National Institute of Mental Health [MH048514]; National Human Genome Research institute [HG002915]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K22HG002915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064168, R01MH060877, R01MH048514] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Human Genome Research institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Institute of Mental Health (MH048514) and the National Human Genome Research institute (HG002915). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERKOWITZ EM, 1983, J NEUROCHEM, V41, P516, DOI 10.1111/j.1471-4159.1983.tb04769.x; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Cui W, 2009, J NEUROSCI RES, V87, P1123, DOI 10.1002/jnr.21936; EHRLICH M, 1981, SCIENCE, V212, P1350, DOI 10.1126/science.6262918; ERMINI M, 1978, FEBS LETT, V90, P167, DOI 10.1016/0014-5793(78)80322-6; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; JAEGER AW, 1982, EMBO J, V1, P811, DOI 10.1002/j.1460-2075.1982.tb01252.x; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kelly TM, 1996, ACTA PSYCHIAT SCAND, V94, P337, DOI 10.1111/j.1600-0447.1996.tb09869.x; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li JZ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-336; Putignano E, 2007, NEURON, V53, P747, DOI 10.1016/j.neuron.2007.02.007; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Takizawa T, 2008, TRENDS NEUROSCI, V31, P343, DOI 10.1016/j.tins.2008.03.005; THOMAS JO, 1977, CELL, V10, P633, DOI 10.1016/0092-8674(77)90096-4; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739	25	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11357	10.1371/journal.pone.0011357	http://dx.doi.org/10.1371/journal.pone.0011357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596539	Green Published, gold, Green Submitted			2022-12-27	WOS:000279259900025
J	Alaoui-El-Azher, M; Mans, JJ; Baker, HV; Chen, C; Progulske-Fox, A; Lamont, RJ; Handfield, M				Alaoui-El-Azher, Mounia; Mans, Jeffrey J.; Baker, Henry V.; Chen, Casey; Progulske-Fox, Ann; Lamont, Richard J.; Handfield, Martin			Role of the ATM-Checkpoint Kinase 2 Pathway in CDT-Mediated Apoptosis of Gingival Epithelial Cells	PLOS ONE			English	Article							CYTOLETHAL DISTENDING TOXIN; HUMAN T-CELLS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; CYCLE ARREST; DNA-DAMAGE; G(2) ARREST; PROTEIN; PHOSPHORYLATION; FIBROBLASTS; INHIBITION	The cytolethal distending toxin (CDT) of the oral pathogen Aggregatibacter actinomycetemcomitans induces cell cycle arrest and apoptosis in various cell types. Western analysis, pharmacological inhibition and siRNA silencing were performed in human immortalized gingival keratinocytes (HIGK) to dissect the functional role of the ataxia telangiectasia mutated (ATM) pathway in the signal transduction steps triggered by the CDT. Infection of HIGK was associated with a time-dependent induction of cytoplasmic histone-associated DNA fragmentation. However, in the absence of CDT, infected HIGK underwent reversible DNA strand breaks but not apoptosis, while caspase 3 activity, p21 levels, and HIGK viability were unaffected. Caspase 9 activity was attenuated in the CDT mutant-infected HIGK compared to wild-type infected cells. Pharmacological inhibition and siRNA-silencing of the ATM downstream effector, the protein kinase checkpoint kinase 2 (Chk2), significantly impacted CDT-mediated apoptosis. Together, these findings provide insight on the specificity of the ATM-Chk2 pathway in response to the CDT of A. actinomycetemcomitans in oral epithelial cells, which ultimately leads to apoptosis. We further propose the existence of an unidentified factor that is distinct from the CDT, and involved with a reversible DNA fragmentation that does not trigger terminal apoptosis in oral epithelial cells. This model potentially explains conflicting reports on the biological activity of the A. actinomycetemcomitans CDT.	[Alaoui-El-Azher, Mounia; Mans, Jeffrey J.; Progulske-Fox, Ann; Lamont, Richard J.; Handfield, Martin] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Alaoui-El-Azher, Mounia; Mans, Jeffrey J.; Progulske-Fox, Ann; Lamont, Richard J.; Handfield, Martin] Univ Florida, Coll Dent, Ctr Mol Microbiol, Gainesville, FL USA; [Baker, Henry V.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Chen, Casey] Univ So Calif, Herman Ostrow Sch Dent, Div Periodontol Diagnost Sci & Dent Hyg, Los Angeles, CA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Southern California	Alaoui-El-Azher, M (corresponding author), Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA.	mhandfield@dental.ufl.edu		Baker, Henry/0000-0002-8273-5320	United States National Institute of Dental and Craniofacial Research, National Institutes of Health, NIH/NIDCR [DE16715, DE11111]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE011111, R01DE011111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016715] Funding Source: NIH RePORTER	United States National Institute of Dental and Craniofacial Research, National Institutes of Health, NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding was provided by the United States National Institute of Dental and Craniofacial Research, National Institutes of Health, NIH/NIDCR DE16715 (MH) and DE11111() RL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan LA, 2009, FEBS J, V276, P6063, DOI 10.1111/j.1742-4658.2009.07330.x; Belibasakis GN, 2004, APMIS, V112, P674, DOI 10.1111/j.1600-0463.2004.apm1121006.x; Cortes-Bratti X, 2001, J BIOL CHEM, V276, P5296, DOI 10.1074/jbc.M008527200; da Silva RM, 2005, J PERIODONTOL, V76, P590, DOI 10.1902/jop.2005.76.4.590; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Dlakic M, 2000, TRENDS BIOCHEM SCI, V25, P272, DOI 10.1016/S0968-0004(00)01582-6; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Elwell C, 2001, INFECT IMMUN, V69, P3418, DOI 10.1128/IAI.69.5.3418-3422.2001; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Frisan T, 2002, INT J MED MICROBIOL, V291, P495; Frisk A, 2001, MICROB PATHOGENESIS, V30, P313, DOI 10.1006/mpat.2000.0436; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Handfield M, 2005, CELL MICROBIOL, V7, P811, DOI 10.1111/j.1462-5822.2005.00513.x; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; LAGERGARD T, 1993, MICROB PATHOGENESIS, V14, P417, DOI 10.1006/mpat.1993.1041; Lara-Tejero M, 2001, INFECT IMMUN, V69, P4358, DOI 10.1128/IAI.69.7.4358-4365.2001; Levenbrown Y, 2008, NEUROSCI LETT, V447, P96, DOI 10.1016/j.neulet.2008.09.076; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Mintz KP, 2000, INFECT IMMUN, V68, P6580, DOI 10.1128/IAI.68.12.6580-6586.2000; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; Oda D, 1996, EXP CELL RES, V226, P164, DOI 10.1006/excr.1996.0215; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Ohguchi M, 1998, INFECT IMMUN, V66, P5980, DOI 10.1128/IAI.66.12.5980-5987.1998; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sato T, 2002, INFECT IMMUN, V70, P528, DOI 10.1128/IAI.70.2.528-534.2002; Shenker BJ, 2006, INFECT IMMUN, V74, P2080, DOI 10.1128/IAI.74.4.2080-2092.2006; Shenker BJ, 1999, J IMMUNOL, V162, P4773; Shenker BJ, 2001, J IMMUNOL, V167, P435, DOI 10.4049/jimmunol.167.1.435; Shenker BJ, 2000, J IMMUNOL, V165, P2612, DOI 10.4049/jimmunol.165.5.2612; Shenker BJ, 2007, J IMMUNOL, V178, P5099, DOI 10.4049/jimmunol.178.8.5099; Smith JL, 2006, CRIT REV MICROBIOL, V32, P227, DOI 10.1080/10408410601023557; SREENIVASAN PK, 1991, INFECT IMMUN, V59, P4621, DOI 10.1128/IAI.59.12.4621-4627.1991; Sugai M, 1998, INFECT IMMUN, V66, P5008, DOI 10.1128/IAI.66.10.5008-5019.1998; van Winkelhoff AJ, 1999, PERIODONTOL 2000, V20, P122; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang S, 2000, P NATL ACAD SCI USA, V97, P1584, DOI 10.1073/pnas.97.4.1584; Wang Y, 2005, INFECT IMMUN, V73, P3749, DOI 10.1128/IAI.73.6.3749-3753.2005; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; Yang ST, 2002, NAT CELL BIOL, V4, P865, DOI 10.1038/ncb869; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	43	25	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11714	10.1371/journal.pone.0011714	http://dx.doi.org/10.1371/journal.pone.0011714			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668524	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800006
J	Jovanovic, K; Pastor, AM; O'Donovan, MJ				Jovanovic, Ksenija; Pastor, Angel M.; O'Donovan, Michael J.			The Use of PRV-Bartha to Define Premotor Inputs to Lumbar Motoneurons in the Neonatal Spinal Cord of the Mouse	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RETROGRADE TRANSSYNAPTIC TRANSPORT; PSEUDORABIES VIRUS; RENSHAW CELLS; SUPRACHIASMATIC NUCLEUS; SYNAPTIC ACTIONS; REFLEX PATHWAYS; INTERNEURONS; NEURONS; PARVALBUMIN	Background: The neonatal mouse has become a model system for studying the locomotor function of the lumbar spinal cord. However, information about the synaptic connectivity within the governing neural network remains scarce. A neurotropic pseudorabies virus (PRV) Bartha has been used to map neuronal connectivity in other parts of the nervous system, due to its ability to travel trans-neuronally. Its use in spinal circuits regulating locomotion has been limited and no study has defined the time course of labelling for neurons known to project monosynaptically to motoneurons. Methodology/Principal Findings: Here we investigated the ability of PRV Bartha, expressing green and/or red fluorescence, to label spinal neurons projecting monosynaptically to motoneurons of two principal hindlimb muscles, the tibialis anterior (TA) and gastrocnemius (GC). As revealed by combined immunocytochemistry and confocal microscopy, 24-32 h after the viral muscle injection the label was restricted to the motoneuron pool while at 32-40 h the fluorescence was seen in interneurons throughout the medial and lateral ventral grey matter. Two classes of ipsilateral interneurons known to project monosynaptically to motoneurons (Renshaw cells and cells of origin of C-terminals) were consistently labeled at 40 h post-injection but also a group in the ventral grey matter contralaterally. Our results suggest that the labeling of last order interneurons occurred 8-12 h after motoneuron labeling and we presume this is the time taken by the virus to cross one synapse, to travel retrogradely and to replicate in the labeled cells. Conclusions/Significance: The study establishes the time window for virally - labelling monosynaptic projections to lumbar motoneurons following viral injection into hindlimb muscles. Moreover, it provides a good foundation for intracellular targeting of the labeled neurons in future physiological studies and better understanding the functional organization of the lumbar neural networks.	[Jovanovic, Ksenija; O'Donovan, Michael J.] Natl Inst Neurol Disorders & Stroke, Dev Neurobiol Sect, NIH, Bethesda, MD 20892 USA; [Jovanovic, Ksenija] Hosp Nacl Paraplejicos, Lab Reparac Neural & Biomat, Toledo, Spain; [Pastor, Angel M.] Univ Seville, Dept Fisiol & Zool, Fac Biol, Seville, Spain	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Hospital Nacional de Paraplejicos; University of Sevilla	Jovanovic, K (corresponding author), Natl Inst Neurol Disorders & Stroke, Dev Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	ODonovM@ninds.nih.gov	o'donovan, michael/A-2357-2015; Pastor, Angel M. M/A-6385-2010	o'donovan, michael/0000-0003-2487-7547; Pastor, Angel M. M/0000-0002-6213-7454	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland; MICINN-FEDER, Spain [PET2008-0226, BFU2009-07121]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002787] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MICINN-FEDER, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The study was funded by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland to Michael O'Donovan and the grants PET2008-0226 and BFU2009-07121 from MICINN-FEDER, Spain to Angel M. Pastor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Alvarez FJ, 2007, J PHYSIOL-LONDON, V584, P31, DOI 10.1113/jphysiol.2007.136200; Anelli R, 2005, J NEUROCYTOL, V34, P369, DOI 10.1007/s11068-006-8724-2; Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/NMETH.1292, 10.1038/nmeth.1292]; BRINK E, 1983, J PHYSIOL-LONDON, V343, P361, DOI 10.1113/jphysiol.1983.sp014897; Brittle EE, 2004, J VIROL, V78, P12951, DOI 10.1128/JVI.78.23.12951-12963.2004; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARD JP, 1990, J NEUROSCI, V10, P1974; Carr PA, 1998, NEUROREPORT, V9, P2657, DOI 10.1097/00001756-199808030-00043; Chamberlin NL, 2007, J PHYSIOL-LONDON, V579, P515, DOI 10.1113/jphysiol.2006.121889; Clowry GJ, 1997, DEV BRAIN RES, V102, P197, DOI 10.1016/S0165-3806(97)00098-9; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dekkers J, 2004, NEUROSCIENCE, V123, P459, DOI 10.1016/j.neuroscience.2003.07.013; DOBBINS EG, 1995, J COMP NEUROL, V357, P376, DOI 10.1002/cne.903570305; DOBBINS EG, 1994, J COMP NEUROL, V86, P47; Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010; EDGLEY SA, 1989, J PHYSIOL-LONDON, V411, P469, DOI 10.1113/jphysiol.1989.sp017584; Enquist LW, 2002, J INFECT DIS, V186, pS209, DOI 10.1086/344278; GAZELIUS H, 2009, NEUR M PLANN CHIC IL; Geiman RJ, 2000, J COMP NEUROL, V426, P130, DOI 10.1002/1096-9861(20001009)426:1<130::AID-CNE9>3.0.CO;2-7; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2002, CURR OPIN NEUROBIOL, V12, P508, DOI 10.1016/S0959-4388(02)00371-9; Granstedt AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006923; HAMM TM, 1990, J NEUROPHYSIOL, V63, P395, DOI 10.1152/jn.1990.63.3.395; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V226, P805, DOI 10.1113/jphysiol.1972.sp010011; Jankowska E, 2005, J PHYSIOL-LONDON, V565, P645, DOI 10.1113/jphysiol.2005.083014; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P623, DOI 10.1113/jphysiol.1972.sp009818; JANOWSKA E, 1971, ACTA PHYSIOL SCAND, V81, P428, DOI 10.1111/j.1748-1716.1971.tb04918.x; JOVANOVIC K, 2006, 5 FOR EUR NEUR VIENN; Kerman IA, 2003, J NEUROSCI, V23, P4657; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kim ES, 2000, BRAIN RES, V857, P41, DOI 10.1016/S0006-8993(99)02332-X; KUYPERS HGJM, 1990, TRENDS NEUROSCI, V13, P71, DOI 10.1016/0166-2236(90)90071-H; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Marina N, 2008, AUTON NEUROSCI-BASIC, V139, P15, DOI 10.1016/j.autneu.2007.12.004; McCarthy KM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000640; Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Nishimaru H, 2006, J NEUROSCI, V26, P5320, DOI 10.1523/JNEUROSCI.5127-05.2006; NOGA BR, 1987, EXP BRAIN RES, V66, P99; Pastor AM, 2003, J NEUROPHYSIOL, V89, P793, DOI 10.1152/jn.00498.2002; Pickard GE, 2002, J NEUROSCI, V22, P2701, DOI 10.1523/JNEUROSCI.22-07-02701.2002; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; Ptak K, 2005, J NEUROSCI, V25, P5159, DOI 10.1523/JNEUROSCI.4238-04.2005; Puskar Z, 1997, J COMP NEUROL, V389, P377, DOI 10.1002/(SICI)1096-9861(19971222)389:3<377::AID-CNE2>3.0.CO;2-Y; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; RENSHAW B, 1946, J NEUROPHYSIOL, V9, P191, DOI 10.1152/jn.1946.9.3.191; ROTTOPERCELAY DM, 1992, BRAIN RES, V574, P291, DOI 10.1016/0006-8993(92)90829-X; Shintani T, 2003, J APPL PHYSIOL, V95, P1453, DOI 10.1152/japplphysiol.00558.2003; Shneider NA, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-42; Smeraski CA, 2004, J COMP NEUROL, V471, P298, DOI 10.1002/cne.20030; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; STRACK AM, 1990, J NEUROSCI, V10, P2139; THOMAS RC, 1965, NATURE, V206, P211, DOI 10.1038/206211b0; TISSENBAUM HA, 1991, CAN J PHYSIOL PHARM, V69, P1769, DOI 10.1139/y91-261; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089; Xu C, 2006, NEUROSCIENCE, V138, P561, DOI 10.1016/j.neuroscience.2005.11.016; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; ZHANG JH, 1990, J COMP NEUROL, V302, P715, DOI 10.1002/cne.903020404	67	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11743	10.1371/journal.pone.0011743	http://dx.doi.org/10.1371/journal.pone.0011743			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668534	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800017
J	Palepu, A; Marshall, BDL; Lai, C; Wood, E; Kerr, T				Palepu, Anita; Marshall, Brandon D. L.; Lai, Calvin; Wood, Evan; Kerr, Thomas			Addiction Treatment and Stable Housing among a Cohort of Injection Drug Users	PLOS ONE			English	Article							DEPENDENT HOMELESS PERSONS; SUBSTANCE-ABUSING HOMELESS; FOLLOW-UP; EMERGENCY-DEPARTMENT; PSYCHIATRIC DISABILITIES; ALCOHOL-PROBLEMS; MENTAL-ILLNESS; PRIMARY-CARE; RISK-FACTORS; SERVICE USE	Background: Unstable housing and homelessness is prevalent among injection drug users (IDU). We sought to examine whether accessing addiction treatment was associated with attaining stable housing in a prospective cohort of IDU in Vancouver, Canada. Methods: We used data collected via the Vancouver Injection Drug User Study (VIDUS) between December 2005 and April 2010. Attaining stable housing was defined as two consecutive "stable housing" designations (i.e., living in an apartment or house) during the follow-up period. We assessed exposure to addiction treatment in the interview prior to the attainment of stable housing among participants who were homeless or living in single room occupancy (SRO) hotels at baseline. Bivariate and multivariate associations between the baseline and time-updated characteristics and attaining stable housing were examined using Cox proportional hazard regression models. Principal Findings: Of the 992 IDU eligible for this analysis, 495 (49.9%) reported being homeless, 497 (50.1%) resided in SRO hotels, and 380 (38.3%) were enrolled in addiction treatment at the baseline interview. Only 211 (21.3%) attained stable housing during the follow-up period and of this group, 69 (32.7%) had addiction treatment exposure prior to achieving stable housing. Addiction treatment was inversely associated with attaining stable housing in a multivariate model (adjusted hazard ratio [AHR] = 0.71; 95% CI: 0.52-0.96). Being in a partnered relationship was positively associated with the primary outcome (AHR = 1.39; 95% CI: 1.02-1.88). Receipt of income assistance (AHR = 0.65; 95% CI: 0.44-0.96), daily crack use (AHR = 0.69; 95% CI: 0.51-0.93) and daily heroin use (AHR = 0.63; 95% CI: 0.43-0.92) were negatively associated with attaining stable housing. Conclusions: Exposure to addiction treatment in our study was negatively associated with attaining stable housing and may have represented a marker of instability among this sample of IDU. Efforts to stably house this vulnerable group may be occurring in contexts outside of addiction treatment.	[Palepu, Anita] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada; [Palepu, Anita] Univ British Columbia, Dept Med, Div Gen Internal Med, Vancouver, BC, Canada; [Marshall, Brandon D. L.; Lai, Calvin; Wood, Evan; Kerr, Thomas] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Marshall, Brandon D. L.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Wood, Evan; Kerr, Thomas] Univ British Columbia, Div Aids, Dept Med, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia	Palepu, A (corresponding author), St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada.	anita@hivnet.ubc.ca	Marshall, Brandon/B-4895-2010	Marshall, Brandon/0000-0002-0134-7052; Palepu, Anita/0000-0002-7881-4800	US National Institutes of Health [R01 DA011591]; Canadian Institutes of Health Research [HHP-67262, RAA-79918]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011591] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was supported by the US National Institutes of Health (R01 DA011591) and the Canadian Institutes of Health Research (HHP-67262 and RAA-79918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford DP, 2007, J GEN INTERN MED, V22, P171, DOI 10.1007/s11606-006-0023-1; *CAN MORTG HOUS CO, 2008, RENT MARK REP VANC A; Cantor AB., 2003, SAS SURVIVAL ANAL TE; Cheung AM, 2004, CAN MED ASSOC J, V170, P1243, DOI 10.1503/cmaj.1031167; Crits-Christoph P, 1999, ARCH GEN PSYCHIAT, V56, P493, DOI 10.1001/archpsyc.56.6.493; Culhane DP, 2002, HOUS POLICY DEBATE, V13, P107, DOI 10.1080/10511482.2002.9521437; DeBeck K, 2009, CAN MED ASSOC J, V181, P585, DOI 10.1503/cmaj.082054; Fischer B, 1999, CAN J PUBLIC HEALTH, V90, P299, DOI 10.1007/BF03404513; Goering P, 2002, PSYCHIAT SERV, V53, P1472, DOI 10.1176/appi.ps.53.11.1472; Gossop M, 2005, DRUG ALCOHOL DEPEN, V79, P295, DOI 10.1016/j.drugalcdep.2005.01.023; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hwang SW, 2000, JAMA-J AM MED ASSOC, V283, P2152, DOI 10.1001/jama.283.16.2152; Hwang SW, 1998, ARCH INTERN MED, V158, P1454, DOI 10.1001/archinte.158.13.1454; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Kertesz SG, 2007, J BEHAV HEALTH SER R, V34, P17, DOI 10.1007/s11414-006-9041-3; Kertesz SG, 2009, MILBANK Q, V87, P495, DOI 10.1111/j.1468-0009.2009.00565.x; Kertesz SG, 2009, JAMA-J AM MED ASSOC, V301, P1822, DOI 10.1001/jama.2009.596; Kidder DP, 2007, AIDS BEHAV, V11, pS149, DOI 10.1007/s10461-007-9249-0; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Marsden J, 2009, LANCET, V374, P1262, DOI 10.1016/S0140-6736(09)61420-3; Marshall BDL, 2009, HEALTH PLACE, V15, P783, DOI 10.1016/j.healthplace.2008.12.005; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Mercer D.E., 1999, NIH PUBLICATION; Milby JB, 2005, AM J PUBLIC HEALTH, V95, P1259, DOI 10.2105/AJPH.2004.039743; Milby JB, 1996, DRUG ALCOHOL DEPEN, V43, P39, DOI 10.1016/S0376-8716(96)01286-0; Milby JB, 2000, DRUG ALCOHOL DEPEN, V60, P55, DOI 10.1016/S0376-8716(99)00139-8; Milby JB, 2008, J SUBST ABUSE TREAT, V34, P180, DOI 10.1016/j.jsat.2007.03.003; Morrison DS, 2009, INT J EPIDEMIOL, V38, P877, DOI 10.1093/ije/dyp160; NORTH CS, 2009, SOC PSYCHIAT PSYCHIA; Padgett DK, 2006, RES SOCIAL WORK PRAC, V16, P74, DOI 10.1177/1049731505282593; Palepu A, 1999, J URBAN HEALTH, V76, P409, DOI 10.1007/BF02351499; Palepu A, 2001, CAN MED ASSOC J, V165, P415; Ridgway P, 1990, PSYCHOSOC REHABIL, V13, P20; Sadowski LS, 2009, JAMA-J AM MED ASSOC, V301, P1771, DOI 10.1001/jama.2009.561; Schumacher JE, 2007, J CONSULT CLIN PSYCH, V75, P823, DOI 10.1037/0022-006X.75.5.823; Shelton KH, 2009, PSYCHIAT SERV, V60, P465, DOI 10.1176/appi.ps.60.4.465; Smith PC, 2009, J GEN INTERN MED, V24, P783, DOI 10.1007/s11606-009-0928-6; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Tsemberis S, 2000, PSYCHIATR SERV, V51, P487, DOI 10.1176/appi.ps.51.4.487; Tsemberis SJ, 2003, AM J COMMUN PSYCHOL, V32, P305, DOI 10.1023/B:AJCP.0000004750.66957.bf; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; Urban Health Research Initiative of the British Columbia Centre for Excellence in HIV/AIDS, 2009, DRUG SIT VANC; van Laere IR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-3; *VANC COAST HLTH, VANC COMM ADD SERV; Vuchinich R, 2009, EXP CLIN PSYCHOPHARM, V17, P165, DOI 10.1037/a0015296; Walley AY, 2008, AIDS, V22, P415, DOI 10.1097/QAD.0b013e3282f423f8; WERB D, 2010, DRUG ALCOHO IN PRESS; Wood E, 2001, CAN MED ASSOC J, V165, P405	48	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11697	10.1371/journal.pone.0011697	http://dx.doi.org/10.1371/journal.pone.0011697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657732	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500034
J	Cannon, SB; Ilut, D; Farmer, AD; Maki, SL; May, GD; Singer, SR; Doyle, JJ				Cannon, Steven B.; Ilut, Dan; Farmer, Andrew D.; Maki, Sonja L.; May, Gregory D.; Singer, Susan R.; Doyle, Jeff J.			Polyploidy Did Not Predate the Evolution of Nodulation in All Legumes	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; GENE DUPLICATION; WHOLE-GENOME; PHYLOGENY; DIVERSIFICATION; PALEOPOLYPLOIDY; LEGUMINOSAE; ANGIOSPERMS; SEQUENCES; FAMILY	Background: Several lines of evidence indicate that polyploidy occurred by around 54 million years ago, early in the history of legume evolution, but it has not been known whether this event was confined to the papilionoid subfamily (Papilionoideae; e. g. beans, medics, lupins) or occurred earlier. Determining the timing of the polyploidy event is important for understanding whether polyploidy might have contributed to rapid diversification and radiation of the legumes near the origin of the family; and whether polyploidy might have provided genetic material that enabled the evolution of a novel organ, the nitrogen-fixing nodule. Although symbioses with nitrogen-fixing partners have evolved in several lineages in the rosid I clade, nodules are widespread only in legume taxa, being nearly universal in the papilionoids and in the mimosoid subfamily (e. g., mimosas, acacias) - which diverged from the papilionoid legumes around 58 million years ago, soon after the origin of the legumes. Methodology/Principal Findings: Using transcriptome sequence data from Chamaecrista fasciculata, a nodulating member of the mimosoid clade, we tested whether this species underwent polyploidy within the timeframe of legume diversification. Analysis of gene family branching orders and synonymous-site divergence data from C. fasciculata, Glycine max (soybean), Medicago truncatula, and Vitis vinifera (grape; an outgroup to the rosid taxa) establish that the polyploidy event known from soybean and Medicago occurred after the separation of the mimosoid and papilionoid clades, and at or shortly before the Papilionoideae radiation. Conclusions: The ancestral legume genome was not fundamentally polyploid. Moreover, because there has not been an independent instance of polyploidy in the Chamaecrista lineage there is no necessary connection between polyploidy and nodulation in legumes. Chamaecrista may serve as a useful model in the legumes that lacks a paleopolyploid history, at least relative to the widely studied papilionoid models.	[Cannon, Steven B.] Iowa State Univ, USDA ARS, Corn Insects & Crop Genom Res Unit, Ames, IA 50011 USA; [Ilut, Dan; Doyle, Jeff J.] Cornell Univ, Dept Plant Biol, Ithaca, NY USA; [Farmer, Andrew D.; May, Gregory D.] Natl Ctr Genome Resources, Santa Fe, NM USA; [Maki, Sonja L.; Singer, Susan R.] Carleton Coll, Dept Biol, Northfield, MN 55057 USA	Iowa State University; United States Department of Agriculture (USDA); Cornell University; National Center for Genome Resources (NCGR); Carleton College	Cannon, SB (corresponding author), Iowa State Univ, USDA ARS, Corn Insects & Crop Genom Res Unit, Ames, IA 50011 USA.	steven.cannon@ars.usda.gov		Ilut, Daniel/0000-0001-7497-9109	National Science Foundation [DEB-0746571, DUE-0837375]	National Science Foundation(National Science Foundation (NSF))	Supported by the National Science Foundation (grants DEB-0746571 and DUE-0837375). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bertioli DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-45; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Bruneau A, 2008, BOTANY, V86, P697, DOI 10.1139/B08-058; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Cannon SB, 2009, PLANT PHYSIOL, V151, P970, DOI 10.1104/pp.109.144659; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Doyle JJ, 1997, AM J BOT, V84, P541, DOI 10.2307/2446030; DOYLE JJ, 1994, ANNU REV ECOL SYST, V25, P325; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Foster CM, 1998, PLANT SOIL, V205, P103, DOI 10.1023/A:1004309414388; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; James EK, 1999, NEW PHYTOL, V142, P219, DOI 10.1046/j.1469-8137.1999.00394.x; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kenicer G, 2005, ENDINB J BOT, V62, P195; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kistner C, 2002, TRENDS PLANT SCI, V7, P511, DOI 10.1016/S1360-1385(02)02356-7; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lee A, 2006, PLANT SIGNAL BEHAV, V1, P161, DOI 10.4161/psb.1.4.3143; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Mathesius U, 2000, MOL PLANT MICROBE IN, V13, P617, DOI 10.1094/MPMI.2000.13.6.617; MGSC, 2007, MED TRUNC GEN MT2 0; Mudge J, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-15; NAISBITT T, 1992, NEW PHYTOL, V122, P487, DOI 10.1111/j.1469-8137.1992.tb00077.x; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nelson MN, 2006, THEOR APPL GENET, V113, P225, DOI 10.1007/s00122-006-0288-0; OHRI D, 1986, PLANT SYST EVOL, V153, P223, DOI 10.1007/BF00983689; Pennington RT, 2001, SYST BOT, V26, P537; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Ravi V, 2007, MOL PHYLOGENET EVOL, V44, P488, DOI 10.1016/j.ympev.2006.11.014; Sanderson MJ, 2004, AM J BOT, V91, P1656, DOI 10.3732/ajb.91.10.1656; Schlueter JA, 2004, GENOME, V47, P868, DOI [10.1139/g04-047, 10.1139/G04-047]; Schlueter JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-330; SCHMUTZ J, 2009, NATURE IN PRESS; Singer SR, 2009, PLANT PHYSIOL, V151, P1041, DOI 10.1104/pp.109.144774; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Sprent J.I., 2009, LEGUME NODULATION GL; Sprent JI, 2007, NEW PHYTOL, V174, P11, DOI 10.1111/j.1469-8137.2007.02015.x; Stamatakis A, 2008, PHILOS T R SOC B, V363, P3977, DOI 10.1098/rstb.2008.0163; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; TRINICK MJ, 1989, APPL ENVIRON MICROB, V55, P2046, DOI 10.1128/AEM.55.8.2046-2055.1989; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wikstrom N, 2003, SYST ASSOC SPEC VOL, P142; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846	56	57	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11630	10.1371/journal.pone.0011630	http://dx.doi.org/10.1371/journal.pone.0011630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661290	gold, Green Published, Green Submitted			2022-12-27	WOS:000279980800018
J	Hewitt, CA; Ling, KH; Merson, TD; Simpson, KM; Ritchie, ME; King, SL; Pritchard, MA; Smyth, GK; Thomas, T; Scott, HS; Voss, AK				Hewitt, Chelsee A.; Ling, King-Hwa; Merson, Tobias D.; Simpson, Ken M.; Ritchie, Matthew E.; King, Sarah L.; Pritchard, Melanie A.; Smyth, Gordon K.; Thomas, Tim; Scott, Hamish S.; Voss, Anne K.			Gene Network Disruptions and Neurogenesis Defects in the Adult Ts1Cje Mouse Model of Down Syndrome	PLOS ONE			English	Article							TRISOMY 16 MOUSE; HIGH-RESOLUTION MRI; NEURAL STEM-CELL; TS65DN MICE; IN-VIVO; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; BEHAVIORAL ABNORMALITIES; NEURONAL MIGRATION; MAMMALIAN BRAIN	Background: Down syndrome (DS) individuals suffer mental retardation with further cognitive decline and early onset Alzheimer's disease. Methodology/Principal Findings: To understand how trisomy 21 causes these neurological abnormalities we investigated changes in gene expression networks combined with a systematic cell lineage analysis of adult neurogenesis using the Ts1Cje mouse model of DS. We demonstrated down regulation of a number of key genes involved in proliferation and cell cycle progression including Mcm7, Brca2, Prim1, Cenpo and Aurka in trisomic neurospheres. We found that trisomy did not affect the number of adult neural stem cells but resulted in reduced numbers of neural progenitors and neuroblasts. Analysis of differentiating adult Ts1Cje neural progenitors showed a severe reduction in numbers of neurons produced with a tendency for less elaborate neurites, whilst the numbers of astrocytes was increased. Conclusions/Significance: We have shown that trisomy affects a number of elements of adult neurogenesis likely to result in a progressive pathogenesis and consequently providing the potential for the development of therapies to slow progression of, or even ameliorate the neuronal deficits suffered by DS individuals.	[Hewitt, Chelsee A.; Ling, King-Hwa; Merson, Tobias D.; Simpson, Ken M.; Ritchie, Matthew E.; King, Sarah L.; Smyth, Gordon K.; Thomas, Tim; Scott, Hamish S.; Voss, Anne K.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Thomas, Tim; Voss, Anne K.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Hewitt, Chelsee A.] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic, Australia; [Ling, King-Hwa; Scott, Hamish S.] Univ Adelaide, Sch Med, Dept Mol Pathol, Ctr Canc Biol,Inst Med & Vet Sci, Adelaide, SA, Australia; [Ling, King-Hwa; Scott, Hamish S.] Univ Adelaide, Sch Med, Hanson Inst, SA Pathol, Adelaide, SA, Australia; [Ling, King-Hwa; Scott, Hamish S.] Univ Adelaide, Sch Med, Adelaide Canc Res Inst, Adelaide, SA, Australia; [Pritchard, Melanie A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Ling, King-Hwa] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Serdang, Malaysia	Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Centre for Cancer Biology; Institute Medical & Veterinary Science Australia; University of Adelaide; Hanson Institute; SA Pathology; University of Adelaide; University of Adelaide; Monash University; Universiti Putra Malaysia	Hewitt, CA (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	Chelsee.Hewitt@Petermac.org; hamish.scott@health.sa.gov.au	Ritchie, Matthew/I-3874-2019; Smyth, Gordon/B-5276-2008; Ling, King-Hwa/M-2349-2018; Voss, Anne K/F-5110-2013; Merson, Tobias D/D-5375-2015; Scott, Hamish/B-2122-2009	Ritchie, Matthew/0000-0002-7383-0609; Smyth, Gordon/0000-0001-9221-2892; Ling, King-Hwa/0000-0002-3968-7263; Voss, Anne K/0000-0002-3853-9381; Merson, Tobias D/0000-0002-7246-3608; Scott, Hamish/0000-0002-5813-631X; Thomas, Tim/0000-0002-7623-8344; Hewitt, Chelsee/0000-0001-7472-6128	APEX Foundation for Research into Intellectual Disability Limited; National Health and Medical Research Council [171601, 461204, 575512, 219176, 257501, 257529]; Melbourne International Fee Remission Scholarship (MIFRS); Universiti Putra Malaysia Staff Training Scholarship (UPMSTS); Adelaide Fee Scholarship International (AFSI)	APEX Foundation for Research into Intellectual Disability Limited; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Melbourne International Fee Remission Scholarship (MIFRS); Universiti Putra Malaysia Staff Training Scholarship (UPMSTS); Adelaide Fee Scholarship International (AFSI)	This work was supported by the APEX Foundation for Research into Intellectual Disability Limited to C. H.; National Health and Medical Research Council fellowships 171601 and 461204 to H. S. S. and 575512 to A. K. V.; National Health and Medical Research Council Grants 219176, 257501 and 257529 to H. S. S. and G. K. S. K.-H. L. was a recipient of Melbourne International Fee Remission Scholarship (MIFRS) and Universiti Putra Malaysia Staff Training Scholarship (UPMSTS), and an Adelaide Fee Scholarship International (AFSI) equivalent award. The microarrays were performed by the Australian Genome Research Facility, which was established through the Commonwealth-funded Major National Research Facilities program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, J ANAT, V80, P37; Anderson L, 2007, EXP NEUROL, V204, P512, DOI 10.1016/j.expneurol.2006.12.025; Antonarakis SE, 2006, TRENDS MOL MED, V12, P473, DOI 10.1016/j.molmed.2006.08.005; Aylward EH, 1999, AM J PSYCHIAT, V156, P564; Aylward EH, 1997, ARCH NEUROL-CHICAGO, V54, P209, DOI 10.1001/archneur.1997.00550140077016; Bahn S, 2002, LANCET, V359, P310, DOI 10.1016/S0140-6736(02)07497-4; BECKER L, 1991, PROG CLIN BIOL RES, V373, P133; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bersu ET, 1998, DEV BRAIN RES, V109, P115, DOI 10.1016/S0165-3806(98)00070-4; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; CASERTA MT, 1990, MOL BRAIN RES, V7, P269, DOI 10.1016/0169-328X(90)90037-E; Caviness VS, 2003, CEREB CORTEX, V13, P592, DOI 10.1093/cercor/13.6.592; Chakrabarti L, 2007, J NEUROSCI, V27, P11483, DOI 10.1523/JNEUROSCI.3406-07.2007; Chapman RS, 2000, MENT RETARD DEV D R, V6, P84, DOI 10.1002/1098-2779(2000)6:2<84::AID-MRDD2>3.3.CO;2-G; Chen WM, 2004, GENET EPIDEMIOL, V26, P265, DOI 10.1002/gepi.10315; Clark S, 2006, EXP NEUROL, V200, P256, DOI 10.1016/j.expneurol.2006.02.005; Contestabile A, 2007, HIPPOCAMPUS, V17, P665, DOI 10.1002/hipo.20308; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Crane R, 2004, BIOL CELL, V96, P215, DOI 10.1016/j.biolcel.2003.09.008; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; de Graaf K, 2004, J BIOL CHEM, V279, P4612, DOI 10.1074/jbc.M310794200; DELAMONTE SM, 1990, J NEUROPATH EXP NEUR, V49, P509, DOI 10.1097/00005072-199009000-00006; Demas GE, 1998, BEHAV BRAIN RES, V90, P199, DOI 10.1016/S0166-4328(97)00116-2; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dierssen M, 2003, CEREB CORTEX, V13, P758, DOI 10.1093/cercor/13.7.758; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Escorihuela RM, 1998, NEUROSCI LETT, V247, P171, DOI 10.1016/S0304-3940(98)00317-6; ESCORIHUELA RM, 1995, NEUROSCI LETT, V199, P143, DOI 10.1016/0304-3940(95)12052-6; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; FERRER I, 1990, ACTA NEUROPATHOL, V79, P680, DOI 10.1007/BF00294247; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; FLOREZ J, 1992, BIOMEDICAL CONCERNS, P159; GEARHART JD, 1986, BRAIN RES BULL, V16, P789, DOI 10.1016/0361-9230(86)90075-4; GOLDEN JA, 1994, J NEUROPATH EXP NEUR, V53, P513, DOI 10.1097/00005072-199409000-00011; Granholm AC, 2003, HIPPOCAMPUS, V13, P905, DOI 10.1002/hipo.10130; Granholm ACE, 2000, EXP NEUROL, V161, P647, DOI 10.1006/exnr.1999.7289; GRAUSZ H, 1991, PROG CLIN BIOL RES, V373, P169; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Guidi S, 2008, BRAIN PATHOL, V18, P180, DOI 10.1111/j.1750-3639.2007.00113.x; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Haydar TF, 1996, J NEUROSCI, V16, P6175; Haydar TF, 2000, J NEUROSCI, V20, P4156; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Hori T, 2008, MOL BIOL CELL, V19, P843, DOI 10.1091/mbc.E07-06-0556; Hyde LA, 2002, BRAIN RES, V945, P26, DOI 10.1016/S0006-8993(02)02500-3; Hyde LA, 2001, BEHAV BRAIN RES, V118, P53, DOI 10.1016/S0166-4328(00)00313-2; ISHIHARA K, 2009, CEREB CORTEX ADV ACC; JERNIGAN TL, 1993, ARCH NEUROL-CHICAGO, V50, P186, DOI 10.1001/archneur.1993.00540020062019; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; LACEYCASEM ML, 1994, CRIT REV NEUROBIOL, V8, P293; Langaas M, 2005, J ROY STAT SOC B, V67, P555, DOI 10.1111/j.1467-9868.2005.00515.x; Lockrow J, 2009, EXP NEUROL, V216, P278, DOI 10.1016/j.expneurol.2008.11.021; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lorenzi HA, 2006, BRAIN RES, V1104, P153, DOI 10.1016/j.brainres.2006.05.022; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Machon O, 2005, MOL CELL NEUROSCI, V30, P388, DOI 10.1016/j.mcn.2005.08.003; MARINPADILLA M, 1976, J COMP NEUROL, V167, P63, DOI 10.1002/cne.901670105; Merson TD, 2006, J NEUROSCI, V26, P11359, DOI 10.1523/JNEUROSCI.2247-06.2006; Moldrich RX, 2009, J NEUROSCI RES, V87, P3143, DOI 10.1002/jnr.22131; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; ORourke NA, 1996, NEURON, V16, P1061, DOI 10.1016/S0896-6273(00)80130-0; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Pace R, 2006, CLAVIER, V45, P2; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Patterson D, 2009, HUM GENET, V126, P195, DOI 10.1007/s00439-009-0696-8; Pinter JD, 2001, AM J PSYCHIAT, V158, P1659, DOI 10.1176/appi.ajp.158.10.1659; Pinter JD, 2001, NEUROLOGY, V56, P972, DOI 10.1212/WNL.56.7.972; RAZ N, 1995, NEUROLOGY, V45, P356, DOI 10.1212/WNL.45.2.356; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; REEVES RH, 1986, BRAIN RES BULL, V16, P803, DOI 10.1016/0361-9230(86)90076-6; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Richtsmeier JT, 2002, AM J MED GENET, V107, P317, DOI 10.1002/ajmg.10175; Richtsmeier JT, 2000, DEV DYNAM, V217, P137, DOI 10.1002/(SICI)1097-0177(200002)217:2<137::AID-DVDY1>3.0.CO;2-N; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; Rueda N, 2008, NEUROSCI LETT, V433, P22, DOI 10.1016/j.neulet.2007.12.039; Rueda N, 2005, NEUROSCI LETT, V380, P197, DOI 10.1016/j.neulet.2005.01.039; Sago H, 2000, PEDIATR RES, V48, P606, DOI 10.1203/00006450-200011000-00009; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Santa-Olalla J, 2003, EUR J NEUROSCI, V18, P1073, DOI 10.1046/j.1460-9568.2003.02824.x; SCHMIDTSIDOR B, 1990, CLIN NEUROPATHOL, V9, P181; SHIRATORI A, 1995, GENOMICS, V28, P350, DOI 10.1006/geno.1995.1155; Silverman W, 2007, MENT RETARD DEV D R, V13, P228, DOI 10.1002/mrdd.20156; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; SYLVESTER PE, 1983, J MENT DEFIC RES, V27, P227; TAKAHASHI T, 1992, J NEUROCYTOL, V21, P185, DOI 10.1007/BF01194977; TAKASHIMA S, 1989, BRAIN DEV-JPN, V11, P131, DOI 10.1016/S0387-7604(89)80082-8; THOMAS T, 1993, DEVELOPMENT, V117, P253; Thomas T, 2000, DEVELOPMENT, V127, P2537; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Voss AK, 2000, DEVELOPMENT, V127, P5449; Voss AK, 2006, EMBO J, V25, P3652, DOI 10.1038/sj.emboj.7601234; Weitzdoerfer R, 2001, J NEURAL TRANSM-SUPP, P59; Winter TC, 2000, RADIOLOGY, V214, P533, DOI 10.1148/radiology.214.2.r00fe40533; WISNIEWSKI KE, 1990, AM J MED GENET, P274; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	110	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11561	10.1371/journal.pone.0011561	http://dx.doi.org/10.1371/journal.pone.0011561			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661276	Green Published, gold			2022-12-27	WOS:000279980800001
J	Berry, AS; Zanto, TP; Clapp, WC; Hardy, JL; Delahunt, PB; Mahncke, HW; Gazzaley, A				Berry, Anne S.; Zanto, Theodore P.; Clapp, Wesley C.; Hardy, Joseph L.; Delahunt, Peter B.; Mahncke, Henry W.; Gazzaley, Adam			The Influence of Perceptual Training on Working Memory in Older Adults	PLOS ONE			English	Article							VISUAL-EVOKED POTENTIALS; AGE-RELATED-CHANGES; MOTION ADAPTATION; SPATIAL-FREQUENCY; TIME-COURSE; ORIENTATION; DISCRIMINATION; SPECIFICITY; IMPROVEMENT; ATTENTION	Normal aging is associated with a degradation of perceptual abilities and a decline in higher-level cognitive functions, notably working memory. To remediate age-related deficits, cognitive training programs are increasingly being developed. However, it is not yet definitively established if, and by what mechanisms, training ameliorates effects of cognitive aging. Furthermore, a major factor impeding the success of training programs is a frequent failure of training to transfer benefits to untrained abilities. Here, we offer the first evidence of direct transfer-of-benefits from perceptual discrimination training to working memory performance in older adults. Moreover, using electroencephalography to evaluate participants before and after training, we reveal neural evidence of functional plasticity in older adult brains, such that training-induced modifications in early visual processing during stimulus encoding predict working memory accuracy improvements. These findings demonstrate the strength of the perceptual discrimination training approach by offering clear psychophysical evidence of transfer-of-benefit and a neural mechanism underlying cognitive improvement.	[Berry, Anne S.; Zanto, Theodore P.; Clapp, Wesley C.; Gazzaley, Adam] Univ Calif San Francisco, Dept Neurol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Berry, Anne S.; Zanto, Theodore P.; Clapp, Wesley C.; Gazzaley, Adam] Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Hardy, Joseph L.; Delahunt, Peter B.; Mahncke, Henry W.] Posit Sci Corp, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Berry, AS (corresponding author), Univ Calif San Francisco, Dept Neurol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	adam.gazzaley@ucsf.edu		Berry, Anne/0000-0002-5086-3643	Posit Science; National Institutes of Health [R01 AG030395]; NATIONAL INSTITUTE ON AGING [R01AG030395] Funding Source: NIH RePORTER	Posit Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from Posit Science (www.positscience.com) and the National Institutes of Health R01 AG030395. Authors J.L.H., P.B.D., and H.W.M. are or were employees of Posit Science Corporation. The funders had a role in study design and data collection. The funders did not decide to publish or prepare the manuscript.	Ahlfors SP, 1999, J NEUROPHYSIOL, V82, P2545, DOI 10.1152/jn.1999.82.5.2545; Alain C, 2001, J ACOUST SOC AM, V109, P2211, DOI 10.1121/1.1367243; Alain C, 2008, CLIN NEUROPHYSIOL, V119, P356, DOI 10.1016/j.clinph.2007.10.024; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Bach M, 2000, VISION RES, V40, P2379, DOI 10.1016/S0042-6989(00)00106-1; BALL K, 1987, VISION RES, V27, P953, DOI 10.1016/0042-6989(87)90011-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berry A. S., 2009, J NEUROPHYSIOL; Berry AS, 2009, J NEUROPHYSIOL, V102, P1779, DOI 10.1152/jn.00179.2009; Bundo M, 2000, HUM BRAIN MAPP, V11, P33, DOI 10.1002/1097-0193(200009)11:1<33::AID-HBM30>3.3.CO;2-3; CLAPP WC, 2009, CEREB CORTEX; CRAIK FI, 2000, HDB AGING COGNTION, V2; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; Ding YL, 2003, NEUROREPORT, V14, P587, DOI 10.1097/00001756-200303240-00012; Doniger Glen M., 2005, Current Alzheimer Research, V2, P117; Dwolatzky Tzvi, 2003, BMC Geriatr, V3, P4, DOI 10.1186/1471-2318-3-4; Fahle M, 1997, NEUROPSYCHOLOGIA, V35, P1583, DOI 10.1016/S0028-3932(97)00069-9; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; FAHLE M, 1997, NEUROPSYCHOLOGIA, V12; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; FIORENTINI A, 1981, VISION RES, V21, P1149, DOI 10.1016/0042-6989(81)90017-1; Gazzaley A, 2008, P NATL ACAD SCI USA, V105, P13122, DOI 10.1073/pnas.0806074105; GILBERT CD, 1994, P NATL ACAD SCI USA, V91, P1195, DOI 10.1073/pnas.91.4.1195; Heinrich SP, 2004, J VISION, V4, P469, DOI 10.1167/4.6.6; Hoffmann M, 1999, VISION RES, V39, P437, DOI 10.1016/S0042-6989(98)00186-2; Hoffmann MB, 2001, VISION RES, V41, P2187, DOI 10.1016/S0042-6989(01)00112-2; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KINGSMITH PE, 1994, VISION RES, V34, P885, DOI 10.1016/0042-6989(94)90039-6; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Maurer JP, 2003, EXP BRAIN RES, V151, P536, DOI 10.1007/s00221-003-1509-2; Mercier M, 2009, EUR J NEUROSCI, V29, P424, DOI 10.1111/j.1460-9568.2008.06583.x; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Mukai I, 2007, J NEUROSCI, V27, P11401, DOI 10.1523/JNEUROSCI.3002-07.2007; Nacke LE, 2009, CYBERPSYCHOL BEHAV, V12, P493, DOI 10.1089/cpb.2009.0013; RAMACHANDRAN VS, 1973, PERCEPTION, V2, P371, DOI 10.1068/p020371; RUTMAN AM, J COGN NEUROSCI, V22, P1224; Schneider B.A., 2000, HDB AGING COGNITION, P155; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Sigman M, 2000, NAT NEUROSCI, V3, P264, DOI 10.1038/72979; VAINA LM, 1995, COGNITIVE BRAIN RES, V2, P155, DOI 10.1016/0926-6410(95)90004-7; WIGFIELD R, 1994, EARLY HUM DEV, V38, P161, DOI 10.1016/0378-3782(94)90208-9; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; Zanto TP, 2010, NEUROPSYCHOLOGIA, V48, P13, DOI 10.1016/j.neuropsychologia.2009.08.003	47	150	159	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11537	10.1371/journal.pone.0011537	http://dx.doi.org/10.1371/journal.pone.0011537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625HA	20644719	Green Published, gold, Green Submitted			2022-12-27	WOS:000279884900007
J	Jaidee, W; Moher, D; Laopaiboon, M				Jaidee, Wanlop; Moher, David; Laopaiboon, Malinee			Time to Update and Quantitative Changes in the Results of Cochrane Pregnancy and Childbirth Reviews	PLOS ONE			English	Review							SYSTEMATIC REVIEWS	Background: The recommended interval between updates for systematic reviews included in The Cochrane Library is 2 years. However, it is unclear whether this interval is always appropriate. Whereas excessive updating wastes time and resources, insufficient updating allows out-of-date or incomplete evidence to guide clinical decision-making. We set out to determine, for Cochrane pregnancy and childbirth reviews, the frequency of updates, factors associated with updating, and whether updating frequency was appropriate. Methodology/Principal Findings: Cochrane pregnancy and childbirth reviews published in Issue 3, 2007 of the Cochrane Database of Systematic Reviews were retrieved, and data were collected from their original and updated versions. Quantitative changes were determined for one of the primary outcomes (mortality, or the outcome of greatest clinical significance). Potential factors associated with time to update were assessed using the Cox proportional hazard model. Among the 101 reviews in our final sample, the median time before the first update was 3.3 years (95% CI 2.7-3.8). Only 32.7% had been updated within the recommended interval of 2 years. In 75.3% (76/101), a median of 3 new trials with a median of 576 additional participants were included in the updated versions. There were quantitative changes in 71% of the reviews that included new trials (54/76): the median change in effect size was 18.2%, and the median change in 95% CI width was 30.8%. Statistical significance changed in 18.5% (10/54) of these reviews, but conclusions were revised in only 3.7% (2/54). A shorter time to update was associated with the same original review team at updating. Conclusions/Significance: Most reviews were updated less frequently than recommended by Cochrane policy, but few updates had revised conclusions. Prescribed time to update should be reconsidered to support improved decision-making while making efficient use of limited resources.	[Jaidee, Wanlop] Burapha Univ, Fac Publ Hlth, Dept Publ Hlth Fdn, Chon Buri, Thailand; [Moher, David] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Fac Med, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Laopaiboon, Malinee] Khon Kaen Univ, Fac Publ Hlth, Dept Biostat & Demog, Khon Kaen, Thailand	Burapha University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Khon Kaen University	Jaidee, W (corresponding author), Burapha Univ, Fac Publ Hlth, Dept Publ Hlth Fdn, Chon Buri, Thailand.	dmoher@ohri.ca; malinee@kku.ac.th		Moher, David/0000-0003-2434-4206	Higher Educational Strategic Scholarships for Frontier Research Network; Commission on Higher Education, Thailand	Higher Educational Strategic Scholarships for Frontier Research Network; Commission on Higher Education, Thailand(Office of Higher Education Commission (OHEC))	Wanlop Jaidee was supported by a grant under the Higher Educational Strategic Scholarships for Frontier Research Network, the Commission on Higher Education, Thailand, to do the PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASTIAN H, 2003, P 11 COCHR C EV HLTH; CHALMERS I, 1994, BMJ-BRIT MED J, V309, P862, DOI 10.1136/bmj.309.6958.862; Cleves MA, 2002, INTRO SURVIVAL ANAL; *DEP EC SOC AFF, 2009, WORLD EC SOC SURV 20; French Simon D, 2005, BMC Med Res Methodol, V5, P33, DOI 10.1186/1471-2288-5-33; HENDERSON S, 2006, P 14 COCH C DUBL IR; HIGGINS J, 1999, SHOULD WE INTERPRET; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; *LIV WOM NHS FDN T, 2007, COCHR PREGN CHILDB G; Moher D, 2006, LANCET, V367, P881, DOI 10.1016/S0140-6736(06)68358-X; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; Shojania K G, 2001, Eff Clin Pract, V4, P157; Shojania KG, 2007, ANN INTERN MED, V147, P224, DOI 10.7326/0003-4819-147-4-200708210-00179; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Stead L F, 2001, BMC Med Res Methodol, V1, P10, DOI 10.1186/1471-2288-1-10; INTRO COCHRANE PREGN; COCHRANE LIB PREGNAN	18	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11553	10.1371/journal.pone.0011553	http://dx.doi.org/10.1371/journal.pone.0011553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644625	gold, Green Published, Green Submitted			2022-12-27	WOS:000279822300009
J	Marselli, L; Thorne, J; Dahiya, S; Sgroi, DC; Sharma, A; Bonner-Weir, S; Marchetti, P; Weir, GC				Marselli, Lorella; Thorne, Jeffrey; Dahiya, Sonika; Sgroi, Dennis C.; Sharma, Arun; Bonner-Weir, Susan; Marchetti, Piero; Weir, Gordon C.			Gene Expression Profiles of Beta-Cell Enriched Tissue Obtained by Laser Capture Microdissection from Subjects with Type 2 Diabetes	PLOS ONE			English	Article							PANCREATIC-ISLETS; ENDOPLASMIC-RETICULUM; GLUCOSE-TOLERANCE; TRANSCRIPTIONAL REGULATION; INSULIN-SECRETION; GROWTH-REGULATION; PROTEIN; STRESS; APOPTOSIS; DYSFUNCTION	Background: Changes in gene expression in pancreatic beta-cells from type 2 diabetes (T2D) should provide insights into their abnormal insulin secretion and turnover. Methodology/Principal Findings: Frozen sections were obtained from cadaver pancreases of 10 control and 10 T2D human subjects. Beta-cell enriched samples were obtained by laser capture microdissection (LCM). RNA was extracted, amplified and subjected to microarray analysis. Further analysis was performed with DNA-Chip Analyzer (dChip) and Gene Set Enrichment Analysis (GSEA) software. There were changes in expression of genes linked to glucotoxicity. Evidence of oxidative stress was provided by upregulation of several metallothionein genes. There were few changes in the major genes associated with cell cycle, apoptosis or endoplasmic reticulum stress. There was differential expression of genes associated with pancreatic regeneration, most notably upregulation of members of the regenerating islet gene (REG) family and metalloproteinase 7 (MMP7). Some of the genes found in GWAS studies to be related to T2D were also found to be differentially expressed. IGF2BP2, TSPAN8, and HNF1B (TCF2) were upregulated while JAZF1 and SLC30A8 were downregulated. Conclusions/Significance: This study made possible by LCM has identified many novel changes in gene expression that enhance understanding of the pathogenesis of T2D.	[Marselli, Lorella; Thorne, Jeffrey; Sharma, Arun; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol,Res Div, Boston, MA 02115 USA; [Marselli, Lorella; Thorne, Jeffrey; Sharma, Arun; Bonner-Weir, Susan; Weir, Gordon C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Dahiya, Sonika; Sgroi, Dennis C.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Mol Pathol Unit, Boston, MA 02115 USA; [Marchetti, Piero] Univ Pisa, Dept Endocrinol & Metab, Sect Endocrinol & Metab Organ Transplantat, Pisa, Italy	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Pisa	Marselli, L (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol,Res Div, Boston, MA 02115 USA.	gordon.weir@joslin.harvard.edu	Marchetti, Piero/J-7439-2013; Dahiya, Sonika/J-8359-2019; Matýsek, Dalibor/N-1737-2018; Sgroi, Dennis/AAV-2487-2021	Marchetti, Piero/0000-0003-4907-0635; Dahiya, Sonika/0000-0002-5585-0964; Matýsek, Dalibor/0000-0002-1412-1079; Marselli, Lorella/0000-0002-6698-2962; Thorne, Jeffrey/0000-0002-1937-4315; Bonner-Weir, Susan/0000-0003-4682-0656	American Diabetes Association; Juvenile Diabetes Research Foundation; National Institutes of Health, Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center [RO1 DK66056, P30 DK36836]; Diabetes Research and Wellness Foundation; European Community; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK066056] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health, Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Wellness Foundation; European Community(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from the American Diabetes Association, the Juvenile Diabetes Research Foundation, the National Institutes of Health (RO1 DK66056 and P30 DK36836 - the Advanced Microscopy, Bioinformatics, and Genomics Cores of Joslin Diabetes and Endocrinology Research Center), the Diabetes Research and Wellness Foundation and the European Community (EURODIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelli S, 2004, DIABETES, V53, P2815, DOI 10.2337/diabetes.53.11.2815; Boni-Schnetzler M, 2008, J CLIN ENDOCR METAB, V93, P4065, DOI 10.1210/jc.2008-0396; Bottino R, 2004, DIABETES, V53, P2559, DOI 10.2337/diabetes.53.10.2559; BRUNZELL JD, 1976, J CLIN ENDOCR METAB, V42, P222, DOI 10.1210/jcem-42-2-222; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; CLARK A, 1988, DIABETES RES CLIN EX, V9, P151; Cnop M, 2010, DIABETOLOGIA, V53, P321, DOI 10.1007/s00125-009-1562-x; Del Guerra S, 2005, DIABETES, V54, P727, DOI 10.2337/diabetes.54.3.727; Delghingaro-Augusto V, 2009, DIABETOLOGIA, V52, P1122, DOI 10.1007/s00125-009-1317-8; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Di Candia S, 2009, EUR J ENDOCRINOL, V160, P1019, DOI 10.1530/EJE-08-0945; Dodge R, 2009, DIFFERENTIATION, V77, P135, DOI 10.1016/j.diff.2008.09.015; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Ferrannini E, 2005, J CLIN ENDOCR METAB, V90, P493, DOI 10.1210/jc.2004-1133; Fong KW, 2009, MOL BIOL CELL, V20, P3660, DOI 10.1091/mbc.E09-01-0009; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hashimoto O, 2006, BIOCHEM BIOPH RES CO, V341, P416, DOI 10.1016/j.bbrc.2005.12.205; Hemers E, 2005, CANCER RES, V65, P7363, DOI 10.1158/0008-5472.CAN-05-0157; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Inoue KI, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/101659; Jiang Y, 2008, DIABETES, V57, P2718, DOI 10.2337/db08-0170; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kalabis J, 2008, AM J PHYSIOL-GASTR L, V295, pG1182, DOI 10.1152/ajpgi.90294.2008; Katsuta H, 2010, DIABETOLOGIA, V53, P128, DOI 10.1007/s00125-009-1570-x; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Laybutt DR, 2003, J BIOL CHEM, V278, P2997, DOI 10.1074/jbc.M210581200; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Laybutt DR, 2002, DIABETES, V51, P413, DOI 10.2337/diabetes.51.2.413; Lee SH, 2008, EXP DIABETES RES, DOI 10.1155/2008/728763; Levetan Claresa S, 2008, Endocr Pract, V14, P1075; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lieu HT, 2005, HEPATOLOGY, V42, P618, DOI 10.1002/hep.20845; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006558; Lipson KL, 2006, CELL METAB, V4, P245, DOI 10.1016/j.cmet.2006.07.007; Liu ZB, 2009, BIOCHEM BIOPH RES CO, V386, P703, DOI 10.1016/j.bbrc.2009.06.100; MacDonald MJ, 2009, DIABETOLOGIA, V52, P1087, DOI 10.1007/s00125-009-1319-6; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MACLEAN N, 1955, Diabetes, V4, P367; MALOY AL, 1981, HUM PATHOL, V12, P917, DOI 10.1016/S0046-8177(81)80197-9; Marchetti P, 2004, J CLIN ENDOCR METAB, V89, P5535, DOI 10.1210/jc.2004-0150; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Marselli L, 2008, J CLIN ENDOCR METAB, V93, P1046, DOI 10.1210/jc.2007-0931; Marselli L, 2009, METHODS MOL BIOL, V560, P87, DOI 10.1007/978-1-59745-448-3_8; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Okamoto H, 2002, DIABETES, V51, pS462, DOI 10.2337/diabetes.51.2007.S462; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pechhold S, 2009, NAT BIOTECHNOL, V27, P1038, DOI 10.1038/nbt.1579; Planas R, 2006, DIABETOLOGIA, V49, P2379, DOI 10.1007/s00125-006-0365-6; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rosengren AH, 2010, SCIENCE, V327, P217, DOI 10.1126/science.1176827; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sarkar SA, 2009, DIABETOLOGIA, V52, P1092, DOI 10.1007/s00125-009-1331-x; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Sekiya T, 2004, BIOCHEM BIOPH RES CO, V320, P680, DOI 10.1016/j.bbrc.2004.06.017; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TERAZONO K, 1988, J BIOL CHEM, V263, P2111; Theys N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006110; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Unno M, 2002, DIABETES, V51, pS478, DOI 10.2337/diabetes.51.2007.S478; Wei Q, 2008, LUNG CANCER, V62, P181, DOI 10.1016/j.lungcan.2008.06.018; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652; Xu J, 2008, DIABETOLOGIA, V51, P2281, DOI 10.1007/s00125-008-1155-0; Yanagisawa N, 2005, FEMS IMMUNOL MED MIC, V44, P197, DOI 10.1016/j.femsim.2004.11.009; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhou J, 2007, J BIOL CHEM, V282, P7482, DOI 10.1074/jbc.M608289200	79	201	209	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11499	10.1371/journal.pone.0011499	http://dx.doi.org/10.1371/journal.pone.0011499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644627	Green Published, gold, Green Submitted			2022-12-27	WOS:000279822300003
J	Scoglio, C; Schumm, W; Schumm, P; Easton, T; Chowdhury, SR; Sydney, A; Youssef, M				Scoglio, Caterina; Schumm, Walter; Schumm, Phillip; Easton, Todd; Chowdhury, Sohini Roy; Sydney, Ali; Youssef, Mina			Efficient Mitigation Strategies for Epidemics in Rural Regions	PLOS ONE			English	Article								Containing an epidemic at its origin is the most desirable mitigation. Epidemics have often originated in rural areas, with rural communities among the first affected. Disease dynamics in rural regions have received limited attention, and results of general studies cannot be directly applied since population densities and human mobility factors are very different in rural regions from those in cities. We create a network model of a rural community in Kansas, USA, by collecting data on the contact patterns and computing rates of contact among a sampled population. We model the impact of different mitigation strategies detecting closely connected groups of people and frequently visited locations. Within those groups and locations, we compare the effectiveness of random and targeted vaccinations using a Susceptible-Exposed-Infected-Recovered compartmental model on the contact network. Our simulations show that the targeted vaccinations of only 10% of the sampled population reduced the size of the epidemic by 34.5%. Additionally, if 10% of the population visiting one of the most popular locations is randomly vaccinated, the epidemic size is reduced by 19%. Our results suggest a new implementation of a highly effective strategy for targeted vaccinations through the use of popular locations in rural communities.	[Scoglio, Caterina; Schumm, Phillip; Chowdhury, Sohini Roy; Sydney, Ali; Youssef, Mina] Kansas State Univ, Dept Elect & Comp Engn, K State EpiCtr, Manhattan, KS 66506 USA; [Schumm, Walter] Kansas State Univ, Dept Family Studies & Human Sci, Manhattan, KS 66506 USA; [Easton, Todd] Kansas State Univ, Dept Ind & Mfg Syst Engn, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Scoglio, C (corresponding author), Kansas State Univ, Dept Elect & Comp Engn, K State EpiCtr, Manhattan, KS 66506 USA.	caterina@ksu.edu	Schumm, Walter/H-5051-2019; Schumm, Walter/AAF-4347-2020	Schumm, Walter/0000-0003-3097-3551; Easton, Todd/0000-0001-9278-0259; Scoglio, Caterina/0000-0003-4486-9229	National Science Foundation [0841112]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation - Award Number 0841112 SGER: Exploratory research on complex network approach to epidemic spreading in rural regions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Boguna M, 2003, LECT NOTES PHYS, V625, P127; Casey MM, 2001, AM J PREV MED, V21, P182, DOI 10.1016/S0749-3797(01)00349-X; Centers for Disease Control and Prevention, 2009, H1N1 FLU INT SIT UPD; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gallos LK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045104; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; NEWMAN MEJ, 2006, PNAS US, V103; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; [Перминов В.Д. Perminov V.D.], 2007, [Математическое моделирование, Mathematical Models and Computer Simulations, Matematicheskoe modelirovanie], V19, P116; RETAILLIAU HF, 1979, AM J EPIDEMIOL, V109, P639, DOI 10.1093/oxfordjournals.aje.a112727; Saramaki J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.027105; SCHUMM P, 2007, EPIDEMIC SPREADING W, P201; VESPIGNANI A, 2009, GLOBAL EPIDEMIC MOBI; Zimmerman RK, 2003, AM J MED, V114, P31, DOI 10.1016/S0002-9343(02)01421-3	20	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11569	10.1371/journal.pone.0011569	http://dx.doi.org/10.1371/journal.pone.0011569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644715	gold, Green Published, Green Submitted			2022-12-27	WOS:000279822300019
J	Lupyan, G; Spivey, MJ				Lupyan, Gary; Spivey, Michael J.			Making the Invisible Visible: Verbal but Not Visual Cues Enhance Visual Detection	PLOS ONE			English	Article							ATTENTION ALTERS APPEARANCE; WORD IDENTIFICATION; RECOGNITION MEMORY; PERCEPTION; OBJECT; BRAIN; VISION; IMPLICIT; DISCRIMINATION; RESPONSES	Background: Can hearing a word change what one sees? Although visual sensitivity is known to be enhanced by attending to the location of the target, perceptual enhancements of following cues to the identity of an object have been difficult to find. Here, we show that perceptual sensitivity is enhanced by verbal, but not visual cues. Methodology/Principal Findings: Participants completed an object detection task in which they made an object-presence or -absence decision to briefly-presented letters. Hearing the letter name prior to the detection task increased perceptual sensitivity (d'). A visual cue in the form of a preview of the to-be-detected letter did not. Follow-up experiments found that the auditory cuing effect was specific to validly cued stimuli. The magnitude of the cuing effect positively correlated with an individual measure of vividness of mental imagery; introducing uncertainty into the position of the stimulus did not reduce the magnitude of the cuing effect, but eliminated the correlation with mental imagery. Conclusions/Significance: Hearing a word made otherwise invisible objects visible. Interestingly, seeing a preview of the target stimulus did not similarly enhance detection of the target. These results are compatible with an account in which auditory verbal labels modulate lower-level visual processing. The findings show that a verbal cue in the form of hearing a word can influence even the most elementary visual processing and inform our understanding of how language affects perception.	[Lupyan, Gary] Univ Penn, Philadelphia, PA 19104 USA; [Spivey, Michael J.] Univ Calif Merced, Merced, CA USA	University of Pennsylvania; University of California System; University of California Merced	Lupyan, G (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.	lupyan@sas.upenn.edu		Lupyan, Gary/0000-0001-8441-7433; Lauwereyns, Jan/0000-0003-0551-2550	National Science Foundation (NSF) [BCS-0721297]	National Science Foundation (NSF)(National Science Foundation (NSF))	This research was supported by National Science Foundation (NSF) grant BCS-0721297 to MJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; de Sa VR, 1998, NEURAL COMPUT, V10, P1097, DOI 10.1162/089976698300017368; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Enns JT, 2008, TRENDS COGN SCI, V12, P327, DOI 10.1016/j.tics.2008.06.001; FARAH MJ, 1985, J EXP PSYCHOL GEN, V114, P91, DOI 10.1037/0096-3445.114.1.91; Gilbert AL, 2006, P NATL ACAD SCI USA, V103, P489, DOI 10.1073/pnas.0509868103; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; GRAF P, 1990, J EXP PSYCHOL LEARN, V16, P978, DOI 10.1037/0278-7393.16.6.978; Green DM, 1966, SIGNAL DETECTION THE; Greene AJ, 2001, CONSCIOUS COGN, V10, P425, DOI 10.1006/ccog.2001.0502; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; JACOBY LL, 1987, J EXP PSYCHOL LEARN, V13, P456, DOI 10.1037/0278-7393.13.3.456; Joubert OR, 2009, J VISION, V9, DOI 10.1167/9.1.2; Kanwisher N, 2000, NAT REV NEUROSCI, V1, P91, DOI 10.1038/35039043; Kravitz DJ, 2008, J EXP PSYCHOL HUMAN, V34, P298, DOI 10.1037/0096-1523.34.2.298; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lordanescu L, 2008, PSYCHON B REV, V15, P548, DOI 10.3758/PBR.15.3.548; Lu HJ, 2006, J VISION, V6, P75, DOI 10.1167/6.1.7; LUPKER SJ, 1979, PERCEPT PSYCHOPHYS, V25, P60, DOI 10.3758/BF03206111; LUPYAN G, 2010, P 32 ANN C COGN SCI; LUPYAN G, 2010, P 8 INT C EV LANG UT; Lupyan G, 2008, COGNITION, V108, P566, DOI 10.1016/j.cognition.2008.03.009; Lupyan G, 2008, CURR BIOL, V18, pR410, DOI 10.1016/j.cub.2008.02.073; Lupyan G, 2008, J EXP PSYCHOL GEN, V137, P348, DOI 10.1037/0096-3445.137.2.348; Lupyan G, 2010, PSYCHOL SCI, V21, P682, DOI 10.1177/0956797610366099; Ma WJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004638; MARKS DF, 1973, BRIT J PSYCHOL, V64, P17, DOI 10.1111/j.2044-8295.1973.tb01322.x; MarslenWilson W, 1996, J EXP PSYCHOL HUMAN, V22, P1376, DOI 10.1037/0096-1523.22.6.1376; Massaro DW, 1987, SPEECH PERCEPTION EA; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meteyard L, 2007, PSYCHOL SCI, V18, P1007, DOI 10.1111/j.1467-9280.2007.02016.x; Newell FN, 2005, VISION RES, V45, P2065, DOI 10.1016/j.visres.2005.02.021; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; POLLACK I, 1958, J ACOUST SOC AM, V30, P1013, DOI 10.1121/1.1909438; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; Puri AM, 2008, VISION RES, V48, P589, DOI 10.1016/j.visres.2007.11.017; Pylyshyn Z, 1999, BEHAV BRAIN SCI, V22, P341, DOI 10.1017/S0140525X99002022; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Ratcliff R, 1997, PSYCHOL REV, V104, P319, DOI 10.1037/0033-295X.104.2.319; Richardson DC, 2003, COGNITIVE SCI, V27, P767, DOI 10.1016/S0364-0213(03)00064-8; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Soto D, 2007, J EXP PSYCHOL HUMAN, V33, P730, DOI 10.1037/0096-1523.33.3.730; Spivey MJ, 2001, PSYCHOL SCI, V12, P282, DOI 10.1111/1467-9280.00352; Stormer VS, 2009, P NATL ACAD SCI USA, V106, P22456, DOI 10.1073/pnas.0907573106; Theeuwes J, 2007, J EXP PSYCHOL HUMAN, V33, P1335, DOI 10.1037/0096-1523.33.6.1335; Trafton J. G, 2007, 29 ANN M COGN SCI SO, P1247; TULVING E, 1982, J EXP PSYCHOL LEARN, V8, P336, DOI 10.1037/0278-7393.8.4.336; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; Zeelenberg R, 2002, J EXP PSYCHOL GEN, V131, P38, DOI 10.1037//0096-3445.131.1.38	57	32	32	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11452	10.1371/journal.pone.0011452	http://dx.doi.org/10.1371/journal.pone.0011452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621OQ	20628646	Green Published, gold, Green Submitted			2022-12-27	WOS:000279589300004
J	Duncan, B; Nazarov-Stoica, C; Surls, J; Kehl, M; Bona, C; Casares, S; Brumeanu, TD				Duncan, Beverly; Nazarov-Stoica, Cristina; Surls, Jacqueline; Kehl, Margaret; Bona, Constantin; Casares, Sofia; Brumeanu, Teodor-D.			Double Negative (CD3(+)4(-)8(-)) TCR alpha beta Splenic Cells from Young NOD Mice Provide Long-Lasting Protection against Type 1 Diabetes	PLOS ONE			English	Article							REGULATORY T-CELL; INVARIANT NKT CELLS; GAMMA-DELTA; IN-VIVO; INTERFERON-GAMMA; CUTTING EDGE; RECEPTOR; MOUSE; TOLERANCE; LYMPHOCYTES	Background: Double negative CD3(+)4(-)8(-) TCR alpha beta splenic cells (DNCD3) can suppress the immune responses to allo and xenografts, infectious agents, tumors, and some autoimmune disorders. However, little is known about their role in autoimmune diabetes, a disease characterized by the reduction of insulin production subsequent to destruction of pancreatic beta-cells by a polyclonal population of self-reactive T-cells. Herein, we analyzed the function and phenotype of DNCD3 splenic cells in young NOD mice predisposed to several autoimmune disorders among which, the human-like autoimmune diabetes. Methodology/Principal Findings: DNCD3 splenic cells from young NOD mice (1) provided long-lasting protection against diabetes transfer in NOD/Scid immunodeficient mice, (2) proliferated and differentiated in the spleen and pancreas of NOD/Scid mice and pre-diabetic NOD mice into IL-10-secreting T-R-1 like cells in a Th2-like environment, and (3) their anti-diabetogenic phenotype is CD3(+)(CD4(-)CD8(-))CD28(+)CD69(+)CD25(low) Foxp3(-) iCTLA-4(-)TCR alpha beta(+) with a predominant V beta 13 gene usage. Conclusions/Significance: These findings delineate a new T regulatory component in autoimmune diabetes apart from that of NKT and CD4(+)CD25(high) Foxp3(+)T-regulatory cells. DNCD3 splenic cells could be potentially manipulated towards the development of autologous cell therapies in autoimmune diabetes.	[Duncan, Beverly] NCI, NIH, Bethesda, MD 20892 USA; [Nazarov-Stoica, Cristina; Surls, Jacqueline; Kehl, Margaret; Casares, Sofia; Brumeanu, Teodor-D.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Bona, Constantin] Mt Sinai Sch Med, Dept Microbiol, New York, NY USA; [Casares, Sofia] USN, Med Res Ctr, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; Icahn School of Medicine at Mount Sinai; United States Department of Defense; United States Navy	Duncan, B (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	tbrumeanu@usuhs.edu	è-, ä/F-9947-2012; Brumeanu, Teodor/AAB-1965-2020		National Institutes of Health [DK61927, DK61326, DK077521, JDRF-12002-1151]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK061326, R21DK077521, R01DK061927] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK61927 & DK61326) to T.-D.B., and (DK077521 and JDRF-12002-1151) to S. C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Antonelli LRV, 2006, INFECT IMMUN, V74, P6317, DOI 10.1128/IAI.00890-06; Aoki CA, 2005, AUTOIMMUN REV, V4, P373, DOI 10.1016/j.autrev.2005.02.002; Arase H, 2001, J IMMUNOL, V167, P1141, DOI 10.4049/jimmunol.167.3.1141; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bains I, 2009, J IMMUNOL, V183, P4329, DOI 10.4049/jimmunol.0900743; Beetz S, 2008, IMMUNOBIOLOGY, V213, P173, DOI 10.1016/j.imbio.2007.10.006; Berzins SP, 2003, DIABETES, V52, P327, DOI 10.2337/diabetes.52.2.327; Brauner H, 2010, J IMMUNOL, V184, P2272, DOI 10.4049/jimmunol.0804358; Casares S, 2002, NAT IMMUNOL, V3, P383, DOI 10.1038/ni770; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; Chen WH, 2003, J IMMUNOL, V170, P1846, DOI 10.4049/jimmunol.170.4.1846; Chen YG, 2007, IMMUNOGENETICS, V59, P705, DOI 10.1007/s00251-007-0236-4; Chopra P, 2009, IN VIVO, V23, P195; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Dion Marie-Lise, 2007, Methods Mol Biol, V380, P197; Eggena MP, 2004, J EXP MED, V199, P1725, DOI 10.1084/jem.20040124; Fischer K, 2005, BLOOD, V105, P2828, DOI 10.1182/blood-2004-07-2583; Ford MS, 2007, EUR J IMMUNOL, V37, P2234, DOI 10.1002/eji.200636991; Ford MS, 2006, J IMMUNOL, V177, P2803, DOI 10.4049/jimmunol.177.5.2803; Ford MS, 2002, J EXP MED, V196, P261, DOI 10.1084/jem.20020029; FUNDA D, 1995, IMMUNOL LETT, V45, P179, DOI 10.1016/0165-2478(95)00003-N; Godfrey DI, 1997, J AUTOIMMUN, V10, P279, DOI 10.1006/jaut.1997.0129; Gombert JM, 1996, EUR J IMMUNOL, V26, P2989, DOI 10.1002/eji.1830261226; Gonzalez A, 2001, NAT IMMUNOL, V2, P1117, DOI 10.1038/ni738; Gounari F, 2001, NAT IMMUNOL, V2, P863, DOI 10.1038/ni0901-863; Griseri T, 2005, J IMMUNOL, V175, P2091, DOI 10.4049/jimmunol.175.4.2091; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hong S, 2001, NAT MED, V7, P1052, DOI 10.1038/nm0901-1052; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Johansson M, 2003, J IMMUNOL, V170, P1659, DOI 10.4049/jimmunol.170.4.1659; Johansson SE, 2004, INT IMMUNOL, V16, P1, DOI 10.1093/intimm/dxh002; Kadena T, 1997, IMMUNOLOGY, V91, P511, DOI 10.1046/j.1365-2567.1997.00303.x; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Kishimoto H, 2001, NAT IMMUNOL, V2, P1025, DOI 10.1038/ni726; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; LANG FP, 1993, J AUTOIMMUN, V6, P107, DOI 10.1006/jaut.1993.1009; LANG FP, 1991, J AUTOIMMUN, V4, P925, DOI 10.1016/0896-8411(91)90055-H; Lapolla A, 2000, ACTA DIABETOL, V37, P207, DOI 10.1007/s005920070007; Lee KM, 1998, SCIENCE, V282, P2263, DOI 10.1126/science.282.5397.2263; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Livak F, 1999, J IMMUNOL, V162, P2575; Ma YX, 2008, XENOTRANSPLANTATION, V15, P56, DOI 10.1111/j.1399-3089.2008.00444.x; MASUDA T, 1991, J IMMUNOL, V147, P2907; Matsuda JL, 2001, P NATL ACAD SCI USA, V98, P12636, DOI 10.1073/pnas.221445298; McIntyre MSF, 2008, J IMMUNOL, V181, P2271, DOI 10.4049/jimmunol.181.4.2271; MEGAN SF, 2006, J IMMUNOL, V177, P2803; NAZAROVSTOICA C, 2009, OPEN J AUTOIMMUNITY, V1, P64; Ohga S, 2002, BRIT J HAEMATOL, V119, P535, DOI 10.1046/j.1365-2141.2002.03848.x; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; PALATHUMPAT V, 1992, J IMMUNOL, V149, P808; Porcelli SA, 1999, ANNU REV IMMUNOL, V17, P297, DOI 10.1146/annurev.immunol.17.1.297; Poulton LD, 2001, INT IMMUNOL, V13, P887, DOI 10.1093/intimm/13.7.887; Priatel JJ, 2001, J IMMUNOL, V167, P6188, DOI 10.4049/jimmunol.167.11.6188; Radu DL, 1999, AUTOIMMUNITY, V30, P199, DOI 10.3109/08916939908993801; SANTAMARIA P, 1992, DIABETES, V41, P53, DOI 10.2337/diabetes.41.1.53; SANTAMARIA P, 1994, DIABETES, V43, P599, DOI 10.2337/diabetes.43.4.599; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; SCHWADRON RB, 1989, TRANSPLANTATION, V48, P107, DOI 10.1097/00007890-198907000-00025; STROBER S, 1989, J IMMUNOL, V143, P1118; Strober S, 1996, IMMUNOL REV, V149, P217, DOI 10.1111/j.1600-065X.1996.tb00906.x; Thomson CW, 2006, IMMUNOL RES, V35, P163, DOI 10.1385/IR:35:1:163; Utting O, 2001, J IMMUNOL, V166, P1540, DOI 10.4049/jimmunol.166.3.1540; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; Wang B, 2001, J EXP MED, V194, P313, DOI 10.1084/jem.194.3.313; Wang RF, 2002, P NATL ACAD SCI USA, V99, P2181, DOI 10.1073/pnas.042692799; WICKER LS, 1995, ANNU REV IMMUNOL, V13, P179, DOI 10.1146/annurev.iy.13.040195.001143; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415; Young KJ, 2003, CANCER RES, V63, P8014; Young KJ, 2003, J IMMUNOL, V171, P134, DOI 10.4049/jimmunol.171.1.134; Zhang L, 2010, J AUTOIMMUN, V34, P478, DOI 10.1016/j.jaut.2009.12.008; Zhang ZX, 2000, NAT MED, V6, P782, DOI 10.1038/77513	74	30	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11427	10.1371/journal.pone.0011427	http://dx.doi.org/10.1371/journal.pone.0011427			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625402	Green Published, Green Submitted, gold			2022-12-27	WOS:000279465700012
J	Comeau, S; Jeffree, R; Teyssie, JL; Gattuso, JP				Comeau, Steeve; Jeffree, Ross; Teyssie, Jean-Louis; Gattuso, Jean-Pierre			Response of the Arctic Pteropod Limacina helicina to Projected Future Environmental Conditions	PLOS ONE			English	Article							OCEAN ACIDIFICATION; ARAGONITE; CO2; CALCIFICATION; IMPACT; CARBON; SEA; PHOTOSYNTHESIS; TEMPERATURE; MOLLUSKS	Thecosome pteropods (pelagic mollusks) can play a key role in the food web of various marine ecosystems. They are a food source for zooplankton or higher predators such as fishes, whales and birds that is particularly important in high latitude areas. Since they harbor a highly soluble aragonitic shell, they could be very sensitive to ocean acidification driven by the increase of anthropogenic CO2 emissions. The effect of changes in the seawater chemistry was investigated on Limacina helicina, a key species of Arctic pelagic ecosystems. Individuals were kept in the laboratory under controlled pCO(2) levels of 280, 380, 550, 760 and 1020 mu atm and at control (0 degrees C) and elevated (4 degrees C) temperatures. The respiration rate was unaffected by pCO(2) at control temperature, but significantly increased as a function of the pCO(2) level at elevated temperature. pCO(2) had no effect on the gut clearance rate at either temperature. Precipitation of CaCO3, measured as the incorporation of Ca-45, significantly declined as a function of pCO(2) at both temperatures. The decrease in calcium carbonate precipitation was highly correlated to the aragonite saturation state. Even though this study demonstrates that pteropods are able to precipitate calcium carbonate at low aragonite saturation state, the results support the current concern for the future of Arctic pteropods, as the production of their shell appears to be very sensitive to decreased pH. A decline of pteropod populations would likely cause dramatic changes to various pelagic ecosystems.	[Comeau, Steeve; Gattuso, Jean-Pierre] CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Comeau, Steeve; Gattuso, Jean-Pierre] Univ Paris 06, Observ Oceanol Villefranche, Villefranche Sur Mer, France; [Jeffree, Ross; Teyssie, Jean-Louis] IAEA, Marine Environm Labs, Monaco, Monaco	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Comeau, S (corresponding author), CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Villefranche Sur Mer, France.	comeau@obs-vlfr.fr	Gattuso, Jean-Pierre/AAG-8643-2019; Gattuso, Jean-Pierre/E-6631-2010	Gattuso, Jean-Pierre/0000-0002-4533-4114; Gattuso, Jean-Pierre/0000-0002-4533-4114	French Polar Institute (IPEV); European Community [211384]; Government of the Principality of Monaco	French Polar Institute (IPEV); European Community(European Commission); Government of the Principality of Monaco	Logistic support from the Alfred Wegener Institute for Polar and Marine Research (AWIPEV) and Kings Bay and funding from the French Polar Institute (IPEV) are gratefully acknowledged. This work is a contribution to the Svalbard 2009 experiment of the "European Project on Ocean Acidification'' (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007 2013) under grant agreement n<SUP>o</SUP> 211384. The IAEA is grateful for the support provided to its Marine Environment Laboratories by the Government of the Principality of Monaco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard KS, 2009, DEEP-SEA RES PT I, V56, P582, DOI 10.1016/j.dsr.2008.11.007; BERNER RA, 1981, SCIENCE, V211, P940, DOI 10.1126/science.211.4485.940; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; CHRISTOFFERSEN K, 1986, J PLANKTON RES, V8, P973, DOI 10.1093/plankt/8.5.973; Collier R, 2000, DEEP-SEA RES PT II, V47, P3491, DOI 10.1016/S0967-0645(00)00076-X; Comeau S, 2009, BIOGEOSCIENCES, V6, P1877, DOI 10.5194/bg-6-1877-2009; Cottier F, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002757; DAM HG, 1988, J EXP MAR BIOL ECOL, V123, P1, DOI 10.1016/0022-0981(88)90105-0; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; FABRY VJ, 1990, J MAR RES, V48, P209, DOI 10.1357/002224090784984614; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Francois R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001722; Gangsto R, 2008, BIOGEOSCIENCES, V5, P1057, DOI 10.5194/bg-5-1057-2008; Gannefors C, 2005, MAR BIOL, V147, P169, DOI 10.1007/s00227-004-1544-y; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gehlen M, 2007, BIOGEOSCIENCES, V4, P505, DOI 10.5194/bg-4-505-2007; GILMER RW, 1991, MAR ECOL PROG SER, V77, P125, DOI 10.3354/meps077125; GILMER RW, 1986, MAR BIOL, V91, P47, DOI 10.1007/BF00397570; HUNT B, 2010, PLOS ONE, V3, pE9835; Hunt BPV, 2008, PROG OCEANOGR, V78, P193, DOI 10.1016/j.pocean.2008.06.001; IKEDA T, 1985, MAR BIOL, V85, P1, DOI 10.1007/BF00396409; Karnovsky NJ, 2008, MAR ECOL PROG SER, V357, P291, DOI 10.3354/meps07295; Lalli C.M., 1989, PELAGIC SNAILS BIOL; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; Lavigne H., 2010, SEACARB SEAWATER CAR; McNeil BI, 2007, TELLUS B, V59, P191, DOI 10.1111/j.1600-0889.2006.00241.x; Moy AD, 2009, NAT GEOSCI, V2, P276, DOI 10.1038/NGEO460; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ridgwell A, 2007, BIOGEOSCIENCES, V4, P481, DOI 10.5194/bg-4-481-2007; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; RODOLFOMETALPA R, MAR ECOL IN PRESS; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Seibel BA, 2007, INTEGR COMP BIOL, V47, P880, DOI 10.1093/icb/icm089; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Svendsen H, 2002, POLAR RES, V21, P133, DOI 10.1111/j.1751-8369.2002.tb00072.x; Weslawski Jan Marcin, 2000, Oceanologia, V42, P37; Willette TM, 2001, FISH OCEANOGR, V10, P14, DOI 10.1046/j.1054-6006.2001.00043.x; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190	44	133	135	2	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11362	10.1371/journal.pone.0011362	http://dx.doi.org/10.1371/journal.pone.0011362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613868	gold, Green Published, Green Submitted			2022-12-27	WOS:000279369900011
J	Knight, ZA; Hannan, KS; Greenberg, ML; Friedman, JM				Knight, Zachary A.; Hannan, K. Schot; Greenberg, Matthew L.; Friedman, Jeffrey M.			Hyperleptinemia Is Required for the Development of Leptin Resistance	PLOS ONE			English	Article							DIET-INDUCED OBESITY; HIGH-FAT DIET; FEEDBACK INHIBITION; SKELETAL-MUSCLE; GENE-PRODUCT; OB/OB MICE; INSULIN; HYPOTHALAMUS; SENSITIVITY; DEFICIENCY	Leptin regulates body weight by signaling to the brain the availability of energy stored as fat. This negative feedback loop becomes disrupted in most obese individuals, resulting in a state known as leptin resistance. The physiological causes of leptin resistance remain poorly understood. Here we test the hypothesis that hyperleptinemia is required for the development of leptin resistance in diet-induced obese mice. We show that mice whose plasma leptin has been clamped to lean levels develop obesity in response to a high-fat diet, and the magnitude of this obesity is indistinguishable from wild-type controls. Yet these obese animals with constant low levels of plasma leptin remain highly sensitive to exogenous leptin even after long-term exposure to a high fat diet. This shows that dietary fats alone are insufficient to block the response to leptin. The data also suggest that hyperleptinemia itself can contribute to leptin resistance by downregulating cellular response to leptin as has been shown for other hormones.	[Knight, Zachary A.; Hannan, K. Schot; Greenberg, Matthew L.; Friedman, Jeffrey M.] Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Knight, ZA (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA.	friedj@rockefeller.edu	Friedman, Jeffrey M/E-5784-2011	Knight, Zachary/0000-0001-7621-1478	NIH [DK083531, DK041096]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041096, K99DK083531] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK083531 (Z.A.K.) and DK041096 (J.M.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorbaek C, 2000, J BIOL CHEM, V275, P40649, DOI 10.1074/jbc.M007577200; BJORKHOLM JE, 1998, INTEL TECHNOL J Q, V3, P1; Bjornholm M, 2007, J CLIN INVEST, V117, P1354, DOI 10.1172/JCI30688; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; El-Haschimi K, 2000, J CLIN INVEST, V105, P1827, DOI 10.1172/JCI9842; Enriori PJ, 2007, CELL METAB, V5, P181, DOI 10.1016/j.cmet.2007.02.004; Ernst MB, 2009, J NEUROSCI, V29, P11582, DOI 10.1523/JNEUROSCI.5712-08.2009; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hosoi T, 2008, MOL PHARMACOL, V74, P1610, DOI 10.1124/mol.108.050070; Howard JK, 2004, NAT MED, V10, P734, DOI 10.1038/nm1072; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kievit P, 2006, CELL METAB, V4, P123, DOI 10.1016/j.cmet.2006.06.010; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Knobelspies H, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-2; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lin S, 2000, INT J OBESITY, V24, P639, DOI 10.1038/sj.ijo.0801209; MAFFEI M, 1995, NAT MED, V1, P1; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Roth JD, 2008, P NATL ACAD SCI USA, V105, P7257, DOI 10.1073/pnas.0706473105; Scarpace P, 2005, DIABETOLOGIA, V48, P1075, DOI 10.1007/s00125-005-1763-x; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Surwit RS, 2000, DIABETES, V49, P1203, DOI 10.2337/diabetes.49.7.1203; Tanaka T, 2005, DIABETES, V54, P2365, DOI 10.2337/diabetes.54.8.2365; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Townsend KL, 2008, ENDOCRINE, V33, P176, DOI 10.1007/s12020-008-9070-1; Trevaskis JL, 2010, OBESITY, V18, P21, DOI 10.1038/oby.2009.187; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang MY, 2010, P NATL ACAD SCI USA, V107, P4813, DOI 10.1073/pnas.0909422107; White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008; White MF, 2006, CAN J PHYSIOL PHARM, V84, P725, DOI 10.1139/Y06-008; Wisse BE, 2009, CELL METAB, V10, P241, DOI 10.1016/j.cmet.2009.09.003; Wolfgang MJ, 2006, ANNU REV NUTR, V26, P23, DOI 10.1146/annurev.nutr.25.050304.092532; Won JC, 2009, OBESITY, V17, P1861, DOI 10.1038/oby.2009.194; Yu X, 2008, P NATL ACAD SCI USA, V105, P14070, DOI 10.1073/pnas.0806993105; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	53	204	209	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11376	10.1371/journal.pone.0011376	http://dx.doi.org/10.1371/journal.pone.0011376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613882	Green Published, gold, Green Submitted			2022-12-27	WOS:000279369900023
J	Bochmann, L; Sarathchandra, P; Mori, F; Lara-Pezzi, E; Lazzaro, D; Rosenthal, N				Bochmann, Lars; Sarathchandra, Padmini; Mori, Federica; Lara-Pezzi, Enrique; Lazzaro, Domenico; Rosenthal, Nadia			Revealing New Mouse Epicardial Cell Markers through Transcriptomics	PLOS ONE			English	Article							RETINOIC ACID SYNTHESIS; MAMMALIAN HEART; PROTEIN; NEOVASCULARIZATION; PROGENITORS; EXPRESSION; THYMOSIN-BETA-4; IDENTIFICATION; CARDIOGENESIS; REGENERATION	Background: The epicardium has key functions during myocardial development, by contributing to the formation of coronary endothelial and smooth muscle cells, cardiac fibroblasts, and potentially cardiomyocytes. The epicardium plays a morphogenetic role by emitting signals to promote and maintain cardiomyocyte proliferation. In a regenerative context, the adult epicardium might comprise a progenitor cell population that can be induced to contribute to cardiac repair. Although some genes involved in epicardial function have been identified, a detailed molecular profile of epicardial gene expression has not been available. Methodology: Using laser capture microscopy, we isolated the epicardial layer from the adult murine heart before or after cardiac infarction in wildtype mice and mice expressing a transgenic IGF-1 propeptide (mIGF-1) that enhances cardiac repair, and analyzed the transcription profile using DNA microarrays. Principal Findings: Expression of epithelial genes such as basonuclin, dermokine, and glycoprotein M6A are highly enriched in the epicardial layer, which maintains expression of selected embryonic genes involved in epicardial development in mIGF-1 transgenic hearts. After myocardial infarct, a subset of differentially expressed genes are down-regulated in the epicardium representing an epicardium-specific signature that responds to injury. Conclusion: This study presents the description of the murine epicardial transcriptome obtained from snap frozen tissues, providing essential information for further analysis of this important cardiac cell layer.	[Bochmann, Lars; Lara-Pezzi, Enrique; Rosenthal, Nadia] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy; [Bochmann, Lars; Sarathchandra, Padmini; Rosenthal, Nadia] Univ London Imperial Coll Sci Technol & Med, Harefield Heart Sci Ctr, London, England; [Bochmann, Lars; Mori, Federica; Lazzaro, Domenico] Ist Ric Biol Mol P Angeletti SpA, Pomezia, Italy; [Lara-Pezzi, Enrique] CNIC, Cardiovasc Dev Biol Dept, Madrid, Spain	European Molecular Biology Laboratory (EMBL); Imperial College London; Merck & Company; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Bochmann, L (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy.	bochmann@embl.it	Mori, Federica/B-2944-2013; Lara-Pezzi, Enrique/E-2350-2015; Rosenthal, Nadia/O-7009-2015	Mori, Federica/0000-0002-7244-9961; Lara-Pezzi, Enrique/0000-0002-2743-1033; Rosenthal, Nadia/0000-0002-7599-7365	British Heart Foundation [PG/08/111/26226] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Alves CC, 2009, FRONT BIOSCI-LANDMRK, V14, P3041, DOI 10.2741/3433; Andoh A, 1996, J GASTROENTEROL, V31, P633, DOI 10.1007/BF02347609; BASSETSEGUIN N, 1992, ANN DERMATOL VENER, V119, P629; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Brass EP, 2009, J APPL PHYSIOL, V107, P605, DOI 10.1152/japplphysiol.91347.2008; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Hatcher CJ, 2004, PHYSIOL GENOMICS, V18, P129, DOI 10.1152/physiolgenomics.00060.2004; Kang J, 2008, DEV DYNAM, V237, P692, DOI 10.1002/dvdy.21469; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Limana F, 2010, J MOL CELL CARDIOL, V48, P609, DOI 10.1016/j.yjmcc.2009.11.008; Lu JR, 1998, MECH DEVELOP, V73, P23, DOI 10.1016/S0925-4773(98)00030-6; Matsui T, 2004, GENOMICS, V84, P384, DOI 10.1016/j.ygeno.2004.03.010; Moss JB, 1998, DEV BIOL, V199, P55, DOI 10.1006/dbio.1998.8911; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Reese DE, 2002, CIRC RES, V91, P761, DOI 10.1161/01.RES.0000038961.53759.3C; Riley PR, 2009, BIOCHEM SOC T, V37, P1218, DOI 10.1042/BST0371218; Rosati B, 2006, J MOL CELL CARDIOL, V40, P295, DOI 10.1016/j.yjmcc.2005.11.002; Santini MP, 2007, CIRC RES, V100, P1732, DOI 10.1161/CIRCRESAHA.107.148791; Smart N, 2007, ANN NY ACAD SCI, V1112, P171, DOI 10.1196/annals.1415.000; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Tarnavski O, 2004, PHYSIOL GENOMICS, V16, P349, DOI 10.1152/physiolgenomics.00041.2003; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; van Wijk B, 2009, CIRC RES, V105, P431, DOI 10.1161/CIRCRESAHA.109.203083; Vanhoutteghem A, 2004, P NATL ACAD SCI USA, V101, P3468, DOI 10.1073/pnas.0400268101; Winter EM, 2007, CIRCULATION, V116, P917, DOI 10.1161/CIRCULATIONAHA.106.668178; Winter EM, 2007, CELL MOL LIFE SCI, V64, P692, DOI 10.1007/s00018-007-6522-3; Winter EM, 2009, CIRC-HEART FAIL, V2, P643, DOI 10.1161/CIRCHEARTFAILURE.108.843722; Xavier-Neto J, 2000, DEV BIOL, V219, P129, DOI 10.1006/dbio.1999.9588; Zhang TH, 2009, OPHTHALMIC RES, V41, P36, DOI 10.1159/000163220; Zhang XH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001087; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	35	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11429	10.1371/journal.pone.0011429	http://dx.doi.org/10.1371/journal.pone.0011429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596535	gold, Green Submitted, Green Published			2022-12-27	WOS:000279259900026
J	Brauner, R; Bashamboo, A; Rouget, S; Goulet, M; Philibert, P; Sarda-Thibault, H; Trivin, C; Misrahi, M; Sultan, C; McElreavey, K				Brauner, Raja; Bashamboo, Anu; Rouget, Sebastien; Goulet, Marie; Philibert, Pascal; Sarda-Thibault, Helene; Trivin, Christine; Misrahi, Micheline; Sultan, Charles; McElreavey, Ken			Clinical, Biological and Genetic Analysis of Prepubertal Isolated Ovarian Cyst in 11 Girls	PLOS ONE			English	Article							MCCUNE-ALBRIGHT-SYNDROME; LUTEINIZING-HORMONE-RECEPTOR; CENTRAL PRECOCIOUS PUBERTY; ANTI-MULLERIAN HORMONE; GRANULOSA-CELL TUMOR; PREMATURE THELARCHE; FOLLICULAR CYSTS; SEXUAL PRECOCITY; FOLLOW-UP; MUTATIONS	Background: The cause of isolated gonadotropin-independent precocious puberty (PP) with an ovarian cyst is unknown in the majority of cases. Here, we describe 11 new cases of peripheral PP and, based on phenotypes observed in mouse models, we tested the hypothesis that mutations in the GNAS1, NR5A1, LHCGR, FSHR, NR5A1, StAR, DMRT4 and NOBOX may be associated with this phenotype. Methodology/Principal Findings: 11 girls with gonadotropin-independent PP were included in this study. Three girls were seen for a history of prenatal ovarian cyst, 6 girls for breast development, and 2 girls for vaginal bleeding. With one exception, all girls were seen before 8 years of age. In 8 cases, an ovarian cyst was detected, and in one case, suspected. One other case has polycystic ovaries, and the remaining case was referred for vaginal bleeding. Four patients had a familial history of ovarian anomalies and/or infertility. Mutations in the coding sequences of the candidate genes GNAS1, NR5A1, LHCGR, FSHR, NR5A1, StAR, DMRT4 and NOBOX were not observed. Conclusions/Significance: Ovarian PP shows markedly different clinical features from central PP. Our data suggest that mutations in the GNAS1, NR5A1, LHCGR, FSHR StAR, DMRT4 and NOBOX genes are not responsible for ovarian PP. Further research, including the identification of familial cases, is needed to understand the etiology of ovarian PP.	[Brauner, Raja; Rouget, Sebastien; Goulet, Marie] Univ Paris 05, Paris, France; [Brauner, Raja; Rouget, Sebastien; Goulet, Marie] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Paris, France; [Bashamboo, Anu; Sultan, Charles; McElreavey, Ken] Inst Pasteur, Paris, France; [Philibert, Pascal] Hop Lapeyronie, Serv Hormonol Dev & Reprod, Montpellier, France; [Sarda-Thibault, Helene] Ctr Hosp Rene Dubos, Serv Pediat, Pontoise, France; [Trivin, Christine] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France; [Misrahi, Micheline] Univ Paris 11, INSERM, U854, Paris, France; [Misrahi, Micheline] Hop Bicetre, AP HP, Genet Mol Lab, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montpellier; CHU de Montpellier; Centre Hospitalier Rene Dubos, Pontoise; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	kenmce@pasteur.fr	Philibert, Pascal/C-6728-2008	Philibert, Pascal/0000-0001-6384-521X; Rouget, Sebastien/0000-0001-9684-1485	Agence Nationale de la Recherche; GIS Institut des Maladies Rares; March of Dimes Foundation [1-FY07-490)]	Agence Nationale de la Recherche(French National Research Agency (ANR)); GIS Institut des Maladies Rares; March of Dimes Foundation(March of Dimes)	This work was supported by grants from the Agence Nationale de la Recherche, the GIS Institut des Maladies Rares (to Dr. McElreavey) and by a research grant (1-FY07-490) from the March of Dimes Foundation (to Dr. McElreavey). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balciuniene J, 2006, MOL CELL BIOL, V26, P8984, DOI 10.1128/MCB.00959-06; Beau I, 1998, J CLIN INVEST, V102, P1352, DOI 10.1172/JCI3795; BREEN J L, 1977, Clinical Obstetrics and Gynecology, V20, P607, DOI 10.1097/00003081-197709000-00010; BRIDGES NA, 1995, CLIN ENDOCRINOL, V42, P135, DOI 10.1111/j.1365-2265.1995.tb01853.x; Cameron FJ, 1997, ACTA PAEDIATR, V86, P1016, DOI 10.1111/j.1651-2227.1997.tb15193.x; Caron KM, 1997, P NATL ACAD SCI USA, V94, P11540, DOI 10.1073/pnas.94.21.11540; de Vries L, 2006, EUR J ENDOCRINOL, V154, P891, DOI 10.1530/eje.1.02151; FRISCH LS, 1992, PEDIATRICS, V90, P102; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Jeyasuria P, 2004, MOL ENDOCRINOL, V18, P1610, DOI 10.1210/me.2003-0404; Kalfa N, 2006, J CLIN ENDOCR METAB, V91, P1842, DOI 10.1210/jc.2005-2710; KOSLOSKE AM, 1984, AM J DIS CHILD, V138, P147, DOI 10.1001/archpedi.1984.02140400033008; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; Long WQ, 2000, J CLIN ENDOCR METAB, V85, P540, DOI 10.1210/jc.85.2.540; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; Lumbroso S, 2004, J CLIN ENDOCR METAB, V89, P2107, DOI 10.1210/jc.2003-031225; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; Misrahi M, 1997, J CLIN ENDOCR METAB, V82, P2159, DOI 10.1210/jcem.82.7.4039; OERTER KE, 1990, J CLIN ENDOCR METAB, V71, P1251, DOI 10.1210/jcem-71-5-1251; Ottolenghi C, 2002, GENOMICS, V79, P333, DOI 10.1006/geno.2002.6711; Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019; Pienkowski C, 1997, ACTA PAEDIATR, V86, P1019, DOI 10.1111/j.1651-2227.1997.tb15194.x; Prete G, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-27; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Rodriguez-Macias KA, 1999, ARCH DIS CHILD, V81, P53, DOI 10.1136/adc.81.1.53; Roman R, 2004, J PEDIATR-US, V145, P218, DOI 10.1016/j.jpeds.2004.05.025; Sempe M., 1979, AUXOLOGIE METHODE SE; Sir-Petermann T, 2006, J CLIN ENDOCR METAB, V91, P3105, DOI 10.1210/jc.2005-2693; Smits G, 2003, NEW ENGL J MED, V349, P760, DOI 10.1056/NEJMoa030064; STANHOPE R, 1985, ARCH DIS CHILD, V60, P116, DOI 10.1136/adc.60.2.116; Trivin C, 2006, CLIN ENDOCRINOL, V65, P239, DOI 10.1111/j.1365-2265.2006.02582.x; ZIPF WB, 1997, J PEDIAT, V95, P38	32	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11282	10.1371/journal.pone.0011282	http://dx.doi.org/10.1371/journal.pone.0011282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593028	gold, Green Published, Green Submitted			2022-12-27	WOS:000279140800004
J	Cohen, TS; Lawrence, GG; Margulies, SS				Cohen, Taylor S.; Lawrence, Gladys Gray; Margulies, Susan S.			Cultured Alveolar Epithelial Cells From Septic Rats Mimic In Vivo Septic Lung	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; TNF-ALPHA; TIGHT JUNCTIONS; CECAL LIGATION; ANIMAL-MODELS; SYNDROME ARDS; KAPPA-B; INJURY; SEPSIS; EXPRESSION	Sepsis results in the formation of pulmonary edema by increasing in epithelial permeability. Therefore we hypothesized that alveolar epithelial cells isolated from septic animals develop tight junctions with different protein composition and reduced barrier function relative to alveolar epithelial cells from healthy animals. Male rats (200-300g) were sacrificed 24 hours after cecal ligation and double puncture (2CLP) or sham surgery. Alveolar epithelial cells were isolated and plated on fibronectin-coated flexible membranes or permeable, non-flexible transwell substrates. After a 5 day culture period, cells were either lysed for western analysis of tight junction protein expressin (claudin 3, 4, 5, 7, 8, and 18, occludin, ZO-1, and JAM-A) and MAPk (JNK, ERK, an p38) signaling activation, or barrier function was examined by measuring transepithelial resistance (TER) or the flux of two molecular tracers (5 and 20 angstrom). Inhibitors of JNK (SP600125, 20 mu M) and ERK (U0126, 10 mu M) were used to determine the role of these pathways in sepsis induced epithelial barrier dysfunction. Expression of claudin 4, claudin 18, and occludin was significantly lower, and activation of JNK and ERK signaling pathways was significantly increased in 2CLP monolayers, relative to sham monolayers. Transepithelial resistance of the 2CLP monolayers was reduced significantly compared to sham (769 and 1234 ohm-cm(2), respectively), however no significant difference in the flux of either tracer was observed. Inhibition of ERK, not JNK, significantly increased TER and expression of claudin 4 in 2CLP monolayers, and prevented significant differences in claudin 18 expression between 2CLP and sham monolayers. We conclude that alveolar epithelial cells isolated from septic animals form confluent monolayers with impaired barrier function compared to healthy monolayers, and inhibition of ERK signaling partially reverses differences between these monolayers. This model provides a unique preparation for probing the mechanisms by which sepsis alters alveolar epithelium.	[Cohen, Taylor S.; Lawrence, Gladys Gray; Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania	Cohen, TS (corresponding author), Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA.	margulies@seas.upenn.edu	Cohen, Taylor/C-9927-2016	Cohen, Taylor/0000-0001-9368-0903	 [NIH RO1-HL57204]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057204] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Support was provided by NIH RO1-HL57204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHULE MD, 1986, CHEST, V90, P895, DOI 10.1378/chest.90.6.895; Arndt PG, 2005, AM J RESP CRIT CARE, V171, P978, DOI 10.1164/rccm.200406-712OC; Arroliga AC, 2002, CHEST, V121, P1972, DOI 10.1378/chest.121.6.1972; Asaduzzaman M, 2008, CRIT CARE MED, V36, P482, DOI 10.1097/01.CCM.0B013E31816204FA; BAINES DL, 2009, PFLUGERS ARCH; Basuroy S, 2006, BIOCHEM J, V393, P69, DOI 10.1042/BJ20050959; BOROK Z, 1994, IN VITRO CELL DEV-AN, V30A, P99; Cavanaugh KJ, 2006, AM J PHYSIOL-CELL PH, V290, pC1179, DOI 10.1152/ajpcell.00355.2004; Cavanaugh KJ, 2002, AM J PHYSIOL-CELL PH, V283, pC1801, DOI 10.1152/ajpcell.00341.2002; Cohen TS, 2008, EUR RESPIR J, V32, P854, DOI 10.1183/09031936.00141007; Colegio OR, 2003, AM J PHYSIOL-CELL PH, V284, pC1346, DOI 10.1152/ajpcell.00547.2002; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DOBBS LG, 1988, BIOCHIM BIOPHYS ACTA, V970, P146, DOI 10.1016/0167-4889(88)90173-5; Duquesnes N, 2009, INT J BIOCHEM CELL B, V41, P1173, DOI 10.1016/j.biocel.2008.09.032; Eisner MD, 2001, AM J RESP CRIT CARE, V164, P231, DOI 10.1164/ajrccm.164.2.2011093; Escobar GA, 2006, SURGERY, V140, P268, DOI 10.1016/j.surg.2006.03.008; FANG X, 2009, FASEB J, V23; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fein AM, 2000, CRIT CARE CLIN, V16, P289, DOI 10.1016/S0749-0704(05)70111-1; Fernandez AL, 2007, ALCOHOL, V41, P371, DOI 10.1016/j.alcohol.2007.04.010; Flores-Benitez D, 2009, AM J PHYSIOL-CELL PH, V297, pC611, DOI 10.1152/ajpcell.00622.2008; Gomez MI, 2005, J IMMUNOL, V175, P1930, DOI 10.4049/jimmunol.175.3.1930; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Kevil CG, 2000, AM J PHYSIOL-CELL PH, V279, pC21, DOI 10.1152/ajpcell.2000.279.1.C21; KIM KJ, 1982, J APPL PHYSIOL, V52, P1498, DOI 10.1152/jappl.1982.52.6.1498; KOVAL M, AM J RESP CELL MOL B, V42, P172; Lam HS, 2008, PATHOLOGY, V40, P141, DOI 10.1080/00313020701813735; Lee JW, 2007, J BIOL CHEM, V282, P24109, DOI 10.1074/jbc.M700821200; Levine GK, 2006, CRIT CARE MED, V34, P1746, DOI 10.1097/01.CCM.0000218813.77367.E2; Li QR, 2008, CLIN IMMUNOL, V126, P67, DOI 10.1016/j.clim.2007.08.017; Li QR, 2009, J PATHOL, V218, P210, DOI 10.1002/path.2525; Liaw WJ, 2005, SHOCK, V23, P88, DOI 10.1097/01.shk.0000145937.70085.89; Lindert J, 2007, AM J RESP CELL MOL, V36, P688, DOI 10.1165/rcmb.2006-0347OC; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Mazzon E, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-75; McElroy MC, 2004, EUR RESPIR J, V24, P664, DOI 10.1183/09031936.04.00096003; McIntyre RC, 2000, CRIT CARE MED, V28, P3314, DOI 10.1097/00003246-200009000-00034; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Patel AS, 2005, AM J PHYSIOL-LUNG C, V289, pL489, DOI 10.1152/ajplung.00074.2005; Perlman CE, 2007, J APPL PHYSIOL, V103, P1037, DOI 10.1152/japplphysiol.00160.2007; Remick DG, 2005, SHOCK, V24, P7, DOI 10.1097/01.shk.0000191384.34066.85; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rittirsch D, 2007, J LEUKOCYTE BIOL, V81, P137, DOI 10.1189/jlb.0806542; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Shen LH, 2009, SHOCK, V31, P500, DOI 10.1097/SHK.0b013e318189017a; Singleton KD, 2005, SHOCK, V24, P583, DOI 10.1097/01.shk.0000185795.96964.71; Soong G, 2008, J BACTERIOL, V190, P2814, DOI 10.1128/JB.01567-07; THOMSEN GE, 1995, AM J RESP CRIT CARE, V152, P965, DOI 10.1164/ajrccm.152.3.7663811; TICE LW, 1977, TISSUE CELL, V9, P395, DOI 10.1016/0040-8166(77)90002-7; Tortolani PJ, 1999, J BONE JOINT SURG AM, V81A, P1596; Tschumperlin DJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1173, DOI 10.1152/ajplung.1998.275.6.L1173; Uhlig U, 2002, EUR RESPIR J, V20, P946, DOI 10.1183/09031936.02.01612001; Van Itallie C, 2001, J CLIN INVEST, V107, P1319, DOI 10.1172/JCI12464; Van Itallie CM, 2008, J CELL SCI, V121, P298, DOI 10.1242/jcs.021485; VILLAR J, 1994, CRIT CARE MED, V22, P914; Weiss YG, 2000, SHOCK, V13, P19, DOI 10.1097/00024382-200013010-00004; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; ZHOU G, 2009, AM J PHYSL LUNG CELL	60	24	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11322	10.1371/journal.pone.0011322	http://dx.doi.org/10.1371/journal.pone.0011322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593014	Green Published, gold			2022-12-27	WOS:000279140800020
J	Pau, S; Okin, GS; Gillespie, TW				Pau, Stephanie; Okin, Gregory S.; Gillespie, Thomas W.			Asynchronous Response of Tropical Forest Leaf Phenology to Seasonal and EI Nino-Driven Drought	PLOS ONE			English	Article							EL-NINO; PRIMARY PRODUCTIVITY; RAIN-FOREST; IMPACT; PRECIPITATION; HAWAII; PHOTOSYNTHESIS; MORTALITY; GRADIENT; BIOMASS	The Hawaiian Islands are an ideal location to study the response of tropical forests to climate variability because of their extreme isolation in the middle of the Pacific, which makes them especially sensitive to EI Nino-Southern Oscillation (ENSO). Most research examining the response of tropical forests to drought or EI Nino have focused on rainforests, however, tropical dry forests cover a large area of the tropics and may respond very differently than rainforests. We use satellite-derived Normalized Difference Vegetation Index (NDVI) from February 2000-February 2009 to show that rainforests and dry forests in the Hawaiian Islands exhibit asynchronous responses in leaf phenology to seasonal and EI Nino-driven drought. Dry forest NDVI was more tightly coupled with precipitation compared to rainforest NDVI. Rainforest cloud frequency was negatively correlated with the degree of asynchronicity (Delta(NDVI)) between forest types, most strongly at a 1-month lag. Rainforest green-up and dry forest brown-down was particularly apparent during the 2002-003 EI Nino. The spatial pattern of NDVI response to the NINO 3.4 Sea Surface Temperature (SST) index during 2002-2003 showed that the leeward side exhibited significant negative correlations to increased SSTs, whereas the windward side exhibited significant positive correlations to increased SSTs, most evident at an 8 to 9-month lag. This study demonstrates that different tropical forest types exhibit asynchronous responses to seasonal and EI Nino-driven drought, and suggests that mechanisms controlling dry forest leaf phenology are related to water-limitation, whereas rainforests are more light-limited.	[Pau, Stephanie; Okin, Gregory S.; Gillespie, Thomas W.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Pau, S (corresponding author), NCEAS, Santa Barbara, CA USA.	pau@nceas.ucsb.edu	Okin, Greg/D-3226-2019	Okin, Gregory/0000-0002-0484-3537	NASA; UCLA; National Science Foundation [BCS0455052]	NASA(National Aeronautics & Space Administration (NASA)); UCLA; National Science Foundation(National Science Foundation (NSF))	The NASA Earth System Science Fellowship (http://science.nasa.gov/educators/earth-science-education-catalog/higher-education-programs/earthsystemscience-fellowship-program/) and UCLA Dissertation Year Fellowship (http://www.gdnet.ucla.edu/asis/stusup/stusup.htm) both provided dissertation funding (fees and living stipend) for Stephanie Pau. The National Science Foundation BCS0455052 provided additional research support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba SI, 2002, J TROP ECOL, V18, P215, DOI 10.1017/S0266467402002146; Berlin KE, 2000, BIOTROPICA, V32, P90, DOI 10.1111/j.1744-7429.2000.tb00451.x; Bonal D, 2008, GLOBAL CHANGE BIOL, V14, P1917, DOI 10.1111/j.1365-2486.2008.01610.x; BOX EO, 1989, VEGETATIO, V80, P71, DOI 10.1007/BF00048034; Chu PS, 1997, J CLIMATE, V10, P2683, DOI 10.1175/1520-0442(1997)010<2683:TCOITV>2.0.CO;2; Chu PS, 2005, J CLIMATE, V18, P4796, DOI 10.1175/JCLI3578.1; CHU PS, 1995, J CLIMATE, V8, P1697, DOI 10.1175/1520-0442(1995)008<1697:HRAAEN>2.0.CO;2; Condit R, 2004, J TROP ECOL, V20, P51, DOI 10.1017/S0266467403001081; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Eck TF, 1998, J GEOPHYS RES-ATMOS, V103, P31865, DOI 10.1029/98JD00399; ELTAHIR EAB, 1994, Q J ROY METEOR SOC, V120, P861, DOI 10.1002/qj.49712051806; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Goulden Michael L., 2004, Ecological Applications, V14, pS42; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Holbrook NM., 1995, SEASONALLY DRY TROPI; Huete AR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025583; Kolivras KN, 2007, PHYS GEOGR, V28, P76, DOI 10.2747/0272-3646.28.1.76; Korner C, 2003, SCIENCE, V300, P1242, DOI 10.1126/science.1084460; Lepers E, 2005, BIOSCIENCE, V55, P115, DOI 10.1641/0006-3568(2005)055[0115:ASOIOR]2.0.CO;2; Loope LL, 1998, CLIMATIC CHANGE, V39, P503, DOI 10.1023/A:1005372118420; Malhi Y, 2000, TRENDS ECOL EVOL, V15, P332, DOI 10.1016/S0169-5347(00)01906-6; MYNENI RB, 1995, IEEE T GEOSCI REMOTE, V33, P481, DOI 10.1109/36.377948; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; PRICE JP, 2007, HCSU000 U HAW; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Samanta A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042154; Schuur EAG, 2001, OECOLOGIA, V128, P431, DOI 10.1007/s004420100671; SELLERS PJ, 1985, INT J REMOTE SENS, V6, P1335, DOI 10.1080/01431168508948283; STRATTON LC, 2000, OECOLOGIA, V121, P1432; TRATTON LC, 2000, PLANT CELL ENVIRON, V23, P99; TUCKER CJ, 1986, INT J REMOTE SENS, V7, P1395, DOI 10.1080/01431168608948944; TUCKER CJ, 1985, SCIENCE, V227, P369, DOI 10.1126/science.227.4685.369; VANRIPER C, 1980, BIOTROPICA, V12, P282, DOI 10.2307/2387700; Wan ZM, 2008, REMOTE SENS ENVIRON, V112, P59, DOI 10.1016/j.rse.2006.06.026; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552; WRIGHT SJ, 1994, AM NAT, V143, P192, DOI 10.1086/285600	39	18	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11325	10.1371/journal.pone.0011325	http://dx.doi.org/10.1371/journal.pone.0011325			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593034	Green Submitted, gold, Green Published			2022-12-27	WOS:000279140800022
J	Brusko, TM; Koya, RC; Zhu, S; Lee, MR; Putnam, AL; McClymont, SA; Nishimura, MI; Han, SH; Chang, LJ; Atkinson, MA; Ribas, A; Bluestone, JA				Brusko, Todd M.; Koya, Richard C.; Zhu, Shirley; Lee, Michael R.; Putnam, Amy L.; McClymont, Stephanie A.; Nishimura, Michael I.; Han, Shuhong; Chang, Lung-Ji; Atkinson, Mark A.; Ribas, Antoni; Bluestone, Jeffrey A.			Human Antigen-Specific Regulatory T Cells Generated by T Cell Receptor Gene Transfer	PLOS ONE			English	Article							ADOPTIVE TRANSFER; AUTOIMMUNE-DISEASES; MELANOMA ANTIGEN; FOXP3 EXPRESSION; CUTTING EDGE; EX-VIVO; EXPANSION; THERAPY; TOLERANCE; SUPPRESSION	Background: Therapies directed at augmenting regulatory T cell (Treg) activities in vivo as a systemic treatment for autoimmune disorders and transplantation may be associated with significant off-target effects, including a generalized immunosuppression that may compromise beneficial immune responses to infections and cancer cells. Adoptive cellular therapies using purified expanded Tregs represents an attractive alternative to systemic treatments, with results from animal studies noting increased therapeutic potency of antigen-specific Tregs over polyclonal populations. However, current methodologies are limited in terms of the capacity to isolate and expand a sufficient quantity of endogenous antigen-specific Tregs for therapeutic intervention. Moreover, FOXP3+ Tregs fall largely within the CD4+ T cell subset and are thus routinely MHC class II-specific, whereas class I-specific Tregs may function optimally in vivo by facilitating direct tissue recognition. Methodology/Principal Findings: To overcome these limitations, we have developed a novel means for generating large numbers of antigen-specific Tregs involving lentiviral T cell receptor (TCR) gene transfer into in vitro expanded polyclonal natural Treg populations. Tregs redirected with a high-avidity class I-specific TCR were capable of recognizing the melanoma antigen tyrosinase in the context of HLA-A*0201 and could be further enriched during the expansion process by antigen-specific reactivation with peptide loaded artificial antigen presenting cells. These in vitro expanded Tregs continued to express FOXP3 and functional TCRs, and maintained the capacity to suppress conventional T cell responses directed against tyrosinase, as well as bystander T cell responses. Using this methodology in a model tumor system, murine Tregs designed to express the tyrosinase TCR effectively blocked antigen-specific effector T cell (Teff) activity as determined by tumor cell growth and luciferase reporter-based imaging. Conclusions/Significance: These results support the feasibility of class I-restricted TCR transfer as a promising strategy to redirect the functional properties of Tregs and provide for a more efficacious adoptive cell therapy.	[Brusko, Todd M.; Zhu, Shirley; Lee, Michael R.; Putnam, Amy L.; McClymont, Stephanie A.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Koya, Richard C.; Ribas, Antoni] Univ Calif Los Angeles, Sch Med, Dept Surg, Los Angeles, CA 90024 USA; [Nishimura, Michael I.] Med Univ S Carolina, Dept Surg, Charleston, SC 29425 USA; [Han, Shuhong; Chang, Lung-Ji] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Atkinson, Mark A.] Univ Florida, Coll Med, Dept Pathol & Lab Med, Gainesville, FL 32610 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Medical University of South Carolina; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Brusko, TM (corresponding author), Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA.	Jeff.Bluestone@ucsf.edu		Brusko, Todd/0000-0003-2878-9296	NIH Autoimmunity Center of Excellence; Juvenile Diabetes Research Foundation Center; Dee and William Brehm Foundation for Diabetes Research; JDRF; NATIONAL CANCER INSTITUTE [R01CA104947] Funding Source: NIH RePORTER	NIH Autoimmunity Center of Excellence; Juvenile Diabetes Research Foundation Center(Juvenile Diabetes Research Foundation); Dee and William Brehm Foundation for Diabetes Research; JDRF(Juvenile Diabetes Research Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by, in part, by the NIH Autoimmunity Center of Excellence Grant as well as a Juvenile Diabetes Research Foundation Center Grant (Collaborative Center for Cell Therapy), and The Dee and William Brehm Foundation for Diabetes Research. T. B. is supported by a JDRF advanced post-doctoral fellowship grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad JD, 2008, J IMMUNOTHER, V31, P1, DOI 10.1097/CJI.0b013e31815c193f; Allan SE, 2008, MOL THER, V16, P194, DOI 10.1038/sj.mt.6300341; Alyanakian MA, 2003, P NATL ACAD SCI USA, V100, P15806, DOI 10.1073/pnas.2636971100; Battaglia M, 2006, SEMIN IMMUNOL, V18, P120, DOI 10.1016/j.smim.2006.01.007; BLUESTONE JA, 2004, PROCNATLACADSCIUSA; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Brusko TM, 2005, J IMMUNOL, V174, P5181, DOI 10.4049/jimmunol.174.9.5181; Brusko Todd M, 2007, Immunol Invest, V36, P607, DOI 10.1080/08820130701790368; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Brusko TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007980; Chatenoud L, 2001, IMMUNOL REV, V182, P149, DOI 10.1034/j.1600-065X.2001.1820112.x; Chatenoud L, 2007, NAT REV IMMUNOL, V7, P622, DOI 10.1038/nri2134; Cohen CJ, 2007, CANCER RES, V67, P3898, DOI 10.1158/0008-5472.CAN-06-3986; Deaglio S, 2007, J EXP MED; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Govers C, 2010, TRENDS MOL MED, V16, P77, DOI 10.1016/j.molmed.2009.12.004; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Hombach AA, 2009, GENE THER, V16, P1088, DOI 10.1038/gt.2009.75; Huehn J, 2009, NAT REV IMMUNOL, V9, P83, DOI 10.1038/nri2474; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Levine BL, 2002, NAT MED, V8, P47, DOI 10.1038/nm0102-47; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Masteller EL, 2005, J IMMUNOL, V175, P3053, DOI 10.4049/jimmunol.175.5.3053; Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143; MITCHISON NA, 1955, J EXP MED, V102, P157, DOI 10.1084/jem.102.2.157; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Nishimura MI, 1999, CANCER RES, V59, P6230; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Paulos CM, 2008, IMMUNOL RES, V42, P182, DOI 10.1007/s12026-008-8070-9; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Porter DL, 2005, BONE MARROW TRANSPL, V35, P935, DOI 10.1038/sj.bmt.1704953; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Ribas A, 1997, CANCER RES, V57, P2865; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Roszkowski JJ, 2005, CANCER RES, V65, P1570, DOI 10.1158/0008-5472.CAN-04-2076; Roszkowski JJ, 2003, J IMMUNOL, V170, P2582, DOI 10.4049/jimmunol.170.5.2582; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Setiady YY, 2006, BLOOD, V107, P1056, DOI 10.1182/blood-2005-08-3088; St Clair EW, 2007, ANNU REV MED, V58, P329, DOI 10.1146/annurev.med.58.061705.145449; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tahara H, 2003, J IMMUNOL, V171, P2154, DOI 10.4049/jimmunol.171.4.2154; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Thomas S, 2007, EXPERT OPIN BIOL TH, V7, P1207, DOI 10.1517/14712598.7.8.1207; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wright GP, 2009, P NATL ACAD SCI USA, V106, P19078, DOI 10.1073/pnas.0907396106; Yan ZH, 2009, NAT CHEM BIOL, V5, P721, DOI 10.1038/nchembio.212; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	57	110	115	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11726	10.1371/journal.pone.0011726	http://dx.doi.org/10.1371/journal.pone.0011726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20668510	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300026
J	Huijts, T; Perkins, JM; Subramanian, SV				Huijts, Tim; Perkins, Jessica M.; Subramanian, S. V.			Political Regimes, Political Ideology, and Self-Rated Health in Europe: A Multilevel Analysis	PLOS ONE			English	Article							INEQUALITIES	Background: Studies on political ideology and health have found associations between individual ideology and health as well as between ecological measures of political ideology and health. Individual ideology and aggregate measures such as political regimes, however, were never examined simultaneously. Methodology/Principal Findings: Using adjusted logistic multilevel models to analyze data on individuals from 29 European countries and Israel, we found that individual ideology and political regime are independently associated with self-rated health. Individuals with rightwing ideologies report better health than leftwing individuals. Respondents from Eastern Europe and former Soviet republics report poorer health than individuals from social democratic, liberal, Christian conservative, and former Mediterranean dictatorship countries. In contrast to individual ideology and political regimes, country level aggregations of individual ideology are not related to reporting poor health. Conclusions/Significance: This study shows that although both individual political ideology and contextual political regime are independently associated with individuals' self-rated health, individual political ideology appears to be more strongly associated with self-rated health than political regime.	[Perkins, Jessica M.] Harvard Univ, Dept Hlth Policy, Cambridge, MA 02138 USA; [Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Huijts, Tim] Radboud Univ Nijmegen, Dept Sociol, NL-6525 ED Nijmegen, Netherlands	Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Radboud University Nijmegen	Huijts, T (corresponding author), Radboud Univ Nijmegen, Dept Sociol, NL-6525 ED Nijmegen, Netherlands.	svsubram@hsph.harvard.edu	Huijts, Tim/E-7609-2013; Perkins, Jessica M./ABG-2467-2020	Perkins, Jessica M./0000-0002-5475-8816	National Institutes of Health [NHLBI 1 K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No direct funding was available for this study. SVS is supported by the National Institutes of Health Career Development Award (NHLBI 1 K25 HL081275).	Beckfield J, 2009, EPIDEMIOL REV, V31, P152, DOI 10.1093/epirev/mxp002; Eikemo TA, 2008, SOC SCI MED, V66, P2281, DOI 10.1016/j.socscimed.2008.01.022; Espelt A, 2008, INT J EPIDEMIOL, V37, P1095, DOI 10.1093/ije/dyn051; Jowell R, 2003, EUROPEAN SOCIAL SURV; KNUTSEN O, 1995, EUR J POLIT RES, V28; Lundberg O, 2008, INT J EPIDEMIOL, V37, P1105, DOI 10.1093/ije/dyn078; Navarro V, 2001, SOC SCI MED, V52, P481, DOI 10.1016/S0277-9536(00)00197-0; Smith GD, 1996, BRIT MED J, V313, P1573, DOI 10.1136/bmj.313.7072.1573; Subramanian SV, 2010, INT J EPIDEMIOL, V39, P930, DOI 10.1093/ije/dyp152; Subramanian SV, 2009, EUR J PUBLIC HEALTH, V19, P455, DOI 10.1093/eurpub/ckp077; SUBRAMANIAN SV, J EPIDEMIOL COMMUNIT; 2009, EUROPEAN SOCIAL SURV	12	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11711	10.1371/journal.pone.0011711	http://dx.doi.org/10.1371/journal.pone.0011711			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	630AN	20661433	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243300014
J	Xia, CH; Yablonka-Reuveni, Z; Gong, XH				Xia, Chun-hong; Yablonka-Reuveni, Zipora; Gong, Xiaohua			LRP5 Is Required for Vascular Development in Deeper Layers of the Retina	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; MULLER CELLS; NORRIE-DISEASE; EXPRESSION; MUTATIONS; MICE; ANGIOGENESIS; FRIZZLED-4; GROWTH; MODEL	Background: The low-density lipoprotein receptor-related protein 5 (LRP5) plays an important role in the development of retinal vasculature. LRP5 loss-of-function mutations cause incomplete development of retinal vessel network in humans as well as in mice. To understand the underlying mechanism for how LRP5 mutations lead to retinal vascular abnormalities, we have determined the retinal cell types that express LRP5 and investigated specific molecular and cellular functions that may be regulated by LRP5 signaling in the retina. Methods and Findings: We characterized the development of retinal vasculature in LRP5 mutant mice using specific retinal cell makers and a GFP transgene expressed in retinal endothelial cells. Our data revealed that retinal vascular endothelial cells predominantly formed cell clusters in the inner-plexiform layer of LRP5 mutant retina rather than sprouting out or migrating into deeper layers to form normal vascular network in the retina. The IRES-beta-galactosidase (LacZ) report gene under the control of the endogenous LRP5 promoter was highly expressed in Muller cells and was also weakly detected in endothelial cells of the retinal surface vasculature. Moreover, the LRP5 mutant mice had a reduction of a Muller cell-specific glutamine transporter, Slc38a5, and showed a decrease in b-wave amplitude of electroretinogram. Conclusions: LRP5 is not only essential for vascular endothelial cells to sprout, migrate and/or anastomose in the deeper plexus during retinal vasculature development but is also important for the functions of Muller cells and retinal interneurons. Muller cells may utilize LRP5-mediated signaling pathway to regulate vascular development in deeper layers and to maintain the function of retinal interneurons.	[Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Xia, Chun-hong; Gong, Xiaohua] Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; [Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Washington; University of Washington Seattle	Xia, CH (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	chxia@berkeley.edu			East Bay Community Foundation; National Institutes of Health (NIH) [AG021566]; NATIONAL EYE INSTITUTE [R01EY013849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021566] Funding Source: NIH RePORTER	East Bay Community Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by an East Bay Community Foundation grant (XG) and a National Institutes of Health (NIH) grant AG021566 (ZYR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Day K, 2007, DEV BIOL, V304, P246, DOI 10.1016/j.ydbio.2006.12.026; Fruttiger M, 2002, INVEST OPHTH VIS SCI, V43, P522; GARIANO RF, 1994, INVEST OPHTH VIS SCI, V35, P3442; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Jiao XD, 2004, AM J HUM GENET, V75, P878, DOI 10.1086/425080; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kirillova I, 2007, DEV BIOL, V311, P449, DOI 10.1016/j.ydbio.2007.08.056; Li Q, 2002, EXP EYE RES, V74, P615, DOI 10.1006/exer.2002.1170; LIU H, INVEST OPHTHALMOL VI, V51, P1059; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Mizutani M, 1998, DIABETES, V47, P445, DOI 10.2337/diabetes.47.3.445; Mu H, 2009, MOL BIOL REP, V36, P2147, DOI 10.1007/s11033-008-9428-8; Provis JM, 2001, PROG RETIN EYE RES, V20, P799, DOI 10.1016/S1350-9462(01)00012-X; Rehm HL, 2002, J NEUROSCI, V22, P4286, DOI 10.1523/JNEUROSCI.22-11-04286.2002; Richter M, 1998, INVEST OPHTH VIS SCI, V39, P2450; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Schafer NF, 2009, INVEST OPHTH VIS SCI, V50, P906, DOI 10.1167/iovs.08-1731; STONE J, 1995, J NEUROSCI, V15, P4738, DOI 10.1523/jneurosci.15-07-04738.1995; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; Umapathy NS, 2005, INVEST OPHTH VIS SCI, V46, P3980, DOI 10.1167/iovs.05-0488; Xia CH, 2008, HUM MOL GENET, V17, P1605, DOI 10.1093/hmg/ddn047; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	26	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11676	10.1371/journal.pone.0011676	http://dx.doi.org/10.1371/journal.pone.0011676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652025	Green Submitted, Green Published, gold			2022-12-27	WOS:000280109700009
J	Goswami, C; Kuhn, J; Heppenstall, PA; Hucho, T				Goswami, Chandan; Kuhn, Julia; Heppenstall, Paul A.; Hucho, Tim			Importance of Non-Selective Cation Channel TRPV4 Interaction with Cytoskeleton and Their Reciprocal Regulations in Cultured Cells	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-4; PAINFUL PERIPHERAL NEUROPATHY; SUBMEMBRANEOUS MICROTUBULE CYTOSKELETON; ACETYLATED ALPHA-TUBULIN; ROOT GANGLION NEURONS; KINASE-C-EPSILON; MECHANICAL HYPERALGESIA; INFLAMMATORY PAIN; EPITHELIAL-CELLS; DETYROSINATED TUBULIN	Background: TRPV4 and the cellular cytoskeleton have each been reported to influence cellular mechanosensitive processes as well as the development of mechanical hyperalgesia. If and how TRPV4 interacts with the microtubule and actin cytoskeleton at a molecular and functional level is not known. Methodology and Principal Findings: We investigated the interaction of TRPV4 with cytoskeletal components biochemically, cell biologically by observing morphological changes of DRG-neurons and DRG-neuron-derived F-11 cells, as well as functionally with calcium imaging. We find that TRPV4 physically interacts with tubulin, actin and neurofilament proteins as well as the nociceptive molecules PKC epsilon and CamKII. The C-terminus of TRPV4 is sufficient for the direct interaction with tubulin and actin, both with their soluble and their polymeric forms. Actin and tubulin compete for binding. The interaction with TRPV4 stabilizes microtubules even under depolymerizing conditions in vitro. Accordingly, in cellular systems TRPV4 colocalizes with actin and microtubules enriched structures at submembranous regions. Both expression and activation of TRPV4 induces striking morphological changes affecting lamellipodial, filopodial, growth cone, and neurite structures in non-neuronal cells, in DRG-neuron derived F11 cells, and also in IB4-positive DRG neurons. The functional interaction of TRPV4 and the cytoskeleton is mutual as Taxol, a microtubule stabilizer, reduces the Ca2+-influx via TRPV4. Conclusions and Significance: TRPV4 acts as a regulator for both, the microtubule and the actin. In turn, we describe that microtubule dynamics are an important regulator of TRPV4 activity. TRPV4 forms a supra-molecular complex containing cytoskeletal proteins and regulatory kinases. Thereby it can integrate signaling of various intracellular second messengers and signaling cascades, as well as cytoskeletal dynamics. This study points out the existence of cross-talks between nonselective cation channels and cytoskeleton at multiple levels. These cross talks may help us to understand the molecular basis of the Taxol-induced neuropathic pain development commonly observed in cancer patients.	[Goswami, Chandan; Kuhn, Julia; Hucho, Tim] Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany; [Goswami, Chandan] Natl Inst Sci Educ & Res, Bhubaneswar, Orissa, India; [Heppenstall, Paul A.] Charite, Klin Anaesthesiol & Operat Intens Med, D-13353 Berlin, Germany	Max Planck Society; National Institute of Science Education & Research (NISER); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Goswami, C (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Berlin, Germany.	goswami@molgen.mpg.de	Hucho, Tim/Q-5218-2018; Hucho, Tim/F-8973-2010	Hucho, Tim/0000-0002-4147-9308; 	Max Planck Institute for Molecular Genetics (Berlin, Germany); National Institute of Science Education and Research, India	Max Planck Institute for Molecular Genetics (Berlin, Germany); National Institute of Science Education and Research, India	Funding from Max Planck Institute for Molecular Genetics (Berlin, Germany) is gratefully acknowledged. CG is now supported by National Institute of Science Education and Research, India. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 2000, NAT CELL BIOL, V2, P276, DOI 10.1038/35010544; Alenghat FJ, 2004, EXP CELL RES, V301, P23, DOI 10.1016/j.yexcr.2004.08.003; Alessandri-Haber N, 2006, J NEUROSCI, V26, P3864, DOI 10.1523/JNEUROSCI.5385-05.2006; Alessandri-Haber N, 2005, PAIN, V118, P70, DOI 10.1016/j.pain.2005.07.016; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Alessandri-Haber N, 2003, NEURON, V39, P497, DOI 10.1016/S0896-6273(03)00462-8; Alessandri-Haber N, 2008, J NEUROSCI, V28, P1046, DOI 10.1523/JNEUROSCI.4497-07.2008; Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070; Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200; Baas PW, 2001, TRENDS CELL BIOL, V11, P244, DOI 10.1016/S0962-8924(01)02005-0; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Becker D, 2008, MOL MEMBR BIOL, V25, P139, DOI 10.1080/09687680701635237; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Belmadani S, 2004, MOL CELL BIOCHEM, V258, P35, DOI 10.1023/B:MCBI.0000012834.43990.b6; BELTRAMO DM, 1987, EUR J BIOCHEM, V162, P137, DOI 10.1111/j.1432-1033.1987.tb10553.x; Bender FLP, 2005, CELL PHYSIOL BIOCHEM, V15, P183, DOI 10.1159/000083651; Benfenati V, 2007, NEUROSCIENCE, V148, P876, DOI 10.1016/j.neuroscience.2007.06.039; Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Bhave G, 2003, NEURON, V39, P577, DOI 10.1016/S0896-6273(03)00500-2; Blase C, 2009, EUR J CELL BIOL, V88, P131, DOI 10.1016/j.ejcb.2008.10.003; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Boulais N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006528; Boulais N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007759; CANTIELLO HF, 1993, J BIOL CHEM, V268, P4596; Cardone L, 2002, J MOL BIOL, V320, P663, DOI 10.1016/S0022-2836(02)00479-5; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Cuajungco MP, 2007, BBA-MOL BASIS DIS, V1772, P1022, DOI 10.1016/j.bbadis.2007.01.002; Deng HX, 2010, NAT GENET, V42, P165, DOI 10.1038/ng.509; Dina OA, 2003, NEURON, V39, P613, DOI 10.1016/S0896-6273(03)00473-2; Dina OA, 2001, NEUROSCIENCE, V108, P507, DOI 10.1016/S0306-4522(01)00425-0; Drew LJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-12-j0001.2002; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Fan HC, 2009, J BIOL CHEM, V284, P27884, DOI 10.1074/jbc.M109.028803; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Goswami C, 2007, J NEUROCHEM, V103, P1319, DOI 10.1111/j.1471-4159.2007.04846.x; Goswami C, 2007, J NEUROCHEM, V101, P250, DOI 10.1111/j.1471-4159.2006.04338.x; Goswami C, 2007, FEBS J, V274, P760, DOI 10.1111/j.1742-4658.2006.05621.x; Goswami C, 2006, J NEUROCHEM, V96, P254, DOI 10.1111/j.1471-4159.2005.03551.x; Goswami C, 2004, J NEUROCHEM, V91, P1092, DOI 10.1111/j.1471-4159.2004.02795.x; Goswami C, 2008, FEBS J, V275, P4684, DOI 10.1111/j.1742-4658.2008.06617.x; Goswami C, 2008, FEBS J, V275, P4653, DOI 10.1111/j.1742-4658.2008.06613.x; Gradilone SA, 2007, P NATL ACAD SCI USA, V104, P19138, DOI 10.1073/pnas.0705964104; Han P, 2007, BIOCHEM PHARMACOL, V73, P1635, DOI 10.1016/j.bcp.2006.12.035; HUANG MX, 1995, NATURE, V378, P292, DOI 10.1038/378292a0; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Hucho TB, 2006, EUR J NEUROSCI, V24, P527, DOI 10.1111/j.1460-9568.2006.04913.x; Jin HW, 2008, EXP NEUROL, V210, P229, DOI 10.1016/j.expneurol.2007.11.001; Khasar SG, 1999, NEURON, V24, P253, DOI 10.1016/S0896-6273(00)80837-5; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Kuhn J, 2008, EUR J NEUROSCI, V27, P1700, DOI 10.1111/j.1460-9568.2008.06131.x; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Landoure G, 2010, NAT GENET, V42, P170, DOI 10.1038/ng.512; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; LEDIZET M, 1986, J CELL BIOL, V103, P13, DOI 10.1083/jcb.103.1.13; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Liu YJ, 2006, IEEE ANTENN WIREL PR, V5, P4, DOI 10.1109/LAWP.2005.863611; Lorenzo IM, 2008, P NATL ACAD SCI USA, V105, P12611, DOI 10.1073/pnas.0803970105; Luo F, 2008, J PHARMACOL EXP THER, V325, P267, DOI 10.1124/jpet.107.132167; Ma YY, 2008, BIOL PHARM BULL, V31, P426, DOI 10.1248/bpb.31.426; Malik B, 2008, CURR NEUROL NEUROSCI, V8, P56, DOI 10.1007/s11910-008-0010-5; MANESS PF, 1990, CIBA F SYMP, V150, P57; Martinez-Salgado C, 2007, J NEUROPHYSIOL, V98, P3802, DOI 10.1152/jn.00860.2007; McCarter GC, 1999, NEUROSCI LETT, V273, P179, DOI 10.1016/S0304-3940(99)00665-5; McCarter GC, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-28; Mizuno A, 2003, AM J PHYSIOL-CELL PH, V285, pC96, DOI 10.1152/ajpcell.00559.2002; Mofrad MRK, 2005, ACTA BIOMATER, V1, P281, DOI 10.1016/j.actbio.2005.02.008; Nilius B, 2010, NAT GENET, V42, P98, DOI 10.1038/ng0210-98; Odell AF, 2008, J BIOL CHEM, V283, P4395, DOI 10.1074/jbc.M709729200; Pan Z, 2008, CELL CALCIUM, V44, P374, DOI 10.1016/j.ceca.2008.01.008; Peng HQ, 2010, BIOCHEM BIOPH RES CO, V391, P1721, DOI 10.1016/j.bbrc.2009.12.140; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Ramadass R, 2007, ARCH BIOCHEM BIOPHYS, V463, P27, DOI 10.1016/j.abb.2007.01.036; Rock MJ, 2008, NAT GENET, V40, P999, DOI 10.1038/ng.166; RODRIGUEZ JA, 1979, BIOCHEM BIOPH RES CO, V89, P893, DOI 10.1016/0006-291X(79)91862-X; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shibasaki K, 2007, J NEUROSCI, V27, P1566, DOI 10.1523/JNEUROSCI.4284-06.2007; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Tabuchi K, 2005, NEUROSCI LETT, V382, P304, DOI 10.1016/j.neulet.2005.03.035; Tanner KD, 1998, J COMP NEUROL, V395, P481; Teilmann SC, 2005, MOL REPROD DEV, V71, P444, DOI 10.1002/mrd.20312; Topp KS, 2000, J COMP NEUROL, V424, P563; VOTER WA, 1991, CELL MOTIL CYTOSKEL, V18, P55, DOI 10.1002/cm.970180106; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Waning J, 2007, CELL CALCIUM, V42, P17, DOI 10.1016/j.ceca.2006.11.005; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Webster DR, 1997, J MOL CELL CARDIOL, V29, P2813, DOI 10.1006/jmcc.1997.0517; Wegierski T, 2009, J BIOL CHEM, V284, P2923, DOI 10.1074/jbc.M805357200; Wetzel C, 2007, NATURE, V445, P206, DOI 10.1038/nature05394; Xu F, 2003, BRIT J PHARMACOL, V140, P413, DOI 10.1038/sj.bjp.0705443	101	110	112	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11654	10.1371/journal.pone.0011654	http://dx.doi.org/10.1371/journal.pone.0011654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657843	gold, Green Published, Green Submitted			2022-12-27	WOS:000280065600017
J	Hautier, Y; Saner, P; Philipson, C; Bagchi, R; Ong, RC; Hector, A				Hautier, Yann; Saner, Philippe; Philipson, Christopher; Bagchi, Robert; Ong, Robert C.; Hector, Andy			Effects of Seed Predators of Different Body Size on Seed Mortality in Bornean Logged Forest	PLOS ONE			English	Article							DISTANCE-DEPENDENCE; SMALL MAMMALS; RAIN-FORESTS; TREE; DISPERSAL; DENSITY; DIPTEROCARPACEAE; RECRUITMENT; DIVERSITY; DYNAMICS	Background: The Janzen-Connell hypothesis proposes that seed and seedling enemies play a major role in maintaining high levels of tree diversity in tropical forests. However, human disturbance may alter guilds of seed predators including their body size distribution. These changes have the potential to affect seedling survival in logged forest and may alter forest composition and diversity. Methodology/Principal Findings: We manipulated seed density in plots beneath con- and heterospecific adult trees within a logged forest and excluded vertebrate predators of different body sizes using cages. We show that small and large-bodied predators differed in their effect on con- and heterospecific seedling mortality. In combination small and large-bodied predators dramatically decreased both con- and heterospecific seedling survival. In contrast, when larger-bodied predators were excluded small-bodied predators reduced conspecific seed survival leaving seeds coming from the distant tree of a different species. Conclusions/Significance: Our results suggest that seed survival is affected differently by vertebrate predators according to their body size. Therefore, changes in the body size structure of the seed predator community in logged forests may change patterns of seed mortality and potentially affect recruitment and community composition.	[Hautier, Yann; Saner, Philippe; Philipson, Christopher; Bagchi, Robert; Hector, Andy] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Ong, Robert C.] Forest Res Ctr, Sabah Forestry Dept, Sandakan, Sabah, Malaysia	University of Zurich; Pusat Penyelidikan Hutan	Hautier, Y (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	yann.hautier@ieu.uzh.ch	Bagchi, Robert/F-1732-2011; Hautier, Yann/I-2526-2019; Hector, Andrew/H-4199-2011; Hautier, Yann/D-5426-2015	Bagchi, Robert/0000-0003-4035-4105; Hautier, Yann/0000-0003-4347-7741; Hector, Andrew/0000-0002-1309-7716; Hautier, Yann/0000-0003-4347-7741; Philipson, Christopher/0000-0001-8987-7260	Swiss National Foundation [3100A0-107572, 31003A_125461/1]; Royal Society [RS243]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Royal Society(Royal Society of London)	This project is funded by Swiss National Foundation grants 3100A0-107572 and 31003A_125461/1 to A.H. and is part of the Royal Society Southeast Asia Rain Forest Research Programme (Project No. RS243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Economic Planning Unit Sabah, Malaysia approved this field study. This is paper N degrees 2 of the Sabah Biodiversity Experiment.	ASHTON PS, 1988, AM NAT, V132, P44, DOI 10.1086/284837; Bates D, 2005, R NEWS, V5, P27, DOI DOI 10.1111/J.1523-1739.2005.00280.X; Beck H, 2004, OIKOS, V106, P27, DOI 10.1111/j.0030-1299.2004.12864.x; Bennett EL, 2000, BIOL RESOURCE MANAGE, P305; Blate GM, 1998, OIKOS, V82, P522, DOI 10.2307/3546373; Blundell AG, 2004, ECOLOGY, V85, P704, DOI 10.1890/01-4101; BODMER RE, 1991, BIOTROPICA, V23, P255, DOI 10.2307/2388202; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Capistran-Barradas A, 2006, BIOTROPICA, V38, P203, DOI 10.1111/j.1744-7429.2006.00116.x; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Comita LS, 2007, J VEG SCI, V18, P163, DOI 10.1658/1100-9233(2007)18[163:POWPSA]2.0.CO;2; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; Curran LM, 2000, ECOL MONOGR, V70, P129, DOI 10.1890/0012-9615(2000)070[0129:ETOTSS]2.0.CO;2; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; CURRAN LM, 2000, ECOL MONOGR, P101; Dalling JW, 1998, J ECOL, V86, P674, DOI 10.1046/j.1365-2745.1998.00298.x; DeMattia EA, 2004, ECOLOGY, V85, P2161, DOI 10.1890/03-0254; Faraway JJ., 2005, EXTENDING LINEAR MOD; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Gelman A., 2007, DATA ANAL USING REGR; Gilbert Gregory S., 2005, P141, DOI 10.1017/CBO9780511541971.007; Gould K., 1989, Malayan Nature Journal, V42, P245; Hammond D. S., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P51; Harper J. L., 1977, Population biology of plants.; HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; ITOH A, 1995, J TROP ECOL, V11, P517, DOI 10.1017/S0266467400009068; Jansen Patrick A., 2002, P209, DOI 10.1079/9780851995250.0209; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; MAINDONALD D, 2007, DATA ANAL GRAPHICS U; MARSH CW, 1992, PHILOS T ROY SOC B, V335, P331, DOI 10.1098/rstb.1992.0025; Maycock CR, 2005, J VEG SCI, V16, P635, DOI 10.1111/j.1654-1103.2005.tb02406.x; McConkey KR, 2002, INT J PRIMATOL, V23, P123, DOI 10.1023/A:1013253909046; Naito Y, 2008, FOREST ECOL MANAG, V256, P375, DOI 10.1016/j.foreco.2008.04.031; Nakagawa M, 2005, BIOTROPICA, V37, P389, DOI 10.1111/j.1744-7429.2005.00051.x; NATAWIRIA D, 1986, B PENELITIAN HUTAN P, V472, P1; Paine CET, 2007, ECOLOGY, V88, P3076, DOI 10.1890/06-1835.1; R Development Core Team, 2008, LANG ENV STAT COMP; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Sodhi NS, 2004, TRENDS ECOL EVOL, V19, P654, DOI 10.1016/j.tree.2004.09.006; Stoll P, 2005, ECOLOGY, V86, P3048, DOI 10.1890/04-1540; Takeuchi Y, 2007, FOREST ECOL MANAG, V247, P167, DOI 10.1016/j.foreco.2007.04.028; TERBORGH J, 1993, VEGETATIO, V108, P375; TOY RJ, 1991, J TROP ECOL, V7, P49, DOI 10.1017/S0266467400005058; Turner I.M, 2001, ASIAN J TROPICAL BIO, V4, P1; Wells K, 2005, RAFFLES B ZOOL, V53, P281; Wells K, 2006, J ANIM ECOL, V75, P1212, DOI 10.1111/j.1365-2656.2006.01144.x; Wells K, 2009, J TROP ECOL, V25, P555, DOI 10.1017/S0266467409990058; Whitmore T. C., 1998, INTRO TROPICAL RAINF; Wong ST, 2005, J TROP ECOL, V21, P627, DOI 10.1017/S0266467405002622; Wright SJ, 2001, BIOTROPICA, V33, P583, DOI 10.1111/j.1744-7429.2001.tb00217.x; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Wright SJ, 2000, CONSERV BIOL, V14, P227, DOI 10.1046/j.1523-1739.2000.98333.x; Wyatt JL, 2004, OECOLOGIA, V140, P26, DOI 10.1007/s00442-004-1554-y	57	24	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11651	10.1371/journal.pone.0011651	http://dx.doi.org/10.1371/journal.pone.0011651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657841	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000280065600015
J	Sjodin, A; Svensson, K; Lindgren, M; Forsman, M; Larsson, P				Sjodin, Andreas; Svensson, Kerstin; Lindgren, Marie; Forsman, Mats; Larsson, Par			Whole-Genome Sequencing Reveals Distinct Mutational Patterns in Closely Related Laboratory and Naturally Propagated Francisella tularensis Strains	PLOS ONE			English	Article							SCHU S4; IDENTIFICATION; VIRULENCE; REPLICATION; MUTANTS; GENERATION; EVOLUTION; INFECTION; NOVICIDA; SCREEN	The F. tularensis type A strain FSC198 from Slovakia and a second strain FSC043, which has attenuated virulence, are both considered to be derivatives of the North American F. tularensis type A strain SCHU S4. These strains have been propagated under different conditions: the FSC198 has undergone natural propagation in the environment, while the strain FSC043 has been cultivated on artificial media in laboratories. Here, we have compared the genome sequences of FSC198, FSC043, and SCHU S4 to explore the possibility that the contrasting propagation conditions may have resulted in different mutational patterns. We found four insertion/deletion events (INDELs) in the strain FSC043, as compared to the SCHU S4, while no single nucleotide polymorphisms (SNPs) or variable number of tandem repeats (VNTRs) were identified. This result contrasts with previously reported findings for the strain FSC198, where eight SNPs and three VNTR differences, but no INDELs exist as compared to the SCHU S4 strain. The mutations detected in the laboratory and naturally propagated type A strains, respectively, demonstrate distinct patterns supporting that analysis of mutational spectra might be a useful tool to reveal differences in past growth conditions. Such information may be useful to identify leads in a microbial forensic investigation.	[Sjodin, Andreas; Svensson, Kerstin; Forsman, Mats; Larsson, Par] FOI Swedish Def Res Agcy, Div CBRN Secur & Def, Umea, Sweden; [Lindgren, Marie] Umea Univ, Dept Clin Microbiol & Clin Bacteriol, Umea, Sweden; [Lindgren, Marie] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden	FOI - Swedish Defence Research Agency; Umea University; Umea University	Sjodin, A (corresponding author), FOI Swedish Def Res Agcy, Div CBRN Secur & Def, Umea, Sweden.	par.larsson@foi.se	Sjödin, Andreas/A-7245-2008; Forsman, Mats/A-1426-2016	Sjödin, Andreas/0000-0001-5350-4219; Forsman, Mats/0000-0002-4466-5325	Swedish Ministry of Foreign Affairs [A4952]; Swedish Civil Contingencies Agency [B4055]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [AI60689]; Swedish Medical Research Council; Medical Faculty, Umea University, Umea, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060689] Funding Source: NIH RePORTER	Swedish Ministry of Foreign Affairs; Swedish Civil Contingencies Agency; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Medical Faculty, Umea University, Umea, Sweden; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the Swedish Ministry of Foreign Affairs, project A4952, the Swedish Civil Contingencies Agency, project B4055, and the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under grant No. AI60689. Grant support was obtained from the Swedish Medical Research Council and the Medical Faculty, Umea University, Umea, Sweden. The work was performed in part at the Umea Centre for Microbial Research (UCMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JR, 2007, ANN NY ACAD SCI, V1105, P138, DOI 10.1196/annals.1409.010; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beckstrom-Sternberg SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000947; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Chaudhuri RR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000352; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Frank DW, 2007, ANN NY ACAD SCI, V1105, P67, DOI 10.1196/annals.1409.008; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gurycova D, 1998, EUR J EPIDEMIOL, V14, P797, DOI 10.1023/A:1007537405242; HESSELBROCK W, 1945, J BACTERIOL, V49, P209, DOI 10.1128/JB.49.3.209-231.1945; Johansson A, 2004, J BACTERIOL, V186, P5808, DOI 10.1128/JB.186.17.5808-5818.2004; Johansson A, 2000, J CLIN MICROBIOL, V38, P4180, DOI 10.1128/JCM.38.11.4180-4185.2000; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; Kugeler KJ, 2009, CLIN INFECT DIS, V48, P863, DOI 10.1086/597261; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Larsson P, 2005, NAT GENET, V37, P153, DOI 10.1038/ng1499; Larsson P, 2007, EMERG INFECT DIS, V13, P1725, DOI 10.3201/eid1311.070603; Larsson P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000472; Lindgren H, 2009, INFECT IMMUN, V77, P4429, DOI 10.1128/IAI.00702-09; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; MARTH G, MARTHLAB PROJECT PAG; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Nusbaum C, 2009, NAT METHODS, V6, P67, DOI [10.1038/NMETH.1286, 10.1038/nmeth.1286]; Oggioni MR, 1999, MICROBIOL-SGM, V145, P2647, DOI 10.1099/00221287-145-10-2647; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Salomonsson E, 2009, MICROBIOL-SGM, V155, P2546, DOI 10.1099/mic.0.028183-0; Shumway M, 2010, NUCLEIC ACIDS RES, V38, pD870, DOI 10.1093/nar/gkp1078; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Svensson K, 2005, J BACTERIOL, V187, P3903, DOI 10.1128/JB.187.11.3903-3908.2005; Svensson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008360; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Tucker JB, 2009, BIOSECUR BIOTERROR, V7, P389, DOI 10.1089/bsp.2009.0043; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Twine SM, 2006, MICROB PATHOGENESIS, V40, P133, DOI 10.1016/j.micpath.2005.12.004; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	42	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11556	10.1371/journal.pone.0011556	http://dx.doi.org/10.1371/journal.pone.0011556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657845	Green Published, gold, Green Submitted			2022-12-27	WOS:000280065600004
J	Giliberto, L; d'Abramo, C; Acker, CM; Davies, P; D'Adamio, L				Giliberto, Luca; d'Abramo, Cristina; Acker, Christopher Michael; Davies, Peter; D'Adamio, Luciano			Transgenic Expression of the Amyloid-beta Precursor Protein-Intracellular Domain Does Not Induce Alzheimer's Disease-Like Traits In Vivo	PLOS ONE			English	Article							GAMMA-SECRETASE; A-BETA; PRESENILIN MUTATIONS; SYNAPTIC PLASTICITY; TERMINAL FRAGMENT; TALKING POINT; APP; MICE; TAU; PHOSPHORYLATION	Background: Regulated intramembranous proteolysis of the amyloid-beta precursor protein by the gamma-secretase yields amyloid-beta, which is the major component of the amyloid plaques found in Alzheimer's disease (AD), and the APP intracellular domain (AID). In vitro studies have involved AID in apoptosis and gene transcription. In vivo studies, which utilize transgenic mice expressing AID in the forebrain, only support a role for AID in apoptosis but not gene transcription. Methodology/Principal Findings: Here, we have further characterized several lines of AID transgenic mice by crossing them with human Tau-bearing mice, to determine whether over-expression of AID in the forebrain provokes AD-like pathologic features in this background. We have found no evidence that AID overexpression induces AD-like characteristics, such as activation of GSK-3 beta, hyperphosphorylation of Tau and formation of neurofibrillary pathology. Conclusions/Significance: Overall, these data suggest that AID transgenic mice do not represent a model that reproduces the overt biochemical and anatomo-pathologic lesions observed in AD patients. They can still be a valuable tool to understand the role of AID in enhancing the cell sensitivity to apoptotic stimuli, whose pathways still need to be characterized.	[Giliberto, Luca; d'Abramo, Cristina; Davies, Peter] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA; [Acker, Christopher Michael; Davies, Peter] Albert Einstein Coll Med, Dept Pathol, New York, NY USA; [D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, New York, NY USA	Northwell Health; Yeshiva University; Yeshiva University	Giliberto, L (corresponding author), N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA.	lgiliberto@nshs.edu; luciano.dadamio@einstein.yu.edu		D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer Disease Research Grant [A2003-076]; National Institutes of Health (NIH) [RO1 AG22024, RO1 AG21588, R21 AG027139]; NATIONAL INSTITUTE ON AGING [R37AG022102, R21AG027139, R01AG022024, R01AG021588] Funding Source: NIH RePORTER	Alzheimer Disease Research Grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by Alzheimer Disease Research Grant A2003-076 (LD) and National Institutes of Health (NIH) grants RO1 AG22024 (LD), RO1 AG21588 (LD), and R21 AG027139 (LD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bertrand E, 2001, MOL CELL NEUROSCI, V18, P503, DOI 10.1006/mcne.2001.1030; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; DAVIES P, 1999, ALZHEIMERS DIS METHO, P361; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Gao YH, 2001, P NATL ACAD SCI USA, V98, P14979, DOI 10.1073/pnas.261463298; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; Ghosal K, 2009, P NATL ACAD SCI USA, V106, P18367, DOI 10.1073/pnas.0907652106; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Leroy K, 2007, AM J PATHOL, V171, P976, DOI 10.2353/ajpath.2007.070345; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; McGowan E, 2006, TRENDS GENET, V22, P281, DOI 10.1016/j.tig.2006.03.007; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Walsh DM, 2003, BIOCHEMISTRY-US, V42, P6664, DOI 10.1021/bi027375c; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200	53	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11609	10.1371/journal.pone.0011609	http://dx.doi.org/10.1371/journal.pone.0011609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661273	gold, Green Published, Green Submitted			2022-12-27	WOS:000279980800006
J	Lane, SD; Steinberg, JL; Ma, LS; Hasan, KM; Kramer, LA; Zuniga, EA; Narayana, PA; Moeller, FG				Lane, Scott D.; Steinberg, Joel L.; Ma, Liangsuo; Hasan, Khader M.; Kramer, Larry A.; Zuniga, Edward A.; Narayana, Ponnada A.; Moeller, Frederick Gerard			Diffusion Tensor Imaging and Decision Making in Cocaine Dependence	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; NUCLEUS-ACCUMBENS; MEAN DIFFUSIVITY; RISK-TAKING; BRAIN; PERFORMANCE; ABNORMALITIES; REGISTRATION	Background: Chronic stimulant abuse is associated with both impairment in decision making and structural abnormalities in brain gray and white matter. Recent data suggest these structural abnormalities may be related to functional impairment in important behavioral processes. Methodology/Principal Findings: In 15 cocaine-dependent and 18 control subjects, we examined relationships between decision-making performance on the Iowa Gambling Task (IGT) and white matter integrity as measured by diffusion tensor imaging (DTI). Whole brain voxelwise analyses showed that, relative to controls, the cocaine group had lower fractional anisotropy (FA) and higher mean of the second and third eigenvalues (lambda perpendicular to) in frontal and parietal white matter regions and the corpus callosum. Cocaine subjects showed worse performance on the IGT, notably over the last 40 trials. Importantly, FA and lambda perpendicular to values in these regions showed a significant relationship with IGT performance on the last 40 trials. Conclusions: Compromised white matter integrity in cocaine dependence may be related to functional impairments in decision making.	[Lane, Scott D.; Steinberg, Joel L.; Ma, Liangsuo; Zuniga, Edward A.; Moeller, Frederick Gerard] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX USA; [Lane, Scott D.; Hasan, Khader M.; Narayana, Ponnada A.; Moeller, Frederick Gerard] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Program Neurosci, Houston, TX USA; [Hasan, Khader M.; Kramer, Larry A.; Narayana, Ponnada A.] Univ Texas Hlth Sci Ctr Houston, Dept Diagnost & Intervent Imaging, Houston, TX USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Lane, SD (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX USA.	scott.d.lane@uth.tmc.edu	Hasan, Khader M./ABB-5767-2020		National Institutes of Health (NIH) [P50 DA 09262, K02 DA 00403, R01 DA 15392, R01 NS 52505, R01 EB002095, S10 RR19186]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA009262, K02DA000403, R01DA015392] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following National Institutes of Health (NIH) grants: P50 DA 09262 and K02 DA 00403 to FGM, R01 DA 15392 to SDL, R01 NS 52505 to KMH, R01 EB002095 and S10 RR19186 to PAN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersson J.L.R., 2007, TR07JA1 FMRIB; Bartzokis G, 2002, BIOL PSYCHIAT, V51, P605, DOI 10.1016/S0006-3223(02)01315-X; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bjork JM, 2004, J NEUROSCI, V24, P1793, DOI 10.1523/JNEUROSCI.4862-03.2004; Bolla KI, 2003, NEUROIMAGE, V19, P1085, DOI 10.1016/S1053-8119(03)00113-7; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Busemeyer JR, 2002, PSYCHOL ASSESSMENT, V14, P253, DOI 10.1037//1040-3590.14.3.253; Cercignani M, 2001, AM J NEURORADIOL, V22, P952; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Cohen MX, 2008, NEUROIMAGE, V39, P1396, DOI 10.1016/j.neuroimage.2007.10.004; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Cooper JC, 2008, NEUROIMAGE, V39, P538, DOI 10.1016/j.neuroimage.2007.08.009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Doya K, 2008, NAT NEUROSCI, V11, P410, DOI 10.1038/nn2077; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Ernst M, 2005, BIOL PSYCHIAT, V58, P597, DOI 10.1016/j.biopsych.2005.06.004; Fellows LK, 2007, ANN NY ACAD SCI, V1121, P421, DOI 10.1196/annals.1401.023; First M.B., 2014, STRUCTURED CLIN INTE; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Gloria R, 2009, PSYCHOPHYSIOLOGY, V46, P681, DOI 10.1111/j.1469-8986.2009.00823.x; Gulani V, 2001, MAGNET RESON MED, V45, P191, DOI 10.1002/1522-2594(200102)45:2<191::AID-MRM1025>3.0.CO;2-9; Hasan KM, 2006, MAGN RESON MED, V56, P130, DOI 10.1002/mrm.20935; Hasan KM, 2001, J MAGN RESON IMAGING, V13, P769, DOI 10.1002/jmri.1107; Herrera JJ, 2008, J NEUROSCI RES, V86, P443, DOI 10.1002/jnr.21481; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kellogg SH, 2003, DRUG ALCOHOL DEPEN, V69, P137, DOI 10.1016/S0376-8716(02)00308-3; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lane SD, 2006, EXP CLIN PSYCHOPHARM, V14, P254, DOI 10.1037/1064-1297.14.2.254; Lane SD, 2000, DRUG ALCOHOL DEPEN, V60, P179, DOI 10.1016/S0376-8716(99)00155-6; Lee DY, 2007, ANN NY ACAD SCI, V1104, P108, DOI 10.1196/annals.1390.007; Lim KO, 2008, DRUG ALCOHOL DEPEN, V92, P164, DOI 10.1016/j.drugalcdep.2007.07.019; Lim KO, 2002, BIOL PSYCHIAT, V51, P890, DOI 10.1016/S0006-3223(01)01355-5; Ma LS, 2009, DRUG ALCOHOL DEPEN, V104, P262, DOI 10.1016/j.drugalcdep.2009.05.020; Matthews SC, 2004, NEUROREPORT, V15, P2123, DOI 10.1097/00001756-200409150-00025; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Moeller FG, 2007, PSYCHIAT RES-NEUROIM, V154, P253, DOI 10.1016/j.pscychresns.2006.11.004; Moeller FG, 2005, NEUROPSYCHOPHARMACOL, V30, P610, DOI 10.1038/sj.npp.1300617; Mori S., 2005, MRI ATLAS HUMAN WHIT; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Narayana PA, 2009, PSYCHIAT RES-NEUROIM, V171, P242, DOI 10.1016/j.pscychresns.2008.04.004; Northoff G, 2006, HUM BRAIN MAPP, V27, P572, DOI 10.1002/hbm.20202; O'Neill J, 2001, ADDICT BIOL, V6, P347, DOI 10.1080/13556210020077073; Ojima K, 1996, INT J DEV NEUROSCI, V14, P649, DOI 10.1016/0736-5748(95)00105-0; Paulus MP, 2007, SCIENCE, V318, P602, DOI 10.1126/science.1142997; Paulus MP, 2005, NEUROIMAGE, V25, P607, DOI 10.1016/j.neuroimage.2004.12.055; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Shiffman S., 1995, NIAAA RES MONOGRAPH, V30, P17; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Stout JC, 2004, PSYCHON B REV, V11, P742, DOI 10.3758/BF03196629; Tanabe J, 2007, HUM BRAIN MAPP, V28, P1276, DOI 10.1002/hbm.20344; Tucker KA, 2004, BIOL PSYCHIAT, V56, P527, DOI 10.1016/j.biopsych.2004.06.031; van den Bos W, 2007, COGN AFFECT BEHAV NE, V7, P337, DOI 10.3758/CABN.7.4.337; Vorhold V, 2008, ANN NY ACAD SCI, V1128, P41, DOI 10.1196/annals.1399.006; Vul E, 2009, PERSPECT PSYCHOL SCI, V4, P274, DOI 10.1111/j.1745-6924.2009.01125.x; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilson SJ, 2008, J ABNORM PSYCHOL, V117, P428, DOI 10.1037/0021-843X.117.2.428; Yechiam E, 2005, PSYCHON B REV, V12, P387, DOI 10.3758/BF03193783; Yechiam E, 2008, PSYCHON B REV, V15, P44, DOI 10.3758/PBR.15.1.44	72	73	73	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11591	10.1371/journal.pone.0011591	http://dx.doi.org/10.1371/journal.pone.0011591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661285	gold, Green Published, Green Submitted			2022-12-27	WOS:000279980800004
J	Garcia, MJ; Nunez, MC; Cox, RA				Jesus Garcia, Maria; Carmen Nunez, Maria; Cox, Robert Ashley			Measurement of the Rates of Synthesis of Three Components of Ribosomes of Mycobacterium fortuitum: A Theoretical Approach to qRT-PCR Experimentation	PLOS ONE			English	Article							ESCHERICHIA-COLI; RNA TRANSCRIPTION; PROTEIN-SYNTHESIS; GROWTH-RATES; TUBERCULOSIS; ELONGATION; OPERON; BIOSYNTHESIS; INITIATION; PROMOTER	Background: Except for the ribosomal protein L12 (rplL), ribosomal proteins are present as one copy per ribosome; L12 (rplL) is unusual because it is present as four copies per ribosome. Thus, the strategies used by Mycobacterium fortuitum to regulate ribosomal protein synthesis were investigated, including evaluations of the rates of chain elongations of 16S rRNA, rplL and ribosomal protein S12 (rpsL). Methodology: RNA was isolated from cell cultures and cDNA was prepared. The numbers of cDNA copies of 16S rRNA, precursor- 16S rRNA and transcripts of rpsL and rplL were quantified by qRT-PCR and then related to the rates of 16S rRNA, rpsL and rplL chain elongations by means of a mathematical framework for coupled transcription/translation. Principal Findings: The rates of synthesis of 16S rRNA, rpsL and rplL respectively were found to be approximately 50610 3 nucleotides h(-1), 1.6x10(3) amino acid residues h(-1) and 3.4x10(3) amino acid residues h(-1). The number of transcripts of rplL was approximately twice that of rpsL. These data account for the presence of one copy of rpsL and four copies of rplL per ribosome, and reveal that the rate of M. fortuitum ribosome synthesis was closer to that of M. tuberculosis than to E. coli. Except for rplJ, the elongation rate obtained for rpsL was inferred to be appropriate for all other proteins present as one copy per ribosome. Significance: The results obtained provide the basis for a comprehensive view of the kinetics of ribosome synthesis, and of the ways that bacterial cells utilize genes encoding ribosomal proteins. The methodology also applies to proteins involved in transcription, energy generation and to bacterial proteins in general. The method proposed for measuring the fidelity of cDNA preparations is intrinsically much more sensitive than procedures that measure the integrity of 16S rRNA.	[Jesus Garcia, Maria; Carmen Nunez, Maria] Univ Autonoma Madrid, Fac Med, Dept Prevent Med, E-28049 Madrid, Spain; [Cox, Robert Ashley] Natl Inst Med Res, Div Mycobacterial Res, London NW7 1AA, England	Autonomous University of Madrid; MRC National Institute for Medical Research	Garcia, MJ (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Prevent Med, E-28049 Madrid, Spain.	rcox@nimr.mrc.ac.uk	Garcia, Maria Jesus Garcia/B-7624-2014	Cox, Robert Ashley/0000-0002-4854-4379	Centro de Estudios de America Latina (CEAL)	Centro de Estudios de America Latina (CEAL)	This work has been funded in part by the Centro de Estudios de America Latina (CEAL) of the Autonoma University of Madrid (http://www.uam.es). This work is also part of the StopLATENT-TB network (Collaborative Project) supported by the EC under the Health Cooperation Work Programme of the 7th Framework Programme (G. A. no. 200999) (http://cordis.europa.eu/fp7/dc/index.cfm). The financial supporters had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beste DJV, 2005, J BACTERIOL, V187, P1677, DOI 10.1128/JB.187.5.1677-1684.2005; BLANCO G, 2002, BIOCHIM BIOPHYS ACTA, V1517, P243; Bremer H, 1996, ESCHERICHIA COLI SAL; Bruell CM, 2008, BIOCHEMISTRY-US, V47, P8828, DOI 10.1021/bi800527k; BYRNE R, 1964, P NATL ACAD SCI USA, V52, P140, DOI 10.1073/pnas.52.1.140; Cook GM, 2009, ADV MICROB PHYSIOL, V55, P81, DOI 10.1016/S0065-2911(09)05502-7; Cox RA, 2004, MICROBIOL-SGM, V150, P1413, DOI 10.1099/mic.0.26560-0; Cox RA, 2007, MICROBIOL-SGM, V153, P3337, DOI 10.1099/mic.0.2007/005868-0; Cox RA, 2007, CURR MOL MED, V7, P231, DOI 10.2174/156652407780598584; DOWNING WL, 1987, J MOL BIOL, V194, P609, DOI 10.1016/0022-2836(87)90238-5; EGEBJERG J, 1990, J MOL BIOL, V213, P275, DOI 10.1016/S0022-2836(05)80190-1; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; GonzalezyMerchand JA, 1996, MICROBIOL-UK, V142, P667, DOI 10.1099/13500872-142-3-667; GonzalezyMerchand JA, 1997, J BACTERIOL, V179, P6949, DOI 10.1128/jb.179.22.6949-6958.1997; GOTTA SL, 1991, J BACTERIOL, V173, P6647, DOI 10.1128/jb.173.20.6647-6649.1991; HARSHEY RM, 1977, J BACTERIOL, V129, P616, DOI 10.1128/JB.129.2.616-622.1977; IOST I, 1995, EMBO J, V14, P3252, DOI 10.1002/j.1460-2075.1995.tb07328.x; KEMPSELL KE, 1992, J GEN MICROBIOL, V138, P1717, DOI 10.1099/00221287-138-8-1717; KRUMMEL B, 1989, BIOCHEMISTRY-US, V28, P7829, DOI 10.1021/bi00445a045; Menendez MC, 2002, J BACTERIOL, V184, P1078, DOI 10.1128/jb.184.4.1078-1088.2002; Menendez MD, 2005, J BACTERIOL, V187, P534, DOI 10.1128/JB.187.2.534-543.2005; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Noller HF, 1996, ESCHERICHIA COLI SAL, V1, P167; Nomura M, 1999, J BACTERIOL, V181, P6857, DOI 10.1128/JB.181.22.6857-6864.1999; NOMURA M, 1984, ANNU REV BIOCHEM, V53, P75, DOI 10.1146/annurev.bi.53.070184.000451; Nunez MC, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-100; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Paul BJ, 2004, ANNU REV GENET, V38, P749, DOI 10.1146/annurev.genet.38.072902.091347; PEDERSEN S, 1984, EMBO J, V3, P2895, DOI 10.1002/j.1460-2075.1984.tb02227.x; PETERSEN C, 1990, J BACTERIOL, V172, P431, DOI 10.1128/JB.172.1.431-436.1990; Proux F, 2008, METHOD ENZYMOL, V447, P243, DOI 10.1016/S0076-6879(08)02213-1; RICHARDSON JP, 1996, ESCHERICHIA COLI SAL, V2, P822; Sambrook J., 2001, MOL CLONING LAB MANU; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; STENT GS, 1964, SCIENCE, V144, P816, DOI 10.1126/science.144.3620.816; TIMM J, 1999, MYCOBACTERIA MOL BIO, P59; ULBRICH B, 1975, EUR J BIOCHEM, V57, P49, DOI 10.1111/j.1432-1033.1975.tb02275.x; Verma I, 1999, LETT APPL MICROBIOL, V29, P113, DOI 10.1046/j.1365-2672.1999.00597.x; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Wahl MC, 2002, CURR PROTEIN PEPT SC, V3, P93, DOI 10.2174/1389203023380756; WAHL MC, 2002, CURR PROTEIN PEPT SC, V3, P485; Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523; ZENGEL JM, 1994, PROG NUCLEIC ACID RE, V47, P331, DOI 10.1016/S0079-6603(08)60256-1	45	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11575	10.1371/journal.pone.0011575	http://dx.doi.org/10.1371/journal.pone.0011575			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644643	Green Submitted, Green Published, gold			2022-12-27	WOS:000279884900015
J	Mediannikov, O; Sekeyova, Z; Birg, ML; Raoult, D				Mediannikov, Oleg; Sekeyova, Zuzana; Birg, Marie-Laure; Raoult, Didier			A Novel Obligate Intracellular Gamma-Proteobacterium Associated with Ixodid Ticks, Diplorickettsia massiliensis, Gen. Nov., Sp Nov.	PLOS ONE			English	Article							RICKETTSIELLA-GRYLLI; TAXONOMIC POSITION; MOLECULAR EVIDENCE; COXIELLA-BURNETII; RIBOSOMAL-RNA; GENOMIC DNA; HUMANS; AGENT	Background: Obligate intracellular bacteria of arthropods often exhibit a significant role in either human health or arthropod ecology. Methodology/Principal Findings: An obligate intracellular gamma-proteobacterium was isolated from the actively questing hard tick Ixodes ricinus using mammalian and amphibian cell lines. Transmission electron microscopy revealed a unique morphology of the bacterium, including intravacuolar localization of bacteria grouped predominantly in pairs and internal structures composed of electron-dense crystal-like structures and regular multilayer sheath-like structures. The isolate 20B was characterized to determine its taxonomic position using a polyphasic approach. Comparative 16S rRNA gene sequence analysis showed that this strain belongs to the family Coxiellaceae, order Legionellales of Gamma-proteobacteria, and the closest relatives are different Rickettsiella spp. The level of 16S rRNA gene sequence similarity between strain 20B and other recognized species of the family was below 94.5%. Partial sequences of the rpoB, parC and ftsY genes confirmed the phylogenetic position of the new isolate. The G+C content estimated on the basis of whole genome analysis of strain 20B was 37.88%. On the basis of its phenotypic and genotypic properties, together with phylogenetic distinctiveness, we propose that strain 20B to be classified in the new genus Diplorickettsia as the type strain of a novel species named Diplorickettsia massiliensis sp. nov. Conclusions/Significance: Considering the source of its isolation (hard tick, often biting humans) the role of this bacterium in the pathology of humans, animals and ticks should be further investigated.	[Mediannikov, Oleg; Birg, Marie-Laure; Raoult, Didier] Univ La Mediterrane, Inst Rech Dev 198, Ctr Natl Rech Sci 6236, Unite Rech Malad Infect & Emergentes, Marseille, France; [Sekeyova, Zuzana] Slovak Acad Sci, Inst Virol, Bratislava, Slovakia	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Slovak Academy of Sciences	Mediannikov, O (corresponding author), Univ La Mediterrane, Inst Rech Dev 198, Ctr Natl Rech Sci 6236, Unite Rech Malad Infect & Emergentes, Marseille, France.	Didier.Raoult@gmail.com	RAOULT, Didier/A-8434-2008; Sekeyova, Zuzana/E-5956-2018; Mediannikov, Oleg/H-4018-2015	RAOULT, Didier/0000-0002-0633-5974; Mediannikov, Oleg/0000-0001-6039-2008; Sekeyova, Zuzana/0000-0002-2597-4405	VEGA [2/0016/08, 2/0065/09]; CNRS France [22525-CNRS, 2-SAS]; Slovac Academy of Sciences (SAS) [22525-CNRS, 2-SAS]	VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); CNRS France(Centre National de la Recherche Scientifique (CNRS)); Slovac Academy of Sciences (SAS)	This work was partly supported by the VEGA grant Nos. 2/0016/08, 2/0065/09 and a bilateral project between CNRS France and the Slovac Academy of Sciences (SAS) No: 22525-CNRS, 2-SAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BERGEYS MANUAL SYS B; Babudieri B., 1959, ADV VET SCI, V5, P82; Brenner J., 2005, PROBACTERIA A, P27; CROIZIER G, 1972, Annales de Recherches Veterinaires, V3, P373; EZAKI T, 1990, FEMS MICROBIOL LETT, V55, P127; Fournier PE, 2006, INT J SYST EVOL MICR, V56, P1025, DOI 10.1099/ijs.0.63903-0; FRUTOS R, 1994, J INVERTEBR PATHOL, V63, P294, DOI 10.1006/jipa.1994.1054; Gern L, 2005, Ther Umsch, V62, P707, DOI 10.1024/0040-5930.62.11.707; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; GIROUD P, 1958, CR HEBD ACAD SCI, V247, P2499; Glazunova O, 2005, EMERG INFECT DIS, V11, P1211; JACOBS JP, 1970, NATURE, V227, P168, DOI 10.1038/227168a0; Jado I, 2007, EMERG INFECT DIS, V13, P1405, DOI 10.3201/eid1309.060186; KELLY PJ, 1991, T ROY SOC TROP MED H, V85, P397, DOI 10.1016/0035-9203(91)90303-G; Kurtti TJ, 2002, J MED ENTOMOL, V39, P534, DOI 10.1603/0022-2585-39.3.534; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; Leclerque A, 2008, FEMS MICROBIOL LETT, V283, P117, DOI 10.1111/j.1574-6968.2008.01158.x; LOUIS C, 1977, BIOL CELLULAIRE, V29, P77; Mediannikov O, 2003, ANN NY ACAD SCI, V990, P226, DOI 10.1111/j.1749-6632.2003.tb07367.x; Mediannikov O, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000654; Nielsen H, 2004, SCAND J INFECT DIS, V36, P559, DOI 10.1080/00365540410020776; Parola P, 2001, CLIN INFECT DIS, V32, P897, DOI 10.1086/319347; Piesman J, 2006, INT J MED MICROBIOL, V296, P17, DOI 10.1016/j.ijmm.2005.11.007; PUDNEY M, 1973, EXPERIENTIA, V29, P466, DOI 10.1007/BF01926785; Reeves WK, 2005, ANN NY ACAD SCI, V1063, P343, DOI 10.1196/annals.1355.055; Roux V, 1997, INT J SYST BACTERIOL, V47, P1255, DOI 10.1099/00207713-47-4-1255; Spaulding AW, 2001, INSECT MOL BIOL, V10, P57, DOI 10.1046/j.1365-2583.2001.00231.x; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Waller LN, 2004, J MICROBIOL METH, V58, P23, DOI 10.1016/j.mimet.2004.02.012; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	30	55	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11478	10.1371/journal.pone.0011478	http://dx.doi.org/10.1371/journal.pone.0011478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644718	gold, Green Published, Green Submitted			2022-12-27	WOS:000279822300002
J	Muller, I; Boyle, S; Singer, RH; Bickmore, WA; Chubb, JR				Mueller, Iris; Boyle, Shelagh; Singer, Robert H.; Bickmore, Wendy A.; Chubb, Jonathan R.			Stable Morphology, but Dynamic Internal Reorganisation, of Interphase Human Chromosomes in Living Cells	PLOS ONE			English	Article							SCALE CHROMATIN ORGANIZATION; SMALL-MOLECULE INHIBITOR; HUMAN GENOME; NUCLEAR REORGANIZATION; TRANSCRIPTOME MAP; MAMMALIAN-CELLS; GENE-REGULATION; EARLY G1; IN-VIVO; REVEALS	Despite the distinctive structure of mitotic chromosomes, it has not been possible to visualise individual chromosomes in living interphase cells, where chromosomes spend over 90% of their time. Studies of interphase chromosome structure and dynamics use fluorescence in-situ hybridisation (FISH) on fixed cells, which potentially damages structure and loses dynamic information. We have developed a new methodology, involving photoactivation of labelled histone H3 at mitosis, to visualise individual and specific human chromosomes in living interphase cells. Our data revealed bulk chromosome volume and morphology are established rapidly after mitosis, changing only incrementally after the first hour of G1. This contrasted with the behaviour of specific loci on labelled chromosomes, which showed more progressive reorganisation, and revealed that "looping out'' of chromatin from chromosome territories is a dynamic state. We measured considerable heterogeneity in chromosome decondensation, even between sister chromatids, which may reflect local structural impediments to decondensation and could potentially amplify transcriptional noise. Chromosome structure showed tremendous resistance to inhibitors of transcription, histone deacetylation and chromatin remodelling. Together, these data indicate steric constraints determine structure, rather than innate chromosome architecture or function-driven anchoring, with interphase chromatin organisation governed primarily by opposition between needs for decondensation and the space available for this to happen.	[Mueller, Iris; Chubb, Jonathan R.] Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland; [Boyle, Shelagh; Bickmore, Wendy A.] Univ Edinburgh, Human Genet Unit, MRC, Inst Genet & Mol Med, Edinburgh EH8 9YL, Midlothian, Scotland; [Singer, Robert H.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA	University of Dundee; University of Edinburgh; Yeshiva University; Albert Einstein College of Medicine	Muller, I (corresponding author), Univ Dundee, Coll Life Sci, Div Cell & Dev Biol, Dundee, Scotland.	j.chubb@dundee.ac.uk	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735	Medical Research Council; MRC [MC_U127527202, G0600242] Funding Source: UKRI; Medical Research Council [G0600242, MC_U127527202] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086217] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work presented here was supported by a Medical Research Council Career Development Award and Project Grant to JRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney JR, 1997, J CELL BIOL, V137, P1459, DOI 10.1083/jcb.137.7.1459; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Bin Sun H, 2000, BIOPHYS J, V79, P184, DOI 10.1016/S0006-3495(00)76282-5; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chuang CH, 2007, SEMIN CELL DEV BIOL, V18, P698, DOI 10.1016/j.semcdb.2007.08.012; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cioce M, 2006, J CELL BIOL, V175, P401, DOI 10.1083/jcb.200604099; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Ferrai C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000270; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Gierman HJ, 2007, GENOME RES, V17, P1286, DOI 10.1101/gr.6276007; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gilchrist Susan, 2004, Chromosome Res, V12, P505; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hagedorn Monica, 2006, V346, P327; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hepperger C, 2007, CHROMOSOMA, V116, P117, DOI 10.1007/s00412-006-0084-2; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Iannuccelli E, 2010, BIOINFORMATICS, V26, P696, DOI 10.1093/bioinformatics/btq013; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Kobliakova I, 2005, CHROMOSOME RES, V13, P169, DOI 10.1007/s10577-005-0308-y; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Manders EMM, 2003, CHROMOSOME RES, V11, P537, DOI 10.1023/A:1024995215340; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mora-Bermudez F, 2007, METHODS, V41, P158, DOI 10.1016/j.ymeth.2006.07.035; MOREY C, 2009, GENOME RES; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Muramoto T, 2008, DEVELOPMENT, V135, P1647, DOI 10.1242/dev.020115; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799; PERRY RP, 1970, J CELL PHYSIOL, V76, P127, DOI 10.1002/jcp.1040760202; Platani M, 2002, NAT CELL BIOL, V4, P502, DOI 10.1038/ncb809; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; SCHEER U, 1984, J CELL BIOL, V99, P672, DOI 10.1083/jcb.99.2.672; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Stevense M, 2010, DEVELOPMENT, V137, P579, DOI 10.1242/dev.043836; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Tanaka T, 2007, CELL CYCLE, V6, P371, DOI 10.4161/cc.6.3.3835; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vogt A, 1997, J BIOL CHEM, V272, P27224, DOI 10.1074/jbc.272.43.27224; Volpi EV, 2000, J CELL SCI, V113, P1565; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wiesmeijer K, 2008, DIFFERENTIATION, V76, P83, DOI 10.1111/j.1432-0436.2007.00234.x; Williams RRE, 2002, EXP CELL RES, V272, P163, DOI 10.1006/excr.2001.5400; Zink D, 2003, METHODS, V29, P42, DOI 10.1016/S1046-2023(02)00289-X	72	45	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11560	10.1371/journal.pone.0011560	http://dx.doi.org/10.1371/journal.pone.0011560			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644634	Green Published, Green Submitted, gold			2022-12-27	WOS:000279822300014
J	Burli, T; Baer, K; Ewers, H; Sidler, C; Fuhrer, C; Fritschy, JM				Buerli, Thomas; Baer, Kristin; Ewers, Helge; Sidler, Corinne; Fuhrer, Christian; Fritschy, Jean-Marc			Single Particle Tracking of alpha 7 Nicotinic AChR in Hippocampal Neurons Reveals Regulated Confinement at Glutamatergic and GABAergic Perisynaptic Sites	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR SUBUNIT; LONG-TERM PLASTICITY; BUNGAROTOXIN-BINDING; SURFACE TRAFFICKING; GLYCINE RECEPTORS; RAT HIPPOCAMPUS; AMPA RECEPTORS; NEUROTRANSMITTER RECEPTOR; POSTSYNAPTIC RECEPTORS; SYNAPTIC-TRANSMISSION	alpha 7 neuronal nicotinic acetylcholine receptors (alpha 7-nAChR) form Ca(2+)-permeable homopentameric channels modulating cortical network activity and cognitive processing. They are located pre- and postsynaptically and are highly abundant in hippocampal GABAergic interneurons. It is unclear how alpha 7-nAChRs are positioned in specific membrane microdomains, particularly in cultured neurons which are devoid of cholinergic synapses. To address this issue, we monitored by single particle tracking the lateral mobility of individual alpha 7-nAChRs labeled with alpha-bungarotoxin linked to quantum dots in live rat cultured hippocampal interneurons. Quantitative analysis revealed different modes of lateral diffusion of alpha 7-nAChR dependent on their subcellular localization. Confined receptors were found in the immediate vicinity of glutamatergic and GABAergic postsynaptic densities, as well as in extrasynaptic clusters of alpha-bungarotoxin labeling on dendrites. alpha 7-nAChRs avoided entering postsynaptic densities, but exhibited reduced mobility and long dwell times at perisynaptic locations, indicative of regulated confinement. Their diffusion coefficient was lower, on average, at glutamatergic than at GABAergic perisynaptic sites, suggesting differential, synapse-specific tethering mechanisms. Disruption of the cytoskeleton affected alpha 7-nAChR mobility and cell surface expression, but not their ability to form clusters. Finally, using tetrodotoxin to silence network activity, as well as exposure to a selective alpha 7-nAChR agonist or antagonist, we observed that alpha 7-nAChRs cell surface dynamics is modulated by chronic changes in neuronal activity. Altogether, given their high Ca(2+)-permeability, our results suggest a possible role of alpha 7-nAChR on interneurons for activating Ca(2+)-dependent signaling in the vicinity of GABAergic and glutamatergic synapses.	[Buerli, Thomas; Sidler, Corinne; Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Baer, Kristin] Swansea Univ, Sch Med, Inst Life Sci, Swansea, W Glam, Wales; [Ewers, Helge] ETH, Phys Chem Lab, CH-8092 Zurich, Switzerland; [Fuhrer, Christian] Univ Zurich, Brain Res Inst, Dept Neurochem, Zurich, Switzerland	University of Zurich; Swansea University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Burli, T (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	fritschy@pharma.uzh.ch	Ewers, Helge/ABF-3629-2021; Ewers, Helge/I-3455-2012	Ewers, Helge/0000-0003-3948-4332; Fritschy, Jean-Marc/0000-0002-8552-3702	Swiss National Science Foundation; Swiss Foundation for Research on Muscle Diseases; FEBS	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Foundation for Research on Muscle Diseases; FEBS	This work was supported by grants from the Swiss National Science Foundation and the Swiss Foundation for Research on Muscle Diseases and a FEBS long-term fellowship to H.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcor D, 2009, EUR J NEUROSCI, V30, P987, DOI 10.1111/j.1460-9568.2009.06927.x; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Allison DW, 1998, J NEUROSCI, V18, P2423; Baer K, 2007, MOL CELL NEUROSCI, V35, P339, DOI 10.1016/j.mcn.2007.03.009; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; Bertrand D, 1993, CURR OPIN CELL BIOL, V5, P688, DOI 10.1016/0955-0674(93)90141-C; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bruses JL, 2001, J NEUROSCI, V21, P504, DOI 10.1523/JNEUROSCI.21-02-00504.2001; Buerli T, 2007, NAT PROTOC, V2, P3090, DOI 10.1038/nprot.2007.445; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Cincotta SL, 2008, CURR OPIN INVEST DR, V9, P47; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Ehrensperger MV, 2007, BIOPHYS J, V92, P3706, DOI 10.1529/biophysj.106.095596; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 2003, J NEUROPHYSIOL, V89, P3018, DOI 10.1152/jn.01036.2002; FREEDMAN R, 1993, J NEUROSCI, V13, P1965; Fritschy JM, 2008, TRENDS NEUROSCI, V31, P257, DOI 10.1016/j.tins.2008.02.006; Gaiarsa JL, 2002, TRENDS NEUROSCI, V25, P564, DOI 10.1016/S0166-2236(02)02269-5; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Groc L, 2008, MOL MEMBR BIOL, V25, P344, DOI 10.1080/09687680801958364; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Heine M, 2008, SCIENCE, V320, P201, DOI 10.1126/science.1152089; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Kawai H, 2002, J NEUROSCI, V22, P7903; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lardi-Studler B, 2007, J CELL SCI, V120, P1371, DOI 10.1242/jcs.003905; Levi S, 2008, NEURON, V59, P261, DOI 10.1016/j.neuron.2008.05.030; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Levy RB, 2002, J NEUROSCI, V22, P5001, DOI 10.1523/JNEUROSCI.22-12-05001.2002; Li XY, 1998, J NEUROSCI, V18, P1904; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Maggi L, 2001, J PHYSIOL-LONDON, V536, P89, DOI 10.1111/j.1469-7793.2001.00089.x; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Nugent FS, 2008, J PHYSIOL-LONDON, V586, P1487, DOI 10.1113/jphysiol.2007.148098; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Renner M, 2008, CURR OPIN NEUROBIOL, V18, P532, DOI 10.1016/j.conb.2008.09.009; Rozsa B, 2008, EUR J NEUROSCI, V27, P364, DOI 10.1111/j.1460-9568.2007.05999.x; Sage D, 2005, IEEE T IMAGE PROCESS, V14, P1372, DOI 10.1109/TIP.2005.852787; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SEGUELA P, 1993, J NEUROSCI, V13, P596; SIMSON R, 1995, BIOPHYS J, V69, P989, DOI 10.1016/S0006-3495(95)79972-6; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; Wanaverbecq N, 2007, J NEUROSCI, V27, P5683, DOI 10.1523/JNEUROSCI.1732-07.2007; WARD JM, 1990, FEBS LETT, V270, P45, DOI 10.1016/0014-5793(90)81231-C; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008; Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578	60	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11507	10.1371/journal.pone.0011507	http://dx.doi.org/10.1371/journal.pone.0011507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634896	Green Published, Green Accepted, gold			2022-12-27	WOS:000279715300018
J	Frucht, CS; Uduman, M; Duke, JL; Kleinstein, SH; Santos-Sacchi, J; Navaratnam, DS				Frucht, Corey S.; Uduman, Mohamed; Duke, Jamie L.; Kleinstein, Steven H.; Santos-Sacchi, Joseph; Navaratnam, Dhasakumar S.			Gene Expression Analysis of Forskolin Treated Basilar Papillae Identifies MicroRNA181a as a Mediator of Proliferation	PLOS ONE			English	Article							HAIR CELL REGENERATION; FACTOR-BINDING SITES; INNER-EAR; DIRECT TRANSDIFFERENTIATION; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; ACOUSTIC TRAUMA; POCKET PROTEINS; STEM-CELLS; S-PHASE	Background: Auditory hair cells spontaneously regenerate following injury in birds but not mammals. A better understanding of the molecular events underlying hair cell regeneration in birds may allow for identification and eventually manipulation of relevant pathways in mammals to stimulate regeneration and restore hearing in deaf patients. Methodology/Principal Findings: Gene expression was profiled in forskolin treated (i.e., proliferating) and quiescent control auditory epithelia of post-hatch chicks using an Affymetrix whole-genome chicken array after 24 (n = 6), 48 (n = 6), and 72 (n = 12) hours in culture. In the forskolin-treated epithelia there was significant (p<0.05; >two-fold change) upregulation of many genes thought to be relevant to cell cycle control and inner ear development. Gene set enrichment analysis was performed on the data and identified myriad microRNAs that are likely to be upregulated in the regenerating tissue, including microRNA181a (miR181a), which is known to mediate proliferation in other systems. Functional experiments showed that miR181a overexpression is sufficient to stimulate proliferation within the basilar papilla, as assayed by BrdU incorporation. Further, some of the newly produced cells express the early hair cell marker myosin VI, suggesting that miR181a transfection can result in the production of new hair cells. Conclusions/Significance: These studies have identified a single microRNA, miR181a, that can cause proliferation in the chicken auditory epithelium with production of new hair cells.	[Frucht, Corey S.] Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT 06520 USA; [Frucht, Corey S.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA; [Uduman, Mohamed; Duke, Jamie L.; Kleinstein, Steven H.] Yale Univ, Interdept Program Computat Biol & Bioinfomat, New Haven, CT USA; [Uduman, Mohamed; Duke, Jamie L.; Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Surg, Div Otolaryngol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Santos-Sacchi, Joseph; Navaratnam, Dhasakumar S.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Navaratnam, Dhasakumar S.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Frucht, CS (corresponding author), Yale Univ, Sch Med, Med Scientist Training Program, New Haven, CT 06520 USA.	Dhasakumar.Navaratnam@Yale.edu		Duke, Jamie/0000-0002-4768-0846; Uduman, Mohamed/0000-0002-9725-0705	NIH [MSTP TG 2T32GM07205, T15 LM07056]; NIH/NIDCD [DC 007894, DC 000273, DC 008130]; National Organization for Hearing Research; National Library of Medicine; Ohse Grant for Surgical Research at Yale School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008130, R01DC007894, R01DC000273] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Organization for Hearing Research; National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Ohse Grant for Surgical Research at Yale School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	CSF was supported by NIH MSTP TG 2T32GM07205 and an Ohse Grant for Surgical Research at Yale School of Medicine. CSF, JSS and DSN were supported by NIH/NIDCD grants DC 007894, DC 000273 and DC 008130. The authors would like to acknowledge the support of the National Organization for Hearing Research, which provided seed funding for this project to DSN. MU and JLD were supported by NIH Grant T15 LM07056 from the National Library of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HJ, 1996, NEUROSCI LETT, V205, P17, DOI 10.1016/0304-3940(96)12367-3; *AFF INC, 2004, EUK SAMPL ARR PROC G; *AFF INC, 2009, GENECHIP EXPR AN TEC; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashery-Padan R, 2001, CURR OPIN CELL BIOL, V13, P706, DOI 10.1016/S0955-0674(00)00274-X; Baird RA, 1996, ANN NY ACAD SCI, V781, P59, DOI 10.1111/j.1749-6632.1996.tb15693.x; Baird RA, 2000, P NATL ACAD SCI USA, V97, P11722, DOI 10.1073/pnas.97.22.11722; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Brentani H, 2003, P NATL ACAD SCI USA, V100, P13418, DOI 10.1073/pnas.1233632100; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chen P, 1999, DEVELOPMENT, V126, P1581; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Dalmay T, 2008, BIOCHEM SOC T, V36, P1194, DOI 10.1042/BST0361194; Dannenberg JH, 2004, GENE DEV, V18, P2952, DOI 10.1101/gad.322004; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gale JE, 2002, J NEUROBIOL, V50, P81, DOI 10.1002/neu.10002; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Hawkins RD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000525; Heanue TA, 2002, MECH DEVELOP, V111, P75, DOI 10.1016/S0925-4773(01)00611-6; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; JACKSON RJ, 2007, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3672007RE1; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Johnson DG, 2006, CURR MOL MED, V6, P731; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; JORGENSEN JM, 1988, NATURWISSENSCHAFTEN, V75, P319, DOI 10.1007/BF00367330; Jude CD, 2008, CELL CYCLE, V7, P586, DOI 10.4161/cc.7.5.5549; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kumar JP, 2001, NAT REV GENET, V2, P846, DOI 10.1038/35098564; Lee K H, 1996, Audiol Neurootol, V1, P41; Lee YS, 2006, DEVELOPMENT, V133, P2817, DOI 10.1242/dev.02453; Li JM, 1997, P NATL ACAD SCI USA, V94, P4948, DOI 10.1073/pnas.94.10.4948; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Liu Y, 2007, PROTEOMICS, V7, P23, DOI 10.1002/pmic.200600456; Lowenheim H, 1999, P NATL ACAD SCI USA, V96, P4084, DOI 10.1073/pnas.96.7.4084; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Mangiardi DA, 2004, J COMP NEUROL, V475, P1, DOI 10.1002/cne.20129; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Montcouquiol M, 2001, J NEUROSCI, V21, P974, DOI 10.1523/JNEUROSCI.21-03-00974.2001; Narbonne P, 2008, FRONT BIOSCI-LANDMRK, V13, P995, DOI 10.2741/2738; Navaratnam DS, 1996, NAT MED, V2, P1136, DOI 10.1038/nm1096-1136; NEDZELSKI JM, 1993, AM J OTOL, V14, P278; OSHIMA K, 2010, STEM CELLS CELL, V141, P704; Oshima K, 2007, JARO-J ASSOC RES OTO, V8, P18, DOI 10.1007/s10162-006-0058-3; Passerini AG, 2004, P NATL ACAD SCI USA, V101, P2482, DOI 10.1073/pnas.0305938101; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RAPHAEL Y, 1992, J NEUROCYTOL, V21, P663, DOI 10.1007/BF01191727; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Roberson DW, 1996, AUDIT NEUROSCI, V2, P195; Roberson DW, 2004, J NEUROSCI RES, V78, P461, DOI 10.1002/jnr.20271; Rocha-Sanchez SMS, 2007, INT J DEV BIOL, V51, P585, DOI 10.1387/ijdb.072387sr; Roman-Gomez J, 2007, EUR J CANCER, V43, P2736, DOI 10.1016/j.ejca.2007.10.004; Rozen S, 2000, Methods Mol Biol, V132, P365; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; SAUNDERS SS, 1995, J ACOUST SOC AM, V98, P1365, DOI 10.1121/1.413472; SCHMIDT D, SCIENCE; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHUKNECHT HF, 1964, ARCHIV OTOLARYNGOL, V80, P369; SHANG J, 2010, J ASS RES OTOLARYNGO; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Sienknecht UJ, 2009, J COMP NEUROL, V517, P751, DOI 10.1002/cne.22169; Soukup GA, 2009, BRAIN RES, V1277, P104, DOI 10.1016/j.brainres.2009.02.027; Stevens CB, 2003, DEV BIOL, V261, P149, DOI 10.1016/S0012-1606(03)00297-5; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Stone JS, 1999, DEVELOPMENT, V126, P961; STONE JS, 1992, J CELL SCI, V102, P671; STONE JS, 1994, J COMP NEUROL, V341, P50, DOI 10.1002/cne.903410106; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Tsonis PA, 2007, BIOCHEM BIOPH RES CO, V362, P940, DOI 10.1016/j.bbrc.2007.08.077; Vernell R, 2003, J BIOL CHEM, V278, P46124, DOI 10.1074/jbc.M304930200; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; Warchol ME, 1996, J NEUROSCI, V16, P5466; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Weston MD, 2006, BRAIN RES, V1111, P95, DOI 10.1016/j.brainres.2006.07.006; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; *WHO, 2005, WHO DEAFN HEAR IMP; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	93	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11502	10.1371/journal.pone.0011502	http://dx.doi.org/10.1371/journal.pone.0011502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634979	Green Submitted, Green Published, gold			2022-12-27	WOS:000279715300013
J	Liang, XW; Fomenko, DE; Hua, D; Kaya, A; Gladyshev, VN				Liang, Xinwen; Fomenko, Dmitri E.; Hua, Deame; Kaya, Alaattin; Gladyshev, Vadim N.			Diversity of Protein and mRNA Forms of Mammalian Methionine Sulfoxide Reductase B1 Due to Intronization and Protein Processing	PLOS ONE			English	Article							INDUCED CELL-DEATH; OXIDATIVE STRESS; INSERTION; POLYADENYLATION; OVEREXPRESSION; IDENTIFICATION; INTRONS; ROLES; SITES; ZINC	Background: Methionine sulfoxide reductases (Msrs) are repair enzymes that protect proteins from oxidative stress by catalyzing stereospecific reduction of oxidized methionine residues. MsrB1 is a selenocysteine-containing cytosolic/nuclear Msr with high expression in liver and kidney. Principal Findings: Here, we identified differences in MsrB1 gene structure among mammals. Human MsrB1 gene consists of four, whereas the corresponding mouse gene of five exons, due to occurrence of an additional intron that flanks the stop signal and covers a large part of the 3'-UTR. This intron evolved in a subset of rodents through intronization of exonic sequences, whereas the human gene structure represents the ancestral form. In mice, both splice forms were detected in liver, kidney, brain and heart with the five-exon form being the major form. We found that both mRNA forms were translated and supported efficient selenocysteine insertion into MsrB1. In addition, MsrB1 occurs in two protein forms that migrate as 14 and 5 kDa proteins. We found that each mRNA splice form generated both protein forms. The abundance of the 5 kDa form was not influenced by protease inhibitors, replacement of selenocysteine in the active site or mutation of amino acids in the cleavage site. However, mutation of cysteines that coordinate a structural zinc decreased the levels of 5 and 14 kDa forms, suggesting importance of protein structure for biosynthesis and/stability of these forms. Conclusions: This study characterized unexpected diversity of protein and mRNA forms of mammalian selenoprotein MsrB1.	[Liang, Xinwen; Fomenko, Dmitri E.; Hua, Deame; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Liang, Xinwen; Fomenko, Dmitri E.; Hua, Deame; Kaya, Alaattin; Gladyshev, Vadim N.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68583 USA; [Gladyshev, Vadim N.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Liang, XW (corresponding author), Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA.	vgladyshev@rics.bwh.harvard.edu	Kaya, Alaattin/T-6427-2017; Gladyshev, Vadim N/J-6187-2013; Gladyshev, Vadim N/A-9894-2013	Kaya, Alaattin/0000-0002-6132-5197; Gladyshev, Vadim/0000-0002-0372-7016	NIH [AG021518]; NATIONAL INSTITUTE ON AGING [R01AG021518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH AG021518. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Cabreiro F, 2008, J BIOL CHEM, V283, P16673, DOI 10.1074/jbc.M708580200; Cabreiro F, 2006, ANN NY ACAD SCI, V1067, P37, DOI 10.1196/annals.1354.006; Cabreiro F, 2009, ANTIOXID REDOX SIGN, V11, P215, DOI [10.1089/ars.2008.2102, 10.1089/ARS.2008.2102]; Catania F, 2008, PLOS BIOL, V6, P2354, DOI 10.1371/journal.pbio.0060283; Ding D, 2007, BIOCHEM BIOPH RES CO, V361, P629, DOI 10.1016/j.bbrc.2007.07.072; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Harvey NL, 1996, GENES CELLS, V1, P673, DOI 10.1046/j.1365-2443.1996.00255.x; Irimia M, 2008, TRENDS GENET, V24, P378, DOI 10.1016/j.tig.2008.05.007; Kim HY, 2007, BIOCHEM J, V407, P321, DOI 10.1042/BJ20070929; Kim HY, 2004, MOL BIOL CELL, V15, P1055, DOI 10.1091/mbc.E03-08-0629; Koc A, 2004, P NATL ACAD SCI USA, V101, P7999, DOI 10.1073/pnas.0307929101; Kryukov GV, 1999, J BIOL CHEM, V274, P33888, DOI 10.1074/jbc.274.48.33888; Kuersten S, 2003, NAT REV GENET, V4, P626, DOI 10.1038/nrg1125; Kumar RA, 2002, J BIOL CHEM, V277, P37527, DOI 10.1074/jbc.M203496200; Long GL, 1998, J BIOL CHEM, V273, P11521, DOI 10.1074/jbc.273.19.11521; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Marchetti MA, 2006, EXP EYE RES, V83, P1281, DOI 10.1016/j.exer.2006.07.005; Moskovitz J, 1997, P NATL ACAD SCI USA, V94, P9585, DOI 10.1073/pnas.94.18.9585; Novoselov SV, 2007, P NATL ACAD SCI USA, V104, P7857, DOI 10.1073/pnas.0610683104; Nurtdinov RN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-142; OKE TT, 2009, J PARASITOL; Picot CR, 2007, EXP GERONTOL, V42, P859, DOI 10.1016/j.exger.2007.02.006; Prentice HM, 2008, BIOCHEM BIOPH RES CO, V366, P775, DOI 10.1016/j.bbrc.2007.12.043; Roy SW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-192; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Turanov AA, 2009, SCIENCE, V323, P259, DOI 10.1126/science.1164748; Vinokur V, 2009, BIOGERONTOLOGY, V10, P43, DOI 10.1007/s10522-008-9152-8; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	34	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11497	10.1371/journal.pone.0011497	http://dx.doi.org/10.1371/journal.pone.0011497			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634897	Green Published, gold			2022-12-27	WOS:000279715300010
J	Mamtani, M; Matsubara, T; Shimizu, C; Furukawa, S; Akagi, T; Onouchi, Y; Hata, A; Fujino, A; He, WJ; Ahuja, SK; Burns, JC				Mamtani, Manju; Matsubara, Tomoyo; Shimizu, Chisato; Furukawa, Susumu; Akagi, Teiji; Onouchi, Yoshihiro; Hata, Akira; Fujino, Akihiro; He, Weijing; Ahuja, Sunil K.; Burns, Jane C.			Association of CCR2-CCR5 Haplotypes and CCL3L1 Copy Number with Kawasaki Disease, Coronary Artery Lesions, and IVIG Responses in Japanese Children	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INTRAVENOUS IMMUNOGLOBULIN TREATMENT; CONTAINING SEGMENTAL DUPLICATIONS; RECEPTOR GENE POLYMORPHISMS; GAMMA-GLOBULIN THERAPY; RISK-FACTORS; SUSCEPTIBILITY; CCR5; PREDICTION; INVOLVEMENT	Background: The etiology of Kawasaki Disease (KD) is enigmatic, although an infectious cause is suspected. Polymorphisms in CC chemokine receptor 5 (CCR5) and/or its potent ligand CCL3L1 influence KD susceptibility in US, European and Korean populations. However, the influence of these variations on KD susceptibility, coronary artery lesions (CAL) and response to intravenous immunoglobulin (IVIG) in Japanese children, who have the highest incidence of KD, is unknown. Methodology/Principal Findings: We used unconditional logistic regression analyses to determine the associations of the copy number of the CCL3L1 gene-containing duplication and CCR2-CCR5 haplotypes in 133 Japanese KD cases [33 with CAL and 25 with resistance to IVIG] and 312 Japanese controls without a history of KD. We observed that the deviation from the population average of four CCL3L1 copies (i.e., or. four copies) was associated with an increased risk of KD and IVIG resistance (adjusted odds ratio (OR) = 2.25, p = 0.004 and OR = 6.26, p = 0.089, respectively). Heterozygosity for the CCR5 HHF*2 haplotype was associated with a reduced risk of both IVIG resistance (OR = 0.21, p = 0.026) and CAL development (OR = 0.44, p = 0.071). Conclusions/Significance: The CCL3L1-CCR5 axis may play an important role in KD pathogenesis. In addition to clinical and laboratory parameters, genetic markers may also predict risk of CAL and resistance to IVIG.	[Mamtani, Manju; He, Weijing; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA; [Mamtani, Manju; He, Weijing; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Vet Adm Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA; [Matsubara, Tomoyo] Juntendo Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Shimizu, Chisato; Burns, Jane C.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp, Dept Pediat, La Jolla, CA 92093 USA; [Furukawa, Susumu] Yamaguchi Univ, Grad Sch Med, Dept Pediat, Yamaguchi, Japan; [Akagi, Teiji] Okayama Univ Hosp, Pediat Cardiac Care Unit, Okayama, Japan; [Onouchi, Yoshihiro] RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Kanagawa, Japan; [Hata, Akira] Chiba Univ, Dept Publ Hlth, Grad Sch Med, Chiba, Japan; [Fujino, Akihiro] Natl Ctr Child Hlth & Dev, Dept Surg, Tokyo, Japan; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; Juntendo University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Yamaguchi University; Okayama University; RIKEN; Chiba University; National Center for Child Health & Development - Japan; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Mamtani, M (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, S Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA.	ahujas@uthscsa.edu	Burns, Jane C/J-6167-2015; Shimizu, Chisato/J-6516-2015; Fujino, Akihiro/AAH-2243-2019	Fujino, Akihiro/0000-0003-2987-5081	National Institutes of Health, National Heart, Lung, Blood Institute [HL074864, HL69413]; Max and Minnie Tomerlin Voelcker Fund; Burroughs Wellcome Clinical Scientist Award in Translational Research; Doris Duke Distinguished Clinical Scientist Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069413, K24HL074864] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Max and Minnie Tomerlin Voelcker Fund; Burroughs Wellcome Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the National Institutes of Health, National Heart, Lung, Blood Institute, HL074864 and HL69413 awarded to JCB. This work was also supported by the Voelcker Senior Scholar Award from The Max and Minnie Tomerlin Voelcker Fund awarded to SKA. SKA is also supported by a Burroughs Wellcome Clinical Scientist Award in Translational Research, and the Doris Duke Distinguished Clinical Scientist Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGI T, 1992, J PEDIATR-US, V121, P689, DOI 10.1016/S0022-3476(05)81894-3; Asano T, 2000, CLIN EXP IMMUNOL, V122, P514, DOI 10.1046/j.1365-2249.2000.01395.x; Asano T, 2000, SCAND J IMMUNOL, V51, P98; Aukrust P, 2008, ARTERIOSCL THROM VAS, V28, P1909, DOI 10.1161/ATVBAHA.107.161240; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Ballow M, 2005, AM J HEALTH-SYST PH, V62, pS12, DOI 10.2146/ajhp050283; Biezeveld M, 2007, CLIN EXP IMMUNOL, V147, P106, DOI 10.1111/j.1365-2249.2006.03266.x; Breunis WB, 2007, CLIN EXP IMMUNOL, V150, P83, DOI 10.1111/j.1365-2249.2007.03457.x; Burns JC, 2005, J INFECT DIS, V192, P344, DOI 10.1086/430953; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Cha S, 2008, J KOREAN MED SCI, V23, P718, DOI 10.3346/jkms.2008.23.4.718; Cheung YF, 2008, PEDIATRICS, V122, pE608, DOI 10.1542/peds.2008-0646; de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X; DENG XW, 2002, POLYMORPHISMS CORECE; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; Fietta P, 2009, RIV BIOL-BIOL FORUM, V102, P61; Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gonzalez E, 2001, P NATL ACAD SCI USA, V98, P5199, DOI 10.1073/pnas.091056898; Guzman-Cottrill J A, 2004, Minerva Pediatr, V56, P51; Harnden A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1514; Hizawa N, 1999, AM J RESP CRIT CARE, V159, P2021, DOI 10.1164/ajrccm.159.6.9810020; Hsueh KC, 2008, J RHEUMATOL, V35, P1408; JHANG WK, 2008, J CLIN IMMUNOL; Jibiki T, 2001, ARTHRITIS RHEUM, V44, P2211, DOI 10.1002/1529-0131(200109)44:9<2211::AID-ART375>3.0.CO;2-A; Kariyazono H, 2004, PEDIATR RES, V56, P953, DOI 10.1203/01.PDR.0000145280.26284.B9; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; Kim T, 2007, EUR J PEDIATR, V166, P421, DOI 10.1007/s00431-006-0251-8; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kobayashi Tohru, 2008, Nihon Rinsho, V66, P332; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Mamtani M, 2008, ANN RHEUM DIS, V67, P1076, DOI 10.1136/ard.2007.078048; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McCrindle BW, 2007, CIRCULATION, V116, P174, DOI 10.1161/CIRCULATIONAHA.107.690875; Menten P, 2002, CYTOKINE GROWTH F R, V13, P455, DOI 10.1016/S1359-6101(02)00045-X; Minami T, 2005, J PEDIATR-US, V147, P78, DOI 10.1016/j.jpeds.2005.03.037; Miura M, 2004, ARCH DIS CHILD, V89, P776, DOI 10.1136/adc.2003.032748; Miyagishi R, 2003, J NEUROIMMUNOL, V145, P135, DOI 10.1016/j.jneuroim.2003.09.003; Mummidi S, 2000, J BIOL CHEM, V275, P18946, DOI 10.1074/jbc.M000169200; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Nishimura S, 2003, J PEDIATR-US, V143, P357, DOI 10.1067/S0022-3476(03)00330-5; Onouchi Y, 2008, NAT GENET, V40, P35, DOI 10.1038/ng.2007.59; Park JA, 2005, J KOREAN MED SCI, V20, P607, DOI 10.3346/jkms.2005.20.4.607; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rowley AH, 2007, CURR OPIN PEDIATR, V19, P71, DOI 10.1097/MOP.0b013e328012720f; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; Sittiwangkul R., 2006, SMJ Singapore Medical Journal, V47, P780; Takahashi K, 2005, PEDIATR INT, V47, P305, DOI 10.1111/j.1442-200x.2005.02049.x; Terai M, 1999, J LEUKOCYTE BIOL, V65, P566, DOI 10.1002/jlb.65.5.566; Townson JR, 2002, EUR J IMMUNOL, V32, P3016, DOI 10.1002/1521-4141(2002010)32:10<3016::AID-IMMU3016>3.0.CO;2-D; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Wong M, 1997, J RHEUMATOL, V24, P1179; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	58	17	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11458	10.1371/journal.pone.0011458	http://dx.doi.org/10.1371/journal.pone.0011458			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628649	Green Submitted, Green Published, gold			2022-12-27	WOS:000279589300006
J	Kim, HJ; Alonzo, ES; Dorothee, G; Pollard, JW; Sant'Angelo, DB				Kim, Hye-Jung; Alonzo, Eric S.; Dorothee, Guillaume; Pollard, Jeffrey W.; Sant'Angelo, Derek B.			Selective Depletion of Eosinophils or Neutrophils in Mice Impacts the Efficiency of Apoptotic Cell Clearance in the Thymus	PLOS ONE			English	Article							IN-VIVO; RECEPTOR; MACROPHAGES; INFLAMMATION; ACTIVATION; THYMOCYTES; DEFICIENT; TOLERANCE; MONOCYTES; DELETION	Developing thymocytes undergo a rigorous selection process to ensure that the mature T cell population expresses a T cell receptor (TCR) repertoire that can functionally interact with major histocompatibility complexes (MHC). Over 90% of thymocytes fail this selection process and die. A small number of macrophages within the thymus are responsible for clearing the large number of dying thymocytes that must be continuously cleared. We studied the capacity of thymic macrophages to clear apoptotic cells under acute circumstances. This was done by synchronously inducing cell death in the thymus and then monitoring the clearance of apoptotic thymocytes. Interestingly, acute cell death was shown to recruit large numbers of CD11b(+) cells into the thymus. In the absence of a minor CSF-1 dependent population of macrophages, the recruitment of these CD11b(+) cells into the thymus was greatly reduced and the clearance of apoptotic cells was disrupted. To assess a possible role for the CD11b(+) cells in the clearance of apoptotic cells, we analyzed mice deficient for eosinophils and mice with defective trafficking of neutrophils. Failure to attract either eosinophils or neutrophils to the thymus resulted in the impaired clearance of apoptotic cells. These results suggested that there is crosstalk between cells of the innate immune system that is necessary for maximizing the efficiency of apoptotic cell removal.	[Kim, Hye-Jung; Dorothee, Guillaume; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Alonzo, Eric S.; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10021 USA; [Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Pollard, Jeffrey W.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Yeshiva University	Kim, HJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	santangd@mskcc.org	DOROTHEE, Guillaume/O-9760-2016	DOROTHEE, Guillaume/0000-0001-5763-3632	 [NCI P30-CA 08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant # NCI P30-CA 08748, which provides partial support for Memorial Sloan-Kettering's Monoclonal Antibody, Flow Cytometry, Glassware Washing core facilities and the Research Animal Resource Center, the May and Samuel Rudin Family Foundation and funds from MSKCC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R E, 1976, Adv Immunol, V24, P215, DOI 10.1016/S0065-2776(08)60331-4; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Devalaraja RM, 2000, J INVEST DERMATOL, V115, P234, DOI 10.1046/j.1523-1747.2000.00034.x; Esashi E, 2003, J IMMUNOL, V171, P2773, DOI 10.4049/jimmunol.171.6.2773; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Humbles AA, 2002, P NATL ACAD SCI USA, V99, P1479, DOI 10.1073/pnas.261462598; Iyoda T, 2005, J IMMUNOL, V175, P3475, DOI 10.4049/jimmunol.175.6.3475; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Klein L, 2001, EUR J IMMUNOL, V31, P2476, DOI 10.1002/1521-4141(200108)31:8<2476::AID-IMMU2476>3.0.CO;2-T; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; MIYAZAKI T, 1993, INT IMMUNOL, V5, P1023, DOI 10.1093/intimm/5.9.1023; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; NATHAN CF, 1982, J EXP MED, V155, P1291, DOI 10.1084/jem.155.5.1291; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; SHI YF, 1991, J IMMUNOL, V146, P3340; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Throsby M, 2000, J IMMUNOL, V165, P1965, DOI 10.4049/jimmunol.165.4.1965; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xiao YQ, 2008, J IMMUNOL, V181, P3575, DOI 10.4049/jimmunol.181.5.3575; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang M, 2007, BLOOD, V109, P4280, DOI 10.1182/blood-2006-08-039255	35	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11439	10.1371/journal.pone.0011439	http://dx.doi.org/10.1371/journal.pone.0011439			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625428	Green Published, Green Submitted, gold			2022-12-27	WOS:000279522500007
J	Li, QX; Ali, MA; Wang, KN; Sayre, D; Hamel, FG; Fischer, ER; Bennett, RG; Cohen, JI				Li, Qingxue; Ali, Mir A.; Wang, Kening; Sayre, Dean; Hamel, Frederick G.; Fischer, Elizabeth R.; Bennett, Robert G.; Cohen, Jeffrey I.			Insulin Degrading Enzyme Induces a Conformational Change in Varicella-Zoster Virus gE, and Enhances Virus Infectivity and Stability	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; 3-O-SULFATED HEPARAN-SULFATE; VZV GLYCOPROTEIN-E; N-TERMINAL DOMAIN; TO-CELL SPREAD; ENDOCYTIC ENTRY; TYPE-1 ENTRY; IN-VITRO; RECEPTOR; FUSION	Varicella-zoster virus (VZV) glycoprotein E (gE) is essential for virus infectivity and binds to a cellular receptor, insulin-degrading enzyme (IDE), through its unique amino terminal extracellular domain. Previous work has shown IDE plays an important role in VZV infection and virus cell-to-cell spread, which is the sole route for VZV spread in vitro. Here we report that a recombinant soluble IDE (rIDE) enhances VZV infectivity at an early step of infection associated with an increase in virus internalization, and increases cell-to-cell spread. VZV mutants lacking the IDE binding domain of gE were impaired for syncytia formation and membrane fusion. Pre-treatment of cell-free VZV with rIDE markedly enhanced the stability of the virus over a range of conditions. rIDE interacted with gE to elicit a conformational change in gE and rendered it more susceptible to proteolysis. Co-incubation of rIDE with gE modified the size of gE. We propose that the conformational change in gE elicited by IDE enhances infectivity and stability of the virus and leads to increased fusogenicity during VZV infection. The ability of rIDE to enhance infectivity of cell-free VZV over a wide range of incubation times and temperatures suggests that rIDE may be useful for increasing the stability of varicella or zoster vaccines.	[Li, Qingxue; Ali, Mir A.; Wang, Kening; Sayre, Dean; Cohen, Jeffrey I.] NIH, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Hamel, Frederick G.; Bennett, Robert G.] Univ Nebraska Med Ctr, Dept Internal Med, Omaha, NE USA; [Hamel, Frederick G.; Bennett, Robert G.] Omaha VA Med Ctr, Res Serv, Omaha, NE USA; [Fischer, Elizabeth R.] NIH, Res Technol Branch, Rocky Mt Labs, Hamilton, MT USA	National Institutes of Health (NIH) - USA; University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; National Institutes of Health (NIH) - USA	Li, QX (corresponding author), NIH, Lab Clin Infect Dis, Bldg 10, Bethesda, MD 20892 USA.	jcohen@niaid.nih.gov			National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001052, ZIAAI000430] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2009, VIROLOGY, V386, P270, DOI 10.1016/j.virol.2009.01.023; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; Bennett RG, 2009, ANN NY ACAD SCI, V1160, P38, DOI 10.1111/j.1749-6632.2008.03782.x; Berarducci B, 2006, J VIROL, V80, P9481, DOI 10.1128/JVI.00533-06; Berarducci B, 2010, P NATL ACAD SCI USA, V107, P282, DOI 10.1073/pnas.0912373107; Carpenter JE, 2009, J VIROL, V83, P6917, DOI 10.1128/JVI.00081-09; Chen JJ, 2004, CELL, V119, P915, DOI 10.1016/j.cell.2004.11.007; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; CLAPHAM PR, 1992, J VIROL, V66, P3531, DOI 10.1128/JVI.66.6.3531-3537.1992; Cohen JI, 1998, J INFECT DIS, V177, P1390, DOI 10.1086/517821; Cohen JI, 2001, VIROLOGY, V280, P62, DOI 10.1006/viro.2000.0741; COHEN JI, 2007, FIELDS VIROLOGY, P2773; Cole NL, 2003, REV MED VIROL, V13, P207, DOI 10.1002/rmv.377; Damico R, 2000, J VIROL, V74, P6469, DOI 10.1128/JVI.74.14.6469-6475.2000; Delos SE, 2005, J VIROL, V79, P3488, DOI 10.1128/JVI.79.6.3488-3499.2005; Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817; DUCKWORTH WC, 1974, DIABETES, V23, P536, DOI 10.2337/diab.23.6.536; Dveksler GS, 1996, J VIROL, V70, P4142, DOI 10.1128/JVI.70.6.4142-4145.1996; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Geraghty RJ, 1998, SCIENCE, V280, P1618, DOI 10.1126/science.280.5369.1618; Golden JW, 2002, J VIROL, V76, P7430, DOI 10.1128/JVI.76.15.7430-7443.2002; Hambleton S, 2007, J VIROL, V81, P7548, DOI 10.1128/JVI.00486-07; Hamel FG, 2003, ENDOCRINOLOGY, V144, P2404, DOI 10.1210/en.2002-0007; Harpaz Rafael, 2007, Morbidity and Mortality Weekly Report, V57, P1; HARPER DR, 1990, J GEN VIROL, V71, P459, DOI 10.1099/0022-1317-71-2-459; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Kawase M, 2009, J VIROL, V83, P712, DOI 10.1128/JVI.01933-08; KELLER PM, 1984, J VIROL, V52, P293, DOI 10.1128/JVI.52.1.293-297.1984; Kimura H, 1997, VIROLOGY, V233, P382, DOI 10.1006/viro.1997.8625; Kirschner AN, 2009, STRUCTURE, V17, P223, DOI 10.1016/j.str.2008.12.010; Kwon H, 2006, J VIROL, V80, P138, DOI 10.1128/JVI.80.1.138-148.2006; Leissring MA, 2004, BIOCHEM J, V383, P439, DOI 10.1042/BJ20041081; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Li QX, 2007, J VIROL, V81, P8525, DOI 10.1128/JVI.00286-07; Li QX, 2006, CELL, V127, P305, DOI 10.1016/j.cell.2006.08.046; LI QX, 1995, J VIROL, V69, P3987, DOI 10.1128/JVI.69.7.3987-3994.1995; Lopez M, 2001, J VIROL, V75, P5684, DOI 10.1128/JVI.75.12.5684-5691.2001; Lynch JA, 2006, J NEUROSCI RES, V83, P1262, DOI 10.1002/jnr.20809; Mallory S, 1997, J VIROL, V71, P8279, DOI 10.1128/JVI.71.11.8279-8288.1997; Maresova L, 2005, J VIROL, V79, P997, DOI 10.1128/JVI.79.2.997-1007.2005; Maresova L, 2001, J VIROL, V75, P9483, DOI 10.1128/JVI.75.19.9483-9492.2001; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Matsuyama S, 2009, J VIROL, V83, P11133, DOI 10.1128/JVI.00959-09; MCCLAIN DS, 1994, VIROLOGY, V198, P690, DOI 10.1006/viro.1994.1081; Milne RSB, 2005, J VIROL, V79, P6655, DOI 10.1128/JVI.79.11.6655-6663.2005; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Pager CT, 2006, VIROLOGY, V346, P251, DOI 10.1016/j.virol.2006.01.007; Park SS, 2006, J ORTHOP TRAUMA, V20, P11, DOI 10.1097/01.bot.0000189591.40267.09; Pasieka TJ, 2004, J VIROL, V78, P2884, DOI 10.1128/JVI.78.6.2884-2896.2004; PERLMAN RK, 1994, J BIOL CHEM, V269, P33140; PERLMAN RK, 1993, J BIOL CHEM, V268, P21538; Pertel PE, 2001, VIROLOGY, V279, P313, DOI 10.1006/viro.2000.0713; Rojek JM, 2010, J VIROL, V84, P573, DOI 10.1128/JVI.01697-09; Santos RA, 2000, VIROLOGY, V275, P306, DOI 10.1006/viro.2000.0507; Sato H, 2002, J VIROL, V76, P11012, DOI 10.1128/JVI.76.21.11012-11023.2002; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Shukla D, 1999, CELL, V99, P13, DOI 10.1016/S0092-8674(00)80058-6; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Snitkovsky S, 1998, P NATL ACAD SCI USA, V95, P7063, DOI 10.1073/pnas.95.12.7063; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; Subramanian RP, 2007, P NATL ACAD SCI USA, V104, P2903, DOI 10.1073/pnas.0608374104; Tiwari V, 2007, J GEN VIROL, V88, P1075, DOI 10.1099/vir.0.82476-0; Townsley AC, 2007, J VIROL, V81, P8613, DOI 10.1128/JVI.00606-07; Veettil MV, 2008, J VIROL, V82, P12126, DOI 10.1128/JVI.01146-08; Wang KN, 2005, J VIROL, V79, P14079, DOI 10.1128/JVI.79.22.14079-14087.2005	71	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11327	10.1371/journal.pone.0011327	http://dx.doi.org/10.1371/journal.pone.0011327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593027	gold, Green Published, Green Submitted			2022-12-27	WOS:000279140800024
J	Almecija, S; Moya-Sola, S; Alba, DM				Almecija, Sergio; Moya-Sola, Salvador; Alba, David M.			Early Origin for Human-Like Precision Grasping: A Comparative Study of Pollical Distal Phalanges in Fossil Hominins	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; OLDUVAI GORGE; AUSTRALOPITHECUS-AFRICANUS; MORPHOLOGICAL AFFINITIES; POSTCRANIAL SPECIMENS; HAND MORPHOLOGY; TOOL BEHAVIOR; MIOCENE; EVOLUTION; KENYA	Background: The morphology of human pollical distal phalanges (PDP) closely reflects the adaptation of human hands for refined precision grip with pad-to-pad contact. The presence of these precision grip-related traits in the PDP of fossil hominins has been related to human-like hand proportions (i.e. short hands with a long thumb) enabling the thumb and finger pads to contact. Although this has been traditionally linked to the appearance of stone tool-making, the alternative hypothesis of an earlier origin-related to the freeing of the hands thanks to the advent of terrestrial bipedalism-is also possible given the human-like intrinsic hand proportion found in australopiths. Methodology/Principal Findings: We perform morphofunctional and morphometric (bivariate and multivariate) analyses of most available hominin pollical distal phalanges, including Orrorin, Australopithecus, Paranthropous and fossil Homo, in order to investigate their morphological affinities. Our results indicate that the thumb morphology of the early biped Orrorin is more human-like than that of australopiths, in spite of its ancient chronology (ca. 6 Ma). Moreover, Orrorin already displays typical human-like features related to precision grasping. Conclusions: These results reinforce previous hypotheses relating the origin of refined manipulation of natural objects-not stone tool-making-with the relaxation of locomotor selection pressures on the forelimbs. This suggests that human hand length proportions are largely plesiomorphic, in the sense that they more closely resemble the relatively short-handed Miocene apes than the elongated hand pattern of extant hominoids. With the advent of terrestrial bipedalism, these hand proportions may have been co-opted by early hominins for enhanced manipulative capabilities that, in turn, would have been later co-opted for stone tool-making in the genus Homo, more encephalized than the previous australopiths. This hypothesis remains may be further tested by the finding of more complete hands of unequivocally biped early hominins.	[Almecija, Sergio; Alba, David M.] Univ Autonoma Barcelona, Inst Catala Paleontol, Cerdanyola Del Valles, Barcelona, Spain; [Moya-Sola, Salvador] Univ Autonoma Barcelona, Dept BABVE, Inst Catala Paleontol & Unitat Antropol Biol, ICREA, Cerdanyola Del Valles, Barcelona, Spain	Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Autonomous University of Barcelona; ICREA; Institut Catala de Paleontologia Miquel Crusafont (ICP)	Almecija, S (corresponding author), Univ Autonoma Barcelona, Inst Catala Paleontol, Cerdanyola Del Valles, Barcelona, Spain.	sergi.almecija@icp.cat	Almécija, Sergio/ABG-8129-2020; Alba, David/G-9716-2015	Almécija, Sergio/0000-0003-1373-1497; Alba, David/0000-0002-8886-5580; Moya-Sola, Salvador/0000-0001-8506-1061	Generalitat de Catalunya [2006 FI 00065, 2008 BE1 00370, 2009 SGR 754 GRC]; U.S. National Science Foundation under NSF [BCS-0321893]; European Commission; Spanish Ministerio de Ciencia e Innovacion [CGL2008-00325/BTE, RYC-2009-04533]; ICREA Funding Source: Custom	Generalitat de Catalunya(Generalitat de Catalunya); U.S. National Science Foundation under NSF(National Science Foundation (NSF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ICREA(ICREA)	This research has been supported by the Generalitat de Catalunya (predoctoral fellowship 2006 FI 00065 and travel grant 2008 BE1 00370 to S. A., and 2009 SGR 754 GRC), the U.S. National Science Foundation under NSF Award #BCS-0321893, the European Commission's Research Infrastructure (SYNTHESYS project grant to S. A.), and the Spanish Ministerio de Ciencia e Innovacion (CGL2008-00325/BTE, and RYC-2009-04533 to D. M. A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alba DM, 2003, J HUM EVOL, V44, P225, DOI 10.1016/S0047-2484(02)00207-5; ALBA DM, 2010, J ANTHR SCI IN PRESS; Almecija S, 2009, J VERTEBR PALEONTOL, V29, p53A; Almecija S, 2009, J HUM EVOL, V57, P284, DOI 10.1016/j.jhevol.2009.02.008; BEGUN DR, 1994, J HUM EVOL, V26, P89, DOI 10.1006/jhev.1994.1008; Darwin C., 1871, P423; DAY MH, 1966, NATURE, V211, P929, DOI 10.1038/211929a0; ETTER HF, 1973, FOLIA PRIMATOL, V20, P331, DOI 10.1159/000155585; Gommery D, 2006, GEOBIOS-LYON, V39, P372, DOI 10.1016/j.geobios.2005.03.002; Green DJ, 2008, J HUM EVOL, V54, P705, DOI 10.1016/j.jhevol.2007.10.007; Harrison T, 2010, SCIENCE, V327, P532, DOI 10.1126/science.1184703; Hartwig WC, 1998, AM J PHYS ANTHROPOL, V106, P401, DOI 10.1002/(SICI)1096-8644(199807)106:3<401::AID-AJPA11>3.0.CO;2-4; JOLLY CJ, 1970, DIVERSE APPROACHES H, P323; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; Keith A, 1929, J BONE JOINT SURG, V11, P10; LEAKEY LSB, 1959, NATURE, V184, P491, DOI 10.1038/184491a0; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Madar SI, 2002, J HUM EVOL, V42, P705, DOI 10.1006/jhev.2002.0554; Marzke MW, 2010, AM J PHYS ANTHROPOL, V141, P38, DOI 10.1002/ajpa.21112; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; MCHENRY HM, 1976, AM J PHYS ANTHROPOL, V45, P77, DOI 10.1002/ajpa.1330450110; Mittra ES, 2007, AM J PHYS ANTHROPOL, V134, P449, DOI 10.1002/ajpa.20687; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 2008, FOLIA PRIMATOL, V79, P215, DOI 10.1159/000113458; Nakatsukasa M, 2003, PRIMATES, V44, P371, DOI 10.1007/s10329-003-0051-y; Nakatsukasa Masato, 2002, Zeitschrift fuer Morphologie und Anthropologie, V83, P361; NAPIER J. R., 1960, PROC ZOOL SOC LONDON, V134, P647; Napier J. R., 1993, HANDS; Napier JR, 1967, HDB LIVING PRIMATES; PILBEAM DR, 1980, POSTILLA, V181, P1; PREUSCHOFT H, 1973, CHIMPANZEE, V6, P34; Preuschoft H, 1993, HANDS PRIMATES, P245; Richmond BG, 2008, SCIENCE, V319, P1662, DOI 10.1126/science.1154197; Ricklan D. E., 1988, THESIS; RICKLAN DE, 1987, J HUM EVOL, V16, P643, DOI 10.1016/0047-2484(87)90018-2; Robinson J.T., 1972, EARLY HOMINID POSTUR; ROSE MD, 1992, J HUM EVOL, V22, P255, DOI 10.1016/0047-2484(92)90058-H; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shrewsbury MM, 2003, AM J PHYS ANTHROPOL, V121, P30, DOI 10.1002/ajpa.10192; SHREWSBURY MM, 1986, HUM EVOL, V1, P233; SMITH SL, 1995, AM J PHYS ANTHROPOL, V96, P283, DOI 10.1002/ajpa.1330960306; Smith SL, 2000, AM J PHYS ANTHROPOL, V113, P329, DOI 10.1002/1096-8644(200011)113:3<329::AID-AJPA5>3.0.CO;2-B; Straus WL, 1942, Q REV BIOL, V17, P228, DOI 10.1086/394656; SUSMAN RL, 1994, SCIENCE, V265, P1570, DOI 10.1126/science.8079169; SUSMAN RL, 1988, SCIENCE, V240, P781, DOI 10.1126/science.3129783; Susman RL, 1998, J HUM EVOL, V35, P23, DOI 10.1006/jhev.1998.0220; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V51, P311, DOI 10.1002/ajpa.1330510303; SUSMAN RL, 1989, AM J PHYS ANTHROPOL, V79, P451, DOI 10.1002/ajpa.1330790403; Tocheri MW, 2008, J ANAT, V212, P544, DOI 10.1111/j.1469-7580.2008.00865.x; Tocheri MW, 2003, AM J PHYS ANTHROPOL, V122, P101, DOI 10.1002/ajpa.10235; Tuttle R, 1970, CHIMPANZEE, P167; TUTTLE RH, 1966, AM J PHYS ANTHROPOL, V24, P191, DOI 10.1002/ajpa.1330240207; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; TUTTLE RH, 1969, J MORPHOL, V128, P309, DOI 10.1002/jmor.1051280304; VANDERMEERSCH B, 1991, SQUELETTE MOUSTERIEN, V2, P169; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; Whitehead Paul F., 1993, P96	59	68	69	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11727	10.1371/journal.pone.0011727	http://dx.doi.org/10.1371/journal.pone.0011727			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	630AN	20661444	Green Published, gold			2022-12-27	WOS:000280243300027
J	Klein, N				Klein, Nicole			Long Bone Histology of Sauropterygia from the Lower Muschelkalk of the Germanic Basin Provides Unexpected Implications for Phylogeny	PLOS ONE			English	Article							GROWTH-PATTERNS; REPTILIA; INTERRELATIONSHIPS; NETHERLANDS; WINTERSWIJK; NOTHOSAURUS; SKELETON; SIGNAL; BIRTH; SKULL	Background: Sauropterygia is an abundant and successful group of Triassic marine reptiles. Phylogenetic relationships of Triassic Sauropterygia have always been unstable and recently questioned. Although specimens occur in high numbers, the main problems are rareness of diagnostic material from the Germanic Basin and uniformity of postcranial morphology of eosauropterygians. In the current paper, morphotypes of humeri along with their corresponding bone histologies for Lower to Middle Muschelkalk sauropterygians are described and interpreted for the first time in a phylogenetic context. Methodology/Principal Findings: Nothosaurus shows a typical plesiomorphic lamellar-zonal bone type, but varying growth patterns and the occurrence of a new humerus morphotype point to a higher taxonomic diversity than was known. In contrast to the enormous morphological variability of eosauropterygian humeri not assigned to Nothosaurus, their long bone histology is relatively uniform and can be divided into two histotypes. Unexpectedly, both of these histotypes reveal abundant fibrolamellar bone throughout the cortex. This pushes the origin of fibrolamellar bone in Sauropterygia back from the Cretaceous to the early Middle Triassic (early Anisian). Histotype A is assigned to Cymatosaurus, a basal member of the Pistosauroidea, which includes the plesiosaurs as derived members. Histotype B is related to the pachypleurosaur Anarosaurus. Contrary to these new finds, the stratigraphically younger pachypleurosaur Neusticosaurus shows the plesiomorphic lamellar-zonal bone type and an incomplete endochondral ossification, like Nothosaurus. Conclusions/Significance: Histological results hypothetically discussed in a phylogenetical context have a large impact on the current phylogenetic hypothesis of Sauropterygia, leaving the pachypleurosaurs polyphyletic. On the basis of histological data, Neusticosaurus would be related to Nothosaurus, whereas Anarosaurus would follow the pistosaur clade. Furthermore, the presence of fibrolamellar bone, which is accompanied with increased growth rates and presumably even with increased metabolic rates, already in Anarosaurus and Cymatosaurus can explain the success of the Pistosauroidea, the only sauropterygian group to survive into the Jurassic and give rise to the pelagic plesiosaur radiation.	Univ Bonn, Steinmann Inst Geol Mineral & Palaeontol, D-5300 Bonn, Germany	University of Bonn	Klein, N (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaeontol, D-5300 Bonn, Germany.	nklein@uni-bonn.de			Deutsche Forschungsgemeinschaft [KL 2127/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding was provided by the Deutsche Forschungsgemeinschaft (project KL 2127/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERS P, 2005, PALARCHS J VERTEBRAT, P33; Albers P. C., 2005, PALARCHS J VERTEBRAT, P1; Albers PCH, 2003, J PALEONTOL, V77, P738, DOI 10.1666/0022-3360(2003)077<0738:ANSOTS>2.0.CO;2; Bickelmann C, 2008, J VERTEBR PALEONTOL, V28, P326, DOI 10.1671/0272-4634(2008)28[326:APSAIH]2.0.CO;2; Bottcher R., 1990, STUTTGARTER BEITRA B, V164, P1; BUCHWITZ M, 2008, TERRA NOSTRA, pA61; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; CASTANET J, 1994, GERONTOLOGY, V40, P174, DOI 10.1159/000213586; Castanet J., 1993, BONE, P245; Cheng YN, 2004, NATURE, V432, P383, DOI 10.1038/nature03050; Chinsamy-Turan A., 2005, MICROSTRUCTURE DINOS; CORMACK DH, 1987, HAMS HISTOLOGY; Cubo J, 2005, SYST BIOL, V54, P562, DOI 10.1080/10635150591003461; Cubo J, 2008, EVOL DEV, V10, P217, DOI 10.1111/j.1525-142X.2008.00229.x; de Buffrenil Vivian, 1992, Revue de Paleobiologie, V11, P397; de Ricqles A., 1976, Annales Paleont (Vert), V62, P71; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; de Ricqles Armand, 2001, P289; Enlow D. H., 1957, Texas Journal of Science, V9, P186; ENLOW DH, 1969, BIOL REPTILIA, V1, P117; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Fostowicz-Frelik L, 2010, LETHAIA, V43, P137, DOI 10.1111/j.1502-3931.2009.00179.x; Francillon-Vieillot H., 1990, SKELETAL BIOMINERALI, V1, P471; GROSS W, 1934, Z ANAT ENTWICKLUNGS, V203, P731; Hill RV, 2005, SYST BIOL, V54, P530, DOI 10.1080/10635150590950326; Holmes R, 2008, J VERTEBR PALEONTOL, V28, P76, DOI 10.1671/0272-4634(2008)28[76:NIOTSO]2.0.CO;2; KIPRIJANOFF V, 1881, MEMOIRES ACAD IMPERI, V28, P1; Klein N., 2009, TERRA NOSTRA, V2009, p61A; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2009, J VERTEBR PALEONTOL, V29, p127A; Klein N, 2009, ACTA PALAEONTOL POL, V54, P589, DOI 10.4202/app.2008.0083; Klein N, 2009, J VERTEBR PALEONTOL, V29, P665, DOI 10.1671/039.029.0327; Krahl A, 2009, J VERTEBR PALEONTOL, V29, p129A; LUKAS V, 1991, Geologisches Jahrbuch Hessen, V119, P119; NOPSCA F, 1934, ACTA ZOOLOGICA, V15, P431; Oosterink H. W., 2003, STARINGIA, V11, P1; OOSTERINK HW, 1986, WETENSCHAPPELIJKE ME, V178, P1; PEABODY FE, 1961, J MORPHOL, V108, P11, DOI 10.1002/jmor.1051080103; Ray S, 2004, J VERTEBR PALEONTOL, V24, P634, DOI 10.1671/0272-4634(2004)024[0634:BHAGPO]2.0.CO;2; Reid R.E.H., 1997, P403; Rieppel, 1994, FIELDIANA GEOL, V28, P1, DOI DOI 10.5962/BHL.TITLE.3399; Rieppel O, 2002, ZOOL J LINN SOC-LOND, V135, P33, DOI 10.1046/j.1096-3642.2002.00019.x; Rieppel O, 1998, J VERTEBR PALEONTOL, V18, P545, DOI 10.1080/02724634.1998.10011082; Rieppel O, 1998, ZOOL J LINN SOC-LOND, V124, P1; Rieppel O., 2000, HDB PALEOHERPETOLOGY; Rieppel OC, 1997, FIELDIANA, V36, P1; Rieppel Olivier, 1995, Fieldiana Geology, V32, P1; Rieppel Olivier, 1997, P121, DOI 10.1016/B978-012155210-7/50009-0; Rieppel Olivier, 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V197, P383; RUEGG GH, 1981, SEDIMENTOLOGISCHE AF, V63, P7; SANDER P M, 1989, Philosophical Transactions of the Royal Society of London B Biological Sciences, V325, P561, DOI 10.1098/rstb.1989.0103; SANDER PM, 1990, ANN SCI NAT ZOOL, V13, P213; Schroeaer H., 1914, Abhandlungen K Preussischen Geologischen Landesanst Berlin, V65, P1; Seitz ALL, 1907, NOVA ACTA ABHANDLUNG, V87, P230; *SKPT, 2008, SUBK PERM TRIAS; Stein K, 2009, J VERTEBR PALEONTOL, V29, p185A; SUES HD, 1987, ZOOL J LINN SOC-LOND, V90, P109, DOI 10.1111/j.1096-3642.1987.tb01351.x; Volz W., 1902, PAL ONTOGRAPHICA, V49, P121; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Zangerl R, 1935, ABHANDLUNGEN SCHWEIZ, V66, P1	61	64	67	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11613	10.1371/journal.pone.0011613	http://dx.doi.org/10.1371/journal.pone.0011613			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657768	Green Submitted, gold, Green Published			2022-12-27	WOS:000280197500008
J	Krummel, B; Strassburg, A; Ernst, M; Reiling, N; Eker, B; Rath, H; Hoerster, R; Wappler, W; Glaewe, A; Schoellhorn, V; Sotgiu, G; Lange, C				Krummel, Benjamin; Strassburg, Alan; Ernst, Martin; Reiling, Norbert; Eker, Barbara; Rath, Heidrun; Hoerster, Robert; Wappler, Waltraud; Glaewe, Andrea; Schoellhorn, Volker; Sotgiu, Giovanni; Lange, Christoph			Potential Role for IL-2 ELISpot in Differentiating Recent and Remote Infection in Tuberculosis Contact Tracing	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSE; FACTOR-ALPHA; IFN-GAMMA; TNF-ALPHA; SKIN-TEST; T-CELLS; DIAGNOSIS	Interferon (IFN)-gamma release assays (IGRA) have improved tuberculosis contact tracing, but discrimination of recent from remote Mycobacterium tuberculosis contacts is not possible by IGRA alone. We present results of a tuberculosis contact investigation with a new early-secretory-antigenic-target (ESAT)-6 and culture-filtrate-protein (CFP)-10 specific interleukin (IL)-2 ELISpot in addition to ESAT-6 and CFP-10 specific IFN-gamma ELISpot and tuberculin skin testing (TST). Results of the TST, IFN-gamma ELISpot and IL-2 ELISpot were positive in 6/172 (3.4%), 7/167 (4.2%) and 6/196 (3.1%) of contacts, respectively. Close contact (>= 100 hours) to the index case increased the risk of positive results in the IFN-gamma ELISpot, TST, and IL-2 ELISpot by 40.8, 19.3, and 2.5 times, respectively. Individuals with a positive IFN-gamma ELISpot/negative IL-2 ELISpot result had a median (IQR) duration of index case exposure of 568 hours (133_1000) compared to individuals with a positive IFN-gamma ELISpot/positive IL-2 ELISpot result (median = 24 hours; 20_130; p-value = 0.047). Combination of a M. tuberculosis specific IFN-gamma ELISpot with a M. tuberculosis specific IL-2 ELISpot significantly improved the identification of individuals with the highest risk of recent M. tuberculosis infection and is a promising method that should be explored to target tuberculosis preventive chemotherapy.	[Krummel, Benjamin; Strassburg, Alan; Eker, Barbara; Hoerster, Robert; Wappler, Waltraud; Glaewe, Andrea; Lange, Christoph] Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany; [Ernst, Martin] Res Ctr Borstel, Div Immune Cell Analyt, Borstel, Germany; [Reiling, Norbert] Res Ctr Borstel, Div Microbial Interface Biol, Borstel, Germany; [Rath, Heidrun] Dept Publ Hlth, Lubeck, Germany; [Schoellhorn, Volker] Autoimmun Diagnost GmbH, Strassberg, Germany; [Sotgiu, Giovanni] Univ Sassari, Inst Hyg & Prevent Med, I-07100 Sassari, Italy	Forschungszentrum Borstel; Forschungszentrum Borstel; Forschungszentrum Borstel; University of Sassari	Krummel, B (corresponding author), Res Ctr Borstel, Div Clin Infect Dis, Borstel, Germany.	clange@fz-borstel.de	Reiling, Norbert/D-6796-2013; Lange, Christoph/J-6289-2012; Sotgiu, Giovanni/N-1032-2017	Reiling, Norbert/0000-0001-6673-4291; Lange, Christoph/0000-0002-9691-4741; Sotgiu, Giovanni/0000-0002-1600-4474	Research Center Borstel; Leibniz Center for Medicine and Biomedical Research, Germany	Research Center Borstel; Leibniz Center for Medicine and Biomedical Research, Germany	The study was funded by the Research Center Borstel, Leibniz Center for Medicine and Biomedical Research, Germany. ELISPOT plates and reagents were kindly provided free of charge by Autoimmun Diagnostika (AID), Strasberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2005, CLIN INFECT DIS, V41, pS189, DOI 10.1086/429994; Buettner M, 2005, J IMMUNOL, V174, P4203, DOI 10.4049/jimmunol.174.7.4203; Byrd TF, 1997, J CLIN INVEST, V99, P2518, DOI 10.1172/JCI119436; Diel R, 2007, Pneumologie, V61, P440, DOI 10.1055/s-2007-959219; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Goletti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003417; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; GRZYBOWSKI S, 1975, Bulletin of the International Union Against Tuberculosis, V50, P90; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; *IUTLD, 1982, B WORLD HEALTH ORGAN, V60, P555; JAFARI C, 2009, AM J RESP CRIT CARE; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kenyon TA, 1996, NEW ENGL J MED, V334, P933, DOI 10.1056/NEJM199604113341501; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Millington KA, 2007, J IMMUNOL, V178, P5217, DOI 10.4049/jimmunol.178.8.5217; Nienhaus A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002665; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SOKAL JE, 1975, NEW ENGL J MED, V293, P501, DOI 10.1056/NEJM197509042931013; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Vincenti D, 2003, MOL MED, V9, P105, DOI 10.1007/BF03402042; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Wolfe F, 2004, ARTHRITIS RHEUM-US, V50, P372, DOI 10.1002/art.20009	32	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11670	10.1371/journal.pone.0011670	http://dx.doi.org/10.1371/journal.pone.0011670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652022	Green Published, Green Submitted, gold			2022-12-27	WOS:000280109700005
J	Forbi, JC; Vaughan, G; Purdy, MA; Campo, DS; Xia, GL; Ganova-Raeva, LM; Ramachandran, S; Thai, H; Khudyakov, YE				Forbi, Joseph C.; Vaughan, Gilberto; Purdy, Michael A.; Campo, David S.; Xia, Guo-liang; Ganova-Raeva, Lilia M.; Ramachandran, Sumathi; Thai, Hong; Khudyakov, Yury E.			Epidemic History and Evolutionary Dynamics of Hepatitis B Virus Infection in Two Remote Communities in Rural Nigeria	PLOS ONE			English	Article							GENOTYPE-E STRAINS; GENETIC DIVERSITY; C VIRUS; PHYLOGENETIC ANALYSIS; SURFACE-ANTIGEN; BLOOD-DONORS; WEST; AFRICA; SUBGENOTYPES; ERADICATION	Background: In Nigeria, hepatitis B virus (HBV) infection has reached hyperendemic levels and its nature and origin have been described as a puzzle. In this study, we investigated the molecular epidemiology and epidemic history of HBV infection in two semi-isolated rural communities in North/Central Nigeria. It was expected that only a few, if any, HBV strains could have been introduced and effectively transmitted among these residents, reflecting limited contacts of these communities with the general population in the country. Methods and Findings: Despite remoteness and isolation, similar to 11% of the entire population in these communities was HBV-DNA seropositive. Analyses of the S-gene sequences obtained from 55 HBV-seropositive individuals showed the circulation of 37 distinct HBV variants. These HBV isolates belong predominantly to genotype E (HBV/E) (n = 53, 96.4%), with only 2 classified as sub-genotype A3 (HBV/A3). Phylogenetic analysis showed extensive intermixing between HBV/E variants identified in these communities and different countries in Africa. Quasispecies analysis of 22 HBV/E strains using end-point limiting-dilution real-time PCR, sequencing and median joining networks showed extensive intra-host heterogeneity and inter-host variant sharing. To investigate events that resulted in such remarkable HBV/E diversity, HBV full-size genome sequences were obtained from 47 HBV/E infected persons and P gene was subjected to Bayesian coalescent analysis. The time to the most recent common ancestor (tMRCA) for these HBV/E variants was estimated to be year 1952 (95% highest posterior density (95% HPD): 1927-1970). Using additional HBV/E sequences from other African countries, the tMRCA was estimated to be year 1948 (95% HPD: 1924-1966), indicating that HBV/E in these remote communities has a similar time of origin with multiple HBV/E variants broadly circulating in West/Central Africa. Phylogenetic analysis and statistical neutrality tests suggested rapid HBV/E population expansion. Additionally, skyline plot analysis showed an increase in the size of the HBV/E-infected population over the last similar to 30-40 years. Conclusions: Our data suggest a massive introduction and relatively recent HBV/E expansion in the human population in Africa. Collectively, these data show a significant shift in the HBV/E epidemic dynamics in Africa over the last century.	[Forbi, Joseph C.; Vaughan, Gilberto; Purdy, Michael A.; Campo, David S.; Xia, Guo-liang; Ganova-Raeva, Lilia M.; Ramachandran, Sumathi; Thai, Hong; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Forbi, JC (corresponding author), Ctr Dis Control & Prevent, Div Viral Hepatitis, Atlanta, GA 30333 USA.	gzf7@cdc.gov	Campo, David S./C-5072-2011	Campo, David S./0000-0002-8970-3436	American Society for Microbiology (ASM); Coordinating Center for Infectious Diseases (CCID) at the Centers for Disease Control and Prevention (CDC), Atlanta-USA	American Society for Microbiology (ASM); Coordinating Center for Infectious Diseases (CCID) at the Centers for Disease Control and Prevention (CDC), Atlanta-USA(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was directly supported by the American Society for Microbiology (ASM) (www.asm.org) and the Coordinating Center for Infectious Diseases (CCID) at the Centers for Disease Control and Prevention (CDC), Atlanta-USA. J.C.F. received the ASM/CCID postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Mora MVA, 2010, J GEN VIROL, V91, P501, DOI 10.1099/vir.0.015958-0; Andernach IE, 2009, EMERG INFECT DIS, V15, P1222, DOI 10.3201/eid1508.081642; Andernach IE, 2009, REV MED VIROL, V19, P231, DOI 10.1002/rmv.618; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beasley RP, 2009, ANN EPIDEMIOL, V19, P231, DOI 10.1016/j.annepidem.2009.01.017; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Depla E, 2008, J VIROL, V82, P435, DOI 10.1128/JVI.01505-07; Dreesman JM, 2006, EPIDEMIOL INFECT, V134, P1102, DOI 10.1017/S0950268806005942; Drucker E, 2001, LANCET, V358, P1989, DOI 10.1016/S0140-6736(01)06967-7; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fasola FA, 2008, INTERVIROLOGY, V51, P427, DOI 10.1159/000209671; Foege W H, 1973, Prog Med Virol, V15, P205; FOEGE WH, 1975, B WORLD HEALTH ORGAN, V52, P209; Forbi JC, 2008, REV INST MED TROP SP, V50, P219, DOI 10.1590/S0036-46652008000400006; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Fu YX, 1996, GENETICS, V143, P557; GANEM D, 2001, FIELDS VIROLOGY, P2923; Garmiri P, 2009, J GEN VIROL, V90, P2442, DOI 10.1099/vir.0.012013-0; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Grischow JD, 2006, AFRICA, V76, P381, DOI 10.1353/afr.2006.0041; Hawkins AE, 1996, J VIROL METHODS, V60, P81, DOI 10.1016/0166-0934(96)02048-4; HERBERT EW, 1975, J AFR HIST, V16, P539, DOI 10.1017/S0021853700014547; HOUILLON D, 1905, ANN HYGIENE MED COLO, V8, P546; Hubschen JM, 2008, J CLIN VIROL, V43, P376, DOI 10.1016/j.jcv.2008.08.018; Isiugo-Abanihe U C, 2006, Afr J Med Med Sci, V35 Suppl, P45; KALIDI I, 1988, TISSUE ANTIGENS, V31, P98, DOI 10.1111/j.1399-0039.1988.tb02070.x; Kay A, 2007, VIRUS RES, V127, P164, DOI 10.1016/j.virusres.2007.02.021; Kramvis A, 2005, J MED VIROL, V77, P47, DOI 10.1002/jmv.20412; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Lehman EM, 2009, J VIRAL HEPATITIS, V16, P650, DOI 10.1111/j.1365-2893.2009.01115.x; Makuwa M, 2006, J MED VIROL, V78, P1175, DOI 10.1002/jmv.20678; Mast E., 2004, VACCINES, P299; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; Nainan OV, 2002, J MED VIROL, V68, P319, DOI 10.1002/jmv.10206; NEWTON MA, 1994, J R STAT SOC B, V56, P3; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; NORDER H, 1993, J GEN VIROL, V74, P1341, DOI 10.1099/0022-1317-74-7-1341; Odemuyiwa SO, 2001, J MED VIROL, V65, P463, DOI 10.1002/jmv.2058; OKAMOTO H, 1987, J VIROL, V61, P3030, DOI 10.1128/JVI.61.10.3030-3034.1987; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Olubuyide IO, 1997, QJM-MON J ASSOC PHYS, V90, P417, DOI 10.1093/qjmed/90.6.417; Patterson K. David, 1981, HLTH COLONIAL GHANA; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pupko T, 2000, MOL BIOL EVOL, V17, P890, DOI 10.1093/oxfordjournals.molbev.a026369; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Sadoh AE, 2008, PUBLIC HEALTH, V122, P1318, DOI 10.1016/j.puhe.2008.06.003; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson SC, 1997, J VIRAL HEPATITIS, V4, P135, DOI 10.1111/j.1365-2893.1997.tb00216.x; Uko GP, 1997, DIS MARKERS, V13, P123; Uwaezuoke SN, 2007, J TROP PEDIATRICS, V53, P62, DOI 10.1093/tropej/fml081; *WHO, 2005, WHO VACC PREV DIS MO; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981; Zaaijer HL, 2008, J VIRAL HEPATITIS, V15, P239, DOI 10.1111/j.1365-2893.2007.00938.x; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	65	67	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11615	10.1371/journal.pone.0011615	http://dx.doi.org/10.1371/journal.pone.0011615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657838	Green Submitted, gold, Green Published			2022-12-27	WOS:000280065600007
J	Hamilton, DL; Philp, A; MacKenzie, MG; Baar, K				Hamilton, D. Lee; Philp, Andrew; MacKenzie, Matthew G.; Baar, Keith			A Limited Role for PI(3,4,5)P-3 Regulation in Controlling Skeletal Muscle Mass in Response to Resistance Exercise	PLOS ONE			English	Article							PROTEIN-KINASE-B; BANNAYAN-ZONANA-SYNDROME; PHOSPHOINOSITIDE 3-KINASE; SIGNALING PATHWAYS; PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE; GLYCOGEN-METABOLISM; GERMLINE MUTATIONS; INSULIN-RESISTANCE; MAMMALIAN TARGET; TUMOR-SUPPRESSOR	Background: Since activation of the PI3K/(protein kinase B; PKB/akt) pathway has been shown to alter muscle mass and growth, the aim of this study was to determine whether resistance exercise increased insulin like growth factor (IGF) I/phosphoinositide 3-kinase (PI3K) signalling and whether altering PI(3,4,5)P-3 metabolism genetically would increase load induced muscle growth. Methodology/Principal Findings: Acute and chronic resistance exercise in wild type and muscle specific PTEN knockout mice were used to address the role of PI(3,4,5)P-3 regulation in the development of skeletal muscle hypertrophy. Acute resistance exercise did not increase either IGF-1 receptor phosphorylation or IRS1/2 associated p85. Since insulin/IGF signalling to PI3K was unchanged, we next sought to determine whether inactivation of PTEN played a role in load-induced muscle growth. Muscle specific knockout of PTEN resulted in small but significant increases in heart (PTEN+/+ = 5.00 +/- 0.02 mg/g, PTEN-/- = 5.50 +/- 0.09 mg/g), and TA (PTEN+/+ = 1.74 +/- 0.04 mg/g, PTEN-/- = 1.89 +/- 0.03) muscle mass, while the GTN, SOL, EDL and PLN remain unchanged. Following ablation, hypertrophy of the PLN, SOL or EDL muscles was similar between PTEN-/- and PTEN+/+ animals. Even though there were some changes in overload-induced PKB and S6K1 phosphorylation, 1 hr following acute resistance exercise there was no difference in the phosphorylation state of S6K1 Thr389 between genotypes. Conclusions/Significance: These data suggest that physiological loading does not lead to the enhanced activation of thePI3K/PKB/mTORC1 axis and that neither PI3K activation nor PTEN, and by extension PI(3,4,5)P-3 levels, play a significant role in adult skeletal muscle growth.	[Hamilton, D. Lee; Philp, Andrew; MacKenzie, Matthew G.; Baar, Keith] Univ Dundee, Div Mol Physiol, Dundee, Scotland	University of Dundee	Hamilton, DL (corresponding author), Univ Dundee, Div Mol Physiol, Dundee, Scotland.	FMBLab@googlemail.com		Philp, Andrew/0000-0003-3860-4136; Hamilton, David/0000-0002-5620-4788; Baar, Keith/0000-0001-9337-6186	Wellcome Trust [077426]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust Project Grant 077426 awarded to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Baar K, 2006, ESSAYS BIOCHEM, V42, P61, DOI 10.1042/bse0420061; BACKER JM, 1993, J BIOL CHEM, V268, P8204; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cairns SP, 2007, J APPL PHYSIOL, V103, P359, DOI 10.1152/japplphysiol.01267.2006; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/pnas.87.12.4458; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Currie RA, 1999, BIOCHEM J, V337, P575, DOI 10.1042/0264-6021:3370575; Delibegovic M, 2003, DIABETES, V52, P596, DOI 10.2337/diabetes.52.3.596; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Fernandez AM, 2002, J CLIN INVEST, V109, P347, DOI 10.1172/JCI200213503; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Hornberger TA, 2004, BIOCHEM J, V380, P795, DOI 10.1042/BJ20040274; Huang X, 2008, BIOCHEM J, V412, P211, DOI 10.1042/BJ20080557; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Jiang BH, 1998, P NATL ACAD SCI USA, V95, P14179, DOI 10.1073/pnas.95.24.14179; Kishimoto H, 2003, CELL STRUCT FUNCT, V28, P11; Lackey J, 2007, ONCOGENE, V26, P7132, DOI 10.1038/sj.onc.1210520; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Leslie NR, 2000, BIOCHEM J, V346, P827, DOI 10.1042/0264-6021:3460827; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; MacKenzie MG, 2009, J PHYSIOL-LONDON, V587, P253, DOI 10.1113/jphysiol.2008.159830; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; MCGEE SL, 2008, J PHYSL; MOUNIER R, 2009, FASEB J; O'Neil TK, 2009, J PHYSIOL-LONDON, V587, P3691, DOI 10.1113/jphysiol.2009.173609; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599; Park IH, 2005, EXP CELL RES, V309, P211, DOI 10.1016/j.yexcr.2005.05.017; Plyley MJ, 1998, J APPL PHYSIOL, V84, P902, DOI 10.1152/jappl.1998.84.3.902; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sakamoto K, 2002, J BIOL CHEM, V277, P11910, DOI 10.1074/jbc.M112410200; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Song YH, 2005, J INVEST MED, V53, P135, DOI 10.2310/6650.2005.00309; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Takahashi A, 2002, MOL CELL BIOL, V22, P4803, DOI 10.1128/MCB.22.13.4803-4814.2002; Toole BJ, 2007, CELL SIGNAL, V19, P1044, DOI 10.1016/j.cellsig.2006.11.013; Vanhaesebroeck B, 1997, TRENDS BIOCHEM SCI, V22, P267, DOI 10.1016/S0968-0004(97)01061-X; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005	58	58	59	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11624	10.1371/journal.pone.0011624	http://dx.doi.org/10.1371/journal.pone.0011624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661274	Green Published, gold, Green Submitted			2022-12-27	WOS:000279980800013
J	Tseng, HC; Arasteh, A; Paranjpe, A; Teruel, A; Yang, W; Behel, A; Alva, JA; Walter, G; Head, C; Ishikawa, TO; Herschman, HR; Cacalano, N; Pyle, AD; Park, NH; Jewett, A				Tseng, Han-Ching; Arasteh, Aida; Paranjpe, Avina; Teruel, Antonia; Yang, Wendy; Behel, Armin; Alva, Jackelyn A.; Walter, Gina; Head, Christian; Ishikawa, Tomo-o; Herschman, Harvey R.; Cacalano, Nicholas; Pyle, April D.; Park, No-Hee; Jewett, Anahid			Increased Lysis of Stem Cells but Not Their Differentiated Cells by Natural Killer Cells; De-Differentiation or Reprogramming Activates NK Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; CYTOKINE PRODUCTION; T-LYMPHOCYTE; EXPRESSION; CANCER; APOPTOSIS; PROLIFERATION; SECRETION; DEATH; INACTIVATION	The aims of this study are to demonstrate the increased lysis of stem cells but not their differentiated counterparts by the NK cells and to determine whether disturbance in cell differentiation is a cause for increased sensitivity to NK cell mediated cytotoxicity. Increased cytotoxicity and augmented secretion of IFN-gamma were both observed when PBMCs or NK cells were co-incubated with primary UCLA oral squamous carcinoma stem cells (UCLA-OSCSCs) when compared to differentiated UCLA oral squamous carcinoma cells (UCLA-OSCCs). In addition, human embryonic stem cells (hESCs) were also lysed greatly by the NK cells. Moreover, NK cells were found to lyse human Mesenchymal Stem Cells (hMSCs), human dental pulp stem cells (hDPSCs) and human induced pluripotent stem cells (hiPSCs) significantly more than their differentiated counterparts or parental lines from which they were derived. It was also found that inhibition of differentiation or reversion of cells to a less-differentiated phenotype by blocking NF kappa B or targeted knock down of COX2 in monocytes significantly augmented NK cell cytotoxicity and secretion of IFN-gamma. Taken together, these results suggest that stem cells are significant targets of the NK cell cytotoxicity. However, to support differentiation of a subset of tumor or healthy untransformed primary stem cells, NK cells may be required to lyse a number of stem cells and/or those which are either defective or incapable of full differentiation in order to lose their cytotoxic function and gain the ability to secrete cytokines (split anergy). Therefore, patients with cancer may benefit from repeated allogeneic NK cell transplantation for specific elimination of cancer stem cells.	[Tseng, Han-Ching; Arasteh, Aida; Paranjpe, Avina; Teruel, Antonia; Yang, Wendy; Behel, Armin; Walter, Gina; Park, No-Hee; Jewett, Anahid] Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Sch Med & Dent, Div Oral Biol & Oral Med, Los Angeles, CA 90024 USA; [Alva, Jackelyn A.; Pyle, April D.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Sch Med & Dent, BSCRC, Los Angeles, CA USA; [Head, Christian] Univ Calif Los Angeles, Div Head & Neck Surg, Dept Surg, Sch Med & Dent, Los Angeles, CA 90024 USA; [Head, Christian; Herschman, Harvey R.; Cacalano, Nicholas; Pyle, April D.; Park, No-Hee; Jewett, Anahid] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Sch Med & Dent, Los Angeles, CA 90024 USA; [Ishikawa, Tomo-o; Herschman, Harvey R.] Univ Calif Los Angeles, Dept Biol Chem, Sch Med & Dent, Los Angeles, CA 90024 USA; [Cacalano, Nicholas] Univ Calif Los Angeles, Dept Radiat Oncol, Sch Med & Dent, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tseng, HC (corresponding author), Univ Calif Los Angeles, Jane & Jerry Weintraub Ctr Reconstruct Biotechnol, Sch Med & Dent, Div Oral Biol & Oral Med, Los Angeles, CA 90024 USA.	ajewett@ucla.edu			University of California Los Angeles (UCLA) School of Dentistry and Academic Senate Faculty	University of California Los Angeles (UCLA) School of Dentistry and Academic Senate Faculty	This work was funded by University of California Los Angeles (UCLA) School of Dentistry and Academic Senate Faculty seed grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Banerjee AG, 2002, MOL CANCER THER, V1, P1265; Bennett MW, 1998, J IMMUNOL, V160, P5669; Camp BJ, 1996, ANN SURG ONCOL, V3, P176, DOI 10.1007/BF02305798; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Gimmi CD, 1996, NAT MED, V2, P1367, DOI 10.1038/nm1296-1367; Han X, 1997, GYNECOL ONCOL, V65, P391, DOI 10.1006/gyno.1997.4668; Jewett A, 2006, J DENT RES, V85, P1061, DOI 10.1177/154405910608501201; Jewett A, 2006, CANCER IMMUNOL IMMUN, V55, P1052, DOI 10.1007/s00262-005-0093-7; Jewett A, 2006, CLIN CANCER RES, V12, P1994, DOI 10.1158/1078-0432.CCR-05-2306; Jewett A, 1996, J IMMUNOL, V156, P907; Jewett A, 2003, HUM IMMUNOL, V64, P505, DOI 10.1016/S0198-8859(03)00039-9; JEWETT A, 1995, J CLIN IMMUNOL, V15, P35, DOI 10.1007/BF01489488; Jewett A, 1997, J IMMUNOL, V159, P4815; Jewett A, 2008, CANCER IMMUNOL IMMUN, V57, P1053, DOI 10.1007/s00262-007-0437-6; Jewett A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009874; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kolenko V, 1997, J IMMUNOL, V159, P3057; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mancini AJ, 2008, ARCH DERMATOL, V144, P342, DOI 10.1001/archderm.144.3.342; MIESCHER S, 1988, CANCER RES, V48, P6992; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Mulder WMC, 1997, GUT, V40, P113, DOI 10.1136/gut.40.1.113; NAKAGOMI H, 1993, CANCER RES, V53, P5610; Narasimha AJ, 2010, ARTERIOSCL THROM VAS, V30, P260, DOI 10.1161/ATVBAHA.109.198762; Nemeth E, 2009, SEMIN IMMUNOPATHOL, V31, P333, DOI 10.1007/s00281-009-0173-4; Opitz OG, 2002, J CLIN INVEST, V110, P761, DOI 10.1172/JCI200215324; Paranjpe A, 2007, FREE RADICAL BIO MED, V43, P1394, DOI 10.1016/j.freeradbiomed.2007.07.011; PARK NH, 1991, CARCINOGENESIS, V12, P1627, DOI 10.1093/carcin/12.9.1627; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Qin J, 1997, Zhonghua Yi Xue Za Zhi, V77, P167; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; St John MAR, 2004, ARCH OTOLARYNGOL, V130, P929, DOI 10.1001/archotol.130.8.929; Swan EA, 2003, ORAL ONCOL, V39, P648, DOI 10.1016/S1368-8375(03)00049-6; Tae K, 2000, CLIN CANCER RES, V6, P2821; Teruel A, 2008, CANCER IMMUNOL IMMUN, V57, P359, DOI 10.1007/s00262-007-0375-3; Thomas GR, 2004, CANCER IMMUNOL IMMUN, V53, P33, DOI 10.1007/s00262-003-0433-4; TSUBOI I, 1995, CYTOKINE, V7, P372, DOI 10.1006/cyto.1995.0047; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; ZHANG Q, CANC LETT, V289, P151	46	101	103	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11590	10.1371/journal.pone.0011590	http://dx.doi.org/10.1371/journal.pone.0011590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661281	Green Published, Green Submitted, gold			2022-12-27	WOS:000279980800003
J	Whitlock, BA; Hale, AM; Groff, PA				Whitlock, Barbara A.; Hale, Amanda M.; Groff, Paul A.			Intraspecific Inversions Pose a Challenge for the trnH-psbA Plant DNA Barcode	PLOS ONE			English	Article							NONCODING CHLOROPLAST DNA; LAND PLANTS; EVOLUTION; BIOGEOGRAPHY; PHYLOGENY; REGION; SEQUENCES; LACTUCEAE; DYNAMICS; IDENTIFY	Background: The chloroplast trnH-psbA spacer region has been proposed as a prime candidate for use in DNA barcoding of plants because of its high substitution rate. However, frequent inversions associated with palindromic sequences within this region have been found in multiple lineages of Angiosperms and may complicate its use as a barcode, especially if they occur within species. Methodology/Principal Findings: Here, we evaluate the implications of intraspecific inversions in the trnH-psbA region for DNA barcoding efforts. We report polymorphic inversions within six species of Gentianaceae, all narrowly circumscribed morphologically: Gentiana algida, Gentiana fremontii, Gentianopsis crinita, Gentianopsis thermalis, Gentianopsis macrantha and Frasera speciosa. We analyze these sequences together with those from 15 other species of Gentianaceae and show that typical simple methods of sequence alignment can lead to misassignment of conspecifics and incorrect assessment of relationships. Conclusions/Significance: Frequent inversions in the trnH-psbA region, if not recognized and aligned appropriately, may lead to large overestimates of the number of substitution events separating closely related lineages and to uniting more distantly related taxa that share the same form of the inversion. Thus, alignment of the trnH-psbA spacer region will need careful attention if it is used as a marker for DNA barcoding.	[Whitlock, Barbara A.; Groff, Paul A.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Hale, Amanda M.] Texas Christian Univ, Dept Biol Sci, Ft Worth, TX 76129 USA	University of Miami; Texas Christian University	Whitlock, BA (corresponding author), Univ Miami, Dept Biol, Coral Gables, FL 33124 USA.	whitlock@bio.miami.edu			United States National Science Foundation [DEB 0639826]; National Geographic Society Committee on Research and Exploration [8368-07]	United States National Science Foundation(National Science Foundation (NSF)); National Geographic Society Committee on Research and Exploration(National Geographic Society)	This work was funded by the United States National Science Foundation (DEB 0639826) and the National Geographic Society Committee on Research and Exploration (8368-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catalano SA, 2009, CLADISTICS, V25, P93, DOI 10.1111/j.1096-0031.2008.00236.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Azuma H, 1999, J PLANT RES, V112, P291, DOI 10.1007/PL00013885; Bain JF, 2006, CAN J BOT, V84, P862, DOI 10.1139/B06-057; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Edwards D, 2008, TAXON, V57, P1317, DOI 10.1002/tax.574021; Erickson DL, 2008, TAXON, V57, P1304, DOI 10.1002/tax.574020; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; GOLENBERG EM, 1993, MOL PHYLOGENET EVOL, V2, P52, DOI 10.1006/mpev.1993.1006; Graham SW, 2000, CURR GENET, V37, P183, DOI 10.1007/s002940050517; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Janzen DH, 2004, PHILOS T R SOC B, V359, P731, DOI 10.1098/rstb.2003.1444; Kelchner SA, 1996, CURR GENET, V30, P259, DOI 10.1007/s002940050130; Kim CS, 1997, NUCLEIC ACIDS RES, V25, P1085, DOI 10.1093/nar/25.5.1085; Kim KJ, 2005, MOL CELLS, V19, P104; Kirschner J, 2003, PLANT SYST EVOL, V239, P231, DOI 10.1007/s00606-003-0002-5; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mast AR, 2002, AM J BOT, V89, P1311, DOI 10.3732/ajb.89.8.1311; Mes THM, 2000, GENOME, V43, P634, DOI 10.1139/gen-43-4-634; Quandt D, 2004, PLANT BIOLOGY, V6, P545, DOI 10.1055/s-2004-821144; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Scheen AC, 2004, AM J BOT, V91, P943, DOI 10.3732/ajb.91.6.943; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; STERN DB, 1987, CELL, V51, P1145, DOI 10.1016/0092-8674(87)90600-3; Storchova H, 2007, PLANT SYST EVOL, V268, P235, DOI 10.1007/s00606-007-0582-6; STRUWE L, 2002, GENTIANACEAE SYSTEMA, P21, DOI DOI 10.1017/CBO9780511541865.003; SWOFFORD DL, 2003, PAUP 4 0B10 PHYLOGEN; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tate JA, 2003, SYST BOT, V28, P723; Tsumura Y, 2000, MOL BIOL EVOL, V17, P1302, DOI 10.1093/oxfordjournals.molbev.a026414; Vasil IK, 1991, CELL CULTURE SOMAT A, V7a, P5, DOI DOI 10.1016/B978-0-12-715007-9.50009-8; Wang RJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-36	44	105	111	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11533	10.1371/journal.pone.0011533	http://dx.doi.org/10.1371/journal.pone.0011533			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644717	gold, Green Published, Green Submitted			2022-12-27	WOS:000279822300007
J	Castonguay-Vanier, J; Vial, L; Tremblay, J; Deziel, E				Castonguay-Vanier, Josee; Vial, Ludovic; Tremblay, Julien; Deziel, Eric			Drosophila melanogaster as a Model Host for the Burkholderia cepacia Complex	PLOS ONE			English	Article							SURVIVAL IN-VIVO; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; INTRACELLULAR SURVIVAL; CAENORHABDITIS-ELEGANS; III SECRETION; PATHOGEN INTERACTIONS; PULMONARY INFECTION; IMMUNE-RESPONSE	Background: Colonization with bacterial species from the Burkholderia cepacia complex (Bcc) is associated with fast health decline among individuals with cystic fibrosis. In order to investigate the virulence of the Bcc, several alternative infection models have been developed. To this end, the fruit fly is increasingly used as surrogate host, and its validity to enhance our understanding of host-pathogen relationships has been demonstrated with a variety of microorganisms. Moreover, its relevance as a suitable alternative to mammalian hosts has been confirmed with vertebrate organisms. Methodology/Principal Findings: The aim of this study was to establish Drosophila melanogaster as a surrogate host for species from the Bcc. While the feeding method proved unsuccessful at killing the flies, the pricking technique did generate mortality within the populations. Results obtained with the fruit fly model are comparable with results obtained using mammalian infection models. Furthermore, validity of the Drosophila infection model was confirmed with B. cenocepacia K56-2 mutants known to be less virulent in murine hosts or in other alternative models. Competitive index (CI) analyses were also performed using the fruit fly as host. Results of CI experiments agree with those obtained with mammalian models. Conclusions/Significance: We conclude that Drosophila is a useful alternative infection model for Bcc and that fly pricking assays and competition indices are two complementary methods for virulence testing. Moreover, CI results indicate that this method is more sensitive than mortality tests.	[Castonguay-Vanier, Josee; Vial, Ludovic; Tremblay, Julien; Deziel, Eric] Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Castonguay-Vanier, J (corresponding author), Univ Quebec, Inst Armand Frappier, Inst Natl Rech Sci, Laval, PQ, Canada.	eric.deziel@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115; Vial, ludovic/0000-0001-6021-0251; Tremblay, Julien/0000-0002-6085-3481	Canadian Institutes of Health Research (CIHR) [MOP-77642]; Fondation Armand-Frappier; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fondation Armand-Frappier; Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT)	This study was supported by the Canadian Institutes of Health Research (CIHR) Operating grant MOP-77642 to ED. JCV received a master of science (M.Sc.) scholarship and LV a postdoctoral fellowship, both from the Fondation Armand-Frappier. JT was recipient of a doctor of philosophy (Ph.D.) scholarship from the Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron SD, 2000, AM J RESP CRIT CARE, V161, P1206, DOI 10.1164/ajrccm.161.4.9907147; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alexeyev MF, 1999, BIOTECHNIQUES, V26, P824, DOI 10.2144/99265bm05; Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Apidianakis Y, 2004, EUKARYOT CELL, V3, P413, DOI 10.1128/EC.3.2.413-419.2004; Baldini RL, 2002, METHOD ENZYMOL, V358, P3; Bernier SP, 2003, INFECT IMMUN, V71, P5306, DOI 10.1128/IAI.71.9.5306-5313.2003; Brandt SM, 2004, PLOS BIOL, V2, P2067, DOI 10.1371/journal.pbio.0020418; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115; Cardona ST, 2005, FEMS MICROBIOL LETT, V250, P97, DOI 10.1016/j.femsle.2005.06.050; Chiarini L, 2006, TRENDS MICROBIOL, V14, P277, DOI 10.1016/j.tim.2006.04.006; Chu KK, 2002, INFECT IMMUN, V70, P2715, DOI 10.1128/IAI.70.5.2715-2720.2002; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; Coenye T, 2001, INT J SYST EVOL MICR, V51, P1481, DOI 10.1099/00207713-51-4-1481; Coenye T, 2003, J CLIN MICROBIOL, V41, P2797, DOI 10.1128/JCM.41.6.2797-2798.2003; Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001; Corbett CR, 2003, MICROBIOL-SGM, V149, P2263, DOI 10.1099/mic.0.26243-0; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Dionne MS, 2003, INFECT IMMUN, V71, P3540, DOI 10.1128/IAI.71.6.3540-3550.2003; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Fallon PG, 2001, TRENDS IMMUNOL, V22, P63, DOI 10.1016/S1471-4906(00)01800-7; Fauvarque MO, 2002, MICROB PATHOGENESIS, V32, P287, DOI 10.1006/mpat.2002.0504; Flannagan RS, 2007, INFECT IMMUN, V75, P1679, DOI 10.1128/IAI.01581-06; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; Kooi C, 2006, INFECT IMMUN, V74, P4083, DOI 10.1128/IAI.00297-06; Kukavica-Ibrulj I, 2008, J BACTERIOL, V190, P2804, DOI 10.1128/JB.01572-07; Lamothe J, 2007, CELL MICROBIOL, V9, P40, DOI 10.1111/j.1462-5822.2006.00766.x; Laws TR, 2005, FEMS MICROBIOL LETT, V250, P77, DOI 10.1016/j.femsle.2005.06.046; LEWENZA S, 1999, J BACTERIOL, V748, P2073; Loutet SA, 2006, J BACTERIOL, V188, P2073, DOI 10.1128/JB.188.6.2073-2080.2006; Lutter EI, 2008, INFECT IMMUN, V76, P1877, DOI 10.1128/IAI.01165-07; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mahenthiralingam E, 2001, CLIN INFECT DIS, V33, P1469, DOI 10.1086/322684; Markey KM, 2006, J MED MICROBIOL, V55, P967, DOI 10.1099/jmm.0.46618-0; Marolda CL, 1999, MICROBIOL-SGM, V145, P1509, DOI 10.1099/13500872-145-7-1509; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; McClean S, 2009, J MED MICROBIOL, V58, P1, DOI 10.1099/jmm.0.47788-0; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mylonakis E, 2005, INFECT IMMUN, V73, P3833, DOI 10.1128/IAI.73.7.3833-3841.2005; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; NELSON MJK, 1987, APPL ENVIRON MICROB, V53, P949, DOI 10.1128/AEM.53.5.949-954.1987; Nicolas E, 1998, J BIOL CHEM, V273, P10463, DOI 10.1074/jbc.273.17.10463; Riedel K, 2003, ELECTROPHORESIS, V24, P740, DOI 10.1002/elps.200390089; Roh SW, 2008, APPL ENVIRON MICROB, V74, P6171, DOI 10.1128/AEM.00301-08; Sajjan U, 2001, INFECT IMMUN, V69, P5138, DOI 10.1128/IAI.69.8.5138-5150.2001; Seed KD, 2008, INFECT IMMUN, V76, P1267, DOI 10.1128/IAI.01249-07; Sibley CD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000184; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sokol PA, 2003, MICROBIOL-SGM, V149, P3649, DOI 10.1099/mic.0.26540-0; Sousa SA, 2007, CELL MICROBIOL, V9, P2817, DOI 10.1111/j.1462-5822.2007.00998.x; Tomich M, 2003, INFECT IMMUN, V71, P1405, DOI 10.1128/IAI.71.3.1405-1415.2003; Tzou P, 2002, METHOD MICROBIOL, V31, P507, DOI 10.1016/S0580-9517(02)31028-6; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; Vanlaere E, 2008, INT J SYST EVOL MICR, V58, P1580, DOI 10.1099/ijs.0.65634-0; Vial, 2007, J MICROBIOL BIOTECHN, V17, P1407; Vial L, 2008, J BACTERIOL, V190, P5339, DOI 10.1128/JB.00400-08; Vial L, 2008, CELL HOST MICROBE, V4, P505, DOI 10.1016/j.chom.2008.11.005; Vodovar N, 2004, TRENDS MICROBIOL, V12, P235, DOI 10.1016/j.tim.2004.03.007; Weber DJ, 2007, ANTIMICROB AGENTS CH, V51, P4217, DOI 10.1128/AAC.00138-07	66	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11467	10.1371/journal.pone.0011467	http://dx.doi.org/10.1371/journal.pone.0011467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635002	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000279781600002
J	Ancrenaz, M; Ambu, L; Sunjoto, I; Ahmad, E; Manokaran, K; Meijaard, E; Lackman, I				Ancrenaz, Marc; Ambu, Laurentius; Sunjoto, Indra; Ahmad, Eddie; Manokaran, Kennesh; Meijaard, Erik; Lackman, Isabelle			Recent Surveys in the Forests of Ulu Segama Malua, Sabah, Malaysia, Show That Orang-utans (P. p. morio) Can Be Maintained in Slightly Logged Forests	PLOS ONE			English	Article							PONGO-PYGMAEUS; WEST KALIMANTAN; POPULATION-DENSITY; SIZE	Background: Today the majority of wild great ape populations are found outside of the network of protected areas in both Africa and Asia, therefore determining if these populations are able to survive in forests that are exploited for timber or other extractive uses and how this is managed, is paramount for their conservation. Methodology/Principal Findings: In 2007, the "Kinabatangan Orang-utan Conservation Project'' (KOCP) conducted aerial and ground surveys of orang-utan (Pongo pygmaeus morio) nests in the commercial forest reserves of Ulu Segama Malua (USM) in eastern Sabah, Malaysian Borneo. Compared with previous estimates obtained in 2002, our recent data clearly shows that orang-utan populations can be maintained in forests that have been lightly and sustainably logged. However, forests that are heavily logged or subjected to fast, successive coupes that follow conventional extraction methods, exhibit a decline in orang-utan numbers which will eventually result in localized extinction (the rapid extraction of more than 100 m(3) ha(-1) of timber led to the crash of one of the surveyed sub-populations). Nest distribution in the forests of USM indicates that orang-utans leave areas undergoing active disturbance and take momentarily refuge in surrounding forests that are free of human activity, even if these forests are located above 500 m asl. Displaced individuals will then recolonize the old-logged areas after a period of time, depending on availability of food sources in the regenerating areas. Conclusion/Significance: These results indicate that diligent planning prior to timber extraction and the implementation of reduced-impact logging practices can potentially be compatible with great ape conservation.	[Ancrenaz, Marc; Ambu, Laurentius] Sabah Wildlife Dept, Wisma Muis, Sabah, Malaysia; [Ancrenaz, Marc] Chester Zoo, N England Zool Soc, Chester, Cheshire, England; [Sunjoto, Indra] Sabah Forestry Dept, Sabah, Malaysia; [Meijaard, Erik] People & Nat Consulting Int, Kerobokan, Bali, Indonesia; [Lackman, Isabelle] Pittsburgh Zoo, Pittsburgh, PA USA	Pusat Penyelidikan Hutan; People & Nature Consulting International		marc.ancrenaz@yahoo.com	Meijaard, Erik/A-2687-2016	Meijaard, Erik/0000-0001-8685-3685	Australian Regional natural Heritage program; US Fish and Wildlife Services	Australian Regional natural Heritage program; US Fish and Wildlife Services(US Fish & Wildlife Service)	This specific study was supported by a grant from the Australian Regional natural Heritage program and from the US Fish and Wildlife Services Great Ape Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; For permission to work in Sabah we are grateful to the Economic Planning Unit, to late Datuk Patrick Andau (previous Director of the Sabah Wildlife Department) for his continuous support, to staff of the Sabah Forestry and Sabah Wildlife Department who were involved in these surveys. We would also like to thank Katie King and anonymous reviewers for their useful comments on the manuscript. Long-term KOCP activities have been supported by several zoos (Apenheul, Beauval, Cleveland, Columbus, Houston, La Palmyre, Oregon, Philadelphia, Phoenix, Saint Louis, Utah Ogle, Woodland Park); foundations (Abraham, Arcus, BOS-NL, Earth Shared, Elephant Family, Ensemble, Mohamed bin Zhayed, Shining Hope, WoodTiger, World Women Work, Wildlife Conservation Network); US Fish and Wildlife Services, North England Zoological Society. Last but not least, the KOCP would not exist without the commitment of the 40 research assistants employed by the project who are dedicated to conserve the natural resources of the Kinabatangan floodplain and we are extremely grateful to all of them.	Ancrenaz M, 2005, PLOS BIOL, V3, P30, DOI 10.1371/journal.pbio.0030003; Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Ancrenaz M, 2007, PLOS BIOL, V5, P2443, DOI 10.1371/journal.pbio.0050289; BOYKO RH, 2010, PLOS ONE IN PRESS; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Cassey P, 1999, ENVIRONMETRICS, V10, P261, DOI 10.1002/(SICI)1099-095X(199905/06)10:3<261::AID-ENV351>3.0.CO;2-O; Curran LM, 2004, SCIENCE, V303, P1000, DOI 10.1126/science.1091714; Djojosudharmo Suharto, 1992, Tropical Biodiversity, V1, P11; Felton AM, 2003, BIOL CONSERV, V114, P91, DOI 10.1016/S0006-3207(03)00013-2; Goossens B, 2006, MOL ECOL, V15, P2577, DOI 10.1111/j.1365-294X.2006.02952.x; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; HARRISSON T, 1971, SABAH SOC J, P1; HUSSON S, 2009, GEOGRAPHIC VARIATION, P77; JOHNS AD, 1988, BIOTROPICA, V20, P31, DOI 10.2307/2388423; Johnson AE, 2005, BIOL CONSERV, V121, P495, DOI 10.1016/j.biocon.2004.06.002; Knop E, 2004, BIOL CONSERV, V120, P183, DOI 10.1016/j.biocon.2004.02.010; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Kuehl H.S., 2008, BEST PRACTICE GUIDEL; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; MacKinnon K., 1996, ECOLOGY KALIMANTAN, V3; Marsh CW., 1995, DANUM VALLEY CONSERV; MARSHALL AJ, 2009, GEOGRAPHIC VARIATION, P311; MARSHALL AJ, 2009, GEOGRAPHIC VARIATION, P97; Marshall AJ, 2007, AM J PRIMATOL, V69, P212, DOI 10.1002/ajp.20341; Marshall AJ, 2006, BIOL CONSERV, V129, P566, DOI 10.1016/j.biocon.2005.11.025; Mathewson PD, 2008, ECOL APPL, V18, P208, DOI 10.1890/07-0385.1; Meijaard E, 2008, ECOL RES, V23, P21, DOI 10.1007/s11284-007-0342-7; Meijaard Erik, 2005, pi; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; MORROGHBERNARD H, 2009, GEOGRAPHIC VARIATION, P119; Payne J., 1988, 3759 WWF MAL INT; Pryer W.B, 1883, P ROYAL GEOGRAPHICAL, V5, P90; Rao Madhu, 1997, Tropical Biodiversity, V4, P173; RIJKSEN HD, 1978, THESIS WAGENINGEN NE; Rijksen HD, 1999, OUR VANISHING RELATI; Russon AE, 2001, BIOL CONSERV, V97, P21, DOI 10.1016/S0006-3207(00)00087-2; RUSSON AE, 2009, GEOGRAPHIC VARIATION, P135; *SAB FOR DEP, 2008, FOR MAN PLAN UL SEG; SHEIL D, 2010, BIODIVERSIT IN PRESS; Siegert F, 2001, NATURE, V414, P437, DOI 10.1038/35106547; Singleton I, 2001, INT J PRIMATOL, V22, P877, DOI 10.1023/A:1012033919441; TAYLOR AB, 2009, GEOGRAPHIC VARIATION, P15; van Kreveld A., 2009, GREAT APES LOGGING Z; vanSchaik CP, 1995, NEGLECTED APE, P129; VANSCHAIK CP, 2009, GEPGRAPHIC VARIATION, P351; Walsh RPD, 1996, J TROP ECOL, V12, P385, DOI 10.1017/S0266467400009585; Wich SA, 2008, ORYX, V42, P329, DOI 10.1017/S003060530800197X; WILSON K, 2010, ECOL APPL IN PRESS	48	53	54	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11510	10.1371/journal.pone.0011510	http://dx.doi.org/10.1371/journal.pone.0011510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634974	Green Submitted, Green Published, gold			2022-12-27	WOS:000279715300021
J	Ran, LA; Larsson, J; Vigil-Stenman, T; Nylander, JAA; Ininbergs, K; Zheng, WW; Lapidus, A; Lowry, S; Haselkorn, R; Bergman, B				Ran, Liang; Larsson, John; Vigil-Stenman, Theoden; Nylander, Johan A. A.; Ininbergs, Karolina; Zheng, Wei-Wen; Lapidus, Alla; Lowry, Stephen; Haselkorn, Robert; Bergman, Birgitta			Genome Erosion in a Nitrogen-Fixing Vertically Transmitted Endosymbiotic Multicellular Cyanobacterium	PLOS ONE			English	Article							AZOLLA; SEQUENCE; PROTEIN; GENES; PSEUDOGENES; APPEARANCE; EVOLUTION; THOUSANDS; SYMBIOSIS; DYNAMICS	Background: An ancient cyanobacterial incorporation into a eukaryotic organism led to the evolution of plastids (chloroplasts) and subsequently to the origin of the plant kingdom. The underlying mechanism and the identities of the partners in this monophyletic event remain elusive. Methodology/Principal Findings: To shed light on this evolutionary process, we sequenced the genome of a cyanobacterium residing extracellularly in an endosymbiosis with a plant, the water-fern Azolla filiculoides Lam. This symbiosis was selected as it has characters which make it unique among extant cyanobacterial plant symbioses: the cyanobacterium lacks autonomous growth and is vertically transmitted between plant generations. Our results reveal features of evolutionary significance. The genome is in an eroding state, evidenced by a large proportion of pseudogenes (31.2%) and a high frequency of transposable elements (similar to 600) scattered throughout the genome. Pseudogenization is found in genes such as the replication initiator dnaA and DNA repair genes, considered essential to free-living cyanobacteria. For some functional categories of genes pseudogenes are more prevalent than functional genes. Loss of function is apparent even within the 'core' gene categories of bacteria, such as genes involved in glycolysis and nutrient uptake. In contrast, serving as a critical source of nitrogen for the host, genes related to metabolic processes such as cell differentiation and nitrogen-fixation are well preserved. Conclusions/Significance: This is the first finding of genome degradation in a plant symbiont and phenotypically complex cyanobacterium and one of only a few extracellular endosymbionts described showing signs of reductive genome evolution. Our findings suggest an ongoing selective streamlining of this cyanobacterial genome which has resulted in an organism devoted to nitrogen fixation and devoid of autonomous growth. The cyanobacterial symbiont of Azolla can thus be considered at the initial phase of a transition from free-living organism to a nitrogen-fixing plant entity, a transition process which may mimic what drove the evolution of chloroplasts from a cyanobacterial ancestor.	[Ran, Liang; Larsson, John; Vigil-Stenman, Theoden; Nylander, Johan A. A.; Ininbergs, Karolina; Bergman, Birgitta] Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden; [Zheng, Wei-Wen] Fujian Agr & Forestry Univ, Biotechnol Res Ctr, Fuzhou, Peoples R China; [Lapidus, Alla; Lowry, Stephen] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Haselkorn, Robert] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Stockholm University; Fujian Agriculture & Forestry University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Chicago	Ran, LA (corresponding author), Stockholm Univ, Dept Bot, S-10691 Stockholm, Sweden.	bergmanb@botan.su.se	Lapidus, Alla L/I-4348-2013; Ininbergs, Karolina/A-8125-2013	Lapidus, Alla L/0000-0003-0427-8731; 	Swedish Energy Agency; Swedish Research Council; Knut and Alice Wallenberg Foundation; US Department of Energy's Office of Science; University of California; Lawrence Livermore National Laboratory [W-7405-Eng-48, DE-AC02-05CH11231]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]	Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); US Department of Energy's Office of Science(United States Department of Energy (DOE)); University of California(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by The Swedish Energy Agency (http://www.energimyndigheten.se/en/), The Swedish Research Council Formas (http://www.formas.se/) and by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/) (to BB). This work was performed under the auspices of the US Department of Energy's Office of Science (http://www.science.energy.gov), Biological and Environmental Research Program, and by the University of California (http://berkeley.edu/), Lawrence Livermore National Laboratory (https://www.llnl.gov/) under Contract No. W-7405-Eng-48, Lawrence Berkeley National Laboratory (www.lbl.gov/) under contract No. DE-AC02-05CH11231 and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. The work conducted by the U.S. Department of Energy Joint Genome Institute (http://www.jgi.doe.gov/) is supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; Bauer K, 2008, FEMS MICROBIOL ECOL, V63, P205, DOI 10.1111/j.1574-6941.2007.00423.x; Bergman Birgitta, 2008, P447; Bhattacharya D, 2007, BIOESSAYS, V29, P1239, DOI 10.1002/bies.20671; BRAUNHOWLAND EB, 1988, PLANTA, V176, P319, DOI 10.1007/BF00395412; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Deusch O, 2008, MOL BIOL EVOL, V25, P748, DOI 10.1093/molbev/msn022; Douglas AE, 2003, PHILOS T R SOC B, V358, P5, DOI 10.1098/rstb.2002.1188; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; HALL JW, 1968, AM J BOT, V55, P1055, DOI 10.2307/2440472; Haselkorn R, 2007, ASS ENDOPHYTIC NITRO, P233; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Kogoma T, 1997, J BACTERIOL, V179, P2109, DOI 10.1128/jb.179.7.2109-2115.1997; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Lawrence JG, 2001, TRENDS MICROBIOL, V9, P535, DOI 10.1016/S0966-842X(01)02198-9; Lechno-Yossef S, 2002, CYANOBACTERIA IN SYMBIOSIS, P153; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Mavromatis K, 2009, STAND GENOMIC SCI, V1, P63, DOI 10.4056/sigs.632; MEADOW ND, 1990, ANNU REV BIOCHEM, V59, P497, DOI 10.1146/annurev.biochem.59.1.497; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; NIERZWICKIBAUER SA, 1986, EMBO J, V5, P29, DOI 10.1002/j.1460-2075.1986.tb04173.x; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; ORR J, 1982, J BACTERIOL, V152, P626; PETERS GA, 1989, ANNU REV PLANT PHYS, V40, P193, DOI 10.1146/annurev.pp.40.060189.001205; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; RASMUSSEN U, 1994, MOL PLANT MICROBE IN, V7, P696, DOI 10.1094/MPMI-7-0696; Richter S, 1998, J BACTERIOL, V180, P4946, DOI 10.1128/JB.180.18.4946-4949.1998; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stucken K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009235; Swingley WD, 2008, MOL BIOL EVOL, V25, P643, DOI 10.1093/molbev/msn034; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; Walker A, 2008, NAT REV MICROBIOL, V6, P878, DOI 10.1038/nrmicro2044; Wu XQ, 2004, J BACTERIOL, V186, P6422, DOI 10.1128/JB.186.19.6422-6429.2004; ZHENG SP, 2008, CHIN J AGR BIOTECHOL, V16, P508; Zheng WW, 2009, NEW PHYTOL, V181, P53, DOI 10.1111/j.1469-8137.2008.02644.x	49	114	132	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11486	10.1371/journal.pone.0011486	http://dx.doi.org/10.1371/journal.pone.0011486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628610	gold, Green Published, Green Submitted			2022-12-27	WOS:000279637100013
J	Melamed, D; Bar-Ziv, L; Truzman, Y; Arava, Y				Melamed, Daniel; Bar-Ziv, Lavi; Truzman, Yossi; Arava, Yoav			Asc1 Supports Cell-Wall Integrity Near Bud Sites by a Pkc1 Independent Mechanism	PLOS ONE			English	Article							PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; BETA-SUBUNIT; SCAFFOLD PROTEIN; POLARIZED GROWTH; IN-VIVO; RACK1; RECEPTOR; YEAST; LOCALIZATION	Background: The yeast ribosomal protein Asc1 is a WD-protein family member. Its mammalian ortholog, RACK1 was initially discovered as a receptor for activated protein C kinase (PKC) that functions to maintain the active conformation of PKC and to support its movement to target sites. In the budding yeast though, a connection between Asc1p and the PKC signaling pathway has never been reported. Methodology/Principal Findings: In the present study we found that asc1-deletion mutant (asc1 Delta) presents some of the hallmarks of PKC signaling mutants. These include an increased sensitivity to staurosporine, a specific Pkc1p inhibitor, and susceptibility to cell-wall perturbing treatments such as hypotonic- and heat shock conditions and zymolase treatment. Microscopic analysis of asc1 Delta cells revealed cell-wall invaginations near bud sites after exposure to hypotonic conditions, and the dynamic of cells' survival after this stress further supports the involvement of Asc1p in maintaining the cell-wall integrity during the mid-to late stages of bud formation. Genetic interactions between asc1 and pkc1 reveal synergistic sensitivities of a double-knock out mutant (asc1 Delta/pkc1 Delta) to cell-wall stress conditions, and high basal level of PKC signaling in asc1 Delta. Furthermore, Asc1p has no effect on the cellular distribution or redistribution of Pkc1p at optimal or at cell-wall stress conditions. Conclusions/Significance: Taken together, our data support the idea that unlike its mammalian orthologs, Asc1p acts remotely from Pkc1p, to regulate the integrity of the cell-wall. We speculate that its role is exerted through translation regulation of bud-site related mRNAs during cells' growth.	[Melamed, Daniel; Bar-Ziv, Lavi; Truzman, Yossi; Arava, Yoav] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Technion Israel Institute of Technology	Melamed, D (corresponding author), Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.	arava@tx.technion.ac.il			Israeli Science Foundation [1096/05, 1193/09]	Israeli Science Foundation(Israel Science Foundation)	This work was supported by grants from the Israeli Science Foundation (1096/05 and 1193/09) (http://www.isf.org.il/english/default.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PD, 2000, J CELL SCI, V113, P2685; BONORA A, 1982, CURR MICROBIOL, V7, P217, DOI 10.1007/BF01568802; BORZANI W, 1958, J BACTERIOL, V76, P251, DOI 10.1128/JB.76.3.251-255.1958; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang P-S, 1998, CARBOHYDR LETT, V3, P31; Chasse SA, 2006, EUKARYOT CELL, V5, P330, DOI 10.1128/EC.5.2.330-346.2006; Chen SH, 2004, J MOL CELL CARDIOL, V37, P399, DOI 10.1016/j.yjmcc.2004.04.019; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Csukai M, 1999, PHARMACOL RES, V39, P253, DOI 10.1006/phrs.1998.0418; Denis V, 2005, EUKARYOT CELL, V4, P36, DOI 10.1128/EC.4.1.36-45.2005; Eliyahu E, 2010, MOL CELL BIOL, V30, P284, DOI 10.1128/MCB.00651-09; Frey S, 2001, J BIOL CHEM, V276, P15905, DOI 10.1074/jbc.M009430200; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; LEVIN DE, 1994, CELL MOL BIOL RES, V40, P229; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Nanduri J, 2001, MOL BIOL CELL, V12, P1835, DOI 10.1091/mbc.12.6.1835; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; PARAVICINI G, 1992, MOL CELL BIOL, V12, P4896, DOI 10.1128/MCB.12.11.4896; Patterson RL, 2004, P NATL ACAD SCI USA, V101, P2328, DOI 10.1073/pnas.0308567100; Rodriguez MM, 1999, BIOCHEMISTRY-US, V38, P13787, DOI 10.1021/bi991055k; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Usacheva A, 2001, J BIOL CHEM, V276, P22948, DOI 10.1074/jbc.M100087200; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Yarwood SJ, 1999, J BIOL CHEM, V274, P14909, DOI 10.1074/jbc.274.21.14909; YOSHIDA S, 1992, MOL GEN GENET, V231, P337, DOI 10.1007/BF00292700; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200	43	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11389	10.1371/journal.pone.0011389	http://dx.doi.org/10.1371/journal.pone.0011389			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613984	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000018
J	Barr, KL; Hearne, LB; Briesacher, S; Clark, TL; Davis, GE				Barr, Kelli L.; Hearne, Leonard B.; Briesacher, Sandra; Clark, Thomas L.; Davis, Georgia E.			Microbial Symbionts in Insects Influence Down-Regulation of Defense Genes in Maize	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; PATHOGENESIS-RELATED PROTEINS; WOLBACHIA SURFACE PROTEIN; DIABROTICA-VIRGIFERA; CHRYSOMELIDAE; COLEOPTERA; EXPRESSION; RESISTANCE; WSP; ACCUMULATION	Diabrotica virgifera virgifera larvae are root-feeding insects and significant pests to maize in North America and Europe. Little is known regarding how plants respond to insect attack of roots, thus complicating the selection for plant defense targets. Diabrotica virgifera virgifera is the most successful species in its genus and is the only Diabrotica beetle harboring an almost species-wide Wolbachia infection. Diabrotica virgifera virgifera are infected with Wolbachia and the typical gut flora found in soil-living, phytophagous insects. Diabrotica virgifera virgifera larvae cannot be reared aseptically and thus, it is not possible to observe the response of maize to effects of insect gut flora or other transient microbes. Because Wolbachia are heritable, it is possible to investigate whether Wolbachia infection affects the regulation of maize defenses. To answer if the success of Diabrotica virgifera virgifera is the result of microbial infection, Diabrotica virgifera virgifera were treated with antibiotics to eliminate Wolbachia and a microarray experiment was performed. Direct comparisons made between the response of maize root tissue to the feeding of antibiotic treated and untreated Diabrotica virgifera virgifera show down-regulation of plant defenses in the untreated insects compared to the antibiotic treated and control treatments. Results were confirmed via QRT-PCR. Biological and behavioral assays indicate that microbes have integrated into Diabrotica virgifera virgifera physiology without inducing negative effects and that antibiotic treatment did not affect the behavior or biology of the insect. The expression data and suggest that the pressure of microbes, which are most likely Wolbachia, mediate the down-regulation of many maize defenses via their insect hosts. This is the first report of a potential link between a microbial symbiont of an insect and a silencing effect in the insect host plant. This is also the first expression profile for a plant attacked by a root-feeding insect.	[Barr, Kelli L.] Florida Gulf Coast Univ, Ft Myers, FL USA; [Hearne, Leonard B.; Briesacher, Sandra; Davis, Georgia E.] Univ Missouri, Columbia, MO USA; [Clark, Thomas L.] Monsanto Co, St Louis, MO USA	State University System of Florida; Florida Gulf Coast University; University of Missouri System; University of Missouri Columbia; Monsanto	Barr, KL (corresponding author), Florida Gulf Coast Univ, Ft Myers, FL USA.	kbarr@fgcu.edu	Barr, Kelli L./I-7508-2019	Barr, Kelli L./0000-0001-7943-7181	Illinois Missouri Biotechnology Alliance, IMBA [2006-6]	Illinois Missouri Biotechnology Alliance, IMBA	This work was funded by the Illinois Missouri Biotechnology Alliance (http://www.imba.missouri.edu/), IMBA Project 2006-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Anderson CL, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-10; [Anonymous], 1986, METHODS STUDY PEST D; ASSABGUI RA, 1995, J ECON ENTOMOL, V88, P1482, DOI 10.1093/jee/88.5.1482; Balandin M, 2005, PLANT MOL BIOL, V58, P269, DOI 10.1007/s11103-005-3479-1; BALL HJ, 1962, J ECON ENTOMOL, V55, P439, DOI 10.1093/jee/55.4.439; Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x; Bown DP, 2004, INSECT BIOCHEM MOLEC, V34, P305, DOI 10.1016/j.ibmb.2003.11.005; Carle P, 1997, INT J SYST BACTERIOL, V47, P78, DOI 10.1099/00207713-47-1-78; Clark PL, 2006, J ECON ENTOMOL, V99, P722, DOI 10.1603/0022-0493-99.3.722; Clark TL, 2001, ANN ENTOMOL SOC AM, V94, P877, DOI 10.1603/0013-8746(2001)094[0877:OOWISD]2.0.CO;2; Delp G, 2009, MOL GENET GENOMICS, V281, P233, DOI 10.1007/s00438-008-0409-3; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Farag MA, 2005, PLANTA, V220, P900, DOI 10.1007/s00425-004-1404-5; FESLOT AS, 1982, J ECON ENTOMOL, V75, P1098; Garcia-Muniz N, 1998, PLANT MOL BIOL, V38, P623, DOI 10.1023/A:1006056000957; Giordano R, 1997, P NATL ACAD SCI USA, V94, P11439, DOI 10.1073/pnas.94.21.11439; Giovanini MP, 2006, MOL PLANT MICROBE IN, V19, P1023, DOI 10.1094/MPMI-19-1023; Grandi G, 2008, J PARASITOL, V94, P1421, DOI 10.1645/GE-1575.1; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; Hibbard BE, 2007, J PLANT REGIST, V1, P151, DOI 10.3198/jpr2006.12.0774crg; Im KH, 2000, PLANT PHYSIOL, V123, P463, DOI 10.1104/pp.123.2.463; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1123, DOI 10.1098/rspb.2001.1632; Kasprzewska A, 2003, CELL MOL BIOL LETT, V8, P809; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kessler A, 2004, SCIENCE, V305, P665, DOI 10.1126/science.1096931; Kobayashi Y, 1997, PLANT CELL PHYSIOL, V38, P725, DOI 10.1093/oxfordjournals.pcp.a029226; Kramer L, 2005, VET PARASITOL, V133, P133, DOI 10.1016/j.vetpar.2005.04.011; Kramer LH, 2005, VET IMMUNOL IMMUNOP, V106, P303, DOI 10.1016/j.vetimm.2005.03.011; Levine E, 1996, J ECON ENTOMOL, V89, P1010, DOI 10.1093/jee/89.4.1010; LIU JJ, 2010, PLANT CELL REP  0305; MALEHORN DE, 1994, PLANT PHYSIOL, V106, P1471, DOI 10.1104/pp.106.4.1471; McKenzie CL, 2002, ARCH INSECT BIOCHEM, V49, P203, DOI 10.1002/arch.10020; MEAD LJ, 1988, APPL ENVIRON MICROB, V54, P1174, DOI 10.1128/AEM.54.5.1174-1181.1988; Moore KG, 2004, PHYTOPATHOLOGY, V94, P82, DOI 10.1094/PHYTO.2004.94.1.82; Morchon R, 2007, PARASITOL INT, V56, P71, DOI 10.1016/j.parint.2006.10.003; Ogawa J, 2002, CURR OPIN BIOTECH, V13, P367, DOI 10.1016/S0958-1669(02)00331-2; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Polidoros AN, 2001, TRANSGENIC RES, V10, P555, DOI 10.1023/A:1013027920444; Porksakorn C, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/84318; SCHALK J M, 1987, Journal of Agricultural Entomology, V4, P333; SHEN CJ, 2009, J APPL MICROBIO 0828; SIEGFRIED BD, 1989, PESTIC BIOCHEM PHYS, V35, P155, DOI 10.1016/0048-3575(89)90113-2; STINTZI A, 1993, BIOCHIMIE, V75, P687, DOI 10.1016/0300-9084(93)90100-7; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; WRIGHT RJ, 1996, COOP EXT U NEBRASKA, P45; Zhang HZ, 2004, INFECT IMMUN, V72, P498, DOI 10.1128/IAI.72.1.498-507.2004	52	94	99	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11339	10.1371/journal.pone.0011339	http://dx.doi.org/10.1371/journal.pone.0011339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596533	Green Published, Green Submitted, gold			2022-12-27	WOS:000279259900012
J	Cortes, EA; Kaveh, D; Nunez-Garcia, J; Hogarth, PJ; Vordermeier, HM				Cortes, Elihu Aranday; Kaveh, Daryan; Nunez-Garcia, Javier; Hogarth, Philip J.; Vordermeier, H. Martin			Mycobacterium bovis-BCG Vaccination Induces Specific Pulmonary Transcriptome Biosignatures in Mice	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; TUBERCULOSIS INFECTION; GRANULOMA-FORMATION; INDUCED PROTECTION; IMMUNE-RESPONSE; EXPRESSION; INHIBITOR; VACCINES; PROTEIN; IL-17	Background: In the present study, we applied microarray technology to define biosignatures by microarray transcriptome analysis in lung and spleen samples after BCG vaccination and M. bovis infection of BALB/c mice. The aims were two-fold, namely to define biosignatures that could predict vaccine success before challenge, and biomarker patterns that correlated with anamnestic protective responses following exposure to virulent M. bovis. Further, these biosignatures should be detectable without in vitro antigenic challenge. Principal Findings: After BCG vaccination, we defined a specific pulmonary gene expression signature related to the connective tissue development and function network that predicted vaccine success before M. bovis challenge. In addition, a Th17-related cytokine profile was found that correlated with vaccine-induced protective immunity following infection with virulent M. bovis in the lung as well as additional genes that were up-regulated in the spleens of vaccinated animals post-infection related to neutrophil biology and inflammation. Conclusions: This study has therefore prioritized both biomarkers predicting vaccination success before challenge and biosignatures that are potentially associated with protective immune responses that will be useful to evaluate future vaccine candidates.	[Cortes, Elihu Aranday; Kaveh, Daryan; Nunez-Garcia, Javier; Hogarth, Philip J.; Vordermeier, H. Martin] Vet Labs Agcy, TB Res Grp, Addlestone, Surrey, England	Veterinary Laboratories Agency	Cortes, EA (corresponding author), Vet Labs Agcy, TB Res Grp, Addlestone, Surrey, England.	m.vordermeier@vla.defra.gsi.gov.uk	Nunez, Javier/B-1981-2016; Hogarth, Philip/C-6085-2011; Vordermeier, H Martin/C-6936-2011; Nunez, Javier/C-8253-2011; Aranday-Cortes, Elihu/G-3706-2012	Hogarth, Philip/0000-0002-6343-7846; Aranday-Cortes, Elihu/0000-0003-2637-2307; Kaveh, Daryan/0000-0002-1451-0082	Department for Environment, Food and Rural Affairs, United Kingdom	Department for Environment, Food and Rural Affairs, United Kingdom(Department for Environment, Food & Rural Affairs (DEFRA))	Funding was provided by the Department for Environment, Food and Rural Affairs, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELBERG R, 1989, CLIN EXP IMMUNOL, V78, P478; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Augustine CK, 2009, CLIN CANCER RES, V15, P502, DOI 10.1158/1078-0432.CCR-08-1916; Bensadoun ES, 1997, EUR RESPIR J, V10, P2731, DOI 10.1183/09031936.97.10122731; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Borelli V, 2003, INFECT IMMUN, V71, P605, DOI 10.1128/IAI.71.2.605-613.2003; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Burster T, 2010, MOL IMMUNOL, V47, P658, DOI 10.1016/j.molimm.2009.10.003; Chen P, 2008, AM J PATHOL, V172, P1256, DOI 10.2353/ajpath.2008.070891; Driss V, 2009, BLOOD, V113, P3235, DOI 10.1182/blood-2008-07-166595; Elkington PTG, 2006, THORAX, V61, P259, DOI 10.1136/thx.2005.051979; Elkington PTG, 2005, AM J RESP CRIT CARE, V172, P1596, DOI 10.1164/rccm.200505-753OC; Elkington PTG, 2005, CLIN EXP IMMUNOL, V142, P12, DOI 10.1111/j.1365-2249.2005.02840.X; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; GONZALEZJUARRER.M, 2008, AM J RESP CELL MOL B; Goswami S, 2009, NAT IMMUNOL, V10, P496, DOI 10.1038/ni.1719; He XL, 2007, AM J PHYSIOL-LUNG C, V292, pL1039, DOI 10.1152/ajplung.00490.2006; Heuts F, 2009, MICROBES INFECT, V11, P1114, DOI 10.1016/j.micinf.2009.08.005; Hogarth PJ, 2005, VACCINE, V23, P2557, DOI 10.1016/j.vaccine.2004.11.030; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Huang D, 2007, J INFECT DIS, V195, P55, DOI 10.1086/509895; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Irwin SM, 2008, CLIN VACCINE IMMUNOL, V15, P750, DOI 10.1128/CVI.00018-08; Izzo AA, 2004, TUBERCULOSIS, V84, P387, DOI 10.1016/j.tube.2004.07.001; Khader SA, 2008, CYTOKINE, V41, P79, DOI 10.1016/j.cyto.2007.11.022; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kolibab K, 2010, CLIN VACCINE IMMUNOL, V17, P793, DOI 10.1128/CVI.00006-10; Lim J, 2009, CLIN VACCINE IMMUNOL, V16, P122, DOI 10.1128/CVI.00359-08; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Lyons MJ, 2002, INFECT IMMUN, V70, P5471, DOI 10.1128/IAI.70.10.5471-5478.2002; Manicone AM, 2009, AM J PATHOL, V175, P2319, DOI 10.2353/ajpath.2009.090101; Mollenkopf HJ, 2006, MICROBES INFECT, V8, P136, DOI 10.1016/j.micinf.2005.06.015; Moritz E, 2009, AN ACAD BRAS CIENC, V81, P559, DOI 10.1590/S0001-37652009000300019; Nio J, 2004, HISTOCHEM CELL BIOL, V121, P473, DOI 10.1007/s00418-004-0654-4; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Pedrosa J, 2000, INFECT IMMUN, V68, P577, DOI 10.1128/IAI.68.2.577-583.2000; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Plager DA, 2006, J IMMUNOL, V177, P7340, DOI 10.4049/jimmunol.177.10.7340; Rodgers A, 2006, TUBERCULOSIS, V86, P255, DOI 10.1016/j.tube.2006.01.020; Romano M, 2006, VACCINE, V24, P3353, DOI 10.1016/j.vaccine.2005.12.066; Runza VL, 2008, IMMUNOBIOLOGY, V213, P297, DOI 10.1016/j.imbio.2007.10.009; Sheen P, 2009, EUR RESPIR J, V33, P134, DOI 10.1183/09031936.00127807; Skinner MA, 2001, REV SCI TECH OIE, V20, P112, DOI 10.20506/rst.20.1.1276; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2006, VET J, V171, P229, DOI 10.1016/j.tvjl.2004.11.001; Wielockx B, 2004, CYTOKINE GROWTH F R, V15, P111, DOI 10.1016/j.cytogfr.2003.12.001	50	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11319	10.1371/journal.pone.0011319	http://dx.doi.org/10.1371/journal.pone.0011319			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596522	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000279259900004
J	Dvash, T; Lavon, N; Fan, GP				Dvash, Tamar; Lavon, Neta; Fan, Guoping			Variations of X Chromosome Inactivation Occur in Early Passages of Female Human Embryonic Stem Cells	PLOS ONE			English	Article							HUMAN BLASTOCYSTS; LINES; DIFFERENTIATION; PLURIPOTENCY; DERIVATION; FIBROBLASTS; METHYLATION; EXPRESSION; GENOME; CANCER	X chromosome inactivation (XCI) is a dosage compensation mechanism essential for embryonic development and cell physiology. Human embryonic stem cells (hESCs) derived from inner cell mass (ICM) of blastocyst stage embryos have been used as a model system to understand XCI initiation and maintenance. Previous studies of undifferentiated female hESCs at intermediate passages have shown three possible states of XCI; 1) cells in a pre-XCI state, 2) cells that already exhibit XCI, or 3) cells that never undergo XCI even upon differentiation. In this study, XCI status was assayed in ten female hESC lines between passage 5 and 15 to determine whether XCI variations occur in early passages of hESCs. Our results show that three different states of XCI already exist in the early passages of hESC. In addition, we observe one cell line with skewed XCI and preferential expression of X-linked genes from the paternal allele, while another cell line exhibits random XCI. Skewed XCI in undifferentiated hESCs may be due to clonal selection in culture instead of non-random XCI in ICM cells. We also found that XIST promoter methylation is correlated with silencing of XIST transcripts in early passages of hESCs, even in the pre-XCI state. In conclusion, XCI variations already take place in early passages of hESCs, which may be a consequence of in vitro culture selection during the derivation process. Nevertheless, we cannot rule out the possibility that XCI variations in hESCs may reflect heterogeneous XCI states in ICM cells that stochastically give rise to hESCs.	[Dvash, Tamar; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Dvash, Tamar; Fan, Guoping] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Lavon, Neta] Cedars Sinai Med Ctr, Int Stem Cell Res Inst, Los Angeles, CA 90048 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Dvash, T (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA.	gfan@mednet.ucla.edu		Fan, Guoping/0000-0001-5235-6410	California Institute of Regenerative Medicine [TG2-01169, RC1-0111]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	The research was supported by the California Institute of Regenerative Medicine training grant TG2-01169 to T.D. and comprehensive grant RC1-0111 to G.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005; Dvash T, 2009, EPIGENETICS-US, V4, P19, DOI 10.4161/epi.4.1.7438; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Ganesan S, 2005, COLD SH Q B, V70, P93, DOI 10.1101/sqb.2005.70.045; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lavon N, 2008, STEM CELLS, V26, P1874, DOI 10.1634/stemcells.2008-0156; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; LIU W, 2009, HUM REPROD; LU B, 2009, STEM CELLS; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Michienzi A, 2001, METHOD ENZYMOL, V341, P581, DOI 10.1016/S0076-6879(01)41178-5; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; Pera RAR, 2009, DIFFERENTIATION, V78, P18, DOI 10.1016/j.diff.2009.03.004; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; TANASIJEVIC B, 2009, EPIGENETICS, V4; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomkins DJ, 2002, EUR J HUM GENET, V10, P44, DOI 10.1038/sj.ejhg.5200757; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Zeng SM, 2003, PLACENTA, V24, P270, DOI 10.1053/plac.2002.0889; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	38	48	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11330	10.1371/journal.pone.0011330	http://dx.doi.org/10.1371/journal.pone.0011330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593031	Green Published, gold, Green Submitted			2022-12-27	WOS:000279140800027
J	Bi, M; Kao, WHL; Boerwinkle, E; Hoogeveen, RC; Rasmussen-Torvik, LJ; Astor, BC; North, KE; Coresh, J; Kottgen, A				Bi, Mark; Kao, Wen Hong Linda; Boerwinkle, Eric; Hoogeveen, Ron C.; Rasmussen-Torvik, Laura J.; Astor, Brad C.; North, Kari E.; Coresh, Josef; Koettgen, Anna			Association of rs780094 in GCKR with Metabolic Traits and Incident Diabetes and Cardiovascular Disease: The ARIC Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; GLUCOKINASE REGULATORY PROTEIN; CORONARY-ARTERY-DISEASE; FASTING PLASMA-GLUCOSE; MIDDLE-AGED ADULTS; C-REACTIVE PROTEIN; ATHEROSCLEROSIS RISK; TRIGLYCERIDE LEVELS; LOCI	Objective: The minor T-allele of rs780094 in the glucokinase regulator gene (GCKR) associates with a number of metabolic traits including higher triglyceride levels and improved glycemic regulation in study populations of mostly European ancestry. Using data from the Atherosclerosis Risk in Communities (ARIC) Study, we sought to replicate these findings, examine them in a large population-based sample of African American study participants, and to investigate independent associations with other metabolic traits in order to determine if variation in GKCR contributes to their observed clustering. In addition, we examined the association of rs780094 with incident diabetes, coronary heart disease (CHD), and stroke over up mean follow-up times of 8, 15, and 15 years, respectively. Research Design and Methods: Race-stratified analyses were conducted among 10,929 white and 3,960 black participants aged 45-64 at baseline assuming an additive genetic model and using linear and logistic regression and Cox proportional hazards models. Results: Previous findings replicated among white participants in multivariable adjusted models: the T-allele of rs780094 was associated with lower fasting glucose (p = 10(-7)) and insulin levels (p = 10(-6)), lower insulin resistance (HOMA-IR, p = 10(-9)), less prevalent diabetes (p = 10(-6)), and higher CRP (p = 10(-8)), 2-h postprandial glucose (OGTT, p = 10(-6)), and triglyceride levels (p = 10(-31)). Moreover, the T-allele was independently associated with higher HDL cholesterol levels (p = 0.022), metabolic syndrome prevalence (p = 0.043), and lower beta-cell function measured as HOMA-B (p = 0.011). Among black participants, the T-allele was associated only with higher triglyceride levels (p = 0.004) and lower insulin levels (p = 0.002) and HOMA-IR (p = 0.013). Prospectively, the T-allele was associated with reduced incidence of diabetes (p = 10(-4)) among white participants, but not with incidence of CHD or stroke. Conclusions: Our findings indicate rs780094 has independent associations with multiple metabolic traits as well as incident diabetes, but not incident CHD or stroke. The magnitude of association between the SNP and most traits was of lower magnitude among African American compared to white participants.	[Bi, Mark] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Kao, Wen Hong Linda; Astor, Brad C.; Coresh, Josef; Koettgen, Anna] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX USA; [Hoogeveen, Ron C.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Rasmussen-Torvik, Laura J.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [North, Kari E.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [North, Kari E.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Koettgen, Anna] Univ Hosp Freiburg, Div Renal, Freiburg, Germany	University of Nebraska System; University of Nebraska Lincoln; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Freiburg	Bi, M (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	akottgen@jhsph.edu	Kottgen, Anna/D-2920-2012	Rasmussen-Torvik, Laura/0000-0002-0820-7300; Hoogeveen, Ron/0000-0003-2399-4653	National Heart, Lung, and Blood Institute [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055020, N01HC055018, N01HC055022, N01HC055019, N01HC055016, N01HC055021, N01HC055015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R42HL055018, R41HL055019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, AM J EPIDEMIOL, V129, P687; Beer NL, 2009, HUM MOL GENET, V18, P4081, DOI 10.1093/hmg/ddp357; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Chambers JC, 2009, DIABETES, V58, P2703, DOI 10.2337/db08-1805; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; INGELSSON E, 2010, DIABETES; Jaromi L, 2010, J MOL NEUROSCI, V41, P121, DOI 10.1007/s12031-009-9301-9; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; KOZIAN DH, 2010, HORM METAB RES; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; National Heart Lung and Blood Institute, ATH RISK COMM ARIC S; Orho-Melander M, 2008, DIABETES, V57, P3112, DOI 10.2337/db08-0516; Perez-Martinez P, 2009, AM J CLIN NUTR, V89, P391, DOI 10.3945/ajcn.2008.26363; Pollex RL, 2006, NAT CLIN PRACT CARD, V3, P482, DOI 10.1038/ncpcardio0638; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; Reynolds K, 2005, AM J MED SCI, V330, P273, DOI 10.1097/00000441-200512000-00004; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; SJOGREN M, 2008, DIABETOLOGIA; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Slosberg ED, 2001, DIABETES, V50, P1813, DOI 10.2337/diabetes.50.8.1813; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Stark K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007729; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; TAM CH, 2008, DIABETES; van der Harst P, 2010, HUM MOL GENET, V19, P387, DOI 10.1093/hmg/ddp489; Vaxillaire M, 2008, DIABETES, V57, P2253, DOI 10.2337/db07-1807; Wang L, 2003, AM J CLIN NUTR, V78, P91; Weissglas-Volkov D, 2010, CIRC-CARDIOVASC GENE, V3, P31, DOI 10.1161/CIRCGENETICS.109.908004; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	41	43	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11690	10.1371/journal.pone.0011690	http://dx.doi.org/10.1371/journal.pone.0011690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661421	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300005
J	Olea, PP; Mateo-Tomas, P; de Frutos, A				Olea, Pedro P.; Mateo-Tomas, Patricia; de Frutos, Angel			Estimating and Modelling Bias of the Hierarchical Partitioning Public-Domain Software: Implications in Environmental Management and Conservation	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; MULTIPLE-REGRESSION; SPECIES RICHNESS; HABITAT; LANDSCAPE; AUSTRALIA; VARIABLES; ECOLOGY; MAMMALS; BIOLOGY	Background: Hierarchical partitioning (HP) is an analytical method of multiple regression that identifies the most likely causal factors while alleviating multicollinearity problems. Its use is increasing in ecology and conservation by its usefulness for complementing multiple regression analysis. A public-domain software "hier.part package'' has been developed for running HP in R software. Its authors highlight a "minor rounding error'' for hierarchies constructed from >9 variables, however potential bias by using this module has not yet been examined. Knowing this bias is pivotal because, for example, the ranking obtained in HP is being used as a criterion for establishing priorities of conservation. Methodology/Principal Findings: Using numerical simulations and two real examples, we assessed the robustness of this HP module in relation to the order the variables have in the analysis. Results indicated a considerable effect of the variable order on the amount of independent variance explained by predictors for models with >9 explanatory variables. For these models the nominal ranking of importance of the predictors changed with variable order, i.e. predictors declared important by its contribution in explaining the response variable frequently changed to be either most or less important with other variable orders. The probability of changing position of a variable was best explained by the difference in independent explanatory power between that variable and the previous one in the nominal ranking of importance. The lesser is this difference, the more likely is the change of position. Conclusions/Significance: HP should be applied with caution when more than 9 explanatory variables are used to know ranking of covariate importance. The explained variance is not a useful parameter to use in models with more than 9 independent variables. The inconsistency in the results obtained by HP should be considered in future studies as well as in those already published. Some recommendations to improve the analysis with this HP module are given.	[Olea, Pedro P.; Mateo-Tomas, Patricia] IE Univ, Sch Biol, Segovia, Spain; [de Frutos, Angel] Univ Leon, Dept Biodivers & Environm Management, Fac Biol & Environm Sci, E-24071 Leon, Spain	IE University; Universidad de Leon	Olea, PP (corresponding author), IE Univ, Sch Biol, Segovia, Spain.	pedro.perez@ie.edu	Olea, Pedro P/M-1502-2014; Mateo-Tomás, Patricia/L-8471-2014	Olea, Pedro P/0000-0001-5387-9598; Mateo-Tomás, Patricia/0000-0001-6762-9514; de Frutos, Angel/0000-0002-5250-9488				*BIRDLIFE INT, 2010, IUCN 2007 IUCN RED L; *BIRDLIFE INT, 2010, IUCN 2004 IUCN RED L; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; Carrete M, 2007, BIOL CONSERV, V136, P143, DOI 10.1016/j.biocon.2006.11.025; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Cramp S., 1980, BIRDS W PALEARTIC, VII; Crawley M.J., 2007, R BOOK; de Frutos A, 2007, ECOL MODEL, V200, P33, DOI 10.1016/j.ecolmodel.2006.07.007; Gibson LA, 2004, BIOL CONSERV, V120, P75, DOI 10.1016/j.biocon.2004.01.027; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Heikkinen RK, 2005, P ROY SOC B-BIOL SCI, V272, P2203, DOI 10.1098/rspb.2005.3212; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Luoto M, 2006, J BIOGEOGR, V33, P1764, DOI 10.1111/j.1365-2699.2005.01395.x; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Mac Nally R, 2004, BIODIVERS CONSERV, V13, P659; Marini L, 2008, J BIOGEOGR, V35, P1826, DOI 10.1111/j.1365-2699.2008.01924.x; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; Mateo-Tomas P, 2009, ACTA OECOL, V35, P489, DOI 10.1016/j.actao.2009.03.004; McAlpine CA, 2006, BIOL CONSERV, V132, P153, DOI 10.1016/j.biocon.2006.03.021; Millington JDA, 2007, ECOSYSTEMS, V10, P562, DOI 10.1007/s10021-007-9020-4; Muller J, 2009, FOREST ECOL MANAG, V257, P502, DOI 10.1016/j.foreco.2008.09.023; Olea PP, 2009, POPUL ECOL, V51, P161, DOI 10.1007/s10144-008-0106-4; R Development Core Team, 2006, R LANG ENV STAT COMP; Siegfried W. R, 1971, Ostrich, V42, P1, DOI 10.1080/00306525.1971.9634388; Walsh C., 2005, HIER PART PACKAGE VE; Walsh C., 2007, HIER PART PACKAGE VE; Walsh C.J., 2004, HIER PART PACKAGE VE; Walsh CJ, 2004, BIODIVERS CONSERV, V13, P781, DOI 10.1023/B:BIOC.0000011726.38121.b0; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	34	71	73	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11698	10.1371/journal.pone.0011698	http://dx.doi.org/10.1371/journal.pone.0011698			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657734	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500035
J	Von Holle, B; Wei, Y; Nickerson, D				Von Holle, Betsy; Wei, Yun; Nickerson, David			Climatic Variability Leads to Later Seasonal Flowering of Floridian Plants	PLOS ONE			English	Article							PHENOLOGICAL RESPONSE; PERSPECTIVE; SUCCESS	Understanding species responses to global change will help predict shifts in species distributions as well as aid in conservation. Changes in the timing of seasonal activities of organisms over time may be the most responsive and easily observable indicator of environmental changes associated with global climate change. It is unknown how global climate change will affect species distributions and developmental events in subtropical ecosystems or if climate change will differentially favor nonnative species. Contrary to previously observed trends for earlier flowering onset of plant species with increasing spring temperatures from mid and higher latitudes, we document a trend for delayed seasonal flowering among plants in Florida. Additionally, there were few differences in reproductive responses by native and nonnative species to climatic changes. We argue that plants in Florida have different reproductive cues than those from more northern climates. With global change, minimum temperatures have become more variable within the temperate-subtropical zone that occurs across the peninsula and this variation is strongly associated with delayed flowering among Florida plants. Our data suggest that climate change varies by region and season and is not a simple case of species responding to consistently increasing temperatures across the region. Research on climate change impacts need to be extended outside of the heavily studied higher latitudes to include subtropical and tropical systems in order to properly understand the complexity of regional and seasonal differences of climate change on species responses.	[Von Holle, Betsy] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Wei, Yun; Nickerson, David] Univ Cent Florida, Dept Stat, Orlando, FL 32816 USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Von Holle, B (corresponding author), Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA.	vonholle@mail.ucf.edu	Von Holle, Betsy/GZG-5112-2022	Von Holle, Betsy/0000-0002-3116-3027	Invasive Plant Management Section of the Florida Fish and Wildlife Conservation Commission; Office of Research of the University of Central Florida; UCF Department of Biology	Invasive Plant Management Section of the Florida Fish and Wildlife Conservation Commission; Office of Research of the University of Central Florida; UCF Department of Biology	Funding for this research was provided to BVH by the Invasive Plant Management Section of the Florida Fish and Wildlife Conservation Commission, the Office of Research of the University of Central Florida, and research start-up dollars provided by the UCF Department of Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Box EO, 1995, VEGETATIO, V121, P101, DOI 10.1007/BF00044676; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; *CTR FC, 2008, MONTHL TEMP PREC DAT; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; ESTRELLA N, 2009, COMMUNICATION; *FLEPPC, 2007, WILDLAND WEEDS, V10; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Miller-Rushing AJ, 2006, AM J BOT, V93, P1667, DOI 10.3732/ajb.93.11.1667; MOJENA R, 1977, COMPUT J, V20, P359, DOI 10.1093/comjnl/20.4.359; NOAA Satellite and Information Service N, 2009, STAT CLIM GLOB AN AN; Otto S, 2007, WEED RES, V47, P488, DOI 10.1111/j.1365-3180.2007.00594.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Primack D, 2004, AM J BOT, V91, P1260, DOI 10.3732/ajb.91.8.1260; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Rencher AC, 2002, METHODS MULTIVARIATE; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schmitz DC, 2007, NAT AREA J, V27, P251, DOI 10.3375/0885-8608(2007)27[251:FIPRHP]2.0.CO;2; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; VINOD HD, 1973, COMMUN STAT, V2, P115, DOI DOI 10.1080/03610927308827060; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, FOLIA GEOBOT, V37, P129, DOI 10.1007/BF02803195; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARD DB, 1990, PALMETTO, V89, P3; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Woodward F.I., 1987, CLIMATE PLANT DISTRI; Wunderlin R.P., 2003, GUIDE VASCULAR PLANT	31	28	28	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11500	10.1371/journal.pone.0011500	http://dx.doi.org/10.1371/journal.pone.0011500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657765	Green Published, gold			2022-12-27	WOS:000280197500003
J	Demorest, ZL; MacDuff, DA; Brown, WL; Morham, SG; Parise, LV; Harris, RS				Demorest, Zachary L.; MacDuff, Donna A.; Brown, William L.; Morham, Scott G.; Parise, Leslie V.; Harris, Reuben S.			The Interaction between AID and CIB1 Is Nonessential for Antibody Gene Diversification by Gene Conversion or Class Switch Recombination	PLOS ONE			English	Article							ACTIVATION-INDUCED DEAMINASE; INDUCED CYTIDINE DEAMINASE; KINASE-A PHOSPHORYLATION; NF-KAPPA-B; SOMATIC HYPERMUTATION; LENTIVIRAL VECTOR; STRESS GRANULES; URACIL EXCISION; NUCLEAR-EXPORT; EDITING ENZYME	Activation-induced deaminase (AID) initiates somatic hypermutation, gene conversion and class switch recombination by deaminating variable and switch region DNA cytidines to uridines. AID is predominantly cytoplasmic and must enter the nuclear compartment to initiate these distinct antibody gene diversification reactions. Nuclear AID is relatively short-lived, as it is efficiently exported by a CRM1-dependent mechanism and it is susceptible to proteasome-dependent degradation. To help shed light on mechanisms of post-translational regulation, a yeast-based screen was performed to identify AID-interacting proteins. The calcium and integrin binding protein CIB1 was identified by sequencing and the interaction was confirmed by immunoprecipitation experiments. The AID/CIB1 resisted DNase and RNase treatment, and it is therefore unlikely to be mediated by nucleic acid. The requirement for CIB1 in AID-mediated antibody gene diversification reactions was assessed in CIB1-deficient DT40 cells and in knockout mice, but immunoglobulin gene conversion and class switch recombination appeared normal. The DT40 system was also used to show that CIB1 over-expression has no effect on gene conversion and that AID-EGFP subcellular localization is normal. These combined data demonstrate that CIB1 is not required for AID to mediate antibody gene diversification processes. It remains possible that CIB1 has an alternative, a redundant or a subtle non-limiting regulatory role in AID biology.	[Demorest, Zachary L.; MacDuff, Donna A.; Brown, William L.; Harris, Reuben S.] Univ Minnesota, Beckman Ctr Genome Engn, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Morham, Scott G.] Myriad Pharmaceut, Salt Lake City, UT USA; [Parise, Leslie V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA	University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill	Demorest, ZL (corresponding author), Univ Minnesota, Beckman Ctr Genome Engn, Inst Mol Virol, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	rsh@umn.edu	MacDuff, Donna/AAD-2786-2019; Brown, William/GXN-2777-2022	MacDuff, Donna/0000-0002-6183-6827; 	National Institutes of Health [GM090437, 2-P01-HL45100]; University of Minnesota; Doctoral Dissertation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); Doctoral Dissertation Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health, GM090437 (to RSH) and 2-P01-HL45100 (to LVP) and, in part, by a University of Minnesota Leukemia Research Fund Grant (to RSH) and a Doctoral Dissertation Fellowship (to DAM). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SM is an employee of Myriad Pharmaceuticals, Inc., ProNet Division and this funder had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aoufouchi S, 2008, J EXP MED, V205, P1357, DOI 10.1084/jem.20070950; Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bai Y, 2003, GENE THER, V10, P1446, DOI 10.1038/sj.gt.3302026; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Bhutani N., 2009, NATURE; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chatterji M, 2007, J IMMUNOL, V179, P5274, DOI 10.4049/jimmunol.179.8.5274; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; CHIU S, 2005, TAIWAN J ANTHR, V3, P1; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Esnault C, 2006, NUCLEIC ACIDS RES, V34, P1522, DOI 10.1093/nar/gkl054; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Gourzi P, 2007, J EXP MED, V204, P259, DOI 10.1084/jem.20061801; Harris RS, 2002, CURR BIOL, V12, P435, DOI 10.1016/S0960-9822(02)00717-0; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Knuesel M, 2003, MOL CELL PROTEOMICS, V2, P1225, DOI 10.1074/mcp.T300007-MCP200; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; MacDuff DA, 2006, MOL IMMUNOL, V43, P1099, DOI 10.1016/j.molimm.2005.07.024; MacDuff DA, 2009, NUCLEIC ACIDS RES, V37, P1854, DOI 10.1093/nar/gkp030; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2004, J EXP MED, V199, P1235, DOI 10.1084/jem.20040373; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; NAIK MU, 2010, INT J CANC IN PRESS; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Neuberger MS, 2008, IMMUNOL CELL BIOL, V86, P124, DOI 10.1038/sj.icb.7100160; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; POPP C, NATURE; Rada C, 2004, MOL CELL, V16, P163, DOI 10.1016/j.molcel.2004.10.011; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rosenberg Brad R, 2007, Adv Immunol, V94, P215, DOI 10.1016/S0065-2776(06)94007-3; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Wu XS, 2005, J IMMUNOL, V174, P934, DOI 10.4049/jimmunol.174.2.934; Xu KL, 2001, MOL THER, V3, P97, DOI 10.1006/mthe.2000.0238; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06	53	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11660	10.1371/journal.pone.0011660	http://dx.doi.org/10.1371/journal.pone.0011660			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652029	Green Submitted, Green Published, gold			2022-12-27	WOS:000280109700002
J	Fischer, NO; Blanchette, CD; Segelke, BW; Corzett, M; Chromy, BA; Kuhn, EA; Bench, G; Hoeprich, PD				Fischer, Nicholas O.; Blanchette, Craig D.; Segelke, Brent W.; Corzett, Michele; Chromy, Brett A.; Kuhn, Edward A.; Bench, Graham; Hoeprich, Paul D.			Isolation, Characterization, and Stability of Discretely-Sized Nanolipoprotein Particles Assembled with Apolipophorin-III	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; HIGH-DENSITY-LIPOPROTEINS; PHOSPHOLIPID-BILAYER NANODISCS; MEMBRANE-PROTEINS; MOLECULAR-DYNAMICS; LIPID-BILAYERS; AMPHOTERICIN-B; BOMBYX-MORI; BINDING; MORPHOLOGY	Background: Nanolipoprotein particles (NLPs) are discoidal, nanometer-sized particles comprised of self-assembled phospholipid membranes and apolipoproteins. NLPs assembled with human apolipoproteins have been used for myriad biotechnology applications, including membrane protein solubilization, drug delivery, and diagnostic imaging. To expand the repertoire of lipoproteins for these applications, insect apolipophorin-III (apoLp-III) was evaluated for the ability to form discretely-sized, homogeneous, and stable NLPs. Methodology: Four NLP populations distinct with regards to particle diameters (ranging in size from 10 nm to >25 nm) and lipid-to-apoLp-III ratios were readily isolated to high purity by size exclusion chromatography. Remodeling of the purified NLP species over time at 4 degrees C was monitored by native gel electrophoresis, size exclusion chromatography, and atomic force microscopy. Purified 20 nm NLPs displayed no remodeling and remained stable for over 1 year. Purified NLPs with 10 nm and 15 nm diameters ultimately remodeled into 20 nm NLPs over a period of months. Intra-particle chemical cross-linking of apoLp-III stabilized NLPs of all sizes. Conclusions: ApoLp-III-based NLPs can be readily prepared, purified, characterized, and stabilized, suggesting their utility for biotechnological applications.	[Fischer, Nicholas O.; Blanchette, Craig D.; Segelke, Brent W.; Corzett, Michele; Chromy, Brett A.; Kuhn, Edward A.; Bench, Graham; Hoeprich, Paul D.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Fischer, NO (corresponding author), Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA.	hoeprich2@llnl.gov	Fischer, Nicholas/AAE-2409-2019	Fischer, Nicholas/0000-0001-7575-4390; Kuhn, Edward/0000-0002-5521-3404; Bench, Graham/0000-0002-1969-6867; Segelke, Brent/0000-0003-3358-5028	U.S. Department of Energy by Lawrence Livermore National Laboratory [LLNL-JRNL-427664, DE-AC52-07NA27344, LLNL-JRNL-420683]; Lawrence Livermore National Laboratory [06-SI-003, 09-LW-077]	U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	The authors thank Dr. Robert Ryan for providing reagents. This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL-JRNL-427664) under Contract DE-AC52-07NA27344.; This work performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory (LLNL-JRNL-420683) under Contract DE-AC52-07NA27344 with support from Lawrence Livermore National Laboratory (LDRD, 06-SI-003 and 09-LW-077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SE, 2009, J AM CHEM SOC, V131, P7508, DOI 10.1021/ja809251f; Bhat S, 2007, BIOCHEMISTRY-US, V46, P7811, DOI 10.1021/bi700384t; Bhattacharya P, 2010, J VIROL, V84, P361, DOI 10.1128/JVI.01355-09; Blanchette CD, 2008, J LIPID RES, V49, P1420, DOI 10.1194/jlr.M700586-JLR200; Blanchette CD, 2009, INT J MOL SCI, V10, P2958, DOI 10.3390/ijms10072958; Cappuccio JA, 2008, MOL CELL PROTEOMICS, V7, P2246, DOI 10.1074/mcp.M800191-MCP200; Catte A, 2006, BIOPHYS J, V90, P4345, DOI 10.1529/biophysj.105.071456; Cavigiolio G, 2008, BIOCHEMISTRY-US, V47, P4770, DOI 10.1021/bi7023354; Chen B, 2009, PROTEIN SCI, V18, P921, DOI 10.1002/pro.101; Chetty PS, 2003, BIOCHEMISTRY-US, V42, P15061, DOI 10.1021/bi035456i; Chromy BA, 2007, J AM CHEM SOC, V129, P14348, DOI 10.1021/ja074753y; DAMODARAN KV, 1994, BIOPHYS J, V66, P1076, DOI 10.1016/S0006-3495(94)80889-6; Denisov IG, 2005, J PHYS CHEM B, V109, P15580, DOI 10.1021/jp051385g; Fang YL, 2003, BIOCHEMISTRY-US, V42, P13260, DOI 10.1021/bi0354031; Fischer NO, 2010, BIOCONJUGATE CHEM, V21, P1018, DOI 10.1021/bc100083d; Fischer NO, 2009, BIOCONJUGATE CHEM, V20, P460, DOI 10.1021/bc8003155; Frias JC, 2006, NANO LETT, V6, P2220, DOI 10.1021/nl061498r; Gianazza E, 2002, BIOCHEM J, V366, P245, DOI 10.1042/BJ20020058; Gu FF, 2010, J BIOL CHEM, V285, P4652, DOI 10.1074/jbc.M109.069914; JONAS A, 1989, J BIOL CHEM, V264, P4818; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1085, P71, DOI 10.1016/0005-2760(91)90233-8; Jones MK, 2009, BIOPHYS J, V96, P354, DOI 10.1016/j.bpj.2008.09.041; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Kim J, 2009, CHEM SOC REV, V38, P372, DOI 10.1039/b709883a; Li H, 2004, ACAD RADIOL, V11, P1251, DOI 10.1016/j.acra.2004.08.007; LIANG HQ, 1995, BBA-LIPID LIPID MET, V1257, P31, DOI 10.1016/0005-2760(95)00055-H; Lyukmanova EN, 2008, J AM CHEM SOC, V130, P2140, DOI 10.1021/ja0777988; Marcato PD, 2008, J NANOSCI NANOTECHNO, V8, P2216, DOI 10.1166/jnn.2008.274; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Miyazaki M, 2009, BIOCHEMISTRY-US, V48, P7756, DOI 10.1021/bi900785x; Nakano M, 2009, J AM CHEM SOC, V131, P8308, DOI 10.1021/ja9017013; Narayanaswami V, 2000, EUR J BIOCHEM, V267, P728, DOI 10.1046/j.1432-1327.2000.01050.x; Nath A, 2007, BIOCHEMISTRY-US, V46, P2059, DOI 10.1021/bi602371n; Nguyen TS, 2008, BBA-BIOMEMBRANES, V1778, P303, DOI 10.1016/j.bbamem.2007.10.005; Nikanjarn M, 2007, J CONTROL RELEASE, V124, P163, DOI 10.1016/j.jconrel.2007.09.007; Oda MN, 2006, J LIPID RES, V47, P260, DOI 10.1194/jlr.D500033-JLR200; Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Peters-Libeu CA, 2007, J LIPID RES, V48, P1035, DOI 10.1194/jlr.M600545-JLR200; Redmond KA, 2007, INT J PHARM, V339, P246, DOI 10.1016/j.ijpharm.2007.02.033; Rensen PCN, 2001, ADV DRUG DELIVER REV, V47, P251, DOI 10.1016/S0169-409X(01)00109-0; Reviakine I, 2000, LANGMUIR, V16, P1473, DOI 10.1021/la990806g; Richter RP, 2005, BIOPHYS J, V88, P3422, DOI 10.1529/biophysj.104.053728; RYAN RO, 1995, J LIPID RES, V36, P1066; Rye K, 2006, J LIPID RES, V47, P1025, DOI 10.1194/jlr.M500525-JLR200; Schwendener RA, 2007, ADV EXP MED BIOL, V620, P117; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Settasatian N, 2008, J LIPID RES, V49, P115, DOI 10.1194/jlr.M700220-JLR200; Tarek M, 2003, BIOPHYS J, V85, P2287, DOI 10.1016/S0006-3495(03)74653-0; Torchilin V, 2009, EUR J PHARM BIOPHARM, V71, P431, DOI 10.1016/j.ejpb.2008.09.026; Tufteland M, 2008, J PHARM SCI-US, V97, P4425, DOI 10.1002/jps.21325; Weers PMM, 2006, INSECT BIOCHEM MOLEC, V36, P231, DOI 10.1016/j.ibmb.2006.01.001; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; WIENTZEK M, 1994, J BIOL CHEM, V269, P4605; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Yamauchi Y, 2000, ARCH INSECT BIOCHEM, V43, P16, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;16::AID-ARCH3&gt;3.0.CO;2-W; Zhu K, 2007, BIOCHEMISTRY-US, V46, P6299, DOI 10.1021/bi700079w	58	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11643	10.1371/journal.pone.0011643	http://dx.doi.org/10.1371/journal.pone.0011643			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657844	Green Submitted, Green Published, gold			2022-12-27	WOS:000280065600009
J	Nilsson, EE; Savenkova, MI; Schindler, R; Zhang, B; Schadt, EE; Skinner, MK				Nilsson, Eric E.; Savenkova, Marina I.; Schindler, Ryan; Zhang, Bin; Schadt, Eric E.; Skinner, Michael K.			Gene Bionetwork Analysis of Ovarian Primordial Follicle Development	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-4; ANTI-MULLERIAN HORMONE; INITIATES FOLLICULOGENESIS; MOUSE OVARY; IN-VITRO; TRANSITION; NETWORKS; PROMOTES; EXPRESSION	Ovarian primordial follicles are critical for female reproduction and comprise a finite pool of gametes arrested in development. A systems biology approach was used to identify regulatory gene networks essential for primordial follicle development. Transcriptional responses to eight different growth factors known to influence primordial follicles were used to construct a bionetwork of regulatory genes involved in rat primordial follicle development. Over 1,500 genes were found to be regulated by the various growth factors and a network analysis identified critical gene modules involved in a number of signaling pathways and cellular processes. A set of 55 genes was identified as potential critical regulators of these gene modules, and a sub-network associated with development was determined. Within the network two previously identified regulatory genes were confirmed (i.e., Pdgfa and Fgfr2) and a new factor was identified, connective tissue growth factor ( CTGF). CTGF was tested in ovarian organ cultures and found to stimulate primordial follicle development. Therefore, the relevant gene network associated with primordial follicle development was validated and the critical genes and pathways involved in this process were identified. This is one of the first applications of network analysis to a normal developmental process. These observations provide insights into potential therapeutic targets for preventing ovarian disease and promoting female reproduction.	[Nilsson, Eric E.; Savenkova, Marina I.; Schindler, Ryan; Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Mol Biosci, Pullman, WA 99164 USA; [Zhang, Bin; Schadt, Eric E.] Sage Bionetworks, Seattle, WA USA	Washington State University	Nilsson, EE (corresponding author), Washington State Univ, Ctr Reprod Biol, Sch Mol Biosci, Pullman, WA 99164 USA.	skinner@wsu.edu.edu	Nilsson, Eric/AAR-5021-2020; Savenkova, Marina/AAN-9927-2021		National Institutes of Health (NIH) [R01 HD043093-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health (NIH) R01 HD043093-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Dole G, 2008, REPRODUCTION, V135, P671, DOI 10.1530/REP-07-0405; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Garor R, 2009, FERTIL STERIL, V91, P1967, DOI 10.1016/j.fertnstert.2008.04.075; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gressner OA, 2008, LIVER INT, V28, P1065, DOI 10.1111/j.1478-3231.2008.01826.x; Harlow CR, 2002, MOL CELL ENDOCRINOL, V187, P23, DOI 10.1016/S0303-7207(01)00702-X; HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hutt KJ, 2006, BIOL REPROD, V75, P421, DOI 10.1095/biolreprod.106.051516; Kezele P, 2005, BIOL REPROD, V73, P967, DOI 10.1095/biolreprod.105.043117; Kezele PR, 2005, BIOL REPROD, V72, P241, DOI 10.1095/biolreprod.104.032060; Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; Matos MHT, 2007, REPROD FERT DEVELOP, V19, P677, DOI 10.1071/RD07021; Nilsson E, 2001, MOL CELL ENDOCRINOL, V175, P123, DOI 10.1016/S0303-7207(01)00391-4; Nilsson EE, 2004, MOL CELL ENDOCRINOL, V214, P19, DOI 10.1016/j.mce.2003.12.001; Nilsson EE, 2003, BIOL REPROD, V69, P1265, DOI 10.1095/biolreprod.103.018671; Nilsson EE, 2002, MOL CELL ENDOCRINOL, V188, P65, DOI 10.1016/S0303-7207(01)00746-8; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; Nilsson EE, 2006, REPRODUCTION, V131, P1007, DOI 10.1530/rep.1.00978; OKTAY K, 1995, BIOL REPROD, V53, P295, DOI 10.1095/biolreprod53.2.295; Pangas SA, 2007, SEMIN REPROD MED, V25, P225, DOI 10.1055/s-2007-980216; Parrott JA, 1999, ENDOCRINOLOGY, V140, P4262, DOI 10.1210/en.140.9.4262; PETERS H, 1975, J REPROD FERTIL, V45, P559, DOI 10.1530/jrf.0.0450559; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Tanwar PS, 2008, ANIM REPROD SCI, V106, P232, DOI 10.1016/j.anireprosci.2007.04.015; Winrow CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005161; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu J, 2008, ADV GENET, V60, P603, DOI 10.1016/S0065-2660(07)00421-X; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	43	39	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11637	10.1371/journal.pone.0011637	http://dx.doi.org/10.1371/journal.pone.0011637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661288	Green Published, gold, Green Submitted			2022-12-27	WOS:000279980800021
J	Grantham, HS; Pressey, RL; Wells, JA; Beattie, AJ				Grantham, Hedley S.; Pressey, Robert L.; Wells, Jessie A.; Beattie, Andrew J.			Effectiveness of Biodiversity Surrogates for Conservation Planning: Different Measures of Effectiveness Generate a Kaleidoscope of Variation	PLOS ONE			English	Article							NEW-SOUTH-WALES; ENVIRONMENTAL CLUSTER-ANALYSIS; CAPE FLORISTIC REGION; RESERVE SELECTION; SPATIAL PATTERN; SPECIES DISTRIBUTIONS; PLANT-COMMUNITIES; INDICATOR GROUPS; PROTECTED AREAS; VULNERABILITY	Conservation planners represent many aspects of biodiversity by using surrogates with spatial distributions readily observed or quantified, but tests of their effectiveness have produced varied and conflicting results. We identified four factors likely to have a strong influence on the apparent effectiveness of surrogates: (1) the choice of surrogate; (2) differences among study regions, which might be large and unquantified (3) the test method, that is, how effectiveness is quantified, and (4) the test features that the surrogates are intended to represent. Analysis of an unusually rich dataset enabled us, for the first time, to disentangle these factors and to compare their individual and interacting influences. Using two data-rich regions, we estimated effectiveness using five alternative methods: two forms of incidental representation, two forms of species accumulation index and irreplaceability correlation, to assess the performance of 'forest ecosystems' and 'environmental units' as surrogates for six groups of threatened species-the test features-mammals, birds, reptiles, frogs, plants and all of these combined. Four methods tested the effectiveness of the surrogates by selecting areas for conservation of the surrogates then estimating how effective those areas were at representing test features. One method measured the spatial match between conservation priorities for surrogates and test features. For methods that selected conservation areas, we measured effectiveness using two analytical approaches: (1) when representation targets for the surrogates were achieved (incidental representation), or (2) progressively as areas were selected (species accumulation index). We estimated the spatial correlation of conservation priorities using an index known as summed irreplaceability. In general, the effectiveness of surrogates for our taxa (mostly threatened species) was low, although environmental units tended to be more effective than forest ecosystems. The surrogates were most effective for plants and mammals and least effective for frogs and reptiles. The five testing methods differed in their rankings of effectiveness of the two surrogates in relation to different groups of test features. There were differences between study areas in terms of the effectiveness of surrogates for different test feature groups. Overall, the effectiveness of the surrogates was sensitive to all four factors. This indicates the need for caution in generalizing surrogacy tests.	[Grantham, Hedley S.; Pressey, Robert L.; Wells, Jessie A.] Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia; [Grantham, Hedley S.; Beattie, Andrew J.] Macquarie Univ, Key Ctr Biodivers & Bioresources, Sydney, NSW 2109, Australia	University of Queensland; Macquarie University	Grantham, HS (corresponding author), Univ Queensland, Ctr Ecol, St Lucia, Qld, Australia.	h.grantham@uq.edu.au	Wells, Jessie A/F-7318-2010; Pressey, Bob/C-8370-2013	Wells, Jessie A/0000-0002-3555-5108; Pressey, Bob/0000-0003-2740-0330	Australia Research Council	Australia Research Council(Australian Research Council)	Funding was provided by the Australia Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2001, ECOGRAPHY, V24, P103, DOI 10.1034/j.1600-0587.2001.240112.x; Bonn A, 2005, BIODIVERS CONSERV, V14, P1083, DOI 10.1007/s10531-004-8410-6; Brooks T, 2004, CONSERV BIOL, V18, P1682, DOI 10.1111/j.1523-1739.2004.00457.x; Brooks TM, 2004, CONSERV BIOL, V18, P616, DOI 10.1111/j.1523-1739.2004.01836.x; BURBIDGE AA, 1991, NATURE CONSERVATION, P3; Burgman MA, 2001, CONSERV BIOL, V15, P603, DOI 10.1046/j.1523-1739.2001.015003603.x; Cardillo M, 1999, LANDSCAPE ECOL, V14, P423, DOI 10.1023/A:1008088224783; Carmel Y, 2006, ISR J ECOL EVOL, V52, P11, DOI 10.1560/IJEE.52.1.11; Cowling RM, 2004, CONSERV BIOL, V18, P1674, DOI 10.1111/j.1523-1739.2004.00296.x; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Cowling RM, 2003, BIOL CONSERV, V112, P147, DOI 10.1016/S0006-3207(02)00397-X; Dangerfield JM, 2003, AUSTRAL ECOL, V28, P227, DOI 10.1046/j.1442-9993.2003.01240.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; *ENV AUSTR, 1999, RESP DIST FOR SPEC U; Faith DP, 1996, BIODIVERS CONSERV, V5, P399, DOI 10.1007/BF00056387; Favreau JM, 2006, BIODIVERS CONSERV, V15, P3949, DOI 10.1007/s10531-005-2631-1; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2309, DOI 10.1023/A:1021374009951; Ferrier S, 2002, BIODIVERS CONSERV, V11, P2275, DOI 10.1023/A:1021302930424; Ferrier S, 2002, SYST BIOL, V51, P331, DOI 10.1080/10635150252899806; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Ferrier S, 1997, EVALUATION EFFECTIVE; FERRIER S, 1999, CONSERVATION BIODIVE, P68; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Forestry Commission of NSW, 1989, 17 FOR COMM NSW; GARSON J, 2002, J BIOSCIENCE, V27; Grantham HS, 2008, CONSERV LETT, V1, P190, DOI 10.1111/j.1755-263X.2008.00029.x; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Hess GR, 2006, BIOL CONSERV, V132, P448, DOI 10.1016/j.biocon.2006.04.037; Hopkinson P, 2001, BIODIVERS CONSERV, V10, P271, DOI 10.1023/A:1008959829585; Joint ANZECC/MCFFA National Forest Policy Statement Implementation Sub-committee, 1997, NAT AGR CRIT EST COM; KIRKPATRICK JB, 1994, CONSERV BIOL, V8, P217, DOI 10.1046/j.1523-1739.1994.08010217.x; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; LAPIN M, 1995, CONSERV BIOL, V9, P1148, DOI 10.1046/j.1523-1739.1995.9051134.x-i1; Lawler JJ, 2003, ECOL APPL, V13, P1762, DOI 10.1890/02-5337; Lawler JJ, 2003, CONSERV BIOL, V17, P875, DOI 10.1046/j.1523-1739.2003.01638.x; Leathwick JR, 2003, CONSERV BIOL, V17, P1612, DOI 10.1111/j.1523-1739.2003.00469.x; LECHMEREOERTEL RG, 2000, J VEG SCI, V12, P75; Lombard AT, 1995, S AFR J ZOOL, V30, P145; Lombard AT, 2003, BIOL CONSERV, V112, P45, DOI 10.1016/S0006-3207(02)00422-6; LOVELL S, 2002, BIOL CONSERV, V139, P113; Mac Nally R, 2002, ECOL APPL, V12, P900, DOI 10.1890/1051-0761(2002)012[0900:HWDEBP]2.0.CO;2; Manly BFJ, 1997, RANDOMIZATION BOOTST; Manne LL, 2003, ANIM CONSERV, V6, P291, DOI 10.1017/S1367943003003354; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Moritz C, 2001, P ROY SOC B-BIOL SCI, V268, P1875, DOI 10.1098/rspb.2001.1713; Newell D., 2004, CONSERVATION AUSTR F; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Noss RF, 2004, NAT AREA J, V24, P223; NOSS RF, 1987, BIOL CONSERV, V41, P11, DOI 10.1016/0006-3207(87)90045-0; *NSW NAT PARKS WIL, 1999, DER FOR EC EV SURR V; Oliver I, 2004, ECOL APPL, V14, P485, DOI 10.1890/02-5181; Pharo EJ, 2001, AUST J BOT, V49, P23, DOI 10.1071/BT99063; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Pressey R. L., 2009, SPATIAL CONSERVATION, P211; Pressey RL, 1996, FOREST ECOL MANAG, V85, P311, DOI 10.1016/S0378-1127(96)03766-8; Pressey RL, 2004, CONSERV BIOL, V18, P1677, DOI 10.1111/j.1523-1739.2004.00434.x; Pressey RL, 2002, BIOL CONSERV, V106, P57, DOI 10.1016/S0006-3207(01)00229-4; Pressey RL, 1998, ECOLOGY FOR EVERYONE, P73; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Reyers B, 2000, S AFR J SCI, V96, P406; Reyers B, 2002, AFR ZOOL, V37, P185; Rodrigues ASL, 2007, NATURE, V450, pE19, DOI 10.1038/nature06374; RODRIGUES ASL, 2007, ANN REV ECOLOGY EVOL, V38; Rondinini C, 2006, ECOL LETT, V9, P1136, DOI 10.1111/j.1461-0248.2006.00970.x; Sarkar S, 2005, CONSERV BIOL, V19, P815, DOI 10.1111/j.1523-1739.2005.00236.x; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Snelder TH, 2007, CONSERV BIOL, V21, P365, DOI 10.1111/j.1523-1739.2006.00632.x; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Su JC, 2004, CONSERV BIOL, V18, P167, DOI 10.1111/j.1523-1739.2004.00337.x; Trakhtenbrot A, 2005, ECOL APPL, V15, P335, DOI 10.1890/04-0077; Trakhtenbrot A, 2006, CONSERV BIOL, V20, P1087, DOI 10.1111/j.1523-1739.2006.00500.x; Warman LD, 2004, ECOL LETT, V7, P374, DOI 10.1111/j.1461-0248.2004.00590.x; Warman LD, 2004, CONSERV BIOL, V18, P655, DOI 10.1111/j.1523-1739.2004.00538.x; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5; Williams JC, 2005, ENVIRON MODEL ASSESS, V10, P163, DOI 10.1007/s10666-005-9007-5; Williams P, 2006, BIOL CONSERV, V128, P253, DOI 10.1016/j.biocon.2005.09.047	76	113	114	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11430	10.1371/journal.pone.0011430	http://dx.doi.org/10.1371/journal.pone.0011430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644726	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000279884900003
J	Langlois, B; Perrot, G; Schneider, C; Henriet, P; Emonard, H; Martiny, L; Dedieu, S				Langlois, Benoit; Perrot, Gwenn; Schneider, Christophe; Henriet, Patrick; Emonard, Herve; Martiny, Laurent; Dedieu, Stephane			LRP-1 Promotes Cancer Cell Invasion by Supporting ERK and Inhibiting JNK Signaling Pathways	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; DEPENDENT PATHWAY; SCAFFOLD PROTEINS; MIGRATION; KINASE; GROWTH; PHOSPHORYLATION; EXPRESSION; ADHESION	Background: The low-density lipoprotein receptor-related protein-1 (LRP-1) is an endocytic receptor mediating the clearance of various extracellular molecules involved in the dissemination of cancer cells. LRP-1 thus appeared as an attractive receptor for targeting the invasive behavior of malignant cells. However, recent results suggest that LRP-1 may facilitate the development and growth of cancer metastases in vivo, but the precise contribution of the receptor during cancer progression remains to be elucidated. The lack of mechanistic insights into the intracellular signaling networks downstream of LRP-1 has prevented the understanding of its contribution towards cancer. Methodology/Principal Findings: Through a short-hairpin RNA-mediated silencing approach, we identified LRP-1 as a main regulator of ERK and JNK signaling in a tumor cell context. Co-immunoprecipitation experiments revealed that LRP-1 constitutes an intracellular docking site for MAPK containing complexes. By using pharmacological agents, constitutively active and dominant-negative kinases, we demonstrated that LRP-1 maintains malignant cells in an adhesive state that is favorable for invasion by activating ERK and inhibiting JNK. We further demonstrated that the LRP-1-dependent regulation of MAPK signaling organizes the cytoskeletal architecture and mediates adhesive complex turnover in cancer cells. Moreover, we found that LRP-1 is tethered to the actin network and to focal adhesion sites and controls ERK and JNK targeting to talin-rich structures. Conclusions: We identified ERK and JNK as the main molecular relays by which LRP-1 regulates focal adhesion disassembly of malignant cells to support invasion.	[Langlois, Benoit; Perrot, Gwenn; Schneider, Christophe; Emonard, Herve; Martiny, Laurent; Dedieu, Stephane] Univ Reims, Lab SiRMa, CNRS, UMR 6237,MEDyC, Reims, France; [Henriet, Patrick] Duve Inst, Cell Biol Unit, Brussels, Belgium; [Henriet, Patrick] Catholic Univ Louvain, B-1200 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); Universite de Reims Champagne-Ardenne; Universite Catholique Louvain	Langlois, B (corresponding author), Univ Reims, Lab SiRMa, CNRS, UMR 6237,MEDyC, Campus Moulin Housse, Reims, France.	stephane.dedieu@univ-reims.fr	Emonard, Hervé/AAD-5432-2019; Emonard, Herve/R-9718-2019; MARTINY, Laurent/ABI-5531-2020	Dedieu, Stephane/0000-0003-1447-5640; Henriet, Patrick/0000-0003-4602-8888; SCHNEIDER, Christophe/0000-0002-7867-0579	Centre National de la Recherche Scientifique (CNRS); La Ligue Nationale Contre le Cancer (Comite de la Marne); CPER (Contrat de Projets Etat-Region); Fonds National pour la Sante ACI (Action Concertee Incitative)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); La Ligue Nationale Contre le Cancer (Comite de la Marne); CPER (Contrat de Projets Etat-Region); Fonds National pour la Sante ACI (Action Concertee Incitative)	This work was supported by grants from Centre National de la Recherche Scientifique (CNRS), La Ligue Nationale Contre le Cancer (Comite de la Marne), CPER (Contrat de Projets Etat-Region) 2007-2013 and Fonds National pour la Sante ACI (Action Concertee Incitative) 2008 (Canceropole Grand-Est Project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmina OY, 1999, J BIOL CHEM, V274, P30087, DOI 10.1074/jbc.274.42.30087; Barnes H, 2001, J BIOL CHEM, V276, P19119, DOI 10.1074/jbc.M011437200; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Betts GN, 2008, J BIOL CHEM, V283, P15656, DOI 10.1074/jbc.M709514200; Boucher P, 2004, TRENDS CARDIOVAS MED, V14, P55, DOI 10.1016/j.tcm.2003.12.001; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Chazaud B, 2002, AM J PATHOL, V160, P237, DOI 10.1016/S0002-9440(10)64367-2; Chen S, 2007, J CELL SCI, V120, P4009, DOI 10.1242/jcs.013946; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Dedieu S, 2006, CELL SIGNAL, V18, P889, DOI 10.1016/j.cellsig.2005.08.001; Dedieu S, 2008, MOL CELL BIOL, V28, P2980, DOI 10.1128/MCB.02238-07; Dedieu S, 2008, CELL ADHES MIGR, V2, P77, DOI 10.4161/cam.2.2.6374; Degryse B, 2004, J BIOL CHEM, V279, P22595, DOI 10.1074/jbc.M313004200; Desrosiers RR, 2006, PEDIATR BLOOD CANCER, V46, P40, DOI 10.1002/pbc.20566; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Emonard H, 2005, BIOCHIMIE, V87, P369, DOI 10.1016/j.biochi.2004.11.013; Emonard H, 2004, J BIOL CHEM, V279, P54944, DOI 10.1074/jbc.M406792200; Fayard B, 2009, CANCER RES, V69, P5690, DOI 10.1158/0008-5472.CAN-08-4573; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gaultier A, 2006, J BIOL CHEM, V281, P7332, DOI 10.1074/jbc.M511857200; Goretzki P E, 1990, Recent Results Cancer Res, V118, P48; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guttman M, 2009, PROTEOMICS, V9, P5016, DOI 10.1002/pmic.200900457; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang SS, 2004, FASEB J, V18, P1719, DOI 10.1096/fj.04-1872fje; Huang SS, 2003, FASEB J, V17, P2068, DOI 10.1096/fj.03-0256com; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; KANCHA RK, 1994, ONCOL RES, V6, P365; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Langlois B, 2009, PATHOL BIOL, V57, P548, DOI 10.1016/j.patbio.2008.07.015; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Lutz C, 2002, J BIOL CHEM, V277, P43143, DOI 10.1074/jbc.M204426200; Ma Z, 2002, J CELL BIOL, V159, P1061, DOI 10.1083/jcb.200207070; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mang GQ, 2004, J AM SOC NEPHROL, V15, P2090, DOI 10.1097/01.ASN.0000135057; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; McFarland BC, 2009, CANCER RES, V69, P5537, DOI 10.1158/0008-5472.CAN-08-4841; Montel V, 2007, CANCER RES, V67, P9817, DOI 10.1158/0008-5472.CAN-07-0683; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Orr AW, 2004, J BIOL CHEM, V279, P48983, DOI 10.1074/jbc.M404881200; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Pocivavsek A, 2009, J NEUROIMMUNOL, V214, P25, DOI 10.1016/j.jneuroim.2009.06.010; Pullikuth AK, 2007, CELL SIGNAL, V19, P1621, DOI 10.1016/j.cellsig.2007.04.012; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Sid B, 2008, INT J BIOCHEM CELL B, V40, P1890, DOI 10.1016/j.biocel.2008.01.023; Sid B, 2006, INT J BIOCHEM CELL B, V38, P1729, DOI 10.1016/j.biocel.2006.04.005; Smadja-Lamere N, 2008, J BIOL CHEM, V283, P34352, DOI 10.1074/jbc.M803364200; Song H, 2009, CANCER RES, V69, P879, DOI 10.1158/0008-5472.CAN-08-3379; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Takayama Y, 2003, J BIOL CHEM, V278, P22112, DOI 10.1074/jbc.M300894200; van der Geer P, 2002, TRENDS CARDIOVAS MED, V12, P160, DOI 10.1016/S1050-1738(02)00154-8; Webb DJ, 2000, J CELL SCI, V113, P123; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828, DOI 10.1042/BST0340828; Zemskov EA, 2007, J CELL SCI, V120, P3188, DOI 10.1242/jcs.010397; Zhang H, 2008, BIOCHEM J, V409, P53, DOI 10.1042/BJ20071127; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	67	65	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11584	10.1371/journal.pone.0011584	http://dx.doi.org/10.1371/journal.pone.0011584			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644732	Green Submitted, Green Published, gold			2022-12-27	WOS:000279884900020
J	Li, L; Tasic, B; Micheva, KD; Ivanov, VM; Spletter, ML; Smith, SJ; Luo, LQ				Li, Ling; Tasic, Bosiljka; Micheva, Kristina D.; Ivanov, Vsevolod M.; Spletter, Maria L.; Smith, Stephen J.; Luo, Liqun			Visualizing the Distribution of Synapses from Individual Neurons in the Mouse Brain	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CEREBELLAR CORTICAL CIRCUITRY; CULTURED HIPPOCAMPAL-NEURONS; PARALLEL FIBER SYNAPSES; 2 DISTINCT MECHANISMS; LONG-TERM DEPRESSION; EMBRYONIC STEM-CELLS; SYNAPTIC VESICLE; PURKINJE-CELLS; MEMBRANE-PROTEINS	Background: Proper function of the mammalian brain relies on the establishment of highly specific synaptic connections among billions of neurons. To understand how complex neural circuits function, it is crucial to precisely describe neuronal connectivity and the distributions of synapses to and from individual neurons. Methods and Findings: In this study, we present a new genetic synaptic labeling method that relies on expression of a presynaptic marker, synaptophysin-GFP (Syp-GFP) in individual neurons in vivo. We assess the reliability of this method and use it to analyze the spatial patterning of synapses in developing and mature cerebellar granule cells (GCs). In immature GCs, Syp-GFP is distributed in both axonal and dendritic regions. Upon maturation, it becomes strongly enriched in axons. In mature GCs, we analyzed synapses along their ascending segments and parallel fibers. We observe no differences in presynaptic distribution between GCs born at different developmental time points and thus having varied depths of projections in the molecular layer. We found that the mean densities of synapses along the parallel fiber and the ascending segment above the Purkinje cell (PC) layer are statistically indistinguishable, and higher than previous estimates. Interestingly, presynaptic terminals were also found in the ascending segments of GCs below and within the PC layer, with the mean densities two-fold lower than that above the PC layer. The difference in the density of synapses in these parts of the ascending segment likely reflects the regional differences in postsynaptic target cells of GCs. Conclusions: The ability to visualize synapses of single neurons in vivo is valuable for studying synaptogenesis and synaptic plasticity within individual neurons as well as information flow in neural circuits.	[Li, Ling; Tasic, Bosiljka; Ivanov, Vsevolod M.; Spletter, Maria L.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA; [Micheva, Kristina D.; Smith, Stephen J.] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ivanov, Vsevolod M.] Lynbrook High Sch, San Jose, CA USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Li, L (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA.	lluo@stanford.edu	Micheva, Kristina/ABH-6913-2020; Spletter, Maria Lynn/T-5917-2018; Li, Ling/A-2008-2010	Micheva, Kristina/0000-0003-1138-3732; Spletter, Maria Lynn/0000-0002-2068-3350; Smith, Stephen/0000-0002-2290-8701; Luo, Liqun/0000-0001-5467-9264	NIH [R01-NS050835]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC008277] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by an NIH grant (R01-NS050835). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Bower JM, 2002, ANN NY ACAD SCI, V978, P135, DOI 10.1111/j.1749-6632.2002.tb07562.x; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Eccles JC, 1967, CEREBELLUM NEURONAL; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Gallia GL, 1998, ONCOGENE, V16, P1879, DOI 10.1038/sj.onc.1201706; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; HARVEY RJ, 1988, J COMP NEUROL, V274, P151, DOI 10.1002/cne.902740202; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Huang CM, 2006, NEUROBIOL AGING, V27, P1715, DOI 10.1016/j.neurobiolaging.2005.09.025; Huang CM, 2006, EUR J NEUROSCI, V23, P1731, DOI 10.1111/j.1460-9568.2006.04690.x; Imayoshi I, 2006, GENESIS, V44, P233, DOI 10.1002/dvg.20212; Isope P, 2002, J NEUROSCI, V22, P9668; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Joyner AL, 2000, GENE TARGETING PRACT; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kelsch W, 2008, P NATL ACAD SCI USA, V105, P16803, DOI 10.1073/pnas.0807970105; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Lu H, 2009, J COMP NEUROL, V514, P583, DOI 10.1002/cne.22041; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakata T, 1998, J CELL BIOL, V140, P659, DOI 10.1083/jcb.140.3.659; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; PICHITPORNCHAI C, 1994, J COMP NEUROL, V342, P206, DOI 10.1002/cne.903420205; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Walter JT, 2009, J NEUROSCI, V29, P8462, DOI 10.1523/JNEUROSCI.5718-08.2009; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zeng HK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000069; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	71	69	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11503	10.1371/journal.pone.0011503	http://dx.doi.org/10.1371/journal.pone.0011503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634890	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300014
J	Norder, M; Becker, PD; Drexler, I; Link, C; Erfle, V; Guzman, CA				Noerder, Miriam; Becker, Pablo D.; Drexler, Ingo; Link, Claudia; Erfle, Volker; Guzman, Carlos A.			Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; MOUSE BONE-MARROW; RECOMBINANT VIRUSES; IN-VIVO; PLASMA-CELLS; STRAIN MVA; HOST-RANGE; VACCINATION; RESPONSES; IMMUNOGENICITY	Background: Modified vaccinia virus Ankara (MVA), a highly attenuated strain of vaccinia virus, has been used as vaccine delivery vector in preclinical and clinical studies against infectious diseases and malignancies. Here, we investigated whether an MVA which does not encode any antigen (Ag) could be exploited as adjuvant per se. Methodology/Principal Findings: We showed that dendritic cells infected in vitro with non-recombinant (nr) MVA expressed maturation and activation markers and were able to efficiently present exogenously pulsed Ag to T cells. In contrast to the dominant T helper (Th) 1 biased responses elicited against Ags produced by recombinant MVA vectors, the use of nrMVA as adjuvant for the co-administered soluble Ags resulted in a long lasting mixed Th1/Th2 responses. Conclusions/Significance: These findings open new ways to potentiate and modulate the immune responses to vaccine Ags depending on whether they are co-administered with MVA or encoded by recombinant viruses.	[Noerder, Miriam; Becker, Pablo D.; Link, Claudia; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Drexler, Ingo; Erfle, Volker] Helmholtz Ctr Munich, Munich, Germany; [Drexler, Ingo; Erfle, Volker] Tech Univ Munich, Inst Virol, Munich, Germany; [Erfle, Volker] Tech Univ Munich, Clin Cooperat Grp Antigen Specif Immunomodulat, Munich, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich	Norder, M (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	carlos.guzman@helmholtz-hzi.de		Becker, Pablo Daniel/0000-0003-1980-1230	German Research Foundation [SFB456 TP B7]	German Research Foundation(German Research Foundation (DFG))	This study was in part supported by grants from the German Research Foundation to I.D. (SFB456 TP B7) and C.A.G. (Cluster of Excellence REBIRTH; From Regenerative Biology to Reconstructive Therapy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Becker PD, 2007, CLIN VACCINE IMMUNOL, V14, P538, DOI 10.1128/CVI.00316-06; Behboudi S, 2004, VACCINE, V22, P4326, DOI 10.1016/j.vaccine.2004.04.029; Bejon P, 2006, VACCINE, V24, P4709, DOI 10.1016/j.vaccine.2006.03.029; Blanchard TJ, 1998, J GEN VIROL, V79, P1159, DOI 10.1099/0022-1317-79-5-1159; Brimnes MK, 2003, J EXP MED, V198, P133, DOI 10.1084/jem.20030266; Burgers WA, 2008, AIDS RES HUM RETROV, V24, P195, DOI 10.1089/aid.2007.0205; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; CATIPOVIC B, 1992, J EXP MED, V176, P1611, DOI 10.1084/jem.176.6.1611; Chahroudi A, 2006, J VIROL, V80, P8469, DOI 10.1128/JVI.02749-05; Clarke SRM, 2000, IMMUNOL CELL BIOL, V78, P110, DOI 10.1046/j.1440-1711.2000.00889.x; Dorrell L, 2007, VACCINE, V25, P3277, DOI 10.1016/j.vaccine.2007.01.005; Dorrell L, 2006, J VIROL, V80, P4705, DOI 10.1128/JVI.80.10.4705-4716.2006; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Drillien R, 2004, J GEN VIROL, V85, P2167, DOI 10.1099/vir.0.79998-0; Engelmayer J, 1999, J IMMUNOL, V163, P6762; Gasteiger G, 2007, J VIROL, V81, P11925, DOI 10.1128/JVI.00903-07; Humrich JY, 2007, EUR J IMMUNOL, V37, P954, DOI 10.1002/eji.200636230; Hutchings CL, 2005, J IMMUNOL, V175, P599, DOI 10.4049/jimmunol.175.1.599; Hutchings CL, 2007, INFECT IMMUN, V75, P5819, DOI 10.1128/IAI.00828-07; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Kastenmuller W, 2007, J EXP MED, V204, P2187, DOI 10.1084/jem.20070489; Kastenmuller W, 2006, VIROLOGY, V350, P276, DOI 10.1016/j.virol.2006.02.039; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; LIPFORD GB, 1993, J IMMUNOL, V150, P1212; Liu L, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-15; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Meyer RG, 2005, CANCER IMMUNOL IMMUN, V54, P453, DOI 10.1007/s00262-004-0616-7; Molinier-Frenkel V, 2002, J VIROL, V76, P127, DOI 10.1128/JVI.76.1.127-135.2002; Moorthy VS, 2003, J INFECT DIS, V188, P1239, DOI 10.1086/378515; Moser K, 2006, CURR OPIN IMMUNOL, V18, P265, DOI 10.1016/j.coi.2006.03.004; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rocha CD, 2004, INT MICROBIOL, V7, P83; Rock KL, 2005, SPRINGER SEMIN IMMUN, V26, P231, DOI 10.1007/s00281-004-0173-3; Samuelsson C, 2008, J CLIN INVEST, V118, P1776, DOI 10.1172/JCI33940; Schirrmacher V, 2003, TRENDS MOL MED, V9, P526, DOI 10.1016/j.molmed.2003.10.001; Shortman K, 2000, IMMUNOL CELL BIOL, V78, P161, DOI 10.1046/j.1440-1711.2000.00901.x; Slifka Mark K, 2005, Med Immunol, V4, P2, DOI 10.1186/1476-9433-4-2; Souza APD, 2005, BRAZ J MED BIOL RES, V38, P509, DOI 10.1590/S0100-879X2005000400004; Staib C, 2003, BIOTECHNIQUES, V34, P694, DOI 10.2144/03344bm02; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Webster DP, 2006, VACCINE, V24, P3026, DOI 10.1016/j.vaccine.2005.10.058	49	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11400	10.1371/journal.pone.0011400	http://dx.doi.org/10.1371/journal.pone.0011400			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20628596	Green Submitted, gold, Green Published			2022-12-27	WOS:000279370000025
J	Bai, XD; Zhang, W; Orantes, L; Jun, TH; Mittapalli, O; Mian, MAR; Michel, AP				Bai, Xiaodong; Zhang, Wei; Orantes, Lucia; Jun, Tae-Hwan; Mittapalli, Omprakash; Mian, M. A. Rouf; Michel, Andrew P.			Combining Next-Generation Sequencing Strategies for Rapid Molecular Resource Development from an Invasive Aphid Species, Aphis glycines	PLOS ONE			English	Article							PEA APHID; SOYBEAN APHID; ACYRTHOSIPHON-PISUM; ANTIOXIDANT DEFENSE; HORIZONTAL TRANSFER; BACTERIAL SYMBIONT; GENETIC-STRUCTURE; GENOME EVOLUTION; MYZUS-PERSICAE; RESISTANCE	Background: Aphids are one of the most important insect taxa in terms of ecology, evolutionary biology, genetics and genomics, and interactions with endosymbionts. Additionally, many aphids are serious pest species of agricultural and horticultural plants. Recent genetic and genomic research has expanded molecular resources for many aphid species, including the whole genome sequencing of the pea aphid, Acrythosiphon pisum. However, the invasive soybean aphid, Aphis glycines, lacks in any significant molecular resources. Methodology/Principal Findings: Two next-generation sequencing technologies (Roche-454 and Illumina GA-II) were used in a combined approach to develop both transcriptomic and genomic resources, including expressed genes and molecular markers. Over 278 million bp were sequenced among the two methods, resulting in 19,293 transcripts and 56,688 genomic sequences. From this data set, 635 SNPs and 1,382 microsatellite markers were identified. For each sequencing method, different soybean aphid biotypes were used which revealed potential biotype specific markers. In addition, we uncovered 39,822 bp of sequence that were related to the obligatory endosymbiont, Buchnera aphidicola, as well as sequences that suggest the presence of Hamiltonella defensa, a facultative endosymbiont. Conclusions and Significance: Molecular resources for an invasive, non-model aphid species were generated. Additionally, the power of next-generation sequencing to uncover endosymbionts was demonstrated. The resources presented here will complement ongoing molecular studies within the Aphididae, including the pea aphid whole genome, lead to better understanding of aphid adaptation and evolution, and help provide novel targets for soybean aphid control.	[Bai, Xiaodong; Zhang, Wei; Orantes, Lucia; Jun, Tae-Hwan; Mittapalli, Omprakash; Michel, Andrew P.] Ohio State Univ, Dept Entomol, Ohio Agr Res & Dev Ctr, Columbus, OH 43210 USA; [Jun, Tae-Hwan; Mian, M. A. Rouf] ARS, USDA, Columbus, OH USA; [Jun, Tae-Hwan; Mian, M. A. Rouf] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; United States Department of Agriculture (USDA); University System of Ohio; Ohio State University	Bai, XD (corresponding author), Ohio State Univ, Dept Entomol, Ohio Agr Res & Dev Ctr, 1735 Neil Ave, Columbus, OH 43210 USA.	michel.70@osu.edu	Michel, Andrew P./B-5329-2012		Ohio Soybean Council [OSC 10-2-03, OSC 08-2-08]; USDA-ARS, Ohio Plant Biotechnology Consortium; The Ohio State University; The Ohio Agricultural Research and Development Center	Ohio Soybean Council; USDA-ARS, Ohio Plant Biotechnology Consortium(United States Department of Agriculture (USDA)USDA Agricultural Research Service); The Ohio State University(Ohio State University); The Ohio Agricultural Research and Development Center	Funding for this project was obtained through the Ohio Soybean Council (www.soyohio.org), #OSC 10-2-03 and #OSC 08-2-08, USDA-ARS, Ohio Plant Biotechnology Consortium and The Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD S, 1990, PHOTOCHEM PHOTOBIOL, V51, P305, DOI 10.1111/j.1751-1097.1990.tb01715.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blackman R.L., 2000, J ECON ENTOMOL, V2; Blackman RL, 2007, APHIDS AS CROP PESTS, P1, DOI 10.1079/9780851998190.0001; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Degnan PH, 2009, P NATL ACAD SCI USA, V106, P9063, DOI 10.1073/pnas.0900194106; Dixon AF G, 1998, APHID ECOLOGY; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Figueroa CC, 2007, INSECT SCI, V14, P29, DOI 10.1111/j.1744-7917.2007.00123.x; FINSTON TL, 1995, INSECT BIOCHEM MOLEC, V25, P189, DOI 10.1016/0965-1748(94)00050-R; Francis F, 2010, J INSECT PHYSIOL, V56, P575, DOI 10.1016/j.jinsphys.2009.12.001; Funk DJ, 2001, GENETICS, V157, P477; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; GREGORY TR, 2006, ANIMAL GENOME SIZE D; Hales DF, 1997, EUR J ENTOMOL, V94, P1; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Haynes S, 2003, APPL ENVIRON MICROB, V69, P7216, DOI 10.1128/AEM.69.12.7216-7223.2003; Hill CB, 2004, J ECON ENTOMOL, V97, P1071, DOI 10.1603/0022-0493(2004)097[1071:ROGSAV]2.0.CO;2; Hill CB, 2006, CROP SCI, V46, P1601, DOI 10.2135/cropsci2005.11-0421; Hill CB, 2006, CROP SCI, V46, P1606, DOI 10.2135/cropsci2005.11-0438; Huerta-Cepas J, 2010, INSECT MOL BIOL, V19, P13, DOI 10.1111/j.1365-2583.2009.00947.x; Hunter WB, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.9; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Iannone MA, 2000, CYTOMETRY, V39, P131, DOI 10.1002/(SICI)1097-0320(20000201)39:2<131::AID-CYTO6>3.3.CO;2-L; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Lee SH, 2004, THEOR APPL GENET, V110, P167, DOI 10.1007/s00122-004-1827-1; Legeai F, 2010, INSECT MOL BIOL, V19, P5, DOI 10.1111/j.1365-2583.2009.00930.x; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; Mian MAR, 2008, CROP SCI, V48, P1055, DOI 10.2135/cropsci2007.06.0357; Michel AP, 2009, ENVIRON ENTOMOL, V38, P1301, DOI 10.1603/022.038.0442; Mittapalli O, 2007, P NATL ACAD SCI USA, V104, P1889, DOI 10.1073/pnas.0604722104; Moran NA, 2005, P NATL ACAD SCI USA, V102, P16919, DOI 10.1073/pnas.0507029102; Moran NA, 1999, SYST ENTOMOL, V24, P85, DOI 10.1046/j.1365-3113.1999.00076.x; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; MORAN NA, 1992, EVOLUTION APHID LIFE, P321; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Ollivier M, 2010, INSECT MOL BIOL, V19, P33, DOI 10.1111/j.1365-2583.2009.00976.x; Osada M, 2003, INT CONGR SER, V1239, P17, DOI 10.1016/S0531-5131(02)00504-6; OSTLIE K, 2001, SOYBEAN APHID REDUCE; Peccoud J, 2008, MOL ECOL, V17, P4608, DOI 10.1111/j.1365-294X.2008.03949.x; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P16315, DOI 10.1073/pnas.0905129106; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Ramsey JS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-423; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sabater-Munoz B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r21; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tagu D, 2004, INSECT BIOCHEM MOLEC, V34, P809, DOI 10.1016/j.ibmb.2004.05.001; Tagu D, 2008, MOL PLANT MICROBE IN, V21, P701, DOI 10.1094/MPMI-21-6-0701; Tamas I, 2002, SCIENCE, V296, P2376, DOI 10.1126/science.1071278; THURSTON MI, 2005, MSATLINDER DETECTION; van Emden H, 2007, APHIDS AS CROP PESTS, pXXI; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; VIA S, 1991, EVOLUTION, V45, P827, DOI 10.1111/j.1558-5646.1991.tb04353.x; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2; Wang X. B., 1994, Plant Protection, V20, P12; Wilcox JL, 2003, MOL MICROBIOL, V48, P1491, DOI 10.1046/j.1365-2958.2003.03522.x; Wille BD, 2009, ENVIRON ENTOMOL, V38, P110, DOI 10.1603/022.038.0113; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Wilson ACC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-50; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GR, 2009, THEOR APPL GENET, V118, P473, DOI 10.1007/s00122-008-0914-0; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004	81	59	71	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11370	10.1371/journal.pone.0011370	http://dx.doi.org/10.1371/journal.pone.0011370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614011	gold, Green Published, Green Submitted			2022-12-27	WOS:000279369900018
J	Kelly, HA; Mercer, GN; Fielding, JE; Dowse, GK; Glass, K; Carcione, D; Grant, KA; Effler, PV; Lester, RA				Kelly, Heath A.; Mercer, Geoff N.; Fielding, James E.; Dowse, Gary K.; Glass, Kathryn; Carcione, Dale; Grant, Kristina A.; Effler, Paul V.; Lester, Rosemary A.			Pandemic (H1N1) 2009 Influenza Community Transmission Was Established in One Australian State When the Virus Was First Identified in North America	PLOS ONE			English	Article							A H1N1; REPRODUCTION NUMBER	Background: In mid-June 2009 the State of Victoria in Australia appeared to have the highest notification rate of pandemic (H1N1) 2009 influenza in the world. We hypothesise that this was because community transmission of pandemic influenza was already well established in Victoria at the time testing for the novel virus commenced. In contrast, this was not true for the pandemic in other parts of Australia, including Western Australia (WA). Methods: We used data from detailed case follow-up of patients with confirmed infection in Victoria and WA to demonstrate the difference in the pandemic curve in two Australian states on opposite sides of the continent. We modelled the pandemic in both states, using a susceptible-infected-removed model with Bayesian inference accounting for imported cases. Results: Epidemic transmission occurred earlier in Victoria and later in WA. Only 5% of the first 100 Victorian cases were not locally acquired and three of these were brothers in one family. By contrast, 53% of the first 102 cases in WA were associated with importation from Victoria. Using plausible model input data, estimation of the effective reproductive number for the Victorian epidemic required us to invoke an earlier date for commencement of transmission to explain the observed data. This was not required in modelling the epidemic in WA. Conclusion: Strong circumstantial evidence, supported by modelling, suggests community transmission of pandemic influenza was well established in Victoria, but not in WA, at the time testing for the novel virus commenced in Australia. The virus is likely to have entered Victoria and already become established around the time it was first identified in the US and Mexico.	[Kelly, Heath A.; Fielding, James E.; Grant, Kristina A.] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Mercer, Geoff N.; Fielding, James E.; Glass, Kathryn] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Fielding, James E.; Lester, Rosemary A.] Dept Hlth, Melbourne, Vic, Australia; [Dowse, Gary K.; Carcione, Dale; Effler, Paul V.] Dept Hlth Western Australia, Perth, WA, Australia	Victorian Infectious Diseases Reference Laboratory; Australian National University	Kelly, HA (corresponding author), Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.	heath.kelly@mh.org.au		Glass, Kathryn/0000-0001-5905-1310; Fielding, James/0000-0003-2995-9576	Victorian Government Department of Health; Victorian Infectious Diseases Reference Laboratory; Government of Western Australia Department of Health; National Centre for Epidemiology and Population Health at The Australian National University through Australian Government National Health and Medical Research Council	Victorian Government Department of Health; Victorian Infectious Diseases Reference Laboratory; Government of Western Australia Department of Health; National Centre for Epidemiology and Population Health at The Australian National University through Australian Government National Health and Medical Research Council	No specific sources of funding supported this study and all work was undertaken and written as part of salaried employment. The Victorian Government Department of Health funded the salaries of authors Fielding and Lester; the Victorian Infectious Diseases Reference Laboratory funded the salaries of authors Kelly, Fielding and Grant; the Government of Western Australia Department of Health funded the salaries of authors Dowse and Carcione and Effler. The National Centre for Epidemiology and Population Health at The Australian National University funded the salaries of authors Mercer and Glass through several Australian Government National Health and Medical Research Council grants; none of these grants were awarded for the specific purposes of undertaking or the writing of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, LANCET, V25; *AUSTR GOV DEP HLT, 2009, 1 CAS HUM SWIN INFL; *AUSTR GOV DEP HLT, 2009, NEW PAND PHAS PROT; *AUSTR GOV DEP HLT, 2009, 1 CAS SWIN FLU WA; *AUSTR GOV DEP HLT, 2009, 11 AUSTR GOV DEP HLT; Australian Government Department of Health and Ageing, 2008, AUSTR HLTH MAN PLAN; Bettencourt LMA, 2007, LECT NOTES COMPUT SC, V4506, P79; Bettencourt LMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002185; Britton T, 2009, MATH BIOSCI, V222, P109, DOI 10.1016/j.mbs.2009.10.001; Chowell G, 2008, PHYS LIFE REV, V5, P50, DOI 10.1016/j.plrev.2007.12.001; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; CIBLAK MA, 2009, EURO SURVEILL, V14; Cohen J, 2009, YET ANOTHER NEW PATI; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Denholm JT, 2010, MED J AUSTRALIA, V192, P84, DOI 10.5694/j.1326-5377.2010.tb03424.x; Fielding JE, 2009, EURO SURVEILL, V14; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gomez J, 2009, EURO SURVEILL, V4; *HLTH PROT AG HLTH, 2009, EURO SURVEILL, V14; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Lester R, 2009, VICTORIAN INFECT DIS, V12, P43; Martin RM, 2009, EUROSURVEILLANCE, V14; McBryde E, 2009, EURO SURVEILL, V14; Mccaw JM, 2007, MATH BIOSCI, V209, P336, DOI 10.1016/j.mbs.2007.02.003; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Munayco C, 2009, EURO SURVEILL, V14; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Novel influenza A(H1N1) investigation team, 2009, EURO SURVEILL, V14, P19295; Pedroni E, 2010, EURO SURVEILL, V15; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; *PROMED MAIL, 2009, INFL A H1N1 WORLDW 4; PYBUS O, 2009, ORIGIN OUTBREAK HA G; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; *VICT INF DIS REF, 2009, 1 VICT INF DIS REF L; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Watts CG, 2003, AUST NZ J PUBL HEAL, V27, P409, DOI 10.1111/j.1467-842X.2003.tb00418.x; Wilson N, 2009, EUROSURVEILLANCE, V14; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	42	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11341	10.1371/journal.pone.0011341	http://dx.doi.org/10.1371/journal.pone.0011341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596536	Green Published, Green Submitted, gold			2022-12-27	WOS:000279259900014
J	Sergueev, KV; He, YX; Borschel, RH; Nikolich, MP; Filippov, AA				Sergueev, Kirill V.; He, Yunxiu; Borschel, Richard H.; Nikolich, Mikeljon P.; Filippov, Andrey A.			Rapid and Sensitive Detection of Yersinia pestis Using Amplification of Plague Diagnostic Bacteriophages Monitored by Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; GENOME SEQUENCE; REACTION ASSAY; GAMMA-PHAGE; IDENTIFICATION; HYBRIDIZATION; VALIDATION; RESISTANCE; INFECTION; VIRULENCE	Background: Yersinia pestis, the agent of plague, has caused many millions of human deaths and still poses a serious threat to global public health. Timely and reliable detection of such a dangerous pathogen is of critical importance. Lysis by specific bacteriophages remains an essential method of Y. pestis detection and plague diagnostics. Methodology/Principal Findings: The objective of this work was to develop an alternative to conventional phage lysis tests - a rapid and highly sensitive method of indirect detection of live Y. pestis cells based on quantitative real-time PCR (qPCR) monitoring of amplification of reporter Y. pestis-specific bacteriophages. Plague diagnostic phages phi A1122 and L-413C were shown to be highly effective diagnostic tools for the detection and identification of Y. pestis by using qPCR with primers specific for phage DNA. The template DNA extraction step that usually precedes qPCR was omitted. phi A1122-specific qPCR enabled the detection of an initial bacterial concentration of 10(3) CFU/ml (equivalent to as few as one Y. pestis cell per 1-mu l sample) in four hours. L-413C-mediated detection of Y. pestis was less sensitive (up to 100 bacteria per sample) but more specific, and thus we propose parallel qPCR for the two phages as a rapid and reliable method of Y. pestis identification. Importantly, phi A1122 propagated in simulated clinical blood specimens containing EDTA and its titer rise was detected by both a standard plating test and qPCR. Conclusions/Significance: Thus, we developed a novel assay for detection and identification of Y. pestis using amplification of specific phages monitored by qPCR. The method is simple, rapid, highly sensitive, and specific and allows the detection of only live bacteria.	[Sergueev, Kirill V.; He, Yunxiu; Borschel, Richard H.; Nikolich, Mikeljon P.; Filippov, Andrey A.] Walter Reed Army Inst Res, Dept Emerging Bacterial Infect, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Sergueev, KV (corresponding author), Walter Reed Army Inst Res, Dept Emerging Bacterial Infect, Div Bacterial & Rickettsial Dis, Silver Spring, MD USA.	kirill.sergueev@amedd.army.mil; andrey.filippov@amedd.army.mil	Nikolich, Mikeljon P/ABC-9871-2021; Nikolich, Mikeljon/ABD-5270-2020; Filippov, Andrey/B-2856-2011	Nikolich, Mikeljon P/0000-0001-5770-8980; Filippov, Andrey/0000-0003-2256-861X	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division	Defense Threat Reduction Agency, Joint Science and Technology Office, Medical ST Division(United States Department of DefenseDefense Threat Reduction Agency)	This research was supported by the Defense Threat Reduction Agency, Joint Science and Technology Office, Medical S&T Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshire TG, 2005, J CLIN MICROBIOL, V43, P4780, DOI 10.1128/JCM.43.9.4780-4788.2005; ADVIER M., 1933, Bulletin de la Societe de Pathologie Exotique, V26, P94; Amoako KK, 2010, J FOOD PROTECT, V73, P18, DOI 10.4315/0362-028X-73.1.18; Anisimov AP, 2006, J MED MICROBIOL, V55, P1461, DOI 10.1099/jmm.0.46697-0; Aucken HM, 2002, J CLIN MICROBIOL, V40, P292, DOI 10.1128/JCM.40.1.292-293.2002; Awais R, 2006, BIOTECHNOL PROGR, V22, P853, DOI 10.1021/bp060020q; Banaiee N, 2001, J CLIN MICROBIOL, V39, P3883, DOI 10.1128/JCM.39.11.3883-3888.2001; BERTANI LE, 1957, VIROLOGY, V4, P53, DOI 10.1016/0042-6822(57)90043-0; Blasco R, 1998, J APPL MICROBIOL, V84, P661, DOI 10.1046/j.1365-2672.1998.00393.x; BOBROV AG, 1999, PROBL PARTICULARLY D, V79, P138; BUTLER T, 1976, J INFECT DIS, V133, P493, DOI 10.1093/infdis/133.5.493; Butler T, 2009, CLIN INFECT DIS, V49, P736, DOI 10.1086/604718; CAMPBELL J, 1993, J CLIN MICROBIOL, V31, P758, DOI 10.1128/JCM.31.3.758-759.1993; Chase CJ, 2005, CLIN CHEM, V51, P1778, DOI 10.1373/clinchem.2005.051839; CHU MC, 2000, LAB MANUAL PLAGUE DI, P129; CRAIGIE J, 1946, BACTERIOL REV, V10, P73, DOI 10.1128/MMBR.10.3-4.73-88.1946; De Lappe N, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-155; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Edelman DC, 2003, BIOTECHNIQUES, V35, P368, DOI 10.2144/03352rr02; Edgar R, 2006, P NATL ACAD SCI USA, V103, P4841, DOI 10.1073/pnas.0601211103; Ellis EL, 1939, J GEN PHYSIOL, V22, P365, DOI 10.1085/jgp.22.3.365; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FETHERSTON JD, 1992, MOL MICROBIOL, V6, P2693, DOI 10.1111/j.1365-2958.1992.tb01446.x; FILIPPOV AA, 1990, FEMS MICROBIOL LETT, V67, P45, DOI 10.1111/j.1574-6968.1990.tb13833.x; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Gage KL, 2005, ANNU REV ENTOMOL, V50, P505, DOI 10.1146/annurev.ento.50.071803.130337; Galimand M, 2006, ANTIMICROB AGENTS CH, V50, P3233, DOI 10.1128/AAC.00306-06; Garcia E, 2003, J BACTERIOL, V185, P5248, DOI 10.1128/JB.185.17.5248-5262.2003; Garcia E, 2008, VIROLOGY, V372, P85, DOI 10.1016/j.virol.2007.10.032; GUNNISON JB, 1951, J INFECT DIS, V88, P254, DOI 10.1093/infdis/88.3.254; Higgins JA, 1998, J CLIN MICROBIOL, V36, P2284, DOI 10.1128/JCM.36.8.2284-2288.1998; HINNEBUSCH J, 1993, J CLIN MICROBIOL, V31, P1511, DOI 10.1128/JCM.31.6.1511-1514.1993; IMAMALIEV OG, 1986, STANDARDS STRAINS ME, P102; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Iqbal SS, 2000, MOL CELL PROBE, V14, P109, DOI 10.1006/mcpr.2000.0295; Kutin RK, 2009, J MICROBIOL METH, V76, P241, DOI 10.1016/j.mimet.2008.11.008; Kutyrev V V, 1989, Mol Gen Mikrobiol Virusol, P42; Larina VS, 1970, PROBL PARTICULARLY D, V11, P132; Loessner MJ, 1996, APPL ENVIRON MICROB, V62, P1133, DOI 10.1128/AEM.62.4.1133-1140.1996; Loiez C, 2003, J CLIN MICROBIOL, V41, P4873, DOI 10.1128/JCM.41.10.4873-4875.2003; Matero P, 2009, APMIS, V117, P34, DOI 10.1111/j.1600-0463.2008.00013.x; McAvin JC, 2003, MIL MED, V168, P852, DOI 10.1093/milmed/168.10.852; McNerney R, 2004, J CLIN MICROBIOL, V42, P2115, DOI 10.1128/JCM.42.5.2115-2120.2004; Melo AC, 2003, LETT APPL MICROBIOL, V37, P361, DOI 10.1046/j.1472-765X.2003.01377.x; NAUMOV AV, 1992, MANUAL PROPHYLAXIS P; Neubauer H, 2000, J VET MED B, V47, P573, DOI 10.1046/j.1439-0450.2000.00384.x; Neufeld T, 2003, ANAL CHEM, V75, P580, DOI 10.1021/ac026083e; NORKINA OV, 1994, J APPL BACTERIOL, V76, P240, DOI 10.1111/j.1365-2672.1994.tb01622.x; Oda M, 2004, APPL ENVIRON MICROB, V70, P527, DOI 10.1128/AEM.70.1.527-534.2004; Ogorzaly L, 2006, J VIROL METHODS, V138, P131, DOI 10.1016/j.jviromet.2006.08.004; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PERROW C, 1997, ORG ENV, V10, P66, DOI DOI 10.1177/0921810697101009; POKROVSKAYA MP, 1929, GIGIENA EPIDEMIOL, V12, P31; Rahalison L, 2000, J CLIN MICROBIOL, V38, P260; Reiman RW, 2007, J MICROBIOL METH, V68, P651, DOI 10.1016/j.mimet.2006.11.004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samoilova SV, 1996, J MED MICROBIOL, V45, P440, DOI 10.1099/00222615-45-6-440; SANDERS MF, 1995, BIOLUMINESCENCE CHEM, P454; Schofield DA, 2009, J APPL MICROBIOL, V107, P1468, DOI 10.1111/j.1365-2672.2009.04332.x; Schofield DA, 2009, J CLIN MICROBIOL, V47, P3887, DOI 10.1128/JCM.01533-09; Stewart A, 2008, J MED MICROBIOL, V57, P324, DOI 10.1099/jmm.0.47485-0; Tomaso H, 2003, FEMS IMMUNOL MED MIC, V38, P117, DOI 10.1016/S0928-8244(03)00184-6; Tomaso H, 2008, CLIN CHEM LAB MED, V46, P1239, DOI 10.1515/CCLM.2008.251; Trebesius K, 1998, J CLIN MICROBIOL, V36, P2557, DOI 10.1128/JCM.36.9.2557-2564.1998; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welkos SL, 1997, MICROB PATHOGENESIS, V23, P211, DOI 10.1006/mpat.1997.0154; Welkos SL, 1995, CONTRIB TO MICROBIOL, V13, P299; Woron AM, 2006, DIAGN MICR INFEC DIS, V56, P261, DOI 10.1016/j.diagmicrobio.2006.06.009; Yim PB, 2009, BIOTECHNOL BIOENG, V104, P1059, DOI 10.1002/bit.22488	69	37	40	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11337	10.1371/journal.pone.0011337	http://dx.doi.org/10.1371/journal.pone.0011337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596528	Green Submitted, gold, Green Published			2022-12-27	WOS:000279259900010
J	Falentin, H; Deutsch, SM; Jan, G; Loux, V; Thierry, A; Parayre, S; Maillard, MB; Dherbecourt, J; Cousin, FJ; Jardin, J; Siguier, P; Couloux, A; Barbe, V; Vacherie, B; Wincker, P; Gibrat, JF; Gaillardin, C; Lortal, S				Falentin, Helene; Deutsch, Stephanie-Marie; Jan, Gwenael; Loux, Valentin; Thierry, Anne; Parayre, Sandrine; Maillard, Marie-Bernadette; Dherbecourt, Julien; Cousin, Fabien J.; Jardin, Julien; Siguier, Patricia; Couloux, Arnaud; Barbe, Valerie; Vacherie, Benoit; Wincker, Patrick; Gibrat, Jean-Francois; Gaillardin, Claude; Lortal, Sylvie			The Complete Genome of Propionibacterium freudenreichii CIRM-BIA1(T), a Hardy Actinobacterium with Food and Probiotic Applications	PLOS ONE			English	Article							PROPIONATE FORMATION; METABOLIC-ACTIVITY; GROWTH STIMULATOR; PROTEIN-SYNTHESIS; ACID; VITAMIN-B-12; ADAPTATION; GENES; IDENTIFICATION; BIOSYNTHESIS	Background: Propionibacterium freudenreichii is essential as a ripening culture in Swiss-type cheeses and is also considered for its probiotic use [1]. This species exhibits slow growth, low nutritional requirements, and hardiness in many habitats. It belongs to the taxonomic group of dairy propionibacteria, in contrast to the cutaneous species P. acnes. The genome of the type strain, P. freudenreichii subsp. shermanii CIRM-BIA1 (CIP 103027(T)), was sequenced with an 11-fold coverage. Methodology/Principal Findings: The circular chromosome of 2.7 Mb of the CIRM-BIA1 strain has a GC-content of 67% and contains 22 different insertion sequences (3.5% of the genome in base pairs). Using a proteomic approach, 490 of the 2439 predicted proteins were confirmed. The annotation revealed the genetic basis for the hardiness of P. freudenreichii, as the bacterium possesses a complete enzymatic arsenal for de novo biosynthesis of aminoacids and vitamins (except panthotenate and biotin) as well as sequences involved in metabolism of various carbon sources, immunity against phages, duplicated chaperone genes and, interestingly, genes involved in the management of polyphosphate, glycogen and trehalose storage. The complete biosynthesis pathway for a bifidogenic compound is described, as well as a high number of surface proteins involved in interactions with the host and present in other probiotic bacteria. By comparative genomics, no pathogenicity factors found in P. acnes or in other pathogenic microbial species were identified in P. freudenreichii, which is consistent with the Generally Recognized As Safe and Qualified Presumption of Safety status of P. freudenreichii. Various pathways for formation of cheese flavor compounds were identified: the Wood-Werkman cycle for propionic acid formation, amino acid degradation pathways resulting in the formation of volatile branched chain fatty acids, and esterases involved in the formation of free fatty acids and esters. Conclusions/Significance: With the exception of its ability to degrade lactose, P. freudenreichii seems poorly adapted to dairy niches. This genome annotation opens up new prospects for the understanding of the P. freudenreichii probiotic activity.	[Falentin, Helene; Deutsch, Stephanie-Marie; Jan, Gwenael; Thierry, Anne; Parayre, Sandrine; Maillard, Marie-Bernadette; Dherbecourt, Julien; Cousin, Fabien J.; Jardin, Julien; Lortal, Sylvie] INRA, UMR 1253, F-35042 Rennes, France; [Falentin, Helene; Deutsch, Stephanie-Marie; Jan, Gwenael; Thierry, Anne; Parayre, Sandrine; Maillard, Marie-Bernadette; Dherbecourt, Julien; Cousin, Fabien J.; Jardin, Julien; Lortal, Sylvie] AGROCAMPUS OUEST, UMR 1253, Rennes, France; [Loux, Valentin; Gibrat, Jean-Francois] INRA, UR1077, Unite Math Informat & Genome, Jouy En Josas, France; [Siguier, Patricia] CNRS, UMR5100, Lab Microbiol & Genet Mol, Toulouse, France; [Couloux, Arnaud; Barbe, Valerie; Vacherie, Benoit; Wincker, Patrick] Genoscope CEA, CNRS, UMR8030, Evry, France; [Couloux, Arnaud; Barbe, Valerie; Vacherie, Benoit; Wincker, Patrick] Univ Evry, Evry, France; [Gaillardin, Claude] AgroParisTech, CNRS, INRA, UMR2585,UMR1238, Thiverval Grignon, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Falentin, H (corresponding author), INRA, UMR 1253, F-35042 Rennes, France.	helene.falentin@rennes.inra.fr	Jan, Gwenael/K-6767-2014; Falentin, Helene/N-9088-2017; Falentin, Hélène/ABD-2801-2020; Thierry, Anne/C-4760-2014; JARDIN, Julien/A-3241-2012; Thierry, Anne/AAX-1150-2020; Thierry, Anne/AGH-4955-2022	Falentin, Helene/0000-0001-6254-5303; Thierry, Anne/0000-0002-9170-2889; JARDIN, Julien/0000-0003-0520-9391; Thierry, Anne/0000-0002-9170-2889; Siguier, Patricia/0000-0003-1620-6495; Couloux, Arnaud/0000-0003-2356-0062; Loux, Valentin/0000-0002-8268-915X; Vacherie, Benoit/0000-0002-1564-0575; Deutsch, Stephanie-Marie/0000-0002-5570-5193; Cousin, Fabien/0000-0001-6874-387X	INRA; Genoscope	INRA; Genoscope	INRA and Genoscope supported the cost of the complete project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou R, 2006, INT J FOOD MICROBIOL, V108, P301, DOI 10.1016/j.ijfoodmicro.2005.11.015; Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x; Barinov A, 2009, PROTEOMICS, V9, P61, DOI 10.1002/pmic.200800195; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BECK S, 1995, ARCH MICROBIOL, V163, P182; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Benz M, 1998, APPL ENVIRON MICROB, V64, P4507; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bougle D, 1999, SCAND J GASTROENTERO, V34, P144, DOI 10.1080/00365529950172998; Boyaval P, 1999, LAIT, V79, P59, DOI 10.1051/lait:199914; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Bryson K, 2006, NUCLEIC ACIDS RES, V34, P3533, DOI 10.1093/nar/gkl471; Cardoso FS, 2007, MICROBIOL-SGM, V153, P270, DOI 10.1099/mic.0.29262-0; Cardoso FS, 2004, INT J FOOD MICROBIOL, V91, P195, DOI 10.1016/S0168-1605(03)00387-8; Chopin MC, 2002, J BACTERIOL, V184, P2030, DOI 10.1128/JB.184.7.2030-2033.2002; CLARK JE, 1986, J BACTERIOL, V168, P1212, DOI 10.1128/jb.168.3.1212-1219.1986; Cousin FJ, 2011, DAIRY SCI TECHNOL, V91, P1, DOI 10.1051/dst/2010032; CROW VL, 1986, APPL ENVIRON MICROB, V52, P359, DOI 10.1128/AEM.52.2.359-365.1986; Cummins C.S., 1986, BERGEYS MANUAL SYSTE, P1346; CUMMINS CS, 1992, PROKARYOTES; DEBORDE C, 1998, THESIS ENSAR AGROCAM; Deborde C, 1996, J MAGN RESON ANAL, V2, P297; Deutsch SM, 2008, INT J FOOD MICROBIOL, V125, P252, DOI 10.1016/j.ijfoodmicro.2008.04.006; Deutsch SM, 2010, APPL ENVIRON MICROB, V76, P2740, DOI 10.1128/AEM.02591-09; Dherbecourt J, 2008, J APPL MICROBIOL, V105, P977, DOI 10.1111/j.1365-2672.2008.03830.x; Dherbecourt J, 2010, APPL ENVIRON MICROB, V76, P1181, DOI 10.1128/AEM.02453-09; Dherbecourt J, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-16; DUPUIS C, 1995, APPL MICROBIOL BIOT, V42, P750, DOI [10.1007/s002530050326, 10.1007/BF00171957]; de Palencia PF, 2009, APPL ENVIRON MICROB, V75, P4887, DOI 10.1128/AEM.00394-09; FROHLICHWYDER MT, 2004, APPL ENVIRON MICROB, V64, P4507; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guglielmetti S, 2008, APPL ENVIRON MICROB, V74, P4695, DOI 10.1128/AEM.00124-08; HAESELEER F, 1992, NUCLEIC ACIDS RES, V20, P1420, DOI 10.1093/nar/20.6.1420; Hall PR, 2004, EMBO J, V23, P3621, DOI 10.1038/sj.emboj.7600373; Herve C, 2001, APPL ENVIRON MICROB, V67, P231, DOI 10.1128/AEM.67.1.231-238.2001; Herve C, 2007, INT J FOOD MICROBIOL, V113, P303, DOI 10.1016/j.ijfoodmicro.2006.08.013; Hojo K., 2002, Bioscience and Microflora, V21, P115; Isawa K, 2002, BIOSCI BIOTECH BIOCH, V66, P679, DOI 10.1271/bbb.66.679; Jan G, 2002, LAIT, V82, P131, DOI 10.1051/lait:2001012; Jan G, 2002, CELL DEATH DIFFER, V9, P179, DOI 10.1038/sj.cdd.4400935; Jan G, 2001, APPL ENVIRON MICROB, V67, P2029, DOI 10.1128/AEM.67.5.2029-2036.2001; JOHNS AT, 1952, J GEN MICROBIOL, V6, P123, DOI 10.1099/00221287-6-1-2-123; JOHNS AT, 1951, J GEN MICROBIOL, V5, P326, DOI 10.1099/00221287-5-2-326; KANEKO T, 1994, J DAIRY SCI, V77, P393, DOI 10.3168/jds.S0022-0302(94)76965-4; KAPRELYANTS AS, 1993, FEMS MICROBIOL LETT, V104, P271, DOI 10.1016/0378-1097(93)90600-7; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P2029, DOI 10.3748/wjg.14.2029; Kiatpapan P, 2003, ACS SYM SER, V862, P221; Kichenaradja P, 2010, NUCLEIC ACIDS RES, V38, pD62, DOI 10.1093/nar/gkp947; Konstantinov SR, 2008, P NATL ACAD SCI USA, V105, P19474, DOI 10.1073/pnas.0810305105; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lan A, 2008, BRIT J NUTR, V100, P1251, DOI 10.1017/S0007114508978284; Lan A, 2007, BRIT J NUTR, V97, P714, DOI 10.1017/S0007114507433001; Lan A, 2007, APOPTOSIS, V12, P573, DOI 10.1007/s10495-006-0010-3; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; LEMEE R, 1994, LAIT, V74, P241, DOI 10.1051/lait:1994420; Leverrier P, 2005, FOOD MICROBIOL, V22, P11, DOI 10.1016/j.fm.2004.05.003; Leverrier P, 2004, ARCH MICROBIOL, V181, P215, DOI 10.1007/s00203-003-0646-0; Leverrier P, 2003, APPL ENVIRON MICROB, V69, P3809, DOI 10.1128/AEM.69.7.3809-3818.2003; LEVERRIER P, 2003, THESIS; MACY JM, 1978, J BACTERIOL, V134, P84, DOI 10.1128/JB.134.1.84-91.1978; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; MEURICE G, 2004, THESIS ECOLE NATL SU; MEURICE G, 2004, SILICO BIOL, V4; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Murooka Y, 2005, LAIT, V85, P9, DOI 10.1051/lait:2004035; NG SKC, 1973, CAN J MICROBIOL, V19, P715, DOI 10.1139/m73-116; Ouwehand AC, 2002, LAIT, V82, P123, DOI 10.1051/lait:2001011; Piao Y, 2004, J BIOSCI BIOENG, V98, P167, DOI 10.1016/S1389-1723(04)00261-0; Rigoulay C, 2004, FEMS MICROBIOL LETT, V237, P279, DOI 10.1016/j.femsle.2004.06.046; Roessner CA, 2002, MICROBIOL-SGM, V148, P1845, DOI 10.1099/00221287-148-6-1845; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Sanchez B, 2006, ENVIRON MICROBIOL, V8, P1825, DOI 10.1111/j.1462-2920.2006.01067.x; SCHINK B, 1987, ARCH MICROBIOL, V147, P321, DOI 10.1007/BF00406127; Schroeckh V, 2006, ANTON LEEUW INT J G, V89, P359, DOI 10.1007/s10482-005-9039-5; Seufferheld MJ, 2008, APPL ENVIRON MICROB, V74, P5867, DOI 10.1128/AEM.00501-08; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Suoniemi A, 2002, LAIT, V82, P81, DOI 10.1051/lait:2001007; Thierry A, 2005, LAIT, V85, P57, DOI 10.1051/lait:2004036; Thierry A, 2005, J AGR FOOD CHEM, V53, P4157, DOI 10.1021/jf0481195; Thierry A, 2002, LAIT, V82, P17, DOI 10.1051/lait:2001002; Thybert D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-637; TORAYA T, 1980, J BACTERIOL, V141, P1439, DOI 10.1128/JB.141.3.1439-1442.1980; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van Luijk N, 2002, LAIT, V82, P45, DOI 10.1051/lait:201004; von Freudenreich E., 1906, ZENTRALBL BAKTERIOL, V17, P529; Wood H G, 1981, Curr Top Cell Regul, V18, P255; Yebra MJ, 2007, APPL ENVIRON MICROB, V73, P3850, DOI 10.1128/AEM.00243-07	91	131	145	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11748	10.1371/journal.pone.0011748	http://dx.doi.org/10.1371/journal.pone.0011748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668525	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800021
J	Ling, S; Cheng, A; Pumpens, P; Michalak, M; Holoshitz, J				Ling, Song; Cheng, Andrew; Pumpens, Paul; Michalak, Marek; Holoshitz, Joseph			Identification of the Rheumatoid Arthritis Shared Epitope Binding Site on Calreticulin	PLOS ONE			English	Article							CELL-SURFACE CALRETICULIN; RECEPTOR CALRETICULIN; CHAPERONE FUNCTION; P-DOMAIN; PEPTIDE; DISEASE; C1Q; SUSCEPTIBILITY; PATHWAY; ACTIVATION	Background: The rheumatoid arthritis (RA) shared epitope (SE), a major risk factor for severe disease, is a five amino acid motif in the third allelic hypervariable region of the HLA-DR beta chain. The molecular mechanisms by which the SE affects susceptibility to - and severity of - RA are unknown. We have recently demonstrated that the SE acts as a ligand that interacts with cell surface calreticulin (CRT) and activates innate immune signaling. In order to better understand the molecular basis of SE-RA association, here we have undertaken to map the SE binding site on CRT. Principal Findings: Surface plasmon resonance (SPR) experiments with domain deletion mutants suggested that the SE binding site is located in the P-domain of CRT. The role of this domain as a SE-binding region was further confirmed by a sulfosuccinimidyl-2-[6-(biotinamido)-2-(p-azido-benzamido) hexanoamido] ethyl-1,3-dithiopropionate (sulfo-SBED) photoactive cross-linking method. In silico analysis of docking interactions between a conformationally intact SE ligand and the CRT P-domain predicted the region within amino acid residues 217-224 as a potential SE binding site. Site-directed mutagenesis demonstrated involvement of residues Glu(217) and Glu(223) - and to a lesser extent residue Asp(220) - in cell-free SPR-based binding and signal transduction assays. Significance: We have characterized here the molecular basis of a novel ligand-receptor interaction between the SE and CRT. The interaction represents a structurally and functionally well-defined example of cross talk between the adaptive and innate immune systems that could advance our understanding of the pathogenesis of autoimmunity.	[Ling, Song; Cheng, Andrew; Holoshitz, Joseph] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pumpens, Paul] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Michalak, Marek] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Michigan System; University of Michigan; Latvian Biomedical Research & Study Centre; University of Alberta	Ling, S (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.	songlin@med.unich.edu; jholo@med.umich.edu	Pumpens, Paul/A-2163-2008		US National Institutes of Health [AR55170, UL1RR02498, AI47331, GM088560, AR20557, AR56786, AR48310]; University of Michigan Global Reach Collaborative Research; Arthritis Foundation; American College of Rheumatology Research and Education Foundation; Canadian Institutes of Health Research [MOP-15291]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020557, R21AR056786, P30AR048310, R21AR055170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088560] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Global Reach Collaborative Research; Arthritis Foundation; American College of Rheumatology Research and Education Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Joseph Holoshitz was supported by grants from the US National Institutes of Health (AR55170, UL1RR02498, AI47331, GM088560, AR20557, AR56786 and AR48310), by the University of Michigan Global Reach Collaborative Research and by Basic Research Grants from the Arthritis Foundation and the American College of Rheumatology Research and Education Foundation. Marek Michalak was supported by the Canadian Institutes of Health Research (MOP-15291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKSH S, 1992, PROTEIN EXPRES PURIF, V3, P322, DOI 10.1016/1046-5928(92)90008-K; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Donnelly S, 2006, ARTHRITIS RHEUM-US, V54, P1543, DOI 10.1002/art.21783; du Montcel ST, 2005, ARTHRITIS RHEUM-US, V52, P1063, DOI 10.1002/art.20989; Eggleton P, 1999, SCAND J IMMUNOL, V49, P466; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Goicoechea S, 2002, J BIOL CHEM, V277, P37219, DOI 10.1074/jbc.M202200200; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Guo L, 2003, J BIOL CHEM, V278, P50645, DOI 10.1074/jbc.M309497200; Henson PM, 2001, NAT REV MOL CELL BIO, V2, P627, DOI 10.1038/35085094; Holoshitz J, 2007, ANN NY ACAD SCI, V1110, P73, DOI 10.1196/annals.1423.009; Hurst GB, 2004, J AM SOC MASS SPECTR, V15, P832, DOI 10.1016/S1044-0305(04)00154-0; LaCava A, 1997, J CLIN INVEST, V100, P658, DOI 10.1172/JCI119577; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Ling S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2111; Ling S, 2007, J IMMUNOL, V179, P6359, DOI 10.4049/jimmunol.179.9.6359; Ling S, 2006, ARTHRITIS RHEUM-US, V54, P3423, DOI 10.1002/art.22178; Martin V, 2006, J BIOL CHEM, V281, P2338, DOI 10.1074/jbc.M508302200; Mattey DL, 2001, J RHEUMATOL, V28, P232; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; Michalak M, 1999, BIOCHEM J, V344, P281, DOI 10.1042/0264-6021:3440281; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Oladiran A, 2010, DEV COMP IMMUNOL, V34, P396, DOI 10.1016/j.dci.2009.11.005; Radaev S, 2003, ANNU REV BIOPH BIOM, V32, P93, DOI 10.1146/annurev.biophys.32.110601.142347; Santhoshkumar P, 2002, BBA-PROTEINS PROTEOM, V1598, P115, DOI 10.1016/S0167-4838(02)00356-4; Steino A, 2004, SCAND J IMMUNOL, V59, P485, DOI 10.1111/j.0300-9475.2004.01425.x; Stuart GR, 1997, IMMUNOPHARMACOLOGY, V38, P73, DOI 10.1016/S0162-3109(97)00076-3; Thielmann Y, 2009, FEBS J, V276, P1140, DOI 10.1111/j.1742-4658.2008.06857.x; Udupa PEG, 2005, EXP EYE RES, V80, P185, DOI 10.1016/j.exer.2004.08.028; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; WUCHERPFENNIG KW, 1995, J EXP MED, V181, P1597, DOI 10.1084/jem.181.5.1597; Yoshida T, 2003, J COMPUT CHEM, V24, P319, DOI 10.1002/jcc.10161; Zavala-Ruiz Z, 2004, CHEM BIOL, V11, P1395, DOI 10.1016/j.chembiol.2004.08.007	39	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11703	10.1371/journal.pone.0011703	http://dx.doi.org/10.1371/journal.pone.0011703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661469	Green Submitted, Green Published, gold			2022-12-27	WOS:000280243300009
J	Sylvester, M; Kliche, S; Lange, S; Geithner, S; Klemm, C; Schlosser, A; Grossmann, A; Stelzl, U; Schraven, B; Krause, E; Freund, C				Sylvester, Marc; Kliche, Stefanie; Lange, Sabine; Geithner, Sabine; Klemm, Clementine; Schlosser, Andreas; Grossmann, Arndt; Stelzl, Ulrich; Schraven, Burkhart; Krause, Eberhard; Freund, Christian			Adhesion and Degranulation Promoting Adapter Protein (ADAP) Is a Central Hub for Phosphotyrosine-Mediated Interactions in T Cells	PLOS ONE			English	Article							EXTENDED SH3 DOMAIN; PHOSPHORYLATION SITES; FUNCTIONAL ASSOCIATION; INTEGRIN ACTIVATION; INTERACTION NETWORK; ACTIN CYTOSKELETON; MASS-SPECTROMETRY; TYROSINE KINASES; HUMAN PLATELETS; CUTTING EDGE	TCR stimulation leads to an increase in cellular adhesion among other outcomes. The adhesion and degranulation promoting adapter protein (ADAP) is known to be rapidly phosphorylated after T cell stimulation and relays the TCR signal to adhesion molecules of the integrin family. While three tyrosine phosphorylation sites have been characterized biochemically, the binding capabilities and associated functions of several other potential phosphotyrosine motifs remain unclear. Here, we utilize in vitro phosphorylation and mass spectrometry to map novel phosphotyrosine sites in the C-terminal part of human ADAP (486-783). Individual tyrosines were then mutated to phenylalanine and their relevance for cellular adhesion and migration was tested experimentally. Functionally important tyrosine residues include two sites within the folded hSH3 domains of ADAP and two at the C-terminus. Furthermore, using a peptide pulldown approach in combination with stable isotope labeling in cell culture (SILAC) we identified SLP-76, PLC gamma, PIK3R1, Nck, CRK, Gads, and RasGAP as phospho-dependent binding partners of a central YDDV motif of ADAP. The phosphorylation-dependent interaction between ADAP and Nck was confirmed by yeast two-hybrid analysis, immunoprecipitation and binary pulldown experiments, indicating that ADAP directly links integrins to modulators of the cytoskeleton independent of SLP-76.	[Sylvester, Marc; Geithner, Sabine; Freund, Christian] Leibniz Inst Mol Pharmakol FMP, Prot Engn Grp, Berlin, Germany; [Sylvester, Marc; Geithner, Sabine; Freund, Christian] Free Univ Berlin, Fachbereich Biol, D-1000 Berlin, Germany; [Kliche, Stefanie; Schraven, Burkhart] Otto Von Guericke Univ, Inst Mol & Klin Immunol, Magdeburg, Germany; [Lange, Sabine; Klemm, Clementine; Krause, Eberhard] Leibniz Inst Mol Pharmacol, Mass Spectrometry Grp, Berlin, Germany; [Schlosser, Andreas] Charite, Inst Med Immunol CCM, D-13353 Berlin, Germany; [Grossmann, Arndt; Stelzl, Ulrich] Max Planck Inst Mol Genet, Otto Warburg Lab, Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Otto von Guericke University; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Sylvester, M (corresponding author), Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark.		Stelzl, Ulrich/J-9506-2015	Stelzl, Ulrich/0000-0003-2500-3585; Sylvester, Marc/0000-0002-4275-0200	Max-Planck Society; Nationales Genom-Forschungs-Netz-plus [01GS08171]; Deutsche Forschungsgemeinschaft [SFB740]	Max-Planck Society(Max Planck Society); Nationales Genom-Forschungs-Netz-plus; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work in the lab of U.S. is supported by the Max-Planck Society and Nationales Genom-Forschungs-Netz-plus (NeuroNet TP3, 01GS08171). C. F. was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Bezman N, 2007, IMMUNOL REV, V218, P9, DOI 10.1111/j.1600-065X.2007.00541.x; Boerth NJ, 2000, J BIOL CHEM, V275, P5143, DOI 10.1074/jbc.275.7.5143; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Coppolino MG, 2001, J CELL SCI, V114, P4307; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DASILVA AJ, 1993, J EXP MED, V178, P2107, DOI 10.1084/jem.178.6.2107; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Geng LP, 1999, J IMMUNOL, V163, P5753; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goss VL, 2006, BLOOD, V107, P4888, DOI 10.1182/blood-2005-08-3399; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Heuer K, 2005, J MOL BIOL, V348, P1025, DOI 10.1016/j.jmb.2005.02.069; Heuer K, 2004, STRUCTURE, V12, P603, DOI 10.1016/j.str.2004.02.021; Heuer K, 2006, J MOL BIOL, V361, P94, DOI 10.1016/j.jmb.2006.06.004; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hunter AJ, 2000, J IMMUNOL, V164, P1143, DOI 10.4049/jimmunol.164.3.1143; Klemm C, 2006, J MASS SPECTROM, V41, P1623, DOI 10.1002/jms.1129; Kliche S, 2006, MOL CELL BIOL, V26, P7130, DOI 10.1128/MCB.00331-06; Koga S, 2005, J BIOL CHEM, V280, P31564, DOI 10.1074/jbc.M502703200; Kosco KA, 2008, MOL IMMUNOL, V45, P510, DOI 10.1016/j.molimm.2007.05.024; Krause M, 2000, J CELL BIOL, V149, P181, DOI 10.1083/jcb.149.1.181; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Li L, 2008, NUCLEIC ACIDS RES, V36, P3263, DOI 10.1093/nar/gkn161; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Mamchak AA, 2008, J IMMUNOL, V181, P5374, DOI 10.4049/jimmunol.181.8.5374; Marie-Cardine A, 1999, EUR J IMMUNOL, V29, P1175, DOI 10.1002/(SICI)1521-4141(199904)29:04<1175::AID-IMMU1175>3.0.CO;2-Z; Miller ML, 2008, MOL CELL PROTEOMICS, V7, P181, DOI 10.1074/mcp.M700241-MCP200; Mulhern TD, 1997, STRUCTURE, V5, P1313, DOI 10.1016/S0969-2126(97)00283-9; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Okabe S, 2006, BLOOD CELL MOL DIS, V36, P308, DOI 10.1016/j.bcmd.2005.12.035; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peterson EJ, 2001, SCIENCE, V293, P2263, DOI 10.1126/science.1063486; Piotukh K, 2007, FREE RADICAL BIO MED, V43, P1263, DOI 10.1016/j.freeradbiomed.2007.06.010; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Schlosser A, 2005, ANAL CHEM, V77, P5243, DOI 10.1021/ac050232m; Schneider H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001718; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; TORTI M, 1992, P NATL ACAD SCI USA, V89, P7796, DOI 10.1073/pnas.89.16.7796; Trojan P, 2008, BBA-MOL CELL RES, V1783, P1248, DOI 10.1016/j.bbamcr.2008.01.006; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Wang HY, 2004, J EXP MED, V200, P1063, DOI 10.1084/jem.20040780; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Wu CG, 2007, PROTEOMICS, V7, P1775, DOI 10.1002/pmic.200601006; Wunderlich L, 1999, EUR J IMMUNOL, V29, P1068, DOI 10.1002/(SICI)1521-4141(199904)29:04<1068::AID-IMMU1068>3.0.CO;2-P; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zimmermann J, 2007, BIOCHEMISTRY-US, V46, P6971, DOI 10.1021/bi700437r	54	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11708	10.1371/journal.pone.0011708	http://dx.doi.org/10.1371/journal.pone.0011708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661443	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300012
J	Wang, Y; Gao, WL; Svitkin, YV; Chen, APC; Cheng, YC				Wang, Ying; Gao, Wenli; Svitkin, Yuri V.; Chen, Annie Pei-Chun; Cheng, Yung-Chi			DCB-3503, a Tylophorine Analog, Inhibits Protein Synthesis through a Novel Mechanism	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; IN-VITRO TRANSLATION; CELL-FREE SYSTEM; APOLIPOPROTEIN-B; CANCER CELLS; PHOSPHORYLATION; ELONGATION; RESISTANCE; ALKALOIDS; REPRESSOR	Background: DCB-3503, a tylophorine analog, inhibits the growth of PANC-1 (human pancreatic ductal cancer cell line) and HepG2 (human hepatocellular cancer cell line) tumor xenografts in nude mice. The inhibition of growth leads to cancer cell differentiation instead of cell death. However, the mechanisms of action of tylophorine analogs is unknown. Methodology/Principal Findings: In this study, we show that DCB-3503 suppresses the expression of pro-oncogenic or pro-survival proteins with short half-lives, including cyclin D1, survivin, beta-catenin, p53, and p21, without decreasing their mRNA levels. Proteasome inhibitor reversed the inhibitory effect of DCB-3503 on expression of these proteins. DCB-3503 inhibited the incorporation of radiolabeled amino acid and thymidine, and to a much lesser degree of uridine, in a panel of cell lines. The mechanism of inhibition of protein synthesis is different from that of cycloheximide (CHX) as assayed in cell culture and HeLa in vitro translation system. Furthermore, in contrast to rapamycin, DCB-3503 does not affect protein synthesis through the mTOR pathway. DCB-3503 treatment shifts the sedimentation profiles of ribosomes and mRNAs towards the polysomal fractions while diminishing monosome abundance, indicative of the inhibition of the elongation step of protein synthesis. Preferential down regulation of several studied proteins under these conditions is likely due to the relative short half-lives of these proteins. Conclusion/Significance: The inhibitory effect of DCB-3503 on translation is apparently distinct from any of the current anticancer compounds targeting protein synthesis. Translation inhibitors with novel mechanism could complement current chemotherapeutic agents for the treatment of human cancers and suppress the occurrence of drug resistance.	[Wang, Ying; Gao, Wenli; Chen, Annie Pei-Chun; Cheng, Yung-Chi] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Svitkin, Yuri V.] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Svitkin, Yuri V.] McGill Univ, Goodman Canc Ctr, Montreal, PQ, Canada	Yale University; McGill University; McGill University	Wang, Y (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	yccheng@yale.edu	Wang, Ying/T-9438-2018	Wang, Ying/0000-0002-1407-2668; Svitkin, Yuri/0000-0003-3819-2143	NCI [CA-63477]; NATIONAL CANCER INSTITUTE [U01CA063477, R01CA063477] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI grant CA-63477. The funder designed the study, data collection and analysis, prepared and decided to publish the manuscript.	ADELI K, 1992, BIOCHEM CELL BIOL, V70, P1301, DOI 10.1139/o92-177; Adi S, 2001, ENDOCRINOLOGY, V142, P498, DOI 10.1210/en.142.1.498; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Budihardjo II, 2000, MOL PHARMACOL, V57, P529, DOI 10.1124/mol.57.3.529; Buniatian A A, 1979, Akush Ginekol (Mosk), P13; Choi JY, 2006, ARTHRITIS RHEUM, V54, P3277, DOI 10.1002/art.22119; Chopra R. N. L.-C., 1935, INDIAN J MED RES, V23, P263; CREWS CM, 1994, J BIOL CHEM, V269, P15411; DONALDSO.GR, 1968, BIOCHEM BIOPH RES CO, V31, P104, DOI 10.1016/0006-291X(68)90037-5; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; Gao W, 2008, BIOORG MED CHEM LETT, V18, P704, DOI 10.1016/j.bmcl.2007.11.054; Gao WL, 2007, BIOORG MED CHEM LETT, V17, P4338, DOI 10.1016/j.bmcl.2007.05.021; Gao WL, 2004, CANCER RES, V64, P678, DOI 10.1158/0008-5472.CAN-03-1904; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; GRANT P, 1974, J BACTERIOL, V120, P1308, DOI 10.1128/JB.120.3.1308-1314.1974; HUANG MT, 1972, MOL PHARMACOL, V8, P538; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Lee DY, 2010, J BIOL CHEM, V285, P30, DOI 10.1074/jbc.M109.010512; Leung CH, 2006, MOL PHARMACOL, V70, P1946, DOI 10.1124/mol.106.028480; Ma Y, 2005, CANCER RES, V65, P6476, DOI 10.1158/0008-5472.CAN-05-0370; MATHEWS MB, 2007, TRANSLATIONAL CONTRO; Mertens-Talcott SU, 2007, CANCER RES, V67, P11001, DOI 10.1158/0008-5472.CAN-07-2416; Mikami S, 2006, J BIOTECHNOL, V127, P65, DOI 10.1016/j.jbiotec.2006.06.018; Mohammadi A, 1996, BIOCHEM BIOPH RES CO, V228, P852, DOI 10.1006/bbrc.1996.1743; MOLLA A, 1993, J VIROL, V67, P5932, DOI 10.1128/JVI.67.10.5932-5938.1993; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; Nomura M, 2005, BIOCHEM BIOPH RES CO, V335, P900, DOI 10.1016/j.bbrc.2005.07.160; Olie RA, 2000, CANCER RES, V60, P2805; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; Ruvkun G, 2008, NAT MED, V14, P1041, DOI 10.1038/nm1008-1041; Sah NK, 2003, J BIOL CHEM, V278, P20593, DOI 10.1074/jbc.M211010200; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shiah HS, 2006, MOL CANCER THER, V5, P2484, DOI 10.1158/1535-7163.MCT-06-0146; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Suriano G, 2005, GENE CHROMOSOME CANC, V42, P238, DOI 10.1002/gcc.20135; Svitkin Yuri V., 2004, V257, P155; TUJEBAJEVA RM, 1992, BIOCHIM BIOPHYS ACTA, V1129, P177, DOI 10.1016/0167-4781(92)90484-H; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang BB, 2006, MOL CELL, V22, P553, DOI 10.1016/j.molcel.2006.03.034; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WILLINGHAM W, 1981, BIOCHIM BIOPHYS ACTA, V654, P169, DOI 10.1016/0005-2787(81)90168-4; Wu CJ, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-25; Xi Z, 2005, BIOORG MED CHEM LETT, V15, P2673, DOI 10.1016/j.bmcl.2005.02.022; Yamada H, 1996, INT J HEMATOL, V65, P31; Yang CW, 2007, BIOCHEM BIOPH RES CO, V354, P942, DOI 10.1016/j.bbrc.2007.01.065; You X, 2006, ARTHRITIS RHEUM-US, V54, P877, DOI 10.1002/art.21640; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D	48	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11607	10.1371/journal.pone.0011607	http://dx.doi.org/10.1371/journal.pone.0011607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657652	Green Published, Green Submitted, gold			2022-12-27	WOS:000279924500010
J	Delhey, K; Burger, C; Fiedler, W; Peters, A				Delhey, Kaspar; Burger, Claudia; Fiedler, Wolfgang; Peters, Anne			Seasonal Changes in Colour: A Comparison of Structural, Melanin- and Carotenoid-Based Plumage Colours	PLOS ONE			English	Article							TITS CYANISTES-CAERULEUS; BLUE TITS; SEXUAL ATTRACTIVENESS; SPECTRAL SENSITIVITY; BREEDING-SEASON; PARENTAL EFFORT; VISUAL ECOLOGY; PARUS-MAJOR; BILL COLOR; TRADE-OFF	Background: Plumage coloration is important for bird communication, most notably in sexual signalling. Colour is often considered a good quality indicator, and the expression of exaggerated colours may depend on individual condition during moult. After moult, plumage coloration has been deemed fixed due to the fact that feathers are dead structures. Still, many plumage colours change after moult, although whether this affects signalling has not been sufficiently assessed. Methodology/Principal Findings: We studied changes in coloration after moult in four passerine birds (robin, Erithacus rubecula; blackbird, Turdus merula; blue tit, Cyanistes caeruleus; and great tit, Parus major) displaying various coloration types (melanin-, carotenoid-based and structural). Birds were caught regularly during three years to measure plumage reflectance. We used models of avian colour vision to derive two variables, one describing chromatic and the other achromatic variation over the year that can be compared in magnitude among different colour types. All studied plumage patches but one (yellow breast of the blue tit) showed significant chromatic changes over the year, although these were smaller than for a typical dynamic trait (bill colour). Overall, structural colours showed a reduction in relative reflectance at shorter wavelengths, carotenoid-based colours the opposite pattern, while no general pattern was found for melanin- based colours. Achromatic changes were also common, but there were no consistent patterns of change for the different types of colours. Conclusions/Significance: Changes of plumage coloration independent of moult are probably widespread; they should be perceivable by birds and have the potential to affect colour signalling.	[Delhey, Kaspar; Burger, Claudia; Peters, Anne] Max Planck Inst Ornithol, Behav Ecol Sexual Signals Grp, Radolfzell am Bodensee, Germany	Max Planck Society	Delhey, K (corresponding author), Max Planck Inst Ornithol, Behav Ecol Sexual Signals Grp, Radolfzell am Bodensee, Germany.	delhey@orn.mpg.de	Delhey, Kaspar/F-6515-2010; Delhey, Kaspar/AAZ-5362-2020; Fiedler, Wolfgang/AAG-4510-2021; Peters, Anne/A-1821-2010	Delhey, Kaspar/0000-0001-5190-5406; Fiedler, Wolfgang/0000-0003-1082-4161; Peters, Anne/0000-0001-8071-0560	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society, which had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S., 2006, BIRD COLORATION, P76; Baeta R, 2008, P ROY SOC B-BIOL SCI, V275, P427, DOI 10.1098/rspb.2007.1383; Benites P, 2007, CONDOR, V109, P605, DOI 10.1650/8195.1; Blanco G, 2005, P ROY SOC B-BIOL SCI, V272, P1893, DOI 10.1098/rspb.2005.3157; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Bright A, 2004, BEHAV PROCESS, V65, P123, DOI 10.1016/j.beproc.2003.08.003; Burtt E.H., 1986, ORNITHOL MONOGR, V38, P1; Burtt EH, 2004, CONDOR, V106, P681, DOI 10.1650/7383; Campenhausen MV, 1998, J COMP PHYSIOL A, V183, P1; Cramp S., 1988, BIRDS W PALEARCTIC, V5; CRAMP S, 1993, BIRDS W PALEARCTIC, P225; Cuthill IC, 2006, BIRD COLORATION, V1, P3; Delhey K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001689; Delhey K, 2007, AM NAT, V169, pS145, DOI 10.1086/510095; Delhey K, 2007, BEHAV ECOL, V18, P399, DOI 10.1093/beheco/arl096; Delhey K, 2006, BEHAV ECOL, V17, P790, DOI 10.1093/beheco/arl012; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Faivre B, 2003, ANIM BEHAV, V65, P1125, DOI 10.1006/anbe.2003.2142; Figuerola J, 2005, IBIS, V147, P797, DOI 10.1111/j.1474-919x.2005.00461.x; Grande JM, 2004, ARDEOLA, V51, P375; Griffith SC, 2003, J EVOLUTION BIOL, V16, P1045, DOI 10.1046/j.1420-9101.2003.00550.x; Griffith SC, 2006, ANIM BEHAV, V71, P749, DOI 10.1016/j.anbehav.2005.07.016; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hadfield JD, 2006, J EVOLUTION BIOL, V19, P1104, DOI 10.1111/j.1420-9101.2006.01095.x; Hadfield JD, 2006, P ROY SOC B-BIOL SCI, V273, P1347, DOI 10.1098/rspb.2005.3459; Hart NS, 2001, J COMP PHYSIOL A, V187, P685, DOI 10.1007/s00359-001-0240-3; Hegyi G, 2007, J AVIAN BIOL, V38, P698, DOI 10.1111/j.2007.0908-8857.04075.x; Hill G. E., 2006, BIRD COLORATION, V2; Hill GE., 2006, BIRD COLOURATION, P507, DOI [10.4159/9780674273788, DOI 10.4159/9780674273788]; Johnsen A, 2005, ANIM BEHAV, V70, P877, DOI 10.1016/j.anbehav.2005.01.005; JOHNSON NK, 1993, WILSON BULL, V105, P389; Kahn NW, 1998, AUK, V115, P1074; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; KNIPRATH ERNST, 1967, J ORNITHOL, V108, P1, DOI 10.1007/BF01671355; Korsten P, 2007, BEHAV ECOL SOCIOBIOL, V61, P1933, DOI 10.1007/s00265-007-0433-z; Kose M, 1999, BEHAV ECOL SOCIOBIOL, V45, P430, DOI 10.1007/s002650050581; Limbourg T, 2004, P ROY SOC B-BIOL SCI, V271, P1903, DOI 10.1098/rspb.2004.2825; Lucas A. M., 1972, AVIAN ANATOMY INTE 2; MAIER EJ, 1993, J COMP PHYSIOL A, V172, P295, DOI 10.1007/BF00216611; McGraw K.J., 2006, BIRD COLORATION, V1, P177; McGraw KJ, 2004, CAN J ZOOL, V82, P734, DOI 10.1139/Z04-043; McGraw KJ, 2004, ETHOLOGY, V110, P707, DOI 10.1111/j.1439-0310.2004.01011.x; McGraw KJ., 2006, BIRD COLORATION, P243; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; MONTGOMERIE R, 2006, BIRD COLORATION, V1, P399; Montgomerie R., 2006, BIRD COLORATION, P90; Odeen A, 2003, MOL BIOL EVOL, V20, P855, DOI 10.1093/molbev/msg108; Ornborg J, 2002, BIOL J LINN SOC, V76, P237, DOI 10.1046/j.1095-8312.2002.00061.x; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Peters A, 2004, AM NAT, V164, P51, DOI 10.1086/421302; Prum RO, 2006, BIRD COLORATION, V1, P295; Roberts ML, 2009, BEHAV ECOL, V20, P535, DOI 10.1093/beheco/arp028; Schmidt-Wellenburg CA, 2008, BEHAV ECOL, V19, P1351, DOI 10.1093/beheco/arn066; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2005, BIOL LETTERS, V1, P121, DOI 10.1098/rsbl.2004.0289; Siddiqi A, 2004, J EXP BIOL, V207, P2471, DOI 10.1242/jeb.01047; Surmacki A, 2008, IBIS, V150, P335, DOI 10.1111/j.1474-919X.2007.00796.x; Svensson L., 1992, IDENTIFICATION GUIDE; TEST FREDERICK H., 1940, CONDOR, V42, P76, DOI 10.2307/1364322; Tokolyi J, 2008, BIOL J LINN SOC, V94, P711, DOI 10.1111/j.1095-8312.2008.01027.x; Tubaro PL, 2005, CONDOR, V107, P648, DOI 10.1650/0010-5422(2005)107[0648:CDASCV]2.0.CO;2; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 1998, J COMP PHYSIOL A, V183, P621, DOI 10.1007/s003590050286; Willoughby EJ, 2002, WILSON BULL, V114, P380, DOI 10.1676/0043-5643(2002)114[0380:MPAACC]2.0.CO;2; Zampiga E, 2004, ETHOL ECOL EVOL, V16, P339, DOI 10.1080/08927014.2004.9522625	67	44	44	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11582	10.1371/journal.pone.0011582	http://dx.doi.org/10.1371/journal.pone.0011582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644723	Green Published, Green Submitted, gold			2022-12-27	WOS:000279884900019
J	Steer, CD; Smith, GD; Emmett, PM; Hibbeln, JR; Golding, J				Steer, Colin D.; Smith, George Davey; Emmett, Pauline M.; Hibbeln, Joseph R.; Golding, Jean			FADS2 Polymorphisms Modify the Effect of Breastfeeding on Child IQ	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; GENETIC-VARIANTS; FISH INTAKE; PREGNANCY; N-3; CLUSTER; MILK; ASSOCIATION; CONSUMPTION; DEPRESSION	Background: Breastfeeding is important for child cognitive development. A study by Caspi et al has suggested that rs174575 within the FADS2 gene moderates this effect so that children homozygous in the minor allele (GG genotype) have similar IQs irrespective of feeding method. Methods and Principal Findings: In our study of 5934 children aged 8 years, no genetic main effect with IQ was found for rs174575. However, an interaction with this polymorphism was observed such that breastfed GG children performed better than their formula fed counterparts by an additional 5.8 points [1.4, 10.1] (interaction p = 0.0091). Interaction results were attenuated by about 10% after adjustment for 7 factors. This study also investigated rs1535, another FADS2 polymorphism in linkage disequilibrium with rs174575, together with performance and verbal IQ, finding similar results although effect sizes were generally reduced. Conclusions and Significance: This study did not replicate the findings of Caspi et al. In contrast to their study, GG children exhibited the greatest difference between feeding methods such that breastfed children performed similarly irrespective of child genotype whereas formula fed GG children performed worse than other children on formula milk. Further studies are required to replicate these findings.	[Steer, Colin D.; Emmett, Pauline M.; Golding, Jean] Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Smith, George Davey] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol, Avon, England; [Hibbeln, Joseph R.] NIAAA, NIH, Bethesda, MD USA	University of Bristol; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Steer, CD (corresponding author), Univ Bristol, Dept Community Based Med, Ctr Child & Adolescent Hlth, Bristol, Avon, England.	Colin.Steer@bristol.ac.uk	Emmett, Pauline/AAL-6815-2021; Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Golding, Jean/0000-0003-2826-3307; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Emmett, Pauline/0000-0003-1076-4779; s, hema/0000-0002-3440-9475	National Oceanic and Atmospheric Administration; Waterloo Foundation; UK Medical Research Council; Wellcome Trust; University of Bristol; MRC [G0600705] Funding Source: UKRI; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000262, ZIAAA000235] Funding Source: NIH RePORTER; Medical Research Council [G0600705, G9815508] Funding Source: researchfish	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Waterloo Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	National Oceanic and Atmospheric Administration and the Waterloo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are extremely grateful to all the families who took part in this study, the midwives for their help in recruiting them, and the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists and nurses. The UK Medical Research Council, the Wellcome Trust and the University of Bristol currently provide core support for ALSPAC. This publication is the work of the authors and Colin Steer and Jean Golding will serve as guarantors for the contents of this paper.	[Anonymous], 2005, DIET REF INT EN CARB; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Caspi A, 2007, P NATL ACAD SCI USA, V104, P18860, DOI 10.1073/pnas.0704292104; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Der G, 2006, BMJ-BRIT MED J, V333, P945, DOI 10.1136/bmj.38978.699583.55; Donahue SMA, 2009, PROSTAG LEUKOTR ESS, V80, P289, DOI 10.1016/j.plefa.2009.02.007; Dunstan JA, 2007, PEDIATR RES, V62, P689, DOI 10.1203/PDR.0b013e318159a93a; Fedorova I, 2006, PROSTAG LEUKOTR ESS, V75, P271, DOI 10.1016/j.plefa.2006.07.006; Fleith M, 2005, CRIT REV FOOD SCI, V45, P205, DOI 10.1080/10408690590956378; Gale CR, 2008, J CHILD PSYCHOL PSYC, V49, P1061, DOI 10.1111/j.1469-7610.2008.01908.x; GALE CR, 2008, J CHILD PSYCHOL PSYC; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Helland IB, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e39; Helland IB, 2008, PEDIATRICS, V122, pE472, DOI 10.1542/peds.2007-2762; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Hoddinott P, 2008, BMJ-BRIT MED J, V336, P881, DOI 10.1136/bmj.39521.566296.BE; Horta BL, 2007, EVIDENCE LONG TERM E; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Lauritzen L, 2002, LIPIDS, V37, P237, DOI 10.1007/s11745-002-0886-2; Ministry of Agriculture Fisheries and Food, 1998, FATT AC S; Oken E, 2005, ENVIRON HEALTH PERSP, V113, P1376, DOI 10.1289/ehp.8041; Oken E, 2008, AM J EPIDEMIOL, V167, P1171, DOI 10.1093/aje/kwn034; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Sprecher H, 2000, BBA-MOL CELL BIOL L, V1486, P219, DOI 10.1016/S1388-1981(00)00077-9; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Wechsler D., 1992, WECHSLER INTELLIGENC; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	36	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11570	10.1371/journal.pone.0011570	http://dx.doi.org/10.1371/journal.pone.0011570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644632	gold, Green Submitted, Green Published			2022-12-27	WOS:000279822300020
J	Camlin, CS; Hosegood, V; Newell, ML; McGrath, N; Barnighausen, T; Snow, RC				Camlin, Carol S.; Hosegood, Victoria; Newell, Marie-Louise; McGrath, Nuala; Barnighausen, Till; Snow, Rachel C.			Gender, Migration and HIV in Rural KwaZulu-Natal, South Africa	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RISK; LABOR; MIGRANT; PARTNERSHIPS; MORTALITY; BEHAVIOR; IMPACT	Objectives: Research on migration and HIV has largely focused on male migration, often failing to measure HIV risks associated with migration for women. We aimed to establish whether associations between migration and HIV infection differ for women and men, and identify possible mechanisms by which women's migration contributes to their high infection risk. Design: Data on socio-demographic characteristics, patterns of migration, sexual behavior and HIV infection status were obtained for a population of 11,677 women aged 15-49 and men aged 15-54, resident members of households within a demographic surveillance area participating in HIV surveillance in 2003-04. Methods: Logistic regression was conducted to examine whether sex and migration were independently associated with HIV infection in three additive effects models, using measures of recent migration, household presence and migration frequency. Multiplicative effects models were fitted to explore whether the risk of HIV associated with migration differed for males and females. Further modeling and simulations explored whether composition or behavioral differences accounted for observed associations. Results: Relative to non-migrant males, non-migrant females had higher odds of being HIV-positive (adjusted odds ratio [aOR] = 1.72; 95% confidence interval [1.49-1.99]), but odds were higher for female migrants (aOR = 2.55 [2.07-3.13]). Female migrants also had higher odds of infection relative to female non-migrants (aOR = 1.48 [1.23-1.77]). The association between number of sexual partners over the lifetime and HIV infection was modified by both sex and migrant status: For male non-migrants, each additional partner was associated with 3% higher odds of HIV infection (aOR = 1.03 [1.02-1.05]); for male migrants the association between number of partners and HIV infection was non-significant. Each additional partner increased odds of HIV infection by 22% for female non-migrants (aOR = 1.22 [1.12-1.32]) and 46% for female migrants (aOR = 1.46 [1.25-1.69]). Conclusions: Higher risk sexual behavior in the context of migration increased women's likelihood of HIV infection.	[Camlin, Carol S.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Hosegood, Victoria; McGrath, Nuala] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Hosegood, Victoria; Newell, Marie-Louise; McGrath, Nuala; Barnighausen, Till] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa; [Newell, Marie-Louise] UCL, Ctr Paediat Epidemiol & Biostat, London, England; [Newell, Marie-Louise] UCL, Inst Child Hlth, London, England; [Barnighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Snow, Rachel C.] Univ Michigan, Sch Publ Hlth, Dept Hlth Behav & Hlth Educ, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; University of London; London School of Hygiene & Tropical Medicine; University of Kwazulu Natal; University of London; University College London; University of London; University College London; Harvard University; Harvard T.H. Chan School of Public Health; University of Michigan System; University of Michigan	Camlin, CS (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	carol.camlin@ucsf.edu	Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019	Newell, Marie-Louise/0000-0002-1074-7699; Hosegood, Victoria/0000-0002-2244-2518; McGrath, Nuala/0000-0002-1039-0159	National Institute of Mental Health (NIMH) National Research Service Fellowship [T32-19105-20]; Wellcome Trust [WT082599MA]; Nuala McGrath [WT083495MA]; National Institute of Child Health and Human Development (NICHD) [1R01-HD058482-01]; University of Michigan institutions; Rackham School of Graduate Studies; Center for the Education of Women; Center for Comparative and International Studies; International Institute; Alumni/Alumnae Council; South African Initiatives Office; Global Health Research and Training Initiative; Institute for Research on Women and Gender; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482, R24HD041028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH093205] Funding Source: NIH RePORTER; ESRC [ES/G027153/1] Funding Source: UKRI	National Institute of Mental Health (NIMH) National Research Service Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission); Nuala McGrath; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Michigan institutions; Rackham School of Graduate Studies; Center for the Education of Women; Center for Comparative and International Studies; International Institute; Alumni/Alumnae Council; South African Initiatives Office; Global Health Research and Training Initiative; Institute for Research on Women and Gender; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Carol Camlin was supported by a National Institute of Mental Health (NIMH) National Research Service Fellowship (T32-19105-20) during the preparation of this manuscript. The Africa Centre for Health and Population Studies, University of KwaZulu-Natal (UKZN) is a Wellcome Trust research centre (Grant GR082384/Z/07/Z). Victoria Hosegood was supported by the Wellcome Trust (WT082599MA), as was Nuala McGrath (WT083495MA). Till Barnighausen was supported by Grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development (NICHD). The following University of Michigan institutions provided funding to Dr. Camlin for this dissertation research: The Rackham School of Graduate Studies, the Center for the Education of Women, the Center for Comparative and International Studies, the International Institute, the Alumni/Alumnae Council, the South African Initiatives Office, the Global Health Research and Training Initiative, and the Institute for Research on Women and Gender. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B.A., 2006, MIGRATION S SO AFRIC, P97; Barnighausen T, 2007, AIDS, V21, pS29, DOI 10.1097/01.aids.0000300533.59483.95; Boerma JT, 2002, SEX TRANSM INFECT, V78, pI97, DOI 10.1136/sti.78.suppl_1.i97; Brockerhoff M, 1999, INT MIGR REV, V33, P833, DOI 10.2307/2547354; CAMLIN C, 2007, POP ASS AM 2007 ANN; Casale D, 2002, S AFR J ECON, V70, P156, DOI 10.1111/j.1813-6982.2002.tb00042.x; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Collinson M., 2006, AFRICA MOVE AFRICAN, P194; Desmond N, 2005, SOC SCI MED, V60, P1739, DOI 10.1016/j.socscimed.2004.08.027; Dodson B., 2000, BORDERS PERSPECTIVES, P119; Feinstein CH, 2005, EC HIST S AFRICA CON; GARIN B, 1993, ANN SOC BELG MED TR, V73, P143; GARNETT GP, 2002, SEX TRANSM INFECT S, V78, P14; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Halliday TJ, 2007, SOC SCI MED, V64, P1420, DOI 10.1016/j.socscimed.2006.11.007; HILL C, 2005, 25 INT POP C 18 23 J; Hope K R, 2001, Afr J Reprod Health, V5, P73, DOI 10.2307/3583325; Hope K R Sr, 2000, AIDS Anal Afr, V10, P6; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Hosegood V, 2007, SOC SCI MED, V65, P1249, DOI 10.1016/j.socscimed.2007.05.002; Hosegood V, 2009, DEMOGR RES, V20, P279, DOI 10.4054/DemRes.2009.20.13; Hosegood Victoria., 2016, AFRICAN HOUSEHOLDS C, P58; Hunter M, 2007, SOC SCI MED, V64, P689, DOI 10.1016/j.socscimed.2006.09.015; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K; Kothari U., 2003, J INT DEV, V15, P645, DOI [10.1002/jid.1022, DOI 10.1002/JID.1022, DOI 10.1002/jid.1022]; Krieger N, 2003, INT J EPIDEMIOL, V32, P652, DOI 10.1093/ije/dyg156; Little R. J. A., 2002, STAT ANAL MISSING DA; Lurie M, 1997, S AFR MED J, V87, P908; Lurie M, 1997, HLTH TRANSITION R S3, V7, P17; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Massey D. S., 1998, WORLDS MOTION UNDERS, DOI DOI 10.1111/j.1468-2435.2010.00678.x; MASSEY DS, 2006, AFRICA MOVE AFRICAN; McGrath N, 2009, SEX TRANSM INFECT, V85, pI49, DOI 10.1136/sti.2008.033324; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; Pettifor Audrey, 2004, HIV SEXUAL BEHAV YOU; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Posel D, 2003, S AFR J ECON, V71, P455; Posel D., 2004, J INTERDISC ECON, V15, P277, DOI [10.1177/02601079x04001500303, DOI 10.1177/02601079X04001500303]; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; SABOR RH, 1979, EC DEV URBAN MIGRATI; SHISANA O, 2005, S AFRICAN NATL HIV P; Shisana O., 2002, N MANDELA HSRC STUDY; Stark Oded., 1991, MIGRATION LABOUR; StataCorp L, 2007, STAT DAT AN STAT SOF; Tanser F, 2000, TROP MED INT HEALTH, V5, P40, DOI 10.1046/j.1365-3156.2000.00513.x; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; TIENDA M, 2006, AFRICA MOVE AFRICAN; Tienda Marta, 2006, AFRICA MOVE AFRICAN; Todaro M., 1976, INTERNAL MIGRATION D; Todd J, 2009, SEX TRANSM INFECT, V85, pI72, DOI 10.1136/sti.2008.033985; UDJO E, 2001, MARITAL PATTERNS FER; *UNAIDS, 2005, FEM AIDS EP 2005 GLO; UNAIDS, 2008, REP GLOB AIDS EP; VANDERBERG S, 2002, MIGRATION CHANGING R; Vissers DCJ, 2008, SEX TRANSM DIS, V35, P714, DOI 10.1097/OLQ.0b013e3181723d93; Welaga P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-193; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; White RG, 2008, SEX TRANSM INFECT, V84, P528, DOI 10.1136/sti.2008.032011; Yu DA., 2000, STAT METHODS CATEGOR; ZLOTNICK H, 2006, AFRICA MOVE AFRICAN; Zuberi T, 2004, INT MIGR REV, V38, P1462; Zuma K, 2005, EPIDEMIOL INFECT, V133, P421, DOI 10.1017/S0950268804003607	65	75	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11539	10.1371/journal.pone.0011539	http://dx.doi.org/10.1371/journal.pone.0011539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	623XV	20634965	Green Published, Green Accepted, gold			2022-12-27	WOS:000279781600018
J	Fadini, GP; Maruyama, S; Ozaki, T; Taguchi, A; Meigs, J; Dimmeler, S; Zeiher, AM; de Kreutzenberg, S; Avogaro, A; Nickenig, G; Schmidt-Lucke, C; Werner, N				Fadini, Gian Paolo; Maruyama, Shoichi; Ozaki, Takenori; Taguchi, Akihiko; Meigs, James; Dimmeler, Stefanie; Zeiher, Andreas M.; de Kreutzenberg, Saula; Avogaro, Angelo; Nickenig, Georg; Schmidt-Lucke, Caroline; Werner, Nikos			Circulating Progenitor Cell Count for Cardiovascular Risk Stratification: A Pooled Analysis	PLOS ONE			English	Article							MULTIPLE BIOMARKERS; NATURAL-HISTORY; PERIPHERAL-BLOOD; EVENTS; PREDICTION; DISEASE; POPULATION; INCREASE; NUMBER; CURVE	Background: Circulating progenitor cells (CPC) contribute to the homeostasis of the vessel wall, and a reduced CPC count predicts cardiovascular morbidity and mortality. We tested the hypothesis that CPC count improves cardiovascular risk stratification and that this is modulated by low-grade inflammation. Methodology/Principal Findings: We pooled data from 4 longitudinal studies, including a total of 1,057 patients having CPC determined and major adverse cardiovascular events (MACE) collected. We recorded cardiovascular risk factors and high-sensitive C-reactive protein (hsCRP) level. Risk estimates were derived from Cox proportional hazard analyses. CPC count and/or hsCRP level were added to a reference model including age, sex, cardiovascular risk factors, prevalent CVD, chronic renal failure (CRF) and medications. The sample was composed of high-risk individuals, as 76.3% had prevalent CVD and 31.6% had CRF. There were 331 (31.3%) incident MACE during an average 1.7 +/- 1.1 year follow-up time. CPC count was independently associated with incident MACE even after correction for hsCRP. According to C-statistics, models including CPC yielded a non-significant improvement in accuracy of MACE prediction. However, the integrated discrimination improvement index (IDI) showed better performance of models including CPC compared to the reference model and models including hsCRP in identifying MACE. CPC count also yielded significant net reclassification improvements (NRI) for CV death, non-fatal AMI and other CV events. The effect of CPC was independent of hsCRP, but there was a significant more-than-additive interaction between low CPC count and raised hsCRP level in predicting incident MACE. Conclusions/Significance: In high risk individuals, a reduced CPC count helps identifying more patients at higher risk of MACE over the short term, especially in combination with a raised hsCRP level.	[Fadini, Gian Paolo; de Kreutzenberg, Saula; Avogaro, Angelo] Univ Padua, Sch Med, Dept Clin & Expt Med, Padua, Italy; [Maruyama, Shoichi; Ozaki, Takenori] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Taguchi, Akihiko] Natl Cardiovasc Ctr, Dept Cerebrovasc Dis, Osaka, Japan; [Meigs, James] Harvard Univ, Sch Med, Boston, MA USA; [Meigs, James] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Dimmeler, Stefanie; Zeiher, Andreas M.] Goethe Univ Frankfurt, Frankfurt, Germany; [Nickenig, Georg; Werner, Nikos] Univ Hosp Bonn, Dept Internal Med 2, Div Cardiol Pneumol & Angiol, Bonn, Germany; [Schmidt-Lucke, Caroline] Charite, Dept Cardiol & Pneumol, D-13353 Berlin, Germany	University of Padua; Nagoya University; National Cerebral & Cardiovascular Center - Japan; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Goethe University Frankfurt; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Fadini, GP (corresponding author), Univ Padua, Sch Med, Dept Clin & Expt Med, Padua, Italy.	gianpaolofadini@hotmail.com	Avogaro, Angelo/S-3808-2016; Meigs, James/P-3927-2019; Fadini, Gian Paolo/M-4575-2019	Meigs, James/0000-0002-2439-2657; Fadini, Gian Paolo/0000-0002-6510-2097; Dimmeler, Stefanie/0000-0002-1045-2436; AVOGARO, ANGELO/0000-0002-1177-0516				Adams V, 2004, ARTERIOSCL THROM VAS, V24, P684, DOI 10.1161/01.ATV.0000124104.23702.a0; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Bogunia-Kubik K, 2009, BONE MARROW TRANSPL, V44, P273, DOI 10.1038/bmt.2009.30; Chambless LE, 2006, STAT MED, V25, P3474, DOI 10.1002/sim.2299; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Croce G, 2006, ARTERIOSCL THROM VAS, V26, pE38, DOI 10.1161/01.ATV.0000218504.71680.b5; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI13152; Fadini GP, 2008, ATHEROSCLEROSIS, V197, P496, DOI 10.1016/j.atherosclerosis.2007.12.039; Fadini GP, 2007, ATHEROSCLEROSIS, V194, P46, DOI 10.1016/j.atherosclerosis.2007.03.046; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2010, DIABETES CARE, V33, P1097, DOI 10.2337/dc09-1999; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; FADINI GP, 2009, ATHEROSCLER IN PRESS; FADINI GP, DIABETES CARE; Hackam DG, 2003, JAMA-J AM MED ASSOC, V290, P932, DOI 10.1001/jama.290.7.932; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; MARUYAMA S, 2008, KIDNEY INT; Maruyama S, 2008, KIDNEY INT, V74, P1603, DOI 10.1038/ki.2008.495; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Muller-Ehmsen J, 2008, EUR HEART J, V29, P1560, DOI 10.1093/eurheartj/ehn213; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Prokopi M, 2009, BLOOD, V114, P723, DOI 10.1182/blood-2009-02-205930; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Rosenzweig A, 2005, NEW ENGL J MED, V353, P1055, DOI 10.1056/NEJMe058134; ROTHMAN KJ, 1976, AM J EPIDEMIOL, V103, P506, DOI 10.1093/oxfordjournals.aje.a112252; Sakurai M, 2006, EXP HEMATOL, V34, P905, DOI 10.1016/j.exphem.2006.04.011; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shah SH, 2009, JAMA-J AM MED ASSOC, V302, P92, DOI 10.1001/jama.2009.949; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Taguchi A, 2004, CIRCULATION, V109, P2972, DOI 10.1161/01.CIR.0000133311.25587.DE; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zou GY, 2008, AM J EPIDEMIOL, V168, P212, DOI 10.1093/aje/kwn104	46	87	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11488	10.1371/journal.pone.0011488	http://dx.doi.org/10.1371/journal.pone.0011488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634884	Green Published, Green Submitted, gold			2022-12-27	WOS:000279715300005
J	Dziedzic, R; Kiran, M; Plocinski, P; Ziolkiewicz, M; Brzostek, A; Moomey, M; Vadrevu, IS; Dziadek, J; Madiraju, M; Rajagopalan, M				Dziedzic, Renata; Kiran, Manjot; Plocinski, Przemyslaw; Ziolkiewicz, Malgorzata; Brzostek, Anna; Moomey, Meredith; Vadrevu, Indumati S.; Dziadek, Jaroslaw; Madiraju, Murty; Rajagopalan, Malini			Mycobacterium tuberculosis ClpX Interacts with FtsZ and Interferes with FtsZ Assembly	PLOS ONE			English	Article							DIVISION PROTEIN FTSZ; ESCHERICHIA-COLI FTSZ; CELL-DIVISION; BACILLUS-SUBTILIS; DYNAMICS; EXPRESSION; POLYMERIZATION; CYTOKINESIS; CAULOBACTER; DEGRADATION	FtsZ assembly at the midcell division site in the form of a Z-ring is crucial for initiation of the cell division process in eubacteria. It is largely unknown how this process is regulated in the human pathogen Mycobacterium tuberculosis. Here we show that the expression of clpX was upregulated upon macrophage infection and exposure to cephalexin antibiotic, the conditions where FtsZ-ring assembly is delayed. Independently, we show using pull-down, solid-phase binding, bacterial two-hybrid and mycobacterial protein fragment complementation assays, that M. tuberculosis FtsZ interacts with ClpX, the substrate recognition domain of the ClpXP protease. Incubation of FtsZ with ClpX increased the critical concentration of GTP-dependent polymerization of FtsZ. Immunoblotting revealed that the intracellular ratio of ClpX to FtsZ in wild type M. tuberculosis is approximately 1:2. Overproduction of ClpX increased cell length and modulated the localization of FtsZ at midcell sites; however, intracellular FtsZ levels were unaffected. A ClpX-CFP fusion protein localized to the cell poles and midcell sites and colocalized with the FtsZ-YFP protein. ClpX also interacted with FtsZ mutant proteins defective for binding to and hydrolyzing GTP and possibly for interactions with other proteins. Taken together, our results suggest that M. tuberculosis ClpX interacts stoichiometrically with FtsZ protomers, independent of its nucleotide-bound state and negatively regulates FtsZ activities, hence cell division.	[Dziedzic, Renata; Kiran, Manjot; Plocinski, Przemyslaw; Moomey, Meredith; Vadrevu, Indumati S.; Madiraju, Murty; Rajagopalan, Malini] Univ Texas Hlth Sci Ctr, Tyler, TX USA; [Ziolkiewicz, Malgorzata; Brzostek, Anna; Dziadek, Jaroslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Dziedzic, R (corresponding author), Univ Texas Hlth Sci Ctr, Tyler, TX USA.	malini.rajagopalan@uthct.edu	Płociński, Przemysław A/S-5587-2017	Płociński, Przemysław A/0000-0002-6623-3494; Dziadek, Jaroslaw/0000-0003-1427-884X	NIH [RO1AI48417, RO1AI73966, AI084734]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI073966, R01AI084734, R01AI048417] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by NIH grants RO1AI48417 (MR) and RO1AI73966, AI084734 (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; CAMBERG JL, 2009, P NATL ACAD SCI US; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; Datta P, 2002, J BIOL CHEM, V277, P24983, DOI 10.1074/jbc.M203847200; Datta P, 2006, MOL MICROBIOL, V62, P1655, DOI 10.1111/j.1365-2958.2006.05491.x; Del Sol R, 2006, J BACTERIOL, V188, P1540, DOI 10.1128/JB.188.4.1540-1550.2006; Dziadek J, 2002, MICROBIOL-SGM, V148, P961, DOI 10.1099/00221287-148-4-961; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Engels S, 2004, MOL MICROBIOL, V52, P285, DOI 10.1111/j.1365-2958.2003.03979.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Frees D, 2007, MOL MICROBIOL, V63, P1285, DOI 10.1111/j.1365-2958.2007.05598.x; Galletto R, 2007, CURR BIOL, V17, pR395, DOI 10.1016/j.cub.2007.03.009; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gerth U, 2004, J BACTERIOL, V186, P179, DOI 10.1128/JB.186.1.179-191.2004; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Haeusser DP, 2009, J BACTERIOL, V191, P1986, DOI 10.1128/JB.01606-07; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hett EC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000001; Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Nair N, 2009, MOL MICROBIOL, V71, P291, DOI 10.1111/j.1365-2958.2008.06523.x; Rajagopalan M, 2005, BIOCHEM BIOPH RES CO, V331, P1171, DOI 10.1016/j.bbrc.2005.03.239; Rajagopalan M, 2005, FEMS MICROBIOL LETT, V250, P9, DOI 10.1016/j.femsle.2005.06.043; Romberg L, 2003, ANNU REV MICROBIOL, V57, P125, DOI 10.1146/annurev.micro.57.012903.074300; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sugimoto S, 2010, J BIOL CHEM, V285, P6648, DOI 10.1074/jbc.M109.080739; Sureka K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008590; Viala J, 2002, MOL MICROBIOL, V44, P633, DOI 10.1046/j.1365-2958.2002.02907.x; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000	52	52	53	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11058	10.1371/journal.pone.0011058	http://dx.doi.org/10.1371/journal.pone.0011058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625433	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500002
J	Thaunat, O; Graff-Dubois, S; Brouard, S; Gautreau, C; Varthaman, A; Fabien, N; Field, AC; Louedec, L; Dai, JP; Joly, E; Morelon, E; Soulillou, JP; Michel, JB; Nicoletti, A				Thaunat, Olivier; Graff-Dubois, Stephanie; Brouard, Sophie; Gautreau, Chantal; Varthaman, Aditi; Fabien, Nicole; Field, Anne-Christine; Louedec, Liliane; Dai, Jianping; Joly, Etienne; Morelon, Emmanuel; Soulillou, Jean-Paul; Michel, Jean-Baptiste; Nicoletti, Antonino			Immune Responses Elicited in Tertiary Lymphoid Tissues Display Distinctive Features	PLOS ONE			English	Article							T-CELL; CHRONIC REJECTION; MEDIATED REJECTION; NEOGENESIS; ALLOGRAFT; ALLOANTIBODY; TOLERANCE; SURVIVAL; GRAFTS; RATS	During chronic inflammation, immune effectors progressively organize themselves into a functional tertiary lymphoid tissue (TLT) within the targeted organ. TLT has been observed in a wide range of chronic inflammatory conditions but its pathophysiological significance remains unknown. We used the rat aortic interposition model in which a TLT has been evidenced in the adventitia of chronically rejected allografts one month after transplantation. The immune responses elicited in adventitial TLT and those taking place in spleen and draining lymph nodes (LN) were compared in terms of antibody production, T cell activation and repertoire perturbations. The anti-MHC humoral response was more intense and more diverse in TLT. This difference was associated with an increased percentage of activated CD4+ T cells and a symmetric reduction of regulatory T cell subsets. Moreover, TCR repertoire perturbations in TLT were not only increased and different from the common pattern observed in spleen and LN but also "stochastic,'' since each recipient displayed a specific pattern. We propose that the abnormal activation of CD4+ T cells promotes the development of an exaggerated pathogenic immune humoral response in TLT. Preliminary findings suggest that this phenomenon i) is due to a defective immune regulation in this non-professional inflammatory-induced lymphoid tissue, and ii) also occurs in human chronically rejected grafts.	[Thaunat, Olivier; Fabien, Nicole; Morelon, Emmanuel] Univ Lyon 1, F-69622 Villeurbanne, France; [Thaunat, Olivier; Fabien, Nicole; Morelon, Emmanuel] INSERM, U851, F-69008 Lyon, France; [Thaunat, Olivier; Morelon, Emmanuel] Hop Edouard Herriot, Serv Transplantat Renale & Immunol Clin, Lyon, France; [Graff-Dubois, Stephanie; Varthaman, Aditi; Louedec, Liliane; Dai, Jianping; Michel, Jean-Baptiste; Nicoletti, Antonino] Hop Xavier Bichat, INSERM, U698, Paris, France; [Brouard, Sophie; Soulillou, Jean-Paul] Hop Hotel Dieu, Inst Transplantat & Rech Transplantat, Unite Mixte Rech Sante 643, Nantes, France; [Gautreau, Chantal] Hop St Louis, Lab Reg Histocompatibil IR7, AP HP, Paris, France; [Fabien, Nicole] Ctr Hosp Lyon Sud, Immunol Lab, Hosp Civils Lyon, F-69310 Pierre Benite, France; [Field, Anne-Christine] UCL, Inst Child Hlth, Mol Immunol Unit, London, England; [Joly, Etienne] Inst Pharmacol & Biol Struct, Unite Mixte Rech 5089, Toulouse, France; [Nicoletti, Antonino] Univ Paris 07, Paris, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; University of London; University College London; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Thaunat, O (corresponding author), Univ Lyon 1, F-69622 Villeurbanne, France.	olivier.thaunatpastu@free.fr	Nicoletti, Antonino/A-9460-2015; brouard, sophie c/Q-1285-2016; Joly, Etienne/A-5644-2009; Michel, Jean-Baptiste/AAH-9336-2020; Graff-Dubois, Stephanie/GQA-4845-2022; Thaunat, Olivier/M-2423-2014	Nicoletti, Antonino/0000-0002-2623-0897; Joly, Etienne/0000-0002-7264-2681; Graff-Dubois, Stephanie/0000-0001-7273-3930; Thaunat, Olivier/0000-0002-3648-8963; Field, Anne-Christine/0000-0002-4894-1964; Varthaman, Aditi/0000-0002-8703-5534	Fondation pour la Recherche Medicale; Societe de Nephrologie; Hospices Civils de Lyon; CENTAURE Transplantation Research Network	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Societe de Nephrologie; Hospices Civils de Lyon; CENTAURE Transplantation Research Network	OT is supported by the Fondation pour la Recherche Medicale, the Societe de Nephrologie, the Hospices Civils de Lyon, and the CENTAURE Transplantation Research Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUCHINCLOSS H, 1988, TRANSPLANTATION, V45, P1118, DOI 10.1097/00007890-198806000-00024; Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Brouard S, 1999, J IMMUNOL, V162, P3367; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Deteix C, 2010, J IMMUNOL, V184, P5344, DOI 10.4049/jimmunol.0902999; Douillard P, 1996, J IMMUNOL, V157, P1250; GONZALEZ AL, 1995, TRANSPLANT P, V27, P1516; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Guillet M, 2002, J IMMUNOL, V168, P5088, DOI 10.4049/jimmunol.168.10.5088; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Miqueu P, 2007, MOL IMMUNOL, V44, P1057, DOI 10.1016/j.molimm.2006.06.026; MORTON AL, 1993, EUR J IMMUNOL, V23, P2078, DOI 10.1002/eji.1830230906; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; PANNETIER C, 1995, IMMUNOL TODAY, V16, P176, DOI 10.1016/0167-5699(95)80117-0; Pettigrew GJ, 1998, J IMMUNOL, V161, P1292; PLISSONNIER D, 1995, TRANSPLANTATION, V60, P414, DOI 10.1097/00007890-199509000-00003; PLISSONNIER D, 1991, ARTERIOSCLER THROMB, V11, P1690, DOI 10.1161/01.ATV.11.6.1690; PRINEAS JW, 1979, SCIENCE, V203, P1123, DOI 10.1126/science.424741; ROSENBERG HF, 2003, FUNDAMENTAL IMMUNOLO; RUGGIERO R, 1994, J THORAC CARDIOV SUR, V108, P253; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Stuber E, 1996, J EXP MED, V183, P979, DOI 10.1084/jem.183.3.979; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Thaunat O, 2008, TRANSPLANTATION, V85, P1648, DOI 10.1097/TP.0b013e3181735723; Thaunat O, 2008, CURR OPIN ORGAN TRAN, V13, P16, DOI 10.1097/MOT.0b013e3282f3df15; Thaunat O, 2006, TRENDS IMMUNOL, V27, P441, DOI 10.1016/j.it.2006.08.003; Thaunat O, 2006, CURR OPIN IMMUNOL, V18, P576, DOI 10.1016/j.coi.2006.07.006; Wildbaum G, 2002, J CLIN INVEST, V110, P701, DOI 10.1172/JCI200215176	30	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11398	10.1371/journal.pone.0011398	http://dx.doi.org/10.1371/journal.pone.0011398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613979	Green Published, Green Submitted, gold			2022-12-27	WOS:000279370000024
J	Chou, KC; Shen, HB				Chou, Kuo-Chen; Shen, Hong-Bin			Plant-mPLoc: A Top-Down Strategy to Augment the Power for Predicting Plant Protein Subcellular Localization	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; SUPPORT VECTOR MACHINES; FUNCTIONAL DOMAIN COMPOSITION; COUPLED RECEPTOR CLASSES; LOCATION PREDICTION; APOPTOSIS PROTEINS; GENE ONTOLOGY; EVOLUTION INFORMATION; APPROXIMATE ENTROPY; STRUCTURAL CLASSES	One of the fundamental goals in proteomics and cell biology is to identify the functions of proteins in various cellular organelles and pathways. Information of subcellular locations of proteins can provide useful insights for revealing their functions and understanding how they interact with each other in cellular network systems. Most of the existing methods in predicting plant protein subcellular localization can only cover three or four location sites, and none of them can be used to deal with multiplex plant proteins that can simultaneously exist at two, or move between, two or more different location sits. Actually, such multiplex proteins might have special biological functions worthy of particular notice. The present study was devoted to improve the existing plant protein subcellular location predictors from the aforementioned two aspects. A new predictor called "Plant-mPLoc'' is developed by integrating the gene ontology information, functional domain information, and sequential evolutionary information through three different modes of pseudo amino acid composition. It can be used to identify plant proteins among the following 12 location sites: (1) cell membrane, (2) cell wall, (3) chloroplast, (4) cytoplasm, (5) endoplasmic reticulum, (6) extracellular, (7) Golgi apparatus, (8) mitochondrion, (9) nucleus, (10) peroxisome, (11) plastid, and (12) vacuole. Compared with the existing methods for predicting plant protein subcellular localization, the new predictor is much more powerful and flexible. Particularly, it also has the capacity to deal with multiple-location proteins, which is beyond the reach of any existing predictors specialized for identifying plant protein subcellular localization. As a user-friendly web-server, Plant-mPLoc is freely accessible at http://www.csbio.sjtu.edu.cn/bioinf/plant-multi/. Moreover, for the convenience of the vast majority of experimental scientists, a step-by-step guide is provided on how to use the web-server to get the desired results. It is anticipated that the Plant-mPLoc predictor as presented in this paper will become a very useful tool in plant science as well as all the relevant areas.	[Chou, Kuo-Chen; Shen, Hong-Bin] Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai 200030, Peoples R China; [Chou, Kuo-Chen; Shen, Hong-Bin] Gordon Life Sci Inst, San Diego, CA USA	Shanghai Jiao Tong University	Chou, KC (corresponding author), Shanghai Jiao Tong Univ, Inst Image Proc & Pattern Recognit, Shanghai 200030, Peoples R China.	kcchou@gordonlifescience.org	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60704047]; Science and Technology Commission of Shanghai Municipality [08ZR1410600, 08JC1410600]; Shanghai Pujiang Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by the National Natural Science Foundation of China (Grant No. 60704047), Science and Technology Commission of Shanghai Municipality (Grant No. 08ZR1410600, 08JC1410600) and sponsored by the Shanghai Pujiang Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barrell D, 2009, NUCLEIC ACIDS RES, V37, pD396, DOI 10.1093/nar/gkn803; Cai YD, 2003, BIOPHYS J, V84, P3257, DOI 10.1016/S0006-3495(03)70050-2; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; Chou KC, 2004, BIOCHEM BIOPH RES CO, V316, P636, DOI 10.1016/j.bbrc.2004.02.098; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, BIOCHEM BIOPH RES CO, V376, P321, DOI 10.1016/j.bbrc.2008.08.125; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2007, BIOCHEM BIOPH RES CO, V360, P339, DOI 10.1016/j.bbrc.2007.06.027; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2007, J CELL BIOCHEM, V100, P665, DOI 10.1002/jcb.21096; Chou KC, 2009, CURR PROTEOMICS, V6, P262, DOI 10.2174/157016409789973707; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; DENOEUX T, 1995, IEEE T SYST MAN CYB, V25, P804, DOI 10.1109/21.376493; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Ding YS, 2008, PATTERN RECOGN LETT, V29, P1887, DOI 10.1016/j.patrec.2008.06.007; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Esmaeili M, 2010, J THEOR BIOL, V263, P203, DOI 10.1016/j.jtbi.2009.11.016; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Georgiou DN, 2009, J THEOR BIOL, V257, P17, DOI 10.1016/j.jtbi.2008.11.003; Gerstein M, 2003, CURR OPIN STRUC BIOL, V13, P341, DOI 10.1016/S0959-440X(03)00080-0; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Gonzalez-Diaz H, 2008, PROTEOMICS, V8, P750, DOI 10.1002/pmic.200700638; Gu Q, 2010, PROTEIN PEPTIDE LETT, V17, P559, DOI 10.2174/092986610791112693; He ZS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009603; Jiang XY, 2008, PROTEIN PEPTIDE LETT, V15, P392, DOI 10.2174/092986608784246443; JIANG Y, 2008, J COMPUT CHEM; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2009, ACTA BIOTHEOR, V57, P321, DOI 10.1007/s10441-008-9067-4; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Matsuda S, 2005, PROTEIN SCI, V14, P2804, DOI 10.1110/ps.051597405; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Murvai J, 2001, NUCLEIC ACIDS RES, V29, P58, DOI 10.1093/nar/29.1.58; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Qiu JD, 2009, ANAL BIOCHEM, V390, P68, DOI 10.1016/j.ab.2009.04.009; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shafer G.A., 1976, MATH THEORY EVIDENCE; Shen H.-B., 2009, J BIOMED SCI ENG, V2, DOI DOI 10.4236/JBISE.2009.23024; Shen H.B., 2009, OPEN BIOINFORM J, V3, P31, DOI DOI 10.2174/1875036200903010031; Shen HB, 2005, BIOCHEM BIOPH RES CO, V334, P288, DOI 10.1016/j.bbrc.2005.06.087; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; SMITH C, 2008, SUBCELLULAR TARGETIN; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wang JF, 2009, NAT STRUCT MOL BIOL, V16, P1267, DOI 10.1038/nsmb.1707; Yang JY, 2009, J THEOR BIOL, V257, P618, DOI 10.1016/j.jtbi.2008.12.027; Zeng YH, 2009, J THEOR BIOL, V259, P366, DOI 10.1016/j.jtbi.2009.03.028; Zhang GY, 2008, J THEOR BIOL, V253, P310, DOI 10.1016/j.jtbi.2008.03.015; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zhou GP, 1998, J PROTEIN CHEM, V17, P729, DOI 10.1023/A:1020713915365; Zhou XB, 2007, J THEOR BIOL, V248, P546, DOI 10.1016/j.jtbi.2007.06.001; Zouhal LM, 1998, IEEE T SYST MAN CY C, V28, P263, DOI 10.1109/5326.669565	69	555	593	4	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11335	10.1371/journal.pone.0011335	http://dx.doi.org/10.1371/journal.pone.0011335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596258	Green Submitted, Green Published, gold			2022-12-27	WOS:000279259900008
J	Dibble, CF; Horst, JA; Malone, MH; Park, K; Temple, B; Cheeseman, H; Barbaro, JR; Johnson, GL; Bencharit, S				Dibble, Christopher F.; Horst, Jeremy A.; Malone, Michael H.; Park, Kun; Temple, Brenda; Cheeseman, Holly; Barbaro, Justin R.; Johnson, Gary L.; Bencharit, Sompop			Defining the Functional Domain of Programmed Cell Death 10 through Its Interactions with Phosphatidylinositol-3,4,5-Trisphosphate	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; PROTEIN-STRUCTURE PREDICTION; SIZE-EXCLUSION CHROMATOGRAPHY; LASER-LIGHT SCATTERING; CRYSTAL-STRUCTURE; MEMBRANE CURVATURE; NATURAL-HISTORY; COILED-COILS; BAR-DOMAIN; MUTATIONS	Cerebral cavernous malformations (CCM) are vascular abnormalities of the central nervous system predisposing blood vessels to leakage, leading to hemorrhagic stroke. Three genes, Krit1 (CCM1), OSM (CCM2), and PDCD10 (CCM3) are involved in CCM development. PDCD10 binds specifically to PtdIns(3,4,5) P3 and OSM. Using threading analysis and multi-template modeling, we constructed a three-dimensional model of PDCD10. PDCD10 appears to be a six-helical-bundle protein formed by two heptad-repeat-hairpin structures (alpha 1-3 and alpha 4-6) sharing the closest 3D homology with the bacterial phosphate transporter, PhoU. We identified a stretch of five lysines forming an amphipathic helix, a potential PtdIns(3,4,5) P3 binding site, in the alpha 5 helix. We generated a recombinant wild-type (WT) and three PDCD10 mutants that have two (Delta 2KA), three (Delta 3KA), and five (Delta 5KA) K to A mutations. Delta 2KA and Delta 3KA mutants hypothetically lack binding residues to PtdIns(3,4,5) P3 at the beginning and the end of predicted helix, while Delta 5KA completely lacks all predicted binding residues. The WT, Delta 2KA, and Delta 3KA mutants maintain their binding to PtdIns(3,4,5) P3. Only the Delta 5KA abolishes binding to PtdIns(3,4,5) P3. Both Delta 5KA and WT show similar secondary and tertiary structures; however, Delta 5KA does not bind to OSM. When WT and Delta 5KA are co-expressed with membrane-bound constitutively-active PI3 kinase (p110-CAAX), the majority of the WT is co-localized with p110-CAAX at the plasma membrane where PtdIns(3,4,5) P3 is presumably abundant. In contrast, the Delta 5KA remains in the cytoplasm and is not present in the plasma membrane. Combining computational modeling and biological data, we propose that the CCM protein complex functions in the PI3K signaling pathway through the interaction between PDCD10 and PtdIns(3,4,5) P3.	[Dibble, Christopher F.; Malone, Michael H.; Temple, Brenda; Johnson, Gary L.; Bencharit, Sompop] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Dibble, Christopher F.; Malone, Michael H.; Temple, Brenda; Johnson, Gary L.; Bencharit, Sompop] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Park, Kun; Cheeseman, Holly; Barbaro, Justin R.; Bencharit, Sompop] Univ N Carolina, Sch Dent, Dept Prosthodont, Chapel Hill, NC 27599 USA; [Park, Kun; Cheeseman, Holly; Barbaro, Justin R.; Bencharit, Sompop] Univ N Carolina, Dent Res Ctr, Sch Dent, Chapel Hill, NC 27599 USA; [Horst, Jeremy A.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Horst, Jeremy A.] Univ Washington, Sch Dent, Dept Oral Biol, Seattle, WA 98195 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dibble, CF (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27515 USA.	Sompop_Bencharit@dentistry.unc.edu	Bencharit, Sompop/AAO-8563-2020		National Institutes of Health (NIH) [HL092338, GM068820, GM068820-S1, T32GM80079]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL092338, F30HL108598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F30DE017522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080079, R01GM068820] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by the National Institutes of Health (NIH) grant HL092338 (to S. B.) GM068820 and GM068820-S1 (to G.L.J.), and T32GM80079 (to C. F. D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud F, 1999, P NATL ACAD SCI USA, V96, P12494, DOI 10.1073/pnas.96.22.12494; Becker Y, 2007, VIRUS GENES, V34, P233, DOI 10.1007/s11262-007-0082-3; Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen L, 2009, J NEUROSURG-SPINE, V10, P3, DOI 10.3171/2008.9.SPI0822; Cheng YH, 2007, COMM COM INF SC, V2, P1; Clatterbuck RE, 2002, J NEUROSURG, V97, P227, DOI 10.3171/spi.2002.97.2.0227; Craig HD, 1998, HUM MOL GENET, V7, P1851, DOI 10.1093/hmg/7.12.1851; Davenport WJ, 2001, NEUROLOGY, V56, P540, DOI 10.1212/WNL.56.4.540; DELCURLING O, 1991, J NEUROSURG, V75, P702, DOI 10.3171/jns.1991.75.5.0702; Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718; Derewenda ZS, 2004, STRUCTURE, V12, P529, DOI 10.1016/j.str.2004.03.008; DUBOVSKY J, 1995, HUM MOL GENET, V4, P453, DOI 10.1093/hmg/4.3.453; Dupre N, 2003, CAN J NEUROL SCI, V30, P122, DOI 10.1017/S0317167100053385; Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351; Fernandez-Recio J, 2005, PROTEINS, V58, P134, DOI 10.1002/prot.20285; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gidh AV, 2006, J CHROMATOGR A, V1114, P102, DOI 10.1016/j.chroma.2006.02.044; Ginalski K, 2006, CURR OPIN STRUC BIOL, V16, P172, DOI 10.1016/j.sbi.2006.02.003; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008; Guclu B, 2005, NEUROSURGERY, V57, P1008, DOI 10.1227/01.NEU.0000180811.56157.E1; Guntert Peter, 2004, Methods Mol Biol, V278, P353; He Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000722; Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Hung LH, 2005, NUCLEIC ACIDS RES, V33, pW77, DOI 10.1093/nar/gki403; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Izard T, 2004, NATURE, V427, P171, DOI 10.1038/nature02281; Jiang BH, 2009, ADV CANCER RES, V102, P19, DOI 10.1016/S0065-230X(09)02002-8; Kryshtafovych A, 2005, PROTEINS, V61, P19, DOI 10.1002/prot.20718; Labauge P, 1998, LANCET, V352, P1892, DOI 10.1016/S0140-6736(98)03011-6; Laberge-Le Couteulx S, 2002, ARCH OPHTHALMOL-CHIC, V120, P217; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; LEVITT M, 1995, COMPUT PHYS COMMUN, V91, P215, DOI 10.1016/0010-4655(95)00049-L; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Marti-Renom MA, 2001, BIOINFORMATICS, V17, P746, DOI 10.1093/bioinformatics/17.8.746; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Murphy GA, 2002, J BIOL CHEM, V277, P9966, DOI 10.1074/jbc.M109059200; Oganesyan V, 2005, J BACTERIOL, V187, P4238, DOI 10.1128/JB.187.12.4238-4244.2005; Oliva A, 2001, J PHARMACEUT BIOMED, V25, P833, DOI 10.1016/S0731-7085(01)00359-4; OTTEN P, 1989, NEUROCHIRURGIE, V35, P82; Papakonstanti EA, 2007, EMBO J, V26, P3050, DOI 10.1038/sj.emboj.7601763; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PICKETT SD, 1993, J MOL BIOL, V231, P825, DOI 10.1006/jmbi.1993.1329; Prutzman KC, 2004, STRUCTURE, V12, P881, DOI 10.1016/S0969-2126(04)00097-8; RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605; ROBINSON JR, 1991, J NEUROSURG, V75, P709, DOI 10.3171/jns.1991.75.5.0709; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Russell DS, 1989, PATHOLOGY TUMOURS NE, P730; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Saraf MC, 2003, PROTEIN ENG, V16, P397, DOI 10.1093/protein/gzg053; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Verlaan DJ, 2004, ANN NEUROL, V55, P757, DOI 10.1002/ana.20112; Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9; Voss K, 2009, HUM MUTAT, V30, P1003, DOI 10.1002/humu.20996; Wang K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000181; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Zabramski JM, 1999, NEUROSURG CLIN N AM, V10, P395, DOI 10.1016/S1042-3680(18)30174-8; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zhang J, 2000, NEUROSURGERY, V46, P1272, DOI 10.1097/00006123-200005000-00064; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	70	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11740	10.1371/journal.pone.0011740	http://dx.doi.org/10.1371/journal.pone.0011740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668527	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243800014
J	Chang, NH; Cheung, YH; Loh, C; Pau, E; Roy, V; Cai, YC; Wither, J				Chang, Nan-Hua; Cheung, Yui-Ho; Loh, Christina; Pau, Evelyn; Roy, Valerie; Cai, Yong-Chun; Wither, Joan			B Cell Activating Factor (BAFF) and T Cells Cooperate to Breach B Cell Tolerance in Lupus-Prone New Zealand Black (NZB) Mice	PLOS ONE			English	Article							FC-GAMMA-RIIB; LYMPHOCYTE STIMULATOR; TRANSGENIC MICE; AUTOIMMUNE-DISEASE; PROMOTER REGION; SELF-TOLERANCE; CUTTING EDGE; IN-VIVO; SURVIVAL; ERYTHEMATOSUS	The presence of autoantibodies in New Zealand Black (NZB) mice suggests a B cell tolerance defect however the nature of this defect is unknown. To determine whether defects in B cell anergy contribute to the autoimmune phenotype in NZB mice, soluble hen egg lysozyme (sHEL) and anti-HEL Ig transgenes were bred onto the NZB background to generate double transgenic (dTg) mice. NZB dTg mice had elevated levels of anti-HEL antibodies, despite apparently normal B cell functional anergy in-vitro. NZB dTg B cells also demonstrated increased survival and abnormal entry into the follicular compartment following transfer into sHEL mice. Since this process is dependent on BAFF, BAFF serum and mRNA levels were assessed and were found to be significantly elevated in NZB dTg mice. Treatment of NZB sHEL recipient mice with TACI-Ig reduced NZB dTg B cell survival following adoptive transfer, confirming the role of BAFF in this process. Although NZB mice had modestly elevated BAFF, the enhanced NZB B cell survival response appeared to result from an altered response to BAFF. In contrast, T cell blockade had a minimal effect on B cell survival, but inhibited anti-HEL antibody production. The findings suggest that the modest BAFF elevations in NZB mice are sufficient to perturb B cell tolerance, particularly when acting in concert with B cell functional abnormalities and T cell help.	[Chang, Nan-Hua; Cheung, Yui-Ho; Loh, Christina; Pau, Evelyn; Roy, Valerie; Cai, Yong-Chun] Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada; [Cheung, Yui-Ho; Loh, Christina; Pau, Evelyn; Wither, Joan] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Wither, Joan] Univ Hlth Network, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Chang, NH (corresponding author), Toronto Western Res Inst, Arthrit Ctr Excellence, Toronto, ON, Canada.	jwither@uhnres.utoronto.ca		Wither, Joan/0000-0001-5961-9228	Canadian Institutes of Health Research; Arthritis Centre of Excellence of the University of Toronto	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Arthritis Centre of Excellence of the University of Toronto(University of Toronto)	This work was supported by a grant from the Canadian Institutes of Health Research (Joan Wither). Joan Wither is supported by The Arthritis Centre of Excellence of the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Brownlie RJ, 2008, J EXP MED, V205, P883, DOI 10.1084/jem.20072565; Chang NH, 2004, J IMMUNOL, V172, P1553, DOI 10.4049/jimmunol.172.3.1553; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Craxton A, 2005, J EXP MED, V202, P1363, DOI 10.1084/jem.20051283; Culton DA, 2006, J IMMUNOL, V176, P790, DOI 10.4049/jimmunol.176.2.790; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Fang W, 1998, IMMUNITY, V9, P35, DOI 10.1016/S1074-7613(00)80586-5; FULCHER DA, 1994, J EXP MED, V179, P125, DOI 10.1084/jem.179.1.125; Fulcher DA, 1996, J EXP MED, V183, P2313, DOI 10.1084/jem.183.5.2313; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GOODNOW CC, 1995, ADV IMMUNOL, V59, P279, DOI 10.1016/S0065-2776(08)60633-1; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Halverson R, 2004, NAT IMMUNOL, V5, P645, DOI 10.1038/ni1076; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; Hase H, 2004, BLOOD, V103, P2257, DOI 10.1182/blood-2003-08-2694; Hippen KL, 2005, J IMMUNOL, V175, P909, DOI 10.4049/jimmunol.175.2.909; Hsu BL, 2002, J IMMUNOL, V168, P5993, DOI 10.4049/jimmunol.168.12.5993; Inaoki M, 1997, J EXP MED, V186, P1923, DOI 10.1084/jem.186.11.1923; IZUI S, 1978, J IMMUNOL, V121, P2213; Jiang Y, 1999, INT IMMUNOL, V11, P1685, DOI 10.1093/intimm/11.10.1685; Jongstra-Bilen J, 1997, J IMMUNOL, V159, P5810; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mandik-Nayak L, 2000, INT IMMUNOL, V12, P353, DOI 10.1093/intimm/12.3.353; MANNY N, 1979, J IMMUNOL, V122, P1220; McGaha TL, 2005, SCIENCE, V307, P590, DOI 10.1126/science.1105160; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; MOUTSOPOULOS HM, 1977, J IMMUNOL, V119, P1639; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Rahman ZSM, 2005, J IMMUNOL, V175, P1440, DOI 10.4049/jimmunol.175.3.1440; Rathmell JC, 1998, J EXP MED, V188, P651, DOI 10.1084/jem.188.4.651; RAVECHE ES, 1982, J IMMUNOL, V129, P1219; Roy V, 2005, J IMMUNOL, V175, P7363, DOI 10.4049/jimmunol.175.11.7363; Roy V, 2007, EUR J IMMUNOL, V37, P2645, DOI 10.1002/eji.200737334; Sasaki Y, 2004, J IMMUNOL, V173, P2245, DOI 10.4049/jimmunol.173.4.2245; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Stohl W, 2003, ARTHRITIS RHEUM-US, V48, P3475, DOI 10.1002/art.11354; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; WANGEL AG, 1982, CLIN EXP IMMUNOL, V49, P41; Wither JE, 2000, CLIN IMMUNOL, V94, P51, DOI 10.1006/clim.1999.4806; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Xiu Y, 2002, J IMMUNOL, V169, P4340, DOI 10.4049/jimmunol.169.8.4340; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6	51	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11691	10.1371/journal.pone.0011691	http://dx.doi.org/10.1371/journal.pone.0011691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20661465	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500029
J	Siddappa, NB; Watkins, JD; Wassermann, KJ; Song, RJ; Wang, W; Kramer, VG; Lakhashe, S; Santosuosso, M; Poznansky, MC; Novembre, FJ; Villinger, F; Else, JG; Montefiori, DC; Rasmussen, RA; Ruprecht, RM				Siddappa, Nagadenahalli B.; Watkins, Jennifer D.; Wassermann, Klemens J.; Song, Ruijiang; Wang, Wendy; Kramer, Victor G.; Lakhashe, Samir; Santosuosso, Michael; Poznansky, Mark C.; Novembre, Francis J.; Villinger, Francois; Else, James G.; Montefiori, David C.; Rasmussen, Robert A.; Ruprecht, Ruth M.			R5 Clade C SHIV Strains with Tier 1 or 2 Neutralization Sensitivity: Tools to Dissect Env Evolution and to Develop AIDS Vaccines in Primate Models	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; GP120 ENVELOPE GLYCOPROTEIN; ACUTE HIV-1 INFECTION; PASSAGED IN-VIVO; ANTIBODY-RESPONSE; TYPE-1 GP120; GASTROINTESTINAL-TRACT; LINKED GLYCOSYLATION; RHESUS-MONKEYS	Background: HIV-1 clade C (HIV-C) predominates worldwide, and anti-HIV-C vaccines are urgently needed. Neutralizing antibody (nAb) responses are considered important but have proved difficult to elicit. Although some current immunogens elicit antibodies that neutralize highly neutralization-sensitive (tier 1) HIV strains, most circulating HIVs exhibiting a less sensitive (tier 2) phenotype are not neutralized. Thus, both tier 1 and 2 viruses are needed for vaccine discovery in nonhuman primate models. Methodology/Principal Findings: We constructed a tier 1 simian-human immunodeficiency virus, SHIV-1157ipEL, by inserting an "early,'' recently transmitted HIV-C env into the SHIV-1157ipd3N4 backbone [ 1] encoding a "late'' form of the same env, which had evolved in a SHIV-infected rhesus monkey (RM) with AIDS. SHIV-1157ipEL was rapidly passaged to yield SHIV-1157ipEL-p, which remained exclusively R5-tropic and had a tier 1 phenotype, in contrast to "late'' SHIV-1157ipd3N4 (tier 2). After 5 weekly low-dose intrarectal exposures, SHIV-1157ipEL-p systemically infected 16 out of 17 RM with high peak viral RNA loads and depleted gut CD4(+) T cells. SHIV-1157ipEL-p and SHIV-1157ipd3N4 env genes diverge mostly in V1/V2. Molecular modeling revealed a possible mechanism for the increased neutralization resistance of SHIV-1157ipd3N4 Env: V2 loops hindering access to the CD4 binding site, shown experimentally with nAb b12. Similar mutations have been linked to decreased neutralization sensitivity in HIV-C strains isolated from humans over time, indicating parallel HIV-C Env evolution in humans and RM. Conclusions/Significance: SHIV-1157ipEL-p, the first tier 1 R5 clade C SHIV, and SHIV-1157ipd3N4, its tier 2 counterpart, represent biologically relevant tools for anti-HIV-C vaccine development in primates.	[Siddappa, Nagadenahalli B.; Watkins, Jennifer D.; Wassermann, Klemens J.; Song, Ruijiang; Wang, Wendy; Kramer, Victor G.; Lakhashe, Samir; Rasmussen, Robert A.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Siddappa, Nagadenahalli B.; Watkins, Jennifer D.; Song, Ruijiang; Lakhashe, Samir; Santosuosso, Michael; Poznansky, Mark C.; Rasmussen, Robert A.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Santosuosso, Michael; Poznansky, Mark C.] Massachusetts Gen Hosp E, Partners AIDS Res Ctr & Infect Dis Med, Charlestown, MA USA; [Novembre, Francis J.; Villinger, Francois; Else, James G.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Novembre, Francis J.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Villinger, Francois; Else, James G.] Emory Univ, Div Pathol & Lab Med, Atlanta, GA 30322 USA; [Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Emory University; Emory University; Emory University; Duke University	Siddappa, NB (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	ruth_ruprecht@dfci.harvard.edu	Poznansky, Mark C/M-4996-2015; Lakhashe, Samir/F-1150-2014	Poznansky, Mark C/0000-0003-1344-7103; Wassermann PhD, Klemens/0000-0001-9719-7548; Byrareddy, Siddappa/0000-0002-7423-1763	National Institutes of Health [P01 AI048240, R01 DE012937, R01 DE016013];  [RR-00165]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012937, R01DE016013] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health grants P01 AI048240, R01 DE012937, and R01 DE016013 to R. M. R. Base grant RR-00165 provided support to the Yerkes National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303; Balfe P, 2004, VIROLOGY, V318, P267, DOI 10.1016/j.virol.2003.09.022; BASKIN GB, 1995, AIDS RES HUM RETROV, V11, P273, DOI 10.1089/aid.1995.11.273; Blay WM, 2006, J VIROL, V80, P999, DOI 10.1128/JVI.80.2.999-1014.2006; Bradney AP, 1999, J INFECT DIS, V179, P1264, DOI 10.1086/314711; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Bunnik EM, 2008, J VIROL, V82, P7932, DOI 10.1128/JVI.00757-08; Burke B, 2007, CURR HIV RES, V5, P625, DOI 10.2174/157016207782418533; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Cheng-Mayer C, 1999, J VIROL, V73, P5294, DOI 10.1128/JVI.73.7.5294-5300.1999; Chenine AL, 2010, J INFECT DIS, V201, P1155, DOI 10.1086/651274; Ching LK, 2008, J VIROL, V82, P949, DOI 10.1128/JVI.02143-07; Cline AN, 2005, J MED PRIMATOL, V34, P303; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Etemad-Moghadam B, 1999, J VIROL, V73, P8873, DOI 10.1128/JVI.73.10.8873-8879.1999; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Geffin R, 2003, VIROLOGY, V310, P207, DOI 10.1016/S0042-6822(03)00137-5; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Hofmann-Lehmann R, 2000, AIDS RES HUM RETROV, V16, P1247, DOI 10.1089/08892220050117014; Humbert M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-94; Krachmarov C, 2005, J VIROL, V79, P780, DOI 10.1128/JVI.79.2.780-790.2005; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Kraft Z, 2007, J VIROL, V81, P6402, DOI 10.1128/JVI.00424-07; Kwong PD, 2000, STRUCTURE, V8, P1329, DOI 10.1016/S0969-2126(00)00547-5; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laird ME, 2008, J VIROL, V82, P11054, DOI 10.1128/JVI.01341-08; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2006, J VIROL, V80, P11776, DOI 10.1128/JVI.01730-06; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mattapallil JJ, 1998, J VIROL, V72, P6421, DOI 10.1128/JVI.72.8.6421-6429.1998; Montefiori DC, 2003, J IMMUNOL, V170, P3906, DOI 10.4049/jimmunol.170.7.3906; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Rasmussen RA, 2007, AIDS, V21, P1841, DOI 10.1097/QAD.0b013e32828684ea; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Siddappa NB, 2009, J VIROL, V83, P1422, DOI 10.1128/JVI.02066-08; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; TREMBLAY M, 1990, J INFECT DIS, V162, P735, DOI 10.1093/infdis/162.3.735; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Vlasak J, 2006, AIDS, V20, P2135, DOI 10.1097/QAD.0b013e328010beb5; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu L, 2009, J VIROL, V83, P5077, DOI 10.1128/JVI.02600-08; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Ye YJ, 2000, J VIROL, V74, P11955, DOI 10.1128/JVI.74.24.11955-11962.2000; Zhang H, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-67; Zwick MB, 2003, J VIROL, V77, P6965, DOI 10.1128/JVI.77.12.6965-6978.2003	60	45	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11689	10.1371/journal.pone.0011689	http://dx.doi.org/10.1371/journal.pone.0011689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657739	gold, Green Submitted, Green Published			2022-12-27	WOS:000280197500028
J	Yakub, M; Iqbal, MP				Yakub, Mohsin; Iqbal, Mohammad Perwaiz			Association of Blood Lead (Pb) and Plasma Homocysteine: A Cross Sectional Survey in Karachi, Pakistan	PLOS ONE			English	Article							ASCORBIC-ACID; VITAMINS B6; FOLIC-ACID; HYPERHOMOCYSTEINEMIA; POPULATION; FOLATE; B12	Background: High blood lead (Pb) and hyperhomocysteinemia have been found to be associated with cardiovascular disease (CVD). Mean blood Pb and mean plasma homocysteine levels have been reported to be high in Pakistani population. The objective of the present study was to assess the relationship of blood Pb to the risk of hyperhomocysteinemia in a low income urban population of Karachi, Pakistan. Methodology/Principal Findings: In a cross sectional survey, 872 healthy adults (355 males, 517 females; age 18-60 years) were recruited from a low income urban population of Karachi. Fasting venous blood was obtained and assessed for blood Pb and plasma/serum homocysteine, folate, pyridoxal phosphate (PLP, a coenzymic form of vitamin B6) and vitamin B12. The study population had median (IQR) blood Pb of 10.82 mu g/dL (8.29-13.60). Prevalence of high blood Pb (levels >10 mu g/dL) was higher in males compared to females (62.5% males vs 56% females; p value = 0.05). Mean +/- SD/median (IQR) value of plasma homocysteine was significantly higher in the highest quartile of blood Pb compared to the lowest quartile 16.13 +/- 11.2 mu mol/L vs 13.28 +/- 9.7 mu mol/L/13.15 (10.33-17.81) mu mol/L vs 11.09 (8.65 14.31) mu mol/L (p value < 0.001). Daily consumption of fruit juice had a positive influence on both levels of plasma homocysteine and blood Pb. Compared with the lowest quartile of blood Pb, the OR for hyperhomocysteinemia was 1.69 (95% CI, 1.00 to 2.85) for the fourth quartile when the model was adjusted for age, gender, folate and vitamin B12. Conclusions/Significance: This study showed a relationship between blood Pb and hyperhomocysteinemia in a general population of Karachi, Pakistan. The harmful effect of Pb on cardiovascular system could be due to its association with hyperhomocysteinemia.	[Yakub, Mohsin; Iqbal, Mohammad Perwaiz] Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan	Aga Khan University	Yakub, M (corresponding author), Aga Khan Univ, Dept Biol & Biomed Sci, Karachi, Pakistan.	mohsin.yakub@aku.edu	Iqbal, Mohammed/GYA-1556-2022; Iqbal, Mohammad Perwaiz/I-6763-2015		University Research Council; Aga Khan University [IUJ (70136)]; Pakistan Science Foundation [PSF/Res/S-AKU/Med (210)]; Pakistan Scientific Development Project	University Research Council; Aga Khan University; Pakistan Science Foundation; Pakistan Scientific Development Project	This work was funded by grants from University Research Council, Aga Khan University [IUJ (70136)], Pakistan Science Foundation [PSF/Res/S-AKU/Med (210)] and Pakistan Scientific Development Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamir Muhammad, 2004, J Coll Physicians Surg Pak, V14, P518; Agha Farida, 2005, JPMA Journal of the Pakistan Medical Association, V55, P410; CAMP VM, 1983, CLIN CHEM, V29, P642; CHANARIN I, 1989, LAB HAEMATOLOGY, P131; Chia SE, 2007, OCCUP ENVIRON MED, V64, P688, DOI 10.1136/oem.2006.030882; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; Etzel RA, 1998, PEDIATRICS, V101, P1072; Glenn BS, 2003, EPIDEMIOLOGY, V14, P30, DOI 10.1097/00001648-200301000-00011; HernandezAvila M, 1997, ENVIRON RES, V74, P116, DOI 10.1006/enrs.1997.3756; Hertz-Picciotto I, 2000, AM J EPIDEMIOL, V152, P829, DOI 10.1093/aje/152.9.829; Iqbal M. Perwaiz, 2003, Pakistan Journal of Zoology, V35, P231; Iqbal M Perwaiz, 2006, J Pak Med Assoc, V56, P282; Iqbal MP, 2009, JCPSP-J COLL PHYSICI, V19, P308, DOI 05.2009/JCPSP.308312; Iqbal MP, 2005, NUTR METAB CARDIOVAS, V15, P100, DOI 10.1016/j.numecd.2004.05.003; KHAWAJA MA, 2002, BLOOD LEAD LEVELS SC; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Navas-Acien A, 2004, CIRCULATION, V109, P3196, DOI 10.1161/01.CIR.0000130848.18636.B2; QUADROS EV, 2000, MODERN ANAL METHODOL; Rahbar MH, 2002, B WORLD HEALTH ORGAN, V80, P769; Samman S, 2003, J NUTR, V133, P2188, DOI 10.1093/jn/133.7.2188; Schafer JH, 2005, ENVIRON HEALTH PERSP, V113, P31, DOI 10.1289/ehp.7369; SCHRAGER TF, 2006, IS CTR DIS CONTROLS; Simon JA, 1999, JAMA-J AM MED ASSOC, V281, P2289, DOI 10.1001/jama.281.24.2289; Son JY, 2009, ENVIRON RES, V109, P738, DOI 10.1016/j.envres.2009.03.012; Tariq SA, 2007, MOL BIOTECHNOL, V37, P62, DOI 10.1007/s12033-007-0045-x; Yakub M, 2009, J CHEM SOC PAKISTAN, V31, P319	26	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11706	10.1371/journal.pone.0011706	http://dx.doi.org/10.1371/journal.pone.0011706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657730	Green Submitted, gold, Green Published			2022-12-27	WOS:000280197500038
J	van Kampen, SC; Ramsay, AR; Anthony, RM; Klatser, PR				van Kampen, Sanne C.; Ramsay, Andrew R.; Anthony, Richard M.; Klatser, Paul R.			Retooling National TB Control Programmes (NTPs) with New Diagnostics: The NTP Perspective	PLOS ONE			English	Article							SMEAR MICROSCOPY; SPUTUM; TUBERCULOSIS; FLUORESCENCE	Background: A delay is evident between the development of new policies on TB diagnostics and their implementation at country level. The Stop TB Partnership would benefit from information from national TB program (NTP) managers on progress towards implementation of new recommendations as well as the opportunities and challenges encountered in the process. Methods and Findings: To solicit information on the introduction of new TB diagnostics at country level, questionnaires were sent out to NTP managers of high-burden TB countries and a subset of managers was interviewed. The results indicate that about 50% of high-burden TB countries are using the TB diagnostic tools newly recommended by the World Health Organization (WHO). Most NTP managers reported that new diagnostics would only be implemented when officially endorsed by the WHO. All countries have plans to adopt newly endorsed diagnostics at reference laboratory level, while approaches to optimize smear microscopy at lower levels of the health service are given less attention. NTP managers reported diverse challenges to the implementation of new diagnostics. Conclusions: More information on the obstacles and advantages of introducing new diagnostic tools should be provided to NTP managers to ensure the rational adoption of new diagnostics. A single recommendation covering the introduction of a package of diagnostic tools might be preferable to NTP managers and facilitate implementation in high-burden TB countries.	[van Kampen, Sanne C.; Ramsay, Andrew R.] WHO, UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva, Switzerland; [van Kampen, Sanne C.; Anthony, Richard M.; Klatser, Paul R.] Free Univ Amsterdam, Athena Inst, NL-1081 HV Amsterdam, Netherlands; [van Kampen, Sanne C.; Anthony, Richard M.; Klatser, Paul R.] KIT Biomed Res, Royal Trop Inst KIT, Amsterdam, Netherlands	The World Bank; World Health Organization; Vrije Universiteit Amsterdam	van Kampen, SC (corresponding author), WHO, UNICEF UNDP World Bank WHO Special Programme Res, CH-1211 Geneva, Switzerland.	sanne.vankampen@gmail.com	Anthony, Richard/AAP-3406-2020; Anthony, Richard M/G-5654-2010	Anthony, Richard/0000-0002-0550-5273; Anthony, Richard M/0000-0002-0550-5273; van Kampen, Sanne/0000-0002-1519-5248; Klatser, Paul/0000-0003-3868-2409; Klatser, Paul/0000-0003-2127-9138	WHO/TDR	WHO/TDR(World Health Organization)	This work was essentially unfunded, but costs of telephone interviews were borne by WHO/TDR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony RM, 2006, INT J TUBERC LUNG D, V10, P1060; Bonnet M, 2007, INT J TUBERC LUNG D, V11, P953; Mase SR, 2007, INT J TUBERC LUNG D, V11, P485; Pai M, 2009, EXPERT REV MOL DIAGN, V9, P637, DOI [10.1586/erm.09.48, 10.1586/ERM.09.48]; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; Ramsay A, 2009, J TROP MED-US, V2009, DOI 10.1155/2009/398767; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; *WHO, 2007, REV CAS DEF SPUT SME; *WHO, 2007, EXP GROUP M GEN; *WHO STAG TB, 2009, 9 M 9 11 NOV 2009 GE; *WHO STOP TB PARTN, 2007, GLOB MDR TB XDR TB R; *WHO STOP TB PARTN, 2008, NEW LAB DIAGN TOOLS; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2007, US LIQ TB CULT DRUG; World Health Organization, 2009, GLOB TUB CONTR EP ST	15	14	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11649	10.1371/journal.pone.0011649	http://dx.doi.org/10.1371/journal.pone.0011649			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20661463	Green Published, Green Submitted, gold			2022-12-27	WOS:000280065600013
J	Lindenmeyer, MT; Eichinger, F; Sen, K; Anders, HJ; Edenhofer, I; Mattinzoli, D; Kretzler, M; Rastaldi, MP; Cohen, CD				Lindenmeyer, Maja T.; Eichinger, Felix; Sen, Kontheari; Anders, Hans-Joachim; Edenhofer, Ilka; Mattinzoli, Deborah; Kretzler, Matthias; Rastaldi, Maria P.; Cohen, Clemens D.			Systematic Analysis of a Novel Human Renal Glomerulus-Enriched Gene Expression Dataset	PLOS ONE			English	Article							PODOCYTE-SPECIFIC DELETION; ENDOTHELIAL GROWTH-FACTOR; HUMAN KIDNEY; ACTIN CYTOSKELETON; CELL-MIGRATION; DISEASE; NEURITIN; PROTEINS; IDENTIFICATION; NEPHRIN	Glomerular diseases account for the majority of cases with chronic renal failure. Several genes have been identified with key relevance for glomerular function. Quite a few of these genes show a specific or preferential mRNA expression in the renal glomerulus. To identify additional candidate genes involved in glomerular function in humans we generated a human renal glomerulus-enriched gene expression dataset (REGGED) by comparing gene expression profiles from human glomeruli and tubulointerstitium obtained from six transplant living donors using Affymetrix HG-U133A arrays. This analysis resulted in 677 genes with prominent overrepresentation in the glomerulus. Genes with 'a priori' known prominent glomerular expression served for validation and were all found in the novel dataset (e.g. CDKN1, DAG1, DDN, EHD3, MYH9, NES, NPHS1, NPHS2, PDPN, PLA2R1, PLCE1, PODXL, PTPRO, SYNPO, TCF21, TJP1, WT1). The mRNA expression of several novel glomerulus-enriched genes in REGGED was validated by qRT-PCR. Gene ontology and pathway analysis identified biological processes previously not reported to be of relevance in glomeruli of healthy human adult kidneys including among others axon guidance. This finding was further validated by assessing the expression of the axon guidancemolecules neuritin (NRN1) and roundabout receptor ROBO1 and -2. In diabetic nephropathy, a prevalent glomerulopathy, differential regulation of glomerular ROBO2 mRNA was found. In summary, novel transcripts with predominant expression in the human glomerulus could be identified using a comparative strategy on microdissected nephrons. A systematic analysis of this glomerulus-specifc gene expression dataset allows the detection of target molecules and biological processes involved in glomerular biology and renal disease.	[Lindenmeyer, Maja T.; Edenhofer, Ilka; Cohen, Clemens D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Lindenmeyer, Maja T.; Sen, Kontheari; Cohen, Clemens D.] Univ Zurich, Inst Physiol, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Eichinger, Felix; Kretzler, Matthias] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Anders, Hans-Joachim] Univ Munich, Med Poliklin, D-8000 Munich, Germany; [Mattinzoli, Deborah; Rastaldi, Maria P.] Fdn IRCCS Policlin, Renal Res Lab, Milan, Italy; [Mattinzoli, Deborah; Rastaldi, Maria P.] Fdn DAmico Ric Malattie Renali, Milan, Italy	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Michigan System; University of Michigan; University of Munich; IRCCS Ca Granda Ospedale Maggiore Policlinico	Lindenmeyer, MT (corresponding author), Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland.	clemens.cohen@access.uzh.ch	Anders, Hans-Joachim/ABD-6247-2021; Mattinzoli, Deborah/AAP-9152-2021	Mattinzoli, Deborah/0000-0003-0478-022X; Anders, Hans-Joachim/0000-0003-2434-2956; Lindenmeyer, Maja/0000-0003-4162-9107	Swiss National Science Foundation [32-122439/1]; Else Kroener-Fresenius Foundation [A62/04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079912] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Else Kroener-Fresenius Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the Swiss National Science Foundation (32-122439/1) and the Else Kroener-Fresenius Foundation (A62/04) to CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach J, 2008, NEPHROL DIAL TRANSPL, V23, P3138, DOI 10.1093/ndt/gfn235; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Beltran PJ, 2003, J COMP NEUROL, V456, P384, DOI 10.1002/cne.10532; Cappelletti G, 2007, J NEUROSCI RES, V85, P2702, DOI 10.1002/jnr.21235; Chabardes-Garonne D, 2003, P NATL ACAD SCI USA, V100, P13710, DOI 10.1073/pnas.2234604100; Cohen CD, 2006, P NATL ACAD SCI USA, V103, P5682, DOI 10.1073/pnas.0511257103; Cohen CD, 2005, J AM SOC NEPHROL, V16, P1958, DOI 10.1681/ASN.2005020204; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Cove-Smith A, 2008, NEPHRON EXP NEPHROL, V108, pE74, DOI 10.1159/000127359; Cuellar LM, 2009, NEPHROLOGY, V14, P94, DOI 10.1111/j.1440-1797.2008.01009.x; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; El-Aouni C, 2006, J AM SOC NEPHROL, V17, P1334, DOI 10.1681/ASN.2005090921; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2006, J AM SOC NEPHROL, V17, P724, DOI 10.1681/ASN.2005080810; FAN KLQ, 2009, ROBO2 IS PODOCYTE PR; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Ghose A, 2002, BIOESSAYS, V24, P401, DOI 10.1002/bies.10080; Giardino L, 2009, J AM SOC NEPHROL, V20, P1929, DOI 10.1681/ASN.2008121286; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; Guo JH, 2005, CYTOGENET GENOME RES, V111, P107, DOI 10.1159/000086378; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; He L, 2008, J AM SOC NEPHROL, V19, P260, DOI 10.1681/ASN.2007050588; Higgins JPT, 2004, MOL BIOL CELL, V15, P649, DOI 10.1091/mbc.E03-06-0432; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jefferson JA, 2007, NEPHROL DIAL TRANSPL, V22, P1849, DOI 10.1093/ndt/gfm098; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; KANEHISA M, 2009, NUCL ACIDS RES; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Karamoysoyli E, 2008, DIABETES, V57, P181, DOI 10.2337/db07-0895; Kobayashi Naoto, 2004, Anatomical Science International, V79, P1, DOI 10.1111/j.1447-073x.2004.00066.x; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kwoh C, 2006, ANNU REV PATHOL-MECH, V1, P349, DOI 10.1146/annurev.pathol.1.110304.100119; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Lu WN, 2007, AM J HUM GENET, V80, P616, DOI 10.1086/512735; Marshall CB, 2007, NEPHRON EXP NEPHROL, V106, pE51, DOI 10.1159/000101793; Marshall CB, 2006, NEPHRON EXP NEPHROL, V102, P39, DOI 10.1159/000088400; Matsui K, 1998, J AM SOC NEPHROL, V9, P2013; Meyer-Schwesinger C, 2009, J PATHOL, V217, P452, DOI 10.1002/path.2446; Miao J, 2009, NEPHROL DIAL TRANSPL, V24, P3297, DOI 10.1093/ndt/gfp338; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Morton MJ, 2004, J AM SOC NEPHROL, V15, P2981, DOI 10.1097/01.ASN.0000145046.24268.0D; Naeve GS, 1997, P NATL ACAD SCI USA, V94, P2648, DOI 10.1073/pnas.94.6.2648; Nystrom J, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-13; Patrakka J, 2007, J AM SOC NEPHROL, V18, P689, DOI 10.1681/ASN.2006060675; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Raggo C, 2005, CANCER RES, V65, P5084, DOI 10.1158/0008-5472.CAN-04-2822; Rascle A, 2007, NEPHRON EXP NEPHROL, V106, pE60, DOI 10.1159/000101794; Rastaldi MP, 2006, FASEB J, V20, P976, DOI 10.1096/fj.05-4962fje; Rickhag M, 2007, BRAIN RES, V1151, P203, DOI 10.1016/j.brainres.2007.03.005; RONCO P, J AM SOC NEPHROL; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schmid H, 2003, J AM SOC NEPHROL, V14, P2958, DOI 10.1097/01.ASN.0000090745.85482.06; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Schmieder S, 2004, J AM SOC NEPHROL, V15, P2289, DOI 10.1097/01.ASN.0000135968.49899.E8; SCHNABEL E, 1990, J CELL BIOL, V111, P1255, DOI 10.1083/jcb.111.3.1255; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Thorner PS, 2008, J AM SOC NEPHROL, V19, P495, DOI 10.1681/ASN.2006101115; United States Renal Data System, 2016, EXPL TRIAL EV SAF IM; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616	73	60	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11545	10.1371/journal.pone.0011545	http://dx.doi.org/10.1371/journal.pone.0011545			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634963	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600022
J	Manitt, C; Labelle-Dumais, C; Eng, C; Grant, A; Mimee, A; Stroh, T; Flores, C				Manitt, Colleen; Labelle-Dumais, Cassandre; Eng, Conrad; Grant, Alanna; Mimee, Andrea; Stroh, Thomas; Flores, Cecilia			Peri-Pubertal Emergence of UNC-5 Homologue Expression by Dopamine Neurons in Rodents	PLOS ONE			English	Article							COLORECTAL-CANCER DCC; PREFRONTAL CORTEX; NETRIN RECEPTOR; POSTNATAL-DEVELOPMENT; AXON GUIDANCE; FAMILY; GROWTH; BRAIN; LOCALIZATION; AMPHETAMINE	Puberty is a critical period in mesocorticolimbic dopamine (DA) system development, particularly for the medial prefrontal cortex (mPFC) projection which achieves maturity in early adulthood. The guidance cue netrin-1 organizes neuronal networks by attracting or repelling cellular processes through DCC (deleted in colorectal cancer) and UNC-5 homologue (UNC5H) receptors, respectively. We have shown that variations in netrin-1 receptor levels lead to selective reorganization of mPFC DA circuitry, and changes in DA-related behaviors, in transgenic mice and in rats. Significantly, these effects are only observed after puberty, suggesting that netrin-1 mediated effects on DA systems vary across development. Here we report on the normal expression of DCC and UNC5H in the ventral tegmental area (VTA) by DA neurons from embryonic life to adulthood, in both mice and rats. We show a dramatic and enduring pubertal change in the ratio of DCC: UNC5H receptors, reflecting a shift toward predominant UNC5H function. This shift in DCC: UNC5H ratio coincides with the pubertal emergence of UNC5H expression by VTA DA neurons. Although the distribution of DCC and UNC5H by VTA DA neurons changes during puberty, the pattern of netrin-1 immunoreactivity in these cells does not. Together, our findings suggest that DCC: UNC5H ratios in DA neurons at critical periods may have important consequences for the organization and function of mesocorticolimbic DA systems.	[Manitt, Colleen; Labelle-Dumais, Cassandre; Eng, Conrad; Grant, Alanna; Mimee, Andrea; Flores, Cecilia] McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Stroh, Thomas] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Manitt, C (corresponding author), McGill Univ, Dept Psychiat, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada.	cecilia.flores@mcgill.ca	Flores, Cecilia/N-7799-2017	Flores, Cecilia/0000-0001-8606-5910	Canadian Institutes of Health [MOP-74709]; National Science and Engineering Research Council [298226, 327327-06]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health (C.F., Grant Number: MOP-74709), the National Science and Engineering Research Council (C.F., Grant Number: 298226; T. S., 327327-06, A. G., student fellowship) and Fonds de la Recherche en Sante du Quebec (CF). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Andersen SL, 2000, SYNAPSE, V37, P167, DOI 10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B; Andersen SL, 2003, NEUROSCI BIOBEHAV R, V27, P3, DOI 10.1016/S0149-7634(03)00005-8; Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739; Baker KA, 2006, CURR OPIN NEUROBIOL, V16, P529, DOI 10.1016/j.conb.2006.08.002; Barallobre MJ, 2005, BRAIN RES REV, V49, P22, DOI 10.1016/j.brainresrev.2004.11.003; Bartoe JL, 2006, J NEUROSCI, V26, P3192, DOI 10.1523/JNEUROSCI.3469-05.2006; Benes FM, 2000, CEREB CORTEX, V10, P1014, DOI 10.1093/cercor/10.10.1014; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bouchard JF, 2004, J NEUROSCI, V24, P3040, DOI 10.1523/JNEUROSCI.4934-03.2004; BOUCHARD JF, 2008, J NEUROCHEM; Cao J, 2007, NEUROPSYCHOPHARMACOL, V32, P2279, DOI 10.1038/sj.npp.1301349; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Cooper HM, 1995, ONCOGENE, V11, P2243; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Flores C, 2005, MOL PSYCHIATR, V10, P606, DOI 10.1038/sj.mp.4001607; Ford CP, 2006, J NEUROSCI, V26, P2788, DOI 10.1523/JNEUROSCI.4331-05.2006; Gad JM, 2000, EXP EYE RES, V70, P711, DOI 10.1006/exer.2000.0823; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Gogolla N, 2007, CURR OPIN NEUROBIOL, V17, P516, DOI 10.1016/j.conb.2007.09.002; Grant A, 2007, EUR J NEUROSCI, V26, P3215, DOI 10.1111/j.1460-9568.2007.05888.x; Grant A, 2009, EUR J NEUROSCI, V30, P1318, DOI 10.1111/j.1460-9568.2009.06919.x; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Hutchins BI, 2008, J NEUROSCI, V28, P143, DOI 10.1523/JNEUROSCI.4548-07.2008; Jacobowitz D.M, 1998, CHEMOARCHITECTONIC A; Juarez I, 2008, J COMP NEUROL, V507, P1734, DOI 10.1002/cne.21651; KALSBEEK A, 1988, J COMP NEUROL, V269, P58, DOI 10.1002/cne.902690105; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Keleman K, 2001, NEURON, V32, P605, DOI 10.1016/S0896-6273(01)00505-0; KENNEDY TE, 1994, CELL, V78, P435; Knable MB, 1997, J PSYCHOPHARMACOL, V11, P123, DOI 10.1177/026988119701100205; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; LEMOAL M, 1991, PHYSIOL REV, V71, P155, DOI 10.1152/physrev.1991.71.1.155; Lim YS, 1999, J NEUROSCI, V19, P7048, DOI 10.1523/JNEUROSCI.19-16-07048.1999; Lin L, 2005, MOL CELL NEUROSCI, V28, P547, DOI 10.1016/j.mcn.2004.11.009; Liu GF, 2009, P NATL ACAD SCI USA, V106, P2951, DOI 10.1073/pnas.0811083106; Livesey FJ, 1997, MOL CELL NEUROSCI, V8, P417, DOI 10.1006/mcne.1997.0598; Lu WX, 2002, NEUROPSYCHOPHARMACOL, V26, P1, DOI 10.1016/S0893-133X(01)00272-X; Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030; Manitt C, 2001, J NEUROSCI, V21, P3911, DOI 10.1523/JNEUROSCI.21-11-03911.2001; Manitt C, 2002, PROG BRAIN RES, V137, P425; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Manitt C, 2009, J NEUROSCI, V29, P11065, DOI 10.1523/JNEUROSCI.0947-09.2009; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; McKenna WL, 2008, J NEUROCHEM, V104, P1081, DOI 10.1111/j.1471-4159.2007.05040.x; Mueller D, 2006, NEUROSCIENCE, V137, P727, DOI 10.1016/j.neuroscience.2005.09.038; Muramatsu R, 2010, BRAIN, V133, P60, DOI 10.1093/brain/awp266; Osborne PB, 2005, NEUROSCIENCE, V131, P671, DOI 10.1016/j.neuroscience.2004.11.043; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Paxinos G., 1991, ATLAS DEV RAT BRAIN; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Rajasekharan S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-239; Riddle R, 2003, DEV BRAIN RES, V147, P3, DOI 10.1016/j.devbrainres.2003.09.010; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; Schmitz Y, 2009, J NEUROSCI, V29, P11973, DOI 10.1523/JNEUROSCI.2927-09.2009; Seaman C, 2001, MECH DEVELOP, V103, P173, DOI 10.1016/S0925-4773(01)00350-1; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sesack S R, 1998, Adv Pharmacol, V42, P171; Shu TZ, 2000, J COMP NEUROL, V416, P201, DOI 10.1002/(SICI)1096-9861(20000110)416:2<201::AID-CNE6>3.0.CO;2-Z; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tam SY, 1997, BIOCHEM PHARMACOL, V53, P441; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Tarazi FI, 2000, INT J DEV NEUROSCI, V18, P29, DOI 10.1016/S0736-5748(99)00108-2; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; Tong JF, 2001, J BIOL CHEM, V276, P40917, DOI 10.1074/jbc.M103872200; Tseng KY, 2007, SYNAPSE, V61, P843, DOI 10.1002/syn.20432; Tseng KY, 2007, CEREB CORTEX, V17, P1235, DOI 10.1093/cercor/bhl034; Uesaka N, 2006, NEUROSCIENTIST, V12, P102, DOI 10.1177/1073858405281673; Van den Heuvel DMA, 2008, PROG NEUROBIOL, V85, P75, DOI 10.1016/j.pneurobio.2008.01.003; Volenec A, 1998, NEUROREPORT, V9, P3553, DOI 10.1097/00001756-199811160-00002; VOORN P, 1988, NEUROSCIENCE, V25, P857, DOI 10.1016/0306-4522(88)90041-3; Williams ME, 2003, J NEUROSCI, V23, P11279; WOLF ME, 1989, J NEUROSCI, V9, P106; Yang ZG, 2008, J COMP NEUROL, V511, P19, DOI 10.1002/cne.21819; Yetnikoff L, 2007, NEUROSCIENCE, V150, P764, DOI 10.1016/j.neuroscience.2007.09.069; Yetnikoff L, 2010, EUR J NEUROSCI, V31, P1292, DOI 10.1111/j.1460-9568.2010.07163.x	82	41	41	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11463	10.1371/journal.pone.0011463	http://dx.doi.org/10.1371/journal.pone.0011463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628609	Green Submitted, gold, Green Published			2022-12-27	WOS:000279637100003
J	Tam, CHT; Ho, JSK; Wang, Y; Lee, HM; Lam, VKL; Germer, S; Martin, M; So, WY; Ma, RCW; Chan, JCN; Ng, MCY				Tam, Claudia Ha Ting; Ho, Janice Sin Ka; Wang, Ying; Lee, Heung Man; Lam, Vincent Kwok Lim; Germer, Soren; Martin, Mitchell; So, Wing Yee; Ma, Ronald Ching Wan; Chan, Juliana Chung Ngor; Ng, Maggie Chor Yin			Common Polymorphisms in MTNR1B, G6PC2 and GCK Are Associated with Increased Fasting Plasma Glucose and Impaired Beta-Cell Function in Chinese Subjects	PLOS ONE			English	Article							INSULIN-RESISTANCE; GLUCOKINASE; DEFINITION; TOLERANCE; VARIANT; LOCI; HYPERGLYCEMIA; METAANALYSIS; HOMEOSTASIS; POPULATION	Background: Previous studies identified melatonin receptor 1B (MTNR1B), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2), glucokinase (GCK) and glucokinase regulatory protein (GCKR) as candidate genes for type 2 diabetes (T2D) acting through elevated fasting plasma glucose (FPG). We examined the associations of the reported common variants of these genes with T2D and glucose homeostasis in three independent Chinese cohorts. Methodology/Principal Findings: Five single nucleotide polymorphisms (SNPs), MTNR1B rs10830963, G6PC2 rs16856187 and rs478333, GCK rs1799884 and GCKR rs780094, were genotyped in 1644 controls (583 adults and 1061 adolescents) and 1342 T2D patients. The G-allele of MTNR1B rs10830963 and the C-alleles of both G6PC2 rs16856187 and rs478333 were associated with higher FPG (0.0034<P<6.6x10(-5)) in healthy controls. In addition to our previous report for association with FPG, the A-allele of GCK rs1799884 was also associated with reduced homeostasis model assessment of beta-cell function (HOMA-B) (P=0.0015). Together with GCKR rs780094, the risk alleles of these SNPs exhibited dosage effect in their associations with increased FPG (P=2.9x10(-9)) and reduced HOMA-B (P=1.1x10(-3)). Meta-analyses strongly supported additive effects of MTNR1B rs10830963 and G6PC2 rs16856187 on FPG. Conclusions/Significance: Common variants of MTNR1B, G6PC2 and GCK are associated with elevated FPG and impaired insulin secretion, both individually and jointly, suggesting that these risk alleles may precipitate or perpetuate hyperglycemia in predisposed individuals.	[Tam, Claudia Ha Ting; Ho, Janice Sin Ka; Wang, Ying; Lee, Heung Man; Lam, Vincent Kwok Lim; So, Wing Yee; Ma, Ronald Ching Wan; Chan, Juliana Chung Ngor; Ng, Maggie Chor Yin] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Chan, Juliana Chung Ngor] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Inst Diabet & Obes, Shatin, Hong Kong, Peoples R China; [Germer, Soren; Martin, Mitchell] Roche Pharmaceut, Nutley, NJ USA	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Roche Holding	Tam, CHT (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China.	rcwma@cuhk.edu.hk	Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016	Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194	Hong Kong Government Research Grant Committee [CUHK 1/04C, CUHK472407]; Chinese University of Hong Kong [2006.1.041]	Hong Kong Government Research Grant Committee; Chinese University of Hong Kong(Chinese University of Hong Kong)	This study was funded by the Hong Kong Government Research Grant Committee Central Allocation Scheme (CUHK 1/04C), Research Grant Committee (CUHK472407) and the Chinese University of Hong Kong Direct Grant (2006.1.041).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; BEER NL, 2009, HUM MOL GENET; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Conneely KN, 2007, AM J HUM GENET, V81, P1158, DOI 10.1086/522036; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fernandez-Mejia C, 2001, ENDOCRINOLOGY, V142, P1448, DOI 10.1210/en.142.4.1448; Freeman MS, 2002, DIABETIC MED, V19, P994, DOI 10.1046/j.1464-5491.2002.00843.x; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kelliny C, 2009, DIABETES, V58, P2939, DOI 10.2337/db09-0374; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Li JKY, 2006, DIABETES-METAB RES, V22, P46, DOI 10.1002/dmrr.577; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; MATSCHINSKY F, 1993, J CLIN INVEST, V92, P2092, DOI 10.1172/JCI116809; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Newgard CB, 2002, DIABETES, V51, pS389, DOI 10.2337/diabetes.51.2007.S389; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; PHILLIPS DIW, 1994, DIABETIC MED, V11, P286, DOI 10.1111/j.1464-5491.1994.tb00273.x; Piche ME, 2004, DIABETES CARE, V27, P2470, DOI 10.2337/diacare.27.10.2470; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi Q, 2009, DIABETOLOGIA, V52, P834, DOI 10.1007/s00125-009-1290-2; REILING E, 2009, DIABETOLOGIA; Ronn T, 2009, DIABETOLOGIA, V52, P830, DOI 10.1007/s00125-009-1297-8; Rose CS, 2009, DIABETOLOGIA, V52, P2122, DOI 10.1007/s00125-009-1463-z; Rose CS, 2005, DIABETES, V54, P3026, DOI 10.2337/diabetes.54.10.3026; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shaw JE, 2000, DIABETES CARE, V23, P34, DOI 10.2337/diacare.23.1.34; Sparso T, 2009, DIABETES, V58, P1450, DOI 10.2337/db08-1660; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takeuchi F, 2010, DIABETOLOGIA, V53, P299, DOI 10.1007/s00125-009-1595-1; Tam CHT, 2009, DIABETES, V58, P765, DOI 10.2337/db08-1277; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; VANSCHAFTINGEN E, 1994, DIABETOLOGIA, V37, pS43, DOI 10.1007/BF00400825; Vaxillaire M, 2008, DIABETES, V57, P244, DOI 10.2337/db07-0615; Wang Y, 2008, DIABETES, V57, P133, DOI 10.2337/db07-0092; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; ZHANG S, 2009, OBESITY SILVER SPRIN	50	56	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11428	10.1371/journal.pone.0011428	http://dx.doi.org/10.1371/journal.pone.0011428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628598	Green Published, gold, Green Submitted			2022-12-27	WOS:000279637100002
J	Lawaly, YR; Sakuntabhai, A; Marrama, L; Konate, L; Phimpraphi, W; Sokhna, C; Tall, A; Sarr, FD; Peerapittayamongkol, C; Louicharoen, C; Schneider, BS; Levescot, A; Talman, A; Casademont, I; Menard, D; Trape, JF; Rogier, C; Kaewkunwal, J; Sura, T; Nuchprayoon, I; Ariey, F; Baril, L; Singhasivanon, P; Mercereau-Puijalon, O; Paul, R				Lawaly, Yaye Ramatoulaye; Sakuntabhai, Anavaj; Marrama, Laurence; Konate, Lassana; Phimpraphi, Waraphon; Sokhna, Cheikh; Tall, Adama; Sarr, Fatoumata Diene; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Schneider, Bradley S.; Levescot, Anais; Talman, Arthur; Casademont, Isabelle; Menard, Didier; Trape, Jean-Francois; Rogier, Christophe; Kaewkunwal, Jaranit; Sura, Thanyachai; Nuchprayoon, Issarang; Ariey, Frederic; Baril, Laurence; Singhasivanon, Pratap; Mercereau-Puijalon, Odile; Paul, Rick			Heritability of the Human Infectious Reservoir of Malaria Parasites	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; SICKLE-CELL TRAIT; HOLOENDEMIC AREA; SEGREGATION ANALYSIS; GENETIC COMPLEXITY; ANOPHELES-GAMBIAE; SEX DETERMINATION; KAREN POPULATION; LINKAGE ANALYSIS; DRUG-TREATMENT	Background: Studies on human genetic factors associated with malaria have hitherto concentrated on their role in susceptibility to and protection from disease. In contrast, virtually no attention has been paid to the role of human genetics in eliciting the production of parasite transmission stages, the gametocytes, and thus enhancing the spread of disease. Methods and Findings: We analysed four longitudinal family-based cohort studies from Senegal and Thailand followed for 2-8 years and evaluated the relative impact of the human genetic and non-genetic factors on gametocyte production in infections of Plasmodium falciparum or P. vivax. Prevalence and density of gametocyte carriage were evaluated in asymptomatic and symptomatic infections by examination of Giemsa-stained blood smears and/or RT-PCR (for falciparum in one site). A significant human genetic contribution was found to be associated with gametocyte prevalence in asymptomatic P. falciparum infections. By contrast, there was no heritability associated with the production of gametocytes for P. falciparum or P. vivax symptomatic infections. Sickle cell mutation, HbS, was associated with increased gametocyte prevalence but its contribution was small. Conclusions: The existence of a significant human genetic contribution to gametocyte prevalence in asymptomatic infections suggests that candidate gene and genome wide association approaches may be usefully applied to explore the underlying human genetics. Prospective epidemiological studies will provide an opportunity to generate novel and perhaps more epidemiologically pertinent gametocyte data with which similar analyses can be performed and the role of human genetics in parasite transmission ascertained.	[Lawaly, Yaye Ramatoulaye; Paul, Rick] Inst Pasteur, Lab Entomol Med, Dakar, Senegal; [Sakuntabhai, Anavaj; Phimpraphi, Waraphon; Peerapittayamongkol, Chayanon; Louicharoen, Chalisa; Levescot, Anais; Casademont, Isabelle; Paul, Rick] Inst Pasteur, Lab Genet Reponse Infect Chez Homme, Paris, France; [Sakuntabhai, Anavaj; Schneider, Bradley S.; Casademont, Isabelle; Paul, Rick] Inst Pasteur, Unite Pathogenie, Paris, France; [Marrama, Laurence; Tall, Adama; Sarr, Fatoumata Diene; Baril, Laurence] Inst Pasteur, Epidemiol Unit, Dakar, Senegal; [Konate, Lassana] UCAD, Fac Sci & Tech, Dakar, Senegal; [Phimpraphi, Waraphon; Kaewkunwal, Jaranit; Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, Lab Paludol, Dakar, Senegal; [Louicharoen, Chalisa] Chulalongkorn Univ, Interdept Program Biomed Sci, Fac Grad Sch, Bangkok, Thailand; [Talman, Arthur; Menard, Didier; Ariey, Frederic] Inst Pasteur, Unite Epidemiol Mol, Phnom Penh, Cambodia; [Rogier, Christophe] Inst Trop Med, Serv Sante Armees, Unite Rech Biol & Epidemiol Parasitaires, IFR48, Marseille, France; [Sura, Thanyachai] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Nuchprayoon, Issarang] Chulalongkorn Univ, Fac Med, Dept Pediat, Bangkok 10330, Thailand; [Mercereau-Puijalon, Odile] Inst Pasteur, CNRS, Unite Immunol Mol Parasites, URA 2581, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar; Mahidol University; Institut de Recherche pour le Developpement (IRD); Chulalongkorn University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Mahidol University; Chulalongkorn University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lawaly, YR (corresponding author), Inst Pasteur, Lab Entomol Med, Dakar, Senegal.	rpaul@pasteur.fr	Talman, Arthur/GMW-9116-2022; Peerapittayamongkol, Chayanon/B-4920-2010; ROGIER, Christophe/C-2550-2008; ariey, frederic/P-1185-2017; Menard, Didier/O-3294-2013; Peerapittayamongkol, Chayanon/K-7965-2019; Mercereau-Puijalon, Odile/AAA-2242-2020	ariey, frederic/0000-0002-0680-1090; Menard, Didier/0000-0003-1357-4495; Singhasivanon, Pratap/0000-0002-9759-1702; Nuchprayoon, Issarang/0000-0002-4014-5082; Talman, Arthur/0000-0003-2584-3672; Schneider, Bradley S/0000-0001-7642-0018; Baril, Laurence/0000-0003-2346-883X	Strategic Anopheles Horizontal Research Programme, Institut Pasteur to RELP; BIOTEC [BT-B06-MG14-4507]; Thailand Research Fund [BRG/16/2544]; Mahidol University [OR-9123]; INSERM; Faculty of Medicine Siriraj Hospital; Mahidol University, Thailand; Royal Golden Jubilee Program; Thailand Research Fund; French Embassy in Thailand; Ministry of Research, France; Institut Pasteur research grant	Strategic Anopheles Horizontal Research Programme, Institut Pasteur to RELP; BIOTEC; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Faculty of Medicine Siriraj Hospital; Mahidol University, Thailand; Royal Golden Jubilee Program; Thailand Research Fund(Thailand Research Fund (TRF)); French Embassy in Thailand; Ministry of Research, France(Ministry of Research, France); Institut Pasteur research grant	This work was funded in part by the Strategic Anopheles Horizontal Research Programme, Institut Pasteur to RELP, by grants from BIOTEC (BT-B06-MG14-4507), the Thailand Research Fund (BRG/16/2544), Mahidol University grant (OR-9123) and the Institut Pasteur to A. S. C. P. was supported by post-doctoral fellowships from INSERM and from the Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand. C. T., W. P. and C. L. were supported by the Royal Golden Jubilee Program, the Thailand Research Fund and the French Embassy in Thailand. A. Talman was supported by "Fonds Dedies'' Sanofi-Aventis, Ministry of Research, France and Institut Pasteur research grant to F. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab A, 2002, J INFECT DIS, V185, P1838, DOI 10.1086/340638; ABEL L, 1992, AM J HUM GENET, V50, P1308; Ali E, 2006, T ROY SOC TROP MED H, V100, P176, DOI 10.1016/j.trstmh.2005.04.021; ALLISON AC, 1954, BRIT MED J, V1, P290, DOI 10.1136/bmj.1.4857.290; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BAIRD JK, 1991, AM J TROP MED HYG, V44, P183, DOI 10.4269/ajtmh.1991.44.183; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; BOUDIN C, 1993, AM J TROP MED HYG, V48, P700, DOI 10.4269/ajtmh.1993.48.700; Bousema JT, 2008, AM J TROP MED HYG, V78, P442, DOI 10.4269/ajtmh.2008.78.442; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Buckling A, 1999, PARASITOLOGY, V118, P339, DOI 10.1017/S0031182099003960; Cancre N, 2000, AM J EPIDEMIOL, V152, P760, DOI 10.1093/aje/152.8.760; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Carter R, 1979, Bull World Health Organ, V57 Suppl 1, P37; CARTER R, 1988, MALARIA PRINCIPLES P, P1; Chong SS, 2000, BLOOD, V95, P360; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Drakeley CJ, 2005, J INFECT DIS, V191, P1589, DOI 10.1086/429669; Drakeley CJ, 2000, ANN TROP MED PARASIT, V94, P399, DOI 10.1080/00034983.2000.11813555; Dunyo S, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010020; Dyer M, 2000, PARASITOL TODAY, V16, P102, DOI 10.1016/S0169-4758(99)01608-7; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Garcia A, 1998, AM J TROP MED HYG, V58, P480, DOI 10.4269/ajtmh.1998.58.480; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; Gilmour A. R., ASREML USER GUIDE RE; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; Gouagna LC, 2010, NAT GENET, V42, P328, DOI 10.1038/ng.554; GRAVES PM, 1984, AM J TROP MED HYG, V33, P1045, DOI 10.4269/ajtmh.1984.33.1045; GREENWOOD BM, 1987, PARASITOL TODAY, V3, P206, DOI 10.1016/0169-4758(87)90061-5; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Hayward RE, 1999, P NATL ACAD SCI USA, V96, P4563, DOI 10.1073/pnas.96.8.4563; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; KWIATKOWSKI D, 1990, LANCET, V336, P1201, DOI 10.1016/0140-6736(90)92827-5; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; MACDONALD G, 1951, BRIT MED BULL, V8, P33, DOI 10.1093/oxfordjournals.bmb.a074051; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; MUIRHEADTHOMSON RC, 1954, BRIT MED J, V1, P68, DOI 10.1136/bmj.1.4853.68; Nacher M, 2002, J PARASITOL, V88, P97, DOI 10.1645/0022-3395(2002)088[0097:DHCHAS]2.0.CO;2; Nassir E, 2005, INT J PARASITOL, V35, P49, DOI 10.1016/j.ijpara.2004.10.014; Oesterholt MJAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004364; Paganotti GM, 2006, PARASITOLOGY, V132, P607, DOI 10.1017/S0031182005009601; Paul REL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-39; Paul REL, 2003, ECOL LETT, V6, P866, DOI 10.1046/j.1461-0248.2003.00509.x; Paul REL, 2002, TRENDS PARASITOL, V18, P32, DOI 10.1016/S1471-4922(01)02122-5; Paul REL, 2000, SCIENCE, V287, P128, DOI 10.1126/science.287.5450.128; PERRY EL, 1914, INDIAN J MED RES, V2, P459; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; Piper KP, 1999, INFECT IMMUN, V67, P6369; Price R, 1999, AM J TROP MED HYG, V60, P1019, DOI 10.4269/ajtmh.1999.60.1019; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rihet P, 1998, GENET EPIDEMIOL, V15, P435, DOI 10.1002/(SICI)1098-2272(1998)15:5<435::AID-GEPI1>3.0.CO;2-#; Robert V, 1996, AM J TROP MED HYG, V54, P111, DOI 10.4269/ajtmh.1996.54.111; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P29, DOI 10.1016/0035-9203(90)90369-P; Rozen S, 2000, Methods Mol Biol, V132, P365; Saeed M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002280; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Shekalaghe SA, 2007, TROP MED INT HEALTH, V12, P547, DOI 10.1111/j.1365-3156.2007.01821.x; Sinden RE, 1996, ADV PARASIT, V38, P53, DOI 10.1016/S0065-308X(08)60033-0; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; SMALLEY ME, 1981, T ROY SOC TROP MED H, V75, P316, DOI 10.1016/0035-9203(81)90348-5; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Timmann C, 2007, PLOS GENET, V3, P393, DOI 10.1371/journal.pgen.0030048; TRAGER W, 1992, J PROTOZOOL, V39, P429, DOI 10.1111/j.1550-7408.1992.tb01476.x; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; *VSN INT LTD, GENSTAT WIND; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; WEATHERALL DJ, 1987, ANN TROP MED PARASIT, V81, P539, DOI 10.1080/00034983.1987.11812155; WEATHERALL DJ, 2003, OXFORD TXB MED; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0; WILSON D. Bagster, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P583, DOI 10.1016/S0035-9203(36)90040-8	80	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11358	10.1371/journal.pone.0011358	http://dx.doi.org/10.1371/journal.pone.0011358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20613877	Green Published, gold, Green Submitted			2022-12-27	WOS:000279369900007
J	Li, G; Elder, RT; Dubrovsky, L; Liang, D; Pushkarsky, T; Chiu, K; Fan, T; Sire, J; Bukrinsky, M; Zhao, RY				Li, Ge; Elder, Robert T.; Dubrovsky, Larisa; Liang, Dong; Pushkarsky, Tatiana; Chiu, Karen; Fan, Tao; Sire, Josephine; Bukrinsky, Michael; Zhao, Richard Y.			HIV-1 Replication through hHR23A-Mediated Interaction of Vpr with 26S Proteasome	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL-PROTEIN-R; CELL-CYCLE ARREST; DNA-REPAIR PROTEIN; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; EFFICIENT REPLICATION; NUCLEAR-ENVELOPE; HUMAN HOMOLOG; RAD23	HIV-1 Vpr is a virion-associated protein. Its activities link to viral pathogenesis and disease progression of HIV-infected patients. In vitro, Vpr moderately activates HIV-1 replication in proliferating T cells, but it is required for efficient viral infection and replication in vivo in non-dividing cells such as macrophages. How exactly Vpr contributes to viral replication remains elusive. We show here that Vpr stimulates HIV-1 replication at least in part through its interaction with hHR23A, a protein that binds to 19S subunit of the 26S proteasome and shuttles ubiquitinated proteins to the proteasome for degradation. The Vpr-proteasome interaction was initially discovered in fission yeast, where Vpr was shown to associate with Mts4 and Mts2, two 19S-associated proteins. The interaction of Vpr with the 19S subunit of the proteasome was further confirmed in mammalian cells where Vpr associates with the mammalian orthologues of fission yeast Mts4 and S5a. Consistently, depletion of hHR23A interrupts interaction of Vpr with proteasome in mammalian cells. Furthermore, Vpr promotes hHR23A-mediated protein-ubiquitination, and down-regulation of hHR23A using RNAi significantly reduced viral replication in non-proliferating MAGI-CCR5 cells and primary macrophages. These findings suggest that Vpr-proteasome interaction might counteract certain host restriction factor(s) to stimulate viral replication in non-dividing cells.	[Li, Ge; Liang, Dong; Fan, Tao; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Dept Microbiology Immunol,Inst Human Virol, Baltimore, MD 21201 USA; [Elder, Robert T.; Chiu, Karen; Zhao, Richard Y.] Northwestern Univ, Childrens Mem Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA; [Sire, Josephine] INSERM, U372, F-13258 Marseille, France; [Dubrovsky, Larisa; Pushkarsky, Tatiana; Bukrinsky, Michael] George Washington Univ, Dept Microbiol & Trop Med, Washington, DC USA	University System of Maryland; University of Maryland Baltimore; Northwestern University; Feinberg School of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); George Washington University	Li, G (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Dept Microbiology Immunol,Inst Human Virol, Baltimore, MD 21201 USA.	rzhao@som.umaryland.edu		Zhao, Richard Y./0000-0003-3424-2852	National Institutes of Health [AI40891, GM63080]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040891, R21AI033776, R21AI040891, R01AI033776, R29AI040891, R01AI040386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by National Institutes of Health Grants AI40891 and GM63080 (to R.Y.Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Benko Z, 2004, J VIROL, V78, P11016, DOI 10.1128/JVI.78.20.11016-11029.2004; Benko Z, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-16; BUKRINSKY MI, 1997, FRONT BIOSCI, V2, P578; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Elder RT, 2002, NUCLEIC ACIDS RES, V30, P581, DOI 10.1093/nar/30.2.581; Elder RT, 2001, VIROLOGY, V287, P359, DOI 10.1006/viro.2001.1007; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Franco M, 2007, EXP CELL RES, V313, P2687, DOI 10.1016/j.yexcr.2007.04.003; Goh Teik-Khiang, 1998, Fungal Diversity, V1, P65; GORDON C, 1993, NATURE, V366, P355, DOI 10.1038/366355a0; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gragerov A, 1998, VIROLOGY, V245, P323, DOI 10.1006/viro.1998.9138; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Huard S, 2008, J VIROL, V82, P2904, DOI 10.1128/JVI.01098-07; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Klare N, 2007, J MOL BIOL, V373, P1, DOI 10.1016/j.jmb.2007.07.038; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Li G, 2009, CURR HIV RES, V7, P178, DOI 10.2174/157016209787581436; Li TW, 2000, BIOCHEM BIOPH RES CO, V272, P270, DOI 10.1006/bbrc.2000.2767; Liang D, 2007, MOL MED, V13, P229, DOI 10.2119/2007-00004.Liang; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Mansky LM, 2001, VIROLOGY, V282, P176, DOI 10.1006/viro.2000.0791; Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sherman MP, 2003, J VIROL, V77, P7582, DOI 10.1128/JVI.77.13.7582-7589.2003; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stewart SA, 1997, J VIROL, V71, P5579, DOI 10.1128/JVI.71.7.5579-5592.1997; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Wilkinson CRM, 1999, PHILOS T R SOC B, V354, P1523, DOI 10.1098/rstb.1999.0496; Wilkinson CRM, 1998, EMBO J, V17, P6465, DOI 10.1093/emboj/17.22.6465; Wilkinson CRM, 1997, J BIOL CHEM, V272, P25768, DOI 10.1074/jbc.272.41.25768; WithersWard ES, 1997, J VIROL, V71, P9732, DOI 10.1128/JVI.71.12.9732-9742.1997; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhao RY, 2005, INDIAN J MED RES, V121, P270; ZHAO Y, 1998, BIOTECHNIQUES, V25, P2; Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996; Zhao YQ, 1998, VIROLOGY, V246, P266, DOI 10.1006/viro.1998.9208; Zhu QZ, 2001, CANCER RES, V61, P64; [No title captured]	59	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11371	10.1371/journal.pone.0011371	http://dx.doi.org/10.1371/journal.pone.0011371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614012	gold, Green Published, Green Submitted			2022-12-27	WOS:000279369900019
J	Pool, R; Montgomery, CM; Morar, NS; Mweemba, O; Ssali, A; Gafos, M; Lees, S; Stadler, J; Crook, A; Nunn, A; Hayes, R; McCormack, S				Pool, Robert; Montgomery, Catherine M.; Morar, Neetha S.; Mweemba, Oliver; Ssali, Agnes; Gafos, Mitzy; Lees, Shelley; Stadler, Jonathan; Crook, Angela; Nunn, Andrew; Hayes, Richard; McCormack, Sheena			A Mixed Methods and Triangulation Model for Increasing the Accuracy of Adherence and Sexual Behaviour Data: The Microbicides Development Programme	PLOS ONE			English	Article							CLINICAL-TRIALS; QUALITATIVE METHODS; VALIDITY; WOMEN; FEASIBILITY; MULTIMETHOD; IMPROVEMENT; PREVENTION; BIOMARKERS; HIV/AIDS	Background: The collection of accurate data on adherence and sexual behaviour is crucial in microbicide (and other HIV-related) research. In the absence of a "gold standard'' the collection of such data relies largely on participant self-reporting. After reviewing available methods, this paper describes a mixed method/triangulation model for generating more accurate data on adherence and sexual behaviour in a multi-centre vaginal microbicide clinical trial. In a companion paper some of the results from this model are presented [1]. Methodology/Principal Findings: Data were collected from a random subsample of 725 women (7.7% of the trial population) using structured interviews, coital diaries, in-depth interviews, counting returned gel applicators, focus group discussions, and ethnography. The core of the model was a customised, semi-structured in-depth interview. There were two levels of triangulation: first, discrepancies between data from the questionnaires, diaries, in-depth interviews and applicator returns were identified, discussed with participants and, to a large extent, resolved; second, results from individual participants were related to more general data emerging from the focus group discussions and ethnography. A democratic and equitable collaboration between clinical trialists and qualitative social scientists facilitated the success of the model, as did the preparatory studies preceding the trial. The process revealed some of the underlying assumptions and routinised practices in "clinical trial culture'' that are potentially detrimental to the collection of accurate data, as well as some of the shortcomings of large qualitative studies, and pointed to some potential solutions. Conclusions/Significance: The integration of qualitative social science and the use of mixed methods and triangulation in clinical trials are feasible, and can reveal (and resolve) inaccuracies in data on adherence and sensitive behaviours, as well as illuminating aspects of "trial culture'' that may also affect data accuracy.	[Pool, Robert; Montgomery, Catherine M.] Univ Barcelona, Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Morar, Neetha S.] MRC, HIV Prevent Res Unit, Durban, South Africa; [Mweemba, Oliver] Univ Zambia, Dept Community Med, Lusaka, Zambia; [Ssali, Agnes] Uganda Virus Res Inst, Med Res Council UK, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Gafos, Mitzy] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Lees, Shelley; Hayes, Richard] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; [Stadler, Jonathan] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Crook, Angela; Nunn, Andrew; McCormack, Sheena] MRC, Clin Trials Unit, London, England; [Pool, Robert] Univ Amsterdam, Ctr Global Hlth & Inequal, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; University of Zambia; Uganda Virus Research Institute; University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; Medical Research Council Clinical Trials Unit; University of Amsterdam	Pool, R (corresponding author), Univ Barcelona, Ctr Int Hlth Res CRESIB, Barcelona, Spain.	robert.pool@cresib.cat		Gafos, Mitzy/0000-0002-7894-1498; Montgomery, Catherine/0000-0002-5829-6137; Stadler, Jonathan/0000-0002-2325-2660; Nunn, Andrew/0000-0002-9158-4595; Hayes, Richard/0000-0002-1729-9892; Ssali, Agnes/0000-0003-4801-0411	UK Department for International Development through the Medical Research Council; MRC [G0901756, G0700837, G0100137] Funding Source: UKRI; Medical Research Council [G0901756, G0700837, G0100137] Funding Source: researchfish	UK Department for International Development through the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project described in this paper was funded by the UK Department for International Development through the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CF, 2007, SEX TRANSM INFECT, V83, P490, DOI 10.1136/sti.2007.024810; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Bernabe-Ortiz A, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-11; BLAIKIE NWH, 1991, QUAL QUANT, V25, P115, DOI 10.1007/BF00145701; BRADBURN J, 1995, PSYCHO-ONCOLOGY, V4, P107, DOI 10.1002/pon.2960040204; Bradley F, 1999, BMJ-BRIT MED J, V318, P711; Brewer John., 2006, FDN MULTIMETHOD RES; CAMPBELL DT, 1959, PSYCHOL B, V56; Creswell J, DESIGNING CONDUCTING, V3rd; Creswell JohnW., 2006, RES SCH, V13, P1; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; Evans RL, 2003, J MANIP PHYSIOL THER, V26, P502, DOI 10.1016/S0161-4754(03)00107-6; Gibson G, 2004, AGE AGEING, V33, P422, DOI 10.1093/ageing/afh136; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gregson S, 2004, SEX TRANSM INFECT, V80, P36, DOI 10.1136/sti.2004.012088; Imrie J, 2007, LANCET, V370, P10, DOI 10.1016/S0140-6736(07)61026-5; KAGANSON N, 2006, MICR 2006 C CAP TOWN; Lagakos SW, 2008, METHODOLOGICAL CHALL; Massey A, 1999, STUD EDUC ETHNOG, V2, P183; MAUK CK, 2009, SEXUALLY TRANSMITTED, V36, pS73; MAUK CK, 2009, SEXUALLY TRANSMITTED, V36, pS81; MCVARISH L, 2009, USE COMPUTER ASSISTE; MENSCH BS, 2008, 17 INT AIDS C MEX CI; Minnis AM, 2009, AM J EPIDEMIOL, V170, P918, DOI 10.1093/aje/kwp219; Mueller MR, 2004, QUAL HEALTH RES, V14, P704, DOI 10.1177/1049732304263627; Murtagh J, 2007, QUAL SAF HEALTH CARE, V16, P224, DOI 10.1136/qshc.2006.018499; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; Orr DP, 1997, SEX TRANSM DIS, V24, P261, DOI 10.1097/00007435-199705000-00005; Paterniti DA, 2005, CANCER-AM CANCER SOC, V104, P3015, DOI 10.1002/cncr.21522; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Pool R, 2006, AIDS CARE, V18, P479, DOI 10.1080/09540120500221639; POOL R, 2008, P 2007 ROYAL DUTCH A, P55; POOL R, 2010, PLOS ONE; Rabago D, 2006, ANN FAM MED, V4, P295, DOI 10.1370/afm.552; Sandelowski M, 1996, RES NURS HEALTH, V19, P359, DOI 10.1002/(SICI)1098-240X(199608)19:4<359::AID-NUR9>3.3.CO;2-8; Skoler-Karpoff S, 2008, LANCET, V372, P1977, DOI 10.1016/S0140-6736(08)61842-5; Strauss A., 1998, BASICS QUALITATIVE R; Tashakkori A., 1998, MIXED METHODOLOGY CO; Tolley EE, 2010, AIDS BEHAV, V14, P1124, DOI 10.1007/s10461-009-9635-x; Turner AN, 2009, J CLIN EPIDEMIOL, V62, P759, DOI 10.1016/j.jclinepi.2008.07.011; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; van de Wijgert J, 2009, LANCET, V373, P721, DOI 10.1016/S0140-6736(09)60437-2; Wallace A, 2004, SEX TRANSM DIS, V31, P465, DOI 10.1097/01.olq.0000135986.35216.ba; Wallace AR, 2007, CONTRACEPTION, V76, P53, DOI 10.1016/j.contraception.2006.10.012; ZENILMAN JM, 1995, SEX TRANSM DIS, V22, P15, DOI 10.1097/00007435-199501000-00003; ATN062	47	52	53	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11600	10.1371/journal.pone.0011600	http://dx.doi.org/10.1371/journal.pone.0011600			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657778	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000280197500007
J	Pool, R; Montgomery, CM; Morar, NS; Mweemba, O; Ssali, A; Gafos, M; Lees, S; Stadler, J; Nunn, A; Crook, A; Hayes, R; McCormack, S				Pool, Robert; Montgomery, Catherine M.; Morar, Neetha S.; Mweemba, Oliver; Ssali, Agnes; Gafos, Mitzy; Lees, Shelley; Stadler, Jonathan; Nunn, Andrew; Crook, Angela; Hayes, Richard; McCormack, Sheena			Assessing the Accuracy of Adherence and Sexual Behaviour Data in the MDP301 Vaginal Microbicides Trial Using a Mixed Methods and Triangulation Model	PLOS ONE			English	Article								Background: Accurate data on adherence and sexual behaviour are crucial in microbicide (and other HIV-related) research. In the absence of a "gold standard'' the collection of such data relies largely on participant self-reporting. The Microbicides Development Programme has developed a mixed method/triangulation model for generating more accurate data on adherence and sexual behaviour. Methodology/Principal Findings: Data were collected from a random subsample of 725 women using structured case record form (CRF) interviews, coital diaries (CD) and in-depth interviews (IDI). Returned used and unused gel applicators were counted and additional data collected through focus group discussions and ethnography. The model is described in detail in a companion paper [1]. When CRF, CD and IDI are compared there is some inconsistency with regard to reporting of sexual behaviour, gel or condom use in more than half. Inaccuracies are least prevalent in the IDI and most prevalent in the CRF, where participants tend to under-report frequency of sex and gel and condom use. Women reported more sex, gel and condom use than their partners. IDI data on adherence match the applicator-return data more closely than the CRF. The main reasons for inaccuracies are participants forgetting, interviewer error, desirability bias, problems with the definition and delineation of key concepts (e.g. "sex act''). Most inaccuracies were unintentional and could be rectified during data collection. Conclusions/Significance: The CRF - the main source of self-report data on behaviour and adherence in many studies - was the least accurate with regard to measuring sexual behaviour, gel and condom use. This has important implications for the use of structured questionnaires for the collection of data on sexual behaviour and adherence. Integrating in-depth interviews and triangulation into clinical trials could increase the richness and accuracy of behavioural and adherence data.	[Pool, Robert; Montgomery, Catherine M.] Univ Barcelona, Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Morar, Neetha S.] MRC, HIV Prevent Res Unit, Durban, South Africa; [Mweemba, Oliver] Univ Zambia, Dept Community Med, Lusaka, Zambia; [Ssali, Agnes] Uganda Virus Res Inst, Med Res Council UK, MRC, Uganda Res Unit AIDS, Entebbe, Uganda; [Gafos, Mitzy] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Lees, Shelley; Hayes, Richard] London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; [Stadler, Jonathan] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Nunn, Andrew; Crook, Angela; McCormack, Sheena] MRC, Clin Trials Unit, London, England; [Pool, Robert] Univ Amsterdam, Ctr Global Hlth & Inequal, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; University of Zambia; Uganda Virus Research Institute; University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; Medical Research Council Clinical Trials Unit; University of Amsterdam	Pool, R (corresponding author), Univ Barcelona, Ctr Int Hlth Res CRESIB, Barcelona, Spain.	robert.pool@cresib.cat		Montgomery, Catherine/0000-0002-5829-6137; Stadler, Jonathan/0000-0002-2325-2660; Gafos, Mitzy/0000-0002-7894-1498; Hayes, Richard/0000-0002-1729-9892; Nunn, Andrew/0000-0002-9158-4595; Ssali, Agnes/0000-0003-4801-0411	UK Department for International Development through the Medical Research Council; MRC [G0901756, G0100137, G0700837] Funding Source: UKRI; Medical Research Council [G0100137, G0700837, G0901756] Funding Source: researchfish	UK Department for International Development through the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project described in this paper was funded by the UK Department for International Development through the Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lagakos SW, 2008, METHODOLOGICAL CHALL; Nunn A, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-99; POOL R, 2010, PLOS ONE; *POP COUNC, 2008, INF CONS HIV PREV TR; Tolley EE, 2010, AIDS BEHAV, V14, P1124, DOI 10.1007/s10461-009-9635-x; Whitehead SJ, 2006, AIDS, V20, P2141, DOI 10.1097/QAD.0b013e32801086c9; Wong IY, 2006, JAIDS-J ACQ IMM DEF, V43, pS142, DOI 10.1097/01.qai.0000248345.02760.03	7	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11632	10.1371/journal.pone.0011632	http://dx.doi.org/10.1371/journal.pone.0011632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657774	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000280197500010
J	Rands, SA				Rands, Sean A.			Self-Improvement for Team-Players: The Effects of Individual Effort on Aggregated Group Information	PLOS ONE			English	Article							CONSENSUS DECISION-MAKING; GROUP-SIZE; COLLECTIVE DETECTION; VIGILANCE; RULES; COORDINATION; ADVANTAGE; FOLLOWERS; PREDATORS; EMERGENCE	By putting effort into behaviours like foraging or scanning for predators, an animal can improve the correctness of its personal information about the environment. For animals living in groups, the individual can gain further information if it is able to assess public information about the environment from other group members. Earlier work has shown that consensus group decisions based upon the public information available within the group are more likely to be correct than decisions based upon personal information alone, given that each individual in a group has a fixed probability of being correct. This study develops a model where group members are able to improve their personal likelihood of making a correct decision by conducting some level of (costly) effort. I demonstrate that there is an evolutionarily stable level of effort for all the individuals within the group, and the effort made by an individual should decrease with increasing group size. The relevance of these results to social decision making is discussed: in particular, these results are similar to standard theoretical predictions about the amount of vigilance shown by individuals decreasing with increasing group size. However, this model suggests that these results could come about where individuals are coordinating their effort within the group (unlike standard models, which assume that all individual effort is independent of the actions of others). This ties in with experimental findings where individuals have been shown to monitor the efforts of others.	Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England	University of Bristol	Rands, SA (corresponding author), Univ Bristol, Sch Vet Sci, Ctr Behav Biol, Bristol BS18 7DU, Avon, England.	sean.rands@bristol.ac.uk	Rands, Sean A/B-2243-2008	Rands, Sean A/0000-0002-7400-005X				Austen-Smith D, 2009, PHILOS T R SOC B, V364, P763, DOI 10.1098/rstb.2008.0256; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Beauchamp G, 2009, BIOL LETTERS, V5, P9, DOI 10.1098/rsbl.2008.0490; Bednekoff PA, 1998, TRENDS ECOL EVOL, V13, P284, DOI 10.1016/S0169-5347(98)01327-5; Condorcet N, 1785, ESSAI APPL ANAL PROB; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Dall SRX, 2002, PHILOS T R SOC B, V357, P1519, DOI 10.1098/RSTB.2002.1061; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Ebensperger LA, 2006, ETHOLOGY, V112, P879, DOI 10.1111/j.1439-0310.2006.01242.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P371, DOI 10.1093/beheco/arh017; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Grabisch M, 2010, THEOR DECIS, V69, P69, DOI 10.1007/s11238-008-9109-z; Hastie R, 2005, PSYCHOL REV, V112, P494, DOI 10.1037/0033-295X.112.2.494; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Krause J, 2002, LIVING GROUPS; Laruelle A, 2005, SOC CHOICE WELFARE, V24, P171, DOI 10.1007/s00355-003-0298-7; Lazarus J, 2003, BEHAV PROCESS, V63, P129, DOI 10.1016/S0376-6357(03)00006-8; List C, 2004, TRENDS ECOL EVOL, V19, P168, DOI 10.1016/j.tree.2004.02.004; Maciejovsky B, 2007, J PERS SOC PSYCHOL, V92, P854, DOI 10.1037/0022-3514.92.5.854; Maynard Smith J., 1982, pi; Pays O, 2009, BEHAV ECOL, V20, P22, DOI 10.1093/beheco/arn110; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2010, BEHAV ECOL SOCIOBIOL, V64, P443, DOI 10.1007/s00265-009-0860-0; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; Pratt SC, 2006, P NATL ACAD SCI USA, V103, P15906, DOI 10.1073/pnas.0604801103; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Rands SA, 2004, P ROY SOC B-BIOL SCI, V271, P2613, DOI 10.1098/rspb.2004.2906; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rodriguez-Girones MA, 2002, P ROY SOC B-BIOL SCI, V269, P1803, DOI 10.1098/rspb.2002.2043; Seeley TD, 2004, BEHAV ECOL SOCIOBIOL, V56, P594, DOI 10.1007/s00265-004-0814-5; Shen SF, 2010, AM NAT, V176, P242, DOI 10.1086/653663; Sirot E, 2009, AM NAT, V173, P47, DOI 10.1086/593358; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Taylor PD, 1996, J MATH BIOL, V34, P654; Urfalino P, 2010, SOC SCI INFORM, V49, P5, DOI 10.1177/0539018409354811; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105	44	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11705	10.1371/journal.pone.0011705	http://dx.doi.org/10.1371/journal.pone.0011705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657785	gold, Green Published, Green Submitted			2022-12-27	WOS:000280197500037
J	Schastak, S; Ziganshyna, S; Gitter, B; Wiedemann, P; Claudepierre, T				Schastak, Stanislaw; Ziganshyna, Svitlana; Gitter, Burkhard; Wiedemann, Peter; Claudepierre, Thomas			Efficient Photodynamic Therapy against Gram-Positive and Gram-Negative Bacteria Using THPTS, a Cationic Photosensitizer Excited by Infrared Wavelength	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ANTIMICROBIAL RESISTANCE; PSEUDOMONAS-AERUGINOSA; PORPHYRIN DERIVATIVES; ESCHERICHIA-COLI; BASIC PRINCIPLES; PHOTOINACTIVATION; INFECTIONS; SUSCEPTIBILITY; EPIDEMIOLOGY	The worldwide rise in the rates of antibiotic resistance of bacteria underlines the need for alternative antibacterial agents. A promising approach to kill antibiotic-resistant bacteria uses light in combination with a photosensitizer to induce a phototoxic reaction. Concentrations of 1, 10 and 100 mu M of tetrahydroporphyrin-tetratosylat (THPTS) and different incubation times (30, 90 and 180min) were used to measure photodynamic efficiency against two Gram-positive strains of S. aureus (MSSA and MRSA), and two Gram-negative strains of E. coli and P. aeruginosa. We found that phototoxicity of the drug is independent of the antibiotic resistance pattern when incubated in PBS for the investigated strains. Also, an incubation with 100 mu M THPTS followed by illumination, yielded a 6lg (>= 99.999%) decrease in the viable numbers of all bacteria strains tested, indicating that the THPTS drug has a high degree of photodynamic inactivation. We then modulated incubation time, photosensitizer concentration and monitored the effect of serum on the THPTS activity. In doing so, we established the conditions to obtain the strongest bactericidal effect. Our results suggest that this new and highly pure synthetic compound should improve the efficiency of photodynamic therapy against multiresistant bacteria and has a significant potential for clinical applications in the treatment of nosocomial infections.	[Schastak, Stanislaw; Wiedemann, Peter; Claudepierre, Thomas] Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany; [Ziganshyna, Svitlana] Univ Leipzig, Fac Med, Dept Anaesthesia & Intens Care Med, Leipzig, Germany; [Gitter, Burkhard] Biolitec AG, Res & Dev, Jena, Germany	Leipzig University; Leipzig University; Biolitec AG	Schastak, S (corresponding author), Univ Leipzig, Fac Med, Dept Ophthalmol, Leipzig, Germany.	stas@medizin.uni-leipzig.de		Claudepierre, Thomas/0000-0001-6968-8518	Biolitec AG; Ophthalmology Department at the Faculty of Medicine of the University of Leipzig; Novartis-Pharma Germany; French Foundation "Gueules Cassees"; Stiferverbrand fur die Deutsche Wissenchaft	Biolitec AG; Ophthalmology Department at the Faculty of Medicine of the University of Leipzig; Novartis-Pharma Germany; French Foundation "Gueules Cassees"; Stiferverbrand fur die Deutsche Wissenchaft	This work was funded by Biolitec AG and by the Ophthalmology Department at the Faculty of Medicine of the University of Leipzig. T. C. is supported by grants from Novartis-Pharma Germany, from the French Foundation "Gueules Cassees" and from the "Stiferverbrand fur die Deutsche Wissenchaft". Other than the input of the authors in the wording of the manuscript, and in providing materials and approving permission to publish freely, Biolitec AG as a funder had no direct role in the conception of the method, the study design, data collection, or analysis. Novartis Pharma-Germany, Foundation "Gueules Cassees", "Stiferverbrand fur die Deutsche Wissenchaft" and the Ophthalmology Department as funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-70; Banfi S, 2006, J PHOTOCH PHOTOBIO B, V85, P28, DOI 10.1016/j.jphotobiol.2006.04.003; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Caminos DA, 2006, PHOTOCH PHOTOBIO SCI, V5, P56, DOI 10.1039/b513511g; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Centers for Disease Control and Prevention, 2002, MMWR-MORBID MORTAL W, V51, P565; Costa L, 2008, PHOTOCH PHOTOBIO SCI, V7, P415, DOI 10.1039/b712749a; Diekema DJ, 2004, CLIN INFECT DIS, V38, P78, DOI 10.1086/380457; Engelmann FM, 2007, J BIOENERG BIOMEMBR, V39, P175, DOI 10.1007/s10863-007-9075-0; Felmingham D, 2005, J ANTIMICROB CHEMOTH, V56, P3, DOI 10.1093/jac/dki297; Ferro S, 2007, INT J BIOCHEM CELL B, V39, P1026, DOI 10.1016/j.biocel.2007.02.001; Fotinos N, 2008, ANTIMICROB AGENTS CH, V52, P1366, DOI 10.1128/AAC.01372-07; Fridkin SK, 2001, CLIN INFECT DIS, V32, P108, DOI 10.1086/317542; Gillham MI, 2009, J ANTIMICROB CHEMOTH, V63, P728, DOI 10.1093/jac/dkp007; Gupta MR, 2009, TRANSPL INFECT DIS, V11, P424, DOI 10.1111/j.1399-3062.2009.00422.x; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hamblin MR, 2003, J INFECT DIS, V187, P1717, DOI 10.1086/375244; Jenkins TC, 2009, INFECT CONT HOSP EP, V30, P233, DOI 10.1086/595963; JEVONS MP, 1963, LANCET, V1, P904; Jones RN, 2003, SEMIN RESP CRIT CARE, V24, P121, DOI 10.1055/s-2003-37923; Jori G, 2006, J ENVIRON PATHOL TOX, V25, P505, DOI 10.1615/JEnvironPatholToxicolOncol.v25.i1-2.320; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Lazzeri D, 2004, PHOTOCHEM PHOTOBIOL, V80, P286, DOI 10.1562/2004-03-08-RA-105.1; Lin YM, 2010, J BIOL CHEM, V285, P8985, DOI 10.1074/jbc.M109.078725; MacDonald IJ, 2001, J PORPHYR PHTHALOCYA, V5, P105, DOI 10.1002/jpp.328; MacKenzie FM, 2006, CLIN MICROBIOL INFEC, V12, P1185, DOI 10.1111/j.1469-0691.2006.01549.x; Maisch T, 2007, PHOTOCH PHOTOBIO SCI, V6, P545, DOI 10.1039/b614770d; Maisch T, 2005, ANTIMICROB AGENTS CH, V49, P1542, DOI 10.1128/AAC.49.4.1542-1552.2005; Maisch T, 2007, LASER MED SCI, V22, P83, DOI 10.1007/s10103-006-0409-7; Moet GJ, 2007, DIAGN MICR INFEC DIS, V57, P7, DOI 10.1016/j.diagmicrobio.2006.05.009; NITZAN Y, 1983, CURR MICROBIOL, V8, P279, DOI 10.1007/BF01577728; Raab O, 1900, Z BIOL-MUNICH, V39, P524; Rammelkamp CH, 1942, P SOC EXP BIOL MED, V51, P386, DOI 10.3181/00379727-51-13986; Schastak S, 2008, METHOD FIND EXP CLIN, V30, P129, DOI 10.1358/mf.2008.30.2.1165448; Seaton RA, 2008, J ANTIMICROB CHEMOTH, V62, P15, DOI 10.1093/jac/dkn368; Susin SA, 1998, BBA-BIOENERGETICS, V1366, P151, DOI 10.1016/S0005-2728(98)00110-8; Tappeiner H.v., 1904, DEUT ARCH KLIN MED, V80, P427; Tappeiner H.V., 1904, DMW DTSCH MED WOCHEN, V30, P579, DOI [10.1055/s-0029-1187467, DOI 10.1055/S-0029-1187467]; Wainwright M, 2004, INT BIODETER BIODEGR, V53, P119, DOI 10.1016/j.ibiod.2003.11.006; Witte W, 2007, ZBL CHIR, V132, P124, DOI 10.1055/s-2007-960652; Zolfaghari PS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-27; EARSS EUROPEAN ANTIM, P21	42	69	72	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11674	10.1371/journal.pone.0011674	http://dx.doi.org/10.1371/journal.pone.0011674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652031	gold, Green Submitted, Green Published			2022-12-27	WOS:000280109700007
J	Buchanan, DD; Sweet, K; Drini, M; Jenkins, MA; Win, AK; English, DR; Walsh, MD; Clendenning, M; McKeone, DM; Walters, RJ; Roberts, A; Pearson, SA; Pavluk, E; Hopper, JL; Gattas, MR; Goldblatt, J; George, J; Suthers, GK; Phillips, KD; Woodall, S; Arnold, J; Tucker, K; Muir, A; Field, M; Greening, S; Gallinger, S; Perrier, R; Baron, JA; Potter, JD; Haile, R; Frankel, W; de la Chapelle, A; Macrae, F; Rosty, C; Walker, NI; Parry, S; Young, JP				Buchanan, Daniel D.; Sweet, Kevin; Drini, Musa; Jenkins, Mark A.; Win, Aung Ko; English, Dallas R.; Walsh, Michael D.; Clendenning, Mark; McKeone, Diane M.; Walters, Rhiannon J.; Roberts, Aedan; Pearson, Sally-Ann; Pavluk, Erika; Hopper, John L.; Gattas, Michael R.; Goldblatt, Jack; George, Jill; Suthers, Graeme K.; Phillips, Kerry D.; Woodall, Sonja; Arnold, Julie; Tucker, Kathy; Muir, Amanda; Field, Michael; Greening, Sian; Gallinger, Steven; Perrier, Renee; Baron, John A.; Potter, John D.; Haile, Robert; Frankel, Wendy; de la Chapelle, Albert; Macrae, Finlay; Rosty, Christophe; Walker, Neal I.; Parry, Susan; Young, Joanne P.			Risk Factors for Colorectal Cancer in Patients with Multiple Serrated Polyps: A Cross-Sectional Case Series from Genetics Clinics	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; CIGARETTE-SMOKING; HYPERPLASTIC POLYPOSIS; BRAF MUTATIONS; LIFE-STYLE; MICROSATELLITE INSTABILITY; ADENOMATOUS POLYPOSIS; TOBACCO SMOKING; EARLY-ONSET; LONG-TERM	Background: Patients with multiple serrated polyps are at an increased risk for developing colorectal cancer (CRC). Recent reports have linked cigarette smoking with the subset of CRC that develops from serrated polyps. The aim of this work therefore was to investigate the association between smoking and the risk of CRC in high-risk genetics clinic patients presenting with multiple serrated polyps. Methods and Findings: We identified 151 Caucasian individuals with multiple serrated polyps including at least 5 outside the rectum, and classified patients into non-smokers, current or former smokers at the time of initial diagnosis of polyposis. Cases were individuals with multiple serrated polyps who presented with CRC. Controls were individuals with multiple serrated polyps and no CRC. Multivariate logistic regression was performed to estimate associations between smoking and CRC with adjustment for age at first presentation, sex and co-existing traditional adenomas, a feature that has been consistently linked with CRC risk in patients with multiple serrated polyps. CRC was present in 56 (37%) individuals at presentation. Patients with at least one adenoma were 4 times more likely to present with CRC compared with patients without adenomas (OR = 4.09; 95% CI 1.27 to 13.14; P = 0.02). For females, the odds of CRC decreased by 90% in current smokers as compared to never smokers (OR = 0.10; 95% CI 0.02 to 0.47; P = 0.004) after adjusting for age and adenomas. For males, there was no relationship between current smoking and CRC. There was no statistical evidence of an association between former smoking and CRC for both sexes. Conclusion: A decreased odds for CRC was identified in females with multiple serrated polyps who currently smoke, independent of age and the presence of a traditional adenoma. Investigations into the biological basis for these observations could lead to non-smoking-related therapies being developed to decrease the risk of CRC and colectomy in these patients.	[Buchanan, Daniel D.; Walsh, Michael D.; Clendenning, Mark; McKeone, Diane M.; Walters, Rhiannon J.; Roberts, Aedan; Pearson, Sally-Ann; Pavluk, Erika; Rosty, Christophe; Young, Joanne P.] Queensland Inst Med Res, Familial Canc Lab, Herston, Qld, Australia; [Buchanan, Daniel D.; Walsh, Michael D.; Young, Joanne P.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Sweet, Kevin; Frankel, Wendy; de la Chapelle, Albert] Ohio State Univ, Columbus, OH 43210 USA; [Drini, Musa] Canberra Hosp, Dept Gastroenterol & Hepatol, Garran, ACT, Australia; [Jenkins, Mark A.; Win, Aung Ko; English, Dallas R.; Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr MEGA Epidemiol, Carlton, Vic 3053, Australia; [Gattas, Michael R.] Royal Childrens Hosp, Queensland Clin Genet Serv, Herston, Qld, Australia; [Goldblatt, Jack] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia; [Goldblatt, Jack; George, Jill] Genet Serv Western Australia, Subiaco, WA, Australia; [Suthers, Graeme K.] Univ Adelaide, Dept Paediat, Adelaide, SA, Australia; [Suthers, Graeme K.; Phillips, Kerry D.] S Australian Clin Genet Serv, Adelaide, SA, Australia; [Woodall, Sonja; Arnold, Julie; Parry, Susan] Auckland City Hosp, Familial GI Canc Registry, Auckland, New Zealand; [Tucker, Kathy] Prince Wales Hosp, Hereditary Canc Clin, Randwick, NSW 2031, Australia; [Muir, Amanda; Field, Michael] Royal N Shore Hosp, Dept Clin Genet, Sydney, NSW, Australia; [Greening, Sian] Wollongong Hosp, Illawarra Canc Ctr, Wollongong, NSW, Australia; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Mt Sinai Hosp, D Zane Cohen Digest Dis Clin Res Ctr, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Canc Care Ontario, Toronto, ON, Canada; [Perrier, Renee] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Perrier, Renee] BC Canc Agcy, Vancouver, BC, Canada; [Baron, John A.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03756 USA; [Potter, John D.] Fred Hutchinson Canc Res Ctr, Canc Prevent Program, Seattle, WA 98104 USA; [Haile, Robert] Univ So Calif, USC Norris Comprehens Canc Ctr, Los Angeles, CA USA; [Macrae, Finlay] Royal Melbourne Hosp, Dept Colorectal Med & Genet, Parkville, Vic 3050, Australia; [Rosty, Christophe] Univ Queensland, Dept Mol & Cellular Pathol, Herston, Qld, Australia; [Walker, Neal I.] Envoi Pathol, Herston, Qld, Australia; [Parry, Susan] Middlemore Hosp, Dept Gastroenterol, Auckland 6, New Zealand	QIMR Berghofer Medical Research Institute; University of Queensland; University System of Ohio; Ohio State University; Australian National University; Canberra Hospital; University of Melbourne; Royal Children's Hospital Brisbane; University of Western Australia; University of Adelaide; Auckland City Hospital; Royal North Shore Hospital; University of Sydney; Wollongong Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Cancer Care Ontario; University of British Columbia; British Columbia Cancer Agency; Dartmouth College; Fred Hutchinson Cancer Center; University of Southern California; Royal Melbourne Hospital; University of Queensland	Buchanan, DD (corresponding author), Queensland Inst Med Res, Familial Canc Lab, Herston, Qld, Australia.	Joanne.Young@qimr.edu.au	Win, Aung K./J-6204-2015; Rosty, Christophe/F-1796-2010; Sweet, Kevin/E-4172-2011; Walker, Neal I/E-7233-2011; Young, Joanne P/H-7774-2014; Walker, Neal I/E-7039-2011; Young, Joanne P/B-9981-2011; Gallinger, Steven/E-4575-2013; Roberts, Aedan/B-9878-2013; Toon, Christopher W/G-3610-2012; English, Dallas/AAH-5005-2019; Jenkins, Mark/P-7803-2015	Win, Aung K./0000-0002-2794-5261; Roberts, Aedan/0000-0002-6429-6133; English, Dallas/0000-0001-7828-8188; Jenkins, Mark/0000-0002-8964-6160; Potter, John/0000-0001-5439-1500; Rosty, Christophe/0000-0001-7671-2651; Frankel, Wendy/0000-0003-1658-1009; Buchanan, Daniel/0000-0003-2225-6675; Woodall, Sonja/0000-0002-9910-5560; Young, Joanne/0000-0002-1514-1522; Pearson, Sally-Ann/0000-0002-7421-7195	Cancer Council Queensland; Hicks Foundation in Victoria; National Cancer Institute [1R01CA123010]; RFA [CA-95-011, U01 CA097735]; NATIONAL CANCER INSTITUTE [U01CA097735, R01CA123010] Funding Source: NIH RePORTER	Cancer Council Queensland(Cancer Council Queensland); Hicks Foundation in Victoria; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); RFA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Cancer Council Queensland, the Hicks Foundation in Victoria, and the National Cancer Institute through 1R01CA123010 (Genetics of Serrated Neoplasia) and RFA #CA-95-011 through cooperative agreements with the Australasian Colorectal Cancer Family Registry (U01 CA097735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams JA, 2008, GASTROENTEROLOGY, V134, P617, DOI 10.1053/j.gastro.2007.12.015; Anderson JC, 2003, AM J GASTROENTEROL, V98, P2777, DOI 10.1111/j.1572-0241.2003.08671.x; Anderson JC, 2006, ARCH INTERN MED, V166, P1669, DOI 10.1001/archinte.166.15.1669-b; Beach R, 2005, AM J PATHOL, V166, P1069, DOI 10.1016/S0002-9440(10)62327-9; BOPARAI KS, 2009, GUT; Botteri E, 2008, GASTROENTEROLOGY, V134, P388, DOI 10.1053/j.gastro.2007.11.007; Buc E, 2006, DIS COLON RECTUM, V49, P1893, DOI 10.1007/s10350-006-0704-1; BUCHANAN D, 2010, INT J IN PRESS  0115; Burt R, 2000, WHO INT CLASSIFICATI, P135; Burt RW, 1996, GASTROENTEROLOGY, V110, P950, DOI 10.1053/gast.1996.v110.agast960950; Chow E, 2006, GASTROENTEROLOGY, V131, P30, DOI 10.1053/j.gastro.2006.03.046; Colangelo LA, 2004, CANCER-AM CANCER SOC, V100, P288, DOI 10.1002/cncr.11923; Colditz GA, 2004, CANCER, V100, P223, DOI 10.1002/cncr.20011; Ferrandez A, 2004, AM J GASTROENTEROL, V99, P2012, DOI 10.1111/j.1572-0241.2004.30021.x; Giovannucci E, 2004, DIGEST LIVER DIS, V36, P643, DOI 10.1016/j.dld.2004.06.012; Gupta C, 2007, AM J GASTROENTEROL, V102, P211; Hannan LM, 2009, CANCER EPIDEM BIOMAR, V18, P3362, DOI 10.1158/1055-9965.EPI-09-0661; Huang CS, 2008, GASTROENTEROLOGY, V134, pA606; Hyman NH, 2004, DIS COLON RECTUM, V47, P2101, DOI 10.1007/s10350-004-0709-6; Jarrar AM, 2009, DIS COLON RECTUM, V52, P1949, DOI 10.1007/DCR.0b013e3181b5450c; Jass JR, 2008, PATHOL RES PRACT, V204, P431, DOI 10.1016/j.prp.2008.03.008; Jass JR, 2007, GASTROENTEROL CLIN N, V36, P927, DOI 10.1016/j.gtc.2007.08.009; Jass JR, 2005, NAT CLIN PRACT ONCOL, V2, P398, DOI 10.1038/ncponc0248; Ji BT, 2006, CANCER EPIDEM BIOMAR, V15, P897, DOI 10.1158/1055-9965.EPI-05-0883; Lage P, 2004, AM J GASTROENTEROL, V99, P1779, DOI 10.1111/j.1572-0241.2004.30178.x; Leggett BA, 2001, AM J SURG PATHOL, V25, P177, DOI 10.1097/00000478-200102000-00005; Limburg PJ, 2003, CLIN GASTROENTEROL H, V1, P202, DOI 10.1053/jcgh.2003.50030; Luchtenborg M, 2005, AM J EPIDEMIOL, V161, P806, DOI 10.1093/aje/kwi114; LUCHTENBORG M, 2007, HAWAII MED J, V66; MILLAR P, 2005, BIC STATA MODULE EVA; MORABIA A, 1990, AM J CLIN NUTR, V52, P933, DOI 10.1093/ajcn/52.5.933; Morimoto LM, 2002, CANCER EPIDEM BIOMAR, V11, P1012; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; PAI RK, AM J SURG PATHOL; Paskett ED, 2007, JNCI-J NATL CANCER I, V99, P1729, DOI 10.1093/jnci/djm176; PEPPONE LJ, 2008, J CANC RES CLIN ONCO; Rashid A, 2000, GASTROENTEROLOGY, V119, P323, DOI 10.1053/gast.2000.9361; Renaut A. J, 2002, Colorectal Dis, V4, P213, DOI 10.1046/j.1463-1318.2002.00354.x; Rozek LS, 2010, CANCER EPIDEM BIOMAR, V19, P838, DOI 10.1158/1055-9965.EPI-09-1112; Rubio CA, 2006, ENDOSCOPY, V38, P266, DOI 10.1055/s-2006-925026; Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHRUBSOLE MJ, 2008, AM J EPIDEMIOL; Slattery ML, 2007, INT J CANCER, V120, P656, DOI 10.1002/ijc.22342; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; SODERLUND S, GASTROENTEROLOGY; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; StataCorp L, 2007, STAT DAT AN STAT SOF; Strine TW, 2005, AM J PREV MED, V28, P182, DOI 10.1016/j.amepre.2004.10.002; Sweet K, 2005, JAMA-J AM MED ASSOC, V294, P2465, DOI 10.1001/jama.294.19.2465; Terry MB, 1998, AM J EPIDEMIOL, V147, P903; Torlakovic E, 1996, GASTROENTEROLOGY, V110, P748, DOI 10.1053/gast.1996.v110.pm8608884; Toyomura K, 2004, CANCER SCI, V95, P72, DOI 10.1111/j.1349-7006.2004.tb03173.x; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; WALKER RG, 2010, AM J GASTROENTEROL; Wallace K, 2009, CANCER EPIDEM BIOMAR, V18, P2310, DOI 10.1158/1055-9965.EPI-09-0211; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Widome R, 2007, PREV MED, V45, P442, DOI 10.1016/j.ypmed.2007.07.016; WILLIAMS GT, 1980, HISTOPATHOLOGY, V4, P155, DOI 10.1111/j.1365-2559.1980.tb02909.x; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Yeoman Andrew, 2007, N Z Med J, V120, pU2827; Young J, 2008, GASTROENTEROLOGY, V135, P323, DOI 10.1053/j.gastro.2008.03.080; Young J, 2006, CANCER EPIDEM BIOMAR, V15, P1778, DOI 10.1158/1055-9965.EPI-06-0164	63	57	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11636	10.1371/journal.pone.0011636	http://dx.doi.org/10.1371/journal.pone.0011636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661287	Green Published, gold, Green Submitted			2022-12-27	WOS:000279980800020
J	Kim, H; Lee, W; Lee, S				Kim, Hyojoong; Lee, Wonhoon; Lee, Seunghwan			Morphometric Relationship, Phylogenetic Correlation, and Character Evolution in the Species-Rich Genus Aphis (Hemiptera: Aphididae)	PLOS ONE			English	Article							MYZUS-PERSICAE HEMIPTERA; GOSSYPII GLOVER; HOST-PLANT; MORPHOLOGICAL VARIATION; MITOCHONDRIAL; NUCLEAR; RATES; DNA; DIVERSITY; POPULATIONS	Background: The species-rich genus Aphis consists of more than 500 species, many of them host-specific on a wide range of plants, yet very similar in general appearance due to convergence toward particular morphological types. Most species have been historically clustered into four main phenotypic groups (gossypii, craccivora, fabae, and spiraecola groups). To confirm the morphological hypotheses between these groups and to examine the characteristics that determine them, multivariate morphometric analyses were performed using 28 characters measured/counted from 40 species. To infer whether the morphological relationships are correlated with the genetic relationships, we compared the morphometric dataset with a phylogeny reconstructed from the combined dataset of three mtDNA and one nuclear DNA regions. Principal Findings: Based on a comparison of morphological and molecular datasets, we confirmed morphological reduction or regression in the gossypii group unlike in related groups. Most morphological characteristics of the gossypii group were less variable than for the other groups. Due to these, the gossypii group could be morphologically well separated from the craccivora, fabae, and spiraecola groups. In addition, the correlation of the rates of evolution between morphological and DNA datasets was highly significant in their diversification. Conclusions: The morphological separation between the gossypii group and the other species-groups are congruent with their phylogenetic relationships. Analysis of trait evolution revealed that the morphological traits found to be significant based on the morphometric analyses were confidently correlated with the phylogeny. The dominant patterns of trait evolution resulting in increased rates of short branches and temporally later evolution are likely suitable for the modality of Aphis speciation because they have adapted species-specifically, rapidly, and more recently on many different host plants.	[Kim, Hyojoong] Ewha Womans Univ, Div EcoSci, Seoul, South Korea; [Kim, Hyojoong] Ewha Womans Univ, Res Inst EcoSci, Seoul, South Korea; [Lee, Wonhoon; Lee, Seunghwan] Seoul Natl Univ, Dept Agr Biotechnol, Res Inst Agr & Life Sci, Seoul, South Korea	Ewha Womans University; Ewha Womans University; Seoul National University (SNU)	Kim, H (corresponding author), Ewha Womans Univ, Div EcoSci, Seoul, South Korea.	seung@snu.ac.kr	Kim, Hyojoong/AAT-8734-2021; Lee, Seunghwan/E-4992-2011	Kim, Hyojoong/0000-0002-1706-2991	Korean Government [KRF-2009-371-C00001]; Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [500-20080241]; USDA-ARS [58-1926-7-154F]	Korean Government(Korean Government); Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (KRF-2009-371-C00001) (http://www.nrf.go.kr). This research was supported by the grant no. 500-20080241 from the Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (http://www.ipet.re.kr). H. Kim and S. Lee were also supported by USDA-ARS Specific Cooperative Agreement no. 58-1926-7-154F (http://www.ars.usda.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2009, EVOLUTION, V63, P663, DOI 10.1111/j.1558-5646.2008.00573.x; Ahrens D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-234; [Anonymous], APHIDS WORLDS HERBAC; Armbruster WS, 2009, P NATL ACAD SCI USA, V106, P18085, DOI 10.1073/pnas.0907051106; Blackman RL, 2002, SYST ENTOMOL, V27, P323, DOI 10.1046/j.1365-3113.2002.00181.x; BLACKMAN RL, 1994, EUR J ENTOMOL, V91, P7; BONER C, 1952, MITTEILUNGEN THTIRIN, V3, P1; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Brevault T, 2008, AGR FOREST ENTOMOL, V10, P215, DOI 10.1111/j.1461-9563.2008.00377.x; Bromham L, 2002, EVOLUTION, V56, P1921; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Charaabi K, 2008, B ENTOMOL RES, V98, P333, DOI 10.1017/S0007485307005585; Coeur d'Acier A, 2007, MOL PHYLOGENET EVOL, V42, P598, DOI 10.1016/j.ympev.2006.10.006; Cooper N, 2009, J EVOLUTION BIOL, V22, P1024, DOI 10.1111/j.1420-9101.2009.01714.x; Dixon AFG, 1987, APHIDS THEIR BIOL NA, P197; Durante MPM, 2003, CAN ENTOMOL, V135, P187, DOI 10.4039/n02-065; Fourment M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-1; Fuller SJ, 1999, MOL ECOL, V8, P1867, DOI 10.1046/j.1365-294x.1999.00782.x; Hales D, 2000, AUST J ENTOMOL, V39, P123, DOI 10.1046/j.1440-6055.2000.00160.x; Heie O. E., 1995, APHIDOIDEA HEMIPTE 3, VVI; Heie OE, 1994, APHIDOIDEA HEMIPTE 2; HEIE OE, 1986, APHIDOIDEA HEMIPTERA, V3; Heie Ole E., 1994, P409; HOLMAN J, 1987, ACTA ENTOMOL BOHEMOS, V84, P353; Iglisch I., 1970, Z. angew. Ent., V65, P304; Jacob F. H., 1945, Proceedings of the Royal Entomological Society of London (B), V14, P102; Kim H, 2008, SYST ENTOMOL, V33, P711, DOI 10.1111/J.1365-3113.2008.00440.x; Kim H, 2008, MOL CELLS, V25, P510; Kim H, 2006, ENTOMOL NEWS, V117, P155, DOI 10.3157/0013-872X(2006)117[155:TNSOTG]2.0.CO;2; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee S, 2006, EC INSECTS KOREA S35; Lozier JD, 2008, ZOOTAXA, P1; Lozier JD, 2007, EVOLUTION, V61, P1353, DOI 10.1111/j.1558-5646.2007.00110.x; Margaritopoulos JT, 2007, APPL ENTOMOL ZOOL, V42, P329, DOI 10.1303/aez.2007.329; Margaritopoulos JT, 2007, BIOL J LINN SOC, V91, P687, DOI 10.1111/j.1095-8312.2007.00828.x; Margaritopoulos JT, 2000, B ENTOMOL RES, V90, P233, DOI 10.1017/S0007485300000353; Margaritopoulos JT, 2006, B ENTOMOL RES, V96, P153, DOI 10.1079/BER2005410; Moran NA, 1999, SYST ENTOMOL, V24, P85, DOI 10.1046/j.1365-3113.1999.00076.x; MORAN NA, 1992, ANNU REV ENTOMOL, V37, P321, DOI 10.1146/annurev.en.37.010192.001541; Nylander JAA, 2004, MRMODELTEST 2 0 PROG; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.1111/j.1558-5646.1997.tb01461.x, 10.2307/2411190]; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL M, 2008, CONTINUOUS DRAFT MAN; Pagel M., 2007, BAYESTRAITS VERSION; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; PASHCHENKO NF, 1997, ENTOMOLOGICAL REV, V77, P871; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; PICKETT JA, 1992, ANNU REV ENTOMOL, V37, P67, DOI 10.1146/annurev.en.37.010192.000435; Poultos KD, 2007, EUR J ENTOMOL, V104, P235, DOI 10.14411/eje.2007.037; Powell G, 2006, ANNU REV ENTOMOL, V51, P309, DOI 10.1146/annurev.ento.51.110104.151107; Qiao GX, 2008, ZOOTAXA, P1; Rakauskas R, 2008, CENT EUR J BIOL, V3, P307, DOI 10.2478/s11535-008-0020-y; Rambaut A., 2007, TRACER 1 5; Raymond B, 2001, BIOL J LINN SOC, V74, P205, DOI 10.1111/j.1095-8312.2001.tb01387.x; Remaudiere G., 1997, CATALOGUE APHIDIDAE; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sloane MA, 2001, GENET RES, V77, P251, DOI 10.1017/S0016672301005018; Soria-Carrasco V, 2007, BIOINFORMATICS, V23, P2954, DOI 10.1093/bioinformatics/btm466; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STROYAN HLG, 1984, HDB IDENT BR INSEC 6, V2; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Takahashi R., 1966, Transactions of the American Entomological Society, V92, P519; Thieme T., 1987, P314; Tosh CR, 2004, ECOL ENTOMOL, V29, P488, DOI 10.1111/j.0307-6946.2004.00621.x; Von Dohlen CD, 2003, ANN ENTOMOL SOC AM, V96, P107, DOI 10.1603/0013-8746(2003)096[0107:PAHBON]2.0.CO;2	66	62	63	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11608	10.1371/journal.pone.0011608	http://dx.doi.org/10.1371/journal.pone.0011608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657654	gold, Green Published, Green Submitted			2022-12-27	WOS:000279924500011
J	Meech, R; Gomez, M; Woolley, C; Barro, M; Hulin, JA; Walcott, EC; Delgado, J; Makarenkova, HP				Meech, Robyn; Gomez, Mariana; Woolley, Christopher; Barro, Marietta; Hulin, Julie-Ann; Walcott, Elisabeth C.; Delgado, Jary; Makarenkova, Helen P.			The Homeobox Transcription Factor Barx2 Regulates Plasticity of Young Primary Myofibers	PLOS ONE			English	Article							MUSCLE SATELLITE CELL; PLURIPOTENT STEM-CELLS; LIMB REGENERATION; SKELETAL-MUSCLE; MYOGENIC DIFFERENTIATION; HOMEODOMAIN PROTEIN; SELF-RENEWAL; DIGIT TIP; EXPRESSION; GENE	Background: Adult mammalian muscle retains incredible plasticity. Muscle growth and repair involves the activation of undifferentiated myogenic precursors called satellite cells. In some circumstances, it has been proposed that existing myofibers may also cleave and produce a pool of proliferative cells that can re-differentiate into new fibers. Such myofiber dedifferentiation has been observed in the salamander blastema where it may occur in parallel with satellite cell activation. Moreover, ectopic expression of the homeodomain transcription factor Msx1 in differentiated C2C12 myotubes has been shown to induce their dedifferentiation. While it remains unclear whether dedifferentiation and redifferentiaton occurs endogenously in mammalian muscle, there is considerable interest in induced dedifferentiation as a possible regenerative tool. Methodology/Principal Findings: We previously showed that the homeobox protein Barx2 promotes myoblast differentiation. Here we report that ectopic expression of Barx2 in young immature myotubes derived from cell lines and primary mouse myoblasts, caused cleavage of the syncytium and downregulation of differentiation markers. Microinjection of Barx2 cDNA into immature myotubes derived from primary cells led to cleavage and formation of mononucleated cells that were able to proliferate. However, injection of Barx2 cDNA into mature myotubes did not cause cleavage. Barx2 expression in C2C12 myotubes increased the expression of cyclin D1, which may promote cell cycle re-entry. We also observed differential muscle gene regulation by Barx2 at early and late stages of muscle differentiation which may be due to differential recruitment of transcriptional activator or repressor complexes to muscle specific genes by Barx2. Conclusions/Significance: We show that Barx2 regulates plasticity of immature myofibers and might act as a molecular switch controlling cell differentiation and proliferation.	[Meech, Robyn; Gomez, Mariana; Woolley, Christopher; Barro, Marietta; Hulin, Julie-Ann; Makarenkova, Helen P.] Scripps Res Inst, La Jolla, CA 92037 USA; [Meech, Robyn] Flinders Univ S Australia, Beford Pk, SA, Australia; [Walcott, Elisabeth C.; Delgado, Jary; Makarenkova, Helen P.] Inst Neurosci, San Diego, CA USA	Scripps Research Institute; Flinders University South Australia	Meech, R (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	hmakarenk@scripps.edu		Hulin, Julie-Ann/0000-0003-4886-0416; Meech, Robyn/0000-0002-6831-0801	National Institutes of Health [5R01AR053163-02]; Association Francaise contre les Myopathies; Neurosciences Support Foundation; French and Masserini Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Neurosciences Support Foundation; French and Masserini Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grant 5R01AR053163-02 (to H. P. M.) and by a grant from the Association Francaise contre les Myopathies (to H. P. M.). The study was also supported by Neurosciences Support Foundation (to H. P. M. and E. C. W). Additional support (to M. G.) was provided by the French and Masserini Charitable Trusts and (to J.D.) by the G. Harold and Leila Y. Mathers Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan CH, 2006, WOUND REPAIR REGEN, V14, P398, DOI 10.1111/j.1743-6109.2006.00139.x; Anderson DM, 2009, DEV DYNAM, V238, P572, DOI 10.1002/dvdy.21873; Bedelbaeva K, 2010, P NATL ACAD SCI USA, V107, P5845, DOI 10.1073/pnas.1000830107; Bendall AJ, 1999, DEVELOPMENT, V126, P4965; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; CAMPION DR, 1984, INT REV CYTOL, V87, P225, DOI 10.1016/S0074-7696(08)62444-4; Christen B, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-5; Cossins J, 2002, DEVELOPMENT, V129, P2195; CRAWFORD K, 1988, DEVELOPMENT, V102, P687; CREWS L, 1995, P ROY SOC B-BIOL SCI, V259, P161, DOI 10.1098/rspb.1995.0024; Desai NS, 2006, J NEUROSCI, V26, P2215, DOI 10.1523/JNEUROSCI.4310-05.2006; Duca KA, 1998, BBA-MOL CELL RES, V1401, P1, DOI 10.1016/S0167-4889(97)00118-3; Ebelt H, 2008, CARDIOVASC RES, V80, P219, DOI 10.1093/cvr/cvn194; Edelman DB, 2000, J BIOL CHEM, V275, P21737, DOI 10.1074/jbc.M909998199; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Han M, 2008, DEV BIOL, V315, P125, DOI 10.1016/j.ydbio.2007.12.025; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Koshiba K, 1998, J EXP ZOOL, V282, P703, DOI 10.1002/(SICI)1097-010X(19981215)282:6<703::AID-JEZ6>3.0.CO;2-P; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; MAKARENKOVA HP, 2009, J BIOL CHEM; Meech R, 2003, J BIOL CHEM, V278, P8269, DOI 10.1074/jbc.M207617200; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; Mescher AL, 1996, INT J DEV BIOL, V40, P785; Nelson TJ, 2009, CIRCULATION, V120, P408, DOI 10.1161/CIRCULATIONAHA.109.865154; Odelberg SJ, 2004, PLOS BIOL, V2, P1068, DOI 10.1371/journal.pbio.0020232; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Olson LE, 2005, P NATL ACAD SCI USA, V102, P3708, DOI 10.1073/pnas.0500519102; Oviedo NJ, 2009, SEMIN CELL DEV BIOL, V20, P557, DOI 10.1016/j.semcdb.2009.04.005; Prindull GA, 2007, EXP HEMATOL, V35, P691, DOI 10.1016/j.exphem.2007.01.047; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rudnicki MA, 2008, COLD SH Q B, V73, P323, DOI 10.1101/sqb.2008.73.064; Shinin Vasily, 2009, V482, P295, DOI 10.1007/978-1-59745-060-7_19; Slack JMW, 2006, TRENDS CELL BIOL, V16, P273, DOI 10.1016/j.tcb.2006.04.007; SONG KN, 1992, NATURE, V360, P477, DOI 10.1038/360477a0; Springer ML, 2002, CELL MOTIL CYTOSKEL, V51, P177, DOI 10.1002/cm.10022; Stocum DL, 1997, SCIENCE, V276, P15, DOI 10.1126/science.276.5309.15; Straube WL, 2004, CLONING STEM CELLS, V6, P333, DOI 10.1089/clo.2004.6.333; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Tsonis PA, 2004, MOL INTERV, V4, P81, DOI 10.1124/mi.4.2.4; TSONIS PA, 1995, SEMIN CELL BIOL, V6, P127, DOI 10.1006/scel.1995.0018; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	51	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11612	10.1371/journal.pone.0011612	http://dx.doi.org/10.1371/journal.pone.0011612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657655	Green Submitted, Green Published, gold			2022-12-27	WOS:000279924500014
J	Yang, A; Zhu, Z; Kettenbach, A; Kapranov, P; McKeon, F; Gingeras, TR; Struhl, K				Yang, Annie; Zhu, Zhou; Kettenbach, Arminja; Kapranov, Philipp; McKeon, Frank; Gingeras, Thomas R.; Struhl, Kevin			Genome-Wide Mapping Indicates That p73 and p63 Co-Occupy Target Sites and Have Similar DNA-Binding Profiles In Vivo	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; TUMOR-SUPPRESSOR; CHROMATIN IMMUNOPRECIPITATION; TETRAMERIZATION DOMAIN; P53; DIFFERENTIATION; IDENTIFICATION; DELTA-N-P63; EVOLUTION; FAMILY	Background: The p53 homologs, p63 and p73, share similar to 85% amino acid identity in their DNA-binding domains, but they have distinct biological functions. Principal Findings: Using chromatin immunoprecipitation and high-resolution tiling arrays covering the human genome, we identify p73 DNA binding sites on a genome-wide level in ME180 human cervical carcinoma cells. Strikingly, the p73 binding profile is indistinguishable from the previously described binding profile for p63 in the same cells. Moreover, the p73:p63 binding ratio is similar at all genomic loci tested, suggesting that there are few, if any, targets that are specific for one of these factors. As assayed by sequential chromatin immunoprecipitation, p63 and p73 co-occupy DNA target sites in vivo, suggesting that p63 and p73 bind primarily as heterotetrameric complexes in ME180 cells. Conclusions: The observation that p63 and p73 associate with the same genomic targets suggest that their distinct biological functions are due to cell-type specific expression and/or protein domains that involve functions other than DNA binding.	[Yang, Annie; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhu, Zhou] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Kettenbach, Arminja; McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Kapranov, Philipp; Gingeras, Thomas R.] Affymetrix, Santa Clara, CA USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Affymetrix	Yang, A (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Kutalik, Zoltan/HHZ-5697-2022	Kutalik, Zoltan/0000-0001-8285-7523; Gingeras, Thomas/0000-0001-9106-3573; Kettenbach, Arminja/0000-0003-3979-4576; Kapranov, Philipp/0000-0003-2647-4856	National Institutes of Health [GM 30186, N01-CO-12400, U01 HG003147, CA73430, CA83944]; NATIONAL CANCER INSTITUTE [R01CA083944] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083348, R37GM030186, R01GM030186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a predoctoral fellowship to A.Y. from the Department of Defense (Breast Cancer Research Program; W81XWH-04-1-0386) and by research grants from the National Institutes of Health to K.S. (GM 30186), T.R.G. (Contract N01-CO-12400 and U01 HG003147), and F.M. (CA73430 and CA83944). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Belyi VA, 2009, P NATL ACAD SCI USA, V106, P17609, DOI 10.1073/pnas.0910634106; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Coutandin D, 2009, CELL DEATH DIFFER, V16, P1582, DOI 10.1038/cdd.2009.139; De Laurenzi V, 2000, BIOCHEM BIOPH RES CO, V273, P342, DOI 10.1006/bbrc.2000.2932; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; DeYoung MP, 2006, CANCER RES, V66, P9362, DOI 10.1158/0008-5472.CAN-06-1619; FRIEDMAN PN, 1993, P NATL ACAD SCI USA, V90, P3319, DOI 10.1073/pnas.90.8.3319; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Harmes DC, 2003, ONCOGENE, V22, P7607, DOI 10.1038/sj.onc.1207129; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Joerger AC, 2009, P NATL ACAD SCI USA, V106, P17705, DOI 10.1073/pnas.0905867106; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kommagani R, 2010, CELL DEATH DIFFER, V17, P398, DOI 10.1038/cdd.2009.135; Li N, 2006, ONCOGENE, V25, P2349, DOI 10.1038/sj.onc.1209270; LI W, 2010, DISTINGUISHING UNPUB; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nelson EA, 2004, J BIOL CHEM, V279, P54724, DOI 10.1074/jbc.M408464200; Rocco JW, 2006, CELL CYCLE, V5, P936, DOI 10.4161/cc.5.9.2716; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; van Bokhoven H, 2002, TRENDS MOL MED, V8, P133, DOI 10.1016/S1471-4914(01)02260-2; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	33	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11572	10.1371/journal.pone.0011572	http://dx.doi.org/10.1371/journal.pone.0011572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644729	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000279884900012
J	Jang, SW; Liu, X; Chan, CB; France, SA; Sayeed, I; Tang, WX; Lin, X; Xiao, G; Andero, R; Chang, QA; Ressler, KJ; Ye, KQ				Jang, Sung-Wuk; Liu, Xia; Chan, Chi Bun; France, Stefan A.; Sayeed, Iqbal; Tang, Wenxue; Lin, Xi; Xiao, Ge; Andero, Raul; Chang, Qiang; Ressler, Kerry J.; Ye, Keqiang			Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CEREBRAL-ARTERY OCCLUSION; ANTIDEPRESSANT DRUGS; FUNCTIONAL RECOVERY; SIGNAL-TRANSDUCTION; NERVOUS-SYSTEM; TRK RECEPTORS; INFARCT SIZE; FACTOR BDNF; BRAIN	Gedunin, a family of natural products from the Indian neem tree, possess a variety of biological activities. Here we report the discovery of deoxygedunin, which activates the mouse TrkB receptor and its downstream signaling cascades. Deoxygedunin is orally available and activates TrkB in mouse brain in a BDNF-independent way. Strikingly, it prevents the degeneration of vestibular ganglion in BDNF -/- pups. Moreover, deoxygedunin robustly protects rat neurons from cell death in a TrkB-dependent manner. Further, administration of deoxygedunin into mice displays potent neuroprotective, anti-depressant and learning enhancement effects, all of which are mediated by the TrkB receptor. Hence, deoxygedunin imitates BDNF's biological activities through activating TrkB, providing a powerful therapeutic tool for treatment of various neurological diseases.	[Jang, Sung-Wuk; Liu, Xia; Chan, Chi Bun; Ye, Keqiang] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [France, Stefan A.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Sayeed, Iqbal] Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA; [Tang, Wenxue; Lin, Xi] Emory Univ, Sch Med, Dept Otolaryngol & Cell Biol, Atlanta, GA 30322 USA; [Xiao, Ge] Ctr Dis Control & Prevent, Atlanta, GA USA; [Andero, Raul] Autonomous Univ Barcelona, Anim Physiol Unit, Inst Neurosci, Barcelona, Spain; [Chang, Qiang] Univ Wisconsin, Waisman Ctr, Dept Genet & Neurol, Madison, WI 53705 USA; [Ressler, Kerry J.] Emory Univ, Sch Med, Howard Hughes Med Inst, Atlanta, GA 30322 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University; Centers for Disease Control & Prevention - USA; Autonomous University of Barcelona; University of Wisconsin System; University of Wisconsin Madison; Emory University; Howard Hughes Medical Institute	Jang, SW (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	kye@emory.edu	Ressler, Kerry J/N-8741-2018; lin, xi/GZL-4959-2022; Andero, Raul/C-1217-2017	Ressler, Kerry J/0000-0002-5158-1103; Andero, Raul/0000-0003-3641-8903; France, Stefan/0000-0001-5998-6167; Tang, Wenxue/0000-0001-8087-0900	National Institute of Health [RO1 CA127119]; NATIONAL CANCER INSTITUTE [R01CA127119] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by grants from National Institute of Health RO1 CA127119 to K. Ye. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; ASKANAS V, 1995, ADV NEUROL, V68, P241; Castren E, 2004, CURR OPIN PHARMACOL, V4, P58, DOI 10.1016/j.coph.2003.10.004; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chhatwal JP, 2007, GENE THER, V14, P575, DOI 10.1038/sj.gt.3302898; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; Cunningham ME, 1998, EMBO J, V17, P7282, DOI 10.1093/emboj/17.24.7282; Duman RS, 2004, BIOL PSYCHIAT, V56, P140, DOI 10.1016/j.biopsych.2004.02.033; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Fletcher JM, 2006, J PEPT SCI, V12, P515, DOI 10.1002/psc.760; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jang SW, 2007, P NATL ACAD SCI USA, V104, P16329, DOI 10.1073/pnas.0706662104; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Jones SV, 2007, LEARN MEMORY, V14, P816, DOI 10.1101/lm.781507; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KHALID SA, 1989, J NAT PROD, V52, P922, DOI 10.1021/np50065a002; Koda M, 2004, J NEUROTRAUM, V21, P329, DOI 10.1089/089771504322972112; KOKAIA Z, 1993, P NATL ACAD SCI USA, V90, P6711, DOI 10.1073/pnas.90.14.6711; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Lindsay RM, 1996, PHILOS T ROY SOC B, V351, P365, DOI 10.1098/rstb.1996.0030; Maguschak KA, 2008, NAT NEUROSCI, V11, P1319, DOI 10.1038/nn.2198; Nathan SS, 2006, CHEMOSPHERE, V62, P1388, DOI 10.1016/j.chemosphere.2005.07.009; O'Leary PD, 2003, J BIOL CHEM, V278, P25738, DOI 10.1074/jbc.M303209200; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Ou LC, 2007, MOL PHARMACOL, V72, P350, DOI 10.1124/mol.107.034934; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Qian MD, 2006, J NEUROSCI, V26, P9394, DOI 10.1523/JNEUROSCI.1118-06.2006; Rattiner LM, 2004, LEARN MEMORY, V11, P727, DOI 10.1101/lm.83304; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Saarelainen T, 2003, J NEUROSCI, V23, P349; Sayeed I, 2006, ANN EMERG MED, V47, P381, DOI 10.1016/j.annemergmed.2005.12.011; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; Siegel GJ, 2000, BRAIN RES REV, V33, P199, DOI 10.1016/S0165-0173(00)00030-8; Siuciak JA, 1997, PHARMACOL BIOCHEM BE, V56, P131, DOI 10.1016/S0091-3057(96)00169-4; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thoenen H, 2002, NAT NEUROSCI, V5, P1046, DOI 10.1038/nn938; THOENEN H, 1991, TRENDS NEUROSCI, V14, P165, DOI 10.1016/0166-2236(91)90097-E; Uddin SJ, 2007, PHYTOTHER RES, V21, P757, DOI 10.1002/ptr.2159	52	73	86	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11528	10.1371/journal.pone.0011528	http://dx.doi.org/10.1371/journal.pone.0011528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644624	Green Published, Green Submitted, gold			2022-12-27	WOS:000279822300006
J	Mauney, JR; Ramachandran, A; Yu, RN; Daley, GQ; Adam, RM; Estrada, CR				Mauney, Joshua R.; Ramachandran, Aruna; Yu, Richard N.; Daley, George Q.; Adam, Rosalyn M.; Estrada, Carlos R.			All-Trans Retinoic Acid Directs Urothelial Specification of Murine Embryonic Stem Cells via GATA4/6 Signaling Mechanisms	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR GATA6; GENE-EXPRESSION; MOLECULAR-MECHANISMS; EXTERNAL GENITALIA; STROMAL CELLS; GUT ENDODERM; DIFFERENTIATION; BLADDER; MOUSE	The urinary bladder and associated tract are lined by the urothelium, a transitional epithelium that acts as a specialized permeability barrier that protects the underlying tissue from urine via expression of a highly specific group of proteins known as the uroplakins (UP). To date, our understanding of the developmental processes responsible for urothelial differentiation has been hampered due to the lack of suitable models. In this study, we describe a novel in vitro cell culture system for derivation of urothelial cells from murine embryonic stem cells (ESCs) following cultivation on collagen matrices in the presence all trans retinoic acid (RA). Upon stimulation with micromolar concentrations of RA, ESCs significantly downregulated the pluripotency factor OCT-4 but markedly upregulated UP1A, UP1B, UP2, UP3A, and UP3B mRNA levels in comparison to naive ESCs and spontaneously differentiating controls. Pan-UP protein expression was associated with both p63- and cytokeratin 20-positive cells in discrete aggregating populations of ESCs following 9 and 14 days of RA stimulation. Analysis of endodermal transcription factors such as GATA4 and GATA6 revealed significant upregulation and nuclear enrichment in RA-treated UP2-GFP+ populations. GATA4-/- and GATA6-/- transgenic ESC lines revealed substantial attenuation of RA-mediated UP expression in comparison to wild type controls. In addition, EMSA analysis revealed that RA treatment induced formation of transcriptional complexes containing GATA4/6 on both UP1B and UP2 promoter fragments containing putative GATA factor binding sites. Collectively, these data suggest that RA mediates ESC specification toward a urothelial lineage via GATA4/6-dependent processes.	[Mauney, Joshua R.; Ramachandran, Aruna; Yu, Richard N.; Adam, Rosalyn M.; Estrada, Carlos R.] Childrens Hosp, Urol Dis Res Ctr, Boston, MA 02115 USA; [Mauney, Joshua R.; Ramachandran, Aruna; Yu, Richard N.; Adam, Rosalyn M.; Estrada, Carlos R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Daley, George Q.] Harvard Stem Cell Inst, Boston, MA USA; [Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Mauney, JR (corresponding author), Childrens Hosp, Urol Dis Res Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	rosalyn.adam@childrens.harvard.edu; carlos.estrada@childrens.harvard.edu	Estrada, Carlos R/H-2199-2015	Estrada, Carlos R/0000-0003-0586-9832	Children's Hospital Boston, Office of Sponsored Programs Support for Pilot Studies (Estrada); National Institutes of Health (NIH), NIDDK [P50 DK065298-06]; Harvard Catalyst/Harvard Clinical and Translational Science Center, Estrada [UL1 RR025758-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK065298] Funding Source: NIH RePORTER	Children's Hospital Boston, Office of Sponsored Programs Support for Pilot Studies (Estrada); National Institutes of Health (NIH), NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harvard Catalyst/Harvard Clinical and Translational Science Center, Estrada; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from Children's Hospital Boston, Office of Sponsored Programs Support for Pilot Studies (Estrada) and the National Institutes of Health (NIH), NIDDK P50 DK065298-06 (Freeman). This work was also conducted with support from the Faculty Career Development Award program of the Harvard Catalyst/Harvard Clinical and Translational Science Center (Award # UL1 RR025758-01, Estrada). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboushwareb T, 2009, NEUROUROL URODYNAM, V28, P1028, DOI 10.1002/nau.20688; Adachi W, 2000, INVEST OPHTH VIS SCI, V41, P2900; ANG SL, 1993, DEVELOPMENT, V119, P1301; ARMS L, 2009, AM J PHYSL IN PRESS; Axell MZ, 2009, J NEUROSCI METH, V184, P275, DOI 10.1016/j.jneumeth.2009.08.015; Baker LA, 1998, SEMIN NEPHROL, V18, P569; Barbara PD, 2002, DEVELOPMENT, V129, P551; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; BOYLAN JF, 1995, MOL CELL BIOL, V15, P843; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Cheng W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/dev.02621; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; Darlington GJ, 1999, CURR OPIN CELL BIOL, V11, P678, DOI 10.1016/S0955-0674(99)00035-6; Erickson DR, 2008, J UROLOGY, V180, P2681, DOI 10.1016/j.juro.2008.08.007; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kanematsu A, 2007, AM J PHYSIOL-CELL PH, V293, pC1093, DOI 10.1152/ajpcell.00225.2007; Keijzer R, 2001, DEVELOPMENT, V128, P503; Kinebuchi Y, 2008, CELL TISSUE RES, V331, P605, DOI 10.1007/s00441-007-0553-9; Kondo T, 1996, DEVELOPMENT, V122, P2651; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Lazarevich NL, 2000, BIOCHEMISTRY-MOSCOW+, V65, P117; Liang FX, 2005, J CELL BIOL, V171, P835, DOI 10.1083/jcb.200505035; LIN JH, 1995, P NATL ACAD SCI USA, V92, P679, DOI 10.1073/pnas.92.3.679; LIN TP, 1994, DEV BIOL, V166, P170, DOI 10.1006/dbio.1994.1305; Malpel S, 2000, DEVELOPMENT, V127, P3057; Matusik RJ, 2008, DIFFERENTIATION, V76, P682, DOI 10.1111/j.1432-0436.2008.00276.x; Mauney JR, 2004, BIOMATERIALS, V25, P3233, DOI 10.1016/j.biomaterials.2003.10.005; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; MOLLOY CJ, 1988, EXP MOL PATHOL, V49, P128, DOI 10.1016/0014-4800(88)90027-5; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrison B, 1998, SWINE HEALTH PROD, V6, P4; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; Niimi T, 2004, J BIOL CHEM, V279, P38055, DOI 10.1074/jbc.M403724200; Oottamasathien S, 2007, DEV BIOL, V304, P556, DOI 10.1016/j.ydbio.2007.01.010; Otto A, 2009, J ANAT, V215, P477, DOI 10.1111/j.1469-7580.2009.01138.x; Park JM, 1999, AM J PHYSIOL-CELL PH, V277, pC294, DOI 10.1152/ajpcell.1999.277.2.C294; Penington EC, 2003, J PEDIATR SURG, V38, P1287, DOI 10.1016/S0022-3468(03)00384-1; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Plateroti M, 1997, J CELL SCI, V110, P1227; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Schlager TA, 2004, SPINAL CORD, V42, P163, DOI 10.1038/sj.sc.3101565; Scott V, 2005, J BIOCHEM, V137, P671, DOI 10.1093/jb/mvi086; Shanks JH, 2009, HISTOPATHOLOGY, V54, P885, DOI 10.1111/j.1365-2559.2008.03167.x; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Staack A, 2005, DIFFERENTIATION, V73, P121, DOI 10.1111/j.1432-0436.2005.00014.x; Stehr M, 2004, J UROLOGY, V172, P2451, DOI 10.1097/01.ju.0000138084.53577.ca; Suzuki YJ, 2003, J BIOL CHEM, V278, P17525, DOI 10.1074/jbc.M210465200; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Warot X, 1997, DEVELOPMENT, V124, P4781; Watt AJ, 2004, P NATL ACAD SCI USA, V101, P12573, DOI 10.1073/pnas.0400752101; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; WERT SE, 1993, DEV BIOL, V156, P426, DOI 10.1006/dbio.1993.1090; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yamada G, 2006, DEV DYNAM, V235, P1738, DOI 10.1002/dvdy.20807; Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zhuang Y, 2003, MOL CANCER RES, V1, P619	69	49	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11513	10.1371/journal.pone.0011513	http://dx.doi.org/10.1371/journal.pone.0011513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644631	gold, Green Submitted, Green Published			2022-12-27	WOS:000279822300004
J	Blanco-Kelly, F; Matesanz, F; Alcina, A; Teruel, M; Diaz-Gallo, LM; Gomez-Garcia, M; Lopez-Nevot, MA; Rodrigo, L; Nieto, A; Cardena, C; Alcain, G; Diaz-Rubio, M; de la Concha, EG; Fernandez, O; Arroyo, R; Martin, J; Urcelay, E				Blanco-Kelly, Fiona; Matesanz, Fuencisla; Alcina, Antonio; Teruel, Maria; Diaz-Gallo, Lina M.; Gomez-Garcia, Maria; Lopez-Nevot, Miguel A.; Rodrigo, Luis; Nieto, Antonio; Cardena, Carlos; Alcain, Guillermo; Diaz-Rubio, Manuel; de la Concha, Emilio G.; Fernandez, Oscar; Arroyo, Rafael; Martin, Javier; Urcelay, Elena			CD40: Novel Association with Crohn's Disease and Replication in Multiple Sclerosis Susceptibility	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GRAVES-DISEASE; T-CELLS; DENDRITIC CELLS; GENE; LIGAND; EXPRESSION; INTERLEUKIN-17; TRANSLATION	Background: A functional polymorphism located at -1 from the start codon of the CD40 gene, rs1883832, was previously reported to disrupt a Kozak sequence essential for translation. It has been consistently associated with Graves' disease risk in populations of different ethnicity and genetic proxies of this variant evaluated in genome-wide association studies have shown evidence of an effect in rheumatoid arthritis and multiple sclerosis (MS) susceptibility. However, the protective allele associated with Graves' disease or rheumatoid arthritis has shown a risk role in MS, an effect that we aimed to replicate in the present work. We hypothesized that this functional polymorphism might also show an association with other complex autoimmune condition such as inflammatory bowel disease, given the CD40 overexpression previously observed in Crohn's disease (CD) lesions. Methodology: Genotyping of rs1883832C>T was performed in 1564 MS, 1102 CD and 969 ulcerative colitis (UC) Spanish patients and in 2948 ethnically matched controls by TaqMan chemistry. Principal Findings: The observed effect of the minor allele rs1883832T was replicated in our independent Spanish MS cohort [p=0.025; OR (95% CI)=1.12 (1.01-1.23)]. The frequency of the minor allele was also significantly higher in CD patients than in controls [p=0.002; OR (95% CI)=1.19 (1.06-1.33)]. This increased predisposition was not detected in UC patients [p=0.5; OR (95% CI)=1.04 (0.93-1.17)]. Conclusion: The impact of CD40 rs1883832 on MS and CD risk points to a common signaling shared by these autoimmune conditions.	[Blanco-Kelly, Fiona; de la Concha, Emilio G.; Urcelay, Elena] Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain; [Matesanz, Fuencisla; Alcina, Antonio; Teruel, Maria; Diaz-Gallo, Lina M.; Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Gomez-Garcia, Maria] Hosp Univ Virgen de la Nieves, Serv Digest, Granada, Spain; [Lopez-Nevot, Miguel A.] Hosp Univ Virgen de la Nieves, Serv Inmunol, Granada, Spain; [Rodrigo, Luis] Hosp Univ Cent Asturias, Serv Digest, Oviedo, Spain; [Nieto, Antonio] Hosp Puerta del Mar, Serv Inmunol, Cadiz, Spain; [Cardena, Carlos] Hosp Clin San Cecilio, Serv Digest, Granada, Spain; [Alcain, Guillermo] Hosp Virgen de la Victoria, Serv Digest, Malaga, Spain; [Diaz-Rubio, Manuel] Hosp Clin San Carlos, Digest Dept, Madrid, Spain; [Fernandez, Oscar] Hosp Carlos Haya, Inst Neurociencias Clin, Serv Neurol, Malaga, Spain; [Arroyo, Rafael] Hosp Clin San Carlos, Dept Neurol, Multiple Sclerosis Unit, Madrid, Spain	Hospital Clinico San Carlos; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; Central University Hospital Asturias; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Universitario San Cecilio; Hospital Virgen de la Victoria; Hospital Clinico San Carlos; Hospital Carlos Haya; Hospital Clinico San Carlos	Blanco-Kelly, F (corresponding author), Hosp Clin San Carlos, Dept Clin Immunol, Madrid, Spain.	eurcelay.hcsc@salud.madrid.org	Teruel, Maria/V-3205-2017; Alcina, Antonio/T-1893-2017; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022; Martín, Javier/AAV-5209-2021; Matesanz, Fuencisla/F-3715-2016; Rodrigo, Luis/A-6278-2010; Diaz-Gallo, Lina Marcela/F-1181-2018	Teruel, Maria/0000-0002-5315-2660; Alcina, Antonio/0000-0001-7294-0948; Martin, Javier/0000-0002-2202-0622; Matesanz, Fuencisla/0000-0002-9429-1819; Rodrigo, Luis/0000-0003-1717-9345; Diaz-Gallo, Lina Marcela/0000-0002-5688-0102; Lopez Nevot, Miguel Angel/0000-0002-3465-6062; Urcelay, Elena/0000-0001-8470-8396; Blanco-Kelly, Fiona/0000-0003-0052-5651	Fundacion Mutua Madrilena; Fundacion Ramon Areces; Junta de Andalucia-Feder [P07-CVI-02551]; Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) [PI081636, PI0816763, PI070353, RD07/0060]; Ministerio de Ciencia e Innovacion-Feder [SAF2009-11491, SAF2006-00398]	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Fundacion Ramon Areces; Junta de Andalucia-Feder(Junta de AndaluciaEuropean Commission); Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder)(European Commission); Ministerio de Ciencia e Innovacion-Feder(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Elena Urcelay works for the "Fundacion para la Investigacion Biomedica-Hospital Clinico San Carlos''. This work was supported by grants from: "Fundacion Mutua Madrilena'', "Fundacion Ramon Areces'', Junta de Andalucia-Feder P07-CVI-02551, Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional (Feder) (PI081636, PI081676, PI070353 and RETICS-REEM RD07/0060) and Ministerio de Ciencia e Innovacion-Feder (SAF2009-11491, SAF2006-00398). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Balasa B, 1997, J IMMUNOL, V159, P4620; Ban Y, 2006, THYROID, V16, P443, DOI 10.1089/thy.2006.16.443; Battaglia E, 1999, AM J GASTROENTEROL, V94, P3279, DOI 10.1111/j.1572-0241.1999.01538.x; Boon L, 2001, J IMMUNOL, V167, P2942, DOI 10.4049/jimmunol.167.5.2942; Buck D, 2006, TISSUE ANTIGENS, V68, P335, DOI 10.1111/j.1399-0039.2006.00672.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chadha S, 2006, EUR J HUM GENET, V14, P69, DOI 10.1038/sj.ejhg.5201527; Chen CR, 2006, THYROID, V16, P427, DOI 10.1089/thy.2006.16.427; Cooper JD, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-71; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gao D, 2005, GUT, V54, P70, DOI 10.1136/gut.2003.029587; Gerritse K, 1996, P NATL ACAD SCI USA, V93, P2499, DOI 10.1073/pnas.93.6.2499; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kurylowicz A, 2005, THYROID, V15, P1119, DOI 10.1089/thy.2005.15.1119; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; MOHAN C, 1995, J IMMUNOL, V154, P1470; Murugaiyan G, 2008, J IMMUNOL, V181, P7480, DOI 10.4049/jimmunol.181.11.7480; Peters A.L., 2009, SEMIN IMMUNOL, V10, P10; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; 't Hart BA, 2008, NEURODEGENER DIS, V5, P38, DOI 10.1159/000109937; Tomer Y, 2002, THYROID, V12, P1129, DOI 10.1089/105072502321085234; Zheng J, 2010, CELL MOL IMMUNOL, V7, P44, DOI 10.1038/cmi.2009.103; Zheng J, 2009, J IMMUNOL, V183, P3742, DOI 10.4049/jimmunol.0901329	32	49	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11520	10.1371/journal.pone.0011520	http://dx.doi.org/10.1371/journal.pone.0011520			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634952	Green Published, gold, Green Submitted			2022-12-27	WOS:000279781600008
J	Chertemps, T; Mitri, C; Perrot, S; Sautereau, J; Jacques, JC; Thiery, I; Bourgouin, C; Rosinski-Chupin, I				Chertemps, Thomas; Mitri, Christian; Perrot, Sylvie; Sautereau, Jean; Jacques, Jean-Claude; Thiery, Isabelle; Bourgouin, Catherine; Rosinski-Chupin, Isabelle			Anopheles Gambiae PRS1 Modulates Plasmodium Development at Both Midgut and Salivary Gland Steps	PLOS ONE			English	Article							MALARIA PARASITE; MOLECULAR-INTERACTIONS; BERGHEI SPOROZOITES; MOSQUITO; INVASION; INFECTION; PROTEIN; VECTOR; CELLS; FALCIPARUM	Background: Invasion of the mosquito salivary glands by Plasmodium is a critical step for malaria transmission. From a SAGE analysis, we previously identified several genes whose expression in salivary glands was regulated coincident with sporozoite invasion of salivary glands. To get insights into the consequences of these salivary gland responses, here we have studied one of the genes, PRS1 (Plasmodium responsive salivary 1), whose expression was upregulated in infected glands, using immunolocalization and functional inactivation approaches. Methodology/Principal Findings: PRS1 belongs to a novel insect superfamily of genes encoding proteins with DM9 repeat motifs of uncharacterized function. We show that PRS1 is induced in response to Plasmodium, not only in the salivary glands but also in the midgut, the other epithelial barrier that Plasmodium has to cross to develop in the mosquito. Furthermore, this induction is observed using either the rodent parasite Plasmodium berghei or the human pathogen Plasmodium falciparum. In the midgut, PRS1 overexpression is associated with a relocalization of the protein at the periphery of invaded cells. We also find that sporozoite invasion of salivary gland cells occurs sequentially and induces intra-cellular modifications that include an increase in PRS1 expression and a relocalization of the corresponding protein into vesicle-like structures. Importantly, PRS1 knockdown during the onset of midgut and salivary gland invasion demonstrates that PRS1 acts as an agonist for the development of both parasite species in the two epithelia, highlighting shared vector/parasite interactions in both tissues. Conclusions/Significance: While providing insights into potential functions of DM9 proteins, our results reveal that PRS1 likely contributes to fundamental interactions between Plasmodium and mosquito epithelia, which do not depend on the specific Anopheles/P. falciparum coevolutionary history.	[Chertemps, Thomas; Perrot, Sylvie; Sautereau, Jean; Rosinski-Chupin, Isabelle] Inst Pasteur, Ctr Natl Rech Sci URA 3012, Dept Parasitol & Mycol, Unite Biochim & Biol Mol Insectes, Paris, France; [Mitri, Christian; Jacques, Jean-Claude; Thiery, Isabelle; Bourgouin, Catherine] Inst Pasteur, Dept Parasitol & Mycol, CEPIA, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chertemps, T (corresponding author), Univ Paris 06, UMR Physiol Insecte Signalisat & Commun 1272A, Paris, France.	ichupin@pasteur.fr	Bourgouin, Catherine/F-1253-2014	Bourgouin, Catherine/0000-0002-9209-845X; Mitri, Christian/0000-0003-3882-2029	Institut Pasteur (Paris); Fonds Dedie Sanofi-Aventis/Ministere de la Recherche "Combattre les Maladies Parasitaires''	Institut Pasteur (Paris); Fonds Dedie Sanofi-Aventis/Ministere de la Recherche "Combattre les Maladies Parasitaires''(Sanofi-AventisMinistry of Research, France)	This research has received financial support from the Institut Pasteur (Paris) and the Fonds Dedie Sanofi-Aventis/Ministere de la Recherche "Combattre les Maladies Parasitaires''. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amino R, 2008, CELL HOST MICROBE, V3, P88, DOI 10.1016/j.chom.2007.12.007; [Anonymous], 1932, STAT METHODS RES WOR; Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; Danielli A, 2005, CELL MICROBIOL, V7, P181, DOI 10.1111/j.1462-5822.2004.00445.x; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gomez SM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r39; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Hillyer JF, 2007, INT J PARASITOL, V37, P673, DOI 10.1016/j.ijpara.2006.12.007; Holford KC, 2004, INSECT BIOCHEM MOLEC, V34, P785, DOI 10.1016/j.ibmb.2004.04.003; Matuschewski K, 2006, CELL MICROBIOL, V8, P1547, DOI 10.1111/j.1462-5822.2006.00778.x; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Natarajan R, 2001, CELL MICROBIOL, V3, P371, DOI 10.1046/j.1462-5822.2001.00117.x; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; PIMENTA PF, 1994, J EUKARYOT MICROBIOL, V41, P608, DOI 10.1111/j.1550-7408.1994.tb01523.x; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Rosinski-Chupin I, 2007, CELL MICROBIOL, V9, P708, DOI 10.1111/j.1462-5822.2006.00822.x; Shiao SH, 2006, PLOS PATHOG, V2, P1152, DOI 10.1371/journal.ppat.0020133; Sinden RE, 2002, CELL MICROBIOL, V4, P713, DOI 10.1046/j.1462-5822.2002.00229.x; STERLING CR, 1973, J PARASITOL, V59, P593, DOI 10.2307/3278847; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Tahar R, 2002, EMBO J, V21, P6673, DOI 10.1093/emboj/cdf664; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Vlachou D, 2006, CURR OPIN GENET DEV, V16, P384, DOI 10.1016/j.gde.2006.06.012; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516	38	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11538	10.1371/journal.pone.0011538	http://dx.doi.org/10.1371/journal.pone.0011538			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634948	gold, Green Published, Green Submitted			2022-12-27	WOS:000279781600017
J	Eberle, AB; Hessle, V; Helbig, R; Dantoft, W; Gimber, N; Visa, N				Eberle, Andrea B.; Hessle, Viktoria; Helbig, Roger; Dantoft, Widad; Gimber, Niclas; Visa, Neus			Splice-Site Mutations Cause Rrp6-Mediated Nuclear Retention of the Unspliced RNAs and Transcriptional Down-Regulation of the Splicing-Defective Genes	PLOS ONE			English	Article							PRE-MESSENGER-RNA; QUALITY-CONTROL; POLYMERASE-II; IN-VIVO; EXOSOME; EXPORT; MRNP; TERMINATION; CEREVISIAE; EXPRESSION	Background: Eukaryotic cells have developed surveillance mechanisms to prevent the expression of aberrant transcripts. An early surveillance checkpoint acts at the transcription site and prevents the release of mRNAs that carry processing defects. The exosome subunit Rrp6 is required for this checkpoint in Saccharomyces cerevisiae, but it is not known whether Rrp6 also plays a role in mRNA surveillance in higher eukaryotes. Methodology/Principal Findings: We have developed an in vivo system to study nuclear mRNA surveillance in Drosophila melanogaster. We have produced S2 cells that express a human beta-globin gene with mutated splice sites in intron 2 (mut beta-globin). The transcripts encoded by the mut beta-globin gene are normally spliced at intron 1 but retain intron 2. The levels of the mut beta-globin transcripts are much lower than those of wild type (wt) beta-globin mRNAs transcribed from the same promoter. We have compared the expression of the mut and wt beta-globin genes to investigate the mechanisms that down-regulate the production of defective mRNAs. Both wt and mut beta-globin transcripts are processed at the 3', but the mut beta-globin transcripts are less efficiently cleaved than the wt transcripts. Moreover, the mut beta-globin transcripts are less efficiently released from the transcription site, as shown by FISH, and this defect is restored by depletion of Rrp6 by RNAi. Furthermore, transcription of the mut beta-globin gene is significantly impaired as revealed by ChIP experiments that measure the association of the RNA polymerase II with the transcribed genes. We have also shown that the mut beta-globin gene shows reduced levels of H3K4me3. Conclusions/Significance: Our results show that there are at least two surveillance responses that operate cotranscriptionally in insect cells and probably in all metazoans. One response requires Rrp6 and results in the inefficient release of defective mRNAs from the transcription site. The other response acts at the transcription level and reduces the synthesis of the defective transcripts through a mechanism that involves histone modifications.	[Eberle, Andrea B.; Hessle, Viktoria; Helbig, Roger; Dantoft, Widad; Gimber, Niclas; Visa, Neus] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden	Stockholm University	Eberle, AB (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden.	Neus.Visa@molbio.su.se	Visa, Neus/C-9459-2016; Visa, Neus/R-8037-2019	Visa, Neus/0000-0003-3145-3953; Visa, Neus/0000-0003-3145-3953; Gimber, Niclas/0000-0001-9456-3063	Swedish Research Council [dnr. 2006-5398]; Swedish Cancer Society [CAN 2006/1193]; European Science Foundation; Wenner-Gren Foundation; Swiss National Science Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); European Science Foundation(European Science Foundation (ESF)European Commission); Wenner-Gren Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by grants from the Swedish Research Council (dnr. 2006-5398, www.vr.se), the Swedish Cancer Society (CAN 2006/1193, www.cancerfonden.se), and the European Science Foundation, Eurocores RNA Quality Programme (VR dnr. 2007-7323, http://www.esf.org/activities/eurocores/runningprogrammes/rnaquality.html). ABE is supported by fellowships from the Wenner-Gren Foundation (http://www.swgc.org) and the Swiss National Science Foundation (www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemand E, 2008, CURR OPIN GENET DEV, V18, P145, DOI 10.1016/j.gde.2008.01.006; ALMEIDA SF, 2008, FEBS LETT, V582, P1971; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Antoniou M, 1998, NUCLEIC ACIDS RES, V26, P721, DOI 10.1093/nar/26.3.721; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855; Custodio N, 2007, J CELL BIOL, V179, P199, DOI 10.1083/jcb.200612109; Damgaard CK, 2008, MOL CELL, V29, P271, DOI 10.1016/j.molcel.2007.11.035; Doma MK, 2007, CELL, V131, P660, DOI 10.1016/j.cell.2007.10.041; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Dziembowski A, 2004, EMBO J, V23, P4847, DOI 10.1038/sj.emboj.7600482; Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945; Fong YW, 2001, NATURE, V414, P929, DOI 10.1038/414929a; Furger A, 2002, GENE DEV, V16, P2792, DOI 10.1101/gad.983602; Galy V, 2004, CELL, V116, P63, DOI 10.1016/S0092-8674(03)01026-2; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Graham AC, 2009, MOL BIOL CELL, V20, P2242, DOI 10.1091/mbc.E08-08-0825; Hase ME, 2006, J BIOL CHEM, V281, P39135, DOI 10.1074/jbc.M604235200; Hessle V, 2009, MOL BIOL CELL, V20, P3459, DOI 10.1091/mbc.E09-01-0079; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jensen TH, 2004, MOL CELL, V16, P235, DOI 10.1016/j.molcel.2004.09.019; Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6; Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Kurmangaliyev YZ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-13; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669; Saguez C, 2005, CURR OPIN CELL BIOL, V17, P287, DOI 10.1016/j.ceb.2005.04.009; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schmid M, 2008, CHROMOSOMA, V117, P419, DOI 10.1007/s00412-008-0166-4; Sjolinder M, 2005, GENE DEV, V19, P1871, DOI 10.1101/gad.339405; Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005; Vinciguerra P, 2005, EMBO J, V24, P813, DOI 10.1038/sj.emboj.7600527; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035	44	37	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11540	10.1371/journal.pone.0011540	http://dx.doi.org/10.1371/journal.pone.0011540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634951	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000279781600019
J	Kitahara, MV; Cairns, SD; Stolarski, J; Blair, D; Miller, DJ				Kitahara, Marcelo V.; Cairns, Stephen D.; Stolarski, Jaroslaw; Blair, David; Miller, David J.			A Comprehensive Phylogenetic Analysis of the Scleractinia (Cnidaria, Anthozoa) Based on Mitochondrial CO1 Sequence Data	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; PHYLUM CNIDARIA; CORALS; SYSTEMATICS; CLASSIFICATION; INFERENCE; ATLANTIC; PACIFIC; MRBAYES; GENOME	Background: Classical morphological taxonomy places the approximately 1400 recognized species of Scleractinia (hard corals) into 27 families, but many aspects of coral evolution remain unclear despite the application of molecular phylogenetic methods. In part, this may be a consequence of such studies focusing on the reef-building (shallow water and zooxanthellate) Scleractinia, and largely ignoring the large number of deep-sea species. To better understand broad patterns of coral evolution, we generated molecular data for a broad and representative range of deep sea scleractinians collected off New Caledonia and Australia during the last decade, and conducted the most comprehensive molecular phylogenetic analysis to date of the order Scleractinia. Methodology: Partial (595 bp) sequences of the mitochondrial cytochrome oxidase subunit 1 (CO1) gene were determined for 65 deep-sea (azooxanthellate) scleractinians and 11 shallow-water species. These new data were aligned with 158 published sequences, generating a 234 taxon dataset representing 25 of the 27 currently recognized scleractinian families. Principal Findings/Conclusions: There was a striking discrepancy between the taxonomic validity of coral families consisting predominantly of deep-sea or shallow-water species. Most families composed predominantly of deep-sea azooxanthellate species were monophyletic in both maximum likelihood and Bayesian analyses but, by contrast (and consistent with previous studies), most families composed predominantly of shallow-water zooxanthellate taxa were polyphyletic, although Acroporidae, Poritidae, Pocilloporidae, and Fungiidae were exceptions to this general pattern. One factor contributing to this inconsistency may be the greater environmental stability of deep-sea environments, effectively removing taxonomic "noise'' contributed by phenotypic plasticity. Our phylogenetic analyses imply that the most basal extant scleractinians are azooxanthellate solitary corals from deep-water, their divergence predating that of the robust and complex corals. Deep-sea corals are likely to be critical to understanding anthozoan evolution and the origins of the Scleractinia.	[Kitahara, Marcelo V.; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reefs Studies, Townsville, Qld 4811, Australia; [Kitahara, Marcelo V.; Miller, David J.] James Cook Univ, Coral Genom Grp, Townsville, Qld 4811, Australia; [Cairns, Stephen D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Stolarski, Jaroslaw] Polish Acad Sci, Inst Paleobiol, Warsaw, Poland; [Blair, David] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University; Smithsonian Institution; Smithsonian National Museum of Natural History; Polish Academy of Sciences; Institute of Paleobiology of the Polish Academy of Sciences; James Cook University	Kitahara, MV (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reefs Studies, Townsville, Qld 4811, Australia.	mvkitahara@yahoo.com.br	Blair, David/O-2786-2019; Kitahara, Marcelo Visentini/D-5560-2011; Stolarski, Jaroslaw/V-9586-2017; Blair, David/G-6052-2011; Stolarski, Jaroslaw/AAF-7331-2019	Blair, David/0000-0002-4658-3251; Kitahara, Marcelo Visentini/0000-0003-4011-016X; Stolarski, Jaroslaw/0000-0003-0994-6823; Blair, David/0000-0002-4658-3251; Stolarski, Jaroslaw/0000-0003-0994-6823	Australian Research Council (through the Centre of Excellence for Coral Reef Studies); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES); Fisheries Research and Development Corporation (FRDC); Australian Government Department of Environment, Water, Heritage and the Arts; Australian CSIRO (Commonwealth Scientific and Industrial Research Organization) Wealth [SS102005, SS022007]	Australian Research Council (through the Centre of Excellence for Coral Reef Studies)(Australian Research Council); Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fisheries Research and Development Corporation (FRDC)(Fisheries R&D Corp); Australian Government Department of Environment, Water, Heritage and the Arts(Australian Government); Australian CSIRO (Commonwealth Scientific and Industrial Research Organization) Wealth	This study was supported through funding from the Australian Research Council (through the Centre of Excellence for Coral Reef Studies) grants to DJM. MVK is a recipient of a PhD scholarship from the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES). The Australian specimens examined in the present study were collected with funding from the Fisheries Research and Development Corporation (FRDC) and Environment Australia (now the Australian Government Department of Environment, Water, Heritage and the Arts); the 2005/2007 cruises (SS102005 and SS022007) were funded by the Australian CSIRO (Commonwealth Scientific and Industrial Research Organization) Wealth from Oceans Flagship with the assistance of the Australian Government Department of the Environment, Water, Heritage and the Arts; and the NORFANZ cruise was a collaboration between Australia's National Oceans Office (now the Australian Government Department of Environment, Water, Heritage and the Arts), Australia's CSIRO Marine and Atmospheric Research, New Zealand's Ministry of Fisheries and New Zealand's National Institute of Water and Atmospheric Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock A., 1902, TIJDSCHRIFT NEDERLAN, V7, P89; ALLOITEAU J, 1957, CONTRIBUTION SYSTEMA, V1; Baron-Szabo RC, 2006, J PALEONTOL, V80, P1033, DOI 10.1666/0022-3360(2006)80[1033:SCFTCF]2.0.CO;2; BEAUVAIS L, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V194, P1; Benzoni F, 2007, CONTRIB ZOOL, V76, P35, DOI 10.1163/18759866-07601004; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; BOSCHMA H, 1959, 15 INT C ZOOL SECT, V3, P1; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Brugler MR, 2007, MOL PHYLOGENET EVOL, V42, P776, DOI 10.1016/j.ympev.2006.08.016; Budd AF, 2009, ACTA ZOOL-STOCKHOLM, V90, P142, DOI 10.1111/j.1463-6395.2008.00345.x; CAIRNS S D, 1984, Occasional Papers Bernice P. Bishop Museum, V25, P1; Cairns S. D., 2009, COLD WATER CORALS BI; Cairns S. D., 1982, ANTARCT RES SER, V34, P1, DOI [DOI 10.1029/AR034P0001, 10.1029/AR034p0001]; Cairns S. D., 1997, SMITHSONIAN CONTRIBU, V591, P1, DOI DOI 10.5479/SI.00810282.591; Cairns SD, 1999, MEMOIR MUS NATL HIST, V180, P31; Cairns SD., 1995, NZ OCEANOGRAPHIC I M, V103, P210, DOI DOI 10.1017/CBO9781107415324.004; CAIRNS SD, 2001, SMITHSON CONTRIB ZOO, V615, P75; Cairns Stephen D., 1999, Atoll Research Bulletin, V459, P13; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Chen L, 2002, BIOORG MED CHEM LETT, V12, P137, DOI 10.1016/S0960-894X(01)00711-9; CHEVALIER JP, 1987, TRAITE ZOOLOGIE, V3; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cuif JP, 2003, ZOOL SCR, V32, P459, DOI 10.1046/j.1463-6409.2003.00133.x; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Filkorn HF, 2004, J PALEONTOL, V78, P501, DOI 10.1666/0022-3360(2004)078<0501:ANECCD>2.0.CO;2; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forsman ZH, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-45; Forsman ZH, 2005, CORAL REEFS, V24, P343, DOI 10.1007/s00338-005-0497-z; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Fukami H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003222; George RY, 2007, B MAR SCI, V81, P309; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoeksema BW, 1989, ZOOLOGISCHE VERHANDE, V254, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keller N.B., 1976, T INSTITUTA OKEANOLO, V99, P31; KERBY T, 2007, SECONDARY SCI REV, V18, P14; Kerr AM, 2005, BIOL REV, V80, P543, DOI 10.1017/S1464793105006780; Kitahara MV, 2010, SYST BIODIVERS, V8, P91, DOI 10.1080/14772000903571088; Le Goff-Vitry MC, 2004, MOL PHYLOGENET EVOL, V30, P167, DOI 10.1016/S1055-7903(03)00162-3; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Medina M, 2006, P NATL ACAD SCI USA, V103, P9096, DOI 10.1073/pnas.0602444103; Nunes F, 2008, CORAL REEFS, V27, P423, DOI 10.1007/s00338-007-0349-0; Nylander JAA, 2004, MRMODELTEST 2 0 PROG; OWENS JM, 1984, GEOLOGOS, V11, P87; PANDOLFI JM, 1992, J BIOGEOGR, V19, P593, DOI 10.2307/2845703; Roberts J.M., 2009, COLD WATER CORALS BI; Romano SL, 1997, J MOL EVOL, V45, P397, DOI 10.1007/PL00006245; Romano SL, 2000, B MAR SCI, V67, P1043; Romano SL, 1996, SCIENCE, V271, P640, DOI 10.1126/science.271.5249.640; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Song ZC, 1997, CRETACEOUS RES, V18, P1; SQUIRES DONALD F., 1967, STUD TROP OCEANOGR INST MAR SCI UNIV MIAMIMIAMI BEACH FLA FRIEDRICH FRANS KOCZY MEMORIAL VOLUME, V5, P502; STANLEY GD, 1995, PALEOBIOLOGY, V21, P179, DOI 10.1017/S0094837300013191; Stolarski J, 2001, J PALEONTOL, V75, P1090, DOI 10.1666/0022-3360(2001)075<1090:TANSOE>2.0.CO;2; Stolarski J, 2000, LETHAIA, V33, P13, DOI 10.1080/00241160050150276; VAUGHAN TW, 1943, SPEC PAP GEOL SOC AM, V44, P1; VAUGHAN TW, 2007, B US NATL MUSEUM, V59, P427; Veron JEN, 1996, CORAL REEFS, V15, P1; VERON JEN, 1995, CORALS SPACE TIME BI; Veron JEN, 2000, CORALS WORLD, V3; Wallace CC, 2007, CORAL REEFS, V26, P231, DOI 10.1007/s00338-007-0203-4; Wallace C.C., 1999, STAGHORN CORALS WORL, DOI 10.1071/9780643101388; Wells J.W., 1956, TREATISE INVERTEBR F; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; YABE HISAKATSU, 1941, SCI REPTS TOHOKU IMP UNIV SER 2 GEOL SPECIAL VOL, V2, P67; ZIBROWIUS H, 1990, Scientia Marina, V54, P19	69	171	174	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11490	10.1371/journal.pone.0011490	http://dx.doi.org/10.1371/journal.pone.0011490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628613	gold, Green Published, Green Accepted			2022-12-27	WOS:000279637100015
J	Taylor, KR; Mills, RE; Costanzo, AE; Jameson, JM				Taylor, Kristen R.; Mills, Robyn E.; Costanzo, Anne E.; Jameson, Julie M.			gamma delta T Cells Are Reduced and Rendered Unresponsive by Hyperglycemia and Chronic TNF alpha in Mouse Models of Obesity and Metabolic Disease	PLOS ONE			English	Article							INSULIN-RESISTANCE; LANGERHANS CELLS; DENDRITIC CELLS; WOUND REPAIR; HUMAN SKIN; RECEPTOR; MICE; ACTIVATION; EXPRESSION; COMPLEX	Epithelial cells provide an initial line of defense against damage and pathogens in barrier tissues such as the skin; however this balance is disrupted in obesity and metabolic disease. Skin gamma delta T cells recognize epithelial damage, and release cytokines and growth factors that facilitate wound repair. We report here that hyperglycemia results in impaired skin gamma delta T cell proliferation due to altered STAT5 signaling, ultimately resulting in half the number of gamma delta T cells populating the epidermis. Skin gamma delta T cells that overcome this hyperglycemic state are unresponsive to epithelial cell damage due to chronic inflammatory mediators, including TNF alpha. Cytokine and growth factor production at the site of tissue damage was partially restored by administering neutralizing TNF alpha antibodies in vivo. Thus, metabolic disease negatively impacts homeostasis and functionality of skin gamma delta T cells, rendering host defense mechanisms vulnerable to injury and infection.	[Taylor, Kristen R.; Mills, Robyn E.; Costanzo, Anne E.; Jameson, Julie M.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Taylor, KR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jamesonj@scripps.edu		Jameson, Julie/0000-0003-0727-4066	National Institutes of Health (NIH) [DK073098, DK080048, UL1 RR055774]; Leukemia and Lymphoma Society; Department of Immunology Institutional Training Grant [5T32 AI007244-24]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080048, R21DK073098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Department of Immunology Institutional Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health (NIH) grant DK073098 and DK080048 (J.M.J), a Scripps Translational Science Institute Award from NIH UL1 RR055774 (J.M.J.), The Leukemia and Lymphoma Society (J.M.J.) and a Department of Immunology Institutional Training Grant 5T32 AI007244-24 (K. R. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Blakytny R, 2006, DIABETIC MED, V23, P594, DOI 10.1111/j.1464-5491.2006.01773.x; Boismenu R, 1996, Semin Immunol, V8, P323, DOI 10.1006/smim.1996.0043; Boismenu R, 1996, J IMMUNOL, V157, P985; Born W K, 2000, Respir Res, V1, P151, DOI 10.1186/rr26; Born WK, 2007, J CLIN IMMUNOL, V27, P133, DOI 10.1007/s10875-007-9077-z; Bubici C, 2004, CELL CYCLE, V3, P1524, DOI 10.4161/cc.3.12.1321; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Cavanagh PR, 2005, LANCET, V366, P1725, DOI 10.1016/S0140-6736(05)67699-4; Cheroutre H, 2005, IMMUNOL REV, V206, P114, DOI 10.1111/j.0105-2896.2005.00284.x; Clark J, 2005, ANN RHEUM DIS, V64, P70, DOI 10.1136/ard.2005.042523; COPE AP, 1994, J CLIN INVEST, V94, P749, DOI 10.1172/JCI117394; Cope AP, 1997, J EXP MED, V185, P1573, DOI 10.1084/jem.185.9.1573; Daniel T, 2007, SHOCK, V28, P278, DOI 10.1097/shk.0b013e318034264c; DUPUY P, 1990, J INVEST DERMATOL, V94, P764, DOI 10.1111/1523-1747.ep12874626; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Fu YC, 2007, J BIOL CHEM, V282, P31525, DOI 10.1074/jbc.M701132200; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Girardi M, 2006, J INVEST DERMATOL, V126, P808, DOI 10.1038/sj.jid.5700120; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Henri S, 2010, J EXP MED, V207, P189, DOI 10.1084/jem.20091964; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Jameson JM, 2005, J EXP MED, V201, P1269, DOI 10.1084/jem.20042057; Jameson JM, 2004, J IMMUNOL, V172, P3573, DOI 10.4049/jimmunol.172.6.3573; Jameson J, 2007, IMMUNOL REV, V215, P114, DOI 10.1111/j.1600-065X.2006.00483.x; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Komori H, 2006, CURR OPIN IMMUNOL, V18, P534, DOI 10.1016/j.coi.2006.06.001; Lee DF, 2008, INT J MOL MED, V22, P633, DOI 10.3892/ijmm_00000065; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Mills RE, 2008, J IMMUNOL, V181, P3974, DOI 10.4049/jimmunol.181.6.3974; Misawa M, 2008, GLYCOBIOLOGY, V18, P20, DOI 10.1093/glycob/cwm115; Nanno M, 2007, IMMUNOL REV, V215, P103, DOI 10.1111/j.1600-065X.2006.00474.x; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Poulin LF, 2007, J EXP MED, V204, P3119, DOI 10.1084/jem.20071724; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Relchelt J, 2002, J CELL SCI, V115, P2639; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Tough DF, 1998, J EXP MED, V187, P357, DOI 10.1084/jem.187.3.357; Toulon A, 2009, J EXP MED, V206, P743, DOI 10.1084/jem.20081787; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wofford JA, 2008, BLOOD, V111, P2101, DOI 10.1182/blood-2007-06-096297; Xiong N, 2007, IMMUNOL REV, V215, P15, DOI 10.1111/j.1600-065X.2006.00478.x; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Yoshida T, 1997, BIOCHEM BIOPH RES CO, V232, P822, DOI 10.1006/bbrc.1997.6378	57	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11422	10.1371/journal.pone.0011422	http://dx.doi.org/10.1371/journal.pone.0011422			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625397	Green Submitted, gold, Green Published			2022-12-27	WOS:000279465700009
J	Tsai, WB; Chung, YM; Zou, YY; Park, SH; Xu, ZH; Nakayama, K; Lin, SH; Hu, MCT				Tsai, Wen-Bin; Chung, Young Min; Zou, Yiyu; Park, See-Hyoung; Xu, Zhaohui; Nakayama, Keiko; Lin, Sue-Hwa; Hu, Mickey C-T.			Inhibition of FOXO3 Tumor Suppressor Function by beta TrCP1 through Ubiquitin-Mediated Degradation in a Tumor Mouse Model	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; I-KAPPA-B; BETA-TRCP; OXIDATIVE STRESS; PROTEASOME PATHWAY; DNA-DAMAGE; CELL-CYCLE; PHOSPHORYLATION; PROMOTES; PROTEIN	Background: The ubiquitin-proteasome system is the primary proteolysis machine for controlling protein stability of the majority of regulatory proteins including those that are critical for cancer development. The forkhead box transcription factor FOXO3 plays a key role in regulating tumor suppression; however, the control of FOXO3 protein stability remains to be established. It is crucial to elucidate the molecular mechanisms underlying the ubiquitin-mediated degradation of FOXO3 tumor suppressor. Methodology and Principal Findings: Here we show that beta TrCP1 oncogenic ubiquitin E3-ligase interacts with FOXO3 and induces its ubiquitin-dependent degradation in an I kappa B kinase-beta phosphorylation dependent manner. Silencing beta TrCP1 augments FOXO3 protein level, resulting in promoting cellular apoptosis in cancer cells. In animal models, increasing FOXO3 protein level by silencing beta TrCP1 suppresses tumorigenesis, whereas decreasing FOXO3 by over-expressing beta TrCP1 promotes tumorigenesis and tumor growth in vivo. Conclusions/Significance: This is a unique demonstration that the beta TrCP1-mediated FOXO3 degradation plays a crucial role in tumorigenesis. These findings significantly contribute to understanding of the control of FOXO3 stability in cancer cells and may provide opportunities for developing innovative anticancer therapeutic modalities.	[Tsai, Wen-Bin; Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA; [Chung, Young Min; Park, See-Hyoung; Hu, Mickey C-T.] Stanford Univ, Div Gynecol Oncol, Sch Med, Stanford, CA 94305 USA; [Zou, Yiyu] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Xu, Zhaohui] Baylor Coll Med, Dept Pediat Infect Dis, Houston, TX 77030 USA; [Nakayama, Keiko] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res Human Dis, Div Dev Genet, Sendai, Miyagi 980, Japan	University of Texas System; UTMD Anderson Cancer Center; Stanford University; Yeshiva University; Baylor College of Medicine; Tohoku University	Tsai, WB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77030 USA.	mhu1@stanford.edu	Chung, Young Min/AAV-7656-2020		National Institutes of Health [R01CA113859];  [BCTR0504415]; NATIONAL CANCER INSTITUTE [R01CA113859] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grant R01CA113859 and Susan G. Komen for the Cure grant BCTR0504415 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Arden KC, 2007, CELL, V128, P235, DOI 10.1016/j.cell.2007.01.009; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burgering BMT, 2002, TRENDS BIOCHEM SCI, V27, P352, DOI 10.1016/S0968-0004(02)02113-8; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fuchs SY, 2002, CANCER BIOL THER, V1, P337; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Nakayama K, 2003, P NATL ACAD SCI USA, V100, P8752, DOI 10.1073/pnas.1133216100; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Seo E, 2009, CELL SIGNAL, V21, P43, DOI 10.1016/j.cellsig.2008.09.009; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tran Hien, 2003, Sci STKE, V2003, pRE5, DOI 10.1126/stke.2003.172.re5; Tsai WB, 2008, NAT CELL BIOL, V10, P460, DOI 10.1038/ncb1709; Vogt PK, 2005, CELL CYCLE, V4, P908, DOI 10.4161/cc.4.7.1796; Xia YF, 2009, P NATL ACAD SCI USA, V106, P2629, DOI 10.1073/pnas.0812256106; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	30	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11171	10.1371/journal.pone.0011171	http://dx.doi.org/10.1371/journal.pone.0011171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625400	gold, Green Submitted, Green Published			2022-12-27	WOS:000279465700001
J	Ballingall, KT; Rocchi, MS; McKeever, DJ; Wright, F				Ballingall, Keith T.; Rocchi, Mara S.; McKeever, Declan J.; Wright, Frank			Trans-Species Polymorphism and Selection in the MHC Class II DRA Genes of Domestic Sheep	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; POSITIVE SELECTION; EVOLUTION; DIVERSITY; CATTLE; WILD; IDENTIFICATION; NOMENCLATURE; INFERENCE; LINEAGES	Highly polymorphic genes with central roles in lymphocyte mediated immune surveillance are grouped together in the major histocompatibility complex (MHC) in higher vertebrates. Generally, across vertebrate species the class II MHC DRA gene is highly conserved with only limited allelic variation. Here however, we provide evidence of trans-species polymorphism at the DRA locus in domestic sheep (Ovis aries). We describe variation at the Ovar-DRA locus that is far in excess of anything described in other vertebrate species. The divergent DRA allele (Ovar-DRA*0201) differs from the sheep reference sequences by 20 nucleotides, 12 of which appear non-synonymous. Furthermore, DRA*0201 is paired with an equally divergent DRB1 allele (Ovar-DRB1*0901), which is consistent with an independent evolutionary history for the DR sub-region within this MHC haplotype. No recombination was observed between the divergent DRA and B genes in a range of breeds and typical levels of MHC class II DR protein expression were detected at the surface of leukocyte populations obtained from animals homozygous for the DRA*0201, DRB1*0901 haplotype. Bayesian phylogenetic analysis groups Ovar-DRA*0201 with DRA sequences derived from species within the Oryx and Alcelaphus genera rather than clustering with other ovine and caprine DRA alleles. Tests for Darwinian selection identified 10 positively selected sites on the branch leading to Ovar-DRA*0201, three of which are predicted to be associated with the binding of peptide antigen. As the Ovis, Oryx and Alcelaphus genera have not shared a common ancestor for over 30 million years, the DRA*0201 and DRB1*0901 allelic pair is likely to be of ancient origin and present in the founding population from which all contemporary domestic sheep breeds are derived. The conservation of the integrity of this unusual DR allelic pair suggests some selective advantage which is likely to be associated with the presentation of pathogen antigen to T-cells and the induction of protective immunity.	[Ballingall, Keith T.; Rocchi, Mara S.] Moredun Res Inst, Div Epidemiol & Populat Biol, Penicuik, Midlothian, Scotland; [McKeever, Declan J.] Univ London Royal Vet Coll, Dept Pathol & Infect Dis, Hatfield, Herts, England; [Wright, Frank] Scotland BIOSS, Edinburgh, Midlothian, Scotland	Moredun Research Institute; University of London; University of London Royal Veterinary College; James Hutton Institute	Ballingall, KT (corresponding author), Moredun Res Inst, Div Epidemiol & Populat Biol, Penicuik, Midlothian, Scotland.	keith.ballingall@moredun.ac.uk	Ballingall, Keith/T-1262-2019; Wright, Frank/N-3510-2013		Scottish Governments Rural and Environment Directorate (RERAD); Moredun Research Institute	Scottish Governments Rural and Environment Directorate (RERAD); Moredun Research Institute	This work was funded by the Scottish Governments Rural and Environment Directorate (RERAD) and the Moredun Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1994, BIOCHEM BIOPH RES CO, V204, P195, DOI 10.1006/bbrc.1994.2444; ANDERSSON L, 1995, IMMUNOL REV, V143, P5, DOI 10.1111/j.1600-065X.1995.tb00667.x; Anisimova M, 2007, MOL BIOL EVOL, V24, P1219, DOI 10.1093/molbev/msm042; Arrieta-Aguirre I, 2006, TISSUE ANTIGENS, V67, P222, DOI 10.1111/j.1399-0039.2006.00556.x; AYALA FJ, 1994, P NATL ACAD SCI USA, V91, P6787, DOI 10.1073/pnas.91.15.6787; Ballingall KT, 2008, IMMUNOGENETICS, V60, P95, DOI 10.1007/s00251-008-0278-2; BALLINGALL KT, 1995, ANIM GENET, V26, P79, DOI 10.1111/j.1365-2052.1995.tb02637.x; Ballingall KT, 2001, IMMUNOGENETICS, V52, P276, DOI 10.1007/s002510000276; BALLINGALL KT, 1992, ANIM GENET, V23, P347, DOI 10.1111/j.1365-2052.1992.tb00157.x; BOKONYI S, 1976, NATURE, V264, P19, DOI 10.1038/264019a0; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; DEVERSON EV, 1991, ANIM GENET, V22, P211, DOI 10.1111/j.1365-2052.1991.tb00671.x; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; FABB SA, 1993, ANIM GENET, V24, P249, DOI 10.1111/j.1365-2052.1993.tb00307.x; Flajnik MF, 2001, IMMUNITY, V15, P351, DOI 10.1016/S1074-7613(01)00198-4; FRASER DC, 1994, IMMUNOGENETICS, V40, P311, DOI 10.1007/BF00189981; Gruszczynska Joanna, 2005, Journal of Applied Genetics, V46, P311; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; KLEIN J, 1990, IMMUNOGENETICS, V31, P217, DOI 10.1007/BF00204890; KLEIN J, 1986, NATURAL HIST MAJOR H; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LOFTUS RT, 1994, P NATL ACAD SCI USA, V91, P2757, DOI 10.1073/pnas.91.7.2757; MacHugh DE, 1997, GENETICS, V146, P1071; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meyer D, 2001, ANN HUM GENET, V65, P1, DOI 10.1046/j.1469-1809.2001.6510001.x; MIKKO S, 1995, IMMUNOGENETICS, V42, P408, DOI 10.1007/BF00179403; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Ploegh H, 1998, CURR OPIN IMMUNOL, V10, P57, DOI 10.1016/S0952-7915(98)80032-0; Richman A, 2000, MOL ECOL, V9, P1953, DOI 10.1046/j.1365-294X.2000.01125.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ropiquet A, 2006, MOL PHYLOGENET EVOL, V41, P395, DOI 10.1016/j.ympev.2006.05.033; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHWAIGER FW, 1994, MOL BIOL EVOL, V11, P239; Sena L, 2003, ANIM GENET, V34, P1, DOI 10.1046/j.1365-2052.2003.00920.x; Takada T, 1998, IMMUNOGENETICS, V48, P408, DOI 10.1007/s002510050452; Uenishi H, 2004, NUCLEIC ACIDS RES, V32, pD484, DOI 10.1093/nar/gkh037; VANDERPOEL JJ, 1990, IMMUNOGENETICS, V31, P29, DOI 10.1007/BF00702486; VANEIJK MJT, 1992, ANIM GENET, V23, P483, DOI 10.1111/j.1365-2052.1992.tb00168.x; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; Viret C, 1999, Rev Immunogenet, V1, P91; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhou H, 2007, J DAIRY SCI, V90, P1943, DOI 10.3168/jds.2006-578	49	26	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11402	10.1371/journal.pone.0011402	http://dx.doi.org/10.1371/journal.pone.0011402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613987	gold, Green Submitted, Green Published			2022-12-27	WOS:000279370000027
J	Davenport, LC				Davenport, Lisa C.			Aid to a Declining Matriarch in the Giant Otter (Pteronura brasiliensis)	PLOS ONE			English	Article							AFRICAN ELEPHANTS; MENOPAUSE; EVOLUTION; SURVIVAL; CULTURES; MAMMALS; MONKEYS; WHALES; DOGS	Scientists are increasingly revealing the commonalities between the intellectual, emotional and moral capacities of animals and humans. Providing assistance to elderly and ailing family members is a human trait rarely documented for wild animals, other than anecdotal accounts. Here I report observations of multiple forms of assistance to the declining matriarch of a habituated group of giant otters (Pteronura brasiliensis) in Manu National Park, Peru. The otter group had been observed annually for several years and all members were known individually. In 2007, the breeding female of the group failed to reproduce and appeared to be in physical decline. She begged from other family members 43 times over 41 contact hours and received food 11 times. Comparisons with 2004-2006 demonstrate that the family's behavior in 2007 constitutes a role-reversal, in which the majority of assistance and prey transfers accrued from young-to-old rather than from old-to-young. As in human societies, both non-adaptive and adaptive hypotheses could explain the family members' aid to their declining matriarch. I suggest that giant otter families may benefit from the knowledge and experience of an elderly matriarch and "grandparent helper,'' consistent with the "Grandmother Hypothesis'' of adaptive menopause in women.	Duke Univ, Ctr Trop Conservat, Durham, NC 27710 USA	Duke University	Davenport, LC (corresponding author), Duke Univ, Ctr Trop Conservat, Durham, NC 27710 USA.	ldavenport@parkswatch.org		Davenport, Lisa/0000-0002-2573-1622	Conservation Food and Health Foundation; Disney Worldwide Conservation Fund; Paul Hardin Dissertation Fellowship at the University of North Carolina, Chapel Hill	Conservation Food and Health Foundation; Disney Worldwide Conservation Fund; Paul Hardin Dissertation Fellowship at the University of North Carolina, Chapel Hill	This study was supported by the Conservation Food and Health Foundation, http://cfhfoundation.grantsmanagement08.com/, the Disney Worldwide Conservation Fund, http://conservation.wdwpublicaffairs.com/, and by the Paul Hardin Dissertation Fellowship at the University of North Carolina, Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AN BEH SOC, 2007, AN BEH SOC HDB; *AUD AUD, 2002, PERS VOIC REC SOFTW; Bates LA, 2008, J CONSCIOUSNESS STUD, V15, P204; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Carter SK, 1997, MAMMAL REV, V27, P1, DOI 10.1111/j.1365-2907.1997.tb00370.x; CORREDOR GL, COMMUNICATION; Corredor Londono G., 2006, International Zoo Yearbook, V40, P360; Davenport L. C., 2008, THESIS U N CAROLINA; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; DEWAAL FBM, 2007, FREE ENTERPRISE VALU; Diamond Jared, 1997, WHY IS SEX FUN EVOLU; Douglas-Hamilton I, 2006, APPL ANIM BEHAV SCI, V100, P87, DOI 10.1016/j.applanim.2006.04.014; Duplaix N, 1980, REV ECOL-TERRE VIE, V34, P495, DOI DOI 10.1016/J.ENCEP.2013.04.017; Foley C, 2008, BIOL LETTERS, V4, P541, DOI 10.1098/rsbl.2008.0370; Fossey Diane, 1983, GORILLAS IN THE MIST; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GENTRY AH, 1990, 4 NEOTROPICAL RAINFO, P542; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goulding M., 2003, AMAZON HEADWATERS RI; Greve W, 2009, BIOL HYP, V2, P213; Groenendijk J, 2006, GIANTS MADRE DIOS; GROENENDIJK J, COMMUNICATION; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARRINGTON FH, 1983, BEHAV ECOL SOCIOBIOL, V13, P19, DOI 10.1007/BF00295072; Hart BL, 2008, NEUROSCI BIOBEHAV R, V32, P86, DOI 10.1016/j.neubiorev.2007.05.012; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hill K, 1991, Hum Nat, V2, P313, DOI 10.1007/BF02692196; Kalliola R., 1993, AMAZONIA PERUANA VEG, P9; LEE PC, 1987, ANIM BEHAV, V35, P278, DOI 10.1016/S0003-3472(87)80234-8; LORCH P, 2002, EVENT RECORDER 1 3 P; MALCOLM J, 1980, SMITHSONIAN, V11, P62; Manly BFJ, 1997, RANDOMIZATION BOOTST; Marsh H., 1986, Reports of the International Whaling Commission Special Issue, P57; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; McAuliffe K, 2005, TRENDS ECOL EVOL, V20, P650, DOI 10.1016/j.tree.2005.09.003; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Mech L. D., 2007, WOLVES BEHAV ECOLOGY; Packer C, 1998, NATURE, V392, P807, DOI 10.1038/33910; PAVELKA MSM, 1991, YEARB PHYS ANTHROPOL, V34, P13; PIEJA GC, COMMUNICATION; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Richardson DS, 2007, EVOLUTION, V61, P2790, DOI 10.1111/j.1558-5646.2007.00222.x; SCHENCK C, 1999, THESIS U LUDWIGMAXIM; Sharp SP, 2010, J ANIM ECOL, V79, P176, DOI 10.1111/j.1365-2656.2009.01616.x; STAIB E, 2001, THESIS; *STAT COM LLC, 2009, RES STAT ADD EXC 200, V4; STRUHSAKER TT, 1977, BIOTROPICA, V9, P124, DOI 10.2307/2387666; Sykes-Gatz S., 2005, INT GIANT OTTER STUD; Terborgh J, 1983, 5 NEW WORLD PRIMATES; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Wynne CDL, 2004, NATURE, V428, P140, DOI [10.1038/428140a, 10.1038/428140b]	54	22	23	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11385	10.1371/journal.pone.0011385	http://dx.doi.org/10.1371/journal.pone.0011385			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613978	gold, Green Published, Green Submitted			2022-12-27	WOS:000279370000014
J	Delogu, M; De Marco, MA; Di Trani, L; Raffini, E; Cotti, C; Puzelli, S; Ostanello, F; Webster, RG; Cassone, A; Donatelli, I				Delogu, Mauro; De Marco, Maria A.; Di Trani, Livia; Raffini, Elisabetta; Cotti, Claudia; Puzelli, Simona; Ostanello, Fabio; Webster, Robert G.; Cassone, Antonio; Donatelli, Isabella			Can Preening Contribute to Influenza A Virus Infection in Wild Waterbirds?	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; THIOESTERASE GENE; UROPYGIAL GLAND; MALLARD DUCKS; H5N1; BIRDS; PERSISTENCE; WATERFOWL; FEATHERS; BEHAVIOR	Wild aquatic birds in the Orders Anseriformes and Charadriiformes are the main reservoir hosts perpetuating the genetic pool of all influenza A viruses, including pandemic viruses. High viral loads in feces of infected birds permit a fecal-oral route of transmission. Numerous studies have reported the isolation of avian influenza viruses (AIVs) from surface water at aquatic bird habitats. These isolations indicate aquatic environments have an important role in the transmission of AIV among wild aquatic birds. However, the progressive dilution of infectious feces in water could decrease the likelihood of virus/host interactions. To evaluate whether alternate mechanisms facilitate AIV transmission in aquatic bird populations, we investigated whether the preen oil gland secretions by which all aquatic birds make their feathers waterproof could support a natural mechanism that concentrates AIVs from water onto birds' bodies, thus, representing a possible source of infection by preening activity. We consistently detected both viral RNA and infectious AIVs on swabs of preened feathers of 345 wild mallards by using reverse transcription-polymerase chain reaction (RT-PCR) and virus-isolation (VI) assays. Additionally, in two laboratory experiments using a quantitative real-time (qR) RT-PCR assay, we demonstrated that feather samples (n=5) and cotton swabs (n = 24) experimentally impregnated with preen oil, when soaked in AIV-contaminated waters, attracted and concentrated AIVs on their surfaces. The data presented herein provide information that expands our understanding of AIV ecology in the wild bird reservoir system.	[Delogu, Mauro; Cotti, Claudia; Ostanello, Fabio] Univ Bologna, Fac Vet Med, Dept Vet Publ Hlth & Anim Pathol, Ozzano Dell Emilia, Italy; [De Marco, Maria A.; Puzelli, Simona; Cassone, Antonio; Donatelli, Isabella] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Di Trani, Livia] Ist Super Sanita, Dept Food Safety & Vet Publ Hlth, I-00161 Rome, Italy; [Raffini, Elisabetta] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Lugo, Italy; [Webster, Robert G.] St Jude Childrens Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA	University of Bologna; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IZS Lombardia e Emilia; St Jude Children's Research Hospital	Delogu, M (corresponding author), Univ Bologna, Fac Vet Med, Dept Vet Publ Hlth & Anim Pathol, Ozzano Dell Emilia, Italy.	mauro.delogu@unibo.it	Ostanello, Fabio/L-7225-2015; Ostanello, Fabio/AAC-3402-2019; Cassone, Antonio/J-4666-2019; Puzelli, Simona/C-2542-2016	Ostanello, Fabio/0000-0003-1122-8628; Ostanello, Fabio/0000-0003-1122-8628; Puzelli, Simona/0000-0003-4497-9719	University of Bologna	University of Bologna	This work was supported by 2006 and 2008 RFO grants from the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Capua I, 2000, VET REC, V147, P640; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; COTGREAVE P, 1994, BEHAVIOUR, V131, P171, DOI 10.1163/156853994X00424; DAUB BC, 1989, J FIELD ORNITHOL, V60, P305; De Marco MA, 2004, VET MICROBIOL, V98, P197, DOI 10.1016/j.vetmic.2003.10.018; De Marco MA, 2003, AVIAN DIS, V47, P861, DOI 10.1637/0005-2086-47.s3.861; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; DELOGU M, 2008, AVIAN INFLUENZA RES, P91; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; DONATELLI IDE, 2008, RES SIGNPOST, V37, P1; Ellstrom P, 2008, VACCINE, V26, P4414, DOI 10.1016/j.vaccine.2008.06.027; Feare CJ, 2007, AVIAN DIS, V51, P440, DOI 10.1637/7575-040106R1.1; Feare CJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-96; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Henson Shandelle M., 2007, Journal of Biological Dynamics, V1, P95, DOI 10.1080/17513750601032679; JACOB J, 1978, J LIPID RES, V19, P148; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; KOLATTUKUDY PE, 1985, J BIOL CHEM, V260, P789; KOLATTUKUDY PE, 1991, ARCH BIOCHEM BIOPHYS, V284, P201, DOI 10.1016/0003-9861(91)90284-P; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Melville DS, 2006, LETT APPL MICROBIOL, V42, P435, DOI 10.1111/j.1472-765X.2006.01892.x; Montalti D., 2000, ORNITOL NEOTROP, V11, P297; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Puzelli S, 2004, J MED VIROL, V74, P629, DOI 10.1002/jmv.20225; Reneerkens J., 2006, ACTA ZOOLOGICA SINCA, V52, P272; Rijpstra WIC, 2007, J NAT PROD, V70, P1804, DOI 10.1021/np070254z; ROEPKE DC, 1989, AVIAN DIS, V33, P649, DOI 10.2307/1591139; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; ROSE K, 2006, FAO ANIMAL PRODUCTIO, V4; ROSE K, 2006, 4 FAO; ROWE RA, 1983, WILSON BULL, V95, P690; SIEBINGA JT, 1988, ARCH VIROL, V100, P75, DOI 10.1007/BF01310909; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Suarez DL, 2000, DEV COMP IMMUNOL, V24, P269, DOI 10.1016/S0145-305X(99)00078-6; Tsiodras S, 2008, J INFECTION, V56, P83, DOI 10.1016/j.jinf.2007.11.001; UVA B, 1983, ACTA HISTOCHEM, V73, P175, DOI 10.1016/S0065-1281(83)80026-9; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Villegas P., 2006, LAB MANUAL ISOLATION, P248; Wachtmeister CA, 2001, ANIM BEHAV, V61, P861, DOI 10.1006/anbe.2001.1684; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Webster RG, 2006, EMERG INFECT DIS, V12, P3, DOI 10.3201/eid1201.051024; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; World Health Organization, 2004, WHO MAN AN INFL DIAG; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P1671, DOI [10.3201/1410.080415, 10.3201/eid1410.080415]; Yamamoto Y, 2007, AVIAN DIS, V51, P744, DOI 10.1637/0005-2086(2007)51[744:PICDII]2.0.CO;2; Yamamoto Y, 2008, EMERG INFECT DIS, V14, P149, DOI 10.3201/eid1401.071036; Yamamoto Y, 2007, AVIAN DIS, V51, P52, DOI 10.1637/0005-2086(2007)051[0052:SNEWMA]2.0.CO;2	60	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11315	10.1371/journal.pone.0011315	http://dx.doi.org/10.1371/journal.pone.0011315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593026	Green Published, gold			2022-12-27	WOS:000279140800016
J	Zhao, HW; Zhou, D; Nizet, V; Haddad, GG				Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.			Experimental Selection for Drosophila Survival in Extremely High O-2 Environments	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; ANTIMICROBIAL PEPTIDE; NEUTROPHIL DEFENSINS; EUROPEAN ANCESTRY; CELL APOPTOSIS; HYPEROXIA; MELANOGASTER; OXYGEN; EXPRESSION	Although oxidative stress is deleterious to mammals, the mechanisms underlying oxidant susceptibility or tolerance remain to be elucidated. In this study, through a long-term laboratory selection over many generations, we generated a Drosophila melanogaster strain that can live and reproduce in very high O-2 environments (90% O-2), a lethal condition to naive flies. We demonstrated that tolerance to hyperoxia was heritable in these flies and that these hyperoxia-selected flies exhibited phenotypic differences from naive flies, such as a larger body size and increased weight by 20%. Gene expression profiling revealed that 227 genes were significantly altered in expression and two third of these genes were down-regulated. Using a mutant screen strategy, we studied the role of some altered genes (up-or down-regulated in the microarrays) by testing the survival of available corresponding P-element or UAS construct lines under hyperoxic conditions. We report that down-regulation of several candidate genes including Tropomyosin 1, Glycerol 3 phosphate dehydrogenase, CG33129, and UGP as well as up-regulation of Diptericin and Attacin conferred tolerance to severe hyperoxia. In conclusion, we identified several genes that were not only altered in hyperoxia-selected flies but we also prove that these play an important role in hyperoxia survival. Thus our study provides a molecular basis for understanding the mechanisms of hyperoxia tolerance.	[Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Infect Dis, La Jolla, CA 92093 USA; [Zhao, Huiwen W.; Zhou, Dan; Nizet, Victor; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Pharmacol & Drug Discovery, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nizet, Victor; Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Zhao, HW (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu	Nizet, Victor/AAF-3190-2019; Zhou, Dan/T-7203-2017	Zhou, Dan/0000-0001-6401-9040; Nizet, Victor/0000-0003-3847-0422	NIH [RO1NS037756, 1R21HL093611, PO1HD032573]; American Heart Association [0835188N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant RO1NS037756, 1R21HL093611 and PO1HD032573 to Gabriel G. Haddad and American Heart Association grant 0835188N to Dan Zhou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Barker GF, 2006, AM J RESP CELL MOL, V35, P277, DOI 10.1165/rcmb.2005-0340OC; Bhandari V, 2008, FRONT BIOSCI-LANDMRK, V13, P6653, DOI 10.2741/3179; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Bhandari V, 2006, FREE RADICAL BIO MED, V41, P4, DOI 10.1016/j.freeradbiomed.2006.01.027; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Chen L, 2004, MOL BRAIN RES, V131, P93, DOI 10.1016/j.molbrainres.2004.08.013; Chetty A, 2008, PEDIATR PULM, V43, P297, DOI 10.1002/ppul.20777; Cooper JA, 2002, CURR BIOL, V12, pR523, DOI 10.1016/S0960-9822(02)01028-X; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Dudley R, 1998, J EXP BIOL, V201, P1043; Fatma N, 2009, FREE RADICAL RES, V43, P783, DOI 10.1080/10715760903062887; Frazier MR, 2001, PHYSIOL BIOCHEM ZOOL, V74, P641, DOI 10.1086/322172; Gorter AD, 1998, J INFECT DIS, V178, P1067, DOI 10.1086/515667; GREKSA LP, 1988, AM J PHYS ANTHROPOL, V75, P77, DOI 10.1002/ajpa.1330750109; GREKSA LP, 1985, ANN HUM BIOL, V12, P225, DOI 10.1080/03014468500007721; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Harrison J, 2006, RESP PHYSIOL NEUROBI, V154, P4, DOI 10.1016/j.resp.2006.02.008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs EGJ, 2000, J PEDIATR ENDOCR MET, V13, P387; Kaiser A, 2007, P NATL ACAD SCI USA, V104, P13198, DOI 10.1073/pnas.0611544104; Khurana V, 2008, J ALZHEIMERS DIS, V15, P541; Kreuz AJ, 1996, J CELL BIOL, V135, P673, DOI 10.1083/jcb.135.3.673; KUBO E, AM J PHYSL CELL PHYS, V298, pC342; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lee PJ, 2003, FREE RADICAL BIO MED, V35, P341, DOI 10.1016/S0891-5849(03)00279-X; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Mantell LL, 2000, MOL GENET METAB, V71, P359, DOI 10.1006/mgme.2000.3046; Masalunga C, 2007, PEDIATR RES, V62, P78, DOI 10.1203/PDR.0b013e3180674dc6; Meng M, 2007, GENE, V389, P186, DOI 10.1016/j.gene.2006.11.006; Merritt TJS, 2006, GENETICS, V172, P293, DOI 10.1534/genetics.105.047035; Morrow Genevieve, 2008, Biotechnology Journal, V3, P728, DOI 10.1002/biot.200800015; Ogawa Y, 2007, INFLAMM RES, V56, P334, DOI 10.1007/s00011-007-7052-z; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; PARK MK, 1992, CLIN INFECT DIS, V14, P720, DOI 10.1093/clinids/14.3.720; Peck LS, 2005, J EXP ZOOL PART A, V303A, P968, DOI 10.1002/jez.a.211; Perez-Gracia E, 2009, ACTA NEUROPATHOL, V118, P497, DOI 10.1007/s00401-009-0574-4; Ross CR, 2007, CHEM BIOL DRUG DES, V70, P154, DOI 10.1111/j.1747-0285.2007.00540.x; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; van Wetering S, 1999, J ALLERGY CLIN IMMUN, V104, P1131, DOI 10.1016/S0091-6749(99)70004-7; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; WEBSTER NR, 1987, BRIT J ANAESTH, V59, P760, DOI 10.1093/bja/59.6.760; Wright CJ, 2009, AM J PHYSIOL-LUNG C, V296, pL296, DOI 10.1152/ajplung.90499.2008; Wu JP, 2004, CIRCULATION, V109, P1660, DOI 10.1161/01.CIR.0000124067.35915.E0; Xun ZY, 2008, J PROTEOME RES, V7, P3911, DOI 10.1021/pr800207h; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490	53	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2010	5	7							e11701	10.1371/journal.pone.0011701	http://dx.doi.org/10.1371/journal.pone.0011701			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AQ	20668515	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243800004
J	Anzures, G; Ge, LZ; Wang, Z; Itakura, S; Lee, K				Anzures, Gizelle; Ge, Liezhong; Wang, Zhe; Itakura, Shoji; Lee, Kang			Culture Shapes Efficiency of Facial Age Judgments	PLOS ONE			English	Article							UNFAMILIAR FACES; OWN-AGE; ENVIRONMENT; PERCEPTION; ACCURACY; MEMORY; BIAS	Background: Cultural differences in socialization can lead to characteristic differences in how we perceive the world. Consistent with this influence of differential experience, our perception of faces (e. g., preference, recognition ability) is shaped by our previous experience with different groups of individuals. Methodology/Principal Findings: Here, we examined whether cultural differences in social practices influence our perception of faces. Japanese, Chinese, and Asian-Canadian young adults made relative age judgments (i.e., which of these two faces is older?) for East Asian faces. Cross-cultural differences in the emphasis on respect for older individuals was reflected in participants' latency in facial age judgments for middle-age adult faces-with the Japanese young adults performing the fastest, followed by the Chinese, then the Asian-Canadians. In addition, consistent with the differential behavioural and linguistic markers used in the Japanese culture when interacting with individuals younger than oneself, only the Japanese young adults showed an advantage in judging the relative age of children's faces. Conclusions/Significance: Our results show that different sociocultural practices shape our efficiency in processing facial age information. The impact of culture may potentially calibrate other aspects of face processing.	[Anzures, Gizelle; Lee, Kang] Univ Toronto, Dept Human Dev & Appl Psychol, Toronto, ON, Canada; [Ge, Liezhong; Wang, Zhe] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Itakura, Shoji] Kyoto Univ, Dept Psychol, Kyoto, Japan	University of Toronto; Zhejiang Sci-Tech University; Kyoto University	Anzures, G (corresponding author), Univ Toronto, Dept Human Dev & Appl Psychol, Toronto, ON, Canada.	gizelle.anzures@utoronto.ca; kang.lee@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); National Institutes of Health (NIH) [R01 HD046526]; National Natural Science Foundation of China (NSFC) [0713610-A]; Zhejiang Provincial Natural Science Foundation of China [Y207234]; Nissan Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20330150] Funding Source: KAKEN	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Nissan Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant and a National Institutes of Health (NIH) Grant R01 HD046526 to Kang Lee, and an NSERC Canada Graduate Scholarship to Gizelle Anzures. This research was also funded by a National Natural Science Foundation of China (NSFC) grant (0713610-A) and a Zhejiang Provincial Natural Science Foundation of China grant (Y207234) to Liezhong Ge, and a Nissan Science Foundation grant to Shoji Itakura. The funders had no role in the study design, data collection, data analysis, decision to publish, or in the preparation of this manuscript.	ANNIS RC, 1973, SCIENCE, V182, P729, DOI 10.1126/science.182.4113.729; [Anonymous], 1985, HONORABLE ELDERS REV; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; BURT DM, 1995, P ROY SOC B-BIOL SCI, V259, P137, DOI 10.1098/rspb.1995.0021; CHIU LH, 1972, INT J PSYCHOL, V7, P235, DOI 10.1080/00207597208246604; FULTON A, 1991, PSYCHOL AGING, V6, P623, DOI 10.1037/0882-7974.6.4.623; George PA, 2000, VIS COGN, V7, P485, DOI 10.1080/135062800394621; GEORGE PA, 1995, PERCEPTION, V24, P1059, DOI 10.1068/p241059; HENSS R, 1991, J APPL SOC PSYCHOL, V21, P933, DOI 10.1111/j.1559-1816.1991.tb00451.x; Ji LJ, 2001, PSYCHOL SCI, V12, P450, DOI 10.1111/1467-9280.00384; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; McCarthy A, 2006, J CROSS CULT PSYCHOL, V37, P717, DOI 10.1177/0022022106292079; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; MILLER JG, 1984, J PERS SOC PSYCHOL, V46, P961; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; Palmore Erdman B, 2004, J Cross Cult Gerontol, V19, P41, DOI 10.1023/B:JCCG.0000015098.62691.ab; Townsend J. T., 1983, STOCHASTIC MODELING; Wiese H, 2008, NEUROPSYCHOLOGIA, V46, P2973, DOI 10.1016/j.neuropsychologia.2008.06.007; Wright DB, 2002, LAW HUMAN BEHAV, V26, P641, DOI 10.1023/A:1020981501383; Yue X., 1999, ASIAN J SOC PSYCHOL, V2, P215, DOI DOI 10.1111/1467-839X.00035	23	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11679	10.1371/journal.pone.0011679	http://dx.doi.org/10.1371/journal.pone.0011679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KQ	20657780	Green Published, Green Submitted, gold			2022-12-27	WOS:000280197500020
J	Aboul-Enein, F; Krssak, M; Hoftberger, R; Prayer, D; Kristoferitsch, W				Aboul-Enein, Fahmy; Krssak, Martin; Hoeftberger, Romana; Prayer, Daniela; Kristoferitsch, Wolfgang			Reduced NAA-Levels in the NAWM of Patients with MS Is a Feature of Progression. A Study with Quantitative Magnetic Resonance Spectroscopy at 3 Tesla	PLOS ONE			English	Article							APPEARING WHITE-MATTER; H-1 MR SPECTROSCOPY; MULTIPLE-SCLEROSIS; METABOLITE CONCENTRATIONS; RELAXATION-TIMES; HUMAN BRAIN; ABSOLUTE QUANTIFICATION; AXONAL DAMAGE; WATER; DEMYELINATION	Background: Reduced N-acetyl-aspartate (NAA) levels in magnetic resonance spectroscopy (MRS) may visualize axonal damage even in the normal appearing white matter (NAWM). Demyelination and axonal degeneration are a hallmark in multiple sclerosis (MS). Objective: To define the extent of axonal degeneration in the NAWM in the remote from focal lesions in patients with relapsing-remitting (RRMS) and secondary progressive MS (SPMS). Material and Methods: 37 patients with clinical definite MS (27 with RRMS, 10 with SPMS) and 8 controls were included. We used 2D H-1-MR-chemical shift imaging (TR = 1500ms, TE = 135ms, nominal resolution 1ccm) operating at 3Tesla to assess the metabolic pattern in the fronto-parietal NAWM. Ratios of NAA to creatine (Cr) and choline (Cho) and absolute concentrations of the metabolites in the NAWM were measured in each voxel matching exclusively white matter on the anatomical T2 weighted MR images. Results: No significant difference of absolute concentrations for NAA, Cr and Cho or metabolite ratios were found between RRMS and controls. In SPMS, the NAA/Cr ratio and absolute concentrations for NAA and Cr were significantly reduced compared to RRMS and to controls. Conclusions: In our study SPMS patients, but not RRMS patients were characterized by low NAA levels. Reduced NAA-levels in the NAWM of patients with MS is a feature of progression.	[Aboul-Enein, Fahmy; Kristoferitsch, Wolfgang] SMZ Ost Donauspital, Dept Neurol, Vienna, Austria; [Krssak, Martin; Prayer, Daniela] Med Univ Vienna, Dept Radiol, Vienna, Austria; [Hoeftberger, Romana] Med Univ Vienna, Inst Neurol, Vienna, Austria	Donauspital; Medical University of Vienna; Medical University of Vienna	Aboul-Enein, F (corresponding author), SMZ Ost Donauspital, Dept Neurol, Vienna, Austria.	fahmy.aboul-enein@telering.at	Krssak, Martin/AAU-8183-2020	Krssak, Martin/0000-0001-9717-803X	Multiple Sklerose Forschungsgesellschaft Wien; Medical Research Society Vienna, DC; European Union [HCM-CHRX-CT94-0432, ERB-FMRX-CT970160]	Multiple Sklerose Forschungsgesellschaft Wien; Medical Research Society Vienna, DC; European Union(European Commission)	This study was funded by the Multiple Sklerose Forschungsgesellschaft Wien (www.ms-ges.or.at) and by the Medical Research Society Vienna, DC (www.mfg22.at). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; For MR Spectroscopy analysis MRUI software was used (http://www.mrui.uab.es./mrui). MRUI development and improvement was secured thanks to the European Union project HCM-CHRX-CT94-0432 (1994-1997) and TMR/Networks ERB-FMRX-CT970160 (1998-2001).<SUP>17</SUP>	Aboul-Enein F, 2005, ACTA NEUROPATHOL, V109, P49, DOI 10.1007/s00401-004-0954-8; Aboul-Enein F, 2003, J NEUROPATH EXP NEUR, V62, P25, DOI 10.1093/jnen/62.1.25; Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; BAGORY M, 2007, C P IEEE ENG MED BIO, V1, P3458; Bellmann-Strobl J, 2009, EUR RADIOL, V19, P2066, DOI 10.1007/s00330-009-1364-z; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; Bonneville F, 2002, AM J NEURORADIOL, V23, P371; Brief EE, 2009, NMR BIOMED, V22, P349, DOI 10.1002/nbm.1349; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; CONFAVREUX C, 1996, MCALPINES MULTIPLE S, P183; De Stefano N, 2007, NEUROLOGY, V69, P1942, DOI 10.1212/01.wnl.0000291557.62706.d3; De Stefano N, 1999, BRAIN, V122, P1933, DOI 10.1093/brain/122.10.1933; DEBEER R, 1992, NMR BIOMED, V5, P171, DOI 10.1002/nbm.1940050403; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Fu L, 1998, BRAIN, V121, P103, DOI 10.1093/brain/121.1.103; Helms G, 2000, MAGNET RESON MED, V43, P102, DOI 10.1002/(SICI)1522-2594(200001)43:1<102::AID-MRM12>3.0.CO;2-I; Jansen JFA, 2006, RADIOLOGY, V240, P318, DOI 10.1148/radiol.2402050314; Kirov II, 2009, J NEUROL NEUROSUR PS, V80, P1330, DOI 10.1136/jnnp.2009.176263; Kolind SH, 2009, MAGN RESON MED, V62, P106, DOI 10.1002/mrm.21966; Kreis R, 1997, PROG NUCL MAG RES SP, V31, P155, DOI 10.1016/S0079-6565(97)00014-9; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Leary SM, 2000, MAGN RESON IMAGING, V18, P455, DOI 10.1016/S0730-725X(00)00131-4; Li DKB, 2006, NEUROLOGY, V66, P1384, DOI 10.1212/01.wnl.0000210506.00078.5c; Miller DH, 2008, MULT SCLER J, V14, P1157, DOI 10.1177/1352458508096878; Mlynarik V, 2001, NMR BIOMED, V14, P325, DOI 10.1002/nbm.713; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Sarchielli P, 1999, BRAIN, V122, P513, DOI 10.1093/brain/122.3.513; Sijens PE, 2006, EUR RADIOL, V16, P489, DOI 10.1007/s00330-005-2839-1; Tintore M, 2000, AM J NEURORADIOL, V21, P702; Traber F, 2004, J MAGN RESON IMAGING, V19, P537, DOI 10.1002/jmri.20053; van Walderveen MAA, 1999, ANN NEUROL, V46, P79, DOI 10.1002/1531-8249(199907)46:1<79::AID-ANA12>3.3.CO;2-0; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vrenken H, 2005, MAGNET RESON MED, V53, P256, DOI 10.1002/mrm.20366; Wansapura JP, 1999, JMRI-J MAGN RESON IM, V9, P531, DOI 10.1002/(SICI)1522-2586(199904)9:4<531::AID-JMRI4>3.0.CO;2-L; Wattjes MP, 2007, AM J NEURORADIOL, V28, P1517, DOI 10.3174/ajnr.A0594; Wattjes MP, 2006, EUR RADIOL, V16, P2067, DOI 10.1007/s00330-006-0195-4	38	53	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11625	10.1371/journal.pone.0011625	http://dx.doi.org/10.1371/journal.pone.0011625			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652023	gold, Green Submitted, Green Published			2022-12-27	WOS:000280109700001
J	Sugimoto, C; Watanabe, S; Naruse, T; Kajiwara, E; Shiino, T; Umano, N; Ueda, K; Sato, H; Ohgimoto, S; Hirsch, V; Villinger, F; Ansari, AA; Kimura, A; Miyazawa, M; Suzuki, Y; Yamamoto, N; Nagai, Y; Mori, K				Sugimoto, Chie; Watanabe, Satoru; Naruse, Taeko; Kajiwara, Eiji; Shiino, Teiichiro; Umano, Natsuko; Ueda, Kayoko; Sato, Hirotaka; Ohgimoto, Shinji; Hirsch, Vanessa; Villinger, Francois; Ansari, Aftab A.; Kimura, Akinori; Miyazawa, Masaaki; Suzuki, Yasuo; Yamamoto, Naoki; Nagai, Yoshiyuki; Mori, Kazuyasu			Protection of Macaques with Diverse MHC Genotypes against a Heterologous SIV by Vaccination with a Deglycosylated Live-Attenuated SIV	PLOS ONE			English	Article							SIMIAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; CLASS-I; RHESUS MACAQUES; REPLICATION; SIVMAC239; NEUTRALIZATION; INFECTION; AIDS; GLYCOSYLATION	HIV vaccine development has been hampered by issues such as undefined correlates of protection and extensive diversity of HIV. We addressed these issues using a previously established SIV-macaque model in which SIV mutants with deletions of multiple gp120 N-glycans function as potent live attenuated vaccines to induce near-sterile immunity against the parental pathogenic SIVmac239. In this study, we investigated the protective efficacy of these mutants against a highly pathogenic heterologous SIVsmE543-3 delivered intravenously to rhesus macaques with diverse MHC genotypes. All 11 vaccinated macaques contained the acute-phase infection with blood viral loads below the level of detection between 4 and 10 weeks postchallenge (pc), following a transient but marginal peak of viral replication at 2 weeks in only half of the challenged animals. In the chronic phase, seven vaccinees contained viral replication for over 80 weeks pc, while four did not. Neutralizing antibodies against challenge virus were not detected. Although overall levels of SIV specific T cell responses did not correlate with containment of acute and chronic viral replication, a critical role of cellular responses in the containment of viral replication was suggested. Emergence of viruses with altered fitness due to recombination between the vaccine and challenge viruses and increased gp120 glycosylation was linked to the failure to control SIV. These results demonstrate the induction of effective protective immune responses in a significant number of animals against heterologous virus by infection with deglycosylated attenuated SIV mutants in macaques with highly diverse MHC background. These findings suggest that broad HIV cross clade protection is possible, even in hosts with diverse genetic backgrounds. In summary, results of this study indicate that deglycosylated live-attenuated vaccines may provide a platform for the elucidation of correlates of protection needed for a successful HIV vaccine against diverse isolates.	[Sugimoto, Chie; Watanabe, Satoru; Shiino, Teiichiro; Ueda, Kayoko; Sato, Hirotaka; Yamamoto, Naoki; Mori, Kazuyasu] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Sugimoto, Chie; Watanabe, Satoru; Ueda, Kayoko; Sato, Hirotaka; Mori, Kazuyasu] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Tsukuba, Ibaraki, Japan; [Sugimoto, Chie; Suzuki, Yasuo; Mori, Kazuyasu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Naruse, Taeko; Kimura, Akinori] Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Div Med Sci,Chiyoda Ku, Tokyo, Japan; [Kajiwara, Eiji; Umano, Natsuko; Miyazawa, Masaaki] Kinki Univ, Sch Med, Dept Immunol, Osaka 589, Japan; [Ohgimoto, Shinji] Osaka City Univ, Grad Sch Med, Dept Virol, Abeno Ku, Osaka 558, Japan; [Hirsch, Vanessa] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Villinger, Francois; Ansari, Aftab A.; Mori, Kazuyasu] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Villinger, Francois] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Dept Biomed Sci, Aichi, Japan; [Nagai, Yoshiyuki] RIKEN, Ctr Res Network Infect Dis, Chiyoda Ku, Tokyo, Japan	National Institute of Infectious Diseases (NIID); National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Kindai University (Kinki University); Osaka Metropolitan University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University; Emory University; Chubu University; RIKEN	Sugimoto, C (corresponding author), Tulane Natl Primate Res Ctr, Div Immunol, Covington, LA USA.	mori@nibio.go.jp	Kimura, Akinori/I-5989-2018; Miyazawa, Masaaki/AAA-3916-2020; Naruse, Taeko/ABA-3089-2021	Kimura, Akinori/0000-0002-4933-2132; Miyazawa, Masaaki/0000-0002-7300-119X; Yasuo, Suzuki/0000-0003-3518-5642; Mori, Kazuyasu/0000-0002-1841-6376; Sato, Hirotaka/0000-0002-8321-9731	Health Sciences Research Grants; Ministry of Health, Labor, and Welfare in Japan; Ministry of Education, Culture, Sports, Science and Technology in Japan; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000686] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21390143] Funding Source: KAKEN	Health Sciences Research Grants; Ministry of Health, Labor, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by AIDS research grants from the Health Sciences Research Grants, from the Ministry of Health, Labor, and Welfare in Japan, and from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetrei C, 2005, J VIROL, V79, P8991, DOI 10.1128/JVI.79.14.8991-9005.2005; Casimiro DR, 2005, J VIROL, V79, P15547, DOI 10.1128/JVI.79.24.15547-15555.2005; Chackerian B, 1997, J VIROL, V71, P7719, DOI 10.1128/JVI.71.10.7719-7727.1997; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Goulder PJR, 2008, NAT REV IMMUNOL, V8, P619, DOI 10.1038/nri2357; Hendel H, 1999, J IMMUNOL, V162, P6942; Hirsch V, 1997, J VIROL, V71, P1608, DOI 10.1128/JVI.71.2.1608-1620.1997; Johnson WE, 2003, J VIROL, V77, P9993, DOI 10.1128/JVI.77.18.9993-10003.2003; KESTLER H, 1990, SCIENCE, V248, P1109, DOI 10.1126/science.2160735; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kim EY, 2005, J VIROL, V79, P4886, DOI 10.1128/JVI.79.8.4886-4895.2005; Loffredo JT, 2008, J VIROL, V82, P1723, DOI 10.1128/JVI.02084-07; Matano T, 2004, J EXP MED, V199, P1709, DOI 10.1084/jem.20040432; Means RE, 1997, J VIROL, V71, P7895, DOI 10.1128/JVI.71.10.7895-7902.1997; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Mori K, 2005, J VIROL, V79, P10386, DOI 10.1128/JVI.79.16.10386-10396.2005; Mori K, 2001, J VIROL, V75, P4023, DOI 10.1128/JVI.75.9.4023-4028.2001; O'Connor DH, 2003, J VIROL, V77, P9029, DOI 10.1128/JVI.77.16.9029-9040.2003; Ohgimoto S, 1998, J VIROL, V72, P8365, DOI 10.1128/JVI.72.10.8365-8370.1998; REGIER DA, 1990, AIDS RES HUM RETROV, V6, P1221, DOI 10.1089/aid.1990.6.1221; Reimann KA, 2005, J VIROL, V79, P8878, DOI 10.1128/JVI.79.14.8878-8885.2005; Reitter JN, 1998, NAT MED, V4, P679, DOI 10.1038/nm0698-679; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Sugimoto C, 2003, J VIROL, V77, P4169, DOI 10.1128/JVI.77.7.4169-4180.2003; Sugimoto C, 2008, J GEN VIROL, V89, P554, DOI 10.1099/vir.0.83186-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsukamoto T, 2008, AIDS, V22, P993, DOI 10.1097/QAD.0b013e3282f88d1b; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Yant LJ, 2006, J VIROL, V80, P5074, DOI 10.1128/JVI.80.10.5074-5077.2006	31	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11678	10.1371/journal.pone.0011678	http://dx.doi.org/10.1371/journal.pone.0011678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652030	Green Published, Green Submitted, gold			2022-12-27	WOS:000280109700010
J	Sheeba, V; Fogle, KJ; Holmes, TC				Sheeba, Vasu; Fogle, Keri J.; Holmes, Todd C.			Persistence of Morning Anticipation Behavior and High Amplitude Morning Startle Response Following Functional Loss of Small Ventral Lateral Neurons in Drosophila	PLOS ONE			English	Article							PIGMENT-DISPERSING FACTOR; CIRCADIAN PACEMAKER NEURONS; PDF NEURONS; HUNTINGTONS-DISEASE; CLOCK NEURONS; RHYTHMS; MELANOGASTER; NEUROPEPTIDE; CELLS; OSCILLATOR	Light-activated large ventral lateral clock neurons (large LNv) modulate behavioral arousal and sleep in Drosophila while their counterparts, the small LNv (s-LNv) are important for circadian behavior. Recently, it has been proposed that the pattern of day-night locomotor behavioral activity is mediated by two anatomically distinct oscillators composed of a morning oscillator in the small LNv and an evening oscillator in the lateral dorsal neurons and an undefined number of dorsal pacemaker neurons. This contrasts with a circuit described by network models which are not as anatomically constrained. By selectively ablating the small LNv while sparing the large LNv, we tested the relative importance of the small and large LNv for regulating morning behavior of animals living in standard light/dark cycles. Behavioral anticipation of the onset of morning and the high amplitude morning startle response which coincides with light onset are preserved in small LNv functionally-ablated animals. However, the amplitude of the morning behavioral peak is severely attenuated in these animals during the transition from regular light/dark cycles to constant darkness, providing further support that small LNv are necessary for circadian behavior. The large LNv, in combination with the network of other circadian neurons, in the absence of functional small LNv are sufficient for the morning anticipation and the high amplitude light-activated morning startle response.	[Sheeba, Vasu; Fogle, Keri J.; Holmes, Todd C.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA	University of California System; University of California Irvine	Sheeba, V (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	tholmes@uci.edu		Holmes, Todd/0000-0001-8152-8832; Vasu, Sheeba/0000-0003-2924-7130	National Science Foundation (NSF) [IBN-0757242]; National Institutes of Health (NIH) [NS046750]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046750] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Science Foundation (NSF) grant IBN-0757242 (www.nsf.gov), and National Institutes of Health (NIH) grant NS046750 (www.nih.gov) to TCH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchardon E, 2001, EUR J NEUROSCI, V13, P871, DOI 10.1046/j.0953-816x.2000.01450.x; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Choi C, 2009, CURR BIOL, V19, P1167, DOI 10.1016/j.cub.2009.06.029; Chung BY, 2009, CURR BIOL, V19, P386, DOI 10.1016/j.cub.2009.01.040; Cowan CM, 2006, CURR TOP DEV BIOL, V75, P25, DOI 10.1016/S0070-2153(06)75002-5; Cusumano P, 2009, NAT NEUROSCI, V12, P1431, DOI 10.1038/nn.2429; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Gu HY, 2006, J NEUROSCI, V26, P265, DOI 10.1523/JNEUROSCI.4109-05.2006; Gusella JF, 2006, TRENDS BIOCHEM SCI, V31, P533, DOI 10.1016/j.tibs.2006.06.009; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Helfrich-Forster C, 2007, J COMP NEUROL, V500, P47, DOI 10.1002/cne.21146; Helfrich-Forster C, 2009, J BIOL RHYTHM, V24, P259, DOI 10.1177/0748730409339614; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; Holmes TC, 2007, COLD SPRING HARB MON, V49, P19; Im SH, 2010, J COMP NEUROL, V518, P1925, DOI 10.1002/cne.22311; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Nitabach MN, 2008, CURR BIOL, V18, pR84, DOI 10.1016/j.cub.2007.11.061; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Petri B, 1997, J NEUROSCI, V17, P4087; Picot M, 2007, PLOS BIOL, V5, P2513, DOI 10.1371/journal.pbio.0050315; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Quintero JE, 2003, J NEUROSCI, V23, P8070; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2009, J BIOL RHYTHM, V24, P271, DOI 10.1177/0748730409338508; Schaap J, 2003, P NATL ACAD SCI USA, V100, P15994, DOI 10.1073/pnas.2436298100; Shafer OT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008298; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Sheeba V, 2008, CURR BIOL, V18, P1537, DOI 10.1016/j.cub.2008.08.033; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sheeba V, 2008, CRIT REV BIOCHEM MOL, V43, P37, DOI [10.1080/10409230701829128, 10.1080/10409230701829128 ]; Sheeba V, 2008, J NEUROSCI, V28, P217, DOI 10.1523/JNEUROSCI.4087-07.2008; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Stoleru D, 2007, CELL, V129, P207, DOI 10.1016/j.cell.2007.02.038; Taghert PH, 2006, J BIOL RHYTHM, V21, P445, DOI 10.1177/0748730406293910; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wu Y, 2008, PLOS BIOL, V6, P2512, DOI 10.1371/journal.pbio.0060273; Wu Y, 2008, J BIOL RHYTHM, V23, P117, DOI 10.1177/0748730407312984; Wulbeck C, 2008, J BIOL RHYTHM, V23, P409, DOI 10.1177/0748730408322699; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; ZHANG L, CURR BIOL, V20, P591; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	63	47	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11628	10.1371/journal.pone.0011628	http://dx.doi.org/10.1371/journal.pone.0011628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661292	Green Published, gold			2022-12-27	WOS:000279980800016
J	Zimmer, SM; Crevar, CJ; Carter, DM; Stark, JH; Giles, BM; Zimmerman, RK; Ostroff, SM; Lee, BY; Burke, DS; Ross, TM				Zimmer, Shanta M.; Crevar, Corey J.; Carter, Donald M.; Stark, James H.; Giles, Brendan M.; Zimmerman, Richard K.; Ostroff, Stephen M.; Lee, Bruce Y.; Burke, Donald S.; Ross, Ted M.			Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza in Pittsburgh, PA, USA	PLOS ONE			English	Article							ORIGINAL ANTIGENIC SIN; IMMUNE-RESPONSES; VIRUS; ANTIBODIES; HUMANS	Background: In April 2009, a new pandemic strain of influenza infected thousands of persons in Mexico and the United States and spread rapidly worldwide. During the ensuing summer months, cases ebbed in the Northern Hemisphere while the Southern Hemisphere experienced a typical influenza season dominated by the novel strain. In the fall, a second wave of pandemic H1N1 swept through the United States, peaking in most parts of the country by mid October and returning to baseline levels by early December. The objective was to determine the seroprevalence of antibodies against the pandemic 2009 H1N1 influenza strain by decade of birth among Pittsburgh-area residents. Methods and Findings: Anonymous blood samples were obtained from clinical laboratories and categorized by decade of birth from 1920-2009. Using hemagglutination-inhibition assays, approximately 100 samples per decade (n = 846) were tested from blood samples drawn on hospital and clinic patients in mid-November and early December 2009. Age specific seroprevalences against pandemic H1N1 (A/California/7/2009) were measured and compared to seroprevalences against H1N1 strains that had previously circulated in the population in 2007, 1957, and 1918. (A/Brisbane/59/2007, A/Denver/1/1957, and A/South Carolina/1/1918). Stored serum samples from healthy, young adults from 2008 were used as a control group (n = 100). Seroprevalences against pandemic 2009 H1N1 influenza varied by age group, with children age 10-19 years having the highest seroprevalence (45%), and persons age 70-79 years having the lowest (5%). The baseline seroprevalence among control samples from 18-24 year-olds was 6%. Overall seroprevalence against pandemic H1N1 across all age groups was approximately 21%. Conclusions: After the peak of the second wave of 2009 H1N1, HAI seroprevalence results suggest that 21% of persons in the Pittsburgh area had become infected and developed immunity. Extrapolating to the entire US population, we estimate that at least 63 million persons became infected in 2009. As was observed among clinical cases, this sero-epidemiological study revealed highest infection rates among school-age children.	[Zimmer, Shanta M.; Zimmerman, Richard K.; Lee, Bruce Y.] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA; [Crevar, Corey J.; Carter, Donald M.; Giles, Brendan M.; Burke, Donald S.; Ross, Ted M.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA; [Stark, James H.; Lee, Bruce Y.; Burke, Donald S.; Ross, Ted M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Ostroff, Stephen M.] Penn Dept Hlth, Pittsburgh, PA USA; [Ross, Ted M.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zimmer, SM (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh, PA 15260 USA.	tmr15@pitt.edu	Stark, James/A-2895-2019	Stark, James/0000-0002-0728-876X; Zimmerman, Richard/0000-0001-5941-6092; /0000-0002-5704-8094	NIH/NIAID supplemental A.R.R.A. [U01AI077771]; University of Pittsburgh, Graduate School of Public Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077771] Funding Source: NIH RePORTER	NIH/NIAID supplemental A.R.R.A.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh, Graduate School of Public Health(University of Pittsburgh); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH/NIAID supplemental A.R.R.A. to U01AI077771 to T. M. R. and a research pilot award from the University of Pittsburgh, Graduate School of Public Health (D. S. B. and S. M.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; Bright RA, 2007, VACCINE, V25, P3871, DOI 10.1016/j.vaccine.2007.01.106; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Control CfD Prevention, 1998, MMWR-MORBID MORTAL W, V47, pi, DOI DOI 10.1001/jamahealthforum.2021.0325; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; FRANCIS T, 1955, ANN INTERN MED, V43, P534, DOI 10.7326/0003-4819-43-3-534; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HANCOCK K, 2009, N ENGL J MED; Ikonen N, 2010, EUROSURVEILLANCE, V15, P16; JENSEN KE, 1956, J EXP MED, V104, P199, DOI 10.1084/jem.104.2.199; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398; Langmuir A D, 1976, Hosp Pract, V11, P49; MILLER E, 2010, LANCET; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Rao BL, 2003, NATL MED J INDIA, V16, P143; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; *US BUR CENS, 2000, 1 US CENS BUR; Webster R G, 1972, Curr Top Microbiol Immunol, V59, P75; WEBSTER RG, 1966, J IMMUNOL, V97, P177; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	32	74	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11601	10.1371/journal.pone.0011601	http://dx.doi.org/10.1371/journal.pone.0011601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644650	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000279884900029
J	Khurana, S; Verma, S; Verma, N; Crevar, CJ; Carter, DM; Manischewitz, J; King, LR; Ross, TM; Golding, H				Khurana, Surender; Verma, Swati; Verma, Nitin; Crevar, Corey J.; Carter, Donald M.; Manischewitz, Jody; King, Lisa R.; Ross, Ted M.; Golding, Hana			Properly Folded Bacterially Expressed H1N1 Hemagglutinin Globular Head and Ectodomain Vaccines Protect Ferrets against H1N1 Pandemic Influenza Virus	PLOS ONE			English	Article							INSECT CELLS; TRANSPORT; RESPONSES; EFFICACY; SITES	Background: In the face of impending influenza pandemic, a rapid vaccine production and mass vaccination is the most effective approach to prevent the large scale mortality and morbidity that was associated with the 1918 "Spanish Flu''. The traditional process of influenza vaccine production in eggs is time consuming and may not meet the demands of rapid global vaccination required to curtail influenza pandemic. Methodology/Principal Findings: Recombinant technology can be used to express the hemagglutinin (HA) of the emerging new influenza strain in a variety of systems including mammalian, insect, and bacterial cells. In this study, two forms of HA proteins derived from the currently circulating novel H1N1 A/California/07/2009 virus, HA1 (1-330) and HA (1-480), were expressed and purified from E. coli under controlled redox refolding conditions that favoured proper protein folding. However, only the recombinant HA1 (1-330) protein formed oligomers, including functional trimers that bound receptor and caused agglutination of human red blood cells. These proteins were used to vaccinate ferrets prior to challenge with the A/California/07/2009 virus. Both proteins induced neutralizing antibodies, and reduced viral loads in nasal washes. However, the HA1 (1-330) protein that had higher content of multimeric forms provided better protection from fever and weight loss at a lower vaccine dose compared with HA (1-480). Protein yield for the HA1 (1-330) ranged around 40 mg/Liter, while the HA (1-480) yield was 0.4-0.8 mg/Liter. Conclusions/Significance: This is the first study that describes production in bacterial system of properly folded functional globular HA1 domain trimers, lacking the HA2 transmembrane protein, that elicit potent neutralizing antibody responses following vaccination and protect ferrets from in vivo challenge. The combination of bacterial expression system with established quality control methods could provide a mechanism for rapid large scale production of influenza vaccines in the face of influenza pandemic threat.	[Khurana, Surender; Verma, Swati; Verma, Nitin; Manischewitz, Jody; King, Lisa R.; Golding, Hana] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA; [Crevar, Corey J.; Carter, Donald M.; Ross, Ted M.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA USA	US Food & Drug Administration (FDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Khurana, S (corresponding author), US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.	hana.golding@fda.hhs.gov			American Recovery and Reinvestment Act supplement [UO1-AI077771]; DMID, NIH [IAA 224-10-1006]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077771] Funding Source: NIH RePORTER	American Recovery and Reinvestment Act supplement; DMID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded in part by an American Recovery and Reinvestment Act supplement to NIH/NIAID grant UO1-AI077771 to TMR. This study was also partly supported by IAA 224-10-1006 from DMID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Biesova Z, 2009, VACCINE, V27, P6234, DOI 10.1016/j.vaccine.2009.07.107; CERIOTTI A, 1990, J CELL BIOL, V111, P409, DOI 10.1083/jcb.111.2.409; Cheng X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004436; Chiu FF, 2009, BIOCHEM BIOPH RES CO, V383, P27, DOI 10.1016/j.bbrc.2009.03.106; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Curtis-Fisk J, 2008, PROTEIN EXPRES PURIF, V61, P212, DOI 10.1016/j.pep.2008.06.009; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Kobinger GP, 2010, J INFECT DIS, V201, P1000, DOI 10.1086/651171; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Monto AS, 2006, EMERG INFECT DIS, V12, P55, DOI 10.3201/eid1201.051068; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; ROBERTS PC, 1993, J VIROL, V67, P3048, DOI 10.1128/JVI.67.6.3048-3060.1993; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Shen S, 2008, J MED VIROL, V80, P1972, DOI 10.1002/jmv.21298; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Treanor JJ, 2006, J INFECT DIS, V193, P1223, DOI 10.1086/503050; Treanor JJ, 1996, J INFECT DIS, V173, P1467, DOI 10.1093/infdis/173.6.1467; Wei CJ, 2008, J VIROL, V82, P6200, DOI 10.1128/JVI.00187-08; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Xie QM, 2009, POULTRY SCI, V88, P1608, DOI 10.3382/ps.2009-00092; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	29	75	82	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11548	10.1371/journal.pone.0011548	http://dx.doi.org/10.1371/journal.pone.0011548			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634959	Green Accepted, Green Published, gold			2022-12-27	WOS:000279781600025
J	Maronde, E; Schilling, AF; Seitz, S; Schinke, T; Schmutz, I; van der Horst, G; Amling, M; Albrecht, U				Maronde, Erik; Schilling, Arndt F.; Seitz, Sebastian; Schinke, Thorsten; Schmutz, Isabelle; van der Horst, Gijsbertus; Amling, Michael; Albrecht, Urs			The Clock Genes Period 2 and Cryptochrome 2 Differentially Balance Bone Formation	PLOS ONE			English	Article							CIRCADIAN-CLOCK; STEM-CELLS; EXPRESSION; RESORPTION; PHENOTYPE; PATHWAY; MURINE; TIME	Background: Clock genes and their protein products regulate circadian rhythms in mammals but have also been implicated in various physiological processes, including bone formation. Osteoblasts build new mineralized bone whereas osteoclasts degrade it thereby balancing bone formation. To evaluate the contribution of clock components in this process, we investigated mice mutant in clock genes for a bone volume phenotype. Methodology/Principal Findings: We found that Per2(Brdm1) mutant mice as well as mice lacking Cry2(-/-) displayed significantly increased bone volume at 12 weeks of age, when bone turnover is high. Per2(Brdm1) mutant mice showed alterations in parameters specific for osteoblasts whereas mice lacking Cry2(-/-) displayed changes in osteoclast specific parameters. Interestingly, inactivation of both Per2 and Cry2 genes leads to normal bone volume as observed in wild type animals. Importantly, osteoclast parameters affected due to the lack of Cry2, remained at the level seen in the Cry2(-/-) mutants despite the simultaneous inactivation of Per2. Conclusions/Significance: This indicates that Cry2 and Per2 affect distinct pathways in the regulation of bone volume with Cry2 influencing mostly the osteoclastic cellular component of bone and Per2 acting on osteoblast parameters.	[Maronde, Erik] Goethe Univ Frankfurt, Inst Anat 3, Frankfurt, Germany; [Schilling, Arndt F.; Seitz, Sebastian; Schinke, Thorsten; Amling, Michael] Univ Hamburg, Dept Osteol & Biomech, Hamburg, Germany; [Schmutz, Isabelle; Albrecht, Urs] Univ Fribourg, Dept Med, Biochem Unit, CH-1700 Fribourg, Switzerland; [van der Horst, Gijsbertus] Erasmus MC, Ctr Biomed Genet, Dept Genet, Rotterdam, Netherlands	Goethe University Frankfurt; University of Hamburg; University of Fribourg; Erasmus University Rotterdam; Erasmus MC	Maronde, E (corresponding author), Goethe Univ Frankfurt, Inst Anat 3, Frankfurt, Germany.	E.Maronde@em.uni-frankfurt.de; urs.albrecht@unifr.ch	van der Horst, Gijsbertus TJ/E-3661-2015; Albrecht, Urs/A-9831-2011; Maronde, Erik/J-1915-2019	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Albrecht, Urs/0000-0002-0663-8676; Maronde, Erik/0000-0002-5574-6323	Swiss National Science Foundation; European Union; Kurt-Eberhard-Bode-Trust; Stifterverband fur die Deutsche Wissenschaft, Essen, Germany	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); Kurt-Eberhard-Bode-Trust; Stifterverband fur die Deutsche Wissenschaft, Essen, Germany	This research was supported by the Swiss National Science Foundation and the European Union Framework 6 Integrated Project EUCLOCK (UA and GvdH). AFS is supported by an unrestricted grant of the Kurt-Eberhard-Bode-Trust, Stifterverband fur die Deutsche Wissenschaft, Essen, Germany. In the past five years AFS has provided consulting services to Biomet, Curasan, Eucro, Heraeus and IPB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Bae K, 2006, MOL CELLS, V22, P275; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Dallmann R, 2006, J COMP PHYSIOL A, V192, P769, DOI 10.1007/s00359-006-0114-9; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gimble JM, 2009, J CELL BIOCHEM, V107, P569, DOI 10.1002/jcb.22153; Grundberg E, 2008, PHYSIOL GENOMICS, V33, P301, DOI 10.1152/physiolgenomics.00028.2008; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Henriksen K, 2009, BONE, V44, P1026, DOI 10.1016/j.bone.2009.03.671; Hoffman AE, 2009, CANCER RES, V69, P3605, DOI 10.1158/0008-5472.CAN-08-4572; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Merrow M, 2007, CURR BIOL, V17, pR636, DOI 10.1016/j.cub.2007.06.041; Neutzsky-Wulff AV, 2008, CALCIFIED TISSUE INT, V83, P425, DOI 10.1007/s00223-008-9185-7; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pilorz V, 2008, REPRODUCTION, V135, P559, DOI 10.1530/REP-07-0434; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosen CJ, 2008, CELL METAB, V7, P7, DOI 10.1016/j.cmet.2007.12.004; Rucinski M, 2008, INT J MOL MED, V22, P363, DOI 10.3892/ijmm_00000031; Sato S, 2007, NAT MED, V13, P1234, DOI 10.1038/nm1640; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shidara K, 2008, CALCIFIED TISSUE INT, V82, P278, DOI 10.1007/s00223-008-9127-4; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Stephan S, 2007, EUR J MED RES, V12, P13; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Viswambharan H, 2007, CIRCULATION, V115, P2188, DOI 10.1161/CIRCULATIONAHA.106.653303; Wu XY, 2008, BONE, V42, P861, DOI 10.1016/j.bone.2007.12.226; Wu XY, 2007, OBESITY, V15, P2560, DOI 10.1038/oby.2007.308; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zvonic S, 2007, J BONE MINER RES, V22, P357, DOI 10.1359/jbmr.061114	37	80	84	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11527	10.1371/journal.pone.0011527	http://dx.doi.org/10.1371/journal.pone.0011527			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634945	Green Published, gold, Green Submitted			2022-12-27	WOS:000279781600012
J	Klee, SR; Brzuszkiewicz, EB; Nattermann, H; Bruggemann, H; Dupke, S; Wollherr, A; Franz, T; Pauli, G; Appel, B; Liebl, W; Couacy-Hymann, E; Boesch, C; Meyer, FD; Leendertz, FH; Ellerbrok, H; Gottschalk, G; Grunow, R; Liesegang, H				Klee, Silke R.; Brzuszkiewicz, Elzbieta B.; Nattermann, Herbert; Brueggemann, Holger; Dupke, Susann; Wollherr, Antje; Franz, Tatjana; Pauli, Georg; Appel, Bernd; Liebl, Wolfgang; Couacy-Hymann, Emmanuel; Boesch, Christophe; Meyer, Frauke-Dorothee; Leendertz, Fabian H.; Ellerbrok, Heinz; Gottschalk, Gerhard; Grunow, Roland; Liesegang, Heiko			The Genome of a Bacillus Isolate Causing Anthrax in Chimpanzees Combines Chromosomal Properties of B. cereus with B. anthracis Virulence Plasmids	PLOS ONE			English	Article							SEQUENCE CONSERVATION; GENETIC-RELATIONSHIPS; POPULATION-STRUCTURE; THURINGIENSIS; IDENTIFICATION; BACTERIA; PLCR; SPORULATION; SECRETION; REVEALS	Anthrax is a fatal disease caused by strains of Bacillus anthracis. Members of this monophyletic species are non motile and are all characterized by the presence of four prophages and a nonsense mutation in the plcR regulator gene. Here we report the complete genome sequence of a Bacillus strain isolated from a chimpanzee that had died with clinical symptoms of anthrax. Unlike classic B. anthracis, this strain was motile and lacked the four prohages and the nonsense mutation. Four replicons were identified, a chromosome and three plasmids. Comparative genome analysis revealed that the chromosome resembles those of non-B. anthracis members of the Bacillus cereus group, whereas two plasmids were identical to the anthrax virulence plasmids pXO1 and pXO2. The function of the newly discovered third plasmid with a length of 14 kbp is unknown. A detailed comparison of genomic loci encoding key features confirmed a higher similarity to B. thuringiensis serovar konkukian strain 97-27 and B. cereus E33L than to B. anthracis strains. For the first time we describe the sequence of an anthrax causing bacterium possessing both anthrax plasmids that apparently does not belong to the monophyletic group of all so far known B. anthracis strains and that differs in important diagnostic features. The data suggest that this bacterium has evolved from a B. cereus strain independently from the classic B. anthracis strains and established a B. anthracis lifestyle. Therefore we suggest to designate this isolate as "B. cereus variety (var.) anthracis''.	[Klee, Silke R.; Nattermann, Herbert; Dupke, Susann; Franz, Tatjana; Pauli, Georg; Appel, Bernd; Ellerbrok, Heinz; Grunow, Roland] Robert Koch Inst, Ctr Biol Secur ZBS, D-1000 Berlin, Germany; [Leendertz, Fabian H.] Robert Koch Inst, Res Grp Emerging Zoonoses NG2, D-1000 Berlin, Germany; [Brzuszkiewicz, Elzbieta B.; Brueggemann, Holger; Wollherr, Antje; Liebl, Wolfgang; Meyer, Frauke-Dorothee; Gottschalk, Gerhard; Liesegang, Heiko] Univ Gottingen, Inst Microbiol & Genet, Goettingen Genom Lab, Gottingen, Germany; [Couacy-Hymann, Emmanuel] LANADA Lab Cent Pathol Anim, Bingerville, Cote Ivoire; [Boesch, Christophe] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Robert Koch Institute; Robert Koch Institute; University of Gottingen; Max Planck Society	Klee, SR (corresponding author), Robert Koch Inst, Ctr Biol Secur ZBS, D-1000 Berlin, Germany.	klees@rki.de	Liebl, Wolfgang/D-3766-2014; Leendertz, Fabian Hubertus/H-8902-2019	Liebl, Wolfgang/0000-0002-8421-2478; Bruggemann, Holger/0000-0001-7433-0190; Liesegang, Heiko/0000-0003-1792-2047	Federal Ministry of Health [Foko 1-121-42261]; Ministry for Science and Culture of Lower Saxony	Federal Ministry of Health; Ministry for Science and Culture of Lower Saxony	This work was supported in part by grants from the Federal Ministry of Health (grant Foko 1-121-42261) and the Ministry for Science and Culture of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen GL, 1996, J BACTERIOL, V178, P377, DOI 10.1128/jb.178.2.377-384.1996; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BATTISTI L, 1985, J BACTERIOL, V162, P543, DOI 10.1128/JB.162.2.543-550.1985; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002; Bouillaut L, 2008, NUCLEIC ACIDS RES, V36, P3791, DOI 10.1093/nar/gkn149; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Brunsing RL, 2005, J BACTERIOL, V187, P6972, DOI 10.1128/JB.187.20.6972-6981.2005; Brzuszkiewicz E, 2009, GENOME DYNAM, V6, P110, DOI 10.1159/000235766; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Challacombe JF, 2007, J BACTERIOL, V189, P3680, DOI 10.1128/JB.00241-07; Daffonchio D, 2000, APPL ENVIRON MICROB, V66, P5460, DOI 10.1128/AEM.66.12.5460-5468.2000; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Ehling-Schulz M, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-20; Ellerbrok H, 2002, FEMS MICROBIOL LETT, V214, P51, DOI 10.1016/S0378-1097(02)00837-6; Ellis RJ, 2004, J MICROBIOL METH, V56, P287, DOI 10.1016/j.mimet.2003.10.005; Fagerlund A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-43; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fouet A, 2002, CURR TOP MICROBIOL, V271, P87; Gohar M, 2002, PROTEOMICS, V2, P784, DOI 10.1002/1615-9861(200206)2:6<784::AID-PROT784>3.0.CO;2-R; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Guinebretiere MH, 2008, ENVIRON MICROBIOL, V10, P851, DOI 10.1111/j.1462-2920.2007.01495.x; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; Harwood CR, 2008, TRENDS MICROBIOL, V16, P73, DOI 10.1016/j.tim.2007.12.001; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Helgason E, 2004, APPL ENVIRON MICROB, V70, P191, DOI 10.1128/AEM.70.1.191-201.2004; Hernandez E, 1999, FEMS IMMUNOL MED MIC, V24, P43, DOI 10.1111/j.1574-695X.1999.tb01263.x; Hernandez E, 1998, J CLIN MICROBIOL, V36, P2138, DOI 10.1128/JCM.36.7.2138-2139.1998; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 1999, J APPL MICROBIOL, V87, P279, DOI 10.1046/j.1365-2672.1999.00887.x; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hotopp JCD, 2006, MICROBIOL-SGM, V152, P3733, DOI 10.1099/mic.0.29261-0; Hu XM, 2009, APPL ENVIRON MICROB, V75, P3016, DOI 10.1128/AEM.02709-08; Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582; Jensen GB, 2003, ENVIRON MICROBIOL, V5, P631, DOI 10.1046/j.1462-2920.2003.00461.x; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kern JW, 2008, MOL MICROBIOL, V68, P504, DOI 10.1111/j.1365-2958.2008.06169.x; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2006, J APPL MICROBIOL, V100, P673, DOI 10.1111/j.1365-2672.2006.02809.x; Koch R, 1876, BEITR BIOL PFLANZ, V2, P277; Kozel TR, 2007, INFECT IMMUN, V75, P152, DOI 10.1128/IAI.01133-06; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Leendertz FH, 2006, PLOS PATHOG, V2, P632, DOI 10.1371/journal.ppat.0020008; Leendertz FH, 2006, AM J PRIMATOL, V68, P928, DOI 10.1002/ajp.20298; Leendertz FH, 2004, NATURE, V430, P451, DOI 10.1038/nature02722; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Mignot T, 2003, MOL MICROBIOL, V47, P917, DOI 10.1046/j.1365-2958.2003.03345.x; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Okinaka R, 2006, PLOS PATHOG, V2, P1025, DOI 10.1371/journal.ppat.0020122; Overbeek R, 2003, NUCLEIC ACIDS RES, V31, P164, DOI 10.1093/nar/gkg148; Pannucci J, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-34; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; Perego M, 2008, TRENDS MICROBIOL, V16, P215, DOI 10.1016/j.tim.2008.01.010; Priest FG, 2004, J BACTERIOL, V186, P7959, DOI 10.1128/JB.186.23.7959-7970.2004; Radnedge L, 2003, APPL ENVIRON MICROB, V69, P2755, DOI 10.1128/AEM.69.5.2755-2764.2003; Rasko DA, 2004, NUCLEIC ACIDS RES, V32, P977, DOI 10.1093/nar/gkh258; Rasko DA, 2007, J BACTERIOL, V189, P52, DOI 10.1128/JB.01313-06; Ravel J, 2009, J BACTERIOL, V191, P445, DOI 10.1128/JB.01347-08; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; REDDY A, 1987, J BACTERIOL, V169, P5263, DOI 10.1128/jb.169.11.5263-5270.1987; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Roh JY, 2007, J MICROBIOL BIOTECHN, V17, P547; Sacchi CT, 2002, EMERG INFECT DIS, V8, P1117, DOI 10.3201/eid0810.020391; Saile E, 2006, APPL ENVIRON MICROB, V72, P3168, DOI 10.1128/AEM.72.5.3168-3174.2006; SATO T, 1990, J BACTERIOL, V172, P1092, DOI 10.1128/jb.172.2.1092-1098.1990; Schmeisser C, 2009, APPL ENVIRON MICROB, V75, P4035, DOI 10.1128/AEM.00515-09; Slamti L, 2002, EMBO J, V21, P4550, DOI 10.1093/emboj/cdf450; STRAGIER P, 1989, SCIENCE, V243, P507, DOI 10.1126/science.2536191; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tech Maike, 2003, In Silico Biology, V3, P441; Turner KME, 2007, INT J ANTIMICROB AG, V29, P129, DOI 10.1016/j.ijantimicag.2006.11.002; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; Van der Auwera GA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-103; Van der Auwera GA, 2008, PLASMID, V59, P134, DOI 10.1016/j.plasmid.2007.11.007; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; Vilain S, 2006, APPL ENVIRON MICROB, V72, P4970, DOI 10.1128/AEM.03076-05	87	112	119	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e10986	10.1371/journal.pone.0010986	http://dx.doi.org/10.1371/journal.pone.0010986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634886	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300001
J	Oleksyk, TK; Nelson, GW; An, P; Kopp, JB; Winkler, CA				Oleksyk, Taras K.; Nelson, George W.; An, Ping; Kopp, Jeffrey B.; Winkler, Cheryl A.			Worldwide Distribution of the MYH9 Kidney Disease Susceptibility Alleles and Haplotypes: Evidence of Historical Selection in Africa	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; NATURAL-SELECTION; LINKAGE DISEQUILIBRIUM; POPULATION; GENETICS; SOFTWARE; GENOTYPE; GENOME; NEPHROPATHY; PREVALENCE	MYH9 was recently identified as renal susceptibility gene (OR 3-8, p<10(-8)) for major forms of kidney disease disproportionately affecting individuals of African descent. The risk haplotype (E-1) occurs at much higher frequencies in African Americans (>= 60%) than in European Americans (<4%), revealing a genetic basis for a major health disparity. The population distributions of MYH9 risk alleles and the E-1 risk haplotype and the demographic and selective forces acting on the MYH9 region are not well explored. We reconstructed MYH9 haplotypes from 4 tagging single nucleotide polymorphisms (SNPs) spanning introns 12-23 using available data from HapMap Phase II, and by genotyping 938 DNAs from the Human Genome Diversity Panel (HGDP). The E-1 risk haplotype followed a cline, being most frequent within sub-Saharan African populations (range 50-80%), less frequent in populations from the Middle East (9-27%) and Europe (0- 9%), and rare or absent in Asia, the Americas, and Oceania. The fixation indexes (F-ST) for pairwise comparisons between the risk haplotypes for continental populations were calculated for MYH9 haplotypes; F-ST ranged from 0.27-0.40 for Africa compared to other continental populations, possibly due to selection. Uniquely in Africa, the Yoruba population showed high frequency extended haplotype length around the core risk allele (C) compared to the alternative allele (T) at the same locus (rs4821481, iHs = 2.67), as well as high population differentiation (F-ST(CEU vs. YRI) = 0.51) in HapMap Phase II data, also observable only in the Yoruba population from HGDP (F-ST = 0.49), pointing to an instance of recent selection in the genomic region. The population-specific divergence in MYH9 risk allele frequencies among the world's populations may prove important in risk assessment and public health policies to mitigate the burden of kidney disease in vulnerable populations.	[Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Nelson, George W.; An, Ping; Winkler, Cheryl A.] SAIC Frederick, Lab Genom Divers, Frederick, MD USA; [Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD USA	University of Puerto Rico; University of Puerto Rico Mayaguez; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Oleksyk, TK (corresponding author), Univ Puerto Rico, Dept Biol, Mayaguez, PR USA.	winklerc@mail.nih.gov	Rinaldi2, Carlos/D-4479-2011; Kopp, Jeffrey B/O-2681-2015; Taras, Oleksyk/J-8805-2013	Kopp, Jeffrey B/0000-0001-9052-186X; Taras, Oleksyk/0000-0002-8148-3918; An, Ping/0000-0002-5322-3510	National Cancer Institute; National Institutes of Health [HHSN261200800001E, RO1 DK 070941, RO1 RFA-CA-09-003]; National Institute for Diabetes, Digestive, and Kidney Diseases [ZO-1 DK043308]; NATIONAL CANCER INSTITUTE [ZIABC010022, ZIABC010297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070941, ZIADK043308, Z01DK043308] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E, the Intramural Research Programs of the National Institute for Diabetes, Digestive, and Kidney Diseases (ZO-1 DK043308), and by a grant from the NIH (RO1 DK 070941 (BIF)) and (RO1 RFA-CA-09-003 (CAW)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amato R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007927; BANDELT HJ, 1995, GENETICS, V141, P743; Behar DM, 2006, AM J KIDNEY DIS, V47, P88, DOI 10.1053/j.ajkd.2005.09.023; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Eck R.V., 1966, ATLAS PROTEIN SEQUEN; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fabian J, 2009, NAT REV NEPHROL, V5, P591, DOI 10.1038/nrneph.2009.141; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P710, DOI 10.1016/0272-6386(95)90546-4; FREEDMAN BI, 2009, NEPHROL DIAL TRANSPL; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; KOPP JB, 2003, KIDNEY INT S, pS46; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; LEWONTIN RC, 1973, GENETICS, V74, P175; Lohmueller KE, 2006, AM J HUM GENET, V78, P130, DOI 10.1086/499287; NEEL JV, 1962, AM J HUM GENET, V14, P353; Neel JV, 1998, PERSPECT BIOL MED, V42, P44; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; PAYS E, 2009, CURR OPIN IMMUNOL; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Shrestha S, 2006, J INFECT DIS, V193, P16, DOI 10.1086/498532; Sumaili EK, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-18; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; *USRDS, 1999, US REN DAT SYST 1999; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yu FL, 2009, HUM MOL GENET, V18, P4853, DOI 10.1093/hmg/ddp457; Zakharia F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r141	44	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11474	10.1371/journal.pone.0011474	http://dx.doi.org/10.1371/journal.pone.0011474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634883	Green Published, Green Submitted, gold			2022-12-27	WOS:000279715300002
J	Villa-Cuesta, E; Sage, BT; Tatar, M				Villa-Cuesta, Eugenia; Sage, Brian T.; Tatar, Marc			A Role for Drosophila dFoxO and dFoxO 5 ' UTR Internal Ribosomal Entry Sites during Fasting	PLOS ONE			English	Article							CAP-INDEPENDENT TRANSLATION; INSULIN-RECEPTOR; MESSENGER-RNA; PROTEIN-SYNTHESIS; STARVATION; STRESS; FOXO; DIFFERENTIATION; TRANSCRIPTION; HOMEOSTASIS	One way animals may cope with nutrient deprivation is to broadly repress translation by inhibiting 5'-cap initiation. However, under these conditions specific proteins remain essential to survival during fasting. Such peptides may be translated through initiation at 5'UTR Internal Ribosome Entry Sites (IRES). Here we show that the Drosophila melanogaster Forkhead box type O (dFoxO) transcription factor is required for adult survival during fasting, and that the 5'UTR of dfoxO has the ability to initiate IRES-mediated translation in cell culture. Previous work has shown that insulin negatively regulates dFoxO through AKT-mediated phosphorylation while dFoxO itself induces transcription of the insulin receptor dInR, which also harbors IRES. Here we report that IRES-mediated translation of both dFoxO and dInR is activated in fasted Drosophila S2 cells at a time when cap-dependent translation is reduced. IRES mediated translation of dFoxO and dInR may be essential to ensure function and sensitivity of the insulin signaling pathway during fasting.	[Villa-Cuesta, Eugenia; Sage, Brian T.; Tatar, Marc] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Brown University	Villa-Cuesta, E (corresponding author), Brown Univ, Dept Pediat, Providence, RI 02912 USA.	eugenia_villa-cuesta@brown.edu		Villa-Cuesta, Eugenia/0000-0002-8919-6788; Tatar, Marc/0000-0003-3232-6884	National Institutes of Health [RO1 AGO21953]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the National Institutes of Health grant RO1 AGO21953. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; BAILLIE AGS, 1991, AM J PHYSIOL, V260, pE891, DOI 10.1152/ajpendo.1991.260.6.E891; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; Dyer JR, 2003, NAT NEUROSCI, V6, P219, DOI 10.1038/nn1018; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Graber TE, 2007, MOL BIOSYST, V3, P825, DOI 10.1039/b708867a; HATADA EN, 1989, J BIOL CHEM, V264, P6741; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; JANG S, 2007, J VIROL, V62, P2636; Jefferson LS, 2003, J NUTR, V133, p2046S, DOI 10.1093/jn/133.6.2046S; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kramer JM, 2008, GENOME, V51, P668, DOI 10.1139/G08-047; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; Lasko P, 2007, GENE DEV, V21, P235, DOI 10.1101/gad.1524707; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marr MT, 2007, GENE DEV, V21, P175, DOI 10.1101/gad.1506407; MCNURLAN MA, 1979, BIOCHEM J, V178, P373, DOI 10.1042/bj1780373; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Parmer MKB, 1995, SURVIVAL ANAL PRACTI; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Weber K, 2005, GENETICS, V169, P1461, DOI 10.1534/genetics.104.027748	33	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11521	10.1371/journal.pone.0011521	http://dx.doi.org/10.1371/journal.pone.0011521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634900	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300025
J	Virk, J; Li, J; Vestergaard, M; Obel, C; Lu, M; Olsen, J				Virk, Jasveer; Li, Jiong; Vestergaard, Mogens; Obel, Carsten; Lu, Michael; Olsen, Jorn			Early Life Disease Programming during the Preconception and Prenatal Period: Making the Link between Stressful Life Events and Type-1 Diabetes	PLOS ONE			English	Article							MELLITUS; RISK; SYSTEM	Background: To assess the risk of developing Type-1 diabetes among children who were exposed to maternal bereavement during the prenatal or 1-year preconception period. Methods: We identified N = 1,548,746 singleton births born in Denmark between January 1(st) 1979 through December 31(st) 2004, and their next of kin. Altogether, 39,857 children were exposed to bereavement during their prenatal life. The main outcome of interest was hospitalization for type-1 diabetes (ICD 8: 249; ICD 10: E10). Results: We found the strongest association for type-1 diabetes among children exposed to traumatic father or sibling deaths (aIRR: 2.03, 1.22-3.38); the association was mainly seen for girls (aIRR: 2.91, 1.61-5.26). Conclusions: We found evidence to suggest that female fetuses exposed to severe prenatal stress are at increased risk for developing type-1 diabetes.	[Virk, Jasveer; Lu, Michael; Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA; [Li, Jiong; Olsen, Jorn] Aarhus Univ, Danish Epidemiol Sci Ctr, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Res Unit Gen Practice, Aarhus, Denmark; [Vestergaard, Mogens; Obel, Carsten] Aarhus Univ, Inst Publ Hlth, Dept Gen Practice, Aarhus, Denmark; [Lu, Michael] Univ Calif Los Angeles, Dept Obstet & Gynecol, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; Aarhus University; Aarhus University; Aarhus University; University of California System; University of California Los Angeles	Virk, J (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA.	jasvirk@ucla.edu	Vestergaard, Mogens/M-9333-2014; Olsen, Jørn/F-8801-2015; li, jiong/L-6534-2014; Obel, Carsten/H-9605-2016	Vestergaard, Mogens/0000-0001-8830-2174; Olsen, Jørn/0000-0001-7462-5140; li, jiong/0000-0002-1716-8067; Obel, Carsten/0000-0001-5004-1933; Huicho, Luis/0000-0002-5272-5885; li, jiong/0000-0003-1125-026X	Danish Medical Research Council [271-05-0616, 271-07-0437]; NordForsk [070331]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NordForsk	The study was supported by the Danish Medical Research Council (projects no. 271-05-0616 and 271-07-0437) and NordForsk (070331). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Concannon P, 2009, NEW ENGL J MED, V360, P1646, DOI 10.1056/NEJMra0808284; Dahlquist G, 2002, DIABETES CARE, V25, P1755; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Entringer S, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.006; Gale EAM, 2002, DIABETOLOGIA, V45, P588, DOI 10.1007/s00125-002-0801-1; Harder T, 2009, AM J EPIDEMIOL, V169, P1428, DOI 10.1093/aje/kwp065; Krupnick J.L., 1984, BEREAVEMENT REACTION, P99; McKinney PA, 2000, DIABETIC MED, V17, P236, DOI 10.1046/j.1464-5491.2000.00220.x; Nielsen G L, 1996, J Med Syst, V20, P1, DOI 10.1007/BF02260869; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rubin S.S., 2001, HDB BEREAVEMENT RES, P219, DOI DOI 10.1037/10436-009; Rubin Simon Shimshon, 1993, P285, DOI 10.1017/CBO9780511664076.020; Svensson J, 2002, DIABETES CARE, V25, P2197, DOI 10.2337/diacare.25.12.2197; WAREHAM NJ, 2002, MED INT, V30, P11; WEINSTOCK M, 1992, BRAIN RES, V595, P195, DOI 10.1016/0006-8993(92)91049-K	18	32	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11523	10.1371/journal.pone.0011523	http://dx.doi.org/10.1371/journal.pone.0011523			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634978	Green Submitted, gold, Green Published			2022-12-27	WOS:000279715300026
J	Grant, PM; Komarow, L; Andersen, J; Sereti, I; Pahwa, S; Lederman, MM; Eron, J; Sanne, I; Powderly, W; Hogg, E; Suckow, C; Zolopa, A				Grant, Philip M.; Komarow, Lauren; Andersen, Janet; Sereti, Irini; Pahwa, Savita; Lederman, Michael M.; Eron, Joseph; Sanne, Ian; Powderly, William; Hogg, Evelyn; Suckow, Carol; Zolopa, Andrew			Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; CRYPTOCOCCAL MENINGITIS; HIV; INITIATION; MORTALITY	Background: Immune reconstitution inflammatory syndrome (IRIS) is reported widely in patients initiating antiretroviral therapy (ART). However, few studies are prospective, and no study has evaluated the impact of the timing of ART when allocated randomly during an acute opportunistic infection (OI). Methodology/Principal Findings: A5164 randomized 282 subjects with AIDS-related OIs (tuberculosis excluded), to early or deferred ART. IRIS was identified prospectively using pre-defined criteria. We evaluated associations between IRIS and baseline variables in subjects with follow-up on ART using Wilcoxon and Fisher's exact tests, logistic regression, and Cox models with time-varying covariates. Twenty of 262 (7.6%) subjects developed IRIS after a median of 33 days on ART. Subjects with fungal infections (other than pneumocystis) developed IRIS somewhat more frequently (OR = 2.7; 95% CI: 1.02, 7.2; p-value = 0.06 (using Fisher's exact test)). In Cox models, lower baseline and higher on-treatment CD4+ T-cell counts and percentage were associated with IRIS. Additionally, higher baseline and lower on-treatment HIV RNA levels were associated with IRIS. Corticosteroids during OI management and the timing of ART were not associated with the development of IRIS. Implications: In patients with advanced immunosuppression and non-tuberculous OIs, the presence of a fungal infection, lower CD4+ T-cell counts and higher HIV RNA levels at baseline, and higher CD4+ T-cell counts and lower HIV RNA levels on treatment are associated with IRIS. Early initiation of ART does not increase the incidence of IRIS, and concern about IRIS should not prompt deferral of ART.	[Grant, Philip M.; Zolopa, Andrew] Stanford Univ, Palo Alto, CA 94304 USA; [Komarow, Lauren; Andersen, Janet] Harvard Univ, Sch Publ Hlth, Stat & Data Anal Ctr, Boston, MA 02115 USA; [Sereti, Irini] NIAID, NIH, Bethesda, MD 20892 USA; [Pahwa, Savita] Univ Miami, Miami, FL USA; [Lederman, Michael M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Eron, Joseph] Univ N Carolina, Chapel Hill, NC USA; [Sanne, Ian] Helen Joseph Hosp, Wits Hlth Consortium, Johannesburg, South Africa; [Powderly, William] Univ Coll Dublin, Dublin 2, Ireland; [Hogg, Evelyn] Social & Sci Syst Inc, Silver Spring, MD USA; [Suckow, Carol] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA	Stanford University; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Miami; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; University of Witwatersrand; University College Dublin; Social & Scientific Systems; Frontier Science Foundation	Grant, PM (corresponding author), Stanford Univ, Palo Alto, CA 94304 USA.	pmgrant@stanford.edu	Pahwa, Savita/AAA-4900-2019; Sanne, Ian/ABH-2231-2020	Pahwa, Savita/0000-0002-4470-4216; Sereti, Irini/0000-0002-0076-0224; Powderly, William/0000-0001-7808-3086	National Institute of Allergy and Infectious Diseases [AI38858, AI68636, AI68634]; National Center for Research Resources [AI069556]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069423, U01AI038858, U01AI069556, U01AI068634, P30AI050410, UM1AI069556, ZIAAI001121, UM1AI068634, U01AI068636, UM1AI068636] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the AIDS Clinical Trials Group funded by the National Institute of Allergy and Infectious Diseases, AI38858, and AI68636, and AI68634. Also supported in part by the General Clinical Research Center Units funded by the National Center for Research Resources (AI069556) and intramural support by the National Institute of Allergy and Infectious Diseases (I. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bicanic T, 2009, JAIDS-J ACQ IMM DEF, V51, P130, DOI 10.1097/QAI.0b013e3181a56f2e; Breton G, 2004, CLIN INFECT DIS, V39, P1709, DOI 10.1086/425742; Foudraine NA, 1999, AIDS, V13, P177, DOI 10.1097/00002030-199902040-00005; French M A, 2000, HIV Med, V1, P107, DOI 10.1046/j.1468-1293.2000.00012.x; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; HAZZARD BG, 2008, HIV MED, V9, P563; Jevtovic D, 2005, HIV MED, V6, P140, DOI 10.1111/j.1468-1293.2005.00277.x; Lortholary O, 2005, AIDS, V19, P1043, DOI 10.1097/01.aids.0000174450.70874.30; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Manabe YC, 2007, JAIDS-J ACQ IMM DEF, V46, P456, DOI 10.1097/QAI.0b013e3181594c8c; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Park WB, 2006, AIDS, V20, P2390, DOI 10.1097/QAD.0b013e328010f201; Race EM, 1998, LANCET, V351, P252, DOI 10.1016/S0140-6736(97)04352-3; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Robertson J, 2006, CLIN INFECT DIS, V42, P1639, DOI 10.1086/503903; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; Sungkanuparph S, 2009, CLIN INFECT DIS, V49, P931, DOI 10.1086/605497; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	20	100	107	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11416	10.1371/journal.pone.0011416	http://dx.doi.org/10.1371/journal.pone.0011416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YF	20617176	Green Published, gold, Green Submitted			2022-12-27	WOS:000279465500005
J	van Kampen, JJA; Reedijk, ML; Burgers, PC; Dekker, LJM; Hartwig, NG; van der Ende, IE; de Groot, R; Osterhaus, ADME; Burger, DM; Luider, TM; Gruters, RA				van Kampen, Jeroen J. A.; Reedijk, Mariska L.; Burgers, Peter C.; Dekker, Lennard J. M.; Hartwig, Nico G.; van der Ende, Ineke E.; de Groot, Ronald; Osterhaus, Albert D. M. E.; Burger, David M.; Luider, Theo M.; Gruters, Rob A.			Ultra-Fast Analysis of Plasma and Intracellular Levels of HIV Protease Inhibitors in Children: A Clinical Application of MALDI Mass Spectrometry	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; ASSISTED-LASER-DESORPTION/IONIZATION; REVERSE-TRANSCRIPTASE INHIBITORS; IMMUNODEFICIENCY-VIRUS TYPE-1; STEADY-STATE PHARMACOKINETICS; P-GLYCOPROTEIN EXPRESSION; INFECTED PATIENTS; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; ANTIRETROVIRAL DRUGS	HIV protease inhibitors must penetrate into cells to exert their action. Differences in the intracellular pharmacokinetics of these drugs may explain why some patients fail on therapy or suffer from drug toxicity. Yet, there is no information available on the intracellular levels of HIV protease inhibitors in HIV infected children, which is in part due to the large amount of sample that is normally required to measure the intracellular concentrations of these drugs. Therefore, we developed an ultra-fast and sensitive assay to measure the intracellular concentrations of HIV protease inhibitors in small amounts of peripheral blood mononuclear cells (PBMCs), and determined the intracellular concentrations of lopinavir and ritonavir in HIV infected children. An assay based on matrix-assisted laser desorption/ionization (MALDI) - triple quadrupole mass spectrometry was developed to determine the concentrations of HIV protease inhibitors in 10 mu L plasma and 1 x 10(6) PBMCs. Precisions and accuracies were within the values set by the FDA for bioanalytical method validation. Lopinavir and ritonavir did not accumulate in PBMCs of HIV infected children. In addition, the intracellular concentrations of lopinavir and ritonavir correlated poorly to the plasma concentrations of these drugs. MALDI-triple quadrupole mass spectrometry is a new tool for ultra-fast and sensitive determination of drug concentrations which can be used, for example, to assess the intracellular pharmacokinetics of HIV protease inhibitors in HIV infected children.	[van Kampen, Jeroen J. A.; Burgers, Peter C.; Dekker, Lennard J. M.; Luider, Theo M.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [van Kampen, Jeroen J. A.; Hartwig, Nico G.] Erasmus MC Sophia, Dept Paediat, Rotterdam, Netherlands; [van Kampen, Jeroen J. A.; Reedijk, Mariska L.; Osterhaus, Albert D. M. E.; Gruters, Rob A.] Erasmus MC, Dept Virol, Rotterdam, Netherlands; [van der Ende, Ineke E.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [de Groot, Ronald] Univ Med Ctr Nijmegen, Dept Paediat, Nijmegen, Netherlands; [Burger, David M.] Univ Med Ctr Nijmegen, Dept Clin Pharm, Nijmegen, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Radboud University Nijmegen; Radboud University Nijmegen	van Kampen, JJA (corresponding author), Erasmus MC, Dept Neurol, Rotterdam, Netherlands.	t.luider@erasmusmc.nl	Gruters, Rob/AAM-2362-2020; Burger, David/C-9929-2013; Hartwig, Nico/ABI-5467-2020; de Groot, R./H-8039-2014	Osterhaus, Albert/0000-0002-6074-1172; Gruters, Rob/0000-0002-8486-5903; van Kampen, Jeroen/0000-0002-7625-8230	Top Institute Pharma [T4-212]; Aids Fonds, the Netherlands [2004051]; VIRGO	Top Institute Pharma; Aids Fonds, the Netherlands; VIRGO	This work was supported by a grant from Top Institute Pharma (project T4-212). The consortium of project T4-212 consists of the departments of Neurology and Virology of the Erasmus MC (Rotterdam, the Netherlands), the departments of Pediatrics and Clinical Pharmacy of the UMC St. Radboud (Nijmegen, the Netherlands), TNO Quality-of-Life (Zeist, the Netherlands), and GlaxoSmithKline (Zeist, the Netherlands). Jeroen van Kampen is supported by a grant from Aids Fonds, the Netherlands (project 2004051), and Rob Gruters is supported by VIRGO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergshoeff AS, 2003, ANTIVIR THER, V8, P215; Bilello JA, 1996, ANTIMICROB AGENTS CH, V40, P1491, DOI 10.1128/AAC.40.6.1491; Breilh D, 2004, AIDS, V18, P1305, DOI 10.1097/00002030-200406180-00009; Colombo S, 2005, J CHROMATOGR B, V819, P259, DOI 10.1016/j.jchromb.2005.02.010; Colombo S, 2006, THER DRUG MONIT, V28, P332, DOI 10.1097/01.ftd.0000211807.74192.62; Corr JJ, 2006, J AM SOC MASS SPECTR, V17, P1129, DOI 10.1016/j.jasms.2006.04.026; Crommentuyn KML, 2004, ANTIVIR THER, V9, P779; Cvetkovic RS, 2003, DRUGS, V63, P769, DOI 10.2165/00003495-200363080-00004; Denissen JF, 1997, DRUG METAB DISPOS, V25, P489; Droste JAH, 2003, THER DRUG MONIT, V25, P393, DOI 10.1097/00007691-200306000-00023; Ehrhardt M, 2007, J CHROMATOGR B, V850, P249, DOI 10.1016/j.jchromb.2006.11.037; Ford J, 2004, J ANTIMICROB CHEMOTH, V54, P982, DOI 10.1093/jac/dkh487; Ford J, 2004, ANTIVIR THER, V9, P77; Ford J, 2004, ANTIMICROB AGENTS CH, V48, P2388, DOI 10.1128/AAC.48.7.2388-2393.2004; Ford J, 2006, J ANTIMICROB CHEMOTH, V58, P1009, DOI 10.1093/jac/dkl379; Fraaij PLA, 2005, CLIN PHARMACOKINET, V44, P935, DOI 10.2165/00003088-200544090-00004; Fraaij PLA, 2004, THER DRUG MONIT, V26, P122, DOI 10.1097/00007691-200404000-00006; Fraaij PLA, 2003, J ANTIMICROB CHEMOTH, V52, P727, DOI 10.1093/jac/dkg391; Gobey J, 2005, ANAL CHEM, V77, P5643, DOI 10.1021/ac0506130; Hatsis P, 2003, RAPID COMMUN MASS SP, V17, P2303, DOI 10.1002/rcm.1192; Hennessy M, 2004, ANTIVIR THER, V9, P115; Hennessy M, 2003, ANTIVIR THER, V8, P191; Hoggard PG, 2003, J ANTIMICROB CHEMOTH, V51, P493, DOI 10.1093/jac/dkg137; Jones K, 2001, BRIT J CLIN PHARMACO, V51, P99, DOI 10.1046/j.1365-2125.2001.01324.x; Khoo SH, 2002, ANTIMICROB AGENTS CH, V46, P3228, DOI 10.1128/AAC.46.10.3228-3235.2002; Koal T, 2005, RAPID COMMUN MASS SP, V19, P2995, DOI 10.1002/rcm.2158; Kumar GN, 2004, PHARM RES-DORDR, V21, P1622, DOI 10.1023/B:PHAM.0000041457.64638.8d; Pelerin H, 2005, J CHROMATOGR B, V819, P47, DOI 10.1016/j.jchromb.2005.01.024; Ribera E, 2004, ANTIMICROB AGENTS CH, V48, P4256, DOI 10.1128/AAC.48.11.4256-4262.2004; Sleno L, 2005, RAPID COMMUN MASS SP, V19, P1928, DOI 10.1002/rcm.2006; Sleno L, 2005, ANAL CHEM, V77, P1509, DOI 10.1021/ac0486600; ter Heine R, 2009, J CHROMATOGR B, V877, P575, DOI 10.1016/j.jchromb.2009.01.011; U.S. FDA, 1998, GUIDANCE IND BIOANAL; van Kampen JJA, 2008, ANAL CHEM, V80, P4969, DOI 10.1021/ac800218a; van Kampen JJA, 2007, J CHROMATOGR B, V847, P38, DOI 10.1016/j.jchromb.2006.10.001; van Kampen JJA, 2011, MASS SPECTROM REV, V30, P101, DOI 10.1002/mas.20268; VANBUEREN J, 1994, J HOSP INFECT, V28, P137, DOI 10.1016/0195-6701(94)90140-6; Volmer DA, 2007, ANAL CHEM, V79, P9000, DOI 10.1021/ac7016234; Wagner M, 2008, J CHROMATOGR B, V872, P68, DOI 10.1016/j.jchromb.2008.07.009; Yang Yong, 2007, J Biomol Tech, V18, P226	40	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11409	10.1371/journal.pone.0011409	http://dx.doi.org/10.1371/journal.pone.0011409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YF	20625386	Green Submitted, Green Published, gold			2022-12-27	WOS:000279465500002
J	Chano, T; Ikebuchi, K; Ochi, Y; Tameno, H; Tomita, Y; Jin, YF; Inaji, H; Ishitobi, M; Teramoto, K; Nishimura, I; Minami, K; Inoue, H; Isono, T; Saitoh, M; Shimada, T; Hisa, Y; Okabe, H				Chano, Tokuhiro; Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Tomita, Yasuhiko; Jin, Yufen; Inaji, Hideo; Ishitobi, Makoto; Teramoto, Koji; Nishimura, Ichiro; Minami, Kahori; Inoue, Hirokazu; Isono, Takahiro; Saitoh, Masao; Shimada, Taketoshi; Hisa, Yasuo; Okabe, Hidetoshi			RB1CC1 Activates RB1 Pathway and Inhibits Proliferation and Cologenic Survival in Human Cancer	PLOS ONE			English	Article							HUMAN BREAST-CANCER; TUMOR-CELLS; COMPLEX; FIP200; AUTOPHAGY; GENE; PHOSPHORYLATION; TRANSCRIPTION; SENESCENCE; MUTATIONS	RB1-inducible coiled-coil 1 (RB1CC1, also known as FIP200) plays a role in the enhancement of the RB1 pathway through the direct binding to a GC-rich region 201bp upstream (from the initiation ATG) of the RB1 promoter. Here, we identified hSNF5 and p53 as the binding partners of RB1CC1 by immunoprecipitation and immunofluorescence assays. Interaction between these molecules and the RB1 pathway was analyzed by the assays of chromatin immunoprecipitation, luciferase-reporter, reverse transcription-polymerase chain reaction and immunoblot. The tumor growth suppression by RB1CC1 was evaluated by flow cytometry or by a cell growth assay. The nuclear RB1CC1 complex involving hSNF5 and/or p53 activated transcription of RB1, p16 and p21, and suppressed tumor cell growth. Furthermore, nuclear RB1CC1 expression significantly correlated with those of RB1 and p16 in breast cancer tissue in vivo, and the Ki-67 proliferation index was dependent on p53 as well as RB1CC1. The present study indicates that RB1CC1 together with hSNF5 and/or p53 enhances the RB1 pathway through transcriptional activation of RB1, p16 and p21. Evaluation of RB1CC1 expression combined with RB1 and p53 status is expected to provide useful information in clinical practice and future therapeutic strategies in breast cancer.	[Chano, Tokuhiro; Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Nishimura, Ichiro; Minami, Kahori; Okabe, Hidetoshi] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan; [Ikebuchi, Kaichiro; Ochi, Yasuko; Tameno, Hitosuke; Shimada, Taketoshi; Hisa, Yasuo] Kyoto Prefectural Univ Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Tomita, Yasuhiko; Jin, Yufen] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pathol, Osaka, Japan; [Inaji, Hideo; Ishitobi, Makoto] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Breast & Endocrine Surg, Osaka, Japan; [Teramoto, Koji] Shiga Univ Med Sci, Dept Thorac Surg, Otsu, Shiga 52021, Japan; [Inoue, Hirokazu] Shiga Univ Med Sci, Dept Microbiol, Otsu, Shiga 52021, Japan; [Isono, Takahiro] Shiga Univ Med Sci, Cent Res Lab, Otsu, Shiga 52021, Japan; [Saitoh, Masao] Tokyo Med & Dent Univ, Tokyo, Japan	Shiga University of Medical Science; Kyoto Prefectural University of Medicine; Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka Medical Center for Cancer & Cardiovascular Diseases; Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Tokyo Medical & Dental University (TMDU)	Chano, T (corresponding author), Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 52021, Japan.	chano@belle.shiga-med.ac.jp	Chano, Tokuhiro/F-5816-2018	Chano, Tokuhiro/0000-0002-9959-1183	Ministry of Education, Culture, Sports, Science, and Technology, Japan [20012025]; Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research	This study was supported in part by KAKENHI (Grant-in-Aid for Scientific Research on Priority Areas; No. 20012025) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and the Japanese Society of Laboratory Medicine Fund for the Promotion of Scientific Research. These funding sources had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript.	Betz BL, 2002, ONCOGENE, V21, P5193, DOI 10.1038/sj.onc.1205706; Chai JJ, 2005, CANCER RES, V65, P10192, DOI 10.1158/0008-5472.CAN-05-1896; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Chano T, 2006, INT J MOL MED, V18, P425; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gresh L, 2005, EMBO J, V24, P3313, DOI 10.1038/sj.emboj.7600802; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2009, AUTOPHAGY, V5, P85, DOI 10.4161/auto.5.1.7180; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Ikebuchi K, 2009, INT J CANCER, V125, P861, DOI 10.1002/ijc.24466; Lee D, 2002, J BIOL CHEM, V277, P22330, DOI 10.1074/jbc.M111987200; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schmidt-Kittler O, 2003, P NATL ACAD SCI USA, V100, P7737, DOI 10.1073/pnas.1331931100; Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709	19	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11404	10.1371/journal.pone.0011404	http://dx.doi.org/10.1371/journal.pone.0011404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614030	Green Submitted, Green Published, gold			2022-12-27	WOS:000279370000029
J	Madsen, L; Pedersen, LM; Lillefosse, HH; Fjaere, E; Bronstad, I; Hao, Q; Petersen, RK; Hallenborg, P; Ma, T; De Matteis, R; Araujo, P; Mercader, J; Bonet, ML; Hansen, JB; Cannon, B; Nedergaard, J; Wang, J; Cinti, S; Voshol, P; Doskeland, SO; Kristiansen, K				Madsen, Lise; Pedersen, Lone M.; Lillefosse, Haldis Haukaas; Fjaere, Even; Bronstad, Ingeborg; Hao, Qin; Petersen, Rasmus K.; Hallenborg, Philip; Ma, Tao; De Matteis, Rita; Araujo, Pedro; Mercader, Josep; Luisa Bonet, M.; Hansen, Jacob B.; Cannon, Barbara; Nedergaard, Jan; Wang, Jun; Cinti, Saverio; Voshol, Peter; Doskeland, Stein Ove; Kristiansen, Karsten			UCP1 Induction during Recruitment of Brown Adipocytes in White Adipose Tissue Is Dependent on Cyclooxygenase Activity	PLOS ONE			English	Article							DIET-INDUCED OBESITY; MITOCHONDRIAL UNCOUPLING PROTEIN; PROSTANOID RECEPTORS; INSULIN-RESISTANCE; LEAN PHENOTYPE; C57BL/6J MICE; GENE; FAT; EXPRESSION; DEFICIENT	Background: The uncoupling protein 1 (UCP1) is a hallmark of brown adipocytes and pivotal for cold- and diet-induced thermogenesis. Methodology/Principal Findings: Here we report that cyclooxygenase (COX) activity and prostaglandin E-2 (PGE(2)) are crucially involved in induction of UCP1 expression in inguinal white adipocytes, but not in classic interscapular brown adipocytes. Cold-induced expression of UCP1 in inguinal white adipocytes was repressed in COX2 knockout (KO) mice and by administration of the COX inhibitor indomethacin in wild-type mice. Indomethacin repressed beta-adrenergic induction of UCP1 expression in primary inguinal adipocytes. The use of PGE(2) receptor antagonists implicated EP4 as a main PGE(2) receptor, and injection of the stable PGE(2) analog (EP3/4 agonist) 16,16 dm PGE(2) induced UCP1 expression in inguinal white adipose tissue. Inhibition of COX activity attenuated diet-induced UCP1 expression and increased energy efficiency and adipose tissue mass in obesity-resistant mice kept at thermoneutrality. Conclusions/Significance: Our findings provide evidence that induction of UCP1 expression in white adipose tissue, but not in classic interscapular brown adipose tissue is dependent on cyclooxygenase activity. Our results indicate that cyclooxygenase-dependent induction of UCP1 expression in white adipose tissues is important for diet-induced thermogenesis providing support for a surprising role of COX activity in the control of energy balance and obesity development.	[Madsen, Lise; Lillefosse, Haldis Haukaas; Fjaere, Even; Hao, Qin; Petersen, Rasmus K.; Hallenborg, Philip; Ma, Tao; Wang, Jun; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Pedersen, Lone M.] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Madsen, Lise; Lillefosse, Haldis Haukaas; Fjaere, Even; Araujo, Pedro] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Bronstad, Ingeborg; Doskeland, Stein Ove] Univ Bergen, Dept Biomed, Bergen, Norway; [De Matteis, Rita] Univ Urbino, Dept Biomol Sci, I-61029 Urbino, Italy; [Mercader, Josep; Luisa Bonet, M.] Univ Illes Balears, Lab Mol Biol Nutr & Biotechnol, Palma de Mallorca, Spain; [Mercader, Josep; Luisa Bonet, M.] CIBERobn, Palma de Mallorca, Spain; [Hansen, Jacob B.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Cannon, Barbara; Nedergaard, Jan] Stockholm Univ, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Wang, Jun; Kristiansen, Karsten] BGI Shenzhen, Shenzhen, Peoples R China; [Cinti, Saverio] Univ Ancona, Dept Mol Pathol & Innovat Therapies, Ancona, Italy; [Voshol, Peter] Univ Cambridge, Metab Res Labs, Cambridge, England	University of Copenhagen; University of Southern Denmark; University of Bergen; University of Urbino; Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Copenhagen; Stockholm University; Beijing Genomics Institute (BGI); Marche Polytechnic University; University of Cambridge	Madsen, L (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	lise.madsen@nifes.no; kk@bio.ku.dk	Mercader, J/I-1867-2017; Hansen, Jacob B/F-3775-2010; Madsen, Lise/C-6246-2012; De+Matteis, Rita/AAG-6904-2019; Nedergaard, Jan/Q-8286-2019; Nedergaard, Jan/A-1706-2010; Kristiansen, Karsten/J-5148-2014; Bonet, M.Luisa/H-6722-2015; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Cannon, Barbara/B-3089-2016	Hansen, Jacob B/0000-0001-5249-2586; Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Bonet, M.Luisa/0000-0002-8698-0630; Wang, Jun/0000-0002-8540-8931; Nedergaard, Jan/0000-0003-2070-1587; DE MATTEIS, Rita/0000-0003-4665-4547; Wang, Jun/0000-0002-2113-5874; CINTI, Saverio/0000-0003-0362-5017; Mercader Barcelo, Josep/0000-0002-5293-2809; Cannon, Barbara/0000-0001-6594-2363; Araujo, Pedro/0000-0002-1962-6084; Hao, Qin/0000-0002-6775-2181; Doskeland, Stein Ove/0000-0002-4009-4756	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Danish Council [2101 06 0005]	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Danish Council(Danish Medical Research Council)	This work was supported by the Danish Natural Science Research Council, the Novo Nordisk Foundation and the Carlsberg Foundation. Part of the work was carried out as a part of the research program of the Danish Obesity Research Centre (DanORC). DanORC is supported by The Danish Council for Strategic Research (Grant No 2101 06 0005). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of the ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Bauer AK, 2000, CARCINOGENESIS, V21, P543, DOI 10.1093/carcin/21.4.543; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; CINTI S, 2009, AM J PHYSIOL-ENDOC M; Collins S, 1997, ENDOCRINOLOGY, V138, P405, DOI 10.1210/en.138.1.405; Cummings DE, 1996, NATURE, V382, P622, DOI 10.1038/382622a0; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fain JN, 2001, PROSTAG OTH LIPID M, V65, P199, DOI 10.1016/S0090-6980(01)00136-8; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; GARRUTI G, 1992, INT J OBESITY, V16, P383; GASKINS HR, 1989, J NUTR, V119, P458, DOI 10.1093/jn/119.3.458; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Grujic D, 1997, J BIOL CHEM, V272, P17686, DOI 10.1074/jbc.272.28.17686; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Hetu PO, 2007, OBESITY, V15, P60, DOI 10.1038/oby.2007.514; Himms-Hagen J, 2000, AM J PHYSIOL-CELL PH, V279, pC670, DOI 10.1152/ajpcell.2000.279.3.C670; HYMAN BT, 1982, BIOCHIM BIOPHYS ACTA, V713, P375, DOI 10.1016/0005-2760(82)90256-9; Jimenez M, 2003, EUR J BIOCHEM, V270, P699, DOI 10.1046/j.1432-1033.2003.03422.x; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE768, DOI 10.1152/ajpendo.1996.270.5.E768; Kopecky J, 1996, AM J PHYSIOL-ENDOC M, V270, pE776, DOI 10.1152/ajpendo.1996.270.5.E776; Koza RA, 2000, J BIOL CHEM, V275, P34486, DOI 10.1074/jbc.M002136200; Kunikata T, 2002, DIGEST DIS SCI, V47, P894, DOI 10.1023/A:1014725024519; LEAN MEJ, 1986, INT J OBESITY, V10, P219; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Mercader J, 2009, AM J PHYSIOL-ENDOC M, V297, pE184, DOI 10.1152/ajpendo.00163.2009; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Muller-Decker K, 2002, J INVEST DERMATOL, V119, P1189, DOI 10.1046/j.1523-1747.2002.19501.x; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nolan MA, 2004, MOL ENDOCRINOL, V18, P2302, DOI 10.1210/me.2004-0194; Oberkofler H, 1997, J LIPID RES, V38, P2125; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; PETROVIC N, 2009, J BIOL CHEM      DEC; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; ROTHWELL NJ, 1979, NATURE, V281, P31, DOI 10.1038/281031a0; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Sakuma Y, 2000, INFECT IMMUN, V68, P6819, DOI 10.1128/IAI.68.12.6819-6825.2000; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; Stenbit AE, 1997, NAT MED, V3, P1096, DOI 10.1038/nm1097-1096; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; USHIKUBI F, 1995, J LIPID MEDIAT CELL, V12, P343, DOI 10.1016/0929-7855(95)00022-I; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Watson PM, 2000, AM J PHYSIOL-ENDOC M, V279, pE356, DOI 10.1152/ajpendo.2000.279.2.E356; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	60	155	164	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11391	10.1371/journal.pone.0011391	http://dx.doi.org/10.1371/journal.pone.0011391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613988	Green Submitted, Green Published, gold			2022-12-27	WOS:000279370000020
J	Rogers, C; Guo, ZH; Stiller, JW				Rogers, Carlyle; Guo, Zhenhua; Stiller, John W.			Connecting Mutations of the RNA Polymerase II C-Terminal Domain to Complex Phenotypic Changes Using Combined Gene Expression and Network Analyses	PLOS ONE			English	Article							GDP-MANNOSE PYROPHOSPHORYLASE; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; CHROMOSOME SEGREGATION; LARGEST SUBUNIT; YEAST MEDIATOR; DNA-REPAIR; PROTEINS; CTD; RECOMBINATION	The C-terminal domain (CTD) of the largest subunit in DNA-dependent RNA polymerase II (RNAP II) is essential for mRNA synthesis and processing, through coordination of an astounding array of protein-protein interactions. Not surprisingly, CTD mutations can have complex, pleiotropic impacts on phenotype. For example, insertions of five alanine residues between CTD diheptads in yeast, which alter the CTD's overall tandem structure and physically separate core functional units, dramatically reduce growth rate and result in abnormally large cells that accumulate increased DNA content over time. Patterns by which specific CTD-protein interactions are disrupted by changes in CTD structure, as well as how downstream metabolic pathways are impacted, are difficult to target for direct experimental analyses. In an effort to connect an altered CTD to complex but quantifiable phenotypic changes, we applied network analyses of genes that are differentially expressed in our five alanine CTD mutant, combined with established genetic interactions from the Saccharomyces cerevisiae Genome Database (SGD). We were able to identify candidate genetic pathways, and several key genes, that could explain how this change in CTD structure leads to the specific phenotypic changes observed. These hypothetical networks identify links between CTD-associated proteins and mitotic function, control of cell cycle checkpoint mechanisms, and expression of cell wall and membrane components. Such results can help to direct future genetic and biochemical investigations that tie together the complex impacts of the CTD on global cellular metabolism.	[Rogers, Carlyle; Stiller, John W.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [Guo, Zhenhua] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China	University of North Carolina; East Carolina University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Rogers, C (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	acr1002@ecu.edu		Stiller, John/0000-0002-0668-8243	National Science Foundation [MCB0133295]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation grant MCB0133295. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LA, 1988, MOL CELL BIOL, V8, P321, DOI 10.1128/MCB.8.1.321; Ashkenazi M, 2008, BIOINFORMATICS, V24, P1465, DOI 10.1093/bioinformatics/btn208; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Bertuch AA, 2003, GENE DEV, V17, P2347, DOI 10.1101/gad.1146603; Biddick R, 2005, CR BIOL, V328, P773, DOI 10.1016/j.crvi.2005.03.004; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; BROWN MT, 1993, J CELL BIOL, V123, P387, DOI 10.1083/jcb.123.2.387; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; de Almeida SF, 2008, FEBS LETT, V582, P1971, DOI 10.1016/j.febslet.2008.04.019; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Farr KA, 1998, MOL CELL BIOL, V18, P2738, DOI 10.1128/MCB.18.5.2738; Guo ZH, 2005, MOL BIOL EVOL, V22, P2166, DOI 10.1093/molbev/msi215; Han SJ, 1999, MOL CELL BIOL, V19, P979; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; KATO R, 1994, NUCLEIC ACIDS RES, V22, P3104, DOI 10.1093/nar/22.15.3104; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Liu PD, 2008, MOL BIOL EVOL, V25, P719, DOI 10.1093/molbev/msn017; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marquez MG, 2000, CYTOMETRY, V41, P115, DOI 10.1002/1097-0320(20001001)41:2<115::AID-CYTO6>3.3.CO;2-X; Milne DM, 2001, EXP CELL RES, V263, P43, DOI 10.1006/excr.2000.5100; Nair D, 2005, J BIOL CHEM, V280, P33739, DOI 10.1074/jbc.M506067200; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Ren Q, 2008, COMP FUNCT GENOM, DOI 10.1155/2008/634283; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stiller JW, 2004, EUKARYOT CELL, V3, P735, DOI 10.1128/EC.3.3.735-740.2004; Stiller JW, 2002, P NATL ACAD SCI USA, V99, P6091, DOI 10.1073/pnas.082646199; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tanaka TU, 2005, NAT REV MOL CELL BIO, V6, P929, DOI 10.1038/nrm1764; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; VANBAKEL H, 2007, TUTORIAL DNA MICROAR; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WEST ML, 1995, GENETICS, V140, P1223; Wolfger H, 2004, J BIOL CHEM, V279, P11593, DOI 10.1074/jbc.M311282200; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; Xu YX, 2007, GENE DEV, V21, P2950, DOI 10.1101/gad.1592807; Xu YX, 2007, MOL CELL, V26, P287, DOI 10.1016/j.molcel.2007.03.020; Yoda K, 2000, BIOSCI BIOTECH BIOCH, V64, P1937, DOI 10.1271/bbb.64.1937; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838	53	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11386	10.1371/journal.pone.0011386	http://dx.doi.org/10.1371/journal.pone.0011386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613981	gold, Green Published, Green Submitted			2022-12-27	WOS:000279370000015
J	Woodard, LE; Keravala, A; Jung, WE; Wapinski, OL; Yang, QW; Felsher, DW; Calos, MP				Woodard, Lauren E.; Keravala, Annahita; Jung, W. Edward; Wapinski, Orly L.; Yang, Qiwei; Felsher, Dean W.; Calos, Michele P.			Impact of Hydrodynamic Injection and phiC31 Integrase on Tumor Latency in a Mouse Model of MYC-Induced Hepatocellular Carcinoma	PLOS ONE			English	Article							PHAGE PHI-C31 INTEGRASE; GENE-THERAPY; CHROMOSOMAL REARRANGEMENTS; INDUCED TUMORIGENESIS; GENOMIC INTEGRATION; VECTOR INTEGRATION; MAMMALIAN-CELLS; PLASMID DNA; C-MYC; DELIVERY	Background: Hydrodynamic injection is an effective method for DNA delivery in mouse liver and is being translated to larger animals for possible clinical use. Similarly, phi C31 integrase has proven effective in mediating long-term gene therapy in mice when delivered by hydrodynamic injection and is being considered for clinical gene therapy applications. However, chromosomal aberrations have been associated with phi C31 integrase expression in tissue culture, leading to questions about safety. Methodology/Principal Findings: To study whether hydrodynamic delivery alone, or in conjunction with delivery of phi C31 integrase for long-term transgene expression, could facilitate tumor formation, we used a transgenic mouse model in which sustained induction of the human C-MYC oncogene in the liver was followed by hydrodynamic injection. Without injection, mice had a median tumor latency of 154 days. With hydrodynamic injection of saline alone, the median tumor latency was significantly reduced, to 105 days. The median tumor latency was similar, 106 days, when a luciferase donor plasmid and backbone plasmid without integrase were administered. In contrast, when active or inactive phi C31 integrase and donor plasmid were supplied to the mouse liver, the median tumor latency was 153 days, similar to mice receiving no injection. Conclusions/Significance: Our data suggest that phi C31 integrase does not facilitate tumor formation in this C-MYC transgenic mouse model. However, in groups lacking phi C31 integrase, hydrodynamic injection appeared to contribute to C-MYC-induced hepatocellular carcinoma in adult mice. Although it remains to be seen to what extent these findings may be extrapolated to catheter-mediated hydrodynamic delivery in larger species, they suggest that caution should be used during translation of hydrodynamic injection to clinical applications.	[Woodard, Lauren E.; Keravala, Annahita; Jung, W. Edward; Wapinski, Orly L.; Calos, Michele P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Yang, Qiwei; Felsher, Dean W.] Stanford Univ, Dept Med, Sch Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Stanford University	Woodard, LE (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	calos@stanford.edu			PHS [CA09302]; National Cancer Institute, DHHS; NIH [HL068112, CA89305-01A1, CA034233]; NATIONAL CANCER INSTITUTE [T32CA009302, P01CA034233, R01CA089305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL068112, R01HL068112] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	PHS Grant Number CA09302, awarded by the National Cancer Institute, DHHS, www.cancer.gov. Amgen Scholars Program through the Stanford Summer Research Program, www.amgenscholars.eu. NIH grant HL068112 to MPC, www.nih.gov. NIH grants CA89305-01A1 and CA034233 to DWF, www.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouElella A, 1996, MODERN PATHOL, V9, P95; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Beer S, 2010, MOL THER, V18, P161, DOI 10.1038/mt.2009.222; Beer S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002493; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Calos MP, 2006, CURR GENE THER, V6, P633, DOI 10.2174/156652306779010642; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chavez CL, 2010, HUM GENE THER, V21, P1287, DOI 10.1089/hum.2010.049; Chen JZ, 2006, NUCLEIC ACIDS RES, V34, P6298, DOI 10.1093/nar/gkl890; Donaldson TD, 2004, CURR BIOL, V14, pR425, DOI 10.1016/j.cub.2004.05.035; Donsante A, 2007, SCIENCE, V317, P477, DOI 10.1126/science.1142658; Ehrhardt A, 2005, MOL THER, V11, P695, DOI 10.1016/j.ymthe.2005.01.010; Ehrhardt A, 2006, HUM GENE THER, V17, P1077, DOI 10.1089/hum.2006.17.1077; Fabre JW, 2008, GENE THER, V15, P452, DOI 10.1038/sj.gt.3303079; Felsher Dean W., 2008, Lymphatic Research and Biology, V6, P149, DOI 10.1089/lrb.2008.63403; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Kamimura K, 2009, MOL THER, V17, P491, DOI 10.1038/mt.2008.294; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; Khorsandi SE, 2008, CANCER GENE THER, V15, P225, DOI 10.1038/sj.cgt.7701119; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu J, 2006, GENE THER, V13, P1188, DOI 10.1038/sj.gt.3302789; Liu J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-31; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Portlock JL, 2006, HUM GENE THER, V17, P871, DOI 10.1089/hum.2006.17.871; Ryu BY, 2008, BLOOD, V111, P1866, DOI 10.1182/blood-2007-04-085506; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shou Y, 2006, P NATL ACAD SCI USA, V103, P11730, DOI 10.1073/pnas.0603635103; Sivalingam J, 2010, MOL THER, V18, P1346, DOI 10.1038/mt.2010.61; Suda T, 2008, MOL THER, V16, P1098, DOI 10.1038/mt.2008.66; Suda T, 2009, HEPATOL RES, V39, P325, DOI 10.1111/j.1872-034X.2008.00479.x; Themis M, 2005, MOL THER, V12, P763, DOI 10.1016/j.ymthe.2005.07.358; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Thyagarajan Haskar, 2005, V308, P99; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Wang BY, 2010, MOL BIOL REP, V37, P2809, DOI 10.1007/s11033-009-9829-3; Woodard LE, 2010, GENE THER, V17, P217, DOI 10.1038/gt.2009.136; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	42	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 29	2010	5	6							e11367	10.1371/journal.pone.0011367	http://dx.doi.org/10.1371/journal.pone.0011367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QD	20614008	Green Submitted, Green Published, gold			2022-12-27	WOS:000279369900016
J	Bhardwaj, A; Leelavathi, S; Mazumdar-Leighton, S; Ghosh, A; Ramakumar, S; Reddy, VS				Bhardwaj, Amit; Leelavathi, Sadhu; Mazumdar-Leighton, Sudeshna; Ghosh, Amit; Ramakumar, Suryanarayanarao; Reddy, Vanga S.			The Critical Role of N- and C-Terminal Contact in Protein Stability and Folding of a Family 10 Xylanase under Extreme Conditions	PLOS ONE			English	Article							ALKALI-THERMOSTABLE XYLANASE; CATION-PI INTERACTIONS; STRUCTURAL BASIS; STABILIZATION CENTERS; HYDROPHOBIC RESIDUES; THERMAL-STABILITY; SEQUENCE-ANALYSIS; BARREL PROTEINS; SWISS-MODEL; CLONING	Background: Stabilization strategies adopted by proteins under extreme conditions are very complex and involve various kinds of interactions. Recent studies have shown that a large proportion of proteins have their N- and C-terminal elements in close contact and suggested they play a role in protein folding and stability. However, the biological significance of this contact remains elusive. Methodology: In the present study, we investigate the role of N- and C-terminal residue interaction using a family 10 xylanase (BSX) with a TIM-barrel structure that shows stability under high temperature, alkali pH, and protease and SDS treatment. Based on crystal structure, an aromatic cluster was identified that involves Phe4, Trp6 and Tyr343 holding the Nand C-terminus together; this is a unique and important feature of this protein that might be crucial for folding and stability under poly-extreme conditions. Conclusion: A series of mutants was created to disrupt this aromatic cluster formation and study the loss of stability and function under given conditions. While the deletions of Phe4 resulted in loss of stability, removal of Trp6 and Tyr343 affected in vivo folding and activity. Alanine substitution with Phe4, Trp6 and Tyr343 drastically decreased stability under all parameters studied. Importantly, substitution of Phe4 with Trp increased stability in SDS treatment. Mass spectrometry results of limited proteolysis further demonstrated that the Arg344 residue is highly susceptible to trypsin digestion in sensitive mutants such as DF4, W6A and Y343A, suggesting again that disruption of the Phe4-Trp6-Tyr343 (F-W-Y) cluster destabilizes the N- and C-terminal interaction. Our results underscore the importance of N- and C-terminal contact through aromatic interactions in protein folding and stability under extreme conditions, and these results may be useful to improve the stability of other proteins under suboptimal conditions.	[Bhardwaj, Amit; Leelavathi, Sadhu; Reddy, Vanga S.] Int Ctr Genet Engn & Biotechnol, New Delhi, India; [Bhardwaj, Amit; Mazumdar-Leighton, Sudeshna] Univ Delhi, Dept Bot, Delhi 110007, India; [Ghosh, Amit] Natl Inst Cholera & Enter Dis, Kolkata, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Ramakumar, Suryanarayanarao] Indian Inst Sci, Bioinformat Ctr, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; University of Delhi; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Bhardwaj, A (corresponding author), Int Ctr Genet Engn & Biotechnol, New Delhi, India.	vsreddy@icgeb.res.in	Ghosh, Amit/AAB-3140-2019; Bhardwaj, Amit/AAZ-7110-2020; Bhardwaj, Amit/AAC-5393-2020	Bhardwaj, Amit/0000-0002-0172-2027; Bhardwaj, Amit/0000-0002-0172-2027	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India	International Centre for Genetic Engineering and Biotechnology, New Delhi; Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	This work was supported by funds from the International Centre for Genetic Engineering and Biotechnology, New Delhi and the Department of Biotechnology (DBT), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharadwaj A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003063; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang PC, 2004, BIOCHEM BIOPH RES CO, V319, P1017, DOI 10.1016/j.bbrc.2004.05.078; CHOU KC, 1991, PROTEINS, V9, P280, DOI 10.1002/prot.340090406; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Dosztanyi Z, 2003, BIOINFORMATICS, V19, P899, DOI 10.1093/bioinformatics/btg110; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Funahashi J, 2000, BIOCHEMISTRY-US, V39, P14448, DOI 10.1021/bi0015717; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Georis J, 2000, PROTEIN SCI, V9, P466; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta N, 2000, APPL ENVIRON MICROB, V66, P2631, DOI 10.1128/AEM.66.6.2631-2635.2000; Harris GW, 1997, PROTEINS, V29, P77, DOI 10.1002/(SICI)1097-0134(199709)29:1<77::AID-PROT6>3.3.CO;2-K; Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2; HUGHSON FM, 1990, SCIENCE, V249, P1544, DOI 10.1126/science.2218495; Ihsanawati, 2005, PROTEINS, V61, P999, DOI 10.1002/prot.20700; JENNINGS PA, 1993, SCIENCE, V262, P892, DOI 10.1126/science.8235610; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; Kay MS, 1999, P NATL ACAD SCI USA, V96, P2007, DOI 10.1073/pnas.96.5.2007; Knochel T, 2002, J BIOL CHEM, V277, P8626, DOI 10.1074/jbc.M109517200; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; LESK AM, 1989, PROTEINS, V5, P139, DOI 10.1002/prot.340050208; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; Machius M, 2003, J BIOL CHEM, V278, P11546, DOI 10.1074/jbc.M212618200; Mamo G, 2006, MOL BIOTECHNOL, V33, P149; Manikandan K, 2005, ACTA CRYSTALLOGR F, V61, P747, DOI 10.1107/S1744309105020518; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; Meyer EL, 2003, J BIOL CHEM, V278, P23786, DOI 10.1074/jbc.M301360200; ORNSTEIN L, 1964, ANN NY ACAD SCI, V121, P321, DOI 10.1111/j.1749-6632.1964.tb14207.x; PAKULA AA, 1990, NATURE, V344, P363, DOI 10.1038/344363a0; Park CW, 2005, NAT METHODS, V2, P207, DOI 10.1038/NMETH740; Peng BH, 2003, J BIOL CHEM, V278, P49644, DOI 10.1074/jbc.M302782200; Perl D, 2000, NAT STRUCT BIOL, V7, P380; Prajapati RS, 2006, BIOCHEMISTRY-US, V45, P15000, DOI 10.1021/bi061275f; Puchkaev AV, 2003, ARCH BIOCHEM BIOPHYS, V409, P52, DOI 10.1016/S0003-9861(02)00402-2; Rodriguez HM, 2000, PROTEIN SCI, V9, P1993, DOI 10.1110/ps.9.10.1993; Rodriguez J, 2008, J PROTEOME RES, V7, P300, DOI 10.1021/pr0705035; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schindler T, 1998, PROTEINS, V30, P401, DOI 10.1002/(SICI)1097-0134(19980301)30:4<401::AID-PROT7>3.3.CO;2-G; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selvaraj S, 1998, J PROTEIN CHEM, V17, P407, DOI 10.1023/A:1022514400583; TABERNERO C, 1995, APPL ENVIRON MICROB, V61, P2420, DOI 10.1128/AEM.61.6.2420-2424.1995; Tanford C., 1991, HYDROPHOBIC EFFECT F, V2nd; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Wang L, 1998, PROTEIN SCI, V7, P2460, DOI 10.1002/pro.5560071124; Watanabe K, 1997, J MOL BIOL, V269, P142, DOI 10.1006/jmbi.1997.1018; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; Xie HF, 2006, J MOL BIOL, V360, P157, DOI 10.1016/j.jmb.2006.05.002; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078	50	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11347	10.1371/journal.pone.0011347	http://dx.doi.org/10.1371/journal.pone.0011347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596542	Green Submitted, Green Published, gold			2022-12-27	WOS:000279259900018
J	Lindberg, J; Wijbrandts, CA; van Baarsen, LG; Nader, G; Klareskog, L; Catrina, A; Thurlings, R; Vervoordeldonk, M; Lundeberg, J; Tak, PP				Lindberg, Johan; Wijbrandts, Carla A.; van Baarsen, Lisa G.; Nader, Gustavo; Klareskog, Lars; Catrina, Anca; Thurlings, Rogier; Vervoordeldonk, Margriet; Lundeberg, Joakim; Tak, Paul P.			The Gene Expression Profile in the Synovium as a Predictor of the Clinical Response to Infliximab Treatment in Rheumatoid Arthritis	PLOS ONE			English	Article							FACTOR-ALPHA THERAPY; COLLEGE-OF-RHEUMATOLOGY; LYMPHOID NEOGENESIS; SET ENRICHMENT; BLOOD-CELLS; MICROARRAY; CANCER; TISSUE; RESPONSIVENESS; INFLAMMATION	Background: Although the use of TNF inhibitors has fundamentally changed the way rheumatoid arthritis (RA) is treated, not all patients respond well. It is desirable to facilitate the identification of responding and non-responding patients prior to treatment, not only to avoid unnecessary treatment but also for financial reasons. In this work we have investigated the transcriptional profile of synovial tissue sampled from RA patients before anti-TNF treatment with the aim to identify biomarkers predictive of response. Methodology/Principal Findings: Synovial tissue samples were obtained by arthroscopy from 62 RA patients before the initiation of infliximab treatment. RNA was extracted and gene expression profiling was performed using an in-house spotted long oligonucleotide array covering 17972 unique genes. Tissue sections were also analyzed by immunohistochemistry to evaluate cell infiltrates. Response to infliximab treatment was assessed according to the EULAR response criteria. The presence of lymphocyte aggregates dominated the expression profiles and a significant overrepresentation of lymphocyte aggregates in good responding patients confounded the analyses. A statistical model was set up to control for the effect of aggregates, but no differences could be identified between responders and non-responders. Subsequently, the patients were split into lymphocyte aggregate positive-and negative patients. No statistically significant differences could be identified except for 38 transcripts associated with differences between good- and non-responders in aggregate positive patients. A profile was identified in these genes that indicated a higher level of metabolism in good responding patients, which indirectly can be connected to increased inflammation. Conclusions/Significance: It is pivotal to account for the presence of lymphoid aggregates when studying gene expression patterns in rheumatoid synovial tissue. In spite of our original hypothesis, the data do not support the notion that microarray analysis of whole synovial biopsy specimens can be used in the context of personalized medicine to identify non-responders to anti-TNF therapy before the initiation of treatment.	[Lindberg, Johan; Lundeberg, Joakim] Royal Inst Technol, AlbaNova Univ Ctr, Sch Biotechnol, Dept Gene Technol, Stockholm, Sweden; [Wijbrandts, Carla A.; van Baarsen, Lisa G.; Thurlings, Rogier; Vervoordeldonk, Margriet; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Nader, Gustavo; Klareskog, Lars; Catrina, Anca] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Solna, Sweden	Royal Institute of Technology; University of Amsterdam; Academic Medical Center Amsterdam; Karolinska Institutet; Karolinska University Hospital	Lindberg, J (corresponding author), Royal Inst Technol, AlbaNova Univ Ctr, Sch Biotechnol, Dept Gene Technol, Stockholm, Sweden.	P.P.Tak@amc.uva.nl	Lindberg, Johan/F-4104-2011; Nader, Gustavo/E-9161-2013; Thurlings, R.M./L-4689-2015; van Baarsen, Lisa G/N-3646-2015	van Baarsen, Lisa G/0000-0003-3346-8921; Lindberg, Johan/0000-0003-3610-6774; Klareskog, Lars/0000-0001-9601-6186	The Netherlands Organization for Health Research and Development (ZonMw), The Netherlands Organization for Scientific Research (NWO) [945-02-029]; Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association; European Community; Swedish Knowledge Foundation	The Netherlands Organization for Health Research and Development (ZonMw), The Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development); Center for Translational Molecular Medicine (TRACER); Dutch Arthritis Association; European Community(European Commission); Swedish Knowledge Foundation(General Electric)	This study was funded by a Health Care Efficiency Research Programme grant from The Netherlands Organization for Health Research and Development (ZonMw) in assignment of The Netherlands Organization for Scientific Research (NWO) (grant number 945-02-029), the Center for Translational Molecular Medicine (TRACER), the Dutch Arthritis Association, the European Community's FP6 funding (Autocure), and the Swedish Knowledge Foundation through the Industrial PhD program in Medical Bioinformatics at the Centre for Medical Innovations (CMI) at the Karolinska Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badot V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2678; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497; Cantaert T, 2008, J IMMUNOL, V181, P785, DOI 10.4049/jimmunol.181.1.785; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Koczan D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2419; Kraan MC, 2002, ARTHRITIS RHEUM-US, V46, P2034, DOI 10.1002/art.10556; Kraan TCV, 2008, ANN RHEUM DIS, V67, P563, DOI 10.1136/ard.2007.081950; Kraan TCTMV, 2003, ARTHRITIS RHEUM-US, V48, P2132, DOI 10.1002/art.11096; Lequerre T, 2007, RHEUMATOLOGY, V46, P446, DOI 10.1093/rheumatology/kel262; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2090; Lindberg J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1903; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Marotte H, 2005, ARTHRITIS RES THER, V7, pR149, DOI 10.1186/ar1465; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Smolen JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tak PP, 2000, ARTHRITIS RHEUM-US, V43, P2619, DOI 10.1002/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V; Thurlings RM, 2008, ARTHRITIS RHEUM, V58, P1582, DOI 10.1002/art.23505; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulfgren AK, 2000, ARTHRITIS RHEUM, V43, P2391, DOI 10.1002/1529-0131(200011)43:11<2391::AID-ANR3>3.0.CO;2-F; van der Helm-van Mil AHM, 2007, ARTHRITIS RHEUM-US, V56, P1728, DOI 10.1002/art.22716; van Vollenhoven RF, 2003, ARTHRITIS RHEUM, V48, P1500, DOI 10.1002/art.11027; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Wijbrandts CA, 2008, ANN RHEUM DIS, V67, P1139, DOI 10.1136/ard.2007.080440; Wolbink GJ, 2005, ANN RHEUM DIS, V64, P704, DOI 10.1136/ard.2004.030452; Yang YH, 2002, NAT REV GENET, V3, P579, DOI 10.1038/nrg863; [No title captured]; [No title captured]	46	66	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11310	10.1371/journal.pone.0011310	http://dx.doi.org/10.1371/journal.pone.0011310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593016	Green Published, gold, Green Submitted			2022-12-27	WOS:000279140800011
J	Utskarpen, A; Massol, R; van Deurs, B; Lauvrak, SU; Kirchhausen, T; Sandvig, K				Utskarpen, Audrun; Massol, Ramiro; van Deurs, Bo; Lauvrak, Silje Ugland; Kirchhausen, Tomas; Sandvig, Kirsten			Shiga Toxin Increases Formation of Clathrin-Coated Pits through Syk Kinase	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; RETROGRADE TRANSPORT; PLASMA-MEMBRANE; ACTIVATION; RECEPTOR; BINDING; INTERNALIZATION; PROTEIN; CELLS; TRAFFICKING	Clathrin-dependent endocytosis is a main entry mechanism for the glycolipid-binding Shiga toxin (Stx), although clathrin-independent pathways are also involved. Binding of Stx to its receptor Gb3 not only is essential for Stx retrograde transport to the endoplasmic reticulum and toxicity but also activates signaling through the tyrosine kinase Syk. We previously described that Syk activity is important for Stx entry, but it remained unclear how this kinase modulates endocytosis of Stx. Here we characterized the effects of Stx and Syk on clathrin-coated pit formation. We found that acute treatment with Stx results in an increase in the number of clathrin-coated profiles as determined by electron microscopy and on the number of structures containing the endocytic AP-2 adaptor at the plasma membrane determined by live-cell spinning disk confocal imaging. These responses to Stx require functional Syk activity. We propose that a signaling pathway mediated by Syk and modulated by Stx leads to an increased number of endocytic clathrin-coated structures, thus providing a possible mechanism by which Stx enhances its own endocytosis.	[Utskarpen, Audrun; Lauvrak, Silje Ugland; Sandvig, Kirsten] Univ Oslo, Ctr Canc Biomed, Fac Div Norwegian Radium Hosp, Oslo, Norway; [Utskarpen, Audrun; Lauvrak, Silje Ugland; Sandvig, Kirsten] Oslo Univ Hosp, Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Utskarpen, Audrun; Sandvig, Kirsten] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Massol, Ramiro] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Massol, Ramiro] Harvard Univ, Sch Med, Childrens Hospital Boston, Boston, MA 02115 USA; [van Deurs, Bo] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA USA; [Kirchhausen, Tomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	University of Oslo; University of Oslo; University of Oslo; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Copenhagen; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Utskarpen, A (corresponding author), Univ Oslo, Ctr Canc Biomed, Fac Div Norwegian Radium Hosp, Oslo, Norway.	kirchhausen@crystal.harvard.edu; ksandvig@radium.uio.no	Utskarpen, Audrun/GRS-0436-2022		Norwegian Cancer Society; Rikshospitalet University Hospital; Norwegian Research Council; University of Oslo; EMBO (European Molecular Biology Organization); National Institutes of Health [GM075252]; Harvard Digestive Diseases Center National Institutes of Health [P30 DK034854]; Danish Medical Research Council; Danish Cancer Society; NERCE [U54 A1057159]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK084424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	Norwegian Cancer Society(Norwegian Cancer Society); Rikshospitalet University Hospital; Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Oslo; EMBO (European Molecular Biology Organization)(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Cancer Society(Danish Cancer Society); NERCE; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was received from the Norwegian Cancer Society, Rikshospitalet University Hospital, the Norwegian Research Council, and the University of Oslo (AU, KS, SL). AU received an EMBO (European Molecular Biology Organization) short-term fellowship. The work was supported in part by a National Institutes of Health grant GM075252 (TK) and a NERCE grant U54 A1057159 (TK), a grant (P30 DK034854) from the Harvard Digestive Diseases Center National Institutes of Health (RM), and the Danish Medical Research Council and the Danish Cancer Society (BvD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie EC, 2000, J NEUROSCI, V20, P7325; Boucrot E, 2007, P NATL ACAD SCI USA, V104, P7939, DOI 10.1073/pnas.0702511104; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Chakrabandhu K, 2008, CELL DEATH DIFFER, V15, P1824, DOI 10.1038/cdd.2008.115; CONNOLLY JL, 1984, J CELL BIOL, V98, P457, DOI 10.1083/jcb.98.2.457; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Katagiri YU, 1999, J BIOL CHEM, V274, P35278, DOI 10.1074/jbc.274.49.35278; Kirchhausen T, 2009, TRENDS CELL BIOL, V19, P596, DOI 10.1016/j.tcb.2009.09.002; Lau C, 2008, J IMMUNOL, V180, P870, DOI 10.4049/jimmunol.180.2.870; Lauvrak SU, 2006, MOL BIOL CELL, V17, P1096, DOI 10.1091/mbc.E05-08-0766; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; Mori T, 2000, EXP HEMATOL, V28, P1260, DOI 10.1016/S0301-472X(00)00538-5; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; SANDVIG K, 1989, J CELL BIOL, V108, P1331, DOI 10.1083/jcb.108.4.1331; Sandvig K., 2005, COMPREHENSIVE SOURCE, P310; Shimizu T, 2003, BBA-BIOMEMBRANES, V1612, P186, DOI 10.1016/S0005-2736(03)00130-5; Torgersen ML, 2007, J BIOL CHEM, V282, P16317, DOI 10.1074/jbc.M610886200; Torgersen ML, 2005, FEBS J, V272, P4103, DOI 10.1111/j.1742-4658.2005.04835.x; Walchli S, 2008, MOL BIOL CELL, V19, P95, DOI 10.1091/mbc.E07-06-0565; Walchli S, 2009, CELL SIGNAL, V21, P1161, DOI 10.1016/j.cellsig.2009.03.005; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4	28	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2010	5	7							e10944	10.1371/journal.pone.0010944	http://dx.doi.org/10.1371/journal.pone.0010944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631TQ	20668539	Green Submitted, Green Published, gold			2022-12-27	WOS:000280371800001
J	Sznitman, R; Gupta, M; Hager, GD; Arratia, PE; Sznitman, J				Sznitman, Raphael; Gupta, Manaswi; Hager, Gregory D.; Arratia, Paulo E.; Sznitman, Josue			Multi-Environment Model Estimation for Motility Analysis of Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; MACHINE VISION; NEMATODE; BEHAVIOR; TRACKING; SYSTEM; LOCOMOTION; LINEAGE; GENE	The nematode Caenorhabditis elegans is a well-known model organism used to investigate fundamental questions in biology. Motility assays of this small roundworm are designed to study the relationships between genes and behavior. Commonly, motility analysis is used to classify nematode movements and characterize them quantitatively. Over the past years, C. elegans' motility has been studied across a wide range of environments, including crawling on substrates, swimming in fluids, and locomoting through microfluidic substrates. However, each environment often requires customized image processing tools relying on heuristic parameter tuning. In the present study, we propose a novel Multi-Environment Model Estimation (MEME) framework for automated image segmentation that is versatile across various environments. The MEME platform is constructed around the concept of Mixture of Gaussian (MOG) models, where statistical models for both the background environment and the nematode appearance are explicitly learned and used to accurately segment a target nematode. Our method is designed to simplify the burden often imposed on users; here, only a single image which includes a nematode in its environment must be provided for model learning. In addition, our platform enables the extraction of nematode 'skeletons' for straightforward motility quantification. We test our algorithm on various locomotive environments and compare performances with an intensity-based thresholding method. Overall, MEME outperforms the threshold-based approach for the overwhelming majority of cases examined. Ultimately, MEME provides researchers with an attractive platform for C. elegans' segmentation and 'skeletonizing' across a wide range of motility assays.	[Sznitman, Raphael; Gupta, Manaswi; Hager, Gregory D.] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Arratia, Paulo E.] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Sznitman, Josue] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA	Johns Hopkins University; University of Pennsylvania; Princeton University	Sznitman, R (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	sznitman@princeton.edu	Hager, Gregory D/A-3222-2010	Sznitman, Raphael/0000-0001-6791-4753	National Institutes of Health (Bethesda MD, USA); Lewis-Sigler Institute for Integrative Genomics, Princeton U.; Department of Mechanical Engineering and Applied Mechanics, U. of Penn; MRC Lab of Molecular Biology, Cambridge U.	National Institutes of Health (Bethesda MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lewis-Sigler Institute for Integrative Genomics, Princeton U.; Department of Mechanical Engineering and Applied Mechanics, U. of Penn; MRC Lab of Molecular Biology, Cambridge U.	Strains of C. elegans were obtained from the Caenorhabditis elegans Genetic Stock Center (University of Minnesota), supported by the National Institutes of Health (Bethesda MD, USA). The authors would like to thank Dr. R. Ghosh (Lewis-Sigler Institute for Integrative Genomics, Princeton U.), X. Shen (Department of Mechanical Engineering and Applied Mechanics, U. of Penn), and Dr. A. E. X. Brown (MRC Lab of Molecular Biology, Cambridge U.) for their support and helpful discussions.	Baek JH, 2002, J NEUROSCI METH, V118, P9, DOI 10.1016/S0165-0270(02)00117-6; Barrow H. G., 1977, P 5 INT JOINT C ART, P659; Berri S, 2009, HFSP J, V3, P186, DOI 10.2976/1.3082260; Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; BRENNER S, 1974, GENETICS, V77, P71; Buckingham SD, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-84; Buckingham Steven D., 2008, Invertebrate Neuroscience, V8, P121, DOI 10.1007/s10158-008-0077-3; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chamberlain JS, 2000, CURR BIOL, V10, pR795, DOI 10.1016/S0960-9822(00)00768-5; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Cronin CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-5; DUBLINTHALER BJ, 2008, PLOS ONE, V3, pE3735; Feng ZY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-115; FLEURET F, 2005, P ANN C NEUR INF PRO, P371; Gavrila DM, 2007, IEEE T PATTERN ANAL, V29, P1408, DOI 10.1109/TPAMI.2007.1062; Geng W, 2003, GENETICS, V165, P1117; Ghosh R, 2008, J EXP BIOL, V211, P3703, DOI 10.1242/jeb.023606; Hoshi K, 2006, J NEUROSCI METH, V157, P355, DOI 10.1016/j.jneumeth.2006.05.002; Huang KM, 2008, J NEUROSCI METH, V171, P153, DOI 10.1016/j.jneumeth.2008.01.027; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Huang KM, 2009, J SIGNAL PROCESS SYS, V55, P113, DOI 10.1007/s11265-008-0182-x; Isard M, 1998, INT J COMPUT VISION, V29, P5, DOI 10.1023/A:1008078328650; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Karbowski J, 2006, J THEOR BIOL, V242, P652, DOI 10.1016/j.jtbi.2006.04.012; Korta J, 2007, J EXP BIOL, V210, P2383, DOI 10.1242/jeb.004572; LAIRD NM, 1997, J ROY STAT SOC, V39, P1; Li FF, 2006, IEEE T PATTERN ANAL, V28, P594, DOI 10.1109/TPAMI.2006.79; Li K, 2008, MED IMAGE ANAL, V12, P546, DOI 10.1016/j.media.2008.06.001; Link E M, 2000, Pharmacogenomics, V1, P203, DOI 10.1517/14622416.1.2.203; Lockery SR, 2008, J NEUROPHYSIOL, V99, P3136, DOI 10.1152/jn.91327.2007; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Piccardi M, 2004, IEEE SYS MAN CYBERN, P3099, DOI 10.1109/ICSMC.2004.1400815; Pierce-Shimomura JT, 2008, P NATL ACAD SCI USA, V105, P20982, DOI 10.1073/pnas.0810359105; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Qin JH, 2007, LAB CHIP, V7, P186, DOI 10.1039/b613414a; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rankin CH, 2002, NAT REV GENET, V3, P622, DOI 10.1038/nrg864; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Roussel N, 2007, IEEE T BIO-MED ENG, V54, P1786, DOI 10.1109/TBME.2007.894981; Shi WW, 2008, LAB CHIP, V8, P1432, DOI 10.1039/b808753a; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Stauffer C., 1999, Proceedings. 1999 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (Cat. No PR00149), P246, DOI 10.1109/CVPR.1999.784637; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sznitman J, 2010, EXP MECH, V50, P1303, DOI 10.1007/s11340-010-9339-1; Sznitman J, 2010, BIOPHYS J, V98, P617, DOI 10.1016/j.bpj.2009.11.010; SZNITMAN R, 2010, IEEE T PATT IN PRESS, V99; SZNITMAN R, 2009, IEEE 12 INT C COMP V, P1222; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; Tsechpenakis G, 2008, IEEE T BIO-MED ENG, V55, P1539, DOI 10.1109/TBME.2008.918582; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Wei G, 2004, IEEE T BIO-MED ENG, V51, P1811, DOI 10.1109/TBME.2004.831532; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xiong GL, 2006, PATTERN RECOGN LETT, V27, P838, DOI 10.1016/j.patrec.2005.11.015	55	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11631	10.1371/journal.pone.0011631	http://dx.doi.org/10.1371/journal.pone.0011631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661478	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243300002
J	Zhang, QX; Shi, YH; Wada, J; Malakauskas, SM; Liu, MD; Ren, YZ; Du, CY; Duan, HJ; Li, YM; Li, Y; Zhang, YL				Zhang, Qingxian; Shi, Yonghong; Wada, Jun; Malakauskas, Sandra M.; Liu, Maodong; Ren, Yunzhuo; Du, Chunyang; Duan, Huijun; Li, Yingmin; Li, Ying; Zhang, Yanling			In Vivo Delivery of Gremlin siRNA Plasmid Reveals Therapeutic Potential against Diabetic Nephropathy by Recovering Bone Morphogenetic Protein-7	PLOS ONE			English	Article							GROWTH-FACTOR; CELL-PROLIFERATION; ANTAGONIST GREMLIN-1; MESANGIAL CELLS; RENAL FIBROSIS; MESSENGER-RNA; HIGH GLUCOSE; EXPRESSION; KIDNEY; MODEL	Diabetic nephropathy is a complex and poorly understood disease process, and our current treatment options are limited. It remains critical, then, to identify novel therapeutic targets. Recently, a developmental protein and one of the bone morphogenetic protein antagonists, Gremlin, has emerged as a novel modulator of diabetic nephropathy. The high expression and strong co-localization with transforming growth factor-beta 1 in diabetic kidneys suggests a role for Gremlin in the pathogenesis of diabetic nephropathy. We have constructed a gremlin siRNA plasmid and have examined the effect of Gremlin inhibition on the progression of diabetic nephropathy in a mouse model. CD-1 mice underwent uninephrectomy and STZ treatment prior to receiving weekly injections of the plasmid. Inhibition of Gremlin alleviated proteinuria and renal collagen IV accumulation 12 weeks after the STZ injection and inhibited renal cell proliferation and apoptosis. In vitro experiments, using mouse mesangial cells, revealed that the transfect ion of gremlin siRNA plasmid reversed high glucose induced abnormalities, such as increased cell proliferation and apoptosis and increased collagen IV production. The decreased matrix metalloprotease level was partially normalized by transfection with gremlin siRNA plasmid. Additionally, we observed recovery of bone morphogenetic protein-7 signaling activity, evidenced by increases in phosphorylated Smad 5 protein levels. We conclude that inhibition of Gremlin exerts beneficial effects on the diabetic kidney mainly through maintenance of BMP-7 activity and that Gremlin may serve as a novel therapeutic target in the management of diabetic nephropathy.	[Zhang, Qingxian; Liu, Maodong; Li, Ying; Zhang, Yanling] Hebei Med Univ, Dept Nephrol, Third Hosp, Shijiazhuang, Peoples R China; [Shi, Yonghong; Ren, Yunzhuo; Du, Chunyang; Duan, Huijun; Li, Yingmin] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Wada, Jun] Okayama Univ, Grad Sch Med, Dept Med & Clin Sci, Okayama, Japan; [Malakauskas, Sandra M.] Univ Alabama, Div Nephrol, Birmingham, AL USA	Hebei Medical University; Hebei Medical University; Okayama University; University of Alabama System; University of Alabama Birmingham	Zhang, QX (corresponding author), Hebei Med Univ, Dept Nephrol, Third Hosp, Shijiazhuang, Peoples R China.	zhang2199@126.com	WADA, Jun/B-2023-2011	WADA, Jun/0000-0003-1468-5170	Scientific Research Foundation for Returned Scholars, Ministry of Education of China [2008139]; Natural Science Foundation of Hebei Province [C20080000940]; Science and Technology Commission Foundation of Hebei Province [072761229]; Health Commission of Hebei Province [08007]; Natural Science Foundation of China [30940035]; Science Fund for Distinguished Young Scholars of Hebei Province	Scientific Research Foundation for Returned Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China); Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province); Science and Technology Commission Foundation of Hebei Province; Health Commission of Hebei Province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Distinguished Young Scholars of Hebei Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the Scientific Research Foundation for Returned Scholars, Ministry of Education of China (No. 2008139; http://www.moe.edu.cn/), the Natural Science Foundation of Hebei Province (No. C20080000940; www.hensf.gov.cn), a grant from the Key Applied Basic Research Programs of Science and Technology Commission Foundation of Hebei Province (No. 072761229; www.heinfo.gov.cn), the Health Commission of Hebei Province (No. 08007; www.hebwst.gov.cn), the Natural Science Foundation of China (No. 30940035, www.nsfc.gov.cn), and the Science Fund for Distinguished Young Scholars of Hebei Province (www.hee.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bani-Hani AH, 2008, J UROLOGY, V180, P461, DOI 10.1016/j.juro.2008.04.001; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Chen B, 2002, BIOCHEM BIOPH RES CO, V295, P1135, DOI 10.1016/S0006-291X(02)00828-8; Dolan V, 2005, AM J KIDNEY DIS, V45, P1034, DOI 10.1053/j.ajkd.2005.03.014; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Fioretto P, 2006, KIDNEY INT, V69, P907, DOI 10.1038/sj.ki.5000153; Fioretto P, 1998, CURR OPIN NEPHROL HY, V7, P489, DOI 10.1097/00041552-199809000-00001; Griffith DL, 1996, P NATL ACAD SCI USA, V93, P878, DOI 10.1073/pnas.93.2.878; HELDER MN, 1995, J HISTOCHEM CYTOCHEM, V43, P1035, DOI 10.1177/43.10.7560881; Hensey C, 2002, NEPHROL DIAL TRANSPL, V17, P73, DOI 10.1093/ndt/17.suppl_9.73; Hruska KA, 2000, AM J PHYSIOL-RENAL, V279, pF130, DOI 10.1152/ajprenal.2000.279.1.F130; Kitten AM, 1999, J CELL PHYSIOL, V181, P410, DOI 10.1002/(SICI)1097-4652(199912)181:3<410::AID-JCP4>3.0.CO;2-H; Lappin DWP, 2002, NEPHROL DIAL TRANSPL, V17, P65, DOI 10.1093/ndt/17.suppl_9.65; Maciel TT, 2008, J MOL CELL CARDIOL, V44, P370, DOI 10.1016/j.yjmcc.2007.10.021; Marchant Karen, 2008, Br J Nurs, V17, P356; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; McMahon R, 2000, J BIOL CHEM, V275, P9901, DOI 10.1074/jbc.275.14.9901; Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861; Morrissey J, 2002, J AM SOC NEPHROL, V13, pS14; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Nishimura R, 2003, FRONT BIOSCI, V8, pS275, DOI 10.2741/1049; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Otani H, 2007, AM J PHYSIOL-RENAL, V292, pF1513, DOI 10.1152/ajprenal.00402.2006; OZKAYNAK E, 1991, BIOCHEM BIOPH RES CO, V179, P116, DOI 10.1016/0006-291X(91)91342-A; Pavel E, 2007, INT J DEV BIOL, V51, P273, DOI 10.1387/ijdb.062249ep; Petrovic MG, 2008, MOL VIS, V14, P1382; Preisig P, 1999, KIDNEY INT, V56, P1193, DOI 10.1046/j.1523-1755.1999.00708.x; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; *US REN DAT SYST, 1999, AM J KIDNEY DIS S, V34, pS1; VUKICEVIC S, 1994, BIOCHEM BIOPH RES CO, V198, P693, DOI 10.1006/bbrc.1994.1100; Vukicevic S, 1996, P NATL ACAD SCI USA, V93, P9021, DOI 10.1073/pnas.93.17.9021; Wang S, 2003, KIDNEY INT, V63, P2037, DOI 10.1046/j.1523-1755.2003.00035.x; Wang SN, 2006, J AM SOC NEPHROL, V17, P2504, DOI 10.1681/ASN.2006030278; Wang SN, 2003, AM J PHYSIOL-RENAL, V284, pF1006, DOI 10.1152/ajprenal.00382.2002	36	43	51	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11709	10.1371/journal.pone.0011709	http://dx.doi.org/10.1371/journal.pone.0011709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661431	gold, Green Published, Green Submitted			2022-12-27	WOS:000280243300013
J	Chaminade, T; Zecca, M; Blakemore, SJ; Takanishi, A; Frith, CD; Micera, S; Dario, P; Rizzolatti, G; Gallese, V; Umilta, MA				Chaminade, Thierry; Zecca, Massimiliano; Blakemore, Sarah-Jayne; Takanishi, Atsuo; Frith, Chris D.; Micera, Silvestro; Dario, Paolo; Rizzolatti, Giacomo; Gallese, Vittorio; Umilta, Maria Alessandra			Brain Response to a Humanoid Robot in Areas Implicated in the Perception of Human Emotional Gestures	PLOS ONE			English	Article							PROBABILISTIC CYTOARCHITECTONIC MAPS; HUMAN PREMOTOR CORTEX; MIRROR-NEURON SYSTEM; FUSIFORM FACE AREA; BIOLOGICAL MOTION; ACTION REPRESENTATION; SPEECH-PERCEPTION; RECOGNITION; MOTOR; IMITATION	Background: The humanoid robot WE4-RII was designed to express human emotions in order to improve human-robot interaction. We can read the emotions depicted in its gestures, yet might utilize different neural processes than those used for reading the emotions in human agents. Methodology: Here, fMRI was used to assess how brain areas activated by the perception of human basic emotions (facial expression of Anger, Joy, Disgust) and silent speech respond to a humanoid robot impersonating the same emotions, while participants were instructed to attend either to the emotion or to the motion depicted. Principal Findings: Increased responses to robot compared to human stimuli in the occipital and posterior temporal cortices suggest additional visual processing when perceiving a mechanical anthropomorphic agent. In contrast, activity in cortical areas endowed with mirror properties, like left Broca's area for the perception of speech, and in the processing of emotions like the left anterior insula for the perception of disgust and the orbitofrontal cortex for the perception of anger, is reduced for robot stimuli, suggesting lesser resonance with the mechanical agent. Finally, instructions to explicitly attend to the emotion significantly increased response to robot, but not human facial expressions in the anterior part of the left inferior frontal gyrus, a neural marker of motor resonance. Conclusions: Motor resonance towards a humanoid robot, but not a human, display of facial emotion is increased when attention is directed towards judging emotions. Significance: Artificial agents can be used to assess how factors like anthropomorphism affect neural response to the perception of human actions.	[Chaminade, Thierry; Frith, Chris D.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Chaminade, Thierry] Aix Marseille Univ, CNRS, Mediterranean Inst Cognit Neurosci INCM, Marseille, France; [Zecca, Massimiliano; Takanishi, Atsuo] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care ASMeW, Inst Biomed Engn, Tokyo, Japan; [Zecca, Massimiliano; Takanishi, Atsuo] Waseda Univ, HRI, Tokyo, Japan; [Zecca, Massimiliano; Takanishi, Atsuo; Micera, Silvestro; Dario, Paolo] Italy Japan Joint Lab Humanoid & Personal Robot R, Tokyo, Japan; [Blakemore, Sarah-Jayne] UCL, Inst Cognit Neurosci, London, England; [Takanishi, Atsuo] Waseda Univ, Dept Modern Mech Engn, Tokyo, Japan; [Frith, Chris D.] Aarhus Univ Hosp, CFIN, Aarhus, Denmark; [Micera, Silvestro; Dario, Paolo] Scuola Super Sant Anna, ARTS Lab, Pisa, Italy; [Micera, Silvestro] Swiss Fed Inst Technol Zurich ETHZ, Inst Automat, Neuroprosthesis Control Grp, Zurich, Switzerland; [Rizzolatti, Giacomo; Gallese, Vittorio; Umilta, Maria Alessandra] Univ Parma, Dipartimento Neurosci, Sez Fisiol, I-43100 Parma, Italy; [Rizzolatti, Giacomo; Gallese, Vittorio; Umilta, Maria Alessandra] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Waseda University; Waseda University; University of London; University College London; Waseda University; Aarhus University; Scuola Superiore Sant'Anna; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Parma; Istituto Italiano di Tecnologia - IIT	Chaminade, T (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.	tchamina@gmail.com	Frith, Chris D/A-2171-2009; Micera, Silvestro/AAD-6630-2021; Chaminade, Thierry/F-8367-2010; Chaminade, Thierry/AAF-6072-2020; Zecca, Massimiliano/G-5773-2013; Gallese, Vittorio/ABD-5097-2021; Blakemore, Sarah-Jayne/A-1792-2010	Frith, Chris D/0000-0002-8665-0690; Chaminade, Thierry/0000-0003-4952-1467; Chaminade, Thierry/0000-0003-4952-1467; Zecca, Massimiliano/0000-0003-4741-4334; Gallese, Vittorio/0000-0003-4815-3607; Lauwereyns, Jan/0000-0003-0551-2550; Blakemore, Sarah-Jayne/0000-0002-1690-2805; Umilta', Maria Alessandra/0000-0003-0180-6818	Wellcome Trust; ANR [ANR-09-BLAN-0405-02]; Royal Society; Danish National Research Foundation; European Union; ASMeW [11]; JSPS [19700389]; Gifu Prefecture; Waseda University [266740]	Wellcome Trust(Wellcome Trust); ANR(French National Research Agency (ANR)); Royal Society(Royal Society of London); Danish National Research Foundation(Danmarks Grundforskningsfond); European Union(European Commission); ASMeW; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Gifu Prefecture; Waseda University	TC was supported by a Wellcome Trust post-doctoral fellowship and an ANR grant (SCAD # ANR-09-BLAN-0405-02). SJB is supported by a Royal Society Research Fellowship. CDF is supported by the Wellcome Trust and the Danish National Research Foundation. PD, VG, SM, GR, MAU, and MZ were supported by the European Union grant NEUROBOTICS. VG was also supported by the EU grants NESTCOM and DISCOS. MZ was partially supported by the ASMeW Priority Research C Grant # 11, and by the JSPS Grant-in-aid for Scientific Research # 19700389. Partial support was provided by a Grant-in-Aid for the WABOT-HOUSE Project by Gifu Prefecture and by Waseda University Grant for Special Research Projects (No. 266740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Arbib MA, 2004, TRENDS COGN SCI, V8, P554, DOI 10.1016/j.tics.2004.10.004; Barnikol UB, 2006, NEUROIMAGE, V31, P86, DOI 10.1016/j.neuroimage.2005.11.045; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Blakemore SJ, 2005, BRAIN, V128, P1571, DOI 10.1093/brain/awh500; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Chaminade T, 2001, BEHAV BRAIN SCI, V24, P879, DOI 10.1017/S0140525X01230106; CHAMINADE T, 2006, ACQUIRING PROBING SE; Chaminade T, 2007, SOC COGN AFFECT NEUR, V2, P206, DOI 10.1093/scan/nsm017; Chao LL, 1999, NEUROREPORT, V10, P2945, DOI 10.1097/00001756-199909290-00013; Cohen L, 2008, NEUROIMAGE, V40, P353, DOI 10.1016/j.neuroimage.2007.11.036; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; DISALVO C, 2002, P C DES INT SYST PRO; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; DUCHAINE B, 2008, SENSES COMPREHENSIVE, P329; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Ebisch SJH, 2008, J COGNITIVE NEUROSCI, V20, P1611, DOI 10.1162/jocn.2008.20111; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ekman P., 2002, FACIAL ACTION CODING; Epley N, 2007, PSYCHOL REV, V114, P864, DOI 10.1037/0033-295X.114.4.864; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Friston K, STAT PARAMETRIC MAPP; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 2008, NEURON, V60, P503, DOI 10.1016/j.neuron.2008.10.032; Fujita M, 2004, P IEEE, V92, P1804, DOI 10.1109/JPROC.2004.835364; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; GATES B, 2007, SCI AM, V1, P58; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Goldstein RZ, 2001, NEUROREPORT, V12, P2595, DOI 10.1097/00001756-200108080-00060; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; HIGUCHI S, 2009, NEUROREPORT; HIRAI K, 1998, DEV HONDA HUMANOID R, P1321; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Ishiguro H, 2007, J ARTIF ORGANS, V10, P133, DOI 10.1007/s10047-007-0381-4; ITOH K, 2005, BEHAV MODEL HUMANOID, P220; ITOH K, 2004, VARIOUS EMOTIONAL EX, P35; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; JOVICICH J, 2000, HUMAN PERCEPTION FAC; KANEKO K, 2004, HUMANOID ROBOT HRP, V2, P1083; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; *KOK CO LTD, 2004, ACTR; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Kozima H, 2007, PROG BRAIN RES, V164, P385, DOI 10.1016/S0079-6123(07)64021-7; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Malikovic A, 2007, CEREB CORTEX, V17, P562, DOI 10.1093/cercor/bhj181; MORTON J, 1991, PSYCHOL REV, V98, P164, DOI 10.1037/0033-295X.98.2.164; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; *OECD, 2004, POP STAT; Oztop E., 2005, P 4 IEEE RAS INT C H, V2, P537, DOI [10.1142/S0219843605000582, DOI 10.1142/S0219843605000582]; Peeters R, 2009, J NEUROSCI, V29, P11523, DOI 10.1523/JNEUROSCI.2040-09.2009; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Pinker S., 1997, MIND WORKS, VXII; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Puce A, 1996, J NEUROSCI, V16, P5205; RHODES G, 1990, PERCEPTION, V19, P773, DOI 10.1068/p190773; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2006, SCI AM, V295, P54, DOI 10.1038/scientificamerican1106-54; Santi A, 2003, J COGNITIVE NEUROSCI, V15, P800, DOI 10.1162/089892903322370726; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; WADA K, PSYCHOL SOCIAL EFFEC, P2785; Weismann August, 1906, Archiv Rassenbiol Berlin, V3; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wright P, 2008, NEUROIMAGE, V39, P894, DOI 10.1016/j.neuroimage.2007.09.014; ZECCA M, 2007, EMOTIONAL EXPRESSION	87	74	74	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11577	10.1371/journal.pone.0011577	http://dx.doi.org/10.1371/journal.pone.0011577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657777	Green Submitted, Green Published, gold			2022-12-27	WOS:000280197500005
J	Habchi, J; Mamelli, L; Darbon, H; Longhi, S				Habchi, Johnny; Mamelli, Laurent; Darbon, Herve; Longhi, Sonia			Structural Disorder within Henipavirus Nucleoprotein and Phosphoprotein: From Predictions to Experimental Assessment	PLOS ONE			English	Article							MEASLES-VIRUS NUCLEOPROTEIN; C-TERMINAL DOMAIN; INTRINSICALLY UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION FEATURES; NUCLEOCAPSID-BINDING DOMAIN; NATIVELY UNFOLDED PROTEINS; HENDRA-VIRUS; P-PROTEINS; V-PROTEIN; CRYSTAL-STRUCTURE	Henipaviruses are newly emerged viruses within the Paramyxoviridae family. Their negative-strand RNA genome is packaged by the nucleoprotein (N) within alpha-helical nucleocapsid that recruits the polymerase complex made of the L protein and the phosphoprotein (P). To date structural data on Henipaviruses are scarce, and their N and P proteins have never been characterized so far. Using both computational and experimental approaches we herein show that Henipaviruses N and P proteins possess large intrinsically disordered regions. By combining several disorder prediction methods, we show that the N-terminal domain of P (PNT) and the C-terminal domain of N (N-TAIL) are both mostly disordered, although they contain short order-prone segments. We then report the cloning, the bacterial expression, purification and characterization of Henipavirus PNT and N-TAIL domains. By combining gel filtration, dynamic light scattering, circular dichroism and nuclear magnetic resonance, we show that both N-TAIL and PNT belong to the premolten globule sub-family within the class of intrinsically disordered proteins. This study is the first reported experimental characterization of Henipavirus P and N proteins. The evidence that their respective N-terminal and C-terminal domains are highly disordered under native conditions is expected to be invaluable for future structural studies by helping to delineate N and P protein domains amenable to crystallization. In addition, following previous hints establishing a relationship between structural disorder and protein interactivity, the present results suggest that Henipavirus PNT and N-TAIL domains could be involved in manifold protein-protein interactions.	[Habchi, Johnny] CNRS, UMR 6098, Marseille, France; Univ Aix Marseille 1, Marseille, France; Univ Aix Marseille 2, F-13284 Marseille 07, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Habchi, J (corresponding author), CNRS, UMR 6098, Campus Luminy, Marseille, France.	Sonia.Longhi@afmb.univ-mrs.fr	LONGHI, Sonia/M-5305-2014	LONGHI, Sonia/0000-0002-6829-6771	Agence Nationale de la Recherche [ANR-08-PCVI-0020-01]; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was carried out with the financial support of the Agence Nationale de la Recherche, specific program "Physico-Chimie du Vivant'', ANR-08-PCVI-0020-01. LM was supported by a post-doctoral fellowship by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belle V, 2008, PROTEINS, V73, P973, DOI 10.1002/prot.22125; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Bhella D, 2004, J MOL BIOL, V340, P319, DOI 10.1016/j.jmb.2004.05.015; Bhella D, 2002, J GEN VIROL, V83, P1831, DOI 10.1099/0022-1317-83-8-1831; BHELLA D, 2007, MEASLES VIRUS NUCLOP; Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029; Bodart JF, 2008, J MAGN RESON, V192, P252, DOI 10.1016/j.jmr.2008.03.006; Boumlic A, 2010, FEBS J, V277, P774, DOI 10.1111/j.1742-4658.2009.07527.x; Bourhis J.-M., 2005, Virologie (Montrouge), V9, P367, DOI 10.1684/vir.2011.2399; Bourhis J.M., 2007, MEASLES VIRUS NUCLEO, P1; Bourhis JM, 2007, CURR PROTEIN PEPT SC, V8, P135, DOI 10.2174/138920307780363451; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; Bourhis JM, 2005, PROTEIN SCI, V14, P1975, DOI 10.1110/ps.051411805; BOWDEN TA, 2010, ARCHITECTURE HENDRA; Bowden TA, 2008, NAT STRUCT MOL BIOL, V15, P567, DOI 10.1038/nsmb.1435; Bowden TA, 2008, J VIROL, V82, P11628, DOI 10.1128/JVI.01344-08; Brocca S, 2009, PROTEINS, V76, P731, DOI 10.1002/prot.22385; Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Chandonia JM, 1999, PROTEINS, V35, P293; Chen A, 2003, VIRUS RES, V98, P123, DOI 10.1016/j.virusres.2003.09.003; Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005; CHINCHAR VG, 1981, VIROLOGY, V109, P59, DOI 10.1016/0042-6822(81)90471-2; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Colombo M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-59; COUTURIER M, 2009, J MOL RECOG IN PRESS; Csizmok V, 2006, MOL CELL PROTEOMICS, V5, P265, DOI 10.1074/mcp.M500181-MCP200; CURRAN J, 1995, J VIROL, V69, P849, DOI 10.1128/JVI.69.2.849-855.1995; CURRAN J, 1994, VIROLOGY, V202, P875, DOI 10.1006/viro.1994.1409; DahlmanWright K, 1996, BIOCHEMISTRY-US, V35, P1323, DOI 10.1021/bi952409k; De BP, 1999, MICROSC RES TECHNIQ, V47, P114, DOI 10.1002/(SICI)1097-0029(19991015)47:2<114::AID-JEMT4>3.3.CO;2-5; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; DESHPANDE KL, 1985, VIROLOGY, V140, P125, DOI 10.1016/0042-6822(85)90451-9; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2007, CURR PROTEIN PEPT SC, V8, P161, DOI 10.2174/138920307780363406; Drexler JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006367; Dunker AK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S1; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; DUNKER AK, 1998, PAC S BIOCOMP, V3, P473; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eaton BT, 2006, NAT REV MICROBIOL, V4, P23, DOI 10.1038/nrmicro1323; Eaton BT, 2007, FIELDS VIROLOGY, P1587; Ferron F, 2005, J GEN VIROL, V86, P743, DOI 10.1099/vir.0.80590-0; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Fontana A, 1997, FOLD DES, V2, pR17, DOI 10.1016/S1359-0278(97)00010-2; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; GELY S, 2010, J MOL RECOG IN PRESS; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; HE B, 2009, CELL RES; Houben K, 2007, BIOPHYS J, V93, P2830, DOI 10.1529/biophysj.107.108829; Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Hubbard SJ, 1998, BBA-PROTEIN STRUCT M, V1382, P191, DOI 10.1016/S0167-4838(97)00175-1; Hwang TL, 1998, J MAGN RESON, V135, P280, DOI 10.1006/jmre.1998.1598; IWASAKI M, 2009, J VIROL; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Jordan IK, 2000, MOL BIOL EVOL, V17, P75, DOI 10.1093/oxfordjournals.molbev.a026240; Karlin D, 2003, J GEN VIROL, V84, P3239, DOI 10.1099/vir.0.19451-0; Karlin D, 2002, VIROLOGY, V302, P420, DOI 10.1006/viro.2002.1634; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Kavalenka A, 2010, BIOPHYS J, V98, P1055, DOI 10.1016/j.bpj.2009.11.036; KAWAHARA K, 1966, J BIOL CHEM, V241, P3228; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kingston RL, 2008, J MOL BIOL, V379, P719, DOI 10.1016/j.jmb.2007.12.080; Kovacs E, 2010, P NATL ACAD SCI USA, V107, P5429, DOI 10.1073/pnas.0907841107; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Laine D, 2003, J VIROL, V77, P11332, DOI 10.1128/JVI.77.21.11332-11346.2003; Laine D, 2005, J GEN VIROL, V86, P1771, DOI 10.1099/vir.0.80791-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; LISTON P, 1995, VIRUS RES, V38, P241, DOI 10.1016/0168-1702(95)00067-Z; Liu JF, 2002, J MOL BIOL, V322, P53, DOI 10.1016/S0022-2836(02)00736-2; Longhi S, 2003, J BIOL CHEM, V278, P18638, DOI 10.1074/jbc.M300518200; Longhi S, 2009, CURR TOP MICROBIOL, V329, P103; Lou ZY, 2006, FEBS J, V273, P4538, DOI 10.1111/j.1742-4658.2006.05459.x; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morin B, 2006, J PHYS CHEM B, V110, P20596, DOI 10.1021/jp063708u; MOYER SA, 1990, J GEN VIROL, V71, P775, DOI 10.1099/0022-1317-71-4-775; Narechania A, 2005, J GEN VIROL, V86, P1307, DOI 10.1099/vir.0.80747-0; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; RANCUREL C, 2009, J VIROL; Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Sato H, 2006, VIROLOGY, V352, P121, DOI 10.1016/j.virol.2006.04.013; Schoehn G, 2004, J MOL BIOL, V339, P301, DOI 10.1016/j.jmb.2004.03.073; Sivakolundu SG, 2005, J MOL BIOL, V353, P1118, DOI 10.1016/j.jmb.2005.08.074; Sleeman K, 2008, J GEN VIROL, V89, P1300, DOI 10.1099/vir.0.83582-0; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Tarbouriech N, 2000, VIROLOGY, V266, P99, DOI 10.1006/viro.1999.0066; Tell G, 1998, BIOCHEM J, V329, P395, DOI 10.1042/bj3290395; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky V. N., 2002, J BIOL CHEM, V25, P25; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Uversky VN, 2003, CELL MOL LIFE SCI, V60, P1852, DOI 10.1007/s00018-003-3096-6; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; UVERSKY VN, 2010, INSTRUMENTAL ANAL IN, P525; Vacic V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-211; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VANHOY M, 1993, CELL, V72, P587, DOI 10.1016/0092-8674(93)90077-4; Wang LF, 2000, J VIROL, V74, P9972, DOI 10.1128/JVI.74.21.9972-9979.2000; Watanabe N, 1996, MED MICROBIOL IMMUN, V185, P89, DOI 10.1007/s004300050019; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; WU J, 1992, ANAL BIOCHEM, V200, P359, DOI 10.1016/0003-2697(92)90479-Q; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang XS, 2005, VIROLOGY, V337, P162, DOI 10.1016/j.virol.2005.03.035; Zhang XS, 2002, J VIROL, V76, P8737, DOI 10.1128/JVI.76.17.8737-8746.2002	138	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11684	10.1371/journal.pone.0011684	http://dx.doi.org/10.1371/journal.pone.0011684			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657787	gold, Green Published, Green Submitted			2022-12-27	WOS:000280197500024
J	Steer, B; Adler, B; Jonjic, S; Stewart, JP; Adler, H				Steer, Beatrix; Adler, Barbara; Jonjic, Stipan; Stewart, James P.; Adler, Heiko			A Gammaherpesvirus Complement Regulatory Protein Promotes Initiation of Infection by Activation of Protein Kinase Akt/PKB	PLOS ONE			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; BACTERIAL ARTIFICIAL CHROMOSOME; FOCAL ADHESION KINASE; EPSTEIN-BARR VIRUS; PHOSPHATIDYLINOSITOL 3-KINASE; MONOCLONAL-ANTIBODIES; MICROTUBULE DYNAMICS; SIGNAL-TRANSDUCTION; PSEUDORABIES VIRUS; IMMUNE EVASION	Background: Viruses have evolved to evade the host's complement system. The open reading frames 4 (ORF4) of gammaherpesviruses encode homologs of regulators of complement activation (RCA) proteins, which inhibit complement activation at the level of C3 and C4 deposition. Besides complement regulation, these proteins are involved in heparan sulfate and glycosaminoglycan binding, and in case of MHV-68, also in viral DNA synthesis in macrophages. Methodology/Principal Findings: Here, we made use of MHV-68 to study the role of ORF4 during infection of fibroblasts. While attachment and penetration of virions lacking the RCA protein were not affected, we observed a delayed delivery of the viral genome to the nucleus of infected cells. Analysis of the phosphorylation status of a variety of kinases revealed a significant reduction in phosphorylation of the protein kinase Akt in cells infected with ORF4 mutant virus, when compared to cells infected with wt virus. Consistent with a role of Akt activation in initial stages of infection, inhibition of Akt signaling in wt virus infected cells resulted in a phenotype resembling the phenotype of the ORF4 mutant virus, and activation of Akt by addition of insulin partially reversed the phenotype of the ORF4 mutant virus. Importantly, the homologous ORF4 of KSHV was able to rescue the phenotype of the MHV-68 ORF4 mutant, indicating that ORF4 is functionally conserved and that ORF4 of KSHV might have a similar function in infection initiation. Conclusions/Significance: In summary, our studies demonstrate that ORF4 contributes to efficient infection by activation of the protein kinase Akt and thus reveal a novel function of a gammaherpesvirus RCA protein.	[Steer, Beatrix; Adler, Heiko] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Hematopoiet Cell Transplantat, Inst Mol Immunol, Munich, Germany; [Adler, Barbara] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Jonjic, Stipan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia; [Stewart, James P.] Univ Liverpool, Dept Med Microbiol, Ctr Comparat Infect Dis, Liverpool L69 3BX, Merseyside, England	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Rijeka; University of Liverpool	Steer, B (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Hematopoiet Cell Transplantat, Inst Mol Immunol, Munich, Germany.	h.adler@helmholtz-muenchen.de	Adler, Heiko/M-7355-2014; Stewart, James/A-6034-2012; Jonjic, Stipan/C-5657-2016	Adler, Heiko/0000-0002-6481-6709; Stewart, James/0000-0002-8928-2037; Jonjic, Stipan/0000-0001-5003-3108	Deutsche Forschungsgemeinschaft (DFG) [Ad 121/2-1, 2-4]; Bundesministerium fuer Bildung und Forschung (BMBF); Nationales Genomforschungsnetz [FKZ 01GS0802]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fuer Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Nationales Genomforschungsnetz	This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG), Ad 121/2-1 to 2-4, and from the Bundesministerium fuer Bildung und Forschung (BMBF), Nationales Genomforschungsnetz (NGFNplus, FKZ 01GS0802), to H.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2000, J VIROL, V74, P6964, DOI 10.1128/JVI.74.15.6964-6974.2000; Akula SM, 2003, J VIROL, V77, P7978, DOI 10.1128/JVI.77.14.7978-7990.2003; ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; Alcami A, 2000, IMMUNOL TODAY, V21, P447, DOI 10.1016/S0167-5699(00)01699-6; BLASKOVIC D, 1980, ACTA VIROL, V24, P468; Blue CE, 2004, VIROLOGY, V319, P176, DOI 10.1016/j.virol.2003.11.029; Borst EM, 1999, J VIROL, V73, P8320, DOI 10.1128/JVI.73.10.8320-8329.1999; COOPER NR, 1991, IMMUNOL TODAY, V12, P327, DOI 10.1016/0167-5699(91)90010-Q; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; Covarrubias S, 2009, J VIROL, V83, P9554, DOI 10.1128/JVI.01051-09; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; FODOR WL, 1995, J VIROL, V69, P3889, DOI 10.1128/JVI.69.6.3889-3892.1995; Gill MB, 2006, J GEN VIROL, V87, P1465, DOI 10.1099/vir.0.81760-0; Gillet L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000347; Gillet L, 2006, J GEN VIROL, V87, P3515, DOI 10.1099/vir.0.82313-0; Gillet L, 2009, J GEN VIROL, V90, P602, DOI 10.1099/vir.0.005785-0; Gillet L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001669; HARRIS SL, 1990, J INFECT DIS, V162, P331, DOI 10.1093/infdis/162.2.331; Johnson RA, 2001, J VIROL, V75, P6022, DOI 10.1128/JVI.75.13.6022-6032.2001; Kapadia SB, 2002, IMMUNITY, V17, P143, DOI 10.1016/S1074-7613(02)00369-2; Kapadia SB, 1999, J VIROL, V73, P7658, DOI 10.1128/JVI.73.9.7658-7670.1999; KARGER A, 1993, VIROLOGY, V194, P654, DOI 10.1006/viro.1993.1305; Klupp BG, 1998, J VIROL, V72, P1949, DOI 10.1128/JVI.72.3.1949-1958.1998; Kotwal GJ, 2000, IMMUNOL TODAY, V21, P242, DOI 10.1016/S0167-5699(00)01606-6; Krishnan HH, 2006, J VIROL, V80, P1167, DOI 10.1128/JVI.80.3.1167-1180.2006; Lachmann PJ, 1997, IMMUNOL REV, V159, P69, DOI 10.1111/j.1600-065X.1997.tb01007.x; Laquerre S, 1998, J VIROL, V72, P6119, DOI 10.1128/JVI.72.7.6119-6130.1998; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mark L, 2006, MOL IMMUNOL, V43, P1665, DOI 10.1016/j.molimm.2005.09.016; Mark L, 2007, MOL IMMUNOL, V44, P11, DOI 10.1016/j.molimm.2006.06.018; Mark L, 2007, J VIROL, V81, P4166, DOI 10.1128/JVI.02069-06; Mathew E, 1998, J VIROL, V72, P2429, DOI 10.1128/JVI.72.3.2429-2438.1998; MCNEARNEY TA, 1987, J EXP MED, V166, P1525, DOI 10.1084/jem.166.5.1525; McPherson PS, 2001, TRAFFIC, V2, P375, DOI 10.1034/j.1600-0854.2001.002006375.x; Messerle M, 1997, P NATL ACAD SCI USA, V94, P14759, DOI 10.1073/pnas.94.26.14759; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; MILLER N, 1988, J VIROL, V62, P2366, DOI 10.1128/JVI.62.7.2366-2372.1988; Mullick J, 2003, J VIROL, V77, P3878, DOI 10.1128/JVI.77.6.3878-3881.2003; Nakano MY, 2000, J VIROL, V74, P7085, DOI 10.1128/JVI.74.15.7085-7095.2000; Naranatt PP, 2003, J VIROL, V77, P1524, DOI 10.1128/JVI.77.2.1524-1539.2003; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; NEMEROW GR, 1989, CELL, V56, P369, DOI 10.1016/0092-8674(89)90240-7; Okamura H, 2007, CELL BIOL INT, V31, P119, DOI 10.1016/j.cellbi.2006.09.014; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Peng L, 2010, J GEN VIROL, V91, P463, DOI 10.1099/vir.0.015073-0; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Raghu H, 2007, J VIROL, V81, P7941, DOI 10.1128/JVI.02848-06; ROIZMAN B, 1985, VIROLOGY, P69; ROTHER RP, 1994, J VIROL, V68, P730, DOI 10.1128/JVI.68.2.730-737.1994; Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sahu A, 1998, IMMUNOL RES, V17, P109, DOI 10.1007/BF02786436; Sanlioglu S, 2000, J VIROL, V74, P9184, DOI 10.1128/JVI.74.19.9184-9196.2000; SHAMAWALIA N, 2005, J VIROL, V79, P10308; Sharma-Walia N, 2004, J VIROL, V78, P4207, DOI 10.1128/JVI.78.8.4207-4223.2004; Sieczkarski SB, 2005, CURR TOP MICROBIOL, V285, P1; Singh AK, 2006, J BIOL CHEM, V281, P23119, DOI 10.1074/jbc.M603085200; Spiller OB, 2006, J VIROL, V80, P4068, DOI 10.1128/JVI.80.8.4068-4078.2006; Spiller OB, 2003, J VIROL, V77, P592, DOI 10.1128/JVI.77.1.592-599.2003; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Tarakanova VL, 2010, VIROLOGY, V396, P323, DOI 10.1016/j.virol.2009.10.030; Tomlinson CC, 2004, J VIROL, V78, P1918, DOI 10.1128/JVI.78.4.1918-1927.2004; Tomlinson CC, 2008, J VIROL, V82, P6514, DOI 10.1128/JVI.02637-07; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Wu TT, 2000, J VIROL, V74, P3659, DOI 10.1128/JVI.74.8.3659-3667.2000; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	69	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11672	10.1371/journal.pone.0011672	http://dx.doi.org/10.1371/journal.pone.0011672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657771	Green Submitted, Green Published, gold			2022-12-27	WOS:000280197500017
J	Andreasson, K; Eriksson, M; Tegerstedt, K; Ramqvist, T; Dalianis, T				Andreasson, Kalle; Eriksson, Mathilda; Tegerstedt, Karin; Ramqvist, Torbjorn; Dalianis, Tina			CD4(+) and CD8(+) T Cells Can Act Separately in Tumour Rejection after Immunization with Murine Pneumotropic Virus Chimeric Her2/neu Virus-Like Particles	PLOS ONE			English	Article							NK CELLS; ANTITUMOR IMMUNITY; IFN-GAMMA; DNA VACCINATION; HEPARAN-SULFATE; DENDRITIC CELLS; POLYOMA-VIRUS; ANTIGEN; MICE; EXPRESSION	Background: Immunization with murine pneumotropic virus virus-like particles carrying Her2/neu (Her2MPtVLPs) prevents tumour outgrowth in mice when given prophylactically, and therapeutically if combined with the adjuvant CpG. We investigated which components of the immune system are involved in tumour rejection, and whether long-term immunological memory can be obtained. Methodology and Results: During the effector phase in BALB/c mice, only depletion of CD4(+) and CD8(+) in combination, with or without NK cells, completely abrogated tumour protection. Depletion of single CD4(+), CD8(+) or NK cell populations only had minor effects. During the immunization/induction phase, combined depletion of CD4(+) and CD8(+) cells abolished protection, while depletion of each individual subset had no or negligible effect. When tumour rejection was studied in knock-out mice with a C57B1/6 background, protection was lost in CD4(-/-) CD8(-/-) and CD4(-/-), but not in CD8(-/-) mice. In contrast, when normal C57B1/6 mice were depleted of different cell types, protection was lost irrespective of whether only CD4(+), only CD8(+), or CD4(+) and CD8(+) cells in combination were eradicated. No anti-Her2/neu antibodies were detected but a Her2/neu-specific IFN gamma response was seen. Studies of long-term memory showed that BALB/c mice could be protected against tumour development when immunized together with CpG as long as ten weeks before challenge. Conclusion: Her2MPtVLP immunization is efficient in stimulating several compartments of the immune system, and induces an efficient immune response including long-term memory. In addition, when depleting mice of isolated cellular compartments, tumour protection is not as efficiently abolished as when depleting several immune compartments together.	[Andreasson, Kalle; Eriksson, Mathilda; Tegerstedt, Karin; Ramqvist, Torbjorn; Dalianis, Tina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet	Andreasson, K (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Karl.Andreasson@ltv.se		Dalianis, Tina/0000-0001-7022-2424; Andreasson, Karl-Magnus/0000-0002-5981-1962	Swedish Cancer Foundation; Swedish Medical Research Council; Gustav Vth Jubilee Society; Stockholm Cancer Society; European Union [LSHB-CT-2004-005246]; Stockholm City Council; Karolinska Institutet	Swedish Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Gustav Vth Jubilee Society; Stockholm Cancer Society; European Union(European Commission); Stockholm City Council; Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Cancer Foundation, the Swedish Medical Research Council, the Gustav Vth Jubilee Society, the Stockholm Cancer Society, a European Union Sixth Framework Programme project (LSHB-CT-2004-005246, COMPUVAC), the Stockholm City Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson K, 2009, INT J CANCER, V124, P150, DOI 10.1002/ijc.23920; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; Boura E, 2005, FEBS LETT, V579, P6549, DOI 10.1016/j.febslet.2005.10.062; Braun SE, 2000, J IMMUNOL, V164, P4025, DOI 10.4049/jimmunol.164.8.4025; Bronte V, 2000, CANCER RES, V60, P253; Cheng WF, 2003, GENE THER, V10, P1311, DOI 10.1038/sj.gt.3301982; Disis ML, 2000, BREAST CANCER RES TR, V62, P245, DOI 10.1023/A:1006438507898; FRIED H, 1981, VIROLOGY, V109, P188, DOI 10.1016/0042-6822(81)90485-2; Giroglou T, 2001, J VIROL, V75, P1565, DOI 10.1128/JVI.75.3.1565-1570.2001; GORER PA, 1950, BRIT J CANCER, V4, P372, DOI 10.1038/bjc.1950.36; Greenstone HL, 1998, P NATL ACAD SCI USA, V95, P1800, DOI 10.1073/pnas.95.4.1800; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; Hikono H, 2007, J EXP MED, V204, P1625, DOI 10.1084/jem.20070322; Huebener N, 2009, MOL CANCER THER, V8, P2392, DOI 10.1158/1535-7163.MCT-09-0107; Joura EA, 2007, LANCET, V369, P1693, DOI 10.1016/S0140-6736(07)60777-6; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Kosaka A, 2007, INT IMMUNOL, V19, P249, DOI 10.1093/intimm/dxl140; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Lin ML, 2006, XENOTRANSPLANTATION, V13, P536, DOI 10.1111/j.1399-3089.2006.00348.x; Lindencrona JA, 2004, INT J CANCER, V109, P259, DOI 10.1002/ijc.11654; Mendiratta SK, 2001, CANCER RES, V61, P859; Moore ML, 2008, VIRAL IMMUNOL, V21, P327, DOI 10.1089/vim.2008.0003; Najar HM, 2007, EUR J IMMUNOL, V37, P2242, DOI 10.1002/eji.200636212; Nawrath M, 2001, J MOL MED-JMM, V79, P133, DOI 10.1007/s001090000159; O IS, 2003, CANCER GENE THER, V10, P678, DOI 10.1038/sj.cgt.7700620; Overwijk WW, 1999, P NATL ACAD SCI USA, V96, P2982, DOI 10.1073/pnas.96.6.2982; Piechocki MP, 2001, CELL IMMUNOL, V212, P138, DOI 10.1006/cimm.2001.1853; PUPA SM, 1993, CANCER RES, V53, P5864; REDMOND MJ, 1993, VACCINE, V11, P273, DOI 10.1016/0264-410X(93)90029-W; Riezebos-Brilman A, 2007, GENE THER, V14, P1695, DOI 10.1038/sj.gt.3303036; SALUNKE DM, 1986, CELL, V46, P895, DOI 10.1016/0092-8674(86)90071-1; Schafer K, 1999, INT J CANCER, V81, P881, DOI 10.1002/(SICI)1097-0215(19990611)81:6<881::AID-IJC8>3.3.CO;2-K; Shafti-Keramat S, 2003, J VIROL, V77, P13125, DOI 10.1128/JVI.77.24.13125-13135.2003; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Snyder LA, 2006, VACCINE, V24, P3340, DOI 10.1016/j.vaccine.2006.01.014; Song K, 2000, GENE THER, V7, P1527, DOI 10.1038/sj.gt.3301274; Sorensen MR, 2009, EUR J IMMUNOL, V39, P2725, DOI 10.1002/eji.200939543; Sugiura D, 2008, CANCER SCI, V99, P2477, DOI 10.1111/j.1349-7006.2008.00967.x; Takehara T, 2007, INT J CANCER, V120, P1252, DOI 10.1002/ijc.22152; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; Tegerstedt K, 2003, J GEN VIROL, V84, P3443, DOI 10.1099/vir.0.19443-0; Tegerstedt K, 2007, CANCER IMMUNOL IMMUN, V56, P1335, DOI 10.1007/s00262-007-0281-8; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Ueda R, 2008, INT J CANCER, V122, P2274, DOI 10.1002/ijc.23366; Wang LF, 2009, VACCINE, V28, P561, DOI 10.1016/j.vaccine.2009.09.119; Wen T, 1998, IMMUNOL LETT, V61, P187, DOI 10.1016/S0165-2478(98)00022-4; Wu HJ, 2007, J EXP MED, V204, P1911, DOI 10.1084/jem.20070285; Zhai YF, 1996, J IMMUNOL, V156, P700	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11580	10.1371/journal.pone.0011580	http://dx.doi.org/10.1371/journal.pone.0011580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657846	Green Submitted, Green Published, gold			2022-12-27	WOS:000280065600005
J	Maestre, A; Muskus, C; Duque, V; Agudelo, O; Liu, P; Takagi, A; Ntumngia, FB; Adams, JH; Sim, KL; Hoffman, SL; Corradin, G; Velez, ID; Wang, RB				Maestre, Amanda; Muskus, Carlos; Duque, Victoria; Agudelo, Olga; Liu, Pu; Takagi, Akihide; Ntumngia, Francis B.; Adams, John H.; Sim, Kim Lee; Hoffman, Stephen L.; Corradin, Giampietro; Velez, Ivan D.; Wang, Ruobing			Acquired Antibody Responses against Plasmodium vivax Infection Vary with Host Genotype for Duffy Antigen Receptor for Chemokines (DARC)	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; PAPUA-NEW-GUINEA; BLOOD-GROUP LOCUS; FALCIPARUM MALARIA; IMMUNE-RESPONSES; PREERYTHROCYTIC ANTIGENS; NEGATIVE INDIVIDUALS; NATURAL-SELECTION; DENDRITIC CELLS; STAGE INFECTION	Background: Polymorphism of the Duffy Antigen Receptor for Chemokines (DARC) is associated with susceptibility to and the severity of Plasmodium vivax malaria in humans. P. vivax uses DARC to invade erythrocytes. Individuals lacking DARC are 'resistant' to P. vivax erythrocytic infection. However, susceptibility to P. vivax in DARC+ individuals is reported to vary between specific DARC genotypes. We hypothesized that the natural acquisition of antibodies to P. vivax blood stages may vary with the host genotype and the level of DARC expression. Furthermore, high parasitemia has been reported to effect the acquisition of immunity against pre-erythrocytic parasites. We investigated the correlation between host DARC genotypes and the frequency and magnitude of antibodies against P. vivax erythrocytic stage antigens. Methodology/Findings: We assessed the frequencies and magnitudes of antibody responses against P. vivax and P. falciparum sporozoite and erythrocytic antigens in Colombian donors from malaria-endemic regions. The frequency and level of naturally-acquired antibodies against the P. vivax erythrocytic antigens merozoite surface protein 1 (PvMSP1) and Duffy binding protein (PvDBP) varied with the host DARC genotypes. Donors with one negative allele (FY*B/FY*Bnull and FY*A/FY*Bnull) were more likely to have anti-PvMSP1 and anti-PvDBP antibodies than those with two positive alleles (FY*B/FY*B and FY*A/FY*B). The lower IgG3 and IgG1 components of the total IgG response may account for the decreased responses to P. vivax erythrocytic antigens with FY*A/FY*B and FY*B/FY*B genotypes. No such association was detected with P. falciparum erythrocytic antigens, which does not use DARC for erythrocyte invasion. Conclusion/Significance: Individuals with higher DARC expression, which is associated with higher susceptibility to P. vivax infection, exhibited low frequencies and magnitudes of P. vivax blood-stage specific antibody responses. This may indicate that one of the primary mechanisms by which P. vivax evades host immunity is through DARC indirectly down-regulating humoral responses against erythrocytic invasion and development.	[Maestre, Amanda] Univ Antioquia, Fac Med, Grp Salud & Comunidad, Medellin, Colombia; [Muskus, Carlos; Duque, Victoria; Agudelo, Olga; Velez, Ivan D.] Univ Antioquia, Fac Med, PECET, Medellin, Colombia; [Liu, Pu; Takagi, Akihide; Wang, Ruobing] SBRI, Seattle, WA USA; [Ntumngia, Francis B.; Adams, John H.] Univ S Florida, Tampa, FL USA; [Sim, Kim Lee] Prot Potential LLC, Rockville, MD USA; [Hoffman, Stephen L.] Sanaria, Rockville, MD USA; [Corradin, Giampietro] Univ Lausanne, Dept Biochem, Lausanne, Switzerland	Universidad de Antioquia; Universidad de Antioquia; Center for Infectious Disease Research; State University System of Florida; University of South Florida; Sanaria Inc.; University of Lausanne	Maestre, A (corresponding author), Univ Antioquia, Fac Med, Grp Salud & Comunidad, Medellin, Colombia.	ruobing.wang@seattlebiomed.org	Muskus, Carlos Enrique/AAF-5247-2022; Muskus, Carlos Enrique/AFJ-8423-2022; Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Ntumngia, Francis/0000-0001-9867-3534	NIH [R01 AI057592]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057592, R01AI064478] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by NIH R01 grant (AI057592) and Non-Government research support. The funders had no role in study design, data collection and analysis, decision for publication, or preparation of the manuscript.	Baird JK, 2007, TRENDS PARASITOL, V23, P533, DOI 10.1016/j.pt.2007.08.011; Barbedo MB, 2007, MEM I OSWALDO CRUZ, V102, P335, DOI 10.1590/S0074-02762007005000040; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Blair S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-14; Carmona-Fonseca J, 2004, LATREIA, V17, P34; CARMONAFONSECA J, 2003, LATREIA, V16, P34; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; Cavasini CE, 2006, HUM BIOL, V78, P215, DOI 10.1353/hub.2006.0034; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Chittenden VA, 2008, VOICES, V34, P24; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; DARBONNE WC, 1991, J CLIN INVEST, V88, P1362, DOI 10.1172/JCI115442; Darko CA, 2005, INFECT IMMUN, V73, P287, DOI 10.1128/IAI.73.1.287-297.2005; DONAHUE RP, 1968, P NATL ACAD SCI USA, V61, P949, DOI 10.1073/pnas.61.3.949; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; FORABOSCO P, 1995, ANN HUM GENET, V59, P291, DOI 10.1111/j.1469-1809.1995.tb00749.x; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Gardner L, 2004, BIOCHEM BIOPH RES CO, V321, P306, DOI 10.1016/j.bbrc.2004.06.146; GELPI AP, 1976, SCIENCE, V191, P1284, DOI 10.1126/science.1257752; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; GREENWOOD BM, 1972, LANCET, V1, P169; Gruner AC, 2003, TRENDS PARASITOL, V19, P74, DOI 10.1016/S1471-4922(02)00067-3; GUERINMARCHAND C, 1987, NATURE, V329, P164, DOI 10.1038/329164a0; Guerra CA, 2008, PLOS MED, V5, P300, DOI 10.1371/journal.pmed.0050038; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; Herrera S, 2005, AM J TROP MED HYG, V73, P3, DOI 10.4269/ajtmh.2005.73.3; Herrera S, 2007, TRENDS PARASITOL, V23, P122, DOI 10.1016/j.pt.2007.01.008; Horne K, 2009, INFLAMM RES, V58, P431, DOI 10.1007/s00011-009-0023-9; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kalmbach Y, 2009, PARASITOL RES, V104, P575, DOI 10.1007/s00436-008-1232-9; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; Kasehagen LJ, 2006, AM J TROP MED HYG, V75, P588, DOI 10.4269/ajtmh.2006.75.588; Kemp K, 2002, CLIN EXP IMMUNOL, V127, P151, DOI 10.1046/j.1365-2249.2002.01714.x; KREMSNER PG, 1990, J INFECT DIS, V161, P1025, DOI 10.1093/infdis/161.5.1025; Kumar R, 2007, OPT LASER TECHNOL, V39, P256, DOI 10.1016/j.optlastec.2005.08.008; LIVINGSTONE FB, 1984, HUM BIOL, V56, P413; Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M; LYON JA, 1987, J IMMUNOL, V138, P895; MARCHAND C, 1990, B WORLD HEALTH ORGAN, V68, P158; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; MENARD D, 2010, P NATL ACAD SCI US; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Moreno A, 2008, VACCINE, V26, P4338, DOI 10.1016/j.vaccine.2008.06.010; Mueller I, 2009, VACCINE, V27, P5633, DOI [10.1016/j.vaccine.2009.07.018, 10.1016/j.vaccine.2009.08.112]; Nogueira PA, 2006, INFECT IMMUN, V74, P2726, DOI 10.1128/IAI.74.5.2726-2733.2006; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Oliveira-Ferreira J, 2004, ACTA TROP, V92, P63, DOI 10.1016/j.actatropica.2004.02.011; ORJIH AU, 1979, CLIN EXP IMMUNOL, V38, P1; *PAHO, 2003, CD44INF3 PAHO; Pogo AO, 2000, SEMIN HEMATOL, V37, P122, DOI 10.1016/S0037-1963(00)90037-4; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; RILEY E, 1990, IMMUNOL LETT, V25, P221, DOI 10.1016/0165-2478(90)90119-B; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; SMITH MT, 1993, HUMAN ADAPTATION; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Urban BC, 1999, NATURE, V400, P73, DOI 10.1038/21900; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Valderrama-Aguirre A, 2005, AM J TROP MED HYG, V73, P16, DOI 10.4269/ajtmh.2005.73.16; Vergara C, 2008, AM J RESP CRIT CARE, V178, P1017, DOI 10.1164/rccm.200801-182OC; Wang RB, 2005, EUR J IMMUNOL, V35, P1859, DOI 10.1002/eji.200425807; WERTHEIMER SP, 1989, EXP PARASITOL, V69, P340, DOI 10.1016/0014-4894(89)90083-0; Wickramarachchi T, 2007, INT J PARASITOL, V37, P199, DOI 10.1016/j.ijpara.2006.09.002; Wipasa J, 2001, J IMMUNOL, V167, P3903, DOI 10.4049/jimmunol.167.7.3903; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Woolley IJ, 2000, TRANSFUSION, V40, P949, DOI 10.1046/j.1537-2995.2000.40080949.x; Yalaoui S, 2008, CELL HOST MICROBE, V4, P283, DOI 10.1016/j.chom.2008.07.013; Zijlstra A, 2006, CANCER CELL, V10, P177, DOI 10.1016/j.ccr.2006.08.012; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	79	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11437	10.1371/journal.pone.0011437	http://dx.doi.org/10.1371/journal.pone.0011437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20664684	Green Submitted, Green Published, gold			2022-12-27	WOS:000279924500001
J	Tang, K; Huang, HZ; Jiao, NZ; Wu, CH				Tang, Kai; Huang, Hongzhan; Jiao, Nianzhi; Wu, Cathy H.			Phylogenomic Analysis of Marine Roseobacters	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; GENOME INNOVATION; EVOLUTION; BACTERIA; DATABASE; CORE; IDENTIFICATION; METABOLISM; DIVERSITY; ALGORITHM	Background: Members of the Roseobacter clade which play a key role in the biogeochemical cycles of the ocean are diverse and abundant, comprising 10-25% of the bacterioplankton in most marine surface waters. The rapid accumulation of whole-genome sequence data for the Roseobacter clade allows us to obtain a clearer picture of its evolution. Methodology/Principal Findings: In this study about 1,200 likely orthologous protein families were identified from 17 Roseobacter bacteria genomes. Functional annotations for these genes are provided by iProClass. Phylogenetic trees were constructed for each gene using maximum likelihood (ML) and neighbor joining (NJ). Putative organismal phylogenetic trees were built with phylogenomic methods. These trees were compared and analyzed using principal coordinates analysis (PCoA), approximately unbiased (AU) and Shimodaira-Hasegawa (SH) tests. A core set of 694 genes with vertical descent signal that are resistant to horizontal gene transfer (HGT) is used to reconstruct a robust organismal phylogeny. In addition, we also discovered the most likely 109 HGT genes. The core set contains genes that encode ribosomal apparatus, ABC transporters and chaperones often found in the environmental metagenomic and metatranscriptomic data. These genes in the core set are spread out uniformly among the various functional classes and biological processes. Conclusions/Significance: Here we report a new multigene-derived phylogenetic tree of the Roseobacter clade. Of particular interest is the HGT of eleven genes involved in vitamin B12 synthesis as well as key enzynmes for dimethylsulfoniopropionate (DMSP) degradation. These aquired genes are essential for the growth of Roseobacters and their eukaryotic partners.	[Tang, Kai; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Huang, Hongzhan; Wu, Cathy H.] Georgetown Univ, Washington, DC USA; [Huang, Hongzhan; Wu, Cathy H.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE USA	Xiamen University; Georgetown University; University of Delaware	Tang, K (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	jiao@xmu.edu.cn; wuc@georgetown.edu	Crozier, Laura B./A-4821-2010	Wu, Cathy/0000-0001-6379-8601	National Institutes of Health (NIH) [U01-HG02712]; NSFC [40906079]; MOST [2007CB815904]; Ph.D. Programs Foundation of Ministry of Education of China [200803841021]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG002712] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSFC(National Natural Science Foundation of China (NSFC)); MOST; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The bioinformatics infrastructure for this study was supported in part by National Institutes of Health (NIH) grant U01-HG02712. This work was supported by NSFC 40906079, the MOST project 2007CB815904 and Ph.D. Programs Foundation of Ministry of Education of China 200803841021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bapteste E, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-33; Beiko RG, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-15; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bouxin G, 2005, J VEG SCI, V16, P355, DOI 10.1111/j.1654-1103.2005.tb02374.x; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Brown JR, 2004, BIOESSAYS, V26, P463, DOI 10.1002/bies.20030; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Castresana J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-216; Charlebois RL, 2003, NATURE, V421, P217, DOI 10.1038/421217a; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Dutta C, 2002, J BIOSCIENCES, V27, P27, DOI 10.1007/BF02703681; Eisen JA, 2003, SCIENCE, V300, P1706, DOI 10.1126/science.1086292; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Galtier N, 2008, PHILOS T R SOC B, V363, P4023, DOI 10.1098/rstb.2008.0144; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jain R, 2003, MOL BIOL EVOL, V20, P1598, DOI 10.1093/molbev/msg154; Jiao NZ, 2007, ENVIRON MICROBIOL, V9, P3091, DOI 10.1111/j.1462-2920.2007.01419.x; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Poptsova MS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-45; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schouls LM, 2003, J BACTERIOL, V185, P7241, DOI 10.1128/JB.185.24.7241-7246.2003; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tang KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007233; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taylor GT, 2008, LIMNOL OCEANOGR, V53, P1862, DOI 10.4319/lo.2008.53.5.1862; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wagner-Dobler I, 2010, ISME J, V4, P61, DOI 10.1038/ismej.2009.94; Wu CH, 2004, COMPUT BIOL CHEM, V28, P87, DOI 10.1016/j.compbiolchem.2003.10.003; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78; Zhao YL, 2009, ISME J, V3, P364, DOI 10.1038/ismej.2008.115; Zhaxybayeva O, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-37; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	59	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11604	10.1371/journal.pone.0011604	http://dx.doi.org/10.1371/journal.pone.0011604			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657646	Green Submitted, Green Published, gold			2022-12-27	WOS:000279924500008
J	Forsberg, K; Jonsson, PA; Andersen, PM; Bergemalm, D; Graffmo, KS; Hultdin, M; Jacobsson, J; Rosquist, R; Marklund, SL; Brannstrom, T				Forsberg, Karin; Jonsson, P. Andreas; Andersen, Peter M.; Bergemalm, Daniel; Graffmo, Karin S.; Hultdin, Magnus; Jacobsson, Johan; Rosquist, Roland; Marklund, Stefan L.; Brannstrom, Thomas			Novel Antibodies Reveal Inclusions Containing Non-Native SOD1 in Sporadic ALS Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN SUPEROXIDE-DISMUTASE; MOTOR-NEURON DEGENERATION; MOLECULAR PATHOLOGY; GENE MUTATION; LINKED SOD1; MUTANT SOD1; MICE; DISEASE; IMMUNOREACTIVITY	Mutations in CuZn-superoxide dismutase (SOD1) cause amyotrophic lateral sclerosis (ALS) and are found in 6% of ALS patients. Non-native and aggregation-prone forms of mutant SOD1s are thought to trigger the disease. Two sets of novel antibodies, raised in rabbits and chicken, against peptides spaced along the human SOD1 sequence, were by enzyme-linked immunosorbent assay and an immunocapture method shown to be specific for denatured SOD1. These were used to examine SOD1 in spinal cords of ALS patients lacking mutations in the enzyme. Small granular SOD1-immunoreactive inclusions were found in spinal motoneurons of all 37 sporadic and familial ALS patients studied, but only sparsely in 3 of 28 neurodegenerative and 2 of 19 non-neurological control patients. The granular inclusions were by confocal microscopy found to partly colocalize with markers for lysosomes but not with inclusions containing TAR DNA binding protein-43, ubiquitin or markers for endoplasmic reticulum, autophagosomes or mitochondria. Granular inclusions were also found in carriers of SOD1 mutations and in spinobulbar muscular atrophy (SBMA) patients and they were the major type of inclusion detected in ALS patients homozygous for the wild type-like D90A mutation. The findings suggest that SOD1 may be involved in ALS pathogenesis in patients lacking mutations in the enzyme.	[Forsberg, Karin; Jonsson, P. Andreas; Bergemalm, Daniel; Graffmo, Karin S.; Hultdin, Magnus; Marklund, Stefan L.; Brannstrom, Thomas] Umea Univ, Dept Med Biosci, Umea, Sweden; [Forsberg, Karin; Graffmo, Karin S.; Hultdin, Magnus; Brannstrom, Thomas] Umea Univ, Dept Pathol, S-90187 Umea, Sweden; [Jonsson, P. Andreas; Bergemalm, Daniel; Marklund, Stefan L.] Umea Univ, Dept Clin Chem, Umea, Sweden; [Andersen, Peter M.; Jacobsson, Johan] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Rosquist, Roland] Umea Univ, Dept Mol Biol, Umea, Sweden	Umea University; Umea University; Umea University; Umea University; Umea University	Forsberg, K (corresponding author), Umea Univ, Dept Med Biosci, Umea, Sweden.	thomas.brannstrom@medbio.umu.se		Jonsson, Andreas/0000-0002-1938-0707	Swedish Science Council	Swedish Science Council	This work was supported by the Swedish Science Council (Grants no: 2008: 2786; 2009: 3548; 2009-4942), the Swedish Brain Fund/Hallsten Fund, the Swedish Medical Society/Bjorklund Fund for ALS Research, King Gustaf and Queen Victoria Fund, the Swedish Association for Individuals with Neurological Disabilities, the Torsten and Ragnar Soderbergs Foundations, the Vasterbotten County Council, and the Research Fund of the Medical Faculty, Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; BOWLING AC, 1995, J NEUROCHEM, V64, P2366; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Gruzman A, 2007, P NATL ACAD SCI USA, V104, P12524, DOI 10.1073/pnas.0705044104; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hirano A, 1998, NEUROPATHOLOGY, V18, P363, DOI 10.1111/j.1440-1789.1998.tb00132.x; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Ince PG, 1996, ACTA NEUROPATHOL, V92, P395, DOI 10.1007/s004010050535; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jacobsson J, 2001, BRAIN, V124, P1461, DOI 10.1093/brain/124.7.1461; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2009, NEUROBIOL DIS, V36, P421, DOI 10.1016/j.nbd.2009.08.006; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Liu HN, 2009, ANN NEUROL, V66, P75, DOI 10.1002/ana.21704; Liu Y, 1998, ACTA NEUROPATHOL, V95, P63, DOI 10.1007/s004010050766; MARKLUND SL, 1984, J CLIN INVEST, V74, P1398, DOI 10.1172/JCI111550; Marklund SL, 1997, J NEUROCHEM, V69, P675; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; Shaw PJ, 1997, J NEUROL SCI, V147, P115, DOI 10.1016/S0022-510X(96)05316-6; SHIBATA N, 1994, NEUROSCI LETT, V179, P149, DOI 10.1016/0304-3940(94)90956-3; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Stewart HG, 2006, MUSCLE NERVE, V33, P701, DOI 10.1002/mus.20495; Valentine JS, 2003, P NATL ACAD SCI USA, V100, P3617, DOI 10.1073/pnas.0730423100; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wooley CM, 2005, MUSCLE NERVE, V32, P43, DOI 10.1002/mus.20228; Zetterstrom P, 2007, P NATL ACAD SCI USA, V104, P14157, DOI 10.1073/pnas.0700477104; 1994, J NEUROL SCI S, V124, P1	44	233	237	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11552	10.1371/journal.pone.0011552	http://dx.doi.org/10.1371/journal.pone.0011552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644736	gold, Green Published, Green Submitted			2022-12-27	WOS:000279884900009
J	Werth, N; Beerlage, C; Rosenberger, C; Yazdi, AS; Edelmann, M; Amr, A; Bernhardt, W; von Eiff, C; Becker, K; Schafer, A; Peschel, A; Kempf, VAJ				Werth, Nadine; Beerlage, Christiane; Rosenberger, Christian; Yazdi, Amir S.; Edelmann, Markus; Amr, Amro; Bernhardt, Wanja; von Eiff, Christof; Becker, Karsten; Schaefer, Andrea; Peschel, Andreas; Kempf, Volkhard A. J.			Activation of Hypoxia Inducible Factor 1 Is a General Phenomenon in Infections with Human Pathogens	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SMALL COLONY VARIANTS; FACTOR-I; BARTONELLA ADHESIN; HIF-ALPHA; HIF-1-ALPHA; LIPOPOLYSACCHARIDE; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; STABILIZATION; EXPRESSION	Background: Hypoxia inducible factor (HIF)-1 is the key transcriptional factor involved in the adaptation process of cells and organisms to hypoxia. Recent findings suggest that HIF-1 plays also a crucial role in inflammatory and infectious diseases. Methodology/Principal Findings: Using patient skin biopsies, cell culture and murine infection models, HIF-1 activation was determined by immunohistochemistry, immunoblotting and reporter gene assays and was linked to cellular oxygen consumption. The course of a S. aureus peritonitis was determined upon pharmacological HIF-1 inhibition. Activation of HIF-1 was detectable (i) in all ex vivo in biopsies of patients suffering from skin infections, (ii) in vitro using cell culture infection models and (iii) in vivo using murine intravenous and peritoneal S. aureus infection models. HIF-1 activation by human pathogens was induced by oxygen-dependent mechanisms. Small colony variants (SCVs) of S. aureus known to cause chronic infections did not result in cellular hypoxia nor in HIF-1 activation. Pharmaceutical inhibition of HIF-1 activation resulted in increased survival rates of mice suffering from a S. aureus peritonitis. Conclusions/Significance: Activation of HIF-1 is a general phenomenon in infections with human pathogenic bacteria, viruses, fungi and protozoa. HIF-1-regulated pathways might be an attractive target to modulate the course of life-threatening infections.	[Werth, Nadine; Edelmann, Markus; Amr, Amro; Schaefer, Andrea; Peschel, Andreas] Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany; [Beerlage, Christiane; Kempf, Volkhard A. J.] Klinikum Johann Wolfgang Goethe Univ, Inst Med Mikrobiol & Krankenhaushyg, Frankfurt, Germany; [Rosenberger, Christian] Charite, Med Klin Schwerpunkt Nephrol & Internist Intens M, Berlin, Germany; [Yazdi, Amir S.] Univ Lausanne, Dept Biochim, CH-1066 Epalinges, Switzerland; [Yazdi, Amir S.] Univ Tubingen, Univ Hautklin, Tubingen, Germany; [Bernhardt, Wanja] Univ Erlangen Nurnberg, Med Klin Nephrol & Hypertensiol 4, Erlangen, Germany; [von Eiff, Christof; Becker, Karsten] Univ Klinikum Munster, Inst Med Mikrobiol, Munster, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Lausanne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster	Werth, N (corresponding author), Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany.	volkhard.kempf@kgu.de	Becker, Karsten/O-2302-2018	Becker, Karsten/0000-0002-6391-1341	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft to V.A.J.K. and K.B. (Priority Program 1316) and to A.S.Y. and A.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt WM, 2006, KIDNEY INT, V69, P114, DOI 10.1038/sj.ki.5000062; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Chavakis T, 2002, NAT MED, V8, P687, DOI 10.1038/nm728; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; ENKHBAATAR P, 2008, YB INTENSIVE CARE EM, P404; Essin K, 2007, AM J PHYSIOL-CELL PH, V293, pC45, DOI 10.1152/ajpcell.00450.2006; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jantsch J, 2008, J IMMUNOL, V180, P4697, DOI 10.4049/jimmunol.180.7.4697; Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kempf VAJ, 2002, TRENDS MICROBIOL, V10, P269, DOI 10.1016/S0966-842X(02)02372-7; Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x; KERL H, 2003, HISTOPATHOLOGIE HAUT, P3; Lang SA, 2007, CLIN CANCER RES, V13, P6459, DOI 10.1158/1078-0432.CCR-07-1104; Lannergard J, 2008, ANTIMICROB AGENTS CH, V52, P4017, DOI 10.1128/AAC.00668-08; Mazure NM, 2004, BIOCHEM PHARMACOL, V68, P971, DOI 10.1016/j.bcp.2004.04.022; Meyer-Hoffert U, 2008, GUT, V57, P764, DOI 10.1136/gut.2007.141481; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Pickkers P, 2005, SHOCK, V24, P508, DOI 10.1097/01.shk.0000190827.36406.6e; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; RALEIGH JA, 1990, BIOCHEM PHARMACOL, V40, P2457, DOI 10.1016/0006-2952(90)90086-Z; Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500; Rupp J, 2007, CELL MICROBIOL, V9, P2181, DOI 10.1111/j.1462-5822.2007.00948.x; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sheta EA, 2001, ONCOGENE, V20, P7624, DOI 10.1038/sj.onc.1204972; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL202, DOI 10.1152/ajplung.2001.281.1.L202; Sifri CD, 2006, INFECT IMMUN, V74, P1091, DOI 10.1128/IAI.74.2.1091-1096.2006; van der Flier M, 2005, SHOCK, V23, P35, DOI 10.1097/01.shk.0000150728.91155.41; van der Flier M, 2001, J INFECT DIS, V183, P149, DOI 10.1086/317643; von Eiff C, 2008, INT J ANTIMICROB AG, V31, P507, DOI 10.1016/j.ijantimicag.2007.10.026; vonEiff C, 1997, J BACTERIOL, V179, P4706, DOI 10.1128/jb.179.15.4706-4712.1997; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yeo M, 2006, GUT, V55, P26, DOI 10.1136/gut.2005.067454	48	127	134	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11576	10.1371/journal.pone.0011576	http://dx.doi.org/10.1371/journal.pone.0011576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644645	Green Published, gold, Green Submitted			2022-12-27	WOS:000279884900016
J	Autore, F; Bergeron, JRC; Malim, MH; Fraternali, F; Huthoff, H				Autore, Flavia; Bergeron, Julien R. C.; Malim, Michael H.; Fraternali, Franca; Huthoff, Hendrik			Rationalisation of the Differences between APOBEC3G Structures from Crystallography and NMR Studies by Molecular Dynamics Simulations	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SINGLE-STRANDED-DNA; CYTIDINE DEAMINATION; CATALYTIC DOMAIN; RETROVIRAL INFECTION; CRYSTAL-STRUCTURE; MODEL STRUCTURE; HIV-1 VIF; PROTEINS; RNA	The human APOBEC3G (A3G) protein is a cellular polynucleotide cytidine deaminase that acts as a host restriction factor of retroviruses, including HIV-1 and various transposable elements. Recently, three NMR and two crystal structures of the catalytic deaminase domain of A3G have been reported, but these are in disagreement over the conformation of a terminal beta-strand, beta 2, as well as the identification of a putative DNA binding site. We here report molecular dynamics simulations with all of the solved A3G catalytic domain structures, taking into account solubility enhancing mutations that were introduced during derivation of three out of the five structures. In the course of these simulations, we observed a general trend towards increased definition of the beta 2 strand for those structures that have a distorted starting conformation of beta 2. Solvent density maps around the protein as calculated from MD simulations indicated that this distortion is dependent on preferential hydration of residues within the beta 2 strand. We also demonstrate that the identification of a pre-defined DNA binding site is prevented by the inherent flexibility of loops that determine access to the deaminase catalytic core. We discuss the implications of our analyses for the as yet unresolved structure of the full-length A3G protein and its biological functions with regard to hypermutation of DNA.	[Autore, Flavia; Bergeron, Julien R. C.; Fraternali, Franca] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Bergeron, Julien R. C.; Malim, Michael H.; Huthoff, Hendrik] Kings Coll London, Dept Infect Dis, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Autore, F (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England.	franca.fraternalli@kc.ac.uk; hendrik.huthoff@kcl.ac.uk	Bergeron, Julien/AGY-1707-2022; Fraternali, Franca/C-8912-2009; Fraternali, Franca/D-4410-2011	Fraternali, Franca/0000-0002-3143-6574; Malim, Michael/0000-0002-7699-2064	Medical Research Council [G0401570]; Guy's & St Thomas' Charity [R041069]; Wellcome Trust [084280/Z/07/Z]; BHF Centre of Excellence; Wellcome Trust; European Molecular Biology Organisation; Guy's & St Thomas' Charity; MRC [G1000196, G0401570] Funding Source: UKRI; Medical Research Council [G1000196] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Guy's & St Thomas' Charity; Wellcome Trust(Wellcome Trust); BHF Centre of Excellence; Wellcome Trust(Wellcome Trust); European Molecular Biology Organisation; Guy's & St Thomas' Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (G0401570), the Guy's & St Thomas' Charity (R041069), the Wellcome Trust (084280/Z/07/Z) and the BHF Centre of Excellence. HH is a Wellcome Trust fellow, FA is supported by a short-term fellowship of the European Molecular Biology Organisation, JB is supported by a grant from the Guy's & St Thomas' Charity, and FF is supported by a priming grant from the BHF Centre of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman K, 2008, BARIAT NURS SURG PAT, V3, P7, DOI 10.1089/bar.2008.9997; Bennett RP, 2008, J BIOL CHEM, V283, P33329, DOI 10.1074/jbc.M803726200; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bransteitter R, 2009, CELL MOL LIFE SCI, V66, P3137, DOI 10.1007/s00018-009-0070-y; Bulliard Y, 2009, J VIROL, V83, P12611, DOI 10.1128/JVI.01491-09; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; CARPENTER MA, 2010, DNA REPAIR, V579, P3; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chelico L, 2009, NAT STRUCT MOL BIOL, V16, P454, DOI 10.1038/nsmb0509-454; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Darden T, 1999, STRUCT FOLD DES, V7, pR55, DOI 10.1016/S0969-2126(99)80033-1; Daura X, 1998, J COMPUT CHEM, V19, P535, DOI 10.1002/(SICI)1096-987X(19980415)19:5<535::AID-JCC6>3.0.CO;2-N; De Simone A, 2005, P NATL ACAD SCI USA, V102, P7535, DOI 10.1073/pnas.0501748102; ESPINOSA R, 1994, GENOMICS, V24, P414, DOI 10.1006/geno.1994.1645; Friew YN, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-56; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Holmes RK, 2007, TRENDS BIOCHEM SCI, V32, P118, DOI 10.1016/j.tibs.2007.01.004; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huthoff H, 2005, VIROLOGY, V334, P147, DOI 10.1016/j.virol.2005.01.038; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Huthoff H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000330; Iwatani Y, 2006, J VIROL, V80, P5992, DOI 10.1128/JVI.02680-05; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Lavens D, 2010, NUCLEIC ACIDS RES, V38, P1902, DOI 10.1093/nar/gkp1154; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SIMON JHM, 1995, J VIROL, V69, P4166, DOI 10.1128/JVI.69.7.4166-4172.1995; Stauch B, 2009, P NATL ACAD SCI USA, V106, P12079, DOI 10.1073/pnas.0900979106; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang KL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000378; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	55	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11515	10.1371/journal.pone.0011515	http://dx.doi.org/10.1371/journal.pone.0011515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20635000	Green Submitted, gold, Green Published			2022-12-27	WOS:000279781600004
J	Chen, F; Lee, Y; Jiang, YL; Wang, SL; Peatman, E; Abernathy, J; Liu, H; Liu, SK; Kucuktas, H; Ke, CH; Liu, ZJ				Chen, Fei; Lee, Yoona; Jiang, Yanliang; Wang, Shaolin; Peatman, Eric; Abernathy, Jason; Liu, Hong; Liu, Shikai; Kucuktas, Huseyin; Ke, Caihuan; Liu, Zhanjiang			Identification and Characterization of Full-Length cDNAs in Channel Catfish (Ictalurus punctatus) and Blue Catfish (Ictalurus furcatus)	PLOS ONE			English	Article							POLYADENYLATION SIGNAL; GENE-EXPRESSION; SEQUENCES; SELENIUM; TOOL	Background: Genome annotation projects, gene functional studies, and phylogenetic analyses for a given organism all greatly benefit from access to a validated full-length cDNA resource. While increasingly common in model species, full-length cDNA resources in aquaculture species are scarce. Methodology and Principal Findings: Through in silico analysis of catfish (Ictalurus spp.) ESTs, a total of 10,037 channel catfish and 7,382 blue catfish cDNA clones were identified as potentially encoding full-length cDNAs. Of this set, a total of 1,169 channel catfish and 933 blue catfish full-length cDNA clones were selected for re-sequencing to provide additional coverage and ensure sequence accuracy. A total of 1,745 unique gene transcripts were identified from the full-length cDNA set, including 1,064 gene transcripts from channel catfish and 681gene transcripts from blue catfish, with 416 transcripts shared between the two closely related species. Full-length sequence characteristics (ortholog conservation, UTR length, Kozak sequence, and conserved motifs) of the channel and blue catfish were examined in detail. Comparison of gene ontology composition between full-length cDNAs and all catfish ESTs revealed that the full-length cDNA set is representative of the gene diversity encoded in the catfish transcriptome. Conclusions: This study describes the first catfish full-length cDNA set constructed from several cDNA libraries. The catfish full-length cDNA sequences, and data gleaned from sequence characteristics analysis, will be a valuable resource for ongoing catfish whole-genome sequencing and future gene-based studies of function and evolution in teleost fishes.	[Chen, Fei; Lee, Yoona; Jiang, Yanliang; Wang, Shaolin; Peatman, Eric; Abernathy, Jason; Liu, Hong; Liu, Shikai; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA; [Chen, Fei; Lee, Yoona; Jiang, Yanliang; Wang, Shaolin; Peatman, Eric; Abernathy, Jason; Liu, Hong; Liu, Shikai; Kucuktas, Huseyin; Liu, Zhanjiang] Auburn Univ, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Chen, Fei; Ke, Caihuan] Xiamen Univ, Coll Oceanog & Environm Sci, State Key Lab Marine Environm Sci, Xiamen, Peoples R China	Auburn University System; Auburn University; Auburn University System; Auburn University; Xiamen University	Chen, F (corresponding author), Auburn Univ, Dept Fisheries & Allied Aquacultures, Aquat Genom Unit, Fish Mol Genet & Biotechnol Lab, Auburn, AL 36849 USA.	liuzhan@auburn.edu	Liu, Shikai/AAO-2247-2021; Liu, Zhanjiang/R-9633-2019; Liu, Shikai/D-4664-2013; Wang, Shaolin/M-2282-2013; Wang, Shaolin/FDL-8163-2022; Ke, CH/G-4635-2010	Liu, Shikai/0000-0001-5777-489X; Liu, Shikai/0000-0001-5777-489X; Wang, Shaolin/0000-0003-0866-4584; Wang, Shaolin/0000-0003-0866-4584; Abernathy, Jason/0000-0001-6084-8239	United States Department of Agriculture National Institute for Food and Agriculture Animal Genome Basic Genome Reagents and Tools Program [2009-35205-05101]; Korean Government (MOEHRD) [KRF-2008-357-F00035]	United States Department of Agriculture National Institute for Food and Agriculture Animal Genome Basic Genome Reagents and Tools Program; Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government)	This project was supported in part by a grant from the United States Department of Agriculture National Institute for Food and Agriculture Animal Genome Basic Genome Reagents and Tools Program (USDA/NRICGP award# 2009-35205-05101) and in part by a Korea Research Foundation Grant funded by the Korean Government (MOEHRD), KRF-2008-357-F00035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-502; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Bjornstedt M, 1997, BIOMED ENVIRON SCI, V10, P271; Castelli V, 2004, GENOME RES, V14, P406, DOI 10.1101/gr.1515604; Chapman BA, 2004, BIOINFORMATICS, V20, P180, DOI 10.1093/bioinformatics/bth022; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fagegaltier D, 2000, NUCLEIC ACIDS RES, V28, P2679, DOI 10.1093/nar/28.14.2679; Fischer A, 2001, BIOCHEM BIOPH RES CO, V285, P470, DOI 10.1006/bbrc.2001.5171; Harhay GP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-166; Hayashizaki Y, 2003, CR BIOL, V326, P923, DOI 10.1016/j.crvi.2003.09.018; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hurowitz EH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000460; Kaldy P, 1999, EMBO J, V18, P6073, DOI 10.1093/emboj/18.21.6073; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Li P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-177; Liu H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-592; MacDonald CC, 2002, MOL CELL ENDOCRINOL, V190, P1, DOI 10.1016/S0303-7207(02)00044-8; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55; Satoh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001235; Soderlund C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000740; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Walczak R, 1996, RNA, V2, P367; WANG S, GENOME, V11, pR8; Wang Y, 2007, PHYSIOL GENOMICS, V28, P141, DOI 10.1152/physiolgenomics.00097.2006; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377	31	28	30	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11546	10.1371/journal.pone.0011546	http://dx.doi.org/10.1371/journal.pone.0011546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634964	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600023
J	Kuka, M; Baronio, R; Valentini, S; Monaci, E; Muzzi, A; Aprea, S; De Gregorio, E; D'Oro, U				Kuka, Mirela; Baronio, Roberta; Valentini, Sara; Monaci, Elisabetta; Muzzi, Alessandro; Aprea, Susanna; De Gregorio, Ennio; D'Oro, Ugo			Src Kinases Are Required for a Balanced Production of IL-12/IL-23 in Human Dendritic Cells Activated by Toll-Like Receptor Agonists	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; T-HELPER-CELLS; TYROSINE KINASES; C-REL; DIFFERENTIATION; INTERLEUKIN-23; PROTEIN; INFLAMMATION; CYTOKINE; TLR	Background: Pathogen recognition by dendritic cells (DC) is crucial for the initiation of both innate and adaptive immune responses. Activation of Toll-like Receptors (TLRs) by microbial molecular patterns leads to the maturation of DC, which present the antigen and activate T cells in secondary lymphoid tissues. Cytokine production by DC is critical for shaping the adaptive immune response by regulating T helper cell differentiation. It was previously shown by our group that Src kinases play a key role in cytokines production during TLR4 activation in human DC. Principal Findings: In this work we investigated the role of Src kinases during different TLRs triggering in human monocyte-derived DC (MoDC). We found that Src family kinases are important for a balanced production of inflammatory cytokines by human MoDC upon stimulation of TLR3 and 8 with their respective agonists. Disruption of this equilibrium through pharmacological inhibition of Src kinases alters the DC maturation pattern. In particular, while expression of IL-12 and other inflammatory cytokines depend on Src kinases, the induction of IL-23 and co-stimulatory molecules do not. Accordingly, DC treated with Src inhibitors are not compromised in their ability to induce CD4 T cell proliferation and to promote the Th17 subset survival but are less efficient in inducing Th1 differentiation. Conclusions: We suggest that the pharmacological modulation of DC maturation has the potential to shape the quality of the adaptive immune response and could be exploited for the treatment of inflammation-related diseases.	[Kuka, Mirela; Baronio, Roberta; Valentini, Sara; Monaci, Elisabetta; Muzzi, Alessandro; Aprea, Susanna; De Gregorio, Ennio; D'Oro, Ugo] Novartis Vaccines, Siena, Italy	Novartis	Kuka, M (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	ugo.doro@novartis.com	KUKA, MIRELA/G-6410-2018; KUKA, MIRELA/M-5336-2019; De Gregorio, Ennio/J-8073-2012	KUKA, MIRELA/0000-0001-9418-1559; KUKA, MIRELA/0000-0001-9418-1559; 	European Network of Excellence DC-THERA [LSHB-CT-2004-512074]; Novartis Vaccines and Diagnostics; DC-THERA	European Network of Excellence DC-THERA; Novartis Vaccines and Diagnostics; DC-THERA	This work was partially supported by the European Network of Excellence DC-THERA (contract number LSHB-CT-2004-512074). Mirela Kuka was supported by a Fellowship from the DC-THERA network. The DC-THERA Network had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novartis Vaccines and Diagnostics partially funded this work, and approved all the author's decision about study design, data collection and analysis, and decision to publish.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ahern PP, 2008, IMMUNOL REV, V226, P147, DOI 10.1111/j.1600-065X.2008.00705.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; CHAN SH, 1992, J IMMUNOL, V148, P92; Chan VWF, 1998, J EXP MED, V188, P93, DOI 10.1084/jem.188.1.93; Coffman RL, 2006, NAT IMMUNOL, V7, P539, DOI 10.1038/ni0606-539; Cornelissen F, 2009, CURR OPIN INVEST DR, V10, P452; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Lanzavecchia A, 2000, SCIENCE, V290, P92, DOI 10.1126/science.290.5489.92; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Masumi A, 2002, FEBS LETT, V531, P348, DOI 10.1016/S0014-5793(02)03556-1; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Napolitani G, 2003, EUR J IMMUNOL, V33, P2832, DOI 10.1002/eji.200324073; OCONNOR W, 2009, NAT IMMUNOL; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; Page TH, 2009, CURR MOL MED, V9, P69, DOI 10.2174/156652409787314507; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; ROMAGNANI S, 2009, MOL IMMUNOL; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Trinchieri Giorgio, 1992, Progress in Growth Factor Research, V4, P355, DOI 10.1016/0955-2235(92)90016-B; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhao J, 2006, J BIOL CHEM, V281, P10073, DOI 10.1074/jbc.M507788200	37	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11491	10.1371/journal.pone.0011491	http://dx.doi.org/10.1371/journal.pone.0011491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634889	Green Published, gold, Green Submitted			2022-12-27	WOS:000279715300006
J	Tsurui, K; Honma, A; Nishida, T				Tsurui, Kaori; Honma, Atsushi; Nishida, Takayoshi			Camouflage Effects of Various Colour-Marking Morphs against Different Microhabitat Backgrounds in a Polymorphic Pygmy Grasshopper Tetrix japonica	PLOS ONE			English	Article							DISRUPTIVE COLORATION; CRYPTIC COLORATION; EVOLUTION; PATTERN; SELECTION; TESTS; SIZE	Background: Colour-marking polymorphism is widely distributed among cryptic species. To account for the adaptive significance of such polymorphisms, several hypotheses have been proposed to date. Although these hypotheses argue over the degree of camouflage effects of marking morphs (and the interactions between morphs and their microhabitat backgrounds), as far as we know, most empirical evidence has been provided under unnatural conditions (i.e., using artificial prey). Methodology/Principal Findings: Tetrix japonica, a pygmy grasshopper, is highly polymorphic in colour-markings and occurs in both sand and grass microhabitats. Even within a microhabitat, T. japonica is highly polymorphic. Using humans as dummy predators and printed photographs in which various morphs of grasshoppers were placed against different backgrounds, we addressed three questions to test the neutral, background heterogeneity, and differential crypsis hypotheses in four marking-type morphs: 1) do the morphs differ in the degree of crypsis in each microhabitat, 2) are different morphs most cryptic in specific backgrounds of the microhabitats, and 3) does the morph frequency reflect the degree of crypsis? Conclusions/Significance: The degree of camouflage differed among the four morphs; therefore, the neutral hypothesis was rejected. Furthermore, the order of camouflage advantage among morphs differed depending on the two types of backgrounds (sand and grass), although the grass background consistently provided greater camouflage effects. Thus, based on our results, we could not reject the background heterogeneity hypothesis. Under field conditions, the more cryptic morphs comprised a minority of the population. Overall, our results demonstrate that the different morphs were not equivalent in the degree of crypsis, but the degree of camouflage of the morphs was not consistent with the morph frequency. These findings suggest that trade-offs exist between the camouflage benefit of body colouration and other fitness components, providing a better understanding of the adaptive significance of colour-markings and presumably supporting the differential crypsis hypothesis.	[Tsurui, Kaori; Honma, Atsushi; Nishida, Takayoshi] Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Sakyo Ku, Kyoto, Japan	Kyoto University	Tsurui, K (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Insect Ecol, Sakyo Ku, Kyoto, Japan.	tsurik@kais.kyoto-u.ac.jp			MEXT [16657008, K18]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by a Grant-in-aid for Exploratory Research (16657008) from MEXT to T.N. (http://kaken.nii.ac.jp/ja/p/16657008) and the 21st Century COE Program for Innovative Food and Environmental Studies pioneered by Entomomimetic Sciences (K18) from MEXT (http://www.jsps.go.jp/english/e-21coe/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnesjo J, 2003, J EVOLUTION BIOL, V16, P1308, DOI 10.1046/j.1420-9101.2003.00610.x; Alan BB, 2007, ANNU REV ECOL EVOL S, V38, P489, DOI [10.1146/annurev.ecolsys.38.091206.095728, DOI 10.1146/ANNUREV.ECOLSYS.38.091206.095728]; Arnqvist Goran, 2005, pUnpaginated; Beatty CD, 2004, NATURE, V431, P63, DOI 10.1038/nature02818; Bond AB, 2006, P NATL ACAD SCI USA, V103, P3214, DOI 10.1073/pnas.0509963103; Cott H.B., 1940, ADAPTIVE COLORATION; COX DR, 1972, J R STAT SOC B, V187, P220; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Cuthill IC, 2005, NATURE, V434, P72, DOI 10.1038/nature03312; Cuthill IC, 2006, P ROY SOC B-BIOL SCI, V273, P1267, DOI 10.1098/rspb.2005.3438; Endler J.A., 1991, P169; Endler J.A., 1978, Evolutionary Biology (New York), V11, P319; Forsman A, 1998, BEHAV ECOL, V9, P409, DOI 10.1093/beheco/9.4.409; Forsman A, 2001, OECOLOGIA, V129, P357, DOI 10.1007/s004420100743; Forsman A, 1997, ANN ZOOL FENN, V34, P145; Forsman A, 2000, EVOL ECOL, V14, P25, DOI 10.1023/A:1011024320725; Fraser S, 2007, P ROY SOC B-BIOL SCI, V274, P1325, DOI 10.1098/rspb.2007.0153; Hancock JL, 1902, TETTIGIDAE N AM; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hochkirch A, 2000, ENTOMOL GEN, V25, P39; Holst K.T., 1986, Fauna Entomologica Scandinavica, V16, P1; Ichikawa A, 2006, ORTHOPTERA JAPANESE; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Majerus M, 1998, MELANISM EVOLUTION A; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Merilaita S, 2001, P ROY SOC B-BIOL SCI, V268, P1925, DOI 10.1098/rspb.2001.1747; R Core Team, 2020, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruxton GD, 2004, AVOIDING ATTACK EVOL; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2009, PHILOS T R SOC B, V364, P481, DOI 10.1098/rstb.2008.0216; Thayer GH., 1909, CONCEALING COLORATIO; Therneau T.M., 2000, MODELING SURVIVAL DA; TINBERGEN L., 1960, ARCH NEERLAND ZOOL, V13, P265; Tsurui Kaori, 2010, Bulletin of the Osaka Museum of Natural History, P19; Webster RJ, 2009, PHILOS T R SOC B, V364, P503, DOI 10.1098/rstb.2008.0215	37	26	29	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11446	10.1371/journal.pone.0011446	http://dx.doi.org/10.1371/journal.pone.0011446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625405	Green Published, gold, Green Submitted			2022-12-27	WOS:000279522500013
J	Meachen-Samuels, JA; Van Valkenburgh, B				Meachen-Samuels, Julie A.; Van Valkenburgh, Blaire			Radiographs Reveal Exceptional Forelimb Strength in the Sabertooth Cat, Smilodon fatalis	PLOS ONE			English	Article							PREDATORY BEHAVIOR; BODY-SIZE; POSTCRANIAL ROBUSTICITY; LATE PLEISTOCENE; TOOTHED CATS; LATE MIOCENE; BITE FORCE; BONE; PATTERNS; MACHAIRODONTINAE	Background: The sabertooth cat, Smilodon fatalis, was an enigmatic predator without a true living analog. Their elongate canine teeth were more vulnerable to fracture than those of modern felids, making it imperative for them to immobilize prey with their forelimbs when making a kill. As a result, their need for heavily muscled forelimbs likely exceeded that of modern felids and thus should be reflected in their skeletons. Previous studies on forelimb bones of S. fatalis found them to be relatively robust but did not quantify their ability to withstand loading. Methodology/Principal Findings: Using radiographs of the sabertooth cat, Smilodon fatalis, 28 extant felid species, and the larger, extinct American lion Panthera atrox, we measured cross-sectional properties of the humerus and femur to provide the first estimates of limb bone strength in bending and torsion. We found that the humeri of Smilodon were reinforced by cortical thickening to a greater degree than those observed in any living felid, or the much larger P. atrox. The femur of Smilodon also was thickened but not beyond the normal variation found in any other felid measured. Conclusions/Significance: Based on the cross-sectional properties of its humerus, we interpret that Smilodon was a powerful predator that differed from extant felids in its greater ability to subdue prey using the forelimbs. This enhanced forelimb strength was part of an adaptive complex driven by the need to minimize the struggles of prey in order to protect the elongate canines from fracture and position the bite for a quick kill.	[Meachen-Samuels, Julie A.; Van Valkenburgh, Blaire] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Meachen-Samuels, JA (corresponding author), Natl Evolutionary Synth Ctr, Durham, NC 27705 USA.	meachensamuels@nescent.org			University of California Los Angeles (UCLA); National Science Foundation (NSF) [EF-0423641]	University of California Los Angeles (UCLA)(University of California System); National Science Foundation (NSF)(National Science Foundation (NSF))	JMS was partially funded by a University of California Los Angeles (UCLA) Graduate Assistance in Areas of National Need (GAANN) fellowship for collection of data at the Smithsonian Institution and by National Science Foundation (NSF) grant # EF-0423641 to the National Evolutionary Synthesis Center (NESCent) during the writing of this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akersten W.A, 1985, CONTRIB SCI NAT HIST, V356, P1; Alexander R., 1983, ANIMAL MECH; Anton M, 2005, QUATERNARY SCI REV, V24, P1287, DOI 10.1016/j.quascirev.2004.09.008; Anton M, 1998, ZOOL J LINN SOC-LOND, V124, P369, DOI 10.1111/j.1096-3642.1998.tb00582.x; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; Anyonge W, 1996, J ZOOL, V238, P395, DOI 10.1111/j.1469-7998.1996.tb05402.x; Barnett R, 2009, MOL ECOL, V18, P1668, DOI 10.1111/j.1365-294X.2009.04134.x; Beisiegel Beatriz de Mello, 2005, Mammalian Species, P1, DOI 10.1644/783.1; BERTRAM JEA, 1988, J THEOR BIOL, V131, P75, DOI 10.1016/S0022-5193(88)80122-X; BIKNEVICIUS AR, 1993, J MAMMAL, V74, P95, DOI 10.2307/1381908; Bryant Harold N., 1996, P283; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; Coltrain JB, 2004, PALAEOGEOGR PALAEOCL, V205, P199, DOI 10.1016/j.palaeo.2003.12.008; COTGREAVE P, 1994, OIKOS, V71, P89, DOI 10.2307/3546175; DEMES B, 1991, AM J PHYS ANTHROPOL, V86, P537, DOI 10.1002/ajpa.1330860409; Demes B, 2001, AM J PHYS ANTHROPOL, V116, P257, DOI 10.1002/ajpa.1122.abs; Demes B, 1998, AM J PHYS ANTHROPOL, V106, P87, DOI 10.1002/(SICI)1096-8644(199805)106:1<87::AID-AJPA6>3.0.CO;2-A; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Ewer, 1998, CARNIVORES; Felidae Martin L.D., 1998, EVOLUTION TERTIARY M, P236; GONYEA W J, 1976, Paleobiology, V2, P332; Heinrich RE, 1998, J MORPHOL, V235, P121, DOI 10.1002/(SICI)1097-4687(199802)235:2<121::AID-JMOR3>3.0.CO;2-C; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; MacDonald DW, 1996, J ZOOL, V239, P525, DOI 10.1111/j.1469-7998.1996.tb05941.x; Martin RB, 1998, SKELETAL TISSUE MECH; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Meachen-Samuels J, 2008, J VERTEBR PALEONTOL, V28, p115A; MEACHENSAMUELS JA, 2010, J MAMMAL EV IN PRESS; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; RASBAND W, 2007, IMAGEJ; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; RUBIN CT, 1995, J BONE MINER RES, V10, P488; RUBIN CT, 1982, J EXP BIOL, V101, P187; Ruff C, 2006, AM J PHYS ANTHROPOL, V129, P484, DOI 10.1002/ajpa.20371; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Runestad JA, 1997, J ZOOL, V242, P261; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; Sasaki M, 2005, ANN ANAT, V187, P153, DOI 10.1016/j.aanat.2004.10.001; Schaller G. B., 1972, SERENGETI LION STUDY; Schaller GB., 1967, DEER TIGER; SCHULTZ C B, 1970, Bulletin of the University of Nebraska State Museum, V9, P33; Sorkin B, 2008, LETHAIA, V41, P333, DOI 10.1111/j.1502-3931.2007.00091.x; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; Turner A., 1997, BIG CATS THEIR FOSSI; van Valkenburgh B., 1987, Journal of Vertebrate Paleontology, V7, P162; Van Valkenburgh Blaire, 1998, Illinois State Museum Scientific Papers, V27, P357; VANVALKENBURGH B, 1987, J ZOOL, V212, P379; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, ZOOLOGY, V111, P196, DOI 10.1016/j.zool.2007.07.008	55	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11412	10.1371/journal.pone.0011412	http://dx.doi.org/10.1371/journal.pone.0011412			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20625398	Green Published, gold			2022-12-27	WOS:000279465700004
J	Hess, D; Chisholm, JW; Igal, RA				Hess, Daniel; Chisholm, Jeffrey W.; Igal, R. Ariel			Inhibition of StearoylCoA Desaturase Activity Blocks Cell Cycle Progression and Induces Programmed Cell Death in Lung Cancer Cells	PLOS ONE			English	Article							ACETYL-COA CARBOXYLASE; FATTY-ACID SYNTHASE; GROWTH-FACTOR RECEPTOR; MEMBRANE-FLUIDITY; ACTIVATION; PROLIFERATION; PATHWAY; ENZYMES; PROTEIN; BIOSYNTHESIS	Lung cancer is the most frequent form of cancer. The survival rate for patients with metastatic lung cancer is similar to 5%, hence alternative therapeutic strategies to treat this disease are critically needed. Recent studies suggest that lipid biosynthetic pathways, particularly fatty acid synthesis and desaturation, are promising molecular targets for cancer therapy. We have previously reported that inhibition of stearoylCoA desaturase-1 (SCD1), the enzyme that produces monounsaturated fatty acids (MUFA), impairs lung cancer cell proliferation, survival and invasiveness, and dramatically reduces tumor formation in mice. In this report, we show that inhibition of SCD activity in human lung cancer cells with the small molecule SCD inhibitor CVT-11127 reduced lipid synthesis and impaired proliferation by blocking the progression of cell cycle through the G(1)/S boundary and by triggering programmed cell death. These alterations resulting from SCD blockade were fully reversed by either oleic (18: 1n-9), palmitoleic acid (16: 1n-7) or cis-vaccenic acid (18: 1n-7) demonstrating that cis-MUFA are key molecules for cancer cell proliferation. Additionally, co-treatment of cells with CVT-11127 and CP-640186, a specific acetylCoA carboxylase (ACC) inhibitor, did not potentiate the growth inhibitory effect of these compounds, suggesting that inhibition of ACC or SCD1 affects a similar target critical for cell proliferation, likely MUFA, the common fatty acid product in the pathway. This hypothesis was further reinforced by the observation that exogenous oleic acid reverses the anti-growth effect of SCD and ACC inhibitors. Finally, exogenous oleic acid restored the globally decreased levels of cell lipids in cells undergoing a blockade of SCD activity, indicating that active lipid synthesis is required for the fatty acid-mediated restoration of proliferation in SCD1-inhibited cells. Altogether, these observations suggest that SCD1 controls cell cycle progression and apoptosis and, consequently, the overall rate of proliferation in cancer cells through MUFA-mediated activation of lipid synthesis.	[Hess, Daniel; Igal, R. Ariel] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA; [Hess, Daniel; Igal, R. Ariel] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08903 USA; [Chisholm, Jeffrey W.] Gilead Sci Inc, Biol, Palo Alto, CA USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Gilead Sciences	Hess, D (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08903 USA.	igal@aesop.rutgers.edu			Pfizer [CP-480186]; School of Environmental and Biological Sciences; Johanna and Charles Busch Foundation, Rutgers University; US Department of Agriculture; Gilead Sciences Inc. [CVT-11127]	Pfizer(Pfizer); School of Environmental and Biological Sciences; Johanna and Charles Busch Foundation, Rutgers University; US Department of Agriculture(United States Department of Agriculture (USDA)); Gilead Sciences Inc.(Gilead Sciences)	We are indebted to Dr Donnie Owens, Pfizer, for the generous donation of CP-480186.; This work was supported in part by funds from the School of Environmental and Biological Sciences and the Johanna and Charles Busch Foundation, Rutgers University, and a Hatch grant from the US Department of Agriculture. Gilead Sciences Inc. provided CVT-11127 in support of the studies and JWC contributed scientifically to the interpretation of the data and writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chang YS, 2005, J LIPID RES, V46, P2624, DOI 10.1194/jlr.M500154-JLR200; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Cui Z, 1996, J BIOL CHEM, V271, P14668, DOI 10.1074/jbc.271.25.14668; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Demoulin JB, 2004, J BIOL CHEM, V279, P35392, DOI 10.1074/jbc.M405924200; Dubey S, 2006, LANCET ONCOL, V7, P416, DOI 10.1016/S1470-2045(06)70693-3; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Falvella FS, 2002, CARCINOGENESIS, V23, P1933, DOI 10.1093/carcin/23.11.1933; Ge GX, 2001, BIOCHEM BIOPH RES CO, V282, P511, DOI 10.1006/bbrc.2001.4600; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Harwood HJ, 2003, J BIOL CHEM, V278, P37099, DOI 10.1074/jbc.M304481200; JACKOWSKI S, 1994, J BIOL CHEM, V269, P3858; Jackowski S, 1996, J BIOL CHEM, V271, P20219, DOI 10.1074/jbc.271.34.20219; Knowles LM, 2004, J BIOL CHEM, V279, P30540, DOI 10.1074/jbc.M405061200; Koltun DO, 2009, BIOORG MED CHEM LETT, V19, P2048, DOI 10.1016/j.bmcl.2009.02.019; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; LI LO, BIOCH BIOPHYS ACTA, V1801, P246; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; McDonnel AC, 2003, EXP BIOL MED, V228, P308, DOI 10.1177/153537020322800310; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; Porstmann T, 2005, ONCOGENE, V24, P6465, DOI 10.1038/sj.onc.1208802; Scaglia N, 2005, J BIOL CHEM, V280, P25339, DOI 10.1074/jbc.M501159200; Scaglia N, 2005, BBA-MOL CELL BIOL L, V1687, P141, DOI 10.1016/j.bbalip.2004.11.015; Scaglia N, 2008, INT J ONCOL, V33, P839, DOI 10.3892/ijo_00000072; Scaglia N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006812; Sok M, 2002, ANN THORAC SURG, V73, P1567, DOI 10.1016/S0003-4975(02)03458-6; Sok M, 1999, CANCER LETT, V139, P215, DOI 10.1016/S0304-3835(99)00044-0; Takahashi-Yanaga F, 2008, CELL SIGNAL, V20, P581, DOI 10.1016/j.cellsig.2007.10.018; Vacaresse N, 1999, CIRC RES, V85, P892; Wang J, 2005, BIOCHEM BIOPH RES CO, V332, P735, DOI 10.1016/j.bbrc.2005.05.013; Yahagi N, 2005, EUR J CANCER, V41, P1316, DOI 10.1016/j.ejca.2004.12.037; Zhang L, 1999, BIOCHEM J, V340, P255, DOI 10.1042/0264-6021:3400255	37	131	143	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11394	10.1371/journal.pone.0011394	http://dx.doi.org/10.1371/journal.pone.0011394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613975	Green Published, Green Submitted, gold			2022-12-27	WOS:000279370000022
J	Borkow, G; Zhou, SS; Page, T; Gabbay, J				Borkow, Gadi; Zhou, Steve S.; Page, Tom; Gabbay, Jeffrey			A Novel Anti-Influenza Copper Oxide Containing Respiratory Face Mask	PLOS ONE			English	Article							VIRUS; INFLUENZA; INACTIVATION; INFECTION; IONS; INTERVENTIONS; TRANSMISSION; EMERGENCE; FILTERS; HUMANS	Background: Protective respiratory face masks protect the nose and mouth of the wearer from vapor drops carrying viruses or other infectious pathogens. However, incorrect use and disposal may actually increase the risk of pathogen transmission, rather than reduce it, especially when masks are used by non-professionals such as the lay public. Copper oxide displays potent antiviral properties. A platform technology has been developed that permanently introduces copper oxide into polymeric materials, conferring them with potent biocidal properties. Methodology/Principal Findings: We demonstrate that impregnation of copper oxide into respiratory protective face masks endows them with potent biocidal properties in addition to their inherent filtration properties. Both control and copper oxide impregnated masks filtered above 99.85% of aerosolized viruses when challenged with 5.66 +/- 0.51 and 6.17 +/- 0.37 log(10)TCID(50) of human influenza A virus (H1N1) and avian influenza virus (H9N2), respectively, under simulated breathing conditions (28.3 L/min). Importantly, no infectious human influenza A viral titers were recovered from the copper oxide containing masks within 30 minutes (<= 0.88 log(10)TCID(50)), while 4.67 +/- 1.35 log(10)TCID(50) were recovered from the control masks. Similarly, the infectious avian influenza titers recovered from the copper oxide containing masks were <= 0.97 +/- 0.01 log(10)TCID(50) and from the control masks 5.03 +/- 0.54 log(10)TCID(50). The copper oxide containing masks successfully passed Bacterial Filtration Efficacy, Differential Pressure, Latex Particle Challenge, and Resistance to Penetration by Synthetic Blood tests designed to test the filtration properties of face masks in accordance with the European EN 14683: 2005 and NIOSH N95 standards. Conclusions/Significance: Impregnation of copper oxide into respiratory protective face masks endows them with potent anti-influenza biocidal properties without altering their physical barrier properties. The use of biocidal masks may significantly reduce the risk of hand or environmental contamination, and thereby subsequent infection, due to improper handling and disposal of the masks.	[Borkow, Gadi; Page, Tom; Gabbay, Jeffrey] Cupron Sci, Modiin, Israel; [Zhou, Steve S.] Microbac Labs Inc, Microbiotest, Sterling, VA USA		Borkow, G (corresponding author), Cupron Sci, Modiin, Israel.	gadi@cupron.com	Borkow, Gadi/W-4294-2019		Cupron Scientific	Cupron Scientific	The study was funded by Cupron Scientific, a company that conducts research and development of medical devices using copper oxide as the active ingredient. Cupron Scientific developed the antiviral mask, and had a role in the study design and decision to publish and preparation of the manuscript.	Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; [Anonymous], 2004, TOX PROF COPP; Aragon D, 2005, AACN ADV CRIT CARE, V16, P121, DOI 10.1097/00044067-200504000-00002; Borkow G, 2005, CURR MED CHEM, V12, P2163, DOI 10.2174/0929867054637617; Borkow G, 2004, FASEB J, V18, P1728, DOI 10.1096/fj.04-2029fje; Borkow G, 2009, CURR CHEM BIOL, V3, P272, DOI DOI 10.2174/187231309789054887; Borkow G, 2008, ANTIMICROB AGENTS CH, V52, P518, DOI 10.1128/AAC.00899-07; Borkow G, 2007, ANTIMICROB AGENTS CH, V51, P2605, DOI 10.1128/AAC.00125-07; *CDCP, 2006, INT GUID PROT PERS I; Chatterjee A, 2004, INFECT CONT HOSP EP, V25, P786, DOI 10.1086/502479; Cohen B, 2003, PEDIATR INFECT DIS J, V22, P494, DOI 10.1097/00006454-200306000-00003; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Edmiston CE, 2005, SURGERY, V138, P573, DOI 10.1016/j.surg.2005.06.045; Gabbay J., 2006, J IND TEXT, V35, P323, DOI [10.1177/1528083706060785, DOI 10.1177/1528083706060785]; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gorter Robert W, 2004, Am J Ther, V11, P453, DOI 10.1097/01.mjt.0000127148.83065.e5; Gould D, 1996, INT J NURS STUD, V33, P143, DOI 10.1016/0020-7489(95)00048-8; Hensley Scott E, 2009, Expert Rev Anti Infect Ther, V7, P763, DOI 10.1586/eri.09.62; Horie M, 2008, ARCH VIROL, V153, P1467, DOI 10.1007/s00705-008-0154-2; Hostynek Jurij J, 2003, Rev Environ Health, V18, P153; *INT, 2009, EDANA REIT WHO ADV F; JEFFERSON T, 2007, COCHRANE DATABASE SY, V6207; Jefferson T, 2008, BMJ-BRIT MED J, V336, P77, DOI 10.1136/bmj.b3675; JORDAN FTW, 1971, VET REC, V89, P609, DOI 10.1136/vr.89.23.609; KARLSTROM AR, 1991, P NATL ACAD SCI USA, V88, P5552, DOI 10.1073/pnas.88.13.5552; Katz Jonathan D, 2004, Anesthesiol Clin North Am, V22, P457, DOI 10.1016/S0889-8537(04)00027-6; Landolt Gabriele A., 2007, Animal Health Research Reviews, V8, P1, DOI 10.1017/S1466252307001272; Noyce JO, 2007, APPL ENVIRON MICROB, V73, P2748, DOI 10.1128/AEM.01139-06; *OSHA, 2004, GUID PROT WORK AV FL; Owers KL, 2004, J HOSP INFECT, V58, P230, DOI 10.1016/j.jhin.2004.06.028; Sagripanti JL, 1996, AIDS RES HUM RETROV, V12, P333, DOI 10.1089/aid.1996.12.333; Sagripanti JL, 1997, ANTIMICROB AGENTS CH, V41, P812, DOI 10.1128/AAC.41.4.812; SAGRIPANTI JL, 1993, APPL ENVIRON MICROB, V59, P4374, DOI 10.1128/AEM.59.12.4374-4376.1993; Schnitzler SU, 2009, VIRUS GENES, V39, P279, DOI 10.1007/s11262-009-0404-8; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SPEARMAN C, TITERBESTRIMMUNG, P37; Yahaya M. T., 2001, INACTIVATION POLIOVI; Zatcoff Richard C, 2008, Foot (Edinb), V18, P136, DOI 10.1016/j.foot.2008.03.005	39	206	209	7	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11295	10.1371/journal.pone.0011295	http://dx.doi.org/10.1371/journal.pone.0011295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20592763	gold, Green Published, Green Submitted			2022-12-27	WOS:000279140800006
J	Nemeth, D; Janacsek, K; Balogh, V; Londe, Z; Mingesz, R; Fazekas, M; Jambori, S; Danyi, I; Vetro, A				Nemeth, Dezso; Janacsek, Karolina; Balogh, Virag; Londe, Zsuzsa; Mingesz, Robert; Fazekas, Marta; Jambori, Szilvia; Danyi, Izabella; Vetro, Agnes			Learning in Autism: Implicitly Superb	PLOS ONE			English	Article							SEQUENCE; EXPLICIT; MEMORY; CONSOLIDATION; SPECTRUM; AGE; INDIVIDUALS; PERFORMANCE; NETWORKS; BENEFITS	Background: Although autistic people have shown impairments in various learning and memory tasks, recent studies have reported mixed findings concerning implicit learning in ASD. Implicit skill learning, with its unconscious and statistical properties, underlies not only motor but also cognitive and social skills, and it therefore plays an important role from infancy to old age. Methodology/Principal Findings: We investigated probabilistic implicit sequence learning and its consolidation in Autism Spectrum Disorder (ASD). Three groups of children participated: thirteen with high-functioning ASD, 14 age-matched controls, and 13 IQ-matched controls. All were tested on the Alternating Serial Reaction Time Task (ASRT), making it possible to separate general skill learning from sequence-specific learning. The ASRT task was repeated after 16 hours. We found that control and ASD children showed similar sequence-specific and general skill learning in the learning phase. Consolidation of skill learning and sequence-specific learning were also intact in the ASD compared to the control groups. Conclusions/Significance: These results suggest that autistic children can use the effects/results of implicit learning not only for a short period, but also for a longer stretch of time. Using these findings, therapists can design more effective educational and rehabilitation programs.	[Nemeth, Dezso; Janacsek, Karolina; Balogh, Virag; Fazekas, Marta; Jambori, Szilvia] Univ Szeged, Inst Psychol, Szeged, Hungary; [Londe, Zsuzsa] Univ So Calif, Amer Language Inst, Los Angeles, CA USA; [Mingesz, Robert] Univ Szeged, Dept Expt Phys, Szeged, Hungary; [Danyi, Izabella; Vetro, Agnes] Univ Szeged, Dept Child & Adolescent Psychiat, Szeged, Hungary; [Balogh, Virag] Univ Szeged, Grad Sch Educ Sci, Szeged, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Szeged University; University of Southern California; Szeged University; Szeged University; Szeged University	Nemeth, D (corresponding author), Univ Szeged, Inst Psychol, Szeged, Hungary.	nemethd@edpsy.u-szeged.hu	Nemeth, Dezso/B-9142-2009; Janacsek, Karolina/H-8639-2017; Janacsek, Karolina/P-2957-2019	Nemeth, Dezso/0000-0002-9629-5856; Janacsek, Karolina/0000-0001-7829-8220; Janacsek, Karolina/0000-0001-7829-8220	Hungarian Scientific Research Fund [OTKA K69018, OTKA K82068]; Bolyai Scholarship Program	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Scholarship Program	The authors are grateful to the Hungarian Scientific Research Fund (OTKA K69018 and OTKA K82068) and Bolyai Scholarship Program for supporting their work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; APA A. P. A, 1994, DIAGN STAT MAN MENT; Barnes KA, 2008, NEUROPSYCHOLOGY, V22, P563, DOI 10.1037/0894-4105.22.5.563; Ben Shalom D, 2003, CORTEX, V39, P1129; BROWN J, 2010, Q J EXPT PSYCHOL, P1; Dawson M, 2008, LEARNING MEMORY COMP, P759; Destrebecqz A, 2001, PSYCHON B REV, V8, P343, DOI 10.3758/BF03196171; Destrebecqz A., 2003, ADV CONSCIOUSNESS RE, V48, P181, DOI [10.1075/aicr.48.11des, DOI 10.1075/AICR.48.11DES]; Doyon J, 2009, BEHAV BRAIN RES, V199, P61, DOI 10.1016/j.bbr.2008.11.012; Fletcher PC, 2005, CEREB CORTEX, V15, P1002, DOI 10.1093/cercor/bhh201; Gebauer GF, 2007, J EXP PSYCHOL LEARN, V33, P34, DOI 10.1037/0278-7393.33.1.34; Gordon B., 2007, FOCUS AUTISM DEV DIS, V22, P14, DOI [DOI 10.1177/10883576070220010201, 10.1177/10883576070220010201]; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hikosaka O, 2002, CURR OPIN NEUROBIOL, V12, P217, DOI 10.1016/S0959-4388(02)00307-0; Hill E, 2004, J AUTISM DEV DISORD, V34, P229, DOI 10.1023/B:JADD.0000022613.41399.14; Howard DV, 2004, PSYCHOL AGING, V19, P79, DOI 10.1037/0882-7974.19.1.79; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; JIMENEZ L, 1996, PSYCHE INTERDISCIPLI, V2; Kineses ZT, 2008, NEUROIMAGE, V39, P1950, DOI 10.1016/j.neuroimage.2007.09.070; Krakauer JW, 2006, TRENDS NEUROSCI, V29, P58, DOI 10.1016/j.tins.2005.10.003; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Minshew NJ, 2001, J CHILD PSYCHOL PSYC, V42, P1095, DOI 10.1111/1469-7610.00808; Mostofsky SH, 2000, J INT NEUROPSYCH SOC, V6, P752, DOI 10.1017/S1355617700677020; Muller RA, 2001, BIOL PSYCHIAT, V49, P665, DOI 10.1016/S0006-3223(00)01004-0; Nemeth D, 2010, EXP BRAIN RES, V201, P351, DOI 10.1007/s00221-009-2024-x; Nemeth D, 2009, NEUROREPORT, V20, P1654, DOI 10.1097/WNR.0b013e328333ba08; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Rauch SL, 1997, HUM BRAIN MAPP, V5, P124, DOI 10.1002/(SICI)1097-0193(1997)5:2<124::AID-HBM6>3.3.CO;2-P; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1991, J EXP PSYCHOL LEARN, V17, P888, DOI 10.1037/0278-7393.17.5.888; Remillard G, 2008, Q J EXP PSYCHOL, V61, P400, DOI 10.1080/17470210701210999; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Robertson EM, 2004, CURR BIOL, V14, P208, DOI 10.1016/j.cub.2004.01.027; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schvaneveldt RW, 1998, PSYCHOL RES-PSYCH FO, V61, P175, DOI 10.1007/s004260050023; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Song SB, 2009, BEHAV BRAIN RES, V196, P180, DOI 10.1016/j.bbr.2008.09.034; Toichi M, 2003, J AUTISM DEV DISORD, V33, P151, DOI 10.1023/A:1022935325843; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Willingham DB, 1997, NEURON, V18, P5, DOI 10.1016/S0896-6273(01)80040-4	44	54	54	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11731	10.1371/journal.pone.0011731	http://dx.doi.org/10.1371/journal.pone.0011731			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	630AN	20661300	Green Published, gold, Green Accepted			2022-12-27	WOS:000280243300029
J	Silva, LCR; Anand, M; Leithead, MD				Silva, Lucas C. R.; Anand, Madhur; Leithead, Mark D.			Recent Widespread Tree Growth Decline Despite Increasing Atmospheric CO2	PLOS ONE			English	Article							WATER-USE EFFICIENCY; NITROGEN LIMITATION; CLIMATE-CHANGE; RING EVIDENCE; ELEVATED CO2; FOREST; DELTA-C-13; CARBON; ECOSYSTEMS; FEEDBACKS	Background: The synergetic effects of recent rising atmospheric CO2 and temperature are expected to favor tree growth in boreal and temperate forests. However, recent dendrochronological studies have shown site-specific unprecedented growth enhancements or declines. The question of whether either of these trends is caused by changes in the atmosphere remains unanswered because dendrochronology alone has not been able to clarify the physiological basis of such trends. Methodology/Principal Findings: Here we combined standard dendrochronological methods with carbon isotopic analysis to investigate whether atmospheric changes enhanced water use efficiency (WUE) and growth of two deciduous and two coniferous tree species along a 9 degrees latitudinal gradient across temperate and boreal forests in Ontario, Canada. Our results show that although trees have had around 53% increases in WUE over the past century, growth decline (measured as a decrease in basal area increment - BAI) has been the prevalent response in recent decades irrespective of species identity and latitude. Since the 1950s, tree BAI was predominantly negatively correlated with warmer climates and/or positively correlated with precipitation, suggesting warming induced water stress. However, where growth declines were not explained by climate, WUE and BAI were linearly and positively correlated, showing that declines are not always attributable to warming induced stress and additional stressors may exist. Conclusions: Our results show an unexpected widespread tree growth decline in temperate and boreal forests due to warming induced stress but are also suggestive of additional stressors. Rising atmospheric CO2 levels during the past century resulted in consistent increases in water use efficiency, but this did not prevent growth decline. These findings challenge current predictions of increasing terrestrial carbon stocks under climate change scenarios.	[Silva, Lucas C. R.; Anand, Madhur; Leithead, Mark D.] Univ Guelph, Sch Environm Sci, Global Ecol Change Lab, Guelph, ON N1G 2W1, Canada	University of Guelph	Silva, LCR (corresponding author), Univ Guelph, Sch Environm Sci, Global Ecol Change Lab, Guelph, ON N1G 2W1, Canada.	manand@uoguelph.ca	Silva, Lucas/AAA-2476-2022; Silva, Lucas C R/E-1202-2016	Silva, Lucas/0000-0002-4838-327X; Silva, Lucas C R/0000-0002-4838-327X	Inter-American Institute for Global Change Research; Natural Sciences and Engineering Council of Canada; Canadian Foundation for Innovation; University of Guelph	Inter-American Institute for Global Change Research; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); University of Guelph	This work was funded by Inter-American Institute for Global Change Research, the Natural Sciences and Engineering Council of Canada, the Canadian Foundation for Innovation, and the University of Guelph grants to M.A. who holds the Canada Research Chair in Global Ecological Change. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigelow SW, 2007, FOREST ECOL MANAG, V243, P310, DOI 10.1016/j.foreco.2007.03.027; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Caplat P, 2008, THEOR ECOL-NETH, V1, P209, DOI 10.1007/s12080-008-0021-5; D'Arrigo R, 2008, GLOBAL PLANET CHANGE, V60, P289, DOI 10.1016/j.gloplacha.2007.03.004; DeLuca TH, 2008, SCIENCE, V320, P1181, DOI 10.1126/science.1154836; Finzi AC, 2006, ECOLOGY, V87, P15, DOI 10.1890/04-1748; FRANCEY RJ, 1982, NATURE, V297, P28, DOI 10.1038/297028a0; Gradowski T, 2006, FOREST ECOL MANAG, V226, P104, DOI 10.1016/j.foreco.2005.12.062; Guiot J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009972; Hietz P, 2005, TREE PHYSIOL, V25, P745, DOI 10.1093/treephys/25.6.745; Hill AR, 1999, WATER RESOUR RES, V35, P811, DOI 10.1029/1998WR900083; Huang JG, 2007, CRIT REV PLANT SCI, V26, P265, DOI 10.1080/07352680701626978; Jeziorski A, 2008, SCIENCE, V322, P1374, DOI 10.1126/science.1164949; LAMARCHE VC, 1984, SCIENCE, V225, P1019, DOI 10.1126/science.225.4666.1019; Leotard G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005377; Linares JC, 2009, OECOLOGIA, V161, P611, DOI 10.1007/s00442-009-1409-7; Lloyd J, 2008, PHILOS T R SOC B, V363, P1811, DOI 10.1098/rstb.2007.0032; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Manning WJ, 2005, ENVIRON POLLUT, V137, P443, DOI 10.1016/j.envpol.2005.01.031; McCarroll D, 2004, QUATERNARY SCI REV, V23, P771, DOI 10.1016/j.quascirev.2003.06.017; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Novak K, 2007, TREE PHYSIOL, V27, P941, DOI 10.1093/treephys/27.7.941; Penuelas J, 2008, GLOBAL CHANGE BIOL, V14, P1076, DOI 10.1111/j.1365-2486.2008.01563.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Salzer MW, 2009, P NATL ACAD SCI USA, V106, P20348, DOI 10.1073/pnas.0903029106; Saurer M, 2004, GLOBAL CHANGE BIOL, V10, P2109, DOI 10.1111/j.1365-2486.2004.00869.x; Schleser GH, 1985, OECOLOGIA, V65, P536, DOI 10.1007/BF00379669; Schulman E., 1956, DENDROCLIMATIC CHANG; Silva LCR, 2009, GLOBAL CHANGE BIOL, V15, P2387, DOI 10.1111/j.1365-2486.2009.01859.x; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; STERNBERG LDL, 1989, OECOLOGIA, V81, P51, DOI 10.1007/BF00377009; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Weiner J, 2001, OIKOS, V94, P374, DOI 10.1034/j.1600-0706.2001.940219.x	34	123	130	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 21	2010	5	7							e11543	10.1371/journal.pone.0011543	http://dx.doi.org/10.1371/journal.pone.0011543			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KQ	20657763	Green Published, gold, Green Submitted			2022-12-27	WOS:000280197500004
J	Devignot, S; Sapet, C; Duong, V; Bergon, A; Rihet, P; Ong, S; Lorn, PT; Chroeung, N; Ngeav, S; Tolou, HJ; Buchy, P; Couissinier-Paris, P				Devignot, Stephanie; Sapet, Cedric; Duong, Veasna; Bergon, Aurelie; Rihet, Pascal; Ong, Sivuth; Lorn, Patrich T.; Chroeung, Norith; Ngeav, Sina; Tolou, Hugues J.; Buchy, Philippe; Couissinier-Paris, Patricia			Genome-Wide Expression Profiling Deciphers Host Responses Altered during Dengue Shock Syndrome and Reveals the Role of Innate Immunity in Severe Dengue	PLOS ONE			English	Article							EOSINOPHIL-DERIVED NEUROTOXIN; DENSITY-LIPOPROTEIN RECEPTOR-1; GENE TRANSCRIPT ABUNDANCE; BLOOD MONONUCLEAR-CELLS; LIPID BODY FORMATION; PERIPHERAL-BLOOD; T-CELLS; MATRIX METALLOPROTEINASES; SYSTEMIC INFLAMMATION; OXIDATIVE STRESS	Background: Deciphering host responses contributing to dengue shock syndrome (DSS), the life-threatening form of acute viral dengue infections, is required to improve both the differential prognosis and the treatments provided to DSS patients, a challenge for clinicians. Methodology/Principal Findings: Based on a prospective study, we analyzed the genome-wide expression profiles of whole blood cells from 48 matched Cambodian children: 19 progressed to DSS while 16 and 13 presented respectively classical dengue fever (DF) or dengue hemorrhagic fever grades I/II (DHF). Using multi-way analysis of variance (ANOVA) and adjustment of p-values to control the False Discovery Rate (FDR<10%), we identified a signature of 2959 genes differentiating DSS patients from both DF and DHF, and showed a strong association of this DSS-gene signature with the dengue disease phenotype. Using a combined approach to analyse the molecular patterns associated with the DSS-gene signature, we provide an integrative overview of the transcriptional responses altered in DSS children. In particular, we show that the transcriptome of DSS children blood cells is characterized by a decreased abundance of transcripts related to T and NK lymphocyte responses and by an increased abundance of anti-inflammatory and repair/remodeling transcripts. We also show that unexpected pro-inflammatory gene patterns at the interface between innate immunity, inflammation and host lipid metabolism, known to play pathogenic roles in acute and chronic inflammatory diseases associated with systemic vascular dysfunction, are transcriptionnally active in the blood cells of DSS children. Conclusions/Significance: We provide a global while non exhaustive overview of the molecular mechanisms altered in of DSS children and suggest how they may interact to lead to final vascular homeostasis breakdown. We suggest that some mechanisms identified should be considered putative therapeutic targets or biomarkers of progression to DSS.	[Devignot, Stephanie; Sapet, Cedric; Tolou, Hugues J.; Couissinier-Paris, Patricia] Antenne de Marseille IMTSSA, French Army Biomed Res Inst, IRBA, Marseille, France; [Devignot, Stephanie; Sapet, Cedric; Tolou, Hugues J.; Couissinier-Paris, Patricia] Unite Virol, Marseille, France; [Duong, Veasna; Ong, Sivuth; Buchy, Philippe] Inst Pasteur Cambodia, Dept Virol, Phnom Penh, Cambodia; [Bergon, Aurelie; Rihet, Pascal] TAGC INSERM, U928, Marseille, France; [Lorn, Patrich T.; Chroeung, Norith; Ngeav, Sina] Kampong Cham Prov Hosp, Kampong Cham, Cambodia	UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Devignot, S (corresponding author), Antenne de Marseille IMTSSA, French Army Biomed Res Inst, IRBA, Marseille, France.	parisp@imtssa.fr	Rihet, Pascal/AAD-2018-2022; Devignot, Stéphanie/AAC-5765-2019; Rihet, Pascal/L-2173-2016; Veasna, Duong/I-9684-2014; Bergon, Aurélie/M-4977-2016; Rihet, Pascal/GQP-1381-2022	Rihet, Pascal/0000-0002-9459-3905; Devignot, Stéphanie/0000-0002-0618-5611; Rihet, Pascal/0000-0002-9459-3905; Veasna, Duong/0000-0003-0353-1678; Bergon, Aurélie/0000-0003-1518-4562; Rihet, Pascal/0000-0002-9459-3905; BUCHY, Philippe/0000-0003-1372-3008	French Army Medical Health Service (Service de Sante des Armees Francaises) [PRC 2007-13]	French Army Medical Health Service (Service de Sante des Armees Francaises)	This work was supported by a clinical research program PRC 2007-13 from the French Army Medical Health Service (Service de Sante des Armees Francaises). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2001, J LIPID RES, V42, P1717; Bandyopadhyay S, 2006, TROP MED INT HEALTH, V11, P1238, DOI 10.1111/j.1365-3156.2006.01678.x; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boot RG, 1999, ARTERIOSCL THROM VAS, V19, P687, DOI 10.1161/01.ATV.19.3.687; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Buchy Philippe, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P178; Butthep P, 1993, Southeast Asian J Trop Med Public Health, V24 Suppl 1, P246; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Chaturvedi UC, 2007, FEMS IMMUNOL MED MIC, V50, P285, DOI 10.1111/j.1574-695X.2007.00273.x; Chen XP, 2007, CARDIOVASC DRUG REV, V25, P146, DOI 10.1111/j.1527-3466.2007.00009.x; Cho HJ, 2009, CURR ATHEROSCLER REP, V11, P206, DOI 10.1007/s11883-009-0032-8; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Cipollone F, 2004, ARTERIOSCL THROM VAS, V24, P1259, DOI 10.1161/01.ATV.0000133192.39901.be; Claus RA, 2010, CURR MOL MED, V10, P227, DOI 10.2174/156652410790963358; Cobb JP, 2005, P NATL ACAD SCI USA, V102, P4801, DOI 10.1073/pnas.0409768102; de Assis EF, 2003, J IMMUNOL, V171, P2090, DOI 10.4049/jimmunol.171.4.2090; de Kruif MD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000215; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Deng YM, 2010, J MOL CELL CARDIOL, V48, P331, DOI 10.1016/j.yjmcc.2009.10.022; Didier G, 2002, BIOINFORMATICS, V18, P490, DOI 10.1093/bioinformatics/18.3.490; DiStasi MR, 2009, TRENDS IMMUNOL, V30, P539, DOI 10.1016/j.it.2009.07.012; Dyrskjot L, 2007, CLIN CANCER RES, V13, P3545, DOI 10.1158/1078-0432.CCR-06-2940; Eady JJ, 2005, PHYSIOL GENOMICS, V22, P402, DOI 10.1152/physiolgenomics.00080.2005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Feezor RJ, 2005, CLIN INFECT DIS, V41, pS427, DOI 10.1086/431993; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Forte TM, 2002, J LIPID RES, V43, P477; Galley HF, 2004, BRIT J ANAESTH, V93, P105, DOI 10.1093/bja/aeh163; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gilroy DW, 2004, FASEB J, V18, P489, DOI 10.1096/fj.03-0837com; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Green S, 2006, CURR OPIN INFECT DIS, V19, P429, DOI 10.1097/01.qco.0000244047.31135.fa; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hennuyer N, 2005, ARTERIOSCL THROM VAS, V25, P1897, DOI 10.1161/01.ATV.0000175756.56818.ee; Homaidan FR, 2002, CURR PROTEIN PEPT SC, V3, P467, DOI 10.2174/1389203023380585; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Howard JK, 2006, TRENDS ENDOCRIN MET, V17, P365, DOI 10.1016/j.tem.2006.09.007; Hung NT, 2005, AM J TROP MED HYG, V72, P370; Joshi PC, 2001, J IMMUNOL, V166, P885, DOI 10.4049/jimmunol.166.2.885; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378; Kerr MK, 2000, J COMPUT BIOL, V7, P819, DOI 10.1089/10665270050514954; Khanapure SP, 2007, CURR TOP MED CHEM, V7, P311, DOI 10.2174/156802607779941314; Khun S, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-10; Kim KD, 2007, NAT MED, V13, P1248, DOI 10.1038/nm1633; Koraka P, 2004, J MED VIROL, V72, P445, DOI 10.1002/jmv.20007; Kruger PS, 2009, CRIT CARE RESUSC, V11, P305; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; LEE CY, 2008, ANTIOXID REDOX SIGNA; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Lima JJ, 2009, CURR OPIN PULM MED, V15, P57, DOI 10.1097/MCP.0b013e32831da8be; Lin CF, 2006, VIRAL IMMUNOL, V19, P127, DOI 10.1089/vim.2006.19.127; Long HT, 2009, J INFECT DIS, V199, P537, DOI 10.1086/596507; Lorente L, 2010, CRIT CARE, V14, DOI 10.1186/cc8211; Luplerdlop N, 2006, EMBO REP, V7, P1176, DOI 10.1038/sj.embor.7400814; Mairuhu ATA, 2005, J MED VIROL, V76, P547, DOI 10.1002/jmv.20397; Makowski L, 2005, CURR OPIN LIPIDOL, V16, P543, DOI 10.1097/01.mol.0000180166.08196.07; Marik PE, 2006, CRIT CARE CLIN, V22, P151, DOI 10.1016/j.ccc.2005.08.008; Michelsen KS, 2004, J IMMUNOL, V173, P5901, DOI 10.4049/jimmunol.173.10.5901; Mockenhaupt FP, 2006, P NATL ACAD SCI USA, V103, P177, DOI 10.1073/pnas.0506803102; Mosig S, 2009, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-60; Murgue B, 2000, J MED VIROL, V60, P432, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;432::AID-JMV11&gt;3.0.CO;2-7; Murgue B, 2010, MICROBES INFECT, V12, P113, DOI 10.1016/j.micinf.2009.11.006; Mustafa AS, 2001, FEMS IMMUNOL MED MIC, V30, P229, DOI 10.1111/j.1574-695X.2001.tb01575.x; Ng CFS, 2007, J CLIN VIROL, V40, P202, DOI 10.1016/j.jcv.2007.08.017; O'Neill LA, 2003, CURR OPIN PHARMACOL, V3, P396, DOI 10.1016/S1471-4892(03)00080-8; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Pang T, 2007, IMMUNOL CELL BIOL, V85, P43, DOI 10.1038/sj.icb.7100008; Panpanich R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003488.pub2; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Pedra JHF, 2009, CURR OPIN IMMUNOL, V21, P10, DOI 10.1016/j.coi.2009.01.006; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Peters KG, 1998, CIRC RES, V83, P342, DOI 10.1161/01.RES.83.3.342; Predescu D, 2005, AM J PHYSIOL-LUNG C, V289, pL371, DOI 10.1152/ajplung.00175.2004; QATANANI M, 2009, J CLIN INVEST; Quinn K, 2008, AM J PHYSIOL-HEART C, V295, pH1817, DOI 10.1152/ajpheart.00472.2008; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Ray G, 1999, J TROP PEDIATRICS, V45, P4, DOI 10.1093/tropej/45.1.4; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Renier G, 2007, CURR DIABETES REV, V3, P103, DOI 10.2174/157339907780598225; Reynes JM, 2003, J CLIN MICROBIOL, V41, P3864, DOI 10.1128/JCM.41.8.3864-3867.2003; Rossi A, 2009, CURR VASC PHARMACOL, V7, P185, DOI 10.2174/157016109787455725; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schaible UE, 2007, PLOS MED, V4, P806, DOI 10.1371/journal.pmed.0040115; Schmitz G, 2008, REV PHYSIOL BIOCH P, V160, P93, DOI 10.1007/112_2008_802; Sesti G, 2001, FASEB J, V15, P2099, DOI 10.1096/fj.01-0009rev; Simmons CP, 2007, J INFECT DIS, V195, P1097, DOI 10.1086/512162; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Soundravally R, 2008, PLATELETS, V19, P447, DOI 10.1080/09537100802155284; STOBO JD, 1979, J CLIN INVEST, V64, P1188, DOI 10.1172/JCI109572; Sur S, 1998, J LEUKOCYTE BIOL, V63, P715, DOI 10.1002/jlb.63.6.715; Suvarna JC, 2009, TROP MED INT HEALTH, V14, P576, DOI 10.1111/j.1365-3156.2009.02261.x; Szanto A, 2008, FEBS LETT, V582, P106, DOI 10.1016/j.febslet.2007.11.020; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tseng CS, 2005, FEMS IMMUNOL MED MIC, V43, P99, DOI 10.1016/j.femsim.2004.10.004; Ubol S, 2008, J INFECT DIS, V197, P1459, DOI 10.1086/587699; van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; WHO, 1997, DENG HAEM FEV DIAGN; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wittwer J, 2007, PROSTAG LEUKOTR ESS, V77, P67, DOI 10.1016/j.plefa.2007.08.001; World Health Organization, 2009, DENGUE GUIDELINES DI; Yagmur E, 2006, AM J GASTROENTEROL, V101, P1244, DOI 10.1111/j.1572-0241.2006.00543.x; Yang D, 2004, J IMMUNOL, V173, P6134, DOI 10.4049/jimmunol.173.10.6134; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zhang JR, 2008, J CLIN INVEST, V118, P2281, DOI [10.1172/JCI32561, 10.1172/JC132561]; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105	136	49	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2010	5	7							e11671	10.1371/journal.pone.0011671	http://dx.doi.org/10.1371/journal.pone.0011671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628II	20652028	Green Published, Green Submitted, gold			2022-12-27	WOS:000280109700006
J	Chan, TC; King, CC; Yen, MY; Chiang, PH; Huang, CS; Hsiao, CK				Chan, Ta-Chien; King, Chwan-Chuen; Yen, Muh-Yong; Chiang, Po-Huang; Huang, Chao-Sheng; Hsiao, Chuhsing K.			Probabilistic Daily ILI Syndromic Surveillance with a Spatio-Temporal Bayesian Hierarchical Model	PLOS ONE			English	Article							INFLUENZA SURVEILLANCE; HEALTH SURVEILLANCE; TRANSMISSION; VIRUS; TEMPERATURE; OUTBREAKS; HUMIDITY; DISEASE; TAIWAN; IMPACT	Background: For daily syndromic surveillance to be effective, an efficient and sensible algorithm would be expected to detect aberrations in influenza illness, and alert public health workers prior to any impending epidemic. This detection or alert surely contains uncertainty, and thus should be evaluated with a proper probabilistic measure. However, traditional monitoring mechanisms simply provide a binary alert, failing to adequately address this uncertainty. Methods and Findings: Based on the Bayesian posterior probability of influenza-like illness (ILI) visits, the intensity of outbreak can be directly assessed. The numbers of daily emergency room ILI visits at five community hospitals in Taipei City during 2006-2007 were collected and fitted with a Bayesian hierarchical model containing meteorological factors such as temperature and vapor pressure, spatial interaction with conditional autoregressive structure, weekend and holiday effects, seasonality factors, and previous ILI visits. The proposed algorithm recommends an alert for action if the posterior probability is larger than 70%. External data from January to February of 2008 were retained for validation. The decision rule detects successfully the peak in the validation period. When comparing the posterior probability evaluation with the modified Cusum method, results show that the proposed method is able to detect the signals 1-2 days prior to the rise of ILI visits. Conclusions: This Bayesian hierarchical model not only constitutes a dynamic surveillance system but also constructs a stochastic evaluation of the need to call for alert. The monitoring mechanism provides earlier detection as well as a complementary tool for current surveillance programs.	[Chan, Ta-Chien; King, Chwan-Chuen; Hsiao, Chuhsing K.] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan; [Chan, Ta-Chien; Chiang, Po-Huang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Hlth Policy Res, Zhunan, Taiwan; [King, Chwan-Chuen; Hsiao, Chuhsing K.] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Yen, Muh-Yong] Taipei City Hosp, Taipei City Govt, Dept Dis Control & Prevent, Taipei, Taiwan; [Huang, Chao-Sheng] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan	National Taiwan University; National Health Research Institutes - Taiwan; National Taiwan University; Taipei City Hospital; Taipei Medical University	Chan, TC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei 10764, Taiwan.	ckhsiao@ntu.edu.tw	Chiang, Po-Huang/E-3996-2010; Chan, Ta-Chien/C-8992-2012	hsiao, chuhsing kate/0000-0003-4905-8484; King, Chwan-Chuen/0000-0002-6078-2601	National Science Council, R.O.C. [NSC-98-2922-I-002-462]; Taipei City Government [96001-62-032]	National Science Council, R.O.C.(Ministry of Science and Technology, Taiwan); Taipei City Government	The preliminary results of this study were partially presented in the 2009 International Society for Disease Surveillance Eighth Annual Conference. The traveling subsidy was from National Science Council, R.O.C. (NSC-98-2922-I-002-462). This study was financially supported in part by Taipei City Government Grant 96001-62-032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2008, J Prev Med Hyg, V49, P131; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cazelles B, 2006, PLOS MED, V3, P1212, DOI 10.1371/journal.pmed.0030328; *CDC, 2008, LAB VIR SURV REP; Chan TC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-26; Charland KML, 2009, EPIDEMIOL INFECT, V137, P1377, DOI 10.1017/S0950268809002283; CHARLAND KM, 2009, EPIDEMIOL INFECT, P1; CHINGYIHSIAO, 2007, COMP CHIEF COMPLAINT; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Georgantopoulos P, 2009, AM J EPIDEMIOL, V170, P1533, DOI 10.1093/aje/kwp305; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Kelly H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005079; Klauss G, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-33; Le Strat Y, 1999, STAT MED, V18, P3463, DOI 10.1002/(SICI)1097-0258(19991230)18:24<3463::AID-SIM409>3.3.CO;2-9; Lee JE, 2007, GEOSPATIAL HEALTH, V1, P243, DOI 10.4081/gh.2007.272; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Martinez-Beneito MA, 2008, STAT MED, V27, P4455, DOI 10.1002/sim.3320; MNATSAKANYAN ZR, 2009, J AM MED INFORM ASS; Mugglin AS, 2002, STAT MED, V21, P2703, DOI 10.1002/sim.1217; Plummer M, 2009, CODA OUTPUT ANAL DIA; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; R Core Team, 2018, R LANG ENV STAT COMP; Sebastiani P, 2006, STAT MED, V25, P1803, DOI 10.1002/sim.2566; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Spiegelhalter D. J., 2008, WINBUGS VERSION 1 4; STROUP DF, 1989, STAT MED, V8, P323, DOI 10.1002/sim.4780080312; van Dijk A, 2009, EMERG INFECT DIS, V15, P799, DOI 10.3201/eid1505.081174; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zheng W, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-250; Zhou HF, 2008, STAT MED, V27, P5907, DOI 10.1002/sim.3409	35	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11626	10.1371/journal.pone.0011626	http://dx.doi.org/10.1371/journal.pone.0011626			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661275	gold, Green Submitted, Green Published			2022-12-27	WOS:000279980800014
J	Cattuto, C; Van den Broeck, W; Barrat, A; Colizza, V; Pinton, JF; Vespignani, A				Cattuto, Ciro; Van den Broeck, Wouter; Barrat, Alain; Colizza, Vittoria; Pinton, Jean-Francois; Vespignani, Alessandro			Dynamics of Person-to-Person Interactions from Distributed RFID Sensor Networks	PLOS ONE			English	Article							SCALE	Background: Digital networks, mobile devices, and the possibility of mining the ever-increasing amount of digital traces that we leave behind in our daily activities are changing the way we can approach the study of human and social interactions. Large-scale datasets, however, are mostly available for collective and statistical behaviors, at coarse granularities, while high-resolution data on person-to-person interactions are generally limited to relatively small groups of individuals. Here we present a scalable experimental framework for gathering real-time data resolving face-to-face social interactions with tunable spatial and temporal granularities. Methods and Findings: We use active Radio Frequency Identification (RFID) devices that assess mutual proximity in a distributed fashion by exchanging low-power radio packets. We analyze the dynamics of person-to-person interaction networks obtained in three high-resolution experiments carried out at different orders of magnitude in community size. The data sets exhibit common statistical properties and lack of a characteristic time scale from 20 seconds to several hours. The association between the number of connections and their duration shows an interesting super-linear behavior, which indicates the possibility of defining super-connectors both in the number and intensity of connections. Conclusions: Taking advantage of scalability and resolution, this experimental framework allows the monitoring of social interactions, uncovering similarities in the way individuals interact in different contexts, and identifying patterns of super-connector behavior in the community. These results could impact our understanding of all phenomena driven by face-to-face interactions, such as the spreading of transmissible infectious diseases and information.	[Cattuto, Ciro; Van den Broeck, Wouter; Barrat, Alain; Colizza, Vittoria] Inst Sci Interchange Fdn, Complex Networks & Syst Grp, Turin, Italy; [Barrat, Alain] CNRS, Ctr Phys Theor, UMR 6207, F-13288 Marseille, France; [Pinton, Jean-Francois] CNRS, ENS Lyon, Phys Lab, UMR 5672, Lyon, France; [Vespignani, Alessandro] Indiana Univ, Sch Informat & Comp, Ctr Complex Networks & Syst Res, Bloomington, IN USA; [Vespignani, Alessandro] Indiana Univ, Pervas Technol Inst, Bloomington, IN USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Cattuto, C (corresponding author), Inst Sci Interchange Fdn, Complex Networks & Syst Grp, Turin, Italy.	ciro.cattuto@isi.it		Colizza, Vittoria/0000-0002-2113-2374; Vespignani, Alessandro/0000-0003-3419-4205	National Institutes of Health; National Science Foundation; Defense Threat Reduction Agency; Lilly Endowment Foundation; Future and Emerging Technologies (FET); European Research Council (ERC) [ERC-2007-Stg204863]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Lilly Endowment Foundation; Future and Emerging Technologies (FET); European Research Council (ERC)(European Research Council (ERC))	AV is partially supported by the National Institutes of Health, National Science Foundation, Defense Threat Reduction Agency, Lilly Endowment Foundation, and the Future and Emerging Technologies (FET) projects Epiwork and Dynanets. VC is partially supported by the European Research Council (ERC) Ideas contract n.ERC-2007-Stg204863, and by the FET projects Epiwork and Dynanets. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alani H, 2009, LECT NOTES COMPUT SC, V5823, P698, DOI 10.1007/978-3-642-04930-9_44; ANDERSON R M, 1991; [Anonymous], DELIBERATIVE DEMOCRA, DOI [10.7551/mitpress/11633.003.0005, DOI 10.7551/MITPRESS/2324.003.0014, DOI 10.7551/MITPRESS/8022.001.0001]; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Clauset A., 2007, DIMACS WORKSH COMP M; Currarini S, 2009, ECONOMETRICA, V77, P1003, DOI 10.3982/ECTA7528; Eagle N, 2006, PERS UBIQUIT COMPUT, V10, P255, DOI 10.1007/s00779-005-0046-3; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; GOLDER SA, 2007, P 3 INT C COMM TECHN; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Haritaoglu I, 2000, IEEE T PATTERN ANAL, V22, P809, DOI 10.1109/34.868683; Hui P, 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Karagiannis T., 2007, MOBICOM, V07, P183; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Meiss MR, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224022; Moody J, 2002, SOC FORCES, V81, P25, DOI 10.1353/sof.2002.0056; O'Neill E, 2006, LECT NOTES COMPUT SC, V4206, P315; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Pentland A, 2009, SOCIAL COMPUTING AND BEHAVIORAL MODELING, P1, DOI 10.1007/978-1-4419-0056-2_1; Ratti C, 2006, ENVIRON PLANN B, V33, P727, DOI 10.1068/b32047; Seshadri M., 2008, PROC 14 ACM SIGKDD I, P596, DOI DOI 10.1145/1401890.1401963; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a	30	461	470	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11596	10.1371/journal.pone.0011596	http://dx.doi.org/10.1371/journal.pone.0011596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657651	Green Submitted, Green Published, gold			2022-12-27	WOS:000279924500005
J	Wilson, MR; O'Dea, KP; Dorr, AD; Yamamoto, H; Goddard, ME; Takata, M				Wilson, Michael R.; O'Dea, Kieran P.; Dorr, Anthony D.; Yamamoto, Hirotoshi; Goddard, Michael E.; Takata, Masao			Efficacy and Safety of Inhaled Carbon Monoxide during Pulmonary Inflammation in Mice	PLOS ONE			English	Article							ACUTE LUNG INJURY; HEME OXYGENASE-1/CARBON MONOXIDE; NEUTROPHIL RECRUITMENT; ENDOTOXIC-SHOCK; PROTECTION; MECHANISM; LAVAGE; MODEL	Background: Pulmonary inflammation is a major contributor to morbidity in a variety of respiratory disorders, but treatment options are limited. Here we investigate the efficacy, safety and mechanism of action of low dose inhaled carbon monoxide (CO) using a mouse model of lipopolysaccharide (LPS)-induced pulmonary inflammation. Methodology: Mice were exposed to 0-500 ppm inhaled CO for periods of up to 24 hours prior to and following intratracheal instillation of 10 ng LPS. Animals were sacrificed and assessed for intraalveolar neutrophil influx and cytokine levels, flow cytometric determination of neutrophil number and activation in blood, lung and lavage fluid samples, or neutrophil mobilisation from bone marrow. Principal Findings: When administered for 24 hours both before and after LPS, inhaled CO of 100 ppm or more reduced intraalveolar neutrophil infiltration by 40-50%, although doses above 100 ppm were associated with either high carboxyhemoglobin, weight loss or reduced physical activity. This anti-inflammatory effect of CO did not require pre-exposure before induction of injury. 100 ppm CO exposure attenuated neutrophil sequestration within the pulmonary vasculature as well as LPS-induced neutrophilia at 6 hours after LPS, likely due to abrogation of neutrophil mobilisation from bone marrow. In contrast to such apparently beneficial effects, 100 ppm inhaled CO induced an increase in pulmonary barrier permeability as determined by lavage fluid protein content and translocation of labelled albumin from blood to the alveolar space. Conclusions: Overall, these data confirm some protective role for inhaled CO during pulmonary inflammation, although this required a dose that produced carboxyhemoglobin values close to potentially toxic levels for humans, and increased lung permeability.	[Wilson, Michael R.; O'Dea, Kieran P.; Dorr, Anthony D.; Yamamoto, Hirotoshi; Goddard, Michael E.; Takata, Masao] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, London, England	Imperial College London	Wilson, MR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, London, England.	michael.wilson@imperial.ac.uk			Carburos Metalicos, Madrid, Spain; Medical Research Council, London, United Kingdom [G0000101]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom [BB/D01820X/1]; Biotechnology and Biological Sciences Research Council [BB/D01820X/1] Funding Source: researchfish; Medical Research Council [G0000101] Funding Source: researchfish; BBSRC [BB/D01820X/1] Funding Source: UKRI; MRC [G0000101] Funding Source: UKRI	Carburos Metalicos, Madrid, Spain; Medical Research Council, London, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by grants from Carburos Metalicos, Madrid, Spain; Medical Research Council, London, United Kingdom (G0000101: URL www.mrc.ac.uk/index.htm); and Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom (BB/D01820X/1: URL www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg AM, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-13; Althaus M, 2009, AM J RESP CELL MOL, V41, P639, DOI 10.1165/rcmb.2008-0458OC; Bathoorn E, 2007, EUR RESPIR J, V30, P1131, DOI 10.1183/09031936.00163206; Chapman JT, 2001, AM J PHYSIOL-LUNG C, V281, pL209, DOI 10.1152/ajplung.2001.281.1.L209; Choudhury S, 2004, AM J PHYSIOL-LUNG C, V287, pL902, DOI 10.1152/ajplung.00187.2004; Clayton CE, 2001, AM J PHYSIOL-LUNG C, V281, pL949, DOI 10.1152/ajplung.2001.281.4.L949; Dolinay T, 2004, AM J RESP CRIT CARE, V170, P613, DOI 10.1164/rccm.200401-023OC; Foresti R, 2008, INTENS CARE MED, V34, P649, DOI 10.1007/s00134-008-1011-1; FREVERT CW, 1995, J IMMUNOL, V154, P335; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Ghio AJ, 2008, AM J RESP CELL MOL, V38, P715, DOI 10.1165/rcmb.2007-0179OC; Ghosh S, 2005, AM J PHYSIOL-LUNG C, V288, pL1003, DOI 10.1152/ajplung.00451.2004; Hoetzel A, 2007, ANTIOXID REDOX SIGN, V9, P2013, DOI 10.1089/ars.2007.1762; Kohmotoa J, 2007, AM J TRANSPLANT, V7, P2279, DOI 10.1111/j.1600-6143.2007.01940.x; Leite JHP, 2008, CRIT CARE MED, V36, P2621, DOI 10.1097/CCM.0b013e3181847b43; Mayr FB, 2005, AM J RESP CRIT CARE, V171, P354, DOI 10.1164/rccm.200404-446OC; Mazzola S, 2005, FASEB J, V19, P2045, DOI 10.1096/fj.05-3782fje; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Nemzek JA, 2008, AM J PHYSIOL-LUNG C, V294, pL644, DOI 10.1152/ajplung.00324.2007; O'Dea KP, 2009, J IMMUNOL, V182, P1155, DOI 10.4049/jimmunol.182.2.1155; Otterbein LE, 1999, AM J PHYSIOL-LUNG C, V276, pL688; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Perkins GD, 2006, CRIT CARE MED, V34, P57, DOI 10.1097/01.CCM.0000190197.69945.C5; Piantadosi CA, 2002, ANTIOXID REDOX SIGN, V4, P259, DOI 10.1089/152308602753666316; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Ritter C, 2006, CRIT CARE MED, V34, P471, DOI 10.1097/01.CCM.0000199069.19193.89; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sarady JK, 2004, FASEB J, V18, P854, DOI 10.1096/fj.03-0643fje; Sarady JK, 2002, AM J RESP CELL MOL, V27, P739, DOI 10.1165/rcmb.4816; Spoelstra EN, 2007, LAB ANIM-UK, V41, P128, DOI 10.1258/002367707779399400; Thom SR, 2005, AM J RESP CRIT CARE, V171, P1318, DOI 10.1164/ajrccm.171.11.952; Wang S, 2009, P NATL ACAD SCI USA, V106, P2957, DOI 10.1073/pnas.0809100106; Wang XM, 2009, J IMMUNOL, V182, P3809, DOI 10.4049/jimmunol.0712437; WATSON ES, 1987, J ANAL TOXICOL, V11, P19, DOI 10.1093/jat/11.1.19; Wilson MR, 2007, AM J PHYSIOL-LUNG C, V293, pL60, DOI 10.1152/ajplung.00284.2006; Wilson MR, 2003, J APPL PHYSIOL, V95, P1385, DOI 10.1152/japplphysiol.00213.2003; Zhou ZH, 2005, AM J PATHOL, V166, P27, DOI 10.1016/S0002-9440(10)62229-8	39	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11565	10.1371/journal.pone.0011565	http://dx.doi.org/10.1371/journal.pone.0011565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644637	Green Submitted, Green Published, gold			2022-12-27	WOS:000279822300016
J	Lehmann, R; Zhao, XJ; Weigert, C; Simon, P; Fehrenbach, E; Fritsche, J; Machann, J; Schick, F; Wang, JS; Hoene, M; Schleicher, ED; Haring, HU; Xu, GW; Niess, AM				Lehmann, Rainer; Zhao, Xinjie; Weigert, Cora; Simon, Perikles; Fehrenbach, Elvira; Fritsche, Jens; Machann, Juergen; Schick, Fritz; Wang, Jiangshan; Hoene, Miriam; Schleicher, Erwin D.; Haering, Hans-Ulrich; Xu, Guowang; Niess, Andreas M.			Medium Chain Acylcarnitines Dominate the Metabolite Pattern in Humans under Moderate Intensity Exercise and Support Lipid Oxidation	PLOS ONE			English	Article							STRENUOUS PHYSICAL-EXERCISE; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; CARNITINE METABOLISM; INSULIN SENSITIVITY; PROLONGED EXERCISE; IDENTIFICATION; METABOLOMICS; MEN; CARBOHYDRATE	Background: Exercise is an extreme physiological challenge for skeletal muscle energy metabolism and has notable health benefits. We aimed to identify and characterize metabolites, which are components of the regulatory network mediating the beneficial metabolic adaptation to exercise. Methodology and Principal Findings: First, we investigated plasma from healthy human subjects who completed two independent running studies under moderate, predominantly aerobic conditions. Samples obtained prior to and immediately after running and then 3 and 24 h into the recovery phase were analyzed by a non-targeted (NT-) metabolomics approach applying liquid chromatography-qTOF-mass spectrometry. Under these conditions medium and long chain acylcarnitines were found to be the most discriminant plasma biomarkers of moderately intense exercise. Immediately after a 60 min (at 93% V(IAT)) or a 120 min run (at 70% V(IAT)) a pronounced, transient increase dominated by octanoyl-, decanoyl-, and dodecanoyl-carnitine was observed. The release of acylcarnitines as intermediates of partial beta-oxidation was verified in skeletal muscle cell culture experiments by probing (13)C-palmitate metabolism. Further investigations in primary human myotubes and mouse muscle tissue revealed that octanoyl-, decanoyl-, and dodecanoylcarnitine were able to support the oxidation of palmitate, proving more effective than L-carnitine. Conclusions: Medium chain acylcarnitines were identified and characterized by a functional metabolomics approach as the dominating biomarkers during a moderately intense exercise bout possessing the power to support fat oxidation. This physiological production and efflux of acylcarnitines might exert beneficial biological functions in muscle tissue.	[Lehmann, Rainer; Weigert, Cora; Hoene, Miriam; Schleicher, Erwin D.] Univ Hosp Tuebingen, Div Clin Chem & Pathobiochem, Cent Lab, Tubingen, Germany; [Zhao, Xinjie; Wang, Jiangshan; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Simon, Perikles] Johannes Gutenberg Univ Mainz, Dept Sports Med Dis Prevent & Rehabil, Mainz, Germany; [Fehrenbach, Elvira] Univ Hosp Tuebingen, Inst Clin & Expt Transfus Med, Tubingen, Germany; [Fritsche, Jens] Immat Biotechnol GmbH, Tubingen, Germany; [Machann, Juergen; Schick, Fritz] Univ Hosp Tuebingen, Sect Expt Radiol, Tubingen, Germany; [Haering, Hans-Ulrich] Univ Hosp Tuebingen, Dept Internal Med 4, Tubingen, Germany; [Niess, Andreas M.] Univ Hosp Tuebingen, Dept Sports Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Immatics Biotechnologies GmbH; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lehmann, R (corresponding author), Univ Hosp Tuebingen, Div Clin Chem & Pathobiochem, Cent Lab, Tubingen, Germany.	Rainer.Lehmann@med.uni-tuebingen.de; xugw@dicp.ac.cn	Simon, Perikles D/B-2293-2013; Xu, Guowang/L-6910-2014; Lehmann, Rainer/AAF-4281-2019	Simon, Perikles D/0000-0002-7996-4034; Xu, Guowang/0000-0003-4298-3554; Lehmann, Rainer/0000-0003-1218-6810; Schick, Fritz/0000-0002-4231-3406; Fritsche, J./0000-0002-5557-8577	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); Federal Ministry of Education and Research [FKZ 01GI0803-04]; Sino-German Center for Research Promotion; German Federal Ministry of Education and Research (BMBF); National Basic Research Program of China [2006CB503902]; Chinese Academy of Sciences [KSCX1-YW-02]; University Clinic of Tuebingen [F1211]	Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Sino-German Center for Research Promotion; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); University Clinic of Tuebingen	This investigation was supported in parts by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI0803-04), the Sino-German Center for Research Promotion (DFG and NSFC, GZ 364), the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e. V.), the National Basic Research Program of China (No. 2006CB503902), by the Knowledge Innovation Program (KSCX1-YW-02) of the Chinese Academy of Sciences and by a grant from the University Clinic of Tuebingen (FORTUENE, F1211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT MJ, 1994, CLIN CHIM ACTA, V226, P211, DOI 10.1016/0009-8981(94)90216-X; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Burke LM, 2006, CURR OPIN CLIN NUTR, V9, P476, DOI 10.1097/01.mco.0000232911.69236.3b; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; CARLIN JI, 1986, J APPL PHYSIOL, V61, P1275, DOI 10.1152/jappl.1986.61.4.1275; Chen J, 2008, ANAL CHEM, V80, P1280, DOI 10.1021/ac702089h; Chorell E, 2009, J PROTEOME RES, V8, P2966, DOI 10.1021/pr900081q; COGGAN AR, 1990, J APPL PHYSIOL, V68, P990, DOI 10.1152/jappl.1990.68.3.990; Dela F, 2006, ESSAYS BIOCHEM, V42, P75, DOI 10.1042/bse0420075; Dickhuth H.H, 1991, ADV ERGOMETRY, P73; Enea C, 2010, ANAL BIOANAL CHEM, V396, P1167, DOI 10.1007/s00216-009-3289-4; Eriksson L., 2001, MULTI MEGAVARIATE DA; FRIOLET R, 1994, J CLIN INVEST, V94, P1490, DOI 10.1172/JCI117488; HIATT WR, 1989, J CLIN INVEST, V84, P1167, DOI 10.1172/JCI114281; Ho JK, 2002, J LIPID RES, V43, P1429, DOI 10.1194/jlr.M200137-JLR200; Hodson MP, 2007, ANAL BIOCHEM, V362, P182, DOI 10.1016/j.ab.2006.12.037; Hoppel C, 2003, AM J KIDNEY DIS, V41, pS4, DOI 10.1016/S0272-6386(03)00112-4; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Ivy J L, 1997, Sports Med, V24, P321; KIENS B, 1993, J PHYSIOL-LONDON, V469, P459, DOI 10.1113/jphysiol.1993.sp019823; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; LENNON DLF, 1983, J APPL PHYSIOL, V55, P489, DOI 10.1152/jappl.1983.55.2.489; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Lindon JC, 2004, BIOMARKERS, V9, P1, DOI 10.1080/13547500410001668379; MARTIN WH, 1993, AM J PHYSIOL, V265, pE708, DOI 10.1152/ajpendo.1993.265.5.E708; MCCONNELL TR, 1988, SPORTS MED, V5, P57, DOI 10.2165/00007256-198805010-00005; MIHALIK SJ, 2010, OBESITY SILVER SPRIN; Mourtzakis M, 2006, J APPL PHYSIOL, V100, P1822, DOI 10.1152/japplphysiol.00571.2005; Noland RC, 2009, J BIOL CHEM, V284, P22840, DOI 10.1074/jbc.M109.032888; Olsen RH, 2008, JAMA-J AM MED ASSOC, V299, P1261, DOI 10.1001/jama.299.11.1259; ORAM JF, 1975, J BIOL CHEM, V250, P73; PANDE SV, 1976, J BIOL CHEM, V251, P6683; Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007; Pohjanen E, 2007, J PROTEOME RES, V6, P2113, DOI 10.1021/pr070007g; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; SAHLIN K, 1990, ACTA PHYSIOL SCAND, V138, P259, DOI 10.1111/j.1748-1716.1990.tb08845.x; Soeters MR, 2009, CLIN SCI, V116, P585, DOI 10.1042/CS20080433; Spriet LL, 2003, ACTA PHYSIOL SCAND, V178, P443, DOI 10.1046/j.1365-201X.2003.01152.x; SPURWAY NC, 1992, BRIT MED BULL, V48, P569, DOI 10.1093/oxfordjournals.bmb.a072564; STANLEY CA, 1991, ANN NEUROL, V30, P709, DOI 10.1002/ana.410300512; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Thamer C, 2003, J CLIN ENDOCR METAB, V88, P1785, DOI 10.1210/jc.2002-021674; TURCOTTE LP, 1992, AM J PHYSIOL, V262, P791; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Wu ZM, 2009, CHROMATOGRAPHIA, V69, pS23, DOI 10.1365/s10337-009-0956-8; Yan B, 2009, J APPL PHYSIOL, V106, P531, DOI 10.1152/japplphysiol.90816.2008; Zhang ZF, 2009, FEBS LETT, V583, P470, DOI 10.1016/j.febslet.2008.12.053; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	53	106	109	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11519	10.1371/journal.pone.0011519	http://dx.doi.org/10.1371/journal.pone.0011519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	20634953	Green Published, gold, Green Submitted			2022-12-27	WOS:000279781600007
J	Marathe, SA; Ray, S; Chakravortty, D				Marathe, Sandhya A.; Ray, Seemun; Chakravortty, Dipshikha			Curcumin Increases the Pathogenicity of Salmonella enterica Serovar Typhimurium in Murine Model	PLOS ONE			English	Article							ESCHERICHIA-COLI; OXIDATIVE STRESS; INVASION GENES; TRANSCRIPTIONAL REGULATOR; INTRACELLULAR SALMONELLA; ANTIMICROBIAL PEPTIDES; RESISTANCE; PATHOGENESIS; TRANSPORT; VIRULENCE	Curcumin has gained immense importance for its vast therapeutic and prophylactic applications. Contrary to this, our study reveals that it regulates the defense pathways of Salmonella enterica serovar Typhimurium ( S. Typhimurium) to enhance its pathogenicity. In a murine model of typhoid fever, we observed higher bacterial load in Peyer's patches, mesenteric lymph node, spleen and liver, when infected with curcumin-treated Salmonella. Curcumin increased the resistance of S. Typhimurium against antimicrobial agents like antimicrobial peptides, reactive oxygen and nitrogen species. This increased tolerance might be attributed to the up-regulation of genes involved in resistance against antimicrobial peptides - pmrD and pmrHFIJKLM and genes with antioxidant function - mntH, sodA and sitA. We implicate that iron chelation property of curcumin have a role in regulating mntH and sitA. Interestingly, we see that the curcumin-mediated modulation of pmr genes is through the PhoPQ regulatory system. Curcumin downregulates SPI1 genes, required for entry into epithelial cells and upregulates SPI2 genes required to intracellular survival. Since it is known that the SPI1 and SPI2 system can be regulated by the PhoPQ system, this common regulator could explain curcumin's mode of action. This data urges us to rethink the indiscriminate use of curcumin especially during Salmonella outbreaks.	[Marathe, Sandhya A.] Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India; Indian Inst Sci, Biosafety Labs, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Marathe, SA (corresponding author), Indian Inst Sci, Ctr Infect Dis Res, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; chakravortty, dipshikha/A-9492-2009	Chakravortty, Dipshikha/0000-0002-7838-5145	Director of Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology [DBT 197, DBT 172]; ICMR (Center for Advanced Study in Molecular Medicine); DST (FIST); UGC; C.S.I.R.	Director of Indian Institute of Science, Bangalore, India; Department of Biotechnology; ICMR (Center for Advanced Study in Molecular Medicine)(Indian Council of Medical Research (ICMR)); DST (FIST)(Department of Science & Technology (India)); UGC(University Grants Commission, India); C.S.I.R.(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and the Department of Biotechnology (DBT 197 and DBT 172) to D. C. Infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (FIST) and UGC (special assistance) is acknowledged. S.M. acknowledges C.S.I.R. for the fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams GL, 2006, CELL MICROBIOL, V8, P728, DOI 10.1111/j.1462-5822.2006.00706.x; AGGARWAL BB, 2007, ADV EXP MED BIOL, V1, P75; Aggarwal BB, 2009, INT J BIOCHEM CELL B, V41, P40, DOI 10.1016/j.biocel.2008.06.010; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; Boyer E, 2002, INFECT IMMUN, V70, P6032, DOI 10.1128/IAI.70.11.6032-6042.2002; Buchmeier N, 1997, INFECT IMMUN, V65, P3725, DOI 10.1128/IAI.65.9.3725-3730.1997; BUNTON CA, 1955, NATURE, V175, P83, DOI 10.1038/175083b0; Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; DAHL TA, 1989, ARCH MICROBIOL, V151, P183, DOI 10.1007/BF00414437; Dairam A, 2008, J AGR FOOD CHEM, V56, P3350, DOI 10.1021/jf0734931; Das P, 2009, MICROBIOL-SGM, V155, P2476, DOI 10.1099/mic.0.029611-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De R, 2009, ANTIMICROB AGENTS CH, V53, P1592, DOI 10.1128/AAC.01242-08; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Ellermeier JR, 2008, J BACTERIOL, V190, P476, DOI 10.1128/JB.00926-07; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; Fang FC, 1999, P NATL ACAD SCI USA, V96, P7502, DOI 10.1073/pnas.96.13.7502; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; Freeman JA, 2002, J BACTERIOL, V184, P4971, DOI 10.1128/JB.184.18.4971-4980.2002; Fujisawa S, 2004, ANTICANCER RES, V24, P563; GROISMAN EA, 1992, P NATL ACAD SCI USA, V89, P11939, DOI 10.1073/pnas.89.24.11939; Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Han C, 2006, FEBS J, V273, P4682, DOI 10.1111/j.1742-4658.2006.05469.x; Hansen-Wester I, 2001, MICROBES INFECT, V3, P549, DOI 10.1016/S1286-4579(01)01411-3; HASSETT DJ, 1989, FASEB J, V3, P2574, DOI 10.1096/fasebj.3.14.2556311; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Horsburgh MJ, 2002, TRENDS MICROBIOL, V10, P496, DOI 10.1016/S0966-842X(02)02462-9; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Ingolfsson HI, 2007, BIOCHEMISTRY-US, V46, P10384, DOI 10.1021/bi701013n; Jiao Y, 2006, FREE RADICAL BIO MED, V40, P1152, DOI 10.1016/j.freeradbiomed.2005.11.003; Kehres DG, 2000, MOL MICROBIOL, V36, P1085, DOI 10.1046/j.1365-2958.2000.01922.x; Kehres DG, 2002, J BACTERIOL, V184, P3151, DOI 10.1128/JB.184.12.3151-3158.2002; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; MILLER JH, 1997, EXPT MOL GENETICS; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Murray RA, 2000, INFECT IMMUN, V68, P5050, DOI 10.1128/IAI.68.9.5050-5055.2000; ODA Y, 1995, MUTAT RES LETT, V348, P67, DOI 10.1016/0165-7992(95)00048-8; PEGUES DA, 1995, MOL MICROBIOL, V17, P169, DOI 10.1111/j.1365-2958.1995.mmi_17010169.x; Peschel A, 2002, TRENDS MICROBIOL, V10, P179, DOI 10.1016/S0966-842X(02)02333-8; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Rai D, 2008, BIOCHEM J, V410, P147, DOI 10.1042/BJ20070891; Sabri M, 2006, MICROBIOL-SGM, V152, P745, DOI 10.1099/mic.0.28682-0; SHANK JL, 1962, APPL MICROBIOL, V10, P185, DOI 10.1128/AEM.10.3.185-189.1962; Sharma A, 2000, J AGR FOOD CHEM, V48, P1340, DOI 10.1021/jf990851u; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Shiloh MU, 2000, CURR OPIN MICROBIOL, V3, P35, DOI 10.1016/S1369-5274(99)00048-X; Steele-Mortimer O, 2008, CURR OPIN MICROBIOL, V11, P38, DOI 10.1016/j.mib.2008.01.002; TSOLIS RM, 1995, INFECT IMMUN, V63, P1739, DOI 10.1128/IAI.63.5.1739-1744.1995; Uchiya K, 1999, EMBO J, V18, P3924, DOI 10.1093/emboj/18.14.3924; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004; Zaharik ML, 2002, P NATL ACAD SCI USA, V99, P15705, DOI 10.1073/pnas.252415599; Zhou DG, 1999, INFECT IMMUN, V67, P1974	58	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2010	5	7							e11511	10.1371/journal.pone.0011511	http://dx.doi.org/10.1371/journal.pone.0011511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623CM	20634977	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000279715300022
J	D'Antonio, JM; Griend, DJV; Antony, L; Ndikuyeze, G; Dalrymple, SL; Koochekpour, S; Isaacs, JT				D'Antonio, Jason M.; Griend, Donald J. Vander; Antony, Lizamma; Ndikuyeze, George; Dalrymple, Susan L.; Koochekpour, Shahriar; Isaacs, John T.			Loss of Androgen Receptor-Dependent Growth Suppression by Prostate Cancer Cells Can Occur Independently from Acquiring Oncogenic Addiction to Androgen Receptor Signaling	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; TUMOR-SUPPRESSOR; IN-VITRO; DIFFERENTIATION; EXPRESSION; PROLIFERATION; MECHANISM; DISRUPTION; THERAPY; BINDING	The conversion of androgen receptor (AR) signaling as a mechanism of growth suppression of normal prostate epithelial cells to that of growth stimulation in prostate cancer cells is often associated with AR mutation, amplification and overexpression. Thus, down-regulation of AR signaling is commonly therapeutic for prostate cancer. The E006AA cell line was established from a hormone naive, localized prostate cancer. E006AA cells are genetically aneuploid and grow equally well when xenografted into either intact or castrated male NOG but not nude mice. These cells exhibit: 1) X chromosome duplication and AR gene amplification, although paradoxically not coupled with increased AR expression, and 2) somatic, dominant-negative Serine-599-Glycine loss-of-function mutation within the dimerization surface of the DNA binding domain of the AR gene. No effect on the growth of E006AA cells is observed using targeted knockdown of endogenous mutant AR, ectopic expression of wild-type AR, or treatment with androgens or anti-androgens. E006AA cells represent a prototype for a newly identified subtype of prostate cancer cells that exhibit a dominant-negative AR loss-of-function in a hormonally naive patient. Such loss-of-function eliminates AR-mediated growth suppression normally induced by normal physiological levels of androgens, thus producing a selective growth advantage for these malignant cells in hormonally naive patients. These data highlight that loss of AR-mediated growth suppression is an independent process, and that, without additional changes, is insufficient for acquiring oncogene addiction to AR signaling. Thus, patients with prostate cancer cells harboring such AR loss-of-function mutations will not benefit from aggressive hormone or anti-AR therapies even though they express AR protein.	[D'Antonio, Jason M.; Griend, Donald J. Vander; Antony, Lizamma; Ndikuyeze, George; Dalrymple, Susan L.; Isaacs, John T.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [D'Antonio, Jason M.; Griend, Donald J. Vander; Isaacs, John T.] Johns Hopkins Univ, Sch Med, Brady Urol Inst, Dept Urol, Baltimore, MD 21205 USA; [Koochekpour, Shahriar] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Biochem & Mol Biol, New Orleans, LA USA; [Koochekpour, Shahriar] Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, Dept Urol, New Orleans, LA USA; [Griend, Donald J. Vander] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Chicago	D'Antonio, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.	jdanton1@jhmi.edu; isaacjo@jhmi.edu	Griend, Donald J Vander/H-7532-2019	Griend, Donald J Vander/0000-0003-4421-5698; D'Antonio, Jason/0000-0001-8522-7009	NIH [R01DK52645, T32DK07552, T32DK07552-21A1]; Maryland Stem Cell Research Fund [MSCRF-II-0428]; DOD [PC060843]; NIH/NCRR-Center of Biomedical Research Excellence (COBRE) [1P20 RR021970];  [R21CA149137]; NATIONAL CANCER INSTITUTE [R21CA149137, R21CA143589] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052645, T32DK007552] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD005824] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; DOD(United States Department of Defense); NIH/NCRR-Center of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	NIH Grant R01DK52645 and the Maryland Stem Cell Research Fund MSCRF-II-0428 generously supported this research. Donald Vander Griend was supported by a Urology Training Grant (NIH T32DK07552), and by a DOD Post-Doctoral Training Award (PC060843). Jason DAntonio is supported by a Urology Training Grant (NIH T32DK07552-21A1). Dr. Koochekpour was supported by a grant from the NIH/NCRR-Center of Biomedical Research Excellence (COBRE; 1P20 RR021970) and grant R21CA149137. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Dehm SM, 2007, MOL ENDOCRINOL, V21, P2855, DOI 10.1210/me.2007-0223; Denmeade SR, 2003, PROSTATE, V56, P45, DOI 10.1002/pros.10213; Denmeade SR, 2003, PROSTATE, V54, P249, DOI 10.1002/pros.10199; Denmeade SR, 2002, NAT REV CANCER, V2, P389, DOI 10.1038/nrc801; Gao J, 2001, CANCER RES, V61, P5038; HANNA N, 1980, INT J CANCER, V26, P675, DOI 10.1002/ijc.2910260521; Huang YC, 2006, J CELL PHYSIOL, V209, P363, DOI 10.1002/jcp.20741; Hudson DL, 2001, J HISTOCHEM CYTOCHEM, V49, P271, DOI 10.1177/002215540104900214; Isaacs JT, 2000, JNCI-J NATL CANCER I, V92, P1367, DOI 10.1093/jnci/92.17.1367; Isaacs JT, 2004, NAT MED, V10, P26, DOI 10.1038/nm0104-26; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; JENSEN EV, 1968, P NATL ACAD SCI USA, V59, P632, DOI 10.1073/pnas.59.2.632; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Khalili M, 2010, AM J PATHOL, V176, P2259, DOI 10.2353/ajpath.2010.080747; Koochekpour S, 2004, PROSTATE, V60, P141, DOI 10.1002/pros.20053; Leversha MA, 2009, CLIN CANCER RES, V15, P2091, DOI 10.1158/1078-0432.CCR-08-2036; Li TH, 2007, NUCLEIC ACIDS RES, V35, P2767, DOI 10.1093/nar/gkm198; Ling MT, 2001, J ENDOCRINOL, V170, P287, DOI 10.1677/joe.0.1700287; Litvinov IV, 2004, PROSTATE, V61, P299, DOI 10.1002/pros.20187; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Litvinov IV, 2006, PROSTATE, V66, P1329, DOI 10.1002/pros.20483; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Long RM, 2005, CLIN SCI, V108, P1, DOI 10.1042/CS20040241; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; Shaffer LG, 2005, ISCN 2005 INT SYSTEM; Shaffer PL, 2004, P NATL ACAD SCI USA, V101, P4758, DOI 10.1073/pnas.0401123101; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Simanainen U, 2007, ENDOCRINOLOGY, V148, P2264, DOI 10.1210/en.2006-1223; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Snoek R, 2009, CLIN CANCER RES, V15, P39, DOI 10.1158/1078-0432.CCR-08-1726; Sultan C, 2001, HUM REPROD UPDATE, V7, P314, DOI 10.1093/humupd/7.3.314; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; van Bokhoven A, 2003, PROSTATE, V57, P205, DOI 10.1002/pros.10290; van der Poel HG, 2001, CANCER GENE THER, V8, P927, DOI 10.1038/sj.cgt.7700385; Vander Griend DJ, 2007, CELL CYCLE, V6, P647, DOI 10.4161/cc.6.6.4028; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Whitacre DC, 2002, CELL GROWTH DIFFER, V13, P1; Wu CT, 2007, P NATL ACAD SCI USA, V104, P12679, DOI 10.1073/pnas.0704940104; Yang Q, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-8; Zegarra-Moro OL, 2002, CANCER RES, V62, P1008; ZOPPI S, 1992, MOL ENDOCRINOL, V6, P409, DOI 10.1210/me.6.3.409	46	30	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11475	10.1371/journal.pone.0011475	http://dx.doi.org/10.1371/journal.pone.0011475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628607	Green Published, Green Submitted, gold			2022-12-27	WOS:000279637100006
J	Apicella, MA; Post, DMB; Fowler, AC; Jones, BD; Rasmussen, JA; Hunt, JR; Imagawa, S; Choudhury, B; Inzana, TJ; Maier, TM; Frank, DW; Zahrt, TC; Chaloner, K; Jennings, MP; McLendon, MK; Gibson, BW				Apicella, Michael A.; Post, Deborah M. B.; Fowler, Andrew C.; Jones, Bradley D.; Rasmussen, Jed A.; Hunt, Jason R.; Imagawa, Sayaka; Choudhury, Biswa; Inzana, Thomas J.; Maier, Tamara M.; Frank, Dara W.; Zahrt, Thomas C.; Chaloner, Kathryn; Jennings, Michael P.; McLendon, Molly K.; Gibson, Bradford W.			Identification, Characterization and Immunogenicity of an O-Antigen Capsular Polysaccharide of Francisella tularensis	PLOS ONE			English	Article							STRUCTURAL-ANALYSIS; TULAREMIA VACCINE; ESCHERICHIA-COLI; DEFICIENT MUTANT; LIPID-A; LVS; BACTERIUM; VIRULENCE; BIOSYNTHESIS; DISEASE	Capsular polysaccharides are important factors in bacterial pathogenesis and have been the target of a number of successful vaccines. Francisella tularensis has been considered to express a capsular antigen but none has been isolated or characterized. We have developed a monoclonal antibody, 11B7, which recognizes the capsular polysaccharide of F. tularensis migrating on Western blot as a diffuse band between 100 kDa and 250 kDa. The capsule stains poorly on SDS-PAGE with silver stain but can be visualized using ProQ Emerald glycoprotein stain. The capsule appears to be highly conserved among strains of F. tularensis as antibody 11B7 bound to the capsule of 14 of 14 F. tularensis type A and B strains on Western blot. The capsular material can be isolated essentially free of LPS, is phenol and proteinase K resistant, ethanol precipitable and does not dissociate in sodium dodecyl sulfate. Immunoelectron microscopy with colloidal gold demonstrates 11B7 circumferentially staining the surface of F. tularensis which is typical of a polysaccharide capsule. Mass spectrometry, compositional analysis and NMR indicate that the capsule is composed of a polymer of the tetrasaccharide repeat, 4)-alpha-D-GalNAcAN-(1->4)-alpha-D-GalNAcAN-(1->3)-beta-D-QuiNAc-(1->2)-beta-D-Qui4NFm-(1-, which is identical to the previously described F. tularensis O-antigen subunit. This indicates that the F. tularensis capsule can be classified as an O-antigen capsular polysaccharide. Our studies indicate that F. tularensis O-antigen glycosyltransferase mutants do not make a capsule. An F. tularensis acyltransferase and an O-antigen polymerase mutant had no evidence of an O-antigen but expressed a capsular antigen. Passive immunization of BALB/c mice with 75 mu g of 11B7 protected against a 150 fold lethal challenge of F. tularensis LVS. Active immunization of BALB/c mice with 10 mu g of capsule showed a similar level of protection. These studies demonstrate that F. tularensis produces an O-antigen capsule that may be the basis of a future vaccine.	[Apicella, Michael A.; Fowler, Andrew C.; Jones, Bradley D.; Rasmussen, Jed A.; Hunt, Jason R.; McLendon, Molly K.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Post, Deborah M. B.; Gibson, Bradford W.] Buck Inst Age Res, Novato, CA USA; [Imagawa, Sayaka; Choudhury, Biswa] Univ Calif San Diego, San Diego, CA 92103 USA; [Inzana, Thomas J.] Virginia Polytech Inst & State Univ, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Maier, Tamara M.; Frank, Dara W.; Zahrt, Thomas C.] Med Coll Wisconsin, Ctr Biopreparedness & Infect Dis, Milwaukee, WI 53226 USA; [Chaloner, Kathryn] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA 52242 USA; [Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Australia	University of Iowa; Buck Institute for Research on Aging; University of California System; University of California San Diego; Virginia Polytechnic Institute & State University; Medical College of Wisconsin; University of Iowa; Griffith University	Apicella, MA (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.	michael-apicella@uiowa.edu	Jennings, Michael P/G-4822-2013; Chaloner, Kathryn/B-5090-2013	Jennings, Michael P/0000-0002-1027-4684; Fowler, Andrew/0000-0001-5646-5307; Jones, Brad/0000-0002-2698-8251	National Institutes of Allergy and Infectious Diseases [P01AI44642, AI057160, R01 AI063441]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044642, R01AI063441] Funding Source: NIH RePORTER	National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by Public Health Service grant P01AI44642 (MAA), AI057160 (MAA and BDJ), AI057160 (BDJ) and R01 AI063441 (DWF) from the National Institutes of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamkiewicz TV, 2008, PEDIATRICS, V121, P562, DOI 10.1542/peds.2007-0018; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; ARTENSTEIN MS, 1976, NEW ENGL J MED, V282, P417; Barak JD, 2007, MOL PLANT MICROBE IN, V20, P1083, DOI 10.1094/MPMI-20-9-1083; Buchan BW, 2008, APPL ENVIRON MICROB, V74, P2637, DOI 10.1128/AEM.02882-07; CARLISLE HN, 1962, J IMMUNOL, V89, P638; Chen YS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-20; CHERWONOGRODZKY JW, 1994, VACCINE, V12, P773, DOI 10.1016/0264-410X(94)90284-4; Ciucanu I, 2006, ANAL CHIM ACTA, V576, P147, DOI 10.1016/j.aca.2006.06.009; Conlan JW, 2002, VACCINE, V20, P3465, DOI 10.1016/S0264-410X(02)00345-6; Cross AS, 2007, CLIN INFECT DIS, V45, pS61, DOI 10.1086/518150; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Dodgson C, 1996, J BACTERIOL, V178, P1895, DOI 10.1128/jb.178.7.1895-1902.1996; Elkins KL, 2002, INFECT IMMUN, V70, P1936, DOI 10.1128/IAI.70.4.1936-1948.2002; Goddard T.D., 2008, SPARKY NMR ASSIGNMEN; GOLDMAN RC, 1983, EUR J BIOCHEM, V131, P473, DOI 10.1111/j.1432-1033.1983.tb07286.x; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; HOOD AM, 1977, J HYG-CAMBRIDGE, V79, P47, DOI 10.1017/S0022172400052840; Joklik WK, 1992, ZINSSER MICROBIOLOGY; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaufmann AF, 1997, EMERG INFECT DIS, V3, P83, DOI 10.3201/eid0302.970201; Le Pihive E, 2009, PLASMID, V62, P147, DOI 10.1016/j.plasmid.2009.07.001; Li J, 2007, MICROBIOL-SGM, V153, P3141, DOI 10.1099/mic.0.2007/006460-0; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Maier TM, 2006, APPL ENVIRON MICROB, V72, P1878, DOI 10.1128/AEM.72.3.1878-1885.2006; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McCoy G, 1912, J INFECT DIS, V10, P61, DOI 10.1093/infdis/10.1.61; McLendon MK, 2007, INFECT IMMUN, V75, P5518, DOI 10.1128/IAI.01288-06; Nakhamchik A, 2007, INFECT IMMUN, V75, P5550, DOI 10.1128/IAI.00932-07; NIERENGARTEN MB, 2002, MEDSCAPE INFECT DIS, V4; Phillips NJ, 2004, INFECT IMMUN, V72, P5340, DOI 10.1128/IAI.72.9.5340-5348.2004; Post DMB, 2003, INFECT IMMUN, V71, P647, DOI 10.1128/IAI.71.2.647-655.2003; R Core Team, 2020, R LANG ENV STAT COMP; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, ARCH INTERN MED, V107, P689, DOI 10.1001/archinte.1961.03620050055006; Schilling B, 2007, ANAL CHEM, V79, P1034, DOI 10.1021/ac061654e; Sorokin VM, 1996, FEMS IMMUNOL MED MIC, V13, P249, DOI 10.1111/j.1574-695X.1996.tb00246.x; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; TARNVIK A, 1989, EUR J CLIN MICROBIOL, V8, P146, DOI 10.1007/BF01963900; Therneau T, 2009, SURVIVAL SURVIVAL AN; Thirumalapura NR, 2005, J MED MICROBIOL, V54, P693, DOI 10.1099/jmm.0.45931-0; VINOGRADOV EV, 1991, CARBOHYD RES, V214, P289, DOI 10.1016/0008-6215(91)80036-M; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Zhang F, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-152; 2002, MMWR, V51, P181	50	66	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11060	10.1371/journal.pone.0011060	http://dx.doi.org/10.1371/journal.pone.0011060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625403	gold, Green Published, Green Submitted			2022-12-27	WOS:000279522500003
J	Song, J; Chang, I; Chen, Z; Kang, M; Wang, CY				Song, Jun; Chang, Insoon; Chen, Zhuo; Kang, Mo; Wang, Cun-Yu			Characterization of Side Populations in HNSCC: Highly Invasive, Chemoresistant and Abnormal Wnt Signaling	PLOS ONE			English	Article							CANCER STEM-CELLS; CARCINOMA-CELLS; APOPTOSIS; SUBPOPULATION; TRANSCRIPTION; PHENOTYPE; MODEL; HEAD; LINE	Side Population (SP) cells, a subset of Hoechst-low cells, are enriched with stem cells. Originally, SP cells were isolated from bone marrow but recently have been found in various solid tumors and cancer cell lines that are clonogenic in vitro and tumorigenic in vivo. In this study, SP cells from lymph node metastatic head and neck squamous cell carcinoma (HNSCC) cell lines were examined using flow cytometry and Hoechst 3342 efflux assay. We found that highly metastatic HNSCC cell lines M3a2 and M4e contained more SP cells compared to the low metastatic parental HNSCC cell line 686LN. SP cells in HNSCC were highly invasive in vitro and tumorigenic in vivo compared to non-SP cells. Furthermore, SP cells highly expressed ABCG2 and were chemoresistant to Bortezomib and etoposide. Importantly, we found that SP cells in HNSCC had abnormal activation of Wnt/beta-catenin signaling as compared to non-SP cells. Together, these findings indicate that SP cells might be a major driving force of head and neck tumor formation and metastasis. The Wnt/b-catenin signaling pathway may be an important target for eliminating cancer stem cells in HNSCC.	[Song, Jun; Chang, Insoon; Wang, Cun-Yu] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA; [Song, Jun; Wang, Cun-Yu] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Chen, Zhuo] Emory Univ, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA; [Kang, Mo] Univ Calif Los Angeles, Sch Dent, Div Associated Clin Specialty, Sect Endodont, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Emory University; University of California System; University of California Los Angeles	Song, J (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Lab Mol Signaling, Los Angeles, CA 90024 USA.	cwang@dentistry.ucla.edu			U.S. National Institutes of Dental and Craniofacial Research [R37DE13848, DE15964]; National Institutes of Health [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015964, R37DE013848] Funding Source: NIH RePORTER	U.S. National Institutes of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by U.S. National Institutes of Dental and Craniofacial Research grants R37DE13848 and DE15964. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, CURR OPIN GENET DEV, V14, P43, DOI 10.1016/j.gde.2003.11.007; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Bunting KD, 2002, STEM CELLS, V20, P11, DOI 10.1002/stem.200011; Burkert J, 2006, J PATHOL, V209, P287, DOI 10.1002/path.2016; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dingli D, 2006, STEM CELLS, V24, P2603, DOI 10.1634/stemcells.2006-0136; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Haraguchi Naotsugu, 2006, Hum Cell, V19, P24, DOI 10.1111/j.1749-0774.2005.00004.x; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Kopper L, 2004, PATHOL ONCOL RES, V10, P69, DOI 10.1007/BF02893458; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rehman AO, 2009, INT J ORAL SCI, V1, P105, DOI 10.4248/IJOS.09059; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015; Zhang X, 2002, CANCER-AM CANCER SOC, V95, P1663, DOI 10.1002/cncr.10837; Zhang X, 2006, CLIN EXP METASTAS, V23, P209, DOI 10.1007/s10585-006-9031-0; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	31	106	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2010	5	7							e11456	10.1371/journal.pone.0011456	http://dx.doi.org/10.1371/journal.pone.0011456			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	620TI	20625515	Green Submitted, Green Published, gold			2022-12-27	WOS:000279522500021
J	Radhakrishnan, VM; Martinez, JD				Radhakrishnan, Vijayababu M.; Martinez, Jesse D.			14-3-3 gamma Induces Oncogenic Transformation by Stimulating MAP Kinase and PI3K Signaling	PLOS ONE			English	Article							LUNG-CANCER; TUBEROUS SCLEROSIS; PROTEINS; RAS; PHOSPHORYLATION; 14-3-3-SIGMA; ACTIVATION; RAF-1; TSC2; AKT	The 14-3-3 proteins are a set of highly conserved scaffolding proteins that have been implicated in the regulation of a variety of important cellular processes such as the cell cycle, apoptosis and mitogenic signaling. Recent evidence indicates that the expression of some of the family members is elevated in human cancers suggesting that they may play a role in tumorigenesis. In the present study, the oncogenic potential of 14-3-3 gamma was shown by focus formation and tumor formation in SCID mice using 14-3-3 gamma transfected NIH3T3 mouse fibroblast cells. In contrast, 14-3-3 sigma, a putative tumor suppressor, inhibited NIH3T3 transformation by H-ras and c-myc. We also report that activation of both MAP kinase and PI3K signaling pathways are essential for transformation by 14-3-3 gamma. In addition, we found that 14-3-3 gamma interacts with phosphatidylinositol 3-kinase (PI3K) and TSC2 proteins indicating that it could stimulate PI3K signaling by acting at two points in the signaling pathway. Overall, our studies establish 14-3-3 gamma as an oncogene and implicate MAPK and PI3K signaling as important for 14-3-3 gamma induced transformation.	[Radhakrishnan, Vijayababu M.; Martinez, Jesse D.] Univ Arizona, Arizona Canc Ctr, Dept Cell Biol & Anat, Tucson, AZ 85721 USA	Arizona Center Cancer Care; University of Arizona	Radhakrishnan, VM (corresponding author), Univ Arizona, Arizona Canc Ctr, Dept Cell Biol & Anat, Tucson, AZ 85721 USA.	jmartinez@azcc.arizona.edu			National Institutes of Health (NIH) [RO1 CA107510]; Cancer Center Support [P30 CA023074]; NATIONAL CANCER INSTITUTE [P30CA023074, R01CA107510] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant to JDM from the National Institutes of Health (NIH) (RO1 CA107510) and a Cancer Center Support Grant to the Arizona Cancer Center (P30 CA023074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballare E, 2001, J CLIN ENDOCR METAB, V86, P3809, DOI 10.1210/jc.86.8.3809; BONDY GP, 1985, CANCER RES, V45, P6005; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200; Fan T, 2007, CANCER RES, V67, P7901, DOI 10.1158/0008-5472.CAN-07-0090; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Guweidhi A, 2004, CARCINOGENESIS, V25, P1575, DOI 10.1093/carcin/bgh159; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Higaki M, 1996, J BIOL CHEM, V271, P29342, DOI 10.1074/jbc.271.46.29342; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Iwata N, 2000, ONCOGENE, V19, P5298, DOI 10.1038/sj.onc.1203898; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; LI SF, 1995, EMBO J, V14, P685, DOI 10.1002/j.1460-2075.1995.tb07047.x; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Li Y, 2002, J BIOL CHEM, V277, P44593, DOI 10.1074/jbc.C200510200; Liu Y, 2002, CHEM MATER, V14, P3, DOI 10.1021/cm0109544; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MICHAUD NR, 1995, MOL CELL BIOL, V15, P3390; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; MORRISON DK, 1995, METHOD ENZYMOL, V255, P301; Munday AD, 2000, BLOOD, V96, P577; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Olson MF, 2000, SEMIN IMMUNOL, V12, P63, DOI 10.1006/smim.2000.0208; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Qi WQ, 2007, MOL CARCINOGEN, V46, P847, DOI 10.1002/mc.20314; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; RAY RB, 1995, CANCER RES, V55, P3747; Samuel T, 2001, J BIOL CHEM, V276, P45201, DOI 10.1074/jbc.M106427200; Su TT, 2001, J CELL SCI, V114, P3445; Takihara Y, 2000, CARCINOGENESIS, V21, P2073, DOI 10.1093/carcin/21.11.2073; TUCK SP, 1989, ONCOGENE RES, V4, P81; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Urano T, 2002, NATURE, V417, P871, DOI 10.1038/nature00826; Yang HL, 2006, CANCER RES, V66, P3096, DOI 10.1158/0008-5472.CAN-05-3620; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhao L, 2008, ONCOGENE, V27, P5486, DOI 10.1038/onc.2008.244	41	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 2	2010	5	7							e11433	10.1371/journal.pone.0011433	http://dx.doi.org/10.1371/journal.pone.0011433			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619YH	20628654	Green Published, gold, Green Submitted			2022-12-27	WOS:000279465700015
J	Ajslev, TA; Andersen, CS; Ingstrup, KG; Nohr, EA; Sorensen, TIA				Ajslev, Teresa A.; Andersen, Camilla S.; Ingstrup, Katja G.; Nohr, Ellen A.; Sorensen, Thorkild I. A.			Maternal Postpartum Distress and Childhood Overweight	PLOS ONE			English	Article							BODY-MASS INDEX; POSTTRAUMATIC-STRESS-DISORDER; GESTATIONAL WEIGHT-GAIN; INTERNATIONAL SURVEY; OBESITY; RISK; DEPRESSION; CHILDREN; PREGNANCY; MALTREATMENT	Objective: We investigated associations between maternal postpartum distress covering anxiety, depression and stress and childhood overweight. Methods: We performed a prospective cohort study, including 21 121 mother-child-dyads from the Danish National Birth Cohort (DNBC). Maternal distress was measured 6 months postpartum by 9 items covering anxiety, depression and stress. Outcome was childhood overweight at 7-years-of age. Multiple logistic regression analyses were performed and information on maternal age, socioeconomic status, pre-pregnancy BMI, gestational weight gain, parity, smoking during pregnancy, paternal BMI, birth weight, gestational age at birth, sex, breastfeeding and finally infant weight at 5 and 12 month were included in the analyses. Results: We found, that postpartum distress was not associated with childhood risk of overweight, OR 1.00, 95% Cl [0.98-1.02]. Neither was anxiety, depression, or stress exposure, separately. There were no significant differences between the genders. Adjustment for potential confounders did not alter the results. Conclusion: Maternal postpartum distress is apparently not an independent risk factor for childhood overweight at 7-years-of-age. However, we can confirm previous findings of perinatal determinants as high maternal pre-pregnancy BMI, and smoking during pregnancy being risk factors for childhood overweight.	[Ajslev, Teresa A.; Andersen, Camilla S.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Ingstrup, Katja G.; Nohr, Ellen A.] Univ Aarhus, Inst Publ Hlth, Dept Epidemiol, Aarhus, Denmark	University of Copenhagen; Aarhus University	Ajslev, TA (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	ta@ipm.regionh.dk		Ingstrup, Katja Glejsted/0000-0001-7288-5336	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation; Lundbeck Foundation [195/04]; Danish Medical Research Council [SSVF 0646]	Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Additional support for the Danish National Birth Cohort was obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation. The 7-year follow-up study within the DNBC has received financial support from the Lundbeck Foundation (195/04) and the Danish Medical Research Council (SSVF 0646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x; Brockington I, 2004, LANCET, V363, P303, DOI 10.1016/S0140-6736(03)15390-1; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Forman DR, 2007, DEV PSYCHOPATHOL, V19, P585, DOI 10.1017/S0954579407070289; Grilo CM, 2005, OBES RES, V13, P123, DOI 10.1038/oby.2005.16; Gustafson T B, 2004, Obes Rev, V5, P129, DOI 10.1111/j.1467-789X.2004.00145.x; KNUTSON JF, 2009, J PEDIAT PSYCHOL; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lobstein T, 2003, Obes Rev, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Monasta L, 2010, OBES REV; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Navarro P, 2007, GEN HOSP PSYCHIAT, V29, P1, DOI 10.1016/j.genhosppsych.2006.10.004; Nemeroff CB, 2008, NEURON, V59, P185, DOI 10.1016/j.neuron.2008.07.015; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Nohr EA, 2008, AM J CLIN NUTR, V87, P1750, DOI 10.1093/ajcn/87.6.1750; O'Hara MW, 2009, J CLIN PSYCHOL, V65, P1258, DOI 10.1002/jclp.20644; Oberlander TF, 2008, EARLY HUM DEV, V84, P689, DOI 10.1016/j.earlhumdev.2008.06.008; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Oken E, 2008, INT J OBESITY, V32, P201, DOI 10.1038/sj.ijo.0803760; Oken E, 2008, OBSTET GYNECOL, V112, P999, DOI 10.1097/AOG.0b013e31818a5d50; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Ong KK, 2006, HORM RES, V65, P65, DOI 10.1159/000091508; Padez C, 2005, ACTA PAEDIATR, V94, P1550, DOI 10.1080/08035250510042924; Pederson CL, 2009, PSYCHOL REP, V105, P111, DOI 10.2466/PR0.105.1.111-126; Perkonigg A, 2009, AM J PREV MED, V36, P1, DOI 10.1016/j.amepre.2008.09.026; Plagemann Andreas, 2005, Metabolic Syndrome and Related Disorders, V3, P222, DOI 10.1089/met.2005.3.222; Schmitz N, 2001, COMPR PSYCHIAT, V42, P166, DOI 10.1053/comp.2001.19751; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; STENHAMMAR C, 2010, ACTA PAEDIAT; Surkan PJ, 2008, J EPIDEMIOL COMMUN H, V62, DOI 10.1136/jech.2007.065664; Trombini E, 2003, PERCEPT MOTOR SKILL, V97, P613, DOI 10.2466/PMS.97.5.613-620; Vohr BR, 2008, J MATERN-FETAL NEO M, V21, P149, DOI 10.1080/14767050801929430; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Wisner KL, 2002, NEW ENGL J MED, V347, P194, DOI 10.1056/NEJMcp011542; Zeller MH, 2007, OBESITY, V15, P126, DOI 10.1038/oby.2007.517; 2010, DANISH NATL BIRTH CO	42	31	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11136	10.1371/journal.pone.0011136	http://dx.doi.org/10.1371/journal.pone.0011136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618QE	20614031	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000001
J	Saikkonen, K; Wali, PR; Helander, M				Saikkonen, Kari; Wali, Piippa R.; Helander, Marjo			Genetic Compatibility Determines Endophyte-Grass Combinations	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; MUTUALISM; EVOLUTION; FESCUE; INFECTION; ECOLOGY; SYSTEMS; LOLIUM	Even highly mutually beneficial microbial-plant interactions, such as mycorrhizal- and rhizobial-plant exchanges, involve selfishness, cheating and power-struggles between the partners, which depending on prevailing selective pressures, lead to a continuum of interactions from antagonistic to mutualistic. Using manipulated grass-endophyte combinations in a five year common garden experiment, we show that grass genotypes and genetic mismatches constrain genetic combinations between the vertically (via host seeds) transmitted endophytes and the out-crossing host, thereby reducing infections in established grass populations. Infections were lost in both grass tillers and seedlings in F-1 and F-2 generations, respectively. Experimental plants were collected as seeds from two different environments, i.e., meadows and nearby riverbanks. Endophyte-related benefits to the host included an increased number of inflorescences, but only in meadow plants and not until the last growing season of the experiment. Our results illustrate the importance of genetic host specificity and transgenerational maternal effects on the genetic structure of a host population, which act as destabilizing forces in endophyte-grass symbioses. We propose that (1) genetic mismatches may act as a buffering mechanism against highly competitive endophyte-grass genotype combinations threatening the biodiversity of grassland communities and (2) these mismatches should be acknowledged, particularly in breeding programmes aimed at harnessing systemic and heritable endophytes to improve the agriculturally valuable characteristics of cultivars.	[Saikkonen, Kari] MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland; [Wali, Piippa R.] Univ Oulu, Dept Biol, Oulu, Finland; [Helander, Marjo] Univ Turku, Dept Biol, SF-20500 Turku, Finland	Natural Resources Institute Finland (Luke); University of Oulu; University of Turku	Saikkonen, K (corresponding author), MTT Agrifood Res Finland, Plant Prod Res, Jokioinen, Finland.	kari.saikkonen@mtt.fi	; Wali, Piippa/H-8562-2017	Helander, Marjo/0000-0002-9759-4321; Wali, Piippa/0000-0002-2484-7455	Academy of Finland [110658]	Academy of Finland(Academy of Finland)	This study was funded by the Academy of Finland (Project no. 110658, www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlholm JU, 2002, OIKOS, V99, P173, DOI 10.1034/j.1600-0706.2002.990118.x; [Anonymous], 1998, RETKEILYKASVIO; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; Faeth SH, 2003, AM NAT, V161, P310, DOI 10.1086/345937; Gould F.W., 1983, GRASS SYSTEMATICS, V2; GWINN KD, 1991, PHYTOPATHOLOGY, V81, P747, DOI 10.1094/Phyto-81-747; HARBERD D. J., 1961, NEW PHYTOL, V60, P184, DOI 10.1111/j.1469-8137.1961.tb06251.x; HERRE EA, 1998, ANNU REV ECOL SYST, V39, P439; Jensen AMD, 2004, AGR ECOSYST ENVIRON, V104, P419, DOI 10.1016/j.agee.2004.01.044; Kiers ET, 2008, ANNU REV ECOL EVOL S, V39, P215, DOI 10.1146/annurev.ecolsys.39.110707.173423; LATCH GCM, 1984, MYCOTAXON, V20, P535; LATCH GCM, 1985, ANN APPL BIOL, V107, P17, DOI 10.1111/j.1744-7348.1985.tb01543.x; Lehtonen P, 2005, ECOL LETT, V8, P1256, DOI 10.1111/j.1461-0248.2005.00834.x; MOSSEAU TA, 1998, MATERNAL EFFECTS AAD; Omacini M, 2001, NATURE, V409, P78, DOI 10.1038/35051070; PELLMYR O, 1994, NATURE, V372, P257, DOI 10.1038/372257a0; Rudgers JA, 2008, ECOL LETT, V11, P831, DOI 10.1111/j.1461-0248.2008.01201.x; Saari S, 2009, GRASS FORAGE SCI, V64, P169, DOI 10.1111/j.1365-2494.2009.00680.x; Saari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009845; Sachs JL, 2006, TRENDS ECOL EVOL, V21, P585, DOI 10.1016/j.tree.2006.06.018; SAHA DC, 1988, PHYTOPATHOLOGY, V78, P237, DOI 10.1094/Phyto-78-237; Saikkonen K, 2000, ECOGRAPHY, V23, P360, DOI 10.1034/j.1600-0587.2000.d01-1645.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Thompson J. N., 2005, INTERSPEC INTERACT; Wali PR, 2007, MICROB ECOL, V53, P20, DOI 10.1007/s00248-006-9076-2; Wali P, 2009, OECOLOGIA, V159, P49, DOI 10.1007/s00442-008-1202-z; Wei YK, 2006, GRASS FORAGE SCI, V61, P422, DOI 10.1111/j.1365-2494.2006.00551.x; WILLIAMS MJ, 1984, PLANT DIS, V68, P49, DOI 10.1094/PD-69-49; Zar JH., 2010, BIOSTAT ANAL, V5th	39	64	66	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11395	10.1371/journal.pone.0011395	http://dx.doi.org/10.1371/journal.pone.0011395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614034	Green Submitted, Green Published, gold			2022-12-27	WOS:000279370000023
J	Schimizzi, GV; Currie, JD; Rogers, SL				Schimizzi, Gregory V.; Currie, Joshua D.; Rogers, Stephen L.			Expression Levels of a Kinesin-13 Microtubule Depolymerase Modulates the Effectiveness of Anti-Microtubule Agents	PLOS ONE			English	Article							DYNAMICS; CELLS; COOPERATE; BINDING; TUBULIN; TARGET; DRUGS	Background: Chemotheraputic drugs often target the microtubule cytoskeleton as a means to disrupt cancer cell mitosis and proliferation. Anti-microtubule drugs inhibit microtubule dynamics, thereby triggering apoptosis when dividing cells activate the mitotic checkpoint. Microtubule dynamics are regulated by microtubule-associated proteins (MAPs); however, we lack a comprehensive understanding about how anti-microtubule agents functionally interact with MAPs. In this report, we test the hypothesis that the cellular levels of microtubule depolymerases, in this case kinesin-13 s, modulate the effectiveness of the microtubule disrupting drug colchicine. Methodology/Principal Findings: We used a combination of RNA interference (RNAi), high-throughput microscopy, and time-lapse video microscopy in Drosophila S2 cells to identify a specific MAP, kinesin-like protein 10A (KLP10A), that contributes to the efficacy of the anti-microtubule drug colchicine. KLP10A is an essential microtubule depolymerase throughout the cell cycle. We find that depletion of KLP10A in S2 cells confers resistance to colchicine-induced microtubule depolymerization to a much greater extent than depletion of several other destabilizing MAPs. Using image-based assays, we determined that control cells retained 58% (+/- 2% SEM) of microtubule polymer when after treatment with 2 mu M colchicine for 1 hour, while cells depleted of KLP10A by RNAi retained 74% (+/- 1% SEM). Likewise, overexpression of KLP10A-GFP results in increased susceptibility to microtubule depolymerization by colchicine. Conclusions/Significance: Our results demonstrate that the efficacy of microtubule destabilization by a pharmacological agent is dependent upon the cellular expression of a microtubule depolymerase. These findings suggest that expression levels of Kif2A, the human kinesin-13 family member, may be an attractive biomarker to assess the effectiveness of anti-microtubule chemotherapies. Knowledge of how MAP expression levels affect the action of anti-microtubule drugs may prove useful for evaluating possible modes of cancer treatment.	[Schimizzi, Gregory V.; Currie, Joshua D.; Rogers, Stephen L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Rogers, Stephen L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Rogers, Stephen L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Schimizzi, GV (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	srogers@bio.unc.edu		Schimizzi, Gregory/0000-0001-8744-3434; Currie, Josh/0000-0001-7402-4265	National Institutes of Health (NIH) [RO1GM081645]; Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081645] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) (RO1GM081645) and the Beckman Young Investigator Award from the Arnold and Mabel Beckman Foundation (http://www.beckman-foundation.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Bolanos-Garcia VM, 2009, CURR CANCER DRUG TAR, V9, P131, DOI 10.2174/156800909787580980; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Hedrick DG, 2008, CELL CYCLE, V7, P2146, DOI 10.4161/cc.7.14.6239; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Mennella V, 2005, NAT CELL BIOL, V7, P235, DOI 10.1038/ncb1222; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; UPPULURI S, 1993, P NATL ACAD SCI USA, V90, P11598, DOI 10.1073/pnas.90.24.11598; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9	17	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11381	10.1371/journal.pone.0011381	http://dx.doi.org/10.1371/journal.pone.0011381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20614032	Green Published, Green Submitted, gold			2022-12-27	WOS:000279370000011
J	de Meijer, VE; Sverdlov, DY; Popov, Y; Le, HD; Meisel, JA; Nose, V; Schuppan, D; Puder, M				de Meijer, Vincent E.; Sverdlov, Deanna Y.; Popov, Yury; Le, Hau D.; Meisel, Jonathan A.; Nose, Vania; Schuppan, Detlef; Puder, Mark			Broad-Spectrum Matrix Metalloproteinase Inhibition Curbs Inflammation and Liver Injury but Aggravates Experimental Liver Fibrosis in Mice	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; HEPATIC STELLATE CELLS/; CARBON-TETRACHLORIDE; FACTOR-ALPHA; TRANSGENIC MOUSE; ANTIFIBROTIC THERAPIES; CONVERTING-ENZYME; TISSUE INHIBITOR; FACTOR RECEPTOR; EXPRESSION	Background: Liver fibrosis is characterized by excessive synthesis of extracellular matrix proteins, which prevails over their enzymatic degradation, primarily by matrix metalloproteinases (MMPs). The effect of pharmacological MMP inhibition on fibrogenesis, however, is largely unexplored. Inflammation is considered a prerequisite and important co-contributor to fibrosis and is, in part, mediated by tumor necrosis factor (TNF)-alpha-converting enzyme (TACE). We hypothesized that treatment with a broad-spectrum MMP and TACE-inhibitor (Marimastat) would ameliorate injury and inflammation, leading to decreased fibrogenesis during repeated hepatotoxin-induced liver injury. Methodology/Principal Findings: Liver fibrosis was induced in mice by repeated carbon tetrachloride (CCl4) administration, during which the mice received either Marimastat or vehicle twice daily. A single dose of CCl(4) was administered to investigate acute liver injury in mice pretreated with Marimastat, mice deficient in Mmp9, or mice deficient in both TNF-alpha receptors. Liver injury was quantified by alanine aminotransferase (ALT) levels and confirmed by histology. Hepatic collagen was determined as hydroxyproline, and expression of fibrogenesis and fibrolysis-related transcripts was determined by quantitative reverse-transcription polymerase chain reaction. Marimastat-treated animals demonstrated significantly attenuated liver injury and inflammation but a 25% increase in collagen deposition. Transcripts related to fibrogenesis were significantly less upregulated compared to vehicle-treated animals, while MMP expression and activity analysis revealed efficient pharmacologic MMP-inhibition and decreased fibrolysis following Marimastat treatment. Marimastat pre-treatment significantly attenuated liver injury following acute CCl(4)-administration, whereas Mmp9 deficient animals demonstrated no protection. Mice deficient in both TNF-alpha receptors exhibited an 80% reduction of serum ALT, confirming the hepatoprotective effects of Marimastat via the TNF-signaling pathway. Conclusions/Significance: Inhibition of MMP and TACE activity with Marimastat during chronic CCl(4) administration counterbalanced any beneficial anti-inflammatory effect, resulting in a positive balance of collagen deposition. Since effective inhibition of MMPs accelerates fibrosis progression, MMP inhibitors should be used with caution in patients with chronic liver diseases.	[de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [de Meijer, Vincent E.; Le, Hau D.; Meisel, Jonathan A.; Puder, Mark] Harvard Univ, Sch Med, Childrens Hosp Boston, Vasc Biol Program, Boston, MA USA; [de Meijer, Vincent E.] Univ Med Ctr Rotterdam, Erasmus Med Ctr MC, Dept Surg, Rotterdam, Netherlands; [Sverdlov, Deanna Y.; Popov, Yury; Schuppan, Detlef] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol & Hepatol, Boston, MA 02215 USA; [Nose, Vania] Univ Miami, Miller Sch Med, Dept Anat Pathol, Miami, FL 33136 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Miami	de Meijer, VE (corresponding author), Harvard Univ, Sch Med, Dept Surg, Childrens Hosp Boston, Boston, MA 02115 USA.	mark.puder@childrens.harvard.edu	de Meijer, Vincent Erwin/H-6610-2019; Popov, Yury V./A-7781-2008	de Meijer, Vincent Erwin/0000-0002-7900-5917; Popov, Yury V./0000-0001-7973-942X; Le, Hau/0000-0003-0514-3513	Children's Hospital Surgical Foundation (Boston, MA); Prof. Michael-van Vloten Fonds (Venray, The Netherlands); VSBfonds (Utrecht, The Netherlands); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands)	Children's Hospital Surgical Foundation (Boston, MA); Prof. Michael-van Vloten Fonds (Venray, The Netherlands)(Netherlands Government); VSBfonds (Utrecht, The Netherlands)(Netherlands Government); Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands)(Netherlands Government); Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands)(Netherlands Government); Dr Saal van Zwanenberg Stichting (Oss, The Netherlands)(Netherlands Government)	Dr. de Meijer was recipient of fellowships from the foundations Stichting Prof. Michael-van Vloten Fonds (Venray, The Netherlands), VSBfonds (Utrecht, The Netherlands), Gerrit Jan Mulder Stichting (Rotterdam, The Netherlands), Prins Bernhard Cultuurfonds (Amsterdam, The Netherlands), and Dr Saal van Zwanenberg Stichting (Oss, The Netherlands). Dr. Puder was supported by the Children's Hospital Surgical Foundation (Boston, MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam R, 2009, SEMIN LIVER DIS, V29, P3, DOI 10.1055/s-0029-1192052; Albanis E, 2006, AM J TRANSPLANT, V6, P12, DOI 10.1111/j.1600-6143.2005.01143.x; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; ARTHUR MJP, 1989, J CLIN INVEST, V84, P1076, DOI 10.1172/JCI114270; Bahcecioglu IH, 2008, INFLAMMATION, V31, P215, DOI 10.1007/s10753-008-9067-1; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bramhall SR, 2002, BRIT J CANCER, V86, P1864, DOI 10.1038/sj.bjc.6600310; Cauwe B, 2007, CRIT REV BIOCHEM MOL, V42, P113, DOI 10.1080/10409230701340019; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Clements JM, 1997, J NEUROIMMUNOL, V74, P85, DOI 10.1016/S0165-5728(96)00210-X; *CLINICALTRIALS GO, 2010, NCT01051921 CLINICAL; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; Doggrell SA, 2002, EXPERT OPIN INV DRUG, V11, P1003, DOI 10.1517/13543784.11.7.1003; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Hamada T, 2008, HEPATOLOGY, V47, P186, DOI 10.1002/hep.21922; Hemmann S, 2007, J HEPATOL, V46, P955, DOI 10.1016/j.jhep.2007.02.003; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Kahraman A, 2009, HEPATOL RES, V39, P805, DOI 10.1111/j.1872-034X.2009.00541.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Mohammed FF, 2004, NAT GENET, V36, P969, DOI 10.1038/ng1413; Mohammed FF, 2005, HEPATOLOGY, V41, P857, DOI 10.1002/hep.20618; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; Moses MA, 2006, NEW ENGL J MED, V354, P2621, DOI 10.1056/NEJMc053410; Moss ML, 2008, NAT CLIN PRACT RHEUM, V4, P300, DOI 10.1038/ncprheum0797; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Olle EW, 2006, HEPATOLOGY, V44, P540, DOI 10.1002/hep.21314; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Popov Y, 2006, J BIOL CHEM, V281, P15090, DOI 10.1074/jbc.M600030200; Popov Y, 2009, HEPATOLOGY, V50, P1294, DOI 10.1002/hep.23123; Rasmussen HS, 1997, PHARMACOL THERAPEUT, V75, P69, DOI 10.1016/S0163-7258(97)00023-5; Rosenbaum E, 2005, CLIN CANCER RES, V11, P4437, DOI 10.1158/1078-0432.CCR-04-2252; SCHNEIDER BS, 1992, BIOCHEM BIOPH RES CO, V188, P767, DOI 10.1016/0006-291X(92)91122-7; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Simeonova PP, 2001, TOXICOL APPL PHARM, V177, P112, DOI 10.1006/taap.2001.9304; Sudo K, 2005, CYTOKINE, V29, P236, DOI 10.1016/j.cyto.2004.11.001; Taub R, 2003, J CLIN INVEST, V112, P978, DOI 10.1172/JCI20031200319974; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wells RG, 2000, AM J PHYSIOL-GASTR L, V279, pG845, DOI 10.1152/ajpgi.2000.279.5.G845; Wielockx B, 2001, NAT MED, V7, P1202, DOI 10.1038/nm1101-1202; WINWOOD PJ, 1995, HEPATOLOGY, V22, P304; Yoshiji H, 2000, HEPATOLOGY, V32, P1248, DOI 10.1053/jhep.2000.20521; Yoshiji H, 2002, HEPATOLOGY, V36, P850, DOI 10.1053/jhep.2002.35625	59	46	46	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11256	10.1371/journal.pone.0011256	http://dx.doi.org/10.1371/journal.pone.0011256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593020	Green Published, Green Submitted, gold			2022-12-27	WOS:000279140800002
J	Haggarty, P; Hoad, G; Harris, SE; Starr, JM; Fox, HC; Deary, IJ; Whalley, LJ				Haggarty, Paul; Hoad, Gwen; Harris, Sarah E.; Starr, John M.; Fox, Helen C.; Deary, Ian J.; Whalley, Lawrence J.			Human Intelligence and Polymorphisms in the DNA Methyltransferase Genes Involved in Epigenetic Marking	PLOS ONE			English	Article							DE-NOVO METHYLATION; IMPRINTED GENES; BRAIN-DEVELOPMENT; DNMT3L; DISORDERS; HOMOCYSTEINE; INHERITANCE; EXPRESSION; CHILDHOOD; MUTATIONS	Epigenetic mechanisms have been implicated in syndromes associated with mental impairment but little is known about the role of epigenetics in determining the normal variation in human intelligence. We measured polymorphisms in four DNA methyltransferases (DNMT1, DNMT3A, DNMT3B and DNMT3L) involved in epigenetic marking and related these to childhood and adult general intelligence in a population (n = 1542) consisting of two Scottish cohorts born in 1936 and residing in Lothian (n = 1075) or Aberdeen (n = 467). All subjects had taken the same test of intelligence at age 11yrs. The Lothian cohort took the test again at age 70yrs. The minor T allele of DNMT3L SNP 11330C>T (rs7354779) allele was associated with a higher standardised childhood intelligence score; greatest effect in the dominant analysis but also significant in the additive model (coefficient = 1.40(additive); 95%CI 0.22,2.59; p = 0.020 and 1.99(dominant); 95%CI 0.55,3.43; p = 0.007). The DNMT3L C allele was associated with an increased risk of being below average intelligence (OR 1.25(additive); 95%CI 1.05,1.51; p = 0.011 and OR 1.37(dominant); 95%CI 1.11,1.68; p = 0.003), and being in the lowest 40(th) (p(additive) = 0.009; p(dominant) = 0.002) and lowest 30(th) (p(additive) = 0.004; p(dominant) = 0.002) centiles for intelligence. After Bonferroni correction for the number variants tested the link between DNMT3L 11330C>T and childhood intelligence remained significant by linear regression and centile analysis; only the additive regression model was borderline significant. Adult intelligence was similarly linked to the DNMT3L variant but this analysis was limited by the numbers studied and nature of the test and the association was not significant after Bonferroni correction. We believe that the role of epigenetics in the normal variation in human intelligence merits further study and that this novel finding should be tested in other cohorts.	[Haggarty, Paul; Hoad, Gwen] Univ Aberdeen, Rowett Inst Nutr & Hlth, Nutr & Epigenet Grp, Aberdeen, Scotland; [Harris, Sarah E.] Univ Edinburgh, Med Genet Sect, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Ctr Cognit Ageing & Cognit Epidemiol, Geriatr Med Unit, Edinburgh, Midlothian, Scotland; [Fox, Helen C.; Whalley, Lawrence J.] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	University of Aberdeen; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh	Haggarty, P (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Nutr & Epigenet Grp, Aberdeen, Scotland.	p.haggarty@abdn.ac.uk	Haggarty, Paul/C-1696-2009; whalley, lawrence j/E-9019-2011; Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Alzheimer's Research Trust; BBSRC; EPSRC; ESRC; MRC; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704] Funding Source: researchfish	Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); Alzheimer's Research Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The genotype measurements were funded by the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD) and the Alzheimer's Research Trust. PH and GH acknowledge the support of RERAD. The Aberdeen data and sample collection was funded by BBSRC. The Lothian work was undertaken within The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative, with funding from BBSRC, EPSRC, ESRC and MRC. The Lothian data collection was supported by a programme grant from Research Into Ageing, which continues as the Disconnected Mind project funded by Help the Aged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapola U, 2002, NUCLEIC ACIDS RES, V30, P3602, DOI 10.1093/nar/gkf474; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Arnaud P, 2006, HUM MOL GENET, V15, P589, DOI 10.1093/hmg/ddi475; Ausio J, 2003, CLIN GENET, V64, P83, DOI 10.1034/j.1399-0004.2003.00124.x; Badcock C, 2006, J EVOLUTION BIOL, V19, P1007, DOI 10.1111/j.1420-9101.2006.01091.x; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bonsch D, 2004, J NEURAL TRANSM, V111, P1611, DOI 10.1007/s00702-004-0232-x; Bouchard TJ, 1998, HUM BIOL, V70, P257; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Buiting K, 2003, AM J HUM GENET, V72, P571, DOI 10.1086/367926; Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142; Catchpoole D, 1997, J MED GENET, V34, P353, DOI 10.1136/jmg.34.5.353; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Chamary JV, 2009, SCI AM, V300, P46, DOI 10.1038/scientificamerican0609-46; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Cooney CA, 2002, J NUTR, V132, p2393S; Cunningham MD, 2010, DEV CELL, V18, P169, DOI 10.1016/j.devcel.2010.01.012; Davies W, 2001, ANN MED, V33, P428, DOI 10.3109/07853890108995956; Davies W, 2008, FRONT NEUROENDOCRIN, V29, P413, DOI 10.1016/j.yfrne.2007.12.001; Davies W, 2008, ADV EXP MED BIOL, V626, P62; Deary IJ, 2006, EUR J HUM GENET, V14, P690, DOI 10.1038/sj.ejhg.5201588; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; El-Maarri O, 2009, HUM MOL GENET, V18, P1755, DOI 10.1093/hmg/ddp088; Flynn J R, 2000, Novartis Found Symp, V233, P202, DOI 10.1002/0470870850.ch13; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Goos LM, 2008, ADV EXP MED BIOL, V626, P71; Goos LM, 2006, J NEUROGENET, V20, P19, DOI 10.1080/01677060600685840; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; LIU Z, 2008, CANC LETT; LYNN R, 1987, NATURE, V328, P797, DOI 10.1038/328797a0; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sakatani T, 2001, BIOCHEM BIOPH RES CO, V283, P1124, DOI 10.1006/bbrc.2001.4916; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Scottish Council for Research in Education, 1949, TREND SCOTT INT COMP; Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Trasler JM, 2006, REPROD FERT DEVELOP, V18, P63, DOI 10.1071/RD05118; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6; Whittington J, 2004, J INTELL DISABIL RES, V48, P172, DOI 10.1111/j.1365-2788.2004.00556.x; Whittington J, 2009, J INTELL DISABIL RES, V53, P411, DOI 10.1111/j.1365-2788.2009.01157.x; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Xie ZH, 2006, HUM MOL GENET, V15, P1375, DOI 10.1093/hmg/ddl059; Zhao XY, 2007, EPIGENETICS-US, V2, P126, DOI 10.4161/epi.2.2.4236	56	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11329	10.1371/journal.pone.0011329	http://dx.doi.org/10.1371/journal.pone.0011329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593030	Green Submitted, Green Published, gold			2022-12-27	WOS:000279140800026
J	Van Grol, J; Subauste, C; Andrade, RM; Fujinaga, K; Nelson, J; Subauste, CS				Van Grol, Jennifer; Subauste, Cecilia; Andrade, Rosa M.; Fujinaga, Koh; Nelson, Julie; Subauste, Carlos S.			HIV-1 Inhibits Autophagy in Bystander Macrophage/Monocytic Cells through Src-Akt and STAT3	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FOCAL ADHESION KINASE; TAT PROTEIN; T-CELLS; ANTIMICROBIAL ACTIVITY; EPITHELIAL-CELLS; GROWTH-FACTOR; MONOCYTES; APOPTOSIS; IL-10	Autophagy is a homeostatic mechanism of lysosomal degradation. Defective autophagy has been linked to various disorders such as impaired control of pathogens and neurodegeneration. Autophagy is regulated by a complex array of signaling pathways that act upstream of autophagy proteins. Little is known about the role of altered regulatory signaling in disorders associated with defective autophagy. In particular, it is not known if pathogens inhibit autophagy by modulation of upstream regulatory pathways. Cells infected with HIV-1 blocked rapamycin-induced autophagy and CD40-induced autophagic killing of Toxoplasma gondii in bystander (non-HIV-1 infected) macrophage/monocytic cells. Blockade of autophagy was dependent on Src-Akt and STAT3 triggered by HIV-1 Tat and IL-10. Neutralization of the upstream receptors VEGFR, beta-integrin or CXCR4, as well as of HIV-1 Tat or IL-10 restored autophagy in macrophage/monocytic cells exposed to HIV-1-infected cells. Defective autophagic killing of T. gondii was detected in monocyte-derived macrophages from a subset of HIV-1(+) patients. This defect was also reverted by neutralization of Tat or IL-10. These studies revealed that a pathogen can impair autophagy in non-infected cells by activating counter-regulatory pathways. The fact that pharmacologic manipulation of cell signaling restored autophagy in cells exposed to HIV-1-infected cells raises the possibility of therapeutic manipulation of cell signaling to restore autophagy in HIV-1 infection.	[Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Van Grol, Jennifer; Fujinaga, Koh; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Med, Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Van Grol, Jennifer; Subauste, Carlos S.] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Subauste, Cecilia] Univ Texas SW Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Andrade, Rosa M.] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH USA; [Nelson, Julie] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill	Van Grol, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.	carlos.subauste@case.edu	Nelson, Julie/ABE-7315-2021	Subauste, Carlos/0000-0002-5602-1439	NIH [AI48406, EY018341, P30 EY11373]; American Heart Association Ohio Valley Affiliate; Case/UHC Center for AIDS Research NIH [AI36219]; NATIONAL EYE INSTITUTE [R01EY018341, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI048406] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Ohio Valley Affiliate(American Heart Association); Case/UHC Center for AIDS Research NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH Grant AI48406 (C. S. S.), EY EY018341 (C. S. S.), the American Heart Association Ohio Valley Affiliate (C. S. S.), Case/UHC Center for AIDS Research NIH Grant AI36219 and NIH Grant P30 EY11373. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr B, 2005, J BIOL CHEM, V280, P6692, DOI 10.1074/jbc.M408481200; AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Albini A, 1998, J BIOL CHEM, V273, P15895, DOI 10.1074/jbc.273.26.15895; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; Amer AO, 2005, CELL MICROBIOL, V7, P765, DOI 10.1111/j.1462-5822.2005.00509.x; Andrade RM, 2005, INFECT IMMUN, V73, P3115, DOI 10.1128/IAI.73.5.3115-3123.2005; Andrade RM, 2003, J IMMUNOL, V171, P6750, DOI 10.4049/jimmunol.171.12.6750; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Aoki H, 2007, FASEB J, V21, P2918, DOI 10.1096/fj.06-6941com; Avraham HK, 2004, J IMMUNOL, V173, P6228, DOI 10.4049/jimmunol.173.10.6228; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; CHANAKYA HN, 1997, BIOENERGY NEWS, V1, P11; Chaturvedi LS, 2007, J BIOL CHEM, V282, P14, DOI 10.1074/jbc.M605817200; Chehimi J, 1996, AIDS RES HUM RETROV, V12, P1141, DOI 10.1089/aid.1996.12.1141; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Fischer-Smith T, 2001, J NEUROVIROL, V7, P528, DOI 10.1080/135502801753248114; Ganju RK, 1998, J BIOL CHEM, V273, P23169, DOI 10.1074/jbc.273.36.23169; Gee K, 2007, J IMMUNOL, V178, P798, DOI 10.4049/jimmunol.178.2.798; Ghezzi S, 2000, BIOCHEM BIOPH RES CO, V270, P992, DOI 10.1006/bbrc.2000.2523; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; GUTHEIL WG, 1994, P NATL ACAD SCI USA, V91, P6594, DOI 10.1073/pnas.91.14.6594; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hagiwara E, 1996, AIDS RES HUM RETROV, V12, P127, DOI 10.1089/aid.1996.12.127; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Horn Leora, 2009, Proc Am Thorac Soc, V6, P206, DOI 10.1513/pats.200807-066LC; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; King JE, 2006, MICROBES INFECT, V8, P1347, DOI 10.1016/j.micinf.2005.11.014; Konnikova L, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-23; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Leghmari K, 2008, EUR J CELL BIOL, V87, P947, DOI 10.1016/j.ejcb.2008.06.005; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Naif HM, 1998, J VIROL, V72, P830, DOI 10.1128/JVI.72.1.830-836.1998; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pahan K, 2000, J NEUROCHEM, V75, P576, DOI 10.1046/j.1471-4159.2000.0750576.x; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Poggi A, 2006, CLIN DEV IMMUNOL, V13, P369, DOI 10.1080/17402520600645712; Ponnusamy M, 2009, AM J PHYSIOL-RENAL, V297, pF1361, DOI 10.1152/ajprenal.00251.2009; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Scheidegger P, 2001, BIOCHEM J, V353, P569, DOI 10.1042/0264-6021:3530569; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009; Shih WL, 2010, CANCER LETT, V290, P223, DOI 10.1016/j.canlet.2009.09.014; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sonza S, 2001, AIDS, V15, P17, DOI 10.1097/00002030-200101050-00005; Subauste CS, 2007, AUTOPHAGY, V3, P245, DOI 10.4161/auto.3717; Tachado SD, 2008, J BIOL CHEM, V283, P33191, DOI 10.1074/jbc.M805067200; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tangsinmankong N, 2000, CYTOKINE, V12, P1506, DOI 10.1006/cyto.2000.0741; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Zachary I, 2003, BIOCHEM SOC T, V31, P1171; Zhou DJ, 2008, AIDS, V22, P695, DOI 10.1097/QAD.0b013e3282f4a836; Zhou JH, 2001, J IMMUNOL, V167, P4436, DOI 10.4049/jimmunol.167.8.4436; Zhou ZG, 2009, J NEUROCHEM, V110, P1617, DOI 10.1111/j.1471-4159.2009.06263.x	79	95	96	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11733	10.1371/journal.pone.0011733	http://dx.doi.org/10.1371/journal.pone.0011733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661303	Green Published, gold, Green Submitted			2022-12-27	WOS:000280243300031
J	Knapp, B; Omasits, U; Schreiner, W; Epstein, MM				Knapp, Bernhard; Omasits, Ulrich; Schreiner, Wolfgang; Epstein, Michelle M.			A Comparative Approach Linking Molecular Dynamics of Altered Peptide Ligands and MHC with In Vivo Immune Responses	PLOS ONE			English	Article							MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MAJOR HISTOCOMPATIBILITY COMPLEX; BINDING-AFFINITY; RECOGNITION; SIMULATION; EPITOPE; MODEL; PROLIFERATION	Background: The recognition of peptide in the context of MHC by T lymphocytes is a critical step in the initiation of an adaptive immune response. However, the molecular nature of the interaction between peptide and MHC and how it influences T cell responsiveness is not fully understood. Results: We analyzed the immunological consequences of the interaction of MHC class II (I-A(u)) restricted 11-mer peptides of myelin basic protein with amino acid substitutions at position 4. These mutant peptides differ in MHC binding affinity, CD4(+) T cell priming, and alter the severity of peptide-induced experimental allergic encephalomyelitis. Using molecular dynamics, a computational method of quantifying intrinsic movements of proteins at high resolution, we investigated conformational changes in MHC upon peptide binding. We found that irrespective of peptide binding affinity, MHC deformation appears to influence costimulation, which then leads to effective T cell priming and disease induction. Although this study compares in vivo and molecular dynamics results for three altered peptide ligands, further investigation with similar complexes is essential to determine whether spatial rearrangement of peptide-MHC and costimulatory complexes is an additional level of T cell regulation.	[Knapp, Bernhard; Omasits, Ulrich; Schreiner, Wolfgang] Med Univ Vienna, Dept Biomed Comp Simulat & Bioinformat, Vienna, Austria; [Epstein, Michelle M.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Knapp, B (corresponding author), Med Univ Vienna, Dept Biomed Comp Simulat & Bioinformat, Vienna, Austria.	Michelle.Epstein@meduniwien.ac.at		Epstein, Michelle/0000-0002-4755-0224; Goldmann, Ulrich/0000-0003-1120-6912	Austrian Ministry of Education, Science and Culture [GZ 4003/2-VI/4c/2004]; Austrian Science Fund [FWF P22258-B12]; NIAID, NIH [5R01AI026791]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026791] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 22258] Funding Source: researchfish	Austrian Ministry of Education, Science and Culture; Austrian Science Fund(Austrian Science Fund (FWF)); NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is supported in part by the Austrian Grid Project of the Austrian Ministry of Education, Science and Culture (GZ 4003/2-VI/4c/2004), the Austrian Science Fund (FWF P22258-B12), and by grant number 5R01AI026791 from NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cuendet MA, 2008, BIOPHYS J, V95, P3575, DOI 10.1529/biophysj.108.131383; EVAVOLD BD, 1993, J IMMUNOL, V150, P3131; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; FRITZ RB, 1983, J IMMUNOL, V130, P191; Fugger L, 1996, MOL MED, V2, P181, DOI 10.1007/BF03401615; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hansson T, 2002, CURR OPIN STRUC BIOL, V12, P190, DOI 10.1016/S0959-440X(02)00308-1; He XL, 2002, IMMUNITY, V17, P83, DOI 10.1016/S1074-7613(02)00340-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Knapp B, 2009, MOL IMMUNOL, V46, P1839, DOI 10.1016/j.molimm.2009.01.009; KUMAR V, 1995, P NATL ACAD SCI USA, V92, P9510, DOI 10.1073/pnas.92.21.9510; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Macdonald WA, 2003, J EXP MED, V198, P679, DOI 10.1084/jem.20030066; Mantzourani ED, 2006, J MOL GRAPH MODEL, V25, P17, DOI 10.1016/j.jmgm.2005.09.010; Mantzourani ED, 2006, J MED CHEM, V49, P6683, DOI 10.1021/jm060040z; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Omasits U, 2008, MOL SIMULAT, V34, P781, DOI 10.1080/08927020802256298; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Rognan D, 2000, J COMPUT AID MOL DES, V14, P53, DOI 10.1023/A:1008142830353; SMILEK DE, 1991, P NATL ACAD SCI USA, V88, P9633, DOI 10.1073/pnas.88.21.9633; Smith KJ, 1996, IMMUNITY, V4, P203, DOI 10.1016/S1074-7613(00)80429-X; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sundberg EJ, 2002, J MOL BIOL, V319, P449, DOI 10.1016/S0022-2836(02)00370-4; Varani L, 2007, P NATL ACAD SCI USA, V104, P13080, DOI 10.1073/pnas.0703702104; Wan S, 2008, MOL IMMUNOL, V45, P1221, DOI 10.1016/j.molimm.2007.09.022; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; Yaneva R, 2009, BIOPOLYMERS, V91, P14, DOI 10.1002/bip.21078; Zachou Kalliopi, 2004, J Autoimmune Dis, V1, P2, DOI 10.1186/1740-2557-1-2; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0	32	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 19	2010	5	7							e11653	10.1371/journal.pone.0011653	http://dx.doi.org/10.1371/journal.pone.0011653			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	627TK	20657836	gold, Green Published			2022-12-27	WOS:000280065600016
J	Ventura, CL; Malachowa, N; Hammer, CH; Nardone, GA; Robinson, MA; Kobayashi, SD; DeLeo, FR				Ventura, Christy L.; Malachowa, Natalia; Hammer, Carl H.; Nardone, Glenn A.; Robinson, Mary Ann; Kobayashi, Scott D.; DeLeo, Frank R.			Identification of a Novel Staphylococcus aureus Two-Component Leukotoxin Using Cell Surface Proteomics	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; WALL ASSOCIATED PROTEINS; NUCLEOTIDE-SEQUENCE; GAMMA-HEMOLYSIN; POLYMORPHONUCLEAR LEUKOCYTES; GEL-ELECTROPHORESIS; VIRULENCE; GENES; INFECTIONS; LUKF	Staphylococcus aureus is a prominent human pathogen and leading cause of bacterial infection in hospitals and the community. Community-associated methicillin-resistant S. aureus (CA-MRSA) strains such as USA300 are highly virulent and, unlike hospital strains, often cause disease in otherwise healthy individuals. The enhanced virulence of CA-MRSA is based in part on increased ability to produce high levels of secreted molecules that facilitate evasion of the innate immune response. Although progress has been made, the factors that contribute to CA-MRSA virulence are incompletely defined. We analyzed the cell surface proteome (surfome) of USA300 strain LAC to better understand extracellular factors that contribute to the enhanced virulence phenotype. A total of 113 identified proteins were associated with the surface of USA300 during the late-exponential phase of growth in vitro. Protein A was the most abundant surface molecule of USA300, as indicated by combined Mascot score following analysis of peptides by tandem mass spectrometry. Unexpectedly, we identified a previously uncharacterized two-component leukotoxin-herein named LukS-H and LukF-G (LukGH)-as two of the most abundant surface-associated proteins of USA300. Rabbit antibody specific for LukG indicated it was also freely secreted by USA300 into culture media. We used wild-type and isogenic lukGH deletion strains of USA300 in combination with human PMN pore formation and lysis assays to identify this molecule as a leukotoxin. Moreover, LukGH synergized with PVL to enhance lysis of human PMNs in vitro, and contributed to lysis of PMNs after phagocytosis. We conclude LukGH is a novel two-component leukotoxin with cytolytic activity toward neutrophils, and thus potentially contributes to S. aureus virulence.	[Ventura, Christy L.; Malachowa, Natalia; Kobayashi, Scott D.; DeLeo, Frank R.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT USA; [Hammer, Carl H.; Nardone, Glenn A.; Robinson, Mary Ann] NIAID, Res Technol Branch, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ventura, CL (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.	fdeleo@niaid.nih.gov		DeLeo, Frank/0000-0003-3150-2516; Kobayashi, Scott/0000-0002-5705-1381; Ventura, Christy/0000-0002-5084-1567	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI001079] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Billion A, 2006, BIOINFORMATICS, V22, P2819, DOI 10.1093/bioinformatics/btl466; CHOORIT W, 1995, FEBS LETT, V357, P260, DOI 10.1016/0014-5793(94)01372-8; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deleo FR, 2009, INFECT DIS CLIN N AM, V23, P17, DOI 10.1016/j.idc.2008.10.003; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003198; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FINCKBARBANCON V, 1991, RES MICROBIOL, V142, P75, DOI 10.1016/0923-2508(91)90099-V; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatlin CL, 2006, PROTEOMICS, V6, P1530, DOI 10.1002/pmic.200500253; Graves SF, 2010, MICROBES INFECT, V12, P446, DOI 10.1016/j.micinf.2010.02.005; Gravet A, 1998, FEBS LETT, V436, P202, DOI 10.1016/S0014-5793(98)01130-2; Holmes A, 2005, J CLIN MICROBIOL, V43, P2384, DOI 10.1128/JCM.43.5.2384-2390.2005; Jayasinghe L, 2005, PROTEIN SCI, V14, P2550, DOI 10.1110/ps.051648505; Jones RC, 2008, J BACTERIOL, V190, P5265, DOI 10.1128/JB.00383-08; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P1960, DOI 10.1271/bbb.61.1960; Kaneko J, 1998, GENE, V215, P57, DOI 10.1016/S0378-1119(98)00278-9; Kennedy AD, 2008, P NATL ACAD SCI USA, V105, P1327, DOI 10.1073/pnas.0710217105; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Kobayashi SD, 2002, P NATL ACAD SCI USA, V99, P6901, DOI 10.1073/pnas.092148299; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li M, 2009, P NATL ACAD SCI USA, V106, P5883, DOI 10.1073/pnas.0900743106; Luong T, 2002, INFECT IMMUN, V70, P444, DOI 10.1128/IAI.70.2.444-450.2002; Luong TT, 2006, J BACTERIOL, V188, P1899, DOI 10.1128/JB.188.5.1899-1910.2006; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nandakumar R, 2005, J PROTEOME RES, V4, P250, DOI 10.1021/pr049866k; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Nygaard TK, 2008, CURR OPIN INFECT DIS, V21, P147, DOI 10.1097/QCO.0b013e3282f64819; Palazzolo-Ballance AM, 2008, J IMMUNOL, V180, P500, DOI 10.4049/jimmunol.180.1.500; Panton PN, 1932, LANCET, V1, P506; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; Prevost G, 2001, CURR TOP MICROBIOL, V257, P53; PREVOST G, 1995, INFECT IMMUN, V63, P4121; RAHMAN A, 1991, BIOCHEM BIOPH RES CO, V181, P138, DOI 10.1016/S0006-291X(05)81392-0; RAHMAN A, 1992, BIOCHEM BIOPH RES CO, V184, P640, DOI 10.1016/0006-291X(92)90637-Z; RAHMAN A, 1993, BIOSCI BIOTECH BIOCH, V57, P1234, DOI 10.1271/bbb.57.1234; Robert J, 2005, CLIN MICROBIOL INFEC, V11, P585, DOI 10.1111/j.1469-0691.2005.01173.x; Rodriguez-Ortega MJ, 2006, NAT BIOTECHNOL, V24, P191, DOI 10.1038/nbt1179; Sakata N, 2005, CURR MICROBIOL, V50, P47, DOI 10.1007/s00284-004-4381-9; Solis N, 2010, PROTEOMICS, V10, P2037, DOI 10.1002/pmic.200900564; Szmigielski S, 1999, ZBL BAKT-INT J MED M, V289, P185; Szmigielski S, 1998, ZBL BAKT-INT J MED M, V288, P383; Taverna F, 2007, VET MICROBIOL, V119, P240, DOI 10.1016/j.vetmic.2006.09.007; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; von Eiff C, 2004, DIAGN MICR INFEC DIS, V49, P157, DOI 10.1016/j.diagmicrobio.2004.03.009; Voyich JA, 2005, J IMMUNOL, V175, P3907, DOI 10.4049/jimmunol.175.6.3907; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; WOODIN AM, 1960, BIOCHEM J, V75, P158, DOI 10.1042/bj0750158	55	163	173	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11634	10.1371/journal.pone.0011634	http://dx.doi.org/10.1371/journal.pone.0011634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661294	gold, Green Published, Green Submitted			2022-12-27	WOS:000279980800019
J	Wassenberg, MWM; de Wit, GA; van Hout, BA; Bonten, MJM				Wassenberg, Marjan W. M.; de Wit, G. Ardine; van Hout, Ben A.; Bonten, Marc J. M.			Quantifying Cost-Effectiveness of Controlling Nosocomial Spread of Antibiotic-Resistant Bacteria: The Case of MRSA	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS BACTEREMIA; INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; METHICILLIN-RESISTANT; LIFE EXPECTANCY; INFECTION; SURVEILLANCE; MORTALITY; OUTCOMES; HOSPITALS	Background: The costs and benefits of controlling nosocomial spread of antibiotic-resistant bacteria are unknown. Methods: We developed a mathematical algorithm to determine cost-effectiveness of infection control programs and explored the dynamical interactions between different epidemiological variables and cost-effectiveness. The algorithm includes occurrence of nosocomial infections, attributable mortality, costs and efficacy of infection control and how antibiotic-resistant bacteria affect total number of infections: do infections with antibiotic-resistant bacteria replace infections caused by susceptible bacteria (replacement scenario) or occur in addition to them (addition scenario). Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia was used for illustration using observational data on S. aureus bacteremia (SAB) in our hospital (n = 189 between 2001-2004, all being methicillin-susceptible S. aureus [MSSA]). Results: In the replacement scenario, the costs per life year gained range from (sic)45,912 to (sic)6590 for attributable mortality rates ranging from 10% to 50%. Using (sic)20,000 per life year gained as a threshold, completely preventing MRSA would be cost-effective in the replacement scenario if attributable mortality of MRSA is >= 21%. In the addition scenario, infection control would be cost saving along the entire range of estimates for attributable mortality. Conclusions: Cost-effectiveness of controlling antibiotic-resistant bacteria is highly sensitive to the interaction between infections caused by resistant and susceptible bacteria (addition or replacement) and attributable mortality. In our setting, controlling MRSA would be cost saving for the addition scenario but would not be cost-effective in the replacement scenario if attributable mortality would be <21%.	[Wassenberg, Marjan W. M.] Univ Med Ctr, Dept Internal Med & Infect Dis, Utrecht, Netherlands; [Wassenberg, Marjan W. M.; Bonten, Marc J. M.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [de Wit, G. Ardine; van Hout, Ben A.; Bonten, Marc J. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Wit, G. Ardine] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	Wassenberg, MWM (corresponding author), Univ Med Ctr, Dept Internal Med & Infect Dis, Utrecht, Netherlands.	M.W.M.Wassenberg@umcutrecht.nl		de Wit, G. Ardine/0000-0002-1375-7657	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO))	MJMB was supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All other authors have no support or funding to report.	Albertsen PC, 1996, J UROLOGY, V156, P127, DOI 10.1016/S0022-5347(01)65964-0; Ammerlaan H, 2009, CLIN INFECT DIS, V49, P997, DOI 10.1086/605555; Barnett AG, 2009, AM J EPIDEMIOL, V170, P1186, DOI 10.1093/aje/kwp249; Bjorholt I, 2004, EUR J CLIN MICROBIOL, V23, P688, DOI 10.1007/s10096-004-1198-1; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Casparie A F, 1998, Ned Tijdschr Geneeskd, V142, P2075; Chaix C, 1999, JAMA-J AM MED ASSOC, V282, P1745, DOI 10.1001/jama.282.18.1745; Clancy M, 2006, INFECT CONT HOSP EP, V27, P1009, DOI 10.1086/507915; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Engemann JJ, 2003, CLIN INFECT DIS, V36, P592, DOI 10.1086/367653; Graves N, 2007, INFECT CONT HOSP EP, V28, P280, DOI 10.1086/512642; Gross CP, 2006, ANN INTERN MED, V145, P646, DOI 10.7326/0003-4819-145-9-200611070-00006; Jernigan JA, 1995, INFECT CONT HOSP EP, V16, P686; Karchmer TB, 2002, J HOSP INFECT, V51, P126, DOI 10.1053/jhin.2002.1200; Lee BY, 2010, INFECT CONT HOSP EP, V31, P598, DOI 10.1086/652524; LINNEMANN CC, 1982, AM J EPIDEMIOL, V115, P941, DOI 10.1093/oxfordjournals.aje.a113381; Melzer M, 2003, CLIN INFECT DIS, V37, P1453, DOI 10.1086/379321; OOSTENBRINK JB, 2004, STANDAARD KOSTPRIJZE; Papia G, 1999, INFECT CONT HOSP EP, V20, P473, DOI 10.1086/501655; *RAAD VOLKSG ZORG, 2006, ZINN DUURZ ZORG; Reed SD, 2005, INFECT CONT HOSP EP, V26, P175, DOI 10.1086/502523; *RIVM, 2005, EUR ANT RES SURV SYS; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Shurland S, 2007, INFECT CONT HOSP EP, V28, P273, DOI 10.1086/512627; Stelfox HT, 2003, JAMA-J AM MED ASSOC, V290, P1899, DOI 10.1001/jama.290.14.1899; Styers David, 2006, Ann Clin Microbiol Antimicrob, V5, P2; Tacconelli E, 2006, J HOSP INFECT, V64, P251, DOI 10.1016/j.jhin.2006.07.001; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; van Rijen MML, 2009, EUR J CLIN MICROBIOL, V28, P1245, DOI 10.1007/s10096-009-0775-8; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; Vriens M, 2002, EUR J CLIN MICROBIOL, V21, P782, DOI 10.1007/s10096-002-0811-4; *WERKGR INF, 2008, MRSA ZIEK; Wernitz MH, 2005, CLIN MICROBIOL INFEC, V11, P466, DOI 10.1111/j.1469-0691.2005.01153.x; West TE, 2006, INFECT CONT HOSP EP, V27, P233, DOI 10.1086/500372; Wyllie DH, 2006, BRIT MED J, V333, P281, DOI 10.1136/bmj.38834.421713.2F	37	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 16	2010	5	7							e11562	10.1371/journal.pone.0011562	http://dx.doi.org/10.1371/journal.pone.0011562			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	626QE	20661278	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000279980800002
J	Screpanti, E; Santaguida, S; Nguyen, T; Silvestri, R; Gussio, R; Musacchio, A; Hamel, E; De Wulf, P				Screpanti, Emanuela; Santaguida, Stefano; Nguyen, Tam; Silvestri, Romano; Gussio, Rick; Musacchio, Andrea; Hamel, Ernest; De Wulf, Peter			A Screen for Kinetochore-Microtubule Interaction Inhibitors Identifies Novel Antitubulin Compounds	PLOS ONE			English	Article							TUBULIN; COLCHICINE; AGENTS; BINDING; COMPLEX	Background: Protein assemblies named kinetochores bind sister chromatids to the mitotic spindle and orchestrate sister chromatid segregation. Interference with kinetochore activity triggers a spindle checkpoint mediated arrest in mitosis, which frequently ends in cell death. We set out to identify small compounds that inhibit kinetochore-microtubule binding for use in kinetochore-spindle interaction studies and to develop them into novel anticancer drugs. Methodology/Principal Findings: A fluorescence microscopy-based in vitro assay was developed to screen compound libraries for molecules that prevented the binding of a recombinant human Ndc80 kinetochore complex to taxol-stabilized microtubules. An active compound was identified that acted at the microtubule level. More specifically, by localizing to the colchicine-binding site in ab-tubulin the hit compound prevented the Ndc80 complex from binding to the microtubule surface. Next, structure-activity analyses distinguished active regions in the compound and led to the identification of highly potent analogs that killed cancer cells with an efficacy equaling that of established spindle drugs. Conclusions/Significance: The compound identified in our screen and its subsequently identified analogs represent new antitubulin chemotypes that can be synthetically developed into a novel class of antimitotic spindle drugs. In addition, they are stereochemically unique as their R- and S-isomers mimic binding of colchicine and podophyllotoxin, respectively, two antitubulin drugs that interact differently with the tubulin interface. Model-driven manipulation of our compounds promises to advance insight into how antitubulin drugs act upon tubulin. These advances in turn may lead to tailor-made colchicine site agents which would be valuable new assets to fight a variety of tumors, including those that have become resistant to the (antispindle) drugs used today.	[Screpanti, Emanuela; Santaguida, Stefano; Musacchio, Andrea; De Wulf, Peter] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Nguyen, Tam; Gussio, Rick] NCI, Informat Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21701 USA; [Silvestri, Romano] Univ Roma La Sapienza, Dept Med Chem & Technol, Rome, Italy; [Hamel, Ernest] NCI, Toxicol & Pharmacol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21701 USA	IRCCS European Institute of Oncology (IEO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Screpanti, E (corresponding author), European Inst Oncol, Dept Expt Oncol, IFOM IEO Campus, Milan, Italy.	peter.dewulf@ifom-ieo-campus.it	Santaguida, Stefano/ABH-5433-2020; santaguida, stefano/G-2716-2010	Santaguida, Stefano/0000-0002-1501-6190; Silvestri, Romano/0000-0003-2489-0178; De Wulf, Peter/0000-0001-9772-5881; Musacchio, Andrea/0000-0003-2362-8784	Istituto Pasteur - Fondazione Cenci Bolognetti; Progetti di Ricerca di Universita-Anno; Universita di Roma; Associazione Italiana per la Ricerca sul Cancro; Association of International Cancer Research; Fondazione Italiana per la Ricerca sul Cancro	Istituto Pasteur - Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Progetti di Ricerca di Universita-Anno; Universita di Roma; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association of International Cancer Research; Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This research was supported by grants from the Istituto Pasteur - Fondazione Cenci Bolognetti (http://www.istitutopasteur.it/site/index.php), and Progetti di Ricerca di Universita-Anno 2008, Universita di Roma "La Sapienza'' (http://www.uniroma1.it/) to RS, grant 4535 from the Associazione Italiana per la Ricerca sul Cancro (http://www.AIRC.it) to AM, and grant 08-0465 from the Association of International Cancer Research (http://www.AICR.org.uk) to PDW. ES and SS acknowledge a post-doctoral and doctoral fellowship, respectively, from the Fondazione Italiana per la Ricerca sul Cancro (http://www.fondazionefirc.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHATTACHARYYA B, 1977, FEBS LETT, V75, P159, DOI 10.1016/0014-5793(77)80075-6; Cao TM, 2008, AM J HEMATOL, V83, P390, DOI 10.1002/ajh.21104; Carlson RO, 2008, EXPERT OPIN INV DRUG, V17, P707, DOI [10.1517/13543784.17.5.707, 10.1517/13543784.17.5.707 ]; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; GASKIN F, 1974, J MOL BIOL, V89, P737, DOI 10.1016/0022-2836(74)90048-5; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; HAMEL E, 1981, BIOCHIM BIOPHYS ACTA, V675, P226, DOI 10.1016/0304-4165(81)90231-2; Hamel E, 2003, CELL BIOCHEM BIOPHYS, V38, P1, DOI 10.1385/CBB:38:1:1; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; KANG GJ, 1990, J BIOL CHEM, V265, P10255; Liu Song-Tao, 2009, P455, DOI 10.1007/978-0-387-69076-6_15; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nguyen TL, 2005, J MED CHEM, V48, P6107, DOI 10.1021/jm050502t; Parodi B, 2002, BIOTECHNIQUES, V32, P432, DOI 10.2144/02322rr05; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Uphoff CC, 2002, IN VITRO CELL DEV-AN, V38, P79; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107	23	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2010	5	7							e11603	10.1371/journal.pone.0011603	http://dx.doi.org/10.1371/journal.pone.0011603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VR	20657644	Green Published, Green Submitted, gold			2022-12-27	WOS:000279924500007
J	Nilsson, A; Fehniger, TE; Gustavsson, L; Andersson, M; Kenne, K; Marko-Varga, G; Andren, PE				Nilsson, Anna; Fehniger, Thomas E.; Gustavsson, Lena; Andersson, Malin; Kenne, Kerstin; Marko-Varga, Gyoergy; Andren, Per E.			Fine Mapping the Spatial Distribution and Concentration of Unlabeled Drugs within Tissue Micro-Compartments Using Imaging Mass Spectrometry	PLOS ONE			English	Article							MALDI-MS; SECTIONS; PROTEINS; METABOLITES; TECHNOLOGY; DISCOVERY; PEPTIDES; SPECTRA; TIME; RAT	Readouts that define the physiological distributions of drugs in tissues are an unmet challenge and at best imprecise, but are needed in order to understand both the pharmacokinetic and pharmacodynamic properties associated with efficacy. Here we demonstrate that it is feasible to follow the in vivo transport of unlabeled drugs within specific organ and tissue compartments on a platform that applies MALDI imaging mass spectrometry to tissue sections characterized with high definition histology. We have tracked and quantified the distribution of an inhaled reference compound, tiotropium, within the lungs of dosed rats, using systematic point by point MS and MS/MS sampling at 200 mu m intervals. By comparing drug ion distribution patterns in adjacent tissue sections, we observed that within 15 min following exposure, tiotropium parent MS ions (mass-to-charge; m/z 392.1) and fragmented daughter MS/MS ions (m/z 170.1 and 152.1) were dispersed in a concentration gradient (80 fmol-5 pmol) away from the central airways into the lung parenchyma and pleura. These drug levels agreed well with amounts detected in lung compartments by chemical extraction. Moreover, the simultaneous global definition of molecular ion signatures localized within 2-D tissue space provides accurate assignment of ion identities within histological landmarks, providing context to dynamic biological processes occurring at sites of drug presence. Our results highlight an important emerging technology allowing specific high resolution identification of unlabeled drugs at sites of in vivo uptake and retention.	[Nilsson, Anna; Andersson, Malin; Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Fehniger, Thomas E.] Tallinn Univ Technol, Inst Clin Med, Tallinn, Estonia; [Fehniger, Thomas E.; Gustavsson, Lena; Marko-Varga, Gyoergy] AstraZeneca R&D, Lund, Sweden; [Kenne, Kerstin] AstraZeneca R&D, Sodertalje, Sweden; [Marko-Varga, Gyoergy] Lund Univ, Dept Measurement Technol & Ind Elect Engn, Lund, Sweden	Uppsala University; Tallinn University of Technology; AstraZeneca; AstraZeneca; Lund University	Nilsson, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	per.andren@bmms.uu.se	Andersson, Malin/A-9930-2009	Andersson, Malin/0000-0002-1450-8046; Andren, Per/0000-0002-4062-7743	Swedish Research Council [2004-3417, 621-2007-4686, 521-2007-3017]; K&A Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was sponsored by the Swedish Research Council (http://www.vr.se), grant no. 2004-3417, 621-2007-4686, 521-2007-3017, and the K&A Wallenberg Foundation (http://www.wallenberg.com/kaw/). The study has been conducted as a fully shared collaboration between an academic laboratory at the Uppsala University, Sweden and AstraZeneca R&D, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann BL, 2006, CURR DRUG METAB, V7, P525; Andersson M, 2008, NAT METHODS, V5, P101, DOI [10.1038/nmeth1145, 10.1038/NMETH1145]; Atkinson SJ, 2007, RAPID COMMUN MASS SP, V21, P1271, DOI 10.1002/rcm.2952; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chaurand P, 2007, J MASS SPECTROM, V42, P476, DOI 10.1002/jms.1180; DAHLBACK M, 1994, ANN OCCUP HYG, P127; Dickerson BC, 2007, NEUROTHERAPEUTICS, V4, P360, DOI 10.1016/j.nurt.2007.05.007; Drexler Dieter M., 2007, Journal of Pharmacological and Toxicological Methods, V55, P279, DOI 10.1016/j.vascn.2006.11.004; Hilario M, 2006, MASS SPECTROM REV, V25, P409, DOI 10.1002/mas.20072; Hsieh Yunsheng, 2007, Journal of Pharmacological and Toxicological Methods, V55, P193, DOI 10.1016/j.vascn.2006.06.004; Jackson SN, 2005, J AM SOC MASS SPECTR, V16, P2052, DOI 10.1016/j.jasms.2005.08.014; Jain S, 2004, FRONT BIOSCI-LANDMRK, V9, P3167, DOI 10.2741/1470; Jansen FP, 2007, NUCL MED BIOL, V34, P733, DOI 10.1016/j.nucmedbio.2007.06.013; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Leusch A, 2001, BIOPHARM DRUG DISPOS, V22, P199, DOI 10.1002/bdd.280; Norris JL, 2007, INT J MASS SPECTROM, V260, P212, DOI 10.1016/j.ijms.2006.10.005; Reyzer ML, 2007, CURR OPIN CHEM BIOL, V11, P29, DOI 10.1016/j.cbpa.2006.11.035; Reyzer ML, 2003, J MASS SPECTROM, V38, P1081, DOI 10.1002/jms.525; Rohner TC, 2005, MECH AGEING DEV, V126, P177, DOI 10.1016/j.mad.2004.09.032; Signor L, 2007, J MASS SPECTROM, V42, P900, DOI 10.1002/jms.1225; Solon EG, 2010, AAPS J, V12, P11, DOI 10.1208/s12248-009-9158-4; Spengler B, 2002, J AM SOC MASS SPECTR, V13, P735, DOI 10.1016/S1044-0305(02)00376-8; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Suckau D, 2003, ANAL BIOANAL CHEM, V376, P952, DOI 10.1007/s00216-003-2057-0	24	176	176	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11411	10.1371/journal.pone.0011411	http://dx.doi.org/10.1371/journal.pone.0011411			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644728	gold, Green Published, Green Submitted			2022-12-27	WOS:000279884900002
J	Peirce, MJ; Brook, M; Morrice, N; Snelgrove, R; Begum, S; Lanfrancotti, A; Notley, C; Hussell, T; Cope, AP; Wait, R				Peirce, Matthew J.; Brook, Matthew; Morrice, Nicholas; Snelgrove, Robert; Begum, Shajna; Lanfrancotti, Alessandra; Notley, Clare; Hussell, Tracy; Cope, Andrew P.; Wait, Robin			Themis2/ICB1 Is a Signaling Scaffold That Selectively Regulates Macrophage Toll-Like Receptor Signaling and Cytokine Production	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-KINASE; BRUTONS TYROSINE KINASE; MESSENGER-RNA STABILITY; TNF-ALPHA PRODUCTION; CANCER CELL-LINES; NF-KAPPA-B; RICH ELEMENT; POSITIVE SELECTION; MEMBRANE-PROTEINS	Background: Thymocyte expressed molecule involved in selection 1 (Themis1, SwissProt accession number Q8BGW0) is the recently characterised founder member of a novel family of proteins. A second member of this family, Themis2 (Q91YX0), also known as ICB1 (Induced on contact with basement membrane 1), remains unreported at the protein level despite microarray and EST databases reporting Themis2 mRNA expression in B cells and macrophages. Methodology/Principal Findings: Here we characterise Themis2 protein for the first time and show that it acts as a macrophage signalling scaffold, exerting a receptor-, mediator- and signalling pathway-specific effect on TLR responses in RAW 264.7 macrophages. Themis2 over-expression enhanced the LPS-induced production of TNF but not IL-6 or Cox-2, nor TNF production induced by ligands for TLR2 (PAM3) or TLR3 (poly I: C). Moreover, LPS-induced activation of the MAP kinases ERK and p38 was enhanced in cells over-expressing Themis2 whereas the activation of JNK, IRF3 or NF-kappa B p65, was unaffected. Depletion of Themis2 protein by RNA inteference inhibited LPS-induced TNF production in primary human macrophages demonstrating a requirement for Themis2 in this event. Themis2 was inducibly tyrosine phosphorylated upon LPS challenge and interacted with Lyn kinase (P25911), the Rho guanine nucleotide exchange factor, Vav (P27870), and the adaptor protein Grb2 (Q60631). Mutation of either tyrosine 660 or a proline-rich sequence (PPPRPPK) simultaneously interrupted this complex and reduced by approximately 50% the capacity of Themis2 to promote LPS-induced TNF production. Finally, Themis2 protein expression was induced during macrophage development from murine bone marrow precursors and was regulated by inflammatory stimuli both in vitro and in vivo. Conclusions/Significance: We hypothesise that Themis2 may constitute a novel, physiological control point in macrophage inflammatory responses.	[Peirce, Matthew J.; Brook, Matthew; Snelgrove, Robert; Begum, Shajna; Lanfrancotti, Alessandra; Notley, Clare; Hussell, Tracy; Cope, Andrew P.; Wait, Robin] Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London, England; [Morrice, Nicholas] Univ Dundee, MRC, Prot Phosphorylat Unit, Dundee, Scotland	Imperial College London; University of Oxford; University of Dundee	Peirce, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Rheumatol, Kennedy Inst, London, England.	m.pierce@imperial.ac.uk	Hussell, Tracy/O-4630-2014; Brook, Matthew/I-5828-2019; Peirce, Matthew/ABB-9577-2021	Hussell, Tracy/0000-0001-7186-6141; Brook, Matthew/0000-0003-1245-7385; Peirce, Matthew/0000-0003-3648-5639; Cope, Andrew/0000-0001-6735-5496	Arthritis Research Campaign, UK; MRC [G0400795, G0802752, G9900166] Funding Source: UKRI; Medical Research Council [G9900166, G0400795, G0802752] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish	Arthritis Research Campaign, UK(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by a core grant to the Kennedy Institute provided by the Arthritis Research Campaign, UK (http://www.arc.org.uk/) and by the Trustees of the Kennedy Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Blackshear PJ, 2003, J BIOL CHEM, V278, P19947, DOI 10.1074/jbc.M301290200; Bollmann J, 2008, J STEROID BIOCHEM, V109, P16, DOI 10.1016/j.jsbmb.2007.12.007; Brook M, 2006, MOL CELL BIOL, V26, P2408, DOI 10.1128/MCB.26.6.2408-2418.2006; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Chen QZ, 2009, J LEUKOCYTE BIOL, V85, P539, DOI 10.1189/jlb.0308219; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; de Miranda MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001654; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Denys A, 2002, J IMMUNOL, V168, P4837, DOI 10.4049/jimmunol.168.10.4837; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; DUNHAM DM, 1990, J LEUKOCYTE BIOL, V48, P473, DOI 10.1002/jlb.48.6.473; English BK, 1997, J LEUKOCYTE BIOL, V62, P859, DOI 10.1002/jlb.62.6.859; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Gong K, 2001, NAT IMMUNOL, V2, P29, DOI 10.1038/83134; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Herskowitz JH, 2008, J VIROL, V82, P3295, DOI 10.1128/JVI.02234-07; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Horwood NJ, 2003, J EXP MED, V197, P1603, DOI 10.1084/jem.20021845; Inglis JJ, 2008, NAT PROTOC, V3, P612, DOI 10.1038/nprot.2008.19; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Lock LS, 2000, J BIOL CHEM, V275, P31536, DOI 10.1074/jbc.M003597200; Manukyan M, 2009, J IMMUNOL, V182, P3522, DOI 10.4049/jimmunol.0802280; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Peirce MJ, 2005, PROTEOMICS, V5, P2417, DOI 10.1002/pmic.200401176; Peirce MJ, 2004, MOL CELL PROTEOMICS, V3, P56, DOI 10.1074/mcp.M300064-MCP200; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Rutault K, 2001, J BIOL CHEM, V276, P6666, DOI 10.1074/jbc.M005486200; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Shi L, 2002, AM J PHYSIOL-CELL PH, V282, pC1205, DOI 10.1152/ajpcell.00511.2001; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Siegel AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000039; Smolinska MJ, 2008, MOL IMMUNOL, V45, P990, DOI 10.1016/j.molimm.2007.07.026; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; Treeck O, 2005, CYTOKINE, V32, P137, DOI 10.1016/j.cyto.2005.08.008; Treeck O, 2002, LEUKEMIA RES, V26, P765, DOI 10.1016/S0145-2126(02)00005-X; Treeck O, 1998, FEBS LETT, V425, P426, DOI 10.1016/S0014-5793(98)00278-6; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	48	24	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2010	5	7							e11465	10.1371/journal.pone.0011465	http://dx.doi.org/10.1371/journal.pone.0011465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	624MG	20644716	Green Submitted, gold, Green Published			2022-12-27	WOS:000279822300001
J	Meier-Stiegen, F; Schwanbeck, R; Bernoth, K; Martini, S; Hieronymus, T; Ruau, D; Zenke, M; Just, U				Meier-Stiegen, Franziska; Schwanbeck, Ralf; Bernoth, Kristina; Martini, Simone; Hieronymus, Thomas; Ruau, David; Zenke, Martin; Just, Ursula			Activated Notch1 Target Genes during Embryonic Cell Differentiation Depend on the Cellular Context and Include Lineage Determinants and Inhibitors	PLOS ONE			English	Article							STEM-CELLS; PROGENITOR CELLS; SKELETAL-MUSCLE; DOWN-REGULATION; ENDOTHELIAL-CELLS; EXPRESSION; FATE; BINDING; MODEL; HES	Background: Notch receptor signaling controls developmental cell fates in a cell-context dependent manner. Although Notch signaling directly regulates transcription via the RBP-J/CSL DNA binding protein, little is known about the target genes that are directly activated by Notch in the respective tissues. Methodology/Principal Findings: To analyze how Notch signaling mediates its context dependent function(s), we utilized a Tamoxifen-inducible system to activate Notch1 in murine embryonic stem cells at different stages of mesodermal differentiation and performed global transcriptional analyses. We find that the majority of genes regulated by Notch1 are unique for the cell type and vary widely dependent on other signals. We further show that Notch1 signaling regulates expression of genes playing key roles in cell differentiation, cell cycle control and apoptosis in a context dependent manner. In addition to the known Notch1 targets of the Hes and Hey families of transcriptional repressors, Notch1 activates the expression of regulatory transcription factors such as Sox9, Pax6, Runx1, Myf5 and Id proteins that are critically involved in lineage decisions in the absence of protein synthesis. Conclusion/Significance: We suggest that Notch signaling determines lineage decisions and expansion of stem cells by directly activating both key lineage specific transcription factors and their repressors (Id and Hes/Hey proteins) and propose a model by which Notch signaling regulates cell fate commitment and self renewal in dependence of the intrinsic and extrinsic cellular context.	[Meier-Stiegen, Franziska; Schwanbeck, Ralf; Bernoth, Kristina; Martini, Simone; Just, Ursula] Univ Kiel, Dept Biochem, Kiel, Germany; [Hieronymus, Thomas; Ruau, David; Zenke, Martin] Rhein Westfal TH Aachen, Univ Med Sch, Inst Biomed Engn, Dept Cell Biol, Aachen, Germany	University of Kiel; RWTH Aachen University; RWTH Aachen University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf	Meier-Stiegen, F (corresponding author), Tech Univ Munich, Univ Hosp Rechts Isar, Res Grp Diabet, Munich, Germany.	rschwanbeck@biochem.uni-kiel.de; ujust@biochem.uni-kiel.de	Hieronymus, Thomas/AAU-1995-2020; Schwanbeck, Ralf/A-2648-2008; Just, Ursula/E-6992-2010	Hieronymus, Thomas/0000-0002-7879-6518; Schwanbeck, Ralf/0000-0003-0925-929X; 	Deutsche Forschungsgemeinschaft [DFG SPP1109, SFB 415, SPP1356]; Hensel Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hensel Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SPP1109 to UJ (Ju197/5-1, 5-2), and TH and MZ (Ze432/2), SFB 415 project B8 to UJ and partially by DFG SPP1356 to MZ) and partially by Hensel Stiftung to UJ. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HH, 2000, CURR TOP DEV BIOL, V48, P129; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai G, 2007, DEV CELL, V13, P283, DOI 10.1016/j.devcel.2007.05.014; Baonza A, 2000, DEVELOPMENT, V127, P2383; Braun T, 1996, EMBO J, V15, P310, DOI 10.1002/j.1460-2075.1996.tb00361.x; Buas MF, 2009, J CELL PHYSIOL, V218, P84, DOI 10.1002/jcp.21571; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Cormier S, 2004, GENE EXPR PATTERNS, V4, P713, DOI 10.1016/j.modgep.2004.04.003; Demehri S, 2008, PLOS BIOL, V6, P992, DOI 10.1371/journal.pbio.0060123; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Gensch N, 2008, DEVELOPMENT, V135, P1597, DOI 10.1242/dev.019331; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Henning K, 2007, EXP HEMATOL, V35, P1321, DOI 10.1016/j.exphem.2007.05.014; Hirai H, 2005, BLOOD, V106, P1948, DOI 10.1182/blood-2004-12-4872; Hirashima M, 1999, BLOOD, V93, P1253, DOI 10.1182/blood.V93.4.1253.404k31_1253_1263; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; King IN, 2006, BIOCHEM BIOPH RES CO, V345, P446, DOI 10.1016/j.bbrc.2006.04.097; KODAMA H, 1994, EXP HEMATOL, V22, P979; Kopan R, 1997, TRENDS GENET, V13, P465, DOI 10.1016/S0168-9525(97)01318-8; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Kurokawa M, 2006, INT J HEMATOL, V84, P136, DOI 10.1532/IJH97.06070; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell S, 2006, PLOS BIOL, V4, P805, DOI 10.1371/journal.pbio.0040121; Main H, 2010, EXP CELL RES, V316, P1610, DOI 10.1016/j.yexcr.2009.12.012; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Nakagawa M, 2006, BLOOD, V108, P3329, DOI 10.1182/blood-2006-04-019570; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; OKA C, 1995, DEVELOPMENT, V121, P3291; Ong CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002823; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Poellinger L, 2008, CURR OPIN GENET DEV, V18, P449, DOI 10.1016/j.gde.2008.07.013; Reynaud-Deonauth S, 2002, DIFFERENTIATION, V69, P198, DOI 10.1046/j.1432-0436.2002.690413.x; Ruau D, 2006, CELL IMMUNOL, V244, P116, DOI 10.1016/j.cellimm.2007.01.011; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Schwanbeck R, 2008, CELLS TISSUES ORGANS, V188, P91, DOI 10.1159/000113531; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Wobus A M, 2002, Methods Mol Biol, V185, P127; Yokota Y, 2001, ONCOGENE, V20, P8290, DOI 10.1038/sj.onc.1205090; Yoo AS, 2005, SCIENCE, V310, P1330, DOI 10.1126/science.1119481; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	68	75	81	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2010	5	7							e11481	10.1371/journal.pone.0011481	http://dx.doi.org/10.1371/journal.pone.0011481			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CS	20628604	Green Published, gold, Green Submitted			2022-12-27	WOS:000279637100011
J	Hedskog, C; Mild, M; Jernberg, J; Sherwood, E; Bratt, G; Leitner, T; Lundeberg, J; Andersson, B; Albert, J				Hedskog, Charlotte; Mild, Mattias; Jernberg, Johanna; Sherwood, Ellen; Bratt, Goran; Leitner, Thomas; Lundeberg, Joakim; Andersson, Bjorn; Albert, Jan			Dynamics of HIV-1 Quasispecies during Antiviral Treatment Dissected Using Ultra-Deep Pyrosequencing	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; DRUG-RESISTANCE; IN-VIVO; ANTIRETROVIRAL-NAIVE; TYPE-1 VIREMIA; VARIANTS; MUTATION; FIDELITY; THERAPY	Background: Ultra-deep pyrosequencing (UDPS) allows identification of rare HIV-1 variants and minority drug resistance mutations, which are not detectable by standard sequencing. Principal Findings: Here, UDPS was used to analyze the dynamics of HIV-1 genetic variation in reverse transcriptase (RT) (amino acids 180-220) in six individuals consecutively sampled before, during and after failing 3TC and AZT containing antiretroviral treatment. Optimized UDPS protocols and bioinformatic software were developed to generate, clean and analyze the data. The data cleaning strategy reduced the error rate of UDPS to an average of 0.05%, which is lower than previously reported. Consequently, the cut-off for detection of resistance mutations was very low. A median of 16,016 (range 2,406-35,401) sequence reads were obtained per sample, which allowed detection and quantification of minority resistance mutations at amino acid position 181, 184, 188, 190, 210, 215 and 219 in RT. In four of five pre-treatment samples low levels (0.07-0.09%) of the M184I mutation were observed. Other resistance mutations, except T215A and T215I were below the detection limit. During treatment failure, M184V replaced M184I and dominated the population in combination with T215Y, while wild-type variants were rarely detected. Resistant virus disappeared rapidly after treatment interruption and was undetectable as early as after 3 months. In most patients, drug resistant variants were replaced by wild-type variants identical to those present before treatment, suggesting rebound from latent reservoirs. Conclusions: With this highly sensitive UDPS protocol preexisting drug resistance was infrequently observed; only M184I, T215A and T215I were detected at very low levels. Similarly, drug resistant variants in plasma quickly decreased to undetectable levels after treatment interruption. The study gives important insights into the dynamics of the HIV-1 quasispecies and is of relevance for future research and clinical use of the UDPS technology.	[Hedskog, Charlotte; Mild, Mattias; Jernberg, Johanna; Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hedskog, Charlotte; Mild, Mattias; Jernberg, Johanna; Albert, Jan] Swedish Inst Infect Dis Control, Dept Virol, Stockholm, Sweden; [Sherwood, Ellen] Sci Life Lab Stockholm, Solna, Sweden; [Bratt, Goran] Stockholm S Gen Hosp, Stockholm, Sweden; [Bratt, Goran] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Leitner, Thomas] Los Alamos Natl Lab, Los Alamos, NM USA; [Lundeberg, Joakim] AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, Div Gene Technol, Stockholm, Sweden; [Andersson, Bjorn] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Swedish Institute for Infectious Disease Control; Karolinska Institutet; United States Department of Energy (DOE); Los Alamos National Laboratory; Royal Institute of Technology; Karolinska Institutet	Hedskog, C (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	jan.albert@smi.se	Andersson, Bjorn/G-9832-2013	Andersson, Bjorn/0000-0002-4624-0259; Hedskog, Charlotte/0000-0003-0512-7767	Swedish Research Council [2007-1131-49460-36]; Swedish International Development Cooperation Agency [SWE-2006-018]; Europe HIV Resistance (EHR) [LSHP-CT-2006-518211]; CHAIN [223131]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency; Europe HIV Resistance (EHR); CHAIN	M. Mild was funded by a post doctoral fellowship grant from The Swedish Research Council. The research leading to these results has received funding from the Swedish Research Council (grant no. 2007-1131-49460-36); Swedish International Development Cooperation Agency (grant no. SWE-2006-018), a non-commercial organization working according to directives of the Swedish Parliament and Government (http://www.sida.se/English/); Europe HIV Resistance (EHR) (LSHP-CT-2006-518211) and CHAIN (FP7/2007-2013) "Collaborative HIV and Anti-HIV Drug Resistance Network" grant agreement no 223131. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allers K, 2007, JAIDS-J ACQ IMM DEF, V44, P377, DOI 10.1097/QAI.0b013e31803104c0; Back NKT, 1996, EMBO J, V15, P4040, DOI 10.1002/j.1460-2075.1996.tb00777.x; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Barbour Jason D., 2004, Curr Infect Dis Rep, V6, P151, DOI 10.1007/s11908-996-0012-x; Brennan TP, 2009, J VIROL, V83, P8470, DOI 10.1128/JVI.02568-08; Brenner BG, 2002, J VIROL, V76, P1753, DOI 10.1128/JVI.76.4.1753-1761.2002; BRINCHMANN JE, 1991, J VIROL, V65, P2019, DOI 10.1128/JVI.65.4.2019-2023.1991; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cong ME, 2007, J VIROL, V81, P3037, DOI 10.1128/JVI.02712-06; Deeks SG, 2003, LANCET, V362, P2002, DOI 10.1016/S0140-6736(03)15022-2; Diallo K, 2003, ANTIMICROB AGENTS CH, V47, P3377, DOI 10.1128/AAC.47.11.3377-3383.2003; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; EIGEN M, 1977, NATURWISSENSCHAFTEN, V64, P541, DOI 10.1007/BF00450633; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; JI JP, 1994, VIROLOGY, V199, P323, DOI 10.1006/viro.1994.1130; Johnson JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000638; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson NP, 2007, OPTO-ELECTRON REV, V15, P125, DOI 10.2478/s11772-007-0009-5; Johnson Victoria A, 2008, Top HIV Med, V16, P138; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Keulen W, 1997, J VIROL, V71, P3346, DOI 10.1128/JVI.71.4.3346-3350.1997; King MS, 2005, J INFECT DIS, V191, P2046, DOI 10.1086/430387; Kitchen CMR, 2006, AIDS RES HUM RETROV, V22, P1260, DOI 10.1089/aid.2006.22.1260; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Lindstrom A, 2006, ANTIVIR THER, V11, P1031; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martinez-Picado J, 2000, P NATL ACAD SCI USA, V97, P10948, DOI 10.1073/pnas.97.20.10948; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; Mitsuya Y, 2008, J VIROL, V82, P10747, DOI 10.1128/JVI.01827-07; Monie D, 2005, J VIROL, V79, P5185, DOI 10.1128/JVI.79.8.5185-5202.2005; Neher RA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000660; Paredes R, 2009, J VIROL, V83, P2038, DOI 10.1128/JVI.02154-08; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Preston BD, 1997, SCIENCE, V275, P228, DOI 10.1126/science.275.5297.228; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; SRINIVASAN A, 1989, P NATL ACAD SCI USA, V86, P6388, DOI 10.1073/pnas.86.16.6388; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; WAINBERG MA, 1995, AIDS, V9, P351, DOI 10.1097/00002030-199509040-00006; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0	47	94	126	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11345	10.1371/journal.pone.0011345	http://dx.doi.org/10.1371/journal.pone.0011345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628644	Green Submitted, Green Published, gold			2022-12-27	WOS:000279589300001
J	Vanderwert, RE; Marshall, PJ; Nelson, CA; Zeanah, CH; Fox, NA				Vanderwert, Ross E.; Marshall, Peter J.; Nelson, Charles A., III; Zeanah, Charles H.; Fox, Nathan A.			Timing of Intervention Affects Brain Electrical Activity in Children Exposed to Severe Psychosocial Neglect	PLOS ONE			English	Article							INTERNATIONAL RESEARCH COLLABORATION; ETHICAL CONSIDERATIONS; FOLLOW-UP; EEG; PROJECT; DEPRIVATION; PERFORMANCE; ROMANIA; AGE	Background: Early psychosocial deprivation has profound effects on brain activity in the young child. Previous reports have shown increased power in slow frequencies of the electroencephalogram (EEG), primarily in the theta band, and decreased power in higher alpha and beta band frequencies in infants and children who have experienced institutional care. Methodology/Principal Findings: We assessed the consequences of removing infants from institutions and placing them into a foster care intervention on brain electrical activity when children were 8 years of age. We found the intervention was successful for increasing high frequency EEG alpha power, with effects being most pronounced for children placed into foster care before 24 months of age. Conclusions/Significance: The dependence on age of placement for the effects observed on high frequency EEG alpha power suggests a sensitive period after which brain activity in the face of severe psychosocial deprivation is less amenable to recovery.	[Vanderwert, Ross E.; Fox, Nathan A.] Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA; [Marshall, Peter J.] Temple Univ, Dept Psychol, Philadelphia, PA 19122 USA; [Nelson, Charles A., III] Childrens Hosp, Div Dev Med, Boston, MA 02115 USA; [Nelson, Charles A., III] Harvard Univ, Sch Med, Boston, MA USA; [Zeanah, Charles H.] Tulane Univ, Dept Psychiat & Neurol, New Orleans, LA 70118 USA	University System of Maryland; University of Maryland College Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tulane University	Vanderwert, RE (corresponding author), Univ Maryland, Dept Human Dev, College Pk, MD 20742 USA.	fox@umd.edu	Zeanah, Charles H/AAO-3756-2020	Zeanah, Charles/0000-0002-7004-6819; Vanderwert, Ross/0000-0002-2280-8401	John D. and Catherine T. MacArthur Foundation	John D. and Catherine T. MacArthur Foundation	This work was funded by the John D. and Catherine T. MacArthur Foundation through their support of the Early Experience and Brain Development network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P171, DOI 10.1016/S1388-2457(02)00362-0; Bauer PM, 2009, BIOL PSYCHIAT, V66, P1100, DOI 10.1016/j.biopsych.2009.06.014; Beckett C, 2006, CHILD DEV, V77, P696, DOI 10.1111/j.1467-8624.2006.00898.x; Bell M. A., 1998, NEUROIMAGING CHILD N, P97, DOI DOI 10.1007/978-3-642-95848-9; Bell MA, 2001, INFANCY, V2, P311, DOI 10.1207/S15327078IN0203_2; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Fernandez T, 2000, NEUROREPORT, V11, P2663, DOI 10.1097/00001756-200008210-00012; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Marshall PJ, 2008, DEV PSYCHOPATHOL, V20, P861, DOI 10.1017/S0954579408000412; Marshall PJ, 2002, CLIN NEUROPHYSIOL, V113, P1199, DOI 10.1016/S1388-2457(02)00163-3; Marshall PJ, 2004, J COGNITIVE NEUROSCI, V16, P1327, DOI 10.1162/0898929042304723; Millum J, 2007, SCIENCE, V318, P1874, DOI 10.1126/science.1153822; Miskovic V, 2009, CLIN NEUROPHYSIOL, V120, P231, DOI 10.1016/j.clinph.2008.11.004; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; O'Connor TG, 2000, CHILD DEV, V71, P376, DOI 10.1111/1467-8624.00151; Otero G A, 1994, Int J Neurosci, V79, P213; Otero GA, 2003, CLIN NEUROPHYSIOL, V114, P1918, DOI 10.1016/S1388-2457(03)00173-1; Raine A, 2001, PSYCHOPHYSIOLOGY, V38, P254, DOI 10.1111/1469-8986.3820254; Wassenaar DR, 2006, INF MENTAL HLTH J, V27, P577, DOI 10.1002/imhj.20108; Zeanah CH, 2003, DEV PSYCHOPATHOL, V15, P885, DOI 10.1017/S0954579403000452; Zeanah CH, 2006, INF MENTAL HLTH J, V27, P559, DOI 10.1002/imhj.20107	22	104	104	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2010	5	7							e11415	10.1371/journal.pone.0011415	http://dx.doi.org/10.1371/journal.pone.0011415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	619YF	20617175	Green Accepted, Green Published, gold			2022-12-27	WOS:000279465500004
J	Subramanyam, MA; Kawachi, I; Berkman, LF; Subramanian, SV				Subramanyam, Malavika A.; Kawachi, Ichiro; Berkman, Lisa F.; Subramanian, S. V.			Socioeconomic Inequalities in Childhood Undernutrition in India: Analyzing Trends between 1992 and 2005	PLOS ONE			English	Article							MALNUTRITION; DETERMINANTS	Background: India experienced a rapid economic boom between 1991 and 2007. However, this economic growth has not translated into improved nutritional status among young Indian children. Additionally, no study has assessed the trends in social disparities in childhood undernutrition in the Indian context. We examined the trends in social disparities in underweight and stunting among Indian children aged less than three years using nationally representative data. Methods: We analyzed data from the three cross-sectional rounds of National Family Health Survey of India from 1992, 1998 and 2005. The social factors of interest were: household wealth, maternal education, caste, and urban residence. Using multilevel modeling to account for the nested structure and clustering of data, we fit multivariable logistic regression models to quantify the association between the social factors and the binary outcome variables. The final models additionally included age, gender, birth order of child, religion, and age of mother. We analyzed the trend by testing for interaction of the social factor and survey year in a dataset pooled from all three surveys. Results: While the overall prevalence rates of undernutrition among Indian children less than three decreased over the 1992-2005 period, social disparities in undernutrition over these 14 years either widened or stayed the same. The absolute rates of undernutrition decreased for everyone regardless of their social status. The disparities by household wealth were greater than the disparities by maternal education. There were no disparities in undernutrition by caste, gender or rural residence. Conclusions: There was a steady decrease in the rates of stunting in the 1992-2005 period, while the decline in underweight was greater between 1992 and 1998 than between 1998 and 2005. Social disparities in childhood undernutrition in India either widened or stayed the same during a time of major economic growth. While the advantages of economic growth might be reaching everyone, children from better-off households, with better educated mothers appear to have benefited to a greater extent than less privileged children. The high rates of undernutrition (even among the socially advantaged groups) and the persistent social disparities need to be addressed in an urgent and comprehensive manner.	[Subramanyam, Malavika A.] Univ Michigan, Sch Publ Hlth, Ctr Integrat Approaches Hlth Dispar, Ann Arbor, MI 48109 USA; [Kawachi, Ichiro; Berkman, Lisa F.; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Berkman, Lisa F.] Harvard Univ, Sch Publ Hlth, Ctr Populat & Dev Studies, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Subramanyam, MA (corresponding author), Univ Michigan, Sch Publ Hlth, Ctr Integrat Approaches Hlth Dispar, Ann Arbor, MI 48109 USA.	malsub@umich.edu			Harvard Center on the Developing Child; National Institutes of Health [NHLBI K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Harvard Center on the Developing Child; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	No direct financial support or funding was obtained to conduct this study. MAS was supported by The Richmond Fellowship from the Harvard Center on the Developing Child at the time when majority of the analysis was conducted. SVS is supported by a National Institutes of Health Career Development Award (NHLBI K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ANTHROPOMETRIC INDIC; Basu K, 2007, OXFORD REV ECON POL, V23, P143, DOI 10.1093/icb/grm012; Bhagat RB, 2005, SINGAPORE J TROP GEO, V26, P61, DOI 10.1111/j.0129-7619.2005.00204.x; Bharati S, 2008, J BIOSOC SCI, V40, P801, DOI 10.1017/S0021932008002812; Chitnis S., 1997, POLITICS BACKWARDNES; DANZON M, 2000, FEEDING NUTR INFANTS, pR9; Dev S.M., 2007, ECON POLIT WEEKLY, V42, P509; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; IIPS,& ORC Macro, 2007, NAT FAM HLTH SURV IN; Johnson K, 2001, MEDIA CULT SOC, V23, P147, DOI 10.1177/016344301023002001; Kawachi I., 2000, SOCIAL EPIDEMIOLOGY; MEASURE DHS, 2006, WHO WE AR; Nandy S, 2005, B WORLD HEALTH ORGAN, V83, P210; Pongou R, 2006, INT J EPIDEMIOL, V35, P648, DOI 10.1093/ije/dyl016; Rajaram S, 2003, J BIOSOC SCI, V35, P335, DOI 10.1017/S0021932003003353; Rasbash J, 2009, MLWIN VERSION 2 1 CT; Rutstein SO, 2004, DHS COMP REPORTS, V6; SVEDBERG P, 2007, CHILD MALNUTRITION I; Tenhunen S, 2008, J ROY ANTHROPOL INST, V14, P515, DOI 10.1111/j.1467-9655.2008.00515.x; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Thussu DK, 2007, MEDIA CULT SOC, V29, P593, DOI 10.1177/0163443707076191; UNICEF, 1998, STATE WORLDS CHILDRE, P7; UNICEF, 2008, STATE WORLDS CHILDRE, P118; UNICEF, 2007, PROGR CHILDR REP STA; WHO, 2006, WHO CHILD GROWTH STA	25	78	82	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11392	10.1371/journal.pone.0011392	http://dx.doi.org/10.1371/journal.pone.0011392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618QE	20617192	Green Published, gold, Green Submitted			2022-12-27	WOS:000279370000021
J	Xu, FH; Yan, QA; Wang, H; Niu, JJ; Li, LA; Zhu, FC; He, SZ; Zhang, SY; Weng, ZX; Cheng, T; Cai, YJ; He, DL; Chen, YX; Ge, SX; Yeo, AET; Zhang, J; Ng, MH; Xia, NS				Xu, Feihai; Yan, Qiang; Wang, Hua; Niu, Jianjun; Li, Liang; Zhu, Fengcai; He, Shuizhen; Zhang, Shiyin; Weng, Zuxing; Cheng, Tong; Cai, Yijun; He, Delei; Chen, Yixin; Ge, Shengxiang; Yeo, Anthony E. T.; Zhang, Jun; Ng, Mun-Hon; Xia, Ningshao			Performance of Detecting IgM Antibodies against Enterovirus 71 for Early Diagnosis	PLOS ONE			English	Article							CLINICAL SPECIMENS; RAPID DETECTION; INFECTION; OUTBREAK; VIRUSES; DISEASE	Enterovirus 71 (EV71) infection is more likely to induce severe complications and mortality than other enteroviruses. Methods for detection of IgM antibody against EV71 had been established for years, however, the performance of the methods in the very early diagnosis of EV71 infection had not been fully evaluated, which is especially meaningful because of the short incubation period of EV71 infection. In this report, the performance of an IgM anti-EV71 assay was evaluated using acute sera collected from 165 EV71 infected patients, 165 patients infected with other enteroviruses, and more than 2,000 sera from healthy children or children with other infected diseases. The results showed a 90% sensitivity in 20 patients who were in their first illness day, and similar sensitivity remained till 4 days after onset. After then the sensitivity increased to 95% to 100% for more than one month. The specificity of the assay in non-HFMD children is 99.1% (95% Cl: 98.6-99.4), similar as the 99.9% specificity in healthy adults. The cross-reaction rate in patients infected with other non-EV71 enteroviruses was 11.4%. In conclusion, the data here presented show that the detection of IgM anti-EV71 by ELISA affords a reliable, convenient, and prompt diagnosis of EV71 infection.	[Xu, Feihai; Yan, Qiang; Zhang, Shiyin; Weng, Zuxing; Cheng, Tong; Cai, Yijun; He, Delei; Chen, Yixin; Ge, Shengxiang; Yeo, Anthony E. T.; Zhang, Jun; Ng, Mun-Hon; Xia, Ningshao] Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China; [Wang, Hua; Li, Liang; Zhu, Fengcai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Peoples R China; [Niu, Jianjun; He, Shuizhen] Xiamen Ctr Dis Control & Prevent, Xiamen, Peoples R China	Xiamen University; Jiangsu Provincial Center for Disease Control & Prevention	Xu, FH (corresponding author), Xiamen Univ, Natl Inst Diagnost & Vaccine Dev Infect Dis, Xiamen, Peoples R China.	nsxia@xmu.edu.cn	Ge, Shengxiang/Q-2256-2019; Zhang, Jun/G-4598-2010; Ge, SX/G-4693-2010; Chen, YX/G-3937-2010; Yeo, Anthony/AHD-9194-2022; Xia, NS/G-4647-2010	Ge, Shengxiang/0000-0002-7165-3004; Zhang, Jun/0000-0002-6601-9180; Niu, Jianjun/0000-0003-1960-654X; Xia, Ningshao/0000-0003-0179-5266; Cheng, Tong/0000-0002-1638-6214	National Key Technology Research and Development program of China [2008BAI70B00]; Science and Technology Plan Program of Xiamen City [3502Z20093010]; National Natural Science Foundation of China [30972826]	National Key Technology Research and Development program of China(National Key Technology R&D ProgramNational High Technology Research and Development Program of China); Science and Technology Plan Program of Xiamen City; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Key Technology Research and Development program of China (No. 2008BAI70B00), the Science and Technology Plan Program of Xiamen City (No. 3502Z20093010), and National Natural Science Foundation of China (No. 30972826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; Brown BA, 2000, J CLIN VIROL, V16, P107, DOI 10.1016/S1386-6532(00)00065-2; Chang LY, 2004, JAMA-J AM MED ASSOC, V291, P222, DOI 10.1001/jama.291.2.222; Grandien M, 1995, DIAGNOSTIC PROCEDURE, P279; Jin Q, 2001, MED MOL VIROLOGY; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; LIM KA, 1960, J IMMUNOL, V84, P309; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Qiu J, 2008, LANCET NEUROL, V7, P868, DOI 10.1016/S1474-4422(08)70207-2; SCHNURR D, 1992, P351; Shih SR, 2003, J VIROL METHODS, V111, P55, DOI 10.1016/S0166-0934(03)00151-4; Tan EL, 2006, MOL CELL PROBE, V20, P135, DOI 10.1016/j.mcp.2005.11.003; Tan EL, 2008, J CLIN VIROL, V42, P203, DOI 10.1016/j.jcv.2008.01.001; Tee KK, 2009, INT J INFECT DIS, V13, P307, DOI 10.1016/j.ijid.2008.09.005; Tsao KC, 2002, J MED VIROL, V68, P574, DOI 10.1002/jmv.10233; Wang SY, 2004, J VIROL METHODS, V119, P37, DOI 10.1016/j.jviromet.2004.02.017; Yan JJ, 2000, J CLIN VIROL, V17, P13, DOI 10.1016/S1386-6532(00)00067-6; Yang F, 2009, J CLIN MICROBIOL, V47, P2351, DOI 10.1128/JCM.00563-09	20	40	43	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 30	2010	5	6							e11388	10.1371/journal.pone.0011388	http://dx.doi.org/10.1371/journal.pone.0011388			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618QE	20613983	Green Submitted, Green Published, gold			2022-12-27	WOS:000279370000017
J	Dickson, RJ; Wahl, LM; Fernandes, AD; Gloor, GB				Dickson, Russell J.; Wahl, Lindi M.; Fernandes, Andrew D.; Gloor, Gregory B.			Identifying and Seeing beyond Multiple Sequence Alignment Errors Using Intra-Molecular Protein Covariation	PLOS ONE			English	Article							COEVOLVING RESIDUES; COEVOLUTION; INFORMATION; IDENTIFICATION; PHYLOGENY; ACCURACY; SYSTEM	Background: There is currently no way to verify the quality of a multiple sequence alignment that is independent of the assumptions used to build it. Sequence alignments are typically evaluated by a number of established criteria: sequence conservation, the number of aligned residues, the frequency of gaps, and the probable correct gap placement. Covariation analysis is used to find putatively important residue pairs in a sequence alignment. Different alignments of the same protein family give different results demonstrating that covariation depends on the quality of the sequence alignment. We thus hypothesized that current criteria are insufficient to build alignments for use with covariation analyses. Methodology/Principal Findings: We show that current criteria are insufficient to build alignments for use with covariation analyses as systematic sequence alignment errors are present even in hand-curated structure-based alignment datasets like those from the Conserved Domain Database. We show that current non-parametric covariation statistics are sensitive to sequence misalignments and that this sensitivity can be used to identify systematic alignment errors. We demonstrate that removing alignment errors due to 1) improper structure alignment, 2) the presence of paralogous sequences, and 3) partial or otherwise erroneous sequences, improves contact prediction by covariation analysis. Finally we describe two non-parametric covariation statistics that are less sensitive to sequence alignment errors than those described previously in the literature. Conclusions/Significance: Protein alignments with errors lead to false positive and false negative conclusions ( incorrect assignment of covariation and conservation, respectively). Covariation analysis can provide a verification step, independent of traditional criteria, to identify systematic misalignments in protein alignments. Two non-parametric statistics are shown to be somewhat insensitive to misalignment errors, providing increased confidence in contact prediction when analyzing alignments with erroneous regions because of an emphasis on they emphasize pairwise covariation over group covariation.	[Dickson, Russell J.; Fernandes, Andrew D.; Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Wahl, Lindi M.; Fernandes, Andrew D.] Univ Western Ontario, Dept Appl Math, London, ON N6A 5B9, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Dickson, RJ (corresponding author), Univ Western Ontario, Dept Biochem, London, ON, Canada.	ggloor@uwo.ca	Gloor, Greg B/D-1671-2013	Gloor, Gregory/0000-0001-5803-3380	National Sciences and Engineering Council of Canada; Canada Research Chair	National Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	LMW is supported by grants from the National Sciences and Engineering Council of Canada and the Canada Research Chair Program. RJD is supported by a National Sciences and Engineering Council of Canada CGS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2006, CURR OPIN STRUC BIOL, V16, P368, DOI 10.1016/j.sbi.2006.04.004; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096; Floudas CA, 2006, CHEM ENG SCI, V61, P966, DOI 10.1016/j.ces.2005.04.009; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; GLOOR GB, 2010, MOL BIOL EVOL; Gotoh O, 1996, J MOL BIOL, V264, P823, DOI 10.1006/jmbi.1996.0679; Hogue CWV, 1997, TRENDS BIOCHEM SCI, V22, P314, DOI 10.1016/S0968-0004(97)01093-1; Kim CH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-355; KLEINSTIVER BP, 2010, NUCL ACIDS RES; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Buslje CM, 2009, BIOINFORMATICS, V25, P1125, DOI 10.1093/bioinformatics/btp135; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; OLIVEIRA R, 2007, FINDING COEVOLVING A; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601; SHACKELFORD G, 2007, PROTEINS; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Thompson JD, 2005, PROTEINS, V61, P127, DOI 10.1002/prot.20527; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Travers SAA, 2007, MOL BIOL EVOL, V24, P1032, DOI 10.1093/molbev/msm022; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Yip KY, 2008, BIOINFORMATICS, V24, P290, DOI 10.1093/bioinformatics/btm584	31	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11082	10.1371/journal.pone.0011082	http://dx.doi.org/10.1371/journal.pone.0011082			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	617DB	20596526	Green Published, gold, Green Submitted			2022-12-27	WOS:000279259900001
J	Hurt, CB; Torrone, E; Green, K; Foust, E; Leone, P; Hightow-Weidman, L				Hurt, Christopher B.; Torrone, Elizabeth; Green, Kelly; Foust, Evelyn; Leone, Peter; Hightow-Weidman, Lisa			Methamphetamine Use among Newly Diagnosed HIVPositive Young Men in North Carolina, United States, from 2000 to 2005	PLOS ONE			English	Article							SEXUAL RISK BEHAVIORS; EARLY SYPHILIS; SAN-FRANCISCO; BISEXUAL MEN; DRUG-USE; HIV-INFECTION; GAY; TRANSMISSION; EPIDEMIC	Background: Methamphetamine (MA) is a new arrival to the Southeastern United States (US). Incidence of HIV is also increasing regionally, but data are limited regarding any association between this trend and MA use. We examined behavioral data from North Carolina (NC) residents newly diagnosed with HIV, collected by the Department of Health between 2000-2005. Principal Findings: Among 1,460 newly diagnosed HIV-positive young men, an increasing trend was seen from 2000-2005 in MA use (p = 0.01, total n = 20). In bivariate analyses, users of MA had significantly greater odds of reporting other substance use, including alcohol, powder or crack cocaine, marijuana, and methylenedioxymethamphetamine (MDMA, "ecstasy''). They were also more likely to have reported sexual activity while traveling outside NC; sex with anonymous partners; and previous HIV testing. In a predictive model, MA use had a negative association with nonwhite race, and strong positive associations with powder cocaine, "ecstasy,'' or intravenous drug use and being a university student. Conclusions: Similar to trends seen in more urban parts of the US, MA use among newly diagnosed, HIV-positive young men is increasing in NC. These data are among the first to demonstrate this relationship in a region with a burgeoning epidemic of MA use. Opportunities exist for MA-related HIV risk-reduction interventions whenever young men intersect the healthcare system.	[Hurt, Christopher B.; Leone, Peter; Hightow-Weidman, Lisa] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA; [Torrone, Elizabeth] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Green, Kelly] Univ N Carolina, Ctr AIDS Res, Chapel Hill, NC USA; [Foust, Evelyn] N Carolina Dept Hlth & Human Serv, HIV STD Prevent & Care Branch, Raleigh, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hurt, CB (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	churt@med.unc.edu			National Institute of Allergy and Infectious Diseases (NIAID) [5T32AI07001-32]; Health Resources and Services Administration Special Projects of National Significance (HRSA SPNS) [1H97HA03789-01-00]; National Institute of Mental Health (NIMH) [5K23MH075718-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH075718] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Health Resources and Services Administration Special Projects of National Significance (HRSA SPNS); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Hurt was supported by a National Institute of Allergy and Infectious Diseases (NIAID) T32 training grant, #5T32AI07001-32. Dr. Hightow-Weidman received funding through a Health Resources and Services Administration Special Projects of National Significance (HRSA SPNS) grant, #1H97HA03789-01-00; and a National Institute of Mental Health (NIMH) K23 award, #5K23MH075718-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], EP PROF HIV STD PREV; Buchacz K, 2005, AIDS, V19, P1423, DOI 10.1097/01.aids.0000180794.27896.fb; Centers for Disease Control and Prevention, 2008, HIV AIDS SURV REP 20; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P273; Clatts MC, 2005, J URBAN HLTH S1, V82, P9; COLFAX G, 2005, J URBAN HLTH S1, V82, P62; Colfax GN, 2001, J ACQ IMMUN DEF SYND, V28, P373, DOI 10.1097/00126334-200112010-00011; Cook RL, 2006, MED CARE, V44, pS31, DOI 10.1097/01.mlr.0000223710.35008.d9; Fendrich M, 2003, ADDICTION, V98, P1693, DOI 10.1111/j.1360-0443.2003.00577.x; Gerbert B, 1997, J GEN INTERN MED, V12, P698, DOI 10.1046/j.1525-1497.1997.07143.x; Halkitis PN, 2001, J HOMOSEXUAL, V41, P17, DOI 10.1300/J082v41n02_02; Hightow LB, 2005, JAIDS-J ACQ IMM DEF, V38, P531, DOI 10.1097/01.qai.0000155037.10628.cb; IRWIN TW, 2005, J URBAN HLTH; Kalichman SC, 1997, AIDS EDUC PREV, V9, P41; Koblin BA, 2006, AIDS, V20, P731, DOI 10.1097/01.aids.0000216374.61442.55; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Lambert E, 2005, J URBAN HEALTH, V82, pI1, DOI 10.1093/jurban/jti018; Mansergh G, 2006, PUBLIC HEALTH REP, V121, P127, DOI 10.1177/003335490612100205; *NC DEP HLTH HUM S, 2004, 2004 HIV STD SURV RE; *NC DEP HLTH HUM S, 2007, 2007 HIV STD SURV RE; Patinkin N, 2007, SOC WORK HEALTH CARE, V44, P73, DOI 10.1300/J010v44n01_07; Plankey MW, 2007, JAIDS-J ACQ IMM DEF, V45, P85, DOI 10.1097/QAI.0b013e3180417c99; PLANT MA, 1990, ALCOHOL ALCOHOLISM, V25, P293, DOI 10.1093/oxfordjournals.alcalc.a045003; Reback CJ, 2004, AIDS BEHAV, V8, P87, DOI 10.1023/B:AIBE.0000017528.39338.75; SEMPLE SJ, 2008, ARCH SEX BEHAV; Sena AC, 2008, AIDS PATIENT CARE ST, V22, P955, DOI 10.1089/apc.2008.0077; Sexton Rocky L, 2005, J Ethn Subst Abuse, V4, P77, DOI 10.1300/J233v04n01_06; Taylor MM, 2007, INT J STD AIDS, V18, P93, DOI 10.1258/095646207779949709; *US DEP HHS, 2004, SAMPL EL HOSP; *US DRUG ENF ADM, 2009, DEA BRIEFS BACKGR DR; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Waldo CR, 2000, J ACQ IMMUN DEF SYND, V24, P168; Wong W, 2005, SEX TRANSM DIS, V32, P458, DOI 10.1097/01.olq.0000168280.34424.58; Zule WA, 2007, J RURAL HEALTH, V23, P73, DOI 10.1111/j.1748-0361.2007.00127.x	34	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11314	10.1371/journal.pone.0011314	http://dx.doi.org/10.1371/journal.pone.0011314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615NA	20593025	gold, Green Submitted, Green Published			2022-12-27	WOS:000279140800015
J	Singhal, H; Ren, YZR; Kern, SE				Singhal, Hari; Ren, Yunzhao R.; Kern, Scott E.			Improved DNA Electrophoresis in Conditions Favoring Polyborates and Lewis Acid Complexation	PLOS ONE			English	Article							CONDUCTIVE MEDIA; BUFFERS	Spatial compression among the longer DNA fragments occurs during DNA electrophoresis in agarose and non-agarose gels when using certain ions in the conductive buffer, impairing the range of fragment sizes resolved well in a single gel. Substitutions using various polyhydroxyl anions supported the underlying phenomenon as the complexation of Lewis acids to DNA. We saw significant improvements using conditions (lithium borate 10 mM cations, pH 6.5) favoring the formation of borate polyanions and having lower conductance and Joule heating, delayed electrolyte exhaustion, faster electrophoretic run-speed, and sharper separation of DNA bands from 100bp to 12 kb in a single run.	[Singhal, Hari] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Singhal, Hari; Ren, Yunzhao R.; Kern, Scott E.] Johns Hopkins, Sidney Kimmel Comprehens Ctr, Baltimore, MD USA; [Singhal, Hari; Ren, Yunzhao R.; Kern, Scott E.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Singhal, H (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	sk@jhmi.edu			National Institutes of Health [CA62924]; Marjorie Kovler Research Fellowship; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marjorie Kovler Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grant CA62924 and the Marjorie Kovler Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brody JR, 2004, BIOTECHNIQUES, V37, P598, DOI 10.2144/04374ST04; Brody JR, 2004, ANAL BIOCHEM, V333, P1, DOI 10.1016/j.ab.2004.05.054; HASHIMOTO Y, 1952, NATURE, V170, P975, DOI 10.1038/170975b0; INGRI N, 1963, ACTA CHEM SCAND, V17, P581, DOI 10.3891/acta.chem.scand.17-0581; Maeda M, 1978, INORG NUCL CHEM, V41, P1217; SMITH SS, 1983, ANAL BIOCHEM, V128, P138, DOI 10.1016/0003-2697(83)90354-8; Stellwagen NC, 2000, BIOPOLYMERS, V54, P137, DOI 10.1002/1097-0282(200008)54:2<137::AID-BIP6>3.0.CO;2-I; Stellwagen NC, 2000, ANAL BIOCHEM, V287, P167, DOI 10.1006/abio.2000.4848	8	16	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2010	5	6							e11318	10.1371/journal.pone.0011318	http://dx.doi.org/10.1371/journal.pone.0011318			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615NA	20593002	gold, Green Published, Green Submitted			2022-12-27	WOS:000279140800018
J	Ward-Paige, C; Flemming, JM; Lotze, HK				Ward-Paige, Christine; Flemming, Joanna Mills; Lotze, Heike K.			Overestimating Fish Counts by Non-Instantaneous Visual Censuses: Consequences for Population and Community Descriptions	PLOS ONE			English	Article							SIZE-STRUCTURE; REEF; SHARKS; DENSITY; BIOMASS; CARCHARIAS; ABUNDANCE; TRANSECT; IDENTIFICATION; FISHERIES	Background: Increasingly, underwater visual censuses (UVC) are used to assess fish populations. Several studies have demonstrated the effectiveness of protected areas for increasing fish abundance or provided insight into the natural abundance and structure of reef fish communities in remote areas. Recently, high apex predator densities (>100,000 individuals.km(-2)) and biomasses (>4 tonnes.ha(-1)) have been reported for some remote islands suggesting the occurrence of inverted trophic biomass pyramids. However, few studies have critically evaluated the methods used for sampling conspicuous and highly mobile fish such as sharks. Ideally, UVC are done instantaneously, however, researchers often count animals that enter the survey area after the survey has started, thus performing non-instantaneous UVC. Methodology/Principal Findings: We developed a simulation model to evaluate counts obtained by divers deploying non-instantaneous belt-transect and stationary-point-count techniques. We assessed how fish speed and survey procedure (visibility, diver speed, survey time and dimensions) affect observed fish counts. Results indicate that the bias caused by fish speed alone is huge, while survey procedures had varying effects. Because the fastest fishes tend to be the largest, the bias would have significant implications on their biomass contribution. Therefore, caution is needed when describing abundance, biomass, and community structure based on non-instantaneous UVC, especially for highly mobile species such as sharks. Conclusions/Significance: Based on our results, we urge that published literature state explicitly whether instantaneous counts were made and that survey procedures be accounted for when non-instantaneous counts are used. Using published density and biomass values of communities that include sharks we explore the effect of this bias and suggest that further investigation may be needed to determine pristine shark abundances and the existence of inverted biomass pyramids. Because such studies are used to make important management and conservation decisions, incorrect estimates of animal abundance and biomass have serious and significant implications.	[Ward-Paige, Christine; Lotze, Heike K.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Ward-Paige, C (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	globalshark@gmail.com		Ward-Paige, Christine A./0000-0002-2394-9898; Mills Flemming, Joanna/0000-0002-3517-3089; Lotze, Heike/0000-0001-6258-1304	Natural Sciences and Engineering Research Council of Canada; Lenfest Ocean Program; Pew Charitable Trusts; RAM	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Lenfest Ocean Program; Pew Charitable Trusts; RAM	Financial support was provided by the Natural Sciences and Engineering Research Council of Canada to R. A. Myers, H. K. Lotze, J. Mills Flemming, by the Lenfest Ocean Program and The Pew Charitable Trusts with grants to R. A. Myers and H. K. Lotze. These funders did not play a role in conducting the study or in preparing the manuscript.; We thank W. Blanchard for helping to write the simulation AnimDens, C. Minto for initial simulation discussion, and B. Worm, D. Tittensor, H. Whitehead, L. Lucifora, V. Garcia and C. Mora for discussions and valuable comments on the manuscript. We thank RAM for the support and encouragement he always provided.	Arena PT, 2007, HYDROBIOLOGIA, V580, P157, DOI 10.1007/s10750-006-0456-x; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Ault JS, 2006, B MAR SCI, V78, P633; Bansemer CS, 2008, MAR FRESHWATER RES, V59, P322, DOI 10.1071/MF07184; BOHNSACK JA, 1986, NMFSSEFC215 NOAA; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Buck KR, 1996, AQUAT MICROB ECOL, V10, P283; Buray N, 2009, CYBIUM, V33, P21; Cheal AJ, 1997, MAR ECOL PROG SER, V158, P241, DOI 10.3354/meps158241; Creel S, 1997, AFR J ECOL, V35, P83, DOI 10.1111/j.1365-2028.1997.062-89062.x; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Eggleston DB, 2004, B MAR SCI, V75, P175; Forrester GE, 2008, ECOLOGY, V89, P2980, DOI 10.1890/07-1546.1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gasol JM, 1997, LIMNOL OCEANOGR, V42, P1353, DOI 10.4319/lo.1997.42.6.1353; GRAY J, 1971, HOW FISHES SWIM, P228; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; GUTMAN M, 1990, J RANGE MANAGE, V43, P535, DOI 10.2307/4002359; Harborne AR, 2008, ECOL APPL, V18, P1689, DOI 10.1890/07-0454.1; Hawkins JP, 2004, CONSERV BIOL, V18, P215, DOI 10.1111/j.1523-1739.2004.00328.x; Heupel MR, 2007, PAC SCI, V61, P383, DOI 10.2984/1534-6188(2007)61[383:EAORSA]2.0.CO;2; Heupel MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009650; Johansen JL, 2007, MAR FRESHWATER RES, V58, P233, DOI 10.1071/MF06136; McClanahan TR, 2007, ECOL APPL, V17, P1055, DOI 10.1890/06-1450; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Newman MJH, 2006, ECOL LETT, V9, P1216, DOI 10.1111/j.1461-0248.2006.00976.x; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; PIONTKOVSKI SA, 1995, MAR ECOL PROG SER, V117, P219, DOI 10.3354/meps117219; *R CDT, 2005, R LANG ENV STAT COMP; Robbins WD, 2006, CURR BIOL, V16, P2314, DOI 10.1016/j.cub.2006.09.044; Rowat D, 2009, ORYX, V43, P591, DOI 10.1017/S0030605309990408; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SMITH MPL, 1989, ENVIRON BIOL FISH, V26, P29, DOI 10.1007/BF00002473; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; THRESHER RE, 1986, ENVIRON BIOL FISH, V17, P93, DOI 10.1007/BF00001740; Tittensor DP, 2007, ECOL LETT, V10, P760, DOI 10.1111/j.1461-0248.2007.01076.x; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; WATSON RA, 1995, ECOL MODEL, V77, P205, DOI 10.1016/0304-3800(93)E0085-H; Watson RA, 1997, ECOL MODEL, V104, P103, DOI 10.1016/S0304-3800(97)00117-8; WEBB PW, 1982, FISH B-NOAA, V80, P803	46	137	138	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2010	5	7							e11722	10.1371/journal.pone.0011722	http://dx.doi.org/10.1371/journal.pone.0011722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	630AN	20661304	Green Published, Green Submitted, gold			2022-12-27	WOS:000280243300022
J	Sun, J; Wang, XT; Lau, A; Liao, TYA; Bucci, C; Hmama, Z				Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Bucci, Cecilia; Hmama, Zakaria			Mycobacterial Nucleoside Diphosphate Kinase Blocks Phagosome Maturation in Murine Raw 264.7 Macrophages	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; TUBERCULOSIS PHAGOSOME; RAB7; TRANSPORT; RILP; VIRULENCE; DISTINCT; IDENTIFICATION; MANIPULATION	Background: Microorganisms capable of surviving within macrophages are rare, but represent very successful pathogens. One of them is Mycobacterium tuberculosis (Mtb) whose resistance to early mechanisms of macrophage killing and failure of its phagosomes to fuse with lysosomes causes tuberculosis (TB) disease in humans. Thus, defining the mechanisms of phagosome maturation arrest and identifying mycobacterial factors responsible for it are key to rational design of novel drugs for the treatment of TB. Previous studies have shown that Mtb and the related vaccine strain, M. bovis bacille Calmette-Guerin (BCG), disrupt the normal function of host Rab5 and Rab7, two small GTPases that are instrumental in the control of phagosome fusion with early endosomes and late endosomes/lysosomes respectively. Methodology/Principal Findings: Here we show that recombinant Mtb nucleoside diphosphate kinase (Ndk) exhibits GTPase activating protein (GAP) activity towards Rab5 and Rab7. Then, using a model of latex bead phagosomes, we demonstrated that Ndk inhibits phagosome maturation and fusion with lysosomes in murine RAW 264.7 macrophages. Maturation arrest of phagosomes containing Ndk-beads was associated with the inactivation of both Rab5 and Rab7 as evidenced by the lack of recruitment of their respective effectors EEA1 (early endosome antigen 1) and RILP (Rab7-interacting lysosomal protein). Consistent with these findings, macrophage infection with an Ndk knocked-down BCG strain resulted in increased fusion of its phagosome with lysosomes along with decreased survival of the mutant. Conclusion: Our findings provide evidence in support of the hypothesis that mycobacterial Ndk is a putative virulence factor that inhibits phagosome maturation and promotes survival of mycobacteria within the macrophage.	[Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Hmama, Zakaria] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada; [Sun, Jim; Wang, Xuetao; Lau, Alice; Liao, Ting-Yu Angela; Hmama, Zakaria] Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Bucci, Cecilia] Univ Salento, Dept Biol & Environm Sci & Technol, Lecce, Italy	University of British Columbia; Vancouver Coastal Health Research Institute; University of Salento	Sun, J (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada.	hmama@interchange.ubc.ca	Bucci, Cecilia/F-6699-2012	Bucci, Cecilia/0000-0002-6232-6183; Amdur, Richard/0000-0002-4900-653X; Sun, Jim/0000-0002-6873-6052	Canadian Institutes of Health Research [MOP-84557]; British Columbia Lung Association; Michael Smith Foundation for Health Research; TBVets Charitable Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); TBVets Charitable Foundation	This work was supported by an operating grant from the Canadian Institutes of Health Research (MOP-84557) and British Columbia Lung Association. Z. Hmama was supported by scholar awards from the Michael Smith Foundation for Health Research and the TBVets Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar P, 2006, MICROBES INFECT, V8, P2855, DOI 10.1016/j.micinf.2006.09.004; Astarie-Dequeker C, 2002, J CELL SCI, V115, P81; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Beatty WL, 2000, INFECT IMMUN, V68, P6997, DOI 10.1128/IAI.68.12.6997-7002.2000; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Chakrabarty AM, 1998, MOL MICROBIOL, V28, P875, DOI 10.1046/j.1365-2958.1998.00846.x; Chen YX, 2002, PROTEINS, V47, P556, DOI 10.1002/prot.10113; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Chopra P, 2004, FEBS LETT, V571, P212, DOI 10.1016/j.febslet.2004.06.073; Chopra P, 2003, EUR J BIOCHEM, V270, P625, DOI 10.1046/j.1432-1033.2003.03402.x; Chow Chung-Wai, 2004, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1507s22; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Clemens DL, 2000, INFECT IMMUN, V68, P5154, DOI 10.1128/IAI.68.9.5154-5166.2000; Colangeli R, 2009, P NATL ACAD SCI USA, V106, P4414, DOI 10.1073/pnas.0810126106; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; Haas AK, 2005, NAT CELL BIOL, V7, P887, DOI 10.1038/ncb1290; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hayakawa A, 2007, BIOCHEM SOC SYMP, V74, P95, DOI 10.1042/BSS2007c09; Hestvik ALK, 2005, FEMS MICROBIOL REV, V29, P1041, DOI 10.1016/j.femsre.2005.04.013; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Hmama Z, 2004, J CELL SCI, V117, P2131, DOI 10.1242/jcs.01072; Horwitz MA, 2003, INFECT IMMUN, V71, P1672, DOI 10.1128/IAI.71.4.1672-1679.2003; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Johnson EE, 2006, J CELL SCI, V119, P1219, DOI 10.1242/jcs.02833; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kimura N, 2003, J BIOENERG BIOMEMBR, V35, P41, DOI 10.1023/A:1023489722460; LEE BY, 1995, J CLIN INVEST, V96, P245, DOI 10.1172/JCI118028; Lee WL, 2009, MOL MICROBIOL, V71, P583, DOI 10.1111/j.1365-2958.2008.06548.x; Lewin A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-91; LoBue P, 2009, CURR OPIN INFECT DIS, V22, P167, DOI 10.1097/QCO.0b013e3283229fab; Malen H, 2007, PROTEOMICS, V7, P1702, DOI 10.1002/pmic.200600853; North RJ, 2004, ANNU REV IMMUNOL, V22, P599, DOI 10.1146/annurev.immunol.22.012703.104635; PAWELRAMMINGEN U, 2000, MOL MICROBIOL, V36, P737; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x; Ramachandra L, 1999, CELL MICROBIOL, V1, P205, DOI 10.1046/j.1462-5822.1999.00026.x; Roberts RL, 1999, J CELL SCI, V112, P3667; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Saini AK, 2004, J BIOL CHEM, V279, P50142, DOI 10.1074/jbc.M409944200; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190; Tiwari S, 2004, J BIOL CHEM, V279, P43595, DOI 10.1074/jbc.M401704200; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643; Yoshikai Y, 2006, CRIT REV IMMUNOL, V26, P515, DOI 10.1615/CritRevImmunol.v26.i6.40	60	106	111	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2010	5	1							e8769	10.1371/journal.pone.0008769	http://dx.doi.org/10.1371/journal.pone.0008769			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546AH	20613869	Green Submitted, Green Published, gold			2022-12-27	WOS:000273778900013
J	Li, MZ; Xia, YL; Gu, YR; Zhang, K; Lang, QL; Chen, L; Guan, JQ; Luo, ZG; Chen, HS; Li, Y; Li, QH; Li, XA; Jiang, AA; Shuai, SR; Wang, JY; Zhu, Q; Zhou, XC; Gao, XL; Li, XW				Li, Mingzhou; Xia, Youlin; Gu, Yiren; Zhang, Kai; Lang, Qiulei; Chen, Lei; Guan, Jiuqiang; Luo, Zonggang; Chen, Haosi; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Wang, Jinyong; Zhu, Qi; Zhou, Xiaochuan; Gao, Xiaolian; Li, Xuewei			MicroRNAome of Porcine Pre- and Postnatal Development	PLOS ONE			English	Article							RAPID EVOLUTION; SWINE GENOME; EXPRESSION; TRANSCRIPTOME; DISCOVERY; PATHWAYS; MIR-122; TARGETS; CLONING; MIRNAS	The domestic pig is of enormous agricultural significance and valuable models for many human diseases. Information concerning the pig microRNAome (miRNAome) has been long overdue and elucidation of this information will permit an atlas of microRNA (miRNA) regulation functions and networks to be constructed. Here we performed a comprehensive search for porcine miRNAs on ten small RNA sequencing libraries prepared from a mixture of tissues obtained during the entire pig lifetime, from the fetal period through adulthood. The sequencing results were analyzed using mammalian miRNAs, the precursor hairpins (pre-miRNAs) and the first release of the high-coverage porcine genome assembly (Sscrofa9, April 2009) and the available expressed sequence tag (EST) sequences. Our results extend the repertoire of pig miRNAome to 867 pre-miRNAs (623 with genomic coordinates) encoding for 1,004 miRNAs, of which 777 are unique. We preformed real-time quantitative PCR (q-PCR) experiments for selected 30 miRNAs in 47 tissue-specific samples and found agreement between the sequencing and q-PCR data. This broad survey provides detailed information about multiple variants of mature sequences, precursors, chromosomal organization, development-specific expression, and conservation patterns. Our data mining produced a broad view of the pig miRNAome, consisting of miRNAs and isomiRs and a wealth of information of pig miRNA characteristics. These results are prelude to the advancement in pig biology as well the use of pigs as model organism for human biological and biomedical studies.	[Li, Mingzhou; Gu, Yiren; Zhang, Kai; Guan, Jiuqiang; Luo, Zonggang; Li, Yang; Li, Qinghai; Li, Xiang; Jiang, An-an; Shuai, Surong; Li, Xuewei] Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China; [Xia, Youlin; Chen, Haosi; Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Lang, Qiulei] Zhejiang Univ, Dept Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lang, Qiulei; Zhou, Xiaochuan] LC Sci, Houston, TX USA; [Chen, Lei; Wang, Jinyong] Chongqing Acad Anim Sci, Chongqing, Peoples R China; [Gao, Xiaolian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Sichuan Agricultural University; University of Houston System; University of Houston; Zhejiang University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Li, MZ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Inst Anim Genet & Breeding, Yaan, Sichuan, Peoples R China.	xgao@uh.edu; xuewei.li@sicau.edu.cn		Li, Mingzhou/0000-0001-8681-7684; Su, Erzheng/0000-0002-3868-567X	National Special Foundation for Transgenic Species of China [2009ZX08009-155B, 2008ZX08006-003]; National Natural Science Foundation of China [30901024, 30771534]; Department Public Benefit Research Foundation of China [NYHYZX07-034]; NIH [R41 DA029063]	National Special Foundation for Transgenic Species of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department Public Benefit Research Foundation of China; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Special Foundation for Transgenic Species of China (2009ZX08009-155B and 2008ZX08006-003), the National Natural Science Foundation of China (30901024 and 30771534), the Department Public Benefit Research Foundation of China (NYHYZX07-034) to X. L. and M.L., and the NIH (R41 DA029063) to X.Z. and X.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bashir A, 2005, GENOME RES, V15, P998, DOI 10.1101/gr.3493405; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chatterjee S, 2009, NATURE, V461, P546, DOI 10.1038/nature08349; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Glazov EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006349; Green RD, 2007, INT J BIOL SCI, V3, P185; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Jiang ZH, 2007, INT J BIOL SCI, V3, P129; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim HJ, 2006, GENOME, V49, P1283, DOI 10.1139/G06-120; Kim J, 2008, MAMM GENOME, V19, P570, DOI 10.1007/s00335-008-9111-3; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; McDaneld TG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-77; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reddy AM, 2008, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-65; Rocha D, 2006, DRUG DISCOV TODAY, V11, P475, DOI 10.1016/j.drudis.2006.04.009; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schook LB, 2005, COMP FUNCT GENOM, V6, P251, DOI 10.1002/cfg.479; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharbati-Tehrani S, 2008, BIOCHEM BIOPH RES CO, V375, P484, DOI 10.1016/j.bbrc.2008.08.048; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Xie SS, 2010, ANIM GENET, V41, P179, DOI 10.1111/j.1365-2052.2009.01991.x; Xu JZ, 2008, RNA, V14, P1276, DOI 10.1261/rna.997708; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507	51	103	111	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2010	5	7							e11541	10.1371/journal.pone.0011541	http://dx.doi.org/10.1371/journal.pone.0011541			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	623XV	21179198	Green Published, Green Submitted, gold			2022-12-27	WOS:000279781600020
J	Bornmann, L; Daniel, HD				Bornmann, Lutz; Daniel, Hans-Dieter			The Usefulness of Peer Review for Selecting Manuscripts for Publication: A Utility Analysis Taking as an Example a High-Impact Journal	PLOS ONE			English	Article							CITATION ANALYSIS; QUALITY; VALIDITY; COUNTS	Background: High predictive validity - that is, a strong association between the outcome of peer review (usually, reviewers' ratings) and the scientific quality of a manuscript submitted to a journal (measured as citations of the later published paper) - does not as a rule suffice to demonstrate the usefulness of peer review for the selection of manuscripts. To assess usefulness, it is important to include in addition the base rate (proportion of submissions that are fundamentally suitable for publication) and the selection rate (the proportion of submissions accepted). Methodology/Principal Findings: Taking the example of the high-impact journal Angewandte Chemie International Edition (AC-IE), we present a general approach for determining the usefulness of peer reviews for the selection of manuscripts for publication. The results of our study show that peer review is useful: 78% of the submissions accepted by AC-IE are correctly accepted for publication when the editor's decision is based on one review, 69% of the submissions are correctly accepted for publication when the editor's decision is based on two reviews, and 65% of the submissions are correctly accepted for publication when the editor's decision is based on three reviews. Conclusions/Significance: The paper points out through what changes in the selection rate, base rate or validity coefficient a higher success rate (utility) in the AC-IE selection process could be achieved.	[Bornmann, Lutz; Daniel, Hans-Dieter] ETH, Zurich, Switzerland; [Daniel, Hans-Dieter] Univ Zurich, Evaluat Off, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bornmann, L (corresponding author), ETH, Zurich, Switzerland.	bornmann@gess.ethz.ch	Bornmann, Lutz/A-3926-2008; Daniel, Hans-Dieter/A-2419-2013; Leydesdorff, Loet/E-2903-2010	Bornmann, Lutz/0000-0003-0810-7091; de Moya Anegon, Felix/0000-0002-0255-8628; Leydesdorff, Loet/0000-0002-7835-3098	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study, which is also investigating quality assurance of open access journals, is supported by a grant from the Max Planck Society (www.mpg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskerville RL, 2009, MIS QUART, V33, P647; Bornmann L., 2008, ETHICS SCI ENV POLIT, V2014, DOI [10.3354/esep00084, DOI 10.3354/ESEP00084]; BORNMANN L, J INFORMETR IN PRESS; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bornmann L, 2008, ANGEW CHEM INT EDIT, V47, P7173, DOI 10.1002/anie.200800513; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P1841, DOI 10.1002/asi.20901; Bornmann L, 2007, J INFORMETR, V1, P204, DOI 10.1016/j.joi.2007.01.002; Bornmann L, 2010, LIBR INFORM SCI RES, V32, P5, DOI 10.1016/j.lisr.2009.07.010; Bornmann L, 2009, J INFORMETR, V3, P348, DOI 10.1016/j.joi.2009.05.002; Bornmann L, 2009, LEARN PUBL, V22, P117, DOI 10.1087/2009207; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Cabrera EF, 2001, INT J SELECT ASSESS, V9, P92, DOI 10.1111/1468-2389.00166; Cascio W. F., 1991, COSTING HUMAN RESOUR; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Daniel H.D., 1993, GUARDIANS SCI FAIRNE, DOI [10.1002/3527602208, DOI 10.1002/3527602208]; EGGHE L, RES EVALUAT IN PRESS; Grover V, 2009, MIS QUART, V33, pIII; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2786, DOI 10.1001/jama.287.21.2786; LINDSEY D, 1989, SCIENTOMETRICS, V15, P189, DOI 10.1007/BF02017198; MARTIN BR, 1983, RES POLICY, V12, P61, DOI 10.1016/0048-7333(83)90005-7; Neuhaus C, 2009, SCIENTOMETRICS, V78, P219, DOI 10.1007/s11192-007-2007-2; Poschl U, 2004, LEARN PUBL, V17, P105, DOI 10.1087/095315104322958481; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; SCHULTZ DM, SCIENTOMETR IN PRESS; *SENS SCI, 2004, PEER VIEW ACC NEW SC; SMITH LC, 1981, LIBR TRENDS, V30, P83; STEWART JA, 1994, INFORM PROCESS MANAG, V30, P239, DOI 10.1016/0306-4573(94)90067-1; STOSSEL TP, 1985, SCI TECHNOL, V10, P39; Straub D.W., 2008, MIS Q, V32, piii; Straub DW, 2008, MIS QUART, V32, pV; Taylor HC, 1939, J APPL PSYCHOL, V23, P565, DOI 10.1037/h0057079; Thorngate W, 2009, JUDGING MERIT, P1; Van Leeuwen TN, 2007, RES EVALUAT, V16, P93, DOI 10.3152/095820207X227529; van Raan AFJ, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P19; vanRaan AFJ, 1996, SCIENTOMETRICS, V36, P397, DOI 10.1007/BF02129602; VINKLER P, 1986, SCIENTOMETRICS, V10, P157, DOI 10.1007/BF02026039; Vinkler P, 1997, SCIENTOMETRICS, V40, P163, DOI 10.1007/BF02459266	37	42	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11344	10.1371/journal.pone.0011344	http://dx.doi.org/10.1371/journal.pone.0011344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	617DB	20596540	Green Submitted, gold, Green Published			2022-12-27	WOS:000279259900017
J	Hunt, ME; Scherrer, MP; Ferrari, FD; Matz, MV				Hunt, Marguerite E.; Scherrer, Michael P.; Ferrari, Frank D.; Matz, Mikhail V.			Very Bright Green Fluorescent Proteins from the Pontellid Copepod Pontella mimocerami	PLOS ONE			English	Article							CORAL; REPORTER; RED; GFP; AMPHIOXUS; DIVERSITY; EVOLUTION; MUTANTS; EMBRYOS; MARKER	Background: Fluorescent proteins (FP) homologous to the green fluorescent protein (GFP) from the jellyfish Aequorea victoria have revolutionized biomedical research due to their usefulness as genetically encoded fluorescent labels. Fluorescent proteins from copepods are particularly promising due to their high brightness and rapid fluorescence development. Results: Here we report two novel FPs from Pontella mimocerami (Copepoda, Calanoida, Pontellidae), which were identified via fluorescence screening of a bacterial cDNA expression library prepared from the whole-body total RNA of the animal. The proteins are very similar in sequence and spectroscopic properties. They possess high molar extinction coefficients (79,000 M(-1) cm(-)) and quantum yields (0.92), which make them more than two-fold brighter than the most common FP marker, EGFP. Both proteins form oligomers, which we were able to counteract to some extent by mutagenesis of the N-terminal region; however, this particular modification resulted in substantial drop in brightness. Conclusions: The spectroscopic characteristics of the two P. mimocerami proteins place them among the brightest green FPs ever described. These proteins may therefore become valuable additions to the in vivo imaging toolkit.	[Hunt, Marguerite E.; Scherrer, Michael P.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ferrari, Frank D.] Smithsonian Inst, Dept Invertebrate Zool, Natl Museum Nat Hist, Suitland, MD USA; [Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Texas System; University of Texas Austin	Hunt, ME (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	matz@mail.utexas.edu	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819; Janga, Sarath Chandra/0000-0001-7351-6268	National Institutes of Health [R01 GM078247]; Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Ocean Exploration program of the National Oceanic and Atmospheric Administration ("Operation Deep Scope 2007''), and the National Institutes of Health grant R01 GM078247 to M. V. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMSTERDAM A, 1995, DEV BIOL, V171, P123, DOI 10.1006/dbio.1995.1265; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bomati EK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-77; Bryan B., 2001, United States Patent, Patent No. 6232107; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHUDAKOV DM, FLUORESCENT IN PRESS; Cormack B, 1998, CURR OPIN MICROBIOL, V1, P406, DOI 10.1016/S1369-5274(98)80057-X; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; DRUMMOND AJ, 2009, GENEIOUS V4 8; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Fleminger A., 1957, Tulane Studies in Zoology, V5, P19; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966; Harvey E.N., 1952, BIOLUMINESCENCE; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HERRING PJ, 1988, HYDROBIOLOGIA, V167, P183, DOI 10.1007/BF00026304; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; LAND MF, 1988, J EXP BIOL, V140, P381; Masuda H, 2006, GENE, V372, P18, DOI 10.1016/j.gene.2005.11.031; Matz MV, 2006, METHOD BIOCHEM ANAL, V47, P139; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 1999, NAT BIOTECHNOL, V17, P1227; Ohtsuka S, 2001, HYDROBIOLOGIA, V453, P441, DOI 10.1023/A:1013162605809; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shagin DA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e23; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X	35	87	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11517	10.1371/journal.pone.0011517	http://dx.doi.org/10.1371/journal.pone.0011517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644720	gold, Green Published			2022-12-27	WOS:000279884900005
J	Padayatty, SJ; Sun, AY; Chen, Q; Espey, MG; Drisko, J; Levine, M				Padayatty, Sebastian J.; Sun, Andrew Y.; Chen, Qi; Espey, Michael Graham; Drisko, Jeanne; Levine, Mark			Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; RECOMMENDED DIETARY ALLOWANCE; ACUTE OXALATE NEPHROPATHY; ACID-INDUCED HEMOLYSIS; TERMINAL HUMAN CANCER; ASCORBIC-ACID; EXPERIMENTAL POLIOMYELITIS; SUPPLEMENTAL ASCORBATE; SUPPORTIVE TREATMENT; HYDROGEN-PEROXIDE	Background: Anecdotal information and case reports suggest that intravenously administered vitamin C is used by Complementary and Alternate Medicine (CAM) practitioners. The scale of such use in the U. S. and associated side effects are unknown. Methods and Findings: We surveyed attendees at annual CAM Conferences in 2006 and 2008, and determined sales of intravenous vitamin C by major U. S. manufacturers/distributors. We also queried practitioners for side effects, compiled published cases, and analyzed FDA's Adverse Events Database. Of 199 survey respondents (out of 550), 172 practitioners administered IV vitamin C to 11,233 patients in 2006 and 8876 patients in 2008. Average dose was 28 grams every 4 days, with 22 total treatments per patient. Estimated yearly doses used (as 25g/50ml vials) were 318,539 in 2006 and 354,647 in 2008. Manufacturers' yearly sales were 750,000 and 855,000 vials, respectively. Common reasons for treatment included infection, cancer, and fatigue. Of 9,328 patients for whom data is available, 101 had side effects, mostly minor, including lethargy/fatigue in 59 patients, change in mental status in 21 patients and vein irritation/phlebitis in 6 patients. Publications documented serious adverse events, including 2 deaths in patients known to be at risk for IV vitamin C. Due to confounding causes, the FDA Adverse Events Database was uninformative. Total numbers of patients treated in the US with high dose vitamin C cannot be accurately estimated from this study. Conclusions: High dose IV vitamin C is in unexpectedly wide use by CAM practitioners. Other than the known complications of IV vitamin C in those with renal impairment or glucose 6 phosphate dehydrogenase deficiency, high dose intravenous vitamin C appears to be remarkably safe. Physicians should inquire about IV vitamin C use in patients with cancer, chronic, untreatable, or intractable conditions and be observant of unexpected harm, drug interactions, or benefit.	[Padayatty, Sebastian J.; Sun, Andrew Y.; Espey, Michael Graham; Levine, Mark] NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA; [Chen, Qi; Drisko, Jeanne] Univ Kansas, Med Ctr, Program Integrat Med, Kansas City, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Kansas; University of Kansas Medical Center	Padayatty, SJ (corresponding author), NIDDK, Mol & Clin Nutr Sect, NIH, Bethesda, MD 20892 USA.	MarkL@intra.niddk.nih.gov	Padayatty, Sebastian J/A-8581-2012; Ganapathy, Suthakar/C-1266-2013; Chen, Qi/D-8278-2015	Padayatty, Sebastian J/0000-0001-8758-3170; Ganapathy, Suthakar/0000-0003-3828-5382; Chen, Qi/0000-0002-7173-8411; Sun, Andrew/0000-0002-7925-6580	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Intramural Research Program, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2009, J ALTERN COMPLEM MED, V15, P247, DOI 10.1089/acm.2008.0410; Barnes Patricia M, 2004, Adv Data, P1; Bromley J, 2005, ANN PHARMACOTHER, V39, P1566, DOI 10.1345/aph.1E634; CALLEJA H B, 1960, Ohio State Med J, V56, P821; CAMERON E, 1976, P NATL ACAD SCI USA, V73, P3685, DOI 10.1073/pnas.73.10.3685; CAMERON E, 1972, LANCET, V1, P542; CAMERON E, 1978, P NATL ACAD SCI USA, V75, P4538, DOI 10.1073/pnas.75.9.4538; CAMPBELL GD, 1975, ANN INTERN MED, V82, P810, DOI 10.7326/0003-4819-82-6-810_1; Canavese C, 2005, AM J KIDNEY DIS, V45, P540, DOI 10.1053/j.ajkd.2004.10.025; CATHCART RF, 1981, MED HYPOTHESES, V7, P1359, DOI 10.1016/0306-9877(81)90126-2; Chen Q, 2005, P NATL ACAD SCI USA, V102, P13604, DOI 10.1073/pnas.0506390102; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Chen Q, 2007, P NATL ACAD SCI USA, V104, P8749, DOI 10.1073/pnas.0702854104; CREAGAN ET, 1979, NEW ENGL J MED, V301, P687, DOI 10.1056/NEJM197909273011303; DL VP, 2004, JPEN J PARENTER ENTE, V28, P435; Gaby Alan R, 2002, Altern Med Rev, V7, P389; Gonzalez Michael J, 2005, Integr Cancer Ther, V4, P32, DOI 10.1177/1534735404273861; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; Hoffer LJ, 2008, ANN ONCOL, V19, P1969, DOI 10.1093/annonc/mdn377; IWAMOTO N, 1994, AM J HEMATOL, V47, P337, DOI 10.1002/ajh.2830470426; IWAMOTO N, 1994, LANCET, V343, P357, DOI 10.1016/S0140-6736(94)91195-9; Jungeblut CW, 1937, J EXP MED, V66, P459, DOI 10.1084/jem.66.4.459; Jungeblut CW, 1939, J EXP MED, V70, P315, DOI 10.1084/jem.70.3.315; Jungeblut CW, 1935, J EXP MED, V62, P517, DOI 10.1084/jem.62.4.517; KLENNER F R, 1949, South Med Surg, V111, P209; KLENNER F R, 1951, South Med Surg, V113, P101; KLENNER FR, 1971, J APPL NUTR, V23, P61; LAWTON JM, 1985, ARCH INTERN MED, V145, P950, DOI 10.1001/archinte.145.5.950; Levine M, 2001, P NATL ACAD SCI USA, V98, P9842, DOI 10.1073/pnas.171318198; Levine M, 1996, P NATL ACAD SCI USA, V93, P3704, DOI 10.1073/pnas.93.8.3704; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; Levine M, 2009, FREE RADICAL BIO MED, V47, P27, DOI 10.1016/j.freeradbiomed.2009.04.001; Levy T E, 2002, VITAMIN C INFECT DIS; MCALLISTER CJ, 1984, JAMA-J AM MED ASSOC, V252, P1684, DOI 10.1001/jama.1984.03350130016019; McCORMICK W J, 1954, Arch Pediatr, V71, P313; MOERTEL CG, 1985, NEW ENGL J MED, V312, P137, DOI 10.1056/NEJM198501173120301; Padayatty SJ, 2006, NEW ENGL J MED, V355, P1065; Padayatty SJ, 2000, J AM COLL NUTR, V19, P423, DOI 10.1080/07315724.2000.10718941; Padayatty SJ, 2004, ANN INTERN MED, V140, P533, DOI 10.7326/0003-4819-140-7-200404060-00010; PATTERSON JW, 1951, AM J PHYSIOL, V165, P61, DOI 10.1152/ajplegacy.1951.165.1.61; PATTERSON JW, 1950, J BIOL CHEM, V183, P81; Pauling L., 1976, VITAMIN C COMMON COL; REES DC, 1993, BRIT MED J, V306, P841, DOI 10.1136/bmj.306.6881.841; Riordan HD, 1990, J ORTHOMOL MED, V5, P5; RIORDAN NH, 1995, MED HYPOTHESES, V44, P207, DOI 10.1016/0306-9877(95)90137-X; Riordan NH, 2000, J ORTHOMOL MED, V15, P201; Sabin AB, 1939, J EXP MED, V69, P507, DOI 10.1084/jem.69.4.507; Verrax J, 2009, FREE RADICAL BIO MED, V47, P32, DOI 10.1016/j.freeradbiomed.2009.02.016; WITTES RE, 1985, NEW ENGL J MED, V312, P178, DOI 10.1056/NEJM198501173120310; WONG K, 1994, AUST NZ J MED, V24, P410, DOI 10.1111/j.1445-5994.1994.tb01477.x; 2008, NUTR BUSINESS J	51	231	241	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2010	5	7							e11414	10.1371/journal.pone.0011414	http://dx.doi.org/10.1371/journal.pone.0011414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621OQ	20628650	Green Published, gold, Green Submitted			2022-12-27	WOS:000279589300002
J	Sweeney, E; Roberts, D; Corbo, T; Jacenko, O				Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena			Congenic Mice Confirm That Collagen X Is Required for Proper Hematopoietic Development	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IMMUNO-OSSEOUS DYSPLASIA; STEM-CELL NICHE; HEPARAN-SULFATE PROTEOGLYCANS; CARTILAGE-HAIR-HYPOPLASIA; MARROW-STROMAL CELLS; BONE-MARROW; PROGENITOR CELLS; B LYMPHOPOIESIS; NULL MICE	The link between endochondral skeletal development and hematopoiesis in the marrow was established in the collagen X transgenic (Tg) and null (KO) mice. Disrupted function of collagen X, a major hypertrophic cartilage matrix protein, resulted in skeletal and hematopoietic defects in endochondrally derived tissues. Manifestation of the disease phenotype was variable, ranging from perinatal lethality in a subset of mice, to altered lymphopoiesis and impaired immunity in the surviving mice. To exclude contribution of strain specific modifiers to this variable manifestation of the skeleto-hematopoietic phenotype, C57Bl/6 and DBA/2J collagen X congenic lines were established. Comparable disease manifestations confirmed that the skeleto-hematopoietic alterations are an inherent outcome of disrupted collagen X function. Further, colony forming cell assays, complete blood count analysis, serum antibody ELISA, and organ outgrowth studies established altered lymphopoiesis in all collagen X Tg and KO mice and implicated opportunistic infection as a contributor to the severe disease phenotype. These data support a model where endochondral ossification-specific collagen X contributes to the establishment of a hematopoietic niche at the chondro-osseous junction.	[Sweeney, Elizabeth; Roberts, Douglas; Corbo, Tina; Jacenko, Olena] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Sweeney, E (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	jacenko@vet.upenn.edu		Sweeney, Timothy/0000-0002-3596-1093	National Institutes of Health [DK57904, AR053804 NRSA]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR053804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057904, R01DK088334] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by National Institutes of Health; DK57904 (to OJ) and AR053804 NRSA (to ES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Aguila HL, 2005, IMMUNOL REV, V208, P7, DOI 10.1111/j.0105-2896.2005.00333.x; Akintoye SO, 2006, BONE, V38, P758, DOI 10.1016/j.bone.2005.10.027; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3; Borghesi LA, 1999, BLOOD, V93, P140, DOI 10.1182/blood.V93.1.140.401k40_140_148; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; BRUNO E, 1995, EXP HEMATOL, V23, P1212; BUCHINSKY FJ, 1995, J BONE MINER RES, V10, P1556; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Campbell MR, 2004, AM J PATHOL, V164, P487, DOI 10.1016/S0002-9440(10)63139-2; CastriotaScanderbeg A, 1997, J MED GENET, V34, P854, DOI 10.1136/jmg.34.10.854; CEDERBAUM SD, 1976, J PEDIATR-US, V89, P737, DOI 10.1016/S0022-3476(76)80793-7; Cham B, 2002, SEMIN HEMATOL, V39, P107, DOI 10.1053/shem.2002.31916; Chan C.K., 2008, NATURE; Chan D, 1998, MATRIX BIOL, V17, P169, DOI 10.1016/S0945-053X(98)90056-7; Chung KS, 1997, DEV DYNAM, V208, P544; CORDER WT, 1995, AM J MED GENET, V57, P626, DOI 10.1002/ajmg.1320570422; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Dianzani I, 2000, Paediatr Drugs, V2, P345, DOI 10.2165/00128072-200002050-00002; ENG VM, 1995, J EXP MED, V181, P1893, DOI 10.1084/jem.181.5.1893; Gress CJ, 2000, J CELL BIOL, V149, P983, DOI 10.1083/jcb.149.4.983; Guggenheim R, 2006, BONE MARROW TRANSPL, V38, P751, DOI 10.1038/sj.bmt.1705520; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Hermanns P, 2006, AM J MED GENET A, V140A, P2121, DOI 10.1002/ajmg.a.31331; Hirose J, 2002, IMMUNOL REV, V189, P28, DOI 10.1034/j.1600-065X.2002.18904.x; Hubbard V, 2006, PEDIATR DERMATOL, V23, P373, DOI 10.1111/j.1525-1470.2006.00260.x; Jacenko O, 1996, ANN NY ACAD SCI, V785, P278, DOI 10.1111/j.1749-6632.1996.tb56283.x; JACENKO O, 1993, PROG CLIN BIOL RES, V383, P427; Jacenko O, 2002, AM J PATHOL, V160, P2019, DOI 10.1016/S0002-9440(10)61152-2; JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0; Jacenko O, 2001, AM J PATHOL, V159, P2257, DOI 10.1016/S0002-9440(10)63076-3; JACENKO O, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P327; JACENKO O, 1998, CELLS MAT, V8, P123; JACOBSEN SEW, 1994, J EXP MED, V180, P75, DOI 10.1084/jem.180.1.75; Johansson C, 2006, MICROB PATHOGENESIS, V41, P49, DOI 10.1016/j.micpath.2006.03.004; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KLEIN G, 1995, EXPERIENTIA, V51, P914, DOI 10.1007/BF01921741; Kuijpers TW, 2004, PEDIATRICS, V114, pE387, DOI 10.1542/peds.2003-0651-F; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lemoli RM, 2008, HAEMATOLOGICA, V93, P321, DOI 10.3324/haematol.12616; Linder CC, 2006, ILAR J, V47, P132, DOI 10.1093/ilar.47.2.132; Lucke T, 2007, AM J MED GENET A, V143A, P2040, DOI 10.1002/ajmg.a.31878; Marrella V, 2008, TRENDS IMMUNOL, V29, P133, DOI 10.1016/j.it.2007.12.001; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; Mayack SR, 2008, BLOOD, V112, P519, DOI 10.1182/blood-2008-01-133710; Nilsson SK, 1997, BLOOD, V89, P4013, DOI 10.1182/blood.V89.11.4013; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Osmond D G, 1990, Semin Immunol, V2, P173; PATCHEN ML, 1991, BLOOD, V77, P472; Rodgers KD, 2008, DEV DYNAM, V237, P2622, DOI 10.1002/dvdy.21593; ROSATI R, 1994, NAT GENET, V8, P129, DOI 10.1038/ng1094-129; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sekhar RV, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.3.e54; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Siebertz B, 1999, BIOCHEM J, V344, P937, DOI 10.1042/0264-6021:3440937; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; SOYER AD, 1995, SPINE, V20, P2335, DOI 10.1097/00007632-199511000-00012; Spencer CT, 2006, PEDIATRICS, V118, pE337, DOI 10.1542/peds.2005-2667; Sweeney E, 2008, DEV DYNAM, V237, P2693, DOI 10.1002/dvdy.21594; Taichman RS, 1996, BLOOD, V87, P518, DOI 10.1182/blood.V87.2.518.bloodjournal872518; Tischkowitz MD, 2003, J MED GENET, V40, P1, DOI 10.1136/jmg.40.1.1; Verfaillie CATHERINE M., 1999, Hematology, V4, P321; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yoshimoto M, 2003, EXP HEMATOL, V31, P733, DOI 10.1016/S0301-472X(03)00108-5; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384; JACKSON LABS CONGENI	68	62	63	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2010	5	3							e9518	10.1371/journal.pone.0009518	http://dx.doi.org/10.1371/journal.pone.0009518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	562OZ	20657826	Green Submitted, Green Published, gold			2022-12-27	WOS:000275063400023
